PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M				Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Bonhoeffer, Tobias; Huebener, Mark			Experience leaves a lasting structural trace in cortical circuits	NATURE			English	Article							OCULAR DOMINANCE PLASTICITY; MOUSE VISUAL-CORTEX; LONG-TERM POTENTIATION; NEOCORTEX IN-VIVO; DENDRITIC SPINES; ADULT CORTEX; DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; RESPONSES; STABILITY	Sensory experiences exert a powerful influence on the function and future performance of neuronal circuits in the mammalian neocortex(1-3). Restructuring of synaptic connections is believed to be one mechanism by which cortical circuits store information about the sensory world(4,5). Excitatory synaptic structures, such as dendritic spines, are dynamic entities(6-8) that remain sensitive to alteration of sensory input throughout life(6,9). It remains unclear, however, whether structural changes at the level of dendritic spines can outlast the original experience and thereby provide a morphological basis for long- term information storage. Here we follow spine dynamics on apical dendrites of pyramidal neurons in functionally defined regions of adult mouse visual cortex during plasticity of eye- specific responses induced by repeated closure of one eye ( monocular deprivation). The first monocular deprivation episode doubled the rate of spine formation, thereby increasing spine density. This effect was specific to layer-5 cells located in binocular cortex, where most neurons increase their responsiveness to the non-deprived eye(3,10). Restoring binocular vision returned spine dynamics to baseline levels, but absolute spine density remained elevated and many monocular deprivation-induced spines persisted during this period of functional recovery. However, spine addition did not increase again when the same eye was closed for a second time. This absence of structural plasticity stands out against the robust changes of eye- specific responses that occur even faster after repeated deprivation(3). Thus, spines added during the first monocular deprivation experience may provide a structural basis for subsequent functional shifts. These results provide a strong link between functional plasticity and specific synaptic rearrangements, revealing a mechanism of how prior experiences could be stored in cortical circuits.	[Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Bonhoeffer, Tobias; Huebener, Mark] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	mark@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X	Max Planck Society; Wellcome Trust; Humboldt Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Wellcome Trust(Wellcome TrustEuropean Commission); Humboldt Foundation(Alexander von Humboldt Foundation)	We thank T. Keck for contributing control data for Supplementary Fig. 7a, and M. Sperling and B. Pichler for programming help. This work was supported by the Max Planck Society, the Wellcome Trust and the Humboldt Foundation.	BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; Gordon JA, 1996, J NEUROSCI, V16, P3274; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	30	357	364	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					313	U4		10.1038/nature07487	http://dx.doi.org/10.1038/nature07487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19005470	Green Accepted			2022-12-01	WOS:000262440900039
J	Bornholdt, ZA; Prasad, BVV				Bornholdt, Zachary A.; Prasad, B. V. Venkataram			X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus	NATURE			English	Article							ANTIVIRAL CYTOKINE RESPONSES; DOUBLE-STRANDED-RNA; PRE-MESSENGER-RNAS; A VIRUS; EFFECTOR DOMAIN; PROTEIN; BINDING; INTERFERON; ACTIVATION; INFECTION	The recent emergence of highly pathogenic avian (H5N1) influenza viruses, their epizootic and panzootic nature, and their association with lethal human infections have raised significant global health concerns(1,2). Several studies have underlined the importance of non-structural protein NS1 in the increased pathogenicity and virulence of these strains(3,4). NS1, which consists of two domains a double-stranded RNA (dsRNA) binding domain(5,6) and the effector domain(7), separated through a linker - is an antagonist of antiviral type-I interferon response in the host(8,9). Here we report the X-ray structure of the full- length NS1 from an H5N1 strain (A/Vietnam/1203/2004) that was associated with 60% of human deaths in an outbreak in Vietnam(1,2). Compared to the individually determined structures of the RNA binding domain and the effector domain from non- H5N1 strains, the RNA binding domain within H5N1 NS1 exhibits modest structural changes, while the H5N1 effector domain shows significant alteration, particularly in the dimeric interface. Although both domains in the full- length NS1 individually participate in dimeric interactions, an unexpected finding is that these interactions result in the formation of a chain of NS1 molecules instead of distinct dimeric units. Three such chains in the crystal interact with one another extensively to form a tubular organization of similar dimensions to that observed in the cryo- electron microscopy images of NS1 in the presence of dsRNA. The tubular oligomeric organization of NS1, in which residues implicated in dsRNA binding face a 20-angstrom-wide central tunnel, provides a plausible mechanism for how NS1 sequesters varying lengths of dsRNA, to counter cellular antiviral dsRNA response pathways, while simultaneously interacting with other cellular ligands during an infection.	[Bornholdt, Zachary A.; Prasad, B. V. Venkataram] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Prasad, B. V. Venkataram] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Prasad, BVV (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	vprasad@bcm.tmc.edu		Prasad, B.V.Venkataram/0000-0002-1172-2071; Bornholdt, Zachary/0000-0002-7557-9219	NIH [AI36040, AI07471, RR002250]; Robert Welch Foundation; US Department of Energy,; Basic Energy Sciences; Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007471, R37AI036040, R01AI036040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); US Department of Energy,(United States Department of Energy (DOE)); Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Palese for providing us clones of A/Vietnam/1203/2004 H5N1 and A/PR8/34 (H1N1) NS1. This work was supported by the NIH (AI36040) and the Robert Welch Foundation (to B.V.V.P.). Z.A.B. acknowledges support from an NIH virology training grant (AI07471). We thank P. Palese, A. Rice, M. Schmid and B. Carrillo for discussions and comments on the manuscript and H. Chen for technical assistance with cryo-EM. We acknowledge the use of cryo-EM facilities at the National Center for Macromolecular Imaging ( Baylor College of Medicine) supported by the National Institutes of Health (RR002250 to W. Chiu); we also acknowledge the Center for Advanced Microstructures & Devices (CAMD), Baton Rouge, Los Angeles, and H. Bellamy, and the SBC- CAT 19ID beam line at the Advanced Photon Source (supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-38) and its staff for their help during data collection.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000	33	115	125	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					985	U85		10.1038/nature07444	http://dx.doi.org/10.1038/nature07444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18987632	Green Accepted			2022-12-01	WOS:000261768300053
J	Vernes, SC; Newbury, DF; Abrahams, BS; Winchester, L; Nicod, J; Groszer, M; Alarcon, M; Oliver, PL; Davies, KE; Geschwind, DH; Monaco, AP; Fisher, SE				Vernes, Sonja C.; Newbury, Dianne F.; Abrahams, Brett S.; Winchester, Laura; Nicod, Jerome; Groszer, Matthias; Alarcon, Maricela; Oliver, Peter L.; Davies, Kay E.; Geschwind, Daniel H.; Monaco, Anthony P.; Fisher, Simon E.			A Functional Genetic Link between Distinct Developmental Language Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONWORD REPETITION; FOXP2 EXPRESSION; SEVERE SPEECH; HUMAN BRAIN; IMPAIRMENT; AUTISM; ASSOCIATION; PREVALENCE; CHILDREN; CNTNAP2	Background: Rare mutations affecting the FOXP2 transcription factor cause a monogenic speech and language disorder. We hypothesized that neural pathways downstream of FOXP2 influence more common phenotypes, such as specific language impairment. Methods: We performed genomic screening for regions bound by FOXP2 using chromatin immunoprecipitation, which led us to focus on one particular gene that was a strong candidate for involvement in language impairments. We then tested for associations between single-nucleotide polymorphisms (SNPs) in this gene and language deficits in a well-characterized set of 184 families affected with specific language impairment. Results: We found that FOXP2 binds to and dramatically down-regulates CNTNAP2, a gene that encodes a neurexin and is expressed in the developing human cortex. On analyzing CNTNAP2 polymorphisms in children with typical specific language impairment, we detected significant quantitative associations with nonsense-word repetition, a heritable behavioral marker of this disorder (peak association, P=5.0 x 10(-5) at SNP rs17236239). Intriguingly, this region coincides with one associated with language delays in children with autism. Conclusions: The FOXP2-CNTNAP2 pathway provides a mechanistic link between clinically distinct syndromes involving disrupted language.	[Vernes, Sonja C.; Newbury, Dianne F.; Winchester, Laura; Nicod, Jerome; Groszer, Matthias; Monaco, Anthony P.; Fisher, Simon E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Vernes, Sonja C.; Oliver, Peter L.; Davies, Kay E.] Univ Oxford, Med Res Council Funct Genom Unit, Oxford OX3 7BN, England; [Abrahams, Brett S.; Alarcon, Maricela; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fisher, SE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	simon.fisher@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Groszer, Matthias/P-6291-2017; Vernes, Sonja/E-8454-2012; Fisher, Simon E./E-9130-2012; Oliver, Peter/F-1453-2010; Simonoff, Emily A/B-7593-2011	Monaco, Anthony P/0000-0001-7480-3197; Vernes, Sonja/0000-0003-0305-4584; Fisher, Simon E./0000-0002-3132-1996; Groszer, Matthias/0000-0002-6209-305X; Oliver, Peter/0000-0003-3347-2461	Wellcome Trust; Autism Speaks; National Institute of Mental Health [MH75028-R21, MH081754-RO1, MH60233-R37, HD055784-P50]; Christopher Welch Biological Sciences Scholarship; University of Oxford; Tourette Syndrome Association; Marie Curie Intra-European Fellowship; Wellcome Trust Principal Research Fellow; MRC [MC_U137761449] Funding Source: UKRI; Medical Research Council [MC_U137761449] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH060233, R37MH060233, R01MH081754, R21MH075028, R01MH060233] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Autism Speaks; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Christopher Welch Biological Sciences Scholarship; University of Oxford; Tourette Syndrome Association; Marie Curie Intra-European Fellowship(European Commission); Wellcome Trust Principal Research Fellow(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by project and program grants from the Wellcome Trust (to Drs. Fisher and Monaco, respectively), a pilot grant from Autism Speaks (to Dr. Fisher), awards (MH75028-R21, MH081754-RO1, MH60233-R37, and HD055784-P50) from the National Institute of Mental Health (to Dr. Geschwind), a Christopher Welch Biological Sciences Scholarship from the University of Oxford (to Dr. Vernes), a postdoctoral fellowship from the Tourette Syndrome Association (to Dr. Abrahams), and a Marie Curie Intra-European Fellowship (to Dr. Nicod). Dr. Monaco is a Wellcome Trust Principal Research Fellow, and Dr. Fisher is a Royal Society Research Fellow. Drs. Newbury, Monaco, and Fisher and Ms. Winchester are members of the Specific Language Impairment Consortium.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bishop DVM, 2003, NOVART FDN SYMP, V251, P213; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Burden V, 1996, DEV MED CHILD NEUROL, V38, P613; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Clark A, 2007, ARCH DIS CHILD, V92, P614, DOI 10.1136/adc.2006.101758; COHEN NJ, 2001, LANGUAGE IMPAIRMENT; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; Conti-Ramsden G, 2006, J CHILD PSYCHOL PSYC, V47, P621, DOI 10.1111/j.1469-7610.2005.01584.x; De Fosse L, 2004, ANN NEUROL, V56, P757, DOI 10.1002/ana.20275; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Harel S, 1996, PEDIATR NEUROL, V15, P305, DOI 10.1016/S0887-8994(96)00222-6; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Newbury DF, 2005, TRENDS COGN SCI, V9, P528, DOI 10.1016/j.tics.2005.09.002; Newbury DF, 2004, AM J HUM GENET, V74, P1225, DOI 10.1086/421529; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Newbury DF, 2002, AM J HUM GENET, V70, P384; O'Brien EK, 2003, AM J HUM GENET, V72, P1536, DOI 10.1086/375403; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Rasband MN, 2004, J NEUROSCI RES, V76, P749, DOI 10.1002/jnr.20073; Semel EM, 1992, CLIN EVALUATION LANG; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Whitehouse AJO, 2007, J CHILD PSYCHOL PSYC, V48, P822, DOI 10.1111/j.1469-7610.2007.01765.x; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110	45	470	485	2	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2337	2345		10.1056/NEJMoa0802828	http://dx.doi.org/10.1056/NEJMoa0802828			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377SG	18987363	Green Accepted, Green Published			2022-12-01	WOS:000261270300005
J	Wang, ET; Sandberg, R; Luo, SJ; Khrebtukova, I; Zhang, L; Mayr, C; Kingsmore, SF; Schroth, GP; Burge, CB				Wang, Eric T.; Sandberg, Rickard; Luo, Shujun; Khrebtukova, Irina; Zhang, Lu; Mayr, Christine; Kingsmore, Stephen F.; Schroth, Gary P.; Burge, Christopher B.			Alternative isoform regulation in human tissue transcriptomes	NATURE			English	Article							MESSENGER-RNA; SPLICING REGULATION; MICRORNA TARGETS; PROTEIN; GENOME; EXPRESSION; BINDING; FOX-1; MICROARRAYS; HOMOLOGS	Through alternative processing of pre- messenger RNAs, individual mammalian genes often produce multiple mRNA and protein isoforms that may have related, distinct or even opposing functions. Here we report an in- depth analysis of 15 diverse human tissue and cell line transcriptomes on the basis of deep sequencing of complementary DNA fragments, yielding a digital inventory of gene and mRNA isoform expression. Analyses in which sequence reads are mapped to exon - exon junctions indicated that 92 - 94% of human genes undergo alternative splicing,, 86% with a minor isoform frequency of 15% or more. Differences in isoform- specific read densities indicated that most alternative splicing and alternative cleavage and polyadenylation events vary between tissues, whereas variation between individuals was approximately twofold to threefold less common. Extreme or 'switch-like' regulation of splicing between tissues was associated with increased sequence conservation in regulatory regions and with generation of full- length open reading frames. Patterns of alternative splicing and alternative cleavage and polyadenylation were strongly correlated across tissues, suggesting coordinated regulation of these processes, and sequence conservation of a subset of known regulatory motifs in both alternative introns and 39 untranslated regions suggested common involvement of specific factors in tissue- level regulation of both splicing and polyadenylation.	[Wang, Eric T.; Sandberg, Rickard; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wang, Eric T.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Luo, Shujun; Khrebtukova, Irina; Zhang, Lu; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Mayr, Christine] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA	Massachusetts Institute of Technology (MIT); Harvard University; Karolinska Institutet; Illumina; Massachusetts Institute of Technology (MIT); Whitehead Institute; National Center for Genome Resources (NCGR)	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020	kingsmore, stephen/0000-0002-3758-4631; Kingsmore, Stephen/0000-0001-7180-2527; Sandberg, Rickard/0000-0001-6473-1740	NIH; Knut & Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Anderson, D. Black, B. Friedman, and members of the Burge laboratory for comments on the manuscript, N. Spies for analyses, J. Mudge, G. D. May, N. A. Miller, E. Vermaas, T. Kerelska, J. Yan and V. Quijano for assistance in generating the mRNA- Seq data, and R. C. Roberts and N. Perrone- Bizzozero for supplying cerebellar cortex RNA samples. This research was supported by an NIH training grant ( E. T. W.), and by grants from the Knut & Alice Wallenberg Foundation and the Swedish Foundation for Strategic Research ( R. S.) and from the NIH ( C. B. B.).	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Graveley BR, 2008, TRENDS GENET, V24, P5, DOI 10.1016/j.tig.2007.10.004; Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72; *ILL INC, 2008, TRANSCR AN MRNA SEQ; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kim HH, 2008, MOL CELL, V29, P151, DOI 10.1016/j.molcel.2008.01.005; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Ladd AN, 2002, GENOME BIOL, V3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; PAN Q, NATURE GENE IN PRESS; Paz RD, 2006, AM J PSYCHIAT, V163, P1829, DOI 10.1176/appi.ajp.163.10.1829; SCHROTH GP, METHODS MOL IN PRESS; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xing Y, 2005, PLOS GENET, V1, P323, DOI 10.1371/journal.pgen.0010034; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200	41	3357	3532	9	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					470	476		10.1038/nature07509	http://dx.doi.org/10.1038/nature07509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18978772	Green Accepted			2022-12-01	WOS:000261170500031
J	Moldoveanu, T; Gehring, K; Green, DR				Moldoveanu, Tudor; Gehring, Kalle; Green, Douglas R.			Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains	NATURE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; DOMAIN-VI; ACTIVATION; REVEALS; PEPTIDE; ENZYME; COMPLEXES	The Ca2+-dependent cysteine proteases, calpains, regulate cell migration(1), cell death(2), insulin secretion(3), synaptic function(4) and muscle homeostasis(5). Their endogenous inhibitor, calpastatin, consists of four inhibitory repeats, each of which neutralizes an activated calpain with exquisite specificity and potency(6). Despite the physiological importance of this interaction, the structural basis of calpain inhibition by calpastatin is unknown(7). Here we report the 3.0 angstrom structure of Ca2+-bound m-calpain in complex with the first calpastatin repeat, both from rat, revealing the mechanism of exclusive specificity. The structure highlights the complexity of calpain activation by Ca2+ illustrating key residues in a peripheral domain that serve to stabilize the protease core on Ca2+ binding. Fully activated calpain binds ten Ca2+ atoms, resulting in several conformational changes allowing recognition by calpastatin. Calpain inhibition is mediated by the intimate contact with three critical regions of calpastatin. Two regions target the penta- EF- hand domains of calpain and the third occupies the substrate- binding cleft, projecting a loop around the active site thiol to evade proteolysis.	[Moldoveanu, Tudor; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	St Jude Children's Research Hospital; McGill University	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Moldoveanu, Tudor/N-8173-2018; Gehring, Kalle/N-2945-2019; Green, Douglas R/N-8083-2018; Gehring, Kalle/I-4403-2013	Moldoveanu, Tudor/0000-0003-0791-318X; Gehring, Kalle/0000-0001-6500-1184; Green, Douglas R/0000-0002-7332-1417; Gehring, Kalle/0000-0001-6500-1184	US National Institute of Health; National Cancer Institute; Canadian Institute of Health Research; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, R01AI047891, R01AI044828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. L. Davies for facilitating the initial stages of this work and for sharing the coordinates for the calpastatin repeat 4 - calpain complex, M. Osborne for help with the NMR analysis, B. Schulman for collecting the ALS synchrotron data, the staff at Brookhaven National Light Source beam X29 and APS SERCAT for help with data collection, S. White and D. Miller for advice and sharing of synchrotron time, and C. Hosfield, A. Tocilj and R. Kriwacki for reviewing our manuscript. Funding was provided by the US National Institute of Health and National Cancer Institute, the Canadian Institute of Health Research and the American Lebanese Syrian Associated Charities.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Betts R, 2004, BIOCHEMISTRY-US, V43, P2596, DOI 10.1021/bi0359832; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Cuerrier D, 2007, J BIOL CHEM, V282, P9600, DOI 10.1074/jbc.M610372200; Davis TL, 2007, J MOL BIOL, V366, P216, DOI 10.1016/j.jmb.2006.11.037; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutt P, 2000, BIOCHEM J, V348, P37, DOI 10.1042/0264-6021:3480037; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Harris F, 2006, ANN NY ACAD SCI, V1084, P452, DOI 10.1196/annals.1372.011; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kiss R, 2008, FEBS LETT, V582, P2149, DOI 10.1016/j.febslet.2008.05.032; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; Moldoveanu T, 2001, BBA-PROTEIN STRUCT M, V1545, P245, DOI 10.1016/S0167-4838(00)00286-7; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Pal GP, 2003, STRUCTURE, V11, P1521, DOI 10.1016/j.str.2003.11.007; Reverter D, 2002, BIOL CHEM, V383, P1415, DOI 10.1515/BC.2002.160; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	37	112	121	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					404	U73		10.1038/nature07353	http://dx.doi.org/10.1038/nature07353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020622	Green Accepted			2022-12-01	WOS:000261039600047
J	Hongoh, Y; Sharma, VK; Prakash, T; Noda, S; Toh, H; Taylor, TD; Kudo, T; Sakaki, Y; Toyoda, A; Hattori, M; Ohkuma, M				Hongoh, Yuichi; Sharma, Vineet K.; Prakash, Tulika; Noda, Satoko; Toh, Hidehiro; Taylor, Todd D.; Kudo, Toshiaki; Sakaki, Yoshiyuki; Toyoda, Atsushi; Hattori, Masahira; Ohkuma, Moriya			Genome of an Endosymbiont Coupling N-2 Fixation to Cellulolysis Within Protist Cells in Termite Gut	SCIENCE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; COPTOTERMES-FORMOSANUS; NITROGEN-FIXATION; PHYLOGENETIC DIVERSITY; BACTERIA; RHINOTERMITIDAE; COMMUNITY; ISOPTERA	Termites harbor diverse symbiotic gut microorganisms, the majority of which are as yet uncultivable and their interrelationships unclear. Here, we present the complete genome sequence of the uncultured Bacteroidales endosymbiont of the cellulolytic protist Pseudotrichonympha grassii, which accounts for 70% of the bacterial cells in the gut of the termite Coptotermes formosanus. Functional annotation of the chromosome ( 1,114,206 base pairs) unveiled its ability to fix dinitrogen and recycle putative host nitrogen wastes for biosynthesis of diverse amino acids and cofactors, and import glucose and xylose as energy and carbon sources. Thus, nitrogen fixation and cellulolysis are coupled within the protist's cells. This highly evolved symbiotic system probably underlies the ability of the worldwide pest termites Coptotermes to use wood as their sole food.	[Hongoh, Yuichi; Noda, Satoko; Kudo, Toshiaki; Ohkuma, Moriya] RIKEN, Adv Sci Inst, Ecomol Biorecycling Sci Res Team, Wako, Saitama 3510198, Japan; [Sharma, Vineet K.; Prakash, Tulika; Toh, Hidehiro; Taylor, Todd D.; Sakaki, Yoshiyuki; Toyoda, Atsushi; Hattori, Masahira] RIKEN, Genom Sci Ctr, Kanagawa 2300045, Japan; [Sharma, Vineet K.; Prakash, Tulika; Toh, Hidehiro; Taylor, Todd D.] RIKEN, MetaSyst Res Team, Adv Sci Inst, Kanagawa 2300045, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Hattori, Masahira] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Chiba 2778561, Japan	RIKEN; RIKEN; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo	Hongoh, Y (corresponding author), RIKEN, Adv Sci Inst, Ecomol Biorecycling Sci Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yhongo@riken.jp; atoyoda@lab.nig.ac.jp	Srivastava, Tulika/A-7207-2009; Ohkuma, Moriya/A-8100-2011; sharma, vineet/A-7199-2009; Hattori, Masahira/C-6958-2016; Hongoh, Yuichi/A-2303-2014; Hattori, Masahira/AAD-3785-2019; Taylor, Todd/A-7121-2009	Hattori, Masahira/0000-0001-9467-0344; Hongoh, Yuichi/0000-0002-5901-9625; Taylor, Todd/0000-0003-4247-6253; K. Sharma, Vineet/0000-0002-2958-6215	President's Discretionary Fund of RIKEN; RIKEN GSC; Bioarchitect Research Program; Eco Molecular Science Research Program; Discovery Research Institute Research Grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	President's Discretionary Fund of RIKEN; RIKEN GSC; Bioarchitect Research Program; Eco Molecular Science Research Program; Discovery Research Institute Research Grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to all the technical staff of the Sequence Technology Team at RIKEN Genomic Sciences Center (GSC) and the Ecomolecular Biorecycling Science Research Team for their assistance. This work was supported in part by a grant for the President's Discretionary Fund of RIKEN; a Special Fund for RIKEN GSC; grants for the Bioarchitect Research Program and the Eco Molecular Science Research Program from RIKEN; a Discovery Research Institute Research Grant to Y. H. from RIKEN; a Grant- in- Aid for Scientific Research on Priority Areas " Comprehensive Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to M. H.; and a Grant- inAid for Scientific Research from Japan Society for the Promotion of Science to Y. H. and M. O. The authors declare no competing financial interests. The sequence data have been deposited in GenBank/DDBJ/EMBL under accession numbers AP010656-60.	BREZNAK JA, 1973, NATURE, V244, P577, DOI 10.1038/244577a0; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Inoue JI, 2007, EUKARYOT CELL, V6, P1925, DOI 10.1128/EC.00251-07; Lax AR, 2003, PEST MANAG SCI, V59, P788, DOI 10.1002/ps.721; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Noda S, 2005, APPL ENVIRON MICROB, V71, P8811, DOI 10.1128/AEM.71.12.8811-8817.2005; Noda Satoko, 2002, Microbes and Environments, V17, P139, DOI 10.1264/jsme2.17.139; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Shinzato N, 2005, BIOSCI BIOTECH BIOCH, V69, P1145, DOI 10.1271/bbb.69.1145; Su NY, 2003, SOCIOBIOLOGY, V41, P7; Sugimoto A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P409; Tsunoda K, 2003, SOCIOBIOLOGY, V41, P27; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yoshimura Tsuyoshi, 1995, Wood Research, V82, P68	18	148	293	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1108	1109		10.1126/science.1165578	http://dx.doi.org/10.1126/science.1165578			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008447				2022-12-01	WOS:000260867700039
J	Tomas-Loba, A; Flores, I; Fernandez-Marcos, PJ; Cayuela, ML; Maraver, A; Tejera, A; Borras, C; Matheu, A; Klatt, P; Flores, JM; Vina, J; Serrano, M; Blasco, MA				Tomas-Loba, Antonia; Flores, Ignacio; Fernandez-Marcos, Pablo J.; Cayuela, Maria L.; Maraver, Antonio; Tejera, Agueda; Borras, Consuelo; Matheu, Ander; Klatt, Peter; Flores, Juana M.; Vina, Jose; Serrano, Manuel; Blasco, Maria A.			Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice	CELL			English	Article							STEM-CELLS; DYSKERATOSIS-CONGENITA; CELLULAR SENESCENCE; PULMONARY-FIBROSIS; TUMOR-SUPPRESSOR; RNA COMPONENT; HUMAN-DISEASE; DNA-DAMAGE; LIFE-SPAN; IN-VIVO	Telomerase confers limitless proliferative potential to most human cells through its ability to elongate telomeres, the natural ends of chromosomes, which otherwise would undergo progressive attrition and eventually compromise cell viability. However, the role of telomerase in organismal aging has remained unaddressed, in part because of the cancer-promoting activity of telomerase. To circumvent this problem, we have constitutively expressed telomerase reverse transcriptase (TERT), one of the components of telomerase, in mice engineered to be cancer resistant by means of enhanced expression of the tumor suppressors p53, p16, and p19ARF. In this context, TERT over-expression improves the fitness of epithelial barriers, particularly the skin and the intestine, and produces a systemic delay in aging accompanied by extension of the median life span. These results demonstrate that constitutive expression of Tert provides antiaging activity in the context of a mammalian organism.	[Tomas-Loba, Antonia; Flores, Ignacio; Cayuela, Maria L.; Tejera, Agueda; Klatt, Peter; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Madrid 28029, Spain; [Fernandez-Marcos, Pablo J.; Maraver, Antonio; Matheu, Ander; Klatt, Peter; Serrano, Manuel] Spanish Natl Canc Ctr CNIO, Tumor Suppress Grp, Mol Oncol Program, Madrid 28029, Spain; [Borras, Consuelo; Vina, Jose] Univ Valencia, Dept Physiol, Valencia 46010, Spain; [Tomas-Loba, Antonia; Flores, Ignacio] Univ Complutense Madrid, Dept Anim Surg & Med, E-28040 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Valencia; Complutense University of Madrid	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	Maraver, Antonio/G-2666-2015; Tejera, Agueda/Z-1938-2019; Vina, Jose/AAB-3069-2021; Fernandez, Pablo J/F-1840-2016; Tomas-Loba, Antonia/N-6828-2016; Tejera, Agueda/L-1946-2015; Loba, Antonia Tomas/AAB-6814-2019; Serrano, Manuel/H-2634-2015; matheu, ander/G-9906-2014; Blasco, Maria A./M-1694-2014; borras, consuelo/Y-3407-2019; Flores, Ignacio/E-8304-2016; Tejera, Agueda M./AAU-2000-2021	Vina, Jose/0000-0001-9709-0089; Fernandez, Pablo J/0000-0003-3515-4125; Tomas-Loba, Antonia/0000-0002-6440-3373; Serrano, Manuel/0000-0001-7177-9312; matheu, ander/0000-0002-1848-0781; Blasco, Maria A./0000-0002-4211-233X; borras, consuelo/0000-0003-4606-1792; Flores, Ignacio/0000-0001-8789-6396; Tejera, Agueda M/0000-0002-6703-9466; Maraver, Antonio/0000-0002-5527-5680; Flores, Juana M/0000-0002-7995-4426				Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Canela A, 2004, MOL CELL BIOL, V24, P4275, DOI 10.1128/MCB.24.10.4275-4293.2004; Cayuela ML, 2005, EMBO REP, V6, P268, DOI 10.1038/sj.embor.7400359; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Flores I, 2006, MOL CELL BIOL, V26, P6130, DOI 10.1128/MCB.00543-06; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAMMERMAN MR, 1987, ENDOCRIN METAB CLIN, V16, P995, DOI 10.1016/S0889-8529(18)30455-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; INGRAM DK, 1986, EXP AGING RES, V12, P155; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yuen KCJ, 2007, DIABETES OBES METAB, V9, P11, DOI 10.1111/j.1463-1326.2006.00591.x; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	61	310	331	0	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					609	622		10.1016/j.cell.2008.09.034	http://dx.doi.org/10.1016/j.cell.2008.09.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013273	Bronze			2022-12-01	WOS:000260886900013
J	Levens, ED; DeCherney, AH				Levens, Eric D.; DeCherney, Alan H.			Human Oocyte Research The Ethics of Donation and Donor Protection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IVF		[Levens, Eric D.; DeCherney, Alan H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Levens, ED (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bldg 10,CRC,Room E1-3140,10 Ctr Dr, Bethesda, MD 20892 USA.	levense@mail.nih.gov	DeCherney, Alan H/AAS-2944-2020		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		*AM SOC REPR MED P, 2006, FERTIL STERIL, V86, pS38; Blyth E, 2002, HUM REPROD, V17, P3254, DOI 10.1093/humrep/17.12.3254; BROOM H, 1875, W BLACKSTONE COLLECT; Byrd Louise M, 2002, Hum Fertil (Camb), V5, P175, DOI 10.1080/1464727022000199082; Covington SN, 2007, FERTIL STERIL, V87, P1001, DOI 10.1016/j.fertnstert.2006.12.037; Delvigne A, 2002, HUM REPROD UPDATE, V8, P559, DOI 10.1093/humupd/8.6.559; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Holder AR, 2008, J ADOLESCENT HEALTH, V42, P1, DOI 10.1016/j.jadohealth.2007.10.014; Institute of Medicine, 2007, ASS MED RISKS HUM OO; Magnus D, 2005, SCIENCE, V308, P1747, DOI 10.1126/science.1114454; Moreno JD, 2005, NAT BIOTECHNOL, V23, P793, DOI 10.1038/nbt0705-793; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; Roberts C, 2008, SOC SCI MED, V66, P159, DOI 10.1016/j.socscimed.2007.08.011; Robertson JA, 2006, FERTIL STERIL, V86, P1573, DOI 10.1016/j.fertnstert.2006.08.084	15	10	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2174	2176		10.1001/jama.2008.601	http://dx.doi.org/10.1001/jama.2008.601			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001629				2022-12-01	WOS:000260793800028
J	Holden, LG; Prochnow, C; Chang, YP; Bransteitter, R; Chelico, L; Sen, U; Stevens, RC; Goodman, MF; Chen, XJS				Holden, Lauren G.; Prochnow, Courtney; Chang, Y. Paul; Bransteitter, Ronda; Chelico, Linda; Sen, Udayaditya; Stevens, Raymond C.; Goodman, Myron F.; Chen, Xiaojiang S.			Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications	NATURE			English	Article							DNA DEAMINASE DOMAIN; RESTRICTION; MODEL	The APOBEC family members are involved in diverse biological functions. APOBEC3G restricts the replication of human immunodeficiency virus (HIV), hepatitis B virus and retroelements by cytidine deamination on single- stranded DNA or by RNA binding(1-4). Here we report the high- resolution crystal structure of the carboxy- terminal deaminase domain of APOBEC3G (APOBEC3G-CD2) purified from Escherichia coli. The APOBEC3G-CD2 structure has a five- stranded beta- sheet core that is common to all known deaminase structures and closely resembles the structure of another APOBEC protein, APOBEC2 ( ref. 5). A comparison of APOBEC3G-CD2 with other deaminase structures shows a structural conservation of the active- site loops that are directly involved in substrate binding. In the X- ray structure, these APOBEC3G active- site loops form a continuous 'substrate groove' around the active centre. The orientation of this putative substrate groove differs markedly ( by 90 degrees) from the groove predicted by the NMR structure(6). We have introduced mutations around the groove, and have identified residues involved in substrate specificity, single- stranded DNA binding and deaminase activity. These results provide a basis for understanding the underlying mechanisms of substrate specificity for the APOBEC family.	[Holden, Lauren G.; Prochnow, Courtney; Chang, Y. Paul; Bransteitter, Ronda; Chelico, Linda; Sen, Udayaditya; Goodman, Myron F.; Chen, Xiaojiang S.] Univ So Calif, Los Angeles, CA 90089 USA; [Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Southern California; Scripps Research Institute	Chen, XJS (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	xiaojiang.chen@usc.edu	Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725; Sen, Udayaditya/0000-0001-5742-2907; Chelico, Linda/0000-0003-4673-8978; Holden, Lauren/0000-0001-8014-4503	CBM; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087986] Funding Source: NIH RePORTER	CBM; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Berkeley Laboratory's Advanced Light Source (ALS) BL8.2.1 and Advanced Photon Source 19ID in Argonne National Laboratory for assistance in data collection, and M. Klein and other members of the X.S.C. laboratory for help and discussion. This work is supported in part by CBM graduate training grants to L.G.H. and Y.P.C., and by National Institutes of Health grants to M.F.G. and X.S.C.	Bertram JG, 2004, J BIOL CHEM, V279, P33047, DOI 10.1074/jbc.C400265200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678	15	182	205	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					121	U13		10.1038/nature07357	http://dx.doi.org/10.1038/nature07357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18849968	Green Accepted			2022-12-01	WOS:000260674000053
J	de Waal, A				de Waal, Alex			The art of medicine On famine crimes and tragedies	LANCET			English	Editorial Material									[de Waal, Alex] Social Sci Res Council, New York, NY 10019 USA; [de Waal, Alex] Harvard Humanitarian Initiat, Cambridge, MA 02138 USA	Harvard University	de Waal, A (corresponding author), Social Sci Res Council, New York, NY 10019 USA.	dewaal@ssrc.org							0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1538	1539		10.1016/S0140-6736(08)61641-4	http://dx.doi.org/10.1016/S0140-6736(08)61641-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18988330				2022-12-01	WOS:000260590500013
J	Portner, HO; Farrell, AP				Poertner, Hans O.; Farrell, Anthony P.			ECOLOGY Physiology and Climate Change	SCIENCE			English	Editorial Material							THERMAL TOLERANCE; TEMPERATURE; SALMON; OCEAN; SHIFTS; HEAT; COD		[Poertner, Hans O.] Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of British Columbia; University of British Columbia	Portner, HO (corresponding author), Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany.	hans.poertner@awi.de	Pörtner, Hans-O./K-9429-2016	Pörtner, Hans-O./0000-0001-6535-6575				Brander KM, 2003, ICES MARINE SCI S, V219, P261; BRETT JR, 1971, AM ZOOL, V11, P99; Dahle R, 2003, COMP BIOCHEM PHYS A, V136, P641, DOI 10.1016/S1095-6433(03)00215-0; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinkhaus O, 2007, FRESHWATER BIOL, V52, P1537, DOI 10.1111/j.1365-2427.2007.01786.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Takasuka A, 2008, MAR ECOL PROG SER, V360, P211, DOI 10.3354/meps07407; Takasuka A, 2007, CAN J FISH AQUAT SCI, V64, P768, DOI 10.1139/F07-052; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Wiltshire KH, 2004, HELGOLAND MAR RES, V58, P269, DOI 10.1007/s10152-004-0196-0; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	23	6383	6496	55	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					690	692		10.1126/science.1163156	http://dx.doi.org/10.1126/science.1163156			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974339				2022-12-01	WOS:000260605200032
J	Shah, IM; Laaberki, MH; Popham, DL; Dworkin, J				Shah, Ishita M.; Laaberki, Maria-Halima; Popham, David L.; Dworkin, Jonathan			A Eukaryotic-like Ser/Thr Kinase Signals Bacteria to Exit Dormancy in Response to Peptidoglycan Fragments	CELL			English	Article							BACILLUS-SUBTILIS SPORE; MYCOBACTERIUM-TUBERCULOSIS; CELL-WALL; PROTEIN-KINASES; CLOSTRIDIUM-DIFFICILE; RECOGNITION PROTEINS; VEGETATIVE CELLS; BINDING DOMAIN; BETA-LACTAM; GERMINATION	Bacteria can respond to adverse environmental conditions by drastically reducing or even ceasing metabolic activity. They must then determine that conditions have improved before exiting dormancy, and one indication of such a change is the growth of other bacteria in the local environment. Growing bacteria release muropeptide fragments of the cell wall into the extracellular milieu, and we report here that these muropeptides are potent germinants of dormant Bacillus subtilis spores. The ability of a muropeptide to act as a germinant is determined by the identity of a single amino acid. A well-conserved, eukaryotic-like Ser/Thr membrane kinase containing an extracellular domain capable of binding peptidoglycan is necessary for this response, and a small molecule that stimulates related eukaryotic kinases is sufficient to induce germination. Another small molecule, staurosporine, that inhibits related eukaryotic kinases blocks muropeptide-dependent germination. Thus, in contrast to traditional antimicrobials that inhibit metabolically active cells, staurosporine acts by blocking germination of dormant spores.	[Shah, Ishita M.; Laaberki, Maria-Halima; Dworkin, Jonathan] Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; [Popham, David L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Columbia University; Virginia Polytechnic Institute & State University	Dworkin, J (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA.	jonathan.dworkin@columbia.edu	Popham, David L/F-8066-2015; Laaberki, Maria-Halima/M-6369-2014	Popham, David L/0000-0002-2614-143X; Laaberki, Maria-Halima/0000-0001-5796-5995	Department of Microbiology, Columbia University; NIH [GM56695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056695, R01GM081368] Funding Source: NIH RePORTER	Department of Microbiology, Columbia University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Aaron Mitchell and Howard Shuman for helpful discussions and Adriano Henriques, Marjorie Russel, Howard Shuman, and Leslie Vosshall for critically reading the manuscript. We thank C. Price and P. Setlow for B. subtilis strains and D. Garsin, F. Lowy, D. Portnoy, and A. Ratner for additional bacterial strains. This work was supported by startup funds from the Department of Microbiology, Columbia University to J.D. and by NIH grant GM56695 to D. L. P. J.D. is an Irma T. Hirschl Trust Scholar.	Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hecht DW, 2007, ANTIMICROB AGENTS CH, V51, P2716, DOI 10.1128/AAC.01623-06; Hudson KD, 2001, J BACTERIOL, V183, P4317, DOI 10.1128/JB.183.14.4317-4322.2001; HUNGERER KD, 1969, BIOCHEMISTRY-US, V8, P3577, DOI 10.1021/bi00837a013; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105; Keep NH, 2006, TRENDS MICROBIOL, V14, P271, DOI 10.1016/j.tim.2006.04.003; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MAUCK J, 1971, J BIOL CHEM, V246, P1820; McPherson DC, 2003, J BACTERIOL, V185, P1423, DOI 10.1128/JB.185.4.1423-1431.2003; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Onaka H, 2002, J ANTIBIOT, V55, P1063, DOI 10.7164/antibiotics.55.1063; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Paidhungat M, 2001, J BACTERIOL, V183, P3982, DOI 10.1128/JB.183.13.3982-3990.2001; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1970, J BIOL CHEM, V245, P3645; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Tufariello JM, 2006, INFECT IMMUN, V74, P2985, DOI 10.1128/IAI.74.5.2985-2995.2006; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	49	356	379	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					486	496		10.1016/j.cell.2008.08.039	http://dx.doi.org/10.1016/j.cell.2008.08.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984160	Bronze, Green Accepted			2022-12-01	WOS:000260536300019
J	Rohr, JR; Schotthoefer, AM; Raffel, TR; Carrick, HJ; Halstead, N; Hoverman, JT; Johnson, CM; Johnson, LB; Lieske, C; Piwoni, MD; Schoff, PK; Beasley, VR				Rohr, Jason R.; Schotthoefer, Anna M.; Raffel, Thomas R.; Carrick, Hunter J.; Halstead, Neal; Hoverman, Jason T.; Johnson, Catherine M.; Johnson, Lucinda B.; Lieske, Camilla; Piwoni, Marvin D.; Schoff, Patrick K.; Beasley, Val R.			Agrochemicals increase trematode infections in a declining amphibian species	NATURE			English	Article							FROGS RANA-PIPIENS; LIMB DEVELOPMENT; ATRAZINE; EXPOSURE; SURVIVAL; SURVIVORSHIP; DEFORMITIES; HERBICIDE; DISEASE; STAGE	Global amphibian declines have often been attributed to disease(1,2), but ignorance of the relative importance and mode of action of potential drivers of infection has made it difficult to develop effective remediation. In a field study, here we show that the widely used herbicide, atrazine, was the best predictor ( out of more than 240 plausible candidates) of the abundance of larval trematodes ( parasitic flatworms) in the declining northern leopard frog Rana pipiens. The effects of atrazine were consistent across trematode taxa. The combination of atrazine and phosphate - principal agrochemicals in global corn and sorghum production - accounted for 74% of the variation in the abundance of these often debilitating larval trematodes ( atrazine alone accounted for 51%). Analysis of field data supported a causal mechanism whereby both agrochemicals increase exposure and susceptibility to larval trematodes by augmenting snail intermediate hosts and suppressing amphibian immunity. A mesocosm experiment demonstrated that, relative to control tanks, atrazine tanks had immunosuppressed tadpoles, had significantly more attached algae and snails, and had tadpoles with elevated trematode loads, further supporting a causal relationship between atrazine and elevated trematode infections in amphibians. These results raise concerns about the role of atrazine and phosphate in amphibian declines, and illustrate the value of quantifying the relative importance of several possible drivers of disease risk while determining the mechanisms by which they facilitate disease emergence.	[Rohr, Jason R.; Raffel, Thomas R.; Halstead, Neal] Univ S Florida, Dept Biol, Tampa, FL 33620 USA; [Rohr, Jason R.; Raffel, Thomas R.] Penn State Univ, Penn State Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Schotthoefer, Anna M.; Lieske, Camilla; Beasley, Val R.] Univ Illinois, Coll Vet Med, Urbana, IL 61802 USA; [Carrick, Hunter J.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA; [Hoverman, Jason T.] Univ Tennessee, Dept Forest Wildlife & Fisheries, Knoxville, TN 37996 USA; [Johnson, Catherine M.; Johnson, Lucinda B.; Schoff, Patrick K.] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55811 USA; [Piwoni, Marvin D.] Illinois Waste Management & Res Ctr, Champaign, IL 61820 USA	State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Tennessee System; University of Tennessee Knoxville; University of Minnesota System; University of Minnesota Duluth	Rohr, JR (corresponding author), Univ S Florida, Dept Biol, Tampa, FL 33620 USA.	jasonrohr@gmail.com	Rohr, Jason R./AAJ-5856-2021; Hoverman, Jason T/D-1756-2013	Hoverman, Jason T/0000-0002-4002-2728; Johnson, Catherine/0000-0003-3133-9616; Johnson, Catherine/0000-0003-3241-9394	National Science Foundation [DEB-0809487]; US Department of Agriculture [NRI 2008-00622, NRI 2008-01785]; US Environmental Protection Agency STAR [R825867, R833835]	National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture(United States Department of Agriculture (USDA)); US Environmental Protection Agency STAR(United States Environmental Protection Agency)	We thank J. Murphy, A. Antolin, K. Beckman, R. Cole, A. Koehler, C. Hall, T. Hollenhorst and J. Romansic for collection and compilation of field, parasitological or land cover data; R. Cole, M. Martin, M. Mescher, J. Romansic, J. Runyon and the O. Bjornstad, C. De Moraes, E. Holmes, P. Hudson, B. Grenfell and M. Poss laboratories for comments and suggestions on this work; and J. Grace for reviewing sections of the paper on structural equation modelling. We also thank the USGS National Wildlife Health Center for laboratory space and support. Funds came from National Science Foundation (DEB-0809487) and US Department of Agriculture (NRI 2008-00622 and 2008-01785) grants to J.R.R., and US Environmental Protection Agency STAR grants to V. R. B. (R825867) and J.R.R. and T.R.R (R833835). This work does not necessarily reflect the views of these agencies.	Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; [Anonymous], 2004, PESTICIDE IND SALES; BEASLEY VR, 2003, STATUS CONSERVATION, P153; BROCK TCM, 2000, 088 ALT GREEN WORLD; Brodkin MA, 2007, ENVIRON TOXICOL CHEM, V26, P80, DOI 10.1897/05-469.1; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Davidson C, 2001, ECOL APPL, V11, P464, DOI 10.1890/1051-0761(2001)011[0464:DOTCRL]2.0.CO;2; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Dezfuli BS, 2007, J PARASITOL, V93, P1416, DOI 10.1645/GE-1214.1; Forson D, 2006, ENVIRON TOXICOL CHEM, V25, P168, DOI 10.1897/05-260R.1; Gammon DW., 2001, ATRAZINE RISK CHARAC; GRACE JB, 2006, STRUCT EQ MOD NAT, P3; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2003, TRENDS PARASITOL, V19, P332, DOI 10.1016/S1471-4922(03)00148-X; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; Rohr JR, 2006, ENVIRON HEALTH PERSP, V114, P46, DOI 10.1289/ehp.8405; Rohr JR, 2005, ECOL APPL, V15, P1135, DOI 10.1890/03-5353; ROHR JR, ECOL APPL IN PRESS; Rorabaugh JC, 2005, AMPHIBIAN DECLINES C; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI 10.1139/Z03-099; Schotthoefer AM, 2003, J PARASITOL, V89, P475, DOI 10.1645/0022-3395(2003)089[0475:ROTSTL]2.0.CO;2; Skelly David K., 2006, P153; Storrs SI, 2004, ENVIRON HEALTH PERSP, V112, P1054, DOI 10.1289/ehp.6821; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538	30	324	333	3	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1235	U50		10.1038/nature07281	http://dx.doi.org/10.1038/nature07281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972018				2022-12-01	WOS:000260462100043
J	Yamasaki, M; Li, W; Johnson, DJD; Huntington, JA				Yamasaki, Masayuki; Li, Wei; Johnson, Daniel J. D.; Huntington, James A.			Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization	NATURE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; REACTIVE-CENTER LOOP; HUMAN ALPHA(1)-ANTITRYPSIN; MECHANISM; SERPINOPATHIES; DENATURATION; ANTITHROMBIN; DEFICIENCY; PEPTIDES; DEMENTIA	Repeating intermolecular protein association by means of beta-sheet expansion is the mechanism underlying a multitude of diseases including Alzheimer's, Huntington's and Parkinson's and the prion encephalopathies(1). A family of proteins, known as the serpins, also forms large stable multimers by ordered beta-sheet linkages leading to intracellular accretion and disease(2). These 'serpinopathies' include early- onset dementia caused by mutations in neuroserpin, liver cirrhosis and emphysema caused by mutations in alpha(1)- antitrypsin (alpha(1)AT), and thrombosis caused by mutations in antithrombin(3). Serpin structure and function are quite well understood, and the family has therefore become a model system for understanding the beta-sheet expansion disorders collectively known as the conformational diseases(4). To develop strategies to prevent and reverse these disorders, it is necessary to determine the structural basis of the intermolecular linkage and of the pathogenic monomeric state. Here we report the crystallographic structure of a stable serpin dimer which reveals a domain swap of more than 50 residues, including two long antiparallel beta-strands inserting in the centre of the principal b-sheet of the neighbouring monomer. This structure explains the extreme stability of serpin polymers, the molecular basis of their rapid propagation, and provides critical new insights into the structural changes which initiate irreversible beta-sheet expansion.	[Yamasaki, Masayuki; Li, Wei; Johnson, Daniel J. D.; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jah52@cam.ac.uk			National Institutes of Health (USA); Uehara Memorial Foundation Japan	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation Japan(Uehara Memorial Foundation)	We thank R. Carrell, D. Crowther and D. Lomas for their comments on the manuscript. We are also grateful to J. Lowe for access to the robotic crystallisation facility in the MRC-LMB, and to M. Weldon for N- terminal sequencing. This work was supported by the National Institutes of Health ( USA) and the Uehara Memorial Foundation (Japan, to M.Y.), and J.A.H. is a senior MRC non- clinical fellow. Data were collected at beamlines I02 and I04 at the Diamond Light Source and we acknowledge the support of L. Duke, G. Evans, R. Flaig, J. Sandy and T. Sorensen.	Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Corral J, 2004, J THROMB HAEMOST, V2, P931, DOI 10.1111/j.1538-7836.2004.00749.x; Crowther DC, 2003, BIOCHEMISTRY-US, V42, P2355, DOI 10.1021/bi0259305; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Devlin GL, 2002, J MOL BIOL, V324, P859, DOI 10.1016/S0022-2836(02)01088-4; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Im H, 2000, PROTEIN SCI, V9, P1497, DOI 10.1110/ps.9.8.1497; James EL, 1998, ARCH BIOCHEM BIOPHYS, V356, P296, DOI 10.1006/abbi.1998.0751; James EL, 1999, J BIOL CHEM, V274, P9482, DOI 10.1074/jbc.274.14.9482; Jung CH, 2004, PROTEIN SCI, V13, P694, DOI 10.1110/ps.03356604; Kim DY, 1996, BIOCHEM BIOPH RES CO, V226, P378, DOI 10.1006/bbrc.1996.1364; Kjoller L, 1996, EUR J BIOCHEM, V241, P38, DOI 10.1111/j.1432-1033.1996.0038t.x; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Lomas DA, 2005, BIOCHEM SOC T, V33, P321, DOI 10.1042/BST0330321; Lomas DA, 2004, FRONT BIOSCI-LANDMRK, V9, P2873, DOI 10.2741/1444; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Pearce MC, 2007, FEBS J, V274, P3622, DOI 10.1111/j.1742-4658.2007.05897.x; Pedersen KE, 2003, BIOCHEM J, V372, P747, DOI 10.1042/BJ20021868; SHARP HL, 1969, J LAB CLIN MED, V73, P934; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Tew DJ, 2001, J MOL BIOL, V313, P1161, DOI 10.1006/jmbi.2001.5104; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	39	197	198	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1255	U65		10.1038/nature07394	http://dx.doi.org/10.1038/nature07394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18923394				2022-12-01	WOS:000260462100048
J	Chan, EYY; Griffiths, SM; Chan, CW				Chan, E. Y. Y.; Griffiths, S. M.; Chan, C. W.			Public-health risks of melamine in milk products	LANCET			English	Editorial Material									[Chan, E. Y. Y.; Griffiths, S. M.] Chinese Univ Hong Kong, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China; [Chan, C. W.] Int Pediat Assoc, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, EYY (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China.	emily.chan@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017	Chan, Emily Ying Yang/0000-0002-8854-5093				*CDCP, 2008, MEL CHIN MAN INF FOR; Chen K., 2007, PUBLIC HLTH SECURITY, P169; CHEN S, 2008, S CHINA MORNING 0922, pA4; *CTR FOOD SAF, FREQ ASK QUEST; FAN LW, 2007, PUBLIC HLTH LAW SURV, P332; *FOOD STAND AG, 2008, CHIN MILK ADV; GRIFFITHS S, 2008, S CHINA MORNING 1001, pA10; Parry J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1802; World Health Organization, 2008, MEL CYAN AC TOX PREL; XIAOFENG G, 2008, CHINA DAILY HON 1010, P3; 2008, CHINA DAILY     0916	11	179	190	3	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1444	1445		10.1016/S0140-6736(08)61604-9	http://dx.doi.org/10.1016/S0140-6736(08)61604-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	370ZJ	18970965	Green Published, Bronze			2022-12-01	WOS:000260801300006
J	Lee, HH; Elia, N; Ghirlando, R; Lippincott-Schwartz, J; Hurley, JH				Lee, Hyung Ho; Elia, Natalie; Ghirlando, Rodolfo; Lippincott-Schwartz, Jennifer; Hurley, James H.			Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55	SCIENCE			English	Article							LATE DOMAINS; CYTOKINESIS; PROTEIN; HIV-1; ALIX; REQUIREMENTS; RECRUITMENT; RELEASE; PATHWAY; TSG101	The ESCRT (endosomal sorting complex required for transport) machinery is required for the scission of membrane necks in processes including the budding of HIV-1 and cytokinesis. An essential step in cytokinesis is recruitment of the ESCRT-I complex and the ESCRT-associated protein ALIX to the midbody (the structure that tethers two daughter cells) by the protein CEP55. Biochemical experiments show that peptides from ALIX and the ESCRT-I subunit TSG101 compete for binding to the ESCRT- and ALIX-binding region (EABR) of CEP55. We solved the crystal structure of EABR bound to an ALIX peptide at a resolution of 2.0 angstroms. The structure shows that EABR forms an aberrant dimeric parallel coiled coil. Bulky and charged residues at the interface of the two central heptad repeats create asymmetry and a single binding site for an ALIX or TSG101 peptide. Both ALIX and ESCRT-i are required for cytokinesis, which suggests that multiple CEP55 dimers are required for function.	[Lee, Hyung Ho; Ghirlando, Rodolfo; Hurley, James H.] NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; [Elia, Natalie; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Ghirlando, Rodolfo/A-8880-2009		U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NIH intramural suppor; NIDDK; NICHD; IATAP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036125] Funding Source: NIH RePORTER	U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH intramural suppor(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); IATAP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Beach for generating DNA constructs, E. Freed and K. Kutsche for providing DNAs, T. Alber for discussions, and the staff of SER-CAT for user support at the Advanced Photon Source (APS). Use of the APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. Supported by NIH intramural support, NIDDK (J.H.H.), NICHD (J.L.), and IATAP (J.H.H. and J.L.). Crystallographic coordinates have been deposited in the RCSB Protein Data Bank with accession number 3E1R.	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Prekeris R, 2008, J CELL SCI, V121, P1569, DOI 10.1242/jcs.018770; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	26	184	190	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					576	580		10.1126/science.1162042	http://dx.doi.org/10.1126/science.1162042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948538	Green Accepted			2022-12-01	WOS:000260299100040
J	Aiga, H				Aiga, Hirotsugu			How many people are really hungry?	LANCET			English	Editorial Material									[Aiga, Hirotsugu] Japan Int Cooperat Agcy, Dept Human Dev, Shibuya Ku, Tokyo 1518558, Japan; [Aiga, Hirotsugu] UN World Food Programme, Program Design & Support Div, Rome, Italy; [Aiga, Hirotsugu] George Washington Univ, Dept Global Hlth, Washington, DC USA; [Aiga, Hirotsugu] Univ Tokyo, Dept Hlth Policy & Planning, Tokyo, Japan	George Washington University; University of Tokyo	Aiga, H (corresponding author), Japan Int Cooperat Agcy, Dept Human Dev, Shibuya Ku, Tokyo 1518558, Japan.	aiga.hirotsugu@jica.go.jp						Aiga H, 2006, HUMANITARIAN EXCHANG, V36, P36; *FOOD AGR ORG UN, 2003, FAO METH MEAS FOOD D, P2; *FOOD AGR ORG UN, 2006, STAT FOOD INS WORLD, P32; *FOOD AGR ORG UN, 2008, HIGH LEV C WORLD FOO; Food And Agriculture Organisation Of The United Nations-FAO, 1996, ROM DECL WORLD FOOD; LANJOUW JO, 2000, DEMYSTIFYING POVERTY, P4; *MIN FOR AFF JAP, G8 LEAD STAT GLOB FO; STIGLITZ JE, 2003, GLOBALIZATION ITS DI; SVEDBERG P, 1999, POVERTY UNDERNUTRITI, P298; UNICEF, 1990, STRAT IMPR NUTR CHIL, P18; 2008, ECONOMIST       0605, P61; 2007, GOAL 1 ERADICATE EXT	12	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1367	1369		10.1016/S0140-6736(08)61568-8	http://dx.doi.org/10.1016/S0140-6736(08)61568-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940453				2022-12-01	WOS:000260228200007
J	Zimmer, J; Nam, YS; Rapoport, TA				Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.			Structure of a complex of the ATPase SecA and the protein-translocation channel	NATURE			English	Article							SIGNAL-SEQUENCE RECOGNITION; X-RAY-STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; DIMERIC SECA; DENSITY-MODIFICATION; CRYSTAL-STRUCTURES; SECYEG; MEDIATE; EXPORT	Most proteins are secreted from bacteria by the interaction of the cytoplasmic SecA ATPase with a membrane channel, formed by the heterotrimeric SecY complex. Here we report the crystal structure of SecA bound to the SecY complex, with a maximum resolution of 4.5 angstrorm ( A), obtained for components from Thermotoga maritima. One copy of SecA in an intermediate state of ATP hydrolysis is bound to one molecule of the SecY complex. Both partners undergo important conformational changes on interaction. The polypeptide- cross- linking domain of SecA makes a large conformational change that could capture the translocation substrate in a 'clamp'. Polypeptide movement through the SecY channel could be achieved by the motion of a 'two-helix finger' of SecA inside the cytoplasmic funnel of SecY, and by the coordinated tightening and widening of SecA's clamp above the SecY pore. SecA binding generates a 'window' at the lateral gate of the SecY channel and it displaces the plug domain, preparing the channel for signal sequence binding and channel opening.	[Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Zimmer, Jochen/0000-0002-8423-2882; Nam, Yunsun/0000-0002-7939-8626	National Institutes of Health; Damon Runyon Cancer Research Foundation [DRG-#1953-07]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation	We thank B. van den Berg and P. Bendapudi for initial experiments with the B. subtilis SecA and T. maritima SecY complex, G. Skiniotis for electron microscopy analysis, W. Li for his help with data processing, the staff at Advanced Photon Source beamlines ID- 19 and 24ID and at Brookhaven National Laboratory beamline X29, and the SB Grid consortium at Harvard Medical School. We thank A. Brunger and S. Harrison for comments, and A. Brunger, B. van den Berg, W. Li, A. Osborne and S. Schulman for critical reading of the manuscript. The work was supported by a National Institutes of Health grant. T. A. R. is an HHMI investigator. Y.N. is supported by the Damon Runyon Cancer Research Foundation (DRG-#1953-07).	AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bostina M, 2005, J MOL BIOL, V352, P1035, DOI 10.1016/j.jmb.2005.08.005; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chiba K, 2002, J BACTERIOL, V184, P2243, DOI 10.1128/JB.184.8.2243-2250.2002; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JAROSIK GP, 1991, J BACTERIOL, V173, P860, DOI 10.1128/jb.173.2.860-868.1991; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mori H, 2002, J BIOL CHEM, V277, P48550, DOI 10.1074/jbc.M204436200; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, J BIOL CHEM, V281, P36249, DOI 10.1074/jbc.M606906200; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz WA, 1996, EMBO J, V15, P5209, DOI 10.1002/j.1460-2075.1996.tb00906.x; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Satoh Y, 2003, BIOCHEMISTRY-US, V42, P7434, DOI 10.1021/bi034331a; SHIBA K, 1984, EMBO J, V3, P631, DOI 10.1002/j.1460-2075.1984.tb01859.x; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Zhou JH, 2003, NAT STRUCT BIOL, V10, P942, DOI 10.1038/nsb980; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	62	342	354	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					936	U32		10.1038/nature07335	http://dx.doi.org/10.1038/nature07335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923516	Green Accepted			2022-12-01	WOS:000260038300043
J	Takizawa, T; Meaburn, KJ; Misteli, T				Takizawa, Takumi; Meaburn, Karen J.; Misteli, Tom			The meaning of gene positioning	CELL			English	Article							NUCLEAR LAMINA; TRANSCRIPTIONAL REGULATION; DROSOPHILA-MELANOGASTER; CHROMOSOME TERRITORIES; SPATIAL-ORGANIZATION; GENOME FUNCTION; LOCUS; REORGANIZATION; EXPRESSION; LOCALIZATION	There is no doubt that genomes are organized nonrandomly in the nucleus of higher eukaryotes. But what is the functional relevance of this nonrandomness? In this Essay, we explore the biological meaning of spatial gene positioning by examining the functional link between the activity of a gene and its radial position in the nucleus.	[Takizawa, Takumi; Meaburn, Karen J.; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Meaburn, Karen/J-2482-2019; Takizawa, Takumi/AAH-4996-2020	Meaburn, Karen/0000-0002-1327-5957; Takizawa, Takumi/0000-0003-2169-0787	Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Cremer T, 2006, EUR J HISTOCHEM, V50, P161; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gilbert DM, 2001, J CELL BIOL, V152, pF11, DOI 10.1083/jcb.152.2.F11; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lawrence JB, 2008, J CELL BIOL, V182, P1035, DOI 10.1083/jcb.200808121; Meaburn KJ, 2008, J CELL BIOL, V180, P39, DOI 10.1083/jcb.200708204; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murmann AE, 2005, EXP CELL RES, V311, P14, DOI 10.1016/j.yexcr.2005.07.020; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; [No title captured]	38	169	173	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					9	13		10.1016/j.cell.2008.09.026	http://dx.doi.org/10.1016/j.cell.2008.09.026			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854147	Bronze, Green Accepted			2022-12-01	WOS:000259728100001
J	Fischer, SEJ; Butler, MD; Pan, Q; Ruvkun, G				Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary			Trans-splicing in C. elegans generates the negative RNAi regulator ERI-6/7	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; DROSOPHILA; PROTEIN; ARGONAUTE; HELICASE; IDENTIFICATION; PATHWAYS; REVEALS; ENCODES	Mutations that enhance the response to double- stranded RNA ( dsRNA) have revealed components of the RNA interference ( RNAi) pathway or related small RNA pathways. To explore these small RNA pathways, we screened for Caenorhabditis elegans mutants displaying an enhanced response to exogenous dsRNAs. Here we describe the isolation of mutations in two adjacent, divergently transcribed open reading frames ( eri-6 and eri-7) that fail to complement. eri-6 and eri- 7 produce separate pre- messenger RNAs ( pre- mRNAs) that are trans- spliced to form a functional mRNA, eri- 6/ 7. Trans- splicing of eri6/7 is mediated by a direct repeat that flanks the eri- 6 gene. Adenosine to inosine editing within untranslated regions of eri- 6 and eri- 7 pre- mRNAs reveals a double- stranded pre- mRNA intermediate, forming in the nucleus before splicing occurs. The ERI-6/7 protein is a superfamily I helicase that both negatively regulates the exogenous RNAi pathway and functions in an endogenous RNAi pathway.	[Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu			Leukemia and Lymphoma Society; EMBO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044619] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank: S. Kennedy for advice and initiating the enhanced RNAi screen; M. Finney for advice on advanced PCR; C. Zhang for mg441 Eri characterization; Y. Kohara, D. Thierry-Mieg and J. Thierry-Mieg for EST sequences and clones; the Mitani laboratory for deletion strains; the Caenorhabditis Genetics Center for strains; Ruvkun laboratory members for reading the manuscript and many discussions; the laboratories of J. Kaplan and F. Ausubel for discussions; and the Leukemia and Lymphoma Society, and EMBO for funding to S.E.J.F.	Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beitel GJ, 1995, GENE DEV, V9, P3149, DOI 10.1101/gad.9.24.3149; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caplen NJ, 2002, HUM MOL GENET, V11, P175, DOI 10.1093/hmg/11.2.175; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Felix MA, 2004, CURR BIOL, V14, pR75, DOI 10.1016/j.cub.2003.12.050; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garcia-Muse T, 2007, CHROMOSOME RES, V15, P607, DOI 10.1007/s10577-007-1146-x; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Labrador M, 2001, NATURE, V409, P1000, DOI 10.1038/35059000; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Stiernagle T., 2006, WORMBOOK; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; VONMENDE N, 1988, CELL, V55, P567, DOI 10.1016/0092-8674(88)90215-2; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; *WORMBASE, 2007, WORMBASE REL WS170; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	43	70	83	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					491	U23		10.1038/nature07274	http://dx.doi.org/10.1038/nature07274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18784652	Green Accepted			2022-12-01	WOS:000259449600037
J	Kareiva, P; Chang, A; Marvier, M				Kareiva, Peter; Chang, Amy; Marvier, Michelle			Environmental economics - Development and conservation goals in World Bank projects	SCIENCE			English	Editorial Material							NEEDS; HELP		[Kareiva, Peter] Nature Conservancy, Seattle, WA 98105 USA; [Kareiva, Peter; Marvier, Michelle] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Chang, Amy] Nature Conservancy, Santa Clara, CA 95053 USA	Nature Conservancy; Santa Clara University	Kareiva, P (corresponding author), Nature Conservancy, Seattle, WA 98105 USA.	pkareiva@tnc.org		Marvier, Michelle/0000-0001-8360-9265				Agrawal A., 2006, 26 WCS; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Kaimowitz D, 2007, BIOTROPICA, V39, P567, DOI 10.1111/j.1744-7429.2007.00332.x; Koziell I, 2002, PHILOS T ROY SOC A, V360, P1807, DOI 10.1098/rsta.2002.1033; MACKINNON K, 2006, WORLD BANK BIODIVERS; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL, P137; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Robinson J., 2004, GETTING BIODIVERSITY, P10; Sachs JD, 2006, SCIENCE, V312, P1002, DOI 10.1126/science.1124822; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7	12	46	47	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1638	1639		10.1126/science.1162756	http://dx.doi.org/10.1126/science.1162756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	349RG	18801985				2022-12-01	WOS:000259300400019
J	Raschle, M; Knipscheer, P; Enoiu, M; Angelov, T; Sun, JC; Griffith, JD; Ellenberger, TE; Scharer, OD; Walter, JC				Raeschle, Markus; Knipscheer, Puck; Enoiu, Milica; Angelov, Todor; Sun, Jingchuan; Griffith, Jack D.; Ellenberger, Tom E.; Schaerer, Orlando D.; Walter, Johannes C.			Mechanism of replication-coupled DNA interstrand crosslink repair	CELL			English	Article							FANCONI-ANEMIA; RECOMBINATION; RECRUITMENT; ACTIVATION; TOLERANCE; CISPLATIN; PROTEIN; MCM2-7; REV1	DNA interstrand crosslinks (ICLs) are toxic DNA lesions whose repair occurs in the S phase of metazoans via an unknown mechanism. Here, we describe a cell-free system based on Xenopus egg extracts that supports ICL repair. During DNA replication of a plasmid containing a site-specific ICL, two replication forks converge on the crosslink. Subsequent lesion bypass involves advance of a nascent leading strand to within one nucleotide of the ICL, followed by incisions, translesion DNA synthesis, and extension of the nascent strand beyond the lesion. Immunodepletion experiments suggest that extension requires DNA polymerase zeta. Ultimately, a significant portion of the input DNA is fully repaired, but not if DNA replication is blocked. Our experiments establish a mechanism for ICL repair that reveals how this process is coupled to DNA replication.	[Raeschle, Markus; Knipscheer, Puck; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Enoiu, Milica; Angelov, Todor; Schaerer, Orlando D.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Sun, Jingchuan; Griffith, Jack D.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Ellenberger, Tom E.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Harvard University; Harvard Medical School; University of Zurich; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Scharer, Orlando/B-8908-2008; Schärer, Orlando D./AAF-8613-2021	Scharer, Orlando/0000-0003-2425-2715; Walter, Johannes/0000-0002-4186-7570	NIH [GM62267, GM55390, GM31819]; Leukemia and Lymphoma Scholar Award; Dutch Cancer Society Fellowship; New York State Office of Science and Technology and Academic Research NYSTAR [C040069]; Swiss Cancer League [OCS-01413-080-2003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM055390, R01GM062267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); Dutch Cancer Society Fellowship(KWF Kankerbestrijding); New York State Office of Science and Technology and Academic Research NYSTAR; Swiss Cancer League; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Alan D'Andrea for advice and encouragement during early stages of this project. This work was supported by NIH grants GM62267 (J.C.W.), GM55390 (T. E. E.), and GM31819 (J. D. G.), a Leukemia and Lymphoma Scholar Award (J. C. W.), a Dutch Cancer Society Fellowship (P. K.), and grants from the New York State Office of Science and Technology and Academic Research NYSTAR, C040069 (O.D.S.) and the Swiss Cancer League OCS-01413-080-2003 (O.D.S.). We thank Agata Smogorzewska, Ralph Scully, and Alan D'Andrea for critical reading of the manuscript.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Akkari YMN, 2001, MOL GENET METAB, V74, P403, DOI 10.1006/mgme.2001.3259; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Bessho T, 2003, J BIOL CHEM, V278, P5250, DOI 10.1074/jbc.M212323200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Hazrati A, 2008, DNA REPAIR, V7, P230, DOI 10.1016/j.dnarep.2007.09.013; Hofr C, 2001, J BIOL CHEM, V276, P9655, DOI 10.1074/jbc.M010205200; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li L, 1999, MOL CELL BIOL, V19, P5619; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Sobeck A, 2007, MOL CELL BIOL, V27, P4283, DOI 10.1128/MCB.02196-06; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; Toczylowski T, 2006, J BIOL CHEM, V281, P33198, DOI 10.1074/jbc.M605044200; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004	33	367	373	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					969	980		10.1016/j.cell.2008.08.030	http://dx.doi.org/10.1016/j.cell.2008.08.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805090	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000259318100017
J	Schroeder, BC; Cheng, T; Jan, YN; Jan, LY				Schroeder, Bjoern Christian; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh			Expression cloning of TMEM16A as a calcium-activated chloride channel subunit	CELL			English	Article							CYSTIC-FIBROSIS AIRWAY; XENOPUS-LAEVIS OOCYTES; PROTEIN-KINASE-C; TRANSMEMBRANE PROTEIN; GNATHODIAPHYSEAL-DYSPLASIA; TRANSCRIPTOME ANALYSIS; PLASMA-MEMBRANE; SURFACE LIQUID; ION CHANNELS; CELLS	Calcium-activated chloride channels (CaCCs) are major regulators of sensory transduction, epithelial secretion, and smooth muscle contraction. Other crucial roles of CaCCs include action potential generation in Characean algae and prevention of polyspermia in frog egg membrane. None of the known molecular candidates share properties characteristic of most CaCCs in native cells. Using Axolotl oocytes as an expression system, we have identified TMEM16A as the Xenopus oocyte CaCC. The TMEM16 family of "transmembrane proteins with unknown function'' is conserved among eukaryotes, with family members linked to tracheomalacia (mouse TMEM16A), gnatho-diaphyseal dysplasia (human TMEM16E), aberrant X segregation (a Drosophila TMEM16 family member), and increased sodium tolerance (yeast TMEM16). Moreover, mouse TMEM16A and TMEM16B yield CaCCs in Axolotl oocytes and mammalian HEK293 cells and recapitulate the broad CaCC expression. The identification of this new family of ion channels may help the development of CaCC modulators for treating diseases including hypertension and cystic fibrosis.	[Schroeder, Bjoern Christian; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	Human Frontier Science Program; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J.Adelman for SK2 cDNA and N.V. Ravin for the pG591 clone. We are grateful for the help of C. Han with confocal images, T. Muller with image acquisition, X. Qian with patch-clamp experiments, and D. Wang with in situ hybridizations. We also thank P. Lu and P. Soba for discussion. This work was supported by a Human Frontier Science Program fellowship to B.C. S. and a National Institute of Mental Health grant to L.Y.J. L.Y.J. and Y.N.J. are Howard Hughes Medical Institute investigators.	ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; ARREOLA J, 1995, J MEMBRANE BIOL, V147, P95; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BARISH ME, 1984, J PHYSIOL-LONDON, V352, P243, DOI 10.1113/jphysiol.1984.sp015289; BARROSORIA R, 2008, BIOCH BIOPH IN PRESS; Bera TK, 2004, P NATL ACAD SCI USA, V101, P3059, DOI 10.1073/pnas.0308746101; Blaug S, 2003, AM J PHYSIOL-CELL PH, V284, pC897, DOI 10.1152/ajpcell.00238.2002; BOTON R, 1989, J PHYSIOL-LONDON, V408, P511, DOI 10.1113/jphysiol.1989.sp017473; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; Callamaras N, 2000, AM J PHYSIOL-CELL PH, V278, pC667, DOI 10.1152/ajpcell.2000.278.4.C667; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Jego P., 1986, Advances in Experimental Medicine and Biology, V207, P205; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Kramer J, 2003, NAT CELL BIOL, V5, P261, DOI 10.1038/ncb944; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LUPUMEIRI M, 1989, PFLUG ARCH EUR J PHY, V413, P498, DOI 10.1007/BF00594180; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Perez-Cornejo P, 2004, J MEMBRANE BIOL, V198, P125, DOI 10.1007/s00232-004-0659-x; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pusch M, 2004, J GEN PHYSIOL, V123, P323, DOI 10.1085/jgp.200409053; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Runft LL, 1999, DEV BIOL, V214, P399, DOI 10.1006/dbio.1999.9415; SAMEJIMA M, 1982, PLANT CELL PHYSL, V27, P1081; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; TAKAHASHI T, 1987, P NATL ACAD SCI USA, V84, P5063, DOI 10.1073/pnas.84.14.5063; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; YANG YD, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07313	54	880	929	0	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1019	1029		10.1016/j.cell.2008.09.003	http://dx.doi.org/10.1016/j.cell.2008.09.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805094	Bronze, Green Accepted			2022-12-01	WOS:000259318100021
J	Lang, IA; Galloway, TS; Scarlett, A; Henley, WE; Depledge, M; Wallace, RB; Melzer, D				Lang, Iain A.; Galloway, Tamara S.; Scarlett, Alan; Henley, William E.; Depledge, Michael; Wallace, Robert B.; Melzer, David			Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN EXPOSURE; ENDOCRINE DISRUPTORS; US POPULATION; HEALTH; LIVER; METABOLISM; MECHANISMS; REGRESSION; BINDING; OBESITY	Context Bisphenol A ( BPA) is widely used in epoxy resins lining food and beverage containers. Evidence of effects in animals has generated concern over low- level chronic exposures in humans. Objective To examine associations between urinary BPA concentrations and adult health status. Design, Setting, and Participants Cross- sectional analysis of BPA concentrations and health status in the general adult population of the United States, using data from the National Health and Nutrition Examination Survey 2003- 2004. Participants were 1455 adults aged 18 through 74 years with measured urinary BPA and urine creatinine concentrations. Regression models were adjusted for age, sex, race/ ethnicity, education, income, smoking, body mass index, waist circumference, and urinary creatinine concentration. The sample provided 80% power to detect unadjusted odds ratios ( ORs) of 1.4 for diagnoses of 5% prevalence per 1- SD change in BPA concentration, or standardized regression coefficients of 0.075 for liver enzyme concentrations, at a significance level of P <. 05. Main Outcome Measures Chronic disease diagnoses plus blood markers of liver function, glucose homeostasis, inflammation, and lipid changes. Results Higher urinary BPA concentrations were associated with cardiovascular diagnoses in age-, sex-, and fully adjusted models ( OR per 1- SD increase in BPA concentration, 1.39; 95% confidence interval [ CI], 1.18- 1.63; P=. 001 with full adjustment). Higher BPA concentrations were also associated with diabetes ( OR per 1- SD increase in BPA concentration, 1.39; 95% confidence interval [ CI], 1.21- 1.60; P <. 001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes gamma- glutamyltransferase ( OR per 1- SD increase in BPA concentration, 1.29; 95% CI, 1.14- 1.46; P <. 001) and alkaline phosphatase ( OR per 1- SD increase in BPA concentration, 1.48; 95% CI, 1.18- 1.85; P=. 002). Conclusion Higher BPA exposure, reflected in higher urinary concentrations of BPA, may be associated with avoidable morbidity in the community- dwelling adult population.	[Lang, Iain A.; Melzer, David] Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter EX2 5DW, Devon, England; [Depledge, Michael] Peninsula Med Sch, Environm & Human Hlth Grp, Exeter EX2 5DW, Devon, England; [Galloway, Tamara S.; Scarlett, Alan] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Henley, William E.] Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England; [Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA	University of Exeter; University of Exeter; University of Exeter; University of Plymouth; University of Iowa	Melzer, D (corresponding author), Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Barrack Rd, Exeter EX2 5DW, Devon, England.	david.melzer@pms.ac.uk	Lang, Iain A/B-8255-2008; Rose, Rebecca J/B-7812-2011; Galloway, Tamara/C-1662-2009; Scarlett, Alan G/M-3235-2017	Scarlett, Alan G/0000-0002-9559-2154; Depledge, Michael/0000-0002-7216-0439; Lang, Iain/0000-0002-8473-2350; Melzer, David/0000-0002-0170-3838	United Kingdom National Health Service South West Region Public Health Training Scheme	United Kingdom National Health Service South West Region Public Health Training Scheme	Resources for this analysis were provided by the Peninsula College of Medicine and Dentistry. Dr Lang is an Academic Specialty Trainee in Public Health supported by the United Kingdom National Health Service South West Region Public Health Training Scheme.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Birnbaum LS, 2018, TESTIMONY FEDERAL RO; Burridge E., 2003, EUR CHEM NEWS, V78, P17; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; *CDCP, 2005, 20032004 NHANES CDCP; Centers for Disease Control and Prevention, 2004, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2005, 3 CDCP; Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH NUTR EX SUR; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; Goodman JE, 2006, CRIT REV TOXICOL, V36, P387, DOI 10.1080/10408440600758317; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; KORN EL, 1995, J ROY STAT SOC A STA, V158, P263, DOI 10.2307/2983292; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512; Matsumoto J, 2002, ENVIRON HEALTH PERSP, V110, P193, DOI 10.1289/ehp.02110193; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Nakagawa Y, 2000, ARCH TOXICOL, V74, P99, DOI 10.1007/s002040050659; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Oehlmann J, 2006, ENVIRON HEALTH PERSP, V114, P127, DOI 10.1289/ehp.8065; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Ouchi K, 2002, J CHROMATOGR B, V780, P365, DOI 10.1016/S1570-0232(02)00547-0; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Teeguarden JG, 2005, TOXICOL SCI, V85, P823, DOI 10.1093/toxsci/kfi135; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; *U OXF DIAB TRIALS, 2007, HOMA CALC; *VAN U, PS POW SAMPL SIZ CAL; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047	43	958	996	4	256	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1303	1310		10.1001/jama.300.11.1303	http://dx.doi.org/10.1001/jama.300.11.1303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799442	Bronze, Green Published			2022-12-01	WOS:000259231100025
J	Brantley, SL				Brantley, Susan L.			Geology - Understanding soil time	SCIENCE			English	Editorial Material							CHEMISTRY; FOREST		[Brantley, Susan L.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Brantley, SL (corresponding author), Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA.	brantley@eesi.psu.edu	Brantley, Susan L/ABE-4479-2020					Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; BROWN ET, 1995, EARTH PLANET SC LETT, V129, P193, DOI 10.1016/0012-821X(94)00249-X; Chadwick OA, 2001, GEODERMA, V100, P321, DOI 10.1016/S0016-7061(01)00027-1; Filippelli GM, 2002, REV MINERAL GEOCHEM, V48, P391, DOI 10.2138/rmg.2002.48.10; Fletcher RC, 2006, EARTH PLANET SC LETT, V244, P444, DOI 10.1016/j.epsl.2006.01.055; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; TURNER MG, 1993, LANDSCAPE ECOL, V8, P213, DOI 10.1007/BF00125352; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White AF, 2003, CHEM GEOL, V202, P479, DOI 10.1016/j.chemgeo.2003.03.001; WHITE AF, 2008, KINETICS WATER ROCK, P463; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1	17	50	57	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1454	1455		10.1126/science.1161132	http://dx.doi.org/10.1126/science.1161132			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787158				2022-12-01	WOS:000259121800028
J	Francois, M; Caprini, A; Hosking, B; Orsenigo, F; Wilhelm, D; Browne, C; Paavonen, K; Karnezis, T; Shayan, R; Downes, M; Davidson, T; Tutt, D; Cheah, KSE; Stacker, SA; Muscat, GEO; Achen, MG; Dejana, E; Koopman, P				Francois, Mathias; Caprini, Andrea; Hosking, Brett; Orsenigo, Fabrizio; Wilhelm, Dagmar; Browne, Catherine; Paavonen, Karri; Karnezis, Tara; Shayan, Ramin; Downes, Meredith; Davidson, Tara; Tutt, Desmond; Cheah, Kathryn S. E.; Stacker, Steven A.; Muscat, George E. O.; Achen, Marc G.; Dejana, Elisabetta; Koopman, Peter			Sox18 induces development of the lymphatic vasculature in mice	NATURE			English	Article							ENDOTHELIAL-CELLS; BOX GENE; SYSTEM; MOUSE; EXPRESSION; MUTATIONS; PROX1; LYMPHANGIOGENESIS; DIFFERENTIATION; ANGIOGENESIS	The lymphatic system plays a key role in tissue fluid regulation and tumour metastasis, and lymphatic defects underlie many pathological states including lymphoedema, lymphangiectasia, lymphangioma and lymphatic dysplasia(1-3). However, the origins of the lymphatic system in the embryo, and the mechanisms that direct growth of the network of lymphatic vessels, remain unclear. Lymphatic vessels are thought to arise from endothelial precursor cells budding from the cardinal vein under the influence of the lymphatic hallmark gene Prox1 ( prospero homeobox 1; ref. 4). Defects in the transcription factor gene SOX18 ( SRY ( sex determining region Y) box 18) cause lymphatic dysfunction in the human syndrome hypotrichosis- lymphoedema- telangiectasia(5), suggesting that Sox18 may also play a role in lymphatic development or function. Here we use molecular, cellular and genetic assays in mice to show that Sox18 acts as a molecular switch to induce differentiation of lymphatic endothelial cells. Sox18 is expressed in a subset of cardinal vein cells that later co- express Prox1 and migrate to form lymphatic vessels. Sox18 directly activates Prox1 transcription by binding to its proximal promoter. Overexpression of Sox18 in blood vascular endothelial cells induces them to express Prox1 and other lymphatic endothelial markers, while Sox18- null embryos show a complete blockade of lymphatic endothelial cell differentiation from the cardinal vein. Our findings demonstrate a critical role for Sox18 in developmental lymphangiogenesis, and suggest new avenues to investigate for therapeutic management of human lymphangiopathies.	[Francois, Mathias; Hosking, Brett; Wilhelm, Dagmar; Browne, Catherine; Downes, Meredith; Davidson, Tara; Tutt, Desmond; Muscat, George E. O.; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Caprini, Andrea; Orsenigo, Fabrizio; Dejana, Elisabetta] FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy; [Paavonen, Karri; Karnezis, Tara; Shayan, Ramin; Stacker, Steven A.; Achen, Marc G.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; [Shayan, Ramin] Univ Melbourne, Dept Surg, Parkville, Vic 3052, Australia; [Cheah, Kathryn S. E.] Univ Hong Kong, Dept Biochem, Hong Kong, Peoples R China; [Cheah, Kathryn S. E.] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Peoples R China; [Dejana, Elisabetta] Univ Milan, Dept Biomol Sci & Biotechnol, I-20129 Milan, Italy	University of Queensland; IFOM - FIRC Institute of Molecular Oncology; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Melbourne; University of Hong Kong; University of Hong Kong; University of Milan	Koopman, P (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	elisabetta.dejana@ifom-ieo-campus.it; p.koopman@imb.uq.edu.au	Stacker, Steven A/J-2205-2012; francois, mathias/A-9604-2014; Downes, Meredith/B-7370-2013; Downes, Meredith/P-8203-2018; Koopman, Peter A/C-9416-2009; Wilhelm, Dagmar/B-6915-2009; Muscat, George/A-6401-2017	Stacker, Steven A/0000-0003-4096-9273; francois, mathias/0000-0002-9846-6882; Koopman, Peter A/0000-0001-6939-0914; Wilhelm, Dagmar/0000-0002-7757-4075; Achen, Marc/0000-0002-3791-803X; Downes, Meredith/0000-0002-6517-1834; Orsenigo, Fabrizio/0000-0001-9135-8478; DEJANA, ELISABETTA/0000-0002-0007-0426; Muscat, George/0000-0002-5829-5695	National Health and Medical Research Council (Australia); INSERM ( France); Associazione Italiana per la Ricerca sul Cancro (Italy); European Community [LSHG-CT-2004-503573]; Pfizer Foundation (Australia); Australia), the Research Grants Council ( Hong Kong); Research Grants Council (Hong Kong); Raelene Boyle Sporting Chance Foundation (Australia); Royal Australasian College of Surgeons; Heart Foundation of Australia; Australian Research Council	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); INSERM ( France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Associazione Italiana per la Ricerca sul Cancro (Italy)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); Pfizer Foundation (Australia); Australia), the Research Grants Council ( Hong Kong); Research Grants Council (Hong Kong)(Hong Kong Research Grants Council); Raelene Boyle Sporting Chance Foundation (Australia); Royal Australasian College of Surgeons; Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council(Australian Research Council)	We thank A. Nagy, W. Abramow-Newerly, L. Naldini, P. Berta, A. Yap and J. Gamble for gifts of reagents. We also thank L. Bernard, L. Tizzoni and V. Dall'Olio for quantitative real- time PCR analysis, M. Chan and A. Pelling for antibody characterization, and S. Pizzi for technical assistance. Confocal microscopy was performed at the Australian Cancer Research Foundation Dynamic Imaging Centre for Cancer Biology. This work was supported by the National Health and Medical Research Council ( Australia), INSERM ( France), the Associazione Italiana per la Ricerca sul Cancro ( Italy), the European Community (LSHG-CT-2004-503573, Eustroke and Optistem networks), the Pfizer Foundation (Australia), the Research Grants Council (Hong Kong), the Raelene Boyle Sporting Chance Foundation ( Australia), the Royal Australasian College of Surgeons, the Heart Foundation of Australia, and the Australian Research Council.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Balconi G, 2000, ARTERIOSCL THROM VAS, V20, P1443, DOI 10.1161/01.ATV.20.6.1443; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; CARTER TC, 1954, J HERED, V45, P151; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Garlanda C, 1997, EUR J CELL BIOL, V73, P368; GREEN EL, 1961, J HERED, V52, P223, DOI 10.1093/oxfordjournals.jhered.a107077; Hosking BM, 2004, J BIOL CHEM, V279, P5314, DOI 10.1074/jbc.M308512200; Hosking BM, 2001, BIOCHEM BIOPH RES CO, V287, P493, DOI 10.1006/bbrc.2001.5589; Hosking BM, 2001, GENE, V262, P239, DOI 10.1016/S0378-1119(00)00525-4; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Leung KKH, 1998, J CELL BIOL, V141, P1291, DOI 10.1083/jcb.141.6.1291; Liersch R, 2006, BLOOD, V107, P1214, DOI 10.1182/blood-2005-08-3400; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Rodriguez-Niedenfuhr M, 2001, ANAT EMBRYOL, V204, P399, DOI 10.1007/s00429-001-0214-9; Shayan R, 2007, GROWTH FACTORS, V25, P417, DOI 10.1080/08977190801932550; SLEE JOHN, 1957, JOUR GENETICS, V55, P570, DOI 10.1007/BF02984073; SOROKIN L, 1994, EUR J BIOCHEM, V223, P603, DOI 10.1111/j.1432-1033.1994.tb19031.x; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4	33	375	384	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					643	669		10.1038/nature07391	http://dx.doi.org/10.1038/nature07391			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18931657				2022-12-01	WOS:000261340000042
J	Fleming, J; Brayne, C				Fleming, Jane; Brayne, Carol		CC75C Study Grp	Inability to get up after falling, subsequent time on floor, and summoning help: prospective cohort study in people over 90	BRITISH MEDICAL JOURNAL			English	Article							EMERGENCY RESPONSE SYSTEMS; OLDER-ADULTS; RISK-FACTORS; INJURIOUS FALLS; ELDERLY PEOPLE; COMMUNITY; HOME; PREVENTION; DEMENTIA; VIEWS	Objectives To describe the incidence and extent of lying on the floor for a long time after being unable to get up from a fall among people aged over 90; to explore their use of call alarm systems in these circumstances. Design 1 year follow- up of participants in a prospective cohort study of ageing, using fall calendars, phone calls, and visits. Setting Participants' usual place of residence ( own homes or care homes), mostly in Cambridge. Participants 90 women and 20 men aged over 90 ( n= 110), surviving participants of the Cambridge City over-75s Cohort, a population based sample. Main outcome measures Inability to get up without help, lying on floor for a long time after falling, associated factors; availability and use of call alarm systems; participants' views on using call alarms to summon help if needed after falling. Results In one year's intensive follow- up, 54% ( 144/ 265) of fall reports described the participant as being found on the floor and 82% ( 217/ 265) of falls occurred when the person was alone. Of the 60% who fell, 80% ( 53/ 66) were unable to get up after at least one fall and 30% ( 20/ 66) had lain on the floor for an hour or more. Difficulty in getting up was consistently associated with age, reported mobility, and severe cognitive impairment. Cognition was the only characteristic that predicted lyingonthe floor for a long time. Lying on the floor for a long time was strongly associated with serious injuries, admission to hospital, and subsequent moves into long term care. Call alarms were widely available but were not used in most cases of falls that led to lying on the floor for a long time. Comments from older people and carers showed the complexity of issues around the use of call alarms, including perceptions of irrelevance, concerns about independence, and practical difficulties. Conclusions Lying on the floor for a long time after falling is more common among the "oldest old" than previously thought and is associated with serious consequences. Factors indicating higher risk and comments from participants suggest practical implications. People need training in strategies to get up from the floor. Work is needed on access and activation issues for design of call	[Fleming, Jane; Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Fleming, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 0SR, England.	jane.fleming@phpc.cam.ac.uk; carol.brayne@medschl.cam.ac.uk	Brayne, Carol/AAA-4285-2020; Matthews, Fiona/O-6932-2015; Fleming, Jane/L-5300-2015; Dening, Tom/E-1335-2013	Brayne, Carol/0000-0001-5307-663X; Matthews, Fiona/0000-0002-1728-2388; Fleming, Jane/0000-0002-8127-2061; Dening, Tom/0000-0003-3387-4241	MRC [MC_U105292687] Funding Source: UKRI; Medical Research Council [MC_U105292687] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexander NB, 1997, J AM GERIATR SOC, V45, P564, DOI 10.1111/j.1532-5415.1997.tb03088.x; Asbjornsen G, 2000, Tidsskr Nor Laegeforen, V120, P3119; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Bergland A, 2005, AGING CLIN EXP RES, V17, P181; Bernstein M, 2000, Manag Care Q, V8, P38; Brownsell S, 2004, J TELEMED TELECARE, V10, P262, DOI 10.1258/1357633042026251; CAMERON ID, 1994, ARCH GERONTOL GERIAT, V19, P273, DOI 10.1016/0167-4943(94)00573-7; Demiris G, 2004, MED INFORM INTERNET, V29, P87, DOI 10.1080/14639230410001684387; FLEMING J, 2006, THESIS U CAMBRIDGE C; Fleming J, 2007, INT J EPIDEMIOL, V36, P40, DOI 10.1093/ije/dyl293; Fleming Jane, 2008, BMC Geriatr, V8, P6, DOI 10.1186/1471-2318-8-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill T, 2005, GERONTOLOGY, V51, P340, DOI 10.1159/000086372; Gooberman-Hill, 2004, REV CLIN GERONTOLOGY, V14, P63, DOI [10.1017/S0959259804001212, DOI 10.1017/S0959259804001212]; Halter M, 2000, FALLS OLDER POPULATI; Hofmeyer MR, 2002, J AM GERIATR SOC, V50, P1702, DOI 10.1046/j.1532-5415.2002.50463.x; HUPPERT FA, 1995, BRIT J CLIN PSYCHOL, V34, P529, DOI 10.1111/j.2044-8260.1995.tb01487.x; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Koski K, 1998, GERONTOLOGY, V44, P232, DOI 10.1159/000022017; LEVINE DA, 1995, MT SINAI J MED, V62, P293; Lindemann U, 2005, MED BIOL ENG COMPUT, V43, P548, DOI 10.1007/BF02351026; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P240, DOI 10.1111/j.1753-6405.1993.tb00143.x; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; Mann WC, 2005, ASSIST TECHNOL, V17, P82, DOI 10.1080/10400435.2005.10132098; Miskelly FG, 2001, AGE AGEING, V30, P455, DOI 10.1093/ageing/30.6.455; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; REECE A, 1996, PHYSIOTHERAPY, V82, P27; ROUSH RE, 1995, SOUTHERN MED J, V88, P917, DOI 10.1097/00007611-199509000-00006; Shaw FE, 1998, AGE AGEING, V27, P7, DOI 10.1093/ageing/27.1.7; SIMPSON JM, 1993, AGE AGEING, V22, P294, DOI 10.1093/ageing/22.4.294; Skelton D, 2005, AGE AGEING, V34, P636, DOI 10.1093/ageing/afi174; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; Yardley L, 2006, HEALTH EDUC RES, V21, P508, DOI 10.1093/her/cyh077; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650	36	165	167	1	21	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2008	337								a2227	10.1136/bmj.a2227	http://dx.doi.org/10.1136/bmj.a2227			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HP	19015185	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000262653800002
J	Verpy, E; Weil, D; Leibovici, M; Goodyear, RJ; Hamard, G; Houdon, C; Lefevre, GM; Hardelin, JP; Richardson, GP; Avan, P; Petit, C				Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Goodyear, Richard J.; Hamard, Ghislaine; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Richardson, Guy P.; Avan, Paul; Petit, Christine			Stereocilin-deficient mice reveal the origin of cochlear waveform distortions	NATURE			English	Article							OUTER HAIR-CELLS; TECTORIAL MEMBRANE; CHINCHILLA COCHLEA; BASILAR-MEMBRANE; TUNING CURVES; MECHANICS; RESPONSES; LINKS; MUTATIONS; EMISSIONS	Although the cochlea is an amplifier and a remarkably sensitive and finely tuned detector of sounds, it also produces conspicuous mechanical and electrical waveform distortions(1). These distortions reflect nonlinear mechanical interactions within the cochlea. By allowing one tone to suppress another ( masking effect), they contribute to speech intelligibility(2). Tones can also combine to produce sounds with frequencies not present in the acoustic stimulus(3). These sounds compose the otoacoustic emissions that are extensively used to screen hearing in newborns. Because both cochlear amplification and distortion originate from the outer hair cells - one of the two types of sensory receptor cells - it has been speculated that they stem from a common mechanism. Here we show that the nonlinearity underlying cochlear waveform distortions relies on the presence of stereocilin, a protein defective in a recessive form of human deafness(4). Stereocilin was detected in association with horizontal top connectors(5-7), lateral links that join adjacent stereocilia within the outer hair cell's hair bundle. These links were absent in stereocilin- null mutant mice, which became progressively deaf. At the onset of hearing, however, their cochlear sensitivity and frequency tuning were almost normal, although masking was much reduced and both acoustic and electrical waveform distortions were completely lacking. From this unique functional situation, we conclude that the main source of cochlear waveform distortions is a deflection- dependent hair bundle stiffness resulting from constraints imposed by the horizontal top connectors, and not from the intrinsic nonlinear behaviour of the mechanoelectrical transducer channel.	[Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] INSERM, UMRS 587, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Coll France, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Univ Paris 06, F-75015 Paris, France; [Goodyear, Richard J.; Richardson, Guy P.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Hamard, Ghislaine] Inst Cochin Genet Mol, F-75014 Paris, France; [Avan, Paul] Univ Auvergne, Lab Biophys Sensorielle, F-63001 Clermont Ferrand, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; University of Sussex; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Clermont Auvergne (UCA)	Petit, C (corresponding author), Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France.	everpy@pasteur.fr; cpetit@pasteur.fr	Leibovici, Michel/ABB-6745-2020; AVAN, Paul/J-6878-2015	AVAN, Paul/0000-0003-1054-1479; Petit, Christine/0000-0002-9069-002X	European Commission FP6 Integrated Project EuroHear,; Fondation Raymonde et Guy Strittmatter; Region Ile-de-France (Programme Sesame); Wellcome Trust	European Commission FP6 Integrated Project EuroHear,(European CommissionEuropean Commission Joint Research Centre); Fondation Raymonde et Guy Strittmatter; Region Ile-de-France (Programme Sesame)(Region Ile-de-France); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M. Lenoir, S. Guadagnini and M.-C. Prevost for advice on SEM; E. Perret and P. Roux for advice on confocal microscopy, S. Chardenoux, S. Nouaille and A. Mallet for technical help, Y. Lallemand for providing us with PGK- Cre m mice, N. Michalski for help with figure drawing and J. Boutet de Monvel for critical reading of the manuscript. This work was supported by the European Commission FP6 Integrated Project EuroHear, Fondation Raymonde et Guy Strittmatter, Region Ile-de-France (Programme Sesame), and the Wellcome Trust.	ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; Delgutte B., 1996, AUDITORY COMPUTATION, P157, DOI DOI 10.1007/978-1-4612-4070-9_5; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; FLOCK A, 1984, NATURE, V310, P597, DOI 10.1038/310597a0; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GOLDSTEIN JL, 1967, J ACOUST SOC AM, V41, P676, DOI 10.1121/1.1910396; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; KIM DO, 1980, J ACOUST SOC AM, V67, P1704, DOI 10.1121/1.384297; Kimura R S, 1966, Acta Otolaryngol, V61, P55, DOI 10.3109/00016486609127043; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lukashkin AN, 2004, J NEUROPHYSIOL, V91, P163, DOI 10.1152/jn.00680.2003; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Moore B. C. J., 1998, COCHLEAR HEARING LOS; Patuzzi R., 1996, COCHLEA, P186; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Robles L, 1997, J NEUROPHYSIOL, V77, P2385, DOI 10.1152/jn.1997.77.5.2385; RUGGERO MA, 1992, J NEUROPHYSIOL, V68, P1087, DOI 10.1152/jn.1992.68.4.1087; Tsuprun V, 2002, J HISTOCHEM CYTOCHEM, V50, P493, DOI 10.1177/002215540205000406; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726	34	96	98	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					255	U56		10.1038/nature07380	http://dx.doi.org/10.1038/nature07380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849963	Green Accepted			2022-12-01	WOS:000261039300043
J	Vincent, C; Aylin, P; Franklin, BD; Holmes, A; Iskander, S; Jacklin, A; Moorthy, K				Vincent, Charles; Aylin, Paul; Franklin, Bryony Dean; Holmes, Alison; Iskander, Sandra; Jacklin, Ann; Moorthy, Krishna			Is health care getting safer?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; PATIENT SAFETY; ERRORS		[Vincent, Charles; Iskander, Sandra] St Marys Hosp, Imperial Ctr Patient Safety & Serv Qual, Dept Biosurg & Technol, London W2 1NY, England; [Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol & Publ Hlth, London, England; [Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London, England; [Franklin, Bryony Dean; Holmes, Alison; Jacklin, Ann; Moorthy, Krishna] Imperial Coll Healthcare NHS Trust, Ctr Med Safety & Serv Qual, London, England; [Franklin, Bryony Dean; Jacklin, Ann] Univ London, Sch Pharm, London WC1N 1AX, England; [Moorthy, Krishna] Univ London Imperial Coll Sci Technol & Med, Clin Safety Res Unit, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of London; University College London; University of London School of Pharmacy; Imperial College London	Vincent, C (corresponding author), St Marys Hosp, Imperial Ctr Patient Safety & Serv Qual, Dept Biosurg & Technol, Praed St, London W2 1NY, England.	c.vincent@imperial.ac.uk	Vincent, Charles A/D-1134-2010; Aylin, Paul/A-1073-2014	Vincent, Charles A/0000-0003-0270-0222; Aylin, Paul/0000-0003-4589-1743; Moorthy, Krishna/0000-0001-8960-465X; Franklin, Bryony/0000-0002-2892-1245				Agency for Healthcare Research and Quality, 2008, QUAL IND; [Anonymous], 2003, 2003 REP NAT CONF EN; Audit Commission, 2004, INF DAT QUAL NHS KEY; Barber N, 2006, SAFER FASTER BETTER; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Bottle A., 2008, HLTH CARE RISK R MAY, P12; BOTTLE A, QUAL SAFETY IN PRESS; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; Department of Health National Audit Office, 2005, SAF PLAC PAT LEARN I; Franklin BD, 2005, DRUG SAFETY, V28, P891, DOI 10.2165/00002018-200528100-00005; Hansell A, 2001, J PUBLIC HEALTH MED, V23, P51, DOI 10.1093/pubmed/23.1.51; Health Protection Agency, 2006, MAND SURV HEALTHC AS; Healthcare Commission, 2007, HEALTHC ASS INF WHAT; *HLTH PROT AG, 2008, Q REP RES CLOS DIFF; Holmes AH, 2007, J HOSP INFECT, V65, P191, DOI 10.1016/S0195-6701(07)60042-5; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Neale G, 2001, J ROY SOC MED, V94, P322, DOI 10.1177/014107680109400702; O'Neill, 2008, SAFE BIRTHS EVERYBOD; *OFF NAT STAT, 2008, HLTH STAT Q, V37, P7; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; *SCOTT AUD SURG MO, 2008, PERC CAS ADV EV MAN; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Vincent C, 2006, PATIENT SAFETY	23	116	116	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 13	2008	337								a2426	10.1136/bmj.a2426	http://dx.doi.org/10.1136/bmj.a2426			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008272	Green Submitted			2022-12-01	WOS:000261784500010
J	Denny, CC; Emanuel, EJ				Denny, Colleen C.; Emanuel, Ezekiel J.			US Health Aid Beyond PEPFAR The Mother & Child Campaign	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MILLENNIUM DEVELOPMENT GOALS; COST-EFFECTIVENESS ANALYSIS; DEVELOPING-COUNTRIES; INTERVENTIONS; STRATEGIES; HIV/AIDS		[Denny, Colleen C.; Emanuel, Ezekiel J.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov		Denny, Colleen/0000-0001-5671-6540				Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; JAMISON DT, 2006, DIS CONTROL PRIORITI, pCH10; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; *OFF US GLOB AIDS, US PRES EM PLAN AIDS; SINGER P, 1972, PHILOS PUBLIC AFF, V1, P229; *UN AIDS, GLOB SUMM AIDS EP; *UNICEF, MILL DEV GOALS RED C; Varley RCG, 1998, B WORLD HEALTH ORGAN, V76, P617; WHO, WHY DO SO MAN WOM ST; *WHO, 2007, 310 WHO; *WHO, 2007, 104 WHO; WHO, WAT REL DIS; World Health Organization (WHO), CHOOS INT AR COST EF	15	36	37	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2048	2051		10.1001/jama.2008.556	http://dx.doi.org/10.1001/jama.2008.556			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984893				2022-12-01	WOS:000260605400027
J	McElrath, MJ; De Rosa, SC; Moodie, Z; Dubey, S; Kierstead, L; Janes, H; Defawe, OD; Carter, DK; Hural, J; Akondy, R; Buchbinder, SP; Robertson, MN; Mehrotra, DV; Self, SG; Corey, L; Shiver, JW; Casimiro, DR				McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Dubey, Sheri; Kierstead, Lisa; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Akondy, Rama; Buchbinder, Susan P.; Robertson, Michael N.; Mehrotra, Devan V.; Self, Steven G.; Corey, Lawrence; Shiver, John W.; Casimiro, Danilo R.		Step Study Protocol Team	HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis	LANCET			English	Article; Proceedings Paper	15th Conference on Retroviruses and Opportunistic Infections	FEB 03-06, 2008	Boston, MA				T-CELL RESPONSES; VIRAL LOAD; INFECTION; REPLICATION; DIVERSITY; SELECTION; TRIAL; IMMUNOGENICITY; PROLIFERATION; PROTECTION	Background In the Step Study, the MRKAd5 HIV-1 gag/pol/nef vaccine did not reduce plasma viraemia after infection, and HIV-1 incidence was higher in vaccine-treated than in placebo-treated men with pre-existing adenovirus serotype 5 (ALIS) immunity. We assessed vaccine-induced immunity and its potential contributions to infection risk. Methods To assess immunogenicity, we characterised HIV-specific T cells ex vivo with validated interferon-Y ELISPOT and intracelluilar cytokine staining assays, using a case-cohort design. To establish effects of vaccine and pre-existing Ad5 immunity on infection risk, we undertook flow cytometric studies to measure Ad5-specific T cells and circulating activated (Ki-67+/BcL-2(lo)) CD4+ T cells expressing CCR5. Findings We detected interferon-V-secreting HIV-specific T cells (range 1.63/106 to 686/106 peripheral blood mononuclear cells) ex vivo by ELISPOT in 77% (258/354) of people receiving vaccine; 218 of 354 (62%) recognised two to three HIV proteins. We identified HIV-specific CD4+ T cells by intracellular cytokine staining in 58 of 142 (41%) people. In those with reactive CD4+ T cells, the median percentage of CD4+ T cells expressing interleukin 2 was 88%, and the median co-expression of interferon y or tumor necrosis factor a (TNFa), or both, was 72%. We noted HIV-specific CD8+ T cells (range 0.4-1.0%) in 117 of 160 (73%) participants, expressing predominantly either interferon V alone or with TNFa. Vaccine-induced HIV-specific immunity, including response rate, magnitude, and cytokine profile, did not differ between vaccinated male cases (before infection) and non-cases. Ad5-specific T cells were lower in cases than in non-cases in several subgroup analyses. The percentage of circ it la ti jig Ki-67+BcL-2(lo)/CCR5+ CD4+ T cells did not differ between cases and non-cases. Interpretation Consistent with previous trials, the MRKAd5 HIV-1 gag/pol/nef vaccine was highly immunogenic for inducing HIV-specific CD8+ T cells. Our findings suggest that future candidate vaccines have to elicit responses that either exceed in magnitude or differ in breadth or function from those recorded in this trial. Funding National Institute of Allergy and Infectious Diseases, US National Institutes of Health; and Merck Research Laboratories.	[McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Self, Steven G.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Self, Steven G.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98109 USA; [McElrath, M. Juliana; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98195 USA; [McElrath, M. Juliana; De Rosa, Stephen C.; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Self, Steven G.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Akondy, Rama] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, HIV Res Sect, San Francisco, CA USA; [Dubey, Sheri; Kierstead, Lisa; Robertson, Michael N.; Mehrotra, Devan V.; Shiver, John W.; Casimiro, Danilo R.] Merck Res Labs, West Point, PA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; San Francisco Department of Public Health; Merck & Company	McElrath, MJ (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, 1100 Fairview Ave N,D3-100, Seattle, WA 98109 USA.	jmcelrat@fhcrc.org	Akondy, Rama/AAC-4656-2020; Corey, Lawrence/AAE-1796-2020; Frew, Paula M./B-4774-2012; Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019	Corey, Lawrence/0000-0002-2179-2436; Frew, Paula M./0000-0002-3078-9124; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Akondy, Rama/0000-0003-4737-5240	NCATS NIH HHS [UL1 TR000454] Funding Source: Medline; NIAID NIH HHS [P30 AI027757, U01 AI068618-03, U01 AI068618, U01 AI068614, U01 AI068614-03, U01 AI068614-02, U01 AI068618-01, U01 AI068614-01, U01 AI068618-02] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U01AI068614, U01AI068618] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BUCHBINDER SP, 2008, LANCET          1113, DOI DOI 10.1016/S0140-6736(08)61591-3; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Duerr A, 2006, CLIN INFECT DIS, V43, P500, DOI 10.1086/505979; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Li FS, 2007, CURR HIV RES, V5, P97, DOI 10.2174/157016207779316260; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; ROSENBLUM MG, 1989, CRIT REV IMMUNOL, V9, P21; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Shulman N, 2008, CYTOM PART A, V73A, P847, DOI 10.1002/cyto.a.20600; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Trinvuthipong C, 2004, SCIENCE, V303, P954; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	40	572	598	1	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1894	1905		10.1016/S0140-6736(08)61592-5	http://dx.doi.org/10.1016/S0140-6736(08)61592-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	379IA	19012957	Green Accepted			2022-12-01	WOS:000261388700024
J	Lin, GN; Xu, N; Xi, RW				Lin, Guonan; Xu, Na; Xi, Rongwen			Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells	NATURE			English	Article							EXPRESSION; ARMADILLO; NICHE; PROTEIN; MIDGUT; SHAGGY; ROLES; FATES	In the Drosophila midgut, multipotent intestinal stem cells (ISCs) that are scattered along the epithelial basement membrane maintain tissue homeostasis by their ability to steadily produce daughters that differentiate into either enterocytes or enteroendocrine cells, depending on the levels of Notch activity(1-3). However, the mechanisms controlling ISC self- renewal remain elusive. Here we show that a canonical Wnt signalling pathway controls ISC self-renewal. The ligand Wingless (Wg) is specifically expressed in the circular muscles next to ISCs, separated by a thin layer of basement membrane. Reduced function of wg causes ISC quiescence and differentiation, whereas wg overexpression produces excessive ISC- like cells that express high levels of the Notch ligand, Delta. Clonal analysis shows that the main downstream components of the Wg pathway, including Frizzled, Dishevelled and Armadillo, are autonomously required for ISC self- renewal. Furthermore, epistatic analysis suggests that Notch acts downstream of the Wg pathway and a hierarchy of Wg/Notch signalling pathways controls the balance between self- renewal and differentiation of ISCs. These data suggest that the underlying circular muscle constitutes the ISC niche, which produce Wg signals that act directly on ISCs to promote ISC self-renewal. This study demonstrates markedly conserved mechanisms regulating ISCs from Drosophila to mammals. The identification of the Drosophila ISC niche and the principal self- renewal signal will facilitate further understanding of intestinal homeostasis control and tumorigenesis.	[Lin, Guonan; Xu, Na; Xi, Rongwen] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Lin, Guonan] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Lin, Guonan] Chinese Acad Med Sci, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xi, RW (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	xirongwen@nibs.ac.cn			Chinese Ministry of Science and Technology [2007AA02Z1A2]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	We thank G. Struhl, L. Cooley, S. Hayashi, T. Xie, the Bloomington Stock Center for fly stocks, and members of the Xi laboratory for comments and discussions. This work was supported by an '863' grant 2007AA02Z1A2 to R.X. from the Chinese Ministry of Science and Technology.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen CM, 1999, DEVELOPMENT, V126, P5441; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Heslip TR, 1997, DEVELOPMENT, V124, P1069; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pai LM, 1997, DEVELOPMENT, V124, P2255; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	24	249	254	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1119	U11		10.1038/nature07329	http://dx.doi.org/10.1038/nature07329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806781				2022-12-01	WOS:000260252600047
J	Mokotoff, DM				Mokotoff, David M.			Remembering Earl	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dmok@tampabay.rr.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1853	1854		10.1001/jama.300.16.1853	http://dx.doi.org/10.1001/jama.300.16.1853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940964				2022-12-01	WOS:000260223100001
J	Sokol, DK				Sokol, Daniel K.			The harms of medicoplasty	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London St Georges Hosp, London, England	St Georges University London	Sokol, DK (corresponding author), Univ London St Georges Hosp, London, England.	daniel.sokol@talk21.com						Liao LM, 2007, BMJ-BRIT MED J, V334, P1090, DOI 10.1136/bmj.39206.422269.BE; 2008, BMJ, V337, pA1684	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1983	10.1136/bmj.a1983	http://dx.doi.org/10.1136/bmj.a1983			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18840633				2022-12-01	WOS:000259903300030
J	Varambally, S; Cao, Q; Mani, RS; Shankar, S; Wang, XS; Ateeq, B; Laxman, B; Cao, XH; Jing, XJ; Ramnarayanan, K; Brenner, JC; Yu, JD; Kim, JH; Han, B; Tan, P; Kumar-Sinha, C; Lonigro, RJ; Palanisamy, N; Maher, CA; Chinnaiyan, AM				Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Cao, Xuhong; Jing, Xiaojun; Ramnarayanan, Kalpana; Brenner, J. Chad; Yu, Jindan; Kim, Jung H.; Han, Bo; Tan, Patrick; Kumar-Sinha, Chandan; Lonigro, Robert J.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.			Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; H3 LYSINE-27 METHYLATION; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; ZESTE HOMOLOG-2; IN-VIVO; POLYCOMB; ENHANCER; EXPRESSION; TARGETS	Enhancer of zeste homolog 2 ( EZH2) is a mammalian histone methyltransferase that contributes to the epigenetic silencing of target genes and regulates the survival and metastasis of cancer cells. EZH2 is overexpressed in aggressive solid tumors by mechanisms that remain unclear. Here we show that the expression and function of EZH2 in cancer cell lines are inhibited by microRNA- 101 ( miR- 101). Analysis of human prostate tumors revealed that miR- 101 expression decreases during cancer progression, paralleling an increase in EZH2 expression. One or both of the two genomic loci encoding miR- 101 were somatically lost in 37.5% of clinically localized prostate cancer cells ( 6 of 16) and 66.7% of metastatic disease cells ( 22 of 33). We propose that the genomic loss of miR- 101 in cancer leads to overexpression of EZH2 and concomitant dysregulation of epigenetic pathways, resulting in cancer progression.	[Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Cao, Xuhong; Jing, Xiaojun; Brenner, J. Chad; Yu, Jindan; Kim, Jung H.; Han, Bo; Kumar-Sinha, Chandan; Lonigro, Robert J.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Jing, Xiaojun; Brenner, J. Chad; Yu, Jindan; Han, Bo; Kumar-Sinha, Chandan; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Kim, Jung H.; Lonigro, Robert J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ramnarayanan, Kalpana; Tan, Patrick; Palanisamy, Nallasivam] Genome Inst Singapore, Singapore 138672, Singapore; [Brenner, J. Chad; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Tan, Patrick] Natl Canc Ctr, Singapore 169610, Singapore; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Michigan System; University of Michigan; National Cancer Centre Singapore (NCCS); University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Ateeq, Bushra/I-3967-2019; Cao, Qi/A-5517-2010; Palanisamy, Nallasivam/ABC-8844-2020	Ateeq, Bushra/0000-0003-4682-9773; Cao, Qi/0000-0002-5140-3681; Palanisamy, Nallasivam/0000-0002-0633-9772; Varambally, Sooryanarayana/0000-0002-2277-1127; Mani, Ram/0000-0003-3552-7905; Kumar, Chandan/0000-0002-8696-3400	NIH (Prostate Specialized Program of Reasearch Excellence [P50CA69568]; Early Detection Research Network [UO1 111275]; U.S. Department of Defense Era of Hope Scholar [BC075023, PC051081, BC083217]; NIH postdoctoral training; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research; Canary Foundation; American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [K99CA129565, P50CA069568, U01CA111275] Funding Source: NIH RePORTER	NIH (Prostate Specialized Program of Reasearch Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; U.S. Department of Defense Era of Hope Scholar(United States Department of Defense); NIH postdoctoral training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research(Amgen); Canary Foundation; American Cancer Society Early Detection Postdoctoral Fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. M. Dhanasekaran, S. Tomlins, and J. Yu for helpful discussions; J. Siddiqui and M. Pandhi for technical assistance; and J. Granger and K. Giles for critically reading the manuscript. A. M. C. is supported by a Burroughs Welcome Foundation Award in Clinical Translational Research. This work was supported in part by NIH (Prostate Specialized Program of Reasearch Excellence grant P50CA69568 to A.M.C. and Early Detection Research Network grant UO1 111275 to A.M.C.) and the U.S. Department of Defense (Era of Hope Scholar grant BC075023 to A.M.C., PC051081 to A.M.C. and S.V., and BC083217 to J.C.B.). C.A.M. was supported by an NIH postdoctoral training grant and currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research and the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship. The microarray data used in this study have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus with the accession number GSE13286.	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Weikert S, 2005, INT J MOL MED, V16, P349; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016	27	816	903	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1695	1699		10.1126/science.1165395	http://dx.doi.org/10.1126/science.1165395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19008416	Green Accepted			2022-12-01	WOS:000261608300046
J	Holland, MD; Hastings, A				Holland, Matthew D.; Hastings, Alan			Strong effect of dispersal network structure on ecological dynamics	NATURE			English	Article							PERSISTENCE; SYNCHRONIZATION; LANDSCAPES; PREDATORS; CORRIDORS; STABILITY	A central question in ecology with great importance for management, conservation and biological control is how changing connectivity affects the persistence and dynamics of interacting species. Researchers in many disciplines have used large systems of coupled oscillators to model the behaviour of a diverse array of fluctuating systems in nature(1-4). In the well- studied regime of weak coupling, synchronization is favoured by increases in coupling strength and large- scale network structures ( for example 'small worlds') that produce short cuts and clustering(5-9). Here we show that, by contrast, randomizing the structure of dispersal networks in a model of predators and prey tends to favour asynchrony and prolonged transient dynamics, with resulting effects on the amplitudes of population fluctuations. Our results focus on synchronization and dynamics of clusters in models, and on time-scales, more appropriate for ecology, namely smaller systems with strong interactions outside the weak- coupling regime, rather than the better- studied cases of large, weakly coupled systems. In these smaller systems, the dynamics of transients and the effects of changes in connectivity can be well understood using a set of methods including numerical reconstructions of phase dynamics, examinations of cluster formation and the consideration of important aspects of cyclic dynamics, such as amplitude.	[Holland, Matthew D.; Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis	Holland, MD (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, 1 Shields Ave, Davis, CA 95616 USA.	mdholland@ucdavis.edu	Hastings, Alan/O-6864-2019	Hastings, Alan/0000-0002-0717-8026	Quantitative Environmental and Integrative Biology; National Science Foundation	Quantitative Environmental and Integrative Biology; National Science Foundation(National Science Foundation (NSF))	We thank M. Holyoak for comments on an earlier version of the manuscript and D. Wysham for discussions. M. D. H. was funded by a Quantitative Environmental and Integrative Biology grant to A. H. and M. Holyoak from the National Science Foundation.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; [Anonymous], 1999, SMALL WORLDS; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Cohen S. D., 1996, Computers in Physics, V10, P138; Comins HN, 1996, J THEOR BIOL, V183, P19, DOI 10.1006/jtbi.1996.0197; Crooks K.R., 2006, CONNECTIVITY CONSERV; CROWLEY PH, 1981, AM NAT, V118, P673, DOI 10.1086/283861; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; Hastings A, 2001, ECOL LETT, V4, P215, DOI 10.1046/j.1461-0248.2001.00220.x; Hilty J.A., 2006, CORRIDOR ECOLOGY SCI; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; Hong H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026139; Hudgens BR, 2003, AM NAT, V161, P808, DOI 10.1086/374343; Izhikevich, 2007, DYNAMICAL SYSTEMS NE; Jansen VAA, 2001, THEOR POPUL BIOL, V59, P119, DOI 10.1006/tpbi.2000.1506; Kuramoto, 1984, SPRINGER SERIES SYNE; MATTHEWS PC, 1991, PHYSICA D, V52, P293, DOI 10.1016/0167-2789(91)90129-W; McIntire EJB, 2007, J APPL ECOL, V44, P725, DOI 10.1111/j.1365-2664.2007.01326.x; Murdoch W. W., 2003, CONSUMER RESOURCE DY; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Smith S.W., 1997, SCI ENG GUIDE DIGITA; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winfree A.T., 2001, GEOMETRY BIOL TIME, DOI [10.1007/978-1-4757-3484-3, DOI 10.1007/978-1-4757-3484-3]	30	136	139	1	97	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					792	U76		10.1038/nature07395	http://dx.doi.org/10.1038/nature07395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18931656				2022-12-01	WOS:000261559900049
J	Allegranzi, B; Pittet, D				Allegranzi, Benedetta; Pittet, Didier			Preventing infections acquired during health-care delivery	LANCET			English	Editorial Material									[Allegranzi, Benedetta] WHO, Global Patient Safety Challenge 1, World Alliance Patient Safety, CH-1211 Geneva 27, Switzerland; [Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; [Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Pittet, Didier] Univ Geneva, Fac Med, Geneva, Switzerland	World Health Organization; University of Geneva; University of Geneva; World Health Organization; University of Geneva	Allegranzi, B (corresponding author), WHO, Global Patient Safety Challenge 1, World Alliance Patient Safety, CH-1211 Geneva 27, Switzerland.	allegranzib@who.int						Aboelela SW, 2007, J HOSP INFECT, V66, P101, DOI 10.1016/j.jhin.2006.10.019; ALLEGRANZI B, 2008, GENFOR GLOB ACC HLTH; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; *DEP HLTH, SAV LIV DEL PROGR; *HEALTHC COMM, 2008, ANN HLTH CHECK 2007; *HLTH PROT AG, 2008, LAT FIG SHOW MRSA BL; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; *LANC C, 2008, HEALTHC ASS INF MOV; Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006; Pittet D, 2005, LANCET INFECT DIS, V5, P242, DOI 10.1016/S1473-3099(05)70055-4; Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X; Pittet Didier, 2008, J Infect Public Health, V1, P4, DOI 10.1016/j.jiph.2008.08.006; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; *WHO, 2008, COUNTR COMM ADDR HAI; World Health Organisation (WHO), 2008, GLOB BURD DIS UPD 20	16	42	44	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1719	1720		10.1016/S0140-6736(08)61715-8	http://dx.doi.org/10.1016/S0140-6736(08)61715-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	19013310				2022-12-01	WOS:000261077900010
J	Fowler, JH; Schreiber, D				Fowler, James H.; Schreiber, Darren			Biology, Politics, and the Emerging Science of Human Nature	SCIENCE			English	Editorial Material							VOTER TURNOUT; HERITABILITY; BEHAVIOR; FMRI; PARTICIPATION; DEACTIVATE; ATTITUDES; COGNITION; ALTRUISM; AUTISM	In the past 50 years, biologists have learned a tremendous amount about human brain function and its genetic basis. At the same time, political scientists have been intensively studying the effect of the social and institutional environment on mass political attitudes and behaviors. However, these separate fields of inquiry are subject to inherent limitations that may only be resolved through collaboration across disciplines. We describe recent advances and argue that biologists and political scientists must work together to advance a new science of human nature.	[Fowler, James H.; Schreiber, Darren] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Fowler, JH (corresponding author), Univ Calif San Diego, Dept Polit Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhfowler@ucsd.edu	Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638				Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Aristotle, 1996, CAMBRIDGE TEXTS HIST; Baker LA, 2006, TWIN RES HUM GENET, V9, P933, DOI 10.1375/twin.9.6.933; BOHEM C, 1999, HIERARCHY FOREST EVO; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Byrne R., 1988, MACHIAVELLIAN INTELL; Campbell Angus., 1960, AM VOTER; CESARINI D, IN PRESS Q J EC; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; DAWES CT, IN PRESS J POLIT; DEWAAL F, 1982, CHIMPANZEE POLITICS; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Fowler JH, 2008, J POLIT, V70, P579, DOI 10.1017/S0022381608080638; Fowler JH, 2008, AM POLIT SCI REV, V102, P233, DOI 10.1017/S0003055408080209; Fowler JH, 2007, J POLIT, V69, P813, DOI 10.1111/j.1468-2508.2007.00577.x; Fowler JH, 2006, J POLIT, V68, P674, DOI 10.1111/j.1468-2508.2006.00453.x; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Hatemi PK, 2007, BEHAV GENET, V37, P435, DOI 10.1007/s10519-006-9138-8; HATEMI PK, IN PRESS POLIT RES Q; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lieberman MD, 2003, POLIT PSYCHOL, V24, P681, DOI 10.1046/j.1467-9221.2003.00347.x; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; Matsusaka JG, 1999, PUBLIC CHOICE, V98, P431, DOI 10.1023/A:1018328621580; MAY RM, 2006, NATURE, V440, P744; Olson JM, 2001, J PERS SOC PSYCHOL, V80, P845, DOI 10.1037/0022-3514.80.6.845; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Plutzer E, 2002, AM POLIT SCI REV, V96, P41, DOI 10.1017/S0003055402004227; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schreiber D, 2007, AFFECT EFFECT DYNAMI, P48; SETTLE JE, IN PRESS POLIT RES Q; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Westen D, 2006, J COGNITIVE NEUROSCI, V18, P1947, DOI 10.1162/jocn.2006.18.11.1947	37	126	127	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					912	914		10.1126/science.1158188	http://dx.doi.org/10.1126/science.1158188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	369DI	18988845				2022-12-01	WOS:000260674100038
J	de Jong, D; Vasmel, WLE; de Boer, JP; Verhave, G; Barbe, E; Casparie, MK; van Leeuwen, FE				de Jong, Daphne; Vasmel, Wies L. E.; de Boer, Jan Paul; Verhave, Gideon; Barbe, Ellis; Casparie, Mariel K.; van Leeuwen, Flora E.			Anaplastic Large-Cell Lymphoma in Women With Breast Implants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONCERTED ACTION BHM4-CT98-3936; SILICONE; CANCER; NATIONWIDE; PATHOLOGY; ADJACENT; RISK	Context Recently, we identified 2 patients with anaplastic large T- cell lymphoma ( ALCL) negative for tyrosine kinase anaplastic lymphoma kinase ( ALK- negative) in the fibrous capsule of silicone breast prostheses, placed for cosmetic reasons. Similar cases have been reported in the literature. Although an increased risk of ALCL in patients with breast prostheses has been speculated, no studies have been conducted so far. Objective To determine whether ALCL risk is associated with breast prostheses. Design A search for all patients with lymphoma in the breast diagnosed in the Netherlands between 1990 and 2006 was performed through the population- based nationwide pathology database. Subsequently, we performed an individually matched case- control study. Conditional logistic regression analysis was performed to estimate the relative risk of ALCL associated with breast prostheses. Setting and Patients Eleven patients with breast ALCL were identified in the registry. For each case patient with ALCL in the breast, we selected 1 to 5 controls with other lymphomas in the breast, matched on age and year of diagnosis. For all cases and controls ( n= 35), pathological and clinical information was obtained with special emphasis on the presence of a breast prosthesis. Main Outcome Measure Association between breast implants and ALCL of the breast. Results The 11 patients with ALCL of the breast were diagnosed between 1994 and 2006 at a median age of 40 years ( range, 24- 68 years). In 5 of these patients, bilateral silicone breast prostheses had been placed 1 to 23 years before diagnosis. All received prostheses for cosmetic reasons. Lymphoma classes of 35 eligible control patients were 12 diffuse large B- cell lymphomas, including 1 T- cell rich B- cell lymphoma; 5 Burkitt lymphomas; 10 mucosa- associated lymphoid tissue - type lymphoma; 3 follicular lymphomas; 3 peripheral T- cell lymphomas; and 2 indolent B- cell lymphomas, unclassified. One of 35 control patients had a breast implant placed before diagnosis of lymphoma. The odds ratio for ALCL associated with breast prostheses was 18.2 ( 95% confidence interval, 2.1- 156.8). Conclusions These preliminary findings suggest an association between silicone breast prostheses and ALCL, although the absolute risk is exceedingly low due to the rare occurrence of ALCL of the breast ( 11 cases in the Netherlands in 17 years). These findings require confirmation in other studies.	[de Jong, Daphne] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; [de Boer, Jan Paul] Netherlands Canc Inst, Dept Hematol, NL-1066 CX Amsterdam, Netherlands; [van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, NL-1066 CX Amsterdam, Netherlands; [Vasmel, Wies L. E.; Verhave, Gideon] St Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; [Barbe, Ellis] St Lucas Andreas Hosp, Dept Pathol, Amsterdam, Netherlands; [Casparie, Mariel K.] PALGA, Nationwide Network, Utrecht, Netherlands; [Casparie, Mariel K.] PALGA, Registry Histopathol & Cytopathol Netherlands, Utrecht, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Sint Lucas Andreas Hospital; Sint Lucas Andreas Hospital	de Jong, D (corresponding author), Netherlands Canc Inst, Dept Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.d.jong@nki.nl			Netherlands Cancer Institute	Netherlands Cancer Institute	This study was supported by the Netherlands Cancer Institute without external funding.	Angell M, 1996, NEW ENGL J MED, V334, P1513, DOI 10.1056/NEJM199606063342306; BRESLOW NE, 1980, IARC SCI PUBL, V1, P176; Brinton LA, 1997, J NATL CANCER I, V89, P1341, DOI 10.1093/jnci/89.18.1341; Brisson J, 2006, INT J CANCER, V118, P2854, DOI 10.1002/ijc.21711; BRONZHEIM I, 2004, BLOOD, V104, P3358; Casparie M, 2007, CELL ONCOL, V29, P19; COOK PD, 1995, AM J SURG PATHOL, V19, P712, DOI 10.1097/00000478-199506000-00012; DUVIC M, 1995, J AM ACAD DERMATOL, V32, P939, DOI 10.1016/0190-9622(95)91328-9; Evans PAS, 2007, LEUKEMIA, V21, P207, DOI 10.1038/sj.leu.2404479; Fritzsche FR, 2006, VIRCHOWS ARCH, V449, P561, DOI 10.1007/s00428-006-0287-1; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Gaudet G, 2002, LEUKEMIA LYMPHOMA, V43, P115, DOI 10.1080/10428190210189; Jaffe ES, 2001, PATHOLOGY GENETICS T, V3rd; Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105; Keech JA, 1997, PLAST RECONSTR SURG, V100, P554, DOI 10.1097/00006534-199708000-00065; Kleinrock L., 2003, AD HOC NETW, V1, P3; Kraemer DM, 2004, HAEMATOLOGICA, V89, pELT01; McLaughlin JK, 2006, J NATL CANCER I, V98, P557, DOI 10.1093/jnci/djj134; Newman MK, 2008, J PLAST RECONSTR AES, V61, P822, DOI 10.1016/j.bjps.2007.03.027; Roden AC, 2008, MODERN PATHOL, V21, P455, DOI 10.1038/modpathol.3801024; Sahoo Sunati, 2003, Arch Pathol Lab Med, V127, pe115; Said JW, 1996, BLOOD, V88, P3124, DOI 10.1182/blood.V88.8.3124.bloodjournal8883124; Shanklin DR, 1998, IMMUNOL RES, V18, P125, DOI 10.1007/BF02788777; van Diest PJ, 1998, J CLIN PATHOL, V51, P493, DOI 10.1136/jcp.51.7.493; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467	25	251	256	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2030	2035		10.1001/jama.2008.585	http://dx.doi.org/10.1001/jama.2008.585			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984890	Bronze			2022-12-01	WOS:000260605400023
J	Rooker, JR; Secor, DH; De Metrio, G; Schloesser, R; Block, BA; Neilson, JD				Rooker, Jay R.; Secor, David H.; De Metrio, Gregorio; Schloesser, Ryan; Block, Barbara A.; Neilson, John D.			Natal Homing and Connectivity in Atlantic Bluefin Tuna Populations	SCIENCE			English	Article							MARINE FISH; DELTA-C-13; OTOLITHS	Atlantic bluefin tuna populations are in steep decline, and an improved understanding of connectivity between individuals from eastern ( Mediterranean Sea) and western ( Gulf of Mexico) spawning areas is needed to manage remaining fisheries. Chemical signatures in the otoliths of yearlings from regional nurseries were distinct and served as natural tags to assess natal homing and mixing. Adults showed high rates of natal homing to both eastern and western spawning areas. Trans- Atlantic movement ( east to west) was significant and size- dependent, with individuals of Mediterranean origin mixing with the western population in the U. S. Atlantic. The largest ( oldest) bluefin tuna collected near the northern extent of their range in North American waters were almost exclusively of western origin, indicating that this region represents critical habitat for the western population.	[Rooker, Jay R.; Schloesser, Ryan] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77551 USA; [Secor, David H.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [De Metrio, Gregorio] Univ Bari, Dept Anim Hlth & Well Being, I-70010 Bari, Italy; [Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Neilson, John D.] St Andrews Biol Stn, Populat Ecol Sect, Dept Fisheries & Oceans, St Andrews, NB, Canada	Texas A&M University System; University System of Maryland; University of Maryland Center for Environmental Science; Universita degli Studi di Bari Aldo Moro; Stanford University; Fisheries & Oceans Canada	Rooker, JR (corresponding author), Texas A&M Univ, Dept Marine Biol, 5007 Ave U, Galveston, TX 77551 USA.	rookerj@tamug.edu	Secor, David H./D-4367-2012; Rooker, Jay/M-3197-2013	Secor, David H./0000-0001-6007-4827; Rooker, Jay/0000-0002-5934-7688; Schloesser, Ryan/0000-0002-1004-554X	NOAA Observer Program; NOAA (Southeast Fisheries Science Center and Saltonstall-Kennedy Program); International Fisheries Governance Program of Fisheries and Oceans Canada; Monterey Bay Aquarium; Tag-A-Giant Foundation; Large Pelagic Research Center (University of New Hampshire)	NOAA Observer Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA (Southeast Fisheries Science Center and Saltonstall-Kennedy Program)(National Oceanic Atmospheric Admin (NOAA) - USA); International Fisheries Governance Program of Fisheries and Oceans Canada; Monterey Bay Aquarium; Tag-A-Giant Foundation; Large Pelagic Research Center (University of New Hampshire)	We thank S. Campana, J. Graves, and R. D. Wells for insightful comments on earlier versions of the manuscript. Special thanks to A. Belmonte, A. Boustany, B. Campbell, A. Corriero, M. DeFlorio, D. Dettman, J. Kaufman, M. Lutcavage, E. Rodriguez-Marin, P. Mace, E. Prince, N. Santamaria, G. Skomal, M. Stokesbury, S. Teo, P. Thompson, S. Turner, V. Ticina, R. Wingate, NOAA Observer Program, T. F. M. Tuna Farms of the Mediterraneo S. L., Tuna Graso, S. A., and Fish and Fish Ltd. for their assistance. Funding for this study was provided by NOAA ( Southeast Fisheries Science Center and Saltonstall-Kennedy Program), the International Fisheries Governance Program of Fisheries and Oceans Canada, Monterey Bay Aquarium, Tag-A-Giant Foundation, and the Large Pelagic Research Center (University of New Hampshire).	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Ashford J, 2007, GEOCHIM COSMOCHIM AC, V71, P87, DOI 10.1016/j.gca.2006.08.030; BAKER JD, 1995, ANIM BEHAV, V50, P237, DOI 10.1006/anbe.1995.0236; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; CUSHING DH, 1995, POPULATION PRODUCTIO; Fonteneau A., 2007, COL VOL SCI PAP ICCA, V60, P1027; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Maffucci F, 2006, BIOL CONSERV, V127, P183, DOI 10.1016/j.biocon.2005.08.009; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; QUINN TP, 1993, FISH RES, V18, P29, DOI 10.1016/0165-7836(93)90038-9; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; TEA SLH, 2007, MAR BIOL BERLIN, V151, P1; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297	18	226	231	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					742	744		10.1126/science.1161473	http://dx.doi.org/10.1126/science.1161473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18832611				2022-12-01	WOS:000260605200049
J	Wang, Z; Smith, KS; Murphy, M; Piloto, O; Somervaille, TCP; Cleary, ML				Wang, Zhong; Smith, Kevin S.; Murphy, Mark; Piloto, Obdulio; Somervaille, Tim C. P.; Cleary, Michael L.			Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy	NATURE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; STEM-CELLS; BETA-CATENIN; PROTEIN; PROGENITORS; MENIN; PHOSPHORYLATES; REARRANGEMENTS; TRANSFORMATION; SPECIFICATION	Glycogen synthase kinase 3 ( GSK3) is a multifunctional serine/ threonine kinase that participates in numerous signalling pathways involved in diverse physiological processes. Several of these pathways are implicated in disease pathogenesis, which has prompted efforts to develop GSK3- specific inhibitors for therapeutic applications. However, before now, there has been no strong rationale for targeting GSK3 in malignancies. Here we report pharmacological, physiological and genetic studies that demonstrate an oncogenic requirement for GSK3 in the maintenance of a specific subtype of poor prognosis human leukaemia, genetically defined by mutations of the MLL proto- oncogene. In contrast to its previously characterized roles in suppression of neoplasia- associated signalling pathways, GSK3 paradoxically supports MLL leukaemia cell proliferation and transformation by a mechanism that ultimately involves destabilization of the cyclin- dependent kinase inhibitor p27(Kip1). Inhibition of GSK3 in a preclinical murine model of MLL leukaemia provides promising evidence of efficacy and earmarks GSK3 as a candidate cancer drug target.	[Wang, Zhong; Smith, Kevin S.; Murphy, Mark; Piloto, Obdulio; Somervaille, Tim C. P.; Cleary, Michael L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Cleary, ML (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu		Somervaille, Tim/0000-0002-9188-4379	Children's Health Initiative of the Packard Foundation; PHS [CA55029, CA116606]; Leukemia and Lymphoma Society; Williams Lawrence Foundation; Developmental Research Award from the Stanford Cancer Center; NATIONAL CANCER INSTITUTE [R01CA055029, R01CA116606] Funding Source: NIH RePORTER	Children's Health Initiative of the Packard Foundation; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Williams Lawrence Foundation; Developmental Research Award from the Stanford Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Roth for providing AKT constructs, P. J. Roach for providing GSK3 constructs, D. G. Gilliland for providing a TEL-AML1 construct, M. Iwasaki for NUP98-HOXA9 cells, M. Ambrus and C. Nicolas for technical assistance, and members of the Cleary laboratory for discussions. We acknowledge support from the Children's Health Initiative of the Packard Foundation, PHS grants CA55029 and CA116606, the Leukemia and Lymphoma Society, the Williams Lawrence Foundation and a Developmental Research Award from the Stanford Cancer Center.	AMLAK MG, 2002, BIOCHEM BIOPH RES CO, V297, P760; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; CHEN CS, 1993, BLOOD, V81, P2386; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Millar JBA, 2002, GENOME BIOL, V3; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Nickeleit I, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-13; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Smith KS, 1997, ONCOGENE, V14, P2917, DOI 10.1038/sj.onc.1201249; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	43	218	236	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1205	U29		10.1038/nature07284	http://dx.doi.org/10.1038/nature07284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18806775	Green Accepted			2022-12-01	WOS:000260462100036
J	Duncan, EM; Muratore-Schroeder, TL; Cook, RG; Garcia, BA; Shabanowitz, J; Hunt, DF; Allis, CD				Duncan, Elizabeth M.; Muratore-Schroeder, Tara L.; Cook, Richard G.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.; Allis, C. David			Cathepsin L Proteolytically Processes Histone H3 During Mouse Embryonic Stem Cell Differentiation	CELL			English	Article							CYSTEINE PROTEINASES; NUCLEAR-LOCALIZATION; CHROMATIN; METHYLATION; INHIBITOR; MARKS; HETEROCHROMATIN; IDENTIFICATION; PLURIPOTENCY; PROTEOLYSIS	Chromatin undergoes developmentally-regulated structural and chemical changes as cells differentiate, which subsequently lead to differences in cellular function by altering patterns of gene expression. To gain insight into chromatin alterations that occur during mammalian differentiation, we turned to a mouse embryonic stem cell (ESC) model. Here we show that histone H3 is proteolytically cleaved at its N-terminus during ESC differentiation. We map the sites of H3 cleavage and identify Cathepsin L as a protease responsible for proteolytically processing the N-terminal H3 tail. In addition, our data suggest that H3 cleavage may be regulated by covalent modifications present on the histone tail itself. Our studies underscore the intriguing possibility that histone proteolysis, brought about by Cathepsin L and potentially other family members, plays a role in development and differentiation that was not previously recognized.	[Muratore-Schroeder, Tara L.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Duncan, Elizabeth M.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Cook, Richard G.] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	University of Virginia; Rockefeller University; University of Virginia; Baylor College of Medicine	Hunt, DF (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.	dfh@virginia.edu; alliscd@rockefeller.edu	Duncan, Elizabeth/AAJ-3351-2020; Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; Duncan, Elizabeth/0000-0003-2003-6417	Rockefeller University; Starr Foundation; National Institutes of Health [GM37537, GM53512]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, R01GM049351, R37GM053512, R01GM037537] Funding Source: NIH RePORTER	Rockefeller University; Starr Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wysocka, T. Swigut, A. Ruthenburg, D. Shechter, L, Banaszynski, and B. Ueberheide for their advice on biochemical and ESC methods, and J. Wysocka and D. Shechter for their critical reading of the manuscript. Peptides were synthesized at the proteomics facilities at RU and Tufts. E. M. D. is an Anderson Cancer Center fellow (The Rockefeller University). This work was funded by institutional support from The Rockefeller University and grants from the Tri-Institutional Stem Cell Initiative (funded by the Starr Foundation) and National Institutes of Health Grants GM37537 (to D.F.H.) and GM53512 (to C.D.A.).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Barrett A.J., 2003, HDB PROTEOLYTIC ENZY; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Coon JJ, 2005, P NATL ACAD SCI USA, V102, P9463, DOI 10.1073/pnas.0503189102; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FALK MM, 1990, J VIROL, V64, P748, DOI 10.1128/JVI.64.2.748-756.1990; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Giadrossi S, 2007, CURR OPIN GENET DEV, V17, P132, DOI 10.1016/j.gde.2007.02.012; Goulet B, 2004, CELL CYCLE, V3, P986; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Hiwasa T, 1996, CANCER LETT, V99, P87, DOI 10.1016/0304-3835(95)04041-2; Ishidoh K, 1998, BIOCHEM BIOPH RES CO, V252, P202, DOI 10.1006/bbrc.1998.9613; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; MASON RW, 1989, BIOCHEM J, V257, P125, DOI 10.1042/bj2570125; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Morin V, 2008, J CELL PHYSIOL, V216, P790, DOI 10.1002/jcp.21459; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Riccio M, 2001, EXP CELL RES, V262, P84, DOI 10.1006/excr.2000.5085; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Smith AG., 1991, J TISSUE CULTURE MET, V13, P89, DOI [DOI 10.1007/BF01666137, 10.1007/BF01666137, 10.1007/bf01666137]; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Vogel JL, 2006, P NATL ACAD SCI USA, V103, P6817, DOI 10.1073/pnas.0602109103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028	45	250	259	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					284	294		10.1016/j.cell.2008.09.055	http://dx.doi.org/10.1016/j.cell.2008.09.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957203	Green Accepted, Bronze			2022-12-01	WOS:000260130400018
J	Soukup, V; Epperlein, HH; Horacek, I; Cerny, R				Soukup, Vladimir; Epperlein, Hans-Henning; Horacek, Ivan; Cerny, Robert			Dual epithelial origin of vertebrate oral teeth	NATURE			English	Article							CRANIAL NEURAL CREST; EVOLUTIONARY ORIGINS; TOOTH; DENTITIONS; ENDODERM; GENES; MOUTH; JAWS	The oral cavity of vertebrates is generally thought to arise as an ectodermal invagination(1,2). Consistent with this, oral teeth are proposed to arise exclusively from ectoderm, contributing to tooth enamel epithelium, and from neural crest derived mesenchyme, contributing to dentin and pulp(3-5). Yet in many vertebrate groups, teeth are not restricted only to the oral cavity(6-9), but extend posteriorly as pharyngeal teeth that could be derived either directly from the endodermal epithelium, or from the ectodermal epithelium that reached this location through the mouth or through the pharyngeal slits(6). However, when the oropharyngeal membrane, which forms a sharp ecto/ endodermal border(10), is broken, the fate of these cells is poorly known. Here, using transgenic axolotls with a combination of fate- mapping approaches, we present reliable evidence of oral teeth derived from both the ectoderm and endoderm and, moreover, demonstrate teeth with a mixed ecto/ endodermal origin. Despite the enamel epithelia having a different embryonic source, oral teeth in the axolotl display striking developmental uniformities and are otherwise identical. This suggests a dominant role for the neural crest mesenchyme over epithelia in tooth initiation and, from an evolutionary point of view, that an essential factor in teeth evolution was the odontogenic capacity of neural crest cells, regardless of possible 'outside-in'(11) or 'inside-out'(12) influx of the epithelium.	[Soukup, Vladimir; Horacek, Ivan; Cerny, Robert] Charles Univ Prague, Dept Zool, CR-12844 Prague, Czech Republic; [Epperlein, Hans-Henning] Tech Univ Dresden, Dept Anat, D-01307 Dresden, Germany	Charles University Prague; Technische Universitat Dresden	Cerny, R (corresponding author), Charles Univ Prague, Dept Zool, Vinicna 7, CR-12844 Prague, Czech Republic.	cerny8@natur.cuni.cz	Cerny, Robert/H-3801-2017; Horacek, Ivan/V-9741-2017; Soukup, Vladimir/G-3599-2014	Cerny, Robert/0000-0002-0022-0199; Horacek, Ivan/0000-0002-8356-5554; Soukup, Vladimir/0000-0002-1914-283X	Ministry of Youth, Education and Sport of the Czech Republic [MSMT 0021620828]; SMWK (Dresden); COST Action B23	Ministry of Youth, Education and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); SMWK (Dresden); COST Action B23	We wish to thank E. Tanaka and H. Andreas for supplying us with GFP axolotl embryos, L. Mchedlishvili for technical advice and O. Sebesta for help with confocal microscopy. We are grateful to M. Bronner-Fraser, R. Ericsson, D. Meulemans Medeiros, L. Olsson, P. D. Polly, D. W. Stock and A. Tucker for comments on the manuscript. Grants from the Ministry of Youth, Education and Sport of the Czech Republic (MSMT 0021620828), SMWK (Dresden) and COST Action B23 'Oral facial development and regeneration' are gratefully acknowledged.	Adams AE, 1924, J EXP ZOOL, V40, P311, DOI 10.1002/jez.1400400302; BARLOW LA, 1995, DEV BIOL, V169, P273, DOI 10.1006/dbio.1995.1143; Barlow LA, 1997, DEVELOPMENT, V124, P949; Cerny R, 2004, DEV BIOL, V276, P225, DOI 10.1016/j.ydbio.2004.08.046; Cerny R, 2004, DEV BIOL, V266, P252, DOI 10.1016/j.ydbio.2003.09.039; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chibon P., 1966, Memoires de la Societe Zoologique de France, V36, P1; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; Dickinson AJG, 2006, DEV BIOL, V295, P700, DOI 10.1016/j.ydbio.2006.03.054; Epperlein HH, 2000, DEVELOPMENT, V127, P2751; Fraser GJ, 2004, P ROY SOC B-BIOL SCI, V271, P2311, DOI 10.1098/rspb.2004.2878; HALL BK, 1947, P ROY SOC LOND B BIO, V134, P377; Huysseune A, 2002, CONNECT TISSUE RES, V43, P98, DOI 10.1080/03008200290000808; Imai H, 1998, EUR J ORAL SCI, V106, P19, DOI 10.1111/j.1600-0722.1998.tb02148.x; Jackman WR, 2004, DEV BIOL, V274, P139, DOI 10.1016/j.ydbio.2004.07.003; JANVIER P., 1996, EARLY VERTEBRATES; Kardong K.V., 1995, VERTEBRADOSANATOMIA; Mitsiadis TA, 2006, J EXP ZOOL PART B, V306B, P227, DOI 10.1002/jez.b.21094; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; REIF WE, 1982, EVOL BIOL, V15, P287; Reiss JO, 1997, J MORPHOL, V231, P63, DOI 10.1002/(SICI)1097-4687(199701)231:1<63::AID-JMOR6>3.0.CO;2-P; Romer A.S., 1962, VERTEBRATE BODY; Sharpe PT, 1995, CONNECT TISSUE RES, V32, P17, DOI 10.3109/03008209509013701; Sire JY, 2002, MICROSC RES TECHNIQ, V59, P408, DOI 10.1002/jemt.10220; Smith MM, 2003, SCIENCE, V299, P1235, DOI 10.1126/science.1079623; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; Smith MM, 2003, EVOL DEV, V5, P394, DOI 10.1046/j.1525-142X.2003.03047.x; Smith MM, 1998, EUR J ORAL SCI, V106, P482, DOI 10.1111/j.1600-0722.1998.tb02212.x; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Stock DW, 2001, PHILOS T R SOC B, V356, P1633, DOI 10.1098/rstb.2001.0917; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380	31	62	62	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					795	U6		10.1038/nature07304	http://dx.doi.org/10.1038/nature07304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18794902				2022-12-01	WOS:000259854900046
J	Henkind, SJ; Sinnett, JC				Henkind, Steven J.; Sinnett, J. Christopher			Patient care, square-rigger sailing, and safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TEAMWORK		[Henkind, Steven J.] CCI Grp, Larchmont, NY 10538 USA; [Sinnett, J. Christopher] US Coast Guard, US Coast Guard Barque Eagle, New London, CT USA		Henkind, SJ (corresponding author), CCI Grp, 7 S Ridge Rd, Larchmont, NY 10538 USA.	sjh37@verizon.net						Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Baker DP, 2005, JT COMM J QUAL PATIE, V31, P185, DOI 10.1016/S1553-7250(05)31025-7; Gawande Atul, 2007, New Yorker, P86; Grogan EL, 2004, J AM COLL SURGEONS, V199, P843, DOI 10.1016/j.jamcollsurg.2004.08.021; *HLTH SAF EX, 1996, PUBL OTO; *JCAHO, 2006, JT PERSPECTIVES PATI, V6, P9; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Morey JC, 2002, HEALTH SERV RES, V37, P1553, DOI 10.1111/1475-6773.01104; National Institute for Occupational Safety and Health, 2004, NIOSH PUBL, V2004-146; Okie S, 2007, NEW ENGL J MED, V356, P2665, DOI 10.1056/NEJMp078085; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; Pizzi L, 2001, AHRQ PUBLICATION; Salas E, 2001, HUM FACTORS, V43, P641, DOI 10.1518/001872001775870386; *US COAST GUARD, 1998, USCG PUBL; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645	15	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1691	1693		10.1001/jama.300.14.1691	http://dx.doi.org/10.1001/jama.300.14.1691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356YF	18840843				2022-12-01	WOS:000259812800031
J	Eckart, RE; Field, ME; Hruczkowski, TW; Forman, DE; Dorbala, S; Di Carli, MF; Albert, CE; Malsel, WH; Epstein, LM; Stevenson, WG				Eckart, Robert E.; Field, Michael E.; Hruczkowski, Tomasz W.; Forman, Daniel E.; Dorbala, Sharmila; Di Carli, Marcelo F.; Albert, Christine E.; Malsel, William H.; Epstein, Laurence M.; Stevenson, William G.			Association of electrocardiographic morphology of exercise-induced ventricular arrhythmia with mortality	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; OUTFLOW TRACT TACHYCARDIA; PROGNOSTIC VALUE; BRUGADA-SYNDROME; 12-LEAD ELECTROCARDIOGRAM; FRAGMENTED-QRS; HEART; PREDICTOR; ORIGIN; SCORE	Background: The prognostic importance of exercise-induced ventricular arrhythmia (EIVA) may be confounded by the presence of lower-risk idiopathic right ventricular outflow tract arrhythmias with left bundle-branch block (LBBB) morphology. Objective: To determine whether right bundle-branch block (RBBB)-morphology EIVA was associated with increased mortality. Design: Retrospective cohort. Setting: Academic medical center. Patients: 585 unique patients with EIVA and 2340 patients without EIVA, matched by age, sex, and risk factor, who were referred for exercise testing in an academic medical center. Measurements: Deaths and ischemia and infarction found on perfusion scan. Results: During a mean follow-up of 24 months (SD, 13), 31 deaths occurred in the EIVA group compared with 43 deaths in the group without EIVA (5.3% vs. 1.8%; P < 0.001). Worse survival in patients with RBBB-morphology or multiple-morphology EIVA (6.9%) than in patients without EIVA caused this difference. Patients with LBBB-morphology EIVAs had a mortality rate (2.5%) similar to that of patients without EIVA (P = 0.93, log-rank test). Among patients without known atherosclerotic coronary artery disease, any RBBB-morphology EIVA was associated with death (hazard ratio, 2.73 [95% CI, 1.78 to 4.13]; P < 0.001), but LBBB-morphology EIVA was not (hazard ratio, 0.82 [CI, 0.18 to 2.04]; P = 0.72). Limitations: Not all LBBB-morphology EIVA can be dismissed, and not all RBBB-morphology EIVA is high risk. Further evaluation of patients for structural heart disease was clinically driven, not protocol-driven. Conclusion: Right bundle-branch block-or multiple-morphology EIVA is associated with increased mortality. Inclusion of patients with isolated LBBB-morphology EIVA, which often is idiopathic, may contribute to differences in the prognostic importance of EIVA in previous studies.	[Eckart, Robert E.] Brooke Army Med Ctr, Arrhythmia Serv ATTN MCHE MDC, San Antonio, TX 78234 USA; Brigham & Womens Hosp, Boston Vet Adm Med Ctr, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Alberta, Edmonton, AB, Canada	San Antonio Military Medical Center; United States Department of Defense; United States Army; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; University of Alberta	Eckart, RE (corresponding author), Brooke Army Med Ctr, Arrhythmia Serv ATTN MCHE MDC, 3851 Roger Brooke Dr, San Antonio, TX 78234 USA.	robert.eckart@us.army.mil	Epstein, Laurence/AAQ-7571-2021; Epstein, Laurence/ABB-1592-2020	Epstein, Laurence/0000-0001-5410-0291; Albert, Christine/0000-0002-2081-1121	Medtronic; Boston Scientific; Biosense Webster	Medtronic(Medtronic); Boston Scientific(Boston Scientific); Biosense Webster	Honoraria: L. M. Epstein (Medtronic, Boston Scientific, St. Jude). Grants received: L. M. Epstein (Medtronic, Boston Scientific, Biosense Webster).	Bala R, 2007, HEART RHYTHM, V4, P366, DOI 10.1016/j.hrthm.2006.11.012; CALIFF RM, 1983, J AM COLL CARDIOL, V2, P1060, DOI 10.1016/S0735-1097(83)80330-1; Cerqueira MD, 2002, J NUCL CARDIOL, V9, P240, DOI 10.1067/mnc.2002.123122; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892; Das MK, 2007, HEART RHYTHM, V4, P1385, DOI 10.1016/j.hrthm.2007.06.024; Dixit S, 2003, J CARDIOVASC ELECTR, V14, P1, DOI 10.1046/j.1540-8167.2003.02404.x; FLEG JL, 1984, AM J CARDIOL, V54, P762, DOI 10.1016/S0002-9149(84)80204-0; Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353; GOY JJ, 1990, PACE, V13, P1142, DOI 10.1111/j.1540-8159.1990.tb02172.x; Hayashi M, 2008, J AM COLL CARDIOL, V51, P1162, DOI 10.1016/j.jacc.2007.11.050; Iwai S, 2006, J CARDIOVASC ELECTR, V17, P1052, DOI 10.1111/j.1540-8167.2006.00539.x; JADONATH RL, 1995, AM HEART J, V130, P1107, DOI 10.1016/0002-8703(95)90215-5; Josephson ME, 2005, HEART RHYTHM, V2, P443, DOI 10.1016/j.hrthm.2004.12.014; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; Kang XP, 2006, J AM COLL CARDIOL, V47, P1418, DOI 10.1016/j.jacc.2005.11.062; Kim RJ, 2007, J AM COLL CARDIOL, V49, P2035, DOI 10.1016/j.jacc.2007.01.085; Kwok JMF, 1999, JAMA-J AM MED ASSOC, V282, P1047, DOI 10.1001/jama.282.11.1047; Marchlinski FE, 2000, AM HEART J, V139, P1009, DOI 10.1067/mhj.2000.106164; MARIEB MA, 1990, AM J CARDIOL, V66, P172, DOI 10.1016/0002-9149(90)90583-M; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; MONT L, 1991, AM J CARDIOL, V68, P897, DOI 10.1016/0002-9149(91)90405-A; Morita H, 2003, J CARDIOVASC ELECTR, V14, P373, DOI 10.1046/j.1540-8167.2003.02365.x; Morshedi-Meibodi A, 2004, CIRCULATION, V109, P2417, DOI 10.1161/01.CIR.0000129762.41889.41; Nasir K, 2004, CIRCULATION, V110, P1527, DOI 10.1161/01.CIR.0000142293.60725.18; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; O'Neill JO, 2004, J AM COLL CARDIOL, V44, P820, DOI 10.1016/j.jacc.2004.02.063; OHARA GE, 1992, AM J CARDIOL, V70, P875, DOI 10.1016/0002-9149(92)90730-M; Ohkubo K, 2007, CIRC J, V71, P1258, DOI 10.1253/circj.71.1258; Tanner H, 2005, J AM COLL CARDIOL, V45, P418, DOI 10.1016/j.jacc.2004.10.037; Zweytick B, 2004, EUROPACE, V6, P123, DOI 10.1016/j.eupc.2003.11.010	31	21	23	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					451	W82		10.7326/0003-4819-149-7-200810070-00005	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18838725				2022-12-01	WOS:000260004400002
J	Wu, XY; Kodama, A; Fuchs, E				Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine			ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity	CELL			English	Article							MICROTUBULE PLUS-END; LINKING FACTOR MACF; CELL-MIGRATION; STRESS FIBERS; MOTILE CELLS; ACTIN; KINASE; PROTEINS; PROMOTES; SPECTRAPLAKINS	Coordinated interactions between microtubule (MT) and actin cytoskeletons are involved in many polarized cellular processes. Spectraplakins are enormous (>500 kDa) proteins able to bind both MTs and actin filaments (F-actin) directly. To elucidate the physiological significance and functions of mammalian spectraplakin ACF7, we've conditionally targeted it in skin epidermis. Intriguingly, ACF7 deficiency compromises the targeting of microtubules along F-actin to focal adhesions (FAs), stabilizes FA-actin networks, and impairs epidermal migration. Exploring underlying mechanisms, we show that ACF7's binding domains for F-actin, MTs, and MT plus-end proteins are not sufficient to rescue the defects in FA-cytoskeletal dynamics and migration functions of ACF7 null keratinocytes. We've uncovered an intrinsic actin-regulated ATPase domain in ACF7 and demonstrate that it is both functional and essential for these roles. Our findings provide insight into the functions of this important cytoskeletal crosslinking protein in regulating dynamic interactions between MTs and F-actin to sustain directional cell movement.	[Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		National Institutes of Health [R01-AR27883]; American Association for Cancer Research; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to Markus Schober, Mirna Perez-Moreno, Ellen Ezratty, and Michael Hack for discussion and helpful comments and to Ellen Wong, Maria Nikolova, June Racelis, Alison North, and Shivaprasad Bhuvanendran for their technical advice and assistance. We also thank William Earnshaw at University of Edinburgh for sharing reagents. The animal studies were performed with expert assistance from Lisa Polak and Nicole Stokes and were carried out in the Animal Lovers Against Animal Cruelty (ALAAC)-accredited LARC animal research facility at the Rockefeller University. This work was supported by a grant R01-AR27883 from the National Institutes of Health. E.F. is an investigator of the Howard Hughes Medical Institute. X.W. was an Anna D. Barker Fellow in Basic Cancer Research funded by the American Association for Cancer Research and is currently a postdoctoral fellow of the Jane Coffin Childs Memorial Fund for Medical Research.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bernier G, 2000, DEV DYNAM, V219, P216, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1041>3.0.CO;2-O; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Endlich N, 2007, CELL MOTIL CYTOSKEL, V64, P966, DOI 10.1002/cm.20237; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kogan Ilana, 2002, Methods Mol Med, V70, P143; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Sun DM, 2001, J CELL SCI, V114, P161; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X; Yarm F, 2001, CURR OPIN MICROBIOL, V4, P696, DOI 10.1016/S1369-5274(01)00271-5; Yvon AMC, 2000, J CELL BIOL, V151, P1003, DOI 10.1083/jcb.151.5.1003	56	209	221	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					137	148		10.1016/j.cell.2008.07.045	http://dx.doi.org/10.1016/j.cell.2008.07.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854161	Green Accepted, Bronze			2022-12-01	WOS:000259728100015
J	Medzhitov, R; Littman, D				Medzhitov, Ruslan; Littman, Dan			HIV immunology needs a new direction	NATURE			English	Editorial Material									[Medzhitov, Ruslan] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Littman, Dan] NYU, New York, NY 10016 USA	Yale University; New York University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, 300 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu; dan.littman@med.nyu.edu						Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012	3	21	23	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					591	591		10.1038/455591a	http://dx.doi.org/10.1038/455591a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833256				2022-12-01	WOS:000259639700022
J	Kaser, A; Lee, AH; Franke, A; Glickman, JN; Zeissig, S; Tilg, H; Nieuwenhuis, EES; Higgins, DE; Schreiber, S; Glimcher, LH; Blumberg, RS				Kaser, Arthur; Lee, Ann-Hwee; Franke, Andre; Glickman, Jonathan N.; Zeissig, Sebastian; Tilg, Herbert; Nieuwenhuis, Edward E. S.; Higgins, Darren E.; Schreiber, Stefan; Glimcher, Laurie H.; Blumberg, Richard S.			XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; PLASMA-CELL DIFFERENTIATION; UNFOLDED PROTEIN RESPONSE; ALPHA-DEFENSINS; CROHN-DISEASE; PANETH CELLS; GENOME; ASSOCIATION; ACTIVATION; EXPRESSION	Inflammatory bowel disease (IBD) has been attributed to aberrant mucosal immunity to the intestinal microbiota. The transcription factor XBP1, a key component of the endoplasmic reticulum (ER) stress response, is required for development and maintenance of secretory cells and linked to JNK activation. We hypothesized that a stressful environmental milieu in a rapidly proliferating tissue might instigate a proinflammatory response. We report that Xbp1 deletion in intestinal epithelial cells (IECs) results in spontaneous enteritis and increased susceptibility to induced colitis secondary to both Paneth cell dysfunction and an epithelium that is overly reactive to inducers of IBD such as bacterial products (flagellin) and TNF alpha. An association of XBP1 variants with both forms of human IBD (Crohn's disease and ulcerative colitis) was identified and replicated (rs35873774; p value 1.6 x 10(-5)) with novel, private hypomorphic variants identified as susceptibility factors. Hence, intestinal inflammation can originate solely from XBP1 abnormalities in IECs, thus linking cell-specific ER stress to the induction of organ-specific inflammation.	[Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kaser, Arthur; Zeissig, Sebastian; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA; [Glickman, Jonathan N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Franke, Andre; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Tilg, Herbert] Innsbruck Med Univ, Dept Med, Christian Doppler Res Lab Gut Inflammat, A-6020 Innsbruck, Austria; [Tilg, Herbert] Innsbruck Med Univ, Dept Med, Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria; [Nieuwenhuis, Edward E. S.] Erasmus MC Sophia Childrens Hosp, Div Pediat Gastroenterol, NL-3000 GE Rotterdam, Netherlands; [Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Medical University of Innsbruck; Medical University of Innsbruck; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 651 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu; rblumberg@partners.org	Franke, Andre/B-2151-2010; Zeissig, Sebastian/B-6297-2012; Longo, Kenneth A/A-5631-2010	Franke, Andre/0000-0003-1530-5811; Zeissig, Sebastian/0000-0001-5124-0897; 	Crohn's and Colitis Foundation of America; NIH [DK44319, P30 DK034854, AI32412, P01 AI56296]; Ellison Medical Foundation [CDA 1P50CA100707]; Austrian Science Fund; Max Kade Foundation; DFG/BMBF Excellence Cluster "Inflammation at Interfaces"; German Ministry of Education and Research (BMBF); PopGen Biobank; NATIONAL CANCER INSTITUTE [P50CA100707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412, P01AI056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R37DK044319, R01DK044319] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Austrian Science Fund(Austrian Science Fund (FWF)); Max Kade Foundation; DFG/BMBF Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG)Federal Ministry of Education & Research (BMBF)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); PopGen Biobank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. S. Robine and N. Davidson for VCre-ER<SUP>T2</SUP> mice; Dr. S. Ito for help with EM; Drs. J. Rioux, A. Ouelette, and M. Starnbach for helpful discussions; P. Gupta, B. Enrich, and D. Lindenbergh-Kortleve for technical support; and Dr. S. Snapper for critical reading of the manuscript. This work was supported by grants from the Crohn's and Colitis Foundation of America (R. S. B. and A. K.), NIH grants DK44319 (R. S. B.), P30 DK034854 (R. S. B.; Harvard Digestive Diseases Center), and AI32412 and P01 AI56296 (L. H. G.), the Ellison Medical Foundation (L. H. G.), CDA 1P50CA100707(A.- H. L.), the Austrian Science Fund (A. K. and H. T.), the Max Kade Foundation (A. K.), and the DFG/BMBF Excellence Cluster "Inflammation at Interfaces" (S. S. and A. F.). The authors wish to thank the patients, families, and physicians for their cooperation. The cooperativeness of the German Crohn and Colitis patient association (Deutsche Morbus Crohn und Colitis Vereinigung e. V.) and of the German "Kompetenznetz Darmerkrankungen'' are gratefully acknowledged. Genotyping in this study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the PopGen Biobank.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P513, DOI 10.1097/00054725-200409000-00004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Song F, 1999, J IMMUNOL, V162, P2275; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tashiro E, 2007, J ANTIBIOT, V60, P547, DOI 10.1038/ja.2007.69; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van de Wal Y, 2003, GASTROENTEROLOGY, V124, P1420, DOI 10.1016/S0016-5085(03)00219-1; Vermeire S, 2004, GUT, V53, P980, DOI 10.1136/gut.2003.034033; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	47	1006	1047	7	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					743	756		10.1016/j.cell.2008.07.021	http://dx.doi.org/10.1016/j.cell.2008.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775308	Green Accepted, Bronze			2022-12-01	WOS:000258947500015
J	Koerich, LB; Wang, XY; Clark, AG; Carvalho, AB				Koerich, Leonardo B.; Wang, Xiaoyun; Clark, Andrew G.; Carvalho, Antonio Bernardo			Low conservation of gene content in the Drosophila Y chromosome	NATURE			English	Article							SEX-CHROMOSOME; MELANOGASTER; GENOME; EVOLUTION; SEQUENCE; DEGENERATION; ELEMENTS; REGION; SCALE	Chromosomal organization is sufficiently evolutionarily stable that large syntenic blocks of genes can be recognized even between species as distantly related as mammals and puffer fish ( 450 million years (Myr) of divergence)(1-7). In Diptera, the gene content of the X chromosome and the autosomes is well conserved: in Drosophila more than 95% of the genes have remained on the same chromosome arm in the 12 sequenced species ( 63 Myr of divergence, traversing 400 Myr of evolution) 2,4,6, and the same linkage groups are clearly recognizable in mosquito genomes (260 Myr of divergence)(3,5,7). Here we investigate the conservation of Y- linked gene content among the 12 sequenced Drosophila species. We found that only a quarter of the Drosophila melanogaster Y- linked genes ( 3 out of 12) are Y- linked in all sequenced species, and that most of them ( 7 out of 12) were acquired less than 63 Myr ago. Hence, whereas the organization of other Drosophila chromosomes traces back to the common ancestor with mosquitoes, the gene content of the D. melanogaster Y chromosome is much younger. Gene losses are known to have an important role in the evolution of Y chromosomes(8-10), and we indeed found two such cases. However, the rate of gene gain in the Drosophila Y chromosomes investigated is 10.9 times higher than the rate of gene loss ( 95% confidence interval: 2.3 - 52.5), indicating a clear tendency of the Y chromosomes to increase in gene content. In contrast with the mammalian Y chromosome, gene gains have a prominent role in the evolution of the Drosophila Y chromosome.	[Koerich, Leonardo B.; Carvalho, Antonio Bernardo] Univ Fed Rio de Janeiro, Dept Genet, BR-21944970 Rio De Janeiro, Brazil; [Wang, Xiaoyun; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Universidade Federal do Rio de Janeiro; Cornell University	Carvalho, AB (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Caixa Postal 68011, BR-21944970 Rio De Janeiro, Brazil.	bernardo@biologia.ufrj.br	Koerich, Leonardo/J-7004-2014; Carvalho, Antonio/D-5402-2013; Koerich, Leonardo/B-8554-2008	Koerich, Leonardo/0000-0002-5668-3934; Carvalho, Antonio/0000-0001-8959-6469; Koerich, Leonardo/0000-0002-5668-3934; Clark, Andrew/0000-0001-7159-8511	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-CAPES; FAPERJ; FIC-NIH [TW007604-02]; NIH [GM64590]; FOGARTY INTERNATIONAL CENTER [R03TW007604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064590] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIC-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kumar, P. O'Grady, T. Markow, A. J. Bhutkar, S. C. Vaz, E. Betran, A. A. Peixoto, P. H. Krieger and P. Paiva for comments on the manuscript and/or for sharing their unpublished results. We also thank T. Pinhao, A. Bastos and F. Krsticevic for help with the experiments, K. Krishnamoorthy for statistical advice and M. Fetchko for help with GenBank submission. This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior- CAPES, FAPERJ, FIC-NIH grant TW007604-02 (A.B.C.) and NIH grant GM64590 (A.G.C.).	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; ASHBURNER M, 2005, DROSOPHILA LAB HDB, P607; Bachtrog D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r30; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; Bhutkar A, 2007, GENOME RES, V17, P1880, DOI 10.1101/gr.7062307; Carvalho AB, 2000, P NATL ACAD SCI USA, V97, P13239, DOI 10.1073/pnas.230438397; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; Carvalho AB, 2003, GENETICA, V117, P227, DOI 10.1023/A:1022900313650; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; CARVALHO AB, 2003, 44 ANN DROS RES C PH, P113; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; GEPNER J, 1993, P NATL ACAD SCI USA, V90, P11132, DOI 10.1073/pnas.90.23.11132; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; HACKSTEIN JHP, 1995, TRENDS GENET, V11, P195, DOI 10.1016/S0168-9525(00)89043-5; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; HURST LD, 1992, GENETICS, V130, P229; KENNISON JA, 1981, GENETICS, V98, P529; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Sturtevant AH, 1941, GENETICS, V26, P517; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Vibranovski MD, 2008, GENETICS, V179, P2325, DOI 10.1534/genetics.108.086819; YEATES DK, 2005, EVOLUTIONARY BIOL FL, P35; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	30	111	121	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					949	951		10.1038/nature07463	http://dx.doi.org/10.1038/nature07463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011613	Green Accepted			2022-12-01	WOS:000261768300045
J	Li, Y; Van Hooser, SD; Mazurek, M; White, LE; Fitzpatrick, D				Li, Ye; Van Hooser, Stephen D.; Mazurek, Mark; White, Leonard E.; Fitzpatrick, David			Experience with moving visual stimuli drives the early development of cortical direction selectivity	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; OCULAR DOMINANCE COLUMNS; RECEPTIVE-FIELDS; ORIENTATION MAPS; IN-VIVO; CORTEX; CAT; ORGANIZATION; KITTENS; SENSITIVITY	The onset of vision occurs when neural circuits in the visual cortex are immature, lacking both the full complement of connections(1,2) and the response selectivity that defines functional maturity(3,4). Direction- selective responses are particularly vulnerable to the effects of early visual deprivation, but it remains unclear how stimulus- driven neural activity guides the emergence of cortical direction selectivity. Here we report observations from a motion training protocol that allowed us to monitor the impact of experience on the development of direction- selective responses in visually naive ferrets. Using intrinsic signal imaging techniques, we found that training with a single axis of motion induced the rapid emergence of direction columns that were confined to cortical regions preferentially activated by the training stimulus. Using two- photon calcium imaging techniques, we found that single neurons in visually naive animals exhibited weak directional biases and lacked the strong local coherence in the spatial organization of direction preference that was evident in mature animals. Training with a moving stimulus, but not with a flashed stimulus, strengthened the direction- selective responses of individual neurons and preferentially reversed the direction biases of neurons that deviated from their neighbours. Both effects contributed to an increase in local coherence. We conclude that early experience with moving visual stimuli drives the rapid emergence of direction-selective responses in the visual cortex.	[Li, Ye; Van Hooser, Stephen D.; Mazurek, Mark; White, Leonard E.; Fitzpatrick, David] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [White, Leonard E.] Duke Univ, Sch Med, Dept Community & Family Med, Doctor Phys Therapy Div, Durham, NC 27710 USA; [Fitzpatrick, David] Duke Univ, Duke Inst Brain Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	fitzpat@neuro.duke.edu		Van Hooser, Stephen/0000-0002-1112-5832	Whitehall Foundation; US National Institutes of Health; NATIONAL EYE INSTITUTE [F32EY018064, P30EY005722, R01EY011488] Funding Source: NIH RePORTER	Whitehall Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank P. Kara, T. Mrsic-Flogel and A. Kerlin for help with two- photon imaging techniques, T. Tucker and J. Heiner for technical assistance and M. Christensson and the members of the Fitzpatrick lab for comments on the manuscript. This work was supported by grants from the Whitehall Foundation to L.E.W. and the US National Institutes of Health to D.F. and S.D.V.H.	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; DAW NW, 1978, SCIENCE, V199, P565, DOI 10.1126/science.622560; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Kawasaki H, 2004, J NEUROSCI, V24, P9962, DOI 10.1523/JNEUROSCI.2165-04.2004; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Shmuel A, 1996, J NEUROSCI, V16, P6945; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tanaka S, 2006, NEUROIMAGE, V30, P462, DOI 10.1016/j.neuroimage.2005.09.056; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Yao HS, 2007, NAT NEUROSCI, V10, P772, DOI 10.1038/nn1895; ZHOU YF, 1995, J NEUROSCI, V15, P689	30	129	131	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					952	956		10.1038/nature07417	http://dx.doi.org/10.1038/nature07417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18946471	Green Accepted			2022-12-01	WOS:000261768300046
J	Gowaty, PA; Serageldin, I; Persson, PE; Eldredge, N; Lynch, M; Nei, M; Kutschera, U; Akyol, M; Nesse, R; Greaves, M				Gowaty, Patricia Adair; Serageldin, Ismail; Persson, Per-Edvin; Eldredge, Niles; Lynch, Michael; Nei, Masatoshi; Kutschera, Ulrich; Akyol, Mustafa; Nesse, Randolph; Greaves, Mel			Darwin 200: Great expectations	NATURE			English	Editorial Material									[Gowaty, Patricia Adair] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Gowaty, Patricia Adair] Univ Calif Los Angeles, Inst Environm, Los Angeles, CA USA; [Serageldin, Ismail] New Lib Alexandria, Alexandria, Egypt; [Persson, Per-Edvin] Heureka, Finnish Sci Ctr, Vantaa, Finland; [Eldredge, Niles] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN USA; [Nei, Masatoshi] Penn State Univ, Inst Mol Evolut Genet, University Pk, PA 16802 USA; [Kutschera, Ulrich] Univ Kassel, Inst Biol, Kassel, Germany; [Nesse, Randolph] Univ Michigan, Ann Arbor, MI 48109 USA; [Greaves, Mel] Inst Canc Res, Sect Haematooncol, Sutton, Surrey, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; American Museum of Natural History (AMNH); Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universitat Kassel; University of Michigan System; University of Michigan; University of London; Institute of Cancer Research - UK									0	1	1	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2008	456	7220					317	318		10.1038/456317a	http://dx.doi.org/10.1038/456317a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020598	Green Submitted, Bronze			2022-12-01	WOS:000261039600020
J	Deary, I				Deary, Ian			Why do intelligent people live longer?	NATURE			English	Editorial Material							CHILDHOOD IQ; SOCIAL-CLASS; MORTALITY; RISK; LIFE		[Deary, Ian] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh	Deary, I (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland.	i.deary@ed.ac.uk	Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X	Medical Research Council [G0700704B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Batty GD, 2008, DIABETOLOGIA, V51, P436, DOI 10.1007/s00125-007-0908-5; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; BATTY GD, EPIDEMIOLOG IN PRESS; Deary I.J., 2001, INTELLIGENCE VERY SH, DOI [10.1093/actrade/9780192893215.001.0001, DOI 10.1093/ACTRADE/9780192893215.001.0001]; Deary IJ, 2008, PSYCHOL SCI, V19, P874, DOI 10.1111/j.1467-9280.2008.02171.x; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; OTOOLE BI, 1992, PERS INDIV DIFFER, V13, P699, DOI 10.1016/0191-8869(92)90241-G; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	11	102	104	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					175	176		10.1038/456175a	http://dx.doi.org/10.1038/456175a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	374JJ	19005537	Bronze			2022-12-01	WOS:000261039300019
J	Cotton, RGH; Auerbach, AD; Axton, M; Barash, CI; Berkovic, SF; Brookes, AJ; Burn, J; Cutting, G; den Dunnen, JT; Flicek, P; Freimer, N; Greenblatt, MS; Howard, HJ; Katz, M; Macrae, FA; Maglott, D; Moslein, G; Povey, S; Ramesar, RS; Richards, CS; Seminara, D; Smith, TD; Sobrido, MJ; Solbakk, JH; Tanzi, RE; Tavtigian, SV; Taylor, GR; Utsunomiya, J; Watson, M				Cotton, Richard G. H.; Auerbach, Arleen D.; Axton, Myles; Barash, Carol Isaacson; Berkovic, Samuel F.; Brookes, Anthony J.; Burn, John; Cutting, Garry; den Dunnen, Johan T.; Flicek, Paul; Freimer, Nelson; Greenblatt, Marc S.; Howard, Heather J.; Katz, Michael; Macrae, Finlay A.; Maglott, Donna; Moeslein, Gabriela; Povey, Sue; Ramesar, Rajkumar S.; Richards, Carolyn S.; Seminara, Daniela; Smith, Timothy D.; Sobrido, Maria-Jesus; Solbakk, Jan Helge; Tanzi, Rudolph E.; Tavtigian, Sean V.; Taylor, Graham R.; Utsunomiya, Joji; Watson, Michael			GENETICS The Human Variome Project	SCIENCE			English	Editorial Material									[Cotton, Richard G. H.; Howard, Heather J.; Smith, Timothy D.] Howard Florey Inst Expt Physiol & Med, Genom Disorders Res Ctr, Melbourne, Vic, Australia; [Berkovic, Samuel F.] Univ Melbourne, Austin Hlth W, Epilepsy Res Ctr, Heidelberg, Vic, Australia; [Freimer, Nelson] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Sobrido, Maria-Jesus] Fdn Publ Galega Med Xenomica, Santiago De Compostela, Spain; [Sobrido, Maria-Jesus] Inst Hlth Carlos III, Ctr Network Biomed Res Rare Dis CIBERER, Madrid, Spain; [Tanzi, Rudolph E.] Harvard Univ, Sch Med, Charlestown, MA USA; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA	Florey Institute of Neuroscience & Mental Health; Austin Research Institute; University of Melbourne; University of California System; University of California Los Angeles; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Harvard University; Harvard University; Massachusetts General Hospital	Cotton, RGH (corresponding author), Howard Florey Inst Expt Physiol & Med, Genom Disorders Res Ctr, Melbourne, Vic, Australia.	cotton@unimelb.edu.au	Tanzi, Rudolph/AAE-9622-2019; Axton, Myles/AAZ-4093-2020; dunnen, johan den/ABH-4228-2020; Ramesar, Raj S/I-6941-2015; Smith, Timothy/A-2873-2009	Tanzi, Rudolph/0000-0002-7032-1454; Axton, Myles/0000-0002-8042-4131; dunnen, johan den/0000-0002-6304-1710; Ramesar, Raj S/0000-0001-5688-1634; Smith, Timothy/0000-0001-9068-4642; Berkovic, Samuel/0000-0003-4580-841X; Auerbach, Arleen/0000-0002-6911-8379; Burn, John/0000-0002-9823-2322; Flicek, Paul/0000-0002-3897-7955	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044003] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37 DK044003-19, R37 DK044003] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2007, NAT GENET, V39, P423; Baraitser M, 2001, LONDON DYSMORPHOLOGY; COSTA T, 1985, AM J MED GENET, V21, P231, DOI 10.1002/ajmg.1320210205; Cotton RGH, 2007, NAT GENET, V39, P433, DOI 10.1038/ng2024; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Ring Huijun Z, 2006, Pharmacogenomics, V7, P969, DOI 10.2217/14622416.7.7.969	6	46	49	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					861	862		10.1126/science.1167363	http://dx.doi.org/10.1126/science.1167363			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988827	Green Accepted			2022-12-01	WOS:000260674100022
J	Okita, K; Nakagawa, M; Hong, HJ; Ichisaka, T; Yamanaka, S				Okita, Keisuke; Nakagawa, Masato; Hong, Hyenjong; Ichisaka, Tomoko; Yamanaka, Shinya			Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors	SCIENCE			English	Article							FIBROBLASTS; EXPRESSION; EFFICIENT; MYC	Induced pluripotent stem ( iPS) cells have been generated from mouse and human somatic cells by introducing Oct3/4 and Sox2 with either Klf4 and c-Myc or Nanog and Lin28 using retroviruses or lentiviruses. Patient- specific iPS cells could be useful in drug discovery and regenerative medicine. However, viral integration into the host genome increases the risk of tumorigenicity. Here, we report the generation of mouse iPS cells without viral vectors. Repeated transfection of two expression plasmids, one containing the complementary DNAs ( cDNAs) of Oct3/4, Sox2, and Klf4 and the other containing the c- Myc cDNA, into mouse embryonic fibroblasts resulted in iPS cells without evidence of plasmid integration, which produced teratomas when transplanted into mice and contributed to adult chimeras. The production of virus-free iPS cells, albeit from embryonic fibroblasts, addresses a critical safety concern for potential use of iPS cells in regenerative medicine.	[Okita, Keisuke; Nakagawa, Masato; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan; [Nakagawa, Masato; Hong, Hyenjong; Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Project, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp		Okita, Keisuke/0000-0001-5806-1090				Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	19	1438	1736	5	579	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					949	953		10.1126/science.1164270	http://dx.doi.org/10.1126/science.1164270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18845712				2022-12-01	WOS:000260674100049
J	Zhao, J; Sun, BK; Erwin, JA; Song, JJ; Lee, JT				Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.			Polycomb Proteins Targeted by a Short Repeat RNA to the Mouse X Chromosome	SCIENCE			English	Article							INACTIVE-X; XIST RNA; DOMAINS; RECRUITMENT; METHYLATION; TSIX	To equalize X- chromosome dosages between the sexes, the female mammal inactivates one of her two X chromosomes. X- chromosome inactivation ( XCI) is initiated by expression of Xist, a 17- kb noncoding RNA ( ncRNA) that accumulates on the X in cis. Because interacting factors have not been isolated, the mechanism by which Xist induces silencing remains unknown. We discovered a 1.6- kilobase ncRNA ( RepA) within Xist and identified the Polycomb complex, PRC2, as its direct target. PRC2 is initially recruited to the X by RepA RNA, with Ezh2 serving as the RNA binding subunit. The antisense Tsix RNA inhibits this interaction. RepA depletion abolishes full- length Xist induction and trimethylation on lysine 27 of histone H3 of the X. Likewise, PRC2 deficiency compromises Xist up- regulation. Therefore, RepA, together with PRC2, is required for the initiation and spread of XCI. We conclude that a ncRNA cofactor recruits Polycomb complexes to their target locus.	[Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Lee, Jeannie T.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02493 USA; [Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	lee@molbio.mgh.harvard.edu	Song, Ji-Joon/C-1721-2011	Erwin, Jennifer/0000-0002-6784-9290; Sun, Bryan/0000-0002-0740-0125	Massachusetts General Hospital Fund for Medical Discovery; NSF predoctoral award; Jane Coffin Childs Fellowship; NIH [R01GM58839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839, R01GM110090] Funding Source: NIH RePORTER	Massachusetts General Hospital Fund for Medical Discovery; NSF predoctoral award(National Science Foundation (NSF)); Jane Coffin Childs Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Spencer and Y. Jeon for unpublished data and technical advice and Y. Ogawa for critical reading of the manuscript. Grant support: Massachusetts General Hospital Fund for Medical Discovery (J.Z.), NSF predoctoral award (J.A.E.), Jane Coffin Childs Fellowship (J.J.S.), and NIH- R01GM58839 (J.T.L.). J.T.L. is an Investigator of the HHMI. The transcript WRepAW for Repeat A has GenBank accession number FJ361197.	BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sado T, 2001, DEVELOPMENT, V128, P1275; Schmitt S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-218; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	19	1200	1286	1	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					750	756		10.1126/science.1163045	http://dx.doi.org/10.1126/science.1163045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974356	Green Accepted			2022-12-01	WOS:000260605200052
J	Keown, P; Mercer, G; Scott, J				Keown, Patrick; Mercer, Gavin; Scott, Jan			Retrospective analysis of hospital episode statistics, involuntary admissions under the Mental Health Act 1983, and number of psychiatric beds in England 1996-2006	BRITISH MEDICAL JOURNAL			English	Article							CARE; REINSTITUTIONALISATION	Objective To analyse the number of voluntary and involuntary (detentions under the Mental Health Act 1983) admissions for mental disorders between 1996 and 2006 in England. Design Retrospective analysis. Setting England. Main outcome measures Number of voluntary and involuntary admissions for mental disorders in England's health service, number of involuntary admissions to private beds, and number of NHS beds for patients with mental disorders or learning disabilities. Results Admissions for mental disorders in the NHS in England peaked in 1998 and then started to fall. Reductions in admissions were confined to patients with depression, learning disabilities, or dementia. Admissions for schizophrenic and manic disorders did not change whereas those for drug and alcohol problems increased. The number of NHS psychiatric beds decreased by 29%. The total number of involuntary admissions per annum increased by 20%, with a threefold increase in the likelihood of admission to a private facility. Patients admitted involuntarily occupied 23% of NHS psychiatric beds in 1996 but 36% in 2006. Conclusions Psychiatric inpatient care changed considerably in the decade from 1996 to 2006, with more involuntary admissions to fewer NHS beds. The case mix has shifted further towards psychotic and substance misuse disorders, which has changed the milieu of inpatient wards. Increasing proportions of involuntary patients were admitted to private facilities.	[Keown, Patrick; Mercer, Gavin] NHS Ctr, E Community Mental Hlth Team, Newcastle Upon Tyne NE6 1SG, Tyne & Wear, England; [Scott, Jan] Royal Victoria Infirm, Univ Dept Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Keown, P (corresponding author), NHS Ctr, E Community Mental Hlth Team, Molineux St, Newcastle Upon Tyne NE6 1SG, Tyne & Wear, England.	p.j.keown@newcastle.ac.uk	Scott, Jan/F-2966-2010	Scott, Jan/0000-0002-7203-8601				Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Davidge M., 1993, SURVEY ENGLISH MENTA; *DEP HLTH, 2006, BED AV OCC; Glover G, 2006, BRIT J PSYCHIAT, V189, P441, DOI 10.1192/bjp.bp.105.020362; *INF CTR, 2007, INP FORM DET HOSP ME; JOHNSON S, 2005, BRIT MED J, V331, P4; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Priebe S, 2003, BRIT MED J, V326, P175, DOI 10.1136/bmj.326.7382.175; Wall S, 1999, BRIT MED J, V318, P1520, DOI 10.1136/bmj.318.7197.1520	9	48	48	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1837	10.1136/bmj.a1837	http://dx.doi.org/10.1136/bmj.a1837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18845592	Green Published, hybrid			2022-12-01	WOS:000260298800035
J	Boyer, P				Boyer, Pascal			Religion: Bound to believe?	NATURE			English	Editorial Material									[Boyer, Pascal] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Boyer, Pascal] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Boyer, P (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	pboyer@wustl.edu							0	101	103	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1038	1039		10.1038/4551038a	http://dx.doi.org/10.1038/4551038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	363FG	18948934	Bronze			2022-12-01	WOS:000260252600019
J	Galiana, G; Branca, RT; Jenista, ER; Warren, WS				Galiana, Gigi; Branca, Rosa T.; Jenista, Elizabeth R.; Warren, S. Warren			Accurate temperature imaging based on intermolecular coherences in magnetic resonance	SCIENCE			English	Article							PROTON CHEMICAL-SHIFT; SOLUTION NMR; INHOMOGENEOUS FIELDS; QUANTUM COHERENCES; HIGH-RESOLUTION; HYPERTHERMIA; WATER; SPECTROSCOPY; THERMOMETRY; LIPOSOMES	Conventional magnetic resonance methods that provide interior temperature profiles, which find use in clinical applications such as hyperthermic therapy, can develop inaccuracies caused by the inherently inhomogeneous magnetic field within tissues or by probe dynamics, and work poorly in important applications such as fatty tissues. We present a magnetic resonance method that is suitable for imaging temperature in a wide range of environments. It uses the inherently sharp resonances of intermolecular zero-quantum coherences, in this case flipping up a water spin while flipping down a nearby fat spin. We show that this method can rapidly and accurately assign temperatures in vivo on an absolute scale.	[Galiana, Gigi; Branca, Rosa T.; Jenista, Elizabeth R.; Warren, S. Warren] Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA; [Galiana, Gigi] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Duke University; Princeton University	Warren, WS (corresponding author), Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA.	warren.warren@duke.edu			NIH [EB2122, EB5979]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB005979, R01EB002122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by NIH grants EB2122 and EB5979. We thank M. Dewhirst for useful discussions.	Boss A, 2005, J MAGN RESON IMAGING, V22, P813, DOI 10.1002/jmri.20438; Chen Z, 2004, J AM CHEM SOC, V126, P446, DOI 10.1021/ja036491f; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; De Senneville BD, 2005, INT J HYPERTHER, V21, P515, DOI 10.1080/02656730500133785; Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668; Faber C, 2003, J MAGN RESON, V161, P265, DOI 10.1016/S1090-7807(03)00006-5; Gaber MH, 1996, INT J RADIAT ONCOL, V36, P1177, DOI 10.1016/S0360-3016(96)00389-6; Galiana G, 2005, J AM CHEM SOC, V127, P17574, DOI 10.1021/ja054463m; Gellermann J, 2005, INT J HYPERTHER, V21, P497, DOI 10.1080/02656730500070102; HE QH, 1993, J CHEM PHYS, V98, P6779, DOI 10.1063/1.464770; Hehr T, 2003, ONKOLOGIE, V26, P295, DOI 10.1159/000071628; Hekmatyar SK, 2005, MAGN RESON MED, V53, P294, DOI 10.1002/mrm.20345; HINDMAN JC, 1966, J CHEM PHYS, V44, P4582, DOI 10.1063/1.1726676; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Jones EL, 2005, J CLIN ONCOL, V23, P3079, DOI 10.1200/JCO.2005.05.520; Kong G, 2000, CANCER RES, V60, P4440; Kuroda K, 2000, MAGNET RESON MED, V43, P220, DOI 10.1002/(SICI)1522-2594(200002)43:2<220::AID-MRM8>3.0.CO;2-9; Lee S, 1996, J CHEM PHYS, V105, P874, DOI 10.1063/1.471968; Lin YY, 2000, PHYS REV LETT, V85, P3732, DOI 10.1103/PhysRevLett.85.3732; Lin YY, 2000, SCIENCE, V290, P118, DOI 10.1126/science.290.5489.118; McDannold N, 2004, RADIOLOGY, V230, P743, DOI 10.1148/radiol.2303021713; Needham D, 2000, CANCER RES, V60, P1197; Peters RD, 1999, MAGNET RESON MED, V41, P909, DOI 10.1002/(SICI)1522-2594(199905)41:5<909::AID-MRM9>3.0.CO;2-N; Raaphorst GP, 1990, INTRO PRACTICAL ASPE, P10; Rieke V, 2004, MAGNET RESON MED, V51, P1223, DOI 10.1002/mrm.20090; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Vathyam S, 1996, SCIENCE, V272, P92, DOI 10.1126/science.272.5258.92; WARREN WS, 1993, SCIENCE, V262, P2005, DOI 10.1126/science.8266096; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; [No title captured]; [No title captured]	32	54	56	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					421	424		10.1126/science.1163242	http://dx.doi.org/10.1126/science.1163242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927389	Green Accepted, Green Submitted			2022-12-01	WOS:000260094500041
J	Erlandson, KJ; Miller, SBM; Nam, Y; Osborne, AR; Zimmer, J; Rapoport, TA				Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.			A role for the two-helix finger of the SecA ATPase in protein translocation	NATURE			English	Article							ESCHERICHIA-COLI; PORE RESIDUES; CHANNEL; MEMBRANE; COMPLEX; MEDIATE; RECOGNITION; PROTEOLYSIS; HYDROLYSIS; PEPTIDASE	An important step in the biosynthesis of many proteins is their partial or complete translocation across the plasma membrane in prokaryotes or the endoplasmic reticulum membrane in eukaryotes(1). In bacteria, secretory proteins are generally translocated after completion of their synthesis by the interaction of the cytoplasmic ATPase SecA and a protein- conducting channel formed by the SecY complex(2). How SecA moves substrates through the SecY channel is unclear. However, a recent structure of a SecA - SecY complex raises the possibility that the polypeptide chain is moved by a two- helix finger domain of SecA that is inserted into the cytoplasmic opening of the SecY channel(3). Here we have used disulphide- bridge cross-linking to show that the loop at the tip of the two- helix finger of Escherichia coli SecA interacts with a polypeptide chain right at the entrance into the SecY pore. Mutagenesis demonstrates that a tyrosine in the loop is particularly important for translocation, but can be replaced by some other bulky, hydrophobic residues. We propose that the two- helix finger of SecA moves a polypeptide chain into the SecY channel with the tyrosine providing the major contact with the substrate, a mechanism analogous to that suggested for hexameric, protein- translocating ATPases.	[Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Nam, Yunsun/0000-0002-7939-8626; Zimmer, Jochen/0000-0002-8423-2882	NIH; Damon Runyon Cancer Research Foundation [DRG 1953-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. DeLaBarre and B. Burton for critical reading of the manuscript, and R. Sauer, T. Baker and A. Horwich for discussion. The work was supported by an NIH grant. T.A.R. is a HHMI investigator. Y.N. was supported by the Damon Runyon Cancer Research Foundation (DRG 1953-07)	Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JAROSIK GP, 1991, J BACTERIOL, V173, P860, DOI 10.1128/jb.173.2.860-868.1991; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; MATSUYAMA S, 1990, J BIOL CHEM, V265, P8760; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vrontou E, 2004, J BIOL CHEM, V279, P22490, DOI 10.1074/jbc.M401008200; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200	27	105	107	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					984	U67		10.1038/nature07439	http://dx.doi.org/10.1038/nature07439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923526	Green Submitted, Green Accepted			2022-12-01	WOS:000260038300054
J	Walsh, M; Spurling, G				Walsh, Maie; Spurling, Geoffrey			Aspirin in type 2 diabetes: is there any evidence base?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW-DOSE ASPIRIN; CARDIOVASCULAR EVENTS; PRIMARY PREVENTION; RANDOMIZED TRIALS; METAANALYSIS; MELLITUS; DISEASE		[Spurling, Geoffrey] Univ Queensland, Royal Brisbane Hosp, Discipline Gen Practice, Brisbane, Qld 4072, Australia; [Walsh, Maie] Univ Queensland, Royal Brisbane Hosp, Herston, Qld 4029, Australia	Royal Brisbane & Women's Hospital; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland	Spurling, G (corresponding author), Univ Queensland, Royal Brisbane Hosp, Discipline Gen Practice, Brisbane, Qld 4072, Australia.	g.spurling@uq.edu.au	Spurling, Geoffrey K/F-1783-2010	Spurling, Geoffrey K/0000-0002-3525-4663				Ajjan R, 2008, DIABETOLOGIA, V51, P385, DOI 10.1007/s00125-007-0898-3; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BUSE J, 1997, DIABETES CARE, V20, P1767; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Halushka MK, 2002, CIRCULATION, V105, P1620, DOI 10.1161/01.CIR.0000015422.86569.52; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; *MACR DIS EXP WORK, 2001, PREV DET MACR DIS TY; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; RYDEN L, EUR HEART J, V28, P88; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265	14	4	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2008	337								a1902	10.1136/bmj.a1902	http://dx.doi.org/10.1136/bmj.a1902			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FF	18927174				2022-12-01	WOS:000261027900002
J	Lupardus, PJ; Shen, A; Bogyo, M; Garcia, KC				Lupardus, Patrick J.; Shen, Aimee; Bogyo, Matthew; Garcia, K. Christopher			Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain	SCIENCE			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; BACTERIAL; CLEAVAGE; DEPENDS; MICE	Vibrio cholerae RTX (repeats in toxin) is an actin-disrupting toxin that is autoprocessed by an internal cysteine protease domain (CPD). The RTX CPD is efficiently activated by the eukaryote-specific small molecule inositol hexakisphosphate (InsP(6)), and we present the 2.1 angstrom structure of the RTX CPD in complex with InsP(6). InsP(6) binds to a conserved basic cleft that is distant from the protease active site. Biochemical and kinetic analyses of CPD mutants indicate that InsP(6) binding induces an allosteric switch that leads to the autoprocessing and intracellular release of toxin-effector domains.	[Shen, Aimee; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mbogyo@stanford.edu; kcgarcia@stanford.edu		Shen, Aimee/0000-0002-9786-5742; Bogyo, Matthew/0000-0003-3753-4412	Damon Runyon Cancer Research Foundation; NIH Keck Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Foundation; Searle Scholars Program; NIH National Technology Center for Networks and Pathways [U54RR020843]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH Keck Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Searle Scholars Program; NIH National Technology Center for Networks and Pathways(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank S. Juo for assistance with data collection and structure determination, E.D. Sandoval for assistance with kinetic analyses and helpful discussion, M. Blokech and G. Schoolnik for help with V. cholerae strain construction, and A. Guzzetta for intact mass analysis of SeMet-labeled CPD. P.J.L. is a Damon Runyon Fellow, supported by the Damon Runyon Cancer Research Foundation. K.C.G. is supported by the NIH Keck Foundation and the Howard Hughes Medical Institute. M.B. is supported by the Burroughs Wellcome Foundation, the Searle Scholars Program, and the NIH National Technology Center for Networks and Pathways (grant U54RR020843). P.J.L, A.S., M.B., and K.C.G. are listed as inventors on a patent application related to use of the V. cholerae RTX CPD for biotechnical applications. Coordinates and structure factors have been deposited in the Protein Data Bank (www.rcsb.org) under accession number 3EEB.	Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700	13	95	96	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					265	268		10.1126/science.1162403	http://dx.doi.org/10.1126/science.1162403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845756	Green Accepted			2022-12-01	WOS:000259902300050
J	Tang, JW; Settles, GS				Tang, J. W.; Settles, G. S.			Coughing and aerosols	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Settles, Gary S/D-5260-2009						0	52	52	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					E19	E19		10.1056/NEJMicm072576	http://dx.doi.org/10.1056/NEJMicm072576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843121				2022-12-01	WOS:000259903100010
J	Jacobsen, SJ; Cheetham, TC; Haque, R; Shi, JM; Loo, RK				Jacobsen, Steven J.; Cheetham, T. Craig; Haque, Reina; Shi, Jiaxiao M.; Loo, Ronald K.			Association between 5-alpha reductase inhibition and risk of hip fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; BENIGN PROSTATIC HYPERPLASIA; FINASTERIDE; MEN; TESTOSTERONE	Context For more than 15 years, 5-alpha reductase inhibitors, which block the conversion of testosterone to dihydrotestosterone, have been used in the treatment of benign prostatic hyperplasia ( BPH). Short- term studies show no effects of these agents on bone metabolism, but long- term data are not available. Objective To assess the association between use of 5-alpha reductase inhibitors ( eg, finasteride) for BPH and occurrence of hip fracture. Design, Setting, and Patients Population- based case- control study using data from Kaiser Permanente Southern California, a managed care organization with more than 3 million members. Case patients included 7076 men 45 years and older with incident hip fracture from 1997- 2006. Control patients were 7076 men without incident hip fracture, optimally matched at a 1: 1 ratio to case patients on age and medical center. Electronic information on pharmaceutical use was used to identify use of finasteride from 1991 forward. Results Overall, 2547 ( 36%) and 2488 ( 35%) case and control patients, respectively, had a diagnosis of BPH ( P=. 30), and 109 ( 1.5%) and 141 ( 2.0%) of case and control patients, respectively, had been exposed to finasteride prior to the index date ( matched odds ratio, 0.77; 95% confidence interval, 0.59- 1.00; P=. 04). There was no suggestion of a dose- response relationship between exposure to 5- alpha reductase inhibitors when the exposure was stratified into tertiles of total exposure ( P=. 12). By contrast, there was a slightly higher prevalence of alpha-blocker use in case vs control patients ( 32% vs 30%, respectively; P=. 04). Conclusions Exposure to 5-alpha reductase inhibitors was not associated with increased risk of hip fracture. The reduction in risk observed with exposure to 5-alpha reductase inhibitors and the modest increase in risk associated with exposure to alpha-blockers require replication and warrant further investigation.	[Jacobsen, Steven J.; Haque, Reina; Shi, Jiaxiao M.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Cheetham, T. Craig] Kaiser Permanente So Calif, Pharm Analyt Serv, Downey, CA USA; [Loo, Ronald K.] Kaiser Permanente So Calif, Dept Urol, Bellflower Med Ctr, Bellfower, CA USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Jacobsen, SJ (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, 100 S Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	steven.j.jacobsen@kp.org		Jacobsen, Steven/0000-0002-8174-8533	Kaiser Foundation Community Benefit; Southern California Permanente Medical Group	Kaiser Foundation Community Benefit; Southern California Permanente Medical Group	This study was supported through the Kaiser Foundation Community Benefit fund and the Southern California Permanente Medical Group.	Amory JK, 2004, J CLIN ENDOCR METAB, V89, P503, DOI 10.1210/jc.2003-031110; Andriole G, 2004, J UROLOGY, V172, P1399, DOI 10.1097/01.ju.0000139539.94828.29; AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; Bergstralh EJ, 1996, EPIDEMIOLOGY, V7, P331; CastroMagana M, 1996, J ANDROL, V17, P516; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clayman Ralph V, 2005, J Urol, V173, P1200; COLVARD DS, 1989, P NATL ACAD SCI USA, V86, P854, DOI 10.1073/pnas.86.3.854; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Djavan B, 1999, EUR UROL, V36, P1, DOI 10.1159/000019919; Issa S, 2002, J CLIN ENDOCR METAB, V87, P5401, DOI 10.1210/jc.2001-011902; JACOBSEN SJ, 1995, ARCH INTERN MED, V155, P477, DOI 10.1001/archinte.155.5.477; JACOBSEN SJ, 1990, AM J PUBLIC HEALTH, V80, P871, DOI 10.2105/AJPH.80.7.871; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; Matsumoto AM, 2002, J UROLOGY, V167, P2105, DOI 10.1016/S0022-5347(05)65095-1; Orwoll E, 2006, ARCH INTERN MED, V166, P2124, DOI 10.1001/archinte.166.19.2124; SANDLER RB, 1987, CALCIFIED TISSUE INT, V41, P65; Sobel V, 2006, J CLIN ENDOCR METAB, V91, P3017, DOI 10.1210/jc.2005-2809; Somjen D, 2007, J STEROID BIOCHEM, V107, P238, DOI 10.1016/j.jsbmb.2007.03.048; Tollin SR, 1996, J CLIN ENDOCR METAB, V81, P1031, DOI 10.1210/jc.81.3.1031; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe	22	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1660	1664		10.1001/jama.300.14.1660	http://dx.doi.org/10.1001/jama.300.14.1660			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356YF	18840839	Bronze			2022-12-01	WOS:000259812800027
J	Liu, OW; Chun, CD; Chow, ED; Chen, CB; Madhani, HD; Noble, SM				Liu, Oliver W.; Chun, Cheryl D.; Chow, Eric D.; Chen, Changbin; Madhani, Hiten D.; Noble, Suzanne M.			Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans	CELL			English	Article							SIGNATURE-TAGGED MUTAGENESIS; HUMAN-IMMUNODEFICIENCY-VIRUS; UDP-GLUCOSE DEHYDROGENASE; CENTRAL-NERVOUS-SYSTEM; INSERTIONAL MUTAGENESIS; YEAST; CELL; GENOME; ENZYME; STRESS	The fungus Cryptococcus neoformans is a leading cause of mortality and morbidity among HIV-infected individuals. We utilized the completed genome sequence and optimized methods for homologous DNA replacement using high-velocity particle bombardment to engineer 1201 gene knockout mutants. We screened this resource in vivo for proliferation in murine lung tissue and in vitro for three well-recognized virulence attributes-polysaccharide capsule formation, melanization, and growth at body temperature. We identified dozens of previously uncharacterized genes that affect these known attributes as well as 40 infectivity mutants without obvious defects in these traits. The latter mutants affect predicted regulatory factors, secreted proteins, and immune-related factors, and represent powerful tools for elucidating novel virulence mechanisms. In particular, we describe a GATA family transcription factor that inhibits phagocytosis by murine macrophages independently of the capsule, indicating a previously unknown mechanism of innate immune modulation.	[Liu, Oliver W.; Chun, Cheryl D.; Chow, Eric D.; Chen, Changbin; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Noble, Suzanne M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Noble, Suzanne M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,GH-N372C, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Noble, Suzanne/0000-0001-9855-8448; Madhani, Hiten/0000-0001-7400-6657	Herb and Marion Sandler Foundation; NIAID [R01AI065519]; Howard Hughes Medical Institute (HHMI); Host Defense Training Program [T32AI060537]; National Science Foundation; Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship; Stewart Family Trust; HHMI Postdoctoral Fellowship for Physicians; Burroughs-Wellcome Fund Career Development Award; NIH [K08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, R01AI065519] Funding Source: NIH RePORTER	Herb and Marion Sandler Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Host Defense Training Program; National Science Foundation(National Science Foundation (NSF)); Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship; Stewart Family Trust; HHMI Postdoctoral Fellowship for Physicians(Howard Hughes Medical Institute); Burroughs-Wellcome Fund Career Development Award(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to J. Lodge, C. Hull, J. Heitman, T. Kozel, and G. Cox for strains, reagents, training, and assistance with protocols, to S. O'Brien for assistance with bioinformatics, and to J. Cox and J. Brown for helpful discussion and comments on the manuscript. This work was supported by an Opportunity Grant from the Herb and Marion Sandler Foundation to H.D.M. and a grant from the NIAID (R01AI065519) to H.D.M. O.W.L. was supported by a Howard Hughes Medical Institute (HHMI) Predoctoral Fellowship and by the NIAID-sponsored UCSF Microbial Pathogenesis and Host Defense Training Program (T32AI060537). C.D.C. was supported by a National Science Foundation Predoctoral Fellowship. C.C. was supported by a Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship and a grant from the Stewart Family Trust. S.M.N. was supported by a HHMI Postdoctoral Fellowship for Physicians, a Burroughs-Wellcome Fund Career Development Award, and an NIH K08 award. O.W.L. and E.D.C. generated and profiled the deletion library. O.W.L. and C.C. reconstructed and retested deletion strains. C.C. constructed the overexpression strain and performed microarray experiments. C.D.C. and O.W.L. constructed double mutant strains and performed macrophage phagocytosis experiments. S.M.N. developed protocols for the STM assay, and provided reagents, training, and guidance. Strain requests should be addressed to H.D.M.	Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bader GD, 2003, TRENDS CELL BIOL, V13, P344, DOI 10.1016/S0962-8924(03)00127-2; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Bekondi C, 2006, INT J INFECT DIS, V10, P387, DOI 10.1016/j.ijid.2005.07.004; Belay T, 1997, INFECT IMMUN, V65, P718, DOI 10.1128/IAI.65.2.718-728.1997; Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chow ED, 2007, CURR GENET, V52, P137, DOI 10.1007/s00294-007-0147-9; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Fujimoto D, 2002, PHYSIOL MOL PLANT P, V61, P77, DOI 10.1006/pmpp.2002.0418; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Hull CM, 2004, INFECT IMMUN, V72, P3643, DOI 10.1128/IAI.72.6.3643-3645.2004; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; KOZEL TR, 1976, INFECT IMMUN, V14, P62, DOI 10.1128/IAI.14.1.62-67.1976; Liu OW, 2007, EUKARYOT CELL, V6, P630, DOI 10.1128/EC.00398-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Monari C, 2006, FEMS YEAST RES, V6, P537, DOI 10.1111/j.1567-1364.2006.00072.x; Moyrand F, 2004, EUKARYOT CELL, V3, P1601, DOI 10.1128/EC.3.6.1601-1608.2004; Moyrand F, 2004, EUKARYOT CELL, V3, P1513, DOI 10.1128/EC.3.6.1513-1524.2004; Nelson RT, 2001, GENETICS, V157, P935; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; Okabayashi K, 2007, MYCOPATHOLOGIA, V163, P1, DOI 10.1007/s11046-006-0083-0; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Siafakas AR, 2007, J BIOL CHEM, V282, P37508, DOI 10.1074/jbc.M707913200; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Warnock DW, 2006, MED MYCOL, V44, P697, DOI 10.1080/13693780601009493	46	307	315	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					174	188		10.1016/j.cell.2008.07.046	http://dx.doi.org/10.1016/j.cell.2008.07.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854164	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000259728100018
J	Blau, HM				Blau, Helen M.			Cell therapies for muscular dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS; TRANSPLANTATION		[Blau, Helen M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282	5	20	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1403	1405		10.1056/NEJMcibr0805708	http://dx.doi.org/10.1056/NEJMcibr0805708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815403				2022-12-01	WOS:000259440900015
J	Tzemos, N; Therrien, J; Yip, J; Thanassoulis, G; Tremblay, S; Jamorski, MT; Webb, GD; Siu, SC				Tzemos, Nikolaos; Therrien, Judith; Yip, James; Thanassoulis, George; Tremblay, Sonia; Jamorski, Michal T.; Webb, Gary D.; Siu, Samuel C.			Outcomes in adults with bicuspid aortic valves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASCENDING AORTA; NATURAL-HISTORY; HEART-DISEASE; FOLLOW-UP; STENOSIS; DILATATION; COARCTATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; PREDICTORS	Context Bicuspid aortic valve is the most common congenital cardiac anomaly in the adult population. Cardiac outcomes in a contemporary population of adults with bicuspid aortic valve have not been systematically determined. Objective To determine the frequency and predictors of cardiac outcomes in a large consecutive series of adults with bicuspid aortic valve. Design, Setting, and Participants Cohort study examining cardiac outcomes in 642 consecutive ambulatory adults ( mean [ SD] age, 35 [ 16] years; 68% male) with bicuspid aortic valve presenting to a Canadian congenital cardiac center from 1994 through 2001 and followed up for a mean ( SD) period of 9 ( 5) years. Frequency and predictors of major cardiac events were determined by multivariate analysis. Mortality rate in the study group was compared with age- and sex- matched population estimates. Main Outcome Measures Mortality and cause of death were determined. Primary cardiac events were defined as the occurrence of any of the following complications: cardiac death, intervention on the aortic valve or ascending aorta, aortic dissection or aneurysm, or congestive heart failure requiring hospital admission during the follow- up period. Results During the follow- up period, there were 28 deaths ( mean [ SD], 4% [ 1%]). One or more primary cardiac events occurred in 161 patients ( mean [ SD], 25% [ 2%]), which included cardiac death in 17 patients ( mean [ SD], 3% [ 1%]), intervention on aortic valve or ascending aorta in 142 patients ( mean [ SD], 22% [ 2%]), aortic dissection or aneurysm in 11 patients ( mean [ SD], 2% [ 1%]), or congestive heart failure requiring hospital admission in 16 patients ( mean [ SD], 2% [ 1%]). Independent predictors of primary cardiac events were age older than 30 years ( hazard ratio [ HR], 3.01; 95% confidence interval [ CI], 2.15- 4.19; P <. 001), moderate or severe aortic stenosis ( HR, 5.67; 95% CI, 4.16- 7.80; P <. 001), and moderate or severe aortic regurgitation ( HR, 2.68; 95% CI, 1.93- 3.76; P <. 001). The 10- year survival rate of the study group ( mean [ SD], 96% [ 1%]) was not significantly different from population estimates ( mean [ SD], 97% [ 1%]; P=. 71). At last follow- up, 280 patients ( mean [ SD], 45% [ 2%]) had dilated aortic sinus and/ or ascending aorta. Conclusions In this study population of young adults with bicuspid aortic valve, age, severity of aortic stenosis, and severity of aortic regurgitation were independently associated with primary cardiac events. Over the mean follow- up duration of 9 years, survival rates were not lower than for the general population.	[Siu, Samuel C.] Univ Western Ontario Hosp, Div Cardiol, London, ON N6A 5A5, Canada; [Tzemos, Nikolaos; Jamorski, Michal T.; Siu, Samuel C.] Univ Toronto, Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Tzemos, Nikolaos; Jamorski, Michal T.; Siu, Samuel C.] Univ Toronto, Univ Hlth Network, Toronto Congenital Cardiac Ctr Adults, Toronto, ON, Canada; [Yip, James] Natl Univ Singapore Hosp, Singapore 117548, Singapore; [Therrien, Judith; Thanassoulis, George; Tremblay, Sonia] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Dept Med, Montreal, PQ, Canada; [Webb, Gary D.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia Adult Congenital Heart Ctr, Dept Med, Philadelphia, PA 19104 USA; [Siu, Samuel C.] Univ Western Ontario, Div Cardiol, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Toronto Congenital Cardiac Centre for Adults; University Toronto Affiliates; University Health Network Toronto; National University of Singapore; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Western University (University of Western Ontario)	Siu, SC (corresponding author), Univ Western Ontario Hosp, Div Cardiol, C6-005,339 Windermere Rd, London, ON N6A 5A5, Canada.	Samuel.Siu@lhsc.on.ca	Siu, Sam C/G-3346-2011	Siu, Sam C/0000-0002-1104-3669	University of Toronto Department of Medicine; Fonds de Recherche en Sante du Quebec; Canadian Institutes of Health Research [53130]; Heart and Stroke Foundation of Canada [NA5662]	University of Toronto Department of Medicine(University of Toronto); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	Dr Tzemos was partially supported by a fellowship grant from the University of Toronto Department of Medicine. Dr Thanassoulis was supported by a research fellowship from the Fonds de Recherche en Sante du Quebec. The study was supported by operating grants from the Canadian Institutes of Health Research (grant 53130) and the Heart and Stroke Foundation of Canada (grant NA5662).	Aboulhosn J, 2006, CIRCULATION, V114, P2412, DOI 10.1161/CIRCULATIONAHA.105.592089; Bireley WR, 2007, J MAGN RESON IMAGING, V26, P1480, DOI 10.1002/jmri.21085; Bonderman D, 1999, CIRCULATION, V99, P2138, DOI 10.1161/01.CIR.99.16.2138; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; FENOGLIO JJ, 1977, AM J CARDIOL, V39, P164, DOI 10.1016/S0002-9149(77)80186-0; Ferencik M, 2003, AM J CARDIOL, V92, P43, DOI 10.1016/S0002-9149(03)00462-4; Fernandes SM, 2004, J AM COLL CARDIOL, V44, P1648, DOI 10.1016/j.jacc.2004.05.063; Fernandes SM, 2007, J AM COLL CARDIOL, V49, P2211, DOI 10.1016/j.jacc.2007.01.090; Gurvitz M, 2004, AM J CARDIOL, V94, P1337, DOI 10.1016/j.amjcard.2004.07.130; Hager A, 2004, CHEST, V126, P1169, DOI 10.1378/chest.126.4.1169; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; Keane MG, 2000, CIRCULATION, V102, P35; Konen E, 2004, AM J ROENTGENOL, V182, P1333, DOI 10.2214/ajr.182.5.1821333; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LINDSAY J, 1988, AM J CARDIOL, V61, P182, DOI 10.1016/0002-9149(88)91327-6; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; Manuel DG, 2003, CAN J CARDIOL, V19, P997; Matura LA, 2007, CIRCULATION, V116, P1663, DOI 10.1161/CIRCULATIONAHA.106.685487; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; MILLS P, 1978, BRIT HEART J, V40, P951; Nistri S, 1999, HEART, V82, P19, DOI 10.1136/hrt.82.1.19; Nkomo VT, 2003, ARTERIOSCL THROM VAS, V23, P351, DOI 10.1161/01.ATV.0000055441.28842.0A; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Sabet HY, 1999, MAYO CLIN PROC, V74, P14, DOI 10.4065/74.1.14; Schaefer BM, 2007, AM J CARDIOL, V99, P686, DOI 10.1016/j.amjcard.2006.09.118; THANASSOULIS G, IN PRESS NAT CLIN PR; Therrien J, 2001, CAN J CARDIOL, V17, P1029; Tutar E, 2005, AM HEART J, V150, P513, DOI 10.1016/j.ahj.2004.10.036; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Weyman AE, 1994, PRINCIPLES PRACTICE, P1289; Yap SC, 2007, INT J CARDIOL, V122, P224, DOI 10.1016/j.ijcard.2006.11.092; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	37	389	413	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1317	1325		10.1001/jama.300.11.1317	http://dx.doi.org/10.1001/jama.300.11.1317			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799444	Bronze			2022-12-01	WOS:000259231100027
J	Ramachandran, V; Chen, XM				Ramachandran, Vanitharani; Chen, Xuemei			Degradation of microRNAs by a family of exoribonucleases in Arabidopsis	SCIENCE			English	Article							RIBOSOMAL-RNA; 5.8S; METHYLATION; PROTEIN; YEAST; ERI1	microRNAs ( miRNAs) play crucial roles in numerous developmental and metabolic processes in plants and animals. The steady- state levels of miRNAs need to be properly controlled to ensure normal development. Whereas the framework of miRNA biogenesis is established, factors involved in miRNA degradation remain unknown. Here, we show that a family of exoribonucleases encoded by the SMALL RNA DEGRADING NUCLEASE ( SDN) genes degrades mature miRNAs in Arabidopsis. SDN1 acts specifically on single- stranded miRNAs in vitro and is sensitive to the 2'-O-methyl modification on the 3' terminal ribose of miRNAs. Simultaneous knockdown of three SDN genes in vivo results in elevated miRNA levels and pleiotropic developmental defects. Therefore, we have uncovered the enzymes that degrade miRNAs and demonstrated that miRNA turnover is crucial for plant development.	[Ramachandran, Vanitharani; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Chen, XM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	xuemei.chen@ucr.edu		Chen, Xuemei/0000-0002-5209-1157	NSF [MCB-0718029]; NIH [GM61146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Bi for technical assistance and T. Dinh, L. Ji, B. Yu, and B. Zheng for helpful discussions and careful reading of the manuscript. This work was supported by grants from NSF (MCB-0718029) and NIH (GM61146) to X. C.	Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Faber AW, 2004, RNA, V10, P1946, DOI 10.1261/rna.7155904; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	17	306	323	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1490	1492		10.1126/science.1163728	http://dx.doi.org/10.1126/science.1163728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787168	Green Accepted			2022-12-01	WOS:000259121800041
J	Blehert, DS; Hicks, AC; Behr, M; Meteyer, CU; Berlowski-Zier, BM; Buckles, EL; Coleman, JTH; Darling, SR; Gargas, A; Niver, R; Okoniewski, JC; Rudd, RJ; Stone, WB				Blehert, David S.; Hicks, Alan C.; Behr, Melissa; Meteyer, Carol U.; Berlowski-Zier, Brenda M.; Buckles, Elizabeth L.; Coleman, Jeremy T. H.; Darling, Scott R.; Gargas, Andrea; Niver, Robyn; Okoniewski, Joseph C.; Rudd, Robert J.; Stone, Ward B.			Bat White-Nose Syndrome: An Emerging Fungal Pathogen?	SCIENCE			English	Article									[Blehert, David S.; Meteyer, Carol U.; Berlowski-Zier, Brenda M.] US Geol Survey, Natl Wildlife Hlth Res Ctr, Madison, WI 53711 USA; [Hicks, Alan C.; Okoniewski, Joseph C.; Stone, Ward B.] New York Dept Environm Conservat, Albany, NY 12233 USA; [Behr, Melissa; Rudd, Robert J.] New York State Dept Hlth, Albany, NY 12201 USA; [Buckles, Elizabeth L.] Cornell Univ, Ithaca, NY 14853 USA; [Coleman, Jeremy T. H.; Niver, Robyn] US Fish & Wildlife Serv, Cortland, NY 13045 USA; [Darling, Scott R.] Vermont Fish & Wildlife Dept, Rutland, VT 05701 USA; [Gargas, Andrea] Symbiol Ltd Liabil Corp, Middleton, WI 53562 USA	United States Department of the Interior; United States Geological Survey; State University of New York (SUNY) System; Cornell University; United States Department of the Interior; US Fish & Wildlife Service	Blehert, DS (corresponding author), US Geol Survey, Natl Wildlife Hlth Res Ctr, 6006 Schroeder Rd, Madison, WI 53711 USA.	dblehert@usgs.gov	Gargas, Andrea/T-1028-2016	Gargas, Andrea/0000-0002-6586-047X; Berlowski-Zier, Brenda/0000-0002-7922-8352; Coleman, Jeremy/0000-0002-2762-947X; Blehert, David/0000-0002-1065-9760				[Anonymous], [No title captured]; Duncan SM, 2008, ANTARCT SCI, V20, P463, DOI 10.1017/S0954102008001314; Marshall WA, 1998, MICROBIAL ECOL, V36, P212, DOI 10.1007/s002489900108; Rice AV, 2006, MYCOLOGIA, V98, P307, DOI 10.3852/mycologia.98.2.307; SIGLER L, 1976, Mycotaxon, V4, P349; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5	6	628	662	4	518	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					227	227		10.1126/science.1163874	http://dx.doi.org/10.1126/science.1163874			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	18974316				2022-12-01	WOS:000262290600030
J	Rebouissou, S; Amessou, M; Couchy, G; Poussin, K; Imbeaud, S; Pilati, C; Izard, T; Balabaud, C; Bioulac-Sage, P; Zucman-Rossi, J				Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Imbeaud, Sandrine; Pilati, Camilla; Izard, Tina; Balabaud, Charles; Bioulac-Sage, Paulette; Zucman-Rossi, Jessica			Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours	NATURE			English	Article							SIGNAL TRANSDUCER; MOLECULAR-CLONING; CYTOKINE RECEPTOR; IL-6; INTERLEUKIN-6; BINDING; ADENOMA; GENE; CLASSIFICATION; TRANSCRIPTION	Inflammatory hepatocellular adenomas are benign liver tumours defined by the presence of inflammatory infiltrates and by the increased expression of inflammatory proteins in tumour hepatocytes(1,2). Here we show a marked activation of the interleukin ( IL)- 6 signalling pathway in this tumour type; sequencing candidate genes pinpointed this response to somatic gain- of- function mutations in the IL6ST gene, which encodes the signalling co- receptor gp130. Indeed, 60% of inflammatory hepatocellular adenomas harbour small in- frame deletions that target the binding site of gp130 for IL- 6, and expression of four different gp130 mutants in hepatocellular cells activates signal transducer and activator of transcription 3 ( STAT3) in the absence of ligand. Furthermore, analysis of hepatocellular carcinomas revealed that rare gp130 alterations are always accompanied by beta-catenin-activating mutations, suggesting a cooperative effect of these signalling pathways in the malignant conversion of hepatocytes. The recurrent gain- of function gp130 mutations in these human hepatocellular adenomas fully explains activation of the acute inflammatory phase observed in tumourous hepatocytes, and suggests that similar alterations may occur in other inflammatory epithelial tumours with STAT3 activation.	[Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Pilati, Camilla; Zucman-Rossi, Jessica] INSERM, Genom Fonct Tumeurs Solides U674, F-75010 Paris, France; [Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Pilati, Camilla; Zucman-Rossi, Jessica] Univ Paris 07, Inst Univ Hematol, F-75010 Paris, France; [Imbeaud, Sandrine] CNRS, Arrays IMAGE Genexpress Funct Genom & Syst Biol H, UMR 7091, F-94801 Villejuif, France; [Imbeaud, Sandrine] Univ Paris 06, F-94801 Villejuif, France; [Imbeaud, Sandrine] CNRS, Ctr Genet Mol, Gif Orsay DNA Microarray Platform GODMAP, UPR 2167, F-91198 Gif Sur Yvette, France; [Imbeaud, Sandrine] Univ Paris 11, F-91198 Gif Sur Yvette, France; [Izard, Tina] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Balabaud, Charles; Bioulac-Sage, Paulette] INSERM, U889, F-33076 Bordeaux, France; [Balabaud, Charles; Bioulac-Sage, Paulette] Univ Bordeaux 2, IFR66, F-33076 Bordeaux, France; [Balabaud, Charles] Hop St Andre, Serv Hepatol, CHU Bordeaux, F-33076 Bordeaux, France; [Bioulac-Sage, Paulette] Hop Pellegrin, Serv Anat Pathol, CHU Bordeaux, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux	Zucman-Rossi, J (corresponding author), INSERM, Genom Fonct Tumeurs Solides U674, F-75010 Paris, France.	zucman@cephb.fr	j, zucman-rossi/AAV-3594-2021; zucman-rossi, Jessica/B-5098-2009; Rebouissou, Sandra/O-5938-2017; Imbeaud, Sandrine/P-8780-2017	j, zucman-rossi/0000-0002-5687-0334; zucman-rossi, Jessica/0000-0002-5687-0334; Rebouissou, Sandra/0000-0003-0188-2271; Imbeaud, Sandrine/0000-0001-8439-6732; Pilati, Camilla/0000-0002-1781-5180	Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations); Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program); ARC [5158]; Fondation de France; la Ligue Nationale Contre le Cancer; Inca; Inserm; Bordeaux Hospital; National Institutes of Health [GM071596, AI055894, AI067949]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055894, R01AI067949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071596] Funding Source: NIH RePORTER	Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program); ARC(Australian Research Council); Fondation de France(Fondation de France); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Inca(Institut National du Cancer (INCA) France); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Bordeaux Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to P. Bois and O. Bernard for scientific discussion and critical reading of this manuscript. We thank C. Thomas and G. Cubel for their participation to this work. We also thank J. Saric, C. Laurent, A. Sa Cunha, B. Le Bail and A. Rullier for contributing to the tissue collection (CHU Bordeaux). This work was supported by Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations), the Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program), ARC (grant 5158), and the Fondation de France. S.R. and M.A. are supported by a fellowship from la Ligue Nationale Contre le Cancer and the Inca, respectively. J.Z.-R. is supported by an interface contract between Inserm and Bordeaux Hospital. T. I. is supported by the National Institutes of Health grants GM071596, AI055894 and AI067949.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Bioulac-Sage P, 2005, GASTROENTEROLOGY, V128, P1211, DOI 10.1053/j.gastro.2005.02.004; Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Chen YW, 2002, HEPATOLOGY, V36, P927, DOI 10.1053/jhep.2002.36126; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Coulouarn C, 2005, HEPATOLOGY, V42, P946, DOI 10.1002/hep.20848; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Li H, 2002, J VIROL, V76, P5627, DOI 10.1128/JVI.76.11.5627-5636.2002; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Maione D, 1998, EMBO J, V17, P5588, DOI 10.1093/emboj/17.19.5588; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Rebouissou S, 2007, J BIOL CHEM, V282, P14437, DOI 10.1074/jbc.M610725200; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; WARD LD, 1994, J BIOL CHEM, V269, P23286; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068	34	341	349	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					200	U96		10.1038/nature07475	http://dx.doi.org/10.1038/nature07475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19020503	Green Submitted, Green Accepted			2022-12-01	WOS:000262360200034
J	Samson, RY; Obita, T; Freund, SM; Williams, RL; Bell, SD				Samson, Rachel Y.; Obita, Takayuki; Freund, Stefan M.; Williams, Roger L.; Bell, Stephen D.			A Role for the ESCRT System in Cell Division in Archaea	SCIENCE			English	Article							III RECOGNITION; SULFOLOBUS; ALIX	Archaea are prokaryotic organisms that lack endomembrane structures. However, a number of hyperthermophilic members of the Kingdom Crenarchaea, including members of the Sulfolobus genus, encode homologs of the eukaryotic endosomal sorting system components Vps4 and ESCRT- III ( endosomal sorting complex required for transport- III). We found that Sulfolobus ESCRT- III and Vps4 homologs underwent regulation of their expression during the cell cycle. The proteins interacted and we established the structural basis of this interaction. Furthermore, these proteins specifically localized to the mid- cell during cell division. Overexpression of a catalytically inactive mutant Vps4 in Sulfolobus resulted in the accumulation of enlarged cells, indicative of failed cell division. Thus, the archaeal ESCRT system plays a key role in cell division.	[Samson, Rachel Y.; Bell, Stephen D.] MRC, Canc Cell Unit, Cambridge CB2 0XZ, England; [Obita, Takayuki; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Freund, Stefan M.] MRC, Ctr Prot Engn, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; University of Cambridge	Bell, SD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	stephen.bell@path.ox.ac.uk		Williams, Roger/0000-0001-7754-4207; Bell, Stephen/0000-0002-8474-6592	Wellcome Trust [083639/Z/07/Z]; Edward Penley Abraham Trust; MRC; MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Edward Penley Abraham Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank O. Perisic and I. Duggin for advice and helpful discussions, C. Mueller-Dieckmann for help with European Synchrotron Radiation Facility beamline ID29, and S. McCallum for flow cytometry. The work was supported by Wellcome Trust (grant 083639/Z/07/Z to R. L. W.), the Edward Penley Abraham Trust (S.D.B.). and the MRC (R.L.W. and S.D.B.). The coordinates for the structure reported in this work have been deposited in the Protein Data Bank (accession number 2w2u).	Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Duggin IG, 2008, P NATL ACAD SCI USA, V105, P16737, DOI 10.1073/pnas.0806414105; Dye NA, 2007, TRENDS CELL BIOL, V17, P239, DOI 10.1016/j.tcb.2007.03.005; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Hobel CFV, 2008, BIOCHEM SOC T, V36, P94, DOI 10.1042/BST0360094; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Lubelska JM, 2006, EXTREMOPHILES, V10, P383, DOI 10.1007/s00792-006-0510-7; Maaty WSA, 2006, J VIROL, V80, P7625, DOI 10.1128/JVI.00522-06; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Pogliano J, 2008, CURR OPIN CELL BIOL, V20, P19, DOI 10.1016/j.ceb.2007.12.006; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	21	242	253	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1710	1713		10.1126/science.1165322	http://dx.doi.org/10.1126/science.1165322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19008417	Green Accepted			2022-12-01	WOS:000261608300050
J	Cheng, J; Turkel, N; Hemati, N; Fuller, MT; Hunt, AJ; Yamashita, YM				Cheng, Jun; Turkel, Nezaket; Hemati, Nahid; Fuller, Margaret T.; Hunt, Alan J.; Yamashita, Yukiko M.			Centrosome misorientation reduces stem cell division during ageing	NATURE			English	Article							SELF-RENEWAL; DROSOPHILA SPERMATOGENESIS; GERMLINE; NICHE; MELANOGASTER; ORIENTATION; CANCER	Asymmetric division of adult stem cells generates one self- renewing stem cell and one differentiating cell, thereby maintaining tissue homeostasis. A decline in stem cell function has been proposed to contribute to tissue ageing, although the underlying mechanism is poorly understood. Here we show that changes in the stem cell orientation with respect to the niche during ageing contribute to the decline in spermatogenesis in the male germ line of Drosophila. Throughout the cell cycle, centrosomes in germline stem cells ( GSCs) are oriented within their niche and this ensures asymmetric division. We found that GSCs containing misoriented centrosomes accumulate with age and that these GSCs are arrested or delayed in the cell cycle. The cell cycle arrest is transient, and GSCs appear to re- enter the cell cycle on correction of centrosome orientation. On the basis of these findings, we propose that cell cycle arrest associated with centrosome misorientation functions as a mechanism to ensure asymmetric stem cell division, and that the inability of stem cells to maintain correct orientation during ageing contributes to the decline in spermatogenesis. We also show that some of the misoriented GSCs probably originate from dedifferentiation of spermatogonia.	[Turkel, Nezaket; Hemati, Nahid; Yamashita, Yukiko M.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Cheng, Jun; Hunt, Alan J.] Univ Michigan, Dept Biomed Engn, Ctr Ultrafast Opt Sci, Ann Arbor, MI 48109 USA; [Yamashita, Yukiko M.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fuller, Margaret T.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Fuller, Margaret T.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Stanford University	Yamashita, YM (corresponding author), Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	yukikomy@umich.edu		Fuller, Margaret T/0000-0002-3804-4987; Turkel, Nezaket/0000-0002-4480-7282; Yamashita, Yukiko/0000-0001-5541-0216	University of Michigan; March of Dimes Basil O'Conner Starter Scholar Research Award; Searle Scholar Program; NIH [P01 DK53074, R01GM072006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072006, R01GM086481, R01GM080501] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); March of Dimes Basil O'Conner Starter Scholar Research Award(March of Dimes); Searle Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Gonzalez, D. McKearin, N. Rusan, M. Peifer and the Bloomington Stock Center for fly stocks; R. Lehmann, C. Field and the Developmental Studies Hybridoma Bank for antibodies; M. Kiel and D. Nakada for help with X-ray irradiation; and S. Morrison and T. Mahowald for comments on the manuscript. This research was supported by a University of Michigan start-up fund, March of Dimes Basil O'Conner Starter Scholar Research Award and the Searle Scholar Program (to Y.M.Y.), and NIH grants P01 DK53074 (to M.T.F.) and R01GM072006 (to A.J.H.).	Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; DING D, 1993, P NATL ACAD SCI USA, V90, P2512, DOI 10.1073/pnas.90.6.2512; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fuller Margaret T., 1993, P71; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	27	229	238	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					599	U40		10.1038/nature07386	http://dx.doi.org/10.1038/nature07386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18923395	Green Accepted, Green Published			2022-12-01	WOS:000261340000032
J	Difilippantonio, S; Gapud, E; Wong, N; Huang, CY; Mahowald, G; Chen, HT; Kruhlak, MJ; Callen, E; Livak, F; Nussenzweig, MC; Sleckman, BP; Nussenzweig, A				Difilippantonio, Simone; Gapud, Eric; Wong, Nancy; Huang, Ching-Yu; Mahowald, Grace; Chen, Hua Tang; Kruhlak, Michael J.; Callen, Elsa; Livak, Ferenc; Nussenzweig, Michel C.; Sleckman, Barry P.; Nussenzweig, Andre			53BP1 facilitates long-range DNA end-joining during V(D)J recombination	NATURE			English	Article							SWITCH REGION RECOMBINATION; GENOMIC INSTABILITY; CHROMOSOME BREAKS; IN-VIVO; DAMAGE; ATM; H2AX; P53; METHYLATION; PREVENTS	Variable, diversity and joining (V(D)J) recombination and class-switch recombination use overlapping but distinct non- homologous end joining pathways to repair DNA double- strand- break intermediates. 53BP1 is a DNA- damage- response protein that is rapidly recruited to sites of chromosomal double- strand breaks, where it seems to function in a subset of ataxia telangiectasia mutated ( ATM) kinase-, H2A histone family member X ( H2AX, also known as H2AFX)- and mediator of DNA damage checkpoint 1 (MDC1)- dependent events(1,2). A 53BP1- dependent end- joining pathway has been described that is dispensable for V( D) J recombination but essential for class- switch recombination(3,4). Here we report a previously unrecognized defect in the joining phase of V( D) J recombination in 53BP1- deficient lymphocytes that is distinct from that found in classical non- homologous- end- joining-, H2ax-, Mdc1- and Atm- deficient mice. Absence of 53BP1 leads to impairment of distal V - DJ joining with extensive degradation of unrepaired coding ends and episomal signal joint reintegration at V( D) J junctions. This results in apoptosis, loss of T- cell receptor a locus integrity and lymphopenia. Further impairment of the apoptotic checkpoint causes propagation of lymphocytes that have antigen receptor breaks. These data suggest a more general role for 53BP1 in maintaining genomic stability during long- range joining of DNA breaks.	[Difilippantonio, Simone; Wong, Nancy; Chen, Hua Tang; Kruhlak, Michael J.; Callen, Elsa; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Gapud, Eric; Huang, Ching-Yu; Mahowald, Grace; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Livak, Ferenc] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; Rockefeller University; Howard Hughes Medical Institute	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Huang, Ching-Yu/E-3981-2010; Nussenzweig, Michel/AAE-7292-2019	Huang, Ching-yu/0000-0002-5758-281X; Mahowald, Grace/0000-0003-4541-4920	NIH [R01AI074953]; Cancer Research Institute; Intramural Research Program; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010283, ZICBC010915, ZICBC009255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Intramural Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to M. McAuliffe and co-workers for developing the three- dimensional- FISH measurement algorithm; D.G. Schatz and J. Haber for discussions; A. Wynshaw-Boris for Atm<SUP>-/-</SUP> mice and J. Chen for 53BP1<SUP>-/-</SUP> and Mdc1<SUP>-/-</SUP> mice; D. Venzon for help with statistical analysis; and numbers of the A. Nussenzweig laboratory (J. Daniel and A. Celeste) for comments on the manuscript. B.P.S. is supported by NIH grant R01AI074953. E.G. is supported by pre-doctoral fellowship from the Cancer Research Institute. M.C.N. is a HHMI investigator. A.N. is supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Huang CY, 2007, J IMMUNOL, V179, P449, DOI 10.4049/jimmunol.179.1.449; Huang CY, 2007, J EXP MED, V204, P1371, DOI 10.1084/jem.20061460; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021	30	228	231	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					529	U57		10.1038/nature07476	http://dx.doi.org/10.1038/nature07476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18931658	Green Accepted			2022-12-01	WOS:000261170500044
J	Pearce, MJ; Mintseris, J; Ferreyra, J; Gygi, SP; Darwin, KH				Pearce, Michael J.; Mintseris, Julian; Ferreyra, Jessica; Gygi, Steven P.; Darwin, K. Heran			Ubiquitin-Like Protein Involved in the Proteasome Pathway of Mycobacterium tuberculosis	SCIENCE			English	Article							NUCLEAR-PORE COMPLEX; 20S PROTEASOME; RESOLUTION; PROGRAMS; RANGAP1; SYSTEM	The protein modifier ubiquitin is a signal for proteasome-mediated degradation in eukaryotes. Proteasome- bearing prokaryotes have been thought to degrade proteins via a ubiquitinin-dependent pathway. We have identified a prokaryotic ubiquitin- like protein, Pup ( Rv2111c), which was specifically conjugated to proteasome substrates in the pathogen Mycobacterium tuberculosis. Pupylation occurred on lysines and required proteasome accessory factor A (PafA). In a pafA mutant, pupylated proteins were absent and substrates accumulated, thereby connecting pupylation with degradation. Although analogous to ubiquitylation, pupylation appears to proceed by a different chemistry. Thus, like eukaryotes, bacteria may use a small- protein modifier to control protein stability.	[Pearce, Michael J.; Ferreyra, Jessica; Darwin, K. Heran] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Mintseris, Julian; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	New York University; Harvard University; Harvard Medical School	Darwin, KH (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	heran.darwin@med.nyu.edu		Darwin, K Heran/0000-0002-5043-7548	NIH [AI065437, HL092774, GM67945, HG3456, HG3616];  [5T32AI07189-25]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456, R01HG003616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065437, F32AI007189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ehrt, D. Ladant, V. Miller, and A. Steyn for plasmids used in this study. We are grateful to C. Arias and C. Perez for advice on pulse- labeling experiments and to T. Huang, I. Mohr, and M. Pagano for helpful discussions. We thank A. Darwin and M. Pagano for critical review of this manuscript. This work was supported by NIH grants AI065437 and HL092774 ( to K. H. D.) and GM67945, HG3456, and HG3616 ( to S. P. G.). M. J. P. was supported by grant 5T32AI07189-25.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Darwin KH, 2001, J BACTERIOL, V183, P1452, DOI 10.1128/JB.183.4.1452-1454.2001; Festa RA, 2007, J BACTERIOL, V189, P3044, DOI 10.1128/JB.01597-06; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7	22	290	318	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1104	1107		10.1126/science.1163885	http://dx.doi.org/10.1126/science.1163885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	18832610	Green Accepted			2022-12-01	WOS:000260867700038
J	Serganov, A; Huang, LL; Patel, DJ				Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.			Structural insights into amino acid binding and gene control by a lysine riboswitch	NATURE			English	Article							CRYSTAL-STRUCTURE; S-ADENOSYLMETHIONINE; RNA; EXPRESSION; REFINEMENT; BIOSYNTHESIS; RECOGNITION; BACTERIA; ANALOGS; DOMAIN	In bacteria, the intracellular concentration of several amino acids is controlled by riboswitches(1-4). One of the important regulatory circuits involves lysine- specific riboswitches, which direct the biosynthesis and transport of lysine and precursors common for lysine and other amino acids(1-3). To understand the molecular basis of amino acid recognition by riboswitches, here we present the crystal structure of the 174- nucleotide sensing domain of the Thermotoga maritima lysine riboswitch in the lysine- bound (1.9 angstrom (angstrom)) and free (3.1 angstrom) states. The riboswitch features an unusual and intricate architecture, involving three-helical and two- helical bundles connected by a compact five- helical junction and stabilized by various long- range tertiary interactions. Lysine interacts with the junctional core of the riboswitch and is specifically recognized through shape- complementarity within the elongated binding pocket and through several direct and K(+)-mediated hydrogen bonds to its charged ends. Our structural and biochemical studies indicate preformation of the riboswitch scaffold and identify conformational changes associated with the formation of a stable lysine- bound state, which prevents alternative folding of the riboswitch and facilitates formation of downstream regulatory elements. We have also determined several structures of the riboswitch bound to different lysine analogues(5), including antibiotics, in an effort to understand the ligand-binding capabilities of the lysine riboswitch and understand the nature of antibiotic resistance. Our results provide insights into a mechanism of lysine- riboswitch- dependent gene control at the molecular level, thereby contributing to continuing efforts at exploration of the pharmaceutical and biotechnological potential of riboswitches.	[Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Serganov, A (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	serganoa@mskcc.org; pateld@mskcc.org		Serganov, Alexander/0000-0001-8328-9310	US Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073618] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank personnel of beamline X29 at the Brookhaven National Laboratory and beamlines 24-ID-C/E at the Advanced Photon Source, Argonne National Laboratory, funded by the US Department of Energy. We thank O. Ouerfelli for the synthesis of iridium hexamine. D.J.P. was supported by funds from the National Institutes of Health.	Ataide SF, 2007, ACS CHEM BIOL, V2, P819, DOI 10.1021/cb7002253; Basu S, 1998, NAT STRUCT BIOL, V5, P986, DOI 10.1038/2960; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Feig A. L., 1999, RNA WORLD, P287; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Grundy FJ, 2003, P NATL ACAD SCI USA, V100, P12057, DOI 10.1073/pnas.2133705100; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; LU Y, 1992, FEMS MICROBIOL LETT, V92, P23, DOI 10.1016/0378-1097(92)90536-W; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Patte JC, 1998, FEMS MICROBIOL LETT, V169, P165, DOI 10.1016/S0378-1097(98)00479-0; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336	32	183	188	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1263	U76		10.1038/nature07326	http://dx.doi.org/10.1038/nature07326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18784651	Green Accepted			2022-12-01	WOS:000260462100050
J	Johnson, AP; Cleaves, HJ; Dworkin, JP; Glavin, DP; Lazcano, A; Bada, JL				Johnson, Adam P.; Cleaves, H. James; Dworkin, Jason P.; Glavin, Daniel P.; Lazcano, Antonio; Bada, Jeffrey L.			The Miller volcanic spark discharge experiment	SCIENCE			English	Article							AMINO-ACIDS		[Bada, Jeffrey L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Johnson, Adam P.] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47401 USA; [Cleaves, H. James] Carnegie Inst Washington, Washington, DC 20015 USA; [Dworkin, Jason P.; Glavin, Daniel P.] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Lazcano, Antonio] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; Indiana University System; Indiana University Bloomington; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universidad Nacional Autonoma de Mexico	Bada, JL (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jbada@ucsd.edu	Dworkin, Jason P./C-9417-2012; Glavin, Daniel P/D-6194-2012	Dworkin, Jason P./0000-0002-3961-8997; Glavin, Daniel P/0000-0001-7779-7765; Cleaves, Henderson/0000-0003-4101-0654; Lazcano, Antonio/0000-0001-7365-8557				HILL RD, 1991, ORIGINS LIFE EVOL B, V22, P277; Lazcano A, 2003, ORIGINS LIFE EVOL B, V33, P235, DOI 10.1023/A:1024807125069; Leman L, 2004, SCIENCE, V306, P283, DOI 10.1126/science.1102722; McNutt SR, 2000, J VOLCANOL GEOTH RES, V102, P45, DOI 10.1016/S0377-0273(00)00181-5; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; MILLER SL, 1955, J AM CHEM SOC, V77, P2351, DOI 10.1021/ja01614a001; RING D, 1984, ORIGINS LIFE EVOL B, V15, P7, DOI 10.1007/BF01809389; RING D, 1972, P NATL ACAD SCI USA, V69, P765, DOI 10.1073/pnas.69.3.765	8	211	220	4	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					404	404		10.1126/science.1161527	http://dx.doi.org/10.1126/science.1161527			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927386				2022-12-01	WOS:000260094500036
J	Lee, J; Natarajan, M; Nashine, VC; Socolich, M; Vo, T; Russ, WP; Benkovic, SJ; Ranganathan, R				Lee, Jeeyeon; Natarajan, Madhusudan; Nashine, Vishal C.; Socolich, Michael; Vo, Tina; Russ, William P.; Benkovic, Stephen J.; Ranganathan, Rama			Surface sites for engineering allosteric control in proteins	SCIENCE			English	Article							COLI DIHYDROFOLATE-REDUCTASE; PHOTOACTIVE YELLOW PROTEIN; BLUE-LIGHT RECEPTOR; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; ENZYME CATALYSIS; STRUCTURAL BASIS; FUNCTIONAL-ROLE; AVENA-SATIVA; PHOTOTROPIN	Statistical analyses of protein families reveal networks of coevolving amino acids that functionally link distantly positioned functional surfaces. Such linkages suggest a concept for engineering allosteric control into proteins: The intramolecular networks of two proteins could be joined across their surface sites such that the activity of one protein might control the activity of the other. We tested this idea by creating PAS-DHFR, a designed chimeric protein that connects a light-sensing signaling domain from a plant member of the Per/Arnt/Sim (PAS) family of proteins with Escherichia coli dihydrofolate reductase (DHFR). With no optimization, PAS-DHFR exhibited light-dependent catalytic activity that depended on the site of connection and on known signaling mechanisms in both proteins. PAS-DHFR serves as a proof of concept for engineering regulatory activities into proteins through interface design at conserved allosteric sites.	[Natarajan, Madhusudan; Socolich, Michael; Vo, Tina; Russ, William P.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Natarajan, Madhusudan; Socolich, Michael; Vo, Tina; Russ, William P.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Lee, Jeeyeon; Nashine, Vishal C.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu		Socolich, Michael/0000-0002-0702-1061; Natarajan, Madhusudan/0000-0003-1607-2917	Robert A. Welch foundation; Defense Advanced Research Projects Agency; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	Robert A. Welch foundation(The Welch Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Ranganathan and Benkovic labs for discussions, M. Rosen and K. H. Gardner for discussions and sharing of unpublished data and materials, and J. Wang for solvent accessibility calculations. Supported by the Robert A. Welch foundation (R.R.) and a grant from the Defense Advanced Research Projects Agency (R.R. and S.J.B.).	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; CHEN JT, 1987, BIOCHEMISTRY-US, V26, P4093, DOI 10.1021/bi00387a053; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Cusanovich MA, 2003, BIOCHEMISTRY-US, V42, P4759, DOI 10.1021/bi020690e; EPSTEIN DM, 1995, BIOCHEMISTRY-US, V34, P11037, DOI 10.1021/bi00035a009; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Rajagopalan PTR, 2002, CHEM REC, V2, P24, DOI 10.1002/tcr.10009; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Saraf MC, 2004, P NATL ACAD SCI USA, V101, P4142, DOI 10.1073/pnas.0400065101; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99	34	260	262	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					438	442		10.1126/science.1159052	http://dx.doi.org/10.1126/science.1159052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927392	Green Accepted			2022-12-01	WOS:000260094500046
J	Styer, KL; Singh, V; Macosko, E; Steele, SE; Bargmann, CI; Aballay, A				Styer, Katie L.; Singh, Varsha; Macosko, Evan; Steele, Sarah E.; Bargmann, Cornelia I.; Aballay, Alejandro			Innate immunity in Caenorhabditis elegans is regulated by neurons expressing NPR-1/GPCR	SCIENCE			English	Article							C-ELEGANS; SIGNALING PATHWAY; BACILLUS-THURINGIENSIS; SALMONELLA-TYPHIMURIUM; CHEMOSENSORY NEURONS; INFLAMMATORY REFLEX; LARVAL DEVELOPMENT; GENE FAMILIES; MODEL HOST; BODY-FLUID	A large body of evidence indicates that metazoan innate immunity is regulated by the nervous system, but the mechanisms involved in the process and the biological importance of such control remain unclear. We show that a neural circuit involving npr-1, which encodes a G protein-coupled receptor (GPCR) related to mammalian neuropeptide Y receptors, functions to suppress innate immune responses. The immune inhibitory function requires a guanosine 3',5'-monophosphategated ion channel encoded by tax-2 and tax-4 as well as the soluble guanylate cyclase GCY-35. Furthermore, we show that npr-1- and gcy-35-expressing sensory neurons actively suppress immune responses of nonneuronal tissues. A full-genome microarray analysis on animals with altered neural function due to mutation in npr-1 shows an enrichment in genes that are markers of innate immune responses, including those regulated by a conserved PMK-1/p38 mitogen-activated protein kinase signaling pathway. These results present evidence that neurons directly control innate immunity in C. elegans, suggesting that GPCRs may participate in neural circuits that receive inputs from either pathogens or infected sites and integrate them to coordinate appropriate immune responses.	[Styer, Katie L.; Singh, Varsha; Steele, Sarah E.; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Macosko, Evan; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Macosko, Evan; Bargmann, Cornelia I.] Rockefeller Univ, Lab Neural Circuits & Behav, New York, NY 10021 USA	Duke University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	a.aballay@duke.edu	Macosko, Evan/X-4664-2019	Jeney, Sarah Elizabeth Steele/0000-0001-5222-2981; Bargmann, Cornelia/0000-0002-8484-0618	Whitehead Scholars Program; NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NIH [GM070977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER	Whitehead Scholars Program; NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center (University of Minnesota) for strains used in this study. A.A. is funded by the Whitehead Scholars Program, the NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense (grant U54 AI057157), and NIH grant GM070977. C.I.B. is an Investigator of the Howard Hughes Medical Institute.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Andersson J, 2005, J INTERN MED, V257, P122, DOI 10.1111/j.1365-2796.2004.01440.x; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hasshoff M, 2007, FASEB J, V21, P1801, DOI 10.1096/fj.06-6551com; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Laws TR, 2006, MICROB PATHOGENESIS, V40, P293, DOI 10.1016/j.micpath.2006.03.001; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Sattelle David B., 2006, Invertebrate Neuroscience, V6, P1, DOI 10.1007/s10158-005-0014-7; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	47	157	219	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					460	464		10.1126/science.1163673	http://dx.doi.org/10.1126/science.1163673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18801967	Green Accepted			2022-12-01	WOS:000260094500052
J	Deng, XZ; Yin, XL; Allan, R; Lu, DD; Maurer, CW; Haimovitz-Friedman, A; Fuks, Z; Shaham, S; Kolesnick, R				Deng, Xinzhu; Yin, Xianglei; Allan, Richard; Lu, Diane D.; Maurer, Carine W.; Haimovitz-Friedman, Adriana; Fuks, Zvi; Shaham, Shai; Kolesnick, Richard			Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C-elegans	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; DNA-DAMAGE CHECKPOINT; CAENORHABDITIS-ELEGANS; EGL-1; MEMBRANE; CED-4; COMPLEX	Ceramide engagement in apoptotic pathways has been a topic of controversy. To address this controversy, we tested loss- of- function (lf) mutants of conserved genes of sphingolipid metabolism in Caenorhabditis elegans. Although somatic ( developmental) apoptosis was unaffected, ionizing radiation- induced apoptosis of germ cells was obliterated upon inactivation of ceramide synthase and restored upon microinjection of long- chain natural ceramide. Radiation- induced increase in the concentration of ceramide localized to mitochondria and was required for BH3- domain protein EGL-1-mediated displacement of CED-4 ( an APAF-1-like protein) from the CED-9 ( a Bcl-2 family member)/CED- 4 complex, an obligate step in activation of the CED-3 caspase. These studies define CEP-1 ( the worm homolog of the tumor suppressor p53)-mediated accumulation of EGL- 1 and ceramide synthase-mediated generation of ceramide through parallel pathways that integrate at mitochondrial membranes to regulate stress-induced apoptosis.	[Deng, Xinzhu; Yin, Xianglei; Allan, Richard; Lu, Diane D.; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Maurer, Carine W.; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10021 USA; [Haimovitz-Friedman, Adriana; Fuks, Zvi] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org		Maurer, Carine/0000-0002-7892-7127	 [CA85704];  [CA105125-03];  [2R01HD42680-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042680] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085704, R01CA105125] Funding Source: NIH RePORTER	; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Caenorhabitis Genetics Center and National BioResource Project-Japan for the strains provided; H. R. Horwitz for the anti-CED-4 antibody; Y. Gruenbaum for the anti-Ce-lamin-antibody; M.O. Hengartner for the strain opls219; and S. Davidor, D. Chau, H. Lee, J. Mesicek, and the Molecular Cytology and Genomics Core Laboratory of MSKCC for the technical assistance. This work was supported by grants CA85704 (R.K.), CA105125-03 (A.H.-F.), and 2R01HD42680-06 (S.S.).	Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; del Peso L, 2000, J BIOL CHEM, V275, P27205; Deng XZ, 2004, NAT GENET, V36, P906, DOI 10.1038/ng1396; DUERR JS, 2007, WORM BOOK; Fairlie WD, 2006, CELL DEATH DIFFER, V13, P426, DOI 10.1038/sj.cdd.4401762; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P374, DOI 10.1016/S0968-0004(98)01289-4; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; RIEZMAN H, COMMUNICATION; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Yan NG, 2004, MOL CELL, V15, P999, DOI 10.1016/j.molcel.2004.08.022; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030	21	135	160	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					110	115		10.1126/science.1158111	http://dx.doi.org/10.1126/science.1158111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832646	Green Accepted			2022-12-01	WOS:000259680200049
J	Ebersbach, G; Briegel, A; Jensen, GJ; Jacobs-Wagner, C				Ebersbach, Gitte; Briegel, Ariane; Jensen, Grant J.; Jacobs-Wagner, Christine			A self-associating protein critical for chromosome attachment, division, and polar organization in Caulobacter	CELL			English	Article							CELL-CYCLE PROGRESSION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BACTERIAL-CELL; DNA-REPLICATION; ROD-SHAPE; SEGREGATION; CRESCENTUS; LOCALIZATION; DIVIVA	Cell polarization is an integral part of many unrelated bacterial processes. How intrinsic cell polarization is achieved is poorly understood. Here, we provide evidence that Caulobacter crescentus uses a multimeric pole-organizing factor (PopZ) that serves as a hub to concurrently achieve several polarizing functions. During chromosome segregation, polar PopZ captures the ParB.ori complex and thereby anchors sister chromosomes at opposite poles. This step is essential for stabilizing bipolar gradients of a cell division inhibitor and setting up division near midcell. PopZ also affects polar stalk morphogenesis and mediates the polar localization of the morphogenetic and cell cycle signaling proteins CckA and DivJ. Polar accumulation of PopZ, which is central to its polarizing activity, can be achieved independently of division and does not appear to be dictated by the pole curvature. Instead, evidence suggests that localization of PopZ largely relies on PopZ multimerization in chromosome-free regions, consistent with a self-organizing mechanism.	[Ebersbach, Gitte; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jacobs-Wagner, Christine] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; California Institute of Technology; Howard Hughes Medical Institute	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu	Briegel, Ariane/AAC-1085-2021	Briegel, Ariane/0000-0003-3733-3725; Jacobs-Wagner, Christine/0000-0003-0980-5334	Villum Kann Rasmussen Foundation; Danish Natural Science Research Council; National Institutes of Health [GM065835, AI067548]; Pew Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	Villum Kann Rasmussen Foundation(Villum Fonden); Danish Natural Science Research Council(Danish Natural Science Research Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Mooseker, E. Dufresne, T. Emonet, and J. Wolenski for valuable discussions; K. Gerdes, J. Gober, A. Newton, N. Ohta, L. Shapiro, M. Thanbichler, and P. Viollier for supplying strains or antibody; P. Angelastro, A. Jackson, H. Lam, and W. Schofield for construction of strains; H. J. Ding and D. Rosenman for computational help; M. Mooseker, Z. Jiang, and G. Charbon for assistance with EM; E. Folta-Stogniew and the Keck Foundation Biotechnology Resource Laboratory at Yale for the biophysical analyses, and the Jacobs-Wagner laboratory and T. Emonet for critical reading of the manuscript. G. E. was supported by postdoctoral fellowships from the Villum Kann Rasmussen Foundation and the Danish Natural Science Research Council. This work was funded in part by National Institutes of Health (GM065835 to C.J.-W. and AI067548 to G. J. J.), gifts to Caltech from the Gordon and Betty Moore Foundation and Agouron Institute (to G. J. J.) and the Pew Scholars Program in the Biological Sciences sponsored by the Pew Charitable trust (to C.J.-W.). C.J.-W. is a Howard Hughes Medical Institute investigator.	Bardy SL, 2007, CURR OPIN MICROBIOL, V10, P617, DOI 10.1016/j.mib.2007.10.006; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Dai MH, 2005, METAB ENG, V7, P45, DOI 10.1016/j.ymben.2004.09.002; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2007, TRENDS MICROBIOL, V15, P101, DOI 10.1016/j.tim.2007.01.004; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Folta-Stogniew Ewa, 2006, V328, P97; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Hallez R, 2004, TRENDS MICROBIOL, V12, P361, DOI 10.1016/j.tim.2004.06.002; Hamoen LW, 2003, J BACTERIOL, V185, P693, DOI 10.1128/JB.185.2.693-697.2003; Harry EJ, 2003, MOL MICROBIOL, V47, P37, DOI 10.1046/j.1365-2958.2003.03253.x; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Iwai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2658, DOI 10.1271/bbb.66.2658; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Lawler ML, 2007, CURR OPIN MICROBIOL, V10, P630, DOI 10.1016/j.mib.2007.09.007; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; SOMMER JM, 1991, GENETICS, V129, P623; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	42	211	211	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					956	968		10.1016/j.cell.2008.07.016	http://dx.doi.org/10.1016/j.cell.2008.07.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805089	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000259318100016
J	Sarkar, M; Hennessy, S; Yang, YX				Sarkar, Monika; Hennessy, Sean; Yang, Yu-Xiao			Proton-pump inhibitor use and the risk for community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Article							POPULATION; DRUGS; CANCER	Background: Recent studies suggest that proton-pump inhibitors (PPIs) may increase the risk for community-acquired pneumonia (CAP). Objective: To examine the association between PPI use and CAP in adults followed in general practices in the United Kingdom. Design: Nested case-control study. Setting: The General Practice Research Database (1987 to 2002) in the United Kingdom. Participants: Patients age 18 years or older with at least 6 months of initial pneumonia-free follow-up in the database. Case patients (n = 80 066) were defined as those who received an incident diagnosis of CAP. Control participants (n = 799 881) were selected by using incidence density sampling, matching on practice site, calendar period, and follow-up duration. Measurements: Use of PPIs within 30 days before the index date. Adjusted odds ratios (ORs) were estimated by using conditional logistic regression, adjusting for potential confounders. Results: Overall, current PPI use was not associated with an increased risk for CAP (adjusted OR, 1.02 [95% CI, 0.97 to 1.08]) or risk for CAP that required hospitalization (adjusted OR, 1.01 [CI, 0.91 to 1.12]). There was a strong increase in risk for CAP associated with current use of PPI therapy that was started within the previous 2 days (adjusted OR, 6.53 [CI, 3.95 to 10.80]), 7 days (adjusted OR, 3.79 [CI, 2.66 to 5.42]), and 14 days (adjusted OR, 3.21 [CI, 2.46 to 4.18]), but there was no statistically significant association for longer-term current PPI therapy. A separate matched case-control analysis, which included the 3 strongest confounders as additional matching factors, yielded similar results as the primary analysis (adjusted OR, 0.96 [CI, 0.91 to 1.02]). Limitations: Adherence to PPI prescription was assumed to be 100%. No radiographic evidence was available to corroborate a diagnosis of CAP. Conclusion: Proton-pump inhibitor therapy started within the past 30 days was associated with an increased risk for CAP, whereas longer-term current use was not.	[Yang, Yu-Xiao] Univ Penn, Ctr Clin Epidemiol & Biostat, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Yang, YX (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, Sch Med, 722 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	yangy@mail.med.upenn.edu	yang, yx/GZM-0464-2022		the Department of Medicine, University of Pennsylvania	the Department of Medicine, University of Pennsylvania	By an Academic Development Fund by the Department of Medicine, University of Pennsylvania (Dr. Yang).	Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; CHISHOLM J, 1990, BRIT MED J, V300, P1092, DOI 10.1136/bmj.300.6732.1092; de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Hartmann M, 1996, ALIMENT PHARM THERAP, V10, P359, DOI 10.1111/j.0953-0673.1996.00359.x; Hollowell J, 1997, Popul Trends, P36; HORWITZ RI, 1980, AM J MED, V68, P255, DOI 10.1016/0002-9343(80)90363-0; Ip S, 2005, COMP EFFECTIVENESS R, V1; Irwin RS, 2006, CHEST, V129, p80S, DOI 10.1378/chest.129.1_suppl.80S; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Martin RM, 1998, ALIMENT PHARM THERAP, V12, P797; Meier CR, 2002, PHARMACOTHERAPY, V22, P303, DOI 10.1592/phco.22.5.303.33189; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; *NAT I HEALTH CAR, 2008, PRESCR DRUG EXP 2001; Perry J, 1978, OXMIS PROBLEM CODES; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; WESSLING A, 1990, EUR J CLIN PHARMACOL, V39, P207, DOI 10.1007/BF00315097; Yang YX, 2007, GASTROENTEROLOGY, V133, P748, DOI 10.1053/j.gastro.2007.06.022; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	27	202	215	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					391	W75		10.7326/0003-4819-149-6-200809160-00005	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794558				2022-12-01	WOS:000259230200003
J	Drogemuller, C; Karlsson, EK; Hytonen, MK; Perloski, M; Dolf, G; Sainio, K; Lohi, H; Lindblad-Toh, K; Leeb, T				Droegemueller, Cord; Karlsson, Elinor K.; Hytonen, Marjo K.; Perloski, Michele; Dolf, Gaudenz; Sainio, Kirsi; Lohi, Hannes; Lindblad-Toh, Kerstin; Leeb, Tosso			A mutation in hairless dogs implicates FOXI3 in ectodermal development	SCIENCE			English	Article									[Droegemueller, Cord; Dolf, Gaudenz; Leeb, Tosso] Univ Bern, CH-3001 Bern, Switzerland; [Karlsson, Elinor K.; Perloski, Michele; Lindblad-Toh, Kerstin] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Karlsson, Elinor K.; Perloski, Michele; Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02142 USA; [Hytonen, Marjo K.; Sainio, Kirsi] Inst Biomed, Helsinki 00014, Finland; [Hytonen, Marjo K.; Lohi, Hannes] Univ Helsinki, FIN-00014 Helsinki, Finland; [Lindblad-Toh, Kerstin] Uppsala Univ, S-75124 Uppsala, Sweden	University of Bern; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; Uppsala University	Leeb, T (corresponding author), Univ Bern, CH-3001 Bern, Switzerland.	Tosso.Leeb@itz.unibe.ch	Leeb, Tosso/G-3187-2014; Lohi, Hannes/F-4596-2011	Leeb, Tosso/0000-0003-0553-4880; Lohi, Hannes/0000-0003-1087-5532; Karlsson, Elinor/0000-0002-4343-3776; Drogemuller, Cord/0000-0001-9773-522X; Hytonen, Marjo/0000-0003-1976-5874	UniBern Research Foundation; Academy of Finland; Sigrid Juselius Foundation.	UniBern Research Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation.(Sigrid Juselius Foundation)	Supported by the UniBern Research Foundation, the Academy of Finland, and the Sigrid Juselius Foundation.	Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kimura T, 1996, EXP ANIM TOKYO, V45, P1, DOI 10.1538/expanim.45.1; O'Brien DP, 2005, J HERED, V96, P727, DOI 10.1093/jhered/esi086; Ohyama T, 2004, DEV DYNAM, V231, P640, DOI 10.1002/dvdy.20160; ROBINSON R, 1985, J HERED, V76, P217, DOI 10.1093/oxfordjournals.jhered.a110074; VONLINNE C, 1958, SYSTEMA NATURAE, P39	6	118	121	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1462	1462		10.1126/science.1162525	http://dx.doi.org/10.1126/science.1162525			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787161				2022-12-01	WOS:000259121800031
J	Morey, M; Yee, SK; Herman, T; Nern, A; Blanco, E; Zipursky, SL				Morey, Marta; Yee, Susan K.; Herman, Tory; Nern, Aljoscha; Blanco, Enrique; Zipursky, S. Lawrence			Coordinate control of synaptic-layer specificity and rhodopsins in photoreceptor neurons	NATURE			English	Article							DROSOPHILA VISUAL-SYSTEM; AXON-TARGET INTERACTIONS; TRANSCRIPTION FACTOR; CELL FATES; NF-Y; R7; SENSELESS; DIFFERENTIATION; SELECTION; PROSPERO	How neurons make specific synaptic connections is a central question in neurobiology. The targeting of the Drosophila R7 and R8 photoreceptor axons to different synaptic layers in the brain provides a model with which to explore the genetic programs regulating target specificity. In principle this can be accomplished by cell- type- specific molecules mediating the recognition between synaptic partners(1). Alternatively, specificity could also be achieved through cell- type- specific repression of particular targeting molecules. Here we show that a key step in the targeting of the R7 neuron is the active repression of the R8 targeting program. Repression is dependent on NF-YC, a subunit of the NF-Y ( nuclear factor Y) transcription factor(2). In the absence of NF-YC, R7 axons terminate in the same layer as R8 axons. Genetic experiments indicate that this is due solely to the derepression of the R8specific transcription factor Senseless(3) ( Sens) late in R7 differentiation. Sens is sufficient to control R8 targeting specificity and we demonstrate that Sens directly binds to an evolutionarily conserved DNA sequence upstream of the start of transcription of an R8- specific cell- surface protein, Capricious ( Caps) that regulates R8 target specificity. We show that R7 targeting requires the R7- specific transcription factor Prospero(4,5) ( Pros) in parallel to repression of the R8 targeting pathway by NF-YC. Previous studies demonstrated that Sens(6,7) and Pros(8) directly regulate the expression of specific rhodopsins in R8 and R7. We propose that the use of the same transcription factors to promote the cell- type- specific expression of sensory receptors and cell- surface proteins regulating synaptic target specificity provides a simple and general mechanism for ensuring that transmission of sensory information is processed by the appropriate specialized neural circuits.	[Morey, Marta; Yee, Susan K.; Herman, Tory; Nern, Aljoscha; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Blanco, Enrique] Univ Barcelona, Dept Genet, E-08028 Barcelona, Catalunya, Spain; [Blanco, Enrique] Univ Barcelona, IBUB, E-08028 Barcelona, Catalunya, Spain	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Barcelona; University of Barcelona	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Blanco, Enrique/I-5902-2015; Ramonell, Marta Morey/AAS-1160-2020; Ramonell, Marta Morey/F-8864-2015	Blanco, Enrique/0000-0001-6261-7370; Ramonell, Marta Morey/0000-0001-9732-1983; Ramonell, Marta Morey/0000-0001-9732-1983; Zipursky, Stephen/0000-0001-5630-7181	Ruth L. Kirschstein National Research Service Award [GM7185]; Burroughs Wellcome Fund for Biomedical Research; European Molecular Biology Organization; Human Frontiers Science Program; Juan de la Cierva postdoctoral contract; Ministerio de Educacion y Ciencia [BMC2006- 07334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund for Biomedical Research(Burroughs Wellcome Fund); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); Juan de la Cierva postdoctoral contract; Ministerio de Educacion y Ciencia(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. N. Jan, H. J. Bellen, A. Nose, S. Britt, C. Desplan, T. Cook, U. Banerjee, the Developmental Studies Hybridoma Bank and Bloomington Stock Center for reagents; H. Schjerven, S. T. Smale and M. Carey for advice and assistance with gel-shift assays; and members of the Zipursky laboratory for comments on the manuscript. S.L.Z. is an investigator of the Howard Hughes Medical Institute. M.M. was supported by the Howard Hughes Medical Institute. S.K.Y. was supported by the Ruth L. Kirschstein National Research Service Award GM7185. T.H. was supported by the Burroughs Wellcome Fund for Biomedical Research. A.N. was supported by the European Molecular Biology Organization and the Human Frontiers Science Program. E. B. was supported by Juan de la Cierva postdoctoral contract and the grant BMC2006- 07334 from the Ministerio de Educacion y Ciencia (MEC), Spain.	Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Domingos PM, 2004, DEV BIOL, V273, P121, DOI 10.1016/j.ydbio.2004.05.026; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Miller AC, 2008, DEVELOPMENT, V135, P707, DOI 10.1242/dev.016386; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yoshioka Y, 2007, GENESIS, V45, P21, DOI 10.1002/dvg.20260	29	64	64	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					795	U82		10.1038/nature07419	http://dx.doi.org/10.1038/nature07419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18978774	Green Accepted			2022-12-01	WOS:000261559900050
J	Dimitrova, N; Chen, YCM; Spector, DL; de Lange, T				Dimitrova, Nadya; Chen, Yi-Chun M.; Spector, David L.; de Lange, Titia			53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility	NATURE			English	Article							DNA-DAMAGE; PROTEIN 53BP1; MDC1; TRF2; ATM; BINDING; PROTECTION; DYNAMICS; MEDIATOR; LENGTH	Double- strand breaks activate the ataxia telangiectasia mutated ( ATM) kinase, which promotes the accumulation of DNA damage factors in the chromatin surrounding the break. The functional significance of the resulting DNA damage foci is poorly understood. Here we show that 53BP1 ( also known as TRP53BP1), a component of DNA damage foci, changes the dynamic behaviour of chromatin to promote DNA repair. We used conditional deletion of the shelterin component TRF2 ( also known as TERF2) from mouse cells ( TRF2(fl/-)) to deprotect telomeres, which, like doublestrand breaks, activate the ATM kinase, accumulate 53BP1 and are processed by non- homologous end joining (NHEJ)(1,2). Deletion of TRF2 from 53BP1- deficient cells established that NHEJ of dysfunctional telomeres is strongly dependent on the binding of 53BP1 to damaged chromosome ends. To address the mechanism by which 53BP1 promotes NHEJ, we used time- lapse microscopy to measure telomere dynamics before and after their deprotection. Imaging showed that deprotected telomeres are more mobile and sample larger territories within the nucleus. This change in chromatin dynamics was dependent on 53BP1 and ATM but did not require a functional NHEJ pathway. We propose that the binding of 53BP1 near DNA breaks changes the dynamic behaviour of the local chromatin, thereby facilitating NHEJ repair reactions that involve distant sites, including joining of dysfunctional telomeres and AID ( also known as AICDA)- induced breaks in immunoglobulin class- switch recombination.	[Dimitrova, Nadya; de Lange, Titia] Rockefeller Univ, New York, NY 10065 USA; [Chen, Yi-Chun M.; Spector, David L.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Rockefeller University; Cold Spring Harbor Laboratory	de Lange, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIH [GM049046]; NIH Director's Pioneer Award [OD000379, EY18244, GM42694]; HHMI pre-doctoral fellowship; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046, R01GM049046, R01GM042694] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI pre-doctoral fellowship(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Chen for his gift of 53BP1- and MDC1-deficient mice. We thank D. White for expert mouse husbandry. We thank the Bio- Imaging Facilities at Cold Spring Harbor Laboratory and at The Rockefeller University. J. Petrini is thanked for his gift of NBS1 antibody, A. Sfeir for providing the TRF1 antibody and A. Konishi for the BP1- 2 construct. M. Dimitrov is thanked for mathematical advice on data analysis, and S. Jaramillo and Y. Fu for Matlab programming. Members of the de Lange laboratory are thanked for comments on the manuscript. This work was supported by a grant from the NIH (GM049046) and by the NIH Director's Pioneer Award (OD000379) to T. d. L., and grants from the NIH to D. L. S. (EY18244 and GM42694). N. D. was supported by an HHMI pre-doctoral fellowship.	Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fernandez-Capetillo O, 2003, J CELL BIOL, V163, P15, DOI 10.1083/jcb.200305124; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	31	422	428	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					524	U51		10.1038/nature07433	http://dx.doi.org/10.1038/nature07433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18931659	Green Accepted			2022-12-01	WOS:000261170500043
J	Ennis, S; Jomary, C; Mullins, R; Cree, A; Chen, XL; MacLeod, A; Jones, S; Collins, A; Stone, E; Lotery, A				Ennis, Sarah; Jomary, Catherine; Mullins, Robert; Cree, Angela; Chen, Xaoli; MacLeod, Alex; Jones, Stephen; Collins, Andrew; Stone, Edwin; Lotery, Andrew			Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study	LANCET			English	Article							COMPLEMENT FACTOR-H; RANIBIZUMAB; RISK; POLYMORPHISM; METAANALYSIS; BEVACIZUMAB; MECHANISMS; INHIBITOR; COMPONENT; DISEASE	Background Age-related macular degeneration is the most prevalent form of visual impairment and blindness in developed countries. Genetic studies have made advancements in establishing the molecular cause of this disease, identifying mutations in the complement factor H (CFH) gene and a locus on chromosome 10 encompassing the HTRA1/LOC387715/ARMS2 genes. Variants in complement 3 (C3) and an HLA locus containing both factor B and C2 genes have also been implicated. We aimed to identify further genetic risk factors for this disease. Methods We used a case-control study design in a UK sample of patients with age-related macular degeneration (n=479) and controls (n=479) and undertook a low-density screen of 32 genes using 93 single nucleotide polymorphisms (SNPs). Genes were selected as candidates on the basis of potential functional relevance to age-related macular degeneration. Significant initial findings were confirmed by replication in an independent US cohort of 248 unrelated patients with disease and 252 controls, and by high-density genotyping around association signals. Findings The SNP variant rs2511989, located within intron six of the SERPING1 gene, showed highly significant genotypic association with age-related macular degeneration (uncorrected p=4.0x10(-5), corrected p=0.00372). We detected no evidence for association between disease and the other 31 candidate genes. The odds ratio for age-related macular degeneration in rs251.1989 G/A heterozygotes compared with wild type G/G homozygotes was 0 . 63 (95% CI 0 . 47-0 . 84). A similar comparison of the A/A homozygotes with the wild type yielded an odds ratio of 0 . 44 (0.31-0 . 64). We replicated the observed genotypic association in a US cohort (p=0.008). Furthermore, a secondary high-density genotyping study across the SERPING1 gene region identified five additional S N P variants similarly associated with age-related macular degeneration (rs2244169, rs2511990, rs2509897, rs1005510, and rs2511988). Interpretation Genetic variation in SERPING1 significantly alters susceptibility to age-related macular degeneration. SERPING1 encodes the C1 inhibitor, which has a crucial role in inhibition of complement component 1 (C1) and might implicate the classic pathway of complement activation in this disease. Funding Macula Vision Research Foundation, the Macular Disease Society, the Wellcome Trust, Brian Mercer Trust, the American Health Assistance Foundation, National institutes of Health, the Howard Hughes Medical Institute.	[Jomary, Catherine; Cree, Angela; Chen, Xaoli; Lotery, Andrew] Southampton Gen Hosp, Clin Neurosci Div, Southampton SO16 6YD, Hants, England; [MacLeod, Alex; Lotery, Andrew] Southampton Gen Hosp, Southampton Eye Unit, Southampton SO16 6YD, Hants, England; [Ennis, Sarah; Collins, Andrew] Southampton Gen Hosp, Div Human Genet, Genet Epidemiol & Bioinformat Grp, Southampton SO16 6YD, Hants, England; [Mullins, Robert; Stone, Edwin] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Jones, Stephen] Kings Coll London, Rayne Inst, St Thomas Hosp, London WC2R 2LS, England; [Stone, Edwin] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Southampton; University of Southampton; University of Southampton; University of Iowa; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Howard Hughes Medical Institute	Lotery, A (corresponding author), Southampton Gen Hosp, Clin Neurosci Div, Mailpoint 806, Southampton SO16 6YD, Hants, England.	a.j.lotery@southampton.ac.uk	Jomary, Catherine/A-2854-2011; Collins, Andrew/A-6595-2010; Mullins, Robert F/I-6717-2013; Collins, Andrew/S-2196-2019	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; Cree, Angela/0000-0002-1987-8900; Stone, Edwin M./0000-0003-3343-4414; Lotery, Andrew/0000-0001-5541-4305; Mullins, Robert/0000-0002-5006-0891	Macula Vision Research Foundation (MVRF); Macular Disease Society; Wellcome Trust; Brian Mercer Trust; American Health Assistance Foundation; N I H [EY-017451, EY-016822]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY017451, R01EY016822] Funding Source: NIH RePORTER	Macula Vision Research Foundation (MVRF); Macular Disease Society; Wellcome Trust(Wellcome TrustEuropean Commission); Brian Mercer Trust; American Health Assistance Foundation; N I H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	For the UK studies. this research was supported by the Macula Vision Research Foundation (MVRF), the Macular Disease Society, the Wellcome Trust, Brian Mercer Trust, and the American Health Assistance Foundation. Aspects of the US-based study were Funded by the MVRF (RM), N I H grants EY-017451 (RM) and EY-016822 (B). and the Howard Hughes Medical Institute (ES). We thank Helen Griffiths, Elizabeth Faidley. Benjamin Roos, and Jessica Skeie for providing laboratory assistance; The Southampton WTCRF muses for help with sample collection; Lee Murphy and Angie Fawkes at the Edinburgh WTCRF: Jane Collier at KBioscience: and all study participants for agreeing to contribute to this research.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Bonastre J, 2002, Eur J Health Econ, V3, P94, DOI 10.1007/s10198-002-0104-y; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Cicardi M, 1996, NEW ENGL J MED, V334, P1666, DOI 10.1056/NEJM199606203342510; DAVIS AE, 1992, NAT GENET, V1, P354, DOI 10.1038/ng0892-354; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lotery A, 2007, HUM GENET, V122, P219, DOI 10.1007/s00439-007-0406-3; Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mullins RF, 2006, MOL VIS, V12, P224; Raftery J, 2007, BRIT J OPHTHALMOL, V91, P1244, DOI 10.1136/bjo.2007.116616; Raftery JP, 2007, BRIT MED J, V334, P381, DOI 10.1136/bmj.39128.708565.3A; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Steemers FJ, 2005, PHARMACOGENOMICS, V6, P777, DOI 10.2217/14622416.6.7.777; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	129	132	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1828	1834		10.1016/S0140-6736(08)61348-3	http://dx.doi.org/10.1016/S0140-6736(08)61348-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18842294	Green Accepted			2022-12-01	WOS:000261112000025
J	Athale, CA; Dinarina, A; Mora-Coral, M; Pugieux, C; Nedelec, F; Karsenti, E				Athale, Chaitanya A.; Dinarina, Ana; Mora-Coral, Maria; Pugieux, Celine; Nedelec, Francois; Karsenti, Eric			Regulation of Microtubule Dynamics by Reaction Cascades Around Chromosomes	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; MITOTIC-SPINDLE; GRADIENT; EFFICIENT; CHROMATIN; SYSTEMS; GTPASES; CELLS	During spindle assembly, chromosomes generate gradients of microtubule stabilization through a reaction- diffusion process, but how this is achieved is not well understood. We measured the spatial distribution of microtubule aster asymmetry around chromosomes by incubating centrosomes and micropatterned chromatin patches in frog egg extracts. We then screened for microtubule stabilization gradient shapes that would generate such spatial distributions with the use of computer simulations. Only a long- range, sharply decaying microtubule stabilization gradient could generate aster asymmetries fitting the experimental data. We propose a reaction- diffusion model that combines the chromosome generated Ran- guanosine triphosphate- Importin reaction network to a secondary phosphorylation network as a potential mechanism for the generation of such gradients.	[Athale, Chaitanya A.; Dinarina, Ana; Mora-Coral, Maria; Pugieux, Celine; Nedelec, Francois; Karsenti, Eric] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Karsenti, E (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, Heidelberg, Germany.	karsenti@embl.de	Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019; Athale, Chaitanya/G-8883-2011	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Athale, Chaitanya/0000-0002-9506-2153	Modeling and Simulation the Bioscience (BIOMS); Spanish ministry of education; European Union Specific Targeted Research Project BioMics; Human Frontier Science Program [RGY85]	Modeling and Simulation the Bioscience (BIOMS); Spanish ministry of education(Spanish Government); European Union Specific Targeted Research Project BioMics(European Commission); Human Frontier Science Program(Human Frontier Science Program)	We thank D. Foethke for inputs about the Cytosim code, M. Caudron and R. Carazo-Salas for sharing data, M. Loose for help in the initial set up of chromatin bead patterns, and the EMBL Advanced Light Microscopy Facility for invaluable help with microscopy. We acknowledge the center for Modeling and Simulation the Bioscience (BIOMS) for funding F.N. and C.A.A., the Spanish ministry of education for funding M.M.-C., European Union Specific Targeted Research Project BioMics for funding A.D., and support from Human Frontier Science Program grant RGY85.	Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; STADTMAN ER, 1977, P NATL ACAD SCI USA, V74, P2761, DOI 10.1073/pnas.74.7.2761; Stelling J, 2009, J MATH BIOL, V58, P35, DOI 10.1007/s00285-008-0162-6; Van Albada SB, 2007, PLOS COMPUT BIOL, V3, P1925, DOI 10.1371/journal.pcbi.0030195; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yokoyama H, 2008, J CELL BIOL, V180, P867, DOI 10.1083/jcb.200706189	25	62	62	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1243	1247		10.1126/science.1161820	http://dx.doi.org/10.1126/science.1161820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18948504				2022-12-01	WOS:000261033400041
J	McAlonan, K; Cavanaugh, J; Wurtz, RH				McAlonan, Kerry; Cavanaugh, James; Wurtz, Robert H.			Guarding the gateway to cortex with attention in visual thalamus	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; RETICULAR NUCLEUS; MACAQUE MONKEY; ORGANIZATION; NEURONS; GALAGO; SECTOR; MODULATION; PROJECTION; RESPONSES	The massive visual input from the eye to the brain requires selective processing of some visual information at the expense of other information, a process referred to as visual attention. Increases in the responses of visual neurons with attention have been extensively studied along the visual processing streams in monkey cerebral cortex, from primary visual areas to parietal and frontal cortex(1-4). Here we show, by recording neurons in attending macaque monkeys ( Macaca mulatta), that attention modulates visual signals before they even reach cortex by increasing responses of both magnocellular and parvocellular neurons in the first relay between retina and cortex, the lateral geniculate nucleus ( LGN). At the same time, attention decreases neuronal responses in the adjacent thalamic reticular nucleus ( TRN). Crick(5) argued for such modulation of the LGN by observing that it is inhibited by the TRN, and suggested that " the thalamus is the gateway to the cortex, the reticular complex might be described as the guardian of the gateway'', a reciprocal relationship we now show to be more than just hypothesis. The reciprocal modulation in LGN and TRN appears only during the initial visual response, but the modulation of LGN reappears later in the response, suggesting separate early and late sources of attentional modulation in LGN.	[McAlonan, Kerry; Cavanaugh, James; Wurtz, Robert H.] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	McAlonan, K (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	km@nei.nih.gov			National Eye Institute; NATIONAL EYE INSTITUTE [Z01EY000109] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural research program of the National Eye Institute. We are grateful for the assistance of J. McClurkin, A. Nichols, M. Smith, T. Ruffner and G. Tansey.	Briggs F, 2007, J NEUROSCI, V27, P5431, DOI 10.1523/JNEUROSCI.1035-07.2007; Casagrande VA, 2005, PROG BRAIN RES, V149, P11, DOI 10.1016/S0079-6123(05)49002-0; CONLEY M, 1990, EUR J NEUROSCI, V2, P211, DOI 10.1111/j.1460-9568.1990.tb00414.x; CRABTREE JW, 1989, EUR J NEUROSCI, V1, P94, DOI 10.1111/j.1460-9568.1989.tb00777.x; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fitzgibbon T, 2007, VISUAL NEUROSCI, V24, P857, DOI 10.1017/S0952523807070770; HARTING JK, 1991, J COMP NEUROL, V310, P411, DOI 10.1002/cne.903100310; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jones E. G., 2007, THALAMUS, P1270; JONES EG, 1975, J COMP NEUROL, V162, P285, DOI 10.1002/cne.901620302; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Kolmac CI, 1998, J COMP NEUROL, V396, P531; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; MONTERO VM, 1977, BRAIN RES, V138, P407, DOI 10.1016/0006-8993(77)90681-3; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Uhlrich DJ, 2003, J COMP NEUROL, V458, P128, DOI 10.1002/cne.10568; WILSON JR, 1995, ANAT REC, V242, P566, DOI 10.1002/ar.1092420413	30	334	336	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					391	U56		10.1038/nature07382	http://dx.doi.org/10.1038/nature07382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18849967	Green Accepted			2022-12-01	WOS:000261039600044
J	Matos, J; Lipp, JJ; Bogdanova, A; Guillot, S; Okaz, E; Junqueira, M; Shevchenko, A; Zachariae, WG				Matos, Joao; Lipp, Jesse J.; Bogdanova, Aliona; Guillot, Sylvine; Okaz, Elwy; Junqueira, Magno; Shevchenko, Andrej; Zachariae, Wolfgang			Dbf4-Dependent Cdc7 Kinase Links DNA Replication to the Segregation of Homologous Chromosomes in Meiosis I	CELL			English	Article							MEIOTIC RECOMBINATION; YEAST MEIOSIS; S-PHASE; CENTROMERIC COHESION; SYNAPTONEMAL COMPLEX; MONOPOLAR ATTACHMENT; MOLECULAR-BIOLOGY; FISSION YEAST; PROTEIN; INITIATION	Meiosis differs from mitosis in that DNA replication is followed by the segregation of homologous chromosomes but not sister chromatids. This depends on the formation of interhomolog connections through crossover recombination and on the attachment of sister kinetochores to microtubules emanating from the same spindle pole. We show that in yeast, the Dbf4-dependent Cdc7 kinase (DDK) provides a link between premeiotic S phase, recombination, and monopolar attachment. Independently from its established role in initiating DNA replication, DDK promotes double-strand break formation, the first step of recombination, and the recruitment of the monopolin complex to kinetochores, which is essential for monopolar attachment. DDK regulates monopolin localization together with the polo-kinase Cdc5 bound to Spo13, probably through phosphorylation of the monopolin subunit Lrs4. Thus, activation of DDK both initiates DNA replication and commits meiotic cells to reductional chromosome segregation in the first division of meiosis.	[Matos, Joao; Lipp, Jesse J.; Bogdanova, Aliona; Guillot, Sylvine; Okaz, Elwy; Junqueira, Magno; Shevchenko, Andrej; Zachariae, Wolfgang] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Zachariae, WG (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zachariae@mpi-cbg.de	Matos, Joao/C-1488-2014; Junqueira, Magno/A-7495-2012	Matos, Joao/0000-0002-3754-3709; Junqueira, Magno/0000-0002-7036-0728				Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lo HC, 2008, MOL BIOL CELL, V19, P4956, DOI 10.1091/mbc.E08-07-0755; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Ogino K, 2006, P NATL ACAD SCI USA, V103, P8131, DOI 10.1073/pnas.0602498103; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Sclafani RA, 2000, J CELL SCI, V113, P2111; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Valentin G, 2006, J BIOL CHEM, V281, P2828, DOI 10.1074/jbc.M510626200; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	42	114	115	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					662	678		10.1016/j.cell.2008.10.026	http://dx.doi.org/10.1016/j.cell.2008.10.026			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013276	Bronze			2022-12-01	WOS:000260886900017
J	Mercier, R; Petit, MA; Schbath, S; Robin, S; El Karoui, M; Boccard, F; Espeli, O				Mercier, Romain; Petit, Marie-Agnes; Schbath, Sophie; Robin, Stephane; El Karoui, Meriem; Boccard, Frederic; Espeli, Olivier			The MatP/matS Site-Specific System Organizes the Terminus Region of the E-coli Chromosome into a Macrodomain	CELL			English	Article							SEPARATE CELL HALVES; BACILLUS-SUBTILIS; DNA-REPLICATION; BINDING-SITES; SEGREGATION; PROTEIN; IDENTIFICATION; MOVEMENT; ARMS; MAINTENANCE	The organization of the Escherichia coli chromosome into insulated macrodomains influences the segregation of sister chromatids and the mobility of chromosomal DNA. Here, we report that organization of the Terminus region (Ter) into a macrodomain relies on the presence of a 13 bp motif called matS repeated 23 times in the 800-kb-long domain. matS sites are the main targets in the E. coli chromosome of a newly identified protein designated MatP. MatP accumulates in the cell as a discrete focus that colocalizes with the Ter macrodomain. The effects of MatP inactivation reveal its role as main organizer of the Ter macrodomain: in the absence of MatP, DNA is less compacted, the mobility of markers is increased, and segregation of Ter macrodomain occurs early in the cell cycle. Our results indicate that a specific organizational system is required in the Terminus region for bacterial chromosome management during the cell cycle.	[Mercier, Romain; Boccard, Frederic; Espeli, Olivier] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Petit, Marie-Agnes; El Karoui, Meriem] INRA, Unite Bacteries Lact & Pathogenes Opportuniste, UR888, F-78350 Jouy En Josas, France; [Schbath, Sophie] INRA, UR Math Informat & Genome 1077, F-78350 Jouy En Josas, France; [Robin, Stephane] AgroParisTech INRA, Unite Math & Informat Appl, UMR518, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Boccard, F (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.	boccard@cgm.cnrs-gif.fr; espeli@cgm.cnrs-gif.fr	Mercier, Romain/E-3642-2012; espeli, olivier/A-6337-2009	Petit, Marie-Agnes/0000-0003-2242-2768; El Karoui, Meriem/0000-0003-2522-613X; Boccard, Frederic/0000-0002-1866-2489; espeli, olivier/0000-0003-2804-2192; SCHBATH, Sophie/0000-0003-3574-8222	Agence Nationale de la Recherche; Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire; ACI Biologie Cellulaire, Moleculaire, Structurale; Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire; ACI Biologie Cellulaire, Moleculaire, Structurale; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank Kenneth Marians, Benedicte Michel, and Linda Sperling for critical reading of the manuscript, Stuart Austin, Flemming Hansen, Takashi Horiuchi, Christophe Possoz, and David Sherratt for the kind gift of FROS systems and the Ssb-YFP strain, and Francois-Xavier Barre, Philippe Bouloc, Nelly Dubarry, Alexandra Gruss, Christelle Hennequet-Antier, Sandrine Imbault, Christian Lesterlin, and Michele Valens for helpful discussions. The Migale bioinformatics platform (Institut National de la Recherche Agronomique) provided computational resources. Macroarrays were obtained in the framework of Program "Puces a ADN'' from Centre National de la Recherche Scientifique and the program "Microbiologie, Maladies Infectieuses et parasitaires'' of the French Ministere de l'Education Nationale, de la Recherche et de la Technologie. This study was supported by the Agence Nationale de la Recherche (F.B.), the Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire (S. S., F. B., and M. E.), the ACI Biologie Cellulaire, Moleculaire, Structurale (F. B.), and the Association pour la Recherche sur le Cancer (F. B.).	Adachi S, 2008, GENES CELLS, V13, P181, DOI 10.1111/j.1365-2443.2007.01157.x; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; BLAKELY G, 1991, NEW BIOL, V3, P789; Brezellec P, 2006, BIOINFORMATICS, V22, P1935, DOI 10.1093/bioinformatics/btl336; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Esnault E, 2007, PLOS GENET, V3, P2486, DOI 10.1371/journal.pgen.0030226; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; Guarne A, 2005, EMBO J, V24, P1502, DOI 10.1038/sj.emboj.7600634; Halpern D, 2007, PLOS GENET, V3, P1614, DOI 10.1371/journal.pgen.0030153; HILDEBRANDT ER, 1995, CELL, V81, P331, DOI 10.1016/0092-8674(95)90386-0; Hojgaard A, 1999, MOL MICROBIOL, V33, P1027, DOI 10.1046/j.1365-2958.1999.01545.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mearini G, 2006, CELL CYCLE, V5, P1989, DOI 10.4161/cc.5.17.3186; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Murtin C, 1998, J MOL BIOL, V284, P949, DOI 10.1006/jmbi.1998.2256; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Niki H, 2000, GENE DEV, V14, P212; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Robin S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-84; Sunako Y, 2001, MOL MICROBIOL, V42, P1233, DOI 10.1046/j.1365-2958.2001.02680.x; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	33	187	189	4	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					475	485		10.1016/j.cell.2008.08.031	http://dx.doi.org/10.1016/j.cell.2008.08.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984159	Green Submitted, Bronze			2022-12-01	WOS:000260536300018
J	Tang, W; Zeve, D; Suh, JM; Bosnakovski, D; Kyba, M; Hammer, RE; Tallquist, MD; Graff, JM				Tang, Wei; Zeve, Daniel; Suh, Jae Myoung; Bosnakovski, Darko; Kyba, Michael; Hammer, Robert E.; Tallquist, Michelle D.; Graff, Jonathan M.			White fat progenitor cells reside in the adipose vasculature	SCIENCE			English	Article							STEM-CELL; GENE-EXPRESSION; OBESITY; TISSUE; DIFFERENTIATION; ADIPOCYTES; PERICYTES	White adipose (fat) tissues regulate metabolism, reproduction, and life span. Adipocytes form throughout life, with the most marked expansion of the lineage occurring during the postnatal period. Adipocytes develop in coordination with the vasculature, but the identity and location of white adipocyte progenitor cells in vivo are unknown. We used genetically marked mice to isolate proliferating and renewing adipogenic progenitors. We found that most adipocytes descend from a pool of these proliferating progenitors that are already committed, either prenatally or early in postnatal life. These progenitors reside in the mural cell compartment of the adipose vasculature, but not in the vasculature of other tissues. Thus, the adipose vasculature appears to function as a progenitor niche and may provide signals for adipocyte development.	[Tang, Wei; Zeve, Daniel; Suh, Jae Myoung; Bosnakovski, Darko; Kyba, Michael; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tallquist, Michelle D.; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Graff, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	jon.graff@utsouthwestern.edu	Tallquist, Michelle/AAU-5277-2021; Suh, Jae Myoung/B-3268-2015; Bosnakovski, Darko/T-8292-2019	Tallquist, Michelle/0000-0002-1383-144X; Suh, Jae Myoung/0000-0001-8097-4662; Zeve, Daniel/0000-0002-4117-1282; Kyba, Michael/0000-0002-5579-7534; Bosnakovski, Darko/0000-0002-7198-2019	NIH; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK064261, 1R01DK066556]; University of Texas Southwestern Medical Center Excellence in Education Fund; University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064261, R01DK066556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Texas Southwestern Medical Center Excellence in Education Fund; University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Kennedy, T. Wang, R. Adams, R. Evans, S. Kernie, L. Monteggia, M. Osawa, R. Perlingeiro, Q. LaPlant, and M. Iacovino, as well as members of the Graff lab. J.M.G. is a founder of Reata Pharmaceuticals, a privately held company designed to address unmet needs in cancer, neurodegenerative, and inflammatory conditions. This work was supported by NIH and the National Institute of Diabetes and Digestive and Kidney Diseases (grants 1R01DK064261 and 1R01DK066556) and the University of Texas Southwestern Medical Center Excellence in Education Fund. W.T., J.M.G., and the University of Texas Southwestern Medical Center may file. a patent application related to the work reported here.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; CINTI S, 1984, J SUBMICR CYTOL PATH, V16, P243; COOK JR, 1982, DEV BIOL, V92, P440, DOI 10.1016/0012-1606(82)90189-0; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; IYAMA KI, 1979, VIRCHOWS ARCH B, V31, P143, DOI 10.1007/BF02889932; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; KLAUS S, 1991, J CELL BIOL, V115, P1783, DOI 10.1083/jcb.115.6.1783; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110	28	793	816	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					583	586		10.1126/science.1156232	http://dx.doi.org/10.1126/science.1156232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18801968	Green Accepted			2022-12-01	WOS:000260299100042
J	Gavathiotis, E; Suzuki, M; Davis, ML; Pitter, K; Bird, GH; Katz, SG; Tu, HC; Kim, H; Cheng, EHY; Tjandra, N; Walensky, LD				Gavathiotis, Evripidis; Suzuki, Motoshi; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.; Tjandra, Nico; Walensky, Loren D.			BAX activation is initiated at a novel interaction site	NATURE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; STABILIZED ALPHA-HELICES; BCL-X-L; BH3-ONLY PROTEINS; CELL-DEATH; INTRACELLULAR-LOCALIZATION; PROAPOPTOTIC ACTIVITY; BH3 DOMAINS; APOPTOSIS; FAMILY	BAX is a pro- apoptotic protein of the BCL- 2 family that is stationed in the cytosol until activated by a diversity of stress stimuli to induce cell death. Anti- apoptotic proteins such as BCL- 2 counteract BAX- mediated cell death. Although an interaction site that confers survival functionality has been defined for anti- apoptotic proteins, an activation site has not been identified for BAX, rendering its explicit trigger mechanism unknown. We previously developed stabilized alpha- helix of BCL- 2 domains ( SAHBs) that directly initiate BAX- mediated mitochondrial apoptosis. Here we demonstrate by NMR analysis that BIM SAHB binds BAX at an interaction site that is distinct from the canonical binding groove characterized for anti- apoptotic proteins. The specificity of the human BIM- SAHB - BAX interaction is highlighted by point mutagenesis that disrupts functional activity, confirming that BAX activation is initiated at this novel structural location. Thus, we have now defined a BAX interaction site for direct activation, establishing a new target for therapeutic modulation of apoptosis.	[Suzuki, Motoshi; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Suzuki, Motoshi; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Walensky, Loren D.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov; loren_walensky@dfci.harvard.edu		Pitter, Kenneth/0000-0002-9450-313X; Suzuki, Motoshi/0000-0002-4346-7677; Gavathiotis, Evripidis/0000-0001-6319-8331	National Cancer Institute [5P01CA92625, 5RO1CA50239, 5RO1CA125562]; Burroughs Wellcome Fund Career Award; Culpeper Scholarship in Medical Science; American Society of Hematology Junior Faculty Scholar Award; William Lawrence Children's Foundation; Intramural Research Program of the National Heart, Lung and Blood Institute; Searle Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Culpeper Scholarship in Medical Science; American Society of Hematology Junior Faculty Scholar Award; William Lawrence Children's Foundation; Intramural Research Program of the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Searle Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. Smith for editorial and graphics assistance, W. Beavers for amino acid analyses, A. Perry for technical assistance, C. Turner and A. Bielecki of the MIT/Harvard Center for Magnetic Resonance for NMR technical advice, and R. Youle for feedback on the manuscript. We acknowledge the indelible contributions of the late S.J. Korsmeyer, who inspired this work. L.D.W. is supported by National Cancer Institute (NCI) grant 5P01CA92625, a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, a Culpeper Scholarship in Medical Science from the Goldman Philanthropic Partnerships, an American Society of Hematology Junior Faculty Scholar Award, and a grant from the William Lawrence Children's Foundation. This research was also supported by NCI grant 5RO1CA50239. N.T. is supported by the Intramural Research Program of the National Heart, Lung and Blood Institute, NIH. E.H.-Y.C. is supported by the Searle Scholars Program and NCI grant 5RO1CA125562.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OLTVAI ZN, 1993, CELL, V74, P619; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Pitter K, 2008, METHOD ENZYMOL, V446, P387, DOI 10.1016/S0076-6879(08)01623-6; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	50	533	573	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1076	U6		10.1038/nature07396	http://dx.doi.org/10.1038/nature07396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948948	Green Accepted			2022-12-01	WOS:000260252600037
J	Tay, Y; Zhang, JQ; Thomson, AM; Lim, B; Rigoutsos, I				Tay, Yvonne; Zhang, Jinqiu; Thomson, Andrew M.; Lim, Bing; Rigoutsos, Isidore			MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation	NATURE			English	Article							RNA INTERFERENCE; GENE-REGULATION; BINDING-SITES; ES CELLS; PLURIPOTENCY; EXPRESSION; TARGETS; IDENTIFICATION; MECHANISMS; PATHWAY	MicroRNAs ( miRNAs) are short RNAs that direct messenger RNA degradation or disrupt mRNA translation in a sequence- dependent manner(1-7). For more than a decade, attempts to study the interaction of miRNAs with their targets were confined to the 3' untranslated regions of mRNAs(1), fuelling an underlying assumption that these regions are the principal recipients of miRNA activity. Here we focus on the mouse Nanog, Oct4 ( also known as Pou5f1) and Sox2 genes(8-11) and demonstrate the existence of many naturally occurring miRNA targets in their amino acid coding sequence ( CDS). Some of the mouse targets analysed do not contain the miRNA seed, whereas others span exon - exon junctions or are not conserved in the human and rhesus genomes. miR-134, miR- 296 and miR- 470, upregulated on retinoic- acid- induced differentiation of mouse embryonic stem cells, target the CDS of each transcription factor in various combinations, leading to transcriptional and morphological changes characteristic of differentiating mouse embryonic stem cells, and resulting in a new phenotype. Silent mutations at the predicted targets abolish miRNA activity, prevent the down regulation of the corresponding genes and delay the induced phenotype. Our findings demonstrate the abundance of CDS- located miRNA targets, some of which can be species- specific, and support an augmented model whereby animal miRNAs exercise their control on mRNAs through targets that can reside beyond the 39 untranslated region.	[Rigoutsos, Isidore] IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA; [Tay, Yvonne; Zhang, Jinqiu; Thomson, Andrew M.; Lim, Bing] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Beth Israel Med Ctr, Boston, MA 02215 USA	International Business Machines (IBM); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rigoutsos, I (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, POB 218, Yorktown Hts, NY 10598 USA.	rigoutso@us.ibm.com	Rigoutsos, Isidore/C-5381-2012; Kumar, Rajesh/E-7957-2010	Rigoutsos, Isidore/0000-0003-1529-8631	Agency for Science, Technology and Research of Singapore; A*STAR graduate scholarship; National Institutes of Health [DK47636, AI54973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR graduate scholarship(Agency for Science Technology & Research (A*STAR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Huynh for assistance with building the rna22 pipeline that was used to make the miRNA target predictions, and H. Zhang and Y.L. Lee for their help with some of the constructs. The work of Y.T., J.Z., A.M.T. and B.L. was supported by the Agency for Science, Technology and Research of Singapore. Y.T. was the recipient of an A*STAR graduate scholarship. B.L. was also partially supported by National Institutes of Health grants DK47636 and AI54973.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thomson AM, 2005, J BIOL CHEM, V280, P30032, DOI 10.1074/jbc.M502951200	30	1077	1156	0	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1124	U12		10.1038/nature07299	http://dx.doi.org/10.1038/nature07299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806776				2022-12-01	WOS:000260252600048
J	Hamilton, EE; Kay, SA				Hamilton, Elizabeth E.; Kay, Steve A.			SnapShot: Circadian Clock Proteins	CELL			English	Editorial Material									[Hamilton, Elizabeth E.; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hamilton, EE (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.		Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878				Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Hardin PE, 2006, CURR OPIN NEUROBIOL, V16, P686, DOI 10.1016/j.conb.2006.09.001; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030	10	20	21	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					368	U16	368.e1	10.1016/j.cell.2008.09.042	http://dx.doi.org/10.1016/j.cell.2008.09.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957209	Bronze			2022-12-01	WOS:000260130400027
J	Sugarman, J; Siegel, AW				Sugarman, Jeremy; Siegel, Andrew W.			When embryonic stem cell lines fail to meet consent standards	SCIENCE			English	Editorial Material									[Sugarman, Jeremy; Siegel, Andrew W.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA	Johns Hopkins University	Sugarman, J (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA.	jsugarm1@jhmi.edu		Sugarman, Jeremy/0000-0001-7022-8332				BAKER M, 2008, N NEWS          0728; *COMM GUID EMBR ST, 2005, GUID HUMAN EMBR STEM; *HUM EMBR STEM CEL, 2007, AM NAT AC GUID HUM E; KELLER J, 2008, CHRON HIGHER ED 0728; Lyerly AD, 2007, SCIENCE, V317, P46, DOI 10.1126/science.1145067; National Bioethics Advisory Committee, 1999, RES INV HUM BIOL MAT, V1; National Institute of Health, 1994, REP HUM EMBR RES PAN; *NIH, 2000, FED REGISTER, V65, P51976; Streiffer R, 2008, HASTINGS CENT REP, V38, P40; Sugarman J, 2008, CELL STEM CELL, V3, P238, DOI 10.1016/j.stem.2008.08.012; The International Society for Stem Cell Research (ISSCR), 2006, GUID COND HUM EMBR S; WEISS R, 2008, ETHICALLY CHALLENGED	12	11	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					379	379		10.1126/science.1164441	http://dx.doi.org/10.1126/science.1164441			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927375				2022-12-01	WOS:000260094500025
J	Janoueix-Lerosey, I; Lequin, D; Brugieres, L; Ribeiro, A; de Pontual, L; Combaret, V; Raynal, V; Puisieux, A; Schleiermacher, G; Pierron, G; Valteau-Couanet, D; Frebourg, T; Michon, J; Lyonnet, S; Amiel, J; Delattre, O				Janoueix-Lerosey, Isabelle; Lequin, Delphine; Brugieres, Laurence; Ribeiro, Agnes; de Pontual, Loic; Combaret, Valerie; Raynal, Virginie; Puisieux, Alain; Schleiermacher, Gudrun; Pierron, Gaelle; Valteau-Couanet, Dominique; Frebourg, Thierry; Michon, Jean; Lyonnet, Stanislas; Amiel, Jeanne; Delattre, Olivier			Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; GENE; IDENTIFICATION; NPM; INHIBITOR; PROTEIN; FUSION; FLT3	Neuroblastoma, a tumour derived from the peripheral sympathetic nervous system, is one of the most frequent solid tumours in childhood(1,2). It usually occurs sporadically but familial cases are observed, with a subset of cases occurring in association with congenital malformations of the neural crest being linked to germline mutations of the PHOX2B gene(1-4). Here we conducted genome-wide comparative genomic hybridization analysis on a large series of neuroblastomas. Copy number increase at the locus encoding the anaplastic lymphoma kinase (ALK)(5) tyrosine kinase receptor was observed recurrently. One particularly informative case presented a high- level gene amplification that was strictly limited to ALK, indicating that this gene may contribute on its own to neuroblastoma development. Through subsequent direct sequencing of cell lines and primary tumour DNAs we identified somatic mutations of the ALK kinase domain that mainly clustered in two hotspots. Germline mutations were observed in two neuroblastoma families, indicating that ALK is a neuroblastoma predisposition gene. Mutated ALK proteins were overexpressed, hyperphosphorylated and showed constitutive kinase activity. The knockdown of ALK expression in ALK- mutated cells, but also in cell lines overexpressing a wild- type ALK, led to a marked decrease of cell proliferation. Altogether, these data identify ALK as a critical player in neuroblastomadevelopment that may hence represent a very attractive therapeutic target in this disease that is still frequently fatal with current treatments(6,7).	[Janoueix-Lerosey, Isabelle; Lequin, Delphine; Raynal, Virginie; Schleiermacher, Gudrun; Delattre, Olivier] Inst Curie, Ctr Rech, F-94805 Villejuif, France; [Janoueix-Lerosey, Isabelle; Lequin, Delphine; Raynal, Virginie; Schleiermacher, Gudrun; Delattre, Olivier] INSERM, U830, F-94805 Villejuif, France; [Brugieres, Laurence; Valteau-Couanet, Dominique] Inst Gustave Roussy, Dept Pediat, F-94805 Villejuif, France; [Ribeiro, Agnes; Pierron, Gaelle; Delattre, Olivier] Inst Curie, Unite Genet Somat, F-75248 Paris, France; [de Pontual, Loic; Lyonnet, Stanislas; Amiel, Jeanne] Univ Paris 05, Dept Genet, Fac Med, F-75743 Paris 15, France; [de Pontual, Loic; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, INSERM, U781, F-75743 Paris 15, France; [Combaret, Valerie; Puisieux, Alain] Ctr Leon Berard, FNCLCC, Lab Rech Translat, F-69008 Lyon, France; [Puisieux, Alain] INSERM, U590, F-69008 Lyon, France; [Puisieux, Alain] Univ Lyon 1, Inst Sci Pharmaceut & Biol, F-69008 Lyon, France; [Schleiermacher, Gudrun; Michon, Jean] Inst Curie, Dept Pediat, F-75248 Paris, France; [Frebourg, Thierry] CHU Rouen, Serv Genet, F-76183 Rouen, France; [Frebourg, Thierry] Fac Med Pharm, INSERM, U614, F-76183 Rouen, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Delattre, O (corresponding author), Inst Curie, Ctr Rech, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	olivier.delattre@curie.fr	Lyonnet, Stanislas/H-5483-2017; Frebourg, Thierry/AAK-8390-2020; Schleiermacher, Gudrun/AAN-4711-2021; amiel, jeanne/H-3501-2017; amiel, jeanne/AGX-1124-2022; Janoueix-Lerosey, Isabelle/G-1758-2018	Lyonnet, Stanislas/0000-0001-5426-9417; Schleiermacher, Gudrun/0000-0002-0133-5879; amiel, jeanne/0000-0001-5973-4728; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; delattre, olivier/0000-0002-8730-2276; PUISIEUX, Alain/0000-0002-9938-3798; Frebourg, Thierry/0000-0003-0399-4007; DE PONTUAL, LOIC/0000-0002-3123-0453	Agence Nationale pour la Recherche; Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project); APAESIC; Association Hubert Gouin; Comite de l'Ain of the Ligue Nationale contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project)(Institut National du Cancer (INCA) France); APAESIC; Association Hubert Gouin; Comite de l'Ain of the Ligue Nationale contre le Cancer	We are grateful to F. Moreau-Gachelin, I. Gallais, D. Surdez, F. Tirode, A. Fix, F. Bourdeaut, A. Almeida, C. Lucchesi, S. Roman Roman, B. Bressac, J. Benard and G. Vassal for their critical help. We thank C. Decraene, D. Gentien and B. Albaud from the translational department of Institut Curie for profiling the paediatric tumours, and P. Rosa and E. Barillot for the development of bioinformatic tools. We thank M. Lathrop and the Centre National de Genotypage for the Affymetrix 100K SNP analysis and A. Chompret for collecting families. This work was supported by grants from the Agence Nationale pour la Recherche, the Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project), the APAESIC ( Association des Parents et des Amis des Enfants Soignes a l'Institut Curie), the Association Hubert Gouin, les amis de Claire, Les Bagouz a Manon and Enfance et Sante. A. P. and V. C. are supported by the Comite de l'Ain of the Ligue Nationale contre le Cancer.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT MED, V14, P676, DOI 10.1038/nm1769; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Griffin CA, 1999, CANCER RES, V59, P2776; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tonini GP, 2003, CANCER LETT, V197, P41, DOI 10.1016/S0304-3835(03)00080-6; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	27	633	665	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					967	U51		10.1038/nature07398	http://dx.doi.org/10.1038/nature07398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923523				2022-12-01	WOS:000260038300050
J	Jenkins, HE; Aylward, RB; Gasasira, A; Donnelly, CA; Abanida, EA; Koleosho-Adelekan, T; Grassly, NC				Jenkins, Helen E.; Aylward, R. Bruce; Gasasira, Alex; Donnelly, Christl A.; Abanida, Emmanuel A.; Koleosho-Adelekan, Titi; Grassly, Nicholas C.			Effectiveness of immunization against paralytic poliomyelitis in Nigeria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL POLIOVIRUS VACCINE; ACUTE FLACCID PARALYSIS; IMMUNOGENICITY; SURVEILLANCE; ERADICATION; BRAZIL; INDIA; RISK	Background: The number of cases of paralytic poliomyelitis has declined in Nigeria since the introduction of newly licensed monovalent oral poliovirus vaccines and new techniques of vaccine delivery. Understanding the relative contribution of these vaccines and the improved coverage to the decline in incident cases is essential for future planning. Methods: We estimated the field efficacies of monovalent type 1 oral poliovirus vaccine and trivalent oral poliovirus vaccine, using the reported number of doses received by people with poliomyelitis and by matched controls as identified in Nigeria's national surveillance database, in which 27,379 cases of acute flaccid paralysis were recorded between 2001 and 2007. Our estimates of vaccine coverage and vaccine-induced immunity were based on the number of doses received by children listed in the database who had paralysis that was not caused by poliovirus. Results: The estimated efficacies per dose of monovalent type 1 oral poliovirus vaccine and trivalent oral poliovirus vaccine against type 1 paralytic poliomyelitis were 67% (95% confidence interval [CI], 39 to 82) and 16% (95% CI, 10 to 21), respectively, and the estimated efficacy per dose of trivalent oral poliovirus vaccine against type 3 paralytic poliomyelitis was 18% (95% CI, 9 to 26). In the northwestern region of Nigeria, which reported the majority of cases during the study period, coverage with at least one dose of vaccine increased from 59 to 78%. Between 2005 and 2007, vaccine-induced immunity levels among children under the age of 5 years more than doubled, to 56%. Conclusions: The higher efficacy of monovalent type 1 oral poliovirus vaccine (four times as effective as trivalent oral poliovirus vaccine) and the moderate gains in coverage dramatically increased vaccine-induced immunity against serotype 1 in northern Nigeria. Further increases in coverage in Nigerian states with infected populations are required to achieve the levels of vaccine-induced immunity associated with the sustained elimination achieved in other parts of the country.	[Jenkins, Helen E.; Donnelly, Christl A.; Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modeling, Dept Infect Dis Epidemiol, Fac Med, London W2 1PG, England; [Aylward, R. Bruce] WHO, Global Polio Eradicat Initiat, CH-1211 Geneva, Switzerland; [Gasasira, Alex] WHO Nigeria, Abuja, Nigeria; [Abanida, Emmanuel A.; Koleosho-Adelekan, Titi] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria	Imperial College London; World Health Organization	Jenkins, HE (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modeling, Dept Infect Dis Epidemiol, Fac Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	h.jenkins@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Donnelly, Christl/0000-0002-0195-2463; Jenkins, Helen/0000-0003-4749-1591	MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719B] Funding Source: researchfish; Medical Research Council [G0600719] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDRUS JK, 1995, B WORLD HEALTH ORGAN, V73, P33; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; CIRNE MD, 1995, J INFECT DIS, V171, P1097, DOI 10.1093/infdis/171.5.1097; *FED REP NIG NAT P, 2006, NAT IMM COV SURV 200; *FED REP NIG NAT P, 2007, LEG NOT PUBL 2006 CE; *FED REP NIG NAT P, 2003, DEM HLTH SURV NIG 20; Gary HE, 1997, J INFECT DIS, V175, pS135, DOI 10.1093/infdis/175.Supplement_1.S135; Grassly NC, 2007, LANCET, V369, P1790; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Kohler KA, 2002, B WORLD HEALTH ORGAN, V80, P210; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; Pallansch MA, 2006, NEW ENGL J MED, V355, P2508, DOI 10.1056/NEJMp068200; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; *WHO, 2004, GLOB POL ER IN PROGR; 1999, MMWR MORB MORTAL WKL, V48, P312; 2007, MMWR MORB MORTAL WKL, V56, P996	17	43	47	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1666	U111		10.1056/NEJMoa0803259	http://dx.doi.org/10.1056/NEJMoa0803259			33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923171				2022-12-01	WOS:000260041400005
J	Donovan, CA				Donovan, Cory A.			Babies having babies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												coryadonovan@gmail.com							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1739	1740		10.1001/jama.300.15.1739	http://dx.doi.org/10.1001/jama.300.15.1739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854523				2022-12-01	WOS:000260002000001
J	Holman, CM				Holman, Christopher M.			Trends in human gene patent litigation	SCIENCE			English	Editorial Material									[Holman, Christopher M.] Univ Missouri, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Holman, CM (corresponding author), Univ Missouri, Kansas City, MO 64110 USA.	holmancm@umkc.edu						Barton JH, 2006, NAT BIOTECHNOL, V24, P939, DOI 10.1038/nbt0806-939; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Crichton M, 2007, NY TIMES, pA23; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Holman Christopher M, 2007, UMKC L REV, V76, P295; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Lemley MA, 2005, J ECON PERSPECT, V19, P75, DOI 10.1257/0895330054048650; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; Williams-Jones Bryn, 2002, Health Law J, V10, P123	12	25	25	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					198	199		10.1126/science.1160687	http://dx.doi.org/10.1126/science.1160687			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	358FK	18845733				2022-12-01	WOS:000259902300024
J	Hou, XG; Siveter, DJ; Aldridge, RJ; Siveter, DJ				Hou, Xian-Guang; Siveter, Derek J.; Aldridge, Richard J.; Siveter, David J.			Collective behavior in an early Cambrian arthropod	SCIENCE			English	Article									[Hou, Xian-Guang] Yunnan Univ, Yunnan Key Lab Paleobiol, Kunming 650091, Peoples R China; [Siveter, Derek J.] Univ Oxford, Univ Museum, Oxford, England; [Siveter, Derek J.] Univ Oxford, Dept Earth Sci, Oxford, England; [Aldridge, Richard J.; Siveter, David J.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England	Yunnan University; University of Oxford; University of Oxford; University of Leicester	Hou, XG (corresponding author), Yunnan Univ, Yunnan Key Lab Paleobiol, Kunming 650091, Peoples R China.	xghou@ynu.edu.cn			National Natural Foundation [40730211]; 973 Program of China [2006CB806400]; Science and Technology Department of Yunnan [2005D0002Z]; Royal Society	National Natural Foundation(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); Science and Technology Department of Yunnan; Royal Society(Royal Society of London)	Thanks to National Natural Foundation (40730211) and 973 Program of China (2006CB806400); Science and Technology Department of Yunnan (2005D0002Z); the Royal Society; and G. Boxshall, S. de Grave, G. McGavin, and A. Parker for discussion.	BONE Q, 1998, BIOL PELAGIC TUNICAT, P5; CHATTERTON BDE, 2008, ADV TRILOBITE RES CU, V9, P73; HERRNKIN.W, 1969, SCIENCE, V164, P1425, DOI 10.1126/science.164.3886.1425; Holldobler B., 1990, pi; Scoble M.J., 1992, LEPIDOPTERA FORM FUN; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733	6	25	31	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					224	224		10.1126/science.1162794	http://dx.doi.org/10.1126/science.1162794			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845748				2022-12-01	WOS:000259902300038
J	Sander, PM; Clauss, M				Sander, P. Martin; Clauss, Marcus			Sauropod gigantism	SCIENCE			English	Editorial Material							GROWTH-RATES; EVOLUTION; PHYSIOLOGY; HISTOLOGY; DINOSAURS		[Sander, P. Martin] Univ Bonn, Div Paleontol, Steinmann Inst, D-53115 Bonn, Germany; [Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, CH-8057 Zurich, Switzerland	University of Bonn; University of Zurich	Sander, PM (corresponding author), Univ Bonn, Div Paleontol, Steinmann Inst, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de; mclauss@vetclinics.uzh.ch	Clauss, Marcus/A-4710-2008; Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207				Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Christian Andreas, 2007, Fossil Record, V10, P38; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Farlow J.O., 1990, P43; Gaudin Timothy J., 2006, P1; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Hummel J, 2008, EVOL ECOL RES, V10, P925; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; JANIS CM, 1991, ANN ZOOL FENN, V28, P201; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; PERRY SF, J EXP ZOOL A; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Senter P, 2007, J ZOOL, V271, P45, DOI 10.1111/j.1469-7998.2006.00197.x; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763	24	79	79	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					200	201		10.1126/science.1160904	http://dx.doi.org/10.1126/science.1160904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845734				2022-12-01	WOS:000259902300025
J	Curran, DP				Curran, Dennis P.			Chemistry - Fluorous tags unstick messy chemical biology problems	SCIENCE			English	Editorial Material							MASS-SPECTROMETRY; MICROARRAYS		[Curran, Dennis P.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Curran, DP (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15208 USA.	curran@pitt.edu						Brittain SM, 2005, NAT BIOTECHNOL, V23, P463, DOI 10.1038/nbt1076; Jaipuri FA, 2008, ANGEW CHEM INT EDIT, V47, P1707, DOI 10.1002/anie.200704262; Ko KS, 2005, J AM CHEM SOC, V127, P13162, DOI 10.1021/ja054811k; KOBOS RK, 1989, TRENDS BIOTECHNOL, V7, P101, DOI 10.1016/0167-7799(89)90008-5; Northen TR, 2008, P NATL ACAD SCI USA, V105, P3678, DOI 10.1073/pnas.0712332105; Vegas AJ, 2007, ANGEW CHEM INT EDIT, V46, P7960, DOI 10.1002/anie.200703198; Zhang W, 2006, TETRAHEDRON, V62, P11837, DOI 10.1016/j.tet.2006.08.051	7	51	52	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1645	1646		10.1126/science.1158721	http://dx.doi.org/10.1126/science.1158721			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801990				2022-12-01	WOS:000259300400024
J	Dai, J; Hyland, EM; Yuan, DS; Huang, HL; Bader, JS; Boeke, JD				Dai, Junbiao; Hyland, Edel M.; Yuan, Daniel S.; Huang, Hailiang; Bader, Joel S.; Boeke, Jef D.			Probing nucleosome function: A highly versatile library of synthetic histone H3 and H4 mutants	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; LYSINE METHYLATION; H2B UBIQUITYLATION; GLOBULAR DOMAIN; GENE-EXPRESSION; MATING-TYPE; DNA-REPAIR; CELL-CYCLE; YEAST; ACETYLATION	Nucleosome structural integrity underlies the regulation of DNA metabolism and transcription. Using a synthetic approach, a versatile library of 486 systematic histone H3 and H4 substitution and deletion mutants that probes the contribution of each residue to nucleosome function was generated in Saccharomyces cerevisiae. We probed fitness contributions of each residue to perturbations of chromosome integrity and transcription, mapping global patterns of chemical sensitivities and requirements for transcriptional silencing onto the nucleosome surface. Each histone mutant was tagged with unique molecular barcodes, facilitating identification of histone mutant pools through barcode amplification, labeling, and TAG microarray hybridization. Barcodes were used to score complex phenotypes such as competitive fitness in a chemostat, DNA repair proficiency, and synthetic genetic interactions, revealing new functions for distinct histone residues and new interdependencies among nucleosome components and their modifiers.	[Dai, Junbiao; Hyland, Edel M.; Yuan, Daniel S.; Huang, Hailiang; Bader, Joel S.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Huang, Hailiang; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jboeke@jhmi.edu	Dai, Junbiao/AAB-8328-2021; Bader, Joel/A-1818-2009	Dai, Junbiao/0000-0002-5299-4700; Bader, Joel/0000-0002-6020-4625; Huang, Hailiang/0000-0003-1461-5762; Boeke, Jef/0000-0001-5322-4946	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020839, RR020839, U54 RR020839-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; CHATTOO BB, 1979, GENETICS, V93, P51; Cheung WL, 2005, CURR BIOL, V15, P656, DOI 10.1016/j.cub.2005.02.049; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; HORIUCHI T, 1962, BIOCHIM BIOPHYS ACTA, V55, P152; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jessulat M, 2008, ARCH BIOCHEM BIOPHYS, V469, P157, DOI 10.1016/j.abb.2007.11.001; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kamiya K, 2007, MOL CELL BIOL, V27, P3489, DOI 10.1128/MCB.00665-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Ooi SL, 2003, NAT GENET, V35, P277, DOI 10.1038/ng1258; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwartz BE, 2006, CURR TOP DEV BIOL, V74, P31, DOI 10.1016/S0070-2153(06)74002-9; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Yu CL, 2006, J BIOL CHEM, V281, P9755, DOI 10.1074/jbc.M513178200; Yuan DS, 2006, BIOINFORMATICS, V22, P3054, DOI 10.1093/bioinformatics/btl542; Yuan DS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni105; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	65	156	158	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1066	1078		10.1016/j.cell.2008.07.019	http://dx.doi.org/10.1016/j.cell.2008.07.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805098	Bronze, Green Accepted			2022-12-01	WOS:000259318100025
J	Navarro, P; Chambers, I; Karwacki-Neisius, V; Chureau, C; Morey, C; Rougeulle, C; Avner, P				Navarro, Pablo; Chambers, Ian; Karwacki-Neisius, Violetta; Chureau, Corinne; Morey, Celine; Rougeulle, Claire; Avner, Philip			Molecular coupling of Xist regulation and pluripotency	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME INACTIVATION; EARLY MOUSE EMBRYOS; TSIX TRANSCRIPTION; ES CELLS; NANOG; EXPRESSION; DIFFERENTIATION; DETERMINES; OCT3/4	During mouse embryogenesis, reversion of imprinted X chromosome inactivation in the pluripotent inner cell mass of the female blastocyst is initiated by the repression of Xist from the paternal X chromosome. Here we report that key factors supporting pluripotency-Nanog, Oct3/4, and Sox2-bind within Xist intron 1 in undifferentiated embryonic stem ( ES) cells. Whereas Nanog null ES cells display a reversible and moderate up- regulation of Xist in the absence of any apparent modification of Oct3/4 and Sox2 binding, the drastic release of all three factors from Xist intron 1 triggers rapid ectopic accumulation of Xist RNA. We conclude that the three main genetic factors underlying pluripotency cooperate to repress Xist and thus couple X inactivation reprogramming to the control of pluripotency during embryogenesis.	[Navarro, Pablo; Chureau, Corinne; Morey, Celine; Rougeulle, Claire; Avner, Philip] CNRS, Inst Pasteur, Unite Genet Mol Murine, URA2578, F-75015 Paris, France; [Chambers, Ian; Karwacki-Neisius, Violetta] Univ Edinburgh, MRC, Ctr Dev Stem Cell Biol, Inst Stem Cell Res,Sch Biol Sci, Edinburgh EH9 3JQ, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Edinburgh	Rougeulle, C (corresponding author), CNRS, Inst Pasteur, Unite Genet Mol Murine, URA2578, F-75015 Paris, France.	rougeull@pasteur.fr; pavner@pasteur.fr	, Celine/ABB-7420-2020; Chambers, Ian/H-5416-2011; Morey, Celine/N-5179-2018	, Celine/0000-0001-9513-0278; Chambers, Ian/0000-0003-2605-1597; Rougeulle, Claire/0000-0003-3861-4940	CNRS; Institut Pasteur [05-JCJC-0166-01, 07-BLAN-0047-01]; EU Epigenome Network of Excellence; Wellcome Trust; Juvenile Diabetes Research Foundation; Biotechnological and Biological Sciences and Medical Research Councils of the UK; Medical Research Council [G0700711B] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); EU Epigenome Network of Excellence; Wellcome Trust(Wellcome Trust); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Biotechnological and Biological Sciences and Medical Research Councils of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Colby for technical assistance, members of our laboratories for stimulating discussion, and A. Smith for the gift of the ZHBTc4 ES cell line. P.N., C.C., C.R., and P.A. were supported by recurrent funding from the CNRS and the Institut Pasteur, contracts 05-JCJC-0166-01 and 07-BLAN-0047-01 from the Agence Nationale de Recherche, and funding from the EU Epigenome Network of Excellence. Research in I.C.'s laboratory was supported by the Wellcome Trust, the Juvenile Diabetes Research Foundation, and the Biotechnological and Biological Sciences and Medical Research Councils of the UK.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; de Napoles M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000860; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103	24	257	263	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1693	1695		10.1126/science.1160952	http://dx.doi.org/10.1126/science.1160952			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802003				2022-12-01	WOS:000259300400041
J	Loaiza, E; Wardlaw, T; Salama, P				Loaiza, Edilberto; Wardlaw, Tessa; Salama, Peter			Child mortality 30 years after the Alma-Ata Declaration	LANCET			English	Editorial Material							SURVIVAL; NEWBORN		[Loaiza, Edilberto; Wardlaw, Tessa; Salama, Peter] UNICEF, New York, NY 10017 USA	UNICEF	Loaiza, E (corresponding author), UNICEF, 3 United Nations Plaza, New York, NY 10017 USA.	eloaiza@unicef.org						Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bustreo F, 2008, LANCET, V371, P1221, DOI 10.1016/S0140-6736(08)60535-8; UNICEF, 2007, 6 UNICEF; *UNICEF, 2008, MON SIT CHILDR WOM; *UNICEF UNAIDS WHO, 2008, UN ACC SCAL HIV SERV; *UNICEF WHO WORLD, 2007, LEV TRENDS CHILD MOR; 2008, COUNTDOWN 2015 TRACK	7	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					874	876		10.1016/S0140-6736(08)61378-1	http://dx.doi.org/10.1016/S0140-6736(08)61378-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790298				2022-12-01	WOS:000259266900010
J	Englund, M; Guermazi, A; Gale, D; Hunter, DJ; Aliabadi, P; Clancy, M; Felson, DT				Englund, Martin; Guermazi, Ali; Gale, Daniel; Hunter, David J.; Aliabadi, Piran; Clancy, Margaret; Felson, David T.			Incidental meniscal findings on knee MRI in middle-aged and elderly persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIXED-FLEXION RADIOGRAPHY; JOINT SPACE WIDTH; IMAGING FINDINGS; CARTILAGE LOSS; LOAD-BEARING; RISK-FACTORS; FOLLOW-UP; OSTEOARTHRITIS; PREVALENCE; ABNORMALITIES	Background: Magnetic resonance imaging (MRI) of the knee is often performed in patients who have knee symptoms of unclear cause. When meniscal tears are found, it is commonly assumed that the symptoms are attributable to them. However, there is a paucity of data regarding the prevalence of meniscal damage in the general population and the association of meniscal tears with knee symptoms and with radiographic evidence of osteoarthritis. Methods: We studied persons from Framingham, Massachusetts, who were drawn from census-tract data and random-digit telephone dialing. Subjects were 50 to 90 years of age and ambulatory; selection was not made on the basis of knee or other joint problems. We assessed the integrity of the menisci in the right knee on 1.5-tesla MRI scans obtained from 991 subjects (57% of whom were women). Symptoms involving the right knee were evaluated by questionnaire. Results: The prevalence of a meniscal tear or of meniscal destruction in the right knee as detected on MRI ranged from 19% (95% confidence interval [CI], 15 to 24) among women 50 to 59 years of age to 56% (95% CI, 46 to 66) among men 70 to 90 years of age; prevalences were not materially lower when subjects who had had previous knee surgery were excluded. Among persons with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 2 or higher, on a scale of 0 to 4, with higher numbers indicating more definite signs of osteoarthritis), the prevalence of a meniscal tear was 63% among those with knee pain, aching, or stiffness on most days and 60% among those without these symptoms. The corresponding prevalences among persons without radiographic evidence of osteoarthritis were 32% and 23%. Sixty-one percent of the subjects who had meniscal tears in their knees had not had any pain, aching, or stiffness during the previous month. Conclusions: Incidental meniscal findings on MRI of the knee are common in the general population and increase with increasing age.	[Englund, Martin; Hunter, David J.; Clancy, Margaret; Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Guermazi, Ali] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Gale, Daniel] Vet Affairs Med Ctr, Dept Radiol, Boston, MA USA; [Aliabadi, Piran] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Englund, Martin] Lund Univ, Dept Orthoped, Lund, Sweden	Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Lund University	Englund, M (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, 650 Albany St,Suite X200, Boston, MA 02118 USA.	englund@bu.edu	Englund, Martin/J-7245-2012; Hunter, David J/A-4622-2010	Englund, Martin/0000-0003-3320-2437; Hunter, David J/0000-0003-3197-752X; Felson, David/0000-0002-2668-2447	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER; NIAMS NIH HHS [P60 AR047785-01S1, AR47785, P60 AR047785-07, P60 AR047785] Funding Source: Medline; NIA NIH HHS [R01 AG018393, R01 AG018393-05, AG18393] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Ball J, 1963, ATLAS STANDARD RADIO, V2; Beattie KA, 2005, OSTEOARTHR CARTILAGE, V13, P181, DOI 10.1016/j.joca.2004.11.001; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; Boks SS, 2006, AM J SPORT MED, V34, P1984, DOI 10.1177/0363546506290189; De Smet AA, 2006, AM J ROENTGENOL, V187, P911, DOI 10.2214/AJR.05.1354; Ding CH, 2007, J RHEUMATOL, V34, P776; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Englund M, 2003, ARTHRITIS RHEUM-US, V48, P2178, DOI 10.1002/art.11088; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; FAIRBANK HAT, 1948, J BONE JOINT SURG BR, V30, P164, DOI 10.1302/0301-620X.30B1.164; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Fox MG, 2007, RADIOL CLIN N AM, V45, P1033, DOI 10.1016/j.rcl.2007.08.009; HALL MJ, 1998, ADV DATA VITAL HLTH, V300; Hayes CW, 2005, RADIOLOGY, V237, P998, DOI 10.1148/radiol.2373041989; HEDE A, 1992, J BONE JOINT SURG BR, V74, P118, DOI 10.1302/0301-620X.74B1.1732238; HOWELL JR, 2000, COCHRANE DB SYST REV, V2; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P795, DOI 10.1002/art.21724; Jee WH, 2003, AM J ROENTGENOL, V180, P93, DOI 10.2214/ajr.180.1.1800093; Jordan JM, 2007, J RHEUMATOL, V34, P172; Karlson Elizabeth W., 1995, Annals of Epidemiology, V5, P297, DOI 10.1016/1047-2797(94)00096-C; Kornaat PR, 2006, RADIOLOGY, V239, P811, DOI 10.1148/radiol.2393050253; Kothari M, 2004, EUR RADIOL, V14, P1568, DOI 10.1007/s00330-004-2312-6; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Link TM, 2003, RADIOLOGY, V226, P373, DOI 10.1148/radiol.2262012190; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Nevitt MC, 2007, ARTHRITIS RHEUM-US, V56, P1512, DOI 10.1002/art.22557; NOBLE J, 1975, J BONE JOINT SURG BR, V57, P180, DOI 10.1302/0301-620X.57B2.180; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; POEHLING GG, 1990, CLIN SPORT MED, V9, P539; SHRIVE NG, 1978, CLIN ORTHOP RELAT R, P279; SMILLIE IS, 1962, INJURIES KNEE JOINT, P51; Vande Berg BC, 2001, AM J ROENTGENOL, V176, P771, DOI 10.2214/ajr.176.3.1760771; WALKER PS, 1975, CLIN ORTHOP RELAT R, P184; Zanetti M, 2003, AM J ROENTGENOL, V181, P635, DOI 10.2214/ajr.181.3.1810635	40	587	596	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1108	1115		10.1056/NEJMoa0800777	http://dx.doi.org/10.1056/NEJMoa0800777			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784100	Green Accepted			2022-12-01	WOS:000259078200006
J	Pryor, PR; Jackson, L; Gray, SR; Edeling, MA; Thompson, A; Sanderson, CM; Evans, PR; Owen, DJ; Luzio, JP				Pryor, Paul R.; Jackson, Lauren; Gray, Sally R.; Edeling, Melissa A.; Thompson, Amanda; Sanderson, Christopher M.; Evans, Philip R.; Owen, David J.; Luzio, J. Paul			Molecular basis for the sorting of the SNARE VAMP7 into endocytic clathrin-coated vesicles by the ArfGAP Hrb	CELL			English	Article							MEMBRANE-FUSION; TI-VAMP; PROTEINS; COMPLEX; DOMAIN; LOCALIZATION; SPECIFICITY; LYSOSOMES; TRANSPORT; ADAPTER	SNAREs provide the specificity and energy for the fusion of vesicles with their target membrane, but how they are sorted into the appropriate vesicles on post-Golgi trafficking pathways is largely unknown. We demonstrate that the clathrin-mediated endocytosis of the SNARE VAMP7 is directly mediated by Hrb, a clathrin adaptor and ArfGAP. Hrb wraps 20 residues of its unstructured C-terminal tail around the folded VAMP7 longin domain, demonstrating that unstructured regions of clathrin adaptors can select cargo. Disrupting this interaction by mutation of the VAMP7 longin domain or depletion of Hrb causes VAMP7 to accumulate on the cell's surface. However, the SNARE helix of VAMP7 binds back onto its longin domain, outcompeting Hrb for binding to the same groove and suggesting that Hrb-mediated endocytosis of VAMP7 occurs only when VAMP7 is incorporated into a cis-SNARE complex. These results elucidate the mechanism of retrieval of a postfusion SNARE complex in clathrin-coated vesicles.	[Pryor, Paul R.; Gray, Sally R.; Edeling, Melissa A.; Owen, David J.; Luzio, J. Paul] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Pryor, Paul R.; Gray, Sally R.; Edeling, Melissa A.; Owen, David J.; Luzio, J. Paul] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England; [Jackson, Lauren; Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Thompson, Amanda; Sanderson, Christopher M.] MRC, Rosalind Franklin Ctr Genom Res, Cambridge CB10 1SB, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Laboratory Molecular Biology	Owen, DJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	djo30@cam.ac.uk; jpl10@cam.ac.uk		Pryor, Paul Robert/0000-0001-9123-8329; Jackson, Lauren/0000-0002-3705-6126	MRC [G9310915]; Wellcome Trust [079895]; Medical Research Council [G9310915, MC_U105178845] Funding Source: researchfish; MRC [MC_U105178845] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by MRC programme grant G9310915 to J. P. L., a Wellcome Trust Senior Research Fellowship to D. J. O., and Wellcome Trust Strategic Award 079895 to CIMR. We thank beamline staff at the ESRF and Maria Jose Sanchez Barena for help with data collection, Jenny Martin (IMB Brisbane) for the SNAP23 and syntaxin4 clones, Celina Whalley and Naveed Aziz of the York Technology Facility at the University of York for help with qPCR, Sally Raines and Brett Collins for technical assistance, and Andrew Peden, Katherine Bowers, Margaret Robinson, and Sean Munro for helpful discussions.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Doria M, 1999, J CELL BIOL, V147, P1379, DOI 10.1083/jcb.147.7.1379; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; HONG W, 2005, GENETICS, V144, P1425; KRISSINEL E, 2005, DETECTION PROTEIN AS; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, J CELL SCI, V116, P2805, DOI 10.1242/jcs.00467; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Reaves BJ, 1996, J CELL SCI, V109, P749; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	39	119	119	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					817	827		10.1016/j.cell.2008.07.023	http://dx.doi.org/10.1016/j.cell.2008.07.023			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775314	hybrid, Green Published			2022-12-01	WOS:000258947500021
J	Weavers, H; Prieto-Sanchez, S; Grawe, F; Garcia-Lopez, A; Artero, R; Wilsch-Brauninger, M; Ruiz-Gomez, M; Skaer, H; Denholm, B				Weavers, Helen; Prieto-Sanchez, Silvia; Grawe, Ferdinand; Garcia-Lopez, Amparo; Artero, Ruben; Wilsch-Braeuninger, Michaela; Ruiz-Gomez, Mar; Skaer, Helen; Denholm, Barry			The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm	NATURE			English	Article							CONGENITAL NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; NEPHRIN; DROSOPHILA; ORIGIN; CD2AP; BINDS	The nephron is the basic structural and functional unit of the vertebrate kidney. It is composed of a glomerulus, the site of ultrafiltration, and a renal tubule, along which the filtrate is modified. Although widely regarded as a vertebrate adaptation(1), 'nephronlike' features can be found in the excretory systems of many invertebrates, raising the possibility that components of the vertebrate excretory system were inherited from their invertebrate ancestors(2). Here we show that the insect nephrocyte has remarkable anatomical, molecular and functional similarity to the glomerular podocyte, a cell in the vertebrate kidney that forms the main size-selective barrier as blood is ultrafiltered to make urine. In particular, both cell types possess a specialized filtration diaphragm, known as the slit diaphragm in podocytes or the nephrocyte diaphragm in nephrocytes. We find that fly ( Drosophila melanogaster) orthologues of the major constituents of the slit diaphragm, including nephrin, NEPH1 ( also known as KIRREL), CD2AP, ZO-1 (TJP1) and podocin, are expressed in the nephrocyte and form a complex of interacting proteins that closely mirrors the vertebrate slit diaphragm complex. Furthermore, we find that the nephrocyte diaphragm is completely lost in flies lacking the orthologues of nephrin or NEPH1 - a phenotype resembling loss of the slit diaphragm in the absence of either nephrin ( as in human congenital nephrotic syndrome of the Finnish type, NPHS1) or NEPH1. These changes markedly impair filtration function in the nephrocyte. The similarities we describe between invertebrate nephrocytes and vertebrate podocytes provide evidence suggesting that the two cell types are evolutionarily related, and establish the nephrocyte as a simple model in which to study podocyte biology and podocyte- associated diseases.	[Weavers, Helen; Skaer, Helen; Denholm, Barry] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Prieto-Sanchez, Silvia; Ruiz-Gomez, Mar] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Grawe, Ferdinand] Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany; [Garcia-Lopez, Amparo; Artero, Ruben] Univ Valencia, Dept Genet, E-46100 Valencia, Spain; [Wilsch-Braeuninger, Michaela] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Cambridge; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Heinrich Heine University Dusseldorf; University of Valencia; Max Planck Society	Skaer, H (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	hs17@cam.ac.uk	Ruiz-Gómez, Mar/K-9266-2014; Weavers, Helen/AGX-6323-2022; Artero, Ruben/K-6815-2014	Ruiz-Gómez, Mar/0000-0002-9024-1400; Artero, Ruben/0000-0003-1596-047X; Grawe, Ferdi/0000-0001-6448-4989; Prieto Sanchez, Silvia/0000-0001-7950-8162; Weavers, Helen/0000-0002-5383-6085	Wellcome Trust [072441, 079221]; Deutsche Forschungsgemeinschaft SFB 590 [SFB 590]; ARC [1242]; MEC [BFU2007-62201]; Fundacion Ramon Areces; CBMSO; EC [LSHG-CT-2004-511978]; FPU	Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft SFB 590(German Research Foundation (DFG)); ARC(Australian Research Council); MEC(European Commission); Fundacion Ramon Areces; CBMSO; EC(European CommissionEuropean Commission Joint Research Centre); FPU(Spanish Government)	We thank F. Evers, Z. Cseresnyes, M. Guerra and E. Salvador for technical assistance, and S. Abmayr, L. Cooley, C. Doe, M. Affolter, K. Fischbach and K. Tryggvason for reagents. We thank V. Hartenstein, M. Inamdar, A. Woolf, I. Miguel- Aliaga, F. Evers, M. Landgraf and members of the Skaer laboratory for discussions, and E. Knust and W. B. Huttner for their support. This work was supported by Wellcome Trust grants awarded to H.S. (072441 and 079221; H.W., B.D. and H.S.); Deutsche Forschungsgemeinschaft SFB 590 awarded to E. Knust (F.G.) and ARC 1242 (H.W., B.D., H.S. and F.G.); an MEC grant awarded to M.R.-G. (BFU2007-62201; S.P.-S. and M.R.-G.); a Fundacion Ramon Areces grant to the CBMSO (M.R.-G.); EC grant LSHG-CT-2004-511978 to MYORES (M.R.-G.); and an FPU fellowship from the MEC awarded to A.G.-L.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BERRIDGE MJ, 1972, TRANSPORTING EPITHEL, P11; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Crossley A.C., 1985, P487; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; KOWALEVSKY A, 1889, BIOL CENTRALBL, V9, P74; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Locke M, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P687; Nagel AC, 2002, DEV GENES EVOL, V212, P93, DOI 10.1007/s00427-002-0210-y; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x; RODEWALD R, 1974, J CELL BIOL, V60, P423, DOI 10.1083/jcb.60.2.423; RUGENDORFF A, 1994, ROUX ARCH DEV BIOL, V203, P266, DOI 10.1007/BF00360522; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; RUPPERT EE, 1994, AM ZOOL, V34, P542; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Smith HW., 1953, FISH PHILOS; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Wartiovaara J, 2004, J CLIN INVEST, V114, P1475, DOI 10.1172/JCI200422562	32	208	212	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					322	U5		10.1038/nature07526	http://dx.doi.org/10.1038/nature07526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	18971929	Green Accepted, Green Submitted			2022-12-01	WOS:000262440900041
J	Bakir, M; Millington, KA; Soysal, A; Deeks, JJ; Efee, S; Aslan, Y; Dosanjh, DPS; Lalvani, A				Bakir, Mustafa; Millington, Kerry A.; Soysal, Ahmet; Deeks, Jonathan J.; Efee, Serpil; Aslan, Yasemin; Dosanjh, Davinder P. S.; Lalvani, Ajit			Prognostic Value of a T-Cell-Based, Interferon-gamma Biomarker in Children with Tuberculosis Contact	ANNALS OF INTERNAL MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IFN-GAMMA; SKIN-TEST; CHILDHOOD TUBERCULOSIS; PREDICTIVE-VALUE; RAPID DETECTION; INFECTION; DIAGNOSIS; ENUMERATION	Background: Enzyme-linked immunospot (ELISpot) assay is an increasingly widely used, T-cell-based, interferon-gamma-release assay for diagnosing tuberculosis infection, but whether positive results are prognostic of active tuberculosis is not known. Objective: To determine whether ELISpot results predict the development of active tuberculosis among persons with recent tuberculosis exposure. Design: Longitudinal cohort study of children and adolescents with tuberculosis contact recruited from October 2002 to April 2004. Setting: Community-based contact investigations in Turkey. Patients: 908 children and adolescents with recent household tuberculosis exposure. Intervention: Enzyme-linked immunospot assay, incorporating early secretory antigenic target-6 and culture filtrate protein-10, and tuberculin skin test were done at baseline. Measurements: Incidence rates ratios of progression to active tuberculosis for contacts with positive tuberculin skin test and ELISpot results, and relative incidence rates comparing contacts with positive and negative test results. Results: Isoniazid preventive therapy was given to 688 (76%) contacts according to local guidelines. Fifteen contacts developed active tuberculosis over 1201 person-years of follow-up. Of 381 contacts with positive ELISpot results, 11 developed active tuberculosis over 536 person-years of follow-up ( incidence rate, 21 per 1000 person-years [95% CI, 10.2 to 36.7 per 1000 person-years]), a statistically significant 3- to 4-fold increased risk for progression relative to ELISpot-negative contacts. Of 550 contacts with positive tuberculin skin test results, 12 developed active tuberculosis over 722 person-years of follow-up ( incidence rate, 17 per 1000 person-years [CI, 8.6 to 29.0 per 1000 person-years]). Limitation: Only 3 of the 15 incident cases were confirmed by culture. Conclusion: Positive ELISpot results predict subsequent development of active tuberculosis in recent tuberculosis contacts. Although tuberculosis contacts with positive ELISpot results have an incidence rate of tuberculosis similar to that of contacts with positive tuberculin skin test results, ELISpot testing could allow more focused targeting of preventive therapy to fewer contacts.	[Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, TB Immunol Grp, Dept Resp Med, Natl Heart & Lung Inst, London W2 1PG, England; Marmara Univ, Sch Med, Istanbul, Turkey; Univ Birmingham, Birmingham, W Midlands, England	Imperial College London; Marmara University; University of Birmingham	Lalvani, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, TB Immunol Grp, Dept Resp Med, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England.	a.lalvani@imperial.ac.uk	Deeks, Jon/AAV-5745-2020; Aslan, Yasemin/AAP-7713-2020; ASLAN, YASEMİN/AAP-7409-2020; Dosanjh, Davinder/ABD-8895-2021	Deeks, Jon/0000-0002-8850-1971; Aslan, Yasemin/0000-0001-6292-2332; Dosanjh, Davinder/0000-0002-9169-5607; Lalvani, Ajit/0000-0002-2396-246X	Trust and the United Nations; (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization; UK Department of Health; Centre for Respiratory Infection, Imperial College London	Trust and the United Nations; (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization(World Health Organization); UK Department of Health; Centre for Respiratory Infection, Imperial College London	By the Wellcome Trust and the United Nations (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, a UK Department of Health Senior Fellowship in Evidence Synthesis (Dr. Deeks), and the Sir Halley Stewart Trust ( Dr. Dosanjh's PhD studentship). Dr. Lalvani is a Wellcome Senior Research Fellow in Clinical Science, and Dr. Millington was a Wellcome Trust Prize PhD student. Both are members of the Wellcome Trust-funded Centre for Respiratory Infection, Imperial College London.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Fourth report to the Medical Research Council by its Tuberculosis Vaccines Clinical Trials Committee, 1972, B WHO, V46, P371; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; HSU KHK, 1984, JAMA-J AM MED ASSOC, V251, P1283, DOI 10.1001/jama.251.10.1283; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; LALVANI A, 2008, EUR RESP J IN PRESS; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; *NAT CTR HIV STD T, 2005, MMWR RECOMM REP, V54, P49; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; SCHAAF HS, 1995, PEDIATR INFECT DIS J, V14, P189, DOI 10.1097/00006454-199503000-00004; Schluger Neil W, 2003, Semin Respir Infect, V18, P241; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Shieh FK, 2006, AM J RESP CRIT CARE, V174, P717, DOI 10.1164/rccm.200510-1667OC; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Starke JR, 2006, PEDIATR INFECT DIS J, V25, P941, DOI 10.1097/01.inf.0000239685.49999.d3; Sterling TR, 2006, NEW ENGL J MED, V355, P118, DOI 10.1056/NEJMp068015; Stout JE, 2008, AM J RESP CRIT CARE, V177, P1055, DOI 10.1164/rccm.200802-251ED; *TURK CUMH SAGL BA, 2003, TURK TUB KONTR BASV; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; *WHO, 2007, WHO PUBL; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242	50	127	138	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					777	W163		10.7326/0003-4819-149-11-200812020-00248	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00248			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	18936496	Green Accepted			2022-12-01	WOS:000261645300001
J	Bouskra, D; Brezillon, C; Berard, M; Werts, C; Varona, R; Boneca, IG; Eberl, G				Bouskra, Djahida; Brezillon, Christophe; Berard, Marion; Werts, Catherine; Varona, Rosa; Boneca, Ivo Gomperts; Eberl, Gerard			Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis	NATURE			English	Article							ALTERED SCHAEDLER FLORA; BETA-DEFENSINS; FOLLICLE FORMATION; EPITHELIAL-CELLS; B-LYMPHOCYTES; RECEPTOR; GENERATION; EXPRESSION; INDUCTION; INNATE	Intestinal homeostasis is critical for efficient energy extraction from food and protection from pathogens. Its disruption can lead to an array of severe illnesses with major impacts on public health, such as inflammatory bowel disease characterized by self- destructive intestinal immunity. However, the mechanisms regulating the equilibrium between the large bacterial flora and the immune system remain unclear. Intestinal lymphoid tissues generate flora- reactive IgA- producing B cells, and include Peyer's patches and mesenteric lymph nodes, as well as numerous isolated lymphoid follicles (ILFs)(1,2). Here we show that peptidoglycan from Gram- negative bacteria is necessary and sufficient to induce the genesis of ILFs in mice through recognition by the NOD1 ( nucleotide- binding oligomerization domain containing 1) innate receptor in epithelial cells, and beta-defensin 3- and CCL20- mediated signalling through the chemokine receptor CCR6. Maturation of ILFs into large B- cell clusters requires subsequent detection of bacteria by toll- like receptors. In the absence of ILFs, the composition of the intestinal bacterial community is profoundly altered. Our results demonstrate that intestinal bacterial commensals and the immune system communicate through an innate detection system to generate adaptive lymphoid tissues and maintain intestinal homeostasis.	[Bouskra, Djahida; Eberl, Gerard] Inst Pasteur, Lab Lymphoid Tissue Dev, CNRS, URA1961, F-75724 Paris, France; [Brezillon, Christophe] Inst Pasteur, Lab Bacteries Pathogenes Enteriques, F-75724 Paris, France; [Berard, Marion] Inst Pasteur, Anim Centrale, F-75724 Paris, France; [Werts, Catherine; Boneca, Ivo Gomperts] Inst Pasteur, Grp Biol & Genet Bacterial Cell Wall, F-75724 Paris, France; [Varona, Rosa] CSIC, Dept Immunol & Oncol, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Werts, Catherine; Boneca, Ivo Gomperts] INSERM, Grp AVENIR, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Eberl, G (corresponding author), Inst Pasteur, Lab Lymphoid Tissue Dev, CNRS, URA1961, 25 Rue Dr Roux, F-75724 Paris, France.	gerard.eberl@pasteur.fr	WERTS, Catherine/AAD-5447-2020; Boneca, Ivo G/H-1677-2014; Eberl, Gerard/A-1160-2013	WERTS, Catherine/0000-0003-3079-5476; Boneca, Ivo G/0000-0001-8122-509X; Eberl, Gerard/0000-0002-1119-5638	Institut Pasteur; CNRS; INSERM; ANR; Fondation de la Recherche Medicale; Mairie de Paris; Marie Curie Excellence; La Fondation de France; Ligue Nationale contre le Cancer	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Mairie de Paris(Region Ile-de-France); Marie Curie Excellence(European Commission); La Fondation de France(Fondation de France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	We thank G. Milon, N. Cerf- Bensussan, P. Sansonetti, P. Cossart, A. Phalipon, D. Philpott, G. Marchal and D. Guy-Grand for discussions and critical reading of the manuscript; N. Huntington for intrahepatic injections; M. Cherrier for biochemistry; J. Perez, E. Maranghi and M. Manich for technical assistance; S. Akira, M. Chignard and V. Balloy for Myd88<SUP>-/-</SUP>, Trif<SUP>-/-</SUP>, Tlr2<SUP>-/-</SUP> or Tlr4<SUP>-/-</SUP> mice, J. P. Hugot for card15<SUP>-/-</SUP> mice, Millennium Pharmaceuticals for card4<SUP>-/-</SUP> mice and D. Philpott for card4<SUP>-/-</SUP> mice backcrossed to C57BL/ 6; J. Browning for LT beta R-Ig and Z. Ge for the 16S rDNA plasmids. This work was supported by Institut Pasteur, CNRS, INSERM, ANR, Fondation de la Recherche Medicale, Mairie de Paris, a Marie Curie Excellence grant, La Fondation de France (D.B.) and la Ligue Nationale contre le Cancer (D.B.).	Antignac A, 2003, J BIOL CHEM, V278, P31521, DOI 10.1074/jbc.M304749200; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Ge ZM, 2006, APPL ENVIRON MICROB, V72, P5100, DOI 10.1128/AEM.01934-05; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Lugering A, 2006, ANN NY ACAD SCI, V1072, P210, DOI 10.1196/annals.1326.015; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Pabst O, 2006, J IMMUNOL, V177, P6824, DOI 10.4049/jimmunol.177.10.6824; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rivas-Santiago B, 2006, J INFECT DIS, V194, P697, DOI 10.1086/506454; Sarma-Rupavtarm RB, 2004, APPL ENVIRON MICROB, V70, P2791, DOI 10.1128/AEM.70.5.2791-2800.2004; SCHAEDLER RUSSELL W., 1962, JOUR EXPTL MED, V115, P1149, DOI 10.1084/jem.115.6.1149; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	40	729	767	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					507	U34		10.1038/nature07450	http://dx.doi.org/10.1038/nature07450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18987631				2022-12-01	WOS:000261170500039
J	Lyssenko, V; Jonsson, A; Almgren, P; Pulizzi, N; Isomaa, B; Tuomi, T; Berglund, G; Altshuler, D; Nilsson, P; Groop, L				Lyssenko, Valeriya; Jonsson, Anna; Almgren, Peter; Pulizzi, Nicolo; Isomaa, Bo; Tuomi, Tiinamaija; Berglund, Goran; Altshuler, David; Nilsson, Peter; Groop, Leif			Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN SENSITIVITY; LOCI; PREDICTION; MELLITUS; GENE; REPLICATION; SECRETION; INDEXES	Background: Type 2 diabetes mellitus is thought to develop from an interaction between environmental and genetic factors. We examined whether clinical or genetic factors or both could predict progression to diabetes in two prospective cohorts. Methods: We genotyped 16 single-nucleotide polymorphisms (SNPs) and examined clinical factors in 16,061 Swedish and 2770 Finnish subjects. Type 2 diabetes developed in 2201 (11.7%) of these subjects during a median follow-up period of 23.5 years. We also studied the effect of genetic variants on changes in insulin secretion and action over time. Results: Strong predictors of diabetes were a family history of the disease, an increased body-mass index, elevated liver-enzyme levels, current smoking status, and reduced measures of insulin secretion and action. Variants in 11 genes (TCF7L2, PPARG, FTO, KCNJ11, NOTCH2, WFS1, CDKAL1, IGF2BP2, SLC30A8, JAZF1, and HHEX) were significantly associated with the risk of type 2 diabetes independently of clinical risk factors; variants in 8 of these genes were associated with impaired beta-cell function. The addition of specific genetic information to clinical factors slightly improved the prediction of future diabetes, with a slight increase in the area under the receiver-operating-characteristic curve from 0.74 to 0.75; however, the magnitude of the increase was significant (P=1.0 x 10(-4)). The discriminative power of genetic risk factors improved with an increasing duration of follow-up, whereas that of clinical risk factors decreased. Conclusions: As compared with clinical risk factors alone, common genetic variants associated with the risk of diabetes had a small effect on the ability to predict the future development of type 2 diabetes. The value of genetic factors increased with an increasing duration of follow-up.	[Lyssenko, Valeriya; Jonsson, Anna; Almgren, Peter; Berglund, Goran; Nilsson, Peter; Groop, Leif] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Pulizzi, Nicolo] Univ Pisa, Pisa, Italy; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Altshuler, David] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Boston, MA 02114 USA	Lund University; University of Pisa; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Lyssenko, V (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, CRC, S-20502 Malmo, Sweden.	valeri.lyssenko@med.lu.se		Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tuomi, Tiinamaija/0000-0002-8306-6202; Jonsson, Anna/0000-0003-1252-8673; Altshuler, David/0000-0002-7250-4107	Swedish Research Council; Linne [31475113580]; Heart and Lung Foundation; Swedish Diabetes Research Society; Nordic Center of Excellence Grant in Disease Genetics; Diabetes Program at the Lund University; Finnish Diabetes Research Society; Sigrid Juselius Foundation; Pahlsson Foundation; Crafoord Foundation; Folkhalsan Research Foundation; Novo Nordisk Foundation; European Network of Genomic and Genetic Epidemiology; Wallenberg Foundation; European Foundation for the Study of Diabetes; Tethys; Merck; Eisai; MPM Capital; Novartis; Bristol-Myers Squibb Foundation; Eli Lilly; GlaxoSmithKline; Aventis; Sanofi	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linne; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Research Society; Nordic Center of Excellence Grant in Disease Genetics; Diabetes Program at the Lund University; Finnish Diabetes Research Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Pahlsson Foundation; Crafoord Foundation; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Network of Genomic and Genetic Epidemiology; Wallenberg Foundation(European Commission); European Foundation for the Study of Diabetes; Tethys; Merck(Merck & Company); Eisai(Eisai Co Ltd); MPM Capital; Novartis(Novartis); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Aventis(Sanofi-Aventis); Sanofi	Supported by grants from the Swedish Research Council (including Linne grant 31475113580), the Heart and Lung Foundation, the Swedish Diabetes Research Society, a Nordic Center of Excellence Grant in Disease Genetics, the Diabetes Program at the Lund University, the Finnish Diabetes Research Society, the Sigrid Juselius Foundation, the Pahlsson Foundation, the Crafoord Foundation, the Folkhalsan Research Foundation, the Novo Nordisk Foundation, the European Network of Genomic and Genetic Epidemiology, the Wallenberg Foundation, and the European Foundation for the Study of Diabetes. Dr. Lyssenko reports receiving consulting fees from Tethys; Dr. Altshuler, receiving consulting fees from Merck, Eisai, and MPM Capital and grant support from Novartis, receiving an unrestricted grant from the Bristol-Myers Squibb Foundation, and having an equity interest in MPM Capital; and Dr. Groop, receiving consulting fees from Tethys, Eli Lilly, GlaxoSmithKline, Aventis, and Sanofi, lecture fees from Aventis and Sanofi, and grant support from Novartis. No other potential conflict of interest relevant to this article was reported. We thank the patients for their participation and Anna Berglund, Margareta Svensson, and Malin Neptin for their excellent technical assistance.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cohen J., 2003, APPL MULTIPLE REGRES; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; HEDING LG, 1966, LABELLED PROTEINS TR, P345; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SLEINTHORSDOTTI.VV, 2007, NAT GENET, V39, P770; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; TANG K, 1995, NUCLEIC ACIDS RES, V23, P3126, DOI 10.1093/nar/23.16.3126; Tirosh A, 2006, NEW ENGL J MED, V354, P2401; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	629	660	0	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2220	2232		10.1056/NEJMoa0801869	http://dx.doi.org/10.1056/NEJMoa0801869			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020324				2022-12-01	WOS:000260994000005
J	Meigs, JB; Shrader, P; Sullivan, LM; McAteer, JB; Fox, CS; Dupuis, J; Manning, AK; Florez, JC; Wilson, PWF; D'Agostino, RB; Cupples, LA				Meigs, James B.; Shrader, Peter; Sullivan, Lisa M.; McAteer, Jarred B.; Fox, Caroline S.; Dupuis, Josee; Manning, Alisa K.; Florez, Jose C.; Wilson, Peter W. F.; D'Agostino, Ralph B., Sr.; Cupples, L. Adrienne			Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; GLUCOSE-TOLERANCE; LIFE-STYLE; LOCI; POLYMORPHISMS; MELLITUS; DISEASE; REPLICATION; FAMILIES; CURVE	Background: Multiple genetic loci have been convincingly associated with the risk of type 2 diabetes mellitus. We tested the hypothesis that knowledge of these loci allows better prediction of risk than knowledge of common phenotypic risk factors alone. Methods: We genotyped single-nucleotide polymorphisms (SNPs) at 18 loci associated with diabetes in 2377 participants of the Framingham Offspring Study. We created a genotype score from the number of risk alleles and used logistic regression to generate C statistics indicating the extent to which the genotype score can discriminate the risk of diabetes when used alone and in addition to clinical risk factors. Results: There were 255 new cases of diabetes during 28 years of follow-up. The mean (+/-SD) genotype score was 17.7+/-2.7 among subjects in whom diabetes developed and 17.1+/-2.6 among those in whom diabetes did not develop (P<0.001). The sex-adjusted odds ratio for diabetes was 1.12 per risk allele (95% confidence interval, 1.07 to 1.17). The C statistic was 0.534 without the genotype score and 0.581 with the score (P=>0.01). In a model adjusted for sex and self-reported family history of diabetes, the C statistic was 0.595 without the genotype score and 0.615 with the score (P=0.11). In a model adjusted for age, sex, family history, body-mass index, fasting glucose level, systolic blood pressure, high-density lipoprotein cholesterol level, and triglyceride level, the C statistic was 0.900 without the genotype score and 0.901 with the score (P=0.49). The genotype score resulted in the appropriate risk reclassification of, at most, 4% of the subjects. Conclusions: A genotype score based on 18 risk alleles predicted new cases of diabetes in the community but provided only a slightly better prediction of risk than knowledge of common risk factors alone.	[Meigs, James B.; Shrader, Peter] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Meigs, James B.; Shrader, Peter; Florez, Jose C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [McAteer, Jarred B.; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [McAteer, Jarred B.; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Dept Med, Boston, MA 02114 USA; [Sullivan, Lisa M.; Dupuis, Josee; Manning, Alisa K.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [McAteer, Jarred B.; Florez, Jose C.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA; [Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Wilson, Peter W. F.] Emory Univ, Sch Med, Emory Program Cardiovasc Outcomes Res & Epidemiol, Atlanta, GA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University; Boston University	Meigs, JB (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Fl, Boston, MA 02114 USA.	jmeigs@partners.org	Meigs, James/P-3927-2019; Manning, Alisa Knodle/ABC-7711-2021; Wilson, Peter W.F./J-2455-2016	Meigs, James/0000-0002-2439-2657; Dupuis, Josee/0000-0003-2871-3603; Sullivan, Lisa/0000-0003-0726-7149; Cupples, L. Adrienne/0000-0003-0273-7965	National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195]; National Institute for Diabetes and Digestive and Kidney Diseases [R01 DK078616, K24 DK080140, K23 DK65978]; Boston University Linux Cluster for Genetic Analysis; National Institutes of Health National Center for Research Resources Shared Instrumentation [1S10RR163736-01A1]; Sanofi-Aventis; GlaxoSmithKline; Merck; Publicis Healthcare Communications Group; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078616, K24DK080140, K23DK065978] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston University Linux Cluster for Genetic Analysis; National Institutes of Health National Center for Research Resources Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Sanofi-Aventis(Sanofi-Aventis); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Publicis Healthcare Communications Group; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a contract from the National Heart, Lung, and Blood Institute's Framingham Heart Study (N01-HC-25195), grants from the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) (R01 DK078616 and K24 DK080140, to Dr. Meigs), an NIDDK Research Career Award (K23 DK65978, to Dr. Florez), and the Boston University Linux Cluster for Genetic Analysis, funded by a grant from the National Institutes of Health National Center for Research Resources Shared Instrumentation (1S10RR163736-01A1). Dr. Meigs reports serving on a consultancy board for Interleukin Genetics and receiving grants from Sanofi-Aventis and GlaxoSmithKline; and Dr. Florez, receiving consulting fees from Merck and Publicis Healthcare Communications Group, a global advertising agency engaged by Amylin Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Janssens ACJW, 2006, PLOS MED, V3, P270, DOI 10.1371/journal.pmed.0030114; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; LANGO H, 2008, DIABETES        0630; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Li J, 2007, ARCH INTERN MED, V167, P2528, DOI 10.1001/archinte.167.22.2528-c; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Meigs JB, 2005, J CLIN ENDOCR METAB, V90, P1137, DOI 10.1210/jc.2004-1212; Meigs JB, 1998, ANN INTERN MED, V128, P524, DOI 10.7326/0003-4819-128-7-199804010-00002; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sackett D, 1991, CLIN EPIDEMIOLOGY BA; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Weijnen CF, 2002, DIABETIC MED, V19, P41, DOI 10.1046/j.1464-5491.2002.00624.x; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zeggini E, 2007, SCIENCE, V317, P1036; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	40	550	570	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2208	2219		10.1056/NEJMoa0804742	http://dx.doi.org/10.1056/NEJMoa0804742			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020323	Green Accepted			2022-12-01	WOS:000260994000004
J	Ferlin, A; Zuccarello, D; Zuccarello, B; Chirico, MR; Zanon, GF; Foresta, C				Ferlin, Alberto; Zuccarello, Daniela; Zuccarello, Biagio; Chirico, Maria Rosaria; Zanon, Giovanni Franco; Foresta, Carlo			Genetic Alterations Associated With Cryptorchidism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANDROGEN RECEPTOR GENE; MUTATIONS; PATHOGENESIS; EXPRESSION; DESCENT; TESTIS; INSL3; MICE	Context Cryptorchidism is the most frequent congenital birth defect in male children and represents an important risk factor for infertility and testicular cancer. Major regulators of testicular descent are the hormones insulin- like factor 3 ( INSL3) and testosterone, and disruption of these pathways might cause cryptorchidism. Objective To determine the frequency of genetic alterations in cryptorchidism. Design and Setting Case- control study in 2 departments of pediatric surgery in Italy between January 2003 and March 2005. Patients Six hundred male infants with cryptorchidism. Boys were followed up for 2 to 3 years ( through January 2008) and orchidopexy was performed in those who were persistently cryptorchid. We analyzed 300 noncryptorchid male children aged 1 to 4 years as controls. Main Outcome Measures Karyotype anomalies and INSL3, INSL3 receptor, and androgen receptor gene mutations. Results The frequency of genetic alterations in boys with cryptorchidism was low ( 17/ 600 [ 2.8%; 95% confidence interval {CI}, 1.7%- 4.5%]) and was significantly higher in participants with persistent cryptorchidism ( 16/ 303 [ 5.3%; 95% CI, 3.0%- 8.4%]; P=. 001) and those with bilateral cryptorchidism ( 10/ 120 [ 8.3%; 95% CI, 4.1%- 14.8%]; P=. 001) than in controls ( 1/ 300 [ 0.3%; 95% CI, 0.1%-0.8%]). Boys with persistent cryptorchidism had a 17- fold greater odds of having a genetic alteration ( odds ratio, 16.7; 95% CI, 2.2- 126.5). The most common genetic findings in those with cryptorchidism were 8 cases of Klinefelter syndrome and 5 cases of mutations in the INSL3 receptor gene. Genetic alterations were not found in boys with low birth weight or low gestational age, who had frequent spontaneous descent of the testes. Conclusion In a small percentage of the study population, there was a statistically significant association between bilateral and persistent cryptorchidism and genetic alterations, including Klinefelter syndrome and INSL3 receptor gene mutations.	[Ferlin, Alberto; Zuccarello, Daniela; Foresta, Carlo] Univ Padua, Sect Clin Pathol, I-35121 Padua, Italy; [Ferlin, Alberto; Zuccarello, Daniela; Foresta, Carlo] Univ Padua, Ctr Male Gamete Cryopreservat, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; [Zanon, Giovanni Franco] Univ Padua, Dept Pediat Surg, I-35121 Padua, Italy; [Zuccarello, Biagio; Chirico, Maria Rosaria] Univ Messina, Dept Med & Surg Pediat Sci, Unit Pediat Surg, Messina, Italy	University of Padua; University of Padua; University of Padua; University of Messina	Foresta, C (corresponding author), Univ Padua, Sect Clin Pathol, Via Gabelli 63, I-35121 Padua, Italy.	carlo.foresta@unipd.it	zuccarello, daniela/G-4822-2011; Ferlin, Alberto/AAO-3541-2020	zuccarello, daniela/0000-0001-5826-6715; Ferlin, Alberto/0000-0001-5817-8141	Italian Ministry of University [2005062572]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This study was supported by grant 2005062572 from the Italian Ministry of University to Drs Ferlin, Daniela Zuccarello, and Foresta.	Barthold JS, 2000, J UROLOGY, V164, P497, DOI 10.1016/S0022-5347(05)67411-3; Bay K, 2007, J CLIN ENDOCR METAB, V92, P4020, DOI 10.1210/jc.2007-0974; Bogatcheva NV, 2007, AM J PHYSIOL-ENDOC M, V292, pE138, DOI 10.1152/ajpendo.00228.2006; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Boisen KA, 2004, LANCET, V363, P1264, DOI 10.1016/S0140-6736(04)15998-9; Bojesen A, 2007, NAT CLIN PRACT UROL, V4, P192, DOI 10.1038/ncpuro0775; Cortes D, 2001, HORM RES, V55, P21, DOI 10.1159/000049959; Cortes D, 2008, J UROLOGY, V179, P314, DOI 10.1016/j.juro.2007.08.158; Ferlin A, 2006, MOL HUM REPROD, V12, P401, DOI 10.1093/molehr/gal043; Ferlin A, 2005, EUR J ENDOCRINOL, V152, P419, DOI 10.1530/eje.1.01860; Ferlin A, 2003, J CLIN ENDOCR METAB, V88, P4273, DOI 10.1210/jc.2003-030359; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI 10.1359/JBMR.080204; Ferlin A, 2006, CLIN ENDOCRINOL, V65, P606, DOI 10.1111/j.1365-2265.2006.02635.x; Foresta C, 1996, FERTIL STERIL, V66, P624, DOI 10.1016/S0015-0282(16)58579-3; Foresta C, 2008, ENDOCR REV, V29, P560, DOI 10.1210/er.2007-0042; GIWERCMAN A, 1993, EUR UROL, V23, P104; Husmann DA, 2005, UROLOGY, V66, P424, DOI 10.1016/j.urology.2004.10.020; Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018; Lanfranco F, 2004, LANCET, V364, P273, DOI 10.1016/S0140-6736(04)16678-6; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Nielsen J, 1990, Birth Defects Orig Artic Ser, V26, P209; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x; Suzuki Y, 2001, FERTIL STERIL, V76, P834, DOI 10.1016/S0015-0282(01)02016-7; Truong A, 2003, BIOL REPROD, V69, P1658, DOI 10.1095/biolreprod.103.019166; Virtanen HE, 2008, HUM REPROD UPDATE, V14, P49, DOI 10.1093/humupd/dmm027; Walsh TJ, 2007, J UROLOGY, V178, P1440, DOI 10.1016/j.juro.2007.05.166; Wiener JS, 1998, J UROLOGY, V160, P863, DOI 10.1016/S0022-5347(01)62823-4; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	30	101	105	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2271	2276		10.1001/jama.2008.668	http://dx.doi.org/10.1001/jama.2008.668			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017913	Bronze			2022-12-01	WOS:000260965500027
J	Hildner, K; Edelson, BT; Purtha, WE; Diamond, M; Matsushita, H; Kohyama, M; Calderon, B; Schraml, BU; Unanue, ER; Diamond, MS; Schreiber, RD; Murphy, TL; Murphy, KM				Hildner, Kai; Edelson, Brian T.; Purtha, Whitney E.; Diamond, Mark; Matsushita, Hirokazu; Kohyama, Masako; Calderon, Boris; Schraml, Barbara U.; Unanue, Emil R.; Diamond, Michael S.; Schreiber, Robert D.; Murphy, Theresa L.; Murphy, Kenneth M.			Batf3 Deficiency Reveals a Critical Role for CD8 alpha(+) Dendritic Cells in Cytotoxic T Cell Immunity	SCIENCE			English	Article							IN-VIVO DEPLETION; CROSS-PRESENTATION; CUTTING EDGE; CD8(+); ANTIGENS; VIRUS; INFECTION; SUBSETS; POPULATION; EXPRESSION	Although in vitro observations suggest that cross- presentation of antigens is mediated primarily by CD8 alpha(+) dendritic cells, in vivo analysis has been hampered by the lack of systems that selectively eliminate this cell lineage. We show that deletion of the transcription factor Batf3 ablated development of CD8 alpha(+) dendritic cells, allowing us to examine their role in immunity in vivo. Dendritic cells from Batf3(-/-) mice were defective in cross- presentation, and Batf3(-/-) mice lacked virus- specific CD8(+) T cell responses to West Nile virus. Importantly, rejection of highly immunogenic syngeneic tumors was impaired in Batf3(-/-) mice. These results suggest an important role for CD8 alpha(+) dendritic cells and cross- presentation in responses to viruses and in tumor rejection.	[Hildner, Kai; Edelson, Brian T.; Diamond, Mark; Matsushita, Hirokazu; Kohyama, Masako; Calderon, Boris; Schraml, Barbara U.; Unanue, Emil R.; Diamond, Michael S.; Schreiber, Robert D.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hildner, Kai; Kohyama, Masako; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Purtha, Whitney E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Purtha, Whitney E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Diamond, Michael/AAH-1733-2019; Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Diamond, Michael/0000-0002-8791-3165; Schreiber, Robert D/0000-0001-6311-0432; Edelson, Brian/0000-0003-2856-7650; Calderon, Boris/0000-0003-1575-0739; Schreiber, Robert/0000-0003-1590-2341; Schraml, Barbara/0000-0002-5801-0151	Howard Hughes Medical Institute; Emmy Noether Program of the German Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Emmy Noether Program of the German Research Foundation(German Research Foundation (DFG)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund)	This work was supported by the Howard Hughes Medical Institute (K.M.M.), the Emmy Noether Program of the German Research Foundation (K.H.), and a Burroughs Wellcome Fund Career Award for Medical Scientists (B.T.E.).	Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Iacobelli M, 2000, J IMMUNOL, V165, P860, DOI 10.4049/jimmunol.165.2.860; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wolkers MC, 2001, J IMMUNOL, V167, P3577, DOI 10.4049/jimmunol.167.7.3577; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	29	1299	1337	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1097	1100		10.1126/science.1164206	http://dx.doi.org/10.1126/science.1164206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008445	Green Accepted			2022-12-01	WOS:000260867700036
J	Morgan, DO				Morgan, David O.			SnapShot: Cell-Cycle Regulators I	CELL			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Morgan, David/0000-0001-8753-4416				Morgan DO., 2007, CELL CYCLE PRINCIPLE; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988	2	11	11	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					764	U15	764.e1	10.1016/j.cell.2008.10.039	http://dx.doi.org/10.1016/j.cell.2008.10.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013283	Bronze			2022-12-01	WOS:000260886900025
J	Hachinski, V				Hachinski, Vladimir			Shifts in Thinking About Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIFETIME RISK; STROKE		[Hachinski, Vladimir] Univ Western Ontario, Dept Clin Neurol Sci, London, ON N6A 3K7, Canada	Western University (University of Western Ontario)	Hachinski, V (corresponding author), Univ Western Ontario, Dept Clin Neurol Sci, 339 Windermere Rd, London, ON N6A 3K7, Canada.	vladimir.hachinski@lhsc.on.ca						Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hachinski V, 2007, STROKE, V38, P1118, DOI 10.1161/01.STR.0000259385.54832.e4; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Jin YP, 2008, NEUROLOGY, V70, P9, DOI 10.1212/01.wnl.0000284609.77385.03; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Silver FL, 2006, AM J PREV MED, V31, pS235, DOI 10.1016/j.amepre.2006.08.023	16	69	70	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2172	2173		10.1001/jama.2008.525	http://dx.doi.org/10.1001/jama.2008.525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001628				2022-12-01	WOS:000260793800027
J	Atwal, JK; Pinkston-Gosse, J; Syken, J; Stawicki, S; Wu, Y; Shatz, C; Tessier-Lavigne, M				Atwal, Jasvinder K.; Pinkston-Gosse, Julie; Syken, Josh; Stawicki, Scott; Wu, Yan; Shatz, Carla; Tessier-Lavigne, Marc			PirB is a Functional Receptor for Myelin Inhibitors of Axonal Regeneration	SCIENCE			English	Article							NOGO RECEPTOR; NEURITE OUTGROWTH; VISUAL-CORTEX; GLYCOPROTEIN; RECOVERY; GROWTH; INJURY; CELLS; PLASTICITY; LIGAND	A major barrier to regenerating axons after injury in the mammalian central nervous system is an unfavorable milieu. Three proteins found in myelin- Nogo, MAG, and OMgp- inhibit axon regeneration in vitro and bind to the glycosylphosphatidylinositol- anchored Nogo receptor ( NgR). However, genetic deletion of NgR has only a modest disinhibitory effect, suggesting that other binding receptors for these molecules probably exist. With the use of expression cloning, we have found that paired immunoglobulin- like receptor B ( PirB), which has been implicated in nervous system plasticity, is a high- affinity receptor for Nogo, MAG, and OMgp. Interfering with PirB activity, either with antibodies or genetically, partially rescues neurite inhibition by Nogo66, MAG, OMgp, and myelin in cultured neurons. Blocking both PirB and NgR activities leads to near- complete release from myelin inhibition. Our results implicate PirB in mediating regeneration block, identify PirB as a potential target for axon regeneration therapies, and provide an explanation for the similar enhancements of visual system plasticity in PirB and NgR knockout mice.	[Atwal, Jasvinder K.; Pinkston-Gosse, Julie; Tessier-Lavigne, Marc] Genentech Inc, Neurodegenerat Labs & Res Drug Discovery, San Francisco, CA 94080 USA; [Syken, Josh; Shatz, Carla] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Stawicki, Scott; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Shatz, Carla] Stanford Univ, BioX Program, James H Clark Ctr, Stanford, CA 94305 USA	Roche Holding; Genentech; Harvard University; Harvard Medical School; Roche Holding; Genentech; Stanford University	Tessier-Lavigne, M (corresponding author), Genentech Inc, Neurodegenerat Labs & Res Drug Discovery, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com			Genentech	Genentech(Roche HoldingGenentech)	We thank J. Brady and M. Yan for assistance with expression cloning and members of the Tessier-Lavigne and Shatz laboratories for helpful suggestions and discussions. This work was supported by Genentech.	Chen B, 2002, DEV BIOL, V252, P170, DOI 10.1006/dbio.2002.0847; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mehta NR, 2007, J BIOL CHEM, V282, P27875, DOI 10.1074/jbc.M704055200; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Pereira S, 2004, J IMMUNOL, V173, P5757, DOI 10.4049/jimmunol.173.9.5757; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Walmsey AR, 2007, CURR PHARM DESIGN, V13, P2470; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	22	378	400	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					967	970		10.1126/science.1161151	http://dx.doi.org/10.1126/science.1161151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988857				2022-12-01	WOS:000260674100054
J	Stadtfeld, M; Nagaya, M; Utikal, J; Weir, G; Hochedlinger, K				Stadtfeld, Matthias; Nagaya, Masaki; Utikal, Jochen; Weir, Gordon; Hochedlinger, Konrad			Induced Pluripotent Stem Cells Generated Without Viral Integration	SCIENCE			English	Article							FIBROBLASTS; EXPRESSION; INDUCTION; LIVER	Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome- integrating viruses. We generated mouse induced pluripotent stem ( iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c- Myc. These adenoviral iPS ( adeno- iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient- specific stem cells and for comparing embryonic stem cells and iPS cells.	[Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Nagaya, Masaki; Weir, Gordon] Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, Boston, MA 02115 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Stadtfeld, Matthias; Nagaya, Masaki; Utikal, Jochen; Weir, Gordon; Hochedlinger, Konrad] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University; Harvard Medical School	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu		Utikal, Jochen/0000-0001-5316-0241; Stadtfeld, Matthias/0000-0002-5852-9906	Schering postdoctoral fellowship; Mildred Scheel postdoctoral fellowship; Juvenile Diabetes Research Foundation; NIH Director's Innovator Award; Harvard Stem Cell Institute; Kimmel Foundation; V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Schering postdoctoral fellowship; Mildred Scheel postdoctoral fellowship(Deutsche Krebshilfe); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH Director's Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Kimmel Foundation; V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Hock for critical comments on the manuscript and L. Prickett and K. Folz-Donahue for expert help with flow cytometry. We are especially grateful to J. Lee of the Harvard Gene Therapy Initiative for help with the generation of adenoviral vectors. M. S. was supported by a Schering postdoctoral fellowship, J.U. was supported by a Mildred Scheel postdoctoral fellowship and M.N. and G.W. received support from the Juvenile Diabetes Research Foundation. Support to K.H. was from the NIH Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation. The authors are filing a patent based on the results reported in this paper.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; EMINLI S, 2008, STEM CELLS IN P 0617; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hawley RG, 2008, MOL THER, V16, P1354, DOI 10.1038/mt.2008.142; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; STADTFELD M, 2008, CURR BIOL; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamada S, 2006, ENDOCR J, V53, P789, DOI 10.1507/endocrj.K06-116; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	28	1188	1430	6	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					945	949		10.1126/science.1162494	http://dx.doi.org/10.1126/science.1162494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18818365	Green Accepted			2022-12-01	WOS:000260674100048
J	Grace, C; Begum, R; Subhani, S; Kopelman, P; Greenhalgh, T				Grace, Clare; Begum, Reha; Subhani, Syed; Kopelman, Peter; Greenhalgh, Trisha			Prevention of type 2 diabetes in British Bangladeshis: qualitative study of community, religious, and professional perspectives	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SELF-DETERMINATION THEORY; HEALTH LITERACY; LIFE-STYLE; DISEASE; ADHERENCE; KNOWLEDGE; RISK; INTERVENTION; POPULATION; PAKISTANI	Objective To understand lay beliefs and attitudes, religious teachings, and professional perceptions in relation to diabetes prevention in the Bangladeshi community. Design Qualitative study ( focus groups and semistructured interviews). Setting Tower Hamlets, a socioeconomically deprived London borough, United Kingdom. Participants Bangladeshi people without diabetes ( phase 1), religious leaders and Islamic scholars ( phase 2), and health professionals ( phase 3). Methods 17 focus groups were run using purposive sampling in three sequential phases. Thematic analysis was used iteratively to achieve progressive focusing and to develop theory. To explore tensions in preliminary data fictional vignettes were created, which were discussed by participants in subsequent phases. The PEN- 3 multilevel theoretical framework was used to inform data analysis and synthesis. Results Most lay participants accepted the concept of diabetes prevention and were more knowledgeable than expected. Practical and structural barriers to a healthy lifestyle were commonly reported. There was a strong desire to comply with cultural norms, particularly those relating to modesty. Religious leaders provided considerable support from Islamic teachings for messages about diabetes prevention. Some clinicians incorrectly perceived Bangladeshis to be poorly informed and fatalistic, although they also expressed concerns about their own limited cultural understanding. Conclusion Contrary to the views of health professionals and earlier research, poor knowledge was not the main barrier to healthy lifestyle choices. The norms and expectations of Islam offer many opportunities for supporting diabetes prevention. Interventions designed for the white population, however, need adaptation before they will be meaningful to many Bangladeshis. Religion may have an important part to play in supporting health promotion in this community. The potential for collaborative working between health educators and religious leaders should be explored further and the low cultural understanding of health professionals addressed.	[Grace, Clare] Queen Mary Univ London, Barts & London Sch Med, London E1 2AT, England; [Kopelman, Peter] Univ London St Georges Hosp, London, England; [Greenhalgh, Trisha] Univ London, Dept Primary Care & Populat Sci, London WC1E 7HU, England	University of London; Queen Mary University London; St Georges University London; University of London; University College London	Grace, C (corresponding author), Queen Mary Univ London, Barts & London Sch Med, London E1 2AT, England.	c.m.grace@qmul.ac.uk	Greenhalgh, Trisha/B-1825-2015; Greiver, Michelle/N-8764-2015	Greenhalgh, Trisha/0000-0003-2369-8088; Greiver, Michelle/0000-0001-8957-0285	Diabetes UK [BDA: RD04/0002780]	Diabetes UK(Diabetes UK)	This work was supported by Diabetes UK grant number BDA: RD04/0002780.	Airhihenbuwa C. O., 1995, HLTH CULTURE W PARAD; Ajzen I., 1980, UNDERSTANDING ATTITU, DOI DOI 10.1007/978-3-642-69746-3_2; [Anonymous], 1990, PROSPECT AUSTR J TES; Boutin-Foster Carla, 2005, Health Qual Life Outcomes, V3, P52, DOI 10.1186/1477-7525-3-52; Bush H, 1998, SOCIOL HEALTH ILL, V20, P351, DOI 10.1111/1467-9566.00106; Chowdhury TA, 2003, BRIT MED J, V327, P1059, DOI 10.1136/bmj.327.7423.1059; *CLIN EFF GROUP, 2004, CLIN EFF ANN REP 200; Cote JE, 2002, IDENTITY FORMATION A; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; Dhawan J, 1997, HEART, V78, P550, DOI 10.1136/hrt.78.6.550; *DIR PUBL HLTH TOW, 2007, TOW HAML PUBL HLTH R; Eade John, 1997, LIVING GLOBAL CITY G, P127; ERENS B, 2001, HLTH SURVEY ENGLAND; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; GLASGOW RE, 1988, DIABETES CARE, V11, P377, DOI 10.2337/diacare.11.5.377; Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; HAWTHORNE K, 1990, BRIT J GEN PRACT, V40, P243; Hawthorne K, 1999, DIABETIC MED, V16, P591, DOI 10.1046/j.1464-5491.1999.00102.x; Hayes L, 2002, J PUBLIC HEALTH MED, V24, P170, DOI 10.1093/pubmed/24.3.170; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Hiller, 1996, RES CULTURAL DIFFERE, P220; Johnson M, 2000, BLACK MINORITY ETHNI; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lawton J, 2007, SOCIOL HEALTH ILL, V29, P891, DOI 10.1111/j.1467-9566.2007.01036.x; LEVINE J, 1987, PSYCHOSOM MED, V49, P109, DOI 10.1097/00006842-198703000-00001; MAYCUT P, 1994, BEGINNING QUALITATIV; MIRZA M, 2007, LIVING APART TOGETHE, P53; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; *OFF NAT STAT, 2002, 1 RES POP ENGL WAL 2; PHILLIPSON C, 2003, WOMEN TRANSITION; Rankin J, 2001, PUBLIC HEALTH, V115, P253; REVENSON TA, 1991, SOC SCI MED, V33, P807, DOI 10.1016/0277-9536(91)90385-P; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179; Sher TG, 2002, HEALTH EDUC RES, V17, P597, DOI 10.1093/her/17.5.597; Sherman AM, 2000, CONTROL CLIN TRIALS, V21, p206S, DOI 10.1016/S0197-2456(00)00080-5; SIMMONS D, 1991, DIABETIC MED, V8, P651, DOI 10.1111/j.1464-5491.1991.tb01672.x; SPROTSON K, 2006, HLTH SURVEY ENGLAND; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WHITE M, 1998, EFFECTIVENESS INTERV; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; WILLIAMS R, 1994, INT J EPIDEMIOL, V23, P28, DOI 10.1093/ije/23.1.28; WINTER R, 1986, CAMB J EDUC, V3, P175; [No title captured]	45	77	77	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2008	337								a1931	10.1136/bmj.a1931	http://dx.doi.org/10.1136/bmj.a1931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	377FA	18984633	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-01	WOS:000261235900001
J	Cuttell, L; Vaughan, A; Silva, E; Escaron, CJ; Lavine, M; Van Goethem, E; Eid, JP; Quirin, M; Franc, NC				Cuttell, Leigh; Vaughan, Andrew; Silva, Elizabeth; Escaron, Claire J.; Lavine, Mark; Van Goethem, Emeline; Eid, Jean-Pierre; Quirin, Magali; Franc, Nathalie C.			Undertaker, a Drosophila Junctophilin, Links Draper-Mediated Phagocytosis and Calcium Homeostasis	CELL			English	Article							CELL CORPSE ENGULFMENT; APOPTOTIC CELLS; LYMPHOCYTE-ACTIVATION; RYANODINE RECEPTOR; MEMBRANE-PROTEIN; CA2+ RELEASE; REQUIREMENT; MACROPHAGES; RECOGNITION; MECHANISMS	Phagocytosis is important during development and in the immune response for the removal of apoptotic cells and pathogens, yet its molecular mechanisms are poorly understood. In Caenorhabditis elegans, the CED2/5/10/12 pathway regulates actin during phagocytosis of apoptotic cells, whereas the role of the CED1/6/7 pathway in phagocytosis is unclear. We report that Undertaker (UTA), a Drosophila Junctophilin protein, is required for Draper (CED-1 homolog)-mediated phagocytosis. Junctophilins couple Ca2+ channels at the plasma membrane to those of the endoplasmic reticulum (ER), the Ryanodine receptors. We place Draper, its adaptor drCed-6, UTA, the Ryanodine receptor Rya-r44F, the ER Ca2+ sensor dSTIM, and the Ca2+-release-activated Ca2+ channel dOrai in the same pathway that promotes calcium homeostasis and phagocytosis. Thus, our results implicatea Juncto-philin in phagocytosis and link Draper-mediated phagocytosis to Ca2+ homeostasis, highlighting a previously uncharacterized role for the CED1/6/7 pathway.	[Cuttell, Leigh; Vaughan, Andrew; Silva, Elizabeth; Escaron, Claire J.; Lavine, Mark; Van Goethem, Emeline; Eid, Jean-Pierre; Quirin, Magali; Franc, Nathalie C.] UCL, MRC, Mol Cell Biol Lab, Cell Biol Unit, London WC1E 6BT, England	University of London; University College London	Franc, NC (corresponding author), UCL, MRC, Mol Cell Biol Lab, Cell Biol Unit, Gower St, London WC1E 6BT, England.	n.franc@ucl.ac.uk	Silva, Elizabeth/C-1495-2008; Franc, Nathalie/C-2208-2009; Cuttell, Leigh/F-9281-2011	Silva, Elizabeth/0000-0002-0524-929X; Franc, Nathalie/0000-0002-1617-385X; Silva, Elizabeth/0000-0002-0684-9473; QUIRIN, Magali/0000-0001-7967-5622	Medical Research Council; MRC Cell Biology Unit; The Genetic Society UK; Medical Research Council [MC_U122665005] Funding Source: researchfish; MRC [MC_U122665005] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Cell Biology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Genetic Society UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Bloomington and Szeged Drosophila stock centers, H. Agaisse, D. Ferrandon, M. Freeman, C. Kocks, B. Lemaitre, K. Mecklenberg, Y. Nakai, Y. Nakanishi, N. Perrimon, A. Rao, and D. Reiff for fly stocks and/or reagents and technical advice; A. V. for his help with Ca<SUP>2+</SUP> imaging, and M. Hallett for his advice on its analysis; V. Keasler and W. Yu for the qPCR; H. Agaisse and members of the DRSC for their help with the RNAi screen, and members of the core staff for their help. N. C. F. thanks S. Brown, C. Desplan, and M. Meister for their critical reading of this manuscript. This research was funded by a programme leader-track grant from the Medical Research Council to N. C. F., core support to the MRC Cell Biology Unit, and a studentship from The Genetic Society UK to M. Q.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Beppu M, 2001, ARCH BIOCHEM BIOPHYS, V390, P243, DOI 10.1006/abbi.2001.2381; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; Dewitt S, 2002, J CELL BIOL, V159, P181, DOI 10.1083/jcb.200206089; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Kindzelskii AL, 2003, J IMMUNOL, V170, P64, DOI 10.4049/jimmunol.170.1.64; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Mecklenburg KL, 2007, MOL GENET GENOMICS, V277, P481, DOI 10.1007/s00438-007-0211-7; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Vernon-Wilson EF, 2007, J LEUKOCYTE BIOL, V82, P1278, DOI 10.1189/jlb.0507283; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Xu XH, 2000, BIOPHYS J, V78, P1270, DOI 10.1016/S0006-3495(00)76683-5; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	47	110	112	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					524	534		10.1016/j.cell.2008.08.033	http://dx.doi.org/10.1016/j.cell.2008.08.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984163	Bronze			2022-12-01	WOS:000260536300022
J	Jin, J; Desai, BN; Navarro, B; Donovan, A; Andrews, NC; Clapham, DE				Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Donovan, Adriana; Andrews, Nancy C.; Clapham, David E.			Deletion of Trpm7 Disrupts Embryonic Development and Thymopoiesis Without Altering Mg(2+) Homeostasis	SCIENCE			English	Article							KERATINOCYTE GROWTH-FACTOR; MURINE LYMPHOCYTES-T; POTASSIUM CHANNELS; SECONDARY HYPOCALCEMIA; MIC CHANNELS; PROTEIN; CELLS; HYPOMAGNESEMIA; ACTIVATION; EXPRESSION	The gene transient receptor potential- melastatin- like 7 ( Trpm7) encodes a protein that functions as an ion channel and a kinase. TRPM7 has been proposed to be required for cellular Mg(2+) homeostasis in vertebrates. Deletion of mouse Trpm7 revealed that it is essential for embryonic development. Tissue- specific deletion of Trpm7 in the T cell lineage disrupted thymopoiesis, which led to a developmental block of thymocytes at the double- negative stage and a progressive depletion of thymic medullary cells. However, deletion of Trpm7 in T cells did not affect acute uptake of Mg(2+) or the maintenance of total cellular Mg(2+). Trpm7- deficient thymocytes exhibited dysregulated synthesis of many growth factors that are necessary for the differentiation and maintenance of thymic epithelial cells. The thymic medullary cells lost signal transducer and activator of transcription 3 activity, which accounts for their depletion when Trpm7 is disrupted in thymocytes.	[Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Clapham, David E.] Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Jin, Jie; Donovan, Adriana; Andrews, Nancy C.] Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27702 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27702 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Duke University; Duke University	Clapham, DE (corresponding author), Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Enders Bldg 1309,300 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; /0000-0002-3928-5854; Andrews, Nancy/0000-0003-0243-4462	NIH [T32HL007572-20]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH and NIH postdoctoral fellowship T32HL007572-20 (B.N.D.). We thank F. Alt, H. von Boehmer, M. Fleming, G. Krapivinsky, and M. Delling for helpful discussions. Technical assistance from Y. Fujiwara (Division of Hematology Transgenic core facility), D. Campagna (identification of bacterial artificial chromosome clones), G. Losiyev (Brigham Women's Hospital Flow Cytometry core facility), R. Bronson (mouse necropsy), and Z. Chen (ICP-MS) is deeply appreciated.	CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cernkovich ER, 2007, ENDOCRINOLOGY, V148, P1598, DOI 10.1210/en.2006-1106; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P379, DOI 10.1085/jgp.89.3.379; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Erickson M, 2002, BLOOD, V100, P3269, DOI 10.1182/blood-2002-04-1036; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Huang Y, 2008, CELL CYCLE, V7, P1613, DOI 10.4161/cc.7.11.5952; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rossi S, 2002, BLOOD, V100, P682, DOI 10.1182/blood.V100.2.682; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano S, 2001, IMMUNITY, V15, P261, DOI 10.1016/S1074-7613(01)00180-7; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	25	316	318	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					756	760		10.1126/science.1163493	http://dx.doi.org/10.1126/science.1163493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974357	Green Accepted			2022-12-01	WOS:000260605200053
J	Wen, L; Ley, RE; Volchkov, PY; Stranges, PB; Avanesyan, L; Stonebraker, AC; Hu, CY; Wong, FS; Szot, GL; Bluestone, JA; Gordon, JI; Chervonsky, AV				Wen, Li; Ley, Ruth E.; Volchkov, Pavel Yu.; Stranges, Peter B.; Avanesyan, Lia; Stonebraker, Austin C.; Hu, Changyun; Wong, F. Susan; Szot, Gregory L.; Bluestone, Jeffrey A.; Gordon, Jeffrey I.; Chervonsky, Alexander V.			Innate immunity and intestinal microbiota in the development of Type 1 diabetes	NATURE			English	Article							PANCREATIC LYMPH-NODES; T-CELL REACTIVITY; GUT MICROBIOME; MICE; OBESITY; MOUSE; IDENTIFICATION; DIVERSITY; TOLL; RECOGNITION	Type 1 diabetes (T1D) is a debilitating autoimmune disease that results from T- cell- mediated destruction of insulin- producing beta-cells. Its incidence has increased during the past several decades in developed countries(1,2), suggesting that changes in the environment ( including the human microbial environment) may influence disease pathogenesis. The incidence of spontaneous T1D in nonobese diabetic ( NOD) mice can be affected by the microbial environment in the animal housing facility(3) or by exposure to microbial stimuli, such as injection with mycobacteria or various microbial products(4,5). Here we show that specific pathogen-free NOD mice lacking MyD88 protein ( an adaptor for multiple innate immune receptors that recognize microbial stimuli) do not develop T1D. The effect is dependent on commensal microbes because germ- free MyD88- negative NOD mice develop robust diabetes, whereas colonization of these germ- free MyD88- negative NOD mice with a defined microbial consortium ( representing bacterial phyla normally present in human gut) attenuates T1D. Wealso find thatMyD88 deficiency changes the composition of the distal gut microbiota, and that exposure to the microbiota of specific pathogen- free MyD88negativeNODdonors attenuates T1D in germ- free NOD recipients. Together, these findings indicate that interaction of the intestinal microbes with the innate immune system is a critical epigenetic factor modifying T1D predisposition.	[Volchkov, Pavel Yu.; Stranges, Peter B.; Avanesyan, Lia; Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Stranges, Peter B.; Avanesyan, Lia; Stonebraker, Austin C.; Chervonsky, Alexander V.] Jackson Lab, Bar Harbor, ME 04609 USA; [Wong, F. Susan] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Szot, Gregory L.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Wen, Li; Hu, Changyun] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Ley, Ruth E.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA	University of Chicago; Jackson Laboratory; University of Bristol; University of California System; University of California San Francisco; Yale University; Washington University (WUSTL)	Chervonsky, AV (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achervon@bsd.uchicago.edu	Volchkov, Pavel Y/H-4743-2013; Ley, Ruth E/M-8542-2014; hu, changyun/B-1189-2011	Ley, Ruth E/0000-0002-9087-1672; Szot, Gregory/0000-0002-3921-049X; Wong, F. Susan/0000-0002-2812-8845; Wen, Li/0000-0002-8805-2934; Stranges, Peter Benjamin/0000-0003-1377-7321; Chervonsky, Alexander/0000-0001-7547-871X	ADA [1-05-RA-142]; JDRF [19-2006-1075, 4-2005-1168, 2005-204, 2007-353]; NIH [DK45735, R37 AI46643, P30 DK63720, DK30292, DK70977, DK063452]; W.M. Keck Foundation; NIH/NIDDK Digestive Disease Research Core Center [DK42086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, P30DK042086, P30DK056341, P30DK063720, R21DK063452, R37DK030292, P30DK045735, R01DK070977] Funding Source: NIH RePORTER	ADA(American Diabetes Association); JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NIH/NIDDK Digestive Disease Research Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are thankful to A. Putnam, T. Park, D. Schumann, M. Prokhorovich, W. Du, D. O'Donnell, M. Karlsson and S. Wagoner for help with experiments, and S. Dryden Perkins and M. Garcia for assistance with sequence analysis. This work was supported by the ADA grant 1-05-RA-142 to L.W.; JDRF grant 19-2006-1075 to L.W. and F.S.W.; Animal Genetic Core of Diabetes Endocrinology Research Center (NIH grant DK45735) to L.W.; NIH grants R37 AI46643 and P30 DK63720 as well as the JDRF 4-2005-1168 grant to J.A.B.; NIH grants DK30292 and DK70977, and a W.M. Keck Foundation award to J.I.G.; NIH grant DK063452 to A.V.C.; JDRF grants 2005-204 and 2007-353 to A.V.C.; and the NIH/NIDDK Digestive Disease Research Core Center grant DK42086.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amrani A, 1999, J CLIN INVEST, V103, P1201, DOI 10.1172/JCI6266; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; FUNDA DP, 2007, P 13 INT C IMM BRAZ; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Gray DHD, 2007, P NATL ACAD SCI USA, V104, P18193, DOI 10.1073/pnas.0709160104; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kanagawa O, 2002, J IMMUNOL, V168, P6159, DOI 10.4049/jimmunol.168.12.6159; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lieberman SM, 2004, J IMMUNOL, V173, P6727, DOI 10.4049/jimmunol.173.11.6727; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Patterson CC, 2001, DIABETOLOGIA, V44, pB9, DOI 10.1007/PL00002961; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Stratmann T, 2003, J CLIN INVEST, V112, P902, DOI 10.1172/JCI200318337; Strober W, 2004, NAT MED, V10, P898, DOI 10.1038/nm0904-898; SUZUKI T, 1985, IMMUNE DEFICIENT ANI, P112; Takaki T, 2004, J IMMUNOL, V173, P2530, DOI 10.4049/jimmunol.173.4.2530; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	40	1387	1462	23	514	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1109	U10		10.1038/nature07336	http://dx.doi.org/10.1038/nature07336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806780	Green Accepted			2022-12-01	WOS:000260252600045
J	Barber, LJ; Youds, JL; Ward, JD; McIlwraith, MJ; O'Neil, NJ; Petalcorin, MIR; Martin, JS; Collis, SJ; Cantor, SB; Auclair, M; Tissenbaum, H; West, SC; Rose, AM; Boulton, SJ				Barber, Louise J.; Youds, Jillian L.; Ward, Jordan D.; McIlwraith, Michael J.; O'Neil, Nigel J.; Petalcorin, Mark I. R.; Martin, Julie S.; Collis, Spencer J.; Cantor, Sharon B.; Auclair, Melissa; Tissenbaum, Heidi; West, Stephen C.; Rose, Ann M.; Boulton, Simon J.			RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination	CELL			English	Article							SACCHAROMYCES-CEREVISIAE SRS2; STRAND BREAK REPAIR; BOX DNA HELICASE; BLOOMS-SYNDROME HELICASE; CROSS-LINK REPAIR; CAENORHABDITIS-ELEGANS; C-ELEGANS; HYPER-RECOMBINATION; IONIZING-RADIATION; DAMAGE CHECKPOINT	Homologous recombination (HR) is an important conserved process for DNA repair and ensures maintenance of genome integrity. Inappropriate HR causes gross chromosomal rearrangements and tumorigenesis in mammals. In yeast, the Srs2 helicase eliminates inappropriate recombination events, but the functional equivalent of Srs2 in higher eukaryotes has been elusive. Here, we identify C. elegans RTEL-1 as a functional analog of Srs2 and describe its vertebrate counterpart, RTEL1, which is required for genome stability and tumor avoidance. We find that rtel-1 mutant worms and RTEL1-depleted human cells share characteristic phenotypes with yeast srs2 mutants: lethality upon deletion of the sgs1/BLM homolog, hyperrecombination, and DNA damage sensitivity. In vitro, purified human RTEL1 antagonizes HR by promoting the disassembly of D loop recombination intermediates in a reaction dependent upon ATP hydrolysis. We propose that loss of HR control after deregulation of RTEL1 may be a critical event that drives genome instability and cancer.	[Barber, Louise J.; Youds, Jillian L.; Ward, Jordan D.; Petalcorin, Mark I. R.; Martin, Julie S.; Collis, Spencer J.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Youds, Jillian L.; O'Neil, Nigel J.; Rose, Ann M.] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [McIlwraith, Michael J.; West, Stephen C.] Canc Res UK, London Res Inst, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Cantor, Sharon B.] Univ Massachusetts, Sch Med, Program Canc Biol, Worcester, MA 01605 USA; [Auclair, Melissa; Tissenbaum, Heidi] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Auclair, Melissa; Tissenbaum, Heidi] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Cancer Research UK; University of British Columbia; Cancer Research UK; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	O'Neil, Nigel/J-4012-2014; Ward, Jordan/H-3444-2019; Ward, Jordan/C-1505-2008; Barber, Louise J./L-8579-2019	O'Neil, Nigel/0000-0002-1992-6976; Ward, Jordan/0000-0001-9870-8936; Ward, Jordan/0000-0001-9870-8936; Barber, Louise J./0000-0001-9265-3516; Petalcorin, Mark/0000-0001-8211-9440; Collis, Spencer/0000-0002-7874-1891; West, Stephen/0000-0001-8848-9418; Mcilwraith, Michael/0000-0003-1559-4369	William Randolph Hearst Foundation; National Institutes of Health [AG25891]; Natural Sciences and Engineering Research Council; National Cancer Institute of Canada; Michael Smith Foundation; Louis-Jeantet Foundation; Cancer Research UK; NATIONAL INSTITUTE ON AGING [R01AG031237, R01AG025891] Funding Source: NIH RePORTER	William Randolph Hearst Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Louis-Jeantet Foundation; Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We wish to thank Shohei Mitani (National Bioresource Project, Japan) and the C. elegans Knockout Consortium for providing nematode strains; Cancer Research UK Cell Services, Helen Bryant and Thomas Helleday for cells; Ian Hickson for BLM protein; and Helen Bryant, Thomas Helleday, and Janet Cronshaw for plasmids. H. A. T. is funded by the William Randolph Hearst Foundation; H. A. T. and M. A. are also funded by a grant from the National Institutes of Health (AG25891); A. M. R. is funded by the Natural Sciences and Engineering Research Council; J.L.Y. was funded by National Cancer Institute of Canada and Michael Smith Foundation for Health Research; S. C. W. is supported by the Louis-Jeantet Foundation and is part of the EU DNA Repair Consortium; and the labs of S. C. W and S. J. B. receive funding from Cancer Research UK.	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; AGUILERA A, 1988, GENETICS, V119, P779; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; BRENNER S, 1974, GENETICS, V77, P71; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/417405a, 10.1038/ng928]; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Chiolo I, 2007, MOL CELL BIOL, V27, P7439, DOI 10.1128/MCB.00963-07; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Collis SJ, 2006, DNA REPAIR, V5, P1398, DOI 10.1016/j.dnarep.2006.06.010; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jeong YS, 2003, DNA REPAIR, V2, P1309, DOI 10.1016/j.dnarep.2003.07.003; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Klein H, 2001, GENETICS, V157, P557; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Lee SJ, 2004, DEVELOPMENT, V131, P2565, DOI 10.1242/dev.01136; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; PALLADINO F, 1992, GENETICS, V132, P23; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; RONG L, 1991, GENETICS, V127, P75; ROSE AM, 1979, GENETICS, V92, P409; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang SW, 2001, NUCLEIC ACIDS RES, V29, P2963, DOI 10.1093/nar/29.14.2963; Weidhaas JB, 2006, P NATL ACAD SCI USA, V103, P9946, DOI 10.1073/pnas.0603791103; Wicky C, 2004, MOL CELL BIOL, V24, P5016, DOI 10.1128/MCB.24.11.5016-5027.2004; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Youds JL, 2006, GENETICS, V173, P697, DOI 10.1534/genetics.106.056879; ZIEG J, 1978, J BACTERIOL, V134, P958, DOI 10.1128/JB.134.3.958-966.1978	66	268	279	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					261	271		10.1016/j.cell.2008.08.016	http://dx.doi.org/10.1016/j.cell.2008.08.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957201	Green Accepted, Bronze			2022-12-01	WOS:000260130400016
J	Stathopulos, PB; Zheng, L; Li, GY; Plevin, MJ; Ikura, M				Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko			Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry	CELL			English	Article							STROMAL INTERACTION MOLECULE-1; SAM DOMAIN; CA2+ ENTRY; CRAC CHANNELS; POINT MUTATIONS; I-CRAC; STIM1; PROTEIN; BINDING; ER	Stromal interaction molecule-1 (STIM1) activates store-operated Ca2+ entry (SOCE) in response to diminished luminal Ca2+ levels. Here, we present the atomic structure of the Ca2+-sensing region of STIM1 consisting of the EF-hand and sterile a motif (SAM) domains (EF-SAM). The canonical EF-hand is paired with a previously unidentified EF-hand. Together, the EF-hand pair mediates mutually indispensable hydrophobic interactions between the EF-hand and SAM domains. Structurally critical mutations in the canonical EF-hand, "hidden'' EF-hand, or SAM domain disrupt Ca2+ sensitivity in oligomerization via destabilization of the entire EF-SAM entity. In mammalian cells, EF-SAM destabilization mutations within full-length STIM1 induce punctae formation and activate SOCE independent of luminal Ca2+. We provide atomic resolution insight into the molecular basis for STIM1-mediated SOCE initiation and show that the folded/unfolded state of the Ca2+-sensing region of STIM is crucial to SOCE regulation.	[Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto Med Discovery Tower,MaRS Ctr,101 Coll St, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca		Plevin, Michael/0000-0003-2057-8291; Stathopulos, Peter/0000-0002-0536-6656	Canadian Institutes of Health Research; Canadian Foundation for Innovation [800 MHz NMR]; Natural Sciences and Engineering Research Council of Canada; Ontario Cancer Institute Knudson	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Cancer Institute Knudson	We thank N. Ishiyama for his EM assistance, R.S. Lewis (Stanford University) for providing cherryFP-STIM1, and Bruker Biospin Corporation (Fremont, CA) for 900 MHz NMR time. This research was made possible through a Canadian Institutes of Health Research operating grant, a Canadian Foundation for Innovation grant for an 800 MHz NMR spectrometer, and Natural Sciences and Engineering Research Council of Canada and Ontario Cancer Institute Knudson fellowships (to P.B.S.). M.I. holds the Canada Research Chair in Cancer Structural Biology.	ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cai XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000609; Chen LH, 2007, CARCINOGENESIS, V28, P2328, DOI 10.1093/carcin/bgm173; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; IKURA M, 1985, BIOCHEMISTRY-US, V24, P4264, DOI 10.1021/bi00337a002; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; KASS GEN, 1990, J BIOL CHEM, V265, P17486; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; STAROVASNIK MA, 1992, PROTEIN SCI, V1, P245; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Strange K, 2007, CELL CALCIUM, V42, P193, DOI 10.1016/j.ceca.2007.02.007; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wojcik J, 1997, BIOCHEMISTRY-US, V36, P680, DOI 10.1021/bi961821c; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	56	342	353	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					110	122		10.1016/j.cell.2008.08.006	http://dx.doi.org/10.1016/j.cell.2008.08.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854159	Bronze			2022-12-01	WOS:000259728100013
J	Tan, I; Yong, J; Dong, JM; Lim, L; Leung, T				Tan, Ivan; Yong, Jeffery; Dong, Jing Ming; Lim, Louis; Leung, Thomas			A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow	CELL			English	Article							CDC42-BINDING KINASE-ALPHA; FOCAL ADHESION DYNAMICS; RHO-DEPENDENT KINASE; MIGRATING CELLS; MYOSIN-II; ACTIN CYTOSKELETON; MAMMALIAN-CELLS; PROTRUSION; MOTILITY; CDC42	Actomyosin retrograde flow underlies the contraction essential for cell motility. Retrograde flow in both lamellipodia and lamella is required for membrane protrusion and for force generation by coupling to cell adhesion. We report that the Rac/Cdc42-binding kinase MRCK and myosin II-related MYO18A linked by the adaptor protein LRAP35a form a functional tripartite complex, which is responsible for the assembly of lamellar actomyosin bundles and of a subnuclear actomyosin network. LRAP35a binds independently to MYO18A and MRCK. This binding leads to MRCK activation and its phosphorylation of MYO18A, independently of ROK and MLCK. The MRCK complex moves in concert with the retrograde flow of actomyosin bundles, with MRCK being able to influence other flow components such as MYO2A. The promotion of persistent protrusive activity and inhibition of cell motility by the respective expression of wild-type and dominant-negative mutant components of the MRCK complex show it to be crucial to cell protrusion and migration.	[Tan, Ivan; Yong, Jeffery; Dong, Jing Ming; Lim, Louis; Leung, Thomas] Inst Mol & Cell Biol, GSK IMCB Grp, Singapore 138673, Singapore; [Yong, Jeffery; Leung, Thomas] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 119260, Singapore; [Lim, Louis] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; National University of Singapore; University of London; University College London	Leung, T (corresponding author), Inst Mol & Cell Biol, GSK IMCB Grp, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbthoml@imcb.a-star.edu.sg			GSK (Singapore) Research Fund	GSK (Singapore) Research Fund(GlaxoSmithKline)	We thank Robin Philps for peptide sequencing and Ed Manser for valuable comments on the manuscript. This work was supported by the GSK (Singapore) Research Fund.	Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Groeger G, 2007, BIOCHEM J, V404, P23, DOI 10.1042/BJ20070146; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Ng Y, 2004, J BIOL CHEM, V279, P34156, DOI 10.1074/jbc.M405252200; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumi T, 2001, J BIOL CHEM, V276, P23092, DOI 10.1074/jbc.C100196200; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	37	94	108	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					123	136		10.1016/j.cell.2008.09.018	http://dx.doi.org/10.1016/j.cell.2008.09.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854160	Bronze			2022-12-01	WOS:000259728100014
J	Gandin, V; Miluzio, A; Barbieri, AM; Beugnet, A; Kiyokawa, H; Marchisio, PC; Biffo, S				Gandin, Valentina; Miluzio, Annarita; Barbieri, Anna Maria; Beugnet, Anne; Kiyokawa, Hiroaki; Marchisio, Pier Carlo; Biffo, Stefano			Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation	NATURE			English	Article							INITIATION FACTOR-6; PROTEIN; P27(BBP); TRANSDUCTION; ACTIVATION; MECHANISMS; EXPRESSION; STRESS; CELLS; BOP1	Cell growth and proliferation require coordinated ribosomal biogenesis and translation. Eukaryotic initiation factors ( eIFs) control translation at the rate- limiting step of initiation(1,2). So far, only two eIFs connect extracellular stimuli to global translation rates(3): eIF4E acts in the eIF4F complex and regulates binding of capped messenger RNA to 40S subunits, downstream of growth factors(4,5), and eIF2 controls loading of the ternary complex on the 40S subunit and is inhibited on stress stimuli(6,7). No eIFs have been found to link extracellular stimuli to the activity of the large 60S ribosomal subunit. eIF6 binds 60S ribosomes precluding ribosome joining in vitro(8-10). However, studies in yeasts showed that eIF6 is required for ribosome biogenesis rather than translation(11-14). Here we show that mammalian eIF6 is required for efficient initiation of translation, in vivo. eIF6 null embryos are lethal at preimplantation. Heterozygous mice have 50% reduction of eIF6 levels in all tissues, and show reduced mass of hepatic and adipose tissues due to a lower number of cells and to impaired G1/S cell cycle progression. eIF6(+/-) cells retain sufficient nucleolar eIF6 and normal ribosome biogenesis. The liver of eIF6(+/-) mice displays an increase of 80S in polysomal profiles, indicating a defect in initiation of translation. Consistently, isolated hepatocytes have impaired insulin- stimulated translation. Heterozygous mouse embryonic fibroblasts recapitulate the organism phenotype and have normal ribosome biogenesis, reduced insulin- stimulated translation, and delayed G1/S phase progression. Furthermore, eIF6(+/-) cells are resistant to oncogene- induced transformation. Thus, eIF6 is the first eIF associated with the large 60S subunit that regulates translation in response to extracellular signals.	[Gandin, Valentina; Miluzio, Annarita; Barbieri, Anna Maria; Beugnet, Anne; Marchisio, Pier Carlo; Biffo, Stefano] Ist Sci San Raffaele, Mol Histol & Cell Growth Lab, I-20132 Milan, Italy; [Kiyokawa, Hiroaki] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Marchisio, Pier Carlo] Univ Vita Salute, Sch Med, I-20132 Milan, Italy; [Biffo, Stefano] Univ Piemonte Orientale, DISAV, I-15100 Alessandria, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Northwestern University; Feinberg School of Medicine; Vita-Salute San Raffaele University; University of Eastern Piedmont Amedeo Avogadro	Biffo, S (corresponding author), Ist Sci San Raffaele, Mol Histol & Cell Growth Lab, Via Olgettina 58, I-20132 Milan, Italy.	stefano.biffo@hsr.it	Barbieri, Anna Maria/AAA-6328-2020	Gandin, Valentina/0000-0003-2627-1303; Kiyokawa, Hiroaki/0000-0002-7942-6455; Miluzio, Annarita/0000-0002-2838-2659; biffo, stefano/0000-0002-3780-1050	AIRC [05-360]; TELETHON [GGB05043, CARIPLO, NIH-RO10578]; NATIONAL CANCER INSTITUTE [R01CA112282] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); TELETHON(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants AIRC (S.B., P.C.M.), TELETHON GGB05043, CARIPLO 0578 (S.B.) and NIH-RO1 (H.K.). A. B. is supported by grant AICR 05-360. The manuscript has been improved thanks to suggestions from N. Offenhaeuser and A. Boletta. We are indebted to P. G. Pelicci for anti-NPM antibodies, H. Hirai for preliminary soft agar assays, S. Modina for blastocyst preparation, M. Vidali for hepatocytes preparation, M. Malosio for insulin receptor antibodies, S. Gregori for FACS analysis, D. Bartel for reporter constructs, G. Manfioletti for HMGA2 antibodies and F. Loreni for rpS19 antibodies. We acknowledge L. Magri for preliminary experiments, and V. Volta and S. Grosso for suggestions.	Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Betts DH, 1998, DEV BIOL, V197, P77, DOI 10.1006/dbio.1998.8874; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; CLARK RL, 1980, BIOCHEM J, V190, P615, DOI 10.1042/bj1900615; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; De Palma M, 2002, METHOD ENZYMOL, V346, P514; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gorrini C, 2005, P NATL ACAD SCI USA, V102, P9200, DOI 10.1073/pnas.0409513102; Harris MN, 2004, BLOOD, V104, P1314, DOI 10.1182/blood-2004-01-0046; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Sanvito F, 2000, CANCER RES, V60, P510; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Si K, 1999, MOL CELL BIOL, V19, P1416; Sonenberg N, 2006, SCIENCE, V314, P428, DOI 10.1126/science.1134031; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wood LC, 1999, J BIOL CHEM, V274, P11653, DOI 10.1074/jbc.274.17.11653; Yang YL, 2007, CELL PROLIFERAT, V40, P397, DOI 10.1111/j.1365-2184.2007.00443.x; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	33	160	163	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					684	U81		10.1038/nature07267	http://dx.doi.org/10.1038/nature07267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18784653	Green Accepted			2022-12-01	WOS:000259639700051
J	Busche, MA; Eichhoff, G; Adelsberger, H; Abramowski, D; Wiederhold, KH; Haass, C; Staufenbiel, M; Konnerth, A; Garaschuk, O				Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Abramowski, Dorothee; Wiederhold, Karl-Heinz; Haass, Christian; Staufenbiel, Matthias; Konnerth, Arthur; Garaschuk, Olga			Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease	SCIENCE			English	Article							IN-VIVO; A-BETA; LINKED MUTATIONS; VISUAL-CORTEX; SYNAPSE LOSS; OLIGOMERS; MICE; NETWORKS; MEMORY; DISRUPTION	The neurodegeneration observed in Alzheimer's disease has been associated with synaptic dismantling and progressive decrease in neuronal activity. We tested this hypothesis in vivo by using two- photon Ca(2+) imaging in a mouse model of Alzheimer's disease. Although a decrease in neuronal activity was seen in 29% of layer 2/3 cortical neurons, 21% of neurons displayed an unexpected increase in the frequency of spontaneous Ca(2+) transients. These "hyperactive" neurons were found exclusively near the plaques of amyloid beta-depositing mice. The hyperactivity appeared to be due to a relative decrease in synaptic inhibition. Thus, we suggest that a redistribution of synaptic drive between silent and hyperactive neurons, rather than an overall decrease in synaptic activity, provides a mechanism for the disturbed cortical function in Alzheimer's disease.	[Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Konnerth, Arthur; Garaschuk, Olga] Tech Univ Munich, Inst Neurowissensch, D-80802 Munich, Germany; [Abramowski, Dorothee; Wiederhold, Karl-Heinz; Staufenbiel, Matthias] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Haass, Christian] Univ Munich, Dept Biochem, Lab Neurodegenerat Dis Res, Adolf Butenandt Inst, D-80336 Munich, Germany; [Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Haass, Christian; Konnerth, Arthur; Garaschuk, Olga] Ctr Integrated Prot Sci, D-81377 Munich, Germany	Technical University of Munich; Novartis; University of Munich; University of Munich	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurowissensch, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Garaschuk, Olga/G-5633-2015; Eichhoff, Gerhard/L-4075-2019	Busche, Marc Aurel/0000-0002-4416-7553	Deutsche Forschungsgemeinschaft [SFB 596, GA 654/1-1, HO 2156/2-1]; Helmholtz Gemeinschaft.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Gemeinschaft.(Helmholtz Association)	A. K. is a Carl-von-Linde Fellow of the Institute for Advanced Study of the TUM. We thank L. B. Cohen for comments on the manuscript. Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596, GA 654/1-1, and HO 2156/2-1) and the Helmholtz Gemeinschaft.	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Arns M, 1999, BEHAV BRAIN RES, V106, P151, DOI 10.1016/S0166-4328(99)00103-5; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Christie RH, 2001, J NEUROSCI, V21, P858, DOI 10.1523/JNEUROSCI.21-03-00858.2001; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lozsadi DA, 2006, DEMENT GERIATR COGN, V22, P121, DOI 10.1159/000093664; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Phinney AL, 1999, J NEUROSCI, V19, P8552; Prvulovic D, 2005, PSYCHIAT RES-NEUROIM, V140, P97, DOI 10.1016/j.pscychresns.2005.06.006; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wirths O, 2008, NEUROBIOL AGING, V29, P891, DOI 10.1016/j.neurobiolaging.2006.12.004	40	673	688	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1686	1689		10.1126/science.1162844	http://dx.doi.org/10.1126/science.1162844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802001				2022-12-01	WOS:000259300400039
J	Duda, DM; Borg, LA; Scott, DC; Hunt, HW; Hammel, M; Schulman, BA				Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Hammel, Michal; Schulman, Brenda A.			Structural insights into NEDD8 activation of Cullin-RING ligases: Conformational control of conjugation	CELL			English	Article							UBIQUITIN-LIKE PROTEINS; E3 LIGASE; SACCHAROMYCES-CEREVISIAE; CUL5-RBX2 MODULES; GENOME-WIDE; IN-VIVO; COMPLEX; SCF; BINDING; DOMAIN	Cullin-RING ligases (CRLs) comprise the largest ubiquitin E3 subclass, in which a central cullin subunit links a substrate-binding adaptor with an E2-binding RING. Covalent attachment of the ubiquitin-like protein NEDD8 to a conserved C-terminal domain (ctd) lysine stimulates CRL ubiquitination activity and prevents binding of the inhibitor CAND1. Here we report striking conformational rearrangements in the crystal structure of NEDD8 similar to CuI5(ctd)-Rbx1 and SAXS analysis of NEDD8 similar to CuI1(ctd)-Rbx1 relative to their unmodified counterparts. In NEDD8ylated CRL structures, the cullin WHB and Rbx1 RING subdomains are dramatically reoriented, eliminating a CAND1-binding site and imparting multiple potential catalytic geometries to an associated E2. Biochemical analyses indicate that the structural malleability is important for both CRL NEDD8ylation and subsequent ubiquitination activities. Thus, our results point to a conformational control of CRL activity, with ligation of NEDD8 shifting equilibria to disfavor inactive CAND1-bound closed architectures, and favor dynamic, open forms that promote polyubiquitination.	[Duda, David M.; Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Genet Tumor Cell Biol, Memphis, TN 38105 USA; [Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA.	brenda.schulman@stjude.org		Hammel, Michal/0000-0002-5610-9289	U.S. DOE [DE-AC02-05CH11231]; NSLS [DE-AC02-98CH10886]; American Lebanese Syrian Associated Charities of St. Jude,; NIH [P30CA021765, R01GM069530]; Howard Hughes Medical Institute; Beckman Young Investigator Award; Pew Scholar Award; Phillip and Elizabeth Gross Foundation; DOD [DAMD17-03-0420]; American Cancer Society; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530] Funding Source: NIH RePORTER	U.S. DOE(United States Department of Energy (DOE)); NSLS; American Lebanese Syrian Associated Charities of St. Jude,(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beckman Young Investigator Award; Pew Scholar Award; Phillip and Elizabeth Gross Foundation; DOD(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. King and S. Zhou for mass spectrometry/Edman sequencing, J. Endicott for cdk2 plasmid, C. Ross and Staff at ALS 8.2.1, ALS 12.3.1, and NSLS X25 beamlines, V. Pagala, P. Murray, R. Deshaies, Z.Q. Pan, J. W. Harper, M. Lee, B. Dye, D. Miller, S. Bozeman, and members of the Schulman lab for assistance, advice, and/or discussions. ALS is supported by U.S. DOE Contract No. DE-AC02-05CH11231, and NSLS by DE-AC02-98CH10886. This work was supported in part by American Lebanese Syrian Associated Charities of St. Jude, by NIH P30CA021765 to St. Jude, the Howard Hughes Medical Institute, a Beckman Young Investigator Award, a Pew Scholar Award, the Phillip and Elizabeth Gross Foundation, the NIH (R01GM069530), and DOD (DAMD17-03-0420) to B. A. S. and by an American Cancer Society fellowship to D.M.D. B.A.S. is an Investigator of the Howard Hughes Medical Institute.	Amir RE, 2002, J BIOL CHEM, V277, P23253, DOI 10.1074/jbc.M200967200; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; KRATKY O, 1949, RONTGENUNTERSUCHUNG, P1106; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Laplaza JM, 2004, BIOCHEM J, V377, P459, DOI 10.1042/BJ20030755; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	62	552	566	4	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					995	1006		10.1016/j.cell.2008.07.022	http://dx.doi.org/10.1016/j.cell.2008.07.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805092	Green Accepted, Bronze			2022-12-01	WOS:000259318100019
J	Stuber, GD; Klanker, M; de Ridder, B; Bowers, MS; Joosten, RN; Feenstra, MG; Bonci, A				Stuber, Garret D.; Klanker, Marianne; de Ridder, Bram; Bowers, M. Scott; Joosten, Ruud N.; Feenstra, Matthijs G.; Bonci, Antonello			Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; COCAINE-SEEKING; GLUTAMATE; LTP; AMPHETAMINE; DEPRESSION; RATS	Using sensory information for the prediction of future events is essential for survival. Midbrain dopamine neurons are activated by environmental cues that predict rewards, but the cellular mechanisms that underlie this phenomenon remain elusive. We used in vivo voltammetry and in vitro patch- clamp electrophysiology to show that both dopamine release to reward predictive cues and enhanced synaptic strength onto dopamine neurons develop over the course of cue- reward learning. Increased synaptic strength was not observed after stable behavioral responding. Thus, enhanced synaptic strength onto dopamine neurons may act to facilitate the transformation of neutral environmental stimuli to salient reward- predictive cues.	[Stuber, Garret D.; de Ridder, Bram; Bowers, M. Scott; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA; [Klanker, Marianne; Joosten, Ruud N.; Feenstra, Matthijs G.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Bonci, Antonello] Univ Calif San Francisco, Wheeler Ctr Neurobiol Drug Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of California System; University of California San Francisco	Bonci, A (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA.	antonello.bonci@ucsf.edu	Stuber, Garret/E-1160-2011	Stuber, Garret/0000-0003-1730-4855; Bowers, M Scott/0000-0003-0047-6765	State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; Van Den Houtenfonds; Netherlands Organisation for Scientific Research, NWO;  [DA021937];  [DA015096]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096, F32DA021937] Funding Source: NIH RePORTER	State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); Van Den Houtenfonds; Netherlands Organisation for Scientific Research, NWO(Netherlands Organization for Scientific Research (NWO)); ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank H. Fields, F. W. Hopf, P. Janak, and K. Tye for helpful comments and R. Sadler and L. Wang for technical assistance. This work was supported by DA021937 (G.D.S.), DA015096 (A.B.), funds from the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (A.B.), the Van Den Houtenfonds (M.G.F.), and the Netherlands Organisation for Scientific Research, NWO (M.G.F.).	Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Cheng JJ, 2003, EUR J NEUROSCI, V18, P1306, DOI 10.1046/j.1460-9568.2003.02849.x; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Di Ciano P, 2004, EUR J NEUROSCI, V19, P1661, DOI 10.1111/j.1460-9568.2004.03232.x; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARNELI M, 2007, SCIENCE, V317, P530; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Schuchard M, 1998, NEUROMODULATION, V1, P46, DOI 10.1111/j.1525-1403.1998.tb00029.x; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; You ZB, 2007, J NEUROSCI, V27, P10546, DOI 10.1523/JNEUROSCI.2967-07.2007; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699	23	223	224	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1690	1692		10.1126/science.1160873	http://dx.doi.org/10.1126/science.1160873			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802002	Green Accepted			2022-12-01	WOS:000259300400040
J	Cella, M; Fuchs, A; Vermi, W; Facchetti, F; Otero, K; Lennerz, JKM; Doherty, JM; Mills, JC; Colonna, M				Cella, Marina; Fuchs, Anja; Vermi, William; Facchetti, Fabio; Otero, Karel; Lennerz, Jochen K. M.; Doherty, Jason M.; Mills, Jason C.; Colonna, Marco			A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity	NATURE			English	Article							GROWTH-FACTOR-BETA; ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; EPITHELIAL-CELLS; HOST-DEFENSE; TGF-BETA; DIFFERENTIATION; INTERLEUKIN-22; INFLAMMATION; CYTOKINES	Natural killer ( NK) cells are classically viewed as lymphocytes that provide innate surveillance against virally infected cells and tumour cells through the release of cytolytic mediators and interferon ( IFN)-gamma. In humans, blood CD56(dim) NKcells specialize in the lysis of cell targets(1). In the lymph nodes, CD56(bright) NK cells secrete IFN-gamma cooperating with dendritic cells and T cells in the generation of adaptive responses(1,2). Here we report the characterization of a human NK cell subset located in mucosa- associated lymphoid tissues, such as tonsils and Peyer's patches, which is hard- wired to secrete interleukin (IL)- 22, IL- 26 and leukaemia inhibitory factor. TheseNKcells, whichwe refer to as NK- 22 cells, are triggered by acute exposure to IL- 23. In vitro, NK- 22- secreted cytokines stimulate epithelial cells to secrete IL- 10, proliferate and express a variety of mitogenic and anti- apoptotic molecules. NK- 22 cells are also found in mouse mucosa- associated lymphoid tissues and appear in the small intestine lamina propria during bacterial infection, suggesting that NK- 22 cells provide an innate source of IL- 22 that may help constrain inflammation and protect mucosal sites.	[Cella, Marina; Fuchs, Anja; Otero, Karel; Lennerz, Jochen K. M.; Doherty, Jason M.; Mills, Jason C.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Vermi, William; Facchetti, Fabio] Univ Brescia, Dept Pathol 1, Spedali Civili, I-25123 Brescia, Italy	Washington University (WUSTL); University of Brescia	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Cella, Marina/G-8850-2011; Facchetti, Fabio/E-7190-2010; Cella, Marina/ABA-8564-2020; Mills, Jason/AAA-6688-2021	Facchetti, Fabio/0000-0003-4975-2388; Mills, Jason/0000-0002-0402-4662; VERMI, WILLIAM/0000-0002-2291-2997; Colonna, Marco/0000-0001-5222-4987; Cella, Marina/0000-0003-1230-1313	National Institutes of Health [R01AI056139-05, R21AI067748-02]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK079798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067748, R01AI056139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Hughes, B. Eades and S. Schloehmann for cell sorting; R. Clary and the nursing staff at the Children's Hospital, Washington University School of Medicine, for providing tonsil specimens; S. Lonardi for assistance in immunohistochemistry; J. Pfeifer for providing gut specimens; A. Rapaport and S. McCartney for help in gene chip analysis; and S. Gilfillan for critically reading the manuscript. This work was supported by National Institutes of Health (NIH) grants R01AI056139-05 and R21AI067748-02 (to M.Co.) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK079798 (to J.C.M.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH and NIDDK.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Candiago E, 2000, AM J DERMATOPATH, V22, P1, DOI 10.1097/00000372-200002000-00001; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Kusam S, 2007, IMMUNOL RES, V37, P177, DOI 10.1007/BF02697368; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Strowig T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040027; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	30	955	992	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					722	725		10.1038/nature07537	http://dx.doi.org/10.1038/nature07537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	18978771	Green Accepted			2022-12-01	WOS:000263064700041
J	Keller, GB; Hahnloser, RHR				Keller, Georg B.; Hahnloser, Richard H. R.			Neural processing of auditory feedback during vocal practice in a songbird	NATURE			English	Article							MALE ZEBRA FINCHES; ADULT BIRDSONG; SYSTEM; TELENCEPHALON; PERTURBATION; CONNECTIONS; BEHAVIOR; NEURONS; CORTEX; MODEL	Songbirds are capable of vocal learning and communication(1,2) and are ideally suited to the study of neural mechanisms of complex sensory and motor processing. Vocal communication in a noisy bird colony and vocal learning of a specific song template both require the ability to monitor auditory feedback(3,4) to distinguish self-generated vocalizations from external sounds and to identify mismatches between the developing song and a memorized template acquired from a tutor(5). However, neurons that respond to auditory feedback from vocal output have not been found in song-control areas despite intensive searching(6-8). Here we investigate feedback processing outside the traditional song system, in single auditory forebrain neurons of juvenile zebra finches that were in a late developmental stage of song learning. Overall, we found similarity of spike responses during singing and during playback of the bird's own song, with song responses commonly leading by a few milliseconds. However, brief time- locked acoustic perturbations of auditory feedback revealed complex sensitivity that could not be predicted from passive playback responses. Some neurons that responded to playback perturbations did not respond to song perturbations, which is reminiscent of sensory- motor mirror neurons(8,9). By contrast, some neurons were highly feedback sensitive in that they responded vigorously to song perturbations, but not to unperturbed songs or perturbed playback. These findings suggest that a computational function of forebrain auditory areas may be to detect errors between actual feedback and mirrored feedback deriving from an internal model of the bird's own song or that of its tutor. Such feedback- sensitive spikes could constitute the key signals that trigger adaptive motor responses to song disruptions(10,11) or reinforce exploratory motor gestures for vocal learning(12).	[Keller, Georg B.; Hahnloser, Richard H. R.] Univ Zurich, ETH, Inst Neuroinformat, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Hahnloser, RHR (corresponding author), Univ Zurich, ETH, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	rich@ini.phys.ethz.ch		Keller, Georg/0000-0002-1401-0117; Hahnloser, Richard/0000-0002-4039-7773	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a Swiss National Science Foundation Professorship Grant to R. H. R. H. We thank K. Martin, R. Mooney and R. Douglas for comments on the manuscript.	Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Foster EF, 1998, J COMP NEUROL, V397, P118; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Immelmann K., 1969, P61; Janata P, 1999, J NEUROSCI, V19, P5108; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KARTEN H J, 1968, Brain Research, V11, P134, DOI 10.1016/0006-8993(68)90078-4; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; THORPE WH, 1975, ACTA NEUROBIOL EXP, V35, P517; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Zeng SJ, 2004, J COMP NEUROL, V470, P192, DOI 10.1002/cne.11042	30	138	139	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					187	U78		10.1038/nature07467	http://dx.doi.org/10.1038/nature07467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19005471				2022-12-01	WOS:000262360200031
J	Bouzigon, E; Corda, E; Aschard, H; Dizier, MH; Boland, A; Bousquet, J; Chateigner, N; Gormand, F; Just, J; Le Moual, N; Scheinmann, P; Siroux, V; Vervloet, D; Zelenika, D; Pin, I; Kauffmann, F; Lathrop, M; Demenais, F				Bouzigon, Emmanuelle; Corda, Eve; Aschard, Hugues; Dizier, Marie-Helene; Boland, Anne; Bousquet, Jean; Chateigner, Nicolas; Gormand, Frederic; Just, Jocelyne; Le Moual, Nicole; Scheinmann, Pierre; Siroux, Valerie; Vervloet, Daniel; Zelenika, Diana; Pin, Isabelle; Kauffmann, Francine; Lathrop, Mark; Demenais, Florence			Effect of 17q21 Variants and Smoking Exposure in Early-Onset Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CHILDHOOD ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; ORMDL3 EXPRESSION; CHILDRENS HEALTH; LUNG-FUNCTION; GENE; ASSOCIATION; LIFE; POLYMORPHISM	Background: A genomewide association study has shown an association between variants at chromosome 17q21 and an increased risk of asthma. To elucidate the relationship between this locus and disease, we examined a large, family-based data set that included extensive phenotypic and environmental data from the Epidemiological Study on the Genetics and Environment of Asthma. Methods: We tested 36 single-nucleotide polymorphisms (SNPs) in the 17q21 region in 1511 subjects from 372 families for an association with asthma. We also tested for genetic heterogeneity according to the age at the onset of asthma and exposure to environmental tobacco smoke in early life. Results: Eleven SNPs were significantly associated with asthma (P<0.01), of which three (rs8069176, rs2305480, and rs4795400) were strongly associated (P<0.001). Ordered-subset regression analysis led us to select an onset at 4 years of age or younger to classify patients as having early-onset asthma. Association with early-onset asthma was highly significant (P<10(-5) for four SNPs), whereas no association was found with late-onset asthma. With respect to exposure to environmental tobacco smoke in early life, we observed a significant association with early-onset asthma only in exposed subjects (P<5 x 10(-5) for six SNPs). Under the best-fitting recessive model, homozygous status (GG) at the most strongly associated SNP (rs8069176) conferred an increase in risk by a factor of 2.9, as compared with other genotypes (AG and AA) in the group exposed to environmental tobacco smoke (P=2.8 x 10(-6); P=0.006 for the test for heterogeneity of the SNP effect on early-onset asthma between groups with tobacco exposure and those without such exposure). Conclusions: This study shows that the increased risk of asthma conferred by 17q21 genetic variants is restricted to early-onset asthma and that the risk is further increased by early-life exposure to environmental tobacco smoke. These findings provide a greater understanding of the functional role of the 17q21 variants in the pathophysiology of asthma.	[Bouzigon, Emmanuelle; Corda, Eve; Aschard, Hugues; Chateigner, Nicolas; Lathrop, Mark; Demenais, Florence] Fdn Jean Dausset, CEPH, INSERM, U794, F-75010 Paris, France; [Bouzigon, Emmanuelle; Aschard, Hugues; Chateigner, Nicolas; Demenais, Florence] Univ Evry, Evry, France; [Dizier, Marie-Helene] INSERM, U535, Villejuif, France; [Dizier, Marie-Helene; Le Moual, Nicole; Kauffmann, Francine] Univ Paris 11, Villejuif, France; [Boland, Anne; Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, CEA, Inst Genom, Evry, France; [Bousquet, Jean] Hop Arnaud de Villeneuve, Montpellier, France; [Gormand, Frederic] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France; [Just, Jocelyne] Hop Enfants Armand Trousseau, Paris, France; [Le Moual, Nicole; Kauffmann, Francine] INSERM, U780, Villejuif, France; [Scheinmann, Pierre] Hop Necker Enfants Malad, Paris, France; [Siroux, Valerie; Pin, Isabelle] INSERM, U823, Grenoble, France; [Vervloet, Daniel] Hop St Marguerite, Marseille, France; [Pin, Isabelle] CHU Grenoble, F-38043 Grenoble, France	Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Demenais, F (corresponding author), Fdn Jean Dausset, CEPH, INSERM, U794, 27 Rue Juliette Dodu, F-75010 Paris, France.	demenais@inserm.fr	PIN, Isabelle/N-3020-2013; Bouzigon, Emmanuelle/L-2766-2017; Le Moual, Nicole/R-8976-2016; Le Moual, Nicole/GNP-5114-2022; GORMAND, FREDERIC/I-1414-2017; Dizier, Marie-Hélène/K-8463-2018; siroux, valerie/N-1865-2013; Demenais, Florence/G-3298-2013	Bouzigon, Emmanuelle/0000-0001-5756-4286; Le Moual, Nicole/0000-0002-2723-5569; Le Moual, Nicole/0000-0002-2723-5569; Dizier, Marie-Hélène/0000-0001-8460-7667; siroux, valerie/0000-0001-7329-7237; Demenais, Florence/0000-0001-8361-0936	INSERM; French Ministry of Higher Education and Research; University of Evry; French Agency for Environmental and Occupational Health Safety; Afsset-APR-SE-2004; French National Agency for Research [ANR 05-SEST-020-02/05-9-97, ANR 06-CEBS]; European Commission as part of the Global Allergy and Asthma European Network [FOOD-CT-2004-506378]; GABRIEL consortium; Glaxo SmithKline; Stallergenes; Allerbio; Astra Zeneca; UCB	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Higher Education and Research; University of Evry; French Agency for Environmental and Occupational Health Safety; Afsset-APR-SE-2004; French National Agency for Research(French National Research Agency (ANR)); European Commission as part of the Global Allergy and Asthma European Network(European CommissionEuropean Commission Joint Research Centre); GABRIEL consortium; Glaxo SmithKline(GlaxoSmithKline); Stallergenes; Allerbio; Astra Zeneca(AstraZeneca); UCB(UCB Pharma SA)	Supported by INSERM, the French Ministry of Higher Education and Research, and the University of Evry and by grants from the French Agency for Environmental and Occupational Health Safety (Afsset-APR-SE-2004), the French National Agency for Research (ANR 05-SEST-020-02/05-9-97 and ANR 06-CEBS), and the European Commission as part of the Global Allergy and Asthma European Network (FOOD-CT-2004-506378) and the GABRIEL consortium (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community; HEALTH-LSH-2005-018996). Dr. Vervloet reports receiving lecture fees from Glaxo SmithKline, Stallergenes, and Allerbio and consulting fees from Astra Zeneca, GlaxoSmithKline, Allerbio, and UCB. No other potential conflict of interest relevant to this article was reported.	Barrett R, 2008, J MOTOR BEHAV, V40, P62, DOI 10.3200/JMBR.40.1.62-70; Choudhry S, 2005, AM J RESP CRIT CARE, V172, P173, DOI 10.1164/rccm.200409-1232OC; Colilla S, 2003, J ALLERGY CLIN IMMUN, V111, P840, DOI 10.1067/mai.2003.170; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dizier MH, 2007, EUR J HUM GENET, V15, P810, DOI 10.1038/sj.ejhg.5201830; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Hashimoto Shu, 2008, Allergol Int, V57, P21, DOI 10.2332/allergolint.R-07-156; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Holgate ST, 2007, EUR RESPIR J, V29, P793, DOI 10.1183/09031936.00087506; Kabesch M, 2004, THORAX, V59, P569, DOI 10.1136/thx.2003.016667; Katoh M, 2003, INT J MOL MED, V12, P399; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Kurukulaaratchy RJ, 2004, PEDIATRICS, V113, P345, DOI 10.1542/peds.113.2.345; Kurukulaaratchy RJ, 2003, CLIN EXP ALLERGY, V33, P573, DOI 10.1046/j.1365-2222.2003.01657.x; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Lowe LA, 2005, AM J RESP CRIT CARE, V171, P231, DOI 10.1164/rccm.200406-695OC; Madore AM, 2008, HUM GENET, V123, P93, DOI 10.1007/s00439-007-0444-x; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Meyers DA, 2005, J ALLERGY CLIN IMMUN, V115, P1169, DOI 10.1016/j.jaci.2005.01.070; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Pattaro C, 2007, J CLIN EPIDEMIOL, V60, P704, DOI 10.1016/j.jclinepi.2006.10.010; Salam MT, 2004, ENVIRON HEALTH PERSP, V112, P760, DOI 10.1289/ehp.6662; Schmitt C, 2002, APOPTOSIS, V7, P277, DOI 10.1023/A:1015372322419; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; Siroux V, 2004, EUR J EPIDEMIOL, V19, P841, DOI 10.1023/B:EJEP.0000040528.89863.59; Stein Renato T, 2004, Paediatr Respir Rev, V5, P155, DOI 10.1016/j.prrv.2004.01.007; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Toren K, 2006, J CLIN EPIDEMIOL, V59, P90, DOI 10.1016/j.jclinepi.2005.03.019; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wang ZX, 2001, AM J RESP CRIT CARE, V163, P1404, DOI 10.1164/ajrccm.163.6.2001101; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Zeiger RS, 1999, J ALLERGY CLIN IMMUN, V103, P376, DOI 10.1016/S0091-6749(99)70460-4	38	274	284	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1985	1994		10.1056/NEJMoa0806604	http://dx.doi.org/10.1056/NEJMoa0806604			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18923164				2022-12-01	WOS:000260632700003
J	Roguev, A; Bandyopadhyay, S; Zofall, M; Zhang, K; Fischer, T; Collins, SR; Qu, HJ; Shales, M; Park, HO; Hayles, J; Hoe, KL; Kim, DU; Ideker, T; Grewal, SI; Weissman, JS; Krogan, NJ				Roguev, Assen; Bandyopadhyay, Sourav; Zofall, Martin; Zhang, Ke; Fischer, Tamas; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Park, Han-Oh; Hayles, Jacqueline; Hoe, Kwang-Lae; Kim, Dong-Uk; Ideker, Trey; Grewal, Shiv I.; Weissman, Jonathan S.; Krogan, Nevan J.			Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast	SCIENCE			English	Article							POLYMERASE-II HOLOENZYME; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; HISTONE-3 LYSINE-4; PROTEIN COMPLEXES; GENE-EXPRESSION; DNA-DAMAGE; CHECKPOINT; TRANSCRIPTION; ORGANIZATION	An epistasis map (E-MAP) was constructed in the fission yeast, Schizosaccharomyces pombe, by systematically measuring the phenotypes associated with pairs of mutations. This high-density, quantitative genetic interaction map focused on various aspects of chromosome function, including transcription regulation and DNA repair/replication. The E-MAP uncovered a previously unidentified component of the RNA interference (RNAi) machinery (rsh1) and linked the RNAi pathway to several other biological processes. Comparison of the S. pombe E-MAP to an analogous genetic map from the budding yeast revealed that, whereas negative interactions were conserved between genes involved in similar biological processes, positive interactions and overall genetic profiles between pairs of genes coding for physically associated proteins were even more conserved. Hence, conservation occurs at the level of the functional module (protein complex), but the genetic cross talk between modules can differ substantially.	[Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Program Bioinformat, La Jolla, CA 92093 USA; [Zofall, Martin; Zhang, Ke; Fischer, Tamas; Grewal, Shiv I.] NCI, Biochem & Mol Biol Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Collins, Sean R.; Weissman, Jonathan S.] Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Park, Han-Oh] Bioneer Corp, Taejon, South Korea; [Hayles, Jacqueline] London Res Inst, Canc Res UK, Cell Cycle Lab, London WC2A 3PX, England; [Hoe, Kwang-Lae; Kim, Dong-Uk] Korea Res Inst Biosci & Biotechnol, Genom Res Ctr, Taejon, South Korea; [Roguev, Assen; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Roguev, Assen; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Cancer Research UK; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ideker, T (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu; grewals@mail.nih.gov; weissman@cmp.ucsf.edu; krogan@cmpmail.ucsf.edu	Fischer, Tamas/A-7729-2016	Fischer, Tamas/0000-0002-7996-4042; Collins, Sean/0000-0002-4276-5840; Hoe, Kwang Lae/0000-0002-3943-4549; Ideker, Trey/0000-0002-1708-8454; Weissman, Jonathan/0000-0003-2445-670X	NIH [GM084279]; Sandler Family Foundation; Howard Hughes Medical Institute; National Cancer Institute; Center for Cancer Research; California Institute of Quantitative Biology; NATIONAL CANCER INSTITUTE [ZIABC010523, ZIABC011208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute of Quantitative Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Beltrao and G. Cagney for critical reading of the manuscript; M. Wiren and S. Forsburg for discussion; P. Kemmeren for setting up the web database; S. Wang, C. Wen, and D. Avdic for technical help; and F. Stewart for sharing unpublished data. This work was supported by NIH [National Institute of General Medical Sciences grant GM084279 (T.I. and N.J.K.)], the Sandler Family Foundation (N. J. K), the Howard Hughes Medical Institute (J.S.W.), National Cancer Institute (S.I.G.), Center for Cancer Research (S.I.G.), and the California Institute of Quantitative Biology (N.J.K.).	Ahmed S, 2007, GENETICS, V177, P1487, DOI 10.1534/genetics.107.078691; Asakawa K, 2006, MOL BIOL CELL, V17, P1421, DOI 10.1091/mbc.e05-08-0802; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Kaur R, 2001, MOL BIOL CELL, V12, P3744, DOI 10.1091/mbc.12.12.3744; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Penkett CJ, 2006, NUCLEIC ACIDS RES, V34, pW330, DOI 10.1093/nar/gkl311; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Sakurai H, 1998, GENE, V221, P11, DOI 10.1016/S0378-1119(98)00449-1; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sipiczki M, 2000, GENOME BIOL, V1, DOI DOI 10.1186/GB-2000-1-2-REVIEWS1011; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	39	262	264	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					405	410		10.1126/science.1162609	http://dx.doi.org/10.1126/science.1162609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18818364	Green Accepted			2022-12-01	WOS:000260094500037
J	Dong, XP; Cheng, XP; Mills, E; Delling, M; Wang, FD; Kurz, T; Xu, HX				Dong, Xian-Ping; Cheng, Xiping; Mills, Eric; Delling, Markus; Wang, Fudi; Kurz, Tino; Xu, Haoxing			The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel	NATURE			English	Article							RECEPTOR POTENTIAL CHANNEL; MEMBRANE-PROTEIN; MUTATIONS; METABOLISM; PATHWAY; DISEASE; MICE; SKIN	TRPML1 ( mucolipin 1, also known as MCOLN1) is predicted to be an intracellular late endosomal and lysosomal ion channel protein that belongs to the mucolipin subfamily of transient receptor potential ( TRP) proteins(1-3). Mutations in the human TRPML1 gene cause mucolipidosis type IV disease ( ML4)4,5.ML4 patients have motor impairment, mental retardation, retinal degeneration and iron- deficiency anaemia. Because aberrant iron metabolism may cause neural and retinal degeneration(6,7), it may be a primary cause of ML4 phenotypes. In most mammalian cells, release of iron from endosomes and lysosomes after iron uptake by endocytosis of Fe(3+)- bound transferrin receptors(6), or after lysosomal degradation of ferritin - iron complexes and autophagic ingestion of iron-containing macromolecules(6,8), is the chief source of cellular iron. The divalent metal transporter protein DMT1 ( also known as SLC11A2) is the only endosomal Fe(2+) transporter known at present and it is highly expressed in erythroid precursors(6,9). Genetic studies, however, suggest the existence of a DMT1-independent endosomal and lysosomal Fe(2+) transport protein(9). By measuring radiolabelled iron uptake, by monitoring the levels of cytosolic and intralysosomal iron and by directly patch- clamping the late endosomal and lysosomal membrane, here we show that TRPML1 functions as a Fe(2+) permeable channel in late endosomes and lysosomes. ML4 mutations are shown to impair the ability of TRPML1 to permeate Fe(2+) at varying degrees, which correlate well with the disease severity. A comparison of TRPML1(-/-) ML4 and control human skin fibroblasts showed a reduction in cytosolic Fe(2+) levels, an increase in intralysosomal Fe(2+) levels and an accumulation of lipofuscin- like molecules in TRPML1(-/-) cells. We propose that TRPML1 mediates a mechanism by which Fe(2+) is released from late endosomes and lysosomes. Our results indicate that impaired iron transportmay contribute to both haematological and degenerative symptoms of ML4 patients.	[Dong, Xian-Ping; Cheng, Xiping; Mills, Eric; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Delling, Markus] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Wang, Fudi] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Kurz, Tino] Linkoping Univ, Dept Pharmacol, Fac Hlth Sci, S-58185 Linkoping, Sweden	University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Linkoping University	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 3089 Nat Sci Bldg Kraus,830 N Univ, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	xu, hao/GWQ-7394-2022; Wang, Fudi/L-7888-2018	Wang, Fudi/0000-0001-8730-0003; Dong, Xianping/0000-0002-4496-7104	Department of Molecular, Cellular; Developmental Biology and Biological Science Scholar Program; University of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER	Department of Molecular, Cellular; Developmental Biology and Biological Science Scholar Program; University of Michigan(University of Michigan System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by start-up funds to H. X. from the Department of Molecular, Cellular, and Developmental Biology and Biological Science Scholar Program, University of Michigan. We thank U. Brunk, M. Saito, R. Hume, C. Duan, M. Akaaboune, J. Kuwada, S. Low, S. Punthambaker and S. Dellal for assistance, and D. Clapham, N. Andrews, L. DeFelice, L. Yue, D. Ren, C. Jiang and S. Xu for comments on an earlier version of the manuscript. We also thank K. Kiselyov for sharing his unpublished results on lysosomal iron staining of ML4 cells. We appreciate the encouragement and helpful comments from other members of the Xu laboratory.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Bargal R, 2002, NEUROPEDIATRICS, V33, P199, DOI 10.1055/s-2002-34496; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; GOLDIN E, 1995, PEDIATR RES, V37, P687, DOI 10.1203/00006450-199506000-00003; Goldin E, 2004, HUM MUTAT, V24, P460, DOI 10.1002/humu.20094; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kress GJ, 2002, J NEUROSCI, V22, P5848; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Lee DW, 2006, MOL INTERV, V6, P89, DOI 10.1124/mi.6.2.6; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Petrat F, 2000, ARCH BIOCHEM BIOPHYS, V376, P74, DOI 10.1006/abbi.2000.1711; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004	25	373	381	5	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					992	U78		10.1038/nature07311	http://dx.doi.org/10.1038/nature07311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18794901	Green Published, Green Accepted			2022-12-01	WOS:000260038300056
J	Mefford, HC; Sharp, AJ; Baker, C; Itsara, A; Jiang, ZS; Buysse, K; Huang, SW; Maloney, VK; Crolla, JA; Baralle, D; Collins, A; Mercer, C; Norga, K; de Ravel, T; Devriendt, K; Bongers, EMHF; de Leeuw, N; Reardon, W; Gimelli, S; Bena, F; Hennekam, RC; Male, A; Gaunt, L; Clayton-Smith, J; Simonic, I; Park, SM; Mehta, SG; Nik-Zainal, S; Woods, CG; Firth, HV; Parkin, G; Fichera, M; Reitano, S; Lo Giudice, M; Li, KE; Casuga, I; Broomer, A; Conrad, B; Schwerzmann, M; Raber, L; Gallati, S; Striano, P; Coppola, A; Tolmie, JL; Tobias, ES; Lilley, C; Armengol, L; Spysschaert, Y; Verloo, P; De Coene, A; Goossens, L; Mortier, G; Speleman, F; van Binsbergen, E; Nelen, MR; Hochstenbach, R; Poot, M; Gallagher, L; Gill, M; McClellan, J; King, MC; Regan, R; Skinner, C; Stevenson, RE; Antonarakis, SE; Chen, CF; Estivill, X; Menten, B; Gimelli, G; Gribble, S; Schwartz, S; Sutcliffe, JS; Walsh, T; Knight, SJL; Sebat, J; Romano, C; Schwartz, CE; Veltman, JA; de Vries, BBA; Vermeesch, JR; Barber, JCK; Willatt, L; Tassabehji, M; Eichler, EE				Mefford, Heather C.; Sharp, Andrew J.; Baker, Carl; Itsara, Andy; Jiang, Zhaoshi; Buysse, Karen; Huang, Shuwen; Maloney, Viv K.; Crolla, John A.; Baralle, Diana; Collins, Amanda; Mercer, Catherine; Norga, Koen; de Ravel, Thomy; Devriendt, Koen; Bongers, Ernie M. H. F.; de Leeuw, Nicole; Reardon, William; Gimelli, Stefania; Bena, Frederique; Hennekam, Raoul C.; Male, Alison; Gaunt, Lorraine; Clayton-Smith, Jill; Simonic, Ingrid; Park, Soo Mi; Mehta, Sarju G.; Nik-Zainal, Serena; Woods, C. Geoffrey; Firth, Helen V.; Parkin, Georgina; Fichera, Marco; Reitano, Santina; Lo Giudice, Mariangela; Li, Kelly E.; Casuga, Iris; Broomer, Adam; Conrad, Bernard; Schwerzmann, Markus; Raber, Lorenz; Gallati, Sabina; Striano, Pasquale; Coppola, Antonietta; Tolmie, John L.; Tobias, Edward S.; Lilley, Chris; Armengol, Lluis; Spysschaert, Yves; Verloo, Patrick; De Coene, Anja; Goossens, Linde; Mortier, Geert; Speleman, Frank; van Binsbergen, Ellen; Nelen, Marcel R.; Hochstenbach, Ron; Poot, Martin; Gallagher, Louise; Gill, Michael; McClellan, Jon; King, Mary-Claire; Regan, Regina; Skinner, Cindy; Stevenson, Roger E.; Antonarakis, Stylianos E.; Chen, Caifu; Estivill, Xavier; Menten, Bjorn; Gimelli, Giorgio; Gribble, Susan; Schwartz, Stuart; Sutcliffe, James S.; Walsh, Tom; Knight, Samantha J. L.; Sebat, Jonathan; Romano, Corrado; Schwartz, Charles E.; Veltman, Joris A.; de Vries, Bert B. A.; Vermeesch, Joris R.; Barber, John C. K.; Willatt, Lionel; Tassabehji, May; Eichler, Evan E.			Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPY-NUMBER VARIATION; ARRAY-CGH; SEGMENTAL DUPLICATIONS; MENTAL-RETARDATION; MICRODELETION; DELETION; POLYMORPHISM; MUTATION; WIDE; HYBRIDIZATION	Background: Duplications and deletions in the human genome can cause disease or predispose persons to disease. Advances in technologies to detect these changes allow for the routine identification of submicroscopic imbalances in large numbers of patients. Methods: We tested for the presence of microdeletions and microduplications at a specific region of chromosome 1q21.1 in two groups of patients with unexplained mental retardation, autism, or congenital anomalies and in unaffected persons. Results: We identified 25 persons with a recurrent 1.35-Mb deletion within 1q21.1 from screening 5218 patients. The microdeletions had arisen de novo in eight patients, were inherited from a mildly affected parent in three patients, were inherited from an apparently unaffected parent in six patients, and were of unknown inheritance in eight patients. The deletion was absent in a series of 4737 control persons (P=1.1 x 10(-7))). We found considerable variability in the level of phenotypic expression of the microdeletion; phenotypes included mild-to-moderate mental retardation, microcephaly, cardiac abnormalities, and cataracts. The reciprocal duplication was enriched in nine children with mental retardation or autism spectrum disorder and other variable features (P=0.02). We identified three deletions and three duplications of the 1q21.1 region in an independent sample of 788 patients with mental retardation and congenital anomalies. Conclusions: We have identified recurrent molecular lesions that elude syndromic classification and whose disease manifestations must be considered in a broader context of development as opposed to being assigned to a specific disease. Clinical diagnosis in patients with these lesions may be most readily achieved on the basis of genotype rather than phenotype.	[Mefford, Heather C.; Baker, Carl; Itsara, Andy; Jiang, Zhaoshi; McClellan, Jon; King, Mary-Claire; Walsh, Tom; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Sharp, Andrew J.; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Gimelli, Stefania] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Buysse, Karen; Mortier, Geert; Speleman, Frank; Menten, Bjorn] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Spysschaert, Yves; Verloo, Patrick; De Coene, Anja; Goossens, Linde] Ghent Univ Hosp, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium; [Huang, Shuwen; Crolla, John A.; Barber, John C. K.] Salisbury Natl Hlth Serv NHS Fdn Trust, Natl Genet Reference Lab, Salisbury, Wilts, England; [Maloney, Viv K.; Crolla, John A.; Barber, John C. K.] Salisbury Natl Hlth Serv NHS Fdn Trust, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Baralle, Diana; Collins, Amanda; Mercer, Catherine] Southampton Univ Hosp Trust, Wessex Clin Genet Serv, Southampton, Hants, England; [Hennekam, Raoul C.] UCL, London, England; [Male, Alison] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Gaunt, Lorraine; Clayton-Smith, Jill] Univ Manchester, St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; [Tassabehji, May] Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; [Simonic, Ingrid; Park, Soo Mi; Mehta, Sarju G.; Nik-Zainal, Serena; Woods, C. Geoffrey; Firth, Helen V.; Parkin, Georgina; Willatt, Lionel] Addenbrookes Hosp NHS Trust, Cambridge, England; [Gribble, Susan] Wellcome Trust Sanger Inst, Cambridge, England; [Regan, Regina; Knight, Samantha J. L.] Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford OX3 7LJ, England; [Norga, Koen] Katholieke Univ Leuven, Childrens Hosp, Louvain, Belgium; [Norga, Koen] Katholieke Univ Leuven, Vlaams Interuniv Inst Biotechnol, Louvain, Belgium; [de Ravel, Thomy; Devriendt, Koen; Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Bongers, Ernie M. H. F.; de Leeuw, Nicole; Veltman, Joris A.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Binsbergen, Ellen; Nelen, Marcel R.; Hochstenbach, Ron; Poot, Martin] Univ Med Ctr, Utrecht, Netherlands; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Reardon, William] Our Ladys Hosp Sick Children, Dublin, Ireland; [Gallagher, Louise; Gill, Michael] St James Hosp, Dublin 8, Ireland; [Fichera, Marco; Reitano, Santina; Lo Giudice, Mariangela; Romano, Corrado] IRCCS, Assoc Oasi Maria Santissima, Troina, Italy; [Striano, Pasquale; Coppola, Antonietta] Univ Naples Federico II, Naples, Italy; [Striano, Pasquale] Osped Gaslini, Unita Neuromuscolare, Genoa, Italy; [Gimelli, Giorgio] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Li, Kelly E.; Casuga, Iris; Broomer, Adam; Chen, Caifu] Appl Biosyst Inc, Foster City, CA 94404 USA; [Conrad, Bernard; Gallati, Sabina] Bern Univ Childrens Hosp, Bern, Switzerland; [Schwerzmann, Markus; Raber, Lorenz] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Tolmie, John L.; Tobias, Edward S.; Lilley, Chris] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Armengol, Lluis; Estivill, Xavier] CIBERESP, Biomed Res Ctr Epidemiol & Publ Hlth, Barcelona, Spain; [Armengol, Lluis; Estivill, Xavier] Pompeu Fabra Univ, Barcelona, Spain; [Skinner, Cindy; Stevenson, Roger E.; Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Schwartz, Stuart] Univ Chicago, Chicago, IL 60637 USA; [Sutcliffe, James S.] Vanderbilt Univ, Nashville, TN USA; [Sebat, Jonathan] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Geneva; University of Geneva; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; KU Leuven; KU Leuven; KU Leuven; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Our Ladys Children Hospital Crumlin; Trinity College Dublin; IRCCS Oasi Maria SS; University of Naples Federico II; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Thermo Fisher Scientific; Applied Biosystems; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Glasgow; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Greenwood Genetic Center; University of Chicago; Vanderbilt University; Cold Spring Harbor Laboratory	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Sch Med, Foege Bldg S413A,Box 355065,1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Bongers, M.H.F./L-4214-2015; woods, christopher g/A-1361-2010; Fichera, Marco/K-9220-2016; Menten, Björn/B-3072-2013; Romano, Corrado/B-9695-2008; Antonarakis, Stylianos E/N-8866-2014; Giudice, Mariangela Lo/D-4261-2017; Sander-Effron, Samuel/AAX-2231-2020; Nelen, Marcel R./L-4542-2015; de Leeuw, N./L-4480-2015; /AAB-8553-2019; speleman, frank/AAR-5184-2020; Estivill, Xavier/E-2957-2012; Sutcliffe, James S/C-1348-2012; Estivill, Xavier/A-3125-2013; Resource Center, NINDS Human Genetics/AGF-2474-2022; Tobias, Edward/D-4246-2009; Nik-Zainal, Serena/ABD-4437-2020; Veltman, Joris A/F-5128-2010; Mortier, Geert/D-2542-2012; Poot, Martin/F-9427-2010; Striano, Pasquale/F-9117-2014; Schwerzmann, Markus/AAD-9368-2022; Norga, Koenraad/D-1137-2017	Fichera, Marco/0000-0002-8225-6880; Romano, Corrado/0000-0003-1049-0683; Antonarakis, Stylianos E/0000-0001-8907-5823; Giudice, Mariangela Lo/0000-0001-5961-0362; speleman, frank/0000-0002-6628-8559; Sutcliffe, James S/0000-0001-5200-6007; Estivill, Xavier/0000-0002-0723-2256; Tobias, Edward/0000-0003-2649-7695; Veltman, Joris A/0000-0002-3218-8250; Mortier, Geert/0000-0001-9871-4578; Striano, Pasquale/0000-0002-6065-1476; Schwerzmann, Markus/0000-0002-4006-8929; de Ravel, Thomy/0000-0002-3361-3781; Menten, Bjorn/0000-0001-8182-659X; Norga, Koenraad/0000-0002-9231-0350; Verloo, Patrick/0000-0003-2077-0275; Walsh, Tom/0000-0002-8875-0310; Vermeesch, Joris/0000-0002-3071-1191; Gallagher, Louise/0000-0001-9462-2836; Nik-Zainal, Serena/0000-0001-5054-1727; Sebat, Jonathan/0000-0002-9087-526X; Reardon, Willie/0000-0001-7329-9179; Baralle, Diana/0000-0003-3217-4833; Knight, Samantha/0000-0002-6047-3462; Gill, Michael/0000-0003-0206-5337; King, Mary-Claire/0000-0001-9426-1743	National Institutes of Health [HD043569]; South Carolina Department of Disabilities and Special Needs; Wellcome Trust [061183]; Andre & Cyprien Foundation; University Hospitals of Geneva; European Union [219250]; AnEUploidy [037627]; Wellcome Trust; Health Research Board; Dutch Foundation for Brain Research [2008(1)34]; Oxford Partnership Comprehensive Biomedical Research Centre; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres; United Kingdom Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Department of Disabilities and Special Needs; Wellcome Trust(Wellcome TrustEuropean Commission); Andre & Cyprien Foundation; University Hospitals of Geneva; European Union(European Commission); AnEUploidy; Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Board; Dutch Foundation for Brain Research; Oxford Partnership Comprehensive Biomedical Research Centre; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); United Kingdom Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by grants from the National Institutes of Health (HD043569, to Dr. Eichler), the South Carolina Department of Disabilities and Special Needs ( to Drs. Skinner, Stevenson, and Schwartz), the Wellcome Trust (061183, to Dr. Tassabehji), the Andre & Cyprien Foundation and the University Hospitals of Geneva ( to Drs. Antonarakis, Bena, and Gallati), and the European Union (project 219250, to Dr. Sharp; AnEUploidy project 037627, to Drs. Leeuw, Armengol, Antonarakis, Estivill, Veltman, and de Vries). The Irish Autism Study was funded by the Wellcome Trust and the Health Research Board (a grant to Drs. Gallagher and Gill). Dr. Poot was supported by a grant from the Dutch Foundation for Brain Research (Hersenstichting grant 2008(1)34); Drs. Regan and Knight, by the Oxford Partnership Comprehensive Biomedical Research Centre; Dr. Willatt, by the Cambridge Biomedical Research Centre, with funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Drs. Huang and Maloney, as part of the National Genetics Reference Laboratory (Wessex) by the United Kingdom Department of Health; Ms. Buysse, as a research assistant of the Research Foundation - Flanders (FWO-Vlaanderen); and Dr. Eichler, as an investigator of the Howard Hughes Medical Institute. The views expressed in this publication are those of the authors and not necessarily those of the United Kingdom Department of Health.; Drs. Mefford and Sharp report giving invited Webinars and seminars for NimbleGen, a manufacturer of microarrays; Drs. Li, Casuga, Broomer, and Chen report being employees of Applied Biosystems, manufacturer of the TaqMan assay and reagents; and Dr. Eichler reports being an invited speaker at an Applied Biosystems workshop on human copy- number variation. No other potential conflict of interest relevant to this article was reported. We thank Francesca Antonacci for performing fluorescence in situ hybridization analysis. This study used data from the SNP Database at the National Institute of Neurological Disorders and Stroke Human Genetics Resource Center DNA and Cell Line Repository ( http:// ccr. coriell. org/ ninds), as well as clinical data. The Illumina genotyping was performed in the laboratories of Drs. Singleton and Hardy ( National Institute of Aging [ NIA], Laboratory of Neurogenetics [ LNG]), Bethesda, MD.	Barber JCK, 2008, EUR J HUM GENET, V16, P18, DOI 10.1038/sj.ejhg.5201932; Bearden CE, 2004, AM J PSYCHIAT, V161, P1700, DOI 10.1176/appi.ajp.161.9.1700; Cheroki C, 2008, J MED GENET, V45, P228, DOI 10.1136/jmg.2007.051839; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Cusco I, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-27; de Stahl TD, 2008, HUM MUTAT, V29, P398, DOI 10.1002/humu.20659; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Doggett NA, 2006, GENOMICS, V88, P762, DOI 10.1016/j.ygeno.2006.07.012; Firouzi M, 2004, CIRC RES, V95, P29, DOI 10.1161/01.RES.0000141134.64811.0a; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gu H, 2003, CIRC RES, V93, P201, DOI 10.1161/01.RES.0000084852.65396.70; HANNES FD, 2008, J MED GENET     0611; Hauer RNW, 2006, ADV CARDIOL, V42, P284, DOI 10.1159/000092579; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Juang JM, 2007, INT J CARDIOL, V116, P107, DOI 10.1016/j.ijcard.2006.03.037; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2008, HUM MOL GENET, V17, P466, DOI 10.1093/hmg/ddm321; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; STEFANSSON H, 2008, NATURE          0730; STONE JL, 2008, NATURE          0730; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vanita V, 2008, MOL VIS, V14, P323; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	53	554	570	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1685	U130		10.1056/NEJMoa0805384	http://dx.doi.org/10.1056/NEJMoa0805384			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18784092	Green Accepted, Green Published			2022-12-01	WOS:000260041400007
J	Colwell, RK; Brehm, G; Cardelus, CL; Gilman, AC; Longino, JT				Colwell, Robert K.; Brehm, Gunnar; Cardelus, Catherine L.; Gilman, Alex C.; Longino, John T.			Global warming, elevational range shifts, and lowland biotic attrition in the wet tropics	SCIENCE			English	Article							CLIMATE-CHANGE; SPECIES RICHNESS; FOREST; RESPONSES; BIODIVERSITY; PATTERNS; IMPACTS; GROWTH	Many studies suggest that global warming is driving species ranges poleward and toward higher elevations at temperate latitudes, but evidence for range shifts is scarce for the tropics, where the shallow latitudinal temperature gradient makes upslope shifts more likely than poleward shifts. Based on new data for plants and insects on an elevational transect in Costa Rica, we assess the potential for lowland biotic attrition, range-shift gaps, and mountaintop extinctions under projected warming. We conclude that tropical lowland biotas may face a level of net lowland biotic attrition without parallel at higher latitudes (where range shifts may be compensated for by species from lower latitudes) and that a high proportion of tropical species soon faces gaps between current and projected elevational ranges.	[Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Brehm, Gunnar] Univ Jena, Inst Spezielle Zool, D-07743 Jena, Germany; [Brehm, Gunnar] Univ Jena, Evolutionsbiol Phyletischem Museum, D-07743 Jena, Germany; [Cardelus, Catherine L.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Gilman, Alex C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90950 USA; [Longino, John T.] Evergreen State Coll, Olympia, WA 98505 USA	University of Connecticut; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Colgate University; University of California System; University of California Los Angeles	Colwell, RK (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	colwell@uconn.edu	Brehm, Gunnar/D-5831-2013; Colwell, Robert K/C-7276-2015; Cardelus, Catherine/ABA-8409-2020	Brehm, Gunnar/0000-0002-7599-2847; Cardelus, Catherine/0000-0003-0526-7612	Organization for Tropical Studies; Conservation International; University of Connecticut; U.S. NSF [DEB-0072702, DEB-0640015, DEB-0639979]; Research Fellowship and Dissertation Improvement Grant; Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund; Deutsche Forschungsgemeinschaft [BR 2280/1-1]	Organization for Tropical Studies; Conservation International; University of Connecticut; U.S. NSF(National Science Foundation (NSF)); Research Fellowship and Dissertation Improvement Grant; Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Organization for Tropical Studies; the Tropical Ecology Assessment and Monitoring (TEAM) project of Conservation International; University of Connecticut (R.K.C. and C.L.C.); UCLA (A.C.G.); U.S. NSF (DEB-0072702: R.K.C., G.B., and J.T.L.; DEB-0640015: J.T.L.; DEB-0639979: R.K.C.; Research Fellowship and Dissertation Improvement Grant: C.L.C.); Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund (A.C.G.); and the Deutsche Forschungsgemeinschaft (BR 2280/1-1: G.B.). We thank M. B. Bush, R.L. Chazdon, D.A. Clark, R.R. Dunn, K.M. Kuhn, C. Rahbek, T.F.L.V.B. Rangel, M. R. Silman, and our peer reviewers for comments.	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Bush MB, 2008, PHILOS T R SOC B, V363, P1795, DOI 10.1098/rstb.2007.0014; Bush Mark B., 2005, P125; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Cowling SA, 2004, PHILOS T R SOC B, V359, P539, DOI 10.1098/rstb.2003.1427; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dobzhansky T., 1950, American Scientist, V38, P209; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; FIENLEY JR, 1998, CLIMATIC CHANGE, V39, P177; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; HANNAH L, 2007, TROPICAL RAINFOREST, P351; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI 10.1111/j.1466-822x.2006.00223.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Miles L, 2004, GLOBAL ECOL BIOGEOGR, V13, P553, DOI 10.1111/j.1466-822X.2004.00105.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Phillips O.L., 2007, TROPICAL RAINFOREST, P317; Pounds J. Alan, 2005, P70; Wallace AR, 1878, TROPICAL NATURE OTHE; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	32	801	859	14	474	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					258	261		10.1126/science.1162547	http://dx.doi.org/10.1126/science.1162547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845754				2022-12-01	WOS:000259902300048
J	He, WZ; Ladinsky, MS; Huey-Tubman, KE; Jensen, GJ; McIntosh, JR; Bjorkman, PJ				He, Wanzhong; Ladinsky, Mark S.; Huey-Tubman, Kathryn E.; Jensen, Grant J.; McIntosh, J. Richard; Bjorkman, Pamela J.			FcRn-mediated antibody transport across epithelial cells revealed by electron tomography	NATURE			English	Article							CLATHRIN-COATED VESICLES; RAT-KIDNEY CELL; INTESTINAL TRANSPORT; FREEZE-SUBSTITUTION; IMMUNOGLOBULIN-G; NEONATAL RAT; 3 DIMENSIONS; YOUNG-RAT; RECEPTOR; FUSION	The neonatal Fc receptor ( FcRn) transports maternal IgG across epithelial barriers(1,2), thereby providing the fetus or newborn with humoral immunity before its immune system is fully functional. In newborn rats, FcRn transfers IgG from milk to blood by apical-to-basolateral transcytosis across intestinal epithelial cells. The pH difference between the apical ( pH 6.0-6.5) and basolateral ( pH 7.4) sides of intestinal epithelial cells facilitates the efficient unidirectional transport of IgG, because FcRn binds IgG at pH 6.0-6.5 but not at pH 7 or more(1,2). As milk passes through the neonatal intestine, maternal IgG is removed by FcRn-expressing cells in the proximal small intestine ( duodenum and jejunum); remaining proteins are absorbed and degraded by FcRn- negative cells in the distal small intestine ( ileum)(3-6). Here we use electron tomography to make jejunal transcytosis visible directly in space and time, developing new labelling and detection methods to map individual nanogold-labelled Fc within transport vesicles(7) and simultaneously to characterize these vesicles by immunolabelling. Combining electron tomography with a nonperturbing endocytic label allowed us to conclusively identify receptor- bound ligands, resolve interconnecting vesicles, determine whether a vesicle was microtubule- associated, and accurately trace FcRn- mediated transport of IgG. Our results present a complex picture in which Fc moves through networks of entangled tubular and irregular vesicles, only some of which are microtubuleassociated, as it migrates to the basolateral surface. New features of transcytosis are elucidated, including transport involving multivesicular body inner vesicles/ tubules and exocytosis through clathrin- coated pits. Markers for early, late and recycling endosomes each labelled vesicles in different and overlapping morphological classes, revealing spatial complexity in endo- lysosomal trafficking.	[He, Wanzhong; Huey-Tubman, Kathryn E.; Jensen, Grant J.; Bjorkman, Pamela J.] CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; [Huey-Tubman, Kathryn E.; Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [He, Wanzhong] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Ladinsky, Mark S.; McIntosh, J. Richard] Univ Colorado, Boulder Lab 3D Elect Microscopy Cells, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; National University of Singapore; University of Colorado System; University of Colorado Boulder	Bjorkman, PJ (corresponding author), CALTECH, Div Biol 114 96, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	McIntosh, Richard/GLN-3533-2022		National Institutes of Health [2 R37 AI041239-06A1, RR000592]; Max Planck Research Award; Gordon and Betty Moore Foundation; Agouron Institute; Caltech; National University of Singapore [R-154-000-339-133]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Research Award(Max Planck Society); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Agouron Institute(Pfizer); Caltech; National University of Singapore(National University of Singapore); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Mastronarde for advice about setting up SerialEM on the Caltech microscopes and three- dimensional modelling; C. Kivork for preparing Au-Fc and Au-dextran; B. Tivol for assistance with electron microscopes; M. Murphy for help with schematic figures; M. Morphew for contributions to silver enhancement methods; Y. Nie, A. Feuerabendt, A. Kules, C. Luna, K. McKenzie, R. Sander and L. Zinn-Bjorkman for segmenting tomograms; J. Vielmetter for SPR studies of Au-Fc; and F. Brodsky, F. Maxfield, S. Schmid and D. Tesar for discussions. This work was supported by the National Institutes of Health (2 R37 AI041239-06A1 to P.J.B. and RR000592 to J.R.M.), a Max Planck Research Award (P.J.B.), gifts from the Gordon and Betty Moore Foundation and the Agouron Institute to support electron microscopy at Caltech, and National University of Singapore AcRF start-up funds (R-154-000-339-133 to W.H.).	ALTSTIEL L, 1983, CELL, V32, P921, DOI 10.1016/0092-8674(83)90077-6; BENLOUNES N, 1995, BIOL NEONATE, V67, P254, DOI 10.1159/000244173; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GREENE LE, 1990, J BIOL CHEM, V265, P6682; HALLIDAY R, 1955, PROC R SOC SER B-BIO, V143, P408, DOI 10.1098/rspb.1955.0020; He WZ, 2007, J STRUCT BIOL, V160, P103, DOI 10.1016/j.jsb.2007.07.004; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; HUBER AH, 1993, J MOL BIOL, V230, P1077, DOI 10.1006/jmbi.1993.1220; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ladinsky MS, 2007, METHOD CELL BIOL, V79, P543, DOI 10.1016/S0091-679X(06)79021-5; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCarthy KM, 2000, J CELL SCI, V113, P1277; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Morphew M, 2008, J MICROSC-OXFORD, V230, P263, DOI 10.1111/j.1365-2818.2008.01983.x; Murk JLAN, 2003, P NATL ACAD SCI USA, V100, P13332, DOI 10.1073/pnas.2232379100; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; RODEWALD R, 1980, J CELL BIOL, V85, P18, DOI 10.1083/jcb.85.1.18; RODEWALD R, 1970, J CELL BIOL, V45, P635, DOI 10.1083/jcb.45.3.635; RODEWALD R, 1973, J CELL BIOL, V58, P189, DOI 10.1083/jcb.58.1.189; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x	37	121	130	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					542	U53		10.1038/nature07255	http://dx.doi.org/10.1038/nature07255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818657	Green Accepted			2022-12-01	WOS:000259449600048
J	Napoli, I; Mercaldo, V; Boyl, PP; Eleuteri, B; Zalfa, F; De Rubeis, S; Di Marino, D; Mohr, E; Massimi, M; Falconi, M; Witke, W; Costa-Mattioli, M; Sonenberg, N; Achsel, T; Bagni, C				Napoli, Ilaria; Mercaldo, Valentina; Boyl, Pietro Pilo; Eleuteri, Boris; Zalfa, Francesca; De Rubeis, Silvia; Di Marino, Daniele; Mohr, Evita; Massimi, Marzia; Falconi, Mattia; Witke, Walter; Costa-Mattioli, Mauro; Sonenberg, Nahum; Achsel, Tilmann; Bagni, Claudia			The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP	CELL			English	Article							MENTAL-RETARDATION PROTEIN; INITIATION-FACTOR 4E; MESSENGER-RNA; DROSOPHILA CUP; BC1 RNA; BINDING; FMRP; LOCALIZATION; STABILITY; PATHWAY	Strong evidence indicates that regulated mRNA translation in neuronal dendrites underlies synaptic plasticity and brain development. The fragile X mental retardation protein (FMRP) is involved in this process; here, we show that it acts by inhibiting translation initiation. A binding partner of FMRP, CYFIP1/Sra1, directly binds the translation initiation factor eIF4E through a domain that is structurally related to those present in 4E-BP translational inhibitors. Brain cytoplasmic RNA 1 (BC1), another FMRP binding partner, increases the affinity of FMRP for the CYFIP1-eIF4E complex in the brain. Levels of proteins encoded by known FMRP target mRNAs are increased upon reduction of CYFIP1 in neurons. Translational repression is regulated in an activity-dependent manner because BDNF or DHPG stimulation of neurons causes CYFIP1 to dissociate from eIF4E at synapses, thereby resulting in protein synthesis. Thus, the translational repression activity of FMRP in the brain is mediated, at least in part, by CYFIP1.	[Napoli, Ilaria; Mercaldo, Valentina; Eleuteri, Boris; Zalfa, Francesca; Achsel, Tilmann; Bagni, Claudia] IRCCS, Fdn Santa Lucia, Dept Expt Neurosci, I-00143 Rome, Italy; [Napoli, Ilaria; De Rubeis, Silvia; Di Marino, Daniele; Falconi, Mattia] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Napoli, Ilaria; Mercaldo, Valentina; Boyl, Pietro Pilo; De Rubeis, Silvia; Achsel, Tilmann; Bagni, Claudia] Catholic Univ Louvain VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Zalfa, Francesca; Bagni, Claudia] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Mohr, Evita] Univ Hosp Hamburg Eppendorf, Dept Anat Cellular Neurobiol 1, D-20246 Hamburg, Germany; [Massimi, Marzia; Witke, Walter] European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; [Costa-Mattioli, Mauro; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1V6, Canada	IRCCS Santa Lucia; University of Rome Tor Vergata; Flanders Institute for Biotechnology (VIB); University of Rome Tor Vergata; University of Hamburg; University Medical Center Hamburg-Eppendorf; European Molecular Biology Laboratory (EMBL); McGill University	Bagni, C (corresponding author), IRCCS, Fdn Santa Lucia, Dept Expt Neurosci, I-00143 Rome, Italy.	claudia.bagni@med.kuleuven.be	Zalfa, Francesca/J-7759-2018; Di Marino, Daniele/ABB-2333-2020; Cabrera, Mariel/GMX-2706-2022; Di Marino, Daniele/AAB-9653-2019; Mercaldo, Valentina/AAA-6000-2019; De Rubeis, Silvia/E-9852-2013	Zalfa, Francesca/0000-0002-1922-9468; Di Marino, Daniele/0000-0001-6961-3129; De Rubeis, Silvia/0000-0001-9383-6883; FALCONI, MATTIA/0000-0002-3990-4758; Pilo Boyl, Pietro/0000-0002-7535-4802; Bagni, Claudia/0000-0002-4419-210X; Napoli, Ilaria/0000-0002-0649-1950	FP6 Marie Curie fellowship [MEST-CT-2004-504640]; Conquer Fragile X Foundation; Telethon [GGP05269]; Ministero della Sanita e dell' Universita (FIRB); Flanders Interuniversity Institute for Biotechnology (VIB)	FP6 Marie Curie fellowship(European Commission); Conquer Fragile X Foundation; Telethon(Fondazione Telethon); Ministero della Sanita e dell' Universita (FIRB); Flanders Interuniversity Institute for Biotechnology (VIB)	We thank Rasmus Herlo, Adriana Gambardella, and Emanuela Pasciuto for sharing preliminary data and Antonio Totaro and Caroline Lacoux for some help with protein purifications. We are grateful to Ben Oostra for the FMR1 KO mice and to Jurgen Brosius for the BC1 KO mice. We thank Kris Dickson for critical reading of the manuscript and discussion, Jesus Avila, Itzhak Fisher, and Gary Bassell for MAP1B antibodies, Stefano Biffo for eIF6/p27 antibody, Sebastian Munk for helping us with the confocal images, Nicola Gray and Fatima Gebauer for the MS2 reporter constructs, Oswald Steward for the full-length Arc cDNA, and Massimo Regoli for assistance with the statistical analysis. We thank Giorgio Bernardi for his support. M. M. was supported by a FP6 Marie Curie MEST-CT-2004-504640 fellowship. P. P. B. was partially supported by Conquer Fragile X Foundation. C. B. is supported by grants from the following agencies: Telethon (GGP05269), Ministero della Sanita e dell' Universita (FIRB), and Flanders Interuniversity Institute for Biotechnology (VIB).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Centonze D, 2008, BIOL PSYCHIAT, V63, P963, DOI 10.1016/j.biopsych.2007.09.008; Centonze D, 2007, J NEUROSCI, V27, P8885, DOI 10.1523/JNEUROSCI.0548-07.2007; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RICHTER JD, 2007, TRANSLATIONAL CONTRO, P489; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	58	416	424	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1042	1054		10.1016/j.cell.2008.07.031	http://dx.doi.org/10.1016/j.cell.2008.07.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805096	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000259318100023
J	Ogden, SK; Fei, DL; Schilling, NS; Ahmed, YF; Hwa, J; Robbins, DJ				Ogden, Stacey K.; Fei, Dennis Liang; Schilling, Neal S.; Ahmed, Yashi F.; Hwa, John; Robbins, David J.			G protein G alpha(i) functions immediately downstream of Smoothened in Hedgehog signalling	NATURE			English	Article							HETEROTRIMERIC G-PROTEINS; CUBITUS INTERRUPTUS; DROSOPHILA; EXPRESSION; KINESIN; COMPLEX; TRANSDUCTION; REPRESSOR; ACTIVATOR; RECEPTOR	The hedgehog (Hh) signalling pathway has an evolutionarily conserved role in patterning fields of cells during metazoan development, and is inappropriately activated in cancer(1,2). Hh pathway activity is absolutely dependent on signalling by the seven-transmembrane protein smoothened (Smo), which is regulated by the Hh receptor patched (Ptc). Smo signals to an intracellular multi- protein complex containing the Kinesin related protein Costal2 ( Cos2), the protein kinase Fused ( Fu) and the transcription factor Cubitus interruptus (Ci)(3). In the absence of Hh, this complex regulates the cleavage of full-length Ci to a truncated repressor protein, Ci(75), in a process that is dependent on the proteasome and priming phosphorylations by Protein kinase A (PKA)(4). Binding of Hh to Ptc blocks Ptc-mediated Smo inhibition, allowing Smo to signal to the intracellular components to attenuate Ci cleavage. Because of its homology with the Frizzled family of G-protein-coupled receptors ( GPCR) 5, a likely candidate for an immediate Smo effector would be a heterotrimeric G protein. However, the role that G proteins may have in Hh signal transduction is unclear and quite controversial(6-10), which has led to widespread speculation that Smo signals through a variety of novel G-protein-independent mechanisms. Here we present in vitro and in vivo evidence in Drosophila that Smo activates a G protein to modulate intracellular cyclic AMP levels in response to Hh. Our results demonstrate that Smo functions as a canonical GPCR, which signals through G alpha(i) to regulate Hh pathway activation.	[Ogden, Stacey K.; Fei, Dennis Liang; Schilling, Neal S.; Hwa, John; Robbins, David J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Ahmed, Yashi F.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Hwa, John] Dartmouth Med Sch, Dept Med Cardiol, Hanover, NH 03755 USA; [Ahmed, Yashi F.; Robbins, David J.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Robbins, DJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	david.j.robbins@dartmouth.edu	Ogden, Stacey K/P-9585-2019; Ogden, Stacey K/N-2528-2018	Ogden, Stacey K/0000-0001-8991-3065; Fei, Dennis Liang/0000-0002-1953-0584	National Institutes of Health [CA82628, HL074190]; NATIONAL CANCER INSTITUTE [R01CA105038, R01CA082628] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants CA82628 (D.J.R.) and HL074190 (J.H.). We are grateful to J. Knoblich for the G alpha<INF>i</INF> antibody and G alpha<INF>i</INF> flies; X. Yang and W. Chia for G alpha<INF>i</INF> flies; D. Casso and T. Kornberg for Ptc antibody and UAS-Smo5A flies; J. Hooper for UAS-G alpha<INF>i</INF> and UAS-G alpha<INF>i</INF><SUP>Q205L</SUP> flies; K. Basler, D. Kalderon and P. Ingham for smo alleles; and L. Lum for Smo antibody. All additional fly stocks were provided by the Bloomington Stock Center. G alpha<INF>i</INF> and G alpha<INF>o</INF> cDNAs were obtained from the Drosophila Genomics Resource Center, Bloomington. E. Lee provided G alpha<INF>s</INF> cDNA. We thank the Dartmouth microscopy core for their assistance. We would also like to thank K. Black for technical assistance and members of the Robbins laboratory, E. Lee, J. Hutchinson, R. Taussig, R. Ostrom and C. Pikielny for thoughtful discussion during the course of this work.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Collins RT, 2005, GENETICS, V170, P173, DOI 10.1534/genetics.104.039420; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Muller B, 2000, DEVELOPMENT, V127, P2999; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; PATEL NH, 1989, DEVELOPMENT, V107, P201; Pena-Rangel MT, 2002, GENETICS, V160, P1035; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Stegman MA, 2004, J BIOL CHEM, V279, P7064, DOI 10.1074/jbc.M311794200; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	37	157	164	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					967	U76		10.1038/nature07459	http://dx.doi.org/10.1038/nature07459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18987629	Green Accepted			2022-12-01	WOS:000261768300049
J	Zhang, KL; Detels, R; Liao, SS; Cohen, M; Yu, DB				Zhang, Kong-Lai; Detels, Roger; Liao, Susu; Cohen, Myron; Yu, Dong-Bao			China's HIV/AIDS epidemic: continuing challenges	LANCET			English	Editorial Material							HIV		[Zhang, Kong-Lai] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Cohen, Myron] Univ N Carolina, Chapel Hill, NC USA; [Liao, Susu] Peking Union Med Coll, Dept Epidemiol, Beijing 100021, Peoples R China; [Yu, Dong-Bao] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; World Health Organization	Zhang, KL (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China.	Konglai_Zhang@163.com						*CHIN STAT COUNC A, 2007, JOINT ASS HIV AIDS P; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gill B, 2007, NEW ENGL J MED, V356, P1801, DOI 10.1056/NEJMp078010; Li L, 2007, INT J EPIDEMIOL, V36, P178, DOI 10.1093/ije/dyl256; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; UNAIDS, 2008, REP GLOB EP; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8	8	31	34	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1791	1793		10.1016/S0140-6736(08)61357-4	http://dx.doi.org/10.1016/S0140-6736(08)61357-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375KG	18930521				2022-12-01	WOS:000261112000008
J	Takeuchi, A; Reyes, N; Artigas, P; Gadsby, DC				Takeuchi, Ayako; Reyes, Nicolas; Artigas, Pablo; Gadsby, David C.			The ion pathway through the opened Na+,K+-ATPase pump	NATURE			English	Article							NA,K-ATPASE ALPHA-SUBUNIT; TRANSMEMBRANE SEGMENT M1; CALCIUM-PUMP; CRYSTAL-STRUCTURE; K+-ATPASE; BINDING; CYSTEINE; OCCLUSION; MECHANISM; TRANSPORT	P-type ATPases pump ions across membranes, generating steep electrochemical gradients that are essential for the function of all cells. Access to the ion-binding sites within the pumps alternates between the two sides of the membrane(1) to avoid the dissipation of the gradients that would occur during simultaneous access. In Na+,K+-ATPase pumps treated with the marine agent palytoxin, this strict alternation is disrupted and binding sites are sometimes simultaneously accessible from both sides of the membrane, transforming the pumps into ion channels (see, for example, refs 2, 3). Current recordings in these channels can monitor accessibility of introduced cysteine residues to water-soluble sulphydryl-specific reagents(4). We found previously(5) that Na+,K+ pump-channels open to the extracellular surface through a deep and wide vestibule that emanates from a narrower pathway between transmembrane helices 4 and 6 (TM4 and TM6). Here we report that cysteine scans from TM1 to TM6 reveal a single unbroken cation pathway that traverses palytoxin-bound Na+,K+ pump-channels from one side of the membrane to the other. This pathway comprises residues from TM1, TM2, TM4 and TM6, passes through ion-binding site II,and is probably conserved in structurally and evolutionarily related P-type pumps, such as sarcoplasmic- and endoplasmic-reticulum Ca2+-ATPases and H+,K+-ATPases.	[Takeuchi, Ayako; Reyes, Nicolas; Artigas, Pablo; Gadsby, David C.] Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10065 USA	Rockefeller University	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10065 USA.	gadsby@rockefeller.edu		Reyes, Nicolas/0000-0001-6618-8307	NIH; Vicente Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036783] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vicente Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Fataliev for help with molecular biology, the late R. F. Rakowski for cDNAs encoding Xenopus alpha<INF>1</INF> and beta<INF>3</INF> Na<SUP>+</SUP>,K<SUP>+</SUP>-ATPase subunits, and P. Nissen, B. Vilsen and J. V. Moller for providing atomic coordinates before their publication. The work was supported by a grant from the NIH (to D. C. G.) and a fellowship from the Vicente Trust (to P. A.); N. R. is presently a Jane Coffin Fund Fellow. We dedicate this paper to the memory of our colleague R. F. Rakowski.	Artigas P, 2004, J GEN PHYSIOL, V123, P357, DOI 10.1085/jgp.200308964; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; Guennoun S, 2000, FEBS LETT, V482, P144, DOI 10.1016/S0014-5793(00)02050-0; Guennoun S, 2002, FEBS LETT, V513, P277, DOI 10.1016/S0014-5793(02)02323-2; Harmel N, 2006, J GEN PHYSIOL, V128, P103, DOI 10.1085/jgp.200609505; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; INESI G, 1987, J BIOL CHEM, V262, P16338; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Lauger P., 1991, ELECTROGENIC ION PUM; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Rakowski RF, 2007, J GEN PHYSIOL, V130, P41, DOI 10.1085/jgp.200709770; Reyes N, 2006, NATURE, V443, P470, DOI 10.1038/nature05129; Sakmann B., 1995, SINGLE CHANNEL RECOR; SCHEINERBOBIS G, 1994, MOL PHARMACOL, V45, P1132; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	30	62	65	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					413	416		10.1038/nature07350	http://dx.doi.org/10.1038/nature07350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18849964	Green Accepted			2022-12-01	WOS:000261039600049
J	Choi, EY; Chavakis, E; Czabanka, MA; Langer, HF; Fraemohs, L; Economopoulou, M; Kundu, RK; Orlandi, A; Zheng, YY; Prieto, DA; Ballantyne, CM; Constant, SL; Aird, WC; Papayannopoulou, T; Gahmberg, CG; Udey, MC; Vajkoczy, P; Quertermous, T; Dimmeler, S; Weber, C; Chavakis, T				Choi, Eun Young; Chavakis, Emmanouil; Czabanka, Marcus A.; Langer, Harald F.; Fraemohs, Line; Economopoulou, Matina; Kundu, Ramendra K.; Orlandi, Alessia; Zheng, Ying Yi; Prieto, DaRue A.; Ballantyne, Christie M.; Constant, Stephanie L.; Aird, William C.; Papayannopoulou, Thalia; Gahmberg, Carl G.; Udey, Mark C.; Vajkoczy, Peter; Quertermous, Thomas; Dimmeler, Stefanie; Weber, Christian; Chavakis, Triantafyllos			Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell Recruitment	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; INTEGRINS; MIGRATION; PROTEIN; MOLECULE-1; ICAM-1; LFA-1	Leukocyte recruitment to sites of infection or inflammation requires multiple adhesive events. Although numerous players promoting leukocyte- endothelial interactions have been characterized, functionally important endogenous inhibitors of leukocyte adhesion have not been identified. Here we describe the endothelially derived secreted molecule Del-1 ( developmental endothelial locus-1) as an anti-adhesive factor that interferes with the integrin LFA-1-dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency increased LFA- 1- dependent leukocyte adhesion in vitro and in vivo. Del-1(-/-) mice displayed significantly higher neutrophil accumulation in lipopolysaccharide- induced lung inflammation in vivo, which was reversed in Del- /LFA-1 double- deficient mice. Thus, Del- 1 is an endogenous inhibitor of inflammatory cell recruitment and could provide a basis for targeting leukocyte- endothelial interactions in disease.	[Choi, Eun Young; Langer, Harald F.; Zheng, Ying Yi; Chavakis, Triantafyllos] NCI, Expt Immunol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Chavakis, Emmanouil; Orlandi, Alessia; Dimmeler, Stefanie] Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Czabanka, Marcus A.; Vajkoczy, Peter] Charite Univ Med Berlin, Dept Neurosurg, D-13353 Berlin, Germany; [Fraemohs, Line; Weber, Christian] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res, Aachen, Germany; [Economopoulou, Matina] NCI, Lab Cellular Oncol, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Kundu, Ramendra K.; Quertermous, Thomas] Stanford Univ, Sch Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA; [Prieto, DaRue A.] NCI, Lab Proteom & Anal Technol, SAIC Frederick, Frederick, MD 21701 USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart & Vasc Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX 77030 USA; [Constant, Stephanie L.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Aird, William C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Papayannopoulou, Thalia] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Gahmberg, Carl G.] Univ Helsinki, Div Biochem, Fac Biosci, Helsinki, Finland; [Udey, Mark C.] NCI, Dermatol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Goethe University Frankfurt; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; RWTH Aachen University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; George Washington University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chavakis, T (corresponding author), NCI, Expt Immunol Branch, Canc Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	chavakist@mail.nih.gov	Ballantyne, Christie/A-6599-2008; Gahmberg, Carl/AAE-1876-2019; Chavakis, Triantafyllos/ABE-8845-2020; Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714; Gahmberg, Carl/0000-0001-9892-9296; Ballantyne, Christie/0000-0002-6432-1730; Dimmeler, Stefanie/0000-0002-1045-2436; Choi, Eun Young/0000-0002-5484-4925; Quertermous, Thomas/0000-0002-7645-9067	Intramural Research Program; NIH [AI067254, RO1 HL082927]; NCI; Deutsche Forschungsgemeinschaft [FOR809, TP6, TR-SFB23, Exc 147/1]; NATIONAL CANCER INSTITUTE [ZIABC010790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067254] Funding Source: NIH RePORTER	Intramural Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Feng and M. Sardy for generating the Del-1-Fc protein, N. Hogg for the antibody mAb24, Valentis Inc. for recombinant Del- 1 and the antibody to mouse Del- 1, T. Veenstra for help with mass spectrometry, D. Winkler for help with genotyping, I. Okwumabua for technical assistance, and D. Singer for critically reading the manuscript. This research was supported by the Intramural Research Program of the NIH, NCI (T.C. and M.C.U.); by NIH grants AI067254 (S.L.C.) and RO1 HL082927 (W.C.A.); and by the Deutsche Forschungsgemeinschaft (grants FOR809 and TP6 to C.W.; TR-SFB23 and Exc 147/1 to S.D. and E.C.). A patent application on the anti- inflammatory actions of Del-1 has been filed.	Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Ding ZM, 1999, J IMMUNOL, V163, P5029; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gahmberg CG, 1998, CELL MOL LIFE SCI, V54, P549, DOI 10.1007/s000180050183; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hidai C, 2007, CELL TISSUE RES, V330, P83, DOI 10.1007/s00441-007-0456-9; Ho HKV, 2004, CIRCULATION, V109, P1314, DOI 10.1161/01.CIR.0000118465.36018.2D; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Parry RV, 2007, TRENDS IMMUNOL, V28, P161, DOI 10.1016/j.it.2007.02.004; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Yonekawa K, 2005, J LEUKOCYTE BIOL, V77, P129, DOI 10.1189/jlb.0804460; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhong JP, 2003, J CLIN INVEST, V112, P30, DOI 10.1172/JCI200317034	23	215	227	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1101	1104		10.1126/science.1165218	http://dx.doi.org/10.1126/science.1165218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008446	Green Accepted			2022-12-01	WOS:000260867700037
J	Chesson, P; Kuang, JJ				Chesson, Peter; Kuang, Jessica J.			The interaction between predation and competition	NATURE			English	Article							APPARENT COMPETITION; ECOLOGICAL COMMUNITIES; TOP PREDATORS; RESOURCE; COEXISTENCE; PREY; DIVERSITY; SYSTEMS; MODELS	Competition and predation are the most heavily investigated species interactions in ecology, dominating studies of species diversity maintenance. However, these two interactions are most commonly viewed highly asymmetrically. Competition for resources is seen as the primary interaction limiting diversity, with predation modifying what competition does(1), although theoretical models have long supported diverse views(1-5). Here we show, using a comprehensive three- trophic- level model, that competition and predation should be viewed symmetrically: these two interactions are equally able to either limit or promote diversity. Diversity maintenance requires within- species density feedback loops to be stronger than between- species feedback loops. We quantify the contributions of predation and competition to these loops in a simple, interpretable form, showing their equivalent potential to strengthen or weaken diversity maintenance. Moreover, we show that competition and predation can undermine each other, with the tendency of the stronger interaction to promote or limit diversity prevailing. The past failure to appreciate the symmetrical effects and interactions of competition and predation has unduly restricted diversity maintenance studies. A multitrophic perspective should be adopted to examine a greater variety of possible effects of predation than generally considered in the past. Conservation and management strategies need to be much more concerned with the implications of changes in the strengths of trophic interactions.	[Chesson, Peter; Kuang, Jessica J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Chesson, P (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	pchesson@u.arizona.edu; jjkuang@u.arizona.edu	Chesson, Peter/GRO-6970-2022; Chesson, Peter/GLN-5790-2022	Chesson, Peter/0000-0001-8931-8012; 	National Science Foundation [DEB-0542991, DEB-0717222]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants DEB-0542991 and DEB-0717222.	Abrams PA, 1998, AM NAT, V152, P114, DOI 10.1086/286153; Borrvall C, 2006, ECOL LETT, V9, P435, DOI 10.1111/j.1461-0248.2006.00893.x; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON P, 1990, THEOR POPUL BIOL, V37, P26, DOI 10.1016/0040-5809(90)90025-Q; Chesson P., 2008, UNITY DIVERSITY REFL, P119; EITHAUS MR, 2008, TRENDS ECOL EVOL, V23, P202; Grover JP, 1998, J THEOR BIOL, V191, P353, DOI 10.1006/jtbi.1997.0562; Haygood R, 2002, THEOR POPUL BIOL, V61, P215, DOI 10.1006/tpbi.2001.1566; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; KOTLER BP, 1989, OIKOS, V54, P256, DOI 10.2307/3565279; Krivan V, 2003, EVOL ECOL RES, V5, P1163; Kuang JJ, 2008, AM NAT, V171, pE119, DOI 10.1086/527484; KUANG JJ, ECOLOGY IN PRESS; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Sala E, 2006, TRENDS ECOL EVOL, V21, P479, DOI 10.1016/j.tree.2006.07.006; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Soule ME, 1999, BIOSCIENCE, V49, P809, DOI 10.2307/1313572	24	310	322	8	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					235	238		10.1038/nature07248	http://dx.doi.org/10.1038/nature07248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005554				2022-12-01	WOS:000261039300039
J	Yang, GH; Kong, LZ; Zhao, WH; Wan, X; Zhai, Y; Chen, LC; Koplan, JP				Yang, Gonghuan; Kong, Lingzhi; Zhao, Wenhua; Wan, Xia; Zhai, Yi; Chen, Lincoln C.; Koplan, Jeffrey P.			Health System Reform in China 3 Emergence of chronic non-communicable diseases in China	LANCET			English	Article							VERBAL AUTOPSY PROCEDURES; OF-DEATH STATISTICS; VALIDATION; PREVALENCE; SMOKING	China has experienced an epidemiological transition shifting from the infectious to the chronic diseases in much shorter time than many other countries. The pace and spread of behavioural changes, including changing diets, decreased physical activity high rates of male smoking, and other high risk behaviours, has accelerated to an unprecedented degree. As a result, the burden of chronic diseases, preventable morbidity and mortality and associated health-care costs could now increase substantially. China already has 177 million adults with hypertension; furthermore, 303 million adults smoke, which is a third of the world's total number of smokers, and 530 million people in China are passively exposed to second-hand smoke. The prevalence of overweight people and obesity is increasing in Chinese adults and children, because of dietary changes and reduced physical activity. Emergence of chronic diseases presents special challenges for China's ongoing reform of health care, given the large numbers who require curative treatment and the narrow window of opportunity for timely prevention of disease.	[Yang, Gonghuan; Zhao, Wenhua; Zhai, Yi] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Kong, Lingzhi] Minist Hlth, Bur Dis Prevent & Control, Beijing, Peoples R China; [Yang, Gonghuan; Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Yang, Gonghuan; Wan, Xia] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Chen, Lincoln C.] China Med Board, Cambridge, MA USA; [Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA	Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Emory University	Yang, GH (corresponding author), Chinese Ctr Dis Control & Prevent, 27 Nan Wei Rd, Beijing 100050, Peoples R China.	yanggh@chinacdc.cn		Zhai, Yi/0000-0002-1779-6645				[Anonymous], 2002, WORLD HLTH REP 2002; Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; Chen K, 2004, PIGM CELL RES, V17, P36, DOI 10.1046/j.1600-0749.2003.00106.x; *CHIN AC PREV MED, 1997, SER REP CHIN DIS SUR; *CHIN INT INF CTR, 2008, ISS PROM 3 SURV CAUS; Chinese Academy of Preventive Medicine, 1997, SMOK HLTH CHIN 1996; Chinese Nutrition Society, 2008, CHIN DIET GUID; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; *COMM REV CHIN GUI, 2006, CHIN HYP GUID; GE KY, 1996, J HYGIENE RES S29, V25, P54; HU SL, 2003, CHIN HLTH EC MAG, V22, P18; HUA XL, 2006, CHINA TOBACCO HIST; HUANG R, 1995, MORTALITY DATA CHINA; HUANG XQ, 2008, CHINA TOBACCO, V3, P59; International Institute for Applied Systems Analysis, CHIN POP AG SEX 1950; Li J, 2000, CELL BIOL INT, V24, P9, DOI 10.1006/cbir.1999.0438; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; *MIN HLTH, 2005, ANN CHIN HLTH YB; *MIN HLTH CANC PRE, 1979, STUD CANC DEATH SURV; *MIN HLTH COMM NAT, 1987, 1984 NAT PREV SURV S; *MIN HLTH CTR HLTH, 2004, AN REP NAT HLTH SERV; *MIN HLTH DEP DIS, 2006, REP CHRON DIS CHIN; *MIN HLTH MIN PUBL, 1992, MED CERT DEATH STREN; Population Census Office under the State Council and Department of Population Social Science and Technology Statistics, 2002, TAB 2000 POP CENS PE; Population Census Office under the State Council Department of Population and Employment Statistics of National Bureau of Statistics, 1993, TAB 1990 POP CENS PE; PUSKA P, 1988, EURO REPORTS STUDIES, V106; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Setel PW, 2006, PLOS MED, V3, P1282, DOI 10.1371/journal.pmed.0030268; *STAT STAT BUR PEO, 1996, 1982 POP CENS CHIN; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61364-1; UN Department of Economic and Social Affairs Population Division, 2006, WORLD POP PROSP 2006; Wang LD, 2005, COMPREHENSIVE REPORT; Wang LJ, 2007, J EPIDEMIOL COMMUN H, V61, P519, DOI 10.1136/jech.2005.043927; WANG WZ, 2002, CHIN J GERIATR CARDI, V4, P30; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; WHO, 1986, 1 INT C HLTH PROM OT; WHO, 2008, REP GLOB TOB EP 2008; WHO, 1997, OB PREV MAN GLOB EP; *WHO, 2002, PREV CHRON DIS VIT I; World Health Organization, 1993, MORT GUID CERT RUL C, V2, P30; World Health Organization, 1983, WHOSMO834; Wu Yang-feng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P316; Xie Gaoqiang, 2008, Wei Sheng Yan Jiu, V37, P33; Yang, 2005, DEATHS THEIR RISK FA; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; YANG GH, 2004, TOBACCO SCI POLICY P, P215; YANG GH, 1992, J CHIN EPIDEMIOL, V13, P79; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; [No title captured]; 2007, PERIODIC REPORT IMPL	52	373	418	4	92	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1697	1705		10.1016/S0140-6736(08)61366-5	http://dx.doi.org/10.1016/S0140-6736(08)61366-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18930526				2022-12-01	WOS:000260899900034
J	Costa-Mattioli, M				Costa-Mattioli, Mauro			EPPENDORF WINNER Switching Memories ON and OFF	SCIENCE			English	Editorial Material							SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; NEUROSCIENCE; TERM; MECHANISMS; STORAGE		[Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu						BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borges Jorge Luis, 1962, FICCIONES, P107; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Pestova T. V., 2007, TRANSLATIONAL CONTRO, P87; Ron D., 2007, TRANSLATIONAL CONTRO, P345; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014	21	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					874	875		10.1126/science.1167228	http://dx.doi.org/10.1126/science.1167228			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988834				2022-12-01	WOS:000260674100029
J	Krukowski, ZH; Bruce, J				Krukowski, Zygmunt H.; Bruce, Julie			Commentary: Controversies in NICE guidance on surgical site infection	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bruce, Julie] Univ Aberdeen, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland; [Krukowski, Zygmunt H.] Aberdeen Royal Infirm, Ward 31, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Bruce, J (corresponding author), Univ Aberdeen, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland.	j.bruce@abdn.ac.uk	Bruce, Julie/G-7588-2014	Bruce, Julie/0000-0002-8462-7999	MRC [G106/1178] Funding Source: UKRI; Medical Research Council [G106/1178] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; *HLTH PROT AG, SURG SIT INF SURV EN; *HLTH PROT SCOTL, 2007, SURG SIT INF SURV SC; KRUKOWSKI ZH, 1988, BRIT J SURG, V75, P857, DOI 10.1002/bjs.1800750909; National Institute for Health and Clinical Excellence, 2008, SURG SIT INF; Taylor EW, 2004, BRIT J SURG, V91, P105, DOI 10.1002/bjs.4365	6	10	10	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a2120	10.1136/bmj.a2120	http://dx.doi.org/10.1136/bmj.a2120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18957456				2022-12-01	WOS:000260593700033
J	Bayne, EH; Portoso, M; Kagansky, A; Kos-Braun, IC; Urano, T; Ekwall, K; Alves, F; Rappsilber, J; Allshire, RC				Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Urano, Takeshi; Ekwall, Karl; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.			Splicing factors facilitate RNAi-directed silencing in fission yeast	SCIENCE			English	Article							PRE-MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; CENTROMERE FUNCTION; HETEROCHROMATIN; MUTANTS; RITS; ESTABLISHMENT; TRANSCRIPTION; INTERFERENCE; CHROMATIN	Heterochromatin formation at fission yeast centromeres is directed by RNA interference (RNAi). Noncoding transcripts derived from centromeric repeats are processed into small interfering RNAs (siRNAs) that direct the RNA-induced transcriptional silencing (RITS) effector complex to engage centromer transcripts, resulting in recruitment of the histone H3 lysine 9 methyltransferase Clr4, and hence silencing. We have found that defects in specific splicing factors, but not splicing itself, affect the generation of centromeric siRNAs and consequently centromeric heterochromatin integrity. Moreover, splicing factors physically associate with Cid12, a component of the RNAi machinery, and with centromeric chromatin, consistent with a direct role in RNAi. We propose that spliceosomal complexes provide a platform for siRNA generation and hence facilitate effective centromere repeat silencing.	[Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane 6938501, Japan; [Ekwall, Karl] Univ Coll Sodertorn, Karolinska Inst, Dept Biosci & Med Nutr, S-14157 Huddinge, Sweden	University of Edinburgh; University of Edinburgh; Shimane University; Karolinska Institutet; Sodertorn University	Allshire, RC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, 6-34 Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Bayne, Elizabeth H/G-5411-2010; Rappsilber, Juri/ABF-3328-2020; /C-3697-2019; Rappsilber, Juri/B-7265-2015; Kagansky, Alexander/B-3137-2011	Bayne, Elizabeth H/0000-0001-8775-999X; Rappsilber, Juri/0000-0001-5999-1310; Kagansky, Alexander/0000-0002-6219-6892; Allshire, Robin/0000-0002-8005-3625; Kos-Braun, Isabelle/0000-0002-2380-5720; Ekwall, Karl/0000-0002-3029-4041; Urano, Takeshi/0000-0003-3383-3554	Epigenome Network of Excellence [EC-FP6/Contract/LSHG-CT2004-503433]; UK Medical Research Council [G0301153/ID:69173]; Wellcome Trust Prize Studentship [067844]; Marie Curie Excellence Grant [MEXT-CT-014171]; Wellcome Trust Principal Research Fellowship [065061/Z]; Medical Research Council [G0301153] Funding Source: researchfish; MRC [G0301153] Funding Source: UKRI	Epigenome Network of Excellence; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Prize Studentship(Wellcome Trust); Marie Curie Excellence Grant(European Commission); Wellcome Trust Principal Research Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Beggs, E. S. Chin, A. Pidoux, F. Simmer, I. Stancheva, and D. Tollervey for comments; N. Kaufer, D. Moazed, and T. Tani for materials; and the Allshire lab for support. Supported by Epigenome Network of Excellence (EC-FP6/Contract/LSHG-CT2004-503433), of which R.C.A. and K.E. are members (E.B.); UK Medical Research Council grant G0301153/ID:69173 (A.K.); Wellcome Trust Prize Studentship 067844 (M.P.); Marie Curie Excellence Grant MEXT-CT-014171 from the European Commission (I.R.); and Wellcome Trust Principal Research Fellowship grant 065061/Z (R.C.A.).	Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ekwall K, 1999, GENETICS, V153, P1153; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Goymer P, 2007, NAT REV MOL CELL BIO, V8, P597, DOI 10.1038/nrm2225; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Habara Y, 2001, RNA, V7, P671, DOI 10.1017/S1355838201001200; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; LOCKHART SR, 1994, MOL CELL BIOL, V14, P3623, DOI 10.1128/MCB.14.6.3623; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; VOLPE TA, 2002, SCIENCE, V297, P18533, DOI DOI 10.1112/SCIENCE.1074973	25	99	98	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					602	606		10.1126/science.1164029	http://dx.doi.org/10.1126/science.1164029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948543	Green Accepted			2022-12-01	WOS:000260299100047
J	Schwander, T; Keller, L				Schwander, Tanja; Keller, Laurent			Genetic compatibility affects queen and worker caste determination	SCIENCE			English	Article									[Schwander, Tanja; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Lausanne	Schwander, T (corresponding author), Simon Fraser Univ, Dept Biol Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	tanja.schwander@gmail.com	keller, laurent/AAI-7175-2020	keller, laurent/0000-0002-5046-9953; Schwander, Tanja/0000-0003-1945-5374	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Campbell for help in the field; F. Dessimoz and C. Ohayon for ant care and laboratory work; B.J. Crespi, P. Chnste, M. Chapunsat, and D. Queler for comments; and K. Parker and D. Arbuthnott for help with English. Supported by the Swiss National Science Foundation.	Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508	4	42	42	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					552	552		10.1126/science.1162590	http://dx.doi.org/10.1126/science.1162590			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948532	Green Submitted			2022-12-01	WOS:000260299100032
J	Silberstein, SD				Silberstein, Stephen D.			Recent developments in migraine	LANCET			English	Editorial Material							DOUBLE-BLIND; CONTROLLED-TRIAL; RISK; INTERVENTION; CGRP		[Silberstein, Stephen D.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Jefferson University	Silberstein, SD (corresponding author), Thomas Jefferson Univ, Philadelphia, PA 19107 USA.	stephen.silberstein@jefferson.edu						Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Diener HC, 2007, LANCET NEUROL, V6, P1054, DOI 10.1016/S1474-4422(07)70272-7; Doods H, 2007, TRENDS PHARMACOL SCI, V28, P580, DOI 10.1016/j.tips.2007.10.005; Dowson A, 2008, CIRCULATION, V117, P1397, DOI 10.1161/CIRCULATIONAHA.107.727271; Ho TW, 2008, NEUROLOGY, V70, P1304, DOI 10.1212/01.WNL.0000286940.29755.61; HO TW, 2008, HEADACHE S1, V48, P7; Kurth T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a636; Kurth T, 2007, ARCH INTERN MED, V167, P795, DOI 10.1001/archinte.167.8.795; Lipton RB, 2005, HEADACHE, V45, P792; MATCHAR DB, 2008, HEADACHE        0610, DOI DOI 10.1111/J.1526-4610.2007.01148.X; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Schoonman GG, 2008, BRAIN, V131, P2192, DOI 10.1093/brain/awn094; Silberstein S, 2008, NEUROLOGY, V70, P548, DOI 10.1212/01.wnl.0000297551.27191.70; Silberstein SD, 2008, NEUROLOGY, V71, P114, DOI 10.1212/01.wnl.0000316800.22949.20; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; Vanmolkot Kaate R J, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9486	16	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1369	1371		10.1016/S0140-6736(08)61569-X	http://dx.doi.org/10.1016/S0140-6736(08)61569-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940454				2022-12-01	WOS:000260228200008
J	Win, MN; Smolke, CD				Win, Maung Nyan; Smolke, Christina D.			Higher-order cellular information processing with synthetic RNA devices	SCIENCE			English	Article							GENE-EXPRESSION; ALLOSTERIC RIBOZYMES; MAMMALIAN-CELLS; RIBOSWITCHES; BINDING	The engineering of biological systems is anticipated to provide effective solutions to challenges that include energy and food production, environmental quality, and health and medicine. Our ability to transmit information to and from living systems, and to process and act on information inside cells, is critical to advancing the scale and complexity at which we can engineer, manipulate, and probe biological systems. We developed a general approach for assembling RNA devices that can execute higher-order cellular information processing operations from standard components. The engineered devices can function as logic gates (AND, NOR, NAND, or OR gates) and signal filters, and exhibit cooperativity. RNA devices process and transmit molecular inputs to targeted protein outputs, linking computation to gene expression and thus the potential to control cellular function.	[Win, Maung Nyan; Smolke, Christina D.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Smolke, CD (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 210-41, Pasadena, CA 91125 USA.	smolke@cheme.caltech.edu			Center for Biological Circuit Design at the California Institute of Technology; Arnold and Mabel Beckman Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM074767, R01GM086663] Funding Source: NIH RePORTER	Center for Biological Circuit Design at the California Institute of Technology; Arnold and Mabel Beckman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Chen, J. Liang, and D. Endy for critical reading of the manuscript and A. Babiskin for pRzS. This work was supported by the Center for Biological Circuit Design at the California Institute of Technology, the Arnold and Mabel Beckman Foundation, and the NIH. The authors declare competing financial interests in the form of a pending patent application.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; NELSON DL, 2005, LEHNINGER PRINCIPLES, P167; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103	25	400	433	4	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					456	460		10.1126/science.1160311	http://dx.doi.org/10.1126/science.1160311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927397	Green Accepted			2022-12-01	WOS:000260094500051
J	Karklin, Y; Lewicki, MS				Karklin, Yan; Lewicki, Michael S.			Emergence of complex cell properties by learning to generalize in natural scenes	NATURE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; RECEPTIVE-FIELDS; AREA V4; V1; RESPONSES; MODELS; IMAGES; NORMALIZATION; ORGANIZATION	A fundamental function of the visual system is to encode the building blocks of natural scenes - edges, textures and shapes - that subserve visual tasks such as object recognition and scene understanding. Essential to this process is the formation of abstract representations that generalize from specific instances of visual input. A common view holds that neurons in the early visual system signal conjunctions of image features(1,2), but how these produce invariant representations is poorly understood. Here we propose that to generalize over similar images, higher- level visual neurons encode statistical variations that characterize local image regions. We present a model in which neural activity encodes the probability distribution most consistent with a given image. Trained on natural images, the model generalizes by learning a compact set of dictionary elements for image distributions typically encountered in natural scenes. Model neurons show a diverse range of properties observed in cortical cells. These results provide a new functional explanation for nonlinear effects in complex cells(3-6) and offer insight into coding strategies in primary visual cortex (V1) and higher visual areas.	[Karklin, Yan; Lewicki, Michael S.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Karklin, Yan; Lewicki, Michael S.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Karklin, Y (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	yan.karklin@nyu.edu; michael.lewicki@case.edu			Department of Energy; Computational Science Graduate Fellowship; National Science Foundation [0413152, 0705677]; Office of Naval Research under the Multidisciplinary University Research Initiative [N000140710747]	Department of Energy(United States Department of Energy (DOE)); Computational Science Graduate Fellowship(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research under the Multidisciplinary University Research Initiative(MURI)	This work was supported by the Department of Energy through the Computational Science Graduate Fellowship (to Y.K.), the National Science Foundation Grant under grant numbers 0413152 and 0705677 (to M.S.L.) and the Office of Naval Research under the Multidisciplinary University Research Initiative N000140710747.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Connor CE, 2007, CURR OPIN NEUROBIOL, V17, P140, DOI 10.1016/j.conb.2007.03.002; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hurri J, 2003, NEURAL COMPUT, V15, P663, DOI 10.1162/089976603321192121; Hyvarinen A, 2001, VISION RES, V41, P2413, DOI 10.1016/S0042-6989(01)00114-6; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Yan KL, 2005, NEURAL COMPUT, V17, P397, DOI 10.1162/0899766053011474	31	141	147	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					83	U85		10.1038/nature07481	http://dx.doi.org/10.1038/nature07481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19020501				2022-12-01	WOS:000262104900035
J	Engelkes, T; Morrien, E; Verhoeven, KJF; Bezemer, TM; Biere, A; Harvey, JA; McIntyre, LM; Tamis, WLM; van der Putten, WH				Engelkes, Tim; Morrien, Elly; Verhoeven, Koen J. F.; Bezemer, T. Martijn; Biere, Arjen; Harvey, Jeffrey A.; McIntyre, Lauren M.; Tamis, Wil L. M.; van der Putten, Wim H.			Successful range-expanding plants experience less above-ground and below-ground enemy impact	NATURE			English	Article							CLIMATE-CHANGE; SOIL BIOTA; BRITISH BUTTERFLIES; NATURAL ENEMIES; INVASIVE PLANTS; FEEDBACK; HERBIVORES; RELEASE; COMMUNITIES; PATHOGENS	Many species are currently moving to higher latitudes and altitudes(1-3). However, little is known about the factors that influence the future performance of range- expanding species in their new habitats. Here we show that range- expanding plant species from a riverine area were better defended against shoot and root enemies than were related native plant species growing in the same area. We grew fifteen plant species with and without non- coevolved polyphagous locusts and cosmopolitan, polyphagous aphids. Contrary to our expectations, the locusts performed more poorly on the range- expanding plant species than on the congeneric native plant species, whereas the aphids showed no difference. The shoot herbivores reduced the biomass of the native plants more than they did that of the congeneric range expanders. Also, the range- expanding plants developed fewer pathogenic effects(4,5) in their root- zone soil than did the related native species. Current predictions forecast biodiversity loss due to limitations in the ability of species to adjust to climate warming conditions in their range(6-8). Our results strongly suggest that the plants that shift ranges towards higher latitudes and altitudes may include potential invaders, as the successful range expanders may experience less control by above- ground or below-ground enemies than the natives.	[Engelkes, Tim; Morrien, Elly; Verhoeven, Koen J. F.; Bezemer, T. Martijn; Biere, Arjen; Harvey, Jeffrey A.; van der Putten, Wim H.] Netherlands Inst Ecol, NIOO KNAW, Dept Multitroph Interact, NL-6666 ZG Heteren, Netherlands; [Bezemer, T. Martijn; van der Putten, Wim H.] Univ Wageningen & Res Ctr, Nematol Lab, NL-6700 ES Wageningen, Netherlands; [McIntyre, Lauren M.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [McIntyre, Lauren M.] Univ Florida, Dept Stat, Gainesville, FL 32610 USA; [Tamis, Wil L. M.] Natl Herbarium Nederland, Leiden Univ Branch, NL-2300 RA Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Leiden University; Leiden University - Excl LUMC	van der Putten, WH (corresponding author), Netherlands Inst Ecol, NIOO KNAW, Dept Multitroph Interact, POB 40, NL-6666 ZG Heteren, Netherlands.	w.vanderputten@nioo.knaw.nl	Bezemer, Martijn/A-4068-2009; Morrien, Elly/H-3527-2011; Biere, Arjen/B-8079-2008; Verhoeven, Koen JF/C-9920-2010; McIntyre, Lauren/J-8414-2012; van der Putten, Wim H/C-3707-2011; Harvey, Jeffrey A/B-7439-2008	Bezemer, Martijn/0000-0002-2878-3479; Morrien, Elly/0000-0002-6490-2260; Biere, Arjen/0000-0002-9006-3448; Verhoeven, Koen JF/0000-0003-3002-4102; McIntyre, Lauren/0000-0002-0077-3359; van der Putten, Wim H/0000-0002-9341-4442; Harvey, Jeffrey A/0000-0002-4227-7935	ALW-VICI	ALW-VICI	We thank Staatsbosbeheer Regio Oost for giving us permission to work in Millingerwaard; B. Ode, K. Groen, R. van Grunsven, P. Brinkman and the late R. van der Meijden for discussions; M. Houtekamer for carbon and nitrogen determination; T. Vos, M. Vlag, A. Weerheijm and W. Smant for assistance; L. Koopman for providing the locusts; and L. Young and E. J. Bakker for advice on statistics. This study was funded by an ALW-VICI grant to W.H.v.d.P.	Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Brinkhuis H, 2006, NATURE, V441, P606, DOI 10.1038/nature04692; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Levine JM, 2006, ECOL LETT, V9, P1005, DOI 10.1111/j.1461-0248.2006.00949.x; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Tamis WLM, 2005, CLIMATIC CHANGE, V72, P37, DOI 10.1007/s10584-005-5287-7; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; van der Putten WH, 2007, ECOLOGY, V88, P978, DOI 10.1890/06-1051; van der Putten WH, 2005, BIOL INVASIONS, V7, P733, DOI 10.1007/s10530-004-1196-3; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van Grunsven RHA, 2007, J ECOL, V95, P1050, DOI 10.1111/j.1365-2745.2007.01282.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	28	207	213	5	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					946	948		10.1038/nature07474	http://dx.doi.org/10.1038/nature07474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19020504				2022-12-01	WOS:000261768300044
J	Stricker, J; Cookson, S; Bennett, MR; Mather, WH; Tsimring, LS; Hasty, J				Stricker, Jesse; Cookson, Scott; Bennett, Matthew R.; Mather, William H.; Tsimring, Lev S.; Hasty, Jeff			A fast, robust and tunable synthetic gene oscillator	NATURE			English	Article							ESCHERICHIA-COLI; TOGGLE SWITCH; EXPRESSION; NETWORKS; CIRCUITS; BIOLOGY; PROTEIN; CELLS	One defining goal of synthetic biology is the development of engineering- based approaches that enable the construction of gene- regulatory networks according to 'design specifications' generated from computational modelling(1-6). This approach provides a systematic framework for exploring how a given regulatory network generates a particular phenotypic behaviour. Several fundamental gene circuits have been developed using this approach, including toggle switches(7) and oscillators(8-10), and these have been applied in new contexts such as triggered biofilm development(11) and cellular population control(12). Here we describe an engineered genetic oscillator in Escherichia coli that is fast, robust and persistent, with tunable oscillatory periods as fast as 13 min. The oscillator was designed using a previously modelled network architecture comprising linked positive and negative feedback loops(1,13). Using a microfluidic platform tailored for single- cell microscopy, we precisely control environmental conditions and monitor oscillations in individual cells through multiple cycles. Experiments reveal remarkable robustness and persistence of oscillations in the designed circuit; almost every cell exhibited large- amplitude fluorescence oscillations throughout observation runs. The oscillatory period can be tuned by altering inducer levels, temperature and the media source. Computational modelling demonstrates that the key design principle for constructing a robust oscillator is a time delay in the negative feedback loop, which can mechanistically arise from the cascade of cellular processes involved in forming a functional transcription factor. The positive feedback loop increases the robustness of the oscillations and allows for greater tunability. Examination of our refined model suggested the existence of a simplified oscillator design without positive feedback, and we construct an oscillator strain confirming this computational prediction.	[Stricker, Jesse; Cookson, Scott; Bennett, Matthew R.; Mather, William H.; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bennett, Matthew R.; Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu	Bennett, Matthew/B-3700-2008	Bennett, Matthew/0000-0002-4975-8854; Tsimring, Lev/0000-0003-0709-3548	National Institutes of Health [GM69811-01]; US Department of Defense; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bujard, C. Yang, and Z. Zhang for gifts of reagents, and D. Volfson and M. Simpson for discussions. This work was supported by grants from the National Institutes of Health (GM69811-01) and the US Department of Defense.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; BLISS RD, 1982, J THEOR BIOL, V97, P177, DOI 10.1016/0022-5193(82)90098-4; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rateitschak K, 2007, MATH BIOSCI, V205, P163, DOI 10.1016/j.mbs.2006.08.010; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	771	806	6	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					516	U39		10.1038/nature07389	http://dx.doi.org/10.1038/nature07389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18971928	Green Accepted			2022-12-01	WOS:000261170500041
J	Campbell, JE; Carmichael, GR; Chai, T; Mena-Carrasco, M; Tang, Y; Blake, DR; Blake, NJ; Vay, SA; Collatz, GJ; Baker, I; Berry, JA; Montzka, SA; Sweeney, C; Schnoor, JL; Stanier, CO				Campbell, J. E.; Carmichael, G. R.; Chai, T.; Mena-Carrasco, M.; Tang, Y.; Blake, D. R.; Blake, N. J.; Vay, S. A.; Collatz, G. J.; Baker, I.; Berry, J. A.; Montzka, S. A.; Sweeney, C.; Schnoor, J. L.; Stanier, C. O.			Photosynthetic Control of Atmospheric Carbonyl Sulfide During the Growing Season	SCIENCE			English	Article							CHEMICAL-TRANSPORT MODEL; GROSS PRIMARY PRODUCTION; ECOSYSTEM RESPIRATION; COS; EXCHANGE; FLUXES; CONSUMPTION; VEGETATION; FEEDBACKS	Climate models incorporate photosynthesis- climate feedbacks, yet we lack robust tools for large- scale assessments of these processes. Recent work suggests that carbonyl sulfide ( COS), a trace gas consumed by plants, could provide a valuable constraint on photosynthesis. Here we analyze airborne observations of COS and carbon dioxide concentrations during the growing season over North America with a three- dimensional atmospheric transport model. We successfully modeled the persistent vertical drawdown of atmospheric COS using the quantitative relation between COS and photosynthesis that has been measured in plant chamber experiments. Furthermore, this drawdown is driven by plant uptake rather than other continental and oceanic fluxes in the model. These results provide quantitative evidence that COS gradients in the continental growing season may have broad use as a measurement- based photosynthesis tracer.	[Campbell, J. E.; Schnoor, J. L.] Univ Iowa, Dept Civil & Environm Engn, Iowa City, IA 52242 USA; [Carmichael, G. R.; Tang, Y.; Stanier, C. O.] Univ Iowa, Ctr Global & Reg Environm Res, Iowa City, IA 52242 USA; [Chai, T.] Sci & Technol Corp, Hampton, VA 23666 USA; [Mena-Carrasco, M.] Univ Andres Bello, Dept Environm Engn, Santiago, Chile; [Mena-Carrasco, M.] MIT, Molina Ctr Energy & Environm, Cambridge, MA 02139 USA; [Blake, D. R.; Blake, N. J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Vay, S. A.] NASA, Langley Res Ctr, Hampton, VA 23681 USA; [Collatz, G. J.] NASA, Goddard Space Flight Ctr, Biospher Sci Branch, Greenbelt, MD 20771 USA; [Baker, I.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Berry, J. A.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Montzka, S. A.] NOAA, Earth Syst Res Lab, Global Monitoring Div, Boulder, CO 80305 USA; [Sweeney, C.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80304 USA	University of Iowa; University of Iowa; Universidad Andres Bello; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Colorado State University; Carnegie Institution for Science; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Campbell, JE (corresponding author), Univ Calif Merced, Coll Engn, Merced, CA 95344 USA.	ecampbell3@ucmerced.edu	Chai, Tianfeng/E-5577-2010; Chai, TF/I-5893-2019; Mena-Carrasco, Marcelo/L-9730-2016; montzka, stephen/V-6162-2019; Schnoor, Jerald L/B-1951-2008; Stanier, Charles O/D-4307-2016; Sweeney, Colm/AAE-9291-2019; Berry, Joseph/ABA-8496-2020; Mena-Carrasco, Marcelo/B-8483-2012; collatz, george j/D-5381-2012; Tang, Youhua/D-5205-2016	Chai, Tianfeng/0000-0003-3520-2641; Chai, TF/0000-0003-3520-2641; montzka, stephen/0000-0002-9396-0400; Stanier, Charles O/0000-0001-9924-0853; Berry, Joseph/0000-0002-5849-6438; Tang, Youhua/0000-0001-7089-7915; Mena, Marcelo/0000-0002-8847-7588; Sweeney, Colm/0000-0002-4517-0797; Blake, Donald/0000-0002-8283-5014	NASA Earth System Science Graduate Fellowship; Center for Global and Regional Environmental Research; NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program; NASA INTEX; NSF Information Technology Research; NATIONAL CANCER INSTITUTE [U54CA151662] Funding Source: NIH RePORTER	NASA Earth System Science Graduate Fellowship; Center for Global and Regional Environmental Research; NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program(National Oceanic Atmospheric Admin (NOAA) - USA); NASA INTEX; NSF Information Technology Research(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Kettle for COS flux data and C. Tebaldi, J. Dungan, T. Campbell, and D. Campbell for critical comments on the manuscript. This research was supported by a NASA Earth System Science Graduate Fellowship, Center for Global and Regional Environmental Research, NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program, NASA INTEX, and NSF Information Technology Research grants. NOAA observations of COS and CO<INF>2</INF> were made possible by the assistance of P. Tans, C. Sweeney, L. Miller, T. Conway, P. Lang, C. Siso, and B. Hall.	Blake NJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009163; Bowling DR, 2001, GLOBAL CHANGE BIOL, V7, P127, DOI 10.1046/j.1365-2486.2001.00400.x; Campbell JE, 2007, TELLUS B, V59, P199, DOI 10.1111/j.1600-0889.2006.00239.x; Carmichael GR, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003117; CHIN M, 1995, J GEOPHYS RES-ATMOS, V100, P8993, DOI 10.1029/95JD00275; Choi YH, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008899; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; CRUTZEN PJ, 1976, GEOPHYS RES LETT, V3, P73, DOI 10.1029/GL003i002p00073; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; FRANCEY RJ, 1987, NATURE, V327, P495, DOI 10.1038/327495a0; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerbig C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003770; Kettle AJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002187; Kettle AJ, 2002, ATMOS CHEM PHYS, V2, P343, DOI 10.5194/acp-2-343-2002; Kjellstrom E, 1998, J ATMOS CHEM, V29, P151, DOI 10.1023/A:1005976511096; Matross DM, 2006, TELLUS B, V58, P344, DOI 10.1111/j.1600-0889.2006.00206.x; Montzka SA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007665; Notholt J, 2003, SCIENCE, V300, P307, DOI 10.1126/science.1080320; NOTHOLT J, 2006, SPARC ASSESSMENT STR, P29; Olsen SC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003968; PROTOSCHILL-KREBS G, 1992, BOT ACTA, V105, P206, DOI 10.1111/j.1438-8677.1992.tb00288.x; ProtoschillKrebs G, 1996, ATMOS ENVIRON, V30, P3151, DOI 10.1016/1352-2310(96)00026-X; Rodgers C.D., 2000, INVERSE METHODS ATMO, P238, DOI [10.5194/amt-7-3233-2014, DOI 10.5194/AMT-7-3233-2014]; Sandoval-Soto L, 2005, BIOGEOSCIENCES, V2, P125, DOI 10.5194/bg-2-125-2005; Singh HB, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007905; Steinbacher M, 2004, ATMOS ENVIRON, V38, P6043, DOI 10.1016/j.atmosenv.2004.06.022; Suyker AE, 2005, AGR FOREST METEOROL, V131, P180, DOI 10.1016/j.agrformet.2005.05.007	30	138	142	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1085	1088		10.1126/science.1164015	http://dx.doi.org/10.1126/science.1164015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008442	Green Submitted			2022-12-01	WOS:000260867700033
J	Lampard, GR; MacAlister, CA; Bergmann, DC				Lampard, Gregory R.; MacAlister, Cora A.; Bergmann, Dominique C.			Arabidopsis Stomatal Initiation Is Controlled by MAPK-Mediated Regulation of the bHLH SPEECHLESS	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNALING PATHWAY; DIFFERENTIATION; UNCOVERS	Stomata, epidermal structures that modulate gas exchange between plants and the atmosphere, play critical roles in primary productivity and the global climate. Positively acting transcription factors and negatively acting mitogen- activated protein kinase ( MAPK) signaling control stomatal development in Arabidopsis; however, it is not known how the opposing activities of these regulators are integrated. We found that a unique domain in a basic helix- loop- helix ( bHLH) stomatal initiating factor, SPEECHLESS, renders it a MAPK phosphorylation target in vitro and modulates its function in vivo. MAPK cascades modulate a diverse set of activities including development, cell proliferation, and response to external stresses. The coupling of MAPK signaling to SPEECHLESS activity provides cell type specificity for MAPK output while allowing the integration of multiple developmental and environmental signals into the production and spacing of stomata.	[Lampard, Gregory R.; MacAlister, Cora A.; Bergmann, Dominique C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dbergmann@stanford.edu		Bergmann, Dominique/0000-0003-0873-3543; MacAlister, Cora/0000-0003-1470-0596	NSF [IOS-0544895]; U. S. Department of Energy [DE-FG02-06ER15810]; Terman award; Stanford Genome Training Program (National Human Genome Research Institute)	NSF(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); Terman award; Stanford Genome Training Program (National Human Genome Research Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank lab members for discussion and comments on the manuscript, The Carnegie Department of Plant Biology for use of microscopes, and L. Smith for identification of maize homologs. Supported by NSF grant IOS- 0544895, U. S. Department of Energy grant DE-FG02-06ER15810, a Terman award, and the Stanford Genome Training Program (National Human Genome Research Institute).	Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Joo S, 2008, PLANT J, V54, P129, DOI 10.1111/j.1365-313X.2008.03404.x; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	24	308	323	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1113	1116		10.1126/science.1162263	http://dx.doi.org/10.1126/science.1162263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008449	Green Published			2022-12-01	WOS:000260867700041
J	Saitoh, T; Fujita, N; Jang, MH; Uematsu, S; Yang, BG; Satoh, T; Omori, H; Noda, T; Yamamoto, N; Komatsu, M; Tanaka, K; Kawai, T; Tsujimura, T; Takeuchi, O; Yoshimori, T; Akira, S				Saitoh, Tatsuya; Fujita, Naonobu; Jang, Myoung Ho; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Omori, Hiroko; Noda, Takeshi; Yamamoto, Naoki; Komatsu, Masaaki; Tanaka, Keiji; Kawai, Taro; Tsujimura, Tohru; Takeuchi, Osamu; Yoshimori, Tamotsu; Akira, Shizuo			Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1 beta production	NATURE			English	Article							GENOME-WIDE ASSOCIATION; IMMUNE ACTIVATION; CROHN-DISEASE; INNATE; MACROPHAGES; CELLS; INFLAMMASOME; RECOGNITION; RECEPTORS; MEMBRANE	Systems for protein degradation are essential for tight control of the inflammatory immune response(1,2). Autophagy, a bulk degradation system that delivers cytoplasmic constituents into autolysosomes, controls degradation of long- lived proteins, insoluble protein aggregates and invading microbes, and is suggested to be involved in the regulation of inflammation(3-5). However, the mechanism underlying the regulation of inflammatory response by autophagy is poorly understood. Here we show that Atg16L1 ( autophagy-related 16-like 1), which is implicated in Crohn's disease(6,7), regulates endotoxin- induced inflammasome activation in mice. Atg16L1- deficiency disrupts the recruitment of the Atg12-Atg5 conjugate to the isolation membrane, resulting in a loss of microtubule- associated protein 1 light chain 3 ( LC3) conjugation to phosphatidylethanolamine. Consequently, both autophagosome formation and degradation of long- lived proteins are severely impaired in Atg16L1- deficient cells. Following stimulation with lipopolysaccharide, a ligand for Toll- like receptor 4 ( refs 8, 9), Atg16L1- deficient macrophages produce high amounts of the inflammatory cytokines IL-1 beta and IL-18. In lipopolysaccharide-stimulated macrophages, Atg16L1- deficiency causes Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta ( TRIF)dependent activation of caspase- 1, leading to increased production of IL-1 beta. Mice lacking Atg16L1 in haematopoietic cells are highly susceptible to dextran sulphate sodium- induced acute colitis, which is alleviated by injection of anti-IL-1 beta and IL-18 antibodies, indicating the importance of Atg16L1 in the suppression of intestinal inflammation. These results demonstrate that Atg16L1 is an essential component of the autophagic machinery responsible for control of the endotoxin- induced inflammatory immune response.	[Saitoh, Tatsuya; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Jang, Myoung Ho] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Gastrointestinal Immunol, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; [Fujita, Naonobu; Omori, Hiroko; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Res Inst Microbial Dis, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Yamamoto, Naoki] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Komatsu, Masaaki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Yoshimori, Tamotsu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Osaka University; Osaka University; National Institute of Infectious Diseases (NIID); Tokyo Metropolitan Institute of Medical Science; Juntendo University; Japan Science & Technology Agency (JST); Hyogo College of Medicine; Japan Science & Technology Agency (JST)	Akira, S (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	akira@biken.osaka-u.ac.jp	Fujita, Naonobu/A-1218-2010; Takeuchi, Osamu/D-6007-2011; Komatsu, Masaaki/B-8321-2011; Akira, Shizuo/C-3134-2009; Noda, Takeshi/B-7240-2008; Takeuchi, Osamu/AAG-9359-2019; surname, name s/A-2183-2010; Jang, Myoung Ho/D-1714-2009	Komatsu, Masaaki/0000-0001-7672-7722; Noda, Takeshi/0000-0003-3581-7961; Takeuchi, Osamu/0000-0002-1260-6232; Jang, Myoung Ho/0000-0001-8909-4725; Kawai, Taro/0000-0001-7510-4662; Fujita, Naonobu/0000-0003-1914-8438; Yang, Bo-Gie/0000-0002-1538-8488	NIH [AI070167]; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to T. Kitamura, S. Yamaoka and N. Mizushima for providing materials. We thank K. J. Ishii, M. Yamamoto and members of the Laboratory of Host Defense for discussions; Y. Fujiwara, M. Shiokawa, R. Nakayama and N. Kitagaki for technical assistance; and M. Hashimoto and E. Kamada for secretarial assistance. This work was in part supported by grants from NIH (AI070167) and the Ministry of Health, Labour and Welfare of Japan, and by Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Ishikura T, 2003, J GASTROEN HEPATOL, V18, P960, DOI 10.1046/j.1440-1746.2003.03097.x; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	31	1533	1608	3	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					264	U68		10.1038/nature07383	http://dx.doi.org/10.1038/nature07383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849965				2022-12-01	WOS:000261039300045
J	Penna, A; Demuro, A; Yeromin, AV; Zhang, SYL; Safrina, O; Parker, I; Cahalan, MD				Penna, Aubin; Demuro, Angelo; Yeromin, Andriy V.; Zhang, Shenyuan L.; Safrina, Olga; Parker, Ian; Cahalan, Michael D.			The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers	NATURE			English	Article							CA2+ SENSOR; STORE; SUBUNIT; ARCHITECTURE; PROTEIN; PORE	Ca2+-release- activated Ca2+ (CRAC) channels underlie sustained Ca2+ signalling in lymphocytes and numerous other cells after Ca2+ liberation from the endoplasmic reticulum (ER). RNA interference screening approaches identified two proteins, Stim(1,2) and Orai(3-5), that together form the molecular basis for CRAC channel activity(6,7). Stim senses depletion of the ER Ca2+ store and physically relays this information by translocating from the ER to junctions adjacent to the plasma membrane(1,8,9), and Orai embodies the pore of the plasma membrane calcium channel(10-12). A close interaction between Stim and Orai, identified by co-immunoprecipitation(12) and by Forster resonance energy transfer(13), is involved in the opening of the Ca2+ channel formed by Orai subunits. Most ion channels are multimers of pore- forming subunits surrounding a central channel, which are preassembled in the ER and transported in their final stoichiometry to the plasma membrane. Here we show, by biochemical analysis after cross- linking in cell lysates and intact cells and by using non- denaturing gel electrophoresis without cross- linking, that Orai is predominantly a dimer in the plasma membrane under resting conditions. Moreover, single- molecule imaging of green fluorescent protein (GFP)- tagged Orai expressed in Xenopus oocytes showed predominantly two- step photobleaching, again consistent with a dimeric basal state. In contrast, co- expression of GFP- tagged Orai with the carboxy terminus of Stim as a cytosolic protein to activate the Orai channel without inducing Ca2+ store depletion or clustering of Orai into punctae yielded mostly four- step photobleaching, consistent with a tetrameric stoichiometry of the active Orai channel. Interaction with the C terminus of Stim thus induces Orai dimers to dimerize, forming tetramers that constitute the Ca2+-selective pore. This represents a new mechanism in which assembly and activation of the functional ion channel are mediated by the same triggering molecule.	[Penna, Aubin; Yeromin, Andriy V.; Zhang, Shenyuan L.; Safrina, Olga; Parker, Ian; Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Cahalan, Michael D.] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu	penna, aubin/AAD-2550-2019; PENNA, aubin/E-2208-2018	penna, aubin/0000-0002-1070-5990; PENNA, aubin/0000-0002-1070-5990	National Institutes of Health; George E. Hewitt Foundation; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George E. Hewitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Forrest for assistance in cell culture; T. Holmes and S. Leverrier for discussion during the course of the study; A. Amcheslavsky, A. Froger, K. Kalman and K. Cahalan for help with oocytes; W. Jiang for assistance in some of the co-immunoprecipitation experiments; M. Ramjeesingh for help with the PFO-PAGE technique; F.-A. Rassendren for the P2X2 construct; and E. Isacoff and M. Ulbrich for discussion and help during a pilot photobleaching study. This work was supported by grants from the National Institutes of Health (M.D.C. and I.P.) and by a fellowship from the George E. Hewitt Foundation (A.P.).	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Dargan Sheila L., 2006, V322, P103; Demuro A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846074; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nielsen PA, 2002, J BIOL CHEM, V277, P38272, DOI 10.1074/jbc.M205348200; PARKER I, 1985, PROC R SOC SER B-BIO, V223, P279, DOI 10.1098/rspb.1985.0002; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Raab-Graham KF, 1998, J BIOL CHEM, V273, P19699, DOI 10.1074/jbc.273.31.19699; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	31	294	305	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					116	U12		10.1038/nature07338	http://dx.doi.org/10.1038/nature07338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18820677	Green Accepted, Green Submitted			2022-12-01	WOS:000260674000052
J	Cormie, PJ; Nairn, M; Welsh, J				Cormie, P. J.; Nairn, M.; Welsh, J.		Guideline Dev Grp	Control of pain in adults with cancer: summary of SIGN guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VALIDATION; RELIEF; SCALE		[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Cormie, P. J.] Stow Hlth Ctr, Stow TD1 2SQ, Galashiels, Scotland; [Welsh, J.] Univ Glasgow, Fac Med, Div Canc Sci, Glasgow, Lanark, Scotland; [Welsh, J.] Beatson W Scotland Canc Ctr, Glasgow G12 0YN, Lanark, Scotland	University of Glasgow; Beatson Oncology Centre	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Nairn, Moray/0000-0001-6474-4410; Colvin, Lesley/0000-0002-1563-8600; Mair, Jane/0000-0001-6617-0203				Caraceni A, 2002, J PAIN SYMPTOM MANAG, V23, P239, DOI 10.1016/S0885-3924(01)00409-2; DUAT R, 1983, PAIN, V17, P197; LARUE F, 1995, BRIT MED J, V310, P1034, DOI 10.1136/bmj.310.6986.1034; Launay-Vacher V, 2005, J PAIN, V6, P137, DOI 10.1016/j.jpain.2004.11.009; Mercadante S, 2004, J PAIN, V5, P2, DOI 10.1016/j.jpain.2003.09.007; Pautex S, 2005, J GERONTOL A-BIOL, V60, P524, DOI 10.1093/gerona/60.4.524; PORTENOY RK, 1989, CANCER, V63, P2298, DOI 10.1002/1097-0142(19890601)63:11<2298::AID-CNCR2820631140>3.0.CO;2-A; Scottish Intercollegiate Guidelines Network (SIGN), 2008, 106 SIGN; VENTAFRIDDA V, 1987, CANCER, V59, P850, DOI 10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1; Walker J, 2007, J PSYCHOSOM RES, V63, P83, DOI 10.1016/j.jpsychores.2007.01.009; World Health Organization, 1996, CANC PAIN REL; ZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M; Zwakhalen Sandra M G, 2006, BMC Geriatr, V6, P3, DOI 10.1186/1471-2318-6-3	13	23	23	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2008	337								a2154	10.1136/bmj.a2154	http://dx.doi.org/10.1136/bmj.a2154			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FB	18987038				2022-12-01	WOS:000261236000002
J	Sanz-Moreno, V; Gadea, G; Ahn, J; Paterson, H; Marra, P; Pinner, S; Sahai, E; Marshall, CJ				Sanz-Moreno, Victoria; Gadea, Gilles; Ahn, Jessica; Paterson, Hugh; Marra, Pierfrancesco; Pinner, Sophie; Sahai, Erik; Marshall, Christopher J.			Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement	CELL			English	Article							PRESENILIN-BINDING-PROTEIN; PERICELLULAR PROTEOLYSIS; ARP2/3 COMPLEX; CANCER-CELLS; RHO-GTPASES; MIGRATION; INVASION; KINASE; PHOSPHORYLATION; METASTASIS	Tumor cells exhibit two different modes of individual cell movement. Mesenchymal-type movement is characterized by an elongated cellular morphology and requires extracellular proteolysis. In amoeboid movement, cells have a rounded morphology, are less dependent on proteases, and require high Rho-kinase signaling to drive elevated levels of actomyosin contractility. These two modes of cell movement are interconvertible. We show that mesenchymal-type movement in melanoma cells is driven by activation of the GTPase Rac through a complex containing NEDD9, a recently identified melanoma metastasis gene, and DOCK3, a Rac guanine nucleotide exchange factor. Rac signals through WAVE2 to direct mesenchymal movement and suppress amoeboid movement through decreasing actomyosin contractility. Conversely, in amoeboid movement, Rho-kinase signaling activates a Rac GAP, ARH-GAP22, that suppresses mesenchymal movement by inactivating Rac. We demonstrate tight interplay between Rho and Rac in determining different modes of tumor cell movement, revealing how tumor cells switch between different modes of movement.	[Sanz-Moreno, Victoria; Gadea, Gilles; Ahn, Jessica; Paterson, Hugh; Marra, Pierfrancesco; Marshall, Christopher J.] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; [Pinner, Sophie; Sahai, Erik] London Res Inst Canc Res UK, Tumor Cell Biol Lab, London WC2A 3PX, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK	Marshall, CJ (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.	chris.marshall@icr.ac.uk	Gilles, Gadea/M-9966-2015; Acton, Sophie/G-9784-2012	Gilles, Gadea/0000-0001-6325-4866; Acton, Sophie/0000-0003-2704-716X; Sanz-Moreno, Victoria/0000-0002-5096-9456; Sahai, Erik/0000-0002-3932-5086	Cancer Research UK; European Union	Cancer Research UK(Cancer Research UK); European Union(European Commission)	This work was supported by Cancer Research UK and the European Union. V. S. M. is a Marie Curie Intra-European Fellow, and C.J.M. a Cancer Research UK Gibb Fellow. We thank Demelza Bird for technical help, Annette Self for technical advice, Imanol Arozarena, Richard Marais, Mike Olson, and David Schubert for reagents, and Clare Isacke, Pascal Peschard, and Anna Peyker for helpful comments.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Croft DR, 2006, METHOD ENZYMOL, V406, P541, DOI 10.1016/S0076-6879(06)06042-3; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Namekata K, 2002, J NEUROCHEM, V82, P819, DOI 10.1046/j.1471-4159.2002.01039.x; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; ROSAI M, 2004, ROSAI ACKERMANS SURG, P166; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2003, MOL CELL BIOL, V23, P3079, DOI 10.1128/MCB.23.9.3079-3090.2003; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Tsuji K, 2006, CANCER RES, V66, P303, DOI 10.1158/0008-5472.CAN-05-2958; Wang WG, 2002, CANCER RES, V62, P6278; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	38	692	706	1	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					510	523		10.1016/j.cell.2008.09.043	http://dx.doi.org/10.1016/j.cell.2008.09.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984162	Bronze			2022-12-01	WOS:000260536300021
J	Yang, FC; Ingram, DA; Chen, S; Zhu, Y; Yuan, J; Li, XH; Yang, XL; Knowles, S; Horn, W; Li, Y; Zhang, SB; Yang, YZ; Vakili, ST; Yu, MG; Burns, D; Robertson, K; Hutchins, G; Parada, LF; Clapp, DW				Yang, Feng-Chun; Ingram, David A.; Chen, Shi; Zhu, Yuan; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Knowles, Scott; Horn, Whitney; Li, Yan; Zhang, Shaobo; Yang, Yanzhu; Vakili, Saeed T.; Yu, Menggang; Burns, Dennis; Robertson, Kent; Hutchins, Gary; Parada, Luis F.; Clapp, D. Wade			Nf1-Dependent Tumors Require a Microenvironment Containing Nf1(+/-) and c-kit-Dependent Bone Marrow	CELL			English	Article							MAST-CELLS; GROWTH-FACTOR; NEUROFIBROMATOSIS TYPE-1; GENE-PRODUCT; IN-VIVO; RECEPTOR; CANCER; NF1; CARCINOGENESIS; PROLIFERATION	Interactions between tumorigenic cells and their surrounding microenvironment are critical for tumor progression yet remain incompletely understood. Germline mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1 (NF1), a common genetic disorder characterized by complex tumors called neurofibromas. Genetic studies indicate that biallelic loss of Nf1 is required in the tumorigenic cell of origin in the embryonic Schwann cell lineage. However, in the physiologic state, Schwann cell loss of heterozygosity is not sufficient for neurofibroma formation and Nf1 haploinsufficiency in at least one additional nonneoplastic lineage is required for tumor progression. Here, we establish that Nf1 heterozygosity of bone marrow-derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell Nf1 deficiency. Further, genetic or pharmacologic attenuation of c-kit signaling in Nf1(+/-) hematopoietic cells diminishes neurofibroma initiation and progression. Finally, these studies implicate mast cells as critical mediators of tumor initiation.	[Zhu, Yuan; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Yang, Feng-Chun; Chen, Shi; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Knowles, Scott; Horn, Whitney; Li, Yan; Yang, Yanzhu; Robertson, Kent; Clapp, D. Wade] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Ingram, David A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hutchins, Gary] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA; [Clapp, D. Wade] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zhang, Shaobo; Vakili, Saeed T.] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Yu, Menggang] Indiana Univ, Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Yang, Feng-Chun; Ingram, David A.; Chen, Shi; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Li, Yan; Yang, Yanzhu; Robertson, Kent; Clapp, D. Wade] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Burns, Dennis] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu; dclapp@iupui.edu	Zhu, Yuan/ABF-8405-2020; Knowles, Scott/F-8197-2015; Parada, luis F/B-9400-2014		Department of Defense [NF020026]; P50 Center of Excellence in Neurofibromatosis [P50 NS 052606]; NCI-MMHC; Anna Fuller Foundation;  [R01 CA74177]; NATIONAL CANCER INSTITUTE [R01CA074177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS052606] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); P50 Center of Excellence in Neurofibromatosis; NCI-MMHC; Anna Fuller Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Department of Defense (NF020026) to D. W. C. and L.F.P., a P50 Center of Excellence in Neurofibromatosis P50 NS 052606 (L.F.P., D.W.C., F.C.Y., D.A.I., and G.H.) and R01 CA74177 to D.W.C.L.F.P. is an American Cancer Society Professor and also acknowledges support from the NCI-MMHC. Novartis supplied imatinib mesylate to D.W.C. for these studies. The work was also supported by the Anna Fuller Foundation.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; CHANG TL, 1993, PEDIATR DERMATOL, V10, P224, DOI 10.1111/j.1525-1470.1993.tb00366.x; CLAPP DW, 1995, BLOOD, V86, P2113, DOI 10.1182/blood.V86.6.2113.bloodjournal8662113; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; GALLI SJ, 1993, AM J PATHOL, V142, P965; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haneline LS, 1999, BLOOD, V94, P1; Hiatt K, 2004, AM J PATHOL, V164, P1471, DOI 10.1016/S0002-9440(10)63233-6; HIROTA S, 1993, ARCH PATHOL LAB MED, V117, P996; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KACINSKI BM, 1995, ANN MED, V27, P79, DOI 10.3109/07853899509031941; Li F, 2006, HUM MOL GENET, V15, P1921, DOI 10.1093/hmg/ddl114; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mashour GA, 2004, CLIN CANCER RES, V10, P5677, DOI 10.1158/1078-0432.CCR-03-0769; Munchhof AM, 2006, HUM MOL GENET, V15, P1858, DOI 10.1093/hmg/ddl108; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; RYAN JJ, 1994, J NEUROSCI RES, V37, P415, DOI 10.1002/jnr.490370314; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Tay YK, 1998, DERMATOLOGY, V197, P401, DOI 10.1159/000018046; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yang FC, 2006, HUM MOL GENET, V15, P2421, DOI 10.1093/hmg/ddl165; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	33	242	266	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					437	448		10.1016/j.cell.2008.08.041	http://dx.doi.org/10.1016/j.cell.2008.08.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984156	Green Accepted, Bronze			2022-12-01	WOS:000260536300015
J	White, MA; Eykelenboom, JK; Lopez-Vernaza, MA; Wilson, E; Leach, DRF				White, Martin A.; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; Wilson, Emily; Leach, David R. F.			Non-random segregation of sister chromosomes in Escherichia coli	NATURE			English	Article							SEPARATE CELL HALVES; IMMORTAL STRAND HYPOTHESIS; BACTERIAL CHROMOSOME; DNA-POLYMERASE; STEM-CELLS; REPLICATION; ORGANIZATION; REGION; ARMS; MREB	It has long been known that the 59 to 39 polarity of DNA synthesis results in both a leading and lagging strand at all replication forks(1). Until now, however, there has been no evidence that leading or lagging strands are spatially organized in any way within a cell. Here we show that chromosome segregation in Escherichia coli is not random but is driven in a manner that results in the leading and lagging strands being addressed to particular cellular destinations. These destinations are consistent with the known patterns of chromosome segregation(2,3). Our work demonstrates a new level of organization relating to the replication and segregation of the E. coli chromosome.	[White, Martin A.; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; Wilson, Emily; Leach, David R. F.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Leach, DRF (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	D.Leach@ed.ac.uk	Leach, David R/H-7159-2012	Leach, David R/0000-0003-4964-6913; Lopez Vernaza, Manuel Augusto/0000-0002-9542-7028; Eykelenboom, John/0000-0003-4115-9686; White, Martin/0000-0001-6482-8462	Medical Research Council; MRC [G0401313] Funding Source: UKRI; Medical Research Council [G0401313] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Sherratt for the gifts of plasmids pWX6, pLau43 and pLau44. We also thank E. Darmon and J. Blackwood for reading the manuscript. This work was supported by the Medical Research Council.	CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Darmon E, 2007, J BACTERIOL, V189, P6686, DOI 10.1128/JB.00489-07; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Karczmarek A, 2007, MOL MICROBIOL, V65, P51, DOI 10.1111/j.1365-2958.2007.05777.x; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lew DJ, 2008, CELL, V133, P21, DOI 10.1016/j.cell.2008.03.016; MASON DJ, 1956, J BACTERIOL, V71, P474, DOI 10.1128/JB.71.4.474-479.1956; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Niki H, 2000, GENE DEV, V14, P212; Pinder DJ, 1998, MOL MICROBIOL, V28, P719, DOI 10.1046/j.1365-2958.1998.00831.x; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Rocha EPC, 2003, MOL MICROBIOL, V49, P895, DOI 10.1046/j.1365-2958.2003.03606.x; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; SKARSTAD K, 1993, J BACTERIOL, V175, P5505, DOI 10.1128/JB.175.17.5505-5509.1993; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Woldringh CL, 2006, J STRUCT BIOL, V156, P273, DOI 10.1016/j.jsb.2006.04.013; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	30	58	58	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1248	1250		10.1038/nature07282	http://dx.doi.org/10.1038/nature07282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972020				2022-12-01	WOS:000260462100046
J	Bercovich, D; Ganmore, I; Scott, LM; Wainreb, G; Birger, Y; Elimelech, A; Chen, SC; Cazzaniga, G; Biondi, A; Basso, G; Cario, G; Schrappe, M; Stanulla, M; Strehl, S; Haas, OA; Mann, G; Binder, V; Borkhardt, A; Kempski, H; Trka, J; Bielorei, B; Avigad, S; Stark, B; Smith, O; Dastugue, N; Bourquin, JP; Ben Tal, N; Green, AR; Izraeli, S				Bercovich, Dani; Ganmore, Ithamar; Scott, Linda M.; Wainreb, Gilad; Birger, Yehudit; Elimelech, Arava; Chen, Shochat; Cazzaniga, Giovanni; Biondi, Andrea; Basso, Giuseppe; Cario, Gunnar; Schrappe, Martin; Stanulla, Martin; Strehl, Sabine; Haas, Oskar A.; Mann, Georg; Binder, Vera; Borkhardt, Arndt; Kempski, Helena; Trka, Jan; Bielorei, Bella; Avigad, Smadar; Stark, Batia; Smith, Owen; Dastugue, Nicole; Bourquin, Jean-Pierre; Ben Tal, Nir; Green, Anthony R.; Izraeli, Shai			Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome	LANCET			English	Article							MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; MEGAKARYOBLASTIC LEUKEMIA; ACQUIRED MUTATIONS; GATA1; EXPRESSION; CHILDREN; RECEPTOR	Background Children with Down's syndrome have a greatly increased risk of acute megakaryoblastic and acute lymphoblastic leukaemias. Acute megakaryoblastic leukaemia in Down's syndrome is characterised by a somatic mutation in GATA1. Constitutive activation of the JAK/STAT (Janus kinase and signal transducer and activator of transcription) pathway occurs in several haematopoietic malignant diseases. We tested the hypothesis that mutations in JAK2 might be a common molecular event in acute lymphoblastic leukaemia associated with Down's syndrome. Methods JAK2 DNA mutational analysis was done on diagnostic bone marrow samples obtained from 88 patients with Down's syndrome-associated acute lymphoblastic: leukaemia; and 216 patients with sporadic acute lymphoblastic: leukaemia, Down's syndrome-associated acute megakaryoblastic leukaemia, and essential thrombocythaemia. Functional consequences of identified mutations were studied in mouse haematopoietic progenitor cells. Findings Somatically acquired JAK2 mutations were identified in 16 (18%) patients with Down's syndrome-associated acute lymphoblastic leukaemia. The only patient with non-Down's syndrome-associated leukaemia but with a JAK2 mutation had an isochromosome 21q. Children with a JAK2 mutation were younger (mean [SE] age 4.5 years [0 . 86] vs 8.6 years [0 . 59], p<0 . 0001) at diagnosis. Five mutant alleles were identified, each affecting a highly conserved arginine residue (R683). These mutations immortalised primary mouse haematopoietic progenitor cells in vitro, and caused constitutive Jak/Stat activation and cytokine-independent growth of BaF3 cells, which was sensitive to pharmacological inhibition with JAK inhibitor 1. In modelling studies of the JAK2 pseudokinase domain, R683 was situated in an exposed conserved region separated from the one implicated in myeloproliferative disorders. Interpretation A specific genotype- phenotype association exists between the type of somatic mutation within the JAK2 pseudokinase domain and the development of B-lymphoid or myeloid neoplasms. Somatically acquired R683 JAK2 mutations define a distinct acute lymphoblastic leukaemia subgroup that is uniquely associated with trisomy 21. JAK2 inhibitors could be useful for treatment of this leukaemia. Funding Israel Trade Ministry, Israel Science Ministry, Jewish National Fund UK, Sam Waxman Cancer Research Foundation, Israel Science Foundation, Israel Cancer Association, Curtis Katz, Constantiner Institute for Molecular Genetics, German-Israel Foundation, and European Commission FP6 Integrated Project EUROHEAR.	[Ganmore, Ithamar; Birger, Yehudit; Bielorei, Bella; Izraeli, Shai] Chaim Sheba Med Ctr, Dept Paediat Haematol Oncol, IL-52621 Tel Hashomer, Israel; [Ganmore, Ithamar; Birger, Yehudit; Bielorei, Bella; Izraeli, Shai] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Bercovich, Dani; Elimelech, Arava; Chen, Shochat] Migal Galilee Biotechnol Ctr, Human Mol Genet & Pharmacogenet Lab, Kiryat Shmona, Israel; [Bercovich, Dani; Elimelech, Arava; Chen, Shochat] Tel Hai Acad Coll, Tel Hai, Israel; [Wainreb, Gilad; Ben Tal, Nir] Tel Aviv Univ, Dept Biochem, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Scott, Linda M.; Green, Anthony R.] Cambridge Inst Med Res, Cambridge, England; [Cazzaniga, Giovanni; Biondi, Andrea] Univ Milano Bicocca, Hosp San Gerardo, Res Ctr Tettamanti, Paediat Clin, Monza, Italy; [Basso, Giuseppe] Univ Padua, Dept Paediat, Lab Oncohaematol, Padua, Italy; [Cario, Gunnar; Schrappe, Martin] Univ Hosp Schleswig Holstein, Dept Paediat, Kiel, Germany; [Stanulla, Martin] Hannover Med Sch, Dept Paediat Haematol & Oncol, D-3000 Hannover, Germany; [Strehl, Sabine; Haas, Oskar A.; Mann, Georg] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Binder, Vera; Borkhardt, Arndt] Univ Dusseldorf, Clin Paediat Oncol Haematol & Clin Immunol, Childrens Univ Hosp, Dusseldorf, Germany; [Kempski, Helena] Great Ormond St Hosp Sick Children, Inst Child Hlth, London WC1N 3JH, England; [Trka, Jan] Charles Univ Prague, Sch Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Trka, Jan] Univ Hosp Motol, Motol, Czech Republic; [Avigad, Smadar; Stark, Batia] Schneider Childrens Hosp, Dept Paediat Haematooncol, Petah Tiqwa, Israel; [Smith, Owen] Univ Dublin Trinity Coll, Dept Haematol, Dublin 2, Ireland; [Dastugue, Nicole] Univ Hosp Ctr Toulouse, Toulouse, France; [Bourquin, Jean-Pierre] Univ Zurich, Dept Paediat Oncol, Univ Childrens Hosp, Zurich, Switzerland	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Hai Academy College; Tel Aviv University; University of Cambridge; University of Milano-Bicocca; University of Padua; University of Kiel; Schleswig Holstein University Hospital; Hannover Medical School; Saint Anna Children's Hospital; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Charles University Prague; Motol University Hospital; Trinity College Dublin; CHU de Toulouse; University Children's Hospital Zurich; University of Zurich	Izraeli, S (corresponding author), Chaim Sheba Med Ctr, Dept Paediat Haematol Oncol, IL-52621 Tel Hashomer, Israel.	sizraeli@sheba.health.gov.il	Smith, Owen/AAU-8929-2020; Bourquin, Jean-Pierre/C-2802-2011; Haas, Oskar/AAM-5794-2020; Stanulla, Martin/D-2528-2010; Binder, Vera/N-2078-2015; Scott, Linda/D-9777-2012; Biondi, Andrea/K-9997-2016; Stanulla, Martin/N-4674-2017; Trka, Jan/Y-4820-2019; Schrappe, Martin/ABA-6144-2020; Biondi, Andrea/AAX-1865-2020; Cario, Gunnar/D-2535-2010; Schrappe, Martin/A-8109-2010; Cazzaniga, Giovanni/K-6338-2016	Bourquin, Jean-Pierre/0000-0001-6571-6227; Scott, Linda/0000-0003-0334-1479; Stanulla, Martin/0000-0002-3834-0727; Biondi, Andrea/0000-0002-6757-6173; BASSO, GIUSEPPE/0000-0002-2634-9302; Green, Anthony/0000-0002-9795-0218; Cazzaniga, Giovanni/0000-0003-2955-4528; Ben-Tal, Nir/0000-0001-6901-832X; Strehl, Sabine/0000-0002-0179-0628	Israel Trade Ministry; Israel Science Ministry; Jewish National Fund UK; Sam Waxman Cancer Research Foundation; Israel Science Foundation; Israel Cancer Association; Constantiner Institute for Molecular Genetics; German-Israel Foundation; European Commission FP6 Integrated Project EURCHEAR [LSHG-CT-20054-512063]; Cancer Research UK [8961] Funding Source: researchfish; Medical Research Council [G0300723B] Funding Source: researchfish	Israel Trade Ministry; Israel Science Ministry; Jewish National Fund UK; Sam Waxman Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Constantiner Institute for Molecular Genetics; German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); European Commission FP6 Integrated Project EURCHEAR(European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is an international BFM study. This study has been done as part fulfilment of the requirement for a PhD degree by IG at the Faculty ofmedicine, Tel-Aviv University. We thank Wei Tong, Drorit Neuman, Connie Eavs, and James Griffin for the gifts of reagents; and Inna Muler, Cohava Cohen, Gil Smooha, Nir Gefen, Itamar Goldstein, and Dasa Janousek for their assistance. This study was partly funded by grants from Israel Trade Ministry (to DB) and Israel Science Ministry, Jewish National Fund UK, Sam Waxman Cancer Research Foundation, Israel Science Foundation, Israel Cancer Association (to S I), Curtis Katz (to SI), Constantiner Institute for Molecular Genetics (to IG), and German-Israel Foundation (to Sl and AB). NBT received support from the European Commission FP6 Integrated Project EURCHEAR, LSHG-CT-20054-512063.	Bercovich D, 2003, GENET TEST, V7, P189, DOI 10.1089/109065703322537197; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Forestier E, 2008, BLOOD, V111, P1575, DOI 10.1182/blood-2007-09-114231; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Groet J, 2003, LANCET, V361, P1617, DOI 10.1016/S0140-6736(03)13266-7; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Izraeli S, 2007, BLOOD CELL MOL DIS, V39, P156, DOI 10.1016/j.bcmd.2007.04.004; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Norton A, 2007, BLOOD, V110, P1077, DOI 10.1182/blood-2007-03-080374; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; PRIEST JH, 1988, HUM GENET, V81, P1, DOI 10.1007/BF00283718; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Vyas P, 2006, EARLY HUM DEV, V82, P767, DOI 10.1016/j.earlhumdev.2006.09.016; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Whitlock JA, 2005, BLOOD, V106, P4043, DOI 10.1182/blood-2003-10-3446	29	249	253	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1484	1492		10.1016/S0140-6736(08)61341-0	http://dx.doi.org/10.1016/S0140-6736(08)61341-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18805579				2022-12-01	WOS:000260801300025
J	Perrotta, S; Gallagher, PG; Mohandas, N				Perrotta, Silverio; Gallagher, Patrick G.; Mohandas, Narla			Hereditary spherocytosis	LANCET			English	Review							RED-CELL SKELETON; INCREASED OSMOTIC FRAGILITY; ANEMIA TYPE-II; BAND-3 DEFICIENCY; ANKYRIN GENE; SUBTOTAL SPLENECTOMY; SPECTRIN DEFICIENCY; FRAMESHIFT MUTATION; HEMOLYTIC-ANEMIA; MOLECULAR-BASIS	Hereditary spherocytosis is a common inherited disorder that is characterised by anaemia, jaundice, and splenomegaly. It is reported worldwide and is the most common inherited anaemia in individuals of northern European ancestry. Clinical severity is variable with most patients having a well-compensated haemolytic anaemia. Some individuals are asymptomatic, whereas others have severe haemolytic anaemia requiring erythrocyte transfusion. The primary lesion in hereditary spherocytosis is loss of membrane surface area, leading to reduced deformability due to defects in the membrane proteins ankyrin, band 3, beta spectrin, alpha spectrin, or protein 4.2. Many isolated mutations have been identified in the genes encoding these membrane proteins; common hereditary spherocytosis-associated mutations have not been identified. Abnormal spherocytes are trapped and destroyed in the spleen and this is the main cause of haemolysis in this disorder. Common complications are cholelithiasis, haemolytic episodes, and aplastic crises. Splenectomy is curative but should be undertaken only after careful assessment of the risks and benefits.	[Perrotta, Silverio] Univ Naples 2, Dipartimento Pediat, I-80138 Naples, Italy; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10021 USA	Universita della Campania Vanvitelli; Yale University; New York Blood Center	Perrotta, S (corresponding author), Univ Naples 2, Dipartimento Pediat, Via S Andrea Dame 4, I-80138 Naples, Italy.	silverio.perrotta@unina2.it		Perrotta, Silverio/0000-0001-6149-6845	Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania [LR 5/02, 2005, DK62039, HK65488, DK26263]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062039, R01DK026263, R37DK026263] Funding Source: NIH RePORTER	Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was partly provided by grants from Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania (LR 5/02, 2005) to SP, DK62039 and HK65488 to PGG, and DK26263 to NM.	AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1986, NEW ENGL J MED, V315, P1579, DOI 10.1056/NEJM198612183152504; Akar N, 2002, PEDIATR HEMAT ONCOL, V19, P569, DOI 10.1080/08880010290097431; Alloisio N, 1997, BLOOD, V90, P414; Alloisio N, 1996, BLOOD, V88, P1062; An XL, 2007, BLOOD, V109, P1284, DOI 10.1182/blood-2006-07-036954; Bader-Meunier B, 2001, BLOOD, V97, P399, DOI 10.1182/blood.V97.2.399; Balaguer EJ, 2006, J SURG RES, V134, P68, DOI 10.1016/j.jss.2006.02.053; BECKER PS, 1993, J CLIN INVEST, V92, P612, DOI 10.1172/JCI116628; Bellows CF, 2005, AM FAM PHYSICIAN, V72, P637; Berardi A, 2006, BIOL NEONATE, V90, P243, DOI 10.1159/000093668; Boguslawska DM, 2004, ANN HEMATOL, V83, P28, DOI 10.1007/s00277-003-0739-5; Bolton-Maggs PHB, 2004, BRIT J HAEMATOL, V126, P455, DOI 10.1111/j.1365-2141.2004.05052.x; BOUHASSIRA EE, 1992, BLOOD, V79, P1846; Bracher NA, 2001, BRIT J HAEMATOL, V113, P689, DOI 10.1046/j.1365-2141.2001.02800.x; Brown KE, 2000, BEST PRACT RES CL HA, V13, P245, DOI 10.1053/beha.1999.0071; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; Calhoun SK, 2001, PEDIATR RADIOL, V31, P879, DOI 10.1007/s002470100011; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; Cartron JP, 2001, LANCET, pS57, DOI 10.1016/S0140-6736(01)07069-6; Castagnola E, 2003, EUR J HAEMATOL, V71, P319, DOI 10.1034/j.1600-0609.2003.00158.x; Caterino M, 2006, FEBS LETT, V580, P6527, DOI 10.1016/j.febslet.2006.10.070; Cavill I, 1996, BRIT MED J, V312, P430; CHASIS JA, 1988, J CLIN INVEST, V82, P617, DOI 10.1172/JCI113640; Cherif-Zahar B, 1998, BLOOD, V92, P2535, DOI 10.1182/blood.V92.7.2535.2535_2535_2540; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; Curro G, 2006, SURG ENDOSC, V20, P252, DOI 10.1007/s00464-005-0318-z; Cynober T, 1996, J LAB CLIN MED, V128, P259, DOI 10.1016/S0022-2143(96)90027-X; Da Costa L, 2001, BLOOD, V98, P2894, DOI 10.1182/blood.V98.10.2894; DACIE J, 1985, HAEMOLYTIC ANAEMIA, P134; Dacie JV, 1991, PRACTICAL HAEMATOLOG, P195; Danise P, 2001, CLIN LAB HAEMATOL, V23, P7, DOI 10.1046/j.1365-2257.2001.00354.x; Davies JM, 2002, CLIN MED, V2, P440, DOI 10.7861/clinmedicine.2-5-440; del Giudice EM, 2001, BRIT J HAEMATOL, V112, P42; del Giudice EM, 1999, BLOOD, V94, P2259, DOI 10.1182/blood.V94.7.2259.419k42_2259_2262; del Giudice EM, 1998, BRIT J HAEMATOL, V101, P251, DOI 10.1046/j.1365-2141.1998.00688.x; del Giudice EM, 1998, J PEDIATR-US, V132, P117; Delaunay J, 2004, BRIT J HAEMATOL, V127, P118, DOI 10.1111/j.1365-2141.2004.05160.x; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; delGiudice EM, 1997, HAEMATOLOGICA, V82, P332; DELGIUDICE EM, 1994, BRIT J HAEMATOL, V88, P52; Delhommeau F, 2000, BLOOD, V95, P393, DOI 10.1182/blood.V95.2.393; Dhermy D, 1997, BRIT J HAEMATOL, V98, P32, DOI 10.1046/j.1365-2141.1997.1893005.x; Dhermy D, 2000, CLIN LAB HAEMATOL, V22, P329, DOI 10.1046/j.1365-2257.2000.00319.x; Discher DE, 2001, CELL MOL BIOL LETT, V6, P593; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; EBER SW, 1992, ANN HEMATOL, V64, P88, DOI 10.1007/BF01715351; Eber SW, 1999, ANN HEMATOL, V78, P524, DOI 10.1007/s002770050550; EBER SW, 1990, J PEDIATR-US, V117, P409, DOI 10.1016/S0022-3476(05)81081-9; Edelman EJ, 2007, BLOOD, V109, P5491, DOI 10.1182/blood-2006-09-046573; Farah RA, 1997, J PEDIATR-US, V131, P41, DOI 10.1016/S0022-3476(97)70122-7; Gallagher P., 2003, HEMATOLOGY INFANCY C, P560; Gallagher P. G., 2005, HEMATOLOGY BASIC PRI, P669; Gallagher Patrick G, 2004, Curr Hematol Rep, V3, P85; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Gallagher PG, 2005, HUM MOL GENET, V14, P2501, DOI 10.1093/hmg/ddi254; Gallagher PG, 2001, J BIOL CHEM, V276, P41683, DOI 10.1074/jbc.M105844200; GALLAGHER PG, 1995, J CLIN INVEST, V95, P1174, DOI 10.1172/JCI117766; Gallagher PG, 2000, BRIT J HAEMATOL, V111, P1190, DOI 10.1046/j.1365-2141.2000.02441.x; GALLAGHER PG, 2005, HEMATOLOGY BASIC PRI, P576; Giraldi S, 2003, PEDIATR DERMATOL, V20, P427, DOI 10.1046/j.1525-1470.2003.20512.x; GODAL HC, 1981, SCAND J HAEMATOL, V27, P30; Guarnone R, 1996, BRIT J HAEMATOL, V92, P150, DOI 10.1046/j.1365-2141.1996.00285.x; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; HANSPAL M, 1991, BLOOD, V77, P165; Hassoun H, 1997, BLOOD, V90, P398; Heimpel H, 2003, BLOOD, V102, P4576, DOI 10.1182/blood-2003-02-0613; Hery G, 2008, SURG ENDOSC, V22, P45, DOI 10.1007/s00464-007-9509-0; Huang CH, 2000, SEMIN HEMATOL, V37, P150, DOI 10.1016/S0037-1963(00)90040-4; Iolascon A, 1998, BLOOD, V91, P1093, DOI 10.1182/blood.V91.3.1093; Iolascon Achille, 2003, Rev Clin Exp Hematol, V7, P22; Jalbert F, 2005, J NEUROSURG-SPINE, V2, P491, DOI 10.3171/spi.2005.2.4.0491; Jardine DL, 2004, INTERN MED J, V34, P214, DOI 10.1111/j.1444-0903.2004.00580.x; Jarolim P, 1996, BLOOD, V88, P4366; JAROLIM P, 1994, J CLIN INVEST, V93, P121, DOI 10.1172/JCI116935; JAROLIM P, 1995, BLOOD, V85, P3278, DOI 10.1182/blood.V85.11.3278.bloodjournal85113278; JENSSON O, 1977, ACTA MED SCAND, V201, P187; Jugenburg M, 1999, J PEDIATR SURG, V34, P1064, DOI 10.1016/S0022-3468(99)90565-1; Kaplinsky C, 2006, PEDIATR BLOOD CANCER, V47, P740, DOI 10.1002/pbc.21014; Kedar PS, 2004, CLIN CHIM ACTA, V344, P221, DOI 10.1016/j.cccn.2004.02.021; Kerr R, 2000, CLIN LAB HAEMATOL, V22, P365, DOI 10.1046/j.1365-2257.2000.00338.x; Kimura F, 2003, AM J ROENTGENOL, V181, P1021, DOI 10.2214/ajr.181.4.1811021; King MJ, 2004, BRIT J HAEMATOL, V124, P106, DOI 10.1046/j.1365-2141.2003.04730.x; KORONES D, 1989, J PEDIATR-US, V114, P264, DOI 10.1016/S0022-3476(89)80794-2; Kutter Dolphe, 2002, Clin Lab, V48, P163; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; Lima PRM, 2005, EUR J HAEMATOL, V74, P396, DOI 10.1111/j.1600-0609.2004.00405.x; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; MACKENZIE FA, 1962, LANCET, V1, P1102; MARTINEZCLIMENT JA, 1995, EUR J PEDIATR, V154, P753, DOI 10.1007/BF02276723; MCLANE NJ, 1984, AM J OPHTHALMOL, V97, P444, DOI 10.1016/S0002-9394(14)76127-6; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MOHANDAS N, 1986, BLOOD, V68, P506; Mohler PJ, 2005, FRONT BIOSCI, V10, P2832, DOI 10.2741/1739; MOTTA M, 1999, SURG LAPARO ENDO PER, V9, P203; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Ozcan R, 2003, BRIT J HAEMATOL, V122, P669, DOI 10.1046/j.1365-2141.2003.04479.x; PAJOR A, 1993, ARCH GYNECOL OBSTET, V253, P37, DOI 10.1007/BF02770632; PEKRUN A, 1993, ANN HEMATOL, V67, P89, DOI 10.1007/BF01788132; Perrotta S, 2005, BLOOD, V106, P4359, DOI 10.1182/blood-2005-07-2806; Perrotta S, 1999, HAEMATOLOGICA, V84, P660; Perrotta S, 1999, BLOOD, V93, P2131; Peters LL, 2004, BLOOD, V103, P3233, DOI 10.1182/blood-2003-08-2813; PINTO L, 1995, INT J PEDIAT HEM ONC, V2, P43; Premetis EVANGELOS, 1999, Hematology, V4, P361; Price VE, 2006, PEDIATR BLOOD CANCER, V46, P597, DOI 10.1002/pbc.20477; Reliene R, 2002, BLOOD, V100, P2208, DOI 10.1182/blood.V100.6.2208.h81802002208_2208_2215; Rescorla FJ, 2002, AM SURGEON, V68, P297; Rescorla FJ, 2007, ANN SURG, V246, P683, DOI 10.1097/SLA.0b013e318155abb9; Ribeiro ML, 2000, BLOOD, V96, P1602; Ricard MP, 2000, HAEMATOLOGICA, V85, P994; Ricard MP, 1996, CLIN LAB HAEMATOL, V18, P75, DOI 10.1046/j.1365-2257.1996.00157.x; Rice HE, 2003, ANN SURG, V237, P281, DOI 10.1097/00000658-200302000-00019; Saada V, 2006, PEDIATR HEMAT ONCOL, V23, P387, DOI 10.1080/08880010600646662; Sanchez-Lopez JY, 2003, BLOOD CELL MOL DIS, V31, P357, DOI 10.1016/S1079-9796(03)00207-9; Sandler A, 1999, J PEDIATR SURG, V34, P1077, DOI 10.1016/S0022-3468(99)90569-9; SAVVIDES P, 1993, BLOOD, V82, P2953; SCHILLING RF, 1995, ANN INTERN MED, V122, P187, DOI 10.7326/0003-4819-122-3-199502010-00005; Schilling RF, 1997, LANCET, V350, P1677, DOI 10.1016/S0140-6736(05)64276-6; Schilling RF, 2006, AM J HEMATOL, V81, P315, DOI 10.1002/ajh.20566; SCHROTER W, 1983, J PEDIATR-US, V103, P460, DOI 10.1016/S0022-3476(83)80428-4; Shatz DV, 2005, EXPERT REV VACCINES, V4, P27, DOI 10.1586/14760584.4.1.27; Stewart GW, 1996, BRIT J HAEMATOL, V93, P303, DOI 10.1046/j.1365-2141.1996.4881033.x; Stoehr GA, 2006, BRIT J HAEMATOL, V132, P791, DOI 10.1111/j.1365-2141.2005.05956.x; Stoehr GA, 2006, BRIT J HAEMATOL, V132, P788, DOI 10.1111/j.1365-2141.2005.05918.x; Stoya G, 2006, ACTA HAEMATOL-BASEL, V116, P186, DOI 10.1159/000094679; SUMMERFIELD GP, 1985, LANCET, V2, P1070; Tamary H, 2003, J PEDIAT HEMATOL ONC, V25, P952, DOI 10.1097/00043426-200312000-00009; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Tchernia G, 2000, Hematol J, V1, P146, DOI 10.1038/sj.thj.6200022; TCHERNIA G, 1993, BLOOD, V81, P2014; Tewari M, 2006, J SURG ONCOL, V93, P629, DOI 10.1002/jso.20529; Toye AM, 2005, BLOOD, V105, P4088, DOI 10.1182/blood-2004-05-1895; Troendle SB, 2007, PEDIATR BLOOD CANCER, V49, P781, DOI 10.1002/pbc.21319; Ustun C, 2003, ACTA HAEMATOL-BASEL, V109, P46, DOI 10.1159/000067273; Van Dort HM, 2001, J BIOL CHEM, V276, P46968, DOI 10.1074/jbc.M107855200; Vasilescu C, 2006, SURG ENDOSC, V20, P748, DOI 10.1007/s00464-005-0429-6; Vermeulen S, 2002, AM J MED GENET, V108, P315, DOI 10.1002/ajmg.10295; Wandersee NJ, 2004, BLOOD, V103, P710, DOI 10.1182/blood-2003-02-0492; WHITFIELD CF, 1991, BLOOD, V78, P3043; Wichterle H, 1996, J CLIN INVEST, V98, P2300, DOI 10.1172/JCI119041; Wong EY, 2004, J BIOL CHEM, V279, P55024, DOI 10.1074/jbc.M408886200; Yawata Y, 2000, INT J HEMATOL, V71, P118	147	381	400	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1411	1426		10.1016/S0140-6736(08)61588-3	http://dx.doi.org/10.1016/S0140-6736(08)61588-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940465				2022-12-01	WOS:000260228200028
J	Bakal, C; Linding, R; Llense, F; Heffern, E; Martin-Blanco, E; Pawson, T; Perrimon, N				Bakal, Chris; Linding, Rune; Llense, Flora; Heffern, Elleard; Martin-Blanco, Enrique; Pawson, Tony; Perrimon, Norbert			Phosphorylation networks regulating JNK activity in diverse genetic backgrounds	SCIENCE			English	Article							RECEPTOR TYROSINE KINASE; CELL POLARITY; DORSAL CLOSURE; DROSOPHILA; PATHWAY; PHOSPHATASE; MOVEMENT; INVASION; ENCODES; PROTEIN	Cellular signaling networks have evolved to enable swift and accurate responses, even in the face of genetic or environmental perturbation. Thus, genetic screens may not identify all the genes that regulate different biological processes. Moreover, although classical screening approaches have succeeded in providing parts lists of the essential components of signaling networks, they typically do not provide much insight into the hierarchical and functional relations that exist among these components. We describe a high-throughput screen in which we used RNA interference to systematically inhibit two genes simultaneously in 17,724 combinations to identify regulators of Drosophila JUN NH(2)-terminal kinase (JNK). Using both genetic and phosphoproteomics data, we then implemented an integrative network algorithm to construct a JNK phosphorylation network, which provides structural and mechanistic insights into the systems architecture of JNK signaling.	[Bakal, Chris; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Bakal, Chris; Heffern, Elleard; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02215 USA; [Linding, Rune] Inst Canc Res, Cellular & Mol Log Team, London SW3 6JB, England; [Llense, Flora; Martin-Blanco, Enrique] CSIC, Spanish Council Sci Res, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bakal, C (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02215 USA.	cbakal@receptor.med.harvard.edu	Pawson, Tony J/E-4578-2013; Martin-Blanco, Enrique/ABH-1280-2020	Martin-Blanco, Enrique/0000-0002-6926-910X; Perrimon, Norbert/0000-0001-7542-472X; Bakal, Chris/0000-0002-0413-6744; Linding, Rune/0000-0003-0420-4839	Genome Canada; Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007); European Union (FP6)	Genome Canada(Genome Canada); Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union (FP6)(European Commission)	We are deeply indebted to the Drosophila RNAi Screening Center and to J. Aach, S. Lee, C. Jorgensen, B. Mathey-Prevot, and B. Bodenmiller. The NetworKIN and NetPhorest algorithms are available at http://networkin.info and http://NetPhorest.info, respectively. This work is supported by Genome Canada through the Ontario Genomics Institute, the Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007), and the European Union (FP6). C.B. is a Fellow of the Leukemia and Lymphoma Society. N.P. is an Investigator of the Howard Hughes Medical Institute.	AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Chiariello M, 1998, ONCOGENE, V16, P2435, DOI 10.1038/sj.onc.1201778; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Massimi P, 2003, EXP CELL RES, V290, P265, DOI 10.1016/S0014-4827(03)00317-3; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Primo L, 2007, J CELL BIOL, V176, P1035, DOI 10.1083/jcb.200607053; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	23	99	101	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					453	456		10.1126/science.1158739	http://dx.doi.org/10.1126/science.1158739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927396	Green Accepted			2022-12-01	WOS:000260094500050
J	Cheng, MH				Cheng, Margaret Harris			Nigeria struggles to contain poliomyelitis	LANCET			English	News Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1287	1290		10.1016/S0140-6736(08)61534-2	http://dx.doi.org/10.1016/S0140-6736(08)61534-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18946911	Bronze			2022-12-01	WOS:000260060500011
J	Chivian, D; Brodie, EL; Alm, EJ; Culley, DE; Dehal, PS; DeSantis, TZ; Gihring, TM; Lapidus, A; Lin, LH; Lowry, SR; Moser, DP; Richardson, PM; Southam, G; Wanger, G; Pratt, LM; Andersen, GL; Hazen, TC; Brockman, FJ; Arkin, AP; Onstott, TC				Chivian, Dylan; Brodie, Eoin L.; Alm, Eric J.; Culley, David E.; Dehal, Paramvir S.; DeSantis, Todd Z.; Gihring, Thomas M.; Lapidus, Alla; Lin, Li-Hung; Lowry, Stephen R.; Moser, Duane P.; Richardson, Paul M.; Southam, Gordon; Wanger, Greg; Pratt, Lisa M.; Andersen, Gary L.; Hazen, Terry C.; Brockman, Fred J.; Arkin, Adam P.; Onstott, Tullis C.			Environmental genomics reveals a single-species ecosystem deep within earth	SCIENCE			English	Article							COMMUNITY STRUCTURE; SOUTH-AFRICA; SUBSURFACE; DIVERSITY; PROKARYOTES; METABOLISM; BACTERIUM; WATER; SEA	DNA from low-biodiversity fracture water collected at 2.8-kilometer depth in a South African gold mine was sequenced and assembled into a single, complete genome. This bacterium, Candidatus Desulforudis audaxviator, composes > 99.9% of the microorganisms inhabiting the fluid phase of this particular fracture. Its genome indicates a motile, sporulating, sulfate-reducing, chemoautotrophic thermophile that can fix its own nitrogen and carbon by using machinery shared with archaea. Candidatus Desulforudis audaxviator is capable of an independent life-style well suited to long-term isolation from the photosphere deep within Earth's crust and offers an example of a natural ecosystem that appears to have its biological component entirely encoded within a single genome.	[Chivian, Dylan; Dehal, Paramvir S.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Chivian, Dylan; Brodie, Eoin L.; Alm, Eric J.; Dehal, Paramvir S.; DeSantis, Todd Z.; Andersen, Gary L.; Hazen, Terry C.; Arkin, Adam P.] Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA; [Brodie, Eoin L.; DeSantis, Todd Z.; Andersen, Gary L.; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Culley, David E.] Pacific NW Natl Lab, Energy & Efficiency Technol Div, Richland, WA 99352 USA; [Gihring, Thomas M.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; [Lapidus, Alla; Lowry, Stephen R.; Richardson, Paul M.] US DOE, Joint Genom Inst, Genom Technol Program, Berkeley, CA 94598 USA; [Lin, Li-Hung] Natl Taiwan Univ, Dept Geosci, Taipei 106, Taiwan; [Moser, Duane P.] Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89119 USA; [Southam, Gordon; Wanger, Greg] Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada; [Pratt, Lisa M.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Pratt, Lisa M.; Hazen, Terry C.; Onstott, Tullis C.] NASA Astrobiol Inst, IPTAI, Bloomington, IN 47405 USA; [Brockman, Fred J.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Onstott, Tullis C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University System of Florida; Florida State University; United States Department of Energy (DOE); National Taiwan University; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Western University (University of Western Ontario); Indiana University System; Indiana University Bloomington; National Aeronautics & Space Administration (NASA); United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of California System; University of California Berkeley; Princeton University	Chivian, D (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	DCChivian@lbl.gov	Southam, Gordon/D-1983-2013; Arkin, Adam P/A-6751-2008; Hazen, Terry C/C-1076-2012; Arkin, Adam/M-9941-2019; Andersen, Gary/G-2792-2015; Lin, Li-Hung/K-8091-2012; Lapidus, Alla L/I-4348-2013; Brodie, Eoin L/A-7853-2008	Southam, Gordon/0000-0002-8941-1249; Arkin, Adam P/0000-0002-4999-2931; Hazen, Terry C/0000-0002-2536-9993; Arkin, Adam/0000-0002-4999-2931; Andersen, Gary/0000-0002-1618-9827; Lapidus, Alla L/0000-0003-0427-8731; Brodie, Eoin L/0000-0002-8453-8435; Lin, Li-Hung/0000-0002-0985-1464; Onstott, Tullis/0000-0002-2898-3374	DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL [DE-AC02-05CH11231]; NASA Astrobiology Institute [NNA01CC03A]; Howard Hughes Medical Institute	DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL(United States Department of Energy (DOE)); NASA Astrobiology Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Banfield and G. Tyson for helpful discussion; J. Bruckner and B. Baker for assistance with microscopy; F. Warnecke for advice on 16S fluorescent in situ hybridization; T. Kieft, G. Zane, and the MicrobesOnline team (M. Price, K. Keller, and K. Huang) for advice; and D. Kershaw and colleagues at the Mponeng mine and AngloGold Ashanti Limited, RSA. This work was part of the Virtual Institute for Microbial Stress and Survival (http://vimss.lbl.gov), supported by DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and DOE. This work was also supported by the NASA Astrobiology Institute through award NNA01CC03A to the IPTAI Team co-directed by L.M.P. and T.C.O. A.P.A. received support from the Howard Hughes Medical Institute. The genome sequence and 16S library sequences reported in this study have been deposited in GenBank under the accession numbers CP000860 and EU730965 to EU731008, respectively.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Deutschbauer AM, 2006, CURR OPIN BIOTECH, V17, P229, DOI 10.1016/j.copbio.2006.04.003; Drake HL, 2004, RES MICROBIOL, V155, P868, DOI 10.1016/j.resmic.2004.10.001; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Lefticariu L, 2006, GEOCHIM COSMOCHIM AC, V70, P4889, DOI 10.1016/j.gca.2006.07.026; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Moser DP, 2003, GEOMICROBIOL J, V20, P517, DOI 10.1080/713851170; Mussmann M, 2005, J BACTERIOL, V187, P7126, DOI 10.1128/JB.187.20.7126-7137.2005; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; PHELPS TJ, 1994, MICROBIAL ECOL, V28, P335, DOI 10.1007/BF00662027; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wanger G, 2006, GEOMICROBIOL J, V23, P443, DOI 10.1080/01490450600875746; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Zverlov V, 2005, J BACTERIOL, V187, P2203, DOI 10.1128/JB.187.6.2203-2208.2005	26	305	319	5	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					275	278		10.1126/science.1155495	http://dx.doi.org/10.1126/science.1155495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845759	Green Submitted			2022-12-01	WOS:000259902300053
J	Wright, AA; Zhang, BH; Ray, A; Mack, JW; Trice, E; Balboni, T; Mitchell, SL; Jackson, VA; Block, SD; Maciejewski, PK; Prigerson, HG				Wright, Alexi A.; Zhang, Baohui; Ray, Alaka; Mack, Jennifer W.; Trice, Elizabeth; Balboni, Tracy; Mitchell, Susan L.; Jackson, Vicki A.; Block, Susan D.; Maciejewski, Paul K.; Prigerson, Holly G.			Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVANCED CANCER-PATIENTS; TREATMENT PREFERENCES; FAMILY CAREGIVERS; IMMINENT DEATH; SERIOUSLY ILL; BAD-NEWS; COMMUNICATION; PROGNOSIS; PHYSICIANS; ILLNESS	Context Talking about death can be difficult. Without evidence that end- of- life discussions improve patient outcomes, physicians must balance their desire to honor patient autonomy against a concern of inflicting psychological harm. Objective To determine whether end- of- life discussions with physicians are associated with fewer aggressive interventions. Design, Setting, and Participants A US multisite, prospective, longitudinal cohort study of patients with advanced cancer and their informal caregivers ( n= 332 dy-ads), September 2002- February 2008. Patients were followed up from enrollment to death, a median of 4.4 months later. Bereaved caregivers' psychiatric illness and quality of life was assessed a median of 6.5 months later. Main Outcome Measures Aggressive medical care ( eg, ventilation, resuscitation) and hospice in the final week of life. Secondary outcomes included patients' mental health and caregivers' bereavement adjustment. Results One hundred twenty- three of 332 ( 37.0%) patients reported having end-of-life discussions before baseline. Such discussions were not associated with higher rates of major depressive disorder ( 8.3% vs 5.8%; adjusted odds ratio [ OR], 1.33; 95% confidence interval [ CI], 0.54- 3.32), or more worry ( mean McGill score, 6.5 vs 7.0; P=. 19). After propensity- score weighted adjustment, end- of- life discussions were associated with lower rates of ventilation ( 1.6% vs 11.0%; adjusted OR, 0.26; 95% CI, 0.08- 0.83), resuscitation ( 0.8% vs 6.7%; adjusted OR, 0.16; 95% CI, 0.03- 0.80), ICU admission ( 4.1% vs 12.4%; adjusted OR, 0.35; 95% CI, 0.14- 0.90), and earlier hospice enrollment ( 65.6% vs 44.5%; adjusted OR, 1.65; 95% CI, 1.04- 2.63). In adjusted analyses, more aggressive medical care was associated with worse patient quality of life ( 6.4 vs 4.6; F= 3.61, P=. 01) and higher risk of major depressive disorder in bereaved caregivers ( adjusted OR, 3.37; 95% CI, 1.12- 10.13), whereas longer hospice stays were associated with better patient quality of life ( mean score, 5.6 vs 6.9; F= 3.70, P=. 01). Better patient quality of life was associated with better caregiver quality of life at follow- up (beta=. 20; P=. 001). Conclusions End- of- life discussions are associated with less aggressive medical care near death and earlier hospice referrals. Aggressive care is associated with worse patient quality of life and worse bereavement adjustment.	[Wright, Alexi A.; Trice, Elizabeth] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wright, Alexi A.; Zhang, Baohui; Ray, Alaka; Trice, Elizabeth; Balboni, Tracy; Block, Susan D.; Prigerson, Holly G.] Dana Farber Canc Inst, Ctr Psychooncol & Palliat Care Res, Boston, MA 02115 USA; [Mack, Jennifer W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02115 USA; [Ray, Alaka; Jackson, Vicki A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Balboni, Tracy] Harvard Univ, Harvard Radiat Oncol Program, Boston, MA USA; [Jackson, Vicki A.; Block, Susan D.; Prigerson, Holly G.] Harvard Univ, Sch Med, Ctr Palliat Care, Boston, MA USA; [Mitchell, Susan L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Block, Susan D.; Maciejewski, Paul K.; Prigerson, Holly G.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Wright, AA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 550 Shields Warren,44 Binney St, Boston, MA 02115 USA.	awright2@partners.org	Prigerson, Holly/GWV-3283-2022; Prigerson, Holly/L-3800-2019; Wright, Alexi/T-5793-2019; Balboni, Tracy/AAH-4490-2020	Prigerson, Holly/0000-0002-7075-4268; 	National Cancer Institute [CA 106370]; National Institute of Mental Health [MH63892]; National Cancer Institute's "Program in Cancer Outcomes Research Training" [CA 92044343]; Dana-Farber Cancer Institute's Friends Fellowship; NATIONAL CANCER INSTITUTE [T32CA009172, R01CA106370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG033640] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute's "Program in Cancer Outcomes Research Training"; Dana-Farber Cancer Institute's Friends Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants CA 106370 from the National Cancer Institute and MH63892 from the National Institute of Mental Health. Dr Wright was supported, in part, by grant CA 92044343, which is part of the National Cancer Institute's "Program in Cancer Outcomes Research Training" and by the Dana-Farber Cancer Institute's Friends Fellowship.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Back Anthony L, 2003, Ann Intern Med, V138, P439; Baile WF, 2002, J CLIN ONCOL, V20, P2189, DOI 10.1200/JCO.2002.08.004; Balboni TA, 2007, J CLIN ONCOL, V25, P555, DOI 10.1200/JCO.2006.07.9046; CARALIS PV, 1993, J CLIN ETHIC, V4, P155; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cherlin E, 2005, J PALLIAT MED, V8, P1176, DOI 10.1089/jpm.2005.8.1176; Christakis Nicholas A., 1999, DEATH FORETOLD PROPH; Chu KC, 2007, J NATL MED ASSOC, V99, P1092; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; ENDICOTT J, 1984, CANCER, V53, P2243; First MB., 2002, STRUCTURED CLIN INTE; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Gessert Charles E., 2001, Ethnicity and Disease, V11, P97; Gordon EJ, 2003, BIOETHICS, V17, P142, DOI 10.1111/1467-8519.00330; Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095; Hagerty RG, 2005, J CLIN ONCOL, V23, P1278, DOI 10.1200/JCO.2005.11.138; Hancock K, 2007, PALLIATIVE MED, V21, P507, DOI 10.1177/0269216307080823; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Helft PR, 2005, J CLIN ONCOL, V23, P3146, DOI 10.1200/JCO.2005.07.003; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Kris AE, 2006, AM J GERIAT PSYCHIAT, V14, P264, DOI 10.1097/01.JGP.0000194642.86116.ce; Lamont E B, 2000, J Palliat Med, V3, P27, DOI 10.1089/jpm.2000.3.27; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lehmann L, 2007, J CLIN ONCOL, V25; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Maciejewski PK, 2007, JAMA-J AM MED ASSOC, V297, P716, DOI 10.1001/jama.297.7.716; Mack JW, 2008, CANCER-AM CANCER SOC, V112, P2509, DOI 10.1002/cncr.23476; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; PRIGERSON HG, 1992, J HEALTH SOC BEHAV, V33, P378, DOI 10.2307/2137315; Ptacek JT, 2001, J BEHAV MED, V24, P205, DOI 10.1023/A:1010766732373; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Ray A, 2006, J PALLIAT MED, V9, P1359, DOI 10.1089/jpm.2006.9.1359; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Selman L, 2007, HEART, V93, P963, DOI 10.1136/hrt.2006.106518; Siegel MD, 2008, CRIT CARE MED, V36, P1722, DOI 10.1097/CCM.0b013e318174da72; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Sullivan AM, 2007, J PALLIAT MED, V10, P882, DOI 10.1089/jpm.2007.0189; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; The AM, 2001, WESTERN J MED, V174, P247, DOI 10.1136/ewjm.174.4.247; Trice ED, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.6506; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630	49	1781	1789	7	156	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1665	1673		10.1001/jama.300.14.1665	http://dx.doi.org/10.1001/jama.300.14.1665			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356YF	18840840	Bronze, Green Accepted			2022-12-01	WOS:000259812800028
J	Zhang, XQ; Zhang, G; Zhang, H; Karin, M; Bai, H; Cai, DS				Zhang, Xiaoqing; Zhang, Guo; Zhang, Hai; Karin, Michael; Bai, Hua; Cai, Dongsheng			Hypothalamic IKK beta/NF-kappa B and ER stress link overnutrition to energy imbalance and obesity	CELL			English	Article							INDUCED INSULIN-RESISTANCE; ENHANCED LEPTIN SENSITIVITY; DIET-INDUCED OBESITY; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; BODY-WEIGHT; RECEPTOR; BRAIN; MICE; REPRODUCTION	Overnutrition is associated with chronic inflammation in metabolic tissues. Whether metabolic inflammation compromises the neural regulatory systems and therefore promotes overnutrition-associated diseases remains unexplored. Here we show that a mediator of metabolic inflammation, IKK beta/NF-kappa B, normally remains inactive although enriched in hypothalamic neurons. Overnutrition atypically activates hypothalamic IKK beta/NF-kappa B at least in part through elevated endoplasmic reticulum stress in the hypothalamus. While forced activation of hypothalamic IKK beta/NF-kappa B interrupts central insulin/leptin signaling and actions, site- or cell-specific suppression of IKK beta either broadly across the brain or locally within the mediobasal hypothalamus, or specifically in hypothalamic AGRP neurons significantly protects against obesity and glucose intolerance. The molecular mechanisms involved include regulation by IKK beta/NF-kappa B of SOCS3, a core inhibitor of insulin and leptin signaling. Our results show that the hypothalamic IKK beta/NF-kappa B program is a general neural mechanism for energy imbalance underlying obesity and suggest that suppressing hypothalamic IKK beta/NF-kappa B may represent a strategy to combat obesity and related diseases.	[Zhang, Xiaoqing; Zhang, Guo; Zhang, Hai; Bai, Hua; Cai, Dongsheng] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Zhang, Hai] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53706 USA; [Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego	Cai, DS (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	dcai@physiology.wisc.edu	Zhang, Xiaoqing/O-3424-2017; Zhang, Guo/Q-8513-2016	Zhang, Xiaoqing/0000-0002-7405-1893; Zhang, Guo/0000-0003-0841-4710; Bai, Hua/0000-0002-0448-4052; Zhang, Guo/0000-0002-3880-6996	NIH [R56, R01 DK078750]; American Diabetes Association Junior Faculty Award [1-07-JF-09]; UW-Madison Start-up funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK078750, R01DK078750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Junior Faculty Award(American Diabetes Association); UW-Madison Start-up funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Barsh and A. Xu for AGRP-Cre mice; T. Blackwell for NGL mice; P. Mellon for GT1-7 cells; L. Rui for HEK 293-lepR cells; J. Seufert for SOCS3 cDNA; R. Bruick for SOCS3-pGL3; S. Albelda for Cre adenovirus; G. Francisco for synpasin promoter-controlled lentiviral vector; and S. Miyamoto for p65 antibody. We thank S. Shoelson, M. Hendrickson, A. Attie, D. Sun, C. Berridge, R. Weindruch, and Cai lab members for suggestions and technical assistance. This study was supported by NIH grants (R56 and R01 DK078750), American Diabetes Association Junior Faculty Award (1-07-JF-09), and UW-Madison Start-up funds (all to D. C.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Woods SC, 2004, PHYSIOL BEHAV, V83, P573, DOI 10.1016/j.physbeh.2004.07.026; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	34	1000	1027	0	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					61	73		10.1016/j.cell.2008.07.043	http://dx.doi.org/10.1016/j.cell.2008.07.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854155	Green Accepted, Bronze			2022-12-01	WOS:000259728100009
J	Fatkenheuer, G; Nelson, M; Lazzarin, A; Konourina, I; Hoepelman, AIM; Lampiris, H; Hirschel, B; Tebas, P; Raffi, F; Trottier, B; Bellos, N; Saag, M; Cooper, DA; Westby, M; Tawadrous, M; Sullivan, JF; Ridgway, C; Dunne, MW; Felstead, S; Mayer, H; van der Ryst, E				Faetkenheuer, Gerd; Nelson, Mark; Lazzarin, Adriano; Konourina, Irina; Hoepelman, Andy I. M.; Lampiris, Harry; Hirschel, Bernard; Tebas, Pablo; Raffi, Francois; Trottier, Benoit; Bellos, Nicholaos; Saag, Michael; Cooper, David A.; Westby, Mike; Tawadrous, Margaret; Sullivan, John F.; Ridgway, Caroline; Dunne, Michael W.; Felstead, Steve; Mayer, Howard; van der Ryst, Elna		MOTIVATE 1 Study Team; MOTIVATE 2 Study Team	Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPERIENCED HIV-1-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; DRUG-RESISTANT HIV-1; TMC125 ETRAVIRINE; PROGNOSTIC VALUE; CCR5 ANTAGONIST; DOUBLE-BLIND; EFFICACY; VIRUS; HEPATITIS	Background We conducted subanalyses of the combined results of the Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment- Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 studies to better characterize the efficacy and safety of maraviroc in key subgroups of patients. Methods We analyzed pooled data from week 48 from the two studies according to sex, race or ethnic group, clade, CC chemokine receptor 5 (CCR5) delta32 genotype, viral load at the time of screening, the use or nonuse of enfuvirtide in optimized background therapy (OBT), the baseline CD4 cell count, the number of active antiretroviral drugs coadministered, the first use of selected background agents, and tropism at baseline. Changes in viral tropism and the CD4 count at treatment failure were evaluated. Data on aminotransferase levels in patients coinfected with hepatitis B virus (HBV) or hepatitis C virus (HCV) were also analyzed. Results A treatment benefit of maraviroc plus OBT over placebo plus OBT was shown in all subgroups, including patients with a low CD4 cell count at baseline, those with a high viral load at screening, and those who had not received active agents in OBT. Analyses of the virologic response according to the first use of selected background drugs showed the additional benefit of adding a potent new drug to maraviroc at the initiation of maraviroc therapy. More patients in whom maraviroc failed had a virus binding to the CXC chemokine receptor 4 (CXCR4) at failure, but there was no evidence of a decrease in the CD4 cell count at failure in such patients as compared with those in whom placebo failed. Subanalyses involving patients coinfected with HBV or HCV revealed no evidence of excess hepatotoxic effects as compared with baseline. Conclusions Subanalyses of pooled data from week 48 indicate that maraviroc provides a valuable treatment option for a wide spectrum of patients with R5 HIV-1 infection who have been treated previously. (ClinicalTrials. gov numbers, NCT00098306 and NCT00098722.).	[Faetkenheuer, Gerd] Universitatsklin Koln, D-50924 Cologne, Germany; [Nelson, Mark] Chelsea & Westminster Hosp, London, England; [Konourina, Irina; Westby, Mike; Sullivan, John F.; Ridgway, Caroline; Felstead, Steve; van der Ryst, Elna] Pfizer Global Res & Dev, Sandwich, Kent, England; [Lazzarin, Adriano] Ist Ric & Cura Carattere Sci San Raffaele, Milan, Italy; [Hoepelman, Andy I. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Lampiris, Harry] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lampiris, Harry] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Hirschel, Bernard] Univ Hosp Geneva, Geneva, Switzerland; [Tebas, Pablo] Univ Penn, Philadelphia, PA 19104 USA; [Raffi, Francois] Med Univ Nantes, Hotel Dieu, Univ Hosp, Nantes, France; [Trottier, Benoit] Clin Med Lactuel, Montreal, PQ, Canada; [Bellos, Nicholaos] SW Infect Dis Assoc, Dallas, TX USA; [Saag, Michael] Univ Alabama Birmingham, Birmingham, AL USA; [Tawadrous, Margaret; Dunne, Michael W.; Mayer, Howard] Pfizer Global Res & Dev, New London, CT USA; [Cooper, David A.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of Cologne; Imperial College London; Pfizer; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Geneva; University of Pennsylvania; Nantes Universite; CHU de Nantes; University of Alabama System; University of Alabama Birmingham; Pfizer; University of New South Wales Sydney; Kirby Institute	Fatkenheuer, G (corresponding author), Universitatsklin Koln, D-50924 Cologne, Germany.	g.faetkenheuer@uni-koeln.de	Tawadrous, Margaret/AAY-3551-2020; Montaner, Julio/K-7621-2012; Dunne, Michael W/AAD-7418-2020; LAZZARIN, Adriano/K-3607-2018; Gisslen, Magnus/D-7454-2015; Pulido, Federico/B-8417-2009	Dunne, Michael W/0000-0001-6186-5196; Koirala, Janak/0000-0002-3608-474X; Leen, Clifford/0000-0001-8439-7719; Tebas, Pablo/0000-0001-5345-7942; Smiatacz, Tomasz/0000-0003-2793-3671; LAZZARIN, Adriano/0000-0003-2551-7754; Moutschen, Michel/0000-0002-6405-1785; Easterbrook, Philippa/0000-0002-2603-5418; Gisslen, Magnus/0000-0002-2357-1020; Pulido, Federico/0000-0002-7414-8812; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Stapleton, Jack/0000-0002-2302-9055	Gilead Sciences; GlaxoSmithKline; Monogram Biosciences; Pfizer; Roche; Schering-Plough; Tibotec; Bristol-Myers Squibb; Abbott; Boehringer Ingelheim; Merck Sharp Dohme; JanssenCilag; Novartis; VGX Pharmaceuticals; Wyeth; Avexa; Panacos; Progenics; Virco; Achillion Pharmaceuticals; Serono; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI051966] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Monogram Biosciences; Pfizer(Pfizer); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Tibotec; Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp Dohme(Merck & Company); JanssenCilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); VGX Pharmaceuticals; Wyeth(Wyeth); Avexa; Panacos; Progenics; Virco; Achillion Pharmaceuticals; Serono; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Fatkenheuer reports receiving consulting fees from Gilead Sciences, GlaxoSmithKline, Monogram Biosciences, Pfizer, Roche, Schering-Plough, Tibotec, and Bristol-Myers Squibb, lecture fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, Schering-Plough, and Tibotec, and grant support from Pfizer; Dr. Nelson, receiving consulting fees from Merck Sharp & Dohme, Pfizer, Abbott, Roche, Gilead Sciences, Bristol- Myers Squibb, GlaxoSmithKline, and Boehringer Ingelheim, lecture fees from Merck Sharp & Dohme, Pfizer, Abbott, Gilead Sciences, Bristol-Myers Squibb, and Roche, and grant support from Gilead Sciences, Pfizer, Tibotec, and Merck Sharp & Dohme; Dr. Lazzarin, receiving consulting fees from Abbott, GlaxoSmithKline, Bristol- Myers Squibb, and JanssenCilag and lecture fees from Roche, Boehringer Ingelheim, and Gilead Sciences; Dr. Hoepelman, receiving consulting fees from Pfizer, Bristol-Myers Squibb, Novartis, and Tibotec and lecture fees from Gilead Sciences and Roche; Dr. Lampiris, receiving consulting fees from Abbott and Boehringer Ingelheim, lecture fees from Merck Sharp & Dohme, Monogram Biosciences, and Boehringer Ingelheim, and grant support from Gilead Sciences, Roche, Pfizer; and Tibotec; Dr. Hirschel, receiving consulting fees from Merck Sharp & Dohme, Tibotec, Pfizer, and Bristol-Myers Squibb and lecture fees from GlaxoSmithKline; Dr. Tebas, receiving consulting fees from VGX Pharmaceuticals, Merck Sharp & Dohme, Bristol-Myers Squibb, Tibotec, and Boehringer Ingelheim and grant support from Wyeth, Pfizer, Roche, and GlaxoSmithKline; Dr. Trottier, receiving consulting and lecture fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Pfizer, Roche, and Tibotec; Dr. Bellos, receiving consulting and lecture fees from GlaxoSmithKline, Pfizer, and Tibotec and grant support from Gilead Sciences, Abbott, and GlaxoSmithKline; Dr. Saag, receiving consulting fees from Avexa, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Monogram Biosciences, Panacos, Pfizer, Progenics, Roche, Tibotec, and Virco and grant support from Achillion Pharmaceuticals, Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Panacos, Pfizer, Progenics, Roche, Serono, and Tibotec; Dr. Cooper, holding stock and stock options in Pfizer and receiving consulting fees and grant support from Pfizer; Dr. Westby, being an employee of Pfizer and holding stock options in Pfizer; Drs. Tawadrous, Konourina, Dunne, Felstead, Mayer, and van der Ryst and Mr. Sullivan, being employees of Pfizer and holding stock and stock options in Pfizer; and Ms. Ridgway, being an employee of Pfizer. No other potential conflict of interest relevant to this article was reported.; We thank the study participants as well as the study investigators and site staff at the 239 participating study sites (for a complete list of the investigators, site staff, and study sites, see the Supplementary Appendix).	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Clotet B, 2008, LANCET, V371, P116; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Deeks SG, 2003, AIDS, V17, P361, DOI 10.1097/00002030-200302140-00010; *DEP HHS, 2007, GUID US ANT AG HIV 1; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; FATKENHEUER G, 2008, 15 C RETR OPP INF BO; Goodrich JM, 2007, 45 ANN M INF DIS SOC; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; GULICK R, 2007, 4 IAS C HIV PATH TRE; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Lalezari JP, 2003, NEW ENGL J MED, V349, P1100; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; MCFADYEN L, 2007, 11 EUR AIDS C MADR O; Mocroft A, 2005, ANTIVIR THER, V10, P779; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; *REG COMPL CTR, DIV AIDS TABL GRAD S; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Tierney C, 2003, J INFECT DIS, V187, P144, DOI 10.1086/345870; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Weatherley B., 2008, 9 INT WORKSH CLIN PH; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Westby M, 2007, CURR OPIN HIV AIDS, V2, P137, DOI 10.1097/COH.0b013e3280142007; Wheeler J, 2007, ANTIVIR THER, V12, P233; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P1399; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Woitas RP, 2002, GASTROENTEROLOGY, V122, P1721, DOI 10.1053/gast.2002.33660	38	282	290	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1442	U46		10.1056/NEJMoa0803154	http://dx.doi.org/10.1056/NEJMoa0803154			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832245				2022-12-01	WOS:000259631700005
J	Hampton, T				Hampton, Tracy			Researchers devise innovative method to overcome cancer-related drug resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Dubikovskaya EA, 2008, P NATL ACAD SCI USA, V105, P12128, DOI 10.1073/pnas.0805374105; PARK IH, 2008, CELL            0807; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1507	1508		10.1001/jama.300.13.1507	http://dx.doi.org/10.1001/jama.300.13.1507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827202				2022-12-01	WOS:000259617700004
J	Kaklamani, VG; Wisinski, KB; Sadim, M; Gulden, C; Do, A; Offit, K; Baron, JA; Ahsan, H; Mantzoros, C; Pasche, B				Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Do, Albert; Offit, Kenneth; Baron, John A.; Ahsan, Habibul; Mantzoros, Christos; Pasche, Boris			Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH-FACTOR-I; CORONARY-ARTERY-DISEASE; IGF-I; PLASMA ADIPONECTIN; METABOLIC SYNDROME; BINDING PROTEIN-3; RECTAL-CANCER; COLON-CANCER; APM1 GENE; C-PEPTIDE	Context Current epidemiological evidence suggests an association between obesity, hyperinsulinemia, and colorectal cancer risk. Adiponectin is a hormone secreted by the adipose tissue, and serum levels are inversely correlated with obesity and hyperinsulinemia. While there is evidence of an association between circulating adiponectin levels and colorectal cancer risk, no association between genes of the adiponectin pathway and colorectal cancer have been reported to date. Objective To determine the association of 10 haplotype-tagging single-nucleotide polymorphisms (SNPs) of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes with colorectal cancer risk. Design, Setting, and Patients Two case-control studies including patients with a diagnosis of colorectal cancer and controls were recruited between 2000 and 2007. Case-control study 1 included a total of 441 patients with a diagnosis of colorectal cancer and 658 controls; both groups were of Ashkenazi Jewish ancestry and from new York, New York. Case-control study 2 included 199 patients with a diagnosis of colorectal cancer and 199 controls from Chicago, Illinois, matched 1:1 for sex, age, and ethnicity. Main Outcome Measures ADIPOQ and ADIPOR1 SNP frequency among cases and controls. Results In study 1, after adjustment for age, sex, and SNPs from the same gene, 3 ADIPOQ SNPs and 1 ADIPOR1 SNP were associated with colorectal cancer risk: rs266729 (adjusted odds ratio [AOR], 0.72; 95% confidence interval [CI], 0.55-0.95) and rs822396 (AOR, 0.37; 95% CI, 0.14-1.00) were associated with decreased risk whereas rs822395 (AOR, 1.76; 95% CI, 1.09-2.84) and rs1342387 (AOR, 1.79; 95% CI, 1.18-2.72) were associated with increased risk. In study 2, after adjustment for age, sex, race, and SNPs from the same gene, the ADIPOQ SNP rs266729 was associated with a decreased colorrectal cancer risk of similar magnitude as in study 1 (AOR, 0.52; 95% CI, 0.34-0.78). Combined analysis of both studies shows an association of rs266729 with decreased colorectal cancer risk (AOR, 0.73; 95% Ci, 0.53-0.99). Conclusion The SNP rs266729, which tags the 5' flanking region of the ADIPOQ gene, is associated with decreased colorectal cancer risk. .	[Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Pasche, Boris] Northwestern Univ, Canc Genet Program, Div Hematol & Oncol, Dept Med, Chicago, IL 60611 USA; [Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Pasche, Boris] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Do, Albert; Mantzoros, Christos] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab,Dept Med, Boston, MA USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Baron, John A.] Dartmouth Med Sch, Dept Med & Community, Hanover, NH USA; [Baron, John A.] Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies Med & Human Genet, Chicago, IL 60637 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Dartmouth College; Dartmouth College; University of Chicago	Pasche, B (corresponding author), Univ Alabama Birmingham, Div Hematol Oncol, 1802 6th Ave S,NP 2666, Birmingham, AL 35294 USA.	Boris.Pasche@ccc.uab.edu	Mantzoros, Christos/Y-2902-2019		Walter S. Mander Foundation (Chicago, Illinois); National Institutes of Health [CA112520, CA108741, DK081913, DK79929, DK 58785]; American Institute for Cancer Research; Beth Israel Deaconess Medical Center; Lynn Sage Foundation; American Society of Clinical Oncology Career Development Award; Niehaus Clinical Cancer Genetics Initiative; NATIONAL CANCER INSTITUTE [R01CA112520, R01CA108741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK081913, R56DK058785, R01DK058785, R01DK079929] Funding Source: NIH RePORTER	Walter S. Mander Foundation (Chicago, Illinois); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; Beth Israel Deaconess Medical Center; Lynn Sage Foundation; American Society of Clinical Oncology Career Development Award; Niehaus Clinical Cancer Genetics Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Walter S. Mander Foundation (Chicago, Illinois); grants CA112520, CA108741, DK081913, DK79929, DK 58785 from the National Institutes of Health; the Jeannik M. Littlefield-AACR Grant in Metastatic Colon Cancer Research from the American Institute for Cancer Research; a discretionary grant from Beth Israel Deaconess Medical Center; the Lynn Sage Foundation and the American Society of Clinical Oncology Career Development Award; and the Niehaus Clinical Cancer Genetics Initiative.	Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Crimmins NA, 2007, OBES REV, V8, P419, DOI 10.1111/j.1467-789X.2007.00348.x; Drew JE, 2007, AM J PHYSIOL-GASTR L, V293, pG682, DOI 10.1152/ajpgi.00231.2007; Fenton JI, 2008, INT J CANCER, V122, P2437, DOI 10.1002/ijc.23436; Filippi E, 2005, J MOL MED, V83, P711, DOI 10.1007/s00109-005-0667-z; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; LEE IM, 1992, J NATL CANCER I, V84, P1326, DOI 10.1093/jnci/84.17.1326; Lukanova A, 2006, CANCER EPIDEM BIOMAR, V15, P401, DOI 10.1158/1055-9965.EPI-05-0836; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Ma J, 2000, GROWTH HORM IGF RES, V10, pS28, DOI 10.1016/S1096-6374(00)90013-3; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; Manousos O, 1999, INT J CANCER, V83, P15, DOI 10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Moschos SJ, 2002, ONCOLOGY-BASEL, V63, P317, DOI 10.1159/000066230; Pischon T, 2007, OBESITY, V15, P2051, DOI 10.1038/oby.2007.244; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qi L, 2006, DIABETES, V55, P1512, DOI 10.2337/db05-1520; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Soccio T, 2006, DIABETES, V55, P2763, DOI 10.2337/db06-0613; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; Williams CJ, 2008, ENDOCR-RELAT CANCER, V15, P289, DOI 10.1677/ERC-07-0197	31	104	110	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1523	1531		10.1001/jama.300.13.1523	http://dx.doi.org/10.1001/jama.300.13.1523			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827209	Green Accepted, Bronze			2022-12-01	WOS:000259617700016
J	Beasley, R; Clayton, T; Crane, J; von Mutius, E; Lai, CKW; Montefort, S; Stewart, A				Beasley, Richard; Clayton, Tadd; Crane, Julian; von Mutius, Erika; Lai, Christopher K. W.; Montefort, Stephen; Stewart, Alistair		ISAAC Phase Three Study Grp	Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme	LANCET			English	Article							WORLDWIDE VARIATIONS; ALLERGIC DISEASES; ACETAMINOPHEN USE; EARLY-LIFE; DRUG-USE; PREVALENCE; SYMPTOMS; ASPIRIN; IBUPROFEN; MANAGEMENT	Background Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma. Methods As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, rhinoconjunctivitis, and eczema, and several risk factors, including the use of paracetamol for fever in the child's first year of life and the frequency of paracetamol use in the past 12 months. The primary outcome variable was the odds ratio (OR) of asthma symptoms in these children associated with the use of paracetamol for fever in the first year of life, as calculated by logistic regression. Findings 205 487 children aged 6-7 years from 73 centres in 31. countries were included in the analysis. In the multivariate analyses, use of paracetamol for fever in the first year of life was associated with an increased risk of asthma symptoms when aged 6-7 years (OR 1.46 [95% Cl 1.36-1.56]). Current use of paracetamol was associated with a dose-dependent increased risk of asthma symptoms (1.61 [1.46-1.77] and 3.23 [2.9]-3.60] for medium and high use vs no use, respectively). Use of paracetamol was similarly associated with the risk of severe asthma symptoms, with population-attributable risks between 22% and 38%. Paracetamol use, both in the first year of life and in children aged 6-7 years, was also associated with an increased risk of symptoms of rhinoconjunctivitis and eczema. Interpretation Use of paracetamol in the first year of life and in later childhood, is associated with risk of asthma, rhinoconjunctivitis, and eczema at age 6 to 7 years. We suggest that exposure to paracetamol might be a risk factor for the development of asthma in childhood. Funding The BUPA Foundation, the Health Research Council of New Zealand, the Asthma and Respiratory Foundation of New Zealand, the Hawke's Bay Medical Research Foundation, the Waikato Medical Research Foundation, Glaxo Wellcome New Zealand, the New Zealand Lottery Board, Astra Zeneca New Zealand, and Glaxo Wellcome international Medical Affairs.	[Beasley, Richard] Med Res Inst New Zealand, Wellington 6143, New Zealand; [Clayton, Tadd] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Crane, Julian] Univ Otago, Dept Med, Wellington, New Zealand; [von Mutius, Erika] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; [Lai, Christopher K. W.] Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Montefort, Stephen] Univ Malta, Dept Med, Msida, Malta; [Stewart, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	Medical Research Institute Of New Zealand; University of Auckland; University of Otago; University of Munich; University of Hong Kong; University of Malta; University of Auckland	Beasley, R (corresponding author), Med Res Inst New Zealand, POB 10055, Wellington 6143, New Zealand.	Richard.Beasley@mrinz.ac.nz	Wong, Gary WK/AAY-9207-2020; Martínez-Gimeno, Antonio/A-9416-2010; Clayton, Tadd O/B-7914-2009; González-Díaz, Sandra Nora/H-3271-2018; Anderson, Hugh R/A-7417-2016; Masjedi, Mohammad Reza/J-9776-2017; Ellwood, Philippa/G-7555-2015; Garcia-Almaraz, Roberto/G-8506-2018; Steriu, Andreea/AAQ-5127-2021; Beasley, Richard/AAH-3908-2019	Wong, Gary WK/0000-0001-5939-812X; Martínez-Gimeno, Antonio/0000-0003-4051-1860; González-Díaz, Sandra Nora/0000-0002-3612-0042; Masjedi, Mohammad Reza/0000-0002-6871-382X; Ellwood, Philippa/0000-0002-1994-4023; Garcia-Almaraz, Roberto/0000-0001-5828-1771; Steriu, Andreea/0000-0002-2998-8644; Beasley, Richard/0000-0003-0337-406X; williams, hywel/0000-0002-5646-3093; Garcia-Marcos, Luis/0000-0002-0925-3851; Pattemore, Philip/0000-0002-4968-1287; Huang, Jing-Long/0000-0001-9280-920X; Masjedi, Mohammadreza/0000-0003-4964-3851; Pearce, Neil/0000-0002-9938-7852; Huang, Jing-Long/0000-0002-3530-7753; brunekreef, bert/0000-0001-9908-0060; von Mutius, Erika/0000-0002-8893-4515; Mallol, Javier/0000-0003-2528-8672	ISAAC International Data Centre (IIDC) is The BUPA Foundation	ISAAC International Data Centre (IIDC) is The BUPA Foundation	We thank the children and parents who participated in ISAAC Phase Three, and the school staff for their coordination and assistance. The authors also acknowledge and thank die many funding bodies throughout the world that supported the individual ISAAC centres, collaborators, and their meetings. Currently, the main source of funding for the ISAAC International Data Centre (IIDC) is The BUPA Foundation. Many funding bodies in New Zealand have contributed to support the IIDC during the periods of fieldwork arid data compilation: the Health Research Council of New Zealand, the Asthma arid Respiratory Foundation of New Zealand, the Child Health Research Foundation, the Hawke's Bay Medical Research Foundation, the Waikato Medical Research Foundation, GlaxoWellcome New Zealand, the New Zealand Lottery Board, and Astra Zeneca New Zealand. GlaxoWellcome International Medical Affairs supported the regional coordination for Phase Three and the IIDC.	AGYEPONG IA, 1994, ACTA TROP, V58, P317, DOI 10.1016/0001-706X(94)90025-6; Ajayi I O, 2006, Afr J Med Med Sci, V35, P85; Allmers H, 2005, J ALLERGY CLIN IMMUN, V116, P859, DOI 10.1016/j.jaci.2005.07.019; Anderson HR, 2008, INT J EPIDEMIOL, V37, P573, DOI 10.1093/ije/dyn039; ARROWSMITH JB, 1987, PEDIATRICS, V79, P858; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2000, J ALLERGY CLIN IMMUN, V105, pS466, DOI 10.1016/S0091-6749(00)90044-7; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Benoni Giuseppina, 2005, Pediatr Med Chir, V27, P67; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Cohet C, 2004, J EPIDEMIOL COMMUN H, V58, P852, DOI 10.1136/jech.2003.019182; Davey G, 2005, J ALLERGY CLIN IMMUN, V116, P863, DOI 10.1016/j.jaci.2005.05.045; Del-Rio-Navarro BE, 2007, J INVEST ALLERG CLIN, V17, P77; Dodge R, 1996, J ALLERGY CLIN IMMUN, V98, P48, DOI 10.1016/S0091-6749(96)70225-7; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Fawole O I, 2001, West Afr J Med, V20, P152; GARCIAMARCOS L, 2008, INT ARCH ALLERGY IMM; Koniman R, 2007, PEDIAT ALLERG IMM-UK, V18, P128, DOI 10.1111/j.1399-3038.2006.00484.x; Kuschnir FC, 2007, PEDIAT ALLERG IMM-UK, V18, P142, DOI 10.1111/j.1399-3038.2006.00477.x; Lagerlov Per, 2004, Tidsskr Nor Laegeforen, V124, P1620; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Li SF, 2000, PEDIATR EMERG CARE, V16, P394, DOI 10.1097/00006565-200012000-00003; Maison P, 1998, EUR J CLIN PHARMACOL, V54, P659, DOI 10.1007/s002280050530; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matricardi PM, 2002, ASTHMA: CRITICAL DEBATES, P3; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; Newson RB, 2000, EUR RESPIR J, V16, P817, DOI 10.1183/09031936.00.16581700; Nuttall SL, 2003, J CLIN PHARM THER, V28, P289, DOI 10.1046/j.1365-2710.2003.00493.x; Nuttall SL, 2003, J CLIN PHARM THER, V28, P251, DOI 10.1046/j.1365-2710.2003.00492.x; OLOUGHLIN EV, 1995, J PAEDIATR CHILD H, V31, P189, DOI 10.1111/j.1440-1754.1995.tb00783.x; Pandolfini C, 2005, EUR J PEDIATR, V164, P552, DOI 10.1007/s00431-005-1698-8; REBORDOSA C, 2007, AM J RESP CRIT CARE, V175, pA80; SETTIPANE GA, 1983, AM J MED, V74, P102, DOI 10.1016/0002-9343(83)90537-5; Shaheen SO, 2005, CLIN EXP ALLERGY, V35, P18, DOI 10.1111/j.1365-2222.2005.02151.x; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Sherriff A, 2001, INT J EPIDEMIOL, V30, P1473, DOI 10.1093/ije/30.6.1473; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Taddio A, 2007, PEDIATRICS, V120, pE637, DOI 10.1542/peds.2006-3351; Taylor BJ, 1996, J PAEDIATR CHILD H, V32, P316, DOI 10.1111/j.1440-1754.1996.tb02561.x; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4; VEDANTHAN PK, 1977, J ALLERGY CLIN IMMUN, V60, P8, DOI 10.1016/0091-6749(77)90077-X; Vennemann MMT, 2005, ARCH DIS CHILD, V90, P520, DOI 10.1136/adc.2004.065581; Vlaski E, 2007, IRAN J ALLERGY ASTHM, V6, P143; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WILLIAMS LA, 1991, ASHP MIDY CLIN M, V26; Wong GWK, 2007, CLIN EXP ALLERGY, V37, P174, DOI 10.1111/j.1365-2222.2007.02649.x; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x	54	259	266	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1039	1048		10.1016/S0140-6736(08)61445-2	http://dx.doi.org/10.1016/S0140-6736(08)61445-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805332				2022-12-01	WOS:000259648500030
J	Haydon, DJ; Stokes, NR; Ure, R; Galbraith, G; Bennett, JM; Brown, DR; Baker, PJ; Barynin, VV; Rice, DW; Sedelnikova, SE; Heal, JR; Sheridan, JM; Aiwale, ST; Chauhan, PK; Srivastava, A; Taneja, A; Collins, I; Errington, J; Czaplewski, LG				Haydon, David J.; Stokes, Neil R.; Ure, Rebecca; Galbraith, Greta; Bennett, James M.; Brown, David R.; Baker, Patrick J.; Barynin, Vladimir V.; Rice, David W.; Sedelnikova, Sveta E.; Heal, Jonathan R.; Sheridan, Joseph M.; Aiwale, Sachin T.; Chauhan, Pramod K.; Srivastava, Anil; Taneja, Amit; Collins, Ian; Errington, Jeff; Czaplewski, Lloyd G.			An inhibitor of FtsZ with potent and selective anti-staphylococcal activity	SCIENCE			English	Article							DIVISION PROTEIN FTSZ; CELL-DIVISION; SMALL-MOLECULE; ANTIBIOTICS; TUBULIN; CYTOKINESIS; DISCOVERY; INSIGHTS; TARGET	FtsZ is an essential bacterial guanosine triphosphatase and homolog of mammalian beta-tubulin that polymerizes and assembles into a ring to initiate cell division. We have created a class of small synthetic antibacterials, exemplified by PC190723, which inhibits FtsZ and prevents cell division. PC190723 has potent and selective in vitro bactericidal activity against staphylococci, including methicillin- and multi- drug- resistant Staphylococcus aureus. The putative inhibitor- binding site of PC190723 was mapped to a region of FtsZ that is analogous to the Taxol- binding site of tubulin. PC190723 was efficacious in an in vivo model of infection, curing mice infected with a lethal dose of S. aureus. The data validate FtsZ as a target for antibacterial intervention and identify PC190723 as suitable for optimization into a new anti- staphylococcal therapy.	[Haydon, David J.; Stokes, Neil R.; Ure, Rebecca; Galbraith, Greta; Bennett, James M.; Brown, David R.; Collins, Ian; Errington, Jeff; Czaplewski, Lloyd G.] Prolysis, Oxford OX5 1PF, England; [Baker, Patrick J.; Barynin, Vladimir V.; Rice, David W.; Sedelnikova, Sveta E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Heal, Jonathan R.; Sheridan, Joseph M.] Prosarix, Cambridge CB22 7ZE, England; [Aiwale, Sachin T.; Chauhan, Pramod K.; Srivastava, Anil; Taneja, Amit] Jubilant Chemsys, Noida 201301, India; [Errington, Jeff] Univ Newcastle, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Sheffield; Newcastle University - UK	Stokes, NR (corresponding author), Prolysis, Begbroke Sci Pk, Oxford OX5 1PF, England.	neil.stokes@prolysis.com	Stokes, Neil/ABA-4660-2020; Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388; Baker, Patrick/0000-0003-1995-5643; Bennett, James/0000-0003-1396-8400	L. Clay and East Hill Management (Boston, MA, USA); Wellcome Trust under the Seeding Drug Discovery Initiative; UK Biotechnology and Biological Sciences Research Council; UK Department of Trade and Industry;  [AppGen55]	L. Clay and East Hill Management (Boston, MA, USA); Wellcome Trust under the Seeding Drug Discovery Initiative(Wellcome Trust); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department of Trade and Industry; 	We thank various colleagues for assistance and advice and S. Ruston for support. This work was funded by investments from L. Clay and East Hill Management (Boston, MA, USA), The Wellcome Trust under the Seeding Drug Discovery Initiative, and a grant (AppGen55) in applied genomics from the UK Biotechnology and Biological Sciences Research Council and the UK Department of Trade and Industry. D. J. H., N.R.S., R.U., G.G., J.M.B., D.R.B., I.C., and L.G.C. are or have been paid employees of Prolysis. In addition, each has been offered share options in the company. J. E. founded Prolysis and retains an equity stake (in terms of shares issued) in the organization. He is the chief scientific officer and a director of Prolysis, and for this part-time role he is paid as a consultant. All other coauthors (that is, those not affiliated with Prolysis) do not declare any conflicts of interest. The evaluation of compound activity in vivo was performed by MDS Pharma Services. Compounds are the subject of patent application PCT/GB2007/001012. The atomic coordinates and structure factors of B. subtilis FtsZ have been deposited with the Protein Data Bank under the accession numbers 2vxy and r2vxysf. The sequences of the ftsZ wild-type and mutant strains have been deposited in GenBank with the accession numbers EU914258 to EU914264.	ARNOS LA, 1999, CHEM BIOL, V6, pR65; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Lappchen T, 2005, BIOCHEMISTRY-US, V44, P7879, DOI 10.1021/bi047297o; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; O'Neill AJ, 2004, EXPERT OPIN INV DRUG, V13, P1045, DOI 10.1517/13543784.13.8.1045; Ohashi Y, 1999, J BACTERIOL, V181, P1348, DOI 10.1128/JB.181.4.1348-1351.1999; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Paradis-Bleau C, 2007, BIOORGAN MED CHEM, V15, P1330, DOI 10.1016/j.bmc.2006.11.015; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200	17	338	357	4	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1673	1675		10.1126/science.1159961	http://dx.doi.org/10.1126/science.1159961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	349RG	18801997				2022-12-01	WOS:000259300400034
J	Hiratsuka, T; Furihata, K; Ishikawa, J; Yamashita, H; Itoh, N; Seto, H; Dairi, T				Hiratsuka, Tomoshige; Furihata, Kazuo; Ishikawa, Jun; Yamashita, Haruyuki; Itoh, Nobuya; Seto, Haruo; Dairi, Tohru			An alternative menaquinone biosynthetic pathway operating in microorganisms	SCIENCE			English	Article							COMPLETE GENOME SEQUENCE; STREPTOMYCES-COELICOLOR A3(2); HELICOBACTER-PYLORI; VITAMIN-K; METABOLISM	In microorganisms, menaquinone is an obligatory component of the electron- transfer pathway. It is derived from chorismate by seven enzymes in Escherichia coli. However, a bioinformatic analysis of whole genome sequences has suggested that some microorganisms, including pathogenic species such as Helicobacter pylori and Campylobacter jejuni, do not have orthologs of the men genes, even though they synthesize menaquinone. We deduced the outline of this alternative pathway in a nonpathogenic strain of Streptomyces by bioinformatic screening, gene knockouts, shotgun cloning with isolated mutants, and in vitro studies with recombinant enzymes. As humans and commensal intestinal bacteria, including lactobacilli, lack this pathway, it represents an attractive target for the development of chemotherapeutics.	[Hiratsuka, Tomoshige; Itoh, Nobuya; Dairi, Tohru] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan; [Furihata, Kazuo] Univ Tokyo, Div Agr & Agr Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Ishikawa, Jun] Natl Inst Infect Dis, Shinjuku Ku, Dept Bioact Mol, Tokyo 1628640, Japan; [Yamashita, Haruyuki] ADEKA Corp, Adv Mat Res & Dev Lab, Arakawa Ku, Tokyo 1168553, Japan; [Seto, Haruo] Tokyo Univ Agr, Setagaya Ku, Fac Appl Biosci, Tokyo 1568502, Japan	Toyama Prefectural University; University of Tokyo; National Institute of Infectious Diseases (NIID); Tokyo University of Agriculture	Dairi, T (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan.	dairi@pu-toyama.ac.jp	Hiratsuka, Tomoshige/C-7447-2017; Dairi, Tohru/A-5448-2012	Dairi, Tohru/0000-0002-3406-7970	Grant-in-Aid for Scientific Research (B); Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics"; Ministry of Education, Culture, Sports, Science and Technology of Japan; Urakami Foundation; Skylark Food Science Institute	Grant-in-Aid for Scientific Research (B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Urakami Foundation(Urakami Foundation); Skylark Food Science Institute	This work was supported in part by a Grant-in-Aid for Scientific Research (B) to S. H. and by a Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Urakami Foundation, and the Skylark Food Science Institute to T.D. Author contributions: T.H., H.S., and T.D. conceived and designed the experiments; T.H., K.F., J.I., H.S., and T. D. performed the experiments; T.H., K.F., H.Y., N.I., H.S., and T.D. analyzed the data; and H.S. and T.D. wrote the paper. The DNA sequences determined and characterized in this study have been deposited in the DDBJ, EMBL, and GenBank data banks as follows: SCO4506, AB447888; SCO4327, AB447889; SCO4550, AB447890; SCO4326, AB447891; TTHA0556, AB447892; TTHA1568, AB447893.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; Cranenburg ECM, 2007, THROMB HAEMOSTASIS, V98, P120, DOI 10.1160/TH07-04-0266; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; HOPWOOD DA, 1985, GENE MANIPULATION ST; Hosokawa N, 1999, CHEM PHARM BULL, V47, P1032; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lamson Davis W, 2003, Altern Med Rev, V8, P303; Macheroux P, 1999, PLANTA, V207, P325, DOI 10.1007/s004250050489; Marcelli SW, 1996, FEMS MICROBIOL LETT, V138, P59; Meganathan R, 2001, VITAM HORM, V61, P173; MOSS CW, 1990, J CLIN MICROBIOL, V28, P395, DOI 10.1128/JCM.28.2.395-397.1990; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Plaza SM, 2005, ALTERN MED REV, V10, P24; Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483	22	177	187	7	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1670	1673		10.1126/science.1160446	http://dx.doi.org/10.1126/science.1160446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801996				2022-12-01	WOS:000259300400033
J	Turnbaugh, PJ; Gordon, JI				Turnbaugh, Peter J.; Gordon, Jeffrey I.			An invitation to the marriage of metagenomics and metabolomics	CELL			English	Article							MICROBIOME	Metagenomics seeks to characterize the composition of microbial communities, their operations, and their dynamically coevolving relationships with the habitats they occupy without having to culture community members. Uniting metagenomics with analyses of the products of microbial community metabolism (metabolomics) will shed light on how microbial communities function in a variety of environments, including the human body.	[Turnbaugh, Peter J.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu		Turnbaugh, Peter/0000-0002-0888-2875				DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; DRAKE HL, 2006, PROKARYOTES, V2, P354, DOI DOI 10.1007/0-387-30742-7_13; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Godzik A, 2007, CELL MOL LIFE SCI, V64, P2505, DOI 10.1007/s00018-007-7211-y; Hooper SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002607; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Prentice AM, 2008, J CLIN INVEST, V118, P1322, DOI 10.1172/JCI34034; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rezzi S, 2007, J PROTEOME RES, V6, P4469, DOI 10.1021/pr070431h; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	32	167	178	3	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					708	713		10.1016/j.cell.2008.08.025	http://dx.doi.org/10.1016/j.cell.2008.08.025			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775300	Bronze			2022-12-01	WOS:000258947500007
J	Nagano, T; Mitchell, JA; Sanz, LA; Pauler, FM; Ferguson-Smith, AC; Feil, R; Fraser, P				Nagano, Takashi; Mitchell, Jennifer A.; Sanz, Lionel A.; Pauler, Florian M.; Ferguson-Smith, Anne C.; Feil, Robert; Fraser, Peter			The Air Noncoding RNA Epigenetically Silences Transcription by Targeting G9a to Chromatin	SCIENCE			English	Article							IMPRINTED IGF2R; XIST RNA; GENES; PLACENTA; GROWTH; LOCUS; STATE	A number of large noncoding RNAs ( ncRNAs) epigenetically silence genes through unknown mechanisms. The Air ncRNA is imprinted-monoallelically expressed from the paternal allele. Air is required for allele- specific silencing of the cis- linked Slc22a3, Slc22a2, and Igf2r genes in mouse placenta. We show that Air interacts with the Slc22a3 promoter chromatin and the H3K9 histone methyltransferase G9a in placenta. Air accumulates at the Slc22a3 promoter in correlation with localized H3K9 methylation and transcriptional repression. Genetic ablation of G9a results in nonimprinted, biallelic transcription of Slc22a3. Truncated Air fails to accumulate at the Slc22a3 promoter, which results in reduced G9a recruitment and biallelic transcription. Our results suggest that Air, and potentially other large ncRNAs, target repressive histone- modifying activities through molecular interaction with specific chromatin domains to epigenetically silence transcription.	[Nagano, Takashi; Mitchell, Jennifer A.; Fraser, Peter] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England; [Nagano, Takashi] Univ Fukui, Fac Med Sci, Dept Morphol & Physiol Sci, Div Cell Biol & Neurosci, Fukui 9101193, Japan; [Sanz, Lionel A.; Feil, Robert] CNRS, Inst Mol Genet, UMR 5535, F-34293 Montpellier, France; [Sanz, Lionel A.; Feil, Robert] Univ Montpellier 2, F-34293 Montpellier, France; [Pauler, Florian M.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna Bioctr, A-1030 Vienna, Austria; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Fukui; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); University of Cambridge	Nagano, T (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge CB22 3AT, England.	takashi.nagano@bbsrc.ac.uk; peter.fraser@bbsrc.ac.uk	Ferguson-Smith, Anne C/G-7534-2011; Fraser, Peter/B-7549-2009; Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Fraser, Peter/0000-0002-0041-1227; Mitchell, Jennifer/0000-0002-7147-4604; Ferguson-Smith, Anne/0000-0002-7608-5894	Biotechnology and Biological Sciences Research Council, UK; Agence National de la Recherche and Institut National de Cancer, France; BBSRC [BBS/E/B/0000M232, BBS/E/B/0000C151, BB/D014050/1] Funding Source: UKRI; MRC [G0400156] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D014050/1, BBS/E/B/0000C151, BBS/E/B/0000M232] Funding Source: researchfish; Medical Research Council [G0400156] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agence National de la Recherche and Institut National de Cancer, France(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Segonds-Pichon for statistics, G. Kelsey and W. Reik for critical reading, D. Barlow and members of the Fraser lab for discussions. P. F. is a Senior Fellow of the Medical Research Council, UK. This work was supported by the Biotechnology and Biological Sciences Research Council, UK, and by the Agence National de la Recherche and Institut National de Cancer, France. The authors declare that they have no competing financial interests.	BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Pauler FM, 2005, GENOME RES, V15, P1379, DOI 10.1101/gr.3783805; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; Wagschal A, 2008, MOL CELL BIOL, V28, P1104, DOI 10.1128/MCB.01111-07; Wutz A, 2001, DEVELOPMENT, V128, P1881; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	19	714	782	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1717	1720		10.1126/science.1163802	http://dx.doi.org/10.1126/science.1163802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	18988810				2022-12-01	WOS:000261608300052
J	Moritz, CT; Perlmutter, SI; Fetz, EE				Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.			Direct control of paralysed muscles by cortical neurons	NATURE			English	Article							MOTOR CORTEX CELLS; INTRASPINAL MICROSTIMULATION; ARM MUSCLES; MOVEMENT; COMPUTER; MONKEYS; NEUROPROSTHESIS; STIMULATION; PROSTHESIS; PLASTICITY	A potential treatment for paralysis resulting from spinal cord injury is to route control signals from the brain around the injury by artificial connections. Such signals could then control electrical stimulation of muscles, thereby restoring volitional movement to paralysed limbs(1-3). In previously separate experiments, activity of motor cortex neurons related to actual or imagined movements has been used to control computer cursors and robotic arms(4-10), and paralysed muscles have been activated by functional electrical stimulation(11-13). Here we show that Macaca nemestrina monkeys can directly control stimulation of muscles using the activity of neurons in the motor cortex, thereby restoring goal-directed movements to a transiently paralysed arm. Moreover, neurons could control functional stimulation equally well regardless of any previous association to movement, a finding that considerably expands the source of control signals for brain- machine interfaces. Monkeys learned to use these artificial connections from cortical cells to muscles to generate bidirectional wrist torques, and controlled multiple neuron - muscle pairs simultaneously. Such direct transforms from cortical activity to muscle stimulation could be implemented by autonomous electronic circuitry, creating a relatively natural neuroprosthesis. These results are the first demonstration that direct artificial connections between cortical cells and muscles can compensate for interrupted physiological pathways and restore volitional control of movement to paralysed limbs.	[Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moritz, CT (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	ctmoritz@u.washington.edu		Perlmutter, Steve/0000-0002-1149-4152	National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040867, F32NS051013, R37NS012542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Shupe for programming assistance, C. Kent and L. Miller for advice on nerve block, C. Kirby, A. Price and K. McElwain for animal care, and A. Jackson, Y. Nishimura and A. Richardson for comments on the manuscript. This work was supported by grants from the National Institutes of Health.	Batschelet E., 1981, CIRCULAR STAT BIOL; BRINKMAN C, 1983, SCIENCE, V220, P438, DOI 10.1126/science.6836289; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fagg AH, 2007, J NEUROSCI, V27, P11842, DOI 10.1523/JNEUROSCI.3516-07.2007; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1975, EXP BRAIN RES, V23, P217; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Jackson A, 2007, J NEUROPHYSIOL, V97, P360, DOI 10.1152/jn.00710.2006; Jackson A, 2006, IEEE T NEUR SYS REH, V14, P187, DOI 10.1109/TNSRE.2006.875547; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kuiken TA, 2004, PROSTHET ORTHOT INT, V28, P245; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; Lemay MA, 2004, J NEUROPHYSIOL, V91, P502, DOI 10.1152/jn.00235.2003; LOEB GE, 1985, J NEUROPHYSIOL, V54, P565, DOI 10.1152/jn.1985.54.3.565; Mavoori J, 2005, J NEUROSCI METH, V148, P71, DOI 10.1016/j.jneumeth.2005.04.017; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Mushahwar VK, 2002, IEEE T NEUR SYS REH, V10, P68, DOI 10.1109/TNSRE.2002.1021588; NANNINI N, 1991, IEEE T BIO-MED ENG, V38, P769, DOI 10.1109/10.83589; Nudo RJ, 1996, J NEUROSCI, V16, P785; Peckham PH, 2002, J HAND SURG-AM, V27A, P265, DOI 10.1053/jhsu.2002.30919; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Stein RB, 2002, ARCH ITAL BIOL, V140, P273; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; WOOLSEY CN, 1950, RES PUBL ASSOC RES N, V30, P238	33	392	409	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					639	U63		10.1038/nature07418	http://dx.doi.org/10.1038/nature07418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18923392	Green Accepted			2022-12-01	WOS:000261340000041
J	Yen, HCS; Xu, QK; Chou, DM; Zhao, ZM; Elledge, SJ				Yen, Hsueh-Chi Sherry; Xu, Qikai; Chou, Danny M.; Zhao, Zhenming; Elledge, Stephen J.			Global Protein Stability Profiling in Mammalian Cells	SCIENCE			English	Article							PROTEASOME-MEDIATED DEGRADATION; SCFFBW7 UBIQUITIN LIGASE; CYCLIN-E; SACCHAROMYCES-CEREVISIAE; HUMAN-DISEASES; PHOSPHORYLATION; PROTEOMICS; SYSTEM; PATHOGENESIS; DESTRUCTION	The abundance of cellular proteins is determined largely by the rate of transcription and translation coupled with the stability of individual proteins. Although we know a great deal about global transcript abundance, little is known about global protein stability. We present a highly parallel multiplexing strategy to monitor protein turnover on a global scale by coupling flow cytometry with microarray technology to track the stability of individual proteins within a complex mixture. We demonstrated the feasibility of this approach by measuring the stability of similar to 8000 human proteins and identifying proteasome substrates. The technology provides a general platform for proteome- scale analysis of protein turnover under various physiological and disease conditions.	[Yen, Hsueh-Chi Sherry; Xu, Qikai; Chou, Danny M.; Zhao, Zhenming; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	Jane Coffin Childs Memorial Fund fellow; National Science Foundation; NIH [AG11085]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund fellow; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Vidal, J. W. Harper, G. Hu, and J. Jin for the hORFome v1.1 library; J. Daly and S. Lazo-Kallanian for FACS assistance; and J. Love, S. Gupta, and K. Hurov for helpful discussions. H.-C.S.Y. is a Jane Coffin Childs Memorial Fund fellow. D.M.C. is supported by the National Science Foundation. This work is supported by an NIH grant AG11085 to J.W.H. and S.J.E. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Matsuzawa S, 2005, P NATL ACAD SCI USA, V102, P14982, DOI 10.1073/pnas.0507512102; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Sun Y, 2003, CANCER BIOL THER, V2, P623; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462	33	318	332	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					918	923		10.1126/science.1160489	http://dx.doi.org/10.1126/science.1160489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988847				2022-12-01	WOS:000260674100040
J	Kesselheim, AS				Kesselheim, Aaron S.			Drug Development for Neglected Diseases - The Trouble with FDA Review Vouchers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEVELOPING-COUNTRIES; MARKET		Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Love J, 2007, CHI KENT L REV, V82, P1519; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7	4	35	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1981	1983		10.1056/NEJMp0806684	http://dx.doi.org/10.1056/NEJMp0806684			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368OW	18987367				2022-12-01	WOS:000260632700002
J	Regard, JB; Sato, IT; Coughlin, SR				Regard, Jean B.; Sato, Isaac T.; Coughlin, Shaun R.			Anatomical Profiling of G Protein-Coupled Receptor Expression	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; NICOTINIC-ACID; FUNCTIONAL EXPRESSION; CHEMOKINE RECEPTOR; MICE LACKING; MOLECULAR-IDENTIFICATION; SACCHAROMYCES-CEREVISIAE; PARATHYROID-HORMONE; GABA(B) RECEPTOR; LYMPHOID ORGANS	G protein-coupled receptors (GPCRs) comprise the largest family of transmembrane signaling molecules and regulate a host of physiological and disease processes. To better understand the functions of GPCRs in vivo, we quantified transcript levels of 353 nonodorant GPCRs in 41 adult mouse tissues. Cluster analysis placed many GPCRs into anticipated anatomical and functional groups and predicted previously unidentified roles for less-studied receptors. From one such prediction, we showed that the Gpr91 ligand succinate can regulate lipolysis in white adipose tissue, suggesting that signaling by this citric acid cycle intermediate may regulate energy homeostasis. We also showed that pairwise analysis of GPCR expression across tissues may help predict drug side effects. This resource will aid studies to understand GPCR function in vivo and may assist in the identification of therapeutic targets.	[Regard, Jean B.; Sato, Isaac T.; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Regard, JB (corresponding author), NHGRI, NIH, Bldg 49,Room 4C60,49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	regardj@mail.nih.gov; shaun.coughlin@ucsf.edu			National Institutes of Health; Sandler Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065185, R01HL044907, R01HL065590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Coughlin lab for valuable discussions, Ivo Cornelissen, Gerard Honig, and Grant Li, for technical assistance in isolating mouse tissues, and Stuart Peirson for sharing qPCR efficiency transformations. We also thank Dale Webster and Joseph Derisi for help with informatics, Silvio Gutkind for providing the Adrb2 construct, and Bryan Roth for critical reading of the manuscript. This work was supported by the National Institutes of Health (S.R.C.) and Sandler Family Foundation (J.B.R.).	Amizuka N, 1997, ENDOCRINOLOGY, V138, P469, DOI 10.1210/en.138.1.469; Bates B, 2006, BRAIN RES, V1087, P1, DOI 10.1016/j.brainres.2006.02.123; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; BUTCHER RW, 1970, ACTA PHYSIOL SCAND, V79, P559, DOI 10.1111/j.1748-1716.1970.tb04758.x; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Cheng ZQ, 2007, ENDOCRINOLOGY, V148, P4984, DOI 10.1210/en.2007-0653; CHIU MI, 1994, GENOMICS, V21, P440, DOI 10.1006/geno.1994.1292; COHEN AI, 1992, P NATL ACAD SCI USA, V89, P12093, DOI 10.1073/pnas.89.24.12093; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Date Y, 2000, MOL BRAIN RES, V76, P1, DOI 10.1016/S0169-328X(99)00317-4; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Forni LG, 2005, CRIT CARE, V9, pR591, DOI 10.1186/cc3806; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; HOCHACHKA PW, 1976, EUR J APPL PHYSIOL O, V35, P235, DOI 10.1007/BF00423282; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Joost P, 2002, GENOME BIOL, V3; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; KREBS HA, 1950, ANNU REV BIOCHEM, V19, P409, DOI 10.1146/annurev.bi.19.070150.002205; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kumar U, 1997, ENDOCRINOLOGY, V138, P4473, DOI 10.1210/en.138.10.4473; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kushnir MM, 2001, CLIN CHEM, V47, P1993; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lorsignol A, 1999, J NEUROENDOCRINOL, V11, P171; LOVENBERG TW, 1993, NEURON, V11, P449, DOI 10.1016/0896-6273(93)90149-L; Malone MH, 2004, J BIOL CHEM, V279, P52850, DOI 10.1074/jbc.M408040200; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Mazella J, 1996, J NEUROSCI, V16, P5613; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; MORENO FJ, 1983, J BIOL CHEM, V258, P938; MOSKOWITZ J, 1969, J CLIN INVEST, V48, P1802, DOI 10.1172/JCI106146; Muller G, 2000, CURR MED CHEM, V7, P861, DOI 10.2174/0929867003374534; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NORDMANN J, 1961, ADV CLIN CHEM, V4, P53, DOI 10.1016/S0065-2423(08)60035-9; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Popova N K, 2007, Neurosci Behav Physiol, V37, P631, DOI 10.1007/s11055-007-0062-z; Rao S, 1999, J BIOL CHEM, V274, P34245, DOI 10.1074/jbc.274.48.34245; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; SHUSTER DE, 1995, SCIENCE, V269, P1590, DOI 10.1126/science.7667641; SIMONIN F, 1995, P NATL ACAD SCI USA, V92, P7006, DOI 10.1073/pnas.92.15.7006; SINHA TK, 1976, METABOLISM, V25, P251, DOI 10.1016/0026-0495(76)90083-4; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Soto H, 1998, P NATL ACAD SCI USA, V95, P8205, DOI 10.1073/pnas.95.14.8205; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; TSUTSUMI M, 1992, MOL ENDOCRINOL, V6, P1163, DOI 10.1210/me.6.7.1163; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Valet P, 1998, J CLIN INVEST, V101, P1431, DOI 10.1172/JCI806; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626	94	442	466	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					561	571		10.1016/j.cell.2008.08.040	http://dx.doi.org/10.1016/j.cell.2008.08.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984166	Bronze, Green Accepted			2022-12-01	WOS:000260536300025
J	Stephenson, AE; DeYoreo, JJ; Wu, L; Wu, KJ; Hoyer, J; Dove, PM				Stephenson, A. E.; DeYoreo, J. J.; Wu, L.; Wu, K. J.; Hoyer, J.; Dove, P. M.			Peptides Enhance Magnesium Signature in Calcite: Insights into Origins of Vital Effects	SCIENCE			English	Article							GROWTH; SURFACE; SUPERSATURATION; TEMPERATURE; PRECIPITATION; DESOLVATION; INHIBITION; CARBONATE; PROTEINS; KINETICS	Studies relating the magnesium (Mg) content of calcified skeletons to temperature often report unexplained deviations from the signature expected for inorganically grown calcite. These "vital effects" are believed to have biological origins, but mechanistic bases for measured offsets remain unclear. We show that a simple hydrophilic peptide, with the same carboxyl- rich character as that of macromolecules isolated from sites of calcification, increases calcite Mg content by up to 3 mole percent. Comparisons to previous studies correlating Mg content of carbonate minerals with temperature show that the Mg enhancement due to peptides results in offsets equivalent to 7 degrees to 14 degrees C. The insights also provide a physical basis for anecdotal evidence that organic chemistry modulates the mineralization of inorganic carbonates and suggest an approach to tuning impurity levels in controlled materials synthesis.	[Stephenson, A. E.; Dove, P. M.] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA; [DeYoreo, J. J.; Wu, L.; Wu, K. J.] Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94551 USA; [Wu, L.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; [Hoyer, J.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; University of Delaware	Stephenson, AE (corresponding author), Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA.	aestephe@vt.edu; dove@vt.edu	Wu, Ligang/C-7770-2009; yu, yu/C-7781-2009; Dove, Patricia M/A-7911-2010		NSF [OCE-052667]; U.S. Department of Energy [FG02-00ER15112]	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE))	We thank J.F. Read and D. Rimstidt for thoughtful discussions. This research was supported by awards to P.M.D. from the NSF (grant OCE-052667) and U. S. Department of Energy (grant FG02-00ER15112). This work was also performed under the auspices of the U.S. DOE by an award to J.D.Y. at the University of California, Lawrence Livermore National Laboratory, under Contract No. W-7405-Eng-48. Opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF or DOE.	ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; ADDADI L, 1990, CROAT CHEM ACTA, V63, P539; Astilleros JM, 2003, GEOCHIM COSMOCHIM AC, V67, P1601, DOI 10.1016/S0016-7037(02)01166-3; Bentov S, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001015; BERNER RA, 1978, AM J SCI, V278, P816, DOI 10.2475/ajs.278.6.816; CARTER PW, 1978, GEOCHIM COSMOCHIM AC, V42, P1231, DOI 10.1016/0016-7037(78)90116-3; Chernov AA, 1998, MATER SCI FORUM, V276-2, P57, DOI 10.4028/www.scientific.net/MSF.276-277.57; CHILINGAR GEORGE V., 1962, BULL SOUTHERN CALIFORNIA ACAD SCI, V61, P45; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; DEYOREO JJ, 2007, 233 ANN M AM CHEM SO; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; EPSTEIN S, 1951, GEOL SOC AM BULL, V62, P417, DOI 10.1130/0016-7606(1951)62[417:CITS]2.0.CO;2; Falini G, 1996, CHEM COMMUN, P1037, DOI 10.1039/cc9960001037; FOLK RL, 1974, J SEDIMENT PETROL, V44, P40; Fu G, 2005, ADV MATER, V17, P2678, DOI 10.1002/adma.200500633; FUCHTBAUER H, 1976, GEOL SOC AM ABSTR, V8, P87719; Gledhill DK, 2006, GEOCHIM COSMOCHIM AC, V70, P5802, DOI 10.1016/j.gca.2006.03.024; Huheey JE., 1983, INORGANIC CHEM PRINC; KATZ A, 1973, GEOCHIM COSMOCHIM AC, V37, P1563, DOI 10.1016/0016-7037(73)90091-4; Kowacz M, 2007, GEOCHIM COSMOCHIM AC, V71, P5168, DOI 10.1016/j.gca.2007.09.008; Lea D. W., 2003, OCEANS MARINE GEOCHE, DOI DOI 10.1016/B0-08-043751-6/06114-4; LORENS RB, 1981, GEOCHIM COSMOCHIM AC, V45, P553, DOI 10.1016/0016-7037(81)90188-5; MUCCI A, 1987, GEOCHIM COSMOCHIM AC, V51, P1977, DOI 10.1016/0016-7037(87)90186-4; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Piana S, 2006, J AM CHEM SOC, V128, P13568, DOI 10.1021/ja064706q; Prieto M, 2007, AM J SCI, V307, P1034, DOI 10.2475/07.2007.04; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Reeder RJ, 1996, GEOCHIM COSMOCHIM AC, V60, P1543, DOI 10.1016/0016-7037(96)00034-8; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Vinogradov AP., 1953, ELEMENTARY CHEM COMP; Wasylenki LE, 2005, GEOCHIM COSMOCHIM AC, V69, P4227, DOI 10.1016/j.gca.2005.04.006; Weaver ML, 2007, J CRYST GROWTH, V306, P135, DOI 10.1016/j.jcrysgro.2007.04.053	36	120	127	0	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					724	727		10.1126/science.1159417	http://dx.doi.org/10.1126/science.1159417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974348				2022-12-01	WOS:000260605200043
J	Singh, R; Jamieson, A; Cresswell, P				Singh, Reshma; Jamieson, Amanda; Cresswell, Peter			GILT is a critical host factor for Listeria monocytogenes infection	NATURE			English	Article							THIOL REDUCTASE GILT; MATURATION; HEPATOCYTES; CYTOLYSINS; MUTANTS; PEPTIDE; COMPLEX; PREPORE; SPREAD; GROWTH	Listeria monocytogenes is a Gram- positive, intracellular, foodborne pathogen that can cause severe illness in humans and animals. On infection, it is actively phagocytosed by macrophages(1); it then escapes from the phagosome, replicates in the cytosol, and subsequently spreads from cell to cell by a non- lytic mechanism driven by actin polymerization(2). Penetration of the phagosomal membrane is initiated by the secreted haemolysin listeriolysin O ( LLO), which is essential for vacuolar escape in vitro and for virulence in animal models of infection(3). Reduction is required to activate the lytic activity of LLO in vitro(4-6), and we show here that reduction by the enzyme gamma-interferon- inducible lysosomal thiol reductase ( GILT, also called Ifi30) is responsible for the activation of LLO in vivo. GILT is a soluble thiol reductase expressed constitutively within the lysosomes of antigen- presenting cells(7,8), and it accumulates in macrophage phagosomes as they mature into phagolysosomes(9). The enzyme is delivered by a mannose-6-phosphate receptor- dependent mechanism to the endocytic pathway, where amino- and carboxy- terminal pro- peptides are cleaved to generate a 30- kDa mature enzyme(7,8,10). The active site of GILT contains two cysteine residues in a CXXC motif that catalyses the reduction of disulphide bonds(7,8). Mice lacking GILT are deficient in generating major histocompatibility complex class- II- restricted CD4(+) T-cell responses to protein antigens that contain disulphide bonds(11,12). Here we show that these mice are resistant to L. monocytogenes infection. Replication of the organism in GILT- negative macrophages, or macrophages expressing an enzymatically inactive GILT mutant, is impaired because of delayed escape from the phagosome. GILT activates LLO within the phagosome by the thiol reductase mechanism shared by members of the thioredoxin family. In addition, purified GILT activates recombinant LLO, facilitating membrane permeabilization and red blood cell lysis. The data show that GILT is a critical host factor that facilitates L. monocytogenes infection.	[Singh, Reshma; Jamieson, Amanda; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06250 USA; [Singh, Reshma; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06250 USA	Yale University; Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06250 USA.	peter.cresswell@yale.edu	Jamieson, Amanda/U-7169-2019	Jamieson, Amanda/0000-0002-5781-9231	NIH [AI023081]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023081, R37AI023081] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to D. Portnoy for advice and reagents, and to N. Dometios for manuscript preparation. We acknowledge the valuable contribution of the late M. Pypaert to the electron microscopy. This work was supported by NIH AI023081 (P.C.) and the Howard Hughes Medical Institute (P.C., R.S.).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; ALOUF JE, 2005, BACT TOXINS COMPREHE, P643; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; BARRY RA, 1992, INFECT IMMUN, V60, P1625, DOI 10.1128/IAI.60.4.1625-1632.1992; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bouwer HGA, 1998, INFECT IMMUN, V66, P2814, DOI 10.1128/IAI.66.6.2814-2817.1998; BRYANT RE, 1980, J INFECT DIS, V142, P594, DOI 10.1093/infdis/142.4.594; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; GEOFFROY C, 1987, INFECT IMMUN, V55, P1641, DOI 10.1128/IAI.55.7.1641-1646.1987; Haschtmann D, 2005, MICROBES INFECT, V7, P1177, DOI 10.1016/j.micinf.2005.03.031; Hastings KT, 2006, J IMMUNOL, V177, P8569, DOI 10.4049/jimmunol.177.12.8569; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; Lackman RL, 2006, J IMMUNOL, V177, P4833, DOI 10.4049/jimmunol.177.7.4833; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; PAMER EG, 1992, CELL, V70, P215, DOI 10.1016/0092-8674(92)90097-V; Phan UT, 2002, P NATL ACAD SCI USA, V99, P12298, DOI 10.1073/pnas.182430499; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; PINKNEY M, 1989, INFECT IMMUN, V57, P2553, DOI 10.1128/IAI.57.8.2553-2558.1989; Pizarro-Cerda J, 2004, CR BIOL, V327, P521, DOI 10.1016/j.crvi.2004.05.001; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Sealy R, 2008, CLIN VACCINE IMMUNOL, V15, P713, DOI 10.1128/CVI.00412-07; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Walker KW, 1997, J BIOL CHEM, V272, P8845; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x	30	112	116	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1244	U55		10.1038/nature07344	http://dx.doi.org/10.1038/nature07344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815593	Green Accepted			2022-12-01	WOS:000260462100045
J	Stice, E; Spoor, S; Bohon, C; Small, DM				Stice, E.; Spoor, S.; Bohon, C.; Small, D. M.			Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele	SCIENCE			English	Article							DOPAMINE-RECEPTOR GENE; BINDING CHARACTERISTICS; HEALTHY-VOLUNTEERS; ZUCKER RATS; REWARD; POLYMORPHISMS; REINFORCEMENT; ASSOCIATION; EXPRESSION; PREDICTION	The dorsal striatum plays a role in consummatory food reward, and striatal dopamine receptors are reduced in obese individuals, relative to lean individuals, which suggests that the striatum and dopaminergic signaling in the striatum may contribute to the development of obesity. Thus, we tested whether striatal activation in response to food intake is related to current and future increases in body mass and whether these relations are moderated by the presence of the A1 allele of the TaqIA restriction fragment length polymorphism, which is associated with dopamine D2 receptor (DRD2) gene binding in the striatum and compromised striatal dopamine signaling. Cross- sectional and prospective data from two functional magnetic resonance imaging studies support these hypotheses, which implies that individuals may overeat to compensate for a hypofunctioning dorsal striatum, particularly those with genetic polymorphisms thought to attenuate dopamine signaling in this region.	[Stice, E.; Spoor, S.; Bohon, C.] Oregon Res Inst, Eugene, OR 97403 USA; [Stice, E.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Bohon, C.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Small, D. M.] John B Pierce Fdn Lab, New Haven, CT 06519 USA; [Small, D. M.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA	Oregon Research Institute; University of Texas System; University of Texas Austin; University of Oregon; Yale University; The John B Pierce Laboratory, Inc; Yale University	Stice, E (corresponding author), Oregon Res Inst, 1715 Franklin Blvd, Eugene, OR 97403 USA.	estice@ori.org	Kauk, Rachel C/H-3622-2012	Bohon, Cara/0000-0001-9978-3727; Small, Dana/0000-0001-7363-1100	NIMH NIH HHS [F31 MH081588, F31 MH081588-01A2, R01 MH064560, R01 MH064560-05] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064560, F31MH081588] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Blum K, 1996, PHARMACOGENETICS, V6, P297, DOI 10.1097/00008571-199608000-00003; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Comings DE, 2000, PROG BRAIN RES, V126, P325; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; de Leon J, 2007, J CLIN PSYCHOPHARM, V27, P22, DOI 10.1097/JCP.0b013e31802e513a; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Fetissov SO, 2002, AM J PHYSIOL-REG I, V283, pR905, DOI 10.1152/ajpregu.00092.2002; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kelley AE, 2003, EUR J NEUROSCI, V18, P2592, DOI 10.1046/j.1460-9568.2003.02991.x; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Laruelle M, 1998, MOL PSYCHIATR, V3, P261, DOI 10.1038/sj.mp.4000343; Leddy JJ, 2004, OBES RES, V12, P224, DOI 10.1038/oby.2004.29; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; Orosco M, 1996, APPETITE, V26, P1, DOI 10.1006/appe.1996.0001; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Spitz MR, 2000, NUTR RES, V20, P371, DOI 10.1016/S0271-5317(00)00130-5; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Tataranni PA, 2001, DIABETES, V50, P901, DOI 10.2337/diabetes.50.4.901; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tupala E, 2003, NEUROIMAGE, V19, P145, DOI 10.1016/S1053-8119(03)00060-0; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang Gene-Jack, 2002, Expert Opin Ther Targets, V6, P601, DOI 10.1517/14728222.6.5.601; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6	33	602	614	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					449	452		10.1126/science.1161550	http://dx.doi.org/10.1126/science.1161550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927395	Green Accepted			2022-12-01	WOS:000260094500049
J	Simmons, C; Farrar, J				Simmons, Cameron; Farrar, Jeremy			Insights into inflammation and influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							H5N1 INFECTION		[Simmons, Cameron; Farrar, Jeremy] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford	Simmons, C (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.		Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022	Simmons, Cameron P/0000-0002-9039-7392; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust [079864] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	5	37	40	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1621	1623		10.1056/NEJMcibr0805865	http://dx.doi.org/10.1056/NEJMcibr0805865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843127	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000259903100015
J	Mandal, PK; Kazazian, HH				Mandal, Prabhat K.; Kazazian, Haig H., Jr.			SnapShot: Vertebrate transposons	CELL			English	Editorial Material							GENOME; ELEMENTS		[Mandal, Prabhat K.; Kazazian, Haig H., Jr.] Hosp Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Mandal, PK (corresponding author), Hosp Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.							Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Volff JN, 2003, TRENDS GENET, V19, P674, DOI 10.1016/j.tig.2003.10.006; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wicker T, 2005, GENOME RES, V15, P126, DOI 10.1101/gr.2438005	8	54	56	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1							192.e1	10.1016/j.cell.2008.09.028	http://dx.doi.org/10.1016/j.cell.2008.09.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854165	Bronze			2022-12-01	WOS:000259728100021
J	Williams, RS; Moncalian, G; Williams, JS; Yamada, Y; Limbo, O; Shin, DS; Groocock, LM; Cahill, D; Hitomi, C; Guenther, G; Moiani, D; Carney, JP; Russell, P; Tainer, JA				Williams, R. Scott; Moncalian, Gabriel; Williams, Jessica S.; Yamada, Yoshiki; Limbo, Oliver; Shin, David S.; Groocock, Lynda M.; Cahill, Dana; Hitomi, Chiharu; Guenther, Grant; Moiani, Davide; Carney, James P.; Russell, Paul; Tainer, John A.			Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair	CELL			English	Article							TELANGIECTASIA-LIKE DISORDER; SACCHAROMYCES-CEREVISIAE MRE11; STRUCTURAL BASIS; DAMAGE RESPONSE; PROTEIN COMPLEX; ATM ACTIVATION; REPLICATION; RECOMBINATION; BINDING; RAD50	Mre11 forms the core of the multifunctional Mre11-Rad50-Nbs1 (MRN) complex that detects DNA double-strand breaks (DSBs), activates the ATM checkpoint kinase, and initiates homologous recombination (HR) repair of DSBs. To define the roles of Mre11 in both DNA bridging and nucleolytic processing during initiation of DSB repair, we combined small-angle X-ray scattering (SAXS) and crystal structures of Pyrococcus furiosus Mre11 dimers bound to DNA with mutational analyses of fission yeast Mre11. The Mre11 dimer adopts a four-lobed U-shaped structure that is critical for proper MRN complex assembly and for binding and aligning DNA ends. Further, mutations blocking Mre11 endonuclease activity impair cell survival after DSB induction without compromising MRN complex assembly or Mre11-dependant recruitment of Ctp1, an HR factor, to DSBs. These results show how Mre11 dimerization and nuclease activities initiate repair of DSBs and collapsed replication forks, as well as provide a molecular foundation for understanding cancer-causing Mre11 mutations in ataxia telangiectasia-like disorder (ATLD).	[Williams, R. Scott; Moncalian, Gabriel; Williams, Jessica S.; Yamada, Yoshiki; Limbo, Oliver; Shin, David S.; Groocock, Lynda M.; Hitomi, Chiharu; Guenther, Grant; Moiani, Davide; Russell, Paul; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Russell, Paul] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Williams, R. Scott; Moncalian, Gabriel; Shin, David S.; Hitomi, Chiharu; Moiani, Davide; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cahill, Dana; Carney, James P.] Univ Maryland, Sch Med, Radiat Oncol Res Lab, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Dept Mol Biol, Berkeley, CA 94720 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Russell, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB4, La Jolla, CA 92037 USA.	prussell@scripps.edu; jat@scripps.edu	moiani, davide/AAX-6790-2021; Moncalian, Gabriel/K-3493-2014; Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022; Williams, R Scott/A-6059-2015	Moncalian, Gabriel/0000-0002-3007-6490; Tainer, John/0000-0003-1659-2429; Williams, R Scott/0000-0002-4610-8397; Limbo, Oliver/0000-0003-1686-1414	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Skaggs Institute for Chemical Biology; Uehara Memorial Foundation; National Cancer Institute [CA117638, CA92584, CA77325]; U.S. Department of Energy programs IDAT; MAGGIE [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [R01CA117638, R01CA077325, P01CA092584] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Skaggs Institute for Chemical Biology; Uehara Memorial Foundation(Uehara Memorial Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy programs IDAT(United States Department of Energy (DOE)); MAGGIE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.S.W. is supported by the Canadian Institutes of Health Research, the Alberta Heritage Foundation for Medical Research, and the Skaggs Institute for Chemical Biology fellowships. Y.Y. is supported by a Uehara Memorial Foundation fellowship. Work on the Mre11 complex in the authors' laboratories is supported in part by National Cancer Institute grants CA117638, CA92584, and CA77325. Lawrence Berkeley National Laboratory efforts are supported in part by U.S. Department of Energy programs IDAT (for Integrating crystallography and X-ray scattering) and MAGGIE (for defining Pyrococus complexes) under contract number DE-AC02-05CH11231. We thank Scott Classen, Michal Hammel, Greg Hura, and Susan Tsutakawa for assistance with SAXS and X-ray data collection at the Advanced Light Source SIBYLS beamline and Brian Chapados for discussions and comments.	Bressan DA, 1998, GENETICS, V150, P591; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chahwan C, 2003, MOL CELL BIOL, V23, P6564, DOI 10.1128/MCB.23.18.6564-6573.2003; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Manolis KG, 2001, EMBO J, V20, P210, DOI 10.1093/emboj/20.1.210; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Moreau S, 2001, GENETICS, V159, P1423; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rattray AJ, 2001, GENETICS, V158, P109; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	41	359	363	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					97	109		10.1016/j.cell.2008.08.017	http://dx.doi.org/10.1016/j.cell.2008.08.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854158	Green Accepted, Bronze			2022-12-01	WOS:000259728100012
J	Seehausen, O; Terai, Y; Magalhaes, IS; Carleton, KL; Mrosso, HDJ; Miyagi, R; van der Sluijs, I; Schneider, MV; Maan, ME; Tachida, H; Imai, H; Okada, N				Seehausen, Ole; Terai, Yohey; Magalhaes, Isabel S.; Carleton, Karen L.; Mrosso, Hillary D. J.; Miyagi, Ryutaro; van der Sluijs, Inke; Schneider, Maria V.; Maan, Martine E.; Tachida, Hidenori; Imai, Hiroo; Okada, Norihiro			Speciation through sensory drive in cichlid fish	NATURE			English	Article							LAKE VICTORIA CICHLIDS; TUNING SPECTRAL SENSITIVITY; OPSIN GENE-EXPRESSION; SEXUAL SELECTION; REPRODUCTIVE ISOLATION; MOLECULAR EVOLUTION; COLOR-VISION; DIVERGENT SELECTION; ADAPTIVE DIVERGENCE; NATURAL-SELECTION	Theoretically, divergent selection on sensory systems can cause speciation through sensory drive. However, empirical evidence is rare and incomplete. Here we demonstrate sensory drive speciation within island populations of cichlid fish. We identify the ecological and molecular basis of divergent evolution in the cichlid visual system, demonstrate associated divergence in male colouration and female preferences, and show subsequent differentiation at neutral loci, indicating reproductive isolation. Evidence is replicated in several pairs of sympatric populations and species. Variation in the slope of the environmental gradients explains variation in the progress towards speciation: speciation occurs on all but the steepest gradients. This is the most complete demonstration so far of speciation through sensory drive without geographical isolation. Our results also provide a mechanistic explanation for the collapse of cichlid fish species diversity during the anthropogenic eutrophication of Lake Victoria.	[Seehausen, Ole; Magalhaes, Isabel S.] Univ Bern, Inst Zool, CH-3012 Bern, Switzerland; [Seehausen, Ole; Magalhaes, Isabel S.; Schneider, Maria V.] Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-6047 Kastanienbaum, Switzerland; [Terai, Yohey; Miyagi, Ryutaro; Okada, Norihiro] Tokyo Inst Technol, Midori Ku, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Carleton, Karen L.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Mrosso, Hillary D. J.] Mwanza Ctr, Tanzania Fisheries Res Inst, Mwanza, Tanzania; [van der Sluijs, Inke; Maan, Martine E.] Leiden Univ, Dept Anim Ecol, Inst Biol, NL-2300 RA Leiden, Netherlands; [Tachida, Hidenori] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; [Imai, Hiroo] Kyoto Univ, Dept Cellular & Mol Biol, Primate Res Inst, Kyoto 4848506, Japan	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Tokyo Institute of Technology; University System of Maryland; University of Maryland College Park; Leiden University; Leiden University - Excl LUMC; Kyushu University; Kyoto University	Seehausen, O (corresponding author), Univ Bern, Inst Zool, Baltzerstr 6, CH-3012 Bern, Switzerland.	ole.seehausen@aqua.unibe.ch; nokada@bio.titech.ac.jp	Maan, Martine/B-5444-2008; Seehausen, Ole/C-8272-2011; Schneider, Maria Victoria/E-6317-2010; TATSUTA, HARUKI/F-2997-2010	Maan, Martine/0000-0003-1113-8067; Seehausen, Ole/0000-0001-6598-1434; Carleton, Karen/0000-0001-6306-5643; Okada, Norihiro/0000-0002-3655-8060; Schneider, Maria Victoria/0000-0002-7114-2060; Santos Magalhaes, Isabel/0000-0003-2391-3577; Imai, Hiroo/0000-0003-0729-0322; Mrosso, Hillary Deogratias John/0000-0003-1924-7268	Swiss National Science Foundation [3100A0-106573]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We acknowledge the Tanzania Commission for Science & Technology for research permissions, the Tanzania Fisheries Research Institute, and its Muranza Centre director E. F. B. Katunzi, for hospitality and logistical support; M. Kayeba, M. Haluna, S. Mwaiko, M. Haesler and E. Burgerhout for help with data and fish collection; H. Araki, L. Excoffier, L. Harmon, B. Ibelings, I. Keller, T. Kocher, P. Nosil, M. Pierotti, D. Schluter, A. Sivasundar and O. Svensson for comments on the manuscript; and M. Kawata, J. J. M. van Alphen, K. Young, R. Stelkens and E. Bezault for discussion. This work was supported by Swiss National Science Foundation project 3100A0-106573 (to O.S.), and by the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N.O.).	ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Belkhir K.P.B., 1996, GENETIX VERSION 4 05; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Carleton KL, 2005, MOL ECOL, V14, P4341, DOI 10.1111/j.1365-294X.2005.02735.x; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Chunco AJ, 2007, EVOLUTION, V61, P2504, DOI 10.1111/j.1558-5646.2007.00213.x; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gavrilets S, 2004, FITNESS LANDSCAPES O; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Haesler MP, 2005, P ROY SOC B-BIOL SCI, V272, P237, DOI 10.1098/rspb.2004.2946; HUDSON RR, 1987, GENETICS, V116, P153; Kawata M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-99; Leimar O, 2008, EVOLUTION, V62, P807, DOI 10.1111/j.1558-5646.2008.00334.x; Levring T., 1956, OIKOS, V7, P98; Maan ME, 2006, AM NAT, V167, P947, DOI 10.1086/503532; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; McDonald JH, 1998, MOL BIOL EVOL, V15, P377, DOI 10.1093/oxfordjournals.molbev.a025934; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Okullo W, 2007, APPL OPTICS, V46, P8553, DOI 10.1364/AO.46.008553; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Seehausen O., 1996, LAKE VICTORIA ROCK C; Shichida Yoshinori, 1999, P23; Smit SA, 1997, NETH J ZOOL, V47, P9; Spady TC, 2005, MOL BIOL EVOL, V22, P1412, DOI 10.1093/molbev/msi137; Stelkens RB, 2008, PHILOS T R SOC B, V363, P2861, DOI 10.1098/rstb.2008.0049; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Terai Y, 2002, P NATL ACAD SCI USA, V99, P15501, DOI 10.1073/pnas.232561099; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; van der Sluijs I, 2008, BEHAV ECOL, V19, P177, DOI 10.1093/beheco/arm120; VANDERMEER HJ, 1995, ENVIRON BIOL FISH, V44, P115, DOI 10.1007/BF00005910; Venables WN., 2002, MODERN APPL STAT S 4, V4th Ed., DOI [10.1007/978-0-387-21706-2, 10.1007/978-1-4757-2719-7_7]; Yokoyama S, 2000, GENE, V259, P17, DOI 10.1016/S0378-1119(00)00435-2	49	763	779	5	492	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					620	U23		10.1038/nature07285	http://dx.doi.org/10.1038/nature07285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833272				2022-12-01	WOS:000259639700037
J	Tang, C; Louis, JM; Aniana, A; Suh, JY; Clore, GM				Tang, Chun; Louis, John M.; Aniana, Annie; Suh, Jeong-Yong; Clore, G. Marius			Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease	NATURE			English	Article							ENCOUNTER COMPLEXES; NMR; BINDING; KINETICS; ENHANCEMENT; PRECURSOR; DYNAMICS; CLEAVAGE; ASSOCIATION; INHIBITORS	HIV- 1 protease processes the Gag and Gag- Pol polyproteins into mature structural and functional proteins, including itself, and is therefore indispensable for viral maturation(1,2). The mature protease is active only as a dimer(3-5) with each subunit contributing catalytic residues(6). The full- length transframe region protease precursor appears to be monomeric yet undergoes maturation via intramolecular cleavage of a putative precursor dimer(5,7-11), concomitant with the appearance of mature- like catalytic activity(7,9). How such intramolecular cleavage can occur when the amino and carboxy termini of the mature protease are part of an intersubunit beta-sheet located distal from the active site is unclear. Here we visualize the early events in N- terminal autoprocessing using an inactive mini- precursor with a four- residue N- terminal extension that mimics the transframe region protease precursor(5,12). Using paramagnetic relaxation enhancement, a technique that is exquisitely sensitive to the presence of minor species(13-16), we show that the mini- precursor forms highly transient, lowly populated (3-5%) dimeric encounter complexes that involve the mature dimer interface but occupy a wide range of subunit orientations relative to the mature dimer. Furthermore, the occupancy of the mature dimer configuration constitutes a very small fraction of the self- associated species ( accounting for the very low enzymatic activity of the protease precursor), and the N- terminal extension makes transient intra- and intersubunit contacts with the substrate binding site and is therefore available for autocleavage when the correct dimer orientation is sampled within the encounter complex ensemble.	[Tang, Chun; Louis, John M.; Aniana, Annie; Suh, Jeong-Yong; Clore, G. Marius] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@mail.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Tang, Chun/0000-0001-6477-6500; Louis, John M/0000-0002-0052-1899	Intramural Program of the NIH; NIDDK; AIDS Targeted Antiviral program	Intramural Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AIDS Targeted Antiviral program	We thank R. Ishima for providing initial backbone assignments for the <SUP>SFNF</SUP>PR(D25N) protease construct; C. Schwieters for many discussions; Y. Sheng for help with the CS-Rosetta calculations; Y. Kim for providing the code for structure clustering and d.r.m.s. calculations; and J. Sayer for MALDI measurements. This work was supported by funds from the Intramural Program of the NIH, NIDDK and the AIDS Targeted Antiviral program of the Office of the Director of the NIH (to G.M.C.).	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Cherry E, 1998, J MOL BIOL, V284, P43, DOI 10.1006/jmbi.1998.1968; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; CO E, 1994, BIOCHEMISTRY-US, V33, P1248, DOI 10.1021/bi00171a027; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Katoh E, 2003, PROTEIN SCI, V12, P1376, DOI 10.1110/ps.0300703; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Louis J M, 2000, Adv Pharmacol, V49, P111; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 1999, J BIOL CHEM, V274, P23437, DOI 10.1074/jbc.274.33.23437; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Mahalingam B, 2004, EUR J BIOCHEM, V271, P1516, DOI 10.1111/j.1432-1033.2004.04060.x; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; SPINELLI S, 1991, BIOCHIMIE, V73, P1391, DOI 10.1016/0300-9084(91)90169-2; Tang C, 2008, J AM CHEM SOC, V130, P4048, DOI 10.1021/ja710493m; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; Wondrak EM, 1996, BIOCHEMISTRY-US, V35, P12957, DOI 10.1021/bi960984y; Wondrak EM, 1996, J BIOL CHEM, V271, P4477, DOI 10.1074/jbc.271.8.4477	40	100	102	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					693	U92		10.1038/nature07342	http://dx.doi.org/10.1038/nature07342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833280	Green Accepted			2022-12-01	WOS:000259639700053
J	van Dam, RM; Li, T; Spiegelman, D; Franco, OH; Hu, FB				van Dam, Rob M.; Li, Tricia; Spiegelman, Donna; Franco, Oscar H.; Hu, Frank B.			Combined impact of lifestyle factors on mortality: prospective cohort study in US women	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; ATTRIBUTABLE RISK; DIETARY-FAT; PREVENTION; METAANALYSIS; MEN; CANCER	Objective To evaluate the impact of combinations of lifestyle factors on mortality in middle aged women. Design Prospective cohort study. Setting Nurses' health study, United States. Participants 77 782 women aged 34 to 59 years and free from cardiovascular disease and cancer in 1980. Main outcome measure Relative risk of mortality during 24 years of follow- up in relation to five lifestyle factors ( cigarette smoking, being overweight, taking little moderate to vigorous physical activity, no light to moderate alcohol intake, and low diet quality score). Results 8882 deaths were documented, including 1790 from cardiovascular disease and 4527 from cancer. Each lifestyle factor independently and significantly predicted mortality. Relative risks for five compared with zero lifestyle risk factors were 3.26 ( 95% confidence interval 2.45 to 4.34) for cancer mortality, 8.17 ( 4.96 to 13.47) for cardiovascular mortality, and 4.31 ( 3.51 to 5.31) for all cause mortality. A total of 28% ( 25% to 31%) of deaths during follow- up could be attributed to smoking and 55% ( 47% to 62%) to the combination of smoking, being overweight, lack of physical activity, and a low diet quality. Additionally considering alcohol intake did not substantially change this estimate. Conclusions These results indicate that adherence to lifestyle guidelines is associated with markedly lower mortality in middle aged women. Both efforts to eradicate cigarette smoking and those to stimulate regular physical activity and a healthy diet should be intensified.	[van Dam, Rob M.; Li, Tricia; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [van Dam, Rob M.; Hu, Frank B.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [van Dam, Rob M.; Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Spiegelman, Donna; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Franco, Oscar H.] Unilever Corp Res, Sharnbrook MK44 1LQ, Beds, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Unilever	van Dam, RM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	rvandam@hsph.harvard.edu	van Dam, Rob M/F-9674-2010; Hu, Frank/C-1919-2013; Franco, Óscar H/ABE-2305-2020	van Dam, Rob M/0000-0002-7354-8734; Franco, Óscar H/0000-0002-4606-4929	National Institutes of Health [CA87969, HL60712]; Peanut Foundation; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peanut Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health (NIH) grants CA87969 and HL60712. RMvD was partly supported by an unrestricted research grant from the Peanut Foundation. The funding sources had no role in the collection, management, analysis, or interpretation of the data and had no role in the preparation, review, or approval of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Colhoun H, 1997, BRIT MED J, V314, P1164, DOI 10.1136/bmj.314.7088.1164; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Graubard BI, 2005, BIOMETRICS, V61, P847, DOI 10.1111/j.1541-0420.2005.00355.x; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Key T, 2004, PUBLIC HEALTH NUTR, V7, P187, DOI 10.1079/PHN2003588; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; Martinez ME, 1997, J NATL CANCER I, V89, P948, DOI 10.1093/jnci/89.13.948; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pereira MA, 2002, AM J CLIN NUTR, V75, P848, DOI 10.1093/ajcn/75.5.848; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; VANDERWILK EA, 2008, PREVALENCE OVERWEIGH; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Wannamethee SG, 1998, ARCH INTERN MED, V158, P2433, DOI 10.1001/archinte.158.22.2433; Willett WC, 1998, OXFORD SCHOLARSHIP O; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; World Health Organization, 1997, WHO PUBL, VWHO/NUT/NCD/98.1	42	90	92	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1440	10.1136/bmj.a1440	http://dx.doi.org/10.1136/bmj.a1440			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18796495	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000259797600040
J	Power, C; Rasko, JEJ				Power, Carl; Rasko, John E. J.			Whither prometheus' liver? Greek myth and the science of regeneration	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Stem-cell biologists and those involved in regenerative medicine are fascinated by the story of Prometheus, the Greek god whose immortal liver was feasted on day after day by Zeus' eagle. This myth invariably provokes the question: Did the ancient Greeks know about the liver's amazing capacity for self-repair? The authors address this question by exploring the origins of Greek myth and medicine, adopting a 2-fold strategy. First, the authors consider what opportunities the ancient Greeks had to learn about the liver's structure and function. This involves a discussion of early battlefield surgery, the beginnings of anatomical research, and the ancient art of liver augury. In addition, the authors consider how the Greeks understood Prometheus' immortal liver. Not only do the authors examine the general theme of regeneration in Greek mythology, they survey several scholarly interpretations of Prometheus' torture.	[Rasko, John E. J.] Univ Sydney, Centenary Inst, Newtown, NSW 2042, Australia; Royal Prince Alfred Hosp, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney	Rasko, JEJ (corresponding author), Univ Sydney, Centenary Inst, Locked Bag 6, Newtown, NSW 2042, Australia.	j.rasko@cenint.org	Rasko, John EJ/F-5754-2013	rasko, John/0000-0003-2975-807X				AESCHYLUS, 1952, COMPLETE PLAYS AESCH, P43; ALLEN DS, 2000, WORLD PROMETHEUS POL, P33; ANDRAL G, 1843, MED CLIN, V1, P345; ARISTOTLE, 1965, HIST ANIMALIUM, V1, P57; AURELIANUS C, 1950, ACUTE DIS CHRONIC DI, P752; BURKERT W, 1992, ORIENTALIZING REVOLU, P46; CALDWELL RS, 1987, HESIODS THEOGONY, P58; CHEN TSN, 1994, J ROY SOC MED, V87, P754; CRUVEILHIER LJB, 1829, ANATOMIE PATHOLOGIQU, V33, P398; EDMUNDS L, 1990, APPROACHES GREEK MYT, P141; FULGENTIUS FP, 1971, FULGENTIUS MYTHOGRAP, P71; Gluck T, 1883, ARCH KLIN CHIR, V29, P139; Goss Richard J., 1991, P7; HOMER, 2003, ODYSSEY, P154; Homer, 1999, ILIAD; JASTROW M, 1907, T COLL PHYS PHILA, V29, P117; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; KORNER O, 1922, MUNCHEN MED WCHNSHCR, V69, P1484; LONGRIGG J, 1993, GREEK RATIONAL MED P, P184; LONGRIGG J, 1998, GREEK MED HEROIC HEL, P176; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Milne LS, 1909, J PATHOL BACTERIOL, V13, P127, DOI 10.1002/path.1700130121; PENGLASE C, 1994, GREEK MYTHS MESOPOTA, P197; Pistoi S, 1996, FASEB J, V10, P819, DOI 10.1096/fasebj.10.8.8666158; PONFICK E, 1889, VIRCHOWS ARCH PATH A, V118, P209; PRIORESCHI P, 1996, HIST MED, V1, P38; Reuben A, 2004, HEPATOLOGY, V39, P1460, DOI 10.1002/hep.20227; Richardson N. J., 1985, GREEK RELIG SOC, P50; Rosenthal N, 2003, NEW ENGL J MED, V349, P267, DOI 10.1056/NEJMra020849; SALAZAR CF, 2000, TREATMENT WAR WOUNDS, P20; Saunders KB, 1999, CLASSICAL QUART, V49, P345, DOI 10.1093/cq/49.2.345; Schneider MD, 2004, NATURE, V432, P451, DOI 10.1038/432451a; Spyridonidis A, 2005, STEM CELL REV, V1, P37, DOI 10.1385/SCR:1:1:037; TILLMANNS H, 1879, VIRCHOWS ARCH, V78, P437; van Gend D, 2006, HUM LIFE REV, V32, P15; Vernant J.-P, 1989, CUISINE SACRIFICE GR, P21; Vernant Jean-Pierre, 1991, MORTALS IMMORTALS CO, P27; VONMEISTER E, 1994, BEITR PATHOL ANAT, V15, P1; VONSTADEN H, 1989, HEROPHILUS ART MED E, P162; West M. L., 1966, HESIOD THEOGONY; West Stephanie, 1994, MUSEUM HELVETICUM, V51, P129; 1931, HIPPOCRATES, P203	42	21	21	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					421	W79		10.7326/0003-4819-149-6-200809160-00009	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794562				2022-12-01	WOS:000259230200007
J	Beaglehole, R; Epping-Jordan, J; Patel, V; Chopra, M; Ebrahim, S; Kidd, M; Haines, A				Beaglehole, Robert; Epping-Jordan, JoAnne; Patel, Vikram; Chopra, Mickey; Ebrahim, Shah; Kidd, Michael; Haines, Andy			Alma-Ata: Rebirth and revision 3 - Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care	LANCET			English	Review							COMMON MENTAL-DISORDERS; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; MAINTENANCE ORGANIZATION; ANTIRETROVIRAL TREATMENT; PSYCHIATRIC KNOWLEDGE; DIABETES PREVENTION; INTEGRATED CARE; HUMAN-RESOURCES; DEPRESSION	The burden of chronic diseases, such as heart disease, cancer, diabetes, and mental disorders is high in low-income and middle-income countries and is predicted to increase with the ageing of populations, urbanisation, and globalisation of risk factors. Furthermore, HIV/AIDS is increasingly becoming a chronic disorder. An integrated approach to the management of chronic diseases, irrespective of cause, is needed in primary health care. Management of chronic diseases is fundamentally different from acute care, relying on several features: opportunistic case finding for assessment of risk factors, detection of early disease, and identification of high risk status; a combination of pharmacological and psychosocial interventions, often in a stepped-care fashion; and long-term follow-up with regular monitoring and promotion of adherence to treatment. To meet the challenge of chronic diseases, primary health care will have to be strengthened substantially. In the many countries with shortages of primary-care doctors, non-physician clinicians will have a leading role in preventing and managing chronic diseases, and these personnel need appropriate training and continuous quality assurance mechanisms. More evidence is needed about the cost-effectiveness of prevention and treatment strategies in primary health care. Research on scaling-up should be embedded in large-scale delivery programmes for chronic diseases with a strong emphasis on assessment.	[Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand; [Patel, Vikram; Ebrahim, Shah; Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Chopra, Mickey] MRC S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Kidd, Michael] Univ Sydney, Dept Gen Practice, Sydney, NSW 2006, Australia	University of Auckland	Beaglehole, R (corresponding author), 42 Albert Rd, N Shore City 0624, New Zealand.	r.beaglehole@auckland.ac.nz		Patel, Vikram/0000-0003-1066-8584; Haines, Andy/0000-0002-8053-4605	Wellcome Trust Senior Clinical Research Fellowship	Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust)	We thank Donna Bowers for help with references. VP is supported by a Wellcome Trust Senior Clinical Research Fellowship.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; [Anonymous], 2007, LANCET; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Araya R, 2006, AM J PSYCHIAT, V163, P1379, DOI 10.1176/appi.ajp.163.8.1379; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; BABOR TF, 1994, ADDICTION, V89, P657, DOI 10.1111/j.1360-0443.1994.tb00944.x; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Berwick DM, 2004, BRIT MED J, V328, P1124, DOI 10.1136/bmj.328.7448.1124; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brownstein JN, 2007, AM J PREV MED, V32, P435, DOI 10.1016/j.amepre.2007.01.011; Chatterjee S, 2008, WORLD PSYCHIATRY, V7, P39; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Croudace T, 2003, BRIT J PSYCHIAT, V182, P20, DOI 10.1192/bjp.182.1.20; Davis RM, 2000, BRIT MED J, V320, P525, DOI 10.1136/bmj.320.7234.525; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; EBRAHIM S, 1996, HLTH PROMOTION OLDER; Ebrahim S, 2008, INT J EPIDEMIOL, V37, P225, DOI 10.1093/ije/dyn016; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Foster G, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005108.PUB2; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Funk M, 2004, INT J MENT HLTH, V33, P4, DOI DOI 10.1080/00207411.2004.11043367; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gilbody S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002792.pub2; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Glasgow RE, 2004, AM J PREV MED, V27, P88, DOI 10.1016/j.amepre.2004.04.019; Global Health Workforce Alliance, HLTH WORK ALL ALL HL; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Health organization, 2001, WORLD HLTH REPORT 20; Henderson DC, 2005, J NERV MENT DIS, V193, P551, DOI 10.1097/01.nmd.0000172869.01711.33; Hodges B, 2001, AM J PSYCHIAT, V158, P1579, DOI 10.1176/appi.ajp.158.10.1579; Improving Chronic Illness Care, ICIC OUR WORK; *INT DIAB FED, 2007, DIAB ATL; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jha P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P869; *JOINT UN PROGR HI, 2003, STIGMA DISCRIMINATIO; KANER EFS, 2008, COCHRANE DB SYST REV, V2, P4148; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Management Sciences for Health, INT DRUG PRIC IND GU, V2014; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Nash D, 2008, 15 C RETR OPP INF BO; National Health Priority Action Council, 2006, NAT CHRON DIS STRAT; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Pan American Health Organization, 2007, VER PROJ IMPR DIAB C; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; Patel V., 2003, WHERE THERE IS NO PS; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel VH, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-4; Pruitt SD, 2005, BMJ-BRIT MED J, V330, P637, DOI 10.1136/bmj.330.7492.637; Qureshi NA, 2006, EDUC HEALTH, V19, P52, DOI 10.1080/13576280500525527; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; *SCOTT GOV, PARTN CAR SCOTL HLTH; Simon GE, 1999, GEN HOSP PSYCHIAT, V21, P97, DOI 10.1016/S0163-8343(98)00072-3; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P328, DOI 10.1016/S0163-8343(02)00201-3; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P213, DOI 10.1016/S0163-8343(02)00198-6; Singh D, 2006, IMPROVING CARE PEOPL; Smith SM, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004910.PUB2; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub3; Stead LF, 2008, COCHRANE DATABASE SY, V1; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Tsai AC, 2005, AM J MANAG CARE, V11, P478; UK Department of Health, 2001, EXP PAT NEW APPR CHR; Vergouwen ACM, 2003, J CLIN PSYCHIAT, V64, P1415, DOI 10.4088/JCP.v64n1203; Von Korff M, 2002, BRIT MED J, V325, P92, DOI 10.1136/bmj.325.7355.92; Wagner E H, 1999, Manag Care Q, V7, P56; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; *WHO, 2004, INT MAN AD ILLN EXT; *WHO, 2005, PREP WORKF 21 CENT C; WHO, 2006, WORLD HLTH REPORT 20; WHO WONCA, 2008, INT MENT HLTH PRIM C; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; World Health Organization, 1995, MENT ILLN GEN HLTH C; World Health Organization, 1998, MENT DIS PRIM CAR WH; World Health Organization, 2005, PREVENTING CHRONIC D	106	365	374	5	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					940	949		10.1016/S0140-6736(08)61404-X	http://dx.doi.org/10.1016/S0140-6736(08)61404-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790317				2022-12-01	WOS:000259266900034
J	Hochberg, LR				Hochberg, Leigh R.			Turning thought into action	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CORTICAL CONTROL; DEVICES; ARM		[Hochberg, Leigh R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hochberg, Leigh R.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hochberg, Leigh R.] Dept Vet Affairs Rehabil Res & Dev Serv, Providence, RI USA; [Hochberg, Leigh R.] Brown Univ, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University	Hochberg, LR (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273				GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996	6	12	13	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1175	1177		10.1056/NEJMcibr0805122	http://dx.doi.org/10.1056/NEJMcibr0805122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346ON	18784110				2022-12-01	WOS:000259078200016
J	Mu, TW; Ong, DST; Wang, YJ; Balch, WE; Yates, JR; Segatori, L; Kelly, JW				Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Balch, William E.; Yates, John R.; Segatori, Laura; Kelly, Jeffery W.			Chemical and biological approaches synergize to ameliorate protein-folding diseases	CELL			English	Article							HEAT-SHOCK RESPONSE; LYSOSOMAL STORAGE DISORDERS; GAUCHER-DISEASE; ENDOPLASMIC-RETICULUM; PROTEASOME INHIBITION; PHARMACOLOGICAL CHAPERONE; MOLECULAR CHAPERONES; ENZYME REPLACEMENT; ER STRESS; GLUCOCEREBROSIDASE	Loss-of-function diseases are often caused by a mutation in a protein traversing the secretory pathway that compromises the normal balance between protein folding, trafficking, and degradation. We demonstrate that the innate cellular protein homeostasis, or proteostasis, capacity can be enhanced to fold mutated enzymes that would otherwise misfold and be degraded, using small molecule proteostasis regulators. Two proteostasis regulators are reported that alter the composition of the proteostasis network in the endoplasmic reticulum through the unfolded protein response, increasing the mutant folded protein concentration that can engage the trafficking machinery, restoring function to two nonhomologous mutant enzymes associated with distinct lysosomal storage diseases. Coapplication of a pharmacologic chaperone and a proteostasis regulator exhibits synergy because of the former's ability to further increase the concentration of trafficking-competent mutant folded enzymes. It may be possible to ameliorate loss-of-function diseases by using proteostasis regulators alone or in combination with a pharmacologic chaperone.	[Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Segatori, Laura; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wang, Ya-Juan; Balch, William E.; Yates, John R.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Segatori, Laura; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Segatori, L (corresponding author), Rice Univ, Dept Chem & Biomol Engn, 6100 Main St,MS-362, Houston, TX 77005 USA.	segatori@rice.edu; jkelly@scripps.edu	Longo, Kenneth A/A-5631-2010; Mu, Tingwei/AAU-8596-2020	Mu, Tingwei/0000-0002-6419-9296; Wang, Yajuan (Megan)/0000-0002-3284-9012	NIH [DK75295]; Skaggs Institute of Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075295] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute of Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the reviewers for their insight, Professors Jonathan Weissman and Ernest Beutler for helpful discussions, Professor Evan Powers for the latter and for creating the three-dimensional plots used herein, and Jonathan Zhu for significant help with the figures. This work was supported by the NIH (DK75295), the Skaggs Institute of Chemical Biology, and the Lita Annenberg Hazen Foundation and is dedicated to Ernest Beutler on the occasion of his upcoming 80th birthday. J. W. K. is a founder of, has equity in, and has a paid consulting relationship with two biotechnology companies: FoldRx Pharmaceuticals Inc., which specializes in the development of drug therapies for diseases of protein misfolding and amyloidosis, and Proteostasis Therapeutics Inc., which is focused on understanding the proteostasis network for the development of therapeutics for diseases associated with a loss of proteostasis. Neither company is currently pursuing therapies for lysosomal storage diseases, although this could change in the future.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Awasthi N, 2005, INVEST OPHTH VIS SCI, V46, P2082, DOI 10.1167/iovs.05-0002; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BEUTLER E, 1977, P NATL ACAD SCI USA, V74, P4620, DOI 10.1073/pnas.74.10.4620; Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; Beutler E, 2006, MOL GENET METAB, V88, P208, DOI 10.1016/j.ymgme.2006.01.010; Bouvier M, 2007, CHEM BIOL, V14, P241, DOI 10.1016/j.chembiol.2007.03.004; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; Deuerling E, 2004, CRIT REV BIOCHEM MOL, V39, P261, DOI 10.1080/10409230490892496; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; HORWICH AL, 2004, ENCY BIOL CHEM, V1, P393; Imai J, 2003, CELL CYCLE, V2, P585, DOI 10.4161/cc.2.6.586; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Leclerc D, 2008, J BIOL CHEM, V283, P3151, DOI 10.1074/jbc.M708598200; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Moyer B D, 2001, Expert Opin Ther Targets, V5, P165, DOI 10.1517/14728222.5.2.165; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2005, CHEM BIOL, V12, P1235, DOI 10.1016/j.chembiol.2005.09.007; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i	54	299	308	0	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					769	781		10.1016/j.cell.2008.06.037	http://dx.doi.org/10.1016/j.cell.2008.06.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775310	Green Accepted, Bronze			2022-12-01	WOS:000258947500017
J	Simpson, SW; Quade, J; Levin, NE; Butler, R; Dupont-Nivet, G; Everett, M; Semaw, S				Simpson, Scott W.; Quade, Jay; Levin, Naomi E.; Butler, Robert; Dupont-Nivet, Guillaume; Everett, Melanie; Semaw, Sileshi			A Female Homo erectus Pelvis from Gona, Ethiopia	SCIENCE			English	Article							MIDDLE PLEISTOCENE; BRAIN GROWTH; BODY-SIZE; DMANISI; GEORGIA; MALES; GAIT; EAST	Analyses of the KNM- WT 15000 Homo erectus juvenile male partial skeleton from Kenya concluded that this species had a tall thin body shape due to specialized locomotor and climatic adaptations. Moreover, it was concluded that H. erectus pelves were obstetrically restricted to birthing a small- brained altricial neonate. Here we describe a nearly complete early Pleistocene adult female H. erectus pelvis from the Busidima Formation of Gona, Afar, Ethiopia. This obstetrically capacious pelvis demonstrates that pelvic shape in H. erectus was evolving in response to increasing fetal brain size. This pelvis indicates that neither adaptations to tropical environments nor endurance running were primary selective factors in determining pelvis morphology in H. erectus during the early Pleistocene.	[Everett, Melanie; Semaw, Sileshi] Stone Age Inst, Gosport, IN 47433 USA; [Everett, Melanie; Semaw, Sileshi] Indiana Univ, CRAFT, Bloomington, IN 47405 USA; [Simpson, Scott W.] Case Western Reserve Univ, Dept Anat, Cleveland, OH 44106 USA; [Simpson, Scott W.] Cleveland Museum Nat Hist, Lab Phys Anthropol, Cleveland, OH 44106 USA; [Quade, Jay] Univ Arizona, Dept Geosci, Desert Lab, Tucson, AZ 85721 USA; [Levin, Naomi E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Levin, Naomi E.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Butler, Robert] Univ Portland, Dept Phys, Portland, OR 97203 USA; [Dupont-Nivet, Guillaume] Univ Utrecht, Fac Geosci, NL-3584 CD Utrecht, Netherlands; [Everett, Melanie] Indiana Univ, Dept Geol Sci, Bloomington, IN 47407 USA	Indiana University System; Indiana University Bloomington; Case Western Reserve University; Cleveland Museum of Natural History; University of Arizona; Utah System of Higher Education; University of Utah; California Institute of Technology; University of Portland; Utrecht University; Indiana University System; Indiana University Bloomington	Semaw, S (corresponding author), Stone Age Inst, 1392 W Dittemore Rd, Gosport, IN 47433 USA.	ssemaw@indiana.edu	Levin, Naomi E/B-4124-2010; Simpson, Scott/GRS-0081-2022; Semaw, Sileshi/M-7021-2018	Levin, Naomi E/0000-0001-5703-3717; Semaw, Sileshi/0000-0001-8377-8288; Dupont-Nivet, Guillaume/0000-0001-9905-9739	L. S. B. Leakey Foundation; National Geographic Society; Wenner-Gren Foundation; NSF	L. S. B. Leakey Foundation; National Geographic Society(National Geographic Society); Wenner-Gren Foundation; NSF(National Science Foundation (NSF))	The Gona Project thanks the Authority for Research and Conservation of Cultural Heritage of the Ministry of Culture and Tourism, and the National Museum of Ethiopia, for research permits and support. Support for this research was provided by the L. S. B. Leakey Foundation, National Geographic Society, Wenner-Gren Foundation, and NSF.	Arsuaga JL, 1999, NATURE, V399, P255, DOI 10.1038/20430; Bondioli L, 2006, J HUM EVOL, V50, P479, DOI 10.1016/j.jhevol.2006.01.001; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Coqueugniot H, 2004, NATURE, V431, P299, DOI 10.1038/nature02852; Correia H, 2005, HOMO, V56, P153, DOI 10.1016/j.jchb.2005.05.003; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; DeSilva J, 2006, J HUM EVOL, V51, P207, DOI 10.1016/j.jhevol.2006.05.006; Holloway R.L., 2004, HUMAN FOSSIL RECORD; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; RAK Y, 1987, AM J PHYS ANTHROPOL, V73, P227, DOI 10.1002/ajpa.1330730209; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Rosenberg KR, 2006, P NATL ACAD SCI USA, V103, P3552, DOI 10.1073/pnas.0508681103; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff C, 2007, AM J PHYS ANTHROPOL, V133, P698, DOI 10.1002/ajpa.20568; Ruff Christopher B., 1993, P234; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Tague RG, 1998, J HUM EVOL, V35, P75, DOI 10.1006/jhev.1998.0223; Tague RG, 2005, AM J PHYS ANTHROPOL, V127, P392, DOI 10.1002/ajpa.20226; TAGUE RG, 1989, AM J PHYS ANTHROPOL, V80, P59, DOI 10.1002/ajpa.1330800108; Walker Alan, 1993, P221; WALRATH D, 1997, THESIS U PENNSYLVANI	25	185	189	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1089	1092		10.1126/science.1163592	http://dx.doi.org/10.1126/science.1163592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	371YD	19008443				2022-12-01	WOS:000260867700034
J	Wierzbicki, AT; Haag, JR; Pikaard, CS				Wierzbicki, Andrzej T.; Haag, Jeremy R.; Pikaard, Craig S.			Noncoding Transcription by RNA Polymerase Pol IVb/Pol V Mediates Transcriptional Silencing of Overlapping and Adjacent Genes	CELL			English	Article							DIRECTED DNA-METHYLATION; IV; HETEROCHROMATIN; ELEMENTS; SIRNA; ORGANIZATION; THALIANA; REQUIRES; PATHWAY; CORE	Nuclear transcription is not restricted to genes but occurs throughout the intergenic and noncoding space of eukaryotic genomes. The functional significance of this widespread noncoding transcription is mostly unknown. We show that Arabidopsis RNA polymerase IVb/Pol V, a multisubunit nuclear enzyme required for siRNA-mediated gene silencing of transposons and other repeats, transcribes intergenic and noncoding sequences, thereby facilitating heterochromatin formation and silencing of overlapping and adjacent genes. Pol IVb/Pol V transcription requires the chromatin-remodeling protein DRD1 but is independent of siRNA biogenesis. However, Pol IVb/Pol V transcription and siRNA production are both required to silence transposons, suggesting that Pol IVb/Pol V generates RNAs or chromatin structures that serve as scaffolds for siRNA-mediated heterochromatin-forming complexes. Pol IVb/Pol V function provides a solution to a paradox of epigenetic control: the need for transcription in order to transcriptionally silence the same region.	[Wierzbicki, Andrzej T.; Haag, Jeremy R.; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	NIGMS NIH HHS [GM077590, R01 GM077590, R01 GM077590-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai X, 2007, GENETICS, V176, P1491, DOI 10.1534/genetics.107.071571; Baulcombe DC, 2006, COLD SPRING HARB SYM, V71, P13, DOI 10.1101/sqb.2006.71.052; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Gilbert C., 2006, CURRENT PROTOCOLS MO; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2005, NAT METHODS, V2, P219, DOI 10.1038/nmeth0305-219; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke SM, 2006, COLD SPRING HARB SYM, V71, P497, DOI 10.1101/sqb.2006.71.062; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Myouga F, 2001, GENES GENET SYST, V76, P169, DOI 10.1266/ggs.76.169; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Onodera Y, 2008, GENETICS, V180, P207, DOI 10.1534/genetics.108.090621; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; Willingham AT, 2006, COLD SPRING HARB SYM, V71, P101, DOI 10.1101/sqb.2006.71.068; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zecherle GN, 1996, MOL CELL BIOL, V16, P5801; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	52	494	522	3	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					635	648		10.1016/j.cell.2008.09.035	http://dx.doi.org/10.1016/j.cell.2008.09.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013275	Green Accepted, Bronze			2022-12-01	WOS:000260886900015
J	Long, MA; Fee, MS				Long, Michael A.; Fee, Michale S.			Using temperature to analyse temporal dynamics in the songbird motor pathway	NATURE			English	Article							ZEBRA FINCH SONG; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; CENTRAL PATTERN GENERATOR; VOCAL CONTROL; BRAIN-STEM; SEQUENCE GENERATION; MEMBRANE-PROPERTIES; FOREBRAIN; BIRDSONG; SYSTEM	Many complex behaviours, like speech or music, have a hierarchical organization with structure on many timescales, but it is not known how the brain controls the timing of behavioural sequences, or whether different circuits control different timescales of the behaviour. Here we address these issues by using temperature to manipulate the biophysical dynamics in different regions of the songbird forebrain involved in song production. We find that cooling the premotor nucleus HVC ( formerly known as the high vocal centre) slows song speed across all timescales by up to 45 per cent but only slightly alters the acoustic structure, whereas cooling the downstream motor nucleus RA ( robust nucleus of the arcopallium) has no observable effect on song timing. Our observations suggest that dynamics within HVC are involved in the control of song timing, perhaps through a chain- like organization. Local manipulation of brain temperature should be broadly applicable to the identification of neural circuitry that controls the timing of behavioural sequences and, more generally, to the study of the origin and role of oscillatory and other forms of brain dynamics in neural systems.	[Long, Michael A.; Fee, Michale S.] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fee@mit.edu		Fee, Michale/0000-0001-7539-1745	US National Institutes of Health [MH067105, DC009280]; Human Frontiers Science Project; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC009280, R00DC009280] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Project; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Aronov, T. Gardner, J. Goldberg, L. Las, B. Olveczky, S. Seung and M. Wilson for their comments on earlier versions of this manuscript. This work is supported by funding from the US National Institutes of Health to M. S. F. (MH067105) and to M. A. L. (DC009280) as well as funding from the Human Frontiers Science Project.	ABELES M, 1991, CORTICONICS NEURAL C, P208; ARBAS EA, 1984, J COMP PHYSIOL, V155, P783, DOI 10.1007/BF00611595; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Ashmore RC, 2008, J NEUROSCI, V28, P2613, DOI 10.1523/JNEUROSCI.4547-07.2008; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; HERRMANN K, 1991, J NEUROSCI, V11, P2063; JAMES W, 2001, PSYCHOL BRIEFER COUR, P1; Janata P, 1999, J NEUROSCI, V19, P5108; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Katz PS, 2004, J NEUROPHYSIOL, V92, P1904, DOI 10.1152/jn.00864.2003; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Laje R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.288102; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; MOONEY R, 1992, J NEUROSCI, V12, P2464; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Solis MM, 2005, J NEUROSCI, V25, P2811, DOI 10.1523/JNEUROSCI.5285-04.2005; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; THOMPSON SM, 1985, J NEUROSCI, V5, P817; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Volgushev M, 2000, NEUROSCIENCE, V98, P9, DOI 10.1016/S0306-4522(00)00109-3; VU ET, 1994, J NEUROSCI, V14, P6924; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; [No title captured]	45	306	309	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					189	194		10.1038/nature07448	http://dx.doi.org/10.1038/nature07448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005546	Green Accepted			2022-12-01	WOS:000261039300030
J	Kivimaki, M; Shipley, MJ; Ferrie, JE; Singh-Manoux, A; Batty, GD; Chandola, T; Marmot, MG; Smith, GD				Kivimaki, Mika; Shipley, Martin J.; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Chandola, Tarani; Marmot, Michael G.; Smith, George Davey			Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study	LANCET			English	Article							RISK-FACTORS; CARDIOVASCULAR-DISEASE; SOCIAL INEQUALITIES; YANOMAMO INDIANS; CIVIL-SERVANTS; ABSOLUTE; HEALTH; METAANALYSIS; HYPERTENSION; EFFICACY	Background How much the successful implementation of the most effective (ie, best-practice) interventions could reduce socioeconomic inequalities of coronary heart disease mortality is not known. We assessed this issue in an occupational cohort study comparing low with high socioeconomic groups. Methods We undertook a prospective cohort study on 17 186 male civil servants aged 40-69 years between 1967 and 1970 in the UK (the Whitehall study). Socioeconomic position was based on employment grade. We compared the potential reduction in excess coronary heart disease mortality in men of low with those of high socioeconomic position with either best-practice interventions (reduction of systolic blood pressure by 10 mm Hg, of total cholesterol by 2 mmol/L, and of blood glucose by 1 mmol/L in pre-diabetic people; halving the prevalence of non-insulin-dependent diabetes; and complete cessation of cigarette smoking) or primordial prevention. Findings 15-year absolute risk of death due to coronary heart disease per 100 men, standardised to age 55 years, was 11.0 for men in the low employment grade group and 7.5 for those in the high grade group. Population-wide best-practice interventions would reduce coronary heart disease mortality by 57%, and the difference in mortality between socioeconomic groups by 69%. For primordial prevention, the corresponding reductions would be 73% and 86%, respectively. Interpretation Our results suggest that current best-practice interventions to reduce classic coronary risk factors, if successfully implemented in both high and low socioeconomic groups, could eliminate most of the differences in coronary heart disease mortality. Modest further benefits would result if the classic coronary risk factors could be reduced to primordial levels for the whole population.	[Kivimaki, Mika; Shipley, Martin J.; Ferrie, Jane E.; Singh-Manoux, Archana; Chandola, Tarani; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Singh-Manoux, Archana] Hop Paul Brousse, INSERM, Villejuif, France; [Batty, G. David] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Smith, George Davey] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Bristol	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Chandola, Tarani/I-3192-2013; Singh-Manoux, Archana/F-6804-2013; Kivimaki, Mika/B-3607-2012; Davey Smith, George/A-7407-2013; Batty, GD/Y-4401-2018; Ferrie, Jane/AAZ-2009-2020; Marmot, M G/Y-3920-2019	Chandola, Tarani/0000-0002-1864-3413; Singh-Manoux, Archana/0000-0002-1244-5037; Kivimaki, Mika/0000-0002-4699-5627; Davey Smith, George/0000-0002-1407-8314; Batty, GD/0000-0003-1822-5753; Marmot, M G/0000-0002-2431-6419; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Department of Health and Social Security (UK); Tobacco Research Council (UK); British Heart Foundation (UK); Medical Research Council (UK); European Science Foundation (EU); Wellcome Trust (UK); Academy of Finland (Finland); British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G19/35, G8802774, MC_U130059821, G0100222, G0700704B] Funding Source: researchfish; MRC [MC_U130059821] Funding Source: UKRI	Department of Health and Social Security (UK); Tobacco Research Council (UK); British Heart Foundation (UK)(British Heart Foundation); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Science Foundation (EU)(European Science Foundation (ESF)European Commission); Wellcome Trust (UK)(Wellcome Trust); Academy of Finland (Finland)(Academy of Finland); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding Department of Health and Social Security (UK), Tobacco Research Council (UK), British Heart Foundation (UK), Medical Research Council (UK), European Science Foundation (EU), Wellcome Trust (UK), and Academy of Finland (Finland). The original screening of the Whitehall study was funded by the Department of Health and Social Security, and the Tobacco Research Council (UK). MK was supported by the Academy of Finland (Finland); MJS by the British Heart Foundation (UK); JEF by the Medical Research Council (UK); and ASM by the European Science Foundation (EU). GDB is a Wellcome Trust fellow. MGM is a Medical Research Council professor and, at the time of this work, was supported by the WHO Commission on Determinants of Socioeconomic inequalities in Health, which he chaired.	Acheson D., 1998, INDEPENDENT INQUIRY; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Black D., 1980, INEQUALITIES HLTH RE; Brunner EJ, 2006, DIABETES CARE, V29, P26; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; *DEP HLTH, 2003, NAT STAT RISK FACT C; Durrington P, 2003, LANCET, V362, P717, DOI 10.1016/S0140-6736(03)14234-1; Edwards Jayne E, 2003, BMC Fam Pract, V4, P18, DOI 10.1186/1471-2296-4-18; EYER J, 1975, INT J HEALTH SERV, V5, P539, DOI 10.2190/UT72-3RTX-V0KN-64AF; FAHEY T, 2006, COCHRANE DB SYST REV, V4, P5182; Fuchs FD, 2004, LANCET, V363, P332, DOI 10.1016/S0140-6736(03)15405-0; Getz L, 2005, BMJ-BRIT MED J, V331, P551, DOI 10.1136/bmj.38555.648623.8F; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Khang YH, 2008, HEART, V94, P75, DOI 10.1136/hrt.2007.117747; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; Lynch J, 2006, J EPIDEMIOL COMMUN H, V60, P436, DOI 10.1136/jech.2005.041350; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; MANCILHACARVALHO JJ, 1989, J HUM HYPERTENS, V3, P309; MANCILHACARVALHO JJ, 1990, PREV MED, V19, P66, DOI 10.1016/0091-7435(90)90009-9; Marmot M., 2008, CLOS GAP GEN HLTH EQ, V372, P1661; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; ODEA K, 1992, J INTERN MED, V232, P103, DOI 10.1111/j.1365-2796.1992.tb00559.x; REID DD, 1974, LANCET, V1, P469; ROSE G, 1990, LANCET, V335, P275, DOI 10.1016/0140-6736(90)90082-G; ROSE GA, 1964, LANCET, V1, P296; Rother KI, 2007, NEW ENGL J MED, V356, P1499, DOI 10.1056/NEJMp078030; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Singh-Manoux A, 2008, EPIDEMIOLOGY, V19, P599, DOI 10.1097/EDE.0b013e3181761cdc; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZIMMET P, 1978, AUST NZ J MED, V8, P141, DOI 10.1111/j.1445-5994.1978.tb04500.x	41	90	90	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1648	1654		10.1016/S0140-6736(08)61688-8	http://dx.doi.org/10.1016/S0140-6736(08)61688-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18994662	Green Submitted, Bronze			2022-12-01	WOS:000260899900026
J	Melhuish, E; Belsky, J; Leyland, AH; Barnes, J				Melhuish, Edward; Belsky, Jay; Leyland, Alastair H.; Barnes, Jacqueline		Natl Evaluation Sure Start Res Tea	Effects of fully-established Sure Start Local Programmes on 3-year-old children and their families living in England: a quasi-experimental observational study	LANCET			English	Article							INTERVENTION	Background Sure Start Local Programmes (SSLPs) are area-based interventions to improve services for young children and their families in deprived communities, promote health and development, and reduce inequalities. We therefore investigated whether SSLPs affect the wellbeing of 3-year-old children and their families. Methods In a quasi-experimental observational study, we compared 5883 3-year-old children and their families from 93 disadvantaged SSLP areas with 1879 3-year-old children and their families from 72 similarly deprived areas in England who took part in the Millennium Cohort Study. We studied 14 outcomes--children's immunisations, accidents, language development, positive and negative social behaviours, and independence; parenting risk; home-learning environment; father's involvement; maternal smoking, body-mass index,and life satisfaction; family's service use; and mother's rating of area. Findings After we controlled for background factors, we noted beneficial effects associated with the programmes for five of 14 outcomes. Children in the SSLP areas showed better social development than those in the non-SSLP areas, with more positive social behaviour (mean difference 0.45, 95% CI 0.09 to 0.80, p=0.01) and greater independence (0.32, 0.18 to 0.47, p<0.0001). Families in SSLP areas showed less negative parenting (-0.90, -1.11 to -0.69, p<0.0001) and provided a better home-learning environment (1.30, 0.75 to 1. 86, p<0.0001). These families used more services for supporting child and family development than those not living in SSLP areas (0.98, 0.86 to 1.09, p<0.0001). Effects of SSLPs seemed to apply to all subpopulations and SSLP areas. Interpretation Children and their families benefited from living in SSLP areas. The contrast between these and previous findings on the effect of SSLPs might indicate increased exposure to programmes that have become more effective. Early interventions can improve the life chances of young children living in deprived areas.	[Melhuish, Edward; Belsky, Jay; Barnes, Jacqueline] Univ London Birkbeck Coll, Inst Study Children Families & Social Issues, London WC1B 3RA, England; [Leyland, Alastair H.] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of London; Birkbeck University London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT	Melhuish, E (corresponding author), Univ London Birkbeck Coll, Inst Study Children Families & Social Issues, 7 Bedford Sq, London WC1B 3RA, England.	e.melhuish@bbk.ac.uk	Leyland, Alastair/C-6069-2011	Belsky, Jay/0000-0003-2191-2503; Ram, Bina/0000-0003-0023-1573; Leyland, Alastair/0000-0003-3741-7099	Department for Children, Schools and Families (DCSF); Medical Research Council; Chief Scientist Office of the Scottish Government Health Directorates [wbs U.1300.00.001]; Medical Research Council [MC_U130059823] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [MC_U130059823] Funding Source: UKRI	Department for Children, Schools and Families (DCSF); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorates; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Department for Children, Schools and Families (DCSF) after competitive tender. The Medical Research Council Social and Public Health Sciences Unit is jointly funded by the Medical Research Council and the Chief Scientist Office of the Scottish Government Health Directorates (wbs U.1300.00.001).	Belsky J., 2007, NATL EVALUATION SURE; Belsky J, 2006, BMJ-BRIT MED J, V332, P1476, DOI 10.1136/bmj.38853.451748.2F; Caldwell B.M., 1984, HOME OBSERVATION MEA; Elliott C. D., 1996, BRIT ABILITY SCALES, V2nd; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th, DOI DOI 10.1002/9780470973394; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; HANSEN K, 2006, MILLENNIUM COHORT ST; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; Littell R.C., 2006, SAS SYSTEM MIXED MOD; Love JM, 2005, DEV PSYCHOL, V41, P885, DOI 10.1037/0012-1649.41.6.885; MATHENY AP, 1995, J APPL DEV PSYCHOL, V16, P429, DOI 10.1016/0193-3973(95)90028-4; MEADOWS P, 2007, NATL EVALUATION SURE; MELHUISH E, 2007, NATL EVALUATION SURE; Melhuish EC, 2008, J SOC ISSUES, V64, P95, DOI 10.1111/j.1540-4560.2008.00550.x; *ODPM, 2004, ENGL IND DEPR REV; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; Pianta R.C., 2001, STUDENT TEACHER RELA; Raghunathan TE., 2007, IVEWARE IMPUTATION V; RAMEY CT, 2000, APPL DEV SCI, V0004; Roberts C, 2006, J CLIN CHILD ADOLESC, V35, P180, DOI 10.1207/s15374424jccp3502_2; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; SAMMONS P, 2003, 8B DFES; Schafer J., 1999, ANAL INCOMPLETE MULT; STPIERRE RG, 1997, NATL IMPACT EVALUATI; Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9	26	134	135	2	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1641	1647		10.1016/S0140-6736(08)61687-6	http://dx.doi.org/10.1016/S0140-6736(08)61687-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994661	Bronze, Green Submitted			2022-12-01	WOS:000260899900025
J	Hou, C; Zuo, WY; Moses, ME; Woodruff, WH; Brown, JH; West, GB				Hou, Chen; Zuo, Wenyun; Moses, Melanie E.; Woodruff, William H.; Brown, James H.; West, Geoffrey B.			Energy Uptake and Allocation During Ontogeny	SCIENCE			English	Article							DYNAMIC ACTION; GROWTH; MODEL; SDA	All organisms face the problem of how to fuel ontogenetic growth. We present a model, empirically grounded in data from birds and mammals, that correctly predicts how growing animals allocate food energy between synthesis of new biomass and maintenance of existing biomass. Previous energy budget models have typically had their bases in rates of either food consumption or metabolic energy expenditure. Our model provides a framework that reconciles these two approaches and highlights the fundamental principles that determine rates of food assimilation and rates of energy allocation to maintenance, biosynthesis, activity, and storage. The model predicts that growth and assimilation rates for all animals should cluster closely around two universal curves. Data for mammals and birds of diverse body sizes and taxa support these predictions.	[Hou, Chen; Woodruff, William H.; Brown, James H.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Zuo, Wenyun; Brown, James H.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Woodruff, William H.; West, Geoffrey B.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	The Santa Fe Institute; University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory	Hou, C (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	houc@santafe.edu	Woodruff, William/AAH-6890-2021	Hou, Chen/0000-0002-3665-225X; ZUO, WENYUN/0000-0002-7623-0481	NIH [P20 RR-018754, DK36263]; NSF [DEB-0083422, CCF0621900, PHY 0706174, PHY 0202180]; Thaw Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Thaw Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants P20 RR-018754 (for M.E.M.) and DK36263 (for W.H.W.) and by NSF grants DEB-0083422 and CCF0621900 (for J.H.B.) and PHY 0706174 and PHY 0202180 (for G.B.W.) G.B.W. also acknowledges the Thaw Charitable Trust for its support.	ASHWORTH A, 1969, NATURE, V223, P407, DOI 10.1038/223407a0; BLAXTER KL, 1989, ENERGY METABOLISM AN; Brody S, 1964, BIOENERGETICS GROWTH; Cummins K. W, 1971, Mitt int Verein theor angew Limnol, VNo. 18, P1; EVANS E, 1968, P NUTR SOC, V27, P121, DOI 10.1079/PNS19680036; JOBLING M, 1983, J FISH BIOL, V23, P549, DOI 10.1111/j.1095-8649.1983.tb02934.x; KIRKWOOD JK, 1991, J NUTR S, V121, P29; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Kooijman S.A.L.M, 2000, DYNAMIC ENERGY MASS, DOI DOI 10.1017/CBO9780511565403; KRIEGER I, 1978, AM J CLIN NUTR, V31, P764, DOI 10.1093/ajcn/31.5.764; Makarieva AM, 2004, ECOL MODEL, V176, P15, DOI 10.1016/j.ecolmodel.2003.09.037; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; Moses ME, 2008, AM NAT, V171, P632, DOI 10.1086/587073; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; RICKLEFS R. E., 1974, NUTTALL ORNITHOLOGIC, p[152, 15]; Ricklefs RE, 2003, FUNCT ECOL, V17, P384, DOI 10.1046/j.1365-2435.2003.00745.x; Robbins C.T., 1983, WILDLIFE FEEDING NUT; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; Withers P.C., 1992, COMP ANIMAL PHYSL	19	128	134	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					736	739		10.1126/science.1162302	http://dx.doi.org/10.1126/science.1162302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974352	Green Accepted			2022-12-01	WOS:000260605200047
J	Williams, BR; Prabhu, VR; Hunter, KE; Glazier, CM; Whittaker, CA; Housman, DE; Amon, A				Williams, Bret R.; Prabhu, Vineet R.; Hunter, Karen E.; Glazier, Christina M.; Whittaker, Charles A.; Housman, David E.; Amon, Angelika			Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells	SCIENCE			English	Article							DOWNS-SYNDROME; COLORECTAL ADENOMAS; SOLID TUMORS; TRISOMY; MOUSE; METABOLISM; EXPRESSION; STRESS; YEAST; MICE	Aneuploidy, an incorrect number of chromosomes, is the leading cause of miscarriages and mental retardation in humans and is a hallmark of cancer. We examined the effects of aneuploidy on primary mouse cells by generating a series of cell lines that carry an extra copy of one of four mouse chromosomes. In all four trisomic lines, proliferation was impaired and metabolic properties were altered. Immortalization, the acquisition of the ability to proliferate indefinitely, was also affected by the presence of an additional copy of certain chromosomes. Our data indicate that aneuploidy decreases not only organismal but also cellular fitness and elicits traits that are shared between different aneuploid cells.	[Williams, Bret R.; Prabhu, Vineet R.; Hunter, Karen E.; Glazier, Christina M.; Whittaker, Charles A.; Housman, David E.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Williams, Bret R.; Hunter, Karen E.; Glazier, Christina M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314; Whittaker, Charles/0000-0002-2400-0094	Howard Hughes Medical Institute; David Koch Research Award; Curt W. and Kathy Marble Cancer Research Fund; David Koch Graduate Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); David Koch Research Award; Curt W. and Kathy Marble Cancer Research Fund; David Koch Graduate Fellowship	We thank E. Vazile in the Koch Institute Microscopy and Imaging Facility for help with SKY analysis; M. Luo in the MIT BioMicro Center for help with microarray analysis; L. Chan for assistance with the double linear fit models for immortalization kinetics; A. Regev and M. Guttman for advice and assistance with statistical analysis; and M. Dunham, M. Hemann, J. Lees, F. Solomon, and members of the Amon lab for critical reading of this manuscript. This work was supported by the Howard Hughes Medical Institute, a David Koch Research Award, a grant from the Curt W. and Kathy Marble Cancer Research Fund, and a David Koch Graduate Fellowship (V.R.P.). All microarray data are provided in final processed form in table S1 and as raw data through the Gene Expression Omnibus (www.ncbi.nlm.nih. gov/geo) under accession number GSE12501.	ABERCROMBIE M., 1961, EXPTL CELL RES SUPPL, V8, P188, DOI 10.1016/0014-4827(61)90348-2; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bomme L, 1998, CANCER GENET CYTOGEN, V106, P66, DOI 10.1016/S0165-4608(98)00047-8; Bomme L, 2001, INT J CANCER, V92, P816, DOI 10.1002/ijc.1275; Boveri T., 1902, Verb Ges Wurzburg, Vxxxv, P67; Dyban A.P., 1987, CYTOGENETICS MAMMALI; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; FARBER E, 1990, BIOCHEM PHARMACOL, V39, P1837, DOI 10.1016/0006-2952(90)90599-G; GROPP A, 1983, J EXP ZOOL, V228, P253, DOI 10.1002/jez.1402280210; GROPP A, 1975, CYTOGENET CELL GENET, V14, P42, DOI 10.1159/000130318; Haddow A., 1938, ACTA UNION INT CONTR, V3, P342; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Larson PS, 2006, J PATHOL, V209, P307, DOI 10.1002/path.1973; LINDSLEY DL, 1972, GENETICS, V71, P157; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; McClintock B, 1929, GENETICS, V14, P180; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; NIELSEN K, 1985, HEREDITAS, V102, P77, DOI 10.1111/j.1601-5223.1985.tb00468.x; NIWA O, 1985, CURR GENET, V9, P463, DOI 10.1007/BF00434051; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Pai GS., 2003, HDB CHROMOSOMAL SYND; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Rosner M, 2003, J NEURAL TRANSM-SUPP, P51; Satge D, 2003, INT J CANCER, V106, P297, DOI 10.1002/ijc.11212; Satge D, 1998, AM J MED GENET, V78, P207, DOI 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.0.CO;2-M; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Singh K, 1996, GENETICS, V143, P517; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sung HM, 2003, J BACTERIOL, V185, P2153, DOI 10.1128/JB.185.7.2153-2160.2003; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Tannock I., 2013, BASIC SCI ONCOLOGY; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Warburg O, 1924, BIOCHEM Z, V152, P309; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003	37	416	424	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					703	709		10.1126/science.1160058	http://dx.doi.org/10.1126/science.1160058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974345	Green Accepted			2022-12-01	WOS:000260605200038
J	Moldon, A; Malapeira, J; Gabrielli, N; Gogol, M; Gomez-Escoda, B; Ivanova, T; Seidel, C; Ayte, J				Moldon, Alberto; Malapeira, Jordi; Gabrielli, Natalia; Gogol, Madelaine; Gomez-Escoda, Blanca; Ivanova, Tsvetomira; Seidel, Chris; Ayte, Jose			Promoter-driven splicing regulation in fission yeast	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; DNA-BINDING-DOMAIN; RNA-POLYMERASE-II; SCHIZOSACCHAROMYCES-POMBE; BUDDING YEASTS; MEIOSIS; PROGRAM; SPORULATION; PROTEINS; ENCODES	The meiotic cell cycle is modified from the mitotic cell cycle by having a pre- meiotic S phase that leads to high levels of recombination, two rounds of nuclear division with no intervening DNA synthesis and a reductional pattern of chromosome segregation. Rem1 is a cyclin that is only expressed during meiosis in the fission yeast Schizosaccharomyces pombe. Cells in which rem1 has been deleted show decreased intragenic meiotic recombination and a delay at the onset of meiosis I ( ref. 1). When ectopically expressed in mitotically growing cells, Rem1 induces a G1 arrest followed by severe mitotic catastrophes. Here we show that rem1 expression is regulated at the level of both transcription and splicing, encoding two proteins with different functions depending on the intron retention. We have determined that the regulation of rem1 splicing is not dependent on any transcribed region of the gene. Furthermore, when the rem1 promoter is fused to other intron-containing genes, the chimaeras show a meiotic- specific regulation of splicing, exactly the same as endogenous rem1. This regulation is dependent on two transcription factors of the forkhead family, Mei4 ( ref. 2) and Fkh2 ( ref. 3). Whereas Mei4 induces both transcription and splicing of rem1, Fkh2 is responsible for the intron retention of the transcript during vegetative growth and the pre- meiotic S phase.	[Moldon, Alberto; Malapeira, Jordi; Gabrielli, Natalia; Gomez-Escoda, Blanca; Ivanova, Tsvetomira; Ayte, Jose] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona 08003, Spain; [Gogol, Madelaine] Stowers Inst, Kansas City, MO 64110 USA	Pompeu Fabra University; Stowers Institute for Medical Research	Ayte, J (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, C Doctor Aiguader 88, Barcelona 08003, Spain.	jose.ayte@upf.edu	Ayte, Jose/L-5217-2014; Gomez-Escoda, Blanca/T-1256-2019; Malapeira, Jordi/I-7956-2014	Ayte, Jose/0000-0002-6354-0536; Malapeira, Jordi/0000-0003-3503-1272; Gogol, Madelaine/0000-0002-8738-0995; Gomez Escoda, Blanca/0000-0001-9999-0806	Ministerio de Ciencia y Tecnologia [BFU2006-01785]; Consolider-Ingenio	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank P. Nurse, K. Gould, C. Query, N. Kaufer, H. Murakami and C. McInerny for strains and plasmids; J. Wuand Y. Zhurinskiy for help and advice on ChIPs; E. Hidalgo, J. Valcarcel, J. Vilardell and G. Gil for critical reading of the manuscript; and members of the Oxidative Stress and Cell Cycle Group at Universitat Pompeu Fabra and P. Nurse's laboratory at Rockefeller University for suggestions and comments. We acknowledge the technical support of M. Carmona and K. Zueckert-Gaudenz. J. A. is supported by a contract Ramon y Cajal from the Ministerio de Educacion y Ciencia. This work was supported by grants from the Ministerio de Ciencia y Tecnologia (BFU2006-01785) and the Consolider-Ingenio 2007-0020.	Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Ayte J, 2001, NAT CELL BIOL, V3, P1043, DOI 10.1038/ncb1201-1043; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Burns CG, 1999, P NATL ACAD SCI USA, V96, P13789, DOI 10.1073/pnas.96.24.13789; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Huang T, 2002, EMBO J, V21, P5516, DOI 10.1093/emboj/cdf555; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Malapeira J, 2005, MOL CELL BIOL, V25, P6330, DOI 10.1128/MCB.25.15.6330-6337.2005; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Newo ANS, 2007, NUCLEIC ACIDS RES, V35, P1391, DOI 10.1093/nar/gkl1144; NIELSEN O, 1990, EMBO J, V9, P1401, DOI 10.1002/j.1460-2075.1990.tb08255.x; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Ribar B, 1997, GENE, V202, P1, DOI 10.1016/S0378-1119(97)00390-9; Sinibaldi R, 2001, Methods Mol Biol, V170, P211; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Szilagyi Z, 2005, GENE, V348, P101, DOI 10.1016/j.gene.2004.12.043	29	63	63	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					997	U83		10.1038/nature07325	http://dx.doi.org/10.1038/nature07325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18815595	Green Published			2022-12-01	WOS:000260038300057
J	Mimitou, EP; Symington, LS				Mimitou, Eleni P.; Symington, Lorraine S.			Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; SYNDROME HELICASE; MRE11 COMPLEX; REPAIR; CHECKPOINT; PROTEINS; DAMAGE; YEAST; INTERACTS	DNA ends exposed after introduction of double- strand breaks ( DSBs) undergo 5 '-3 ' nucleolytic degradation to generate single- stranded DNA, the substrate for binding by the Rad51 protein to initiate homologous recombination. This process is poorly understood in eukaryotes, but several factors have been implicated, including the Mre11 complex ( Mre11 - Rad50 - Xrs2/ NBS1), Sae2/ CtIP/ Ctp1 and Exo1. Here we demonstrate that yeast Exo1 nuclease and Sgs1 helicase function in alternative pathways for DSB processing. Novel, partially resected intermediates accumulate in a double mutant lacking Exo1 and Sgs1, which are poor substrates for homologous recombination. The early processing step that generates partly resected intermediates is dependent on Sae2. When Sae2 is absent, in addition to Exo1 and Sgs1, unprocessed DSBs accumulate and homology- dependent repair fails. These results suggest a two- step mechanism for DSB processing during homologous recombination. First, the Mre11 complex and Sae2 remove a small oligonucleotide( s) from the DNA ends to form an early intermediate. Second, Exo1 and/ or Sgs1 rapidly process this intermediate to generate extensive tracts of single- stranded DNA that serve as substrate for Rad51.	[Mimitou, Eleni P.; Symington, Lorraine S.] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA	Columbia University	Symington, LS (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	lss5@columbia.edu			National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank M. Lichten, J. McCusker, A. Rattray and R. Rothstein for gifts of strains and plasmids, and W. K. Holloman and R. Rothstein for comments on the manuscript. This study was supported by a grant from the National Institutes of Health.	Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Borde V, 1999, MOL CELL BIOL, V19, P4832; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Ivanov EL, 1996, GENETICS, V142, P693; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Karmakar P, 2006, BIOCHEM BIOPH RES CO, V348, P62, DOI 10.1016/j.bbrc.2006.07.037; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Mozlin AM, 2008, GENETICS, V178, P113, DOI 10.1534/genetics.107.082677; Mullen JR, 2000, GENETICS, V154, P1101; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; NICKOLOFF JA, 1989, J MOL BIOL, V207, P527, DOI 10.1016/0022-2836(89)90462-2; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Rattray AJ, 2001, GENETICS, V158, P109; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sherman F., 1986, METHODS YEAST GENETI; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	37	738	750	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					770	U3		10.1038/nature07312	http://dx.doi.org/10.1038/nature07312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18806779	Green Accepted			2022-12-01	WOS:000259854900040
J	Wirtz-Peitz, F; Nishimura, T; Knoblich, JA				Wirtz-Peitz, Frederik; Nishimura, Takashi; Knoblich, Juergen A.			Linking cell cycle to asymmetric division: Aurora-A phosphorylates the par complex to regulate Numb localization	CELL			English	Article							LETHAL-GIANT-LARVAE; NEUROBLAST SELF-RENEWAL; NEURAL STEM-CELLS; TUMOR-SUPPRESSOR; DROSOPHILA NEUROBLASTS; MEMBRANE LOCALIZATION; FATE DETERMINANTS; PROTEIN; POLARITY; APKC	Drosophila neural precursor cells divide asymmetrically by segregating the Numb protein into one of the two daughter cells. Numb is uniformly cortical in interphase but assumes a polarized localization in mitosis. Here, we show that a phosphorylation cascade triggered by the activation of Aurora-A is responsible for the asymmetric localization of Numb in mitosis. Aurora-A phosphorylates Par-6, a regulatory subunit of atypical protein kinase C (aPKC). This activates aPKC, which initially phosphorylates Lethal (2) giant larvae (Lgl), a cytoskeletal protein that binds and inhibits aPKC during interphase. Phosphorylated Lgl is released from aPKC and thereby allows the PDZ domain protein Bazooka to enter the complex. This changes substrate specificity and allows aPKC to phosphorylate Numb and release the protein from one side of the cell cortex. Our data reveal a molecular mechanism for the asymmetric localization of Numb and show how cell polarity can be coupled to cell-cycle progression.	[Wirtz-Peitz, Frederik; Nishimura, Takashi; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Nishimura, Takashi/D-7672-2017; Nishimura, Takashi/AAQ-9299-2020; Knoblich, Juergen A/C-2974-2015	Nishimura, Takashi/0000-0002-6773-0302; Nishimura, Takashi/0000-0002-6773-0302; Knoblich, Juergen A/0000-0002-6751-3404	Boehringer Ingelheim Fonds; Human Frontiers Science Program; Austrian Academy of Sciences; Austrian Science Fund; Vienna Science and Technology Fund; European Union EUROSYSTEMS; ONCASYM	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Human Frontiers Science Program(Human Frontier Science Program); Austrian Academy of Sciences; Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund; European Union EUROSYSTEMS(European Commission); ONCASYM	We thank C. Juschke and S.K. Bowman for comments on the manuscript; Y. Bellaiche, T. Hirota, Y.N. Jan, D. St Johnston, K. Kaibuchi, F. Matsuzaki, T. Murphy, S. Ohno, H. Saya, F. Schweisguth, and the Developmental Studies Hybridoma Bank for constructs, antibodies, and fly stocks; J. Betschinger, D. Berdnik, and A. Hutterer for generating transgenic fly lines and constructs; N. Nishimura and S. Farina Lopez for technical assistance; and M.P. Posti-glione, S. Goulas, and other members of our lab for discussion. F.W.P. was supported by a PhD fellowship of the Boehringer Ingelheim Fonds; T.N. is supported by a long-term fellowship of the Human Frontiers Science Program; and work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, the Austrian Science Fund, the Vienna Science and Technology Fund, the European Union EUROSYSTEMS, and ONCASYM.	Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dornan S, 1997, MOL BIOL CELL, V8, P1391, DOI 10.1091/mbc.8.8.1391; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Phair RD, 2004, METHOD ENZYMOL, V375, P393; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roegiers F, 2005, MOL BIOL CELL, V16, P3480, DOI 10.1091/mbc.E05-03-0177; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938	40	271	274	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					161	173		10.1016/j.cell.2008.07.049	http://dx.doi.org/10.1016/j.cell.2008.07.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854163	Green Accepted, Bronze			2022-12-01	WOS:000259728100017
J	Han, BW; Herrin, BR; Cooper, MD; Wilson, IA				Han, Byung Woo; Herrin, Brantley R.; Cooper, Max D.; Wilson, Ian A.			Antigen recognition by variable lymphocyte receptors	SCIENCE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LAMPREY; ANTIBODY; BINDING; PROTEIN; DOMAIN; DIVERSIFICATION; DIVERSITY; EVOLUTION	Variable lymphocyte receptors ( VLRs) rather than antibodies play the primary role in recognition of antigens in the adaptive immune system of jawless vertebrates. Combinatorial assembly of leucine- rich repeat ( LRR) gene segments achieves the required repertoire for antigen recognition. We have determined a crystal structure for a VLR- antigen complex, VLR RBC36 in complex with the H- antigen trisaccharide from human blood type O erythrocytes, at 1.67 angstrom resolution. RBC36 binds the H- trisaccharide on the concave surface of the LRR modules of the solenoid structure where three key hydrophilic residues, multiple van der Waals interactions, and the highly variable insert of the carboxyl- terminal LRR module determine antigen recognition and specificity. The concave surface assembled from the most highly variable regions of the LRRs, along with diversity in the sequence and length of the highly variable insert, can account for the recognition of diverse antigens by VLRs.	[Han, Byung Woo; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Han, Byung Woo; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Herrin, Brantley R.; Cooper, Max D.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Herrin, Brantley R.; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Scripps Research Institute; Scripps Research Institute; Emory University; Emory University	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu		Herrin, Brantley/0000-0002-1842-6806	NIH [AI42266, AI072435]; Georgia Research Alliance; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R37AI042266, T32AI007051, R01AI072435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. L. Stanfield, X. Dai, and X. Zhu for help with data collection and analysis; M. N. Alder for help with VLR cDNA library preparation; J. Paulson and R. McBride for helpful comments and suggestions; and J. Vanhnasy, B. Droese, and H.-J. Kim for technical support and advice. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. Supported by NIH grants AI42266 (I.A.W.) and AI072435 (M.D.C.), the Georgia Research Alliance (M.D.C.), and the Skaggs Institute for Chemical Biology (I.A.W.). This is Scripps Research Institute manuscript 19581-MB. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession code 3E6J.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; BOFFA GA, 1967, NATURE, V214, P700, DOI 10.1038/214700b0; *CHEM COMP GROUP, 2003, MOL OP ENV MOE VERS; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; VON GARA P., 1931, Zeitschrift fur Immunitatsforschung und Experimentelle Therapie, V71, P1; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; POLLARA B, 1970, J IMMUNOL, V105, P738; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; YAMAMOTO F, 1992, BIOCHEM BIOPH RES CO, V187, P366, DOI 10.1016/S0006-291X(05)81502-5	28	133	148	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1834	1837		10.1126/science.1162484	http://dx.doi.org/10.1126/science.1162484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818359	Green Accepted			2022-12-01	WOS:000259501300038
J	Cai, L; Makhov, AM; Schafer, DA; Bear, JE				Cai, Liang; Makhov, Alexander M.; Schafer, Dorothy A.; Bear, James E.			Coronin 1B antagonizes cortactin and remodels Arp2/3-containing actin branches in lamellipodia	CELL			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; ARP2/3 COMPLEX; CELL MOTILITY; F-ACTIN; PROTEIN; NUCLEATION; NETWORKS; MYCOBACTERIA; DISSOCIATION; FILAMENTS	The dendritic actin network generated by the Arp2/3 complex in lamellipodia underlies formation of protrusions, directional sensing, and migration. While the generation of this network is well studied, the mechanisms regulating network disassembly are poorly understood. We report that Coronin 1B disassembles Arp2/3-containing actin filament branches by inducing Arp2/3 dissociation. This activity is antagonized by Cortactin, a filament branch stabilizer. Consistent with this biochemical competition, depletion of both proteins partially rescues defects in lamellipodial dynamics observed upon depletion of either protein alone. Coronin 1B targets actin branches in a manner that is mutually exclusive with the Arp2/3 complex and alters the branch angle. We conclude that Coronin 1B replaces the Arp2/3 complex at actin filament branches as the dendritic network matures and drives the turnover of branched actin networks.	[Cai, Liang; Bear, James E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Makhov, Alexander M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of Virginia	Bear, JE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu			NIH [CA16086, GM31819, GM067222, GM083035]; Sontag Foundation; Carolina Center for Cancer Nanotechnology Excellence (NCI) [1U54CA119343]; NATIONAL CANCER INSTITUTE [U54CA119343, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083035, R01GM031819, R01GM067222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation; Carolina Center for Cancer Nanotechnology Excellence (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge F. Gertler, S. Rogers, R. Cheney, and members of the Bear lab for critical comments on this manuscript; M. Welch for the p41Arc antibody; and the substantial assistance of Jack Griffith in the LCCC Electron Microscopy core (supported by NIH CA16086 and GM31819). This work was supported by NIH grants to D. A. S. (GM067222) and J. E. B. (GM083035). J. E. B. is also supported by the Sontag Foundation and the Carolina Center for Cancer Nanotechnology Excellence (NCI, 1U54CA119343).	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	27	154	158	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					828	842		10.1016/j.cell.2008.06.054	http://dx.doi.org/10.1016/j.cell.2008.06.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775315	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000258947500022
J	Lin, CH; MacGum, JA; Chu, T; Stefan, CJ; Emr, SD				Lin, Charles H.; MacGum, Jason A.; Chu, Tony; Stefan, Christopher J.; Emr, Scott D.			Arrestin-Related Ubiquitin-Ligase Adaptors Regulate Endocytosis and Protein Turnover at the Cell Surface	CELL			English	Article							PLASMA-MEMBRANE ATPASE; QUALITY-CONTROL; NEUROMUSCULAR SYNAPTOGENESIS; SACCHAROMYCES-CEREVISIAE; BETA-ARRESTINS; PY MOTIFS; YEAST; RETROMER; RECEPTOR; BINDING	The diversity of plasma membrane (PM) proteins presents a challenge for the achievement of cargo-specific regulation of endocytosis. Here, we describe a family of proteins in yeast (ARTs, for arrestin-related trafficking adaptors) that function by targeting specific PM proteins to the endocytic system. Two members (Art1 and Art2) of the family were discovered in chemical-genetic screens, and they direct downregulation of distinct amino acid transporters triggered by specific stimuli. Sequence analysis revealed a total of nine ART family members in yeast. In addition to similarity to arrestins, the ARTs each contain multiple PY motifs. These motifs are required for recruitment of the Rsp5/Nedd4-like ubiquitin ligase, which modifies the cargoes as well as the ARTs. As a result, ubiquitinated cargoes are internalized and targeted to the vacuole (lysosome) for degradation. We propose that ARTs provide a cargo-specific quality-control pathway that mediates endocytic downregulation by coupling Rsp5/Nedd4 to diverse plasma membrane proteins.	[Lin, Charles H.; Chu, Tony; Stefan, Christopher J.; Emr, Scott D.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Emr, SD (corresponding author), Cornell Univ, Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	sde26@cornell.edu		Stefan, Christopher/0000-0002-4118-5721	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andoh T, 2002, FEBS LETT, V525, P131, DOI 10.1016/S0014-5793(02)03104-6; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li Y, 1999, MOL CELL BIOL, V19, P3588; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Liu Y, 2006, J CELL SCI, V119, P360, DOI 10.1242/jcs.02749; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Wolf B, 1998, DEVELOPMENT, V125, P3853	36	362	377	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					714	725		10.1016/j.cell.2008.09.025	http://dx.doi.org/10.1016/j.cell.2008.09.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	18976803	Bronze			2022-12-01	WOS:000260886900021
J	Bowler, C; Allen, AE; Badger, JH; Grimwood, J; Jabbari, K; Kuo, A; Maheswari, U; Martens, C; Maumus, F; Otillar, RP; Rayko, E; Salamov, A; Vandepoele, K; Beszteri, B; Gruber, A; Heijde, M; Katinka, M; Mock, T; Valentin, K; Verret, F; Berges, JA; Brownlee, C; Cadoret, JP; Chiovitti, A; Choi, CJ; Coesel, S; De Martino, A; Detter, JC; Durkin, C; Falciatore, A; Fournet, J; Haruta, M; Huysman, MJJ; Jenkins, BD; Jiroutova, K; Jorgensen, RE; Joubert, Y; Kaplan, A; Kroger, N; Kroth, PG; La Roche, J; Lindquist, E; Lommer, M; Martin-Jezequel, V; Lopez, PJ; Lucas, S; Mangogna, M; McGinnis, K; Medlin, LK; Montsant, A; Oudot-Le Secq, MP; Napoli, C; Obornik, M; Parker, MS; Petit, JL; Porcel, BM; Poulsen, N; Robison, M; Rychlewski, L; Rynearson, TA; Schmutz, J; Shapiro, H; Siaut, M; Stanley, M; Sussman, MR; Taylor, AR; Vardi, A; von Dassow, P; Vyverman, W; Willis, A; Wyrwicz, LS; Rokhsar, DS; Weissenbach, J; Armbrust, EV; Green, BR; Van De Peer, Y; Grigoriev, IV				Bowler, Chris; Allen, Andrew E.; Badger, Jonathan H.; Grimwood, Jane; Jabbari, Kamel; Kuo, Alan; Maheswari, Uma; Martens, Cindy; Maumus, Florian; Otillar, Robert P.; Rayko, Edda; Salamov, Asaf; Vandepoele, Klaas; Beszteri, Bank; Gruber, Ansgar; Heijde, Marc; Katinka, Michael; Mock, Thomas; Valentin, Klaus; Verret, Frederic; Berges, John A.; Brownlee, Colin; Cadoret, Jean-Paul; Chiovitti, Anthony; Choi, Chang Jae; Coesel, Sacha; De Martino, Alessandra; Detter, J. Chris; Durkin, Colleen; Falciatore, Angela; Fournet, Jerome; Haruta, Miyoshi; Huysman, Marie J. J.; Jenkins, Bethany D.; Jiroutova, Katerina; Jorgensen, Richard E.; Joubert, Yolaine; Kaplan, Aaron; Kroger, Nils; Kroth, Peter G.; La Roche, Julie; Lindquist, Erica; Lommer, Markus; Martin-Jezequel, Veronique; Lopez, Pascal J.; Lucas, Susan; Mangogna, Manuela; McGinnis, Karen; Medlin, Linda K.; Montsant, Anton; Oudot-Le Secq, Marie-Pierre; Napoli, Carolyn; Obornik, Miroslav; Parker, Micaela Schnitzler; Petit, Jean-Louis; Porcel, Betina M.; Poulsen, Nicole; Robison, Matthew; Rychlewski, Leszek; Rynearson, Tatiana A.; Schmutz, Jeremy; Shapiro, Harris; Siaut, Magali; Stanley, Michele; Sussman, Michael R.; Taylor, Alison R.; Vardi, Assaf; von Dassow, Peter; Vyverman, Wim; Willis, Anusuya; Wyrwicz, Lucjan S.; Rokhsar, Daniel S.; Weissenbach, Jean; Armbrust, E. Virginia; Green, Beverley R.; Van de Peer, Yves; Grigoriev, Igor V.			The Phaeodactylum genome reveals the evolutionary history of diatom genomes	NATURE			English	Article							RECIPROCAL GENE LOSS; THALASSIOSIRA-PSEUDONANA; BACILLARIOPHYCEAE; METABOLISM; MECHANISMS; COMPONENTS; BACTERIA; YEASTS	Diatoms are photosynthetic secondary endosymbionts found throughout marine and freshwater environments, and are believed to be responsible for around one- fifth of the primary productivity on Earth(1,2). The genome sequence of the marine centric diatom Thalassiosira pseudonana was recently reported, revealing a wealth of information about diatom biology(3-5). Here we report the complete genome sequence of the pennate diatom Phaeodactylum tricornutum and compare it with that of T. pseudonana to clarify evolutionary origins, functional significance and ubiquity of these features throughout diatoms. In spite of the fact that the pennate and centric lineages have only been diverging for 90 million years, their genome structures are dramatically different and a substantial fraction of genes (similar to 40%) are not shared by these representatives of the two lineages. Analysis of molecular divergence compared with yeasts and metazoans reveals rapid rates of gene diversification in diatoms. Contributing factors include selective gene family expansions, differential losses and gains of genes and introns, and differential mobilization of transposable elements. Most significantly, we document the presence of hundreds of genes from bacteria. More than 300 of these gene transfers are found in both diatoms, attesting to their ancient origins, and many are likely to provide novel possibilities for metabolite management and for perception of environmental signals. These findings go a long way towards explaining the incredible diversity and success of the diatoms in contemporary oceans.	[Bowler, Chris; Allen, Andrew E.; Jabbari, Kamel; Maheswari, Uma; Maumus, Florian; Rayko, Edda; Heijde, Marc; De Martino, Alessandra; Lopez, Pascal J.; Montsant, Anton; Vardi, Assaf] Ecole Normale Super, CNRS, Dept Biol, UMR8186, F-75005 Paris, France; [Bowler, Chris; Coesel, Sacha; Falciatore, Angela; Mangogna, Manuela; Montsant, Anton; Siaut, Magali] Stn Zool A Dohrn, I-80121 Naples, Italy; [Allen, Andrew E.; Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA 92121 USA; [Grimwood, Jane; Schmutz, Jeremy] Stanford Human Genome Ctr, Joint Genome Inst Stanford, Palo Alto, CA 94304 USA; [Kuo, Alan; Otillar, Robert P.; Salamov, Asaf; Detter, J. Chris; Lindquist, Erica; Lucas, Susan; Shapiro, Harris; Rokhsar, Daniel S.; Grigoriev, Igor V.] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Martens, Cindy; Vandepoele, Klaas; Huysman, Marie J. J.; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Beszteri, Bank; Valentin, Klaus; Medlin, Linda K.] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Gruber, Ansgar; Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Katinka, Michael; Petit, Jean-Louis; Porcel, Betina M.; Weissenbach, Jean] CNRS, CEA Inst Genom, UMR 8030, F-91057 Evry, France; [Mock, Thomas; Durkin, Colleen; Parker, Micaela Schnitzler; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Verret, Frederic; Brownlee, Colin; Medlin, Linda K.; Taylor, Alison R.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Berges, John A.; Choi, Chang Jae] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Cadoret, Jean-Paul] IFREMER, PBA, F-44311 Nantes 03, France; [Chiovitti, Anthony; Willis, Anusuya] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Fournet, Jerome; Joubert, Yolaine; Martin-Jezequel, Veronique] Univ Nantes, Lab Mer Mol Sante, Fac Tech Sci, EA 2160, F-44322 Nantes 3, France; [Haruta, Miyoshi; Robison, Matthew; Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Huysman, Marie J. J.; Vyverman, Wim] Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Jenkins, Bethany D.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Jenkins, Bethany D.] Univ Rhode Isl, Grad Sch Oceanog, Kingston, RI 02881 USA; [Jiroutova, Katerina; Obornik, Miroslav] Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Jiroutova, Katerina; Obornik, Miroslav] Univ S Bohemia, Fac Sci, CR-37005 Ceske Budejovice, Czech Republic; [Jorgensen, Richard E.; McGinnis, Karen; Napoli, Carolyn] Univ Arizona, Bio5 Inst, Tucson, AZ 85719 USA; [Jorgensen, Richard E.; McGinnis, Karen; Napoli, Carolyn] Univ Arizona, Dept Plant Sci, Tucson, AZ 85719 USA; [Kaplan, Aaron] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, IL-91904 Jerusalem, Israel; [Kroger, Nils] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kroger, Nils] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Kroger, Nils] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [La Roche, Julie; Lommer, Markus] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Oudot-Le Secq, Marie-Pierre; Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Poulsen, Nicole] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Rychlewski, Leszek; Wyrwicz, Lucjan S.] BioInfoBank Inst, PL-60744 Poznan, Poland; [Rynearson, Tatiana A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Stanley, Michele] Dunstaffnage Marine Res Lab, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Taylor, Alison R.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA; [Vardi, Assaf] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08901 USA; [von Dassow, Peter] CNRS, Biol Stn, UMR7144, F-29682 Roscoff, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Stazione Zoologica Anton Dohrn di Napoli; J. Craig Venter Institute; Stanford University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Flanders Institute for Biotechnology (VIB); Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Konstanz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; University of Washington; University of Washington Seattle; Marine Biological Association United Kingdom; University of Wisconsin System; University of Wisconsin Milwaukee; Ifremer; University of Melbourne; Nantes Universite; University of Wisconsin System; University of Wisconsin Madison; Ghent University; University of Rhode Island; University of Rhode Island; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Arizona; University of Arizona; Hebrew University of Jerusalem; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of British Columbia; University System of Georgia; Georgia Institute of Technology; University of Rhode Island; UHI Millennium Institute; University of North Carolina; University of North Carolina Wilmington; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Bowler, C (corresponding author), Ecole Normale Super, CNRS, Dept Biol, UMR8186, 46 Rue Ulm, F-75005 Paris, France.	cbowler@biologie.ens.fr	Berges, John A/D-9520-2012; Valentin, Klaus/G-5862-2014; medlin, linda k/G-4820-2010; Schmutz, Jeremy/N-3173-2013; Dasseville, Renaat/B-3561-2010; Grimwood, Jane/ABD-5737-2021; Coesel, Sacha/AAX-5588-2021; Beszteri, Bank M/D-1961-2010; Van de Peer, Yves/AAE-7666-2019; Lopez, Pascal Jean/A-7427-2011; Gruber, Ansgar/B-9587-2008; Bowler, Chris/AAC-6256-2019; Mock, Thomas/A-3127-2008; von Dassow, Peter/A-5399-2012; Van de Peer, Yves/D-4388-2009; Green, Beverley R./AAJ-5199-2021; Lopez, Pascal Jean/P-5813-2019; Wyrwicz, Lucjan/ABD-6558-2021; LaRoche, Julie/A-1109-2010; Stanley, Michele S/D-5859-2013; Obornik, Miroslav/G-9350-2014; Wilis, Anusuya/AAV-6917-2020; Allen, Andrew E/C-4896-2012; Maumus, Florian/O-5426-2016; Vandepoele, Klaas/E-7514-2010; Heijde, Marc/O-8958-2014; Willis, Anusuya/B-6712-2013; Falciatore, Angela/Q-6161-2018; Kaplan, Aaron/GLN-5655-2022; Kroth, Peter G/A-9728-2008	Berges, John A/0000-0002-3124-4783; Valentin, Klaus/0000-0001-7401-9423; Schmutz, Jeremy/0000-0001-8062-9172; Coesel, Sacha/0000-0001-9422-8388; Beszteri, Bank M/0000-0002-6852-1588; Van de Peer, Yves/0000-0003-4327-3730; Gruber, Ansgar/0000-0002-5876-4391; Mock, Thomas/0000-0001-9604-0362; Van de Peer, Yves/0000-0003-4327-3730; Green, Beverley R./0000-0002-4021-9387; Lopez, Pascal Jean/0000-0002-9914-4252; Wyrwicz, Lucjan/0000-0003-0808-6892; Wilis, Anusuya/0000-0003-0829-7446; Allen, Andrew E/0000-0001-5911-6081; Maumus, Florian/0000-0001-7325-0527; Vandepoele, Klaas/0000-0003-4790-2725; Kroth, Peter G/0000-0003-4734-8955; Choi, Chang Jae/0000-0002-0831-7470; Cadoret, Jean-Paul/0000-0001-7542-5474; Petit, Jean-Louis/0000-0002-8566-0571; heijde, marc/0000-0002-8109-8999; von Dassow, Peter/0000-0002-1858-1953; Verret, Frederic/0000-0002-8175-7325; Poulsen, Nicole/0000-0002-4533-8860; Porcel, Betina/0000-0003-0169-5302; Bowler, Chris/0000-0003-3835-6187; Parker, Micaela/0000-0003-1007-4612; Fournet, jerome/0000-0001-8595-9971; Stanley, Michele/0000-0002-2348-3231; Grigoriev, Igor/0000-0002-3136-8903; martin-jezequel, veronique/0000-0002-6633-1334; Falciatore, Angela/0000-0003-3318-9578; Vardi, Assaf/0000-0002-7079-0234; LaRoche, Julie/0000-0003-4809-6411; Kaplan, Aaron/0000-0002-0815-5731; Shunmugam, Uma/0000-0001-7007-9234	EU-funded FP6 Diatomics [LSHG-CT-2004-512035]; EU-FP6 Marine Genomics Network of Excellence [GOCE-CT-2004-505403]; ATIP 'Blanche'; CNRS (France); Agence Nationale de la Recherche (France); NERC [dml010007, mba010002] Funding Source: UKRI; Natural Environment Research Council [mba010002, dml010007] Funding Source: researchfish	EU-funded FP6 Diatomics(European Commission); EU-FP6 Marine Genomics Network of Excellence(European Commission); ATIP 'Blanche'; CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Diatom genome sequencing at the JGI (USA) was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory, under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344 and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. P. tricornutum ESTs were generated at Genoscope (France). Funding for this work was also obtained from the EU-funded FP6 Diatomics project (LSHG-CT-2004-512035), the EU-FP6 Marine Genomics Network of Excellence (GOCE-CT-2004-505403), an ATIP 'Blanche' grant from the CNRS (France) and the Agence Nationale de la Recherche (France). We are grateful to M. Muffato and H.-R. Crollius for the analysis reported in Supplementary Fig. 3a.	Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bhattacharya D, 2007, BIOESSAYS, V29, P1239, DOI 10.1002/bies.20671; Carpenter EJ, 2000, J PHYCOL, V36, P540, DOI 10.1046/j.1529-8817.2000.99163.x; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kooistra Wiebe H. C. F., 2007, P207; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Martens C, 2008, P NATL ACAD SCI USA, V105, P3427, DOI 10.1073/pnas.0712248105; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Montsant A, 2007, J PHYCOL, V43, P585, DOI 10.1111/j.1529-8817.2007.00342.x; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Roy SW, 2007, MOL BIOL EVOL, V24, P1447, DOI 10.1093/molbev/msm048; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schmid AMM, 2003, J PHYCOL, V39, P122, DOI 10.1046/j.1529-8817.2003.02084.x; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4	30	1149	1235	17	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					239	244		10.1038/nature07410	http://dx.doi.org/10.1038/nature07410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18923393	Green Published, hybrid			2022-12-01	WOS:000261039300040
J	Majo, F; Rochat, A; Nicolas, M; Abou Jaoude, G; Barrandon, Y				Majo, Francois; Rochat, Ariane; Nicolas, Michael; Abou Jaoude, Georges; Barrandon, Yann			Oligopotent stem cells are distributed throughout the mammalian ocular surface	NATURE			English	Article							HAIR-FOLLICLES; CORNEAL EPITHELIUM; BASAL CELLS; RENEWAL; LOCATION; KERATINOCYTE; CULTURE; REPAIR	The integrity of the cornea, the most anterior part of the eye, is indispensable for vision. Forty- five million individuals worldwide are bilaterally blind and another 135 million have severely impaired vision in both eyes because of loss of corneal transparency(1); treatments range from local medications to corneal transplants, and more recently to stem cell therapy(2). The corneal epithelium is a squamous epithelium that is constantly renewing, with a vertical turnover of 7 to 14 days in many mammals(3). Identification of slow cycling cells ( label- retaining cells) in the limbus of the mouse has led to the notion that the limbus is the niche for the stem cells responsible for the long- term renewal of the cornea(4); hence, the corneal epithelium is supposedly renewed by cells generated at and migrating from the limbus, in marked opposition to other squamous epithelia in which each resident stem cell has in charge a limited area of epithelium(5,6). Here we show that the corneal epithelium of the mouse can be serially transplanted, is self- maintained and contains oligopotent stem cells with the capacity to generate goblet cells if provided with a conjunctival environment. Furthermore, the entire ocular surface of the pig, including the cornea, contains oligopotent stem cells (holoclones)(7,8) with the capacity to generate individual colonies of corneal and conjunctival cells. Therefore, the limbus is not the only niche for corneal stem cells and corneal renewal is not different from other squamous epithelia. We propose a model that unifies our observations with the literature and explains why the limbal region is enriched in stem cells.	[Majo, Francois; Rochat, Ariane; Nicolas, Michael; Barrandon, Yann] Ecole Polytech Fed Lausanne, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; [Abou Jaoude, Georges] Ecole Polytech Fed Lausanne, Lab Informat & Visualizat, CH-1015 Lausanne, Switzerland; [Majo, Francois; Rochat, Ariane; Nicolas, Michael; Barrandon, Yann] Univ Lausanne Hosp, CHU Vaudois, Dept Expt Surg, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Barrandon, Y (corresponding author), Ecole Polytech Fed Lausanne, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland.	yann.barrandon@epfl.ch			Swiss National Science Foundation [3100A0-104160]; EPFL; CHUV; EuroStemCell; Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche contre le Cancer; Association Francaise contre les Myopathies; Federation des Aveugles et Handicapes Visuels de France; INSERM	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; CHUV; EuroStemCell(European Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Federation des Aveugles et Handicapes Visuels de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We are grateful to F. Radtke and S. Vauclair for Notch1<SUP>lox/lox</SUP> K14Cre ROSA26R mice, to A. Smith for critical reading of the manuscript, to T. Hoang-Xuan, L. Zografos, F. Munier and S. Kinoshita for continuous support and to L. Schnell, J. Vannod and S. Vermot for excellent technical help. The work was supported by grants to Y. B. from the Swiss National Science Foundation (grant 3100A0-104160), the EPFL, the CHUV and EuroStemCell. The early part of the work was supported by grants to Y. B. from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association pour la Recherche contre le Cancer and the Association Francaise contre les Myopathies. F. M. was supported by fellowships from the Federation des Aveugles et Handicapes Visuels de France, the INSERM and then the CHUV.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; BUCK RC, 1979, INVEST OPHTH VIS SCI, V18, P767; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Ferraris C, 2000, DEVELOPMENT, V127, P5487; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Haddad A, 2000, CORNEA, V19, P378, DOI 10.1097/00003226-200005000-00024; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kawasaki S, 2006, INVEST OPHTH VIS SCI, V47, P1359, DOI 10.1167/iovs.05-1084; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Nakamura T, 2004, ACTA OPHTHALMOL SCAN, V82, P468, DOI 10.1111/j.1395-3907.2004.00285.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; POTTEN CS, 1979, BIOCHIM BIOPHYS ACTA, V560, P281, DOI 10.1016/0304-419X(79)90022-2; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SHAPIRO MS, 1981, INVEST OPHTH VIS SCI, V21, P135; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tanioka H, 2006, INVEST OPHTH VIS SCI, V47, P3820, DOI 10.1167/iovs.06-0293; THOFT RA, 1984, AM J OPHTHALMOL, V97, P1; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214	35	296	306	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					250	U51		10.1038/nature07406	http://dx.doi.org/10.1038/nature07406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18830243				2022-12-01	WOS:000261039300042
J	Menon, U; Gentry-Maharaj, A; Ryan, A; Sharma, A; Burnell, M; Hallett, R; Lewis, S; Lopez, A; Godfrey, K; Oram, D; Herod, J; Williamson, K; Seif, M; Scott, I; Mould, T; Woolas, R; Murdoch, J; Dobbs, S; Amso, N; Leeson, S; Cruickshank, D; McGuire, A; Campbell, S; Fallowfield, L; Skates, S; Parmar, M; Jacobs, I				Menon, Usha; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sharma, Aarti; Burnell, Matthew; Hallett, Rachel; Lewis, Sara; Lopez, Alberto; Godfrey, Keith; Oram, David; Herod, Jonathan; Williamson, Karin; Seif, Mourad; Scott, Ian; Mould, Tim; Woolas, Robert; Murdoch, John; Dobbs, Stephen; Amso, Nazar; Leeson, Simon; Cruickshank, Derek; McGuire, Ali; Campbell, Stuart; Fallowfield, Lesley; Skates, Steve; Parmar, Mahesh; Jacobs, Ian			Recruitment to multicentre trials-lessons from UKCTOCS: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; OVARIAN-CANCER; FLEXIBLE SIGMOIDOSCOPY; POSTMENOPAUSAL WOMEN; COLORECTAL-CANCER; CLINICAL-TRIAL; FOLLOW-UP; PROGRAM; DESIGN; COHORT	Objective To describe the factors that contributed to successful recruitment of more than 200 000 women to the UK Collaborative Trial of Ovarian Cancer Screening, one of the largest ever randomised controlled trials. Design Descriptive study. Setting 13 NHS trusts in England, Wales, and Northern Ireland. Participants Postmenopausal women aged 50- 74; exclusion criteria included ovarian malignancy, bilateral oophorectomy, increased risk of familial ovarian cancer, active non- ovarian malignancy, and participation in other ovarian cancer screening trials. Main outcome measures Achievement of target recruitment, acceptance rates of invitation, and recruitment rates. Results The trial was set up in 13 centres with 27 adjoining local health authorities. The coordinating centre team was led by one of the senior investigators, who was closely involved in planning and day to day trial management. Of 1 243 282 women invited, 23.2% ( 288 955) replied that they were eligible and would like to participate. Of those sent appointments, 73.6% ( 205 090) attended for recruitment. The acceptance rate varied from 19% to 33% between trial centres. Measures to ensure target recruitment included named coordinating centre staff supporting and monitoring each centre, prompt identification and resolution of logistic problems, varying the volume of invitations by centre, using local nonattendance rates to determine the size of recruitment clinics, and organising large ad hoc clinics supported by coordinating centre staff. The trial randomised 202 638 women in 4.3 years. Conclusions Planning and trial management are as important as trial design and require equal attention from senior investigators. Successful recruitment needs constant monitoring by a committed proactive management team that is willing to explore individual solutions for different centres and use central resources to improve local recruitment. Automation of trial processes with web based trial management systems is crucial in large multicentre randomised controlled trials. Recruitment can be further enhanced by using information videos and group discussions. Trial registration Current Controlled Trials ISRCTN22488978.	[Menon, Usha; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sharma, Aarti; Burnell, Matthew; Hallett, Rachel; Lewis, Sara; Jacobs, Ian] UCL, EGA Inst Womens Hlth, London W1T 7DN, England; [Oram, David] St Bartholomews Hosp, London EC1A 7BE, England; [Herod, Jonathan] Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England; [Williamson, Karin] City Hosp Nottingham, Nottingham NG5 1PB, England; [Seif, Mourad] St Marys Hosp, Manchester M13 9WL, Lancs, England; [Scott, Ian] Derby City Hosp, Derby DE22 3NE, England; [Mould, Tim] Royal Free Hosp, London NW3 2QG, England; [Woolas, Robert] St Marys Hosp, Portsmouth PO3 6AD, Hants, England; [Murdoch, John] St Michaels Hosp, Bristol BS2 8EG, Avon, England; [Dobbs, Stephen] Belfast City Hosp, Belfast BT9 7AB, Antrim, North Ireland; [Amso, Nazar] Cardiff Univ, Cardiff CF14 4XN, Wales; [Cruickshank, Derek] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; [McGuire, Ali] London Sch Econ, London WC2A 2AE, England; [Campbell, Stuart] Create Hlth Clin, London W1G 6AJ, England; [Fallowfield, Lesley] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England; [Skates, Steve] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Parmar, Mahesh] MRC, Clin Trials Unit, London NW1 2DA, England	University of London; University College London; University of London; Queen Mary University London; University of Liverpool; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Manchester; University of Nottingham; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Belfast City Hospital; Cardiff University; James Cook University Hospital; University of London; London School Economics & Political Science; University of Brighton; University of Sussex; Harvard University; Harvard Medical School; Medical Research Council Clinical Trials Unit	Menon, U (corresponding author), UCL, EGA Inst Womens Hlth, London W1T 7DN, England.	u.menon@ucl.ac.uk	Jacobs, Ian J/F-1743-2013; Menon, Usha/C-4716-2008	Jacobs, Ian J/0000-0002-8112-4624; Menon, Usha/0000-0003-3708-1732; Amso, Nazar/0000-0002-8646-6623; Fallowfield, Lesley/0000-0003-0577-4518; Jacobs, Ian/0000-0002-5005-2672	Medical Research Council; Cancer Research UK; Department of Health; Eve Appeal; Special Trustees of Bart's; London, and Special Trustees of UCLH; MRC [G0000735, G9901012] Funding Source: UKRI; Medical Research Council [G0000735, G9901012] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA086381, P50CA083639] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Department of Health; Eve Appeal; Special Trustees of Bart's; London, and Special Trustees of UCLH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The trial is core funded by the Medical Research Council, Cancer Research UK, and the Department of Health with additional support from the Eve Appeal, Special Trustees of Bart's and the London, and Special Trustees of UCLH. This work was done at UCLH/UCL within the " women's health theme" of the NIHR UCLH/UCL Comprehensive Biomedical Research Centre supported by the Department of Health. The researchers are independent from the funders.	Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2001, J MED SCREEN, V8, P137, DOI 10.1136/jms.8.3.137; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Cambron JA, 2001, J MANIP PHYSIOL THER, V24, P79, DOI 10.1067/mmt.2001.112567; Cosgrove N, 1999, CONTROL CLIN TRIALS, V20, P133, DOI 10.1016/S0197-2456(98)00055-5; Denhaerynck K, 2003, AM J PREV MED, V25, P195, DOI 10.1016/S0749-3797(03)00201-0; Eisinger F, 2001, Fam Cancer, V1, P175, DOI 10.1023/A:1021177417531; Farrell B, 1998, BRIT MED J, V317, P1236, DOI 10.1136/bmj.317.7167.1236; Fegan W, 2008, PLOS MED, V5, P347, DOI 10.1371/journal.pmed.0050006; Froom P, 1999, J CLIN EPIDEMIOL, V52, P731, DOI 10.1016/S0895-4356(99)00070-0; Gordon JS, 2006, NICOTINE TOB RES, V8, pS35, DOI 10.1080/14622200601039014; Gray M, 2000, Health Bull (Edinb), V58, P137; Hasson MA, 2000, CONTROL CLIN TRIALS, V21, p329S, DOI 10.1016/S0197-2456(00)00100-8; JACOBS I, 1988, LANCET, V1, P268; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jacobs IJ, 1996, BMJ-BRIT MED J, V313, P1355, DOI 10.1136/bmj.313.7069.1355; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Lindsted KD, 1996, J CLIN EPIDEMIOL, V49, P783, DOI 10.1016/0895-4356(96)00009-1; MacDonald N, 1999, BRIT J CANCER, V80, P1826, DOI 10.1038/sj.bjc.6690605; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 2007, MENOPAUSE, V14, P462, DOI 10.1097/01.gme.0000243569.70946.9d; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; *OFF NAT, 2001, H CENS 2001 POP DAT; *OFF NAT STAT, 2004, CANC STAT REG REG CA, P24; Ott CD, 2006, CANCER NURS, V29, P21, DOI 10.1097/00002820-200601000-00004; OTT CD, 2006, CANC NURS, V29, P32; Paine BJ, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-5; Parkes C A, 1994, J Med Screen, V1, P209; PRESCOTT RJ, 1999, HEALTH TECHNOL ASSES, V3, P65; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thomson CA, 2005, J CLIN EPIDEMIOL, V58, P378, DOI 10.1016/j.jclinepi.2004.10.013	33	70	70	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2008	337								a2079	10.1136/bmj.a2079	http://dx.doi.org/10.1136/bmj.a2079			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008269	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-01	WOS:000261784500002
J	Bynum, B				Bynum, Bill			The art of medicine Road maps to health	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk						Glacken Clarence J., 1976, TRACES RHODIAN SHORE; Hamlin Christopher, 1998, PUBLIC HLTH SOCIAL J; Lloyd GER., 1978, HIPPOCRATIC WRITINGS; Ramazzini B., 1940, DIS WORKERS; Virchow R., 1848, COLLECTED ESSAYS PUB	5	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1626	1627		10.1016/S0140-6736(08)61676-1	http://dx.doi.org/10.1016/S0140-6736(08)61676-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	19006814				2022-12-01	WOS:000260899900014
J	McDonald, GR; Hudson, AL; Dunn, SMJ; You, HT; Baker, GB; Whittal, RM; Martin, JW; Jha, A; Edmondson, DE; Holt, A				McDonald, G. Reid; Hudson, Alan L.; Dunn, Susan M. J.; You, Haitao; Baker, Glen B.; Whittal, Randy M.; Martin, Jonathan W.; Jha, Amitabh; Edmondson, Dale E.; Holt, Andrew			Bioactive Contaminants Leach from Disposable Laboratory Plasticware	SCIENCE			English	Article									[McDonald, G. Reid; Hudson, Alan L.; Dunn, Susan M. J.; You, Haitao; Holt, Andrew] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2B7, Canada; [Baker, Glen B.] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2R7, Canada; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Martin, Jonathan W.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2G3, Canada; [Jha, Amitabh] Acadia Univ, Dept Chem, Wolfville, NS B4P 2R6, Canada; [Edmondson, Dale E.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Acadia University; Emory University	Holt, A (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2B7, Canada.	aholt@pmcol.ualberta.ca	Jha, Amitabh/B-5452-2010; Jha, Amitabh/AAU-2075-2021; Martin, Jonathan W/J-3824-2013	Jha, Amitabh/0000-0002-6305-0721; Martin, Jonathan W/0000-0001-6265-4294; Hudson, Alan/0000-0003-1105-7646				COOPER I, 1995, FOOD ADDIT CONTAM, V12, P235, DOI 10.1080/02652039509374298; Hiley CR, 2007, CARDIOVASC DRUG REV, V25, P46, DOI 10.1111/j.1527-3466.2007.00004.x; Maher B, 2008, NATURE, V453, P964, DOI 10.1038/453964a; Shotyk W, 2007, ENVIRON SCI TECHNOL, V41, P1560, DOI 10.1021/es061511+; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010	5	166	167	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					917	917		10.1126/science.1162395	http://dx.doi.org/10.1126/science.1162395			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988846				2022-12-01	WOS:000260674100039
J	Zauber, AG; Lansdorp-Vogelaar, I; Knudsen, AB; Wilschut, J; van Ballegooijen, M; Kuntz, KM				Zauber, Ann G.; Lansdorp-Vogelaar, Iris; Knudsen, Amy B.; Wilschut, Janneke; van Ballegooijen, Marjolein; Kuntz, Karen M.			Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							LARGE-INTESTINE; LARGE-BOWEL; CLINICAL GUIDELINES; COST-EFFECTIVENESS; POLYPS; SURVEILLANCE; COLONOSCOPY; MORTALITY; PREVALENCE; CAPACITY	Background: The U. S. Preventive Services Task Force requested a decision analysis to inform their update of recommendations for colorectal cancer screening. Objective: To assess life-years gained and colonoscopy requirements for colorectal cancer screening strategies and identify a set of recommendable screening strategies. Design: Decision analysis using 2 colorectal cancer microsimulation models from the Cancer Intervention and Surveillance Modeling Network. Data Sources: Derived from the literature. Target Population: U. S. average-risk 40-year-old population. Perspective: Societal. Time Horizon: Lifetime. Interventions: Fecal occult blood tests (FOBTs), flexible sigmoidoscopy, or colonoscopy screening beginning at age 40, 50, or 60 years and stopping at age 75 or 85 years, with screening intervals of 1, 2, or 3 years for FOBT and 5, 10, or 20 years for sigmoidoscopy and colonoscopy. Outcome Measures: Number of life-years gained compared with no screening and number of colonoscopies and noncolonoscopy tests required. Results of Base-Case Analysis: Beginning screening at age 50 years was consistently better than at age 60. Decreasing the stop age from 85 to 75 years decreased life-years gained by 1% to 4%, whereas colonoscopy use decreased by 4% to 15%. Assuming equally high adherence, 4 strategies provided similar life-years gained: colonoscopy every 10 years, annual Hemoccult SENSA (Beckman Coulter, Fullerton, California) testing or fecal immunochemical testing, and sigmoidoscopy every 5 years with midinterval Hemoccult SENSA testing. Annual Hemoccult II and flexible sigmoidoscopy every 5 years alone were less effective. Results of Sensitivity Analysis: The results were most sensitive to beginning screening at age 40 years. Limitation: The stop age for screening was based only on chronologic age. Conclusion: The findings support colorectal cancer screening with the following: colonoscopy every 10 years, annual screening with a sensitive FOBT, or flexible sigmoidoscopy every 5 years with a midinterval sensitive FOBT from age 50 to 75 years.	[Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; Erasmus MC, Rotterdam, Netherlands; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Minnesota, Minneapolis, MN USA	Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities	Zauber, AG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St, New York, NY 10065 USA.	zaubera@mskcc.org		Wilschut, Janneke/0000-0002-4921-227X	National Cancer Institute [U01-CA-088204, U01-CA-097426, U01-CA-115953]; Agency for Healthcare Research and Quality [HHSP233200700350P, HHSP233200700210P, HHSP233200700196P]; NATIONAL CANCER INSTITUTE [P30CA008748, U01CA115953, U01CA088204, U01CA097426] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (U01-CA-088204, U01-CA-097426, and U01-CA-115953) and the Agency for Healthcare Research and Quality (HHSP233200700350P, HHSP233200700210P, and HHSP233200700196P).	*AM CANC SOC, CANC FACTS FIG 2008; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Breslow RA, 2008, AM J PREV MED, V35, pS14, DOI 10.1016/j.amepre.2008.04.005; Brown ML, 2003, AM J MED, V115, P129, DOI 10.1016/S0002-9343(03)00297-3; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Mark DH, 2002, JAMA-J AM MED ASSOC, V287, P2428, DOI 10.1001/jama.287.18.2428; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1661, DOI 10.1053/j.gastro.2004.09.052; SEER Program, SEER STAT DAT INC SE; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; ZAUBER AG, COST EFFECTIVENESS D	38	448	451	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					659	+		10.7326/0003-4819-149-9-200811040-00244	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00244			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18838717	Green Accepted			2022-12-01	WOS:000260585700006
J	Brewster, JM; Kaufmann, IM; Hutchison, S; MacWilliam, C				Brewster, Joan M.; Kaufmann, I. Michael; Hutchison, Sarah; MacWilliam, Cynthia			Characteristics and outcomes of doctors in a substance dependence monitoring programme in Canada: prospective descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG PROBLEMS; PHYSICIANS; ALCOHOL; CARE	Objective To describe the characteristics at enrolment and outcomes of doctors in a substance dependence monitoring programme in Canada. Design Prospective descriptive study. Setting Provincial physician health programme, Canada. Participants All 100 doctors consecutively admitted to a substance dependence monitoring programme and followed until completion of monitoring or on leaving the programme. Main outcome measure Relapse during long term monitoring for five years. Results Ninety per cent of the doctors enrolled on the programme were men, 66% were married or living with a partner, 44% had had previous treatment for substance dependence, and 36% had had previous psychiatric treatment. Smokers were over- represented compared with the general population of US doctors ( 38% v 5%). During the monitoring period 71% of participants had no known relapse. An additional 14% went on to complete the programme, after some form of relapse. In total, 85% of the doctors successfully completed the programme. Conclusion In this cohort of doctors enrolled on the Ontario Physician Health Program for substance dependence, most were men who were dependent on alcohol or opioids. Smokers were over- represented compared with the general population of US doctors. Eighty five per cent successfully completed the programme.	[Brewster, Joan M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Kaufmann, I. Michael; Hutchison, Sarah; MacWilliam, Cynthia] Ontario Med Assoc, Ontario Phys Hlth Program, Toronto, ON, Canada	University of Toronto	Brewster, JM (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada.	jmbrewster@sympatico.ca			Ontario Physician Health Program	Ontario Physician Health Program	This research was funded by the Ontario Physician Health Program. JMB was paid as a consultant to carry out data analyses and write the paper. The other authors are employees of the Ontario Physician Health Program or the Ontario Medical Association, and their participation in the research was part of their employment. The research interpretation and outcomes are independent of the funding.	Bohigian GM, 1996, SOUTHERN MED J, V89, P1078, DOI 10.1097/00007611-199611000-00010; *BRIT MED ASS, 2008, DOCT HLTH WELLB; *CAN MED ASS, 2008, CAN PHYS HLTH NETW; GALANTER M, 1990, AM J PSYCHIAT, V147, P64; GLASER FB, 1986, CAN FAM PHYSICIAN, V32, P993; Gossop M, 2001, ALCOHOL ALCOHOLISM, V36, P160, DOI 10.1093/alcalc/36.2.160; MANSKY PA, 2003, PSYCHIAT TIMES  0201, P20; Nelson HD, 1996, WESTERN J MED, V165, P31; Reading E G, 1992, Md Med J, V41, P325; Smith DR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-115; 2008, FEDERATION STATE PHY	11	19	19	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2008	337								a2098	10.1136/bmj.a2098	http://dx.doi.org/10.1136/bmj.a2098			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377EZ	18981018	Green Published, hybrid			2022-12-01	WOS:000261235800001
J	Wing, K; Onishi, Y; Prieto-Martin, P; Yamaguchi, T; Miyara, M; Fehervari, Z; Nomura, T; Sakaguchi, S				Wing, Kajsa; Onishi, Yasushi; Prieto-Martin, Paz; Yamaguchi, Tomoyuki; Miyara, Makoto; Fehervari, Zoltan; Nomura, Takashi; Sakaguchi, Shimon			CTLA-4 control over Foxp3(+) regulatory T cell function	SCIENCE			English	Article							DENDRITIC CELLS; COSTIMULATORY MOLECULES; TARGET GENES; ANTIGEN 4; AUTOIMMUNITY; BLOCKADE; CD25(+); INFLAMMATION; TOLERANCE; IMMUNITY	Naturally occurring Foxp3(+)CD4(+) regulatory T cells (Tregs) are essential for maintaining immunological self-tolerance and immune homeostasis. Here, we show that a specific deficiency of cytotoxic T lymphocyte antigen 4 (CTLA-4) in Tregs results in spontaneous development of systemic lymphoproliferation, fatal T cell-mediated autoimmune disease, and hyperproduction of immunoglobulin E in mice, and it also produces potent tumor immunity. Treg-specific CTLA-4 deficiency impairs in vivo and in vitro suppressive function of Tregs - in particular, Treg-mediated down-regulation of CD80 and CD86 expression on dendritic cells. Thus, natural Tregs may critically require CTLA-4 to suppress immune responses by affecting the potency of antigen-presenting cells to activate other T cells.	[Wing, Kajsa; Onishi, Yasushi; Prieto-Martin, Paz; Yamaguchi, Tomoyuki; Miyara, Makoto; Fehervari, Zoltan; Nomura, Takashi; Sakaguchi, Shimon] Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Onishi, Yasushi] Tohoku Univ, Grad Sch Med, Dept Rheumatol & Haematol, Sendai, Miyagi 9808574, Japan; [Sakaguchi, Shimon] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Sakaguchi, Shimon] Osaka Univ, Expt Immunol Lab, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Kyoto University; Tohoku University; Japan Science & Technology Agency (JST); Osaka University	Sakaguchi, S (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Miyara, Makoto/P-4491-2017; Sakaguchi, Shimon/C-9535-2009	Miyara, Makoto/0000-0001-8743-8846; Wing, Kajsa/0000-0001-7744-4847	Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency [Grants-in-Aid]; Japan Society for the Promotion of Science; Astra-Zeneca, Loughborough, UK	Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astra-Zeneca, Loughborough, UK(AstraZeneca)	We thank M. Ono for discussion and R. Ishii and M. Matsushita for technical assistance. This work was supported by Grants-in-Aid from the Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency. Z.F. was a Japan Society for the Promotion of Science fellow, and K. W. was granted a fellowship by Astra-Zeneca, Loughborough, UK.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Shimizu J, 1999, J IMMUNOL, V163, P5211; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	25	2020	2129	6	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					271	275		10.1126/science.1160062	http://dx.doi.org/10.1126/science.1160062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845758				2022-12-01	WOS:000259902300052
J	Cisse, B; Caton, ML; Lehner, M; Maeda, T; Scheu, S; Locksley, R; Holmberg, D; Zweier, C; den Hollander, NS; Kant, SG; Holter, W; Rauch, A; Zhuang, YA; Reizis, B				Cisse, Babacar; Caton, Michele L.; Lehner, Manfred; Maeda, Takahiro; Scheu, Stefanie; Locksley, Richard; Holmberg, Dan; Zweier, Christiane; den Hollander, Nicolette S.; Kant, Sarina G.; Holter, Wolfgang; Rauch, Anita; Zhuang, Yuan; Reizis, Boris			Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development	CELL			English	Article							T-LYMPHOCYTE DEVELOPMENT; PITT-HOPKINS-SYNDROME; I INTERFERON; AUTOIMMUNE-DISEASES; BONE-MARROW; E2A; PROGENITORS; ACTIVATION; PROTEINS; RECEPTOR	Plasmacytoid dendritic cells (PDCs) represent a unique immune cell type specialized in type I interferon (IFN) secretion in response to viral nucleic acids. The molecular control of PDC lineage specification has been poorly understood. We report that basic helix-loop-helix transcription factor (E protein) E2-2/Tcf4 is preferentially expressed in murine and human PDCs. Constitutive or inducible deletion of murine E2-2 blocked the development of PDCs but not of other lineages and abolished IFN response to unmethylated DNA. Moreover, E2-2 haploinsufficiency in mice and in human Pitt-Hopkins syndrome patients was associated with aberrant expression profile and impaired IFN response of the PDC. E2-2 directly activated multiple PDC-enriched genes, including transcription factors involved in PDC development (SpiB, Irf8) and function (Irf7). These results identify E2-2 as a specific transcriptional regulator of the PDC lineage in mice and humans and reveal a key function of E proteins in the innate immune system.	[Cisse, Babacar; Caton, Michele L.; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; [Lehner, Manfred; Holter, Wolfgang] Univ Erlangen Nurnberg, Childrens Univ Hosp, Dept Hematol & Oncol, D-91054 Erlangen, Germany; [Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8538691, Japan; [Scheu, Stefanie; Locksley, Richard] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med & Microbiol Immunol, San Francisco, CA 94143 USA; [Scheu, Stefanie] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Scheu, Stefanie] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany; [Holmberg, Dan] Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden; [Zweier, Christiane; Rauch, Anita] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Human Genet, D-91054 Erlangen, Germany; [den Hollander, Nicolette S.; Kant, Sarina G.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [Zhuang, Yuan] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA	Columbia University; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Nagasaki University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Umea University; University of Erlangen Nuremberg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Duke University	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA.	bvr2101@columbia.edu	Kant, Sarina/F-8596-2010; Rauch, Anita/C-5568-2014; Scheu, Stefanie/H-3670-2019; Zweier, Christiane/F-2202-2015	Rauch, Anita/0000-0003-2930-3163; Scheu, Stefanie/0000-0002-9707-8191; Zweier, Christiane/0000-0001-8002-2020; Lehner, Manfred/0000-0002-5776-4218; Reizis, Boris/0000-0003-1140-7853; zhuang, yuan/0000-0002-2964-3654	National Institutes of Health (NIH) [AI072571]; Sandler Program for Asthma Research; American Society of Hematology Junior Faculty Scholar; NIH [AI007525, HD055165, GM007367, AI080184, AI078869]; Paul and Daisy Soros Fellowship for New Americans; Deutsche Forschungsgemeinschaft; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI080184, T32AI007525, P01AI078869, R21AI085439, R01AI072571, F31AI066459, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Asthma Research; American Society of Hematology Junior Faculty Scholar; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Daisy Soros Fellowship for New Americans; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Flora, H. Zoghbi, E. Mercer, C. Murre, and T. Ludwig for animals and reagents, B. Jones for help with E2a/HEB strain analysis, B. Kee for communicating data prior to publication, all members of the Reizis lab for helpful discussions, and J. Galan for invaluable help with expression analysis and ChIP. This work was supported by National Institutes of Health (NIH) grant AI072571, the Sandler Program for Asthma Research award, and the American Society of Hematology Junior Faculty Scholar award (B.R.), NIH training grants AI007525 and HD055165 (M.L.C.), NIH training grant GM007367, NIH fellowship AI080184, and the Paul and Daisy Soros Fellowship for New Americans (B.C.), Deutsche Forschungsgemeinschaft (A.R.), and the Howard Hughes Medical Institute and NIH grant AI078869 (R.L.).	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barchet W, 2005, SEMIN IMMUNOL, V17, P253, DOI 10.1016/j.smim.2005.05.008; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Harman BC, 2006, BLOOD, V108, P878, DOI 10.1182/blood-2005-11-4545; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lazorchak A, 2005, TRENDS IMMUNOL, V26, P334, DOI 10.1016/j.it.2005.03.011; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Reizis B, 2001, J EXP MED, V194, P979, DOI 10.1084/jem.194.7.979; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Wikstrom I, 2006, J IMMUNOL, V177, P6723, DOI 10.4049/jimmunol.177.10.6723; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	44	458	469	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					37	48		10.1016/j.cell.2008.09.016	http://dx.doi.org/10.1016/j.cell.2008.09.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854153	Green Accepted, Bronze			2022-12-01	WOS:000259728100007
J	Paux, E; Sourdille, P; Salse, J; Saintenac, C; Choulet, F; Leroy, P; Korol, A; Michalak, M; Kianian, S; Spielmeyer, W; Lagudah, E; Somers, D; Kilian, A; Alaux, M; Vautrin, S; Berges, H; Eversole, K; Appels, R; Safar, J; Simkova, H; Dolezel, J; Bernard, M; Feuillet, C				Paux, Etienne; Sourdille, Pierre; Salse, Jerome; Saintenac, Cyrille; Choulet, Frederic; Leroy, Philippe; Korol, Abraham; Michalak, Monika; Kianian, Shahryar; Spielmeyer, Wolfgang; Lagudah, Evans; Somers, Daryl; Kilian, Andrzej; Alaux, Michael; Vautrin, Sonia; Berges, Helene; Eversole, Kellye; Appels, Rudi; Safar, Jan; Simkova, Hana; Dolezel, Jaroslav; Bernard, Michel; Feuillet, Catherine			A physical map of the 1-gigabase bread wheat chromosome 3B	SCIENCE			English	Article							RUST RESISTANCE GENE; HEXAPLOID WHEAT; RICE; GENOMES; SR2	As the staple food for 35% of the world's population, wheat is one of the most important crop species. To date, sequence- based tools to accelerate wheat improvement are lacking. As part of the international effort to sequence the 17- billion- base- pair hexaploid bread wheat genome ( 2n = 6x = 42 chromosomes), we constructed a bacterial artificial chromosome ( BAC)based integrated physical map of the largest chromosome, 3B, that alone is 995 megabases. A chromosome- specific BAC library was used to assemble 82% of the chromosome into 1036 contigs that were anchored with 1443 molecular markers, providing a major resource for genetic and genomic studies. This physical map establishes a template for the remaining wheat chromosomes and demonstrates the feasibility of constructing physical maps in large, complex, polyploid genomes with a chromosome- based approach.	[Paux, Etienne; Sourdille, Pierre; Salse, Jerome; Saintenac, Cyrille; Choulet, Frederic; Leroy, Philippe; Bernard, Michel; Feuillet, Catherine] Univ Blaise Pascal, INRA, UMR 1095, Clermont Ferrand, France; [Korol, Abraham] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Michalak, Monika; Kianian, Shahryar] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Spielmeyer, Wolfgang; Lagudah, Evans] CSIRO, Canberra, ACT, Australia; [Somers, Daryl] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Kilian, Andrzej] Divers Arrays Technol, Canberra, ACT, Australia; [Alaux, Michael] INRA, Unite Rech Genom Info, F-78026 Versailles, France; [Vautrin, Sonia; Berges, Helene] INRA, Ctr Natl Ressources Genom Vegetales, F-31931 Toulouse, France; [Eversole, Kellye] Eversole Assoc, Int Wheat Genome Sequencing Consortium, Bethesda, MD USA; [Appels, Rudi] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Safar, Jan; Simkova, Hana; Dolezel, Jaroslav] Inst Expt Bot, Lab Mol Cytogenet & Cytometry, Olomouc, Czech Republic	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); University of Haifa; North Dakota State University Fargo; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Agriculture & Agri Food Canada; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Murdoch University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Paux, E (corresponding author), Univ Blaise Pascal, INRA, UMR 1095, Clermont Ferrand, France.		Sourdille, Pierre/CAF-2780-2022; Dolezel, Jaroslav/B-7716-2008; Simkova, Hana/F-7734-2014; Lagudah, Evans/A-2007-2010; Eversole, Kellye/AAN-6141-2020; Spielmeyer, Wolfgang/M-3254-2018; Safar, Jan/G-1038-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Simkova, Hana/0000-0003-4159-7619; Lagudah, Evans/0000-0002-6234-1789; Eversole, Kellye/0000-0002-8784-4913; Spielmeyer, Wolfgang/0000-0002-5115-7820; Kilian, Andrzej/0000-0002-2730-7462; Alaux, Michael/0000-0001-9356-4072; Paux, Etienne/0000-0002-3094-7129; Sourdille, Pierre/0000-0002-1027-2224; BERGES, Helene/0000-0002-5492-1062; Choulet, Frederic/0000-0003-1788-7288	Agence Nationale de la Recherche [ANR-05-BLANC-0258-01]; INRA	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA	We thank D. Boyer, K. Paux, and members of the GENTYANE platform for technical assistance; M. Ganal (Trait Genetics), P. Jack (RAGT), and F. Azanza (Syngenta) for providing SSR markers and genotyping data; the support of F. Legeai and D. Steinbach from Unit, de Recherche en Genomique-Info in establishing the Gbrowse display of the integrated physical map; A. Kumar (Choudhury Charan Singh University Meerut), O. Riera-Lizarazu (Oregon State University), and Y. Gu (U. S. Department of Agriculture- Agricultural Research Service) for significant contributions to the RH mapping work; and F. Quetier ( gence Nationale de la Recherche) for support and discussions. Supported by the Agence Nationale de la Recherche (grant ANR-05-BLANC-0258-01) and the INRA.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cone KC, 2002, PLANT PHYSIOL, V130, P1598, DOI 10.1104/pp.012245; Dilbirligi M, 2004, GENETICS, V166, P461, DOI 10.1534/genetics.166.1.461; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Hossain KG, 2004, GENETICS, V168, P415, DOI 10.1534/genetics.103.022590; Klein PE, 2000, GENOME RES, V10, P789, DOI 10.1101/gr.10.6.789; Kota R, 2006, THEOR APPL GENET, V112, P492, DOI 10.1007/s00122-005-0151-8; La Rota Mauricio, 2004, Functional & Integrative Genomics, V4, P34, DOI 10.1007/s10142-003-0098-2; Liu Sixin, 2006, Functional & Integrative Genomics, V6, P83, DOI 10.1007/s10142-005-0007-y; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; McNeil MD, 2008, MOL BREEDING, V22, P15, DOI 10.1007/s11032-007-9152-4; Munkvold JD, 2004, GENETICS, V168, P639, DOI 10.1534/genetics.104.034819; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Warren RL, 2006, GENOME RES, V16, P768, DOI 10.1101/gr.5090606; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wollenweber B, 2005, CURR OPIN PLANT BIOL, V8, P337, DOI 10.1016/j.pbi.2005.03.001	23	301	325	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					101	104		10.1126/science.1161847	http://dx.doi.org/10.1126/science.1161847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832645				2022-12-01	WOS:000259680200047
J	Arnone, JA; Verburg, PSJ; Johnson, DW; Larsen, JD; Jasoni, RL; Lucchesi, AJ; Batts, CM; von Nagy, C; Coulombe, WG; Schorran, DE; Buck, PE; Braswell, BH; Coleman, JS; Sherry, RA; Wallace, LL; Luo, YQ; Schimel, DS				Arnone, John A., III; Verburg, Paul S. J.; Johnson, Dale W.; Larsen, Jessica D.; Jasoni, Richard L.; Lucchesi, Annmarie J.; Batts, Candace M.; von Nagy, Christopher; Coulombe, William G.; Schorran, David E.; Buck, Paul E.; Braswell, Bobby H.; Coleman, James S.; Sherry, Rebecca A.; Wallace, Linda L.; Luo, Yiqi; Schimel, David S.			Prolonged suppression of ecosystem carbon dioxide uptake after an anomalously warm year	NATURE			English	Article							WATER-VAPOR EXCHANGE; TEMPERATE GRASSLAND; TERRESTRIAL ECOSYSTEMS; TALLGRASS PRAIRIE; PLANT-GROWTH; CO2; VARIABILITY; FLUXES; PRODUCTIVITY; RESPIRATION	Terrestrial ecosystems control carbon dioxide fluxes to and from the atmosphere(1,2) through photosynthesis and respiration, a balance between net primary productivity and heterotrophic respiration, that determines whether an ecosystem is sequestering carbon or releasing it to the atmosphere. Global(1,3-5) and site-specific(6) data sets have demonstrated that climate and climate variability influence biogeochemical processes that determine net ecosystem carbon dioxide exchange (NEE) at multiple timescales. Experimental data necessary to quantify impacts of a single climate variable, such as temperature anomalies, on NEE and carbon sequestration of ecosystems at interannual timescales have been lacking. This derives from an inability of field studies to avoid the confounding effects of natural intra- annual and interannual variability in temperature and precipitation. Here we present results from a four-year study using replicate 12,000-kg intact tallgrass prairie monoliths located in four 184-m(3) enclosed lysimeters(7). We exposed 6 of 12 monoliths to an anomalously warm year in the second year of the study(8) and continuously quantified rates of ecosystem processes, including NEE. We find that warming decreases NEE in both the extreme year and the following year by inducing drought that suppresses net primary productivity in the extreme year and by stimulating heterotrophic respiration of soil biota in the subsequent year. Our data indicate that two years are required for NEE in the previously warmed experimental ecosystems to recover to levels measured in the control ecosystems. This time lag caused net ecosystem carbon sequestration in previously warmed ecosystems to be decreased threefold over the study period, compared with control ecosystems. Our findings suggest that more frequent anomalously warm years(9), a possible consequence of increasing anthropogenic carbon dioxide levels(10), may lead to a sustained decrease in carbon dioxide uptake by terrestrial ecosystems.	[Arnone, John A., III; Verburg, Paul S. J.; Larsen, Jessica D.; Jasoni, Richard L.; Lucchesi, Annmarie J.; Batts, Candace M.; von Nagy, Christopher; Coulombe, William G.; Schorran, David E.; Buck, Paul E.] Univ Nevada, Desert Res Inst, Reno, NV 89512 USA; [Johnson, Dale W.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Braswell, Bobby H.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Coleman, James S.] Rice Univ, Res Off, Houston, TX 77251 USA; [Coleman, James S.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Sherry, Rebecca A.; Wallace, Linda L.; Luo, Yiqi] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Schimel, David S.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; University System Of New Hampshire; University of New Hampshire; Rice University; Rice University; University of Oklahoma System; University of Oklahoma - Norman; National Center Atmospheric Research (NCAR) - USA	Arnone, JA (corresponding author), Univ Nevada, Desert Res Inst, Reno, NV 89512 USA.	jarnone@dri.edu	Verburg, Paul/B-6351-2014; Braswell, Bobby H/D-6411-2016	Braswell, Bobby H/0000-0002-4061-9516	US National Science Foundation's Integrated Research Challenges in Environmental Biology program; Desert Research Institute (DRI)	US National Science Foundation's Integrated Research Challenges in Environmental Biology program(National Science Foundation (NSF)); Desert Research Institute (DRI)	We thank E. Kessler and the University of Oklahoma for the use of the Kessler Farm Field Laboratory; R. Kreidberg for editorial assistance; and J. Amthor, M. Bahn, C. Korner, D. Obrist and G. Wohlfahrt, for critical review of an early draft of this manuscript. This study was funded by the US National Science Foundation's Integrated Research Challenges in Environmental Biology program, with additional support from the Desert Research Institute (DRI) for necessary upgrades to the EcoCELL facility. We are very grateful to DRI, the University of Oklahoma, and the University of Nevada-Reno teams for technical assistance, facilities support, and administrative expertise (also see Supplementary Information).	350-368, 2005, HIST ATMOSPHERIC CO2, P350; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; BUNCE JA, 1982, OECOLOGIA, V54, P233, DOI 10.1007/BF00378397; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Grace J, 1998, AUST J PLANT PHYSIOL, V25, P519, DOI 10.1071/PP97120; Griffin KL, 1996, PLANT CELL ENVIRON, V19, P1210, DOI 10.1111/j.1365-3040.1996.tb00437.x; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Korner Ch, 1994, ECOPHYSIOLOGY PHOTOS, P463; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Novick KA, 2004, OECOLOGIA, V138, P259, DOI 10.1007/s00442-003-1388-z; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Reichstein M, 2007, GLOBAL CHANGE BIOL, V13, P634, DOI 10.1111/j.1365-2486.2006.01224.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Suyker AE, 2003, GLOBAL CHANGE BIOL, V9, P255, DOI 10.1046/j.1365-2486.2003.00567.x; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Verburg PSJ, 2005, GLOBAL CHANGE BIOL, V11, P1720, DOI 10.1111/j.1365-2486.2005.001032.x; Vourlitis GL, 1999, ECOLOGY, V80, P686, DOI 10.1890/0012-9658(1999)080[0686:ECMOCA]2.0.CO;2; Vukicevic T, 2001, TELLUS B, V53, P150, DOI 10.1034/j.1600-0889.2001.d01-13.x; Wever LA, 2002, AGR FOREST METEOROL, V112, P31, DOI 10.1016/S0168-1923(02)00041-2	26	121	121	7	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					383	386		10.1038/nature07296	http://dx.doi.org/10.1038/nature07296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800137				2022-12-01	WOS:000259265200043
J	Finke, DL; Snyder, WE				Finke, Deborah L.; Snyder, William E.			Niche partitioning increases resource exploitation by diverse communities	SCIENCE			English	Article							BIODIVERSITY; NITROGEN; IMPACTS; PREY	Classical ecological theory suggests that the coexistence of consumer species is fostered by resource- use differences, leading to greater resource use in communities with more species. However, explicit empirical support for this idea is lacking, because resource use by species is generally confounded with other species- specific attributes. We overcame this obstacle by co- opting behavioral plasticity in food choice among a group of animal consumers, allowing us to manipulate patterns of resource use while controlling for the effects of species identity and diversity. Within an aphid- parasitoid- radish community, we created a fully factorial manipulation of consumer resource- use breadth ( specialist versus generalist) and species diversity ( one versus three species) and found that resource exploitation improved with greater specialist, but not generalist, diversity. Therefore, resource partitioning, and not diversity per se, fostered greater overall resource consumption in our multispecies consumer communities.	[Finke, Deborah L.; Snyder, William E.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Finke, Deborah L.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	Washington State University; University of Missouri System; University of Missouri Columbia	Finke, DL (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	finked@missouri.edu		Snyder, William/0000-0002-2747-3102	National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service [2004-01215]	National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	We thank A. Ives, J. Owen, A. Storfer, C. Straub, and anonymous reviewers for comments. This project was supported by the National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service, grant 2004-01215.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casula P, 2006, ECOL LETT, V9, P995, DOI 10.1111/j.1461-0248.2006.00945.x; Chalcraft DR, 2003, ECOLOGY, V84, P2407, DOI 10.1890/02-0550; Chase J.M., 2003, ECOLOGICAL NICHES LI; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; May R.M., 1973, STABILITY COMPLEXITY; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Nufio CR, 2001, ENTOMOL EXP APPL, V99, P273, DOI 10.1023/A:1019204817341; Pike KS, 2000, P ENTOMOL SOC WASH, V102, P688; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Tunings T.C., 1992, INSECT LEARNING ECOL, P51; Wilby A, 2002, ECOL LETT, V5, P353, DOI 10.1046/j.1461-0248.2002.00331.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	30	268	276	4	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1488	1490		10.1126/science.1160854	http://dx.doi.org/10.1126/science.1160854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787167	Green Submitted			2022-12-01	WOS:000259121800040
J	Roy, K				Roy, Kaustuv			Evolution - Dynamics of body size evolution	SCIENCE			English	Editorial Material							COPES RULE; CLIMATE-CHANGE; EXTINCTION; DISTRIBUTIONS; TEMPERATURE; SELECTIVITY; PATTERNS		[Roy, Kaustuv] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Roy, K (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kroy@ucsd.edu						Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; BLACKBURN TM, 1994, TRENDS ECOL EVOL, V9, P471, DOI 10.1016/0169-5347(94)90311-5; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; JABLONSKI D, 1995, SCIENCE, V268, P389, DOI 10.1126/science.11536722; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Smith JT, 2006, PALEOBIOLOGY, V32, P408, DOI 10.1666/05078.1; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x	16	21	22	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1451	1452		10.1126/science.1163097	http://dx.doi.org/10.1126/science.1163097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787156				2022-12-01	WOS:000259121800026
J	Barna, M; Pusic, A; Zollo, O; Costa, M; Kondrashov, N; Rego, E; Rao, PH; Ruggero, D				Barna, Maria; Pusic, Aya; Zollo, Ornella; Costa, Maria; Kondrashov, Nadya; Rego, Eduardo; Rao, Pulivarthi H.; Ruggero, Davide			Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency	NATURE			English	Article							KINASE GENE-COMPLEX; C-MYC; CELL-CYCLE; MEDIATED TRANSLATION; ENTRY SITE; CANCER; 1P36; TUMORIGENESIS; CYTOKINESIS; CONTRIBUTES	The Myc oncogene regulates the expression of several components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, RNA polymerase III and ribosomal DNA(1,2). Whether and how increasing the cellular protein synthesis capacity affects the multistep process leading to cancer remains to be addressed. Here we use ribosomal protein heterozygote mice as a genetic tool to restore increased protein synthesis in E mu-Myc/+ transgenic mice to normal levels, and show that the oncogenic potential of Myc in this context is suppressed. Our findings demonstrate that the ability of Myc to increase protein synthesis directly augments cell size and is sufficient to accelerate cell cycle progression independently of known cell cycle targets transcriptionally regulated by Myc. In addition, when protein synthesis is restored to normal levels, Myc- overexpressing precancerous cells are more efficiently eliminated by programmed cell death. Our findings reveal a new mechanism that links increases in general protein synthesis rates downstream of an oncogenic signal to a specific molecular impairment in the modality of translation initiation used to regulate the expression of selective messenger RNAs. We show that an aberrant increase in cap- dependent translation downstream of Myc hyperactivation specifically impairs the translational switch to internal ribosomal entry site ( IRES)- dependent translation that is required for accurate mitotic progression. Failure of this translational switch results in reduced mitotic- specific expression of the endogenous IRES- dependent form of Cdk11 ( also known as Cdc21 and PITSLRE)(3-5), which leads to cytokinesis defects and is associated with increased centrosome numbers and genome instability in E mu-Myc/+ mice. When accurate translational control is re- established in E mu-Myc/+ mice, genome instability is suppressed. Our findings demonstrate how perturbations in translational control provide a highly specific outcome for gene expression, genome stability and cancer initiation that have important implications for understanding the molecular mechanism of cancer formation at the post- genomic level.	[Barna, Maria; Kondrashov, Nadya] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Pusic, Aya; Zollo, Ornella; Costa, Maria; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA; [Pusic, Aya; Zollo, Ornella; Costa, Maria; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Rego, Eduardo] Univ Sao Paulo, Ctr Cell Based Therapy, Fdn Hemoctr Ribeirao Preto, BR-14048900 Sao Paulo, Brazil; [Rao, Pulivarthi H.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Universidade de Sao Paulo; Baylor College of Medicine	Barna, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Rock Hall Room 384C,1550 4th St, San Francisco, CA 94158 USA.	maria.barna@ucsf.edu; Davide.Ruggero@ucsf.edu	Costa, Maria Jose/I-7754-2013; Rego, Eduardo/AFS-7973-2022; Rego, Eduardo M./Y-5572-2019; Rego, Eduardo M/A-1058-2012	Costa, Maria Jose/0000-0001-6111-7614; Rego, Eduardo/0000-0003-1567-4086; Rego, Eduardo M./0000-0003-1567-4086; Rego, Eduardo M/0000-0003-1567-4086	NIH; Sandler Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank F. McCormick, G. Evan and P. O'Farrell for critically reading the manuscript; J. Testa for support and critical discussion during early stages of this work; W. Xu and R. Adamo for technical assistance; J. Copley for editing the manuscript, S. Cornelis for the Cdk11 IRES bicistronic vector. This work was supported by the NIH (D.R.) and the Sandler Foundation (M.B.).	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Chandramouli A, 2007, CARCINOGENESIS, V28, P2028, DOI 10.1093/carcin/bgm066; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Dave BJ, 1999, CANCER GENET CYTOGEN, V108, P120, DOI 10.1016/S0165-4608(98)00138-1; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; LAHTI JM, 1994, NAT GENET, V7, P370, DOI 10.1038/ng0794-370; Lenahan MK, 1996, ONCOGENE, V12, P1847; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Nelson MA, 1999, CANCER GENET CYTOGEN, V108, P91, DOI 10.1016/S0165-4608(98)00122-8; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Wade M, 2006, CURR TOP MICROBIOL, V302, P169; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	35	299	307	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					971	U79		10.1038/nature07449	http://dx.doi.org/10.1038/nature07449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011615	Green Accepted, Green Submitted			2022-12-01	WOS:000261768300050
J	Leong, KG; Wang, BE; Johnson, L; Gao, WQ				Leong, Kevin G.; Wang, Bu-Er; Johnson, Leisa; Gao, Wei-Qiang			Generation of a prostate from a single adult stem cell	NATURE			English	Article							PROXIMAL REGION; MOUSE PROSTATE; C-KIT; MURINE PROSTATE; MARKER; EXPRESSION; IDENTIFICATION; REGENERATION; CANCER; TISSUE	The existence of prostate stem cells ( PSCs) was first postulated from the observation that normal prostate regeneration can occur after repeated cycles of androgen deprivation and replacement in rodents(1). Given the critical role of PSCs in maintaining prostate tissue integrity and their potential involvement in prostate tumorigenesis(2), it is important to define specific markers for normal PSCs. Several cell- surface markers have been reported to identify candidate PSCs, including stem cell antigen-1 ( Sca-1, also known as Ly6a), CD133 (Prom1) and CD44 ( refs 3-10). However, many non- PSCs in the mouse prostate also express these markers and thus identification of a more defined PSC population remains elusive. Here we identify CD117 ( c- kit, stem cell factor receptor) as a new marker of a rare adult mouse PSC population, and demonstrate that a single stem cell defined by the phenotype Lin(-) Sca-1(+)CD133(+)CD44(+)CD117(+) can generate a prostate after transplantation in vivo. CD117 expression is predominantly localized to the region of the mouse prostate proximal to the urethra and is upregulated after castration- induced prostate involution - two characteristics consistent with that of a PSC marker. CD117(+) PSCs can generate functional, secretion- producing prostates when transplanted in vivo. Moreover, CD117(+) PSCs have long- term self-renewal capacity, as evidenced by serial isolation and transplantation in vivo. Our data establish that single cells in the adult mouse prostate with multipotent, self- renewal capacity are defined by a Lin(-)Sca-1(+) CD133(+) CD44(+) CD117(+) phenotype.	[Leong, Kevin G.; Wang, Bu-Er; Johnson, Leisa; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Gao, WQ (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	gao@gene.com	Thomson, Axel/A-7893-2013; Gao, Wei/GXH-0380-2022		Genentech Laboratory Animal Resources	Genentech Laboratory Animal Resources	We thank J. Cupp, L. Gilmour and W. Tombo for FACS support, X.-D. Wang, R. Soriano and Z. Modrusan for microarray services, I. Kasman, L. Komuves and J. Eastham- Anderson for microscopy assistance, B. D. Tarlow for assistance with laser- capture microdissection and PCR- based genotyping, Genentech Laboratory Animal Resources for support services, L. Blocher and J. Simko for human clinical prostate specimens, and F. J. de Sauvage for valuable discussion, input and supervision of the project.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Bonkhoff H, 1996, PROSTATE, V28, P98; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Collins AT, 2001, J CELL SCI, V114, P3865; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; ISAACS JT, 1987, CONTROL CELL PROLIFE, V2, P85; Johnson MA, 2000, PROSTATE, V43, P255, DOI 10.1002/1097-0045(20000601)43:4<255::AID-PROS4>3.0.CO;2-M; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; LEV S, 1994, CRIT REV ONCOGENESIS, V5, P141, DOI 10.1615/CritRevOncog.v5.i2-3.30; Liu AY, 1997, P NATL ACAD SCI USA, V94, P10705, DOI 10.1073/pnas.94.20.10705; Moss KG, 2003, J PHARMACOL EXP THER, V307, P476, DOI 10.1124/jpet.103.052530; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Schmelz M, 2005, EUR J CELL BIOL, V84, P341, DOI 10.1016/j.ejcb.2004.12.019; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tsujimura A, 2007, J UROLOGY, V178, P686, DOI 10.1016/j.juro.2007.03.092; Wang GM, 2007, PROSTATE, V67, P968, DOI 10.1002/pros.20582; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100	30	319	340	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					804	808		10.1038/nature07427	http://dx.doi.org/10.1038/nature07427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18946470				2022-12-01	WOS:000261559900052
J	Beaglehole, R; Bonita, R				Beaglehole, Robert; Bonita, Ruth			Global public health: a scorecard	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; CHRONIC DISEASES 1; IMPROVING HEALTH; PREVENTION; MORTALITY; COSTS; EDUCATION; PRIORITY; TOBACCO; BURDEN	Global health is attracting an unprecedented level of interest. In this paper, we summarise recent trends and identify the unfinished and new agendas in global public health. We propose a global public health scorecard as a simple way to assess progress and suggest actions by public health practitioners and their organisations for improving the effectiveness of public health. Although we find many recent positive developments in global health, the potential for global cooperation and progress is still largely untapped. Compared with other components of development, health improvement should easily foster global cooperation; strong advocacy and political will are keys to continuing progress. We view global public health as a barometer of more general development. Our responses to the current health challenges are at the forefront of the global struggle for survival.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Beaglehole, R (corresponding author), 42 Albert Rd, N Shore City 0624, New Zealand.	r.beaglehole@auckland.ac.nz						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2007, LANCET SERIES GLOBAL; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; Beaglehole R, 1998, LANCET, V351, P590, DOI 10.1016/S0140-6736(97)09494-4; Beaglehole R, 2003, HUM RESOUR HEALTH, V1, P4, DOI DOI 10.1186/1478-4491-1-4; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; BONITA R, 2007, GLOBALIZATION HLTH; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Chen LC, 2006, LANCET, V367, P1800, DOI 10.1016/S0140-6736(06)68783-7; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Cochrane AL, 1972, EFFECTIVENESS EFFICI; Donaldson L, 2007, LANCET, V369, P857, DOI 10.1016/S0140-6736(07)60327-4; Ebrahim S, 2008, INT J EPIDEMIOL, V37, P225, DOI 10.1093/ije/dyn016; *EXT EV TEAM PUBL, 2001, ENH PUBL HLTH DEV CO; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; *GOYAK FRAM ACT GL, 2008, REP G8 HLTH EXP GROU; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; HORTON R, GLOBAL PUBLIC HLTH; Horton R, 2008, LANCET, V371, P1217, DOI 10.1016/S0140-6736(08)60533-4; Horton R, 2007, LANCET, V369, P806, DOI 10.1016/S0140-6736(07)60378-X; IJsselmuiden C, 2007, B WORLD HEALTH ORGAN, V85, P914, DOI 10.2471/BLT.07.045526; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 SCI; JAMSION DT, 2006, DIS CONTROL PRIORITI; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; MacDonald R, 2008, LANCET, V372, P99, DOI 10.1016/S0140-6736(08)61004-1; Marmot M., 2008, CLOS GAP GEN HLTH EQ, V372, P1661; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; MATHERS CD, GLOBAL PUBL IN PRESS; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McCurry J, 2008, LANCET, V372, P191, DOI 10.1016/S0140-6736(08)61054-5; MCKEE M, GLOBAL PUBL IN PRESS; Mckee M, 2007, INT J EPIDEMIOL, V36, P269, DOI 10.1093/ije/dym002; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJI, PLOS MED, V3, pe260; Nuffield Council on Bioethics, 2007, PUBL HLTH ETH ISS; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Sachs J., 2005, END POVERTY CAN WE M; Sadana R, 2007, B WORLD HEALTH ORGAN, V85, P902, DOI 10.2471/BLT.07.049247; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Silberschmidt G, 2008, LANCET, V371, P1483, DOI 10.1016/S0140-6736(08)60634-0; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; STUCKLER D, LANCET IN PRESS; Stuckler D, 2008, LANCET, V372, P95, DOI 10.1016/S0140-6736(08)61013-2; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; *UN ENV PROGR, 2007, GLOB ENV OUTL 2007; *UNAIDS WHO, 2007, AIDS EP UPD DEC 2007; United Nations, MILL DEV GOALS REP; United Nations. Department of Economic and Social Affairs. Population Division, 2007, WORLD POP PROSP 2006; WHO, 2008, WORLD HLTH STAT 2008; *WHO, HLTH MILL DEV GOALS; *WHO, 2008, UPD GLOB BURD DIS 20; Woodward D, 2008, LANCET, V372, P186, DOI 10.1016/S0140-6736(08)61051-X; World Health Organization, 2004, EST US DED TAX HLTH; World Health Organization, 2007, EV BUS STRENGTH HLTH; *WORLD TRAD ORG, LAM WARNS PROT AM FI; 2008, LANCET, V372, P345; 2008, LANCET, V371, P2145; 2008, LANCET, V372, P178; [No title captured]; 2006, LANCET, V367, P1549; 2007, LANCET, V370, P801; 2008, LANCET, V372, P346	68	129	133	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1988	1996		10.1016/S0140-6736(08)61558-5	http://dx.doi.org/10.1016/S0140-6736(08)61558-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18945485				2022-12-01	WOS:000261471600025
J	Coffin, JM				Coffin, John M.			Attenuation by a Thousand Cuts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		[Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University	Coffin, JM (corresponding author), Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.				NCI NIH HHS [R37 CA089441] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA089441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; GRAHAM BS, 2007, FIELDS VIROLOGY, P487; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06	4	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2283	2285		10.1056/NEJMcibr0805820	http://dx.doi.org/10.1056/NEJMcibr0805820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020330				2022-12-01	WOS:000260994000014
J	Hejnol, A; Martindale, MQ				Hejnol, Andreas; Martindale, Mark Q.			Acoel development indicates the independent evolution of the bilaterian mouth and anus	NATURE			English	Article							GENE-EXPRESSION; NERVOUS-SYSTEM; GASTRULATION; BRACHYURY; DROSOPHILA; FLATWORMS; SUGGESTS; ORIGINS; PATTERN	Most bilaterian animals possess a through gut with a separate mouth and anus(1). It is commonly believed that during the transition from radial to bilateral symmetry, both openings evolved simultaneously by the lateral closure of a slit- like blastopore(1-4). Molecular phylogenies however, place the acoel flatworms, which have only one opening to their digestive system, as the sister group to all remaining Bilateria(5-7). To address how this single body opening is related to the mouth and anus of the protostomes and deuterostomes, we studied the expression of genes involved in bilaterian foregut and hindgut patterning during the development of the acoel Convolutriloba longifissura. Here we show that the genes brachyury and goosecoid are expressed in association with the acoel mouth, suggesting that this single opening is homologous to the mouth of other bilaterians(8). In addition, we find that the genes caudal, orthopedia and brachyury - which are expressed in various bilaterian hindguts(8-10) - are expressed in a small region at the posterior end of the animal, separated from the anterior oral brachyury- expressing region by a dorsal domain of ectodermal bmp2/4 expression. These results contradict the hypothesis that the bilaterian mouth and anus evolved simultaneously from a common blastoporal opening, and suggest that a through gut might have evolved independently in different animal lineages.	[Hejnol, Andreas; Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, PBRC, Honolulu, HI 96813 USA	University of Hawaii System	Hejnol, A (corresponding author), Univ Hawaii, Kewalo Marine Lab, PBRC, 41 Ahui St, Honolulu, HI 96813 USA.	hejnol@hawaii.edu	Hejnol, Andreas/C-5577-2012	Hejnol, Andreas/0000-0003-2196-8507	National Science Foundation; AToL program [EF05-31558]; NASA; Deutsche Forschungsgemeinschaft [HE5183/2-1]	National Science Foundation(National Science Foundation (NSF)); AToL program; NASA(National Aeronautics & Space Administration (NASA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is supported by the National Science Foundation under the AToL program (EF05-31558) and NASA to M. Q. M. A. H. received further support from the Deutsche Forschungsgemeinschaft (HE5183/2-1). We thank K. Pang for improving the manuscript and A. Okuso for the drawings of the cnidarian and annelid.	Arendt D, 1997, MECH DEVELOP, V61, P7, DOI 10.1016/S0925-4773(96)00620-X; Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075; Baguna J, 2004, BIOESSAYS, V26, P1046, DOI 10.1002/bies.20113; Christiaen L, 2007, SEMIN CELL DEV BIOL, V18, P502, DOI 10.1016/j.semcdb.2007.06.002; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; Grobben K, 1909, VERH ZOOL BOT GES WI, V58, P491; Haeckel E., 1874, JENAISCHE Z NATURWIS, V8, P1; Haszprunar G, 1996, J ZOOL SYST EVOL RES, V34, P41; Henry JQ, 2000, DEV BIOL, V220, P285, DOI 10.1006/dbio.2000.9628; Hyman L.H., 1951, ACOELOMATE BILATERIA, P550; JAGERSTEN GOSTA, 1955, ZOOL BIDRAG UPPSALA, V30, P321; Lartillot N, 2002, DEVELOPMENT, V129, P1411; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Marcellini S, 2006, BIOESSAYS, V28, P413, DOI 10.1002/bies.20387; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Neidert AH, 2000, EVOL DEV, V2, P303, DOI 10.1046/j.1525-142x.2000.00073.x; Nielsen C, 2001, ANIMAL EVOLUTION, VSecond; Reisinger E., 1961, FORTSCHR ZOOL, V13, P1; Remane A., 1950, ZOOL ANZ, V14, P18; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; SALVINIPLAWEN LV, 1978, Z ZOOL SYST EVOL, V16, P40; SEDGWICK W, 1884, Q J MICROSC SCI, V24, P43; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Tagawa K, 1998, MECH DEVELOP, V75, P139, DOI 10.1016/S0925-4773(98)00078-1; von Graff LV, 1891, ORG TURBELLARIA ACOE; Wallberg A, 2007, ZOOL SCR, V36, P509, DOI 10.1111/j.1463-6409.2007.00295.x; Wu LH, 1998, DEVELOPMENT, V125, P2433	30	98	101	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					382	U45		10.1038/nature07309	http://dx.doi.org/10.1038/nature07309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18806777				2022-12-01	WOS:000261039600042
J	Ganzini, L; Goy, ER; Dobscha, SK				Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.			Prevalence of depression and anxiety in patients requesting physicians' aid in dying: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							MENTAL STATUS QUESTIONNAIRE; REDUCING SUICIDAL IDEATION; TERMINALLY-ILL PATIENTS; PRIMARY-CARE PATIENTS; ASSISTED SUICIDE; HASTENED DEATH; OLDER PATIENTS; CANCER; HOPELESSNESS; DESIRE	Objective To determine the prevalence of depression and anxiety in terminally ill patients pursuing aid in dying from physicians. Design Cross sectional survey. Setting State of Oregon, USA. Participants 58 Oregonians, most terminally ill with cancer or amyotrophic lateral sclerosis, who had either requested aid in dying from a physician or contacted an aid in dying advocacy organisation. Main outcome measures Diagnosis of depression or anxiety according to the hospital anxiety and depression scale and the structured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders. Results 15 study participants met "caseness" criteria for depression, and 13 met criteria for anxiety. 42 patients died by the end of the study; 18 received a prescription fora lethal drug under the Death with Dignity Act, and nine died by lethal ingestion. 15 participants who received a prescription for a lethal drug did not meet criteria for depression; three did. All three depressed participants died by legal ingestion within two months of the research interview. Conclusion Although most terminally ill Oregonians who receive aid in dying do not have depressive disorders, the current practice of the Death with Dignity Act may fail to protect some patients whose choices are influenced by depression from receiving a prescription for a lethal drug.	[Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.] Portland VA Med Ctr, Columbia Ctr Study Chron Comorbid Mental & Phys D, Hlth Serv Res & Dev, Portland, OR 97239 USA; [Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Ganzini, L (corresponding author), Portland VA Med Ctr, Columbia Ctr Study Chron Comorbid Mental & Phys D, Hlth Serv Res & Dev, POB 1034, Portland, OR 97239 USA.	Linda.Ganzini@va.gov			Northwest Health Foundation	Northwest Health Foundation	Northwest Health Foundation. The funding source had no role in any aspect of the study or this paper.	Appelbaum P, 2001, MACARTHUR COMPETENCE; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Blank K, 2001, J AM GERIATR SOC, V49, P153, DOI 10.1046/j.1532-5415.2001.49036.x; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Carlson B, 2005, J PALLIAT MED, V8, P1160, DOI 10.1089/jpm.2005.8.1160; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Conwell Y, 2000, J AM GERIATR SOC, V48, P23, DOI 10.1111/j.1532-5415.2000.tb03024.x; Conwell Y, 2002, BIOL PSYCHIAT, V52, P193, DOI 10.1016/S0006-3223(02)01347-1; Emanuel EJ, 2005, J CLIN ONCOL, V23, P6456, DOI 10.1200/JCO.2005.06.001; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; First MB, 1997, USERS GUIDE STRUCTUR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganzini L, 1999, NEUROLOGY, V52, P1434, DOI 10.1212/WNL.52.7.1434; Ganzini L, 2006, J CLIN ETHIC, V17, P27; Ganzini L, 1996, AM J PSYCHIAT, V153, P1469; Ganzini L, 2000, AM J PSYCHIAT, V157, P595, DOI 10.1176/appi.ajp.157.4.595; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 2002, NEW ENGL J MED, V347, P582, DOI 10.1056/NEJMsa020562; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; Henriksson MM, 1995, J AFFECT DISORDERS, V36, P11, DOI 10.1016/0165-0327(95)00047-X; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1191/02169216302pm507oa; MINKOFF K, 1973, AM J PSYCHIAT, V130, P455; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; PEREZSTABLE EJ, 1990, ARCH INTERN MED, V150, P1083, DOI 10.1001/archinte.150.5.1083; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rosenfeld B, 2006, PSYCHOSOMATICS, V47, P504, DOI 10.1176/appi.psy.47.6.504; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; SMYER MA, 1979, J AM GERIATR SOC, V27, P263, DOI 10.1111/j.1532-5415.1979.tb06128.x; Tolle SW, 2004, J CLIN ETHIC, V15, P111; Unutzer J, 2006, J AM GERIATR SOC, V54, P1550, DOI 10.1111/j.1532-5415.2006.00882.x; Werth JL, 2004, BEHAV SCI LAW, V22, P627, DOI 10.1002/bsl.616; Wilson KG, 2007, HEALTH PSYCHOL, V26, P314, DOI 10.1037/0278-6133.26.3.314; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; 2007, COMPASSION CHOICES O	37	86	87	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1682	10.1136/bmj.a1682	http://dx.doi.org/10.1136/bmj.a1682			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	363WS	18842645	hybrid, Green Published			2022-12-01	WOS:000260298800034
J	Rasmussen, B; Fletcher, IR; Brocks, JJ; Kilburn, MR				Rasmussen, Birger; Fletcher, Ian R.; Brocks, Jochen J.; Kilburn, Matt R.			Reassessing the first appearance of eukaryotes and cyanobacteria	NATURE			English	Article							ISOTOPIC RATIO MEASUREMENTS; PROTEROZOIC MCARTHUR BASIN; MOUNT BRUCE SUPERGROUP; GREAT OXIDATION EVENT; ATMOSPHERIC OXYGEN; MOLECULAR FOSSILS; WESTERN-AUSTRALIA; NORTHERN AUSTRALIA; PETROLEUM GEOLOGY; FLUID INCLUSIONS	The evolution of oxygenic photosynthesis had a profound impact on the Earth's surface chemistry, leading to a sharp rise in atmospheric oxygen between 2.45 and 2.32 billion years (Gyr) ago(1,2) and the onset of extreme ice ages(3). The oldest widely accepted evidence for oxygenic photosynthesis has come from hydrocarbons extracted from similar to 2.7-Gyr-old shales in the Pilbara Craton, Australia, which contain traces of biomarkers ( molecular fossils) indicative of eukaryotes and suggestive of oxygen- producing cyanobacteria(4-7). The soluble hydrocarbons were interpreted to be indigenous and syngenetic despite metamorphic alteration and extreme enrichment ( 10-20 parts per thousand) of (13)C relative to bulk sedimentary organic matter(5,8). Here we present micrometre-scale, in situ (13)C/(12)C measurements of pyrobitumen ( thermally altered petroleum) and kerogen from these metamorphosed shales, including samples that originally yielded biomarkers. Our results show that both kerogen and pyrobitumen are strongly depleted in (13)C, indicating that indigenous petroleum is 10-20 parts per thousand lighter than the extracted hydrocarbons(5). These results are inconsistent with an indigenous origin for the biomarkers. Whatever their origin, the biomarkers must have entered the rock after peak metamorphism 2.2 Gyr ago(9) and thus do not provide evidence for the existence of eukaryotes and cyanobacteria in the Archaeaneon. The oldest fossil evidence for eukaryotes and cyanobacteria therefore reverts to 1.78-1.68 Gyr ago and similar to 2.15 Gyr ago(10,11), respectively. Our results eliminate the evidence for oxygenic photosynthesis similar to 2.7 Gyr ago and exclude previous biomarker evidence for a long delay (similar to 300 million years) between the appearance of oxygen- producing cyanobacteria and the rise in atmospheric oxygen 2.45-2.32 Gyr ago(1).	[Rasmussen, Birger; Fletcher, Ian R.] Curtin Univ Technol, Dept Appl Geol, Bentley, WA 6102, Australia; [Brocks, Jochen J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Brocks, Jochen J.] Australian Natl Univ, Ctr Macroevolut & Macroecol, Canberra, ACT 0200, Australia; [Kilburn, Matt R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Nedlands, WA 6009, Australia	Curtin University; Australian National University; Australian National University; University of Western Australia	Rasmussen, B (corresponding author), Curtin Univ Technol, Dept Appl Geol, Kent St, Bentley, WA 6102, Australia.	B.Rasmussen@curtin.edu.au	Brocks, Jochen/E-3920-2012; Kilburn, Matthew R/C-4515-2011	Brocks, Jochen/0000-0002-8430-8744; Kilburn, Matthew R/0000-0002-1858-8485; Rasmussen, Birger/0000-0002-2745-0904	Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis; University of Western Australia; University, State and Commonwealth Governments	Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis; University of Western Australia; University, State and Commonwealth Governments	We thank S. Bengtson, G.A. Logan, J.R. Muhling, S. Revets and S. Sheppard for discussion and comments; and A.C. Cook for organic reflectivity measurements. We acknowledge the facilities of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, University of Western Australia, a facility funded by the University, State and Commonwealth Governments.	Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; [Anonymous], 1995, PETROLEUM GEOCHEMIST; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4321, DOI 10.1016/S0016-7037(03)00209-6; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4289, DOI 10.1016/S0016-7037(03)00208-4; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Brocks JJ, 2008, GEOCHIM COSMOCHIM AC, V72, P871, DOI 10.1016/j.gca.2007.11.028; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; CRICK IH, 1988, AAPG BULL, V72, P1495; Des Marais DJ, 2001, REV MINERAL GEOCHEM, V43, P555, DOI 10.2138/gsrmg.43.1.555; Dutkiewicz A, 2006, GEOLOGY, V34, P437, DOI 10.1130/G22360.1; FLETCHER IR, INT J MASS IN PRESS; George SC, 2008, GEOCHIM COSMOCHIM AC, V72, P844, DOI 10.1016/j.gca.2007.11.021; Goldblatt C, 2006, NATURE, V443, P683, DOI 10.1038/nature05169; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HAYES JM, 1994, EARLY LIFE EARTH, P220; Hillion F, 2008, GEOCHIM COSMOCHIM AC, V72, pA377; Hinrichs KU, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000286; HOEFS J, 2004, STABLE ISOTOPE GEOCH, P158; HOFMANN HJ, 1976, J PALEONTOL, V50, P1040; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Konhauser KO, 2002, GEOLOGY, V30, P1079, DOI 10.1130/0091-7613(2002)030<1079:CBHFTP>2.0.CO;2; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Rasmussen B, 2005, GEOLOGY, V33, P773, DOI 10.1130/G21666.1; Rasmussen B, 2005, GEOLOGY, V33, P497, DOI 10.1130/G21316.1; Rasmussen B, 2007, EARTH PLANET SC LETT, V258, P249, DOI 10.1016/j.epsl.2007.03.033; Sherman LS, 2007, ORG GEOCHEM, V38, P1987, DOI 10.1016/j.orggeochem.2007.08.012; Slodzian G, 2004, APPL SURF SCI, V231, P874, DOI 10.1016/j.apsusc.2004.03.155; Slodzian G, 2001, EUR PHYS J-APPL PHYS, V14, P199, DOI 10.1051/epjap:2001160; SMITH RE, 1982, J PETROL, V23, P75, DOI 10.1093/petrology/23.1.75; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; SUMMONS RE, 1988, GEOCHIM COSMOCHIM AC, V52, P1747, DOI 10.1016/0016-7037(88)90001-4	33	359	379	3	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1101	U9		10.1038/nature07381	http://dx.doi.org/10.1038/nature07381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948954				2022-12-01	WOS:000260252600043
J	Dartington, T; Brennan, M; Sampson, EL; Coupe, K; Malloy, L				Dartington, Tim; Brennan, Mary; Sampson, Elizabeth L.; Coupe, Kate; Malloy, Lynn			Dying from dementia - a patient's journey	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sampson, Elizabeth L.] UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England; [Dartington, Tim] Tavistock Inst, London EC2A 4UE, England; [Coupe, Kate; Malloy, Lynn] Bamet Enfield & Haringey Mental Hlth Trust, London N15 3TH, England	University of London; University College London; UCL Medical School	Sampson, EL (corresponding author), UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England.	mary.brennan@nmh.nhs.uk; e.sampson@medsch.ucl.ac.uk; Kate.coupe@beh-mht.nhs.uk; lynn.malloy@beh-mht.nhs.uk	Sampson, Elizabeth L/B-8647-2009	Sampson, Elizabeth L/0000-0001-8929-7362					0	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2008	337	7675							a1712	10.1136/bmj.a1712	http://dx.doi.org/10.1136/bmj.a1712			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360YE	18818258				2022-12-01	WOS:000260093900041
J	Bowman, GR; Comolli, LR; Zhu, J; Eckart, M; Koenig, M; Downing, KH; Moerner, WE; Earnest, T; Shapiro, L				Bowman, Grant R.; Comolli, Luis R.; Zhu, Jian; Eckart, Michael; Koenig, Marcelle; Downing, Kenneth H.; Moerner, W. E.; Earnest, Thomas; Shapiro, Lucy			A polymeric protein anchors the chromosomal origin/ParB complex at a bacterial cell pole	CELL			English	Article							BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; ACTIN HOMOLOG; SEGREGATION; CYCLE; MREB; MORPHOGENESIS; LOCALIZATION; DIVISION; POLARITY	Bacterial replication origins move towards opposite ends of the cell during DNA segregation. We have identified a proline-rich polar protein, PopZ, required to anchor the separated Caulobacter crescentus chromosome origins at the cell poles, a function that is essential for maintaining chromosome organization and normal cell division. PopZ interacts directly with the ParB protein bound to specific DNA sequences near the replication origin. As the origin/ParB complex is being replicated and moved across the cell, PopZ accumulates at the cell pole and tethers the origin in place upon arrival. The polar accumulation of PopZ occurs by a diffusion/capture mechanism that requires the MreB cytoskeleton. High molecular weight oligomers of PopZ assemble in vitro into a filamentous network with trimer junctions, suggesting that the PopZ network and ParB-bound DNA interact in an adhesive complex, fixing the chromosome origin at the cell pole.	[Bowman, Grant R.; Shapiro, Lucy] Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Comolli, Luis R.; Downing, Kenneth H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Zhu, Jian; Earnest, Thomas] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Eckart, Michael] Stanford Univ, Stanford Prot & Nucle Acid Facil, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Koenig, Marcelle; Moerner, W. E.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; Stanford University	Shapiro, L (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA.	shapiro@stanford.edu	Moerner, William E/C-3260-2008; Comolli, Luis Raul/C-5907-2017	Moerner, William E/0000-0002-2830-209X; Comolli, Luis Raul/0000-0002-9313-6550; Zhu, Jian/0000-0001-6679-8498; Bowman, Grant/0000-0002-8817-8262	National Institutes of Health [GM32506, GM051426, 5R24GM73011-3, F32GM080008, 5 P20 HG003638-02]; Department of Energy [DE-AC02-05CH11231, DE-FG02-01ER63219]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG003638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032506, R24GM073011, R01GM051426, F32GM080008, R37GM032506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Balaji Srinivasan and Esteban Toro for developing bioinformatics tools. We thank Martin Thanbichler for purified ParB. Mike Fero designed software used for fluorescence microscopy, Bob Glaeser and Byong-Gyoon Han provided advice on EM sample preparation, Greg Hura assisted in SAXS analysis, and James Gober and Christine Jacobs-Wagner provided antibodies and strains. This work is supported by National Institutes of Health grants GM32506, GM051426, and 5R24GM73011-3 to L. S., F32GM080008 to G. B., and 5 P20 HG003638-02 to M. K. and W. E. M.; and Department of Energy grants DE-AC02-05CH11231 to L. R. C., J.X., and T. E., and DE-FG02-01ER63219 to L. S.	Barak I, 2005, MOL MICROBIOL, V57, P611, DOI 10.1111/j.1365-2958.2005.04687.x; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; Fogel MA, 2005, MOL MICROBIOL, V55, P125, DOI 10.1111/j.1365-2958.2004.04379.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Nilsen T, 2005, J BACTERIOL, V187, P6187, DOI 10.1128/JB.187.17.6187-6196.2005; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perry SE, 2006, J BACTERIOL, V188, P6039, DOI 10.1128/JB.01750-05; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Srinivasan BS, 2006, LECT NOTES COMPUT SC, V3909, P1, DOI 10.1007/11732990_1; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x	34	224	224	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					945	955		10.1016/j.cell.2008.07.015	http://dx.doi.org/10.1016/j.cell.2008.07.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805088	Green Accepted, Bronze			2022-12-01	WOS:000259318100015
J	Mak, TK; Hesseling, AC; Hussey, GD; Cotton, MF				Mak, Tippi K.; Hesseling, Anneke C.; Hussey, Gregory D.; Cotton, Mark F.			Making BCG vaccination programmes safer in the HIV era	LANCET			English	Editorial Material							TO-CHILD TRANSMISSION; CLINICS; HEALTH		[Mak, Tippi K.] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland; [Hesseling, Anneke C.] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Hesseling, Anneke C.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Hussey, Gregory D.] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Childrens Infect Dis Clin Res Unit, Dept Pediat & Child Hlth, ZA-7505 Tygerberg, South Africa	University of Basel; Swiss Tropical & Public Health Institute; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; Stellenbosch University	Mak, TK (corresponding author), Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland.	tippi.mak@unibas.ch	Cotton, Mark/AAQ-9936-2020	Cotton, Mark/0000-0003-2559-6034				Chersich MF, 2008, INT J STD AIDS, V19, P42, DOI 10.1258/ijsa.2007.007117; Enserink M, 2007, SCIENCE, V318, P1059, DOI 10.1126/science.318.5853.1059; FALLO A, 2005, INT AIDS SOC C RIO J; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Infuso A, 2006, Euro Surveill, V11, P6, DOI 10.2807/esm.11.03.00604-en; Lotte A, 1988, Bull Int Union Tuberc Lung Dis, V63, P47; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; SALISBURY D, 2006, TUBERCULOSIS IMMUNIS, pCH32; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; *UNAIDS WHO, AIDS EP UPD DEC 2007, P1; VIOLARI A, 2007, 4 INT AIDS SOC C JUL; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; *WHO, 2007, REV BCG VACC GUID IN, V82, P193; *WHO UNAIDS, 2007, GUID PROV IN HIV TES; World Health Organization, 2008, PAED HIV ART CAR GUI	15	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2008	372	9641					786	787		10.1016/S0140-6736(08)61318-5	http://dx.doi.org/10.1016/S0140-6736(08)61318-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774406				2022-12-01	WOS:000259124900008
J	Alexandru, G; Graumann, J; Smith, GT; Kolawa, NJ; Fang, RH; Deshaies, RJ				Alexandru, Gabriela; Graumann, Johannes; Smith, Geoffrey T.; Kolawa, Natalie J.; Fang, Ruihua; Deshaies, Raymond J.			UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1 alpha turnover	CELL			English	Article							AAA-ATPASE CDC48/P97; RETICULUM-ASSOCIATED DEGRADATION; VALOSIN-CONTAINING PROTEIN; POLYUBIQUITIN CHAINS; TRANSCRIPTION FACTOR; SELECTIVE CHAPERONE; MEMBRANE-FUSION; 26S PROTEASOME; ER; COMPLEX	p97 is an ATP-dependent chaperone that plays an important role in endoplasmic reticulum-associated degradation but whose connections to turnover of soluble proteins remain sparse. Binding of p97 to substrates is mediated by cofactors that contain ubiquitin-binding domains. We employed "network proteomics'' to show that p97 assembles with all of the 13 mammalian UBX-domain proteins. The UBX proteins that bind ubiquitin conjugates also interact with dozens of E3 ubiquitin ligases, only one of which had been previously linked to p97. In particular, UBXD7 links p97 to the ubiquitin ligase CUL2/VHL and its substrate hypoxia-inducible factor 1 alpha (HIF1 alpha). Depletion of p97 leads to accumulation of endogenous HIF1 alpha and increased expression of a HIF1 alpha target gene. The large number of ubiquitin ligases found associated with UBX proteins suggests that p97 plays a far broader role than previously anticipated in the global regulation of protein turnover.	[Alexandru, Gabriela; Graumann, Johannes; Smith, Geoffrey T.; Kolawa, Natalie J.; Fang, Ruihua; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Alexandru, G (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	galex@caltech.edu; deshaies@caltech.edu	Graumann, Johannes/C-5241-2008; Deshaies, Raymond/B-8354-2014	Graumann, Johannes/0000-0002-3015-5850; Deshaies, Raymond/0000-0002-3671-9354; Alexandru, Gabriela/0000-0002-7058-5644	Damon Runyon Cancer Research Foundation [DRG-1745-02]; Howard Hughes Medical Institute (HHMI); HHMI	Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); HHMI(Howard Hughes Medical Institute)	We thank G. Kleiger and T. Chou for help with gel filtration, J. Quimby for help with DNA cloning, S. Schwarz for advice on cell culture, R. Oania for technical assistance, and S. Buonomo for experimental protocols. We also thank T. Nagase, G. Warren, H. Katoh, and S. Buonomo for plasmids and Millipore, J. Pastorek, S. Pastorekova, and Z. Xia for antibodies. We are grateful to A. Varshavsky and members of the Deshaies' lab for critical reading of the manuscript. G. A. was supported by DRG-1745-02 of the Damon Runyon Cancer Research Foundation and the Howard Hughes Medical Institute (HHMI). R. J. D. is an HHMI Investigator, and this work was funded by HHMI. R. J. D. is a founder, shareholder, and consultant for Proteolix.	Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carim-Todd L, 2001, BBA-GENE STRUCT EXPR, V1517, P298, DOI 10.1016/S0167-4781(00)00248-7; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Graumann J, 2004, MOL CELL PROTEOMICS, V3, P226, DOI 10.1074/mcp.M300099-MCP200; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kaluz S, 2008, J CELL BIOCHEM, V104, P536, DOI 10.1002/jcb.21644; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mizuno Y, 2003, NEUROSCI LETT, V343, P77, DOI 10.1016/S0304-3940(03)00280-5; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Parker Carol E., 2005, V301, P153; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wykoff CC, 2000, CANCER RES, V60, P7075; Yamabe Y, 1997, GENOMICS, V39, P198, DOI 10.1006/geno.1996.4480; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	62	241	250	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					804	816		10.1016/j.cell.2008.06.048	http://dx.doi.org/10.1016/j.cell.2008.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775313	Green Accepted, Bronze			2022-12-01	WOS:000258947500020
J	Farmer, SR				Farmer, Stephen R.			Brown fat and skeletal muscle: Unlikely cousins?	CELL			English	Editorial Material							ADIPOSE-TISSUE; WHITE FAT; ADIPOCYTES; MICE	Although the functions of white fat and brown fat are increasingly well understood, their developmental origins remain unclear. A recent study published in Nature (Seale et al., 2008) identifies a population of progenitor cells that gives rise to brown fat and skeletal muscle but not white fat.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Farmer, SR (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	farmer@biochem.bumc.bu.edu		Farmer, Stephen/0000-0003-2483-2795				Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104	10	42	68	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					726	727		10.1016/j.cell.2008.08.018	http://dx.doi.org/10.1016/j.cell.2008.08.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775306	Bronze			2022-12-01	WOS:000258947500013
J	Holmes, E; Wilson, ID; Nicholson, JK				Holmes, Elaine; Wilson, Ian D.; Nicholson, Jeremy K.			Metabolic phenotyping in health and disease	CELL			English	Editorial Material							GENE	Analyzing metabolites (small molecules <1 kDa) in body fluids such as urine and plasma using various spectroscopic methods provides information on the metabotype (metabolic phenotype) of individuals or populations, information that can be applied to personalized medicine or public healthcare.	[Holmes, Elaine; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet, Dept Biomol Med, London SW7 2AZ, England; [Wilson, Ian D.] AstraZeneca, Dept Safety Med, Macclesfield SK10 4TG, Cheshire, England	Imperial College London; AstraZeneca	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet, Dept Biomol Med, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk	Holmes, Elaine/A-2189-2015; Wilson, Ian David/ABG-4451-2021; Holmes, Elaine/ABE-6606-2020; Nicholson, Jeremy K/B-3395-2012; Wilson, Ian/Z-3019-2019	Holmes, Elaine/0000-0002-0556-8389; Nicholson, Jeremy K/0000-0002-8123-8349; 				Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Sindic A, 2007, CURR OPIN NEPHROL HY, V16, P484; Westhoff M, 2007, J PHYSIOL PHARMACOL, V58, P739	15	535	559	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					714	717		10.1016/j.cell.2008.08.026	http://dx.doi.org/10.1016/j.cell.2008.08.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775301	Bronze			2022-12-01	WOS:000258947500008
J	Liu, HT; Yu, XH; Li, KW; Klejnot, J; Yang, HY; Lisiero, D; Lin, CT				Liu, Hongtao; Yu, Xuhong; Li, Kunwu; Klejnot, John; Yang, Hongyun; Lisiero, Dominique; Lin, Chentao			Photoexcited CRY2 Interacts with CIB1 to Regulate Transcription and Floral Initiation in Arabidopsis	SCIENCE			English	Article							BLUE-LIGHT PHOTORECEPTORS; SIGNAL-TRANSDUCTION; DNA PHOTOLYASE; CIRCADIAN CLOCK; FLOWERING TIME; CRYPTOCHROMES; THALIANA; PROTEIN; FAMILY; COP1	Cryptochromes (CRY) are photolyase- like blue- light receptors that mediate light responses in plants and animals. How plant cryptochromes act in response to blue light is not well understood. We report here the identification and characterization of the Arabidopsis CIB1 ( cryptochrome- interacting basic- helix- loop- helix) protein. CIB1 interacts with CRY2 ( cryptochrome 2) in a blue light- specific manner in yeast and Arabidopsis cells, and it acts together with additional CIB1- related proteins to promote CRY2- dependent floral initiation. CIB1 binds to G box ( CACGTG) in vitro with a higher affinity than its interaction with other E- box elements ( CANNTG). However, CIB1 stimulates FT messenger RNA expression, and it interacts with chromatin DNA of the FT gene that possesses various E- box elements except G box. We propose that the blue light- dependent interaction of cryptochrome( s) with CIB1 and CIB1- related proteins represents an early photoreceptor signaling mechanism in plants.	[Liu, Hongtao; Yu, Xuhong; Li, Kunwu; Klejnot, John; Yang, Hongyun; Lisiero, Dominique; Lin, Chentao] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Lin, CT (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clin@mcdb.ucla.edu	Liu, Hongtao/A-7556-2010		NIH [GM56265]; University of California-Los Angeles; Sol Leshin UCLA-BGU Academic Cooperation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056265, R29GM056265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Los Angeles(University of California System); Sol Leshin UCLA-BGU Academic Cooperation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Ecker, Z. Wang, W. Laing, S. Poethig, G. Chen, L. Johnson, S. Jacobsen, S. Knowles, E. Tobin, and R. Goldberg for materials and technical assistance. This work is supported in part by NIH (GM56265 to C.L.), University of California-Los Angeles faculty research, and Sol Leshin UCLA-BGU Academic Cooperation programs.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Endo M, 2007, PLANT CELL, V19, P84, DOI 10.1105/tpc.106.048157; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yu X, 2007, PLANT CELL, V19, P3146, DOI 10.1105/tpc.107.053017; Yu XH, 2007, P NATL ACAD SCI USA, V104, P7289, DOI 10.1073/pnas.0701912104	30	472	520	10	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1535	1539		10.1126/science.1163927	http://dx.doi.org/10.1126/science.1163927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	18988809				2022-12-01	WOS:000261377400047
J	Jekely, G; Colombelli, J; Hausen, H; Guy, K; Stelzer, E; Nedelec, F; Arendt, D				Jekely, Gaspar; Colombelli, Julien; Hausen, Harald; Guy, Keren; Stelzer, Ernst; Nedelec, Francois; Arendt, Detlev			Mechanism of phototaxis in marine zooplankton	NATURE			English	Article							PLATYNEREIS-DUMERILII; CHLAMYDOMONAS-REINHARDTII; SPONGE LARVA; BEHAVIOR; ANNELIDA; EYE; NANOSURGERY; POLYCHAETA; ORGANISMS; EVOLUTION	The simplest animal eyes are eyespots composed of two cells only: a photoreceptor and a shading pigment cell. They resemble Darwin's 'proto-eyes', considered to be the first eyes to appear in animal evolution(1-4). Eyespots cannot form images but enable the animal to sense the direction of light. They are characteristic for the zooplankton larvae of marine invertebrates and are thought to mediate larval swimming towards the light. Phototaxis of invertebrate larvae contributes to the vertical migration of marine plankton(5), which is thought to represent the biggest biomass transport on Earth(6,7). Yet, despite its ecological and evolutionary importance, the mechanism by which eyespots regulate phototaxis is poorly understood. Here we show how simple eyespots in marine zooplankton mediate phototactic swimming, using the marine annelid Platynereis dumerilii as a model(8). We find that the selective illumination of one eyespot changes the beating of adjacent cilia by direct cholinergic innervation resulting in locally reduced water flow. Computer simulations of larval swimming show that these local effects are sufficient to direct the helical swimming trajectories towards the light. The computer model also shows that axial rotation of the larval body is essential for phototaxis and that helical swimming increases the precision of navigation. These results provide, to our knowledge, the first mechanistic understanding of phototaxis in a marine zooplankton larva and show how simple eyespots regulate it. We propose that the underlying direct coupling of light sensing and ciliary locomotor control was a principal feature of the proto- eye and an important landmark in the evolution of animal eyes.	[Jekely, Gaspar; Guy, Keren; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Colombelli, Julien; Stelzer, Ernst; Nedelec, Francois] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Hausen, Harald] Free Univ Berlin, Inst Biol Systemat & Evolut Tiere, D-14195 Berlin, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Free University of Berlin	Jekely, G (corresponding author), Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	gaspar.jekely@tuebingen.mpg.de; arendt@embl.de	Nedelec, Francois/AAC-1673-2019; Stelzer, Ernst H K/A-7648-2011; Jékely, Gáspár/I-8708-2012; Nedelec, Francois J/H-3317-2011	Nedelec, Francois/0000-0002-8141-5288; Stelzer, Ernst H K/0000-0003-1545-0736; Jékely, Gáspár/0000-0001-8496-9836; Nedelec, Francois J/0000-0002-8141-5288; Colombelli, Julien/0000-0002-2784-4276	Center for Modelling and Simulation in the Biosciences; Deutsche Forschungsgemeinschaft [HA 4443/1-1, DA Ar387/1-1]; FEBS Long Term Fellowship	Center for Modelling and Simulation in the Biosciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FEBS Long Term Fellowship	We thank K. Miura for advice on behavioural assays and digital image processing, K. Tessmar- Raible for identifying FVRI- amide in our expressed- sequence- tag collection, G. Plickert for advice on antibody production, D. Nilsson for advice on action spectra, and H. Snyman for technical assistance. This work was supported by Center for Modelling and Simulation in the Biosciences and by grants from Deutsche Forschungsgemeinschaft (HA 4443/1-1 and DA Ar387/1-1). G. J. was supported by a FEBS Long Term Fellowship during the initial phase of the project	Angel MV, 2000, HYDROBIOLOGIA, V440, P161, DOI 10.1023/A:1004115010030; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; BRANDENBURGER JL, 1973, Z ZELLFORSCH MIK ANA, V142, P89, DOI 10.1007/BF00306706; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Colombelli J, 2007, METHOD CELL BIOL, V82, P267, DOI 10.1016/S0091-679X(06)82008-X; Darwin C., 1859, ORIGIN SPECIES MEANS; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Denny M. W., 1993, AIR WATER BIOL PHYS; DORRESTEIJN AWC, 1993, ROUX ARCH DEV BIOL, V202, P260, DOI 10.1007/BF00363215; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Jennings HS, 1901, AM NAT, V35, P369, DOI 10.1086/277922; Josef K, 2005, CELL MOTIL CYTOSKEL, V61, P97, DOI 10.1002/cm.20069; Josef K, 2006, CELL MOTIL CYTOSKEL, V63, P758, DOI 10.1002/cm.20158; LACALLI TC, 1988, CAN J ZOOL, V66, P1004, DOI 10.1139/z88-148; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; MARSDEN JR, 1984, MAR BIOL, V83, P13, DOI 10.1007/BF00393081; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; RHODE B, 1992, J MORPHOL, V212, P71, DOI 10.1002/jmor.1052120108; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; THORSON G, 1964, OPHELIA, V1, P167, DOI DOI 10.1080/00785326.1964.10416277; Witman George B., 1993, Trends in Cell Biology, V3, P403, DOI 10.1016/0962-8924(93)90091-E	29	190	191	10	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					395	U62		10.1038/nature07590	http://dx.doi.org/10.1038/nature07590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020621	Bronze			2022-12-01	WOS:000261039600045
J	Redondo, P; Prieto, J; Munoz, IG; Alibes, A; Stricher, F; Serrano, L; Cabaniols, JP; Daboussi, F; Arnould, S; Perez, C; Duchateau, P; Paques, F; Blanco, FJ; Montoya, G				Redondo, Pilar; Prieto, Jesus; Munoz, Ines G.; Alibes, Andreu; Stricher, Francois; Serrano, Luis; Cabaniols, Jean-Pierre; Daboussi, Fayza; Arnould, Sylvain; Perez, Christophe; Duchateau, Philippe; Paques, Frederic; Blanco, Francisco J.; Montoya, Guillermo			Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases	NATURE			English	Article							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; HOMING ENDONUCLEASES; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; DIRECTED EVOLUTION; SITE-SPECIFICITY; CRE RECOMBINASE; GENE CORRECTION; I-CREI	Xeroderma pigmentosum is a monogenic disease characterized by hypersensitivity to ultraviolet light. The cells of xeroderma pigmentosum patients are defective in nucleotide excision repair, limiting their capacity to eliminate ultraviolet- induced DNA damage, and resulting in a strong predisposition to develop skin cancers(1). The use of rare cutting DNA endonucleases - such as homing endonucleases, also known as meganucleases - constitutes one possible strategy for repairing DNA lesions. Homing endonucleases have emerged as highly specific molecular scalpels that recognize and cleave DNA sites, promoting efficient homologous gene targeting through double- strand- break- induced homologous recombination. Here we describe two engineered heterodimeric derivatives of the homing endonuclease I- CreI, produced by a semi- rational approach. These two molecules - Amel3 - Amel4 and Ini3 - Ini4 cleave DNA from the human XPC gene ( xeroderma pigmentosum group C), in vitro and in vivo. Crystal structures of the I- CreI variants complexed with intact and cleaved XPC target DNA suggest that the mechanism of DNA recognition and cleavage by the engineered homing endonucleases is similar to that of the wild- type I- CreI. Furthermore, these derivatives induced high levels of specific gene targeting in mammalian cells while displaying no obvious genotoxicity. Thus, homing endonucleases can be designed to recognize and cleave the DNA sequences of specific genes, opening up new possibilities for genome engineering and gene therapy in xeroderma pigmentosum patients whose illness can be treated ex vivo.	[Redondo, Pilar; Munoz, Ines G.; Montoya, Guillermo] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Macromol Crystallog Grp, Madrid 28029, Spain; [Prieto, Jesus; Blanco, Francisco J.] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, NMR Grp, Madrid 28029, Spain; [Alibes, Andreu; Stricher, Francois; Serrano, Luis] UPF, European Mol Biol Lab, CRG Syst Biol Unit, CRG, Barcelona 08003, Spain; [Serrano, Luis] ICREA, F-93235 Romainville, France; [Cabaniols, Jean-Pierre; Daboussi, Fayza; Arnould, Sylvain; Perez, Christophe; Duchateau, Philippe; Paques, Frederic] CELLECTIS SA, F-93235 Romainville, France	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Blanco, FJ (corresponding author), CIC bioGUNE, Parque Tecnol Vizcaya,Edificio 800, Derio 48160, Spain.	fblanco@cicbiogune.es; gmontoya@cnio.es	Serrano, Luis/B-3355-2013; Blanco, Francisco J/D-4401-2009; Alibés, Andreu/A-5790-2008; Stricher, François/L-2688-2015; Munoz, Ines G/M-3285-2014; Redondo, Pilar/L-7612-2014	Serrano, Luis/0000-0002-5276-1392; Blanco, Francisco J/0000-0003-2545-4319; Alibés, Andreu/0000-0002-0055-3014; Stricher, François/0000-0003-0150-0878; Munoz, Ines G/0000-0001-6732-4059; Redondo, Pilar/0000-0002-6723-0818; Daboussi, Fayza/0000-0001-7689-7975	EU MEGATOOL [LSHG-CT-2006-037226]; CRG-Novartis fellowship	EU MEGATOOL; CRG-Novartis fellowship	We would like to thank J. Casado and D. Megias for technical support and the beamline staff at the ESRF and SLS for advice during data collection. This project received financial support from the EU MEGATOOL project (LSHG-CT-2006-037226). A.A. is partly funded by a CRG-Novartis fellowship.	Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Delacote F, 2002, NUCLEIC ACIDS RES, V30, P3454, DOI 10.1093/nar/gkf452; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Prieto J, 2007, NUCLEIC ACIDS RES, V35, P3262, DOI 10.1093/nar/gkm183; Rimseliene R, 2003, J MOL BIOL, V327, P383, DOI 10.1016/S0022-2836(03)00142-6; Saintigny Y, 2007, ONCOGENE, V26, P2769, DOI 10.1038/sj.onc.1210075; Samuelson JC, 2002, J MOL BIOL, V319, P673, DOI 10.1016/S0022-2836(02)00343-1; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Silva GH, 2004, NUCLEIC ACIDS RES, V32, P3156, DOI 10.1093/nar/gkh618; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Voziyanov Y, 2003, J MOL BIOL, V326, P65, DOI 10.1016/S0022-2836(02)01364-5; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	33	134	145	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					107	U8		10.1038/nature07343	http://dx.doi.org/10.1038/nature07343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987743				2022-12-01	WOS:000260674000050
J	van de Koppel, J; Gascoigne, JC; Theraulaz, G; Rietkerk, M; Mooij, WM; Herman, PMJ				van de Koppel, Johan; Gascoigne, Joanna C.; Theraulaz, Guy; Rietkerk, Max; Mooij, Wolf M.; Herman, Peter M. J.			Experimental Evidence for Spatial Self-Organization and Its Emergent Effects in Mussel Bed Ecosystems	SCIENCE			English	Article							PATTERN-FORMATION; SEMIARID VEGETATION; LOCAL INTERACTIONS; SCALE; DYNAMICS; WAVES	Spatial self- organization is the main theoretical explanation for the global occurrence of regular or otherwise coherent spatial patterns in ecosystems. Using mussel beds as a model ecosystem, we provide an experimental demonstration of spatial self- organization. Under homogeneous laboratory conditions, mussels developed regular patterns, similar to those in the field. An individual- based model derived from our experiments showed that interactions between individuals explained the observed patterns. Furthermore, a field study showed that pattern formation affected ecosystem- level processes in terms of improved growth and resistance to wave action. Our results imply that spatial self- organization is an important determinant of the structure and functioning of ecosystems, and it needs to be considered in their conservation.	[van de Koppel, Johan; Herman, Peter M. J.] Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; [Gascoigne, Joanna C.] Univ Wales Bangor, Sch Ocean Sci, Menai Bridge LL59 5AB, Gwynedd, Wales; [Theraulaz, Guy] Univ Toulouse 3, CNRS, Ctr Rech Cognit Animale, UMR 5169, F-31062 Toulouse 04, France; [Rietkerk, Max] Univ Utrecht, Dept Environm Sci, Copernicus Inst, NL-3508 TC Utrecht, Netherlands; [Mooij, Wolf M.] Netherlands Inst Ecol, Aquat Food Webs Dept, NL-3631 AC Nieuwersluis, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Bangor University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	van de Koppel, J (corresponding author), Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, POB 140, NL-4400 AC Yerseke, Netherlands.	J.vandeKoppel@nioo.knaw.nl	Rietkerk, Max/H-6235-2011; Herman, Peter M.J./A-9018-2011; Mooij, Wolf M/C-2677-2008; Theraulaz, Guy/H-8464-2016; Van de Koppel, Johan/E-7266-2010	Herman, Peter M.J./0000-0003-2188-6341; Mooij, Wolf M/0000-0001-5586-8200; Theraulaz, Guy/0000-0002-3062-4215; Rietkerk, Max/0000-0002-2698-3848	Schure-Beijerinck-Popping; Royal Dutch Academy of Sciences; Vidi; Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW); Biotechnology and Biological Sciences Research Council [D18866]	Schure-Beijerinck-Popping; Royal Dutch Academy of Sciences; Vidi(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Koutstaal, B. Koutstaal, A. Matkin, and J. van Soelen for their assistance during the field work and lab experiments; K. Mould and J. Wilson for access to their mussel lots; and A. Altieri, M. Bertness, T. Bouma, F. Guichard, M. de Jager, A.-M. Neutel, P. de Ruiter, and B. Silliman for critical discussions and reading of the manuscript. The field work at Bangor was supported by a grant from the Schure-Beijerinck-Popping fund of the Royal Dutch Academy of Sciences to J.v.d.K. The research of M. R. is supported by a personal Vidi grant from the Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW). J.C.G. was supported by Biotechnology and Biological Sciences Research Council contract D18866. This is publication 4410 of the Netherlands Institute of Ecology (NIOO-KNAW).	Bertness MD, 1998, ECOLOGY, V79, P1382, DOI 10.2307/176750; BERTNESS MD, 1985, OECOLOGIA, V67, P192, DOI 10.1007/BF00384283; Bjornstad ON, 2002, SCIENCE, V298, P1020, DOI 10.1126/science.1075182; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Gascoigne JC, 2005, OECOLOGIA, V145, P371, DOI 10.1007/s00442-005-0137-x; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Guichard F, 2003, AM NAT, V161, P889, DOI 10.1086/375300; Jonsson PR, 2005, LIMNOL OCEANOGR, V50, P1989, DOI 10.4319/lo.2005.50.6.1989; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Levin S., 1999, FRAGILE DOMINION; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619; Nicolis G., 1977, SELF ORG NONEQUILIBR; Rietkerk M, 2004, AM NAT, V163, P699, DOI 10.1086/383065; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Sole R. V., 2006, SELF ORG COMPLEX ECO; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; TYSON JJ, 1989, DEVELOPMENT, V106, P421; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2006, AM NAT, V168, pE136, DOI 10.1086/508671; Wager H, 1911, PHILOS T R SOC LON B, V201; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595	27	178	181	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					739	742		10.1126/science.1163952	http://dx.doi.org/10.1126/science.1163952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974353	Green Submitted			2022-12-01	WOS:000260605200048
J	Weyand, S; Shimamura, T; Yajima, S; Suzuki, S; Mirza, O; Krusong, K; Carpenter, EP; Rutherford, NG; Hadden, JM; O'Reilly, J; Ma, P; Saidijam, M; Patching, SG; Hope, RJ; Norbertczak, HT; Roach, PCJ; Iwata, S; Henderson, PJF; Cameron, AD				Weyand, Simone; Shimamura, Tatsuro; Yajima, Shunsuke; Suzuki, Shun'ichi; Mirza, Osman; Krusong, Kuakarun; Carpenter, Elisabeth P.; Rutherford, Nicholas G.; Hadden, Jonathan M.; O'Reilly, John; Ma, Pikyee; Saidijam, Massoud; Patching, Simon G.; Hope, Ryan J.; Norbertczak, Halina T.; Roach, Peter C. J.; Iwata, So; Henderson, Peter J. F.; Cameron, Alexander D.			Structure and Molecular Mechanism of a Nucleobase-Cation-Symport-1 Family Transporter	SCIENCE			English	Article							PURINE-CYTOSINE PERMEASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL-ANALYSIS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; BINDING-SITE; PROTEINS; REVEALS	The nucleobase- cation- symport- 1 ( NCS1) transporters are essential components of salvage pathways for nucleobases and related metabolites. Here, we report the 2.85- angstrom resolution structure of the NCS1 benzyl- hydantoin transporter, Mhp1, from Microbacterium liquefaciens. Mhp1 contains 12 transmembrane helices, 10 of which are arranged in two inverted repeats of five helices. The structures of the outward- facing open and substrate- bound occluded conformations were solved, showing how the outward- facing cavity closes upon binding of substrate. Comparisons with the leucine transporter LeuT(Aa) and the galactose transporter vSGLT reveal that the outwardand inward- facing cavities are symmetrically arranged on opposite sides of the membrane. The reciprocal opening and closing of these cavities is synchronized by the inverted repeat helices 3 and 8, providing the structural basis of the alternating access model for membrane transport.	[Weyand, Simone; Carpenter, Elisabeth P.; Iwata, So; Cameron, Alexander D.] Diamond Light Source Ltd, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Weyand, Simone; Shimamura, Tatsuro; Yajima, Shunsuke; Mirza, Osman; Krusong, Kuakarun; Carpenter, Elisabeth P.; Iwata, So; Cameron, Alexander D.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Membrane Prot Crystallog Grp, London SW7 2AZ, England; [Shimamura, Tatsuro; Iwata, So] Japan Sci & Technol Agcy, Human Receptor Crystallog Project, ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Suzuki, Shun'ichi; Rutherford, Nicholas G.; Hadden, Jonathan M.; O'Reilly, John; Ma, Pikyee; Saidijam, Massoud; Patching, Simon G.; Hope, Ryan J.; Norbertczak, Halina T.; Roach, Peter C. J.; Henderson, Peter J. F.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Saidijam, Massoud] Hamedan Univ Med Sci, Sch Med, Hamadan, Iran; [Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London; Japan Science & Technology Agency (JST); University of Leeds; RIKEN	Iwata, S (corresponding author), Diamond Light Source Ltd, Membrane Prot Lab, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England.	s.iwata@imperial.ac.uk; p.j.f.henderson@leeds.ac.uk	Saidijam, Massoud/G-2646-2017; Ma, Pikyee/B-8282-2012; Henderson, Peter JF/Q-1907-2018; Cameron, Alexander/L-7288-2013; Patching, Simon G./Z-3906-2019	Saidijam, Massoud/0000-0001-8910-556X; Ma, Pikyee/0000-0003-4080-2908; Patching, Simon G./0000-0001-6132-5317; Mirza, Osman Asghar/0000-0001-9435-0690; Carpenter, Liz/0000-0001-9138-2937; Cameron, Alexander/0000-0001-8776-3518; Henderson, Peter/0000-0002-9187-0938	Biotechnology and Biological Sciences Research Council [B17935, BB/C51725]; Ajinomoto Incorporated; European Membrane Protein consortium [LSHG-CT-2004-504601]; Membrane Protein Structure Initiative [BBS/B/14418]; Wellcome Trust [062164/Z/00/Z]; Leverhulme Trust; European Molecular Biology Organization long-term fellowship; Biotechnology and Biological Sciences Research Council [BB/C51725X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ajinomoto Incorporated; European Membrane Protein consortium; Membrane Protein Structure Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded primarily by the Biotechnology and Biological Sciences Research Council (grant nos. B17935 and BB/C51725), with important contributions from Ajinomoto Incorporated, the European Membrane Protein consortium (grant no. LSHG-CT-2004-504601), the Membrane Protein Structure Initiative (grant no. BBS/B/14418), and the Wellcome Trust (grant no. 062164/Z/00/Z). We wish to thank the Membrane Protein Laboratory (MPL) at the Diamond Light Source Limited for use of the MPL facilities. J. Abramson kindly provided us with the coordinates of vSGLT before their release from the Protein Data Bank (PDB). We are also grateful to S. Phillips, S. Baldwin, P. Gilmartin, S. Radford, D. Drew, M. Jormakka, K. Watanabe, and M. Iwata for support or advice. The Japan Society for the Promotion of Science provided personal funding to S.Y. and the Leverhulme Trust to P.J.F.H. S.W. was a recipient of a European Molecular Biology Organization long-term fellowship. The coordinates and the structure factors for Mhp1 without substrate and the hydantoin complex have been deposited in the PDB (entries 2JLN and 2JLO, respectively).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BLOCH JC, 1992, MOL MICROBIOL, V6, P2989, DOI 10.1111/j.1365-2958.1992.tb01757.x; Bowie JU, 2006, NAT STRUCT MOL BIOL, V13, P94, DOI 10.1038/nsmb0206-94; BRETHES D, 1992, EUR J BIOCHEM, V204, P699, DOI 10.1111/j.1432-1033.1992.tb16684.x; CHEVALLIER MR, 1975, J BACTERIOL, V122, P629, DOI 10.1128/JB.122.2.629-641.1975; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Ferreira T, 1997, J BIOL CHEM, V272, P9697; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; HENDERSON PJF, 1994, ANTON LEEUW INT J G, V65, P349, DOI 10.1007/BF00872218; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	36	289	291	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					709	713		10.1126/science.1164440	http://dx.doi.org/10.1126/science.1164440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18927357	Green Accepted			2022-12-01	WOS:000260605200039
J	Adilakshmi, T; Bellur, DL; Woodson, SA				Adilakshmi, Tadepalli; Bellur, Deepti L.; Woodson, Sarah A.			Concurrent nucleation of 16S folding and induced fit in 30S ribosome assembly	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOMES; PARALLEL PATHWAYS; RNA; SUBUNIT; PROTEIN; VITRO; DOMAINS; S4	Rapidly growing cells produce thousands of new ribosomes each minute, in a tightly regulated process that is essential to cell growth(1,2). How the Escherichia coli 16S ribosomal RNA and the 20 proteins that make up the 30S ribosomal subunit can assemble correctly in a few minutes remains a challenging problem, partly because of the lack of real- time data on the earliest stages of assembly. By providing snapshots of individual RNA and protein interactions as they emerge in real time, here we show that 30S assembly nucleates concurrently from different points along the rRNA. Time- resolved hydroxyl radical footprinting(3) was used to map changes in the structure of the rRNA within 20 milliseconds after the addition of total 30S proteins. Helical junctions in each domain fold within 100 ms. In contrast, interactions surrounding the decoding site and between the 5', the central and the 3' domains require 2 - 200 seconds to form. Unexpectedly, nucleotides contacted by the same protein are protected at different rates, indicating that initial RNA - protein encounter complexes refold during assembly. Although early steps in assembly are linked to intrinsically stable rRNA structure, later steps correspond to regions of induced fit between the proteins and the rRNA.	[Adilakshmi, Tadepalli; Woodson, Sarah A.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Bellur, Deepti L.] Johns Hopkins Univ, Program Cell Mol & Dev Biol & Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Woodson, SA (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	swoodson@jhu.edu		Woodson, Sarah/0000-0003-0170-1987	National Institutes of Health [GM60819, P41-EB0001979.]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001979, P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Moss, A. Cukras, L. Cochella and R. Green for help with ribosome preparation and peptidyl transferase assays, P. Fleming for help with Calc-Surf software, and S. Gupta, M. Sullivan and M. Brenowitz for help with X-ray footprinting. This work was supported by the National Institutes of Health (NIH; GM60819). The NSLS X28C and the Center for Synchrotron Biosciences are supported by NIH P41-EB0001979.	Adilakshmi T, 2005, J MOL BIOL, V351, P508, DOI 10.1016/j.jmb.2005.06.020; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Culver GM, 2003, BIOPOLYMERS, V68, P234, DOI 10.1002/bip.10221; DODD J, 1991, BIOCHIMIE, V73, P757, DOI 10.1016/0300-9084(91)90055-6; Dutca LM, 2008, J MOL BIOL, V376, P92, DOI 10.1016/j.jmb.2007.10.083; HELD WA, 1973, J BIOL CHEM, V248, P5720; Holmes KL, 2004, NAT STRUCT MOL BIOL, V11, P179, DOI 10.1038/nsmb719; Laederach A, 2006, J MOL BIOL, V358, P1179, DOI 10.1016/j.jmb.2006.02.075; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; Noller H. F, 1987, ESCHERICHIA COLI SAL, P104; NOWOTNY V, 1988, BIOCHEMISTRY-US, V27, P7051, DOI 10.1021/bi00418a057; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; POWERS T, 1993, J MOL BIOL, V232, P362, DOI 10.1006/jmbi.1993.1396; POWERS T, 1995, J BIOL CHEM, V270, P1238, DOI 10.1074/jbc.270.3.1238; POWERS T, 1995, RNA, V1, P194; Ralston CY, 2000, METHOD ENZYMOL, V317, P353; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; Sayers EW, 2000, BIOCHEMISTRY-US, V39, P13602, DOI 10.1021/bi0013391; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Tullius TD, 2005, CURR OPIN CHEM BIOL, V9, P127, DOI 10.1016/j.cbpa.2005.02.009; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Williamson JR, 2003, RNA, V9, P165, DOI 10.1261/rna.2164903; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	28	138	138	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1268	1272		10.1038/nature07298	http://dx.doi.org/10.1038/nature07298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18784650	Green Accepted			2022-12-01	WOS:000260462100051
J	Provan, D; Chapel, HM; Sewell, WAC; O'Shaughnessy, D				Provan, Drew; Chapel, Helen M.; Sewell, W. A. Carrock; O'Shaughnessy, Denise		UK Immunoblobulin Expert Working G	Guidelines - Prescribing intravenous immunoglobulin: summary of Department of Health guidelines	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Provan, Drew] Royal London Hosp, Dept Haematol, Barts & London NHS Trust, London E1 2ES, England; [Chapel, Helen M.] Univ Oxford, Nuffield Dept Med, Oxford OX3 9DU, England; [Chapel, Helen M.] Oxford Radcliffe Hosp NHS Trust, Oxford OX3 9DU, England; [Sewell, W. A. Carrock] Scunthorpe Gen Hosp, N Lincolnshire & Goole NHS Trust, Scunthorpe DN15 7BH, N Lincs, England; [O'Shaughnessy, Denise] Dept Hlth, Blood Policy Unit, London SE13 6LH, England	Barts Health NHS Trust; Royal London Hospital; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Provan, D (corresponding author), Royal London Hosp, Dept Haematol, Barts & London NHS Trust, London E1 2ES, England.	a.provan@virgin.net	Provan, Drew/AAF-2766-2021	Provan, Drew/0000-0002-5110-8455	Department of Health Funding Source: Medline	Department of Health		[Anonymous], 2008, DEM MAN PLAN IMM US; Boulis A, 2002, J HEALTH POLIT POLIC, V27, P977, DOI 10.1215/03616878-27-6-977; Darabi K, 2006, TRANSFUSION, V46, P741, DOI 10.1111/j.1537-2995.2006.00792.x; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Pendergrast JM, 2005, VOX SANG, V89, P150, DOI 10.1111/j.1423-0410.2005.00670.x; Provan D., 2008, IVIG GUIDELINE DEV G, V2nd; *US DEP HHS, 1993, AHCPR PUBL, V1	7	15	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1831	10.1136/bmj.a1831	http://dx.doi.org/10.1136/bmj.a1831			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18936060				2022-12-01	WOS:000260298800038
J	Durniak, KJ; Bailey, S; Steitz, TA				Durniak, Kimberly J.; Bailey, Scott; Steitz, Thomas A.			The structure of a transcribing T7 RNA polymerase in transition from initiation to elongation	SCIENCE			English	Article							MAJOR CONFORMATIONAL-CHANGES; TRANSCRIPTION INITIATION; ANGSTROM RESOLUTION; PROMOTER CLEARANCE; COMPLEX; RELEASE; T7-RNA-POLYMERASE; BACTERIOPHAGE-T7; HOLOENZYME; MECHANISM	Structural studies of the T7 bacteriophage DNA-dependent RNA polymerase (T7 RNAP) have shown that the conformation of the amino-terminal domain changes substantially between the initiation and elongation phases of transcription, but how this transition is achieved remains unclear. We report crystal structures of T7 RNAP bound to promoter DNA containing either a 7- or an 8-nucleotide (nt) RNA transcript that illuminate intermediate states along the transition pathway. The amino-terminal domain comprises the C-helix subdomain and the promoter binding domain (PBD), which consists of two segments separated by subdomain H. The structures of the intermediate complex reveal that the PBD and the bound promoter rotate by -45 degrees upon synthesis of an 8-nt RNA transcript. This allows the promoter contacts to be maintained while the active site is expanded to accommodate a growing heteroduplex. The C-helix subdomain moves modestly toward its elongation conformation, whereas subdomain H remains in its initiation- rather than its elongation-phase location, more than 70 angstroms away.	[Durniak, Kimberly J.; Bailey, Scott; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Bailey, Scott; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Steitz, Thomas A./C-6559-2009	Durniak, Kimberly/0000-0002-4114-7135	NIH [GM57510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source beamline 24-ID and at the. National. Synchrotron Light Source beamline X25. We also thank T. Jorgensen for help with the supplemental movie and the staff of the Center for Structural Biology core facility at Yale University. This work was Supported by NIH grant GM57510 (to T.A.S.). The coordinates have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank with accession numbers 3E2E and 3E3J for the 7- and 8-nt RNA intermediate complex structures, respectively.	Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; CHEETHAM GMT, 1988, SCIENCE, V27, P3966; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; He B, 1997, J MOL BIOL, V265, P275, DOI 10.1006/jmbi.1996.0741; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1987, J BIOL CHEM, V262, P3790; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Ma KY, 2005, P NATL ACAD SCI USA, V102, P17612, DOI 10.1073/pnas.0508865102; Ma KY, 2002, J BIOL CHEM, V277, P43206, DOI 10.1074/jbc.M206658200; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Theis K, 2004, BIOCHEMISTRY-US, V43, P12709, DOI 10.1021/bi0486987; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P6165, DOI 10.1021/bi700058b; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P1714, DOI 10.1021/bi061905d; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	32	75	85	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					553	557		10.1126/science.1163433	http://dx.doi.org/10.1126/science.1163433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948533	Green Accepted			2022-12-01	WOS:000260299100033
J	Yang, GD; Wu, LY; Jiang, B; Yang, W; Qi, JS; Cao, K; Meng, QH; Mustafa, AK; Mu, WT; Zhang, SM; Snyder, SH; Wang, R				Yang, Guangdong; Wu, Lingyun; Jiang, Bo; Yang, Wei; Qi, Jiansong; Cao, Kun; Meng, Qinghe; Mustafa, Asif K.; Mu, Weitong; Zhang, Shengming; Snyder, Solomon H.; Wang, Rui			H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; HYDROGEN-SULFIDE GENERATION; KNOCKOUT MICE; RAT; INHIBITION; RELAXATION; CALMODULIN; MODULATION; LACKING; GENE	Studies of nitric oxide over the past two decades have highlighted the fundamental importance of gaseous signaling molecules in biology and medicine. The physiological role of other gases such as carbon monoxide and hydrogen sulfide (H2S) is now receiving increasing attention. Here we show that H2S is physiologically generated by cystathionine gamma-lyase (CSE) and that genetic deletion of this enzyme in mice markedly reduces H2S levels in the serum, heart, aorta, and other tissues, Mutant mice lacking CSE display pronounced hypertension and diminished endothelium-dependent vasorelaxation. CSE is physiologically activated by calcium-calmodulin, which is a mechanism for H2S formation in response to vascular activation. These findings provide direct evidence that H2S is a physiologic vasodilator and regulator of blood pressure.	[Wu, Lingyun] Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK S7N 5E5, Canada; [Yang, Guangdong; Jiang, Bo; Yang, Wei; Qi, Jiansong; Cao, Kun; Wang, Rui] Univ Saskatchewan, Dept Physiol, Saskatoon, SK S7N 5E5, Canada; [Meng, Qinghe] Univ Saskatchewan, Dept Pathol, Saskatoon, SK S7N 5E5, Canada; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Yang, Guangdong; Zhang, Shengming; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Mu, Weitong] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Lakehead University; Johns Hopkins University	Wu, LY (corresponding author), Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK S7N 5E5, Canada.	lily.wu@usask.ca; ssnyder@jhmi.edu; rwang@lakeheadu.ca	Wang, Rui/C-7824-2012; Yang, Guangdong/G-4129-2011	Wang, Rui/0000-0003-3825-3620; 	U.S. Public Health Service [MH18501]; Research Scientist Award [DA00074]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Watkins for experimental and conceptual assistance. Supported by U.S. Public Health Service grant MH18501 and Research Scientist Award DA00074 to S.H.S., and operating grants of Canadian Institutes of Health Research to L.W. and R.W.	Boehning D, 2004, J BIOL CHEM, V279, P30927, DOI 10.1074/jbc.C400222200; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Brandes RP, 2000, P NATL ACAD SCI USA, V97, P9747, DOI 10.1073/pnas.97.17.9747; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Cooke CLM, 2003, CARDIOVASC RES, V60, P635, DOI 10.1016/j.cardiores.2003.08.011; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; HEINONEN K, 1973, BIOCHEM J, V136, P1011, DOI 10.1042/bj1361011; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Iwata C, 2007, LIFE SCI, V80, P873, DOI 10.1016/j.lfs.2006.11.012; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Lake-Bruse KD, 1999, AM J PHYSIOL-HEART C, V277, pH770, DOI 10.1152/ajpheart.1999.277.2.H770; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Ndisang JF, 2004, J HYPERTENS, V22, P1057, DOI 10.1097/00004872-200406000-00002; Searcy DG, 1998, J EXP ZOOL, V282, P310, DOI 10.1002/(SICI)1097-010X(19981015)282:3<310::AID-JEZ4>3.0.CO;2-P; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhong GZ, 2003, J HYPERTENS, V21, P1879, DOI 10.1097/00004872-200310000-00015; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65	28	1811	1921	10	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					587	590		10.1126/science.1162667	http://dx.doi.org/10.1126/science.1162667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948540	Green Accepted			2022-12-01	WOS:000260299100043
J	Berger, SP				Berger, S. Paul			Brain science and addiction	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; EXPOSURE THERAPY; D-CYCLOSERINE; DISORDER		[Berger, S. Paul] Dept Vet Affairs Med Ctr, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Berger, SP (corresponding author), Dept Vet Affairs Med Ctr, Portland, OR 97239 USA.	bergerp@ohsu.edu						Academy of Medical Sciences, 2008, BRAIN SCI ADD DRUGS; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; BENDER E, 2003, PSYCHIAT NEWS, V38, P12; Berger SP, 2007, NATURE, V449, P972, DOI 10.1038/449972a; Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Pucci E, 2007, COCHRANE DB SYST REV, V1; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1280	1281		10.1016/S0140-6736(08)61530-5	http://dx.doi.org/10.1016/S0140-6736(08)61530-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929888				2022-12-01	WOS:000260060500007
J	Buis, J; Wu, YP; Deng, YB; Leddon, J; Westfield, G; Eckersdorff, M; Sekiguchi, JM; Chang, S; Ferguson, DO				Buis, Jeffrey; Wu, Yipin; Deng, Yibin; Leddon, Jennifer; Westfield, Gerwin; Eckersdorff, Mark; Sekiguchi, JoAnn M.; Chang, Sandy; Ferguson, David O.			Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation	CELL			English	Article							DOUBLE-STRAND BREAKS; END-JOINING PATHWAY; SACCHAROMYCES-CEREVISIAE; V(D)J RECOMBINATION; LIGASE IV; MEIOTIC RECOMBINATION; EMBRYONIC LETHALITY; DAMAGE RESPONSES; HUMAN TELOMERES; COMPLEX	The Mre11/Rad50/NBS1 (MRN) complex maintains genomic stability by bridging DNA ends and initiating DNA damage signaling through activation of the ATM kinase. Mre11 possesses DNA nuclease activities that are highly conserved in evolution but play unknown roles in mammals. To define the functions of Mre11, we engineered targeted mouse alleles that either abrogate nuclease activities or inactivate the entire MRN complex. Mre11 nuclease deficiency causes a striking array of phenotypes indistinguishable from the absence of MRN, including early embryonic lethality and dramatic genomic instability. We identify a crucial role for the nuclease activities in homology-directed double-strand-break repair and a contributing role in activating the ATR kinase. However, the nuclease activities are not required to activate ATM after DNA damage or telomere deprotection. Therefore, nucleolytic processing by Mre11 is an essential function of fundamental importance in DNA repair, distinct from MRN control of ATM signaling.	[Buis, Jeffrey; Wu, Yipin; Leddon, Jennifer; Eckersdorff, Mark; Ferguson, David O.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Deng, Yibin; Chang, Sandy] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Deng, Yibin; Chang, Sandy] Univ Texas Houston, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Westfield, Gerwin; Sekiguchi, JoAnn M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Westfield, Gerwin; Sekiguchi, JoAnn M.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ferguson, DO (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	daviferg@umich.edu		Westfield, Gerwin/0000-0001-9634-2336; Deng, Yibin/0000-0001-5711-3565; Sekiguchi, JoAnn/0000-0002-7178-4258	National Institutes of Health (NIH) [HL079118]; Sidney Kimmel Cancer Research Foundation; University of Michigan Cancer Center [5-P30-CA46592]; Munn Endowment; Cure foundations, the Michael Kadoorie Cancer Genetics Research Program; NIH [AG028888, CA129037, AI063058]; Pew Foundation Scholars Award;  [K08 HL067580];  [1K01CA124461-01]; NATIONAL CANCER INSTITUTE [P30CA046592, T32CA009676, P30CA016672, K01CA124461, R01CA129037] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067580, R01HL079118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Cancer Research Foundation; University of Michigan Cancer Center(University of Michigan System); Munn Endowment; Cure foundations, the Michael Kadoorie Cancer Genetics Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation Scholars Award; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this work to D.O.F. was provided by the National Institutes of Health (NIH) (HL079118), Sidney Kimmel Cancer Research Foundation, University of Michigan Cancer Center Support Grant 5-P30-CA46592, and Munn Endowment, and by K08 HL067580 under initial mentorship of Frederick W. Alt. D.O.F. thanks John Moran, Tom Wilson, Mats Ljungman, Chris Canman, and Tobias Else for advice on the manuscript and experiments. S.C. acknowledges M.D. Anderson Cancer Center's Molecular Cytogenetics Core (CA016672) and support from the Welch, Elsa U. Pardee, and Abraham and Phyllis Katz, and Susan G. Komen for the Cure foundations, the Michael Kadoorie Cancer Genetics Research Program, and the NIH (AG028888, CA129037). Y.D. supported by 1K01CA124461-01. J.M.S. is supported by NIH AI063058 and Pew Foundation Scholars Award.	Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Bressan DA, 1998, GENETICS, V150, P591; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Moreau S, 1999, MOL CELL BIOL, V19, P556; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2005, MOL CELL, V19, P724, DOI 10.1016/j.molcel.2005.07.006; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	52	238	243	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					85	96		10.1016/j.cell.2008.08.015	http://dx.doi.org/10.1016/j.cell.2008.08.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854157	Bronze, Green Accepted			2022-12-01	WOS:000259728100011
J	de Ferranti, S; Ludwig, DS				de Ferranti, Sarah; Ludwig, David S.			Storm over statins - The controversy surrounding pharmacologic treatment of children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[de Ferranti, Sarah] Childrens Hosp, Prevent Cardiol Clin, Boston, MA 02115 USA; [de Ferranti, Sarah; Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Ludwig, David S.] Childrens Hosp, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	de Ferranti, S (corresponding author), Childrens Hosp, Prevent Cardiol Clin, 300 Longwood Ave, Boston, MA 02115 USA.			Ludwig, David/0000-0003-3307-8544	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Lavizzo-Mourey R, 2007, JAMA-J AM MED ASSOC, V298, P920, DOI 10.1001/jama.298.8.920; Valenza M, 2006, PROG NEUROBIOL, V80, P165, DOI 10.1016/j.pneurobio.2006.09.005; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004	5	53	55	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1309	1312		10.1056/NEJMp0805953	http://dx.doi.org/10.1056/NEJMp0805953			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815394				2022-12-01	WOS:000259440900001
J	Arora, VM; Georgitis, E; Siddique, J; Vekhter, B; Woodruff, JN; Humphrey, HJ; Meltzer, DO				Arora, Vineet M.; Georgitis, Emily; Siddique, Juned; Vekhter, Ben; Woodruff, James N.; Humphrey, Holly J.; Meltzer, David O.			Association of workload of on-call medical interns with on-call sleep duration, shift duration, and participation in educational activities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESIDENT DUTY HOURS; HOUR REGULATIONS; DELICATE BALANCE; PATIENT-CARE; TIME; ACTIGRAPHY; OUTCOMES; SERVICE; RISK; MORTALITY	Context Further restrictions in resident duty hours are being considered, and it is important to understand the association between workload, sleep loss, shift duration, and the educational time of on-call medical interns. Objective To assess whether increased on- call intern workload, as measured by the number of new admissions on- call and the number of previously admitted patients remaining on the service, was associated with reductions in on- call sleep, increased total shift duration, and lower likelihood of participation in educational activities. Design, Setting, and Participants Prospective cohort study of medical interns at a single US academic medical center from July 1, 2003, through June 24, 2005. Of the 81 interns, 56 participated ( 69%), for a total of 165 general medicine inpatient months resulting in 1100 call nights. Main Outcome Measures On- call sleep duration, estimated by wrist watch actigraphy; total shift duration, measured from paging logs; and participation in educational activities ( didactic lectures or bedside teaching), measured by experience sampling method via a personal digital assistant. Results Mean ( SD) sleep duration on- call was 2.8 ( 1.5) hours and mean ( SD) shift duration was 29.9 ( 1.7) hours. Interns reported spending 11% of their time in educational activities. Early in the academic year ( July to October), each new on- call admission was associated with less sleep (- 10.5 minutes [ 95% confidence interval {CI}, - 16.8 to - 4.2 minutes]; P <. 001) and a longer shift duration ( 13.2 minutes [ 95% CI, 3.2- 23.3 minutes]; P=. 01). A higher number of previously admitted patients remaining on the service was associated with a lower odds of participation in educational activities ( odds ratio, 0.82 [ 95% CI, 0.70- 0.96]; P=. 01]. Call nights during the week and early in the academic year were associated with the most sleep loss and longest shift durations. Conclusion In this study population, increased on- call workload was associated with more sleep loss, longer shift duration, and a lower likelihood of participation in educational activities.	[Arora, Vineet M.; Georgitis, Emily; Vekhter, Ben; Woodruff, James N.; Humphrey, Holly J.; Meltzer, David O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Siddique, Juned] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Meltzer, David O.] Univ Chicago, Dept Econ & Publ Policy Studies, Chicago, IL 60637 USA; [Arora, Vineet M.; Humphrey, Holly J.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Arora, VM (corresponding author), 5841 S Maryland Ave,MC 2007,AMB B217, Chicago, IL 60637 USA.	varora@medicine.bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393; Arora, Vineet/0000-0002-4745-7599	Department of Medicine, Pritzker School of Medicine, University of Chicago	Department of Medicine, Pritzker School of Medicine, University of Chicago(University of Chicago)	This study was funded by the Department of Medicine, Pritzker School of Medicine, University of Chicago.	*ACCR COUNC GRAD M, ACGME PROGR REQ RES; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], 2007, EXPERIENCE SAMPLING; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BELLINI LM, APDIM LEARNING ENV T; Dawson D, 2005, JAMA-J AM MED ASSOC, V294, P1104, DOI 10.1001/jama.294.9.1104; Dresselhaus TR, 1998, J GEN INTERN MED, V13, P534, DOI 10.1046/j.1525-1497.1998.00164.x; GUARISCO S, 1994, J GEN INTERN MED, V9, P272, DOI 10.1007/BF02599655; HEDEKER D, 2006, LONGITUDINAL DATA AN; Horwitz LI, 2007, ANN INTERN MED, V147, P97, DOI 10.7326/0003-4819-147-2-200707170-00163; *I MED, OPT GRAD MED TRAIN R; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Littell R.C., 2006, SAS SYSTEM MIXED MOD; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; LURIE N, 1989, NEW ENGL J MED, V320, P1673, DOI 10.1056/NEJM198906223202507; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Myers JS, 2006, ACAD MED, V81, P1052, DOI 10.1097/01.ACM.0000246687.03462.59; Okie S, 2007, NEW ENGL J MED, V356, P2665, DOI 10.1056/NEJMp078085; Ong M, 2007, ARCH INTERN MED, V167, P47, DOI 10.1001/archinte.167.1.47; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Reed DA, 2007, ARCH INTERN MED, V167, P1487, DOI 10.1001/archinte.167.14.1487; Reid K, 1999, SLEEP, V22, P378, DOI 10.1093/sleep/22.3.378; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Schafer J. L., 1997, ANAL INCOMPLETE MULT, DOI [10.1201/9781439821862, DOI 10.1201/]; Schuberth JL, 2008, CIRCULATION, V117, P2637, DOI 10.1161/CIRCULATIONAHA.107.740357; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Volpp KG, 2008, CIRCULATION, V117, P2580, DOI 10.1161/CIRCULATIONAHA.108.777508; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Wayne DB, 2008, J GEN INTERN MED, V23, P1120, DOI 10.1007/s11606-008-0671-4; Wilde G J, 1998, Inj Prev, V4, P89	37	84	85	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1146	1153		10.1001/jama.300.10.1146	http://dx.doi.org/10.1001/jama.300.10.1146			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780843	Bronze			2022-12-01	WOS:000259038700007
J	Bernstein, AS; Ludwig, DS				Bernstein, Aaron S.; Ludwig, David S.			The Importance of Biodiversity to Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NATURAL-PRODUCTS; DISEASE; EMERGENCE; RISK		[Bernstein, Aaron S.; Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Bernstein, Aaron S.] Harvard Univ, Sch Med, Ctr Hlth & Global Environm, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bernstein, AS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	aaron.bernstein@childrens.harvard.edu	Bernstein, Aaron/AAF-3522-2021	Bernstein, Aaron/0000-0003-1703-1041; Ludwig, David/0000-0003-3307-8544				Becker S, 2008, APPL MICROBIOL BIOT, V79, P1, DOI 10.1007/s00253-008-1385-6; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Chivian E., 2008, SUSTAINING LIFE HUMA; Dancey JE, 2006, CANCER BIOL THER, V5, P1065, DOI 10.4161/cbt.5.9.3175; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Klotz U, 2006, INT J CLIN PHARM TH, V44, P478; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Oberlies NH, 2004, J NAT PROD, V67, P129, DOI 10.1021/np030498t; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; *PRACT GREENH, WAST RED; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102	14	10	10	4	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2297	2299		10.1001/jama.2008.655	http://dx.doi.org/10.1001/jama.2008.655			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017916				2022-12-01	WOS:000260965500030
J	Masip, J; Mebazaa, A; Filippatos, GS				Masip, Josep; Mebazaa, Alexandre; Filippatos, Gerasimos S.			Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							METAANALYSIS; PRESSURE		[Masip, Josep] Consorci Sanit Integral, Barcelona 08025, Spain; [Mebazaa, Alexandre] Univ Paris 07, F-75010 Paris, France; [Filippatos, Gerasimos S.] Univ Athens, Athens 12461, Greece	UDICE-French Research Universities; Universite Paris Cite; National & Kapodistrian University of Athens	Masip, J (corresponding author), Consorci Sanit Integral, Barcelona 08025, Spain.		Nicholl, Jon/B-8257-2008; Filippatos, Gerasimos/ABA-4656-2021					Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Nieminen MS, 2005, EUR HEART J, V26, P384; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; Plaisance P, 2007, EUR HEART J, V28, P2895, DOI 10.1093/eurheartj/ehm502; Winck JC, 2006, CRIT CARE, V10, DOI 10.1186/cc4905	5	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2068	2069						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18990784				2022-12-01	WOS:000260632700022
J	Mukhopadhyay, J; Das, K; Ismail, S; Koppstein, D; Jang, MY; Hudson, B; Sarafianos, S; Tuske, S; Patel, J; Jansen, R; Irschik, H; Arnold, E; Ebright, RH				Mukhopadhyay, Jayanta; Das, Kalyan; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Jansen, Rolf; Irschik, Herbert; Arnold, Eddy; Ebright, Richard H.			The RNA Polymerase "Switch Region" Is a Target for Inhibitors	CELL			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; MYXOPYRONIN-B ANALOGS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; GLIDING BACTERIA; BINDING; HOLOENZYME; ANTIBIOTICS; ELONGATION; INITIATION	The alpha-pyrone antibiotic myxopyronin (Myx) inhibits bacterial RNA polymerase (RNAP). Here, through a combination of genetic, biochemical, and structural approaches, we show that Myx interacts with the RNAP "switch region''-the hinge that mediates opening and closing of the RNAP active center cleft-to prevent interaction of RNAP with promoter DNA. We define the contacts between Myx and RNAP and the effects of Myx on RNAP conformation and propose that Myx functions by interfering with opening of the RNAP active-center cleft during transcription initiation. We further show that the structurally related alpha-pyrone antibiotic corallopyronin (Cor) and the structurally unrelated macrocyclic-lactone antibiotic ripostatin (Rip) function analogously to Myx. The RNAP switch region is distant from targets of previously characterized RNAP inhibitors, and, correspondingly, Myx, Cor, and Rip do not exhibit crossresistance with previously characterized RNAP inhibitors. The RNAP switch region is an attractive target for identification of	[Das, Kalyan; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Ebright, Richard H.] Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Das, Kalyan; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Arnold, Eddy; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Jansen, Rolf; Irschik, Herbert] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Rutgers State University New Brunswick; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Helmholtz Association; Helmholtz-Center for Infection Research	Arnold, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	arnold@cabm.rutgers.edu; ebright@mbcl.rutgers.edu	Jansen, Rolf/C-1570-2011; Ebright, Richard/O-3321-2019; Das, Kalyan/O-9224-2019; Das, Kalyan/B-2967-2018	Jansen, Rolf/0000-0002-3592-4807; Ebright, Richard/0000-0001-8915-7140; Das, Kalyan/0000-0002-8897-324X; Das, Kalyan/0000-0002-8897-324X; Sarafianos, Stefan G/0000-0002-5840-154X; Koppstein, David/0000-0002-8618-7237	NIH [AI072766, GM41376]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Chakraborty, N. Connell, S. Darst, Y. Korlann, C. Self, Y. Sun, G. Olson, M. Talaue, D. Wang, X. Wang, A. Wasmuth, and S. Weiss for unpublished data and G. Hofle, M. Kalesse, and E. Sineva for discussion. This work was supported by NIH grant AI072766 to R. H. E. and E. A., NIH grant GM41376 to R. H. E., and a Howard Hughes Medical Investigatorship to R. H.	AUGUSTINIAK H, 1996, LIEBIGS ANN CHEM, V10, P1657; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chopra I, 2007, CURR OPIN INVEST DR, V8, P600; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2004, TRENDS BIOCHEM SCI, V29, P159, DOI 10.1016/j.tibs.2004.02.005; Daubendiek SL, 1997, NAT BIOTECHNOL, V15, P273, DOI 10.1038/nbt0397-273; Doundoulakis T, 2004, BIOORG MED CHEM LETT, V14, P5667, DOI 10.1016/j.bmcl.2004.08.045; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; Hu T, 1998, J ORG CHEM, V63, P2401, DOI 10.1021/jo9721610; IRSCHIK H, 1995, J ANTIBIOT, V48, P787, DOI 10.7164/antibiotics.48.787; IRSCHIK H, 1983, J ANTIBIOT, V36, P1651, DOI 10.7164/antibiotics.36.1651; IRSCHIK H, 1985, J ANTIBIOT, V38, P145, DOI 10.7164/antibiotics.38.145; JANSEN R, 1985, LIEBIGS ANN CHEM, P822; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KOHL W, 1983, LIEBIGS ANN CHEM, P1656; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lira R, 2007, BIOORG MED CHEM LETT, V17, P6797, DOI 10.1016/j.bmcl.2007.10.017; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; O'Neill A, 2000, ANTIMICROB AGENTS CH, V44, P3163, DOI 10.1128/AAC.44.11.3163-3166.2000; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665; TRIPATARA A, 1993, J MOL BIOL, V233, P349, DOI 10.1006/jmbi.1993.1516; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	38	178	197	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					295	307		10.1016/j.cell.2008.09.033	http://dx.doi.org/10.1016/j.cell.2008.09.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957204	Bronze, Green Accepted			2022-12-01	WOS:000260130400019
J	Marles-Wright, J; Grant, T; Delumeau, O; van Duinen, G; Firbank, SJ; Lewis, PJ; Murray, JW; Newman, JA; Quin, MB; Race, PR; Rohou, A; Tichelaar, W; van Heel, M; Lewis, RJ				Marles-Wright, Jon; Grant, Tim; Delumeau, Olivier; van Duinen, Gijs; Firbank, Susan J.; Lewis, Peter J.; Murray, James W.; Newman, Joseph A.; Quin, Maureen B.; Race, Paul R.; Rohou, Alexis; Tichelaar, Willem; van Heel, Marin; Lewis, Richard J.			Molecular architecture of the "stressosome," a signal integration and transduction hub	SCIENCE			English	Article							TRANSCRIPTION FACTOR SIGMA(B); BACILLUS-SUBTILIS; SERINE KINASE; PATHWAY; PROTEIN; COMPLEX; PHOSPHORYLATION; ACTIVATION; REGULATORS; RSBR	A commonly used strategy by microorganisms to survive multiple stresses involves a signal transduction cascade that increases the expression of stress- responsive genes. Stress signals can be integrated by a multiprotein signaling hub that responds to various signals to effect a single outcome. We obtained a medium- resolution cryo- electron microscopy reconstruction of the 1.8- megadalton "stressosome" from Bacillus subtilis. Fitting known crystal structures of components into this reconstruction gave a pseudoatomic structure, which had a virus capsid- like core with sensory extensions. We suggest that the different sensory extensions respond to different signals, whereas the conserved domains in the core integrate the varied signals. The architecture of the stressosome provides the potential for cooperativity, suggesting that the response could be tuned dependent on the magnitude of chemophysical insult.	[Grant, Tim; van Duinen, Gijs; Rohou, Alexis; Tichelaar, Willem; van Heel, Marin] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England; [Marles-Wright, Jon; Delumeau, Olivier; Firbank, Susan J.; Murray, James W.; Newman, Joseph A.; Quin, Maureen B.; Race, Paul R.; Lewis, Richard J.] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Lewis, Peter J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Imperial College London; Newcastle University - UK; University of Newcastle	van Heel, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England.	m.vanheel@imperial.ac.uk; r.lewis@ncl.ac.uk		Marles-Wright, Jon/0000-0002-9156-3284; Rohou, Alexis/0000-0002-3343-9621; lewis, richard/0000-0003-2641-8643; Murray, James/0000-0002-8897-0161; Quin, Maureen/0000-0001-7193-639X; newman, Joseph/0000-0003-4488-0516; Grant, Tim/0000-0002-4855-8703	Biotechnology and Biological Sciences Research Council; Newcastle University; Australian Research Council; University of Newcastle (Australia); European Union NOE [LSHG-CT-2004-502828]; Dutch Ministry of Economic Affairs [BSIK 03036]; BBSRC; Glaxo Wellcome; SmithKline Beecham; BBSRC [BB/F001533/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F001533/1, BB/D000521/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University; Australian Research Council(Australian Research Council); University of Newcastle (Australia); European Union NOE(European Commission); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Glaxo Wellcome; SmithKline Beecham(GlaxoSmithKline); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council ( BBSRC), Newcastle University (UK), Australian Research Council, University of Newcastle (Australia) by grants from the European Union NOE, Contract LSHG-CT-2004-502828), and the Dutch Ministry of Economic Affairs ("Cyttron", BSIK 03036). The electron microscopes used for this work were purchased with financial support from the BBSRC, Glaxo Wellcome, and SmithKline Beecham. We are grateful to M. Schatz (Image Science, Berlin, Germany) for IMAGIC software support and to W. Haldenwang for strain BSK5. We thank R. Harris, H. Gilbert, M. Embley, and N. Robinson for advice and useful comments on the manuscript and E. Lowe for help with curve fitting. We are grateful for access to the Diamond synchrotron light source and its beamline scientists for help during data collection. Coordinates and structure factors for MtRsbS are deposited in the Protein Databank with the accession number 2VY9. Electron microscopy-derived molecular envelopes are deposited in the Electron Microscopy Database at the Macromolecular Structure Database Group with the following accession numbers:RsbR<INF>(146-274)</INF>: RsbS, 1558; RsbR: RsbS, 1555; and RsbR: RsbS: RsbT 1556.	Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; BENSON AK, 1993, J BACTERIOL, V175, P1929, DOI 10.1128/JB.175.7.1929-1935.1993; Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; Chen CC, 2004, J BACTERIOL, V186, P6830, DOI 10.1128/JB.186.20.6830-6836.2004; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Dufour A, 1996, J BACTERIOL, V178, P3701, DOI 10.1128/jb.178.13.3701-9sigma.1996; Gaidenko TA, 1999, J MOL BIOL, V288, P29, DOI 10.1006/jmbi.1999.2665; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Hardwick SW, 2007, J BIOL CHEM, V282, P11562, DOI 10.1074/jbc.M609733200; Kang CM, 1996, J BACTERIOL, V178, P3846, DOI 10.1128/jb.178.13.3846-3853.1996; Kang CM, 1998, MOL MICROBIOL, V30, P189, DOI 10.1046/j.1365-2958.1998.01052.x; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; Kuo S, 2004, MICROBIOL-SGM, V150, P4125, DOI 10.1099/mic.0.27421-0; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Woodbury RL, 2004, J BACTERIOL, V186, P2789, DOI 10.1128/JB.186.9.2789-2797.2004; Zhang SY, 2003, J BACTERIOL, V185, P5714, DOI 10.1128/JB.185.19.5714-5721.2003	30	121	123	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					92	96		10.1126/science.1159572	http://dx.doi.org/10.1126/science.1159572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832644				2022-12-01	WOS:000259680200045
J	Graves, N; McGowan, JE				Graves, Nicholas; McGowan, John E., Jr.			Nosocomial Infection, the Deficit Reduction Act, and incentives for hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; PREVENTION; ECONOMICS; SAFETY		[Graves, Nicholas] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [McGowan, John E., Jr.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Queensland University of Technology (QUT); Emory University; Rollins School Public Health	Graves, N (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave,Kelvin Grove Urban Village, Kelvin Grove, Qld 4059, Australia.	n.graves@qut.edu.au	Graves, Nicholas/A-3052-2011; mcgowan, john e/G-5404-2011	Graves, Nicholas/0000-0002-5559-3267				Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P767, DOI 10.1086/518518; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Centers for Medicare and Medicaid Services, 2008, FED REGISTER, V73, P48434; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; Davis MM, 2008, INFECT CONT HOSP EP, V29, P395, DOI 10.1086/587966; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Halton K, 2007, EMERG INFECT DIS, V13, P815, DOI 10.3201/eid1306.070048; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Malani, 2007, EXTENDING CURE POLIC; Persson U, 1999, ACTA ORTHOP SCAND, V70, P163, DOI 10.3109/17453679909011256; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; Zell BL, 2007, INFECT CONT HOSP EP, V28, P261, DOI 10.1086/513722	14	33	34	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1577	1579		10.1001/jama.300.13.1577	http://dx.doi.org/10.1001/jama.300.13.1577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827214				2022-12-01	WOS:000259617700022
J	Hochman, M; Hochman, S; Bor, D; McCormick, D				Hochman, Michael; Hochman, Steven; Bor, David; McCormick, Danny			News media coverage of medication research - Reporting pharmaceutical company funding and use of generic medication names	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	New England Regional Meeting of the Society-General-Internal-Medicine	APR   14, 2008	Worcester, MA	Soc Gen Internal Med, New England Reg			CONFLICTS-OF-INTEREST; BIOMEDICAL-RESEARCH; DRUG NAMES; TRIALS; BRAND; SUBSTITUTION; ASSOCIATION; CONCLUSIONS; DISCLOSURE; JOURNALS	Context The news media are an important source of information about medical research for patients and even some physicians. Little is known about how frequently news articles report when medication research has received funding from pharmaceutical companies or how frequently news articles use generic vs brand medication names. Objectives To assess the reporting of pharmaceutical company funding and generic medication name use in news articles about medication studies and to determine the views of newspaper editors about these issues. Design, Setting, and Participants We reviewed US news articles from newspaper and online sources about all pharmaceutical company - funded medication studies published in the 5 most prominent general medical journals between April 1, 2004, and April 30, 2008. We also surveyed editors at the 100 most widely circulated newspapers in the United States. Main Outcome Measures The percentage of news articles indicating when studies have been pharmaceutical company - funded and the percentage that refer to medications by their generic vs brand names. Also the percentage of newspaper editors who indicate that their articles report pharmaceutical company funding; the percentage of editors who indicate that their articles refer to medications by generic names; and the percentage of newspapers with policies about these issues. Results Of the 306 news articles about medication research identified, 130 ( 42%; 95% confidence interval [ CI], 37%- 48%) did not report that the research had received company funding. Of the 277 of these articles reporting on medications with both generic and brand names, 186 ( 67%; 95% CI, 61%- 73%) referred to the study medications by their brand names in at least half of the medication references. Eighty-two of the 93 ( 88%) newspaper editors who responded to our survey reported that articles from their publications always or often indicated when studies had received company funding ( 95% CI, 80%- 94%), and 71 of 92 ( 77%) responding editors also reported that articles from their publications always or often referred to medications by the generic names ( 95% CI, 67%- 85%). However, only 3 of 92 newspapers ( 3%) had written policies stating that company funding sources of medical studies be reported ( 95% CI 1%- 9%), and 2 of 93 ( 2%) newspapers had written policies stating that medications should be referred to by their generic names ( 95% CI 1%- 8%). Conclusion News articles reporting on medication studies often fail to report pharmaceutical company funding and frequently refer to medications by their brand names despite newspaper editors' contention that this is not the case.	[Hochman, Michael; Bor, David; McCormick, Danny] Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA; [Hochman, Michael; Bor, David; McCormick, Danny] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Hochman, Steven] Pomona Coll, Claremont, CA 91711 USA	Harvard University; Cambridge Health Alliance; Harvard University; Claremont Colleges; Pomona College	Hochman, M (corresponding author), Cambridge Hosp, Dept Med, 1493 Cambridge St, Cambridge, MA 02139 USA.	miehochman@challiance.org						Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; American Society of Hospital Pharmacists, 1993, AM J HOSP PHARM, V50, P305; Ancker JS, 2007, SCI ENG ETHICS, V13, P147, DOI 10.1007/s11948-007-9011-z; *ASS HLTH CAR JOUR, STAT PRINC; *AUD BUR CIRC, 2006, FAS FAX REP MAJ US N; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bromley J, 2006, MED J AUSTRALIA, V185, P687, DOI 10.5694/j.1326-5377.2006.tb00767.x; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Caulfield T, 2004, PLOS MED, V1, P178, DOI 10.1371/journal.pmed.0010038; Cooper RJ, 2006, J GEN INTERN MED, V21, P1248, DOI 10.1111/j.1525-1497.2006.00598.x; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; DeAngelis CD, 2001, JAMA-J AM MED ASSOC, V286, P89, DOI 10.1001/jama.286.1.89; Gundersen L, 1998, ANN INTERN MED, V129, P677, DOI 10.7326/0003-4819-129-8-199810150-00042; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; HENRY J, 2001, PRESCRIPTION DRUG TR; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; *I SAF MED PRACT, 2003, DRAFT GUID SAF EL CO, V8; *INT COMM MED J ED, 2007, UN REQ MAN SUBM BIOM; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; *LEAD DIR INC, 2007, NEWS MED YELL BOOK; Li M, 2008, HEALTH EDUC RES, V23, P543, DOI 10.1093/her/cym028; LIEBERMAN T, 2005, COLUMBIA JOURNAL JUL; Mott DA, 2002, MED CARE, V40, P662, DOI 10.1097/00005650-200208000-00006; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; *NAT I HLTH CAR MA, 2002, PRIM GEN DRUGS PAT P; PARKER WA, 1983, AM J HOSP PHARM, V40, P38, DOI 10.1093/ajhp/40.1.38; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Schwab M, 2002, ARCH INTERN MED, V162, P1065, DOI 10.1001/archinte.162.9.1065; Schwartz RS, 2008, NEW ENGL J MED, V358, P1850, DOI 10.1056/NEJMe0802618; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Sharma V, 2003, ARCH PEDIAT ADOL MED, V157, P257, DOI 10.1001/archpedi.157.3.257; Steinman MA, 2007, J GEN INTERN MED, V22, P645, DOI 10.1007/s11606-006-0074-3; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; 2006, NATL J CITATION REPO	34	36	36	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1544	1550		10.1001/jama.300.13.1544	http://dx.doi.org/10.1001/jama.300.13.1544			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827211	Bronze			2022-12-01	WOS:000259617700018
J	Wu, KM; Lu, YH; Feng, HQ; Jiang, YY; Zhao, JZ				Wu, Kong-Ming; Lu, Yan-Hui; Feng, Hong-Qiang; Jiang, Yu-Ying; Zhao, Jian-Zhou			Suppression of cotton bollworm in multiple crops in china in areas with Bt toxin-containing cotton	SCIENCE			English	Article							PEST-MANAGEMENT; SEASONAL ABUNDANCE; TRANSGENIC COTTON; PINK-BOLLWORM; RESISTANCE; HEMIPTERA; MIRIDAE; FIELD	Transgenic cotton that has been engineered to produce insecticidal toxins from Bacillus thuringiensis (Bt) and so to resist the pest cotton bollworm (Helicoverpa armigera) has been widely planted in Asia. Analysis of the population dynamics of H. armigera from 1992 to 2007 in China indicated that a marked decrease in regional outbreaks of this pest in multiple crops was associated with the planting of Bt cotton. The study area included six provinces in northern China with an annual total of 3 million hectares of cotton and 22 million hectares of other crops (corn, peanuts, soybeans, and vegetables) grown by more than 10 million resource- poor farmers. Our data suggest that Bt cotton not only controls H. armigera on transgenic cotton designed to resist this pest but also may reduce its presence on other host crops and may decrease the need for insecticide sprays in general.	[Wu, Kong-Ming; Lu, Yan-Hui; Feng, Hong-Qiang; Zhao, Jian-Zhou] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Jiang, Yu-Ying] Natl Agrotech Extens & Serv Ctr, Beijing 100026, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn		Lu, Yanhui/0000-0002-6552-0248; Zhao, Jianzhou/0000-0001-9136-2442; Feng, Hongqiang/0000-0002-1171-248X	973 Projects Grant [2007CB109204]; Ministry of Science and Technology of China; National Natural Science Foundation of China [30625028]	973 Projects Grant(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by 973 Projects Grant (2007CB109204) from the Ministry of Science and Technology of China and the National Natural Science Foundation of China (30625028). We thank A. M. Shelton (Cornell University) and two anonymous referees for comments and suggestions.	Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; *EPA, PEST NEWS STOR EPA A; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Gould F, 2000, NAT BIOTECHNOL, V18, P266, DOI 10.1038/73693; HOKKANEN HMT, 1991, ANNU REV ENTOMOL, V36, P119, DOI 10.1146/annurev.en.36.010191.001003; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; JAMES C, 2007, ISAAA BRIEFS, V37; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2007, J INVERTEBR PATHOL, V95, P220, DOI 10.1016/j.jip.2007.03.012	18	534	718	17	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1676	1678		10.1126/science.1160550	http://dx.doi.org/10.1126/science.1160550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801998				2022-12-01	WOS:000259300400035
J	Brusatte, SL; Benton, MJ; Ruta, M; Lloyd, GT				Brusatte, Stephen L.; Benton, Michael J.; Ruta, Marcello; Lloyd, Graeme T.			Superiority, competition, and opportunism in the evolutionary radiation of dinosaurs	SCIENCE			English	Article							TRIASSIC-JURASSIC BOUNDARY; DISPARITY; DIVERSIFICATION; PATTERNS	The rise and diversification of the dinosaurs in the Late Triassic, from 230 to 200 million years ago, is a classic example of an evolutionary radiation with supposed competitive replacement. A comparison of evolutionary rates and morphological disparity of basal dinosaurs and their chief "competitors," the crurotarsan archosaurs, shows that dinosaurs exhibited lower disparity and an indistinguishable rate of character evolution. The radiation of Triassic archosaurs as a whole is characterized by declining evolutionary rates and increasing disparity, suggesting a decoupling of character evolution from body plan variety. The results strongly suggest that historical contingency, rather than prolonged competition or general " superiority," was the primary factor in the rise of dinosaurs.	[Brusatte, Stephen L.; Benton, Michael J.; Ruta, Marcello; Lloyd, Graeme T.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Brusatte, SL (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	brusatte@uchicago.edu	Lloyd, Graeme/F-6677-2010; Benton, Michael J/A-5639-2008; Lloyd, Graeme/E-1798-2011; Brusatte, Stephen/O-9663-2014	Benton, Michael J/0000-0002-4323-1824; Brusatte, Stephen/0000-0001-7525-7319; Ruta, Marcello/0000-0002-6151-0704	Marshall Scholarship and Paleontological Society; UK Natural Environment Research Council; Royal Society; NERC [NE/C518973/1] Funding Source: UKRI; Natural Environment Research Council [NE/C518973/1] Funding Source: researchfish	Marshall Scholarship and Paleontological Society; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank R. Benson, M. Coates, P. Donoghue, M. Foote, M. LaBarbera, and S. Wang for discussion. Supported by the Marshall Scholarship and Paleontological Society (S.L.B.), the UK Natural Environment Research Council (M.J.B., M.R., G.T.L.), and the Royal Society (M.J.B., M.R.).	BAKKER RT, 1971, EVOLUTION, V25, P636, DOI 10.1111/j.1558-5646.1971.tb01922.x; BENTON MJ, 1983, Q REV BIOL, V58, P29, DOI 10.1086/413056; BENTON MJ, 1987, BIOL REV, V62, P305, DOI 10.1111/j.1469-185X.1987.tb00666.x; CHARIG AJ, 1984, S ZOOL SOC LONDON, V52, P597; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; FOOTE M, 1996, EVOLUTIONARY PALEOBI; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; VALENTINE JW, 1980, PALEOBIOLOGY, V6, P444, DOI 10.1017/S0094837300003614; Wagner PJ, 1997, PALEOBIOLOGY, V23, P115, DOI 10.1017/S0094837300016675; Weishampel DB., 2004, DINOSAURIA; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X	21	315	321	4	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1485	1488		10.1126/science.1161833	http://dx.doi.org/10.1126/science.1161833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787166	Green Accepted			2022-12-01	WOS:000259121800039
J	Lette, F; Dwyer, JP				Lette, Francois; Dwyer, Jamie P.			The fluid craze	LANCET			English	Editorial Material							HYPONATREMIA		[Lette, Francois; Dwyer, Jamie P.] Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Jacksonville, FL 32224 USA	Mayo Clinic	Lette, F (corresponding author), Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Jacksonville, FL 32224 USA.	lette.francois@mayo.edu	Dwyer, Jamie/A-4799-2015	Dwyer, Jamie/0000-0002-8402-8961				Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Bleser S, 2005, J FAM PRACTICE, V54, P691; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Chung BD, 1999, J CLIN GASTROENTEROL, V28, P29, DOI 10.1097/00004836-199901000-00006; COLERIDGESMITH PD, 1990, BRIT J SURG, V77, P1055, DOI 10.1002/bjs.1800770933; COMEROTA AJ, 1989, SURGERY, V106, P301; Decaux G, 2006, AM J MED, V119, pS79, DOI 10.1016/j.amjmed.2006.05.013; *I MED, 2005, DIET REF INT DRI WAT; JANVRIN SB, 1980, BRIT J SURG, V67, P690, DOI 10.1002/bjs.1800671004; Kurlansky M, 2003, SALT WORLD HIST; LANDGRAF H, 1994, AVIAT SPACE ENVIR MD, V65, P930; Lindeman RD, 2000, J GERONTOL A-BIOL, V55, pM361, DOI 10.1093/gerona/55.7.M361; Longe AC, 1997, E AFR MED J, V74, P487; Negoianu D, 2008, J AM SOC NEPHROL, V19, P1041, DOI 10.1681/ASN.2008030274; Noakes TD, 2006, BRIT J SPORT MED, V40, P567, DOI 10.1136/bjsm.2005.020354; Noakes TD, 2007, SPORTS MED, V37, P463, DOI 10.2165/00007256-200737040-00050; Sterns RH, 2006, AM J MED, V119, pS12, DOI 10.1016/j.amjmed.2006.05.003	17	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					782	784		10.1016/S0140-6736(08)61316-1	http://dx.doi.org/10.1016/S0140-6736(08)61316-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774404				2022-12-01	WOS:000259124900006
J	Macchiarini, P; Jungebluth, P; Go, T; Asnaghi, MA; Rees, LE; Cogan, TA; Dodson, A; Martorell, J; Bellini, S; Parnigotto, PP; Dickinson, SC; Hollander, AP; Mantero, S; Conconi, MT; Birchall, MA				Macchiarini, Paolo; Jungebluth, Philipp; Go, Tetsuhiko; Asnaghi, M. Adelaide; Rees, Louisa E.; Cogan, Tristan A.; Dodson, Amanda; Martorell, Jaume; Bellini, Silvia; Parnigotto, Pier Paolo; Dickinson, Sally C.; Hollander, Anthony P.; Mantero, Sara; Conconi, Maria Teresa; Birchall, Martin A.			Clinical transplantation of a tissue-engineered airway	LANCET			English	Article							ACELLULAR MATRIX; IN-VITRO; PROSPECTIVE TRIAL; EPITHELIAL-CELLS; HLA ANTIBODIES; CHONDROCYTES; REPLACEMENT; IMPLANTS; ADHESION; IMPROVES	Background The loss of a normal airway is devastating. Attempts to replace large airways have met with serious problems. Prerequisites for a tissue-engineered replacement are a suitable matrix, cells, ideal-mechanical properties, and the absence of antigenicity. We aimed to bicengineer tubular tracheal matrices, using a tissue-engineering protocol, and to assess the application of this technology in a patient with-end-stage airway disease. Methods We removed cells and MHC antigens from a human donor trachea, which was then readily colonised by epithelia] cells and mesenchymal stem-cell.derived chondrocytes that had been cultured from cells taken from the recipient (a 30-year old woman with end-stage bronchomalacia). This graft was then used to replace the recipient's left main bronchus. Findings The graft immediately provided the recipient with a functional airway, improved her quality of life, and had a normal appearance and mechanical properties at 4 months. The patient had no anti-donor antibodies and was not on immunosuppressive drugs. Interpretation The results show that we can produce a cellular, tissue-engineered airway with mechanical properties that allow normal functioning, and which is free from the risks of rejection. The findings suggest that autologous cells combined with appropriate biomaterials might provide successful treatment for patients with serious clinical disorders. Funding Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Spain; Charles Courtenay-Cowlin Fund, University of Bristol; UK Arthritis Research Campaign; and the James Tudor Foundation.	[Macchiarini, Paolo; Jungebluth, Philipp; Go, Tetsuhiko; Martorell, Jaume] Univ Barcelona, Hosp Clin Barcelona, Dept Gen Thorac Surg, E-08036 Barcelona, Spain; [Macchiarini, Paolo] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fdn Clin, Barcelona, Spain; [Macchiarini, Paolo] Univ Barcelona, CIBER Enfermedades Resp, Barcelona, Spain; [Asnaghi, M. Adelaide; Mantero, Sara] Politecn Milan, I-20133 Milan, Italy; [Bellini, Silvia; Parnigotto, Pier Paolo; Conconi, Maria Teresa] Univ Padua, Padua, Italy; [Cogan, Tristan A.; Dickinson, Sally C.; Hollander, Anthony P.] Univ Bristol, Dept Cellular & Mol Med, Bristol, Avon, England; [Rees, Louisa E.; Dodson, Amanda; Birchall, Martin A.] Univ Bristol, Fac Clin Med & Dent, Bristol, Avon, England	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Polytechnic University of Milan; University of Padua; University of Bristol; University of Bristol	Macchiarini, P (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Dept Gen Thorac Surg, C Villarroel 170, E-08036 Barcelona, Spain.	pmacchiarini@ub.edu	Mantero, Sara/F-6587-2013; Macchiarini, Paolo/E-6878-2013	Asnaghi, Maria Adelaide/0000-0002-4261-3767; MANTERO, SARA/0000-0002-1264-0465	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (PI050987), Spain; Charles Courtenay-Cowlin Fund; University of Bristol, UK; UK Arthritis Research Campaign; James Tudor Foundation	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria (PI050987), Spain(Instituto de Salud Carlos III); Charles Courtenay-Cowlin Fund; University of Bristol, UK; UK Arthritis Research Campaign(Versus Arthritis); James Tudor Foundation	This work was supported by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (PI050987), Spain, and the Charles Courtenay-Cowlin Fund, University of Bristol, UK. APH is funded in part by an endowed chair from the UK Arthritis Research Campaign. SCD is funded by a Research Fellowship from the James Tudor Foundation. We thank Laura Morte for her excellent organisation and trouble-shooting; Victor Peinado, and others in his team, for their superb assistance, to whom we are indebted; John Armitage of the Human Tissue Working Group and the Research Enterprise Development team, including Christine Nileshwar, Sean Jauss, Ginny Hope, and Birgit Whitman at the University of Bristol for providing exceptional support and advice on this project; and all the medical and nurse staff at the Institute Clinic of Thorax and Transplant Foundation Services of the Hospital Clinic of Barcelona, without whom accomplishment of this success would have been impossible. None of the authors have any financial interest in the present work.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Birchall M, 2008, TRANSPLANTATION, V85, P1075, DOI 10.1097/TP.0b013e31816a10e4; Burra P, 2004, INT J MOL MED, V14, P511; Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155; Conconi MT, 2009, J BIOMED MATER RES A, V89A, P304, DOI 10.1002/jbm.a.31982; Conconi MT, 2005, TRANSPLANT INT, V18, P727, DOI 10.1111/j.1432-2277.2005.00082.x; Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035; Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6; JUNGEBLUTH P, J THORAC CA IN PRESS; Kafienah W, 2007, STEM CELLS, V25, P2460, DOI 10.1634/stemcells.2007-0059; Macchiarini P, 2004, J THORAC CARDIOV SUR, V128, P638, DOI 10.1016/j.jtcvs.2004.02.042; Macchiarini P, 2004, J THORAC CARDIOV SUR, V128, P14, DOI 10.1016/j.jtcvs.2003.11.069; Macchiarini P, 2006, ANN THORAC SURG, V82, P1989, DOI 10.1016/j.athoracsur.2006.07.016; Marzaro M, 2002, INT J MOL MED, V10, P177; Marzaro M, 2006, J BIOMED MATER RES A, V77A, P795, DOI 10.1002/jbm.a.30666; Parnigotto PP, 2000, J PEDIATR SURG, V35, P1304, DOI 10.1053/jpsu.2000.9309; Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020; Rees LE, 2003, CLIN EXP IMMUNOL, V134, P497, DOI 10.1111/j.1365-2249.2003.02301.x; Rees LEN, 2006, MOL IMMUNOL, V43, P725, DOI 10.1016/j.molimm.2005.03.017; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Sato T, 2008, ANN THORAC SURG, V86, P422, DOI 10.1016/j.athoracsur.2008.04.015; Shaari CM, 1998, HEAD NECK-J SCI SPEC, V20, P522, DOI 10.1002/(SICI)1097-0347(199809)20:6<522::AID-HED6>3.0.CO;2-O; Terasaki PI, 2005, TRANSPLANTATION, V80, P1194, DOI 10.1097/01.tp.0000174338.97313.5a; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Zani BG, 2008, P NATL ACAD SCI USA, V105, P7046, DOI 10.1073/pnas.0802463105	27	1059	1157	5	241	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2023	2030		10.1016/S0140-6736(08)61598-6	http://dx.doi.org/10.1016/S0140-6736(08)61598-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19022496				2022-12-01	WOS:000261746900023
J	Zender, L; Xue, W; Zuber, J; Semighini, CP; Krasnitz, A; Ma, B; Zender, P; Kubicka, S; Luk, JM; Schirmacher, P; McCombie, WR; Wigler, M; Hicks, J; Hannon, GJ; Powers, S; Lowe, SW				Zender, Lars; Xue, Wen; Zuber, Johannes; Semighini, Camile P.; Krasnitz, Alexander; Ma, Beicong; Zender, Peggy; Kubicka, Stefan; Luk, John M.; Schirmacher, Peter; McCombie, W. Richard; Wigler, Michael; Hicks, James; Hannon, Gregory J.; Powers, Scott; Lowe, Scott W.			An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer	CELL			English	Article							HEPATOCELLULAR-CARCINOMA; NUCLEAR EXPORT; OVARIAN-CANCER; BREAST-CANCER; GENOME; MECHANISM; PATHWAY; CELLS; EXPRESSION; INHIBITORS	Cancers are highly heterogeneous and contain many passenger and driver mutations. To functionally identify tumor suppressor genes relevant to human cancer, we compiled pools of short hairpin RNAs (shRNAs) targeting the mouse orthologs of genes recurrently deleted in a series of human hepatocellular carcinomas and tested their ability to promote tumorigenesis in a mosaic mouse model. In contrast to randomly selected shRNA pools, many deletion-specific pools accelerated hepatocarcinogenesis in mice. Through further analysis, we identified and validated 13 tumor suppressor genes, 12 of which had not been linked to cancer before. One gene, XPO4, encodes a nuclear export protein whose substrate, EIF5A2, is amplified in human tumors, is required for proliferation of XPO4-deficient tumor cells, and promotes hepatocellular carcinoma in mice. Our results establish the feasibility of in vivo RNAi screens and illustrate how combining cancer genomics, RNA interference, and mosaic mouse models can facilitate the functional annotation of the cancer genome.	[Zender, Lars; Xue, Wen; Zuber, Johannes; Semighini, Camile P.; Krasnitz, Alexander; Ma, Beicong; Zender, Peggy; McCombie, W. Richard; Wigler, Michael; Hicks, James; Hannon, Gregory J.; Powers, Scott; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hannon, Gregory J.; Lowe, Scott W.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Kubicka, Stefan] Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30625 Hannover, Germany; [Luk, John M.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Hannover Medical School; University of Hong Kong; Ruprecht Karls University Heidelberg	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Luk, John/A-4085-2008; Zuber, Johannes/E-7517-2011	Luk, John/0000-0002-6323-7940; Zuber, Johannes/0000-0001-8810-6835; Wigler, Michael/0000-0003-4396-1971; Powers, Scott/0000-0003-2769-1932; McCombie, W. Richard/0000-0003-1899-0682	Don Monti Memorial Research Foundations; Rebirth Excellence Cluster; Leukemia and Lymphoma Society; National Institutes of Health [CA13106, CA87497, CA105388]; NATIONAL CANCER INSTITUTE [U01CA105388, P01CA013106, P01CA087497, P30CA008748] Funding Source: NIH RePORTER	Don Monti Memorial Research Foundations; Rebirth Excellence Cluster; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ken Nguyen, Stephanie Muller, Kristin Diggins-Lehet, and Lisa Bianco and her team for excellent technical assistance and Ravi Sachidanandam for assistance with computational analyses. We acknowledge members of the Lowe lab for constructive criticism and discussions throughout the course of this work. This work was supported by gifts from the Alan and Edith Seligson and the Don Monti Memorial Research Foundations, grants from the German Research foundation (Emmy Noether Program), the Rebirth Excellence Cluster, the Leukemia and Lymphoma Society (C. P. S.), and grants CA13106, CA87497, and CA105388 from the National Institutes of Health. W. X. is in the Molecular and Cellular Biology graduate program at Stony Brook University. G. J. H. and S. W. L. are Howard Hughes Medical Institute investigators.	BENNE R, 1978, J BIOL CHEM, V253, P3078; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Clement PMJ, 2006, FEBS J, V273, P1102, DOI 10.1111/j.1742-4658.2006.05135.x; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; Guan XY, 2001, CANCER RES, V61, P3806; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Lee JS, 2006, ONCOGENE, V25, P3801, DOI 10.1038/sj.onc.1209561; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; PARK MH, 1994, J BIOL CHEM, V269, P27827; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Velculescu VE, 2008, CARCINOGENESIS, V29, P1087, DOI 10.1093/carcin/bgn096; VONLINDERN M, 1992, BAILLIERE CLIN HAEM, V5, P857, DOI 10.1016/S0950-3536(11)80049-1; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	41	356	364	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					852	864		10.1016/j.cell.2008.09.061	http://dx.doi.org/10.1016/j.cell.2008.09.061			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19012953	Green Accepted, Bronze			2022-12-01	WOS:000261183900017
J	Ro, KEI; Gude, T; Tyssen, R; Aasland, OG				Ro, Karin E. Isaksson; Gude, Tore; Tyssen, Reidar; Aasland, Olaf G.			Counselling for burnout in Norwegian doctors: one year cohort study	BRITISH MEDICAL JOURNAL			English	Article							MENTAL-HEALTH PROBLEMS; JUNIOR HOUSE OFFICERS; JOB STRESS; EMOTIONAL DISTRESS; NATIONWIDE SAMPLE; YOUNG PHYSICIANS; MEDICAL-STUDENTS; SUICIDE RATES; PATIENT-CARE; RESIDENTS	Objective To investigate levels and predictors of change in dimensions of burnout after an intervention for stressed doctors. Design Cohort study followed by self reported assessment at one year. Setting Norwegian resource centre. Participants 227 doctors participating in counselling intervention, 2003- 5. Interventions Counselling ( lasting one day ( individual) or one week ( group based)) aimed at motivating reflection on and acknowledgement of the doctors' situation and personal needs. Main outcome measures Levels of burnout ( Maslach burnout inventory) and predictors of reduction in emotional exhaustion investigated by linear regression. Results 185 doctors ( 81%, 88 men, 97 women) completed one year follow- up. The mean level of emotional exhaustion ( scale 1- 5) was significantly reduced from 3.00 ( SD 0.94) to 2.53 ( SD 0.76) ( t= 6.76, P< 0.001), similar to the level found in a representative sample of 390 Norwegian doctors. Participants had reduced their working hours by 1.6 hours/ week ( SD 11.4). There was a considerable reduction in the proportion of doctors on full time sick leave, from 35% ( 63/ 182) at baseline to 6% ( 10/ 182) at follow- up and a parallel increase in the proportion who had undergone psychotherapy, from 20% ( 36/ 182) to 53% ( 97/ 182). In the whole cohort, reduction in emotional exhaustion was independently associated with reduced number of work hours/ week ( beta= 0.17, P= 0.03), adjusted for sex, age, and personality dimensions. Among men "satisfaction with the intervention" ( beta= 0.25, P= 0.04) independently predicted reduction in emotional exhaustion. Conclusions A short term counselling intervention could contribute to reduction in emotional exhaustion in doctors. This was associated with reduced working hours for the whole cohort and, in men, was predicted by satisfaction with the intervention.	[Ro, Karin E. Isaksson; Gude, Tore] Res Inst, NO-3370 Vikersund, Norway; [Ro, Karin E. Isaksson; Gude, Tore; Tyssen, Reidar] Univ Oslo, Dept Behav Sci Med, Inst Basic Med Sci, Fac Med, NO-0317 Oslo, Norway; [Aasland, Olaf G.] Norwegian Med Assoc, Res Inst, NO-0107 Oslo, Norway; [Aasland, Olaf G.] Univ Oslo, Inst Hlth Management & Hlth Econ, Oslo, Norway	University of Oslo; University of Oslo	Ro, KEI (corresponding author), Res Inst, NO-3370 Vikersund, Norway.	karin.roe@modum-bad.no						Aasland O G, 1994, Tidsskr Nor Laegeforen, V114, P3052; Barnett R C, 1999, J Occup Health Psychol, V4, P307, DOI 10.1037/1076-8998.4.4.307; Barnett R. C., 1999, J APPL BIOBEHAVIORAL, V4, P65, DOI DOI 10.1111/JABR.1999.4.ISSUE-2; Barrack RL, 2006, CLIN ORTHOP RELAT R, P134, DOI 10.1097/01.blo.0000224030.78108.58; Cohen D, 2005, MED EDUC, V39, P476, DOI 10.1111/j.1365-2929.2005.02122.x; COOPER CL, 1989, BRIT MED J, V298, P366, DOI 10.1136/bmj.298.6670.366; DEPUE RA, 1986, PSYCHOL BULL, V99, P36, DOI 10.1037/0033-2909.99.1.36; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; ELLIS JJ, 1988, AM J PSYCHOTHER, V42, P380, DOI 10.1176/appi.psychotherapy.1988.42.3.380; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Falkum E, 2000, Tidsskr Nor Laegeforen, V120, P1122; FALKUM E, 2001, EVALUERING VIRKSOMHE; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; FIRTHCOZENS J, 1997, DEPRESSION PHYSICAL, P95; FRANCIS LJ, 1992, PERS INDIV DIFFER, V13, P443, DOI 10.1016/0191-8869(92)90073-X; Garelick AI, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-26; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; HALL JA, 1988, SOC SCI MED, V27, P935, DOI 10.1016/0277-9536(88)90284-5; Hargreave Marie, 2007, Ugeskr Laeger, V169, P2418; Hem E, 2005, PSYCHOL MED, V35, P873, DOI 10.1017/S0033291704003344; Hem E, 2000, EUR PSYCHIAT, V15, P183, DOI 10.1016/S0924-9338(00)00227-3; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; Holt J, 2006, HEALTH EDUC RES, V21, P501, DOI 10.1093/her/cyh076; HSU K, 1987, AM J PSYCHIAT, V144, P1561; KING MB, 1992, J ROY SOC MED, V85, P605; Kivimaki M, 2001, OCCUP ENVIRON MED, V58, P361, DOI 10.1136/oem.58.6.361; Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; MCCRANIE EW, 1988, BEHAV MED, V14, P30, DOI 10.1080/08964289.1988.9935120; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; Pitt E, 2004, ACAD MED, V79, P840, DOI 10.1097/00001888-200409000-00005; Ro KEI, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-36; Rosvold EO, 2002, SCAND J PUBLIC HEALT, V30, P125, DOI 10.1080/14034940210133744; Rovik JO, 2007, IND HEALTH, V45, P662, DOI 10.2486/indhealth.45.662; Schattner P, 2004, MED J AUSTRALIA, V181, P348, DOI 10.5694/j.1326-5377.2004.tb06321.x; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Silvester S, 1994, PROVISION MED SERVIC; SIVERTZ K, 1998, B C MED J, V40, P156; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; TAMBS K, 1993, ACTA PSYCHIAT SCAND, V87, P364, DOI 10.1111/j.1600-0447.1993.tb03388.x; Taub S, 2006, OCCUP MED-OXFORD, V56, P77, DOI 10.1093/occmed/kqj025; Tyssen R, 2004, SOC PSYCH PSYCH EPID, V39, P989, DOI 10.1007/s00127-004-0831-8; Tyssen R, 2000, MED EDUC, V34, P374, DOI 10.1046/j.1365-2923.2000.00540.x; Tyssen R, 1998, ADDICTION, V93, P1341, DOI 10.1046/j.1360-0443.1998.93913415.x; Tyssen R, 2007, IND HEALTH, V45, P599, DOI 10.2486/indhealth.45.599; Tyssen R, 2007, MED EDUC, V41, P781, DOI 10.1111/j.1365-2923.2007.02802.x; Vaglum P, 1999, J AFFECT DISORDERS, V52, P153, DOI 10.1016/S0165-0327(98)00081-0; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071	52	68	67	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2008	337								a2004	10.1136/bmj.a2004	http://dx.doi.org/10.1136/bmj.a2004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	385AA	19001492	Green Published, hybrid			2022-12-01	WOS:000261784100001
J	Mitchell, R; Popham, F				Mitchell, Richard; Popham, Frank			Effect of exposure to natural environment on health inequalities: an observational population study	LANCET			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC INEQUALITIES; AIR-POLLUTION; GREEN SPACE; MORTALITY; DETERMINANTS; RESTORATION; URBANITY; WALKING; STRESS	Background Studies have shown that exposure to the natural environment, or so-called green space, has an independent effect on health and health-related behaviours. We postulated that income-related inequality in health would be less pronounced in populations with greater exposure to green space, since access to such areas can modify pathways through which low socioeconomic position can lead to disease. Methods We classified the population of England at younger than retirement age (n=40 813 236) into groups on the basis of income deprivation and exposure to green space. We obtained individual mortality records (n=366348) to establish whether the association between income deprivation, all-cause mortality, and cause-specific mortality (circulatory disease, lung cancer, and intentional self-harm) in 2001-05, varied by exposure to green space measured in 2001, with control for potential confounding factors. We used stratified models to identify the nature of this variation. Findings The association between income deprivation and mortality differed significantly across the groups of exposure to green space for mortality from all causes (p<0.0001) and circulatory disease (p=0.0212), but not from lung cancer or intentional self-harm. Health inequalities related to income deprivation in all-cause mortality and mortality from circulatory diseases were lower in populations living in the greenest areas. The incidence rate ratio (IRR) for all-cause mortality for the most income deprived quartile compared with the least deprived was 1.93 (95% CI 1.86-2.01) in the least green areas, whereas it was 1.43 (1.34-1.53) in the most green. For circulatory diseases, the IRR was 2.19 (2.04-2.34) in the least green areas and 1.54 (1.38-1.73) in the most green. There was no effect for causes of death unlikely to be affected by green space, such as lung cancer and intentional self-harm. Interpretation Populations that are exposed to the greenest environments also have lowest levels of health inequality related to income deprivation. Physical environments that promote good health might be important to reduce socioeconomic health inequalities.	[Mitchell, Richard] Univ Glasgow, Glasgow G12 8RZ, Lanark, Scotland; [Popham, Frank] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland	University of Glasgow; University of St Andrews	Mitchell, R (corresponding author), Univ Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.	r.mitchell@clinmed.gla.ac.uk	Popham, Frank/E-7770-2012; Mitchell, Rich JL/E-8056-2011	Popham, Frank/0000-0002-7263-7954				[Anonymous], 2005, GEN LAND US DAT STAT; Bibby P., 2004, DEV NEW CLASSIFICATI; Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; Giles-Corti B, 2005, AM J PREV MED, V28, P169, DOI 10.1016/j.amepre.2004.10.018; Grahn Patrik, 2003, Urban Forestry & Urban Greening, V2, P001, DOI 10.1078/1618-8667-00019; Groenewegen PP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-149; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; *HLTH COUNC NETH D, 2004, NAT ENV NAT HLTH INF; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Jerrett M, 2004, J EPIDEMIOL COMMUN H, V58, P31, DOI 10.1136/jech.58.1.31; Kaczynski AT, 2007, LEISURE SCI, V29, P315, DOI 10.1080/01490400701394865; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; Krewski D, 2007, J TOXICOL ENV HEAL A, V70, P275, DOI 10.1080/15287390600884859; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Macintyre S, 2007, 17 MRC SOC PUBL HLTH; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; Mitchell R, 2002, INT J EPIDEMIOL, V31, P831, DOI 10.1093/ije/31.4.831; Mitchell R, 2007, J EPIDEMIOL COMMUN H, V61, P681, DOI 10.1136/jech.2006.053553; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Popham F, 2007, PREV MED, V45, P182, DOI 10.1016/j.ypmed.2007.06.012; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Prevention CfDCa, 2008, HLTH PLAC TERM; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Smith GD, 2005, CIRCULATION, V112, P332, DOI 10.1161/CIRCULATIONAHA.104.489088; Smith GD, 2000, BRIT MED J, V320, P582, DOI 10.1136/bmj.320.7234.582; Smith GD, 2002, J EPIDEMIOL COMMUN H, V56, P434; Smith GD, 2000, PUBLIC HEALTH, V114, P308, DOI 10.1016/S0033-3506(00)00353-X; Tardon A, 2005, CANCER CAUSE CONTROL, V16, P389, DOI 10.1007/s10552-004-5026-9; *UCLA AC TECHN SER, 2008, AN CORR CLUST DAT; Ulrich R.S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9, DOI 10.1007/978-1-4613-3539-9_4]; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WILKINSON RG, 1992, AM J PUBLIC HEALTH, V82, P1082, DOI 10.2105/AJPH.82.8.1082; Wilkinson RG., 2001, MIND GAP HIERARCHIES; Wilkinson RG, 2008, AM J PUBLIC HEALTH, V98, P699, DOI 10.2105/AJPH.2007.109637; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Woods LM, 2005, J EPIDEMIOL COMMUN H, V59, P115, DOI 10.1136/jech.2003.013003; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	46	1087	1115	31	441	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1655	1660		10.1016/S0140-6736(08)61689-X	http://dx.doi.org/10.1016/S0140-6736(08)61689-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994663	Green Accepted			2022-12-01	WOS:000260899900027
J	Yen, HCS; Elledge, SJ				Yen, Hsueh-Chi Sherry; Elledge, Stephen J.			Identification of SCF Ubiquitin Ligase Substrates by Global Protein Stability Profiling	SCIENCE			English	Article							F-BOX PROTEINS; HISTONE MESSENGER-RNA; KAPPA-B-ALPHA; BETA-CATENIN; CYCLIN-E; S-PHASE; DEGRADATION; PATHWAY; COMPLEX; REVEALS	Ubiquitin- mediated proteolysis regulates all aspects of cellular function, and defects in this process are associated with human diseases. The limited number of identified ubiquitin ligase- substrate pairs is a major bottleneck in the ubiquitin field. We established and applied genetic technologies that combine global protein stability ( GPS) profiling and genetic perturbation of E3 activity to screen for substrates of the Skp1- cullin- F- box ( SCF) ubiquitin ligase in mammalian cells. Among the > 350 potential substrates identified, we found most known SCF targets and many previously unknown substrates involved in cell cycle, apoptosis, and signaling pathways. Exploring cell cycle- stage stability, we found that several substrates used the SCF and other E3s in different cell cycle stages. Our results demonstrate the potential of these technologies as general platforms for the global discovery of E3- substrate regulatory networks.	[Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	Jane Coffin Childs Memorial Fund; NIH [AG 11085]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Vidal, J. W. Harper. J. Jin, and G. Hu for the hORFeome v1.1 library; J. W. Harper for the DNCul1/pcDNA3 construct; D. M. Chou for experimental assistance and discussion; Q. Xu for bioinformatics analysis; M. Schlabach for microarray assistance; J. Daly and S. Lazo-Kallanian for their help with cytometry; and K. Hurov for suggestions. H.-C.S.Y. is a fellow of Jane Coffin Childs Memorial Fund. This work was funded by an NIH grant AG 11085 to J.W. Harper and S.J.E. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kitajima S, 2004, AM J PATHOL, V165, P2147, DOI 10.1016/S0002-9440(10)63264-6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2003, CANCER TREAT REV, V29, P49, DOI 10.1016/S0305-7372(03)00083-5; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Pfleger CM, 2000, GENE DEV, V14, P655; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; Schwartz AL, 1999, ANNU REV MED, V50, P57; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tago K, 2000, GENE DEV, V14, P1741; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	37	148	149	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					923	929		10.1126/science.1160462	http://dx.doi.org/10.1126/science.1160462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988848				2022-12-01	WOS:000260674100041
J	Bentley, DR; Balasubramanian, S; Swerdlow, HP; Smith, GP; Milton, J; Brown, CG; Hall, KP; Evers, DJ; Barnes, CL; Bignell, HR; Boutell, JM; Bryant, J; Carter, RJ; Cheetham, RK; Cox, AJ; Ellis, DJ; Flatbush, MR; Gormley, NA; Humphray, SJ; Irving, LJ; Karbelashvili, MS; Kirk, SM; Li, H; Liu, XH; Maisinger, KS; Murray, LJ; Obradovic, B; Ost, T; Parkinson, ML; Pratt, MR; Rasolonjatovo, IMJ; Reed, MT; Rigatti, R; Rodighiero, C; Ross, MT; Sabot, A; Sankar, SV; Scally, A; Schroth, GP; Smith, ME; Smith, VP; Spiridou, A; Torrance, PE; Tzonev, SS; Vermaas, EH; Walter, K; Wu, XL; Zhang, L; Alam, MD; Anastasi, C; Aniebo, IC; Bailey, DMD; Bancarz, IR; Banerjee, S; Barbour, SG; Baybayan, PA; Benoit, VA; Benson, KF; Bevis, C; Black, PJ; Boodhun, A; Brennan, JS; Bridgham, JA; Brown, RC; Brown, AA; Buermann, DH; Bundu, AA; Burrows, JC; Carter, NP; Castillo, N; Catenazzi, MCE; Chang, S; Cooley, RN; Crake, NR; Dada, OO; Diakoumakos, KD; Dominguez-Fernandez, B; Earnshaw, DJ; Egbujor, UC; Elmore, DW; Etchin, SS; Ewan, MR; Fedurco, M; Fraser, LJ; Fajardo, KVF; Furey, WS; George, D; Gietzen, KJ; Goddard, CP; Golda, GS; Granieri, PA; Green, DE; Gustafson, DL; Hansen, NF; Harnish, K; Haudenschild, CD; Heyer, NI; Hims, MM; Ho, JT; Horgan, AM; Hoschler, K; Hurwitz, S; Ivanov, DV; Johnson, MQ; James, T; Jones, TAH; Kang, GD; Kerelska, TH; Kersey, AD; Khrebtukova, I; Kindwall, AP; Kingsbury, Z; Kokko-Gonzales, PI; Kumar, A; Laurent, MA; Lawley, CT; Lee, SE; Lee, X; Liao, AK; Loch, JA; Lok, M; Luo, SJ; Mammen, RM; Martin, JW; McCauley, PG; McNitt, P; Mehta, P; Moon, KW; Mullens, JW; Newington, T; Ning, ZM; Ng, BL; Novo, SM; O'Neill, MJ; Osborne, MA; Osnowski, A; Ostadan, O; Paraschos, LL; Pickering, L; Pike, AC; Pike, AC; Pinkard, DC; Pliskin, DP; Podhasky, J; Quijano, VJ; Raczy, C; Rae, VH; Rawlings, SR; Rodriguez, AC; Roe, PM; Rogers, J; Bacigalupo, MCR; Romanov, N; Romieu, A; Roth, RK; Rourke, NJ; Ruediger, ST; Rusman, E; Sanches-Kuiper, RM; Schenker, MR; Seoane, JM; Shaw, RJ; Shiver, MK; Short, SW; Sizto, NL; Sluis, JP; Smith, MA; Sohna, JES; Spence, EJ; Stevens, K; Sutton, N; Szajkowski, L; Tregidgo, CL; Turcatti, G; vandeVondele, S; Verhovsky, Y; Virk, SM; Wakelin, S; Walcott, GC; Wang, JW; Worsley, GJ; Yan, JY; Yau, L; Zuerlein, M; Rogers, J; Mullikin, JC; Hurles, ME; McCooke, NJ; West, JS; Oaks, FL; Lundberg, PL; Klenerman, D; Durbin, R; Smith, AJ				Bentley, David R.; Balasubramanian, Shankar; Swerdlow, Harold P.; Smith, Geoffrey P.; Milton, John; Brown, Clive G.; Hall, Kevin P.; Evers, Dirk J.; Barnes, Colin L.; Bignell, Helen R.; Boutell, Jonathan M.; Bryant, Jason; Carter, Richard J.; Cheetham, R. Keira; Cox, Anthony J.; Ellis, Darren J.; Flatbush, Michael R.; Gormley, Niall A.; Humphray, Sean J.; Irving, Leslie J.; Karbelashvili, Mirian S.; Kirk, Scott M.; Li, Heng; Liu, Xiaohai; Maisinger, Klaus S.; Murray, Lisa J.; Obradovic, Bojan; Ost, Tobias; Parkinson, Michael L.; Pratt, Mark R.; Rasolonjatovo, Isabelle M. J.; Reed, Mark T.; Rigatti, Roberto; Rodighiero, Chiara; Ross, Mark T.; Sabot, Andrea; Sankar, Subramanian V.; Scally, Aylwyn; Schroth, Gary P.; Smith, Mark E.; Smith, Vincent P.; Spiridou, Anastassia; Torrance, Peta E.; Tzonev, Svilen S.; Vermaas, Eric H.; Walter, Klaudia; Wu, Xiaolin; Zhang, Lu; Alam, Mohammed D.; Anastasi, Carole; Aniebo, Ify C.; Bailey, David M. D.; Bancarz, Iain R.; Banerjee, Saibal; Barbour, Selena G.; Baybayan, Primo A.; Benoit, Vincent A.; Benson, Kevin F.; Bevis, Claire; Black, Phillip J.; Boodhun, Asha; Brennan, Joe S.; Bridgham, John A.; Brown, Rob C.; Brown, Andrew A.; Buermann, Dale H.; Bundu, Abass A.; Burrows, James C.; Carter, Nigel P.; Castillo, Nestor; Catenazzi, Maria Chiara E.; Chang, Simon; Cooley, R. Neil; Crake, Natasha R.; Dada, Olubunmi O.; Diakoumakos, Konstantinos D.; Dominguez-Fernandez, Belen; Earnshaw, David J.; Egbujor, Ugonna C.; Elmore, David W.; Etchin, Sergey S.; Ewan, Mark R.; Fedurco, Milan; Fraser, Louise J.; Fajardo, Karin V. Fuentes; Furey, W. Scott; George, David; Gietzen, Kimberley J.; Goddard, Colin P.; Golda, George S.; Granieri, Philip A.; Green, David E.; Gustafson, David L.; Hansen, Nancy F.; Harnish, Kevin; Haudenschild, Christian D.; Heyer, Narinder I.; Hims, Matthew M.; Ho, Johnny T.; Horgan, Adrian M.; Hoschler, Katya; Hurwitz, Steve; Ivanov, Denis V.; Johnson, Maria Q.; James, Terena; Jones, T. A. Huw; Kang, Gyoung-Dong; Kerelska, Tzvetana H.; Kersey, Alan D.; Khrebtukova, Irina; Kindwall, Alex P.; Kingsbury, Zoya; Kokko-Gonzales, Paula I.; Kumar, Anil; Laurent, Marc A.; Lawley, Cynthia T.; Lee, Sarah E.; Lee, Xavier; Liao, Arnold K.; Loch, Jennifer A.; Lok, Mitch; Luo, Shujun; Mammen, Radhika M.; Martin, John W.; McCauley, Patrick G.; McNitt, Paul; Mehta, Parul; Moon, Keith W.; Mullens, Joe W.; Newington, Taksina; Ning, Zemin; Ng, Bee Ling; Novo, Sonia M.; O'Neill, Michael J.; Osborne, Mark A.; Osnowski, Andrew; Ostadan, Omead; Paraschos, Lambros L.; Pickering, Lea; Pike, Andrew C.; Pike, Alger C.; Pinkard, D. Chris; Pliskin, Daniel P.; Podhasky, Joe; Quijano, Victor J.; Raczy, Come; Rae, Vicki H.; Rawlings, Stephen R.; Rodriguez, Ana Chiva; Roe, Phyllida M.; Rogers, John; Bacigalupo, Maria C. Rogert; Romanov, Nikolai; Romieu, Anthony; Roth, Rithy K.; Rourke, Natalie J.; Ruediger, Silke T.; Rusman, Eli; Sanches-Kuiper, Raquel M.; Schenker, Martin R.; Seoane, Josefina M.; Shaw, Richard J.; Shiver, Mitch K.; Short, Steven W.; Sizto, Ning L.; Sluis, Johannes P.; Smith, Melanie A.; Sohna, Jean Ernest Sohna; Spence, Eric J.; Stevens, Kim; Sutton, Neil; Szajkowski, Lukasz; Tregidgo, Carolyn L.; Turcatti, Gerardo; vandeVondele, Stephanie; Verhovsky, Yuli; Virk, Selene M.; Wakelin, Suzanne; Walcott, Gregory C.; Wang, Jingwen; Worsley, Graham J.; Yan, Juying; Yau, Ling; Zuerlein, Mike; Rogers, Jane; Mullikin, James C.; Hurles, Matthew E.; McCooke, Nick J.; West, John S.; Oaks, Frank L.; Lundberg, Peter L.; Klenerman, David; Durbin, Richard; Smith, Anthony J.			Accurate whole human genome sequencing using reversible terminator chemistry	NATURE			English	Article							STRUCTURAL VARIATION; CHROMATIN; MAPS	DNA sequence information underpins genetic research, enabling discoveries of important biological or medical benefit. Sequencing projects have traditionally used long ( 400 - 800 base pair) reads, but the existence of reference sequences for the human and many other genomes makes it possible to develop new, fast approaches to re- sequencing, whereby shorter reads are compared to a reference to identify intraspecies genetic variation. Here we report an approach that generates several billion bases of accurate nucleotide sequence per experiment at low cost. Single molecules of DNA are attached to a flat surface, amplified in situ and used as templates for synthetic sequencing with fluorescent reversible terminator deoxyribonucleotides. Images of the surface are analysed to generate high- quality sequence. We demonstrate application of this approach to human genome sequencing on flow- sorted X chromosomes and then scale the approach to determine the genome sequence of a male Yoruba from Ibadan, Nigeria. We build an accurate consensus sequence from. 303 average depth of paired 35- base reads. We characterize four million single- nucleotide polymorphisms and four hundred thousand structural variants, many of which were previously unknown. Our approach is effective for accurate, rapid and economical whole- genome re- sequencing and many other biomedical applications.	[Bentley, David R.; Swerdlow, Harold P.; Smith, Geoffrey P.; Milton, John; Brown, Clive G.; Hall, Kevin P.; Evers, Dirk J.; Barnes, Colin L.; Bignell, Helen R.; Boutell, Jonathan M.; Bryant, Jason; Carter, Richard J.; Cheetham, R. Keira; Cox, Anthony J.; Ellis, Darren J.; Gormley, Niall A.; Humphray, Sean J.; Irving, Leslie J.; Liu, Xiaohai; Maisinger, Klaus S.; Murray, Lisa J.; Obradovic, Bojan; Ost, Tobias; Parkinson, Michael L.; Rasolonjatovo, Isabelle M. J.; Rigatti, Roberto; Rodighiero, Chiara; Ross, Mark T.; Sabot, Andrea; Smith, Mark E.; Smith, Vincent P.; Spiridou, Anastassia; Torrance, Peta E.; Wu, Xiaolin; Anastasi, Carole; Aniebo, Ify C.; Bailey, David M. D.; Bancarz, Iain R.; Barbour, Selena G.; Benoit, Vincent A.; Benson, Kevin F.; Bevis, Claire; Black, Phillip J.; Boodhun, Asha; Brennan, Joe S.; Brown, Rob C.; Brown, Andrew A.; Bundu, Abass A.; Catenazzi, Maria Chiara E.; Cooley, R. Neil; Crake, Natasha R.; Dada, Olubunmi O.; Diakoumakos, Konstantinos D.; Dominguez-Fernandez, Belen; Earnshaw, David J.; Egbujor, Ugonna C.; Fraser, Louise J.; Fajardo, Karin V. Fuentes; Goddard, Colin P.; Green, David E.; Harnish, Kevin; Heyer, Narinder I.; Hims, Matthew M.; Horgan, Adrian M.; Hoschler, Katya; James, Terena; Jones, T. A. Huw; Kang, Gyoung-Dong; Kersey, Alan D.; Kingsbury, Zoya; Kokko-Gonzales, Paula I.; Kumar, Anil; Lee, Sarah E.; Loch, Jennifer A.; Mammen, Radhika M.; McCauley, Patrick G.; Mehta, Parul; Newington, Taksina; Novo, Sonia M.; Osborne, Mark A.; Osnowski, Andrew; Pickering, Lea; Pike, Andrew C.; Raczy, Come; Rae, Vicki H.; Rawlings, Stephen R.; Rodriguez, Ana Chiva; Roe, Phyllida M.; Rogers, John; Bacigalupo, Maria C. Rogert; Romanov, Nikolai; Rourke, Natalie J.; Ruediger, Silke T.; Sanches-Kuiper, Raquel M.; Schenker, Martin R.; Shaw, Richard J.; Smith, Melanie A.; Sohna, Jean Ernest Sohna; Stevens, Kim; Sutton, Neil; Szajkowski, Lukasz; Tregidgo, Carolyn L.; vandeVondele, Stephanie; Wang, Jingwen; Worsley, Graham J.; McCooke, Nick J.; Smith, Anthony J.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Balasubramanian, Shankar; Barnes, Colin L.; Liu, Xiaohai; Earnshaw, David J.; Furey, W. Scott; Osborne, Mark A.; Klenerman, David] Univ Cambridge, Dept Chem, Univ Chem Lab, Cambridge CB2 1EW, England; [Flatbush, Michael R.; Karbelashvili, Mirian S.; Kirk, Scott M.; Pratt, Mark R.; Reed, Mark T.; Sankar, Subramanian V.; Schroth, Gary P.; Tzonev, Svilen S.; Vermaas, Eric H.; Zhang, Lu; Alam, Mohammed D.; Banerjee, Saibal; Baybayan, Primo A.; Bridgham, John A.; Buermann, Dale H.; Burrows, James C.; Castillo, Nestor; Chang, Simon; Elmore, David W.; Etchin, Sergey S.; Ewan, Mark R.; George, David; Golda, George S.; Granieri, Philip A.; Gustafson, David L.; Haudenschild, Christian D.; Ho, Johnny T.; Hurwitz, Steve; Ivanov, Denis V.; Johnson, Maria Q.; Kerelska, Tzvetana H.; Khrebtukova, Irina; Kindwall, Alex P.; Lee, Xavier; Liao, Arnold K.; Lok, Mitch; Luo, Shujun; Martin, John W.; McNitt, Paul; Moon, Keith W.; Mullens, Joe W.; O'Neill, Michael J.; Ostadan, Omead; Paraschos, Lambros L.; Pike, Alger C.; Pinkard, D. Chris; Pliskin, Daniel P.; Podhasky, Joe; Quijano, Victor J.; Roth, Rithy K.; Rusman, Eli; Seoane, Josefina M.; Shiver, Mitch K.; Short, Steven W.; Sizto, Ning L.; Sluis, Johannes P.; Spence, Eric J.; Verhovsky, Yuli; Virk, Selene M.; Wakelin, Suzanne; Walcott, Gregory C.; Yan, Juying; Yau, Ling; Zuerlein, Mike; West, John S.; Oaks, Frank L.; Lundberg, Peter L.] Illumina Hayward, Hayward, CA 94343 USA; [Li, Heng; Scally, Aylwyn; Walter, Klaudia; Carter, Nigel P.; Ning, Zemin; Ng, Bee Ling; Rogers, Jane; Hurles, Matthew E.; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fedurco, Milan; Romieu, Anthony; Turcatti, Gerardo] Manteia Predict Med SA, CH-1267 Coinsins, Switzerland; [Gietzen, Kimberley J.; Laurent, Marc A.; Lawley, Cynthia T.; Ostadan, Omead] Illumina Inc, Corp Headquarters, San Diego, CA 92121 USA; [Hansen, Nancy F.; Mullikin, James C.] NHGRI, NIH, Bethesda, MD 20892 USA	Illumina; University of Cambridge; Illumina; Wellcome Trust Sanger Institute; Illumina; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bentley, DR (corresponding author), Illumina Cambridge Ltd, Chesterford Res Pk, Saffron Walden CB10 1XL, Essex, England.	dbentley@illumina.com	Romieu, Anthony/AAU-4128-2021; Balasubramanian, Shankar/C-1671-2009; Durbin, Richard/AAE-7178-2019; Li, Heng/D-9344-2011; Ning, Zemin/D-2411-2013; Christian, Haudenschild C/D-1602-2009; Osborne, Mark/F-7666-2016	Romieu, Anthony/0000-0002-2300-4499; Durbin, Richard/0000-0002-9130-1006; Li, Heng/0000-0003-4874-2874; Cox, Anthony/0000-0002-6534-749X; Shaw, Richard/0000-0001-8145-1601; Swerdlow, Harold/0000-0002-9510-160X; Osborne, Mark/0000-0001-6660-2985; Klenerman, David/0000-0001-7116-6954; Lawley, Cynthia/0000-0001-7001-4705; Balasubramanian, Shankar/0000-0002-0281-5815; Ning, Zemin/0000-0003-4359-776X; Walter, Klaudia/0000-0003-4448-0301	The Wellcome Trust; Biotechnology and Biological Sciences Research Council; BBSRC Applied Genomics LINK Programme; Intramural Research Program of the National Human Genome Research Institute; National Institutes of Health; MRC [G0701805] Funding Source: UKRI; Medical Research Council [G0701805] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330] Funding Source: NIH RePORTER	The Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Applied Genomics LINK Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge the advice of A. Williamson, T. Rink, S. Benkovic, J. Berriman, J. Todd, R. Waterston, S. Eletr, W. Jack, M. Cooper, T. Brown, C. Reece and R. Cook during this work; E. Margulies for assistance with data analysis; M. Shumway for assistance with data submission; and the contributions of the administrative and support staff at all the institutions. This research was supported in part by The Wellcome Trust (to H.L., A.Sc., K.W., N.P.C, B.N.L., J.R., M.E.H. and R.D.), the Biotechnology and Biological Sciences Research Council (BBSRC) (to S.B. and D.K.), the BBSRC Applied Genomics LINK Programme (to A.Sp. and C.L.B.) and the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (to N.F.H. and J.C.M.). S. Balasubramanian and D. Klenerman are inventors and founders of Solexa Ltd.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lundquist PM, 2008, OPT LETT, V33, P1026, DOI 10.1364/OL.33.001026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MILTON J, 2004, WO2004018497 WORLD I; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; SMITH GP, 2005, WO2005024010 WORLD I; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	32	2309	2730	12	455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					53	59		10.1038/nature07517	http://dx.doi.org/10.1038/nature07517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987734	Green Accepted, hybrid			2022-12-01	WOS:000260674000039
J	Sumbre, G; Muto, A; Baier, H; Poo, MM				Sumbre, German; Muto, Akira; Baier, Herwig; Poo, Mu-ming			Entrained rhythmic activities of neuronal ensembles as perceptual memory of time interval	NATURE			English	Article							EVENT-RELATED POTENTIALS; IN-VIVO; PREFRONTAL CORTEX; LARVAL ZEBRAFISH; OPTIC TECTUM; PSYCHOPHYSICS; NETWORKS; PROTEIN; MACAQUE; RETINA	The ability to process temporal information is fundamental to sensory perception, cognitive processing and motor behaviour of all living organisms, from amoebae to humans(1-4). Neural circuit mechanisms based on neuronal and synaptic properties have been shown to process temporal information over the range of tens of microseconds to hundreds of milliseconds(5-7). How neural circuits process temporal information in the range of seconds to minutes is much less understood. Studies of working memory in monkeys and rats have shown that neurons in the prefrontal cortex(8-10), the parietal cortex(9,11) and the thalamus(12) exhibit ramping activities that linearly correlate with the lapse of time until the end of a specific time interval of several seconds that the animal is trained to memorize. Many organisms can also memorize the time interval of rhythmic sensory stimuli in the timescale of seconds and can coordinate motor behaviour accordingly, for example, by keeping the rhythm after exposure to the beat of music. Here we report a form of rhythmic activity among specific neuronal ensembles in the zebrafish optic tectum, which retains the memory of the time interval ( in the order of seconds) of repetitive sensory stimuli for a duration of up to similar to 20 s. After repetitive visual conditioning stimulation ( CS) of zebrafish larvae, we observed rhythmic post-CS activities among specific tectal neuronal ensembles, with a regular interval that closely matched the CS. Visuomotor behaviour of the zebrafish larvae also showed regular post- CS repetitions at the entrained time interval that correlated with rhythmic neuronal ensemble activities in the tectum. Thus, rhythmic activities among specific neuronal ensembles may act as an adjustable 'metronome' for time intervals in the order of seconds, and serve as a mechanism for the short- term perceptual memory of rhythmic sensory experience.	[Sumbre, German; Poo, Mu-ming] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; [Muto, Akira; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Sumbre, German/K-7538-2017; Muto, Akira/E-2580-2015	Sumbre, German/0000-0003-4436-6840; Muto, Akira/0000-0003-4276-1775	US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY012406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kampff, F. Engert, Y. Fu and S. Smith for their help with two- photon microscopy, C. Niell for advice on the zebrafish preparation, N. Farchi, Y. Loewenstein, B. Hochner, G. de Polavieja and A. Noe for comments on the manuscript, and A. Arrenberg, B. Barak, V. Yoon, R. Chen and J. Sumbre for their technical help. This work was supported by the US National Institutes of Health.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; BULLOCK TH, 1994, ELECTROEN CLIN NEURO, V91, P42, DOI 10.1016/0013-4694(94)90017-5; BULLOCK TH, 1993, J COMP PHYSIOL A, V172, P501, DOI 10.1007/BF00213532; BULLOCK TH, 1990, J NEUROPHYSIOL, V64, P903, DOI 10.1152/jn.1990.64.3.903; BULLOCK TH, 1990, J EXP ZOOL, V256, P142; Buonomano DV, 2007, NAT CHEM BIOL, V3, P594, DOI 10.1038/nchembio1007-594; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Easter SS, 1996, DEV BIOL, V180, P646; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lister JA, 1999, DEVELOPMENT, V126, P3757; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; MEEK J, 1983, BRAIN RES, V287, P247; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; O'Malley DM, 2004, METHOD CELL BIOL, V76, P261; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rainer G, 1999, J NEUROSCI, V19, P5493; Ramdya P, 2006, J NEUROSCI METH, V157, P230, DOI 10.1016/j.jneumeth.2006.04.021; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Schwartz G, 2007, NAT NEUROSCI, V10, P552, DOI 10.1038/nn1887; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; VANEGAS H, 1983, BRAIN RES REV, V6, P117, DOI 10.1016/0165-0173(83)90036-X; Westerfield M., 1993, GUIDE LAB USE ZEBRAF; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	38	108	109	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					102	U6		10.1038/nature07351	http://dx.doi.org/10.1038/nature07351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18923391	Green Accepted			2022-12-01	WOS:000260674000049
J	Ceesay, SJ; Casals-Pascual, C; Erskine, J; Anya, SE; Duah, NO; Fulford, AJC; Sesay, SSS; Abubakar, I; Dunyo, S; Sey, O; Palmer, A; Fofana, M; Corrah, T; Bojang, KA; Whittle, HC; Greenwood, BM; Conway, DJ				Ceesay, Serign J.; Casals-Pascual, Climent; Erskine, Jamie; Anya, Samuel E.; Duah, Nancy O.; Fulford, Anthony J. C.; Sesay, Sanie S. S.; Abubakar, Ismaela; Dunyo, Samuel; Sey, Omar; Palmer, Ayo; Fofana, Malang; Corrah, Tumani; Bojang, Kalifa A.; Whittle, Hilton C.; Greenwood, Brian M.; Conway, David J.			Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis	LANCET			English	Article							TREATED BED NETS; MOSQUITO NETS; RURAL AREA; FOLLOW-UP; MORTALITY; CHILDREN; MORBIDITY; AFRICA; TRIAL; RISK	Background Malaria is a major cause of morbidity and mortality in Africa. International effort and funding for control has been stepped up, with substantial increases from 2003 in the delivery of malaria interventions to pregnant women and children younger than 5 years in The Gambia. We investigated the changes in malaria indices in this country, and the causes and public-health significance of these changes. Methods We undertook a retrospective analysis of original records to establish numbers and proportions of malaria inpatients, deaths, and blood-slide examinations at one hospital over 9 years (January, 1999-December, 2007), and at four health facilities in three different administrative regions over 7 years (January, 2001-December, 2007). We obtained additional data from single sites for haernoglobin concentrations in paediatric admissions and for age distribution of malaria admissions. Findings From 2003 to 2007, at four sites with complete slide examination records, the proportions of malaria-positive slides decreased by 82% (3397/10861 in 2003 to 337/6142 in 2007), 85% (137/1259 to 6/368), 73% (3664/16932 to 666/11333), and 50% (1206/3304 to 336/1853). At three sites with complete admission records, the proportions of malaria admissions fell by 74% (435/2530 to 69/1531), 69% (797/2824 to 89/1032), and 27% (2204/4056 to 496/1251.). Proportions of deaths attributed to malaria in two hospitals decreased by 100% (seven of 115 in 2003 to none of 117 in 2007) and 90% (22/122 in 2003 to one of 58 in 2007). Since 2004, mean haemoglobin concentrations for all-cause admissions increased by 12 g/L (85 g/L in 2000-04 to 97 g/L in 2005-07), and mean age of paediatric malaria admissions increased from 3.9 years (95% CI 3.7-4 . 0) to 5.6 years (5.0-6.2). Interpretation A large proportion of the malaria burden has been alleviated in The Gambia. Our results encourage consideration of a policy to eliminate malaria as a public-health problem, while emphasising the importance of accurate and continuous surveillance. Funding UK Medical Research Council,	[Ceesay, Serign J.; Casals-Pascual, Climent; Duah, Nancy O.; Fulford, Anthony J. C.; Sesay, Sanie S. S.; Abubakar, Ismaela; Dunyo, Samuel; Corrah, Tumani; Bojang, Kalifa A.; Whittle, Hilton C.; Conway, David J.] MRC Labs, Banjul, Gambia; [Erskine, Jamie] WEC Mission Hosp, Sibanor, Western Region, Gambia; [Anya, Samuel E.] Univ Gambia, Sch Med & Allied Hlth Sci, Kanifing, Gambia; [Anya, Samuel E.; Palmer, Ayo] CIAM Publ Hlth Res & Dev Ctr, Kanifing, Gambia; [Fulford, Anthony J. C.; Greenwood, Brian M.; Conway, David J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Sey, Omar] AFPRC Farafenni Hosp, N Bank Region, Gambia; [Fofana, Malang] NMCP, Banjul, Gambia	MRC Laboratory Molecular Biology; University of the Gambia; University of London; London School of Hygiene & Tropical Medicine	Conway, DJ (corresponding author), MRC Labs, POB 273, Banjul, Gambia.	dconway@mrc.gm	Sesay, Sanie Samuel Sogoyan/M-2982-2014; Casals-Pascual, Climent/N-7692-2018	Sesay, Sanie Samuel Sogoyan/0000-0001-6233-7854; Casals-Pascual, Climent/0000-0002-0867-8954; Conway, David/0000-0002-8711-3037; Duah-Quashie, Nancy/0000-0001-8819-1793; Bojang, Kalifa/0000-0001-7506-0938	UK Medical Research Council; MRC [MC_U190074193] Funding Source: UKRI; Medical Research Council [MC_U190074193] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support for the research was provided by the UK Medical Research Council (MRC). We thank Jula Jaiteh. and Lamin Sanyang (Senior Nursing Officers at Government health facilities) for providing hospital records and helping to extract data; Gibril Bah, Lamin Manneh, Bernard Ndaye, Lamin Gibba. Fabakary Sanyang, Hawa Manneh. Demba B T Sainbou, and Yorro Bah (MRC staff) for data extraction of the haematology laboratory) and ward records: Aja Abbie Khan (Head of Regional Health Team for Western Division) for support in implementing the project at the Government health facilities: Andrew Prentice (Head of MRC Nutrition Research Programme) for supporting the Keneba laboratory record database management: Pamela Collier Njie and Muminatou Jallow for help with the provision of clinical data front the MRC ward in Fajara; and many other colleagues and partner organisations who have encouraged this work.	ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; [Anonymous], 2007, LANCET, V370, P1459; Anya SE, 2004, AM J TROP MED HYG, V70, P510, DOI 10.4269/ajtmh.2004.70.510; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Butler D, 2007, NATURE, V450, P144, DOI 10.1038/450144b; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Chambers RG, 2008, LANCET, V371, P1399, DOI 10.1016/S0140-6736(08)60609-1; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; GREENWOOD BM, 1988, LANCET, V1, P1121; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127; MARSDEN P. D., 1964, TRANS ROY SOC TROP MED HYG, V58, P455, DOI 10.1016/0035-9203(64)90101-4; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; MENON A, 1990, T ROY SOC TROP MED H, V84, P768, DOI 10.1016/0035-9203(90)90071-L; MENON A, 1990, T ROY SOC TROP MED H, V84, P638, DOI 10.1016/0035-9203(90)90130-7; *MICS, 2002, GAMB MULT IND CLUST, P1; *MICS, 2007, GAMB MULT IND CLUST, P1; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Shanks GD, 2008, LANCET INFECT DIS, V8, P564, DOI 10.1016/S1473-3099(08)70130-0; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P838, DOI 10.1016/0035-9203(88)90011-9; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; *UNICEF, 2007, MAL CHILDR PROGR INT, P1; *WHO, 2008, IMP LONG LAST INS NE; Williams Christopher J, 2007, Travel Med Infect Dis, V5, P295, DOI 10.1016/j.tmaid.2007.05.001	41	307	311	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1545	1554		10.1016/S0140-6736(08)61654-2	http://dx.doi.org/10.1016/S0140-6736(08)61654-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984187	Green Published, Green Accepted			2022-12-01	WOS:000260590500026
J	Wang, LD; Wang, Y; Jin, SG; Wu, ZY; Chin, DP; Koplan, JP; Wilson, ME				Wang, Longde; Wang, Yu; Jin, Shuigao; Wu, Zunyou; Chin, Daniel P.; Koplan, Jeffrey P.; Wilson, Mary Elizabeth			Health system reform in China 2 Emergence and control of infectious diseases in China	LANCET			English	Article							STREPTOCOCCUS-SUIS; AVIAN INFLUENZA; SARS; BATS; CORONAVIRUSES; TRANSMISSION; OUTBREAK; VIRUS	Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major contributor to the worldwide infectious disease burden because of its population size. The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations. The ecological interaction of people with animals in China favours the emergence of new microbial threats. The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases. To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance. This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases.	[Wang, Yu; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China; [Wang, Longde] Minist Hlth, Beijing, Peoples R China; [Jin, Shuigao] Chinese Ctr Dis Control & Prevent, Natl Ctr Publ Hlth Surveillance & Informat Serv, Beijing 100050, Peoples R China; [Chin, Daniel P.] Bill & Melinda Gates Fdn China Off, Beijing, Peoples R China; [Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Wilson, Mary Elizabeth] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Emory University; Harvard University; Harvard T.H. Chan School of Public Health	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, 27 Nanwei Rd, Beijing 100050, Peoples R China.	wuzy@263.net			FIC NIH HHS [U2R TW06918, U2R TW006918-04, U2R TW006918-05, U2R TW006918] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [U2RTW006918] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; Chen SL, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/11/010; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; *CHIN CTR DIS CONT, NAT DAT NOT DIS CHIN; *CHIN MIN HLTH, 2006, NOT DIS CHIN 2005; *CHIN MIN HLTH, 2005, NOT DIS CHIN 2005; *CHIN MIN HLTH, 2007, NOT DIS CHIN 2006; *CHIN MIN HLTH, 2007, CHIN ANN HLTH STAT 2; Cook IG, 2004, HEALTH POLICY, V67, P329, DOI 10.1016/j.healthpol.2003.07.005; Cui J, 2007, EMERG INFECT DIS, V13, P1526, DOI 10.3201/eid1310.070448; Feng Ping, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P874; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Hai W., 2004, ASIAN ECON PAP, V3, P57, DOI [DOI 10.1162/1535351041747905, 10.1162/1535351041747905]; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Hampton T, 2005, JAMA-J AM MED ASSOC, V294, P2291, DOI 10.1001/jama.294.18.2291; Ho G, 2006, NURS INQ, V13, P2, DOI 10.1111/j.1440-1800.2006.00301.x; Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07; Lam WK, 2003, RESPIROLOGY, V8, pS2, DOI 10.1046/j.1440-1843.2003.00516.x; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lim W, 2006, ANN ACAD MED SINGAP, V35, P354; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Matsui S, 2005, WATER SCI TECHNOL, V51, P91, DOI 10.2166/wst.2005.0234; Mcfee RB, 2007, DM-DIS MON, V53, P343, DOI 10.1016/j.disamonth.2007.05.005; *NAT TECHN STEER G, 2002, CHIN J TUBERC RESP D, V25, P3; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Normile D, 2005, SCIENCE, V309, P1308; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Poland GA, 2007, VACCINE, V25, P3057, DOI 10.1016/j.vaccine.2007.01.050; RANDS G, 1989, J ROY SOC HEALTH, V109, P79, DOI 10.1177/146642408910900302; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shao C, 1996, Chin Med Sci J, V11, P252; Shaw K, 2006, PUBLIC HEALTH, V120, P8, DOI 10.1016/j.puhe.2005.10.002; *STAT COUNC AIDS W, 2007, UN THEM GROUP AIDS C; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)6134-1; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; United Nations Commission on Human Security, 2007, HUM DEV REP 2007 200; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)61358-6; Wang LF, 2007, CURR TOP MICROBIOL, V315, P325; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Watts J, 2004, LANCET, V363, P1370, DOI 10.1016/S0140-6736(04)16087-X; WHO, 2021, CUM NUMB CONF HUM CA; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang FJ, 2006, CHINESE MED J-PEKING, V119, P1999, DOI 10.1097/00029330-200612010-00010; ZHANG K, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)61357-4; Zhang XB, 1996, ARS COMBINATORIA, V42, P3; ZHENG LQ, 2007, HLTH NEWS BEIJI 0608; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	51	260	290	7	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1598	1605		10.1016/S0140-6736(08)61365-3	http://dx.doi.org/10.1016/S0140-6736(08)61365-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18930534	Bronze, Green Published			2022-12-01	WOS:000260590500034
J	Cui, YJ; Costa, RM; Murphy, GG; Elgersma, Y; Zhu, Y; Gutmann, DH; Parada, LF; Mody, I; Silva, AJ				Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Zhu, Yuan; Gutmann, David H.; Parada, Luis F.; Mody, Istvan; Silva, Alcino J.			Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning	CELL			English	Article							LONG-TERM POTENTIATION; MORRIS WATER MAZE; ACTIVATED PROTEIN-KINASE; MOUSE MODEL; SYNAPTIC PLASTICITY; DOWN-SYNDROME; MEMORY; TYPE-1; DEFICITS; RATS	We uncovered a role for ERK signaling in GABA release, long-term potentiation (LTP), and learning, and show that disruption of this mechanism accounts for the learning deficits in a mouse model for learning disabilities in neurofibromatosis type I (NF1). Our results demonstrate that neurofibromin modulates ERK/synapsin I-dependent GABA release, which in turn modulates hippocampal LTP and learning. An Nf1 heterozygous null mutation, which results in enhanced ERK and synapsin I phosphorylation, increased GABA release in the hippocampus, and this was reversed by pharmacological downregulation of ERK signaling. Importantly, the learning deficits associated with the Nf1 mutation were rescued by a subthreshold dose of a GABAA antagonist. Accordingly, Cre deletions of Nf1 showed that only those deletions involving inhibitory neurons caused hippocampal inhibition, LTP, and learning abnormalities. Importantly, our results also revealed lasting increases in GABA release triggered by learning, indicating that the mechanisms uncovered here are of general importance for learning.	[Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; [Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90095 USA; [Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90095 USA; [Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20852 USA; [Murphy, Geoffrey G.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Elgersma, Ype] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Zhu, Yuan] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhu, Yuan] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75235 USA; [Mody, Istvan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Elgersma, Ype/F-5164-2013; Zhu, Yuan/ABF-8405-2020; Parada, luis F/B-9400-2014; Silva, Alcino/ABD-7684-2021	Elgersma, Ype/0000-0002-3758-1297; Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Gutmann, David/0000-0002-3127-5045; Costa, Rui M./0000-0003-0495-8374	NIH [R01 NS38480]; Neurofibromatosis Inc.; Children's Tumor Foundation; United States Army [W81XWH-06-1-0174]; Coelho Endowment [NS30549]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS030549, R01NS038480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurofibromatosis Inc.; Children's Tumor Foundation; United States Army(United States Department of DefenseUnited States Army); Coelho Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the NIH (R01 NS38480), Neurofibromatosis Inc., the Children's Tumor Foundation, and United States Army (W81XWH-06-1-0174) to A.J.S. and NS30549 and the Coelho Endowment to I. M. This work was also supported by a generous donation from C. M. Spivak to A. J.S.Y.C. was supported by a fellowship from the Children's Tumor Foundation. We thank P. Greengard and J.N. Jovanovic for the generous gift of the phospho-Syn I antibodies. We are grateful to Steven Kushner, Brandon M. Stell, and Weizheng Wei for fruitful discussions.	Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dilts CV, 1996, J DEV BEHAV PEDIATR, V17, P229; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Guilding C, 2007, EUR J NEUROSCI, V25, P99, DOI 10.1111/j.1460-9568.2006.05238.x; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; INTROINICOLLISON IB, 1994, BEHAV NEURAL BIOL, V61, P150, DOI 10.1016/S0163-1047(05)80068-8; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782; Lynch TM, 2002, NEUROL CLIN, V20, P841, DOI 10.1016/S0733-8619(01)00019-6; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; McElroy MW, 2005, LEARN MEMORY, V12, P150, DOI 10.1101/lm.86205; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Stenman J, 2003, J NEUROSCI, V23, P167; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Wiltgen BJ, 2005, LEARN MEMORY, V12, P327, DOI 10.1101/lm.89705; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	43	294	302	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					549	560		10.1016/j.cell.2008.09.060	http://dx.doi.org/10.1016/j.cell.2008.09.060			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984165	Green Accepted, Bronze			2022-12-01	WOS:000260536300024
J	Compston, A; Coles, A				Compston, Alastair; Coles, Alasdair			Multiple sclerosis	LANCET			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; STEM-CELL TRANSPLANTATION; DOUBLE-BLIND; INTERFERON BETA-1B; GLATIRAMER ACETATE; NEUROMYELITIS-OPTICA; IN-VITRO; DIAGNOSTIC-CRITERIA; RECURRENCE RISKS; AXONAL DAMAGE	Multiple sclerosis is primarily an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to damage of myelin and axons. Initially, inflammation is transient and remyelination occurs but is not durable. Hence, the early course of disease is characterised by episodes of neurological dysfunction that usually recover. However, over time the pathological changes become dominated by widespread microglial activation associated with extensive and chronic neurodegeneration, the clinical correlate of which is progressive accumulation of disability. Paraclinical investigations show abnormalities that indicate the distribution of inflammatory lesions and axonal loss (MRI); interference of conduction in previously myelinated pathways (evoked electrophysiological potentials); and intrathecal synthesis of oligoclonal antibody (examination by lumbar puncture of the cerebrospinal fluid). Multiple sclerosis is triggered by environmental factors in individuals with complex genetic-risk profiles. Licensed disease modifying agents reduce the frequency of new episodes but do not reverse fixed deficits and have questionable effects on the long-term accumulation of disability and disease progression. We anticipate that future studies in multiple sclerosis will provide a new taxonomy on the basis of mechanisms rather than clinical empiricism, and so inform strategies for improved treatment at all stages of the disease.	[Compston, Alastair; Coles, Alasdair] Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Clin Neurosci, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Coles, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Clin Neurosci, Hills Rd, Cambridge CB2 2QQ, England.	ajc1020@medschl.cam.ac.uk		Coles, Alasdair/0000-0003-4738-0760				Achiron A, 2004, CLIN IMMUNOL, V113, P155, DOI 10.1016/j.clim.2004.06.004; ALPEROVITCH A, 1992, ANN NEUROL, V32, P724; ALTER M, 1962, ARCH NEUROL-CHICAGO, V7, P253, DOI 10.1001/archneur.1962.04210040005001; ANDERSEN O, 1993, J NEUROL, V240, P417, DOI 10.1007/BF00867354; Anderson JM, 2008, BRAIN, V131, P1736, DOI 10.1093/brain/awn119; Barbellion W. N. P., 1919, J DISAPPOINTED MAN; Barbellion W. N. P., 1920, LAST DIARY; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Black JA, 2006, BRAIN, V129, P3196, DOI 10.1093/brain/awl216; Breij ECW, 2008, ANN NEUROL, V63, P16, DOI 10.1002/ana.21311; Broadley SA, 2000, BRAIN, V123, P1102, DOI 10.1093/brain/123.6.1102; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; BROPHY P, 1987, BAROQUE N ROLL, P1; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Cabre P, 2005, BRAIN, V128, P2899, DOI 10.1093/brain/awh624; *CAMMS223 TRIAL IN, 2008, NEW ENGL J MED, V359, P30; Carswell Robert, 1838, PATHOLOGICAL ANATOMY; Carton H, 1997, J NEUROL NEUROSUR PS, V62, P329, DOI 10.1136/jnnp.62.4.329; Chandran S, 2008, PHILOS T R SOC B, V363, P171, DOI 10.1098/rstb.2006.2019; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Cohen JA, 2007, NEUROLOGY, V68, P939, DOI 10.1212/01.wnl.0000257109.61671.06; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Comi G, 2008, J NEUROL, V255, P10; Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Compston A, 2004, CLIN MED, V4, P346, DOI 10.7861/clinmedicine.4-4-346; COMPSTON DAS, 1976, LANCET, V2, P1261; COMPSTON DAS, 2005, MCALPINES MULTIPLE S, P1; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2001, NEW ENGL J MED, V344, P319, DOI 10.1056/NEJM200102013440501; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Davie CA, 1995, BRAIN, V118, P1583, DOI 10.1093/brain/118.6.1583; Dawson J.W, 1916, EARTH ENV SCI T R SO, V50, P517, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Dean G, 2008, NEUROLOGY, V70, P101, DOI 10.1212/01.wnl.0000284598.98525.d7; DEAN G, 1971, BMJ-BRIT MED J, V3, P725, DOI 10.1136/bmj.3.5777.725; DETELS R, 1977, AM J EPIDEMIOL, V105, P303, DOI 10.1093/oxfordjournals.aje.a112387; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.0.CO;2-F; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Edan G, 1997, J NEUROL NEUROSUR PS, V62, P112, DOI 10.1136/jnnp.62.2.112; Eikelenboom MJ, 2003, NEUROLOGY, V60, P219, DOI 10.1212/01.WNL.0000041496.58127.E3; ELIAN M, 1990, J NEUROL NEUROSUR PS, V53, P906, DOI 10.1136/jnnp.53.10.906; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Filippi M, 2008, J NEUROL, V255, P9; Filippi M, 2003, BRAIN, V126, P433, DOI 10.1093/brain/awg038; Filippini G, 2003, LANCET, V361, P545, DOI 10.1016/S0140-6736(03)12512-3; FIRTH D, 1984, CASE A DESTE; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Francis G, 2001, NEUROLOGY, V56, P1628; *GAME COLL GROUP, 2006, J NEUROIMMUNOL, V179, P108; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hensiek AE, 2007, NEUROLOGY, V68, P376, DOI 10.1212/01.wnl.0000252822.53506.46; Hernan MA, 2005, BRAIN, V128, P1461, DOI 10.1093/brain/awh471; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121; King J, 2001, NEUROLOGY, V56, P1496; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kira J, 1999, J NEUROL SCI, V166, P53, DOI 10.1016/S0022-510X(99)00115-X; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; KURTZKE JF, 1975, ACTA NEUROL SCAND, V51, P110; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Le Page E, 2008, J NEUROL NEUROSUR PS, V79, P52, DOI 10.1136/jnnp.2007.124958; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MAGLIOZZI R, 2007, J EXP MED, V204, P2899; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Marrie RA, 2004, LANCET NEUROL, V3, P709, DOI 10.1016/S1474-4422(04)00933-0; MARROSU MG, 1992, NEUROLOGY, V42, P883, DOI 10.1212/WNL.42.4.883; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Metz I, 2007, BRAIN, V130, P1254, DOI 10.1093/brain/awl370; Mikaeloff Y, 2007, BRAIN, V130, P2589, DOI 10.1093/brain/awm198; Miller DH, 1999, ANN NEUROL, V46, P850, DOI 10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q; Miller DM, 2000, MULT SCLER, V6, P267, DOI 10.1191/135245800678827770; MINDEN SL, 1990, ARCH NEUROL-CHICAGO, V47, P98, DOI 10.1001/archneur.1990.00530010124031; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Munari LM, 2004, LANCET NEUROL, V3, P641, DOI 10.1016/S1474-4422(04)00899-3; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Panitch H, 2004, NEUROLOGY, V63, P1788; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; PANITCH HS, 1987, LANCET, V1, P893; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Renoux C, 2007, NEW ENGL J MED, V356, P2603, DOI 10.1056/NEJMoa067597; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Ristori G, 2006, ANN NEUROL, V59, P27, DOI 10.1002/ana.20683; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Robertson NP, 1997, LANCET, V349, P1587, DOI 10.1016/S0140-6736(96)07317-5; Robertson NP, 1996, NEUROLOGY, V47, P347, DOI 10.1212/WNL.47.2.347; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Saccardi R, 2006, MULT SCLER, V12, P814, DOI 10.1177/1352458506071301; SADOVNICK AD, 1988, NEUROLOGY, V38, P990, DOI 10.1212/WNL.38.6.990; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Schmied M, 2003, CLIN IMMUNOL, V106, P163, DOI 10.1016/S1521-6616(03)00020-2; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Smith KJ, 2006, BRAIN, V129, P3147, DOI 10.1093/brain/awl323; SMITH KJ, 1981, BRAIN, V104, P383, DOI 10.1093/brain/104.2.383; Smith KJ, 2001, ANN NEUROL, V49, P470; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Stadelmann C, 2005, BRAIN, V128, P979, DOI 10.1093/brain/awh457; TERASAKI PI, 1976, SCIENCE, V193, P1245, DOI 10.1126/science.1085490; Tienari PJ, 1998, J NEUROIMMUNOL, V81, P158, DOI 10.1016/S0165-5728(97)00171-9; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; *US FDA, 2008, NAT MARK TYS INF; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukusic S, 2004, BRAIN, V127, P1353, DOI 10.1093/brain/awh152; Weinshenker BG, 1999, ANN NEUROL, V46, P878, DOI 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Williams A, 2007, BRAIN, V130, P2554, DOI 10.1093/brain/awm202; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079; Wolswijk G, 1998, PROG BRAIN RES, V117, P233; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437; YUDKIN PL, 1991, LANCET, V338, P1051, DOI 10.1016/0140-6736(91)91909-E; ZAJICEK JP, 1992, BRAIN, V115, P1611, DOI 10.1093/brain/115.6.1611; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291	174	3352	3446	25	884	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1502	1517		10.1016/S0140-6736(08)61620-7	http://dx.doi.org/10.1016/S0140-6736(08)61620-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18970977				2022-12-01	WOS:000260801300027
J	Hawkes, N				Hawkes, Nigel			NHS dentistry: a service with teeth	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a2043	10.1136/bmj.a2043	http://dx.doi.org/10.1136/bmj.a2043			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18940838				2022-12-01	WOS:000260298800030
J	Kipping, RR; Jago, R; Lawlor, DA				Kipping, Ruth R.; Jago, Russell; Lawlor, Debbie A.			Obesity in children. Part 2: Prevention and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHILDHOOD OBESITY; INTERVENTIONS; ADOLESCENTS; METAANALYSIS; OVERWEIGHT; PROGRAMS; OUTCOMES; RISK		[Kipping, Ruth R.; Lawlor, Debbie A.] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Jago, Russell] Univ Bristol, Dept Exercise Nutr & Hlth Sci, Bristol BS8 1TP, Avon, England; [Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England	University of Bristol; University of Bristol; University of Bristol	Kipping, RR (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England.	ruth.kipping@bristol.ac.uk	Jago, Russell/ABD-6271-2021	Jago, Russell/0000-0002-3394-0176; Lawlor, Debbie A/0000-0002-6793-2262; Kipping, Ruth/0000-0002-5446-8077				Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; DeMattia L, 2007, OBES REV, V8, P69, DOI 10.1111/j.1467-789X.2006.00259.x; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Foresight (Program) & Great Britain, 2007, TACKL OB FUT CHOIC P; Freemark M, 2007, DIABETES CARE, V30, P395, DOI 10.2337/dc06-1569; Gately PJ, 2005, PEDIATRICS, V116, P73, DOI 10.1542/peds.2004-0397; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Lawson ML, 2006, J PEDIATR SURG, V41, P137, DOI 10.1016/j.jpedsurg.2005.10.017; National Health and Medical Research Council, 2003, CLIN PRACT GUID MAN; *NIH CLIN EXC, QUICK REF GUID 2 NHS; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; PETTITT DJ, 1993, DIABETES CARE, V16, P310, DOI 10.2337/diacare.16.1.310; Rudolf M, 2006, ARCH DIS CHILD, V91, P736, DOI 10.1136/adc.2005.089896; Sabin MA, 2007, J EVAL CLIN PRACT, V13, P364, DOI 10.1111/j.1365-2753.2006.00706.x; SACHER PM, 2007, OBES REV S3, V8, P7; Schilling PL, 2008, J AM COLL SURGEONS, V206, P1, DOI 10.1016/j.jamcollsurg.2007.07.028; Shield JPH, 2008, ARCH DIS CHILD, V93, P369, DOI 10.1136/adc.2006.113316; Stice E, 2006, PSYCHOL BULL, V132, P667, DOI 10.1037/0033-2909.132.5.667; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Westley H, 2007, BRIT MED J, V335, P1236, DOI 10.1136/bmj.39409.451678.AD; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Young KM, 2007, CLIN PSYCHOL REV, V27, P240, DOI 10.1016/j.cpr.2006.08.003	28	28	28	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2008	337	7676							a1848	10.1136/bmj.a1848	http://dx.doi.org/10.1136/bmj.a1848			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18945733				2022-12-01	WOS:000260298800037
J	Albrechtsen, S; Rasmussen, S; Thoresen, S; Irgens, LM; Iversen, OE				Albrechtsen, Susanne; Rasmussen, Svein; Thoresen, Steinar; Irgens, Lorentz M.; Iversen, Ole Erik			Pregnancy outcome in women before and after cervical conisation: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTRAEPITHELIAL NEOPLASIA; PRETERM DELIVERY	Objectives To examine the consequences of cervical conisation in terms of adverse outcome in subsequent pregnancies. Design Population based cohort study. Data sources Data on cervical conisation derived from the Cancer Registry of Norway and on pregnancy outcome from the Medical Birth Registry of Norway, 1967- 2003. 15 108 births occurred in women who had previously undergone cervical conisation and 57 136 who subsequently underwent cervical conisation. In the same period there were 2 164 006 births to women who had not undergone relevant treatment ( control). Results The proportion of preterm delivery was 17.2% in women who gave birth after cervical conisation versus 6.7% in women who gave birth before cervical conisation and 6.2% in women who had not undergone cervical conisation. The relative risk of a late abortion (< 24 weeks' gestation) was 4.0 ( 95% confidence interval 3.3 to 4.8) in women who gave birth after cervical conisation compared with no cervical conisation. The relative risk of delivery was 4.4 ( 3.8 to 5.0) at 24- 27 weeks, 3.4 ( 3.1 to 3.7) at 28- 32 weeks, and 2.5 ( 2.4 to 2.6) at 33- 36 weeks. The relative risk of preterm delivery declined during the study period and especially of delivery before 28 weeks' gestation. Conclusion Cervical conisation influences outcome in subsequent pregnancies in terms of an increased risk of preterm delivery, especially in the early gestational age groups in which the clinical significance is highest. A careful clinical approach should be taken in the selection of women for cervical conisation and in the clinical care of pregnancies after a cervical conisation.	[Albrechtsen, Susanne; Rasmussen, Svein; Iversen, Ole Erik] Univ Bergen, Dept Obstet & Gynecol, Haukeland Univ Hosp, Inst Clin Med, N-5021 Bergen, Norway; [Albrechtsen, Susanne; Rasmussen, Svein; Thoresen, Steinar; Irgens, Lorentz M.] Univ Bergen, Med Birth Registry Norway, Dept Publ Hlth & Primary Hlth Care, N-5021 Bergen, Norway; [Albrechtsen, Susanne; Rasmussen, Svein; Irgens, Lorentz M.] Norwegian Inst Publ Hlth, Bergen, Norway; [Thoresen, Steinar] Canc Registry Norway, Oslo, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Oslo	Albrechtsen, S (corresponding author), Univ Bergen, Dept Obstet & Gynecol, Haukeland Univ Hosp, Inst Clin Med, N-5021 Bergen, Norway.	Susanne.Albrechtsen@Helse-Bergen.no	Albrechtsen, Susanne/H-4680-2019		Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	Norwegian Cancer Society.	Forsmo S, 1996, ACTA OBSTET GYN SCAN, V75, P139, DOI 10.3109/00016349609033306; HAGEN B, 1993, BRIT J OBSTET GYNAEC, V100, P717, DOI 10.1111/j.1471-0528.1993.tb14261.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jakobsson M, 2007, OBSTET GYNECOL, V109, P309, DOI 10.1097/01.AOG.0000253239.87040.23; KRISTENSEN J, 1993, ACTA OBSTET GYN SCAN, V72, P640, DOI 10.3109/00016349309021157; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; LUND E, 1986, Tidsskrift for den Norske Laegeforening, V106, P543; *MED BIRTH REG NOR, 1998, BIRTH NORW 30 YEARS; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Sjoborg KD, 2007, ACTA OBSTET GYN SCAN, V86, P423, DOI 10.1080/11038120701208158; VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	14	118	122	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1343	10.1136/bmj.a1343	http://dx.doi.org/10.1136/bmj.a1343			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18801869	hybrid, Green Published			2022-12-01	WOS:000259798000037
J	Rogers, CS; Stoltz, DA; Meyerholz, DK; Ostedgaard, LS; Rokhlina, T; Taft, PJ; Rogan, MP; Pezzulo, AA; Karp, PH; Itani, OA; Kabel, AC; Wohlford-Lenane, CL; Davis, GJ; Hanfland, RA; Smith, TL; Samuel, M; Wax, D; Murphy, CN; Rieke, A; Whitworth, K; Uc, A; Starner, TD; Brogden, KA; Shilyansky, J; McCray, PB; Zabner, J; Prather, RS; Welsh, MJ				Rogers, Christopher S.; Stoltz, David A.; Meyerholz, David K.; Ostedgaard, Lynda S.; Rokhlina, Tatiana; Taft, Peter J.; Rogan, Mark P.; Pezzulo, Alejandro A.; Karp, Philip H.; Itani, Omar A.; Kabel, Amanda C.; Wohlford-Lenane, Christine L.; Davis, Greg J.; Hanfland, Robert A.; Smith, Tony L.; Samuel, Melissa; Wax, David; Murphy, Clifton N.; Rieke, August; Whitworth, Kristin; Uc, Aliye; Starner, Timothy D.; Brogden, Kim A.; Shilyansky, Joel; McCray, Paul B., Jr.; Zabner, Joseph; Prather, Randall S.; Welsh, Michael J.			Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs	SCIENCE			English	Article							INFLAMMATION; INFANTS; LOCALIZATION; PANCREAS; DISEASE	Almost two decades after CFTR was identified as the gene responsible for cystic fibrosis ( CF), we still lack answers to many questions about the pathogenesis of the disease, and it remains incurable. Mice with a disrupted CFTR gene have greatly facilitated CF studies, but the mutant mice do not develop the characteristic manifestations of human CF, including abnormalities of the pancreas, lung, intestine, liver, and other organs. Because pigs share many anatomical and physiological features with humans, we generated pigs with a targeted disruption of both CFTR alleles. Newborn pigs lacking CFTR exhibited defective chloride transport and developed meconium ileus, exocrine pancreatic destruction, and focal biliary cirrhosis, replicating abnormalities seen in newborn humans with CF. The pig model may provide opportunities to address persistent questions about CF pathogenesis and accelerate discovery of strategies for prevention and treatment.	[Rogers, Christopher S.; Stoltz, David A.; Ostedgaard, Lynda S.; Rokhlina, Tatiana; Taft, Peter J.; Rogan, Mark P.; Pezzulo, Alejandro A.; Karp, Philip H.; Itani, Omar A.; Kabel, Amanda C.; Davis, Greg J.; Zabner, Joseph; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Karp, Philip H.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Wohlford-Lenane, Christine L.; Uc, Aliye; Starner, Timothy D.; McCray, Paul B., Jr.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Hanfland, Robert A.; Smith, Tony L.; Shilyansky, Joel] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Surg, Iowa City, IA 52242 USA; [Samuel, Melissa; Wax, David; Murphy, Clifton N.; Rieke, August; Whitworth, Kristin; Prather, Randall S.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Brogden, Kim A.] Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA; [Brogden, Kim A.] Univ Iowa, Coll Dent, Dow Inst Dent Res, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Missouri System; University of Missouri Columbia; University of Iowa; University of Iowa; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Prather, Randall S/B-4528-2012; Meyerholz, David/J-8131-2019	Meyerholz, David/0000-0003-1552-3253; Zabner, Joseph/0000-0002-9606-1339; Ostedgaard, Lynda/0000-0001-7717-3442; Shilyansky, Joel/0000-0003-0766-4785; Uc, Aliye/0000-0003-2004-5743; McCray, Paul/0000-0002-4067-577X; Starner, Timothy/0000-0002-1933-7477; Prather, Randall/0000-0002-6012-4035; Stoltz, David/0000-0003-0893-9015; Pezzulo, Alejandro/0000-0001-7544-5109; Welsh, Michael/0000-0002-1646-6206	National Heart Lung and Blood Institute [HL51670]; National Institute of Diabetes and Digestive and Kidney Diseases [DK54759]; Food for the 21st Century, the Cystic Fibrosis Foundation; NIH [HL07638]; National Institute of Allergy and Infectious Diseases [AI076671]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007638, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759, R01DK051315] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Food for the 21st Century, the Cystic Fibrosis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Arias, E. Bagnall, J. Bartlett, B. Bauer, T. Bohnert, E. Burnight, K. Dobbs, C. Dohrn, L. Dowell, L. Gakhar, D. Guilliams, Y. Hao, S. C. Isom, S. Jones, S. Korte, B. Kussman, J. Launspach, M. Linville, E. Mahan, T. Mayhew, C. McHughes, K. Munson, M. Parker, C. Randak, S. Ramachandran, J. Ross, A. Small, L. Spate, D. Vermeer, E. Walters, and J. Whyte for excellent assistance. We thank our patients with CF for inspiration, and we also thank Cystic Fibrosis Foundation Therapeutics and R. Bridges for the gift of GlyH-101. This work was supported by the National Heart Lung and Blood Institute (grant HL51670), the National Institute of Diabetes and Digestive and Kidney Diseases (grant DK54759), Food for the 21st Century, the Cystic Fibrosis Foundation, and HHMI. C. S. R. was supported by NIH training grant HL07638. D. A. S. is a Parker B. Francis Fellow and was supported by the National Institute of Allergy and Infectious Diseases (grant AI076671). M. J. W. is an Investigator of the HHMI. C.S.R., R.S.P., M.J.W., and the University of Iowa Foundation have applied for a patent related to the work reported in this paper, and C. S. R. and M. J. W. are founders of Exemplar Genetics, a company that is licensing materials and technology related to this work. C. S. R. is currently Director of Research and Development at Exemplar Genetics.	Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; Clarke LL, 1996, LAB ANIM SCI, V46, P612; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x; IMRIE JR, 1979, AM J PATHOL, V95, P697; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Oppenheimer E H, 1975, Perspect Pediatr Pathol, V2, P241; OPPENHEIMER EH, 1975, J PEDIATR-US, V86, P683, DOI 10.1016/S0022-3476(75)80351-9; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Welsh MJ., 2001, METABOLIC MOL BASES, P5121; Wilschanski M, 1998, J ROY SOC MED, V91, P40, DOI 10.1177/014107689809134S07	26	571	610	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1837	1841		10.1126/science.1163600	http://dx.doi.org/10.1126/science.1163600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818360	Green Accepted			2022-12-01	WOS:000259501300039
J	Scheerer, P; Park, JH; Hildebrand, PW; Kim, YJ; Krauss, N; Choe, HW; Hofmann, KP; Ernst, OP				Scheerer, Patrick; Park, Jung Hee; Hildebrand, Peter W.; Kim, Yong Ju; Krauss, Norbert; Choe, Hui-Woog; Hofmann, Klaus Peter; Ernst, Oliver P.			Crystal structure of opsin in its G-protein-interacting conformation	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; CATALYZED TRANSDUCIN ACTIVATION; CARBOXYLIC-ACID GROUP; ALPHA-SUBUNIT; NUCLEOTIDE EXCHANGE; COUPLED RECEPTOR; SQUID RHODOPSIN; DARK-ADAPTATION; PROTON UPTAKE; BINDING-SITE	Opsin, the ligand- free form of the G- protein- coupled receptor rhodopsin, at low pH adopts a conformationally distinct, active G- protein- binding state known as Ops*. A synthetic peptide derived from the main binding site of the heterotrimeric G protein - the carboxy terminus of the alpha-subunit (G alpha CT) - stabilizes Ops*. Here we present the 3.2 angstrom crystal structure of the bovine Ops* - G alpha CT peptide complex. G alpha CT binds to a site in opsin that is opened by an outward tilt of transmembrane helix ( TM) 6, a pairing of TM5 and TM6, and a restructured TM7 - helix 8 kink. Contacts along the inner surface of TM5 and TM6 induce an alpha- helical conformation in G alpha CT with a C- terminal reverse turn. Main- chain carbonyl groups in the reverse turn constitute the centre of a hydrogen- bonded network, which links the two receptor regions containing the conserved E( D) RY and NPxxY(x)(5,6)F motifs. On the basis of the Ops* - G alpha CT structure and known conformational changes in G alpha, we discuss signal transfer from the receptor to the G protein nucleotide- binding site.	[Scheerer, Patrick; Park, Jung Hee; Hildebrand, Peter W.; Kim, Yong Ju; Choe, Hui-Woog; Hofmann, Klaus Peter; Ernst, Oliver P.] Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Krauss, Norbert] Univ London Queen Mary Coll, Sch Biol & Chem Sci, London E1 4NS, England; [Choe, Hui-Woog] Chonbuk Natl Univ, Dept Chem, Coll Nat Sci, Chonju 561756, South Korea; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; Queen Mary University London; Jeonbuk National University; Humboldt University of Berlin	Ernst, OP (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	hwchoe@chonbuk.ac.kr; klaus_peter.hofmann@charite.de; oliver.ernst@charite.de	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Scheerer, Patrick/0000-0001-5028-2075; Krauss, Norbert/0000-0002-7128-4632	Protein Structure Factory; Freie Universitat Berlin [BL 14.1, BL 14.2]; Deutsche Forschungsgemeinschaft [Sfb449, Sfb740]; DFG-KOSEF international cooperation [ER 294/1-1, F01-2004-000-10054-0]; CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	Protein Structure Factory; Freie Universitat Berlin; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-KOSEF international cooperation(Korea Science and Engineering Foundation); CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	We thank J. Engelmann and C. Koch for technical assistance; P. Henklein for peptide synthesis; C. Enenkel and M. Sommer for critically reading the manuscript; U. Muller and the scientific staff of the Protein Structure Factory and the Freie Universitat Berlin at beamlines BL 14.1 and BL 14.2 at BESSY for continuous support of the project. This work was supported by the Deutsche Forschungsgemeinschaft Sfb449 ( to O.P.E.), Sfb740 ( to O.P.E. and K.P.H.), DFG-KOSEF international cooperation ER 294/1-1 ( to O.P.E.) and F01-2004-000-10054-0 ( to H.-W.C.), and CBNU funds for overseas research 2006-2007 ( to H.-W.C.) and a fellowship of the Leibniz Graduate School of Molecular Biophysics, Berlin ( to Y.J.K.).	Acharya S, 1997, J BIOL CHEM, V272, P6519, DOI 10.1074/jbc.272.10.6519; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Herrmann R, 2006, VISION RES, V46, P4582, DOI 10.1016/j.visres.2006.07.027; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Hofmann KP, 2006, TRENDS BIOCHEM SCI, V31, P497, DOI 10.1016/j.tibs.2006.07.006; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ridge KD, 2006, J BIOL CHEM, V281, P7635, DOI 10.1074/jbc.M509851200; Sachs K, 2000, METHOD ENZYMOL, V315, P238; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	58	893	914	2	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					497	U30		10.1038/nature07330	http://dx.doi.org/10.1038/nature07330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818650				2022-12-01	WOS:000259449600038
J	Yang, DS; Lao, CS; Zewail, AH				Yang, Ding-Shyue; Lao, Changshi; Zewail, Ahmed H.			4D electron diffraction reveals correlated unidirectional Behavior in zinc oxide nanowires	SCIENCE			English	Article							ZNO; CRYSTALLOGRAPHY; NANOSTRUCTURES; NANOCRYSTALS; MICROSCOPY; DYNAMICS; GROWTH; ARRAYS; ROUTE	The confined electronic structure of nanoscale materials has increasingly been shown to induce behavior quite distinct from that of bulk analogs. Direct atomic- scale visualization of nanowires of zinc oxide was achieved through their unique pancake- type diffraction by using four- dimensional (4D) ultrafast electron crystallography. After electronic excitation of this wide- gap photonic material, the wires were found to exhibit colossal expansions, two orders of magnitude higher than that expected at thermal equilibrium; the expansion is highly anisotropic, a quasi- one- dimensional behavior, and is facilitated by the induced antibonding character. By reducing the density of nanowires, the expansions reach even larger values and occur at shorter times, suggesting a decrease of the structural constraint in transient atomic motions. This unanticipated ultrafast carrier- driven expansion highlights the optoelectronic consequences of nanoscale morphologies.	[Yang, Ding-Shyue; Lao, Changshi; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	Zewail@caltech.edu	Yang, Ding-Shyue/A-8648-2010	Yang, Ding-Shyue/0000-0003-2713-9128; gaber, sarah/0000-0002-5995-7291	NSF; Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the NSF and the Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech. We wish to thank Z.L. Wang for providing the samples, which were made by P. Fei and S. Xu, and K. Xu for the help with the SEM measurement in J.R. Heath's laboratory at Caltech.	Adachi S., 2004, HDB PHYS PROPERTIES; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; Carbone F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035501; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; Greene LE, 2005, NANO LETT, V5, P1231, DOI 10.1021/nl050788p; Gu B, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903576; He J, 2005, OPT EXPRESS, V13, P9235, DOI 10.1364/OPEX.13.009235; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; ICHIMIYA A, 2004, REFLECTION HIGH ENER, P20; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Lee HW, 2007, CHEM PHYS LETT, V447, P86, DOI 10.1016/j.cplett.2007.08.086; MULLER E, 2006, MICROSCOPY SEMICONDU, P303; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Si X, 2008, CHINESE PHYS B, V17, P1291, DOI 10.1088/1674-1056/17/4/024; STEIGERWALD ML, 1990, ACCOUNTS CHEM RES, V23, P183, DOI 10.1021/ar00174a003; Tang J, 2007, J PHYS CHEM C, V111, P8957, DOI 10.1021/jp073015t; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wang ZL, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70076-7; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; WANG ZL, 1996, REFLECTION ELECT MIC; Warren B.E., 1990, XRAY DIFFRACTION; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Yang DS, 2007, J PHYS CHEM C, V111, P4889, DOI 10.1021/jp067466+; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748; Zhang CF, 2006, OPT LETT, V31, P3345, DOI 10.1364/OL.31.003345	30	62	62	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1660	1664		10.1126/science.1162049	http://dx.doi.org/10.1126/science.1162049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801993				2022-12-01	WOS:000259300400030
J	Haddad, RI; Shin, DM				Haddad, Robert I.; Shin, Dong M.			Recent advances in head and neck cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-RECEPTOR; MODULATED RADIATION-THERAPY; LYMPH-NODE METASTASIS; LOCALLY ADVANCED HEAD; MULTICENTER PHASE-II; HUMAN-PAPILLOMAVIRUS; PROTEIN-KINASE; CONCURRENT CHEMOTHERAPY; PREMALIGNANT LESIONS		[Haddad, Robert I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Haddad, Robert I.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Haddad, Robert I.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shin, Dong M.] Emory Univ, Dept Hematol Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Emory University	Haddad, RI (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	robert_haddad@dfci.harvard.edu	Teh, Muy-Teck/B-9284-2016; Ray, Dana M/C-3470-2013; Shin, Dong Moon/G-9649-2013	Teh, Muy-Teck/0000-0002-7725-8355; Shin, Dong Moon/0000-0002-8245-4174; Haddad, Robert/0000-0003-1413-0079	ImClone Systems; Bristol-Myers Squibb; Sanofi-Aventis	ImClone Systems(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis)	Dr. Haddad reports receiving consulting fees from ImClone Systems and Bristol-Myers Squibb and lecture fees from Sanofi-Aventis and Bristol-Myers Squibb; and Dr. Shin, lecture fees from Bristol-Myers Squibb and Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported. We thank Drs. Anthea Hammond and Souheil El-Chemaly for their critical reading of and assistance with the preparation of the manuscript.	Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Ang K, 2007, INT J RADIAT ONCOL, V69, pS12, DOI 10.1016/j.ijrobp.2007.07.023; Ang KK, 2002, CANCER RES, V62, P7350; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; CALLENDER T, 1994, CANCER-AM CANCER SOC, V74, P152, DOI 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO;2-K; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Choi HR, 2003, AM J SURG PATHOL, V27, P1216, DOI 10.1097/00000478-200309000-00004; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; COHEN S, 1980, J BIOL CHEM, V255, P4834; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; COPPER MP, 1995, ARCH OTOLARYNGOL, V121, P157; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Diwakar N, 2005, ORAL ONCOL, V41, P416, DOI 10.1016/j.oraloncology.2004.10.009; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Eisbruch A, 2005, NAT CLIN PRACT ONCOL, V2, P34, DOI 10.1038/ncponc0058; El-Naggar AK, 1997, DIAGN MOL PATHOL, V6, P305, DOI 10.1097/00019606-199712000-00001; ElNaggar AK, 1996, CLIN CANCER RES, V2, P903; ElNaggar AK, 1996, AM J PATHOL, V148, P2067; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FORASTIERE A, 2002, NEW ENGL J MED, V346, P788; Forastiere AA, 2006, J CLIN ONCOL, V24, p284S; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Garden AS, 2007, INT J RADIAT ONCOL, V67, P438, DOI 10.1016/j.ijrobp.2006.08.078; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gasco M, 2003, ORAL ONCOL, V39, P222, DOI 10.1016/S1368-8375(02)00163-X; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Herbst RS, 2002, CANCER-AM CANCER SOC, V94, P1593, DOI 10.1002/cncr.10372; Jang SJ, 2001, ONCOGENE, V20, P2235, DOI 10.1038/sj.onc.1204311; Janot F, 1996, BRIT J CANCER, V73, P531, DOI 10.1038/bjc.1996.92; Jin C, 2002, CANCER GENET CYTOGEN, V132, P85, DOI 10.1016/S0165-4608(01)00535-0; Jin YT, 1999, ORAL ONCOL, V35, P251, DOI 10.1016/S1368-8375(98)00112-2; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; LAI SL, 1995, ONCOL REP, V2, P1115; Laird AD, 2000, CANCER RES, V60, P4152; Lee NY, 2006, INT J RADIAT ONCOL, V66, P966, DOI 10.1016/j.ijrobp.2006.06.040; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Li GJ, 2004, CARCINOGENESIS, V25, P1911, DOI 10.1093/carcin/bgh197; Li MF, 2002, CLIN CANCER RES, V8, P3570; Li Y, 2007, INT J RADIAT ONCOL, V67, P660, DOI 10.1016/j.ijrobp.2006.09.021; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; MASUI H, 1984, CANCER RES, V44, P1002; MENDELSOHN J, 1988, PROG ALLERGY, V45, P147; Mendenhall WM, 2006, J CLIN ONCOL, V24, P2618, DOI 10.1200/JCO.2005.04.7225; Mosher William D, 2005, Adv Data, P1; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Papadimitrakopoulou VA, 2001, CLIN CANCER RES, V7, P3127; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Perrone F, 2007, CLIN CANCER RES, V13, P4313; Pignon JP, 2007, INT J RADIAT ONCOL, V69, pS112, DOI 10.1016/j.ijrobp.2007.04.088; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Seiden MV, 2007, GYNECOL ONCOL, V104, P727, DOI 10.1016/j.ygyno.2006.10.019; SHAH JP, 1990, AM J SURG, V160, P405, DOI 10.1016/S0002-9610(05)80554-9; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; STEWART S, 2007, P AM ASS CANC RES AN; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tseng JE, 2001, CANCER-AM CANCER SOC, V92, P2364, DOI 10.1002/1097-0142(20011101)92:9<2364::AID-CNCR1584>3.0.CO;2-P; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; VERMORKEN J, 2007, EUR J CANCER, V5, P4; VERMORKEN J, 2007, 43 ANN M AM SOC CLIN; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Vokes EE, 2005, J CLIN ONCOL, V23, p501S; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang XH, 2006, ORAL ONCOL, V42, P740, DOI 10.1016/j.oraloncology.2005.11.018; Weber A, 2003, PATHOL RES PRACT, V199, P391, DOI 10.1078/0344-0338-00435; WILLIAMS R, 1993, J BIOL CHEM, V268, P18213; Zhang ZD, 2004, CANCER EPIDEM BIOMAR, V13, P1081	90	685	702	0	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1143	1154		10.1056/NEJMra0707975	http://dx.doi.org/10.1056/NEJMra0707975			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784104				2022-12-01	WOS:000259078200010
J	Liu, JY; O'Brien, KL; Lynch, DM; Simmons, NL; La Porte, A; Riggs, AM; Abbink, P; Coffey, RT; Grandpre, LE; Seaman, MS; Landucci, G; Forthal, DN; Montefiori, DC; Carville, A; Mansfield, KG; Havenga, MJ; Pau, MG; Goudsmit, J; Barouch, DH				Liu, Jinyan; O'Brien, Kara L.; Lynch, Diana M.; Simmons, Nathaniel L.; La Porte, Annalena; Riggs, Ambryice M.; Abbink, Peter; Coffey, Rory T.; Grandpre, Lauren E.; Seaman, Michael S.; Landucci, Gary; Forthal, Donald N.; Montefiori, David C.; Carville, Angela; Mansfield, Keith G.; Havenga, Menzo J.; Pau, Maria G.; Goudsmit, Jaap; Barouch, Dan H.			Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys	NATURE			English	Article							IMMUNODEFICIENCY VIRUS SIVMAC239; SIMIAN-IMMUNODEFICIENCY; ADENOVIRUS VECTORS; REPLICATION; INFECTION; MEMORY; IMMUNOGENICITY; RESPONSES; HIV; MAMU-A-ASTERISK-01	A recombinant adenovirus serotype 5 ( rAd5) vector- based vaccine for HIV-1 has recently failed in a phase 2b efficacy study in humans(1,2). Consistent with these results, preclinical studies have demonstrated that rAd5 vectors expressing simian immunodeficiency virus (SIV) Gag failed to reduce peak or setpoint viral loads after SIV challenge of rhesus monkeys ( Macaca mulatta) that lacked the protective MHC class I allele Mamu-A*01 ( ref. 3). Here we show that an improved T- cell- based vaccine regimen using two serologically distinct adenovirus vectors afforded substantially improved protective efficacy in this challenge model. In particular, a heterologous rAd26 prime/rAd5 boost vaccine regimen expressing SIV Gag elicited cellular immune responses with augmented magnitude, breadth and polyfunctionality as compared with the homologous rAd5 regimen. After SIVMAC251 challenge, monkeys vaccinated with the rAd26/rAd5 regimen showed a 1.4 log reduction of peak and a 2.4 log reduction of setpoint viral loads as well as decreased AIDS- related mortality as compared with control animals. These data demonstrate that durable partial immune control of a pathogenic SIV challenge for more than 500 days can be achieved by a T- cell- based vaccine in Mamu-A*01-negative rhesus monkeys in the absence of a homologous Env antigen. These findings have important implications for the development of next- generation T- cell- based vaccine candidates for HIV- 1.	[Liu, Jinyan; O'Brien, Kara L.; Lynch, Diana M.; Simmons, Nathaniel L.; La Porte, Annalena; Riggs, Ambryice M.; Abbink, Peter; Coffey, Rory T.; Grandpre, Lauren E.; Seaman, Michael S.; Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Sch Med, Irvine, CA 92697 USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Carville, Angela; Mansfield, Keith G.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Havenga, Menzo J.] TNO Biosci, NL-2301 CE Leiden, Netherlands; [Pau, Maria G.; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Irvine; Duke University; Netherlands Organization Applied Science Research; Johnson & Johnson	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019	Simmons, Nathaniel/0000-0001-6080-2783	NIH [AI066305, AI066924, AI078526, AI030034, RR000168]; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058727, U19AI078526, U19AI066305, R01AI066924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Vogels, J. Custers, L. Holterman, A. Lemckert, F. Stephens, R. Dolin, N. Letvin, J. Schmitz, M. Lifton, K. Furr, L. Picker and M. Pensiero for generous advice, assistance and reagents. The SIV peptide pools were obtained from the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program. We acknowledge support from NIH grants AI066305 ( D. H. B.), AI066924 ( D. H. B.), AI078526 ( D. H. B.), AI030034 ( D. C. M.) and RR000168.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; FAUCI AS, 2007, NIH NEWS        1107, P45704; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM, P45704; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Veazey RS, 2008, J VIROL, V82, P5618, DOI 10.1128/JVI.02748-07; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002	30	377	420	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					87	91		10.1038/nature07469	http://dx.doi.org/10.1038/nature07469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18997770	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000262104900036
J	Ip, SCY; Rass, U; Blanco, MG; Flynn, HR; Skehel, JM; West, SC				Ip, Stephen C. Y.; Rass, Ulrich; Blanco, Miguel G.; Flynn, Helen R.; Skehel, J. Mark; West, Stephen C.			Identification of Holliday junction resolvases from humans and yeast	NATURE			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MUS81/MMS4 ENDONUCLEASE; FLAP ENDONUCLEASE-1; MAMMALIAN-CELLS; GENE CONVERSION; NUCLEASE FAMILY; CROSSING-OVER; IN-VITRO; RECOMBINATION	Four-way DNA intermediates, also known as Holliday junctions, are formed during homologous recombination and DNA repair, and their resolution is necessary for proper chromosome segregation. Here we identify nucleases from Saccharomyces cerevisiae and human cells that promote Holliday junction resolution, in a manner analogous to that shown by the Escherichia coli Holliday junction resolvase RuvC. The human Holliday junction resolvase, GEN1, and its yeast orthologue, Yen1, were independently identified using two distinct experimental approaches: GEN1 was identified by mass spectrometry following extensive fractionation of HeLa cell- free extracts, whereas Yen1 was detected by screening a yeast gene fusion library for nucleases capable of Holliday junction resolution. The eukaryotic Holliday junction resolvases represent a new subclass of the Rad2/ XPG family of nucleases. Recombinant GEN1 and Yen1 resolve Holliday junctions by the introduction of symmetrically related cuts across the junction point, to produce nicked duplex products in which the nicks can be readily ligated.	[Ip, Stephen C. Y.; Rass, Ulrich; Blanco, Miguel G.; West, Stephen C.] Clare Hall Labs, London Res Inst, Canc Res UK, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Flynn, Helen R.; Skehel, J. Mark] Clare Hall Labs, London Res Inst, Canc Res UK, Prot Anal & Proteom Lab, S Mimms EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK	West, SC (corresponding author), Clare Hall Labs, London Res Inst, Canc Res UK, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Blanco, Miguel González/J-6424-2012; Blanco, Miguel González/R-5754-2017	Blanco, Miguel González/0000-0002-2883-7326; Blanco, Miguel González/0000-0002-2883-7326; Rass, Ulrich/0000-0001-9275-9062; Flynn, Helen/0000-0001-7002-9130; West, Stephen/0000-0001-8848-9418	Cancer Research UK; Louis-Jeantet Foundation; EU DNA Repair Consortium; Croucher Foundation; Xunta de Galicia; Spanish Ministry of Education	Cancer Research UK(Cancer Research UK); Louis-Jeantet Foundation; EU DNA Repair Consortium; Croucher Foundation; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish Ministry of Education(Spanish Government)	We thank M. Lichten and J. Haber for communication of unpublished work, J.-Y. Bleuyard, A. Deans and other members of our laboratory, past and present, for their input and discussions. We acknowledge the contributions of K. Elborough, H. Hyde, B. Kysela, A. Davies, A. Constantinou and Y. Liu for early studies that underpin this work, which was supported by Cancer Research UK, the Louis-Jeantet Foundation and the EU DNA Repair Consortium. S.C.Y.I. was supported by the Croucher Foundation. M. G. B. is on leave from the University of Santiago de Compostela, and supported by fellowships from the Xunta de Galicia and the Spanish Ministry of Education.	Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; de los Santos T, 2003, GENETICS, V164, P81; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; ELBOROUGH KM, 1990, EMBO J, V9, P2931, DOI 10.1002/j.1460-2075.1990.tb07484.x; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Furukawa T, 2003, PLANT MOL BIOL, V51, P59, DOI 10.1023/A:1020789314722; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HYDE H, 1994, J BIOL CHEM, V269, P5202; Ishikawa G, 2004, NUCLEIC ACIDS RES, V32, P6251, DOI 10.1093/nar/gkh962; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Kanai Y, 2007, FEBS J, V274, P3914, DOI 10.1111/j.1742-4658.2007.05924.x; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Moritoh S, 2005, PLANT CELL PHYSIOL, V46, P699, DOI 10.1093/pcp/pci090; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Rass U, 2006, METHOD ENZYMOL, V408, P485, DOI 10.1016/S0076-6879(06)08030-X; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Smith GR, 2003, GENETICS, V165, P2289; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	43	294	299	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2008	456	7220					357	U39		10.1038/nature07470	http://dx.doi.org/10.1038/nature07470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020614				2022-12-01	WOS:000261039600036
J	Hauser, MD; Bever, T				Hauser, Marc D.; Bever, Thomas			BEHAVIOR A Biolinguistic Agenda	SCIENCE			English	Editorial Material							LANGUAGE; SPEECH; FOXP2		[Hauser, Marc D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Bever, Thomas] Univ Arizona, Dept Linguist, Psychol & Cognit Sci Program, Tucson, AZ 85721 USA	Harvard University; University of Arizona	Hauser, MD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdh@wjh.harvard.edu						Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; BATES E, 1994, DISCUSS NEUROSCI, V10, P136; Bever T. G., 1989, NEURONS READING; Boeckx C, 2005, LINGUIST REV, V22, P447, DOI 10.1515/tlir.2005.22.2-4.447; Chan Shiao-Hui, 2007, THESIS U ARIZONA; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Chomsky N., 1957, SYNTACTIC STRUCTURES, DOI DOI 10.1515/9783112316009; Deacon Terrence, 1997, SYMBOLIC SPECIES COE; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; HUTTON JT, 1977, CORTEX, V13, P195, DOI 10.1016/S0010-9452(77)80009-9; Jackendoff Ray, 2002, FDN LANGUAGE; Lennenberg E.H., 1967, BIOL FDN LANGUAGE; LURIA AR, 1969, TRAUMATIC APHASIA; Murphy RA, 2008, SCIENCE, V319, P1849, DOI 10.1126/science.1151564; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Pinker S., 1984, LANGUAGE LEARNABILIT; Ross DS, 2004, BRAIN LANG, V89, P115, DOI 10.1016/S0093-934X(03)00308-0; Townsend DJ, 2001, BRAIN LANG, V78, P308, DOI 10.1006/brln.2001.2469	22	18	20	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1057	1059		10.1126/science.1167437	http://dx.doi.org/10.1126/science.1167437			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	371YD	19008433				2022-12-01	WOS:000260867700023
J	Heiman, M; Schaefer, A; Gong, S; Peterson, JD; Day, M; Ramsey, KE; Suarez-Farinas, M; Schwarz, C; Stephan, DA; Surmeier, DJ; Greengard, P; Heintz, N				Heiman, Myriam; Schaefer, Anne; Gong, Shiaoching; Peterson, Jayms D.; Day, Michelle; Ramsey, Keri E.; Suarez-farinas, Mayte; Schwarz, Cordelia; Stephan, Dietrich A.; Surmeier, D. James; Greengard, Paul; Heintz, Nathaniel			A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types	CELL			English	Article							INNERVATED BRAIN-REGIONS; CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; RAT-BRAIN; BASAL GANGLIA; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; CAENORHABDITIS-ELEGANS; NUCLEUS-ACCUMBENS; ADENYLYL-CYCLASE	The cellular heterogeneity of the brain confounds efforts to elucidate the biological properties of distinct neuronal populations. Using bacterial artificial chromosome (BAC) transgenic mice that express EGFP-tagged ribosomal protein L10a in defined cell populations, we have developed a methodology for affinity purification of polysomal mRNAs from genetically defined cell populations in the brain. The utility of this approach is illustrated by the comparative analysis of four types of neurons, revealing hundreds of genes that distinguish these four cell populations. We find that even two morphologically indistinguishable, intermixed subclasses of medium spiny neurons display vastly different translational profiles and present examples of the physiological significance of such differences. This genetically targeted translating ribosome affinity purification (TRAP) methodology is a generalizable method useful for the identification of molecular changes in any genetically defined cell type in response to genetic alterations, disease, or pharmacological perturbations.	[Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA; [Heiman, Myriam; Schaefer, Anne; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Schwarz, Cordelia; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Suarez-farinas, Mayte] Rockefeller Univ, Rockefeller Univ Hosp, New York, NY 10065 USA; [Peterson, Jayms D.; Day, Michelle; Surmeier, D. James] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ramsey, Keri E.; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Northwestern University; Feinberg School of Medicine; Translational Genomics Research Institute	Heintz, N (corresponding author), Rockefeller Univ, GENSAT Project, 1230 York Ave, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012	Suarez-Farinas, Mayte/0000-0001-8712-3553; Greengard, Paul/0000-0002-4437-0893	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034696, R01NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021487, P01DA010044] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [5UL1RR024143] Funding Source: Medline; NIA NIH HHS [P01 AG009464, P01 AG009464-16A1, P01 AG009464-17, AG09464] Funding Source: Medline; NIDA NIH HHS [F32 DA021487-02, P01 DA010044-10, P01 DA010044, DA10044, P01 DA010044-09, P01 DA010044-11, F32 DA021487-01, F32 DA021487, 5F32DA021487] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-04, P50 MH074866-01, P50 MH074866-010002, P50 MH074866-049002, P50 MH074866-040001, P50 MH074866-039001, P50 MH074866-030002, P50 MH074866-040002, P50 MH074866-03, P50 MH074866-029001, P50 MH074866, P50 MH074866-020001, P50 MH074866-030001, P50 MH074866-017204, P50 MH074866-029002, P50 MH074866-010001, P50 MH074866-039002, P50 MH074866-019002, P50 MH074866-049001, P50 MH074866-020002, P50 MH074866-010005, P50 MH074866-020005, P50 MH074866-030005, P50 MH074866-040005, P50 MH074866-02, MH074866, P50 MH074866-019001] Funding Source: Medline; NINDS NIH HHS [NS34696, R37 NS034696-12, R37 NS034696-11, R01 NS034696, R37 NS034696-13, R37 NS034696] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Castets F, 1996, J CELL BIOL, V134, P1051, DOI 10.1083/jcb.134.4.1051; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; DI CG, 1988, P NATL ACAD SCI USA, V85, P5274; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.3.CO;2-0; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.ne.15.030192.001441; GIRAULT JA, 1990, J NEUROSCI, V10, P1124; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Ince E, 1997, SYNAPSE, V27, P357, DOI 10.1002/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Kubota Y, 2000, J NEUROSCI, V20, P375, DOI 10.1523/JNEUROSCI.20-01-00375.2000; Kunitomo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r17; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lobo MK, 2007, NAT NEUROSCI, V10, P1395, DOI 10.1038/nn1987; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Mizushima K, 2000, GENOMICS, V69, P314, DOI 10.1006/geno.2000.6340; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; OH JD, 1992, NEUROSCIENCE, V47, P807, DOI 10.1016/0306-4522(92)90031-V; OUIMET CC, 1989, J NEUROSCI, V9, P865; POLLI JW, 1992, P NATL ACAD SCI USA, V89, P11079, DOI 10.1073/pnas.89.22.11079; Ramon y Cajal S., 1899, TEXTURE NERVOUS SYST; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Volkow ND, 1998, AM J PSYCHIAT, V155, P200; WALAAS SI, 1984, J NEUROSCI, V4, P84; WATSON JB, 1994, J NEUROSCI RES, V39, P108, DOI 10.1002/jnr.490390113; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477	56	751	759	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					738	748		10.1016/j.cell.2008.10.028	http://dx.doi.org/10.1016/j.cell.2008.10.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013281	Green Accepted, Bronze			2022-12-01	WOS:000260886900023
J	Friel, S; Marmot, M; McMichael, AJ; Kjellstrom, T; Vagero, D				Friel, Sharon; Marmot, Michael; McMichael, Anthony J.; Kjellstrom, Tord; Vagero, Denny			Global health equity and climate stabilisation: a common agenda	LANCET			English	Article							FOOD	Although health has improved for many people, the extent of health inequities between and within countries is growing. Meanwhile, humankind is disrupting the global climate and other life-supporting environmental systems, thereby creating serious risks for health and wellbeing, especially in vulnerable populations but ultimately for everybody. Underlying determinants of health inequity and environmental change overlap substantially; they are signs of an economic system predicated on asymmetric growth and competition, shaped by market forces that mostly disregard health and environmental consequences rather than by values of fairness and support. A shift is needed in priorities in economic development towards healthy forms of urbanisation, more efficient and renewable energy sources, and a sustainable and fairer food system. Global interconnectedness and interdependence enable the social and environmental determinants of health to be addressed in ways that will increase health equity, reduce poverty, and build societies that live within environmental limits.	[Friel, Sharon; Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, Commission Social Determinants Hlth, Int Inst Soc & Hlth, London WC1E 6BT, England; [Vagero, Denny] Stockholm Univ, Commission Social Determinants Hlth, S-10691 Stockholm, Sweden; [Vagero, Denny] Stockholm Univ, CHESS Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden; [Vagero, Denny] Karolinska Inst, Stockholm, Sweden; [Friel, Sharon; McMichael, Anthony J.; Kjellstrom, Tord] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	University of London; University College London; Stockholm University; Stockholm University; Karolinska Institutet; Australian National University	Friel, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Commission Social Determinants Hlth, Int Inst Soc & Hlth, London WC1E 6BT, England.	s.friel@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Vagero, Denny/0000-0002-1854-2292; Friel, Sharon/0000-0002-8345-5435	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G19/35, G8802774] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alcott B, 2008, ECOL ECON, V64, P770, DOI 10.1016/j.ecolecon.2007.04.015; [Anonymous], 2006, FOOD SECURITY HUNGER; Campbell-Lendrum D, 2007, J URBAN HEALTH, V84, pI109, DOI 10.1007/s11524-007-9170-x; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Dixon J, 2007, J URBAN HEALTH, V84, pI118, DOI 10.1007/s11524-007-9176-4; Epstein Paul, 2005, GLOBALIZATION HLTH E, P239; Friel S, 2007, BRIT MED J, V335, P1241, DOI 10.1136/bmj.39377.622882.47; Garcia FJ, 2007, J INT ECON LAW, V10, P461, DOI 10.1093/jiel/jgm022; Gorham R., 2002, AIR POLLUTION GROUND; Hanlon P, 2008, PUBLIC HEALTH, V122, P647, DOI 10.1016/j.puhe.2008.03.020; Hastings G., 2007, EXTENT NATURE EFFECT; *INT LAB ORG, 2008, GLOB ENV TRENDS; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Kjellstrom T, 2007, J URBAN HEALTH, V84, pI86, DOI 10.1007/s11524-007-9171-9; *KNOWL NETW URB SE, 2007, OUR CIT OUR HLTH OUR; Leon DA, 2008, INT J EPIDEMIOL, V37, P4, DOI 10.1093/ije/dym271; Lobstein T, 2008, LANCET, V372, P628, DOI 10.1016/S0140-6736(08)61270-2; LUNDBERG O, 2007, NORDIC EXPERIENCE WE; McMichael AJ, 2004, LANCET, V364, P2004, DOI 10.1016/S0140-6736(04)17529-6; McMichael AJ, 2008, LANCET, V371, P1895, DOI 10.1016/S0140-6736(08)60811-9; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; *NNC, 2001, SMART GROWTH NEIGHB; Patz JA, 2007, ECOHEALTH, V4, P397, DOI 10.1007/s10393-007-0141-1; Pretty JN, 2005, FOOD POLICY, V30, P1, DOI 10.1016/j.foodpol.2005.02.001; Research Australia, 2007, HLTH PLAN PLAC PEOPL; Royer DL, 2008, TARGET ATMOSPHERIC C; Sachs J., 2005, END POVERTY WE CAN M; Shaffer ER, 2005, AM J PUBLIC HEALTH, V95, P23, DOI 10.2105/AJPH.2004.038091; Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424; Stern N., 2006, STERN REV EC CLIMATE STERN REV EC CLIMATE; Stiglitz J., 2006, MAKING GLOBALIZATION; SWAMINATHAN M, 93 IND SCI C 2006 HY; UNDP, 2007, HUM DEV REP FIGHT CL; United Nations, 1948, UN DECL HUM RIGHTS; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; World Health Organization, 2008, COM SOC DET HLTH, V89; *WORLDWATCH I, 2007, STAT WORLD 2007 OUR; [No title captured]	40	115	115	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1677	1683		10.1016/S0140-6736(08)61692-X	http://dx.doi.org/10.1016/S0140-6736(08)61692-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994666				2022-12-01	WOS:000260899900030
J	Szathmary, E; Szamado, S				Szathmary, Eoers; Szamado, Szabolcs			Being Human: Language: a social history of words	NATURE			English	Editorial Material									[Szathmary, Eoers; Szamado, Szabolcs] Eotvos Lorand Univ, Inst Biol, H-1117 Budapest, Hungary; [Szathmary, Eoers] Collegium Budapest, Budapest, Hungary; [Szathmary, Eoers] Parmenides Ctr Study Thinking, Munich, Germany	Eotvos Lorand University	Szathmary, E (corresponding author), Eotvos Lorand Univ, Inst Biol, 1-C Pazmany Peter Setany, H-1117 Budapest, Hungary.	szathmary@colbud.hu	Számadó, Szabolcs/A-9804-2013; Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021	Számadó, Szabolcs/0000-0003-2204-9705; Szathmary, Eors/0000-0001-5227-2997					0	10	11	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					40	41		10.1038/456040a	http://dx.doi.org/10.1038/456040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	369DH	18987725	Bronze			2022-12-01	WOS:000260674000031
J	Hopkins, BB; Paull, TT				Hopkins, Ben B.; Paull, Tanya T.			The P-furiosus Mre11/Rad50 Complex Promotes 5 ' Strand Resection at a DNA Double-Strand Break	CELL			English	Article							HOMOLOGOUS RECOMBINATION; NUCLEASE ACTIVITIES; MRE11 COMPLEX; RECBCD ENZYME; SBCCD PROTEIN; REPAIR; RAD50; HELICASE; CHECKPOINT; BINDING	The Mre11/Rad50 complex has been implicated in the early steps of DNA double-strand break (DSB) repair through homologous recombination in several organisms. However, the enzymatic properties of this complex are incompatible with the generation of 30 single-stranded DNA for recombinase loading and strand exchange. In thermophilic archaea, the Mre11 and Rad50 genes cluster in an operon with genes encoding a helicase, HerA, and a 50 to 30 exonuclease, NurA, suggesting a common function. Here we show that purified Mre11 and Rad50 from Pyrococcus furiosus act cooperatively with HerA and NurA to resect the 50 strand at a DNA end under physiological conditions in vitro. The 30 single-stranded DNA generated by these enzymes can be utilized by the archaeal RecA homolog RadA to catalyze strand exchange. This work elucidates how the conserved Mre11/Rad50 complex promotes DNA end resection in archaea and may serve as a model for DSB processing in eukaryotes.	[Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA.	tpaull@mail.utexas.edu		Paull, Tanya/0000-0002-2991-651X	NIH [R01 CA094008]; DOD; NATIONAL CANCER INSTITUTE [R01CA094008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Carney for the P. furiosus Mre11/Rad50 expression plasmid, to L. Symington for personal communication of unpublished results, and to members of the Paull lab for comments about this project. This work was supported by NIH grant R01 CA094008 and DOD predoctoral fellowship to B. B.	ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; Constantinesco F, 2002, EMBO REP, V3, P537, DOI 10.1093/embo-reports/kvf112; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Kondo N, 2008, EXTREMOPHILES, V12, P217, DOI 10.1007/s00792-007-0118-6; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Manzan A, 2004, EMBO REP, V5, P54, DOI 10.1038/sj.embor.7400037; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Seitz EM, 2001, ADV APPL MICROBIOL, V50, P101, DOI 10.1016/S0065-2164(01)50005-2; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Zhang ST, 2008, DNA REPAIR, V7, P380, DOI 10.1016/j.dnarep.2007.10.010; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	49	125	129	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					250	260		10.1016/j.cell.2008.09.054	http://dx.doi.org/10.1016/j.cell.2008.09.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957200	Green Accepted, Bronze			2022-12-01	WOS:000260130400015
J	Tsukazaki, T; Mori, H; Fukai, S; Ishitani, R; Mori, T; Dohmae, N; Perederina, A; Sugita, Y; Vassylyev, DG; Ito, K; Nureki, O				Tsukazaki, Tomoya; Mori, Hiroyuki; Fukai, Shuya; Ishitani, Ryuichiro; Mori, Takaharu; Dohmae, Naoshi; Perederina, Anna; Sugita, Yuji; Vassylyev, Dmitry G.; Ito, Koreaki; Nureki, Osamu			Conformational transition of Sec machinery inferred from bacterial SecYE structures	NATURE			English	Article							TRANSLOCATION ATPASE SECA; PROTEIN-TRANSLOCATION; PREPROTEIN TRANSLOCATION; MEMBRANE; CHANNEL; COMPLEX; COMPONENTS; PARALLEL; DOMAIN; PHASE	Over 30% of proteins are secreted across or integrated into membranes. Their newly synthesized forms contain either cleavable signal sequences or non- cleavable membrane anchor sequences, which direct them to the evolutionarily conserved Sec translocon (SecYEG in prokaryotes and Sec61, comprising alpha-, gamma- and beta-subunits, in eukaryotes). The translocon then functions as a protein-conducting channel(1). These processes of protein localization occur either at or after translation. In bacteria, the SecA ATPase(2,3) drives post- translational translocation. The only high- resolution structure of a translocon available so far is that for SecYE beta from the archaeon Methanococcus jannaschii(4), which lacks SecA. Here we present the 3.2- A-resolution crystal structure of the SecYE translocon from a SecA- containing organism, Thermus thermophilus. The structure, solved as a complex with an anti- SecY Fab fragment, revealed a 'pre-open' state of SecYE, in which several transmembrane helices are shifted, as compared to the previous SecYEb structure(4), to create a hydrophobic crack open to the cytoplasm. Fab and SecA bind to a common site at the tip of the cytoplasmic domain of SecY. Molecular dynamics and disulphide mapping analyses suggest that the pre- open state might represent a SecYE conformational transition that is inducible by SecA binding. Moreover, we identified a SecA - SecYE interface that comprises SecA residues originally buried inside the protein, indicating that both the channel and the motor components of the Sec machinery undergo cooperative conformational changes on formation of the functional complex.	[Tsukazaki, Tomoya; Fukai, Shuya; Nureki, Osamu] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, Kanagawa 2268501, Japan; [Mori, Hiroyuki; Ito, Koreaki] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Div Struct Biol, Dept Basic Med Sci, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Dohmae, Naoshi] RIKEN, CREST JST, Wako, Saitama 3510198, Japan; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Tokyo Institute of Technology; Kyoto University; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); RIKEN; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Nureki, O (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta Cho, Kanagawa 2268501, Japan.	Koreaki.Ito@ky5.ecs.kyoto-u.ac.jp; nureki@ims.u-tokyo.ac.jp	Sugita, Yuji/L-6726-2014; NUREKI, OSAMU/G-4960-2014; Mori, Takaharu/AAH-1234-2021; Tsukazaki, Tomoya/N-2299-2019; Vassylyev, Dmitry/A-9005-2008; Fukai, Shuya/X-4838-2018; Dohmae, Naoshi/C-2040-2011	Sugita, Yuji/0000-0001-9738-9216; Tsukazaki, Tomoya/0000-0002-6386-723X; Fukai, Shuya/0000-0002-1241-1443; Dohmae, Naoshi/0000-0002-5242-9410; Mori, Hiroyuki/0000-0002-0429-1269	SORST program; CREST; BIRD; Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine); National Project on Protein Structural and Functional Analyses; NIH; MEXT; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [20247020] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074252, R01GM074840] Funding Source: NIH RePORTER	SORST program; CREST(Core Research for Evolutional Science and Technology (CREST)); BIRD; Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Inaba, Y. Akiyama and M. Hattori for useful suggestions about sample preparation and crystallization; T. Sakamoto and T. Saika for their assistance in the purification of T. thermophilus SecYE; K. Mochizuki, M. Sano, K. Yoshikaie, T. Adachi and Y. Echizen for technical support; and the beamline staff members at BL41XU of SPring- 8 ( Sayo, Japan) and NW12 of PF ( Tsukuba, Japan) for technical help during data collection. We also thank I. Artsimovitch for critically reading the manuscript. This work was supported by a SORST program grant from JST ( Japan Science and Technology) to O. N., by a CREST grant from JST to K. I. and N. D., by a BIRD grant from JST to H. M. and Y. S., by Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine) and a grant for the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology ( MEXT) to O. N., by NIH grants to D. G. V., by grants from MEXT to H.M, S.F., R.I., K.I. and O.N., and by Mitsubishi Foundation grants to O.N.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2003, J BACTERIOL, V185, P405, DOI 10.1128/JB.185.2.405-412.2003; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rusch SL, 2007, BBA-BIOMEMBRANES, V1768, P5, DOI 10.1016/j.bbamem.2006.08.013; Shindo N, 1997, ANAL BIOCHEM, V249, P79, DOI 10.1006/abio.1997.2155; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Vassylyeva MN, 2006, ACTA CRYSTALLOGR F, V62, P909, DOI 10.1107/S1744309106030843; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	43	177	184	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					988	U72		10.1038/nature07421	http://dx.doi.org/10.1038/nature07421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923527	Green Accepted			2022-12-01	WOS:000260038300055
J	Moritz, C; Patton, JL; Conroy, CJ; Parra, JL; White, GC; Beissinger, SR				Moritz, Craig; Patton, James L.; Conroy, Chris J.; Parra, Juan L.; White, Gary C.; Beissinger, Steven R.			Impact of a century of climate change on small-mammal communities in Yosemite National Park, USA	SCIENCE			English	Article							SPECIES RANGE; GREAT-BASIN; 20TH-CENTURY; RESPONSES; EXTINCTION; CALIFORNIA; SHIFT	We provide a century-scale view of small-mammal responses to global warming, without confounding effects of land-use change, by repeating Grinnell's early-20th century survey across a 3000-meter-elevation gradient that spans Yosemite National Park, California, USA. Using occupancy modeling to control for variation in detectability, we show substantial (similar to 500 meters on average) upward changes in elevational limits for half of 28 species monitored, consistent with the observed similar to 3 degrees C increase in minimum temperatures. Formerly low-elevation species expanded their ranges and high-elevation species contracted theirs, leading to changed community composition at mid- and high elevations. Elevational replacement among congeners changed because species' responses were idiosyncratic. Though some high-elevation species are threatened, protection of elevation gradients allows other species to respond via migration.	[Moritz, Craig; Patton, James L.; Conroy, Chris J.; Parra, Juan L.; Beissinger, Steven R.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Moritz, Craig; Patton, James L.; Parra, Juan L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [White, Gary C.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Beissinger, Steven R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Colorado State University; University of California System; University of California Berkeley	Moritz, C (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	craigm@berkeley.edu	White, Gary/CAG-1290-2022; Beissinger, Steven R/F-3809-2012		Yosemite Foundation; National Parks Service; NSF [DEB 0640859]	Yosemite Foundation; National Parks Service; NSF(National Science Foundation (NSF))	Supported by funding from the Yosemite Foundation, the National Parks Service, and NSF (DEB 0640859). Assistance was received from A. Chang, H. Shofi, K. Tsao, D. Yang, W. Monahan, R. Hijmans, and M. Koo. L. Chow (U.S. Geological Survey Yosemite) and S. Thompson (Yosemite National Park) stimulated and participated in the project. Comments from R. Colwell, M. Power, F. Hamer, and L. Shoo improved this manuscript.	Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Burns CE, 2003, P NATL ACAD SCI USA, V100, P11474, DOI 10.1073/pnas.1635115100; Chao A., 2005, ENCY STAT SCI; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Grayson DK, 2006, QUATERNARY SCI REV, V25, P2964, DOI 10.1016/j.quascirev.2006.03.004; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Grinnell J., 1924, ANIMAL LIFE YOSEMITE; Grinnell Joseph, 1910, Popular Science Monthly, V77; Guarin A, 2005, FOREST ECOL MANAG, V218, P229, DOI 10.1016/j.foreco.2005.07.014; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; MacKenzie D.I., 2006, INFERRING PATTERNS D; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rowe RJ, 2007, AM NAT, V170, P242, DOI 10.1086/518948; Rowe RJ, 2005, J BIOGEOGR, V32, P1883, DOI 10.1111/j.1365-2699.2005.01346.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	28	719	756	8	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					261	264		10.1126/science.1163428	http://dx.doi.org/10.1126/science.1163428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845755				2022-12-01	WOS:000259902300049
J	Watts, G				Watts, Geoff			What happened to the polypill?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE					geoff@scileg.freeserve.co.uk						Rodgers A, 2003, BMJ-BRIT MED J, V326, P1407, DOI 10.1136/bmj.326.7404.1407; *U AUCKL CLIN TRIA, 2008, PILL PIL PROGR IMPR; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	3	7	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1822	10.1136/bmj.a1822	http://dx.doi.org/10.1136/bmj.a1822			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18819953				2022-12-01	WOS:000259798000030
J	Katz, MH				Katz, Mitchell H.			Banning tobacco sales in pharmacies - The right prescription	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING; ACCEPTABILITY; CIGARETTES; ADULTS		[Katz, Mitchell H.] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA	San Francisco Department of Public Health	Katz, MH (corresponding author), San Francisco Dept Publ Hlth, 101 Grove St,Room 308, San Francisco, CA 94102 USA.	mitch.katz@sfdph.org						Albers AB, 2004, TOB CONTROL, V13, P347, DOI 10.1136/tc.2003.007336; Alesci NL, 2003, PREV MED, V36, P272, DOI 10.1016/S0091-7435(02)00029-4; BRANDECKER M, NY PHARM COULD BANNE; *CAL MED ASS FDN, 2000, PRESCR CHANG CAL REA; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; DAVIS RM, 1992, TOB CONTROL, V1, P84; Eule B, 2004, TOB CONTROL, V13, P429, DOI 10.1136/tc.2004.007872; Farkas AJ, 2000, JAMA-J AM MED ASSOC, V284, P717, DOI 10.1001/jama.284.6.717; Fong, 2008, WALL STREET J, pB1; Hudmon KS, 2006, TOB CONTROL, V15, P35, DOI 10.1136/tc.2005.012278; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; NATION NI, 2008, MARIN INDEPENDE 0801; *NCI, MON NCI, V19; SCHROEDER SA, 1978, AM J PUBLIC HEALTH, V68, P494, DOI 10.2105/AJPH.68.5.494; TAYLOR MC, BANNING CIGARETTE SA	15	24	24	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1451	1453		10.1001/jama.300.12.1451	http://dx.doi.org/10.1001/jama.300.12.1451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812536				2022-12-01	WOS:000259410400023
J	Clark, AM; Thompson, DR				Clark, Alexander M.; Thompson, David R.			The future of management programmes for heart failure	LANCET			English	Editorial Material									[Clark, Alexander M.] Univ Alberta, Fac Nursing, Edmonton, AB T6R 2RG, Canada; [Thompson, David R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Thompson, David R.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Alberta; University of Leicester; University of Leicester	Clark, AM (corresponding author), Univ Alberta, Fac Nursing, Edmonton, AB T6R 2RG, Canada.	Alex.Clark@ualberta.ca	Thompson, David R/C-6320-2009; Thompson, David R/E-2431-2018	Thompson, David R/0000-0001-8518-6307; Clark, Alexander/0000-0002-2860-0492				Clark AM, 2007, HEALTH-LONDON, V11, P513, DOI 10.1177/1363459307080876; Holland R, 2005, HEART, V91, P899, DOI 10.1136/hrt.2004.048389; Holland R, 2007, BRIT MED J, V334, P1098, DOI 10.1136/bmj.39164.568183.AE; Jaarsma T, 2008, ARCH INTERN MED, V168, P316, DOI 10.1001/archinternmed.2007.83; Ledwidge M, 2005, EUR J HEART FAIL, V7, P385, DOI 10.1016/j.ejheart.2004.10.022; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Nguyen V, 2007, J CARD FAIL, V13, P287, DOI 10.1016/j.cardfail.2007.01.002; Nucifora G, 2006, J CARDIOVASC MED, V7, P614, DOI 10.2459/01.JCM.0000237910.34000.58; Pawson R., 1997, REALISTIC EVALUATION; Smith B, 2005, AM J MANAG CARE, V11, P701; Taylor S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub2; Yu DSF, 2006, EUR HEART J, V27, P596, DOI 10.1093/eurheartj/ehi656	13	36	41	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					784	786		10.1016/S0140-6736(08)61317-3	http://dx.doi.org/10.1016/S0140-6736(08)61317-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774405				2022-12-01	WOS:000259124900007
J	Vezys, V; Yates, A; Casey, KA; Lanier, G; Ahmed, R; Antia, R; Masopust, D				Vezys, Vaiva; Yates, Andrew; Casey, Kerry A.; Lanier, Gibson; Ahmed, Rafi; Antia, Rustom; Masopust, David			Memory CD8 T-cell compartment grows in size with immunological experience	NATURE			English	Article							VIRAL-INFECTIONS; IMMUNITY; HOMEOSTASIS; VACCINATION; POPULATION; PROTECTION; PHENOTYPE; ATTRITION; SURVIVAL; SUBSETS	Memory CD8 T cells, generated by natural pathogen exposure or intentional vaccination, protect the host against specific viral infections(1). It has long been proposed that the number of memory CD8 T cells in the host is inflexible, and that individual cells are constantly competing for limited space(2,3). Consequently, vaccines that introduce over- abundant quantities of memory CD8 T cells specific for an agent of interest could have catastrophic consequences for the host by displacing memory CD8 T cells specific for all previous infections(4-6). To test this paradigm, we developed a vaccination regimen in mice that introduced as many new long- lived memory CD8 T cells specific for a single vaccine antigen as there were memory CD8 T cells in the host before vaccination. Here we show that, in contrast to expectations, the size of the memory CD8 T- cell compartment doubled to accommodate these new cells, a change due solely to the addition of effector memory CD8 T cells. This increase did not affect the number of CD4 T cells, B cells or naive CD8 T cells, and pre- existing memory CD8 T cells specific for a previously encountered infection were largely preserved. Thus, the number of effector memory CD8 T cells in the mammalian host adapts according to immunological experience. Developing vaccines that abundantly introduce new memory CD8 T cells should not necessarily ablate pre- existing immunity to other infections.	[Vezys, Vaiva; Casey, Kerry A.; Masopust, David] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Vezys, Vaiva; Casey, Kerry A.; Masopust, David] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Vezys, Vaiva; Lanier, Gibson; Ahmed, Rafi; Masopust, David] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Yates, Andrew; Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; Emory University	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	Casey, Kerry A/B-5274-2011; masopust, david/B-5027-2008; Casey, Kerry A/N-1456-2019; Vezys, Vaiva/N-3144-2013	Casey, Kerry A/0000-0001-7194-8585; Vezys, Vaiva/0000-0002-2520-809X	University of Minnesota Medical School; NIH [AI30048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048] Funding Source: NIH RePORTER	University of Minnesota Medical School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Jameson, E.J. Wherry and A. Haase for critical discussions and reading of the manuscript, and J. W. Yewdell for recombinant vaccinia virus. This research was supported by start-up funds from the University of Minnesota Medical School (V.V. and D.M.) and NIH grant AI30048 (R. Ahmed).	Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldrath AW, 2002, MICROBES INFECT, V4, P539, DOI 10.1016/S1286-4579(02)01570-8; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; HUNTER RL, 1995, J IMMUNOL, V154, P1762; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jackola DR, 1998, MECH AGEING DEV, V105, P241, DOI 10.1016/S0047-6374(98)00089-X; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Lefrancois L, 1999, J EXP MED, V190, P1275, DOI 10.1084/jem.190.9.1275; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Sad S, 2003, CRIT REV IMMUNOL, V23, P129, DOI 10.1615/CritRevImmunol.v23.i12.70; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009	26	174	176	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					196	U90		10.1038/nature07486	http://dx.doi.org/10.1038/nature07486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19005468				2022-12-01	WOS:000262360200033
J	Lu, JH; Marnell, LL; Marjon, KD; Mold, C; Du Clos, TW; Sun, PD				Lu, Jinghua; Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.; Sun, Peter D.			Structural recognition and functional activation of Fc gamma R by innate pentraxins	NATURE			English	Article							C-REACTIVE PROTEIN; AMYLOID-P-COMPONENT; HUMAN MONOCYTES; CRYSTAL-STRUCTURE; RECEPTOR-II; SERUM; CELLS; RIIA; PHAGOCYTOSIS; EXPRESSION	Pentraxins are a family of ancient innate immune mediators conserved throughout evolution. The classical pentraxins include serum amyloid P component ( SAP) and C- reactive protein, which are two of the acute- phase proteins synthesized in response to infection(1,2). Both recognize microbial pathogens and activate the classical complement pathway through C1q ( refs 3 and 4). More recently, members of the pentraxin family were found to interact with cell- surface Fc gamma receptors (Fc gamma R) and activate leukocyte-mediated phagocytosis(5-8). Here we describe the structural mechanism for pentraxin's binding to Fc gamma R and its functional activation of Fc gamma R- mediated phagocytosis and cytokine secretion. The complex structure between human SAP and Fc gamma RIIa reveals a diagonally bound receptor on each SAP pentamer with both D1 and D2 domains of the receptor contacting the ridge helices from two SAP subunits. The 1: 1 stoichiometry between SAP and Fc gamma RIIa infers the requirement for multivalent pathogen binding for receptor aggregation. Mutational and binding studies show that pentraxins are diverse in their binding specificity for Fc gamma R isoforms but conserved in their recognition structure. The shared binding site for SAP and IgG results in competition for Fc gamma R binding and the inhibition of immune- complex- mediated phagocytosis by soluble pentraxins. These results establish antibody- like functions for pentraxins in the Fc gamma R pathway, suggest an evolutionary overlap between the innate and adaptive immune systems, and have new therapeutic implications for autoimmune diseases.	[Lu, Jinghua; Sun, Peter D.] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Du Clos, Terry W.] Vet Adm Med Ctr, Albuquerque, NM 87108 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of New Mexico; University of New Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sun, PD (corresponding author), NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	psun@nih.gov	lu, jinghua/G-5872-2012		US Department of Energy; Basic Energy Sciences; Office of Science [W-31-109-Eng-83]; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Veterans Affairs;  [RO1 AI28358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007538, ZIAAI000853, R01AI028358] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Klinman, G. Cheng, P. W. Dempsey and S. Bolland for providing the bone marrow from the Myd88 2/2, RIP2 2/2 and wild- type C57BL/6 mice, respectively; M. Pancera and B. Dey for technical support in the isothermal titration calorimetry experiments; V. Deretic and S. Master for assistance with confocal microscopy; and B. Bottazzi for providing PTX-3. The X-ray SER-CAT beamlines (www.ser-cat.org/members.html) at the Advanced Photon Source is supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-83. This work was supported by intramural research funding from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and by RO1 AI28358 and by the Department of Veterans Affairs.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLES VV, 1994, BLOOD, V84, P3483; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bodman-Smith KB, 2002, IMMUNOLOGY, V107, P252, DOI 10.1046/j.1365-2567.2002.01481.x; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARK MR, 1991, EUR J IMMUNOL, V21, P1911, DOI 10.1002/eji.1830210820; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DUCLOS TW, 1989, J IMMUNOL, V143, P2553; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; MARNELL LL, 1995, J IMMUNOL, V155, P2185; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Mold C, 2002, J AUTOIMMUN, V19, P147, DOI 10.1006/jaut.2002.0615; Mold C, 2006, J IMMUNOL, V176, P7598, DOI 10.4049/jimmunol.176.12.7598; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Sondermann P, 1999, BIOL CHEM, V380, P717, DOI 10.1515/BC.1999.090; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Stein MP, 2000, J CLIN INVEST, V105, P369, DOI 10.1172/JCI7817; TAX WJM, 1983, NATURE, V304, P445, DOI 10.1038/304445a0; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Xia DY, 1997, P NATL ACAD SCI USA, V94, P2575, DOI 10.1073/pnas.94.6.2575; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412	41	221	231	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					989	U86		10.1038/nature07468	http://dx.doi.org/10.1038/nature07468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011614	Green Accepted			2022-12-01	WOS:000261768300054
J	Kaiser, TE; Intine, RV; Dundr, M				Kaiser, Trish E.; Intine, Robert V.; Dundr, Miroslav			De Novo Formation of a Subnuclear Body	SCIENCE			English	Article							CAJAL BODIES; IN-VIVO; SMN; PROTEIN; ORGANIZATION; RNA; EXPRESSION; ORGANELLES; DYNAMICS; GENOME	The mammalian cell nucleus contains structurally stable functional compartments. We show here that one of them, the Cajal body ( CB), can be formed de novo. Immobilization on chromatin of both CB structural components, such as coilin, and functional components of the CB, such as the SMN complex, spliceosomal small nuclear ribonucleoproteins ( RNPs), small nucleolar RNPs, and small Cajal body- specific RNPs, is sufficient for the formation of a morphologically normal and apparently functional CB. Biogenesis of the CB does not follow a hierarchical assembly pathway and exhibits hallmarks of a self- organizing structure.	[Kaiser, Trish E.; Intine, Robert V.; Dundr, Miroslav] Rosalind Franklin Univ Med & Sci, Dept Cell Biol, N Chicago, IL 60064 USA; [Intine, Robert V.] Rosalind Franklin Univ Med & Sci, Dr William M Scholl Coll Podiat Med, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Dundr, M (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Cell Biol, N Chicago, IL 60064 USA.	mirek.dundr@rosalindfranklin.edu			Schweppe Career Development Award (the Schweppe Foundation); Rosalind Franklin University of Medicine and Science	Schweppe Career Development Award (the Schweppe Foundation); Rosalind Franklin University of Medicine and Science	We thank A. Belmont, E. Bertrand, J. Gall, M. Hastings, P. Hemmerich, T. Kiss, I. Lemm, R. Luhrmann, G. Matera, T. Meier, T. Misteli, S. Sharma, E. Soutoglou, C. Verheggen, and P. Young for reagents; S. Shevtsov for technical assistance; and T. Misteli for helpful suggestions and critical reading of the manuscript. This research was supported by Schweppe Career Development Award (the Schweppe Foundation) to M.D. and by startup funds from the Rosalind Franklin University of Medicine and Science to M. D.	Belmont AS, 1999, METHOD CELL BIOL, V58, P203; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Carrero G, 2006, J THEOR BIOL, V239, P298, DOI 10.1016/j.jtbi.2005.07.019; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Isaac C, 1998, J CELL BIOL, V142, P319, DOI 10.1083/jcb.142.2.319; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Misteli T, 2008, HISTOCHEM CELL BIOL, V129, P5, DOI 10.1007/s00418-007-0355-x; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Morse R, 2007, HUM MOL GENET, V16, P2349, DOI 10.1093/hmg/ddm192; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Querido E, 2008, METHOD CELL BIOL, V85, P273; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Sleeman JE, 2003, J CELL SCI, V116, P2039, DOI 10.1242/jcs.00400; Sleeman JE, 2001, J CELL SCI, V114, P4407; Stanek D, 2008, MOL BIOL CELL, V19, P2534, DOI 10.1091/mbc.E07-12-1259; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083	25	184	184	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1713	1717		10.1126/science.1165216	http://dx.doi.org/10.1126/science.1165216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	18948503				2022-12-01	WOS:000261608300051
J	Pomerantz, RT; O'Donnell, M				Pomerantz, Richard T.; O'Donnell, Mike			The replisome uses mRNA as a primer after colliding with RNA polymerase	NATURE			English	Article							STALLED REPLICATION FORKS; DISCONTINUOUS DNA-REPLICATION; ESCHERICHIA-COLI; LAGGING-STRAND; LEADING-STRAND; CHAIN GROWTH; TRANSCRIPTION; REPAIR; ORGANIZATION; ELONGATION	Replication forks are impeded by DNA damage and protein - nucleic acid complexes such as transcribing RNA polymerase. For example, head- on collision of the replisome with RNA polymerase results in replication fork arrest. However, co- directional collision of the replisome with RNA polymerase has little or no effect on fork progression. Here we examine co- directional collisions between a replisome and RNA polymerase in vitro. We show that the Escherichia coli replisome uses the RNAtranscript as a primer to continue leading- strand synthesis after the collision with RNA polymerase that is displaced from the DNA. This action results in a discontinuity in the leading strand, yet the replisome remains intact and bound to DNA during the entire process. These findings underscore the notable plasticity by which the replisome operates to circumvent obstacles in its path and may explain why the leading strand is synthesized discontinuously in vivo.	[Pomerantz, Richard T.; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	odonnell@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health; Marie-Josee and Henry Kravis Fellowship at the Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie-Josee and Henry Kravis Fellowship at the Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to W. T. McAllister and R. Castagna for providing T7 RNAP, and to S. Darst and L. Westblade for providing E. coli RNAP proteins and plasmids. This work was supported by a grant from the National Institutes of Health (M.O.D.) and by a Marie-Josee and Henry Kravis Fellowship at the Rockefeller University (R.T.P.).	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOTTESMAN MM, 1973, J MOL BIOL, V77, P531, DOI 10.1016/0022-2836(73)90221-0; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Kobayashi T, 2003, MOL CELL BIOL, V23, P9178, DOI 10.1128/MCB.23.24.9178-9188.2003; KONRAD EB, 1973, J MOL BIOL, V77, P519, DOI 10.1016/0022-2836(73)90220-9; KORNBERG A, 1992, DNA REPLICATION, P246; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU B, 1994, P NATL ACAD SCI USA, V91, P10660, DOI 10.1073/pnas.91.22.10660; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; OLIVERA BM, 1974, NATURE, V250, P513, DOI 10.1038/250513a0; PAULING C, 1969, P NATL ACAD SCI USA, V64, P1195, DOI 10.1073/pnas.64.4.1195; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; STERNGLANZ R, 1976, BIOCHEMISTRY-US, V15, P1838, DOI 10.1021/bi00654a008; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; Tippin B, 2004, TRENDS MICROBIOL, V12, P288, DOI 10.1016/j.tim.2004.04.004; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vilette D, 1996, MOL GEN GENET, V252, P398, DOI 10.1007/BF02173004; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104; WANG TCV, 1994, BIOCHEM BIOPH RES CO, V198, P844, DOI 10.1006/bbrc.1994.1120; Wang TCV, 2005, BIOESSAYS, V27, P633, DOI 10.1002/bies.20233; WANG TCV, 1989, BIOCHEM BIOPH RES CO, V165, P685, DOI 10.1016/S0006-291X(89)80020-8	50	143	145	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					762	U51		10.1038/nature07527	http://dx.doi.org/10.1038/nature07527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19020502	Green Accepted			2022-12-01	WOS:000261559900042
J	Boisvert, CA; Mark-Kurik, E; Ahlberg, PE				Boisvert, Catherine A.; Mark-Kurik, Elga; Ahlberg, Per E.			The pectoral fin of Panderichthys and the origin of digits	NATURE			English	Article							TETRAPOD LIMB; EVOLUTION; FISH; EXPRESSION	One of the identifying characteristics of tetrapods ( limbed vertebrates) is the presence of fingers and toes. Whereas the proximal part of the tetrapod limb skeleton can easily be homologized with the paired fin skeletons of sarcopterygian ( lobe- finned) fish, there has been much debate about the origin of digits. Early hypotheses(1) interpreted digits as derivatives of fin radials, but during the 1990s the idea gained acceptance that digits are evolutionary novelties without direct equivalents in fish fin skeletons. This was partly based on developmental genetic data(2), but also substantially on the pectoral fin skeleton of the elpistostegid ( transitional fish/ tetrapod) Panderichthys, which appeared to lack distal digit- like radials(3). Here we present a CT scan study of an undisturbed pectoral fin of Panderichthys demonstrating that the plate- like 'ulnare' of previous reconstructions is an artefact and that distal radials are in fact present. This distal portion is more tetrapod- like than that found in Tiktaalik(4) and, in combination with new data about fin development in basal actinopterygians(5), sharks(6) and lungfish(7), makes a strong case for fingers not being a novelty of tetrapods but derived from pre- existing distal radials present in all sarcopterygian fish.	[Boisvert, Catherine A.; Ahlberg, Per E.] Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Mark-Kurik, Elga] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	Uppsala University; Tallinn University of Technology	Boisvert, CA (corresponding author), Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Evolutionary Biol Ctr, Norbyvagen 18A, S-75236 Uppsala, Sweden.	catherine.boisvert@ebc.uu.se	Boisvert, Catherine A/A-9782-2019; Ahlberg, Per/E-8086-2013	Boisvert, Catherine A/0000-0002-0618-7270; Ahlberg, Per/0000-0001-9054-2900	Vetenskapsradet	Vetenskapsradet(Swedish Research Council)	We thank P. Ross and the team at East-Tallinn Central Hospital, Estonia for the CT-scanning, E. Vorobyeva for permission to examine the Panderichthys material in her care, N. Shubin for access to Tiktaalik, and M.I. Coates for valuable discussions. C.A.B. and P.E.A. are supported by Vetenskapsradet.	ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; BOISVERT CA, 40 YEARS EARLY VERTE; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; Gegenbaur C., 1874, GRUNDRISS VERGLEICHE; GREGORY WILLIAM K., 1941, ANN NEW YORK ACAD SCI, V42, P273, DOI 10.1111/j.1749-6632.1941.tb55396.x; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Johanson Z, 2007, J EXP ZOOL PART B, V308B, P757, DOI 10.1002/jez.b.21197; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Vorobyeva E., 1991, P68; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x; VOROBYEVA EI, 1992, ZH OBSHCH BIOL, V53, P149; Westoll TS, 1943, PROC R SOC SER B-BIO, V131, P373, DOI 10.1098/rspb.1943.0013	21	91	93	7	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					636	638		10.1038/nature07339	http://dx.doi.org/10.1038/nature07339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18806778	Green Published			2022-12-01	WOS:000261340000040
J	Brohawn, SG; Leksa, NC; Spear, ED; Rajashankar, KR; Schwartz, TU				Brohawn, Stephen G.; Leksa, Nina C.; Spear, Eric D.; Rajashankar, Kanagalaghatta R.; Schwartz, Thomas U.			Structural Evidence for Common Ancestry of the Nuclear Pore Complex and Vesicle Coats	SCIENCE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; CELL-CYCLE; NUCLEOPORINS; ORGANIZATION; FOLD; EVOLUTION; MEMBRANE; PROTEINS	Nuclear pore complexes ( NPCs) facilitate nucleocytoplasmic transport. These massive assemblies comprise an eightfold symmetric scaffold of architectural proteins and central- channel phenylalanine- glycine- repeat proteins forming the transport barrier. We determined the nucleoporin 85 (Nup85).Seh1 structure, a module in the heptameric Nup84 complex, at 3.5 angstroms resolution. Structural, biochemical, and genetic analyses position the Nup84 complex in two peripheral NPC rings. We establish a conserved tripartite element, the ancestral coatomer element ACE1, that reoccurs in several nucleoporins and vesicle coat proteins, providing structural evidence of coevolution from a common ancestor. We identified interactions that define the organization of the Nup84 complex on the basis of comparison with vesicle coats and confirmed the sites by mutagenesis. We propose that the NPC scaffold, like vesicle coats, is composed of polygons with vertices and edges forming a membrane- proximal lattice that provides docking sites for additional nucleoporins.	[Brohawn, Stephen G.; Leksa, Nina C.; Spear, Eric D.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Argonne National Laboratory	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/ABA-1770-2021; Schwartz, Thomas/K-9029-2017	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; Brohawn, Stephen/0000-0001-6768-3406	NIH [GM77537]; Pew Scholar Award; Koch Fellowship Award; Vertex Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537, P50GM068762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award; Koch Fellowship Award; Vertex Scholarship(Vertex Pharmaceuticals); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank staff at beamlines 24-ID-C/-E at Argonne National Laboratory and X6A at National Synchrotron Light Source for excellent assistance with data collection, R. Sauer and T. Baker for critically reading the manuscript, G. Wink for contributions, members of the Schwartz laboratory for discussions, and the Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (NSF-0070319 and NIH GM68762) for providing instrumentation. Supported by NIH grant GM77537 ( T. U. S.), a Pew Scholar Award ( T. U. S.), a Koch Fellowship Award ( S. G. B.), and a Vertex Scholarship ( S. G. B.). Coordinates and structure factors of the Nup85.Seh1 crystal structure have been deposited in the Protein Data Bank ( PDB) with accession code 3EWE.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drummond SP, 2006, CAN J PHYSIOL PHARM, V84, P423, DOI 10.1139/Y05-148; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Jeudy S, 2007, J BIOL CHEM, V282, P34904, DOI 10.1074/jbc.M705479200; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141	38	153	157	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1369	1373		10.1126/science.1165886	http://dx.doi.org/10.1126/science.1165886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	18974315	Green Accepted			2022-12-01	WOS:000261170600036
J	Kim, M; Cui, ML; Cubas, P; Gillies, A; Lee, K; Chapman, MA; Abbott, RJ; Coen, E				Kim, Minsung; Cui, Min-Long; Cubas, Pilar; Gillies, Amanda; Lee, Karen; Chapman, Mark A.; Abbott, Richard J.; Coen, Enrico			Regulatory Genes Control a Key Morphological and Ecological Trait Transferred Between Species	SCIENCE			English	Article							SENECIO-VULGARIS; RADIATE GROUNDSEL; MATING SYSTEMS; CYCLOIDEA GENE; TCP DOMAIN; MADS-BOX; ORIGIN; HIBERNICUS; EVOLUTION	Hybridization between species can lead to introgression of genes from one species to another, providing a potential mechanism for preserving and recombining key traits during evolution. To determine the molecular basis of such transfers, we analyzed a natural polymorphism for flowerhead development in Senecio. We show that the polymorphism arose by introgression of a cluster of regulatory genes, the RAY locus, from the diploid species S. squalidus into the tetraploid S. vulgaris. The RAY genes are expressed in the peripheral regions of the inflorescence meristem, where they promote flower asymmetry and lead to an increase in the rate of outcrossing. Our results highlight how key morphological and ecological traits controlled by regulatory genes may be gained, lost, and regained during evolution.	[Kim, Minsung; Cui, Min-Long; Cubas, Pilar; Lee, Karen; Coen, Enrico] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Gillies, Amanda; Chapman, Mark A.; Abbott, Richard J.] Univ St Andrews, Sch Biol, St Andrews KY16 9TH, Fife, Scotland; [Kim, Minsung] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Cubas, Pilar] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Chapman, Mark A.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of St Andrews; University of Manchester; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University System of Georgia; University of Georgia	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk	Lee, Karen/GVT-9602-2022; Chapman, Mark/E-5260-2011; Cubas, Pilar/ABE-8670-2020; Cubas, Pilar/M-2268-2015	Chapman, Mark/0000-0002-7151-723X; Cubas, Pilar/0000-0003-4679-2173; Cubas, Pilar/0000-0003-4679-2173; Lee, Karen/0000-0003-4544-5217	EMBO; HFSP long-term fellowship; BBSRC [BB-D017742, G10929]; NERC/S/A/2000/03636; NERC [NE/D014166/1] Funding Source: UKRI; Natural Environment Research Council [NE/D014166/1] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); HFSP long-term fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC/S/A/2000/03636(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Walton for critical discussion. Supported by EMBO and HFSP long-term fellowship (M.K.), BBSRC grant BB-D017742 (M.C.), BBSRC grant G10929 (R.J.A.) and NERC/S/A/2000/03636 studentship (M.A.C.). GenBank accession numbers for RAY1 and RAY2 are FJ356698 to FJ356704.	ABBOTT RJ, 1992, HEREDITY, V68, P425, DOI 10.1038/hdy.1992.62; Arnold M., 2006, EVOLUTION GENETIC EX; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Clark JI, 2002, PLANT J, V30, P639, DOI 10.1046/j.1365-313X.2002.01310.x; COEN ES, 1995, PHILOS T R SOC B, V350, P35, DOI 10.1098/rstb.1995.0134; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Harris S. A., 2002, Watsonia, V24, P31; HOLSINGER KE, 1991, AM NAT, V138, P606, DOI 10.1086/285237; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; INGRAM R, 1980, NEW PHYTOL, V84, P543, DOI 10.1111/j.1469-8137.1980.tb04561.x; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kramer EM, 1999, NATURE, V399, P144, DOI 10.1038/20172; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Lowe AJ, 2000, AM J BOT, V87, P1159, DOI 10.2307/2656652; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; MARSHALL DF, 1980, HEREDITY, V45, P133, DOI 10.1038/hdy.1980.57; STACE CA, 1977, HEREDITY, V39, P383, DOI 10.1038/hdy.1977.80; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; TAJIMA F, 1989, GENETICS, V123, P585; Trow AH, 1912, J GENET, V2, P239, DOI 10.1007/BF02981542; Weatherbee, 2001, DNA DIVERSITY MOL GE	28	192	200	1	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1116	1119		10.1126/science.1164371	http://dx.doi.org/10.1126/science.1164371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008450				2022-12-01	WOS:000260867700042
J	Mott, ML; Erzberger, JP; Coons, MM; Berger, JM				Mott, Melissa L.; Erzberger, Jan P.; Coons, Mary M.; Berger, James M.			Structural Synergy and Molecular Crosstalk between Bacterial Helicase Loaders and Replication Initiators	CELL			English	Article							ESCHERICHIA-COLI CHROMOSOME; SINGLE-STRANDED-DNA; N-TERMINAL DOMAIN; AAA PLUS ATPASES; ORIGIN RECOGNITION; CRYSTAL-STRUCTURE; ATP-HYDROLYSIS; PROTEIN COMPLEX; POLYMERASE-III; BINDING	The loading of oligomeric helicases onto replication origins marks an essential step in replisome assembly. In cells, dedicated AAA+ ATPases regulate loading, however, the mechanism by which these factors recruit and deposit helicases has remained unclear. To better understand this process, we determined the structure of the ATPase region of the bacterial helicase loader DnaC from Aquifex aeolicus to 2.7 angstrom resolution. The structure shows that DnaC is a close paralog of the bacterial replication initiator, DnaA, and unexpectedly shares an ability to form a helical assembly similar to that of ATP-bound DnaA. Complementation and ssDNA-binding assays validate the importance of homomeric DnaC interactions, while pull-down experiments show that the DnaC and DnaA AAA+ domains interact in a nucleotide-dependent manner. These findings implicate DnaC as a molecular adaptor that uses ATP-activated DnaA as a docking site for regulating the recruitment and correct spatial deposition of the DnaB helicase onto origins.	[Mott, Melissa L.; Coons, Mary M.; Berger, James M.] Univ Calif Berkeley, Quantitat Biosci Inst, Mol & Cell Biol Dept, Berkeley, CA 94720 USA; [Erzberger, Jan P.] ETH, Inst Mol Biol Biophys, CH-8093 Zurich, Switzerland	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich	Berger, JM (corresponding author), Univ Calif Berkeley, Quantitat Biosci Inst, Mol & Cell Biol Dept, 374D Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071747, R01 GM071747-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN GC, 1991, J BIOL CHEM, V266, P22096; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Biswas SB, 2004, BIOCHEM J, V379, P553, DOI 10.1042/BJ20031255; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Galletto R, 2000, BIOCHEMISTRY-US, V39, P12959, DOI 10.1021/bi0012484; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ioannou C, 2006, NUCLEIC ACIDS RES, V34, P5247, DOI 10.1093/nar/gkl690; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1997, DOI 10.1093/nar/20.8.1997; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; Learn BA, 1997, P NATL ACAD SCI USA, V94, P1154, DOI 10.1073/pnas.94.4.1154; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Marszalek J, 1996, J BIOL CHEM, V271, P18535, DOI 10.1074/jbc.271.31.18535; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; SALUJA D, 1995, J BACTERIOL, V177, P1104, DOI 10.1128/jb.177.4.1104-1111.1995; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Shin JH, 2008, J BACTERIOL, V190, P4091, DOI 10.1128/JB.00233-08; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998	64	89	89	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					623	634		10.1016/j.cell.2008.09.058	http://dx.doi.org/10.1016/j.cell.2008.09.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013274	Bronze, Green Accepted			2022-12-01	WOS:000260886900014
J	Smukalla, S; Caldara, M; Pochet, N; Beauvais, A; Guadagnini, S; Yan, C; Vinces, MD; Jansen, A; Prevost, MC; Latge, JP; Fink, GR; Foster, KR; Verstrepen, KJ				Smukalla, Scott; Caldara, Marina; Pochet, Nathalie; Beauvais, Anne; Guadagnini, Stephanie; Yan, Chen; Vinces, Marcelo D.; Jansen, An; Prevost, Marie Christine; Latge, Jean-Paul; Fink, Gerald R.; Foster, Kevin R.; Verstrepen, Kevin J.			FLO1 Is a Variable Green Beard Gene that Drives Biofilm-like Cooperation in Budding Yeast	CELL			English	Article							CANDIDA; EXPRESSION; RESISTANCE; EVOLUTION; GROWTH	The budding yeast, Saccharomyces cerevisiae, has emerged as an archetype of eukaryotic cell biology. Here we show that S. cerevisiae is also a model for the evolution of cooperative behavior by revisiting flocculation, a self-adherence phenotype lacking in most laboratory strains. Expression of the gene FLO1 in the laboratory strain S288C restores flocculation, an altered physiological state, reminiscent of bacterial biofilms. Flocculation protects the FLO1 expressing cells from multiple stresses, including antimicrobials and ethanol. Furthermore, FLO1(+) cells avoid exploitation by nonexpressing flo1 cells by self/non-self recognition: FLO1(+) cells preferentially stick to one another, regardless of genetic relatedness across the rest of the genome. Flocculation, therefore, is driven by one of a few known "green beard genes,'' which direct cooperation toward other carriers of the same gene. Moreover, FLO1 is highly variable among strains both in expression and in sequence, suggesting that flocculation in S. cerevisiae is a dynamic, rapidly evolving social trait.	[Smukalla, Scott; Caldara, Marina; Pochet, Nathalie; Yan, Chen; Vinces, Marcelo D.; Foster, Kevin R.; Verstrepen, Kevin J.] Harvard Univ, FAS Ctr Syst Biol, Northwest Lab, Cambridge, MA 02138 USA; [Pochet, Nathalie] Univ Ghent, Bioinformat & Evolutionary Genom Grp, B-9052 Ghent, Belgium; [Pochet, Nathalie] Univ Ghent, Quantiat Genom Grp, Dept Plant Syst Biol, Flanders Inst Biotechnol VIB, B-9052 Ghent, Belgium; [Pochet, Nathalie] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Beauvais, Anne; Latge, Jean-Paul] Inst Pasteur, Aspergillus Unit, F-75724 Paris, France; [Guadagnini, Stephanie; Prevost, Marie Christine] Inst Pasteur, Elect Microscopy Platform, F-75724 Paris, France; [Jansen, An; Fink, Gerald R.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Jansen, An; Verstrepen, Kevin J.] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Mol & Microbial Syst, B-3001 Heverlee, Belgium; [Verstrepen, Kevin J.] Katholieke Univ Leuven, Lab Syst Biol, Flanders Inst Biotechnol VIB, B-3001 Heverlee, Belgium	Harvard University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Massachusetts Institute of Technology (MIT); Whitehead Institute; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	Verstrepen, KJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Northwest Lab, 52 Oxford St, Cambridge, MA 02138 USA.	kevin.verstrepen@biw.kuleuven.be	Pochet, Nathalie/Q-1322-2017; Beauvais, Anne/A-6358-2012; Jansen, An/T-9228-2018; Verstrepen, Kevin/AAA-4343-2021; Latge, Jean Paul/C-9846-2014	Pochet, Nathalie/0000-0003-1820-5656; Jansen, An/0000-0003-2412-0456; Yan, Chen/0000-0002-3266-0578; Foster, Kevin/0000-0003-4687-6633; Verstrepen, Kevin/0000-0002-3077-6219; Smukalla, Scott/0000-0002-8260-5606	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, P50GM068763] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM068763, 5P50GM068763, P50 GM068763-06, R01 GM040266, P50 GM068763-01, GM40266] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Arthington-Skaggs BA, 2002, ANTIMICROB AGENTS CH, V46, P2477, DOI 10.1128/AAC.46.8.2477-2481.2002; Beauvais A, 2007, CELL MICROBIOL, V9, P1588, DOI 10.1111/j.1462-5822.2007.00895.x; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458; D'Hautcourt O, 1999, J AM SOC BREW CHEM, V57, P123; Dawkins R., 1976, SELFISH GENE; Foster KR, 2007, TRENDS GENET, V23, P74, DOI 10.1016/j.tig.2006.12.003; Foster KR, 2001, ANN ZOOL FENN, V38, P229; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; GIMENO CJ, 1993, DIMORPHIC FUNGI BIOL; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Kobayashi O, 1998, J BACTERIOL, V180, P6503, DOI 10.1128/JB.180.24.6503-6510.1998; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; MORTIMER RK, 1986, GENETICS, V113, P35; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Palkova Z, 2004, EMBO REP, V5, P470, DOI 10.1038/sj.embor.7400145; Palkova Z, 2006, FEMS MICROBIOL REV, V30, P806, DOI 10.1111/j.1574-6976.2006.00034.x; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Reynolds TB, 2006, EUKARYOT CELL, V5, P1266, DOI 10.1128/EC.00022-06; SHERMAN F, 1991, METHODS YEAST GENETI; Sinervo B, 2006, P NATL ACAD SCI USA, V103, P7372, DOI 10.1073/pnas.0510260103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson DA, 2006, CURR BIOL, V16, P1581, DOI 10.1016/j.cub.2006.06.070; TREJO WH, 1963, J BACTERIOL, V85, P436, DOI 10.1128/JB.85.2.436-439.1963; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	36	302	311	2	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					726	737		10.1016/j.cell.2008.09.037	http://dx.doi.org/10.1016/j.cell.2008.09.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013280	Green Accepted, Bronze			2022-12-01	WOS:000260886900022
J	Reynolds-Wooding, A				Reynolds-Wooding, Abigail			A patient's journey - Common variable immunodeficiency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Stanley.notoes@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2008	337	7676							a1855	10.1136/bmj.a1855	http://dx.doi.org/10.1136/bmj.a1855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18930972				2022-12-01	WOS:000260298800040
J	De Smet, I; Vassileva, V; De Rybel, B; Levesque, MP; Grunewald, W; Van Damme, D; Van Noorden, G; Naudts, M; Van Isterdael, G; De Clercq, R; Wang, JY; Meuli, N; Vanneste, S; Friml, J; Hilson, P; Jurgens, G; Ingram, GC; Inze, D; Benfey, PN; Beeckman, T				De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Levesque, Mitchell P.; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Wang, Jean Y.; Meuli, Nicholas; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Juergens, Gerd; Ingram, Gwyneth C.; Inze, Dirk; Benfey, Philip N.; Beeckman, Tom			Receptor-like kinase ACR4 restricts formative cell divisions in the Arabidopsis root	SCIENCE			English	Article							GENE; DIFFERENTIATION; INITIATION; EPIDERMIS; THALIANA; MERISTEM	During the development of multicellular organisms, organogenesis and pattern formation depend on formative divisions to specify and maintain pools of stem cells. In higher plants, these activities are essential to shape the final root architecture because the functioning of root apical meristems and the de novo formation of lateral roots entirely rely on it. We used transcript profiling on sorted pericycle cells undergoing lateral root initiation to identify the receptor-like kinase ACR4 of Arabidopsis as a key factor both in promoting formative cell divisions in the pericycle and in constraining the number of these divisions once organogenesis has been started. In the root tip meristem, ACR4 shows a similar action by controlling cell proliferation activity in the columella cell lineage. Thus, ACR4 function reveals a common mechanism of formative cell division control in the main root tip meristem and during lateral root initiation.	[De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Inze, Dirk; Beeckman, Tom] Univ Ghent VIB, Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Inze, Dirk; Beeckman, Tom] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Levesque, Mitchell P.; Wang, Jean Y.; Benfey, Philip N.] Duke Univ, Dept Biol, Ctr Syst Biol, Durham, NC 27708 USA; [Levesque, Mitchell P.; Wang, Jean Y.; Benfey, Philip N.] Duke Univ, Inst Genome Sci & Policy, Ctr Syst Biol, Durham, NC 27708 USA; [De Smet, Ive; Juergens, Gerd] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Meuli, Nicholas; Ingram, Gwyneth C.] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Duke University; Duke University; Eberhard Karls University of Tubingen; University of Edinburgh	Beeckman, T (corresponding author), Univ Ghent VIB, Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	tom.beeckman@psb.ugent.be	De Smet, Ive/E-6086-2011; van damme, daniel/ABA-1397-2020; Grunewald, Wim/C-6521-2008; Vanneste, Steffen/K-8353-2013; van damme, daniel/F-6139-2014; De Smet, Ive/A-6583-2011; Beeckman, Tom/ABI-1703-2020; Beeckman, Tom/ABA-1164-2020; Friml, Jiri/D-9511-2012; Inzé, Dirk/AAW-6381-2021	De Smet, Ive/0000-0003-4607-8893; van damme, daniel/0000-0002-9385-4851; Vanneste, Steffen/0000-0002-9948-9672; van damme, daniel/0000-0002-9385-4851; De Smet, Ive/0000-0003-4607-8893; Beeckman, Tom/0000-0001-8656-2060; Friml, Jiri/0000-0002-8302-7596; Inzé, Dirk/0000-0002-3217-8407; Vassileva, Valya/0000-0002-9055-8002; Van Isterdael, Gert/0000-0001-6626-1316; De Rybel, Bert/0000-0002-9551-042X; Ingram, Gwyneth/0000-0002-1425-9545	Interuniversity Poles of Attraction Prograin-Belgian Science Policy [P5/13]; U.S. National Science Foundation Arabidopsis 2010 program; non-European Union researchers from the Belgian Science Policy; European Molecular Biology Organization [ALTF 108-2006, ALTF 142-2007]; Institute for the Promotion of innovation by Science and Technology in Flanders; Bijzonder Onderzoeksfonds van de Universitert Gent; Gatsby Charitable Foundation; Research Foundation of Flanders	Interuniversity Poles of Attraction Prograin-Belgian Science Policy; U.S. National Science Foundation Arabidopsis 2010 program(National Science Foundation (NSF)); non-European Union researchers from the Belgian Science Policy; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Institute for the Promotion of innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Bijzonder Onderzoeksfonds van de Universitert Gent; Gatsby Charitable Foundation; Research Foundation of Flanders(FWO)	We thank B. Scheres, K. Theres, P. Springer, H. Fukaki, and Nottingharn Arabidopsis Stock Centre for providing seeds. This work was funded by grants from the Interuniversity Poles of Attraction Prograin-Belgian Science Policy (P5/13); grants from the U.S. National Science Foundation Arabidopsis 2010 program to P.N.B.; a fellowship for non-European Union researchers from the Belgian Science Policy (BELSPO) to V.V.; long-term fellowships from the European Molecular Biology Organization ALTF 108-2006 to I.D.S. and ALTF 142-2007 to S.V.; predoctoral fellowships from the Institute for the Promotion of innovation by Science and Technology in Flanders to I.D.S. and S.V., from the Bijzonder Onderzoeksfonds van de Universitert Gent to B.D.R., and from the Gatsby Charitable Foundation to N.M.; a travel grant of the Research Foundation of Flanders to I.D.S.; and a postdoctoral fellowship of the Research Foundation of Flanders to D.V.D. We are. grateful to R. Gross-Hardt, U. Voss, S. Lau, and two anonymous referees for critical comments and suggestions on the manuscript.	Becraft PW, 2001, PLANT PHYSIOL, V127, P486, DOI 10.1104/pp.010299; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dinneny JR, 2008, CELL, V132, P553, DOI 10.1016/j.cell.2008.02.001; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Gifford ML, 2003, DEVELOPMENT, V130, P4249, DOI 10.1242/dev.00634; Heidstra Renze, 2007, V45, P1; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Tanaka H, 2007, DEVELOPMENT, V134, P1643, DOI 10.1242/dev.003533; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; WOLPERT L, 1988, J CELL SCI, P1	21	265	270	6	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					594	597		10.1126/science.1160158	http://dx.doi.org/10.1126/science.1160158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948541				2022-12-01	WOS:000260299100045
J	Mercer, SW; Lean, MEJ				Mercer, S. W.; Lean, M. E. J.			Request for slimming tablets	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mercer, S. W.] Univ Glasgow, Fac Med, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland; [Lean, M. E. J.] Univ Glasgow, Fac Med, Div Dev Med, Glasgow G12 9LX, Lanark, Scotland	University of Glasgow; University of Glasgow	Mercer, SW (corresponding author), Univ Glasgow, Fac Med, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland.	s.mercer@clinmed.gla.ac.uk		Mercer, Stewart William/0000-0002-1703-3664					0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 24	2008	337								a1287	10.1136/bmj.a1287	http://dx.doi.org/10.1136/bmj.a1287			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FQ	18952680				2022-12-01	WOS:000261029000004
J	Li, F; Huarte, M; Zaratiegui, M; Vaughn, MW; Shi, Y; Martienssen, R; Cande, WZ				Li, Fei; Huarte, Maite; Zaratiegui, Mikel; Vaughn, Matthew W.; Shi, Yang; Martienssen, Rob; Cande, W. Zacheus			Lid2 Is Required for Coordinating H3K4 and H3K9 Methylation of Heterochromatin and Euchromatin	CELL			English	Article							HISTONE LYSINE METHYLATION; CHROMATIN-BINDING; RNA INTERFERENCE; FISSION; GENE; INTERACT; PROTEINS; RITS	In most eukaryotes, histone methylation patterns regulate chromatin architecture and function: methylation of histone H3 lysine-9 (H3K9) demarcates heterochromatin, whereas H3K4 methylation demarcates euchromatin. We show here that the S. pombe JmjC-domain protein Lid2 is a trimethyl H3K4 demethylase responsible for H3K4 hypomethylation in heterochromatin. Lid2 interacts with the histone lysine-9 methyltransferase, Clr4, through the Dos1/Clr8-Rik1 complex, which also functions in the RNA interference pathway. Disruption of the JmjC domain alone results in severe heterochromatin defects and depletion of siRNA, whereas overexpressing Lid2 enhances heterochromatin silencing. The physical and functional link between H3K4 demethylation and H3K9 methylation suggests that the two reactions act in a coordinated manner. Surprisingly, crossregulation of H3K4 and H3K9 methylation in euchromatin also requires Lid2. We suggest that Lid2 enzymatic activity in euchromatin is regulated through a dynamic interplay with other histone-modification enzymes. Our findings provide mechanistic insight into the coordination of H3K4 and H3K9 methylation.	[Li, Fei; Cande, W. Zacheus] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Huarte, Maite; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zaratiegui, Mikel; Vaughn, Matthew W.; Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory	Li, F (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	feili@nature.berkeley.edu; zcande@berkeley.edu	Huarte, Maite/J-6903-2014; Hu, Ruogu/B-2203-2008	Huarte, Maite/0000-0003-3753-6493; Zaratiegui, Mikel/0000-0002-0342-0268; Li, Fei/0000-0002-1206-9684; Vaughn, Matthew/0000-0002-1384-4283	National Institutes of Health [RO1GM076396, NCI118487]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396, R01GM067992] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Zac Cande laboratory, especially Xie Tang, for kind help and valuable discussions; Michael Myers and the Cold Spring Harbor Laboratory mass spectrometry facility for the mass spectrometry analysis; Erin Osborne for critical reading of the manuscript; and Amikam Cohen, Stephen Kearsey, Jun-ichi Nakayama, and Mitsuhiro Yanagida for kindly providing strains. This work was supported by grants from the National Institutes of Health (RO1GM076396 to W. Z. C. and R. M., and NCI118487 to Y. S.).	Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huarte M, 2007, J BIOL CHEM, V282, P21662, DOI 10.1074/jbc.M703897200; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Lachner M, 2004, COLD SPRING HARB SYM, V69, P209, DOI 10.1101/sqb.2004.69.209; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Singh G, 2008, YEAST, V25, P117, DOI 10.1002/yea.1569; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	34	107	108	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					272	283		10.1016/j.cell.2008.08.036	http://dx.doi.org/10.1016/j.cell.2008.08.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957202	Green Accepted, Bronze			2022-12-01	WOS:000260130400017
J	Huang, TTK; Glass, TA				Huang, Terry T. -K.; Glass, Thomas A.			Transforming research strategies for understanding and preventing obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Huang, Terry T. -K.] NICHHD, Obes Res Strateg Core, NIH, Bethesda, MD 20892 USA; [Glass, Thomas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Huang, TTK (corresponding author), NICHHD, Obes Res Strateg Core, NIH, 6100 Execut Blvd,4B11, Bethesda, MD 20892 USA.	huangter@mail.nih.gov		Glass, Thomas/0000-0003-4399-612X; Huang, Terry/0000-0001-5544-5187				Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; BRATTEBO G, 1990, SCAND J SOC MED, V18, P225, DOI 10.1177/140349489001800312; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Drewnowski A, 2007, SOC SCI MED, V65, P2458, DOI 10.1016/j.socscimed.2007.07.001; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; World Health Organization, SOC DET HLTH; 2003, PROGR GROCER    0813	15	104	104	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1811	1813		10.1001/jama.300.15.1811	http://dx.doi.org/10.1001/jama.300.15.1811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854544				2022-12-01	WOS:000260002000034
J	Schipper, J; Chanson, JS; Chiozza, F; Cox, NA; Hoffmann, M; Katariya, V; Lamoreux, J; Rodrigues, ASL; Stuart, SN; Temple, HJ; Baillie, J; Boitani, L; Lacher, TE; Mittermeier, RA; Smith, AT; Absolon, D; Aguiar, JM; Amori, G; Bakkour, N; Baldi, R; Berridge, RJ; Bielby, J; Black, PA; Blanc, JJ; Brooks, TM; Burton, JA; Butynski, TM; Catullo, G; Chapman, R; Cokeliss, Z; Collen, B; Conroy, J; Cooke, JG; da Fonseca, GAB; Derocher, AE; Dublin, HT; Duckworth, JW; Emmons, L; Emslie, RH; Festa-Bianchet, M; Foster, M; Foster, S; Garshelis, DL; Gates, C; Gimenez-Dixon, M; Gonzalez, S; Gonzalez-Maya, JF; Good, TC; Hammerson, G; Hammond, PS; Happold, D; Happold, M; Hare, J; Harris, RB; Hawkins, CE; Haywood, M; Heaney, LR; Hedges, S; Helgen, KM; Hilton-Taylor, C; Hussain, SA; Ishii, N; Jefferson, TA; Jenkins, RKB; Johnston, CH; Keith, M; Kingdon, J; Knox, DH; Kovacs, KM; Langhammer, P; Leus, K; Lewison, R; Lichtenstein, G; Lowry, LF; Macavoy, Z; Mace, GM; Mallon, DP; Masi, M; McKnight, MW; Medellin, RA; Medici, P; Mills, G; Moehlman, PD; Molur, S; Mora, A; Nowell, K; Oates, JF; Olech, W; Oliver, WRL; Oprea, M; Patterson, BD; Perrin, WF; Polidoro, BA; Pollock, C; Powel, A; Protas, Y; Racey, P; Ragle, J; Ramani, P; Rathbun, G; Reeves, RR; Reilly, SB; Reynolds, JE; Rondinini, C; Rosell-Ambal, RG; Rulli, M; Rylands, AB; Savini, S; Schank, CJ; Sechrest, W; Self-Sullivan, C; Shoemaker, A; Sillero-Zubiri, C; De Silva, N; Smith, DE; Srinivasulu, C; Stephenson, PJ; van Strien, N; Talukdar, BK; Taylor, BL; Timmins, R; Tirira, DG; Tognelli, MF; Tsytsulina, K; Veiga, LM; Vie, JC; Williamson, EA; Wyatt, SA; Xie, Y; Young, BE				Schipper, Jan; Chanson, Janice S.; Chiozza, Federica; Cox, Neil A.; Hoffmann, Michael; Katariya, Vineet; Lamoreux, John; Rodrigues, Ana S. L.; Stuart, Simon N.; Temple, Helen J.; Baillie, Jonathan; Boitani, Luigi; Lacher, Thomas E., Jr.; Mittermeier, Russell A.; Smith, Andrew T.; Absolon, Daniel; Aguiar, John M.; Amori, Giovanni; Bakkour, Noura; Baldi, Ricardo; Berridge, Richard J.; Bielby, Jon; Black, Patricia Ann; Blanc, J. Julian; Brooks, Thomas M.; Burton, James A.; Butynski, Thomas M.; Catullo, Gianluca; Chapman, Roselle; Cokeliss, Zoe; Collen, Ben; Conroy, Jim; Cooke, Justin G.; da Fonseca, Gustavo A. B.; Derocher, Andrew E.; Dublin, Holly T.; Duckworth, J. W.; Emmons, Louise; Emslie, Richard H.; Festa-Bianchet, Marco; Foster, Matt; Foster, Sabrina; Garshelis, David L.; Gates, Cormack; Gimenez-Dixon, Mariano; Gonzalez, Susana; Gonzalez-Maya, Jose Fernando; Good, Tatjana C.; Hammerson, Geoffrey; Hammond, Philip S.; Happold, David; Happold, Meredith; Hare, John; Harris, Richard B.; Hawkins, Clare E.; Haywood, Mandy; Heaney, Lawrence R.; Hedges, Simon; Helgen, Kristofer M.; Hilton-Taylor, Craig; Hussain, Syed Ainul; Ishii, Nobuo; Jefferson, Thomas A.; Jenkins, Richard K. B.; Johnston, Charlotte H.; Keith, Mark; Kingdon, Jonathan; Knox, David H.; Kovacs, Kit M.; Langhammer, Penny; Leus, Kristin; Lewison, Rebecca; Lichtenstein, Gabriela; Lowry, Lloyd F.; Macavoy, Zoe; Mace, Georgina M.; Mallon, David P.; Masi, Monica; McKnight, Meghan W.; Medellin, Rodrigo A.; Medici, Patricia; Mills, Gus; Moehlman, Patricia D.; Molur, Sanjay; Mora, Arturo; Nowell, Kristin; Oates, John F.; Olech, Wanda; Oliver, William R. L.; Oprea, Monik; Patterson, Bruce D.; Perrin, William F.; Polidoro, Beth A.; Pollock, Caroline; Powel, Abigail; Protas, Yelizaveta; Racey, Paul; Ragle, Jim; Ramani, Pavithra; Rathbun, Galen; Reeves, Randall R.; Reilly, Stephen B.; Reynolds, John E., III; Rondinini, Carlo; Rosell-Ambal, Ruth Grace; Rulli, Monica; Rylands, Anthony B.; Savini, Simona; Schank, Cody J.; Sechrest, Wes; Self-Sullivan, Caryn; Shoemaker, Alan; Sillero-Zubiri, Claudio; De Silva, Naamal; Smith, David E.; Srinivasulu, Chelmala; Stephenson, Peter J.; van Strien, Nico; Talukdar, Bibhab Kumar; Taylor, Barbara L.; Timmins, Rob; Tirira, Diego G.; Tognelli, Marcelo F.; Tsytsulina, Katerina; Veiga, Liza M.; Vie, Jean-Christophe; Williamson, Elizabeth A.; Wyatt, Sarah A.; Xie, Yan; Young, Bruce E.			The status of the world's land and marine mammals: Diversity, threat, and knowledge	SCIENCE			English	Article							GLOBAL DISTRIBUTION; EXTINCTION RISK; RANGE SIZE; RED LIST; CONSERVATION; PATTERNS	Knowledge of mammalian diversity is still surprisingly disparate, both regionally and taxonomically. Here, we present a comprehensive assessment of the conservation status and distribution of the world's mammals. Data, compiled by 1700+ experts, cover all 5487 species, including marine mammals. Global macroecological patterns are very different for land and marine species but suggest common mechanisms driving diversity and endemism across systems. Compared with land species, threat levels are higher among marine mammals, driven by different processes (accidental mortality and pollution, rather than habitat loss), and are spatially distinct (peaking in northern oceans, rather than in Southeast Asia). Marine mammals are also disproportionately poorly known. These data are made freely available to support further scientific developments and conservation action.	[Schipper, Jan; Chanson, Janice S.; Cox, Neil A.; Hoffmann, Michael; Katariya, Vineet; Lamoreux, John; Stuart, Simon N.; Polidoro, Beth A.; Ragle, Jim] IUCN, Species Programme, CH-1196 Gland, Switzerland; [Schipper, Jan; Chanson, Janice S.; Cox, Neil A.; Hoffmann, Michael; Stuart, Simon N.; Lacher, Thomas E., Jr.; Mittermeier, Russell A.; Aguiar, John M.; Bakkour, Noura; Brooks, Thomas M.; Foster, Matt; Rylands, Anthony B.; De Silva, Naamal; Wyatt, Sarah A.] Conservat Int, Ctr Appl Biodivers Sci, Arlington, VA 22202 USA; [Chiozza, Federica; Boitani, Luigi; Rondinini, Carlo] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy; [Lamoreux, John; Lacher, Thomas E., Jr.; Aguiar, John M.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Rodrigues, Ana S. L.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Temple, Helen J.; Hilton-Taylor, Craig; Pollock, Caroline] IUCN, Species Programme, Cambridge CB3 0DL, England; [Baillie, Jonathan; Bielby, Jon; Cokeliss, Zoe; Collen, Ben] Zool Soc London, Inst Zool, London NW1 4RY, England; [Smith, Andrew T.; Johnston, Charlotte H.; Langhammer, Penny] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amori, Giovanni] CNR, Inst Ecosyst Studies, I-00161 Rome, Italy; [Bakkour, Noura] Columbia Univ, Sch Int & Publ Affairs, Dept Environm Sci & Policy, New York, NY 10027 USA; [Baldi, Ricardo] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagonico, RA-9120 Puerto Madryn, Argentina; [Baldi, Ricardo] Wildlife Conservat Soc, Patagonian & Andean Steppe Program, RA-9120 Puerto Madryn, Argentina; [Berridge, Richard J.] Mantella Conservat Org, London SE16 7TS, England; [Bielby, Jon; Macavoy, Zoe; Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Black, Patricia Ann] Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Black, Patricia Ann] Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Blanc, J. Julian] MIKE, CITES, Nairobi 00100, Kenya; [Brooks, Thomas M.] Univ Philippines, World Agroforestry Ctr ICRAF, Los Banos 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Hobart, Tas 7001, Australia; [Burton, James A.] Earthwatch Inst Europe, Oxford OX2 7DE, England; [Burton, James A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland; [Butynski, Thomas M.] Eastern Africa Primate Divers & Conservat Program, Nanyuki 10400, Kenya; [Butynski, Thomas M.] Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; [Catullo, Gianluca; Masi, Monica; Rulli, Monica; Savini, Simona] Ist Ecol Applicata, I-00162 Rome, Italy; [Conroy, Jim] Celt Environm Ltd, Banchory AB31 4JG, Kincardine, Scotland; [Cooke, Justin G.] Ctr Ecosyst Management Studies, D-79297 Winden, Germany; [da Fonseca, Gustavo A. B.] Global Environm Facil, Washington, DC 20433 USA; [da Fonseca, Gustavo A. B.] Univ Fed Minas Gerais, Dept Zool, BR-31270901 Belo Horizonte, MG, Brazil; [Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Dublin, Holly T.] Ctr Biodivers Conservat, S African Natl Biodivers Inst, IUCN Species Survival Commiss, ZA-7735 Cape Town, South Africa; [Duckworth, J. W.] Wildlife Conservat Soc, Asia Programs, Bronx, NY 10460 USA; [Emmons, Louise; Helgen, Kristofer M.; Oprea, Monik] Smithsonian Inst, Dept Vertebrate Zool, Div Mammals, Washington, DC 20013 USA; [Emslie, Richard H.] African Rhino Specialist Grp, IUCN SSC Species Survival Commiss, ZA-3245 Hilton, South Africa; [Festa-Bianchet, Marco] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Foster, Sabrina; Ramani, Pavithra; Schank, Cody J.; Sechrest, Wes; Smith, David E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Garshelis, David L.] Minnesota Dept Nat Resources, Grand Rapids, MN 55744 USA; [Gates, Cormack] Univ Calgary, Dept Environm Sci, Calgary, AB T2N 1N4, Canada; [Gonzalez, Susana] IIBCE, Fac Ciencias, Montevideo 11600, Uruguay; [Gonzalez-Maya, Jose Fernando] ProCAT Int, Las Alturas, Coto Brus, Costa Rica; [Good, Tatjana C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Hammerson, Geoffrey; Young, Bruce E.] NatureServ, Arlington, VA 22209 USA; [Hammond, Philip S.] Univ St Andrews, Sea Mammal Res Unit, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland; [Happold, David; Happold, Meredith] Australian Natl Univ, Canberra, ACT 0200, Australia; [Hare, John] Wild Camel Protect Fdn, Sch Farm, Benenden TN17 4EU, Kent, England; [Harris, Richard B.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Hawkins, Clare E.] Dept Primary Ind & Water, Threatened Species Sect, Hobart, Tas 7001, Australia; [Hawkins, Clare E.] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia; [Haywood, Mandy] Univ Otago, Ctr Sci Commun, Dunedin 9054, New Zealand; [Heaney, Lawrence R.; Patterson, Bruce D.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Hussain, Syed Ainul] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Ishii, Nobuo] Tokyo Womans Christian Univ, Suginami Ku, Tokyo 1678585, Japan; [Jefferson, Thomas A.; Perrin, William F.; Reilly, Stephen B.; Taylor, Barbara L.] Natl Ocean & Atmospher Adm Fisheries, SW Fisheries Sci Ctr, La Jolla, CA 92037 USA; [Jenkins, Richard K. B.; Racey, Paul] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 2TZ, Scotland; [Jenkins, Richard K. B.] Madagasikara Voakajy, Antananarivo, Madagascar; [Keith, Mark] Univ Witwatersrand, ZA-2050 Johannesburg, South Africa; [Kingdon, Jonathan] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Knox, David H.] Conservat Int, ZA-7735 Claremont, South Africa; [Kovacs, Kit M.] Norwegian Polar Res Inst, N-9296 Tromso, Norway; [Kovacs, Kit M.] Univ Ctr Svalbard, N-9171 Longyearbyen, Norway; [Leus, Kristin] Copenhagen Zoo & Conservat Breeding Specialist Gr, Reg Off Europe, B-2170 Merksem, Belgium; [Lewison, Rebecca] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Lichtenstein, Gabriela] Inst Nacl Antropol & Pensamiento Latinoamer, RA-1378 Buenos Aires, DF, Argentina; [Lowry, Lloyd F.] Univ Alaska, Sch Fisheries & Ocean Sci, Fairbanks, AK 99701 USA; [Mallon, David P.] Manchester Metropolitan Univ, Dept Biol Sci, Manchester M1 5GD, Lancs, England; [Medellin, Rodrigo A.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Medici, Patricia] Inst Pesquisas Ecol, Inst Ecol Res, Lowland Tapir Conservat Initiat, BR-12960000 Sao Paulo, Brazil; [Medici, Patricia] Univ Kent, DICE, Canterbury CT2 7NZ, Kent, England; [Mills, Gus] Tony & Lisette Lewis Fdn, ZA-2196 Sandton, South Africa; [Moehlman, Patricia D.] Wildlife Trust Alliance, Beijing 100011, Peoples R China; [Molur, Sanjay] Zoo Outreach Org, Coimbatore 641004, Tamil Nadu, India; [Molur, Sanjay] Wildlife Informat & Liaison Dev Soc, Coimbatore 641004, Tamil Nadu, India; [Mora, Arturo] IUCN S Amer Reg Off, Species Unit, Quito, Pichincha, Ecuador; [Nowell, Kristin] Cat Act Treasury, Cape Neddick 03902, ME USA; [Oates, John F.] CUNY, CUNY Hunter Coll, Dept Anthropol, New York, NY 10065 USA; [Olech, Wanda] Warsaw Univ Life Sci, PL-02787 Warsaw, Poland; [Oliver, William R. L.] Fauna & Flora Int, Philippine Biodivers Conservat Programme, Manila 1004, Philippines; [Powel, Abigail] Victoria Univ Wellington, Wellington 6140, New Zealand; [Protas, Yelizaveta] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Rathbun, Galen] Calif Acad Sci, Dept Ornithol & Mammal, Cambria, CA 93428 USA; [Reeves, Randall R.] Okapi Wildlife Assoc, Quebec City, PQ J0P 1H0, Canada; [Reynolds, John E., III] Mote Marine Lab, Sarasota, FL 34236 USA; [Rosell-Ambal, Ruth Grace] CI Philippines, Quezon City 1101, Philippines; [Self-Sullivan, Caryn] Sirenian Int, Fredericksburg, VA 22401 USA; [Shoemaker, Alan] IUCN Tapir Specialist Grp, Columbia, SC 29210 USA; [Sillero-Zubiri, Claudio] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Tubney OX13 5QL, England; [Srinivasulu, Chelmala] Osmania Univ, Dept Zool, Univ Coll Sci, Hyderabad 500007, Andhra Pradesh, India; [Stephenson, Peter J.] WWF Int, CH-1196 Gland, Switzerland; [van Strien, Nico] White Oak Conservat Ctr, Int Rhino Fdn, Yulee, FL 32097 USA; [Talukdar, Bibhab Kumar] Aaranyak, Guwhati 781028, Assam, India; [Tirira, Diego G.] Fdn Mamiferos & Conservac, Quito, Ecuador; [Tognelli, Marcelo F.] Ctr Sci & Technol Mendoza, CONICET, IADIZA Argentinean Arid Res Inst, RA-5500 Mendoza, Argentina; [Tognelli, Marcelo F.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Tsytsulina, Katerina] Russian Bat Res Grp, St Petersburg 195196, Russia; [Veiga, Liza M.] Museu Paraense Emilio Goeldi, Dept Zool, Belem, Para, Brazil; [Williamson, Elizabeth A.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Xie, Yan] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Conservation International; Sapienza University Rome; Texas A&M University System; Texas A&M University College Station; University of Cambridge; Zoological Society of London; Arizona State University; Arizona State University-Tempe	Schipper, J (corresponding author), IUCN, Species Programme, 28 Rue Mauverney, CH-1196 Gland, Switzerland.	jan.schipper@iucn.org	Keith, Mark/A-2458-2015; Derocher, Andrew/J-4469-2012; Gonzalez, Susana A/F-1300-2017; Patterson, Bruce D/O-5068-2019; González-Maya, José F./B-6913-2011; González, Susana/AAC-7053-2021; Keith, Mark/Q-1527-2018; Self-Sullivan, Caryn/H-2605-2012; Collen, Ben/D-5055-2011; Schipper, Jan/N-5266-2015; Veiga, Liza/C-6667-2009; Rodrigues, Ana/GYQ-6273-2022; Rondinini, Carlo/E-9027-2011; Stephenson, PJ/AAC-3081-2021; Williamson, Elizabeth/N-8958-2019; Jenkins, Richard KB/A-4567-2012; Helgen, Kristofer M./AAB-8348-2019; Collen, Ben/F-2543-2016; Srinivasulu, Chelmala/AAU-2204-2020; Keith, Mark/G-7234-2011; Olech, Wanda/AAB-5072-2022; Williamson, Elizabeth/E-4727-2016; Hoffmann, Michael/E-6419-2010; Tirira, Diego G./E-3617-2018; Tognelli, Marcelo/L-3958-2019; Rodrigues, Ana S.L./A-5914-2009; Bielby, Jon/D-5051-2011; Mace, Georgina M/I-3072-2016; Oprea, Monik/E-6204-2010; Williamson, Elizabeth/B-9090-2011	Keith, Mark/0000-0001-6690-2718; Derocher, Andrew/0000-0002-1104-7774; Patterson, Bruce D/0000-0002-2249-7260; González-Maya, José F./0000-0002-8942-5157; González, Susana/0000-0001-6470-6182; Keith, Mark/0000-0001-7179-9989; Self-Sullivan, Caryn/0000-0003-0785-3682; Schipper, Jan/0000-0002-8338-7874; Williamson, Elizabeth/0000-0001-6848-9154; Helgen, Kristofer M./0000-0002-8776-4040; Collen, Ben/0000-0003-2564-4243; Srinivasulu, Chelmala/0000-0003-4331-8580; Olech, Wanda/0000-0002-6166-3954; Williamson, Elizabeth/0000-0001-6848-9154; Hoffmann, Michael/0000-0003-4785-2254; Tirira, Diego G./0000-0002-5344-6175; Tognelli, Marcelo/0000-0002-9761-4505; Rodrigues, Ana S.L./0000-0003-4775-0127; Mace, Georgina M/0000-0001-8965-5211; Rondinini, Carlo/0000-0002-6617-018X; Brooks, Thomas/0000-0001-8159-3116; Bielby, Jon/0000-0003-4586-0429; Hawkins, Clare/0000-0002-1909-2545; Ragle, James/0000-0002-5829-3745; Hammond, Philip/0000-0002-2381-8302; Festa-Bianchet, Marco/0000-0002-2352-3379; STEPHENSON, PJ/0000-0002-0087-466X; Molur, Sanjay/0000-0001-8230-518X; Blanc, Julian/0000-0003-4331-5339; Haywood, Mandy/0000-0002-5012-6926	NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001, smru10001] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; BRYANT PJ, 1995, J MAMMAL, V76, P857, DOI 10.2307/1382754; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; ENTWISTLE AC, 2000, PRIORITIES CONSERVAT, P119; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hawkins BA, 2006, GLOBAL ECOL BIOGEOGR, V15, P461, DOI 10.1111/j.1466-822x.2006.00243.x; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hoffmann M, 2008, NATURE, V454, P159, DOI 10.1038/454159a; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; *IUCN, 1996, 1996 IUCN RED LIST T; MCLEOD B, 2008, ARCTIC, P1; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; REEVES RR, 1978, ATLANTIC WALRUS ODOB; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; SECHREST WW, 2003, THESIS U VIRGINIA CH; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stora J, 2004, MAR MAMMAL SCI, V20, P115, DOI 10.1111/j.1748-7692.2004.tb01143.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Turney CSM, 2008, P NATL ACAD SCI USA, V105, P12150, DOI 10.1073/pnas.0801360105; Turvey ST, 2007, BIOL LETTERS, V3, P193, DOI 10.1098/rsbl.2006.0585; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292	34	994	1047	17	638	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					225	230		10.1126/science.1165115	http://dx.doi.org/10.1126/science.1165115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845749	Green Accepted			2022-12-01	WOS:000259902300039
J	Smith, SA; Donoghue, MJ				Smith, Stephen A.; Donoghue, Michael J.			Rates of molecular evolution are linked to life history in flowering plants	SCIENCE			English	Article							ESTIMATING DIVERGENCE TIMES; GENERATION-TIME; BIODIVERSITY HOTSPOTS; METABOLIC-RATE; BODY-SIZE; SEQUENCES; CLOCK; DIVERSIFICATION; ANGIOSPERMS; MALVACEAE	Variable rates of molecular evolution have been documented across the tree of life, but the cause of this observed variation within and among clades remains uncertain. In plants, it has been suggested that life history traits are correlated with the rate of molecular evolution, but previous studies have yielded conflicting results. Exceptionally large phylogenies of five major angiosperm clades demonstrate that rates of molecular evolution are consistently low in trees and shrubs, with relatively long generation times, as compared with related herbaceous plants, which generally have shorter generation times. Herbs show much higher rates of molecular change but also much higher variance in rates. Correlates of life history attributes have long been of interest to biologists, and our results demonstrate how changes in the rate of molecular evolution that are linked to life history traits can affect measurements of the tempo of evolution as well as our ability to identify and conserve biodiversity.	[Smith, Stephen A.; Donoghue, Michael J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Smith, SA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St,POB 208105, New Haven, CT 06520 USA.	stephen.smith@yale.edu	Smith, Stephen/B-3451-2010; Smith, Stephen/AAE-8623-2019	Smith, Stephen/0000-0003-2035-9531	NSF; Cyberinfrastructure for Phylogenetic Research [EF-0331654]; angiosperm Assembling the Tree of Life [EF-0431258]	NSF(National Science Foundation (NSF)); Cyberinfrastructure for Phylogenetic Research; angiosperm Assembling the Tree of Life	We thank D. Tank, J. Beaulieu, S. Stearns, D. Weinreich, C. Dunn, and E. Edwards for helpful discussions. Funded by the NSF through the Cyberinfrastructure for Phylogenetic Research (EF-0331654) and the angiosperm Assembling the Tree of Life (EF-0431258) projects.	Andreasen K, 2005, CONSERV GENET, V6, P399, DOI 10.1007/s10592-005-4977-z; Andreasen K, 2001, MOL BIOL EVOL, V18, P936, DOI 10.1093/oxfordjournals.molbev.a003894; Barraclough TG, 2001, EVOLUTION, V55, P677, DOI 10.1554/0014-3820(2001)055[0677:ERASDI]2.0.CO;2; Bell CD, 2005, AM J BOT, V92, P284, DOI 10.3732/ajb.92.2.284; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Chase Mark W., 2006, Aliso, V22, P63; Davies TJ, 2006, EVOLUTION, V60, P476; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Hietz P, 2002, J TROP ECOL, V18, P177, DOI 10.1017/S0266467402002122; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; KLEKOWSKI EJ, 1989, NATURE, V340, P389, DOI 10.1038/340389a0; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; MOOERS AO, 1994, MOL PHYLOGENET EVOL, V3, P344, DOI 10.1006/mpev.1994.1040; OHTA T, 1993, P NATL ACAD SCI USA, V90, P10676, DOI 10.1073/pnas.90.22.10676; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sinnott EW, 1916, AM NAT, V50, P466, DOI 10.1086/279557; Soltis D, 2005, PHYLOGENY EVOLUTION; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stevens PF, 2008, ANGIOSPERM PHYLOGENY; Verdu M, 2002, EVOLUTION, V56, P1352, DOI 10.1111/j.0014-3820.2002.tb01449.x; Whittle CA, 2003, J MOL EVOL, V56, P223, DOI 10.1007/s00239-002-2395-0; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004	36	544	561	4	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					86	89		10.1126/science.1163197	http://dx.doi.org/10.1126/science.1163197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832643	Green Published			2022-12-01	WOS:000259680200043
J	Toyama, Y; Peralta, XG; Wells, AR; Kiehart, DP; Edwards, GS				Toyama, Yusuke; Peralta, Xomalin G.; Wells, Adrienne R.; Kiehart, Daniel P.; Edwards, Glenn S.			Apoptotic force and tissue dynamics during Drosophila embryogenesis	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; DORSAL CLOSURE; MORPHOGENESIS; GENE; MECHANISMS	Understanding cell morphogenesis during metazoan development requires knowledge of how cells and the extracellular matrix produce and respond to forces. We investigated how apoptosis, which remodels tissue by eliminating supernumerary cells, also contributes forces to a tissue ( the amnioserosa) that promotes cell- sheet fusion ( dorsal closure) in the Drosophila embryo. We showed that expression in the amnioserosa of proteins that suppress or enhance apoptosis slows or speeds dorsal closure, respectively. These changes correlate with the forces produced by the amnioserosa and the rate of seam formation between the cell sheets ( zipping), key processes that contribute to closure. This apoptotic force is used by the embryo to drive cell- sheet movements during development, a role not classically attributed to apoptosis.	[Wells, Adrienne R.; Kiehart, Daniel P.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Toyama, Yusuke; Peralta, Xomalin G.; Edwards, Glenn S.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Toyama, Yusuke; Peralta, Xomalin G.; Edwards, Glenn S.] Duke Univ, Free Elect Laser Lab, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Kiehart, DP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	dkiehart@duke.edu; edwards@fel.duke.edu	Wells, Adrienne/E-3500-2018; Peralta, Xomalin/F-3710-2014; Toyama, Yusuke/H-8023-2012	Wells, Adrienne/0000-0003-3372-5588; Peralta, Xomalin/0000-0002-4034-3214; Toyama, Yusuke/0000-0003-3230-1062	NIH [GM33830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Venakides, U. S. Tulu, and A. Rodiriguez-Diaz for useful discussions and A. Boury and R. Montangue for fly husbandry. This research was supported by NIH grant GM33830.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; Peralta XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015004; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Reed BH, 2004, CURR BIOL, V14, P372, DOI 10.1016/j.cub.2004.02.029; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Stenn K., 1998, MOL BASIS EPITHELIAL, P111; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116	22	199	199	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1683	1686		10.1126/science.1157052	http://dx.doi.org/10.1126/science.1157052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802000	Green Accepted			2022-12-01	WOS:000259300400038
J	Gordon, GRJ; Choi, HB; Rungta, RL; Ellis-Davies, GCR; MacVicar, BA				Gordon, Grant R. J.; Choi, Hyun B.; Rungta, Ravi L.; Ellis-Davies, Graham C. R.; MacVicar, Brian A.			Brain metabolism dictates the polarity of astrocyte control over arterioles	NATURE			English	Article							CEREBRAL-BLOOD-FLOW; PROSTAGLANDIN TRANSPORTER PGT; RAT HIPPOCAMPAL SLICES; ACTIVATED HUMAN BRAIN; NEURONAL-ACTIVITY; OXIDATIVE-METABOLISM; IN-VIVO; EXTRACELLULAR LACTATE; SENSORY STIMULATION; CORTICAL ASTROCYTES	Calcium signalling in astrocytes couples changes in neural activity to alterations in cerebral blood flow by eliciting vasoconstriction or vasodilation of arterioles. However, the mechanism for how these opposite astrocyte influences provide appropriate changes in vessel tone within an environment that has dynamic metabolic requirements remains unclear. Here we show that the ability of astrocytes to induce vasodilations over vasoconstrictions relies on the metabolic state of the rat brain tissue. When oxygen availability is lowered and astrocyte calcium concentration is elevated, astrocyte glycolysis and lactate release are maximized. External lactate attenuates transporter- mediated uptake from the extracellular space of prostaglandin E(2), leading to accumulation and subsequent vasodilation. In conditions of low oxygen concentration extracellular adenosine also increases, which blocks astrocyte- mediated constriction, facilitating dilation. These data reveal the role of metabolic substrates in regulating brain blood flow and provide a mechanism for differential astrocyte control over cerebrovascular diameter during different states of brain activation.	[Gordon, Grant R. J.; Choi, Hyun B.; Rungta, Ravi L.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC T2N 2B5, Canada; [Ellis-Davies, Graham C. R.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	University of British Columbia; Drexel University	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC T2N 2B5, Canada.	bmacvicar@brain.ubc.ca	MacVicar, Brian/P-1553-2015; MacVicar, Brian/AAI-7729-2020	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Rungta, Ravi/0000-0003-3505-2743	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Natural Science and Engineering Council of Canada; Wilms Foundation; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wilms Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Murphy, T. Phillips and Y. Tian Wang for reading an earlier version of the manuscript. T34 was a gift from V.L. Schuster and Y. Chi. This work was supported by an operating grant from the Canadian Institutes of Health Research. B.A.M. is a Canada Research Chair and a Michael Smith Foundation for Health Research (MSFHR) Distinguished Scholar. G.R.J.G. is supported by fellowships from the Alberta Heritage Foundation for Medical Research, MSFHR and the Natural Science and Engineering Council of Canada. H. B. C. is supported by postdoctoral fellowships from Wilms Foundation and the Heart and Stroke Foundation of Canada.	Ances BM, 2001, NEUROSCI LETT, V306, P106, DOI 10.1016/S0304-3940(01)01868-7; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Brust TB, 2006, J NEUROSCI, V26, P12427, DOI 10.1523/JNEUROSCI.4052-06.2006; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Chan BS, 1998, J BIOL CHEM, V273, P6689, DOI 10.1074/jbc.273.12.6689; Chan BS, 2002, AM J PHYSIOL-RENAL, V282, pF1097, DOI 10.1152/ajprenal.00151.2001; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Chi YL, 2006, J PHARMACOL EXP THER, V316, P1346, DOI 10.1124/jpet.105.091975; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; D'Agostino DP, 2007, J NEUROPHYSIOL, V98, P1030, DOI 10.1152/jn.01003.2006; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Frenguelli BG, 2003, J NEUROCHEM, V86, P1506, DOI 10.1046/j.1471-4159.2003.01957.x; Hein TW, 2006, INVEST OPHTH VIS SCI, V47, P693, DOI 10.1167/iovs.05-1224; Hu YB, 1997, J NEUROCHEM, V69, P1484; Ido Y, 2004, P NATL ACAD SCI USA, V101, P653, DOI 10.1073/pnas.0307458100; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mintun MA, 2004, P NATL ACAD SCI USA, V101, P659, DOI 10.1073/pnas.0307457100; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murphy K, 2003, MOL PHARMACOL, V64, P640, DOI 10.1124/mol.64.3.640; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Ryu JK, 2003, NEUROBIOL DIS, V12, P121, DOI 10.1016/S0969-9961(03)00002-0; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Simard M, 2003, J NEUROSCI, V23, P9254; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Yamanishi S, 2006, AM J PHYSIOL-HEART C, V290, pH925, DOI 10.1152/ajpheart.01012.2005; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	49	509	520	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					745	U45		10.1038/nature07525	http://dx.doi.org/10.1038/nature07525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18971930	Green Accepted			2022-12-01	WOS:000261559900039
J	Byres, E; Paton, AW; Paton, JC; Lofling, JC; Smith, DF; Wilce, MCJ; Talbot, UM; Chong, DC; Yu, H; Huang, SS; Chen, X; Varki, NM; Varki, A; Rossjohn, J; Beddoe, T				Byres, Emma; Paton, Adrienne W.; Paton, James C.; Lofling, Jonas C.; Smith, David F.; Wilce, Matthew C. J.; Talbot, Ursula M.; Chong, Damien C.; Yu, Hai; Huang, Shengshu; Chen, Xi; Varki, Nissi M.; Varki, Ajit; Rossjohn, Jamie; Beddoe, Travis			Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin	NATURE			English	Article							SUBTILASE CYTOTOXIN; CHOLERA-TOXIN; AB(5) TOXIN; MODEL; MICE; TARGETS; BINDING; POTENT; SITE	AB(5) toxins comprise an A subunit that corrupts essential eukaryotic cell functions, and pentameric B subunits that direct targetcell uptake after binding surface glycans. Subtilase cytotoxin (SubAB) is an AB5 toxin secreted by Shiga toxigenic Escherichia coli (STEC)(1), which causes serious gastrointestinal disease in humans(2). SubAB causes haemolytic uraemic syndrome- like pathology in mice(3) through SubA- mediated cleavage of BiP/GRP78, an essential endoplasmic reticulum chaperone(4). Here we show that SubB has a strong preference for glycans terminating in the sialic acid N- glycolylneuraminic acid (Neu5Gc), a monosaccharide not synthesized in humans. Structures of SubB - Neu5Gc complexes revealed the basis for this specificity, and mutagenesis of key SubB residues abrogated in vitro glycan recognition, cell binding and cytotoxicity. SubAB specificity for Neu5Gc was confirmed using mouse tissues with a human- like deficiency of Neu5Gc and human cell lines fed with Neu5Gc. Despite lack of Neu5Gc biosynthesis in humans, assimilation of dietary Neu5Gc creates high- affinity receptors on human gut epithelia and kidney vasculature. This, and the lack of Neu5Gc- containing body fluid competitors in humans, confers susceptibility to the gastrointestinal and systemic toxicities of SubAB. Ironically, foods rich in Neu5Gc are the most common source of STEC contamination. Thus a bacterial toxin's receptor is generated by metabolic incorporation of an exogenous factor derived from food.	[Lofling, Jonas C.; Varki, Nissi M.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Byres, Emma; Wilce, Matthew C. J.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Prot Crystallog Unit, Clayton, Vic 3800, Australia; [Byres, Emma; Wilce, Matthew C. J.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Paton, Adrienne W.; Paton, James C.; Talbot, Ursula M.; Chong, Damien C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Smith, David F.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Yu, Hai; Huang, Shengshu; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Diego; Monash University; Monash University; University of Adelaide; Emory University; University of California System; University of California Davis	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu; jamie.rossjohn@med.monash.edu.au; travis.beddoe@med.monash.edu.au	Chen, Xi/H-1811-2018; Paton, James C/A-9920-2008; Rossjohn, Jamie/F-9032-2013; Beddoe, Travis/F-3415-2014	Chen, Xi/0000-0002-3160-614X; Rossjohn, Jamie/0000-0002-2020-7522; Beddoe, Travis/0000-0003-4550-2277	Program Grant from the National Health; Medical Research Council of Australia; NHMRC Project Grant; National Institute of General Medical Sciences to the Consortium for Functional Glycomics; National Institutes of Health [RO1]; ARC Centre of Excellence in Structural and Functional Microbial Genomics; Australian Research Council Federation Fellowship; NHMRC Career Development Award; NHMRC Australia Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068715] Funding Source: NIH RePORTER	Program Grant from the National Health; Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); National Institute of General Medical Sciences to the Consortium for Functional Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); Australian Research Council Federation Fellowship(Australian Research Council); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff at the General Medicine and Cancer Institutes Collaborative Access Team Advanced Photon Source, Chicago, for assistance with data collection. This research was supported by a Program Grant from the National Health and Medical Research Council of Australia (NHMRC; to A.W.P. and J.C.P.), an NHMRC Project Grant (to T.B. and A.W.P.), a grant from the National Institute of General Medical Sciences to the Consortium for Functional Glycomics, RO1 grants from the National Institutes of Health (to A.W.P., J.C.P., J.R., X.C. and A.V.) and from the ARC Centre of Excellence in Structural and Functional Microbial Genomics (to J.R.). J.R. is supported by an Australian Research Council Federation Fellowship; T.B. by an NHMRC Career Development Award; J. C. P. by an NHMRC Australia Fellowship. We also thank C.J. Gregg for assistance with in vivo experiments and with collection of data, and L. Wiggleton for technical assistance with tissue sectioning and staining.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1997, P CCP4 STUD WEEK REC, P97; Gagneux P, 2001, AM J PHYS ANTHROPOL, V115, P99, DOI 10.1002/ajpa.1061; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merritt EA, 1997, PROTEIN SCI, V6, P1516, DOI 10.1002/pro.5560060716; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; PERRAKIS A, 1997, ACTA CRYSTALLOGR D, V30, P551; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; Talbot UM, 2005, INFECT IMMUN, V73, P4432, DOI 10.1128/IAI.73.7.4432-4436.2005; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Yahiro K, 2006, MOL MICROBIOL, V62, P480, DOI 10.1111/j.1365-2958.2006.05379.x	30	168	172	3	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					648	U75		10.1038/nature07428	http://dx.doi.org/10.1038/nature07428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18971931	Green Accepted			2022-12-01	WOS:000261340000043
J	Wang, LD; Utzinger, J; Zhou, XN				Wang, Longde; Utzinger, Juerg; Zhou, Xiao-Nong			Schistosomiasis control: experiences and lessons from China	LANCET			English	Editorial Material							METAANALYSIS		[Zhou, Xiao-Nong] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China; [Wang, Longde] Minist Hlth, Beijing, Peoples R China; [Utzinger, Juerg] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of Basel; Swiss Tropical & Public Health Institute	Zhou, XN (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China.	ipdzhouxn@sh163.net						BIAN Y, 2004, INT J HLTH PLANN S1, V19, P79; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guo JG, 2005, ACTA TROP, V96, P177, DOI 10.1016/j.actatropica.2005.07.012; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Poon LLM, 2004, LANCET INFECT DIS, V4, P663, DOI 10.1016/S1473-3099(04)01172-7; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; WANG LD, 2008, N ENGL J ME IN PRESS; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	12	167	209	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1793	1795		10.1016/S0140-6736(08)61358-6	http://dx.doi.org/10.1016/S0140-6736(08)61358-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18930529	Bronze, Green Published			2022-12-01	WOS:000261112000009
J	Creyghton, MP; Markoulaki, S; Levine, SS; Hanna, J; Lodato, MA; Sha, K; Young, RA; Jaenisch, R; Boyer, LA				Creyghton, Menno P.; Markoulaki, Styliani; Levine, Stuart S.; Hanna, Jacob; Lodato, Michael A.; Sha, Ky; Young, Richard A.; Jaenisch, Rudolf; Boyer, Laurie A.			H2AZ Is Enriched at Polycomb Complex Target Genes in ES Cells and Is Necessary for Lineage Commitment	CELL			English	Article							HISTONE VARIANT H2A.Z; EMBRYONIC STEM-CELLS; EARLY MAMMALIAN DEVELOPMENT; METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; NUCLEOSOME SURFACE; CHROMATIN STATE; X-INACTIVATION; HUMAN GENOME; PROMOTERS	Elucidating how chromatin influences gene expression patterns and ultimately cell fate is fundamental to understanding development and disease. The histone variant H2AZ has emerged as a key regulator of chromatin function and plays an essential but unknown role during mammalian development. Here, genome-wide analysis reveals that H2AZ occupies the promoters of developmentally important genes in a manner that is remarkably similar to that of the Polycomb group (PcG) protein Suz12. By using RNAi, we demonstrate a role for H2AZ in regulating target gene expression, find that H2AZ and PcG protein occupancy is interdependent at promoters, and further show that H2AZ is necessary for ES cell differentiation. Notably, H2AZ occupies a different subset of genes in lineage-committed cells, suggesting that its dynamic redistribution is necessary for cell fate transitions. Thus, H2AZ, together with PcG proteins, may establish specialized chromatin states in ES cells necessary for the proper execution of developmental gene expression programs.	[Lodato, Michael A.; Sha, Ky; Young, Richard A.; Jaenisch, Rudolf; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Creyghton, Menno P.; Markoulaki, Styliani; Levine, Stuart S.; Hanna, Jacob; Lodato, Michael A.; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu	Hanna, Jacob/K-1339-2012; Young, Richard A/F-6495-2012; Lodato, Michael/AAX-9211-2021	Hanna, Jacob/0000-0003-2042-9974; Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X; Lodato, Michael/0000-0003-4175-1073	NCI NIH HHS [R37 CA084198, 5 R37CA084198, R37 CA084198-09, R37 CA084198-08] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668, R01HG002668, R01 HG002668-05] Funding Source: Medline; NICHD NIH HHS [R01 HD045022-06, R01 HD045022] Funding Source: Medline; PHS HHS [5-RO1-HDO45022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Deschamps J, 2007, CURR OPIN GENET DEV, V17, P422, DOI 10.1016/j.gde.2007.07.008; Dunn RK, 2007, MOL CELL, V28, P708, DOI 10.1016/j.molcel.2007.11.022; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Glaser T, 2005, TRENDS NEUROSCI, V28, P397, DOI 10.1016/j.tins.2005.05.008; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Raisner RM, 2006, CURR OPIN GENET DEV, V16, P119, DOI 10.1016/j.gde.2006.02.005; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; ZILBERMAN D, 2008, NATURE IN PRESS	68	248	252	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					649	661		10.1016/j.cell.2008.09.056	http://dx.doi.org/10.1016/j.cell.2008.09.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	18992931	Green Accepted, Bronze			2022-12-01	WOS:000260886900016
J	Cadwell, K; Liu, JY; Brown, SL; Miyoshi, H; Loh, J; Lennerz, JK; Kishi, C; Kc, W; Carrero, JA; Hunt, S; Stone, CD; Brunt, EM; Xavier, RJ; Sleckman, BP; Li, E; Mizushima, N; Stappenbeck, TS; Virgin, HW				Cadwell, Ken; Liu, John Y.; Brown, Sarah L.; Miyoshi, Hiroyuki; Loh, Joy; Lennerz, Jochen K.; Kishi, Chieko; Kc, Wumesh; Carrero, Javier A.; Hunt, Steven; Stone, Christian D.; Brunt, Elizabeth M.; Xavier, Ramnik J.; Sleckman, Barry P.; Li, Ellen; Mizushima, Noboru; Stappenbeck, Thaddeus S.; Virgin, Herbert W.			A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells	NATURE			English	Article							GENOME-WIDE ASSOCIATION; MESENTERIC ADIPOSE-TISSUE; SUSCEPTIBILITY LOCI; CROHN-DISEASE; PROTEIN; PATHOGENESIS; EXPRESSION; MEMBRANE; COMPLEX	Susceptibility to Crohn's disease, a complex inflammatory disease involving the small intestine, is controlled by over 30 loci(1). One Crohn's disease risk allele is in ATG16L1, a gene homologous to the essential yeast autophagy gene ATG16 ( ref. 2). It is not known how ATG16L1 or autophagy contributes to intestinal biology or Crohn's disease pathogenesis. To address these questions, we generated and characterized mice that are hypomorphic for ATG16L1 protein expression, and validated conclusions on the basis of studies in these mice by analysing intestinal tissues that we collected from Crohn's disease patients carrying the Crohn's disease risk allele of ATG16L1. Here we show that ATG16L1 is a bona fide autophagy protein. Within the ileal epithelium, both ATG16L1 and a second essential autophagy protein ATG5 are selectively important for the biology of the Paneth cell, a specialized epithelial cell that functions in part by secretion of granule contents containing antimicrobial peptides and other proteins that alter the intestinal environment(3). ATG16L1- andATG5- deficient Paneth cells exhibited notable abnormalities in the granule exocytosis pathway. In addition, transcriptional analysis revealed an unexpected gain of function specific to ATG16L1- deficient Paneth cells including increased expression of genes involved in peroxisome proliferator- activated receptor ( PPAR) signalling and lipid metabolism, of acute phase reactants and of two adipocytokines, leptin and adiponectin, known to directly influence intestinal injury responses. Importantly, Crohn's disease patients homozygous for the ATG16L1 Crohn's disease risk allele displayed Paneth cell granule abnormalities similar to those observed in autophagy- protein- deficient mice and expressed increased levels of leptin protein. Thus, ATG16L1, and probably the process of autophagy, have a role within the intestinal epithelium of mice and Crohn's disease patients by selective effects on the cell biology and specialized regulatory properties of Paneth cells.	[Cadwell, Ken; Liu, John Y.; Brown, Sarah L.; Miyoshi, Hiroyuki; Loh, Joy; Lennerz, Jochen K.; Kc, Wumesh; Carrero, Javier A.; Brunt, Elizabeth M.; Sleckman, Barry P.; Stappenbeck, Thaddeus S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hunt, Steven] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Stone, Christian D.; Li, Ellen] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Kishi, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Grad Sch, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Kishi, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Fac Med, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@wustl.edu; virgin@wustl.edu	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Virgin, Herbert/0000-0001-8580-7628; Miyoshi, Hiroyuki/0000-0001-7400-0714; Cadwell, Ken/0000-0002-5860-0661	Broad Foundation; NIH [T32 AR07279, R01 AI062832, AI062773, DK43351]; Lallage Feazel Wall Fellowship [DRG-1972-08]; Damon Runyon Cancer Research Foundation; Pew Foundation; Washington University Digestive Diseases Research Core Center [P30 DK52574]; Barnes Jewish Foundation; Johnson and Johnson Translational Seed Award; Crohn's Colitis Foundation of America; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Toray Science Foundation;  [U54 AI057160 Project 6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, R01AI062832, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK040561, P30DK052574] Funding Source: NIH RePORTER	Broad Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lallage Feazel Wall Fellowship; Damon Runyon Cancer Research Foundation; Pew Foundation; Washington University Digestive Diseases Research Core Center; Barnes Jewish Foundation; Johnson and Johnson Translational Seed Award(Johnson & JohnsonJohnson & Johnson USA); Crohn's Colitis Foundation of America; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Toray Science Foundation(Toray Industries, Inc.); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Abe for technical assistance with fluorescence microscopy, V. Cavalli for microscope use, J. Eisenberg and A. Ng for help with bioinformatics analysis, A. J. Ouellette for technical advice, and I. Mysorekar and J. Mills for help with antibodies. This research was supported by grant U54 AI057160 Project 6 and the Broad Foundation (K.C., J. Loh and H.W.V.), training grant NIH T32 AR07279 (K.C.), the Lallage Feazel Wall Fellowship DRG-1972-08 (K.C.) from the Damon Runyon Cancer Research Foundation; the Pew Foundation (J. Liu, S.L.B., H.M., W.K. and T.S.S.); the Washington University Digestive Diseases Research Core Center P30 DK52574, Barnes Jewish Foundation, Johnson and Johnson Translational Seed Award, and the Crohn's Colitis Foundation of America (E.L., S.H. and C.S.); grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Toray Science Foundation (C.K. and N.M.); NIH R01 AI062832 (J.A.C.); and NIH AI062773 and DK43351 (R.J.X.).	Barbier M, 2003, GASTROEN CLIN BIOL, V27, P987; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; DVORAK AM, 1980, HUM PATHOL, V11, P561; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516	29	1092	1129	5	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					259	U62		10.1038/nature07416	http://dx.doi.org/10.1038/nature07416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849966	Green Accepted			2022-12-01	WOS:000261039300044
J	Dulcis, D; Spitzer, NC				Dulcis, Davide; Spitzer, Nicholas C.			Illumination controls differentiation of dopamine neurons regulating behaviour	NATURE			English	Article							ACTIVITY-DEPENDENT REGULATION; SEASONAL AFFECTIVE-DISORDER; XENOPUS-LAEVIS; MELANOTROPE CELLS; TYROSINE-HYDROXYLASE; SUPRACHIASMATIC NUCLEUS; EXPRESSION; PLASTICITY; ZEBRAFISH; SYSTEM	Specification of the appropriate neurotransmitter is a crucial step in neuronal differentiation because it enables signalling among populations of neurons. Experimental manipulations demonstrate that both autonomous and activity- dependent genetic programs contribute to this process during development, but whether natural environmental stimuli specify transmitter expression in a neuronal population is unknown. We investigated neurons of the ventral suprachiasmatic nucleus that regulate neuroendocrine pituitary function in response to light in teleosts, amphibia and primates. Here we show that altering light exposure, which changes the sensory input to the circuit controlling adaptation of skin pigmentation to background, changes the number of neurons expressing dopamine in larvae of the amphibian Xenopus laevis in a circuit- specific and activity- dependent manner. Neurons newly expressing dopamine then regulate changes in camouflage colouration in response to illumination. Thus, physiological activity alters the numbers of behaviourally relevant amine- transmitter- expressing neurons in the brain at postembryonic stages of development. The results may be pertinent to changes in cognitive states that are regulated by biogenic amines.	[Dulcis, Davide; Spitzer, Nicholas C.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Dulcis, Davide; Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Mol Genet, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dulcis, D (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	ddulcis@biomail.ucsd.edu	Dulcis, Davide/GSN-9883-2022	Dulcis, Davide/0000-0003-4672-7996; Spitzer, Nicholas/0000-0002-3523-1103	N.C.S.; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015918] Funding Source: NIH RePORTER	N.C.S.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Berg, L. Borodinsky and R. Levine for critical comments on the manuscript and I-T. Hsieh and D. Boassa for technical support. This work was supported by a grant to N.C.S. from the National Institutes of Health.	Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Akopian A, 1996, J NEUROPHYSIOL, V76, P1828, DOI 10.1152/jn.1996.76.3.1828; Baquet ZC, 2005, J NEUROSCI, V25, P6251, DOI 10.1523/JNEUROSCI.4601-04.2005; Berghs CAFM, 1997, J HISTOCHEM CYTOCHEM, V45, P1673, DOI 10.1177/002215549704501211; Borodinsky LN, 2007, P NATL ACAD SCI USA, V104, P335, DOI 10.1073/pnas.0607450104; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brosenitsch TA, 2002, MOL CELL NEUROSCI, V20, P447, DOI 10.1006/mcne.2002.1135; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; Catalano SM, 1997, J NEUROSCI, V17, P8376; El Majdoubi M, 2000, BIOCHEM CELL BIOL, V78, P317; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gomez-Lira G, 2005, J NEUROSCI, V25, P6939, DOI 10.1523/JNEUROSCI.1674-05.2005; GONZALEZ A, 1991, J COMP NEUROL, V303, P457, DOI 10.1002/cne.903030311; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Green CB, 1999, DEV BRAIN RES, V117, P109, DOI 10.1016/S0165-3806(99)00109-1; HESS EJ, 1991, NEURON, V6, P123, DOI 10.1016/0896-6273(91)90127-L; Jenks BG, 2007, NEUROENDOCRINOLOGY, V85, P177, DOI 10.1159/000101434; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kolk SM, 2001, ENDOCRINOLOGY, V142, P1950, DOI 10.1210/en.142.5.1950; Kramer BMR, 2001, MICROSC RES TECHNIQ, V54, P188, DOI 10.1002/jemt.1132; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Lam R., 1999, CANADIAN CONSENSUS G; Lam RW, 2001, NEUROPSYCHOPHARMACOL, V25, pS97, DOI 10.1016/S0893-133X(01)00337-2; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Li L, 2000, J NEUROSCI, V20, P1893; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; Michel S, 2002, J NEUROPHYSIOL, V88, P817, DOI 10.1152/jn.2002.88.2.817; Mueller NK, 2005, ENDOCRINOLOGY, V146, P348, DOI 10.1210/en.2004-0539; NORDLAND JJ, 2006, PIGMENTARY SYSTEM PH; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; OLIVE S, 1995, BRAIN RES, V689, P271, DOI 10.1016/0006-8993(95)00555-5; Roubos EW, 2005, ANN NY ACAD SCI, V1040, P172, DOI 10.1196/annals.1327.022; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; TONOSAKI Y, 1995, ENDOCRINOLOGY, V136, P5260, DOI 10.1210/en.136.12.5260; TUINHOF R, 1994, NEUROSCIENCE, V61, P411, DOI 10.1016/0306-4522(94)90241-0; Ubink R, 1998, J COMP NEUROL, V397, P60; Vazquez-Martinez R, 2001, ENDOCRINOLOGY, V142, P3060, DOI 10.1210/en.142.7.3060; WALICKE PA, 1981, J NEUROSCI, V1, P343; Wang Y, 1997, J NEUROPHYSIOL, V78, P439, DOI 10.1152/jn.1997.78.1.439; Wullimann MF, 2001, DEV BRAIN RES, V131, P173, DOI 10.1016/S0165-3806(01)00270-X; Zhang H, 2008, GEN COMP ENDOCR, V156, P104, DOI 10.1016/j.ygcen.2007.12.005	46	89	90	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					195	U20		10.1038/nature07569	http://dx.doi.org/10.1038/nature07569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005547	Green Accepted			2022-12-01	WOS:000261039300031
J	Liu, Y; Dentin, R; Chen, D; Hedrick, S; Ravnskjaer, K; Schenk, S; Milne, J; Meyers, DJ; Cole, P; Yates, J; Olefsky, J; Guarente, L; Montminy, M				Liu, Yi; Dentin, Renaud; Chen, Danica; Hedrick, Susan; Ravnskjaer, Kim; Schenk, Simon; Milne, Jill; Meyers, David J.; Cole, Phil; Yates, John, III; Olefsky, Jerrold; Guarente, Leonard; Montminy, Marc			A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange	NATURE			English	Article							TRANSCRIPTION FACTOR FOXO1; GLUCOSE-HOMEOSTASIS; CATALYTIC SUBUNIT; GENE-EXPRESSION; FACTOR FKHR; GLUCOSE-6-PHOSPHATASE; SIRT1; P300; METABOLISM; STARVATION	During early fasting, increases in skeletal muscle proteolysis liberate free amino acids for hepatic gluconeogenesis in response to pancreatic glucagon. Hepatic glucose output diminishes during the late protein- sparing phase of fasting, when ketone body production by the liver supplies compensatory fuel for glucose- dependent tissues(1-4). Glucagon stimulates the gluconeogenic program by triggering the dephosphorylation and nuclear translocation of the CREB regulated transcription coactivator 2 ( CRTC2; also known as TORC2), while parallel decreases in insulin signalling augment gluconeogenic gene expression through the dephosphorylation and nuclear shuttling of forkhead box O1 (FOXO1)(5-7). Here we show that a fasting- inducible switch, consisting of the histone acetyltransferase p300 and the nutrient- sensing deacetylase sirtuin 1 ( SIRT1), maintains energy balance in mice through the sequential induction of CRTC2 and FOXO1. After glucagon induction, CRTC2 stimulated gluconeogenic gene expression by an association with p300, which we show here is also activated by dephosphorylation at Ser 89 during fasting. In turn, p300 increased hepatic CRTC2 activity by acetylating it at Lys 628, a site that also targets CRTC2 for degradation after its ubiquitination by the E3 ligase constitutive photomorphogenic protein (COP1)(8). Glucagon effects were attenuated during late fasting, when CRTC2 was downregulated owing to SIRT1- mediated deacetylation and when FOXO1 supported expression of the gluconeogenic program. Disrupting SIRT1 activity, by liver- specific knockout of the Sirt1 gene or by administration of a SIRT1 antagonist, increased CRTC2 activity and glucose output, whereas exposure to SIRT1 agonists reduced them. In view of the reciprocal activation of FOXO1 and its coactivator peroxisome proliferator- activated receptor-gamma coactivator-1 alpha (PGC-1 alpha, encoded by Ppargc1 alpha) by SIRT1 activators(9-12), our results illustrate how the exchange of two gluconeogenic regulators during fasting maintains energy balance.	[Liu, Yi; Dentin, Renaud; Hedrick, Susan; Ravnskjaer, Kim; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Chen, Danica; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA; [Schenk, Simon; Olefsky, Jerrold] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Milne, Jill] Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; [Meyers, David J.; Cole, Phil] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yates, John, III] Scripps Res Inst, La Jolla, CA 92037 USA	Salk Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Johns Hopkins University; Scripps Research Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Montminy@salk.edu	Dentin, Renaud/AAV-5818-2020; dentin, Renaud/P-4939-2017	Dentin, Renaud/0000-0003-0988-4458; dentin, Renaud/0000-0003-0988-4458; Schenk, Simon/0000-0002-8224-3203	National Institutes of Health; Clayton Medical Research Foundation, Inc; Hillblom Foundation; Kieckhefer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Medical Research Foundation, Inc; Hillblom Foundation; Kieckhefer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kahn for the gift of phospho-specific p300 antiserum and L. Vera for technical assistance. We also thank R. Shaw and M. Mihaylova for sharing results on p300 phosphorylation. This work was supported by grants from the National Institutes of Health, the Clayton Medical Research Foundation, Inc., the Hillblom Foundation (to Y.L.), and the Kieckhefer Foundation.	Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; FERRE P, 1978, AM J PHYSIOL, V234, pE129, DOI 10.1152/ajpendo.1978.234.2.E129; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; GOODMAN MN, 1980, AM J PHYSIOL, V239, pE277; GOODMAN MN, 1981, AM J PHYSIOL, V241, pE321, DOI 10.1152/ajpendo.1981.241.4.E321; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hornbuckle LA, 2004, AM J PHYSIOL-ENDOC M, V286, pE795, DOI 10.1152/ajpendo.00455.2003; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; MARLISS EB, 1970, J CLIN INVEST, V49, P2256, DOI 10.1172/JCI106445; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schmoll D, 1999, BIOCHEM J, V338, P457, DOI 10.1042/0264-6021:3380457; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544	30	406	430	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					269	U74		10.1038/nature07349	http://dx.doi.org/10.1038/nature07349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849969	Green Accepted			2022-12-01	WOS:000261039300046
J	Pischon, T; Boeing, H; Hoffmann, K; Bergmann, M; Schulze, MB; Overvad, K; van der Schouw, YT; Spencer, E; Moons, KGM; Tjonneland, A; Halkjaer, J; Jensen, MK; Stegger, J; Clavel-Chapelon, F; Boutron-Ruault, MC; Chajes, V; Linseisen, J; Kaaks, R; Trichopoulou, A; Trichopoulos, D; Bamia, C; Sieri, S; Palli, D; Tumino, R; Vineis, P; Panico, S; Peeters, PHM; May, AM; Bueno-De-Mesquita, HB; van Duijnhoven, FJB; Hallmans, G; Weinehall, L; Manjer, J; Hedblad, B; Lund, E; Agudo, A; Arriola, L; Barricarte, A; Navarro, C; Martinez, C; Quiros, JR; Key, T; Bingham, S; Khaw, KT; Boffetta, P; Jenab, M; Ferrari, P; Riboli, E				Pischon, T.; Boeing, H.; Hoffmann, K.; Bergmann, M.; Schulze, M. B.; Overvad, K.; van der Schouw, Y. T.; Spencer, E.; Moons, K. G. M.; Tjonneland, A.; Halkjaer, J.; Jensen, M. K.; Stegger, J.; Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.; Linseisen, J.; Kaaks, R.; Trichopoulou, A.; Trichopoulos, D.; Bamia, C.; Sieri, S.; Palli, D.; Tumino, R.; Vineis, P.; Panico, S.; Peeters, P. H. M.; May, A. M.; Bueno-de-Mesquita, H. B.; van Duijnhoven, F. J. B.; Hallmans, G.; Weinehall, L.; Manjer, J.; Hedblad, B.; Lund, E.; Agudo, A.; Arriola, L.; Barricarte, A.; Navarro, C.; Martinez, C.; Quiros, J. R.; Key, T.; Bingham, S.; Khaw, K. T.; Boffetta, P.; Jenab, M.; Ferrari, P.; Riboli, E.			General and Abdominal Adiposity and Risk of Death in Europe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; PREDICTING MORTALITY; WAIST CIRCUMFERENCE; TISSUE DISTRIBUTION; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; ROC CURVE; FOLLOW-UP; OBESITY	BACKGROUND Previous studies have relied predominantly on the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) to assess the association of adiposity with the risk of death, but few have examined whether the distribution of body fat contributes to the prediction of death. METHODS We examined the association of BMI, waist circumference, and waist-to-hip ratio with the risk of death among 359,387 participants from nine countries in the European Prospective Investigation into Cancer and Nutrition (EPIC). We used a Cox regression analysis, with age as the time variable, and stratified the models according to study center and age at recruitment, with further adjustment for educational level, smoking status, alcohol consumption, physical activity, and height. RESULTS During a mean follow-up of 9.7 years, 14,723 participants died. The lowest risks of death related to BMI were observed at a BMI of 25.3 for men and 24.3 for women. After adjustment for BMI, waist circumference and waist-to-hip ratio were strongly associated with the risk of death. Relative risks among men and women in the highest quintile of waist circumference were 2.05 (95% confidence interval [CI], 1.80 to 2.33) and 1.78 (95% CI, 1.56 to 2.04), respectively, and in the highest quintile of waist-to-hip ratio, the relative risks were 1.68 (95% CI, 1.53 to 1.84) and 1.51 (95% CI, 1.37 to 1.66), respectively. BMI remained significantly associated with the risk of death in models that included waist circumference or waist-to-hip ratio (P<0.001). CONCLUSIONS These data suggest that both general adiposity and abdominal adiposity are associated with the risk of death and support the use of waist circumference or waist-tohip ratio in addition to BMI in assessing the risk of death.	[Pischon, T.; Boeing, H.; Hoffmann, K.; Bergmann, M.; Schulze, M. B.] German Inst Human Nutr, Dept Epidemiol, D-14558 Potsdam, Germany; [Overvad, K.; Jensen, M. K.] Aalborg Hosp, Aarhus Univ Hosp Syst, Dept Clin Epidemiol, Aalborg, Denmark; [Overvad, K.; Stegger, J.] Aalborg Hosp, Aarhus Univ Hosp Syst, Dept Cardiol, Aalborg, Denmark; [van der Schouw, Y. T.; Moons, K. G. M.; Peeters, P. H. M.; May, A. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Spencer, E.; Key, T.] Univ Oxford, Canc Res UK Epidemiol Unit, Oxford, England; [Tjonneland, A.; Halkjaer, J.] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.] INSERM, ERI 20, EA 4045, Villejuif, France; [Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.] Inst Gustave Roussy, Villejuif, France; [Linseisen, J.; Kaaks, R.] German Canc Res Ctr, Div Clin Epidemiol, D-6900 Heidelberg, Germany; [Trichopoulou, A.; Bamia, C.] Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; [Trichopoulos, D.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, D.] Hellen Hlth Fdn, Athens, Greece; [Sieri, S.] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy; [Palli, D.] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Tumino, R.] Azienda Osped Civile MP Arezzo, Canc Registry, Ragusa, Italy; [Vineis, P.; Riboli, E.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Vineis, P.] Univ Turin, Turin, Italy; [Panico, S.] Univ Naples Federico 2, Naples, Italy; [Bueno-de-Mesquita, H. B.; van Duijnhoven, F. J. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr & Hlth, NL-3720 BA Bilthoven, Netherlands; [Hallmans, G.; Weinehall, L.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Manjer, J.] Malmo Univ Hosp, Dept Surg, Malmo, Sweden; [Hedblad, B.] Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Lund, E.] Univ Tromso, Inst Community Med, Tromso, Norway; [Agudo, A.] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain; [Arriola, L.] Publ Hlth Dept Gipuzkoa, San Sebastian, Spain; [Barricarte, A.] Publ Hlth Inst Navarra, Pamplona, Spain; [Navarro, C.] Murcia Hlth Council, Dept Epidemiol, Murcia, Spain; [Navarro, C.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Martinez, C.] Escuela Andaluza Salud Publ, Granada, Spain; [Quiros, J. R.] Publ Hlth & Hlth Planning Directorate, Hlth Informat Unit, Asturias, Spain; [Bingham, S.] Univ Cambridge, Ctr Nutr & Canc, Cambridge, England; [Khaw, K. T.] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Boffetta, P.; Jenab, M.; Ferrari, P.] WHO, Int Agcy Res Canc, Lyon, France	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Utrecht University; Utrecht University Medical Center; Cancer Research UK; University of Oxford; Danish Cancer Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Imperial College London; University of Turin; University of Naples Federico II; Netherlands National Institute for Public Health & the Environment; Umea University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; UiT The Arctic University of Tromso; Catalan Institute of Oncology; Public Health Institute of Navarra; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Escuela Andaluza de Salud Publica; University of Cambridge; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC)	Pischon, T (corresponding author), German Inst Human Nutr, Dept Epidemiol, Arthur Scheunert Allee 114-116, D-14558 Potsdam, Germany.	pischon@dife.de	Schulze, Matthias B/AAH-6906-2021; Panico, Salvatore/K-6506-2016; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Sieri, Sabina/K-4667-2016; Linseisen, Jakob/B-5353-2014; van der Schouw, Yvonne T./F-8327-2014; Boutron-Ruault, Marie-Christine/H-3936-2014; Boffetta, Paolo/AAI-7767-2021; Khaw, Kay-Tee/AAZ-3209-2021; Agudo, Antonio/J-1805-2016; May, Anne M/G-9183-2011; Clavel-Chapelon, Francoise/G-6733-2014; van Duijnhoven, Fränzel/GWC-0059-2022	Schulze, Matthias B/0000-0002-0830-5277; Panico, Salvatore/0000-0002-5498-8312; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Sieri, Sabina/0000-0001-5201-172X; Linseisen, Jakob/0000-0002-9386-382X; van der Schouw, Yvonne T./0000-0002-4605-435X; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Boffetta, Paolo/0000-0002-3811-2791; Agudo, Antonio/0000-0001-9900-5677; Arriola, Larraitz/0000-0001-8487-7181; Riboli, Elio/0000-0001-6795-6080; tumino, rosario/0000-0003-2666-414X; PALLI, Domenico/0000-0002-5558-2437; Jensen, Majken Karoline/0000-0003-4729-7545; Tjonneland, Anne/0000-0003-4385-2097; Chajes, Veronique/0000-0003-1297-3064; Lund, Eiliv/0000-0002-8071-8711; Pischon, Tobias/0000-0003-1568-767X; Spencer, Elizabeth/0000-0002-9079-8006; Navarro, Carmen/0000-0001-8896-7483; Jenab, Mazda/0000-0002-0573-1852; Weinehall, Lars/0000-0003-3025-2690; Overvad, Kim/0000-0001-6429-7921	European Commission: Public Health and Consumer Protection Directorate; Research Directorate-General; Deutsche Krebshilfe; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09); Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK; Medical Research Council, United Kingdom; Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom; Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education; Italian Association for Research on Cancer; Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East; Maastricht of the Netherlands; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; 3M Company; Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; Institut National de la Sante et de la Recherche Medicale, France.	European Commission: Public Health and Consumer Protection Directorate(European CommissionEuropean Commission Joint Research Centre); Research Directorate-General; Deutsche Krebshilfe; German Cancer Research Center(Deutsche Krebshilfe); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09)(Instituto de Salud Carlos III); Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK(Cancer Research UK); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association, United Kingdom; British Heart Foundation(British Heart Foundation); Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom(Wellcome Trust); Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education(Greek Ministry of Development-GSRT); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East; Maastricht of the Netherlands; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; 3M Company(3M); Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; Institut National de la Sante et de la Recherche Medicale, France.(Institut National de la Sante et de la Recherche Medicale (Inserm))	Supported by grants from the European Commission: Public Health and Consumer Protection Directorate 1993-2004; Research Directorate-General 2005-present; Deutsche Krebshilfe; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09); the Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK; Medical Research Council, United Kingdom; the Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; the Wellcome Trust, United Kingdom; Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education; Italian Association for Research on Cancer; Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East, and Maastricht of the Netherlands; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; the 3M Company; Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; and Institut National de la Sante et de la Recherche Medicale, France.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P1254; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Friedenreich C, 2006, CANCER EPIDEM BIOMAR, V15, P2398, DOI 10.1158/1055-9965.EPI-06-0595; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hu FB, 2007, ARCH INTERN MED, V167, P875, DOI 10.1001/archinte.167.9.875; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kalmijn S, 1999, INT J OBESITY, V23, P395, DOI 10.1038/sj.ijo.0800832; Katzmarzyk PT, 2002, INT J OBESITY, V26, P1054, DOI 10.1038/sj.ijo.0802057; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lahmann PH, 2002, OBES RES, V10, P361, DOI 10.1038/oby.2002.50; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Dolan CM, 2007, AM J PUBLIC HEALTH, V97, P913, DOI 10.2105/AJPH.2005.084178; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Poulain M, 2006, CAN MED ASSOC J, V174, P1293, DOI 10.1503/cmaj.051299; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; WORLD H, 2000, WHO TECH REP SER, V894, P1; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	40	1393	1432	2	142	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2105	2120		10.1056/NEJMoa0801891	http://dx.doi.org/10.1056/NEJMoa0801891			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005195	Green Published			2022-12-01	WOS:000260823900009
J	Hoshida, Y; Villanueva, A; Kobayashi, M; Peix, J; Chiang, DY; Camargo, A; Gupta, S; Moore, J; Wrobel, MJ; Lerner, J; Reich, M; Chan, JA; Glickman, JN; Ikeda, K; Hashimoto, M; Watanabe, G; Daidone, MG; Roayaie, S; Schwartz, M; Thung, S; Salvesen, HB; Gabriel, S; Mazzaferro, V; Bruix, J; Friedman, SL; Kumada, H; Llovet, JM; Golub, TR				Hoshida, Yujin; Villanueva, Augusto; Kobayashi, Masahiro; Peix, Judit; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Glickman, Jonathan N.; Ikeda, Kenji; Hashimoto, Masaji; Watanabe, Goro; Daidone, Maria G.; Roayaie, Sasan; Schwartz, Myron; Thung, Swan; Salvesen, Helga B.; Gabriel, Stacey; Mazzaferro, Vincenzo; Bruix, Jordi; Friedman, Scott L.; Kumada, Hiromitsu; Llovet, Josep M.; Golub, Todd R.			Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; LIVER-CANCER; RECURRENCE; RESECTION; INTERFERON; PREVENTION; MANAGEMENT; TUMOR; RISK	Background: It is a challenge to identify patients who, after undergoing potentially curative treatment for hepatocellular carcinoma, are at greatest risk for recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissue. Methods: We aimed to demonstrate the feasibility of gene-expression profiling of more than 6000 human genes in formalin-fixed, paraffin-embedded tissues. We applied the method to tissues from 307 patients with hepatocellular carcinoma, from four series of patients, to discover and validate a gene-expression signature associated with survival. Results: The expression-profiling method for formalin-fixed, paraffin-embedded tissue was highly effective: samples from 90% of the patients yielded data of high quality, including samples that had been archived for more than 24 years. Gene-expression profiles of tumor tissue failed to yield a significant association with survival. In contrast, profiles of the surrounding nontumoral liver tissue were highly correlated with survival in a training set of tissue samples from 82 Japanese patients, and the signature was validated in tissues from an independent group of 225 patients from the United States and Europe (P=0.04). Conclusions: We have demonstrated the feasibility of genomewide expression profiling of formalin-fixed, paraffin-embedded tissues and have shown that a reproducible gene-expression signature correlated with survival is present in liver tissue adjacent to the tumor in patients with hepatocellular carcinoma.	[Hoshida, Yujin; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Gabriel, Stacey; Golub, Todd R.] MIT, Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Hoshida, Yujin; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Gabriel, Stacey; Golub, Todd R.] Harvard Univ, Cambridge, MA 02142 USA; [Golub, Todd R.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Hoshida, Yujin; Chiang, Derek Y.; Golub, Todd R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Glickman, Jonathan N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Villanueva, Augusto; Peix, Judit; Roayaie, Sasan; Schwartz, Myron; Thung, Swan; Friedman, Scott L.; Llovet, Josep M.] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, Div Liver Dis, New York, NY 10029 USA; [Kobayashi, Masahiro; Ikeda, Kenji; Hashimoto, Masaji; Watanabe, Goro; Kumada, Hiromitsu] Toranomon Gen Hosp, Tokyo, Japan; [Daidone, Maria G.; Mazzaferro, Vincenzo] Natl Canc Inst, I-20133 Milan, Italy; [Salvesen, Helga B.] Univ Bergen, Haukeland Univ Hosp, Bergen, Norway; [Bruix, Jordi; Llovet, Josep M.] Hosp Clin Barcelona, Ctr Invest Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer, Barcelona Clin Liver Canc Grp, Barcelona, Spain; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Toranomon Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Bergen; Haukeland University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA	Golub, TR (corresponding author), MIT, Broad Inst, Canc Program, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	josep.llovet@mssm.edu; golub@broad.mit.edu	Chiang, Derek/L-6452-2019; Llovet, Josep M/D-4340-2014; Mazzaferro, Vincenzo/C-2726-2017; salvesen, Helga B/C-1187-2017; Daidone, Maria Grazia/E-9232-2017; Llovet, Josep M/ABB-6264-2021; Augusto, Villanueva/F-9378-2012; Mazzaferro, Vincenzo/AAL-4707-2020; Hoshida, Yujin/R-7513-2019	Llovet, Josep M/0000-0003-0547-2667; Mazzaferro, Vincenzo/0000-0002-4013-8085; salvesen, Helga B/0000-0002-4438-8831; Daidone, Maria Grazia/0000-0002-4786-1321; Llovet, Josep M/0000-0003-0547-2667; Augusto, Villanueva/0000-0003-3585-3727; Bruix, Jordi/0000-0002-9826-0753; Reich, Michael/0000-0003-4735-5514; Chiang, Derek/0000-0002-1131-6065	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK076986-01]; National Cancer Institute [5U54 CA112962-03]; Samuel Waxman Cancer Research Foundation; Spanish National Health Institute [SAF2007-61898]; Institucio Catalana de Recerca i Estudis Avancats; Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas; Fund for Health of Spain of the Institute of Health Carlos III [PI05-0150]; National Institutes of Health [DK37340]; Italian Association for Cancer Research; Norwegian Cancer Society; Harald Andersens grant; Charles A. King Trust fellowship; Fundacion Pedro Barri, de la Maza; Sheila Sherlock Fellowship; National Cancer Center Fellowship; NATIONAL CANCER INSTITUTE [U54CA112962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076986, R01DK037340] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Samuel Waxman Cancer Research Foundation; Spanish National Health Institute(Spanish Government); Institucio Catalana de Recerca i Estudis Avancats(ICREA); Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas; Fund for Health of Spain of the Institute of Health Carlos III(Instituto de Salud Carlos III); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Norwegian Cancer Society(Norwegian Cancer Society); Harald Andersens grant; Charles A. King Trust fellowship; Fundacion Pedro Barri, de la Maza; Sheila Sherlock Fellowship; National Cancer Center Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK076986-01, to Dr. Llovet), the National Cancer Institute (5U54 CA112962-03, to Dr. Golub), the Samuel Waxman Cancer Research Foundation (to Dr. Llovet), the Spanish National Health Institute (SAF2007-61898, to Dr. Llovet), Institucio Catalana de Recerca i Estudis Avancats (to Dr. Llovet), Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas (to Drs. Llovet and Bruix), the Fund for Health of Spain of the Institute of Health Carlos III (PI05-0150, to Dr. Bruix), the National Institutes of Health (DK37340, to Dr. Friedman), the Italian Association for Cancer Research (to Dr. Mazzaferro), Helse Vest and Norwegian Cancer Society, Harald Andersens grant (to Dr. Salvesen), the Charles A. King Trust fellowship (to Dr. Hoshida), and Fundacion Pedro Barri, de la Maza, the Sheila Sherlock Fellowship, and the National Cancer Center Fellowship (all to Dr. Villanueva).	Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Lau WY, 1999, LANCET, V353, P797, DOI 10.1016/S0140-6736(98)06475-7; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takayama T, 2000, LANCET, V356, P1690; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	22	957	993	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1995	2004		10.1056/NEJMoa0804525	http://dx.doi.org/10.1056/NEJMoa0804525			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18923165	Green Accepted			2022-12-01	WOS:000260632700004
J	Gostin, LO				Gostin, Lawrence O.			President's Emergency Plan for AIDS Relief Health Development at the Crossroads	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Oneill Inst Natl Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Law Ctr NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; GARRETT L, 2008, INT HERALD TRIB 0730; Gostin LO, 2007, JAMA-J AM MED ASSOC, V298, P225, DOI 10.1001/jama.298.2.225; *GOV ACC OFF, 2008, GLOB HIV AIDS MOR CO; *HJ KAIS FAM FDN, 2008, REAUTH PEPFAR US LEA; *I MED, 2007, PEPFAR IMPL PROGR PR; Jaffe HW, 2008, JAMA-J AM MED ASSOC, V300, P573, DOI 10.1001/jama.300.5.573; *ON CAMP, 2008, DAT REP 2008 KEEP G8; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schleber GJ, 2007, HEALTH AFFAIR, V26, P921, DOI 10.1377/hlthaff.26.4.921; *UNAIDS, 2008, UN ACC SCAL PRIOR HI; *UNAIDS, 2005, 3 5 IN TREAT 3 MILL	13	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2046	2048		10.1001/jama.2008.588	http://dx.doi.org/10.1001/jama.2008.588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984892				2022-12-01	WOS:000260605400026
J	Zheng, XW; Pontes, O; Zhu, JH; Miki, D; Zhang, F; Li, WX; Iida, K; Kapoor, A; Pikaard, CS; Zhu, JK				Zheng, Xianwu; Pontes, Olga; Zhu, Jianhua; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Pikaard, Craig S.; Zhu, Jian-Kang			ROS3 is an RNA-binding protein required for DNA demethylation in Arabidopsis	NATURE			English	Article							GLYCOSYLASE/LYASE ROS1; METHYLATION PATTERNS; ABSCISIC-ACID; HUMAN-CELLS; PLANTS; PATHWAYS; REPLICATION; MICRORNAS; DEMETER; TARGETS	DNA methylation is an important epigenetic mark for transcriptional gene silencing ( TGS) in diverse organisms(1-6). Recent studies suggest that the methylation status of a number of genes is dynamically regulated by methylation and demethylation(7-10). In Arabidopsis, active DNA demethylation is mediated by the ROS1 ( repressor of silencing 1) subfamily of 5- methylcytosine DNA glycosylases through a base excision repair pathway(8,10-13). These demethylases have critical roles in erasing DNA methylation and preventing TGS of target genes(7,8,10). However, it is not known how the demethylases are targeted to specific sequences. Here we report the identification of ROS3, an essential regulator of DNA demethylation that contains an RNA recognition motif. Analysis of ros3 mutants and ros1ros3 double mutants suggests that ROS3 acts in the same genetic pathway as ROS1 to prevent DNA hypermethylation and TGS. Gel mobility shift assays and analysis of ROS3 immunoprecipitate from plant extracts shows that ROS3 binds to small RNAs in vitro and in vivo. Immunostaining shows that ROS3 and ROS1 proteins co-localize in discrete foci dispersed throughout the nucleus. These results demonstrate a critical role for ROS3 in preventing DNA hypermethylation and suggest that DNA demethylation by ROS1 may be guided by RNAs bound to ROS3.	[Zheng, Xianwu; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Zhu, Jian-Kang] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Zheng, Xianwu; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Pontes, Olga; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Zhu, Jianhua] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Zhang, Fei] Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200240, Peoples R China	University of California System; University of California Riverside; University of California System; University of California Riverside; Washington University (WUSTL); University System of Maryland; University of Maryland College Park; Shanghai Jiao Tong University	Zhu, JK (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Pontes, Olga MF/F-9768-2011; Pikaard, Craig S/K-8772-2012; Grieshaber-Bouyer, Ricardo/R-7512-2016; Zhu, Jian-Kang/F-7658-2011; Zhu, Jianhua/F-7127-2013	Pontes, Olga MF/0000-0003-3316-1145; Pikaard, Craig S/0000-0001-8204-7459; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Zhu, Jian-Kang/0000-0001-5134-731X; IIDA, Kei/0000-0001-7130-8705; Miki, Daisuke/0000-0001-6066-3357	National Institutes of Health [R01GM070795, R01GM059138, R01GM077590, 1R01GM060380]; Edward Mallinckrodt Foundation; China Scholarship Council [2007104542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070795, R01GM077590, R01GM060380, R01GM059138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Foundation; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM070795 and R01GM059138 (J.-K.Z.), R01GM077590 and 1R01GM060380 (C.S.P.), Edward Mallinckrodt Foundation (O.P.) and China Scholarship Council scholarship 2007104542 (F.Z.).	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	34	112	123	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1259	U70		10.1038/nature07305	http://dx.doi.org/10.1038/nature07305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815596	Green Accepted			2022-12-01	WOS:000260462100049
J	Giezen, TJ; Mantel-Teeuwisse, AK; Straus, SMJM; Schellekens, H; Leufkens, HGM; Egberts, ACG				Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Straus, Sabine M. J. M.; Schellekens, Huub; Leufkens, Hubert G. M.; Egberts, Antoine C. G.			Safety-related regulatory actions for biologicals approved in the United States and the European Union	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK; INFECTIONS; BIOPHARMACEUTICALS; PHARMACOVIGILANCE; IMMUNOGENICITY	Context Biologicals are a relatively new class of medicines that carry specific risks (eg, immunogenicity). However, limited information is available on the nature and timing of safety problems with their use that were identified after approval. Objective To determine the nature, frequency, and timing of safety-related regulatory actions for biologicals following approval in the United States and/or the European Union. Design and Setting Follow-up of a group of biologicals approved in the United States and/or European Union between January 1995 and June 2007. Vaccines, allergenic products, and products for further manufacture and transfusion purposes were excluded. Main Outcome Measures Nature, frequency, and timing of safety-related regulatory actions defined as (1) dear healthcare professional letters (United States) and direct healthcare professional communications (European Union), (2) black box warnings (United States), and (3) safety-related marketing withdrawals (United States and European Union) issued between January 1995 and June 2008. Results A total of 174 biologicals were approved (136 in the United States and 105 in the European Union, of which 67 were approved in both regions). Eighty-two safety-related regulatory actions (46 dear healthcare professional letters, 17 direct healthcare professional communications, 19 black box warnings, and no withdrawals) were issued for 41 of the 174 different biologicals (23.6%). The probability of a first safety-related regulatory action, derived from Kaplan-Meier analyses, was 14% (95% confidence interval [CI], 9%-19%) 3 years after approval and 29% (95% CI, 20%-37%) 10 years after approval. Biologicals first in class to obtain approval had a higher risk for a first safety-related regulatory action compared with later approved products in that class (12.0/1000 vs 2.9/1000 months, respectively; hazard ratio, 3.7 [95% CI, 1.5- 9.5]). Warnings mostly concerned the classes general disorders and administration site conditions, infections and infestations, immune system disorders and neoplasms benign, malignant, and unspecified. Conclusions The nature of safety problems identified after approval for biologicals is often related to the immunomodulatory effect (infections). Because the biologicals first to be approved in a class were more likely to be subjected to regulatory action, close monitoring is recommended.	[Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Leufkens, Hubert G. M.; Egberts, Antoine C. G.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Pharmacotherapy, NL-3508 TB Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Div Pharmaceut, NL-3508 TB Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Dept Innovat Sci, NL-3508 TB Utrecht, Netherlands; [Egberts, Antoine C. G.] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Straus, Sabine M. J. M.; Leufkens, Hubert G. M.] Med Evaluat Board, The Hague, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Mantel-Teeuwisse, AK (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Pharmacotherapy, POB 80082, NL-3508 TB Utrecht, Netherlands.	A.K.Mantel@uu.nl	Egberts, Toine/A-6625-2012; Mantel-Teeuwisse, Aukje/I-8902-2016; Egberts, Toine/K-4579-2019	Egberts, Toine/0000-0003-1758-7779; Egberts, Toine/0000-0003-1758-7779	GlaxoSmithKline; Organon; Merck; Novo Nordisk; Roche; Merck-Serono	GlaxoSmithKline(GlaxoSmithKline); Organon; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Roche(Roche Holding); Merck-Serono(Merck & Company)	The department employing Drs Giezen, Mantel-Teeuwisse, Leufkens, and Egberts has received unrestricted research grants from GlaxoSmithKline, Organon, Merck, and Novo Nordisk for the conduct of pharmacoepidemiological research. Dr Schellekens reported receiving research grants from Organon, Roche, and Merck-Serono. Dr Straus did not report any financial disclosures.	Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; Aksamit AJ, 2006, NEUROLOGIST, V12, P293, DOI 10.1097/01.nrl.0000250948.04681.96; BAKKE OM, 1995, CLIN PHARMACOL THER, V58, P108, DOI 10.1016/0009-9236(95)90078-0; Baumann A, 2006, CURR DRUG METAB, V7, P15, DOI 10.2174/138920006774832604; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Botsios C, 2005, AUTOIMMUN REV, V4, P162, DOI 10.1016/j.autrev.2004.09.001; Brennan FR, 2004, MOL BIOTECHNOL, V27, P59, DOI 10.1385/MB:27:1:59; Brune K, 2007, RHEUMATOLOGY, V46, P911, DOI 10.1093/rheumatology/kem070; Crommelin DJA, 2003, INT J PHARMACEUT, V266, P3, DOI 10.1016/S0378-5173(03)00376-4; *EUR COMM, 2007, VOL 9A RUL GOV MED P; Frank RG, 2007, NEW ENGL J MED, V357, P841, DOI 10.1056/NEJMp078095; Hamilton CD, 2004, CURR OPIN RHEUMATOL, V16, P393, DOI 10.1097/01.bor.0000127594.92432.7c; Hartford CG, 2006, DRUG SAFETY, V29, P657, DOI 10.2165/00002018-200629080-00003; Kessler M, 2006, NEPHROL DIAL TRANSPL, V21, P9, DOI 10.1093/ndt/gfl476; Kromminga A, 2005, ANN NY ACAD SCI, V1050, P257, DOI 10.1196/annals.1313.027; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Meyboom RHB, 1996, CLIN DRUG INVEST, V12, P207, DOI 10.2165/00044011-199612040-00006; Nieminen O, 2005, EUR J PHARM BIOPHARM, V60, P319, DOI 10.1016/j.ejpb.2005.01.013; Ryff JC, 2002, TRENDS PHARMACOL SCI, V23, P254, DOI 10.1016/S0165-6147(02)02024-2; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P31, DOI 10.1093/ndt/gfh1085; Schellekens H, 2005, BEST PRACT RES CL HA, V18, P473, DOI 10.1016/j.beha.2005.01.016; Schellekens H, 2002, TRENDS PHARMACOL SCI, V23, P119, DOI 10.1016/S0165-6147(00)01967-2; SCHELLEKENS H, 2001, MED BIOTECHNOLOGIE; Schellekens H, 2006, NAT BIOTECHNOL, V24, P613, DOI 10.1038/nbt0606-613; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Sims J, 2001, TOXICOL LETT, V120, P59, DOI 10.1016/S0378-4274(01)00310-1; Stricker BHC, 2004, BRIT MED J, V329, P44, DOI 10.1136/bmj.329.7456.44; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Temple RJ, 2002, JAMA-J AM MED ASSOC, V287, P2273, DOI 10.1001/jama.287.17.2273; *US FDA, 2007, DRUG SAF INF FDAS CO; Vonberg RP, 2007, J HOSP INFECT, V65, P15, DOI 10.1016/j.jhin.2006.09.018; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336	34	172	178	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1887	1896		10.1001/jama.300.16.1887	http://dx.doi.org/10.1001/jama.300.16.1887			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940975				2022-12-01	WOS:000260223100018
J	Chen, YY; Takita, J; Choi, YL; Kato, M; Ohira, M; Sanada, M; Wang, LL; Soda, M; Kikuchi, A; Igarashi, T; Nakagawara, A; Hayashi, Y; Mano, H; Ogawa, S				Chen, Yuyan; Takita, Junko; Choi, Young Lim; Kato, Motohiro; Ohira, Miki; Sanada, Masashi; Wang, Lili; Soda, Manabu; Kikuchi, Akira; Igarashi, Takashi; Nakagawara, Akira; Hayashi, Yasuhide; Mano, Hiroyuki; Ogawa, Seishi			Oncogenic mutations of ALK kinase in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CASPASE-8 GENE; LUNG-CANCER; PROTEIN; FUSION; SYSTEM; ARRAYS; DNA	Neuroblastoma in advanced stages is one of the most intractable paediatric cancers, even with recent therapeutic advances(1). Neuroblastoma harbours a variety of genetic changes, including a high frequency of MYCN amplification, loss of heterozygosity at 1p36 and 11q, and gain of genetic material from 17q, all of which have been implicated in the pathogenesis of neuroblastoma(2-5). However, the scarcity of reliable molecular targets has hampered the development of effective therapeutic agents targeting neuroblastoma. Here we show that the anaplastic lymphoma kinase (ALK), originally identified as a fusion kinase in a subtype of non- Hodgkin's lymphoma (NPM-ALK)(6-8) and more recently in adenocarcinoma of lung (EML4-ALK)(9,10), is also a frequent target of genetic alteration in advanced neuroblastoma. According to our genome- wide scans of genetic lesions in 215 primary neuroblastoma samples using high- density single- nucleotide polymorphism genotyping microarrays(11-14), the ALK locus, centromeric to the MYCN locus, was identified as a recurrent target of copy number gain and gene amplification. Furthermore, DNA sequencing of ALK revealed eight novel missense mutations in 13 out of 215 (6.1%) fresh tumours and 8 out of 24 ( 33%) neuroblastoma- derived cell lines. All but one mutation in the primary samples ( 12 out of 13) were found in stages 3 - 4 of the disease and were harboured in the kinase domain. The mutated kinases were autophosphorylated and displayed increased kinase activity compared with the wild- type kinase. They were able to transform NIH3T3 fibroblasts as shown by their colony formation ability in soft agar and their capacity to form tumours in nude mice. Furthermore, we demonstrate that downregulation of ALK through RNA interference suppresses proliferation of neuroblastoma cells harbouring mutated ALK. We anticipate that our findings will provide new insights into the pathogenesis of advanced neuroblastoma and that ALK- specific kinase inhibitors might improve its clinical outcome.	[Takita, Junko; Choi, Young Lim; Sanada, Masashi; Wang, Lili; Ogawa, Seishi] Univ Tokyo, Cell Therapy & Transplantat Med, Tokyo 1138655, Japan; [Chen, Yuyan; Takita, Junko; Kato, Motohiro; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Tokyo 1138655, Japan; [Chen, Yuyan; Takita, Junko; Kato, Motohiro; Sanada, Masashi; Wang, Lili; Ogawa, Seishi] Univ Tokyo, Canc Genom Project, Grad Sch Med, Tokyo 1138655, Japan; [Choi, Young Lim; Soda, Manabu; Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Toguchi 3290498, Japan; [Ohira, Miki; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem, Chiba 2608717, Japan; [Sanada, Masashi; Wang, Lili; Mano, Hiroyuki; Ogawa, Seishi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kikuchi, Akira] Saitama Childrens Med Ctr, Div Hematol Oncol, Saitama 3398551, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Shibukawa 3778577, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Jichi Medical University; Chiba Cancer Center; Japan Science & Technology Agency (JST); Saitama Children's Medical Center; Gunma Children's Medical Centre	Ogawa, S (corresponding author), Univ Tokyo, Cell Therapy & Transplantat Med, Tokyo 1138655, Japan.	hayashiy-tky@umin.ac.jp; sogawa-tky@umin.net	wang, lili/HDL-7210-2022; Chen, Yuyan/V-7279-2019; Ogawa, Seishi/AAE-7088-2019	Chen, Yuyan/0000-0002-2894-1430; Kato, Motohiro/0000-0001-5145-1774	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank H. P. Koeffler for critically reading and editing the manuscript. We also thank M. Matsumura, Y. Ogino, S. Ichimura, S. Sohma, E. Matsui, Y. Yin, N. Hoshino and Y. Nakamura for their technical assistance. This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency and by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan for the third-term Comprehensive 10-year Strategy for Cancer Control.	Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Donohoe E, 2005, METH MOLEC MED, V108, P173; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Maris JM, 2000, J CLIN ONCOL, V18, P1888, DOI 10.1200/JCO.2000.18.9.1888; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; SMITH EI, 1989, J PEDIATR SURG, V24, P386, DOI 10.1016/S0022-3468(89)80277-5; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; TAKITA J, 1995, ONCOGENE, V11, P1829; Takita J, 2001, ONCOGENE, V20, P4424, DOI 10.1038/sj.onc.1204521; Takita J, 2000, MED PEDIATR ONCOL, V35, P541, DOI 10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	26	653	692	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					971	U56		10.1038/nature07399	http://dx.doi.org/10.1038/nature07399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923524				2022-12-01	WOS:000260038300051
J	Whitelaw, A				Whitelaw, Andrew			Collapse of GMC hearing into research misconduct	LANCET			English	Editorial Material							NEGATIVE EXTRATHORACIC PRESSURE; FAILURE; TRIAL		[Whitelaw, Andrew] Univ Bristol, Dept Clin Sci, Bristol BS10 5NB, Avon, England	University of Bristol	Whitelaw, A (corresponding author), Univ Bristol, Dept Clin Sci, Bristol BS10 5NB, Avon, England.	andrew.whitelaw@bris.ac.uk						Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Chalmers I, 2001, BRIT MED J, V323, P280, DOI 10.1136/bmj.323.7307.280; Farthing M, 2000, BRIT MED J, V321, P1485, DOI 10.1136/bmj.321.7275.1485; *GEN MED COUNC, 2008, FITN PRACT PAN; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Hey E, 2006, PEDIATRICS, V117, P2244, DOI 10.1542/peds.2006-0819; Hey E, 2002, ARCH DIS CHILD, V86, P1, DOI 10.1136/adc.86.1.1; Jenny C, 2007, PEDIATRICS, V119, P797, DOI 10.1542/peds.2006-2472; Samuels MP, 1996, PEDIATRICS, V98, P1154; Stenson BJ, 2004, ARCH DIS CHILD-FETAL, V89, pF321, DOI 10.1136/adc.2002.021931; Telford K, 2006, LANCET, V367, P1080, DOI 10.1016/S0140-6736(06)68475-4	11	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1283	1284		10.1016/S0140-6736(08)61532-9	http://dx.doi.org/10.1016/S0140-6736(08)61532-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929890				2022-12-01	WOS:000260060500009
J	Shaaban, R; Zureik, M; Soussan, D; Neukirch, C; Heinrich, J; Sunyer, J; Wjst, M; Cerveri, I; Pin, I; Bousquet, J; Jarvis, D; Burney, PG; Neukirch, F; Leynaert, B				Shaaban, Rafea; Zureik, Mahmoud; Soussan, David; Neukirch, Catherine; Heinrich, Joachim; Sunyer, Jordi; Wjst, Matthias; Cerveri, Isa; Pin, Isabelle; Bousquet, Jean; Jarvis, Deborah; Burney, Peter G.; Neukirch, Francoise; Leynaert, Benedicte			Rhinitis and onset of asthma: a longitudinal population-based study	LANCET			English	Article							ASYMPTOMATIC AIRWAY HYPERRESPONSIVENESS; INDEPENDENT RISK-FACTOR; ALLERGIC RHINITIS; BRONCHIAL HYPERRESPONSIVENESS; FOLLOW-UP; PERENNIAL RHINITIS; LUNG-FUNCTION; HEALTH; SENSITIZATION; PERSISTENCE	Background A close relation between asthma and allergic rhinitis has been reported by several epidemiological and clinical studies. However, the nature of this relation remains unclear. We used the follow-up data from the European Community Respiratory Health Survey to investigate the onset of asthma in patients with allergic and non-allergic rhinitis during an 8 . 8-year period. Methods We did a longitudinal population-based study, which included 29 centres (14 countries) mostly in western Europe. Frequency of asthma was studied in 6461 participants, aged 20-44 years, without asthma at baseline. incident asthma was defined as reporting ever having had asthma confirmed by a physician between the two surveys. Atopy was defined as a positive skin-prick test to mites, cat, Alternaria, Cladosporium, grass, birch, Parietaria, olive, or 44 ragweed. Participants were classified into four groups at baseline: controls (no atopy, no rhinitis; n=3163), atopy only (atopy, no rhinitis; n=704), non-allergic rhinitis (rhinitis, no atopy; n=1377), and allergic rhinitis (atopy+rhinitis; 49 n=1217). Cox proportional hazards models were used to study asthma onset in the four groups. Findings The 8.8-year cumulative incidence of asthma was 2.2% (140 events), and was different in the four groups (1 . 1% (36), 1.9% (13), 3.1% (42), and 4.0% (49), respectively; p<0 . 0001). After controlling for country, sex, baseline age, body-mass index, forced expiratory volume in 1 s (FEV1), log total IgE, family history of asthma, and smoking, the adjusted relative risk for asthma was 1.63 (95% CI 0.82-3.24) for atopy only, 2.71 (1.64-4.46) for non-allergic rhinitis, and 3.53 (2.11-5.91) for allergic rhinitis. Only allergic rhinitis with sensitisation to mite was associated with increased risk of asthma independently of other allergens (2.79 [1.57-4.96]). Interpretation Rhinitis, even in the absence of atopy, is a powerful predictor of adult-onset asthma Funding UCB Institute of Allergy and Agence Nationale de la Recherche.	[Shaaban, Rafea; Zureik, Mahmoud; Soussan, David; Neukirch, Catherine; Neukirch, Francoise; Leynaert, Benedicte] Univ Paris 07, Fac Med, Unite 700, INSERM, F-75870 Paris 18, France; [Neukirch, Catherine] Bichat Teaching Hosp, Dept Pneumol, Paris, France; [Heinrich, Joachim; Wjst, Matthias] Natl Res Ctr Environm & Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Sunyer, Jordi] Inst Municipal Invest Med, CREAL, E-08003 Barcelona, Spain; [Jarvis, Deborah; Burney, Peter G.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol & Publ Hlth Grp, London, England; [Cerveri, Isa] Univ Pavia, I-27100 Pavia, Italy; [Pin, Isabelle] INSERM, Natl Inst Hlth & Med Res, Unit 823, Grenoble, France; [Pin, Isabelle] Grenoble Teaching Hosp, Grenoble, France; [Bousquet, Jean] Hosp Arnaud De Villeneuve, Dept Pneumol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pompeu Fabra University; Imperial College London; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes	Zureik, M (corresponding author), Univ Paris 07, Fac Med, Unite 700, INSERM, Site Bichat,BP 416, F-75870 Paris 18, France.	mahmoud.zureik@inserm.fr	Sunyer, Jordi/G-6909-2014; PIN, Isabelle/N-3020-2013; Jarvis, Deborah/E-6494-2011; Heinrich, Joachim/N-1720-2013; Leynaert, Benedicte/N-5251-2018; Zureik, Mahmoud/F-7855-2018	Sunyer, Jordi/0000-0002-2602-4110; Heinrich, Joachim/0000-0002-9620-1629; Zureik, Mahmoud/0000-0002-8393-4217; Jarvis, Deborah/0000-0002-1753-3896; Leynaert, Benedicte/0000-0001-5045-2492; Cerveri, Isa/0000-0003-0337-043X; Burney, Peter/0000-0001-8635-5678	Educational Grant; UCB Institute; Agence Nationale de la Recherche (ANR-SEST); Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris; European Commission; Fondo de Investigaciones Santarias [97/0035-01, 99/0034-01, 99/0034-02]; Hospital Universitario de Albacete; Consejeria de Sanidad; FWO (Fund for Scientific Research)-Flanders Belgium [G.0402.00]; University of Antwerp; Flemish Health Ministry; SEPAR; Public Health Service [ROI HL62633-01]; CIRIT [1999SGR 00241]; Swiss National Science Foundation [4026-28099]; Swiss Federal Office for Education Science; Swiss National Accident Insurance Fund (SUVA); Norwegian Research Council; Norwegian Asthma & Allergy Association (NAAF); Glaxo Wellcome AS; Norway Research Fund; Institut Pneumologique d'Aquitaine; GSF-National Research Centre for Environment Health; Deutsche Forschungsgemeinschaft [FR 1526/1-1, MA 711/4-1]; Basque Health Dept; Swedish Heart Lung Foundation; Swedish Foundation for Health Care Sciences & Allergy Reserch; Swedish Asthma & Allergy Foundation; Swedish Cancer & Allergy Foundation; Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 [2610]; Ministry of Health, Direction de la Recherche Clinique; Ministere de l'Emploi et de la Solidarite; Direction Generale de la Saute; CHU de Grenoble; Comite des Maladies Respiratoires de l'lsere, Hamburg; GSF-National Reasearch Centre for Environment Health; Asthma UK (formerly known as National Asthma Campaign); Aventis (France); Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; UCB-Pharma (France); Glaxo France; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; GlaxoSmithKline Italy; Italian Ministry of University and Scientific and Technological Research (MURST); American Lung Association of Oregon; Northwest Health Foundation; Collins Foundation; Merck Pharmaceutical; Icelandic Research Counci; Icelandic University Hospital Fund; Estonian Science Foundation; ASL 4 Regione Piemonte (Italy); AO CTO/ICORMA Regione Piemonte (Italy); Ministero dell' Universita e della Ricerca Scientifica (Italy); Glaxo Wellcome spa (Verona, Italy); Swedish Foundation for Health Care Sciences & Allergy Research; University of Verona; National Fund for Scientific Research; Ministere de la Sante Glaxo France; Insitut Pneumologique d'Aquitaine; CNMATS; CNMRT [901MR/10, 91AF/6]; Ministre delegue de la sante; RNSP, France; GSF; Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; CNR; Regione Veneto grant [RSF n. 381/05.93]; Norwegian Research Council [101422/310]; Dutch Ministry of Wellbeing; Public Health and Culture, Netherlands; Ministero, Sanidad y Consumo FIS [#91/0016060/00E-05E, #93/0393]; Hospital General de Albacete; Hospital General Juan Ramon Jimenenz; Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council; Swedish Association against Asthma and Allergy; National Asthma Campaign; British Lung Foundation; Department of Health; South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service [#2 S07 RR05521-28]	Educational Grant; UCB Institute; Agence Nationale de la Recherche (ANR-SEST)(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris; European Commission(European CommissionEuropean Commission Joint Research Centre); Fondo de Investigaciones Santarias(Instituto de Salud Carlos III); Hospital Universitario de Albacete; Consejeria de Sanidad; FWO (Fund for Scientific Research)-Flanders Belgium(FWO); University of Antwerp; Flemish Health Ministry; SEPAR; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); CIRIT; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Office for Education Science; Swiss National Accident Insurance Fund (SUVA)(Swiss National Science Foundation (SNSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Asthma & Allergy Association (NAAF); Glaxo Wellcome AS; Norway Research Fund; Institut Pneumologique d'Aquitaine; GSF-National Research Centre for Environment Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Basque Health Dept; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Health Care Sciences & Allergy Reserch; Swedish Asthma & Allergy Foundation; Swedish Cancer & Allergy Foundation; Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000; Ministry of Health, Direction de la Recherche Clinique; Ministere de l'Emploi et de la Solidarite; Direction Generale de la Saute; CHU de Grenoble; Comite des Maladies Respiratoires de l'lsere, Hamburg; GSF-National Reasearch Centre for Environment Health(German Research Foundation (DFG)); Asthma UK (formerly known as National Asthma Campaign); Aventis (France)(Sanofi-Aventis); Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; UCB-Pharma (France)(UCB Pharma SA); Glaxo France; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; GlaxoSmithKline Italy(GlaxoSmithKline); Italian Ministry of University and Scientific and Technological Research (MURST)(Ministry of Education, Universities and Research (MIUR)); American Lung Association of Oregon; Northwest Health Foundation; Collins Foundation; Merck Pharmaceutical(Merck & Company); Icelandic Research Counci; Icelandic University Hospital Fund; Estonian Science Foundation; ASL 4 Regione Piemonte (Italy); AO CTO/ICORMA Regione Piemonte (Italy); Ministero dell' Universita e della Ricerca Scientifica (Italy)(Ministry of Education, Universities and Research (MIUR)); Glaxo Wellcome spa (Verona, Italy); Swedish Foundation for Health Care Sciences & Allergy Research; University of Verona; National Fund for Scientific Research; Ministere de la Sante Glaxo France; Insitut Pneumologique d'Aquitaine; CNMATS; CNMRT; Ministre delegue de la sante; RNSP, France; GSF; Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); CNR(Consiglio Nazionale delle Ricerche (CNR)); Regione Veneto grant; Norwegian Research Council(Research Council of NorwayEuropean Commission); Dutch Ministry of Wellbeing; Public Health and Culture, Netherlands(Netherlands Government); Ministero, Sanidad y Consumo FIS; Hospital General de Albacete; Hospital General Juan Ramon Jimenenz; Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Association against Asthma and Allergy; National Asthma Campaign; British Lung Foundation; Department of Health; South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by an Educational Grant From the UCB Institute, and by the Agence Nationale de la Recherche (ANR-SEST). MZ of Allergy is a recipient of a Contrat d'Interface grant from Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris. The coordination of ECRHS II was supported by the European Commission, as part of their Quality of Life programme. The following bodies funded the local studies in ECRHS II included in this paper Albacete: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02), Hospital Universitario de Albacete, Consejeria de Sanidad; Antwerp: FWO (Fund for Scientific Research)-Flanders Belgium (grant code: G.0402.00), University of Antwerp, Flemish Health Ministry; Barcelona: SEPAR, Public Health Service (grant code: ROI HL62633-01), Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02) CIRIT (grant code: 1999SGR 00241); Basel: Swiss National Science Foundation. Swiss Federal Office for Education & Science, Swiss National Accident Insurance Fund (SUVA); Bergen: Norwegian Research Council, Norwegian Asthma & Allergy Association (NAAF), Glaxo Wellcome AS, Norway Research Fund; Bordeaux: Institut Pneurnologique d'Aquitaine; Erfurt: GSF-NationaI Research Centre for Environment & Health, Deutsche Forschungsgerneinschaft (DFG) (grant code FR 1526/1-1); Galdakao: Basque Health Dept: Goteborg: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Reserch, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Grenoble: Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no. 2610, Ministry of Health, Direction de la Recherche Clinique, Ministere de l'Emploi et de la Solidarite, Direction Generale de la Saute, CHU de Grenoble, Comite des Maladies Respiratoires de l'lsere, Hamburg: GSF-National Reasearch Centre for Environment & Health. Deutsche Forschungsgemeinschaft (DFG) (grant code MA 711/4-1); Ipswich and Norwich: Asthma UK (formerly known as National Asthma Campaign); Huelva: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02); Montpellier, Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no. 2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble, Ministere de l'Emploi et de la Solidarite, Direction Generale de la Saute, Aventis (France), Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; Oviedo: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02); Paris: Ministere de l'Emploi et de la Solidarite, Direction Generale de la Same, UCB-Pharma (France), Aventis (France), Glaxo France, Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no.; 2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; Pavia: GlaxoSmithKline Italy, Italian Ministry of University and Scientific and Technological Research (MURST), Local University Funding for research 1998 & 1999 (Pavia, Italy); Portland: American Lung Association of Oregon, Northwest Health Foundation, Collins Foundation, Merck Pharmaceutical; Reykjavik: Icelandic Research Council, Icelandic University Hospital Fund; Tartu: Estonian Science Foundation: Turin: ASL 4 Regione Piemonte (Italy), AO CTO/ICORMA Regione Piemonte (Italy), Ministero dell' Universita e della Ricerca Scientifica (Italy), Glaxo Wellcome spa (Verona, Italy); Umea: Swedis Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Research, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Uppsala: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Research, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Verona: University of Verona; Italian Ministry of University and Scientific and Technological Research (MURST); GlaxoSmith Kline Italy. Financial support for ECRHS I for centres in ECRHS II: Belgian Science Policy Office, National Fund for Scientific Research; Ministere de la Sante Glaxo France, Insitut Pneumologique d'Aquitaine, Contrat de Plan Etat-Region Languedoc-Rousillon, CNMATS, CNMRT (901MR/10, 91AF/6), Ministre delegue de la sante, RNSP, France; GSF, and the Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto grant RSF n. 381/05.93, Italy; Norwegian Research Council project no. 101422/310; Dutch Ministry of Wellbeing, Public Health and Culture, Netherlands; Ministero, Sanidad y Consumo FIS (grants #91/0016060/00E-05E and #93/0393), and grants from Hospital General de Albacete, Hospital General Juan Ramon Jimenenz, Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council, the Swedish Heart Lung Foundation, the Swedish Association against Asthma and Allergy; Swiss national Science Foundation grant 4026-28099; National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service (grant #2 S07 RR05521-28).	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; BARDIN PG, 1990, J ALLERGY CLIN IMMUN, V86, P82, DOI 10.1016/S0091-6749(05)80126-5; Boulet LP, 2003, AM J RESP CRIT CARE, V167, P371, DOI 10.1164/rccm.200111-084PP; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bousquet PJ, 2007, CLIN EXP ALLERGY, V37, P780, DOI 10.1111/j.1365-2222.2007.02714.x; Braunstahl GJ, 2005, J ALLERGY CLIN IMMUN, V115, P142, DOI 10.1016/j.jaci.2004.10.041; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; BUCCA C, 1995, LANCET, V346, P791, DOI 10.1016/S0140-6736(95)91617-2; Burgess JA, 2007, J ALLERGY CLIN IMMUN, V120, P863, DOI 10.1016/j.jaci.2007.07.020; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Chinn S, 1996, EUR J EPIDEMIOL, V12, P155, DOI 10.1007/BF00145501; Colantonio D, 2002, CLIN EXP ALLERGY, V32, P698, DOI 10.1046/j.1365-2222.2002.01379.x; Corren J, 1997, J ALLERGY CLIN IMMUN, V99, pS781, DOI 10.1016/S0091-6749(97)70127-1; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Durham SR, 1999, ALLERGY, V54, P124, DOI 10.1111/j.1398-9995.1999.tb04414.x; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fontanari P, 1997, EUR RESPIR J, V10, P2250, DOI 10.1183/09031936.97.10102250; GLINDMEYER HW, 1995, AM J RESP CRIT CARE, V151, P412, DOI 10.1164/ajrccm.151.2.7842200; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greisner WA, 1998, ALLERGY ASTHMA PROC, V19, P185, DOI 10.2500/108854198778557836; Grossman J, 1997, CHEST, V111, pS11, DOI 10.1378/chest.111.2_Supplement.11S; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOPP RJ, 1990, AM REV RESPIR DIS, V141, P2, DOI 10.1164/ajrccm/141.1.2; Huovinen E, 1999, CHEST, V115, P928, DOI 10.1378/chest.115.4.928; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Laprise C, 1999, EUR RESPIR J, V14, P63, DOI 10.1034/j.1399-3003.1999.14a12.x; Leynaert B, 1999, J ALLERGY CLIN IMMUN, V104, P301, DOI 10.1016/S0091-6749(99)70370-2; Leynaert N, 2004, J ALLERGY CLIN IMMUN, V113, P86, DOI 10.1016/j.jaci.2003.10.010; MCNICHOL KN, 1973, BRIT MED J, V4, P12, DOI 10.1136/bmj.4.5883.12; Molgaard E, 2007, ALLERGY, V62, P1033, DOI 10.1111/j.1398-9995.2007.01355.x; Panettieri RA, 2008, J ALLERGY CLIN IMMUN, V121, P607, DOI 10.1016/j.jaci.2008.01.006; Plaschke PP, 2000, AM J RESP CRIT CARE, V162, P920, DOI 10.1164/ajrccm.162.3.9912030; Polosa R, 2008, J ALLERGY CLIN IMMUN, V121, P1428, DOI 10.1016/j.jaci.2008.02.041; Riccioni G, 2002, INT J IMMUNOPATH PH, V15, P69, DOI 10.1177/039463200201500110; SETTIPANE RJ, 1994, ALLERGY PROC, V15, P21, DOI 10.2500/108854194778816634; Shaaban R, 2007, AM J RESP CRIT CARE, V176, P659, DOI 10.1164/rccm.200703-427OC; Stirling RG, 2001, AM J RESP CRIT CARE, V164, P1403, DOI 10.1164/ajrccm.164.8.2010002; STRAUSS RH, 1977, NEW ENGL J MED, V297, P743, DOI 10.1056/NEJM197710062971402; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Undem BJ, 1999, ALLERGY, V54, P81, DOI 10.1111/j.1398-9995.1999.tb04409.x; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; Wang J, 1998, J CLIN INVEST, V102, P1132, DOI 10.1172/JCI2686; ZHONG NS, 1992, CHEST, V102, P1104, DOI 10.1378/chest.102.4.1104	52	404	440	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1049	1057		10.1016/S0140-6736(08)61446-4	http://dx.doi.org/10.1016/S0140-6736(08)61446-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805333				2022-12-01	WOS:000259648500031
J	Zhu, Z; Chung, WH; Shim, EY; Lee, SE; Ira, G				Zhu, Zhu; Chung, Woo-Hyun; Shim, Eun Yong; Lee, Sang Eun; Ira, Grzegorz			Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends	CELL			English	Article							STALLED REPLICATION FORKS; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; TOPOISOMERASE-III; ESCHERICHIA-COLI; MITOTIC RECOMBINATION; CHECKPOINT ACTIVATION; ENDONUCLEASE ACTIVITY; GENOME INSTABILITY	Formation of single-strand DNA (ssDNA) tails at a double-strand break (DSB) is a key step in homologous recombination and DNA-damage signaling. The enzyme(s) producing ssDNA at DSBs in eukaryotes remain unknown. We monitored 5'-strand resection at inducible DSB ends in yeast and identified proteins required for two stages of resection: initiation and long-range 50-strand resection. We show that the Mre11-Rad50-Xrs2 complex (MRX) initiates 50 degradation, whereas Sgs1 and Dna2 degrade 50 strands exposing long 30 strands. Deletion of SGS1 or DNA2 reduces resection and DSB repair by single-strand annealing between distant repeats while the remaining long-range resection activity depends on the exonuclease Exo1. In exo1 Delta sgs1 Delta double mutants, the MRX complex together with Sae2 nuclease generate, in a stepwise manner, only few hundred nucleotides of ssDNA at the break, resulting in inefficient gene conversion and G2/M damage checkpoint arrest. These results provide important insights into the early steps of DSB repair in eukaryotes.	[Zhu, Zhu; Chung, Woo-Hyun; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shim, Eun Yong; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Shim, Eun Yong; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA	Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ira, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gira@bcm.edu	Ira, Grzegorz/B-7912-2010		NIH [GM80600-02, GM071011]; Texas Advanced Research Program;  [GM20056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R37GM020056, R01GM080600, R01GM120056, R01GM071011] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Advanced Research Program; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to James Haber, Virginia Zakian, Steve Brill, Rodney Rothstein, and Judith Campbell for strains and plasmids and to Alma Papusha for technical support. We thank James Haber, Phil Hastings, and Neil Hunter for critical comments on the manuscript. This work was supported by NIH grants GM80600-02 (to G. I.) and GM071011 and Texas Advanced Research Program (to S. E. L.). The preliminary work was supported by GM20056 to J.E. Haber. S. E. L. is a scholar of the Leukemia and Lymphoma Society.	Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Branzei D, 2007, GENE DEV, V21, P3019, DOI 10.1101/gad.1624707; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Church G M, 1985, Prog Clin Biol Res, V177, P17; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Formosa T, 1999, GENETICS, V151, P1459; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Inbar O, 1999, MOL CELL BIOL, V19, P4134; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lee SE, 2002, DNA REPAIR, V1, P27, DOI 10.1016/S1568-7864(01)00003-9; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Magner DB, 2007, MOL CELL, V26, P273, DOI 10.1016/j.molcel.2007.03.012; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Melo JA, 2001, GENE DEV, V15, P2809; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moreau S, 1999, MOL CELL BIOL, V19, P556; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Spies Maria, 2005, P389; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Toczylowski T, 2006, J BIOL CHEM, V281, P33198, DOI 10.1074/jbc.M605044200; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Watt PM, 1996, GENETICS, V144, P935; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	75	768	774	2	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					981	994		10.1016/j.cell.2008.08.037	http://dx.doi.org/10.1016/j.cell.2008.08.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805091	Green Accepted, Bronze			2022-12-01	WOS:000259318100018
J	Mao, JH; Kim, IJ; Wu, D; Climent, J; Kang, HC; DelRosario, R; Balmain, A				Mao, Jian-Hua; Kim, Il-Jin; Wu, Di; Climent, Joan; Kang, Hio Chung; DelRosario, Reyno; Balmain, Allan			FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression	SCIENCE			English	Article							FBW7 UBIQUITIN LIGASE; C-MYC; HCDC4	The enzyme mTOR ( mammalian target of rapamycin) is a major target for therapeutic intervention to treat many human diseases, including cancer, but very little is known about the processes that control levels of mTOR protein. Here, we show that mTOR is targeted for ubiquitination and consequent degradation by binding to the tumor suppressor protein FBXW7. Human breast cancer cell lines and primary tumors showed a reciprocal relation between loss of FBXW7 and deletion or mutation of PTEN ( phosphatase and tensin homolog), which also activates mTOR. Tumor cell lines harboring deletions or mutations in FBXW7 are particularly sensitive to rapamycin treatment, which suggests that loss of FBXW7 may be a biomarker for human cancers susceptible to treatment with inhibitors of the mTOR pathway.	[Mao, Jian-Hua; Kim, Il-Jin; Wu, Di; Climent, Joan; Kang, Hio Chung; DelRosario, Reyno; Balmain, Allan] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Balmain, Allan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Balmain, A (corresponding author), Univ Calif San Francisco, Canc Res Inst, 2340 Sutter St, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu	Climent, Joan/O-5877-2017; Mao, Jian-Hua/EIZ-8595-2022	Climent, Joan/0000-0002-8927-6614; Mao, Jian-Hua/0000-0001-9320-6021	NCI [U01 CA84244]; U. S. Department of Energy [DE-FG02-03ER63630]; University of California at San Francisco Research-Evaluation Allocation Committee (REAC); Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE [U01CA084244, R01CA116481] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U. S. Department of Energy(United States Department of Energy (DOE)); University of California at San Francisco Research-Evaluation Allocation Committee (REAC); Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Vogelstein for providing us with the HCT116 WT, HCT116 FBXW7<SUP>-/-</SUP>, DLD1 wild-type, and DLD1 FBXW7<SUP>-/-</SUP> cell lines; K. I. Nakayama for providing Fbxw7 knockout mice and vectors (HA-FBXW7 and HA-FBXW7 Delta F); and O. Tetsu for vector encoding HA-ubiquitin. These studies were supported by NCI grant U01 CA84244 and the U. S. Department of Energy (DE-FG02-03ER63630) to A. B., the University of California at San Francisco Research-Evaluation Allocation Committee (REAC) to J.-H.M.A.B. acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Buolamwini JK, 2005, CURR CANCER DRUG TAR, V5, P57, DOI 10.2174/1568009053332672; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Climent J, 2007, CANCER RES, V67, P818, DOI 10.1158/0008-5472.CAN-06-3307; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Steelman LS, 2008, ONCOGENE, V27, P4086, DOI 10.1038/onc.2008.49; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	18	312	325	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1499	1502		10.1126/science.1162981	http://dx.doi.org/10.1126/science.1162981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787170	Green Accepted			2022-12-01	WOS:000259121800044
J	Salay, R; Lincoln, P				Salay, Rebecca; Lincoln, Paul			Health impact assessments in the European Union	LANCET			English	Editorial Material									[Salay, Rebecca; Lincoln, Paul] Natl Heart Forum, London WC1H 9LG, England		Salay, R (corresponding author), Natl Heart Forum, Tavistock House,S Tavistock Sq, London WC1H 9LG, England.	rebecca.salay@heartforum.org.uk						European Centre for Health Policy W, 1999, HLTH IMP ASS MAIN CO	1	18	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2008	372	9641					860	861		10.1016/S0140-6736(08)61337-9	http://dx.doi.org/10.1016/S0140-6736(08)61337-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	347FB	18774419				2022-12-01	WOS:000259124900028
J	Zimyanin, VL; Belaya, K; Pecreaux, J; Gilchrist, MJ; Clark, A; Davis, I; St Johnston, D				Zimyanin, Vitaly L.; Belaya, Katsiaryna; Pecreaux, Jacques; Gilchrist, Michael J.; Clark, Alejandra; Davis, Ilan; St Johnston, Daniel			In vivo Imaging of oskar mRNA transport reveals the mechanism of posterior localization	CELL			English	Article							DROSOPHILA OOCYTE; MAGO NASHI; KINESIN-I; MAMMALIAN-CELLS; BINDING PROTEIN; AXIS FORMATION; POLE PLASM; GERM PLASM; DYNEIN; STAUFEN	oskar mRNA localization to the posterior of the Drosophila oocyte defines where the abdomen and germ cells form in the embryo. Although this localization requires microtubules and the plus end-directed motor, kinesin, its mechanism is controversial and has been proposed to involve active transport to the posterior, diffusion and trapping, or exclusion from the anterior and lateral cortex. By following oskar mRNA particles in living oocytes, we show that the mRNA is actively transported along microtubules in all directions, with a slight bias toward the posterior. This bias is sufficient to localize the mRNA and is reversed in mago, barentsz, and Tropomyosin II mutants, which mislocalize the mRNA anteriorly. Since almost all transport is mediated by kinesin, oskar mRNA localizes by a biased random walk along a weakly polarized cytoskeleton. We also show that each component of the oskar mRNA complex plays a distinct role in particle formation and transport.	[Zimyanin, Vitaly L.; Belaya, Katsiaryna; Gilchrist, Michael J.; St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Zimyanin, Vitaly L.; Belaya, Katsiaryna; Gilchrist, Michael J.; St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Clark, Alejandra; Davis, Ilan] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Edinburgh	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ds139@mole.bio.cam.ac.uk	Davis, Ilan/F-4975-2010; St Johnston, Daniel/C-9568-2009; Pecreaux, Jacques/A-4248-2008	Pecreaux, Jacques/0000-0001-9998-4844; St Johnston, Daniel/0000-0001-5582-3301; Davis, Ilan/0000-0002-5385-3053	Wellcome Trust; Medical Research Council [G0001292] Funding Source: researchfish; MRC [G0001292] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Liz Gavis and Bill Saxton for providing fly stocks, Simon Bullock for help with the statistical analysis of particle movement, and I. Palacios and C. P. Heisenberg for support during writing. V. L. Z. and K. B. were supported by the Darwin Trust. This work was supported by the Wellcome Trust.	Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Cha BJ, 2002, NAT CELL BIOL, V4, P592, DOI 10.1038/ncb832; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chou TB, 1996, GENETICS, V144, P1673; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Macchi P, 2003, J NEUROSCI, V23, P5778; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Manseau L, 1996, DEVELOPMENT, V122, P2109; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Martin SG, 2003, DEVELOPMENT, V130, P4201, DOI 10.1242/dev.00630; McGrail M, 1997, DEVELOPMENT, V124, P2409; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Mohr SE, 2001, GENE DEV, V15, P2886; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; SERANO TL, 1995, DEVELOPMENT, V121, P3013; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9	54	239	242	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					843	853		10.1016/j.cell.2008.06.053	http://dx.doi.org/10.1016/j.cell.2008.06.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775316	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000258947500023
J	Belogurov, GA; Vassylyeva, MN; Sevostyanova, A; Appleman, JR; Xiang, AX; Lira, R; Webber, SE; Klyuyev, S; Nudler, E; Artsimovitch, I; Vassylyev, DG				Belogurov, Georgiy A.; Vassylyeva, Marina N.; Sevostyanova, Anastasiya; Appleman, James R.; Xiang, Alan X.; Lira, Ricardo; Webber, Stephen E.; Klyuyev, Sergiy; Nudler, Evgeny; Artsimovitch, Irina; Vassylyev, Dmitry G.			Transcription inactivation through local refolding of the RNA polymerase structure	NATURE			English	Article							OPEN COMPLEX-FORMATION; ELECTRON-DENSITY MAPS; II ELONGATION COMPLEX; ANGSTROM RESOLUTION; START SITE; DNA; INHIBITION; HOLOENZYME; MOLSCRIPT	Structural studies of antibiotics not only provide a shortcut to medicine allowing for rational structure- based drug design, but may also capture snapshots of dynamic intermediates that become 'frozen' after inhibitor binding(1,2). Myxopyronin inhibits bacterial RNA polymerase ( RNAP) by an unknown mechanism(3). Here we report the structure of dMyx - a desmethyl derivative of myxopyronin B-4 - complexed with a Thermus thermophilus RNAP holoenzyme. The antibiotic binds to a pocket deep inside the RNAP clamp head domain, which interacts with the DNA template in the transcription bubble(5,6). Notably, binding of dMyx stabilizes refolding of the beta'-subunit switch- 2 segment, resulting in a configuration that might indirectly compromise binding to, or directly clash with, the melted template DNA strand. Consistently, footprinting data show that the antibiotic binding does not prevent nucleation of the promoter DNA melting but instead blocks its propagation towards the active site. Myxopyronins are thus, to our knowledge, a first structurally characterized class of antibiotics that target formation of the pre- catalytic transcription initiation complex the decisive step in gene expression control. Notably, mutations designed in switch- 2 mimic the dMyx effects on promoter complexes in the absence of antibiotic. Overall, our results indicate a plausible mechanism of the dMyx action and a stepwise pathway of open complex formation in which core enzyme mediates the final stage of DNA melting near the transcription start site, and that switch- 2 might act as a molecular checkpoint for DNA loading in response to regulatory signals or antibiotics. The universally conserved switch- 2 may have the same role in all multisubunit RNAPs.	[Belogurov, Georgiy A.; Sevostyanova, Anastasiya; Artsimovitch, Irina] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Vassylyeva, Marina N.; Klyuyev, Sergiy; Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Vassylyeva, Marina N.; Klyuyev, Sergiy; Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Appleman, James R.; Xiang, Alan X.; Lira, Ricardo; Webber, Stephen E.] Anadys Pharmaceut Inc, San Diego, CA 92121 USA; [Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; New York University	Artsimovitch, I (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu; dmitry@uab.edu	Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019	Belogurov, Georgiy/0000-0002-3070-6843; Nudler, Evgeny/0000-0002-8811-3071	US Department of Energy, Office of Energy Research [W-31-109-Eng-38]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750, R01GM074252, R01GM074840] Funding Source: NIH RePORTER	US Department of Energy, Office of Energy Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T. Townes for critical reading of the manuscript and R. Saecker for many stimulating discussions. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Energy Research under contract No. W-31-109-Eng-38. This work was supported by National Institutes of Health grants to I.A. and D.G.V.	Artsimovitch I, 2005, CELL, V122, P351, DOI 10.1016/j.cell.2005.07.014; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 1996, P NATL ACAD SCI USA, V93, P9408, DOI 10.1073/pnas.93.18.9408; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YF, 1997, J MOL BIOL, V267, P47, DOI 10.1006/jmbi.1996.0853; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; IRSCHIK H, 1983, J ANTIBIOT, V36, P1651, DOI 10.7164/antibiotics.36.1651; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Li XY, 1998, J BIOL CHEM, V273, P23558, DOI 10.1074/jbc.273.36.23558; Lira R, 2007, BIOORG MED CHEM LETT, V17, P6797, DOI 10.1016/j.bmcl.2007.10.017; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Severinov K, 1997, P NATL ACAD SCI USA, V94, P13481, DOI 10.1073/pnas.94.25.13481; SUH WC, 1993, SCIENCE, V259, P358, DOI 10.1126/science.8420002; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770	31	106	113	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					332	U8		10.1038/nature07510	http://dx.doi.org/10.1038/nature07510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	18946472	Green Accepted			2022-12-01	WOS:000262440900043
J	Hurtado, A; Holmes, KA; Geistlinger, TR; Hutcheson, IR; Nicholson, RI; Brown, M; Jiang, J; Howat, WJ; Ali, S; Carroll, JS				Hurtado, Antoni; Holmes, Kelly A.; Geistlinger, Timothy R.; Hutcheson, Iain R.; Nicholson, Robert I.; Brown, Myles; Jiang, Jie; Howat, William J.; Ali, Simak; Carroll, Jason S.			Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen	NATURE			English	Article							BREAST-CANCER CELLS; MCF-7 CELLS; RESISTANCE; COACTIVATOR; EXPRESSION; ACTIVATION; AIB1; TRANSCRIPTION; SURVIVAL; THERAPY	Crosstalk between the oestrogen receptor (ER) and ERBB2/HER-2 pathways has long been implicated in breast cancer aetiology and drug eresponse(1), yet no direct connection at a transcriptional level has been shown. Here we show that oestrogen-ER and tamoxifen ER complexes directly repress ERBB2 transcription by means of a cis- regulatory element within the ERBB2 gene in human cell lines. We implicate the paired box 2 gene product ( PAX2), in a previously unrecognized role, as a crucial mediator of ER repression of ERBB2 by the anti- cancer drug tamoxifen. Weshow that PAX2 and the ER co-activator AIB-1/SRC-3 compete for binding and regulation of ERBB2 transcription, the outcome of which determines tamoxifen response in breast cancer cells. The repression of ERBB2 by ER-PAX2 links these two breast cancer subtypes and suggests that aggressive ERBB2- positive tumours can originate from ER- positive luminal tumours by circumventing this repressive mechanism. These data provide mechanistic insight into the molecular basis of endocrine resistance in breast cancer.	[Hurtado, Antoni; Holmes, Kelly A.; Howat, William J.; Carroll, Jason S.] Cambridge Res Inst, Canc Res UK, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Geistlinger, Timothy R.; Brown, Myles] Dana Farber Canc Inst, Boston, MA 02115 USA; [Geistlinger, Timothy R.; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hutcheson, Iain R.; Nicholson, Robert I.] Cardiff Univ, Tenovus Ctr Canc Res, Welsh Sch Pharm, Cardiff CF10 3XF, Wales; [Jiang, Jie; Ali, Simak] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Cardiff University; Imperial College London	Carroll, JS (corresponding author), Cambridge Res Inst, Canc Res UK, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	jason.carroll@cancer.org.uk	Ali, Simak/N-4740-2019; Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021	Ali, Simak/0000-0002-1320-0816; Brown, Myles/0000-0002-8213-1658; Hurtado, Antoni/0000-0002-0145-4763; Coombes, Raoul Charles/0000-0002-4811-1100; Carroll, Jason/0000-0003-3643-0080	National Institute of Diabetes and Digestive and Kidney Disease [R01DK074967]; National Cancer Institute [P01CA8011105]; DF/HCC Breast Cancer SPORE; University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; NATIONAL CANCER INSTITUTE [P01CA080111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074967] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DF/HCC Breast Cancer SPORE; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Carroll, S.-F. Chin, I. Mills, C. Massie and P. Edwards for discussions; J. Mitchell for histology work; M. Eldridge, S. Vowler and B. Adryan for bioinformatic help; S. Buttiglieri for the p-TARGET-PAX2 construct; J. Eeckhoute for the pcDNA- AIB- 1 construct; and M. Iddawela for the gift of Herceptin. This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Disease (R01DK074967 to M. B.) and the National Cancer Institute (P01CA8011105, and the DF/HCC Breast Cancer SPORE Grant to M. B.). We acknowledge support from the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bates NP, 1997, ONCOGENE, V15, P473, DOI 10.1038/sj.onc.1201368; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Clark J, 2002, GENE CHROMOSOME CANC, V34, P104, DOI 10.1002/gcc.10039; Clarke R, 2001, PHARMACOL REV, V53, P25; Dowsett M, 2001, ENDOCR-RELAT CANCER, V8, P191, DOI 10.1677/erc.0.0080191; Dowsett M, 2001, CANCER RES, V61, P8452; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhou ZC, 2005, J CENT SOUTH UNIV T, V12, P1, DOI 10.1007/s11771-005-0190-y	30	244	253	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					663	U93		10.1038/nature07483	http://dx.doi.org/10.1038/nature07483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19005469	Green Accepted, Bronze			2022-12-01	WOS:000261340000046
J	Lin, HH; Murray, M; Cohen, T; Colijn, C; Ezzati, M				Lin, Hsien-Ho; Murray, Megan; Cohen, Ted; Colijn, Caroline; Ezzati, Majid			Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study	LANCET			English	Article							AIR-POLLUTION; HEALTH SYSTEM; RURAL CHINA; MORTALITY; TOBACCO; BURDEN; INTERVENTIONS; CESSATION; DISEASE; IMPROVEMENT	Background Chronic obstructive pulmonary disease (COPD), lung cancer, and tuberculosis are three leading causes of death in China, where prevalences of smoking and solid-fuel use are also high. We aimed to predict the effects of risk-factor trends on COPD, lung cancer, and tuberculosis. Methods We used representative data sources to estimate past trends in smoking and household solid-fuel use and to construct a range of future scenarios. We obtained the aetiological effects of risk factors on diseases from meta-analyses of epidemiological studies and from large studies in China. We modelled future COPD and lung cancer mortality and tuberculosis incidence, taking into account the accumulation of hazardous effects of risk factors on COPD and lung cancer over time, and dependency of the risk of tuberculosis infection on the prevalence of disease. We quantified the sensitivity of our results to methods and data choices. Findings If smoking and solid-fuel use remain at current levels between 2003 and 2033, 65 million deaths from COPD and 18 million deaths from lung cancer are predicted in China; 82% of COPD deaths and 75% of lung cancer deaths will be attributable to the combined effects of smoking and solid-fuel use. Complete gradual cessation of smoking and solid-fuel use by 2033 could avoid 26 million deaths from COPD and 6.3 million deaths from lung cancer; interventions of intermediate magnitude would reduce deaths by 6-31% (COPD) and 8-26% (lung cancer). Complete cessation of smoking and solid-fuel use by 2033 would reduce the projected annual tuberculosis incidence in 2033 by 1.4-52% if 80% DOTS coverage is sustained, 27-62% if 50% coverage is sustained, or 33-71% if 20% coverage is sustained. Interpretation Reducing smoking and solid-fuel use can substantially lower predictions of COPD and lung cancer burden and would contribute to effective tuberculosis control in China. Funding International Union Against Tuberculosis and Lung Disease.	[Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; [Lin, Hsien-Ho; Murray, Megan; Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Lin, Hsien-Ho] Mennonite Christian Hosp, Community Hlth Soc, Hualien, Taiwan; [Murray, Megan] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Murray, Megan; Cohen, Ted] Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA; [Colijn, Caroline] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Ezzati, Majid] Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Bristol; Harvard University	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	majid_ezzati@harvard.edu	Tomescu, Cleopatra M/F-5197-2011; Cohen, Ted/G-8101-2011	LIN, HSIEN-HO/0000-0002-7481-6016; Cohen, Ted/0000-0002-8091-7198; Green, Jonathan/0000-0002-0143-181X	International Union Against Tuberculosis and Lung Disease; World Bank; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055985] Funding Source: NIH RePORTER	International Union Against Tuberculosis and Lung Disease; World Bank(The World Bank India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the International Union Against Tuberculosis and Lung Disease, through a grant from the World Bank. We thank Cheng-Yuan Chiang, Donald Enarson, Ems Baris, and Ziad Obermeyer for Valuable discussion on methods and models, Colin Mathers for mortality projections, Zheng Zhou for help with data on smoking and fuel use, Jonathan Sinton for discussions on fuels use trends in China, and the Chinese Ministry of Health for tuberculosis prevalence data. We thank the China Health and Nutrition Survey, Jill Boreham, Rachel Huxley, and Zhengming Chen for valuable information and data on risk factor exposure and effects.	Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Alcaide J, 1996, TUBERCLE LUNG DIS, V77, P112, DOI 10.1016/S0962-8479(96)90024-6; [Anonymous], 2003, TOBACCO CONTROL POLI; Baris E, 2004, BMJ-BRIT MED J, V329, P1090, DOI 10.1136/bmj.329.7474.1090; Barnes DF, 2005, URBAN HOUSEHOLD ENER; Barroso Elizabeth Clara, 2003, J. Pneumologia, V29, P89, DOI 10.1590/S0102-35862003000200008; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; Chapman Simon, 2003, N S W Public Health Bull, V14, P46, DOI 10.1071/NB03013; Chen XY, 2004, LANCET, V364, P417; *CHIN CDCP CAR POP, CHIN HLTH NUTR SURV; *CHIN DAT CTR, CHIN YEARL MACR STAT; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Colijn C, 2007, J THEOR BIOL, V247, P765, DOI 10.1016/j.jtbi.2007.04.015; *DEP AGR, 1997, CHIN RUR EN YB 1991; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; El Sony A, 2007, INT J TUBERC LUNG D, V11, P150; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2004, ANNU REV ENV RESOUR, V29, P383, DOI 10.1146/annurev.energy.29.062103.121246; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M., 2004, COMP QUANTIFICATION; FERNANDEZ GO, 2006, ENCUESTA NACL SALUD; Florig HK, 1997, ENVIRON SCI TECHNOL, V31, pA274, DOI 10.1021/es972315t; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; GILMORE J, 2002, REPORT SMOKING CANAD; Grimard Franque, IMPACT TUBERCULOSIS; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Huxley R, 2007, AM J EPIDEMIOL, V165, P1280, DOI 10.1093/aje/kwm002; International Energy Agency, 2002, WORLD EN OUTL 2002; Jha P, 2000, TOBACCO CONTROL DEV; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Jiang L., 2004, INT J GLOBAL ENERGY, V21, P2, DOI DOI 10.1504/IJGEI.2004.004691; KOH H, 2002, TOBACCO CONTROL S11, V11, P1; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Laxminarayan R, 2007, EC BENEFIT TUBERCULO; Leung CC, 2004, AM J RESP CRIT CARE, V170, P1027, DOI 10.1164/rccm.200404-512oc; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI 10.1136/tc.3.3.242; Masera, 2005, ENERGY SUSTAIN DEV, V9, P25, DOI [10.1016/S0973-0826(08)60480-9, DOI 10.1016/S0973-0826(08)60480-9]; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; *MIN HLTH, 1994, RES NAT HLTH SERV AN; *MIN HLTH, 1999, RES NAT HLTH SERV AN; *MIN PUBL HLTH PEO, 1985, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 2000, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 1979, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Ministry of Health, 2004, RES NAT HLTH SERV AN; Onyebujoh PC, 1999, LANCET, V354, P116, DOI 10.1016/S0140-6736(98)10448-8; *POP CENS OFF, 2002, TAB 2000 POP CENS PR; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Sassi F., 2008, PREVENTION LIFESTYLE; Schneider NK, 2007, B WORLD HEALTH ORGAN, V85, P820, DOI 10.2471/BLT.07.034797; Shafey O, 2003, TOBACCO CONTROL COUN; Sinton J., 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; SMITH KR, 1993, WORLD DEV, V21, P941, DOI 10.1016/0305-750X(93)90053-C; Smith KR, 2004, COMP QUANTIFICATION, V2, P1435; SPRINGETT V H, 1971, Tubercle, V52, P73, DOI 10.1016/0041-3879(71)90015-8; Squire SB, 2004, LANCET, V364, P391, DOI 10.1016/S0140-6736(04)16777-9; Suhrcke M, 2006, CHRONIC DIS EC PERSP; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; Thun MJ, 1997, NATL CANCER I MONOGR, P305; United Nations Population Division, WORLD POP PROSP 2006; *US DEP HHS, 1990, DHHS PUBL CDC; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Wang Jun, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P837; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; World Bank, 2007, COST POLL CHIN EC ES; Yan F, 2007, HEALTH POLICY, V82, P186, DOI 10.1016/j.healthpol.2006.08.001; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19	79	183	209	2	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1473	1483		10.1016/S0140-6736(08)61345-8	http://dx.doi.org/10.1016/S0140-6736(08)61345-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18835640	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000260801300024
J	Kim, HJ; Oh, SA; Brownfield, L; Hong, SH; Ryu, H; Hwang, I; Twell, D; Nam, HG				Kim, Hyo Jung; Oh, Sung Aeong; Brownfield, Lynette; Hong, Sung Hyun; Ryu, Hojin; Hwang, Ildoo; Twell, David; Nam, Hong Gil			Control of plant germline proliferation by SCFFBL17 degradation of cell cycle inhibitors	NATURE			English	Article							F-BOX PROTEINS; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; EXPRESSION; SIGNAL; GENE; INSIGHTS; MUTANTS; COMPLEX; TOBACCO	Flowering plants possess a unique reproductive strategy, involving double fertilization by twin sperm cells(1). Unlike animal germ lines, the male germ cell lineage in plants only forms after meiosis and involves asymmetric division of haploid microspores, to produce a large, non- germline vegetative cell and a germ cell that undergoes one further division to produce the twin sperm cells(2). Although this switch in cell cycle control is critical for sperm cell production and delivery, the underlying molecular mechanisms are unknown. Here we identify a novel F- box protein of Arabidopsis thaliana, designated FBL17 ( F- box- like 17), that enables this switch by targeting the degradation of cyclin- dependent kinase A; 1 inhibitors specifically in male germ cells. We show that FBL17 is transiently expressed in the male germ line after asymmetric division and forms an SKP1 -Cullin1 - F- box protein ( SCF) E3 ubiquitin ligase complex (SCFFBL17) that targets the cyclin- dependent kinase inhibitors KRP6 and KRP7 for proteasome- dependent degradation. Accordingly, the loss of FBL17 function leads to the stabilization of KRP6 and inhibition of germ cell cycle progression. Our results identify SCFFBL17 as an essential male germ cell proliferation complex that promotes twin sperm cell production and double fertilization in flowering plants.	[Oh, Sung Aeong; Brownfield, Lynette; Twell, David] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England; [Kim, Hyo Jung; Hong, Sung Hyun; Ryu, Hojin; Hwang, Ildoo; Nam, Hong Gil] Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea; [Nam, Hong Gil] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea	University of Leicester; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Twell, D (corresponding author), Univ Leicester, Dept Biol, Univ Rd, Leicester LE1 7RH, Leics, England.	twe@le.ac.uk; nam@postech.ac.kr	Twell, David/D-8043-2011	Twell, David/0000-0003-0483-1461	MOST ( KOSEF) through the National Core Research Center for Systems Bio-Dynamics; Crop Functional Genomics Research Program; Biotechnology and Biological Sciences Research Council; BK21 research fellowship for Life Science, Kyungpook National University; KRF grant; MOHERD; BBSRC [BB/E001017/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C004205/1, BB/E001017/1] Funding Source: researchfish	MOST ( KOSEF) through the National Core Research Center for Systems Bio-Dynamics(Korea Science and Engineering Foundation); Crop Functional Genomics Research Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BK21 research fellowship for Life Science, Kyungpook National University; KRF grant(National Research Foundation of Korea); MOHERD; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K.H. Suh, Y.S. Park and B.H. Kim for technical assistance. This work was supported by MOST (KOSEF) through the National Core Research Center for Systems Bio-Dynamics (to H.G.N.) and the Crop Functional Genomics Research Program (to H.G.N.), by the Biotechnology and Biological Sciences Research Council (to D.T.), by the BK21 research fellowship for Life Science, Kyungpook National University ( to S.A.O.), and by a KRF grant from MOHERD (to I.H.).	Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Duplakova N, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-39; Durbarry A, 2005, PLANT PHYSIOL, V137, P297, DOI 10.1104/pp.104.053165; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Howden R, 1998, GENETICS, V149, P621; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Koo JC, 2004, PLANT J, V37, P439, DOI 10.1046/j.1365-313X.2003.01869.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Padidam M, 2003, TRANSGENIC RES, V12, P101, DOI 10.1023/A:1022113817892; Park SK, 2004, SEX PLANT REPROD, V17, P63, DOI 10.1007/s00497-004-0216-x; Park SK, 1998, DEVELOPMENT, V125, P3789; Park SK, 2001, PLANT PHYSIOL, V126, P899, DOI 10.1104/pp.126.2.899; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toda T, 1999, PHILOS T ROY SOC B, V354, P1551, DOI 10.1098/rstb.1999.0498; Verdaguer B, 1996, PLANT MOL BIOL, V31, P1129, DOI 10.1007/BF00040830; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192	36	147	152	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1134	U14		10.1038/nature07289	http://dx.doi.org/10.1038/nature07289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948957				2022-12-01	WOS:000260252600050
J	Janes, KA; Reinhardt, HC; Yaffe, MB				Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.			Cytokine-Induced Signaling Networks Prioritize Dynamic Range over Signal Strength	CELL			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; GENE-EXPRESSION; ERK ACTIVATION; MESSENGER-RNA; MAP KINASE; CANCER; IDENTIFICATION; MIGRATION; TNF	Signaling networks respond to diverse stimuli, but how the state of the signaling network is relayed to downstream cellular responses is unclear. We modeled how incremental activation of signaling molecules is transmitted to control apoptosis as a function of signal strength and dynamic range. A linear relationship between signal input and response output, with the dynamic range of signaling molecules uniformly distributed across activation states, most accurately predicted cellular responses. When nonlinearized signals with compressed dynamic range relay network activation to apoptosis, we observe catastrophic, stimulus-specific prediction failures. We develop a general computational technique, "model-breakpoint analysis,'' to analyze the mechanism of these failures, identifying new time- and stimulus-specific roles for Akt, ERK, and MK2 kinase activity in apoptosis, which were experimentally verified. Dynamic range is rarely measured in signal-transduction studies, but our experiments using model-break-point analysis suggest it may be a greater determinant of cell fate than measured signal strength.	[Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.] MIT, Dept Biol, Koch Inst Integrat Canc Res, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; [Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Janes, Kevin A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Ctr Cell Decis Proc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu			National Institute of Health [GM68762, CA112967, ES015339]; Deutsche Forschungsgemeinschaft [RE2246/1-1]; David H. Koch Fund; Edgerly Science Innovation Fund; American Cancer Society [PF-05-224-01-MGO]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM060594] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); David H. Koch Fund; Edgerly Science Innovation Fund; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Neil Kumar for providing the phosphoproteomic model and Suzanne Gaudet, Greg Hoffman, and Stephanie Walker for critically reading this manuscript. This work was supported by the National Institute of Health (GM68762, CA112967, ES015339 to M.B.Y.), the Deutsche Forschungsgemeinschaft (RE2246/1-1 to H. C. R.), the David H. Koch Fund, the Edgerly Science Innovation Fund, and the American Cancer Society ( New England Division-SpinOdyssey 2005, PF-05-224-01-MGO to K.A.J.).	Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/cmb.2004.11.544; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Martens H., 2001, MULTIVARIATE ANAL QU, Vsecond; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Miller-Jensen K, 2006, J CELL SCI, V119, P3788, DOI 10.1242/jcs.03102; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pradervand S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r11; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Tufte E., 2006, BEAUTIFUL EVIDENCE; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; WOLD S, 1994, CHEMOMETR INTELL LAB, V23, P149, DOI 10.1016/0169-7439(93)E0075-F; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094	38	75	77	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					343	354		10.1016/j.cell.2008.08.034	http://dx.doi.org/10.1016/j.cell.2008.08.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957207	Bronze, Green Accepted			2022-12-01	WOS:000260130400023
J	Kriegenburg, F; Seeger, M; Saeki, Y; Tanaka, K; Lauridsen, AMB; Hartmann-Petersen, R; Hendil, KB				Kriegenburg, Franziska; Seeger, Michael; Saeki, Yasushi; Tanaka, Keiji; Lauridsen, Anne-Marie B.; Hartmann-Petersen, Rasmus; Hendil, Klavs B.			Mammalian 26S Proteasomes Remain Intact during Protein Degradation	CELL			English	Article							ATP-DEPENDENT PROTEASES; MULTIUBIQUITIN-CHAIN; DEUBIQUITINATING ENZYME; PROTEOLYTIC PATHWAY; REGULATORY COMPLEX; SUBSTRATE ENTRY; 20S PROTEASOME; FISSION YEAST; HELA-CELLS; UBIQUITIN	It has been suggested that degradation of polyubiquitylated proteins is coupled to dissociation of 26S proteasomes. In contrast, using several independent types of experiments, we find that mammalian proteasomes can degrade polyubiquitylated proteins without disassembling. Thus, immobilized, 35 S-labeled 26S proteasomes degraded polyubiquitylated Sic1 and c-IAP1 without releasing any subunits. In addition, it is predicted that if 26S proteasomes dissociate into 20S proteasomes and regulatory complexes during a degradation cycle, the reassembly rate would be limiting at low proteasome concentrations. However, the rate with which each proteasome degraded polyubiquitylated Sic1 was independent of the proteasome concentration. Likewise, substrate-dependent dissociation of 26S proteasomes could not be detected by nondenaturing electrophoresis. Lastly, epoxomicin-inhibited 20S proteasomes can trap released regulatory complexes, forming inactive 26S proteasomes, but addition of epoxomicin-inhibited 20S proteasomes had no effect on the degradation of either polyubiquitylated Sic1 or UbcH10 by 26S proteasomes or of endogenous substrates in cell extracts.	[Kriegenburg, Franziska; Lauridsen, Anne-Marie B.; Hartmann-Petersen, Rasmus; Hendil, Klavs B.] Dept Biol, DK-2100 Copenhagen O, Denmark; [Seeger, Michael] Charite Univ Med Berlin, Inst Biochem, D-10117 Berlin, Germany; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tokyo Metropolitan Institute of Medical Science	Hartmann-Petersen, R (corresponding author), Dept Biol, August Krogh Bldg,Univ Pk 13, DK-2100 Copenhagen O, Denmark.	rhpetersen@bio.ku.dk; kbhendil@bio.ku.dk	Hartmann-Petersen, Rasmus/K-4434-2014; Saeki, Yasushi/AAR-8198-2021	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Saeki, Yasushi/0000-0002-9202-5453				Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GREGORI L, 1990, J BIOL CHEM, V265, P8354; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; HENDIL KB, 1988, BIOCHEM INT, V17, P471; Hendil KB, 2002, J MOL BIOL, V315, P627, DOI 10.1006/jmbi.2001.5285; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kominami K, 1997, MOL BIOL CELL, V8, P171, DOI 10.1091/mbc.8.1.171; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith SE, 2005, WOMAN ART J, V26, P20, DOI 10.2307/3566530; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	64	32	34	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					355	365		10.1016/j.cell.2008.08.032	http://dx.doi.org/10.1016/j.cell.2008.08.032			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957208	Bronze			2022-12-01	WOS:000260130400024
J	Wilson, MD; Barbosa-Morais, NL; Schmidt, D; Conboy, CM; Vanes, L; Tybulewicz, VLJ; Fisher, EMC; Tavare, S; Odom, DT				Wilson, Michael D.; Barbosa-Morais, Nuno L.; Schmidt, Dominic; Conboy, Caitlin M.; Vanes, Lesley; Tybulewicz, Victor L. J.; Fisher, Elizabeth M. C.; Tavare, Simon; Odom, Duncan T.			Species-specific transcription in mice carrying human chromosome 21	SCIENCE			English	Article							FACTOR-BINDING SITES; HUMAN GENOME; HISTONE-H3 LYSINE-4; EVO-DEVO; EVOLUTION; CHROMATIN; RECOGNITION; RESOLUTION; REVEALS; DOMAIN	Homologous sets of transcription factors direct conserved tissue-specific gene expression, yet transcription factor-binding events diverge rapidly between closely related species. We used hepatocytes from an aneuploid mouse strain carrying human chromosome 21 to determine, on a chromosomal scale, whether interspecies differences in transcriptional regulation are primarily directed by human genetic sequence or mouse nuclear environment. Virtually all transcription factor-binding locations, landmarks of transcription initiation, and the resulting gene expression observed in human hepatocytes were recapitulated across the entire human chromosome 21 in the mouse hepatocyte nucleus. Thus, in homologous tissues, genetic sequence is largely responsible for directing transcriptional programs; interspecies differences in epigenetic machinery, cellular environment, and transcription factors themselves play secondary roles.	[Wilson, Michael D.; Barbosa-Morais, Nuno L.; Schmidt, Dominic; Tavare, Simon; Odom, Duncan T.] Li Ka Shing Ctr, Canc Res UK, Cambridge Res Inst, Cambridge CB2 0RE, England; [Barbosa-Morais, Nuno L.; Schmidt, Dominic; Tavare, Simon; Odom, Duncan T.] Hutchison MRC Res Ctr, Dept Oncol, Cambridge CB2 0XZ, England; [Conboy, Caitlin M.] Univ Minnesota, Sch Med, Med Sci Training Program, Minneapolis, MN 55455 USA; [Vanes, Lesley; Tybulewicz, Victor L. J.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; [Fisher, Elizabeth M. C.] UCL, Neurol Inst, London WC1N 3BG, England; [Tavare, Simon] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Minnesota System; University of Minnesota Twin Cities; MRC National Institute for Medical Research; University of London; University College London; University of Cambridge	Odom, DT (corresponding author), Li Ka Shing Ctr, Canc Res UK, Cambridge Res Inst, Robinson Way, Cambridge CB2 0RE, England.	duncan.odom@cancer.org.uk	Pillay, Nischalan/F-9536-2012; Wilson, Michael D/K-6294-2014; Fisher, Elizabeth MC/C-2168-2008; Barbosa-Morais, Nuno L/I-2743-2013	Wilson, Michael D/0000-0002-4015-3066; Fisher, Elizabeth MC/0000-0003-2850-9936; Barbosa-Morais, Nuno L/0000-0002-1215-0538; Odom, Duncan/0000-0001-6201-5599; Tybulewicz, Victor/0000-0003-2439-0798; Conboy, Caitlin/0000-0001-8280-056X	European Research Council; Royal Society Wolfson Research Merit Award; Hutchison Whampoa; Medical Research Council; Wellcome Trust; University of Cambridge; Cancer Research U.K.; MRC [MC_U117527252, G0601056] Funding Source: UKRI; Medical Research Council [MC_U117527252, G0601056] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Hutchison Whampoa; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); Cancer Research U.K.(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to E. Jacobsen, R. Stark, I. Spiteri, B. Liu, J. Marioni, A. Lynch, J. Hadfield, N. Matthews, the Cambridge Research Institute (CRI) Genomics Core, CRI Bioinformatics Core, and Camgrid for technical assistance, and B. Gottgens and J. Ferrer for insightful advice. Supported by the European Research Council (D.T.O.); Royal Society Wolfson Research Merit Award (S.T.); Hutchison Whampoa (D.T.O., ST); Medical Research Council (E.F.,VT); Wellcome Trust (E.F., V.T.); University of Cambridge (D.T.O., D.S., N.B.M., S.T.); and Cancer Research U.K. (D.T.O., M.D.W., N.B.M., S.T., D.S.). Data deposited under ArrayExpress accession numbers E-TABM-473 and E-TABM-474. M.D.W., N.B.M., D.S., D.T.O., and C.M.C. designed and performed experiments; N.B.M., M.D.W., and D.S. analyzed the data; L.V., V.T., M.D.W., and E.F. created, prepared, and provided Tc1 mouse tissues; and M.D.W., N.B.M., D.T.O., and S.T. wrote the manuscript. D.T.O. oversaw the work. The authors declare no competing interests.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Eeckhoute J, 2003, NUCLEIC ACIDS RES, V31, P6640, DOI 10.1093/nar/gkg850; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Park CC, 2008, NAT GENET, V40, P421, DOI 10.1038/ng.113; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3	28	214	218	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					434	438		10.1126/science.1160930	http://dx.doi.org/10.1126/science.1160930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18787134	Green Accepted			2022-12-01	WOS:000260094500045
J	Bshary, R; Grutter, AS; Willener, AST; Leimar, O				Bshary, Redouan; Grutter, Alexandra S.; Willener, Astrid S. T.; Leimar, Olof			Pairs of cooperating cleaner fish provide better service quality than singletons	NATURE			English	Article							TIT-FOR-TAT; PARTNER CONTROL; LABROIDES DIMIDIATUS; ANIMAL SOCIETIES; REEF FISH; MUTUALISM; EVOLUTION; PUNISHMENT; ECOLOGY; RATES	Service providers may vary service quality depending on whether they work alone or provide the service simultaneously with a partner. The latter case resembles a prisoner's dilemma(1-4), in which one provider may try to reap the benefits of the interaction without providing the service. Here we present a game- theory model based on the marginal value theorem(5), which predicts that as long as the client determines the duration, and the providers cooperate towards mutual gain, service quality will increase in the pair situation. This prediction is consistent with field observations and with an experiment on cleaning mutualism, in which stable male - female pairs of the cleaner wrasse Labroides dimidiatus repeatedly inspect client fish jointly. Cleaners cooperate by eating ectoparasites(6) off clients but actually prefer to cheat and eat client mucus(7). Because clients often leave in response to such cheating, the benefits of cheating can be gained by only one cleaner during a pair inspection. In both data sets, the increased service quality during pair inspection was mainly due to the smaller females behaving significantly more cooperatively than their larger male partners. In contrast, during solitary inspections, cleaning behaviour was very similar between the sexes. Our study highlights the importance of incorporating interactions between service providers to make more quantitative predictions about cooperation between species.	[Bshary, Redouan; Willener, Astrid S. T.] Univ Neuchatel, Dept Zool, CH-2009 Neuchatel, Switzerland; [Grutter, Alexandra S.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia; [Leimar, Olof] Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden	University of Neuchatel; University of Queensland; Stockholm University	Bshary, R (corresponding author), Univ Neuchatel, Dept Zool, Rue Emile Argand 11 Case Postale 158, CH-2009 Neuchatel, Switzerland.	redouan.bshary@unine.ch	Leimar, Olof/L-3781-2014; Grutter, Alexandra S/J-2737-2013	Leimar, Olof/0000-0001-8621-6977; Grutter, Alexandra S/0000-0003-1688-2821; Bshary, Redouan/0000-0001-7198-8472	Natural Environment Research Council; Swiss Science Foundation; Australian Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Australian Research Council(Australian Research Council)	We thank the Egyptian Environmental Affairs Agency for permission to work at Ras Mohammed National Park, the Park Rangers and I. Riepl for local support, and M. Wurth and A. Hubl for field assistance. We further thank the Lizard Island Research Station for their support concerning the experiments. R.B. was funded by the Natural Environment Research Council and by the Swiss Science Foundation. A.S.T.W. was funded by the Swiss Science Foundation. A.S.G. was funded by the Australian Research Council. O.L. was funded by the Swedish	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bowles S, 2003, DAHL WS ENV, P153; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Bshary R, 2002, ANIM BEHAV, V63, P557, DOI 10.1006/anbe.2001.1923; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; DUGATKIN LA, 1988, BEHAV ECOL SOCIOBIOL, V23, P395, DOI 10.1007/BF00303714; Dugatkin LA., 1997, COOPERATION ANIMALS; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; HAMMERSTEIN P, 2003, WHY IS RECIPROCITY S, P83; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Johnstone RA, 2002, ECOL LETT, V5, P634, DOI 10.1046/j.1461-0248.2002.00358.x; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; NOE R, 1991, ETHOLOGY, V87, P97; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007	28	88	89	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					964	U46		10.1038/nature07184	http://dx.doi.org/10.1038/nature07184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923522				2022-12-01	WOS:000260038300049
J	Poon, VY; Klassen, MP; Shen, K				Poon, Vivian Y.; Klassen, Matthew P.; Shen, Kang			UNC-6/netrin and its receptor UNC-5 locally exclude presynaptic components from dendrites	NATURE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; NETRIN RECEPTOR; AXON GUIDANCE; COLORECTAL-CANCER; SYNAPSE FORMATION; DROSOPHILA; ENCODES; WNT; EXPRESSION	Polarity is an essential feature of many cell types, including neurons that receive information from local inputs within their dendrites and propagate nerve impulses to distant targets through a single axon. It is generally believed that intrinsic structural differences between axons and dendrites dictate the polarized localization of axonal and dendritic proteins(1). However, whether extracellular cues also instruct this process in vivo has not been explored. Here we show that the axon guidance cue UNC-6/netrin and its receptor UNC-5 act throughout development to exclude synaptic vesicle and active zone proteins from the dendrite of the Caenorhabditis elegans motor neuron DA9, which is proximal to a source of UNC- 6/ netrin. In unc- 6/ netrin and unc- 5 loss- of-function mutants, presynaptic components mislocalize to the DA9 dendrite. In addition, ectopically expressed UNC- 6/ netrin, acting through UNC- 5, is sufficient to exclude endogenous synapses from adjacent subcellular domains within the DA9 axon. Furthermore, this anti- synaptogenic activity is interchangeable with that of LIN- 44/ Wnt despite being transduced through different receptors, suggesting that extracellular cues such as netrin and Wnts not only guide axon navigation but also regulate the polarized accumulation of presynaptic components through local exclusion.	[Poon, Vivian Y.; Klassen, Matthew P.; Shen, Kang] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Sch Med, Neurosci Program, 300 Pasteur Dr, Stanford, CA 94305 USA.	kangshen@stanford.edu			W. M. Keck Foundation; McKnight Endowment Fund; Searle Scholar Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); McKnight Endowment Fund; Searle Scholar Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the W. M. Keck Foundation, the McKnight Endowment Fund, the Searle Scholar Award and the Howard Hughes Medical Institute. We thank the International Caenorhabditis Genetic Center and M. Chalfie for strains. We further thank M. Chalfie for sharing unpublished results on the silencing system. We also thank C. Gao and Y. Fu for technical assistance, and T. Clandinin, C. Bargmann, S. McConnell, and members of the Shen laboratory for comments on the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jin YS, 1999, J NEUROSCI, V19, P539; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Manitt C, 2006, J NEUROSCI RES, V84, P1808, DOI 10.1002/jnr.21070; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Su MW, 2000, DEVELOPMENT, V127, P585; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	29	101	113	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					669	U68		10.1038/nature07291	http://dx.doi.org/10.1038/nature07291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18776887	Green Accepted			2022-12-01	WOS:000259639700048
J	Munck, E; Bominaar, EL				Munck, Eckard; Bominaar, Emile L.			Chemistry - Bringing stability to highly reduced iron-sulfur clusters	SCIENCE			English	Editorial Material							AZOTOBACTER-VINELANDII; FE PROTEIN; NITROGENASE; ANALOG; MOSSBAUER; EPR		[Munck, Eckard; Bominaar, Emile L.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Munck, E (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th St, Pittsburgh, PA 15213 USA.	emunck@cmu.edu; eb7g@andrew.cmu.edu						Angove HC, 1997, J AM CHEM SOC, V119, P8730, DOI 10.1021/ja9712837; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Deng L, 2008, J AM CHEM SOC, V130, P9878, DOI 10.1021/ja802111w; Guo ML, 2002, J AM CHEM SOC, V124, P12100, DOI 10.1021/ja026478f; Hans M, 2008, J BIOL INORG CHEM, V13, P563, DOI 10.1007/s00775-008-0345-z; HERSKOVITZ T, 1972, P NATL ACAD SCI USA, V69, P2437, DOI 10.1073/pnas.69.9.2437; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Lowery TJ, 2006, P NATL ACAD SCI USA, V103, P17131, DOI 10.1073/pnas.0603223103; OSULLIVAN T, 1985, J AM CHEM SOC, V107, P4096, DOI 10.1021/ja00299a066; Rao PV, 2004, CHEM REV, V104, P527, DOI 10.1021/cr020615+; Scott TA, 2005, P NATL ACAD SCI USA, V102, P9741, DOI 10.1073/pnas.0504258102; Strop P, 2001, BIOCHEMISTRY-US, V40, P651, DOI 10.1021/bi0016467; Yoo SJ, 1999, J AM CHEM SOC, V121, P2534, DOI 10.1021/ja9837405	13	19	19	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1452	1453		10.1126/science.1163868	http://dx.doi.org/10.1126/science.1163868			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787157				2022-12-01	WOS:000259121800027
J	Gros, J; Serralbo, O; Marcelle, C				Gros, Jerome; Serralbo, Olivier; Marcelle, Christophe			WNT11 acts as a directional cue to organize the elongation of early muscle fibres	NATURE			English	Article							CONVERGENT EXTENSION MOVEMENTS; CELL POLARITY; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAYS; PLANAR POLARITY; NEURAL-TUBE; GASTRULATION; PRICKLE; MEDIATE; CHICK	The early vertebrate skeletal muscle is a well- organized tissue in which the primitive muscle fibres, the myocytes, are all parallel and aligned along the antero- posterior axis of the embryo. How myofibres acquire their orientation during development is unknown. Here we show that during early chick myogenesis WNT11 has an essential role in the oriented elongation of the myocytes. We find that the neural tube, known to drive WNT11 expression in the medial border of somites(1), is necessary and sufficient to orient myocyte elongation. We then show that the specific inhibition of WNT11 function in somites leads to the disorganization of myocytes. We establish that WNT11 mediates this effect through the evolutionary conserved planar cell polarity ( PCP) pathway, downstream of the WNT/beta-catenin-dependent pathway, required to initiate the myogenic program of myocytes and WNT11 expression. Finally, we demonstrate that a localized ectopic source of WNT11 can markedly change the orientation of myocytes, indicating that WNT11 acts as a directional cue in this process. All together, these data show that the sequential action of the WNT/ PCP and the WNT/beta-catenin pathways is necessary for the formation of fully functional embryonic muscle fibres. This study also provides evidence that WNTs can act as instructive cues to regulate the PCP pathway in vertebrates.	[Gros, Jerome; Serralbo, Olivier; Marcelle, Christophe] Univ Aix Marseille 2, CNRS, Dev Biol Inst Marseille Luminy IBDML, UMR 6216, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marcelle, C (corresponding author), Univ Aix Marseille 2, CNRS, Dev Biol Inst Marseille Luminy IBDML, UMR 6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	marcelle@ibdm.univ-mrs.fr		Serralbo, Olivier/0000-0003-0808-3464; Gros, Jerome/0000-0002-2264-2851	Actions Concertees Incitatives; Agence Nationale de la Recherche; Association Francaise contre les Myopathies; EU 6th Framework Programme Network of Excellence MYORES	Actions Concertees Incitatives; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); EU 6th Framework Programme Network of Excellence MYORES(European Commission)	We thank C. Tabin for critical reading of the manuscript. The help of P. Weber for the two- photon imaging, and of the Zeiss team, are acknowledged. We are grateful to M. Manceau for Supplementary Fig. 1d, and to R. Kanadia for his help. This study was funded by grants from the Actions Concertees Incitatives (ACI), the Agence Nationale de la Recherche (ANR), the Association Francaise contre les Myopathies (AFM) and by the EU 6th Framework Programme Network of Excellence MYORES. J. G. was a Fellow of the AFM.	Anakwe K, 2002, J Anat, V201, P421; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cooper O, 2008, DEV DYNAM, V237, P1442, DOI 10.1002/dvdy.21490; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Djiane A, 2000, DEVELOPMENT, V127, P3091; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Ikeya M, 1998, DEVELOPMENT, V125, P4969; Jiang D, 2005, CURR BIOL, V15, P79; Kahane N, 2007, DEV BIOL, V305, P439, DOI 10.1016/j.ydbio.2007.02.030; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Linker C, 2005, DEVELOPMENT, V132, P3895, DOI 10.1242/dev.01961; Linker C, 2003, DEVELOPMENT, V130, P4797, DOI 10.1242/dev.00688; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Montross WT, 2000, J CELL SCI, V113, P1759; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Tada M, 2000, DEVELOPMENT, V127, P2227; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017	35	142	148	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					589	U97		10.1038/nature07564	http://dx.doi.org/10.1038/nature07564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	18987628				2022-12-01	WOS:000262852200043
J	Hilf, RJC; Dutzler, R				Hilf, Ricarda J. C.; Dutzler, Raimund			Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CHARGED AMINO-ACIDS; CYS-LOOP; GATING MECHANISM; MONO-VALENT; BINDING; SELECTIVITY; DOMAIN; SOFTWARE; REVEALS	The X- ray structure of a pentameric ligand- gated ion channel from Erwinia chrysanthemi ( ELIC) has recently provided structural insight into this family of ion channels at high resolution(1). The structure shows a homo- pentameric protein with a barrel- stave architecture that defines an ion- conduction pore located on the fivefold axis of symmetry. In this structure, the wide aqueous vestibule that is encircled by the extracellular ligand- binding domains of the five subunits narrows to a discontinuous pore that spans the lipid bilayer. The pore is constricted by bulky hydrophobic residues towards the extracellular side, which probably serve as barriers that prevent the diffusion of ions. This interrupted pore architecture in ELIC thus depicts a non- conducting conformation of a pentameric ligand- gated ion channel, the thermodynamically stable state in the absence of bound ligand. As ligand binding promotes pore opening in these ion channels and the specific ligand for ELIC has not yet been identified, we have turned our attention towards a homologous protein from the cyanobacterium Gloebacter violaceus ( GLIC). GLIC was shown to form proton- gated channels that are activated by a pH decrease on the extracellular side and that do not desensitize after activation(2). Both prokaryotic proteins, ELIC and GLIC form ion channels that are selective for cations over anions with poor discrimination among monovalent cations(1,2), characteristics that resemble the conduction properties of the cation- selective branch of the family that includes acetylcholine and serotonin receptors(3,4). Here we present the X- ray structure of GLIC at 3.1 angstrom resolution. The structure reveals a conformation of the channel that is distinct from ELIC and that probably resembles the open state. In combination, both structures suggest a novel gating mechanism for pentameric ligand- gated ion channels where channel opening proceeds by a change in the tilt of the pore- forming helices.	[Hilf, Ricarda J. C.; Dutzler, Raimund] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Dutzler, R (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	dutzler@bioc.uzh.ch			National Center for Competence in Research; EC FP7	National Center for Competence in Research; EC FP7(European Commission)	We thank B. Blattmann and C. Stutz-Duocommun for assistance with crystal screening, C. Schulze-Briese and the staff of the XO6SA beamline for support during data collection, the protein analysis group at the functional genomics centre of the University of Zurich for help with mass spectrometry, R. MacKinnon for comments on the manuscript and members of the Dutzler laboratory for help in all stages of the project. Data collection was performed at the Swiss Light Source of the Paul Scherrer Institute. The research leading to these results was supported by a grant from the National Center for Competence in Research ( NCCR) in Structural Biology and by an EC FP7 grant for the EDICT consortium (HEALTH-201924). R.J.C.H. is affiliated with the Molecular Life Sciences Ph.D. programme of the University/ETH Zurich.	ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; COWTAN K, 1994, AUTOMATED PROCEDURE, P34; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; DANI JA, 1989, J NEUROSCI, V9, P884; DANI JA, 1987, J GEN PHYSIOL, V89, P959, DOI 10.1085/jgp.89.6.959; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leslie AGW, 1992, RECENT CHANGES MOSFL; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tasneem A, 2005, GENOME BIOL, V6; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	42	465	469	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					115	U122		10.1038/nature07461	http://dx.doi.org/10.1038/nature07461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18987630				2022-12-01	WOS:000262104900042
J	Sacco, A; Doyonnas, R; Kraft, P; Vitorovic, S; Blau, HM				Sacco, Alessandra; Doyonnas, Regis; Kraft, Peggy; Vitorovic, Stefan; Blau, Helen M.			Self-renewal and expansion of single transplanted muscle stem cells	NATURE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; MYOBLASTS; FATE; RECONSTITUTION; HETEROGENEITY; EXPRESSION	Adult muscle satellite cells have a principal role in postnatal skeletal muscle growth and regeneration(1). Satellite cells reside as quiescent cells underneath the basal lamina that surrounds muscle fibres(2) and respond to damage by giving rise to transient amplifying cells ( progenitors) and myoblasts that fuse with myofibres. Recent experiments showed that, in contrast to cultured myoblasts, satellite cells freshly isolated(3-5) or satellite cells derived from the transplantation of one intact myofibre(6) contribute robustly to muscle repair. However, because satellite cells are known to be heterogeneous(4,6,7), clonal analysis is required to demonstrate stem cell function. Here we show that when a single luciferase- expressing muscle stem cell is transplanted into the muscle of mice it is capable of extensive proliferation, contributes to muscle fibres, and Pax7(+) luciferase(+) mononucleated cells can be readily re- isolated, providing evidence of muscle stem cell self- renewal. In addition, we show using in vivo bioluminescence imaging that the dynamics of muscle stem cell behaviour during muscle repair can be followed in a manner not possible using traditional retrospective histological analyses. By imaging luciferase activity, real- time quantitative and kinetic analyses show that donor- derived muscle stem cells proliferate and engraft rapidly after injection until homeostasis is reached. On injury, donor- derived mononucleated cells generate massive waves of cell proliferation. Together, these results show that the progeny of a single luciferase- expressing muscle stem cell can both self- renew and differentiate after transplantation in mice, providing new evidence at the clonal level that self- renewal is an autonomous property of a single adult muscle stem cell.	[Sacco, Alessandra; Doyonnas, Regis; Kraft, Peggy; Vitorovic, Stefan; Blau, Helen M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol,Stem Cell Inst, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol,Stem Cell Inst, Stanford, CA 94305 USA.	hblau@stanford.edu		Doyonnas, Regis/0000-0002-3818-0807	NIH [AG009521, AG024987]; Baxter Foundation; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521, R01AG024987, R01AG020961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank O. Alkan for developing the single cell RT-PCR protocol, K. Koleckar, M. Pajcini and T. Doyle for technical support, T. Brazelton, F. Rossi and S. Corbel for comments on the manuscript, J. Ramunas for statistical analysis, and M. Lutolf and P. Gilbert for fabricating the hydrogel microwells. We also thank F. Rossi for providing the integrin-alpha<INF>7</INF>-PE- conjugated antibody, and C. Contag for providing the FLuc mice. This work was supported by NIH grants AG009521, AG024987 and by the Baxter Foundation.	Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; BLAU HM, 1990, ADV EXP MED BIOL, V280, P201; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x; Heslop L, 2000, J CELL SCI, V113, P2299; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RANDO TA, 1995, EXP CELL RES, V220, P383, DOI 10.1006/excr.1995.1329; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	26	589	630	6	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					502	506		10.1038/nature07384	http://dx.doi.org/10.1038/nature07384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18806774	Green Accepted			2022-12-01	WOS:000261170500038
J	Creager, ANH				Creager, Angela N. H.			Atomic transfiguration	LANCET			English	Editorial Material									[Creager, Angela N. H.] Princeton Univ, Dept Hist, Princeton, NJ 08544 USA; [Creager, Angela N. H.] Princeton Univ, Program Hist Sci, Princeton, NJ 08544 USA	Princeton University; Princeton University	Creager, ANH (corresponding author), Princeton Univ, Dept Hist, Princeton, NJ 08544 USA.	creager@princeton.edu		Creager, Angela/0000-0002-7763-6432	NLM NIH HHS [5G13LM009100-2, G13 LM009100-02, G13 LM009100] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [G13LM009100] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Creager ANH, 2006, J HIST BIOL, V39, P649, DOI 10.1007/s10739-006-9108-2; Heilbron J.L., 1989, LAWRENCE HIS LAB HIS, DOI DOI 10.1525/9780520341081; Rentetzi M, 2007, TRAFFICKING MAT GEND; Walker J. Samuel, 2000, PERMISSIBLE DOSE HIS; Welsome Eileen, 1999, PLUTONIUM FILES AM S	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2008	372	9651					1726	1727		10.1016/S0140-6736(08)61721-3	http://dx.doi.org/10.1016/S0140-6736(08)61721-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	19018613	Green Accepted			2022-12-01	WOS:000261077900013
J	Keller, PJ; Schmidt, AD; Wittbrodt, J; Stelzer, EHK				Keller, Philipp J.; Schmidt, Annette D.; Wittbrodt, Joachim; Stelzer, Ernst H. K.			Reconstruction of Zebrafish Early Embryonic Development by Scanned Light Sheet Microscopy	SCIENCE			English	Article							CELL MOVEMENTS; GASTRULATION; EXTENSION; POLARITY; LINEAGE; ONSET	A long- standing goal of biology is to map the behavior of all cells during vertebrate embryogenesis. We developed digital scanned laser light sheet fluorescence microscopy and recorded nuclei localization and movement in entire wild- type and mutant zebrafish embryos over the first 24 hours of development. Multiview in vivo imaging at 1.5 billion voxels per minute provides "digital embryos," that is, comprehensive databases of cell positions, divisions, and migratory tracks. Our analysis of global cell division patterns reveals a maternally defined initial morphodynamic symmetry break, which identifies the embryonic body axis. We further derive a model of germ layer formation and show that the mesendoderm forms from one- third of the embryo's cells in a single event. Our digital embryos, with 55 million nucleus entries, are provided as a resource.	[Keller, Philipp J.; Wittbrodt, Joachim; Stelzer, Ernst H. K.] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Keller, Philipp J.; Schmidt, Annette D.; Wittbrodt, Joachim] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Wittbrodt, Joachim] Heidelberg Univ, Inst Zool, Dept Dev Physiol, INF 230, D-69120 Heidelberg, Germany; [Wittbrodt, Joachim] KIT, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Keller, PJ (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	keller@embl.de; wittbrod@embl.de	Wittbrodt, Joachim/D-4735-2014; Stelzer, Ernst H K/A-7648-2011; Keller, Philipp J/F-2343-2010	Wittbrodt, Joachim/0000-0001-8550-7377; Stelzer, Ernst H K/0000-0003-1545-0736; Keller, Philipp/0000-0003-2896-4920	Studienstiftung des deutschen Volkes; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology;  [EU-FP6-STREP Plurigenes];  [DFG SFB-488]	Studienstiftung des deutschen Volkes; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology; ; 	We thank U. Liebel, M. Alef, and M. Wahlers for excellent KIT/EMBL computer cluster support; the EMBL mechanical workshop for custom hardware; A. Riedinger and G. Ritter for custom electronics; F. Harle and A. Riedinger for custom microscope operating software; W. Dilling for technical drawings; M. Knop, K. Brown, K. Khairy, J. Martinez, D. Gilmour, and C.-P. Heisenberg for critical manuscript comments; L. Centanin for immunostained medaka embryos; C.- P. Heisenberg for MZoep mutants; S. Terjung for Leica SP5 support; G. Giese for Zeiss LSM 510 NLO support. Financial support: EU-FP6-STREP Plurigenes, DFG SFB-488 (J.W.); Studienstiftung des deutschen Volkes (P.J.K.); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, HBIGS (A.D.S.). Contributions: P.J.K. outlined the digital embryo project, designed and built the DSLM, recorded the microscopy data, developed the image processing pipeline, performed the reconstructions and drafted the manuscript. A.D.S. developed the biological methods, performed the biological preparations, contributed to project planning and participated in the writing of the manuscript. E.H.K.S. outlined the DSLM development, cosupervised the project, and participated in manuscript preparation. P.J.K., A.D.S., and J.W. analyzed the digital embryos. J.W. guided the biological research, cosupervised the project, and participated in the writing of the manuscript.	Adams RJ, 2004, GASTRULATION CELLS E, P305; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Concha ML, 1998, DEVELOPMENT, V125, P983; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; England SJ, 2006, DEVELOPMENT, V133, P4613, DOI 10.1242/dev.02678; Gilbert S. F., 2006, DEV BIOL; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003; Hirose Y, 2004, DEVELOPMENT, V131, P2553, DOI 10.1242/dev.01140; HISAOKA KENICHI KENNETH, 1958, J MORPH, V102, P311, DOI 10.1002/jmor.1051020205; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KANE D, 2002, PATTERN FORMATION ZE; KANE DA, 1993, DEVELOPMENT, V119, P447; Kane DA, 1996, DEVELOPMENT, V123, P47; Keller PJ, 2007, NAT METHODS, V4, P843, DOI 10.1038/NMETH1087; Keller PJ, 2006, CURR OPIN CELL BIOL, V18, P117, DOI 10.1016/j.ceb.2005.12.012; Lemaire P, 2006, SCIENCE, V312, P1145, DOI 10.1126/science.1128784; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pezeron G, 2008, CURR BIOL, V18, P276, DOI 10.1016/j.cub.2008.01.028; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; SCHMITZ B, 1994, ROUX ARCH DEV BIOL, V203, P374, DOI 10.1007/BF00188685; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Sepich Diane S., 2004, V294, P211; Sepich DS, 2005, DEV DYNAM, V234, P279, DOI 10.1002/dvdy.20507; SHIH J, 1995, DEVELOPMENT, V121, P2755; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Trinkaus JP, 1984, CELLS ORGANS FORCES; Tsien R. Y., 2006, HDB BIOL CONFOCAL MI, V3rd, P338, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2_16]; WARGA RM, 1990, DEVELOPMENT, V108, P569; Warga RM, 1998, DEV BIOL, V203, P116, DOI 10.1006/dbio.1998.9022; Wolpert L., 2006, PRINCIPLES DEV, V3rd	40	1014	1050	23	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1065	1069		10.1126/science.1162493	http://dx.doi.org/10.1126/science.1162493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	18845710				2022-12-01	WOS:000260867700028
J	Takahashi, JS; Shimomura, K; Kumar, V				Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek			Searching for Genes Underlying Behavior: Lessons from Circadian Rhythms	SCIENCE			English	Editorial Material							DROSOPHILA PERIOD GENE; INDIVIDUAL FIBROBLASTS; PHENOTYPIC VARIATION; REVEALS PERSISTENT; CLOCK GENE; MOUSE; MICE; MUTAGENESIS; EXPRESSION; CLONING	The success of forward genetic ( from phenotype to gene) approaches to uncover genes that drive the molecular mechanism of circadian clocks and control circadian behavior has been unprecedented. Links among genes, cells, neural circuits, and circadian behavior have been uncovered in the Drosophila and mammalian systems, demonstrating the feasibility of finding single genes that have major effects on behavior. Why was this approach so successful in the elucidation of circadian rhythms? This article explores the answers to this question and describes how the methods used successfully for identifying the molecular basis of circadian rhythms can be applied to other behaviors such as anxiety, addiction, and learning and memory.	[Takahashi, Joseph S.; Kumar, Vivek] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek] Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; Northwestern University	Takahashi, JS (corresponding author), Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Kumar, Vivek/0000-0001-6643-7465	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924, R01MH078024, U01MH061915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [F32 DA024556] Funding Source: Medline; NIMH NIH HHS [P50 MH074924, R01 MH078024, U01 MH61915, U01 MH061915] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Beier DR, 2000, MAMM GENOME, V11, P594, DOI 10.1007/s003350010113; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kile BT, 2005, NAT REV GENET, V6, P557, DOI 10.1038/nrg1636; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Matynia A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002121; Moortgat KT, 2000, J NEUROPHYSIOL, V83, P971, DOI 10.1152/jn.2000.83.2.971; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Strunk KE, 2004, GENETICS, V167, P1821, DOI 10.1534/genetics.103.020495; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Thomsen M, 2007, BEHAV GENET, V37, P101, DOI 10.1007/s10519-006-9097-0; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	43	69	71	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					909	912		10.1126/science.1158822	http://dx.doi.org/10.1126/science.1158822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988844	Green Accepted			2022-12-01	WOS:000260674100037
J	Weixlbaumer, A; Jin, H; Neubauer, C; Voorhees, RM; Petry, S; Kelley, AC; Ramakrishnan, V				Weixlbaumer, Albert; Jin, Hong; Neubauer, Cajetan; Voorhees, Rebecca M.; Petry, Sabine; Kelley, Ann C.; Ramakrishnan, Venki			Insights into Translational Termination from the Structure of RF2 Bound to the Ribosome	SCIENCE			English	Article							PEPTIDYL-TRANSFER-RNA; POLYPEPTIDE RELEASE FACTORS; STOP CODON RECOGNITION; GGQ MOTIF; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BOND FORMATION; MESSENGER-RNA; 70S RIBOSOME; HYDROLYSIS	The termination of protein synthesis occurs through the specific recognition of a stop codon in the A site of the ribosome by a release factor ( RF), which then catalyzes the hydrolysis of the nascent protein chain from the P- site transfer RNA. Here we present, at a resolution of 3.5 angstroms, the crystal structure of RF2 in complex with its cognate UGA stop codon in the 70S ribosome. The structure provides insight into how RF2 specifically recognizes the stop codon; it also suggests a model for the role of a universally conserved GGQ motif in the catalysis of peptide release.	[Weixlbaumer, Albert; Jin, Hong; Neubauer, Cajetan; Voorhees, Rebecca M.; Petry, Sabine; Kelley, Ann C.; Ramakrishnan, Venki] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Weixlbaumer, Albert/AAI-8474-2021; Neubauer, Cajetan/B-8935-2016; Weixlbaumer, Albert/P-3587-2016	Weixlbaumer, Albert/0000-0001-9635-3844; Neubauer, Cajetan/0000-0002-5348-5609; Weixlbaumer, Albert/0000-0001-9635-3844; VOORHEES, REBECCA/0000-0003-1640-2293; Ramakrishnan, V/0000-0002-4699-2194; Jin, Hong/0000-0003-2027-9435	MRC UK; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Boehringer-Ingelheim fellowship; Gates-Cambridge fellowship; Medical Research Council [MC_U105184332] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Boehringer-Ingelheim fellowship(Boehringer Ingelheim); Gates-Cambridge fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Schmeing for his useful comments and M. Fuchs and C. Schulze-Briese for their help and advice with data collection at the Swiss Light Source. This work was supported by MRC UK, a program grant from the Wellcome Trust, and awards from the Agouron Institute and Louis- Jeantet Foundation. C.N. is supported by a Boehringer-Ingelheim fellowship and R.M.V. is supported by a Gates-Cambridge fellowship. Coordinates for the structure have been deposited in the Protein Data Bank with accession codes 2jl5 to 2jl8. V.R. holds stock options in Rib-X Pharmaceuticals, a company that develops antibacterial drugs that target the ribosome.	Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Brunelle JL, 2008, RNA, V14, P1526, DOI 10.1261/rna.1057908; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Ejby M, 2007, P NATL ACAD SCI USA, V104, P19410, DOI 10.1073/pnas.0706558104; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zoldak G, 2007, NUCLEIC ACIDS RES, V35, P1343, DOI 10.1093/nar/gkl696	30	232	282	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					953	956		10.1126/science.1164840	http://dx.doi.org/10.1126/science.1164840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988853	Green Accepted			2022-12-01	WOS:000260674100050
J	Chari, A; Golas, MM; Klingenhager, M; Neuenkirchen, N; Sander, B; Englbrecht, C; Sickmann, A; Stark, H; Fischer, U				Chari, Ashwin; Golas, Monika M.; Klingenhaeger, Michael; Neuenkirchen, Nils; Sander, Bjoern; Englbrecht, Clemens; Sickmann, Albert; Stark, Holger; Fischer, Utz			An Assembly Chaperone Collaborates with the SMN Complex to Generate Spliceosomal SnRNPs	CELL			English	Article							NUCLEAR RIBONUCLEOPROTEIN PARTICLE; ELECTRON-MICROSCOPY; CORE STRUCTURE; PROTEINS; RNA; BIOGENESIS; PATHWAY; PICLN; CLAMP; DNA	Spliceosomal small nuclear ribonucleoproteins (snRNPs) are essential components of the nuclear pre-mRNA processing machinery. A hallmark of these particles is a ring-shaped core domain generated by the binding of Sm proteins onto snRNA. PRMT5 and SMN complexes mediate the formation of the core domain in vivo. Here, we have elucidated the mechanism of this reaction by both biochemical and structural studies. We show that pICln, a component of the PRMT5 complex, induces the formation of an otherwise unstable higher-order Sm protein unit. In this state, the Sm proteins are kinetically trapped, preventing their association with snRNA. The SMN complex subsequently binds to these Sm protein units, dissociates pICln, and catalyzes ring closure on snRNA. Our data identify pICln as an assembly chaperone and the SMN complex as a catalyst of spliceosomal snRNP formation. The mode of action of this combined chaperone/catalyst system is reminiscent of the mechanism employed by DNA clamp loaders.	[Chari, Ashwin; Klingenhaeger, Michael; Neuenkirchen, Nils; Englbrecht, Clemens; Fischer, Utz] Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany; [Golas, Monika M.; Sander, Bjoern; Stark, Holger] Max Planck Inst Biophys Chem, Res Grp Electron Cryomicroscopy 3D, D-37070 Gottingen, Germany; [Sickmann, Albert] Rudolf Virchow Ctr Expt Med, D-97078 Wurzburg, Germany	University of Wurzburg; Max Planck Society	Fischer, U (corresponding author), Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany.	utz.fischer@biozentrum.uni-wuerzburg.de	Sander, Bjoern/AAO-9021-2021; Chari, Ashwin/ABC-5304-2020; Sickmann, Albert/A-1010-2011; Fischer, Utz/AAT-8422-2020; Fischer, Utz/A-4090-2016	Sander, Bjoern/0000-0001-8495-2321; Chari, Ashwin/0000-0001-6220-9828; Sickmann, Albert/0000-0002-2388-5265; Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591; Holger, Stark/0000-0002-6161-1118	DFG [SFB581, TP B18]; AFM [ID11730]; BMBF; European "3D Repertoire''	DFG(German Research Foundation (DFG)); AFM(Association Francaise contre les Myopathies); BMBF(Federal Ministry of Education & Research (BMBF)); European "3D Repertoire''	We thank T. Muller, P. Stayton, C. Kambach, J. Steitz, and I. Mattaj for reagents; J. Ohmer for technical assistance; and B. Laggerbauer, M. Kroiss, G. Matera, S. Jentsch, S. Rospert, F. U. Hartl, and R. Luhrmann for comments. This work was supported by grants of the DFG (SFB581, TP B18) and AFM (ID11730) to U. F. and grants of the BMBF and European "3D Repertoire'' to H.S.	Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Ellison V, 2001, CELL, V106, P655, DOI 10.1016/S0092-8674(01)00498-6; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; FISHER DE, 1985, CELL, V42, P751, DOI 10.1016/0092-8674(85)90271-5; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; KASTNER B, 1989, EMBO J, V8, P277, DOI 10.1002/j.1460-2075.1989.tb03374.x; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI [10.1016/j.jsb.2005.04.004, 10.1016/j.jsb,2005.04.004]; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	43	153	173	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					497	509		10.1016/j.cell.2008.09.020	http://dx.doi.org/10.1016/j.cell.2008.09.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984161	Bronze, Green Submitted			2022-12-01	WOS:000260536300020
J	Hedges, LM; Brownlie, JC; O'Neill, SL; Johnson, KN				Hedges, Lauren M.; Brownlie, Jeremy C.; O'Neill, Scott L.; Johnson, Karyn N.			Wolbachia and Virus Protection in Insects	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER		[Hedges, Lauren M.; Brownlie, Jeremy C.; O'Neill, Scott L.; Johnson, Karyn N.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	University of Queensland	Johnson, KN (corresponding author), Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	karynj@uq.edu.au	O'Neill, Scott L/B-3568-2009; Johnson, Karyn N/B-7980-2008; O'Neill, Scott/R-9560-2019	O'Neill, Scott L/0000-0002-4131-3615; Johnson, Karyn N/0000-0001-8647-8985; O'Neill, Scott/0000-0002-4131-3615; Brownlie, Jeremy/0000-0003-0161-2204	University of Queensland; Australian Research Council; Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative	University of Queensland(University of Queensland); Australian Research Council(Australian Research Council); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health Initiative	We thank M. Riegler for advice and E. McGraw and F. Pringle for critical reading of the manuscript. This work was supported by funding from The University of Queensland, Australian Research Council, and the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative.	Brun G., 1980, Genetics and Biology of Drosophila, V2d, P625; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Hoffmann AA, 1998, GENETICS, V148, P221; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; ONeill SL, 1997, INFLUENTIAL PASSENGE; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694	7	787	834	3	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					702	702		10.1126/science.1162418	http://dx.doi.org/10.1126/science.1162418			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974344				2022-12-01	WOS:000260605200037
J	Wang, ZP; Edwards, JG; Riley, N; Provance, DW; Karcher, R; Li, XD; Davison, IG; Ikebe, M; Mercer, JA; Kauer, JA; Ehlers, MD				Wang, Zhiping; Edwards, Jeffrey G.; Riley, Nathan; Provance, D. William, Jr.; Karcher, Ryan; Li, Xiang-dong; Davison, Ian G.; Ikebe, Mitsuo; Mercer, John A.; Kauer, Julie A.; Ehlers, Michael D.			Myosin Vb Mobilizes Recycling Endosomes and AMPA Receptors for Postsynaptic Plasticity	CELL			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SYNAPTIC TRANSMISSION; FAMILY INTERACTING PROTEIN-2; GLOBULAR TAIL DOMAIN; DENDRITIC SPINES; ENDOCYTIC ZONES; TRAFFICKING; VA; MEMBRANE; CALCIUM	Learning-related plasticity at excitatory synapses in the mammalian brain requires the trafficking of AMPA receptors and the growth of dendritic spines. However, the mechanisms that couple plasticity stimuli to the trafficking of postsynaptic cargo are poorly understood. Here we demonstrate that myosin Vb (MyoVb), a Ca2+-sensitive motor, conducts spine trafficking during long-term potentiation (LTP) of synaptic strength. Upon activation of NMDA receptors and corresponding Ca2+ influx, MyoVb associates with recycling endosomes (REs), triggering rapid spine recruitment of endosomes and local exocytosis in spines. Disruption of MyoVb or its interaction with the RE adaptor Rab11-FIP2 abolishes LTP-induced exocytosis from REs and prevents both AMPA receptor insertion and spine growth. Furthermore, induction of tight binding of MyoVb to actin using an acute chemical genetic strategy eradicates LTP in hippocampal slices. Thus, Ca2+-activated MyoVb captures and mobilizes REs for AMPA receptor insertion and spine growth, providing a mechanistic link between the induction and expression of postsynaptic plasticity.	[Wang, Zhiping; Davison, Ian G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wang, Zhiping; Davison, Ian G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Edwards, Jeffrey G.; Riley, Nathan; Kauer, Julie A.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Provance, D. William, Jr.; Karcher, Ryan; Mercer, John A.] McLaughlin Res Inst, Great Falls, MT 59405 USA; [Li, Xiang-dong; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA	Duke University; Duke University; Howard Hughes Medical Institute; Brown University; McLaughlin Research Institute for Biomedical Sciences, Inc.; University of Massachusetts System; University of Massachusetts Worcester	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Provance, David W/D-5294-2013	Provance, David W/0000-0002-9824-0672; Kauer, Julie/0000-0002-3362-1642; Mercer, John/0000-0003-0307-4438	NIH; American Heart Association; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402, R01NS047574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kavita Shah for supplying PE-ADP. We thank Rytis Prekeris for providing Rab11-FIP2 reagents. We thank Marguerita Klein, Irina Lebedeva, and Haiwei Zhang for excellent technical assistance. We thank Benjamin Arenkiel, Kathryn Condon, Ian Davison, Xing Guo, Cyril Hanus, Tom Helton, Juliet Hernandez, Hyun-Soo Je, Matthew Kennedy, Ming-Chia Lee, Jiuyi Lu, Angela Mabb, Thomas Newpher, Mikyoung Park, Ben Philpot, Sridhar Raghavachari, Tingting Wang, Ryohei Yasuda, and Jason Yi for critical discussions of the data and review of the manuscript. This work was supported by grants from the NIH (to M.D.E, J.A.K., J.A.M., and M. I.) and a grant from American Heart Association (to X.d.L.). M. D. E. is an Investigator of the Howard Hughes Medical Institute.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Provance DW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-44; Provance DW, 2004, P NATL ACAD SCI USA, V101, P1868, DOI 10.1073/pnas.0305895101; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	48	353	360	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					535	548		10.1016/j.cell.2008.09.057	http://dx.doi.org/10.1016/j.cell.2008.09.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984164	Green Accepted, Bronze			2022-12-01	WOS:000260536300023
J	Grimson, A; Srivastava, M; Fahey, B; Woodcroft, BJ; Chiang, HR; King, N; Degnan, BM; Rokhsar, DS; Bartel, DP				Grimson, Andrew; Srivastava, Mansi; Fahey, Bryony; Woodcroft, Ben J.; Chiang, H. Rosaria; King, Nicole; Degnan, Bernard M.; Rokhsar, Daniel S.; Bartel, David P.			Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals	NATURE			English	Article							EXPRESSION; GENOME; MECHANISM; EXPANSION; REVEALS; BIOGENESIS; COMPLEX; SIRNAS	In bilaterian animals, such as humans, flies and worms, hundreds of microRNAs ( miRNAs), some conserved throughout bilaterian evolution, collectively regulate a substantial fraction of the transcriptome. In addition to miRNAs, other bilaterian small RNAs, known as Piwi- interacting RNAs (piRNAs), protect the genome from transposons. Here we identify small RNAs from animal phyla that diverged before the emergence of the Bilateria. The cnidarian Nematostella vectensis ( starlet sea anemone), a close relative to the Bilateria, possesses an extensive repertoire of miRNA genes, two classes of piRNAs and a complement of proteins specific to small- RNA biology comparable to that of humans. The poriferan Amphimedon queenslandica ( sponge), one of the simplest animals and a distant relative of the Bilateria, also possesses miRNAs, both classes of piRNAs and a full complement of the small- RNA machinery. Animal miRNA evolution seems to have been relatively dynamic, with precursor sizes and mature miRNA sequences differing greatly between poriferans, cnidarians and bilaterians. Nonetheless, miRNAs and piRNAs have been available as classes of riboregulators to shape gene expression throughout the evolution and radiation of animal phyla.	[Grimson, Andrew; Chiang, H. Rosaria; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Grimson, Andrew; Chiang, H. Rosaria; Bartel, David P.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Fahey, Bryony; Woodcroft, Ben J.; Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Srivastava, Mansi; King, Nicole; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Srivastava, Mansi; King, Nicole; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Rokhsar, Daniel S.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Queensland; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Woodcroft, Ben/0000-0003-0670-7480; Rokhsar, Daniel/0000-0002-8704-2224; Degnan, Bernard/0000-0001-7573-8518	NIH postdoctoral fellowship; NIH; Center for Integrative Genomics; Gordon and Betty Moore Foundation; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrative Genomics; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Abedin and E. Begovic for preparing the Monosiga and Trichoplax samples, respectively, W. Johnston for technical assistance, and J. Grenier, C. Mayr, C. Jan and N. Lau for discussions. This work was supported by an NIH postdoctoral fellowship (A.G.), and by grants from the NIH (D.P.B.), Richard Melmon (M.S., N.K. and D.S.R.), the Center for Integrative Genomics (M.S. and D.S.R.), the Gordon and Betty Moore Foundation (N.K.) and the Australian Research Council (B.F., B.J.W. and B.M.D.). D.P.B. is an investigator of the Howard Hughes Medical Institute.	Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chen K, 2006, COLD SPRING HARB SYM, V71, P149, DOI 10.1101/sqb.2006.71.039; ENGLAND TE, 1977, P NATL ACAD SCI USA, V74, P4839, DOI 10.1073/pnas.74.11.4839; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; KEMPER B, 1976, NATURE, V262, P321, DOI 10.1038/262321a0; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	35	483	560	4	81	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1193	U15		10.1038/nature07415	http://dx.doi.org/10.1038/nature07415			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18830242	Green Accepted			2022-12-01	WOS:000260462100034
J	McCauley, E; Nelson, WA; Nisbet, RM				McCauley, Edward; Nelson, William A.; Nisbet, Roger M.			Small-amplitude cycles emerge from stage-structured interactions in Daphnia-algal systems	NATURE			English	Article							PREY; POPULATION; DYNAMICS; MODEL; ENVIRONMENTS; ZOOPLANKTON; MECHANISMS; PLANKTON	A long-standing issue in ecology is reconciling the apparent stability of many populations with robust predictions of large-amplitude population cycles from general theory on consumer resource interactions(1). Even when consumers are decoupled from dynamic resources, large- amplitude cycles can theoretically emerge from delayed feedback processes found in many consumers(2,3). Here we show that resource- dependent mortality and a dynamic developmental delay in consumers produces a new type of small- amplitude cycle that coexists with large- amplitude fluctuations in coupled consumer - resource systems. A distinctive characteristic of the small- amplitude cycles is slow juvenile development for consumers, leading to a developmental delay that is longer than the cycle period. By contrast, the period exceeds the delay in large-amplitude cycles. These theoretical predictions may explain previous empirical results on coexisting attractors found in Daphnia algal systems(4,5). To test this, we used bioassay experiments that measure the growth rates of individuals in populations exhibiting each type of cycle. The results were consistent with predictions. Together, the new theory and experiments establish that two very general features of consumers - a resource- dependent juvenile stage duration and resource- dependent mortality - combine to produce small- amplitude resource - consumer cycles. This phenomenon may contribute to the prevalence of small- amplitude fluctuations in many other consumer - resource populations(6,7).	[McCauley, Edward] Univ Calgary, Dept Biol Sci, Ecol & Evolut Grp, Calgary, AB T2N 1N4, Canada; [Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of Calgary; Queens University - Canada; University of California System; University of California Santa Barbara	McCauley, E (corresponding author), Univ Calgary, Dept Biol Sci, Ecol & Evolut Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	mccauley@ucalgary.ca	Nelson, William A/D-1405-2013; Nisbet, Roger M/B-6951-2014		NSERC ( Discovery Grants and Accelerator Award); Canada Foundation for Innovation; Canada Research Chairs Program; Alberta Ingenuity; US National Science Foundation [DEB- 0717259]	NSERC ( Discovery Grants and Accelerator Award)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); Alberta Ingenuity; US National Science Foundation(National Science Foundation (NSF))	We acknowledge feedback from A. de Roos, J. Fox, J. Casas, L. Persson and C. Briggs. A. Potapov provided advice on the bifurcation analysis. Experiments and theoretical analysis were supported by NSERC (Discovery Grants and Accelerator Award), Canada Foundation for Innovation, and the Canada Research Chairs Program to E. M. W. A. N. acknowledges support from Alberta Ingenuity. R. M. N. acknowledges support from the US National Science Foundation (Grant DEB- 0717259).	Abrams PA, 2002, THEOR POPUL BIOL, V62, P281, DOI 10.1006/tpbi.2002.1614; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Claessen D, 2004, P ROY SOC B-BIOL SCI, V271, P333, DOI 10.1098/rspb.2003.2555; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; DEROOS AM, 1990, J MATH BIOL, V28, P609, DOI 10.1007/BF00160229; GROVER JP, 1994, AM NAT, V143, P258, DOI 10.1086/285603; HASTINGS A, 1982, THEOR POPUL BIOL, V21, P44, DOI 10.1016/0040-5809(82)90005-3; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; KRETZSCHMAR M, 1993, THEOR POPUL BIOL, V44, P32, DOI 10.1006/tpbi.1993.1017; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCCAULEY E, 1987, AM NAT, V129, P97, DOI 10.1086/284624; McCauley E, 1996, ECOL MONOGR, V66, P479, DOI 10.2307/2963491; MCCAULEY E, 1990, NATURE, V343, P455, DOI 10.1038/343455a0; Medvinsky AB, 2004, CR BIOL, V327, P277, DOI 10.1016/j.crvi.2003.11.013; Murdoch W. W., 2003, CONSUMER RESOURCE DY; MURDOCH WW, 1985, NATURE, V316, P628, DOI 10.1038/316628a0; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; Nelson WA, 2007, EVOL ECOL, V21, P499, DOI 10.1007/s10682-006-9131-y; Nisbet RM, 2004, ECOLOGY, V85, P3132, DOI 10.1890/03-0429; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	24	59	61	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1240	1243		10.1038/nature07220	http://dx.doi.org/10.1038/nature07220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972019				2022-12-01	WOS:000260462100044
J	Lin, GA; Dudley, RA; Lucas, FL; Malenka, DJ; Vittinghoff, E; Redberg, RF				Lin, Grace A.; Dudley, R. Adams; Lucas, F. L.; Malenka, David J.; Vittinghoff, Eric; Redberg, Rita F.			Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CONTROLLED CLINICAL-TRIAL; 3 THERAPEUTIC STRATEGIES; OPTIMAL MEDICAL THERAPY; ARTERY-DISEASE; UNITED-STATES; MASS-II; ANGINA-PECTORIS; HEART-DISEASE; RITA-2 TRIAL	Context Guidelines call for documenting ischemia in patients with stable coronary artery disease prior to elective percutaneous coronary intervention ( PCI). Objective To determine the frequency and predictors of stress testing prior to elective PCI in a Medicare population. Design, Setting, and Patients Retrospective, observational cohort study using claims data from a 20% random sample of 2004 Medicare fee- for- service beneficiaries aged 65 years or older who had an elective PCI ( N= 23 887). Main Outcome Measures Percentage of patients who underwent stress testing within 90 days prior to elective PCI; variation in stress testing prior to PCI across 306 hospital referral regions; patient, physician, and hospital characteristics that predicted the appropriate use of stress testing prior to elective PCI. Results In the United States, 44.5% ( n= 10 629) of patients underwent stress testing within the 90 days prior to elective PCI. There was wide regional variation among the hospital referral regions with stress test rates ranging from 22.1% to 70.6% ( national mean, 44.5%; interquartile range, 39.0%- 50.9%). Female sex ( adjusted odds ratio [ AOR], 0.91; 95% confidence interval [ CI], 0.86- 0.97), age of 85 years or older ( AOR, 0.83; 95% CI, 0.72- 0.95), a history of congestive heart failure ( AOR, 0.85; 95% CI, 0.79- 0.92), and prior cardiac catheterization ( AOR, 0.45; 95% CI, 0.38- 0.54) were associated with a decreased likelihood of prior stress testing. A history of chest pain ( AOR, 1.28; 95% CI, 1.09- 1.54) and black race ( AOR, 1.26; 95% CI, 1.09- 1.46) increased the likelihood of stress testing prior to PCI. Patients treated by physicians performing 150 or more PCIs per year were less likely to have stress testing prior to PCI ( AOR, 0.84; 95% CI, 0.77- 0.93). No hospital characteristics were associated with receipt of stress testing. Conclusion The majority of Medicare patients with stable coronary artery disease do not have documentation of ischemia by noninvasive testing prior to elective PCI.	[Redberg, Rita F.] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA; [Lin, Grace A.] Univ Calif San Francisco, Sch Med, Div Gen Internal Med, San Francisco, CA 94143 USA; [Vittinghoff, Eric] Univ Calif San Francisco, Sch Med, Div Epidemiol & Biostat, San Francisco, CA 94143 USA; [Dudley, R. Adams] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Lucas, F. L.] Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, OR USA; [Malenka, David J.] Dartmouth Hitchcock Med Ctr, Div Cardiol, Lebanon, NH 03766 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Dartmouth College	Redberg, RF (corresponding author), Univ Calif San Francisco, Sch Med, Div Cardiol, 505 Parnassus Ave,Ste M-1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu			Blue Shield of California Foundation; Robert Wood Johnson Foundation	Blue Shield of California Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was funded by the Blue Shield of California Foundation. A portion of Dr Dudley's work was supported by an Investigator Award in Health Policy from the Robert Wood Johnson Foundation.	Anderson HV, 2005, CIRCULATION, V112, P2786, DOI 10.1161/CIRCULATIONAHA.105.553727; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campione Joanne R, 2005, Am J Geriatr Pharmacother, V3, P229, DOI 10.1016/j.amjopharm.2005.12.001; Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Folland ED, 1997, J AM COLL CARDIOL, V29, P1505, DOI 10.1016/S0735-1097(97)00097-1; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hannan EL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-35; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Lee CH, 2008, ARCH INTERN MED, V168, P291, DOI 10.1001/archinternmed.2007.78; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; Lucas F L, 1999, Eff Clin Pract, V2, P71; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Lucas FL, 2007, AM HEART J, V154, P502, DOI 10.1016/j.ahj.2007.04.044; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3; Poses RM, 2002, CHEST, V122, P122, DOI 10.1378/chest.122.1.122; Rogers AM, 2007, AM HEART J, V154, P461, DOI 10.1016/j.ahj.2007.05.003; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Shaw LJ, 2008, J NUCL CARDIOL, V15, P762, DOI [10.1016/j.nuclcard.2008.07.005, 10.1007/BF03007357]; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 1999, J AM COLL CARDIOL, V33, P661, DOI 10.1016/S0735-1097(98)00606-8; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; STRAUSS WE, 1995, CIRCULATION, V92, P1710, DOI 10.1161/01.CIR.92.7.1710; TOBIN JN, 1987, ANN INTERN MED, V107, P19, DOI 10.7326/0003-4819-107-1-19; TOPOL EJ, 1993, CIRCULATION, V87, P1489, DOI 10.1161/01.CIR.87.5.1489; Wennberg D, 1997, J Health Serv Res Policy, V2, P75; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; Wennberg DE, 1997, J GEN INTERN MED, V12, P172; Wennberg JE, 1996, DARTMOUTH ATLAS HLTH; Zellweger MJ, 2003, J AM COLL CARDIOL, V42, P33, DOI 10.1016/S0735-1097(03)00557-6	50	185	188	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1765	1773		10.1001/jama.300.15.1765	http://dx.doi.org/10.1001/jama.300.15.1765			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854538	Bronze			2022-12-01	WOS:000260002000028
J	Ludwig, DS; Nestle, M				Ludwig, David S.; Nestle, Marion			Can the food industry play a constructive role in the obesity epidemic?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSULIN		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Nestle, Marion] NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY USA	Harvard University; Boston Children's Hospital; New York University	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544				*AM DIET ASS, AM DIET ASS WELC COC; *COC COL CO, CORP RESP ACT LIF; HABER GB, 1977, LANCET, V2, P679; *KRAFT, HLTH WELLN; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lewin A, 2006, J PUBLIC HEALTH POL, V27, P327, DOI 10.1057/palgrave.jphp.3200098; *MCD CORP, BAL ACT LIF 2006 WOR; *PEPSICO, PEPSICO JOINS AM YMC; *PEPSICO, HLTH WELLN PEPSICOS; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; SARGENT G, AM PROSPECT BERMANS; Simon M., 2006, LOYOLA LOS ANGELES L, V39, P169; WOOTAN MG, STUDY SHOWS PROGR GE	13	151	152	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1808	1811		10.1001/jama.300.15.1808	http://dx.doi.org/10.1001/jama.300.15.1808			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854543				2022-12-01	WOS:000260002000033
J	Qu, LT; Dai, LM; Stone, M; Xia, ZH; Wang, ZL				Qu, Liangti; Dai, Liming; Stone, Morley; Xia, Zhenhai; Wang, Zhong Lin			Carbon nanotube arrays with strong shear binding-on and easy normal lifting-off	SCIENCE			English	Article							GECKO FOOT-HAIR; DRY ADHESIVES; MECHANICS; FRICTION; BIOLOGY; GROWTH; FORCE	The ability of gecko lizards to adhere to a vertical solid surface comes from their remarkable feet with aligned microscopic elastic hairs. By using carbon nanotube arrays that are dominated by a straight body segment but with curly entangled top, we have created gecko-foot-mimetic dry adhesives that show macroscopic adhesive forces of similar to 100 newtons per square centimeter, almost 10 times that of a gecko foot, and a much stronger shear adhesion force than the normal adhesion force, to ensure strong binding along the shear direction and easy lifting in the normal direction. This anisotropic force distribution is due to the shear-induced alignments of the curly segments of the nanotubes. The mimetic adhesives can be alternatively binding-on and lifting-off over various substrates for simulating the walking of a living gecko.	[Qu, Liangti; Dai, Liming] Univ Dayton, Dept Chem & Mat Engn, Sch Engn, Dayton, OH 45469 USA; [Stone, Morley] USAF, Res Lab, Human Effectiveness Directorate, AFRL RH, Wright Patterson AFB, OH 45433 USA; [Xia, Zhenhai] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Wang, Zhong Lin] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University of Dayton; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; University System of Ohio; University of Akron; University System of Georgia; Georgia Institute of Technology	Dai, LM (corresponding author), Univ Dayton, Dept Chem & Mat Engn, Sch Engn, 300 Coll Pk, Dayton, OH 45469 USA.	ldai@udayton.edu; zlwang@gatech.edu	Dai, Liming/AAV-4376-2020; wang, jie/GRS-0942-2022; Wang, Zhong Lin/E-2176-2011	Dai, Liming/0000-0001-7536-160X; Wang, Zhong Lin/0000-0002-5530-0380; Xia, Zhenhai/0000-0002-0881-2906	AFRL/Air Force Office of Scientific Research; NSF [CMS-0609077]	AFRL/Air Force Office of Scientific Research(United States Department of DefenseUS Air Force Research LaboratoryAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF))	L.D., Z.L.W., and M.S. thank AFRL/Air Force Office of Scientific Research for financial support. L.D. also thanks T. Yamada, S. Sangwook, A. Roy, J. Baur, and T. Benson-Tolle for useful discussions as well as financial support from NSF (grant CMS-0609077).	Akita S, 2002, JPN J APPL PHYS 1, V41, P4242, DOI 10.1143/JJAP.41.4242; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Dickrell PL, 2005, TRIBOL LETT, V18, P59, DOI 10.1007/s11249-004-1752-0; Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008; Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101; Ge L, 2007, P NATL ACAD SCI USA, V104, P10792, DOI 10.1073/pnas.0703505104; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Huang SM, 2002, J PHYS CHEM B, V106, P3543, DOI 10.1021/jp014047y; Huang SM, 1999, J PHYS CHEM B, V103, P4223, DOI 10.1021/jp990342v; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1006/bijl.1996.0052; Jin MHC, 2006, CARBON NANOTECHNOLOGY: RECENT DEVELOPMENTS IN CHEMISTRY, PHYSICS, MATERIALS SCIENCE AND DEVICE APPLICATIONS, P611, DOI 10.1016/B978-044451855-2/50020-6; Kinoshita H, 2004, APPL PHYS LETT, V85, P2780, DOI 10.1063/1.1804254; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lee J, 2008, J R SOC INTERFACE, V5, P835, DOI 10.1098/rsif.2007.1308; Lu XK, 1999, APPL PHYS LETT, V75, P193, DOI 10.1063/1.124316; Majidi CS, 2005, J APPL PHYS, V98, DOI 10.1063/1.2128697; Qu L, 2007, ADV MATER, V19, P3844, DOI 10.1002/adma.200700023; Qu L, 2007, J MATER CHEM, V17, P3401, DOI 10.1039/b703046k; Sitti M, 2003, J ADHES SCI TECHNOL, V17, P1055, DOI 10.1163/156856103322113788; Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103; Yao H, 2006, J MECH PHYS SOLIDS, V54, P1120, DOI 10.1016/j.jmps.2006.01.002; Yu MF, 2001, PHYS REV LETT, V86, P87, DOI 10.1103/PhysRevLett.86.87; Yurdumakan B, 2005, CHEM COMMUN, P3799, DOI 10.1039/b506047h; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528; Zhao Y, 2006, J VAC SCI TECHNOL B, V24, P331, DOI 10.1116/1.2163891	27	579	644	18	601	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					238	242		10.1126/science.1159503	http://dx.doi.org/10.1126/science.1159503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845750				2022-12-01	WOS:000259902300042
J	Qi, H; Cannons, JL; Klauschen, F; Schwartzberg, PL; Germain, RN				Qi, Hai; Cannons, Jennifer L.; Klauschen, Frederick; Schwartzberg, Pamela L.; Germain, Ronald N.			SAP-controlled T-B cell interactions underlie germinal centre formation	NATURE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; HUMORAL IMMUNITY; DENDRITIC CELLS; IN-VIVO; LYMPH-NODES; CYTOKINE REGULATION; ANTIBODY-RESPONSES; GENE-PRODUCT; ACTIVATION; INFECTION	Generation of long- term antibody- mediated immunity depends on the germinal centre reaction, which requires cooperation between antigen- specific T and B lymphocytes. In human X- linked lymphoproliferative disease and its gene- targeted mouse model, loss- of- function mutations in signalling lymphocyte activation molecule- associated protein ( SAP, encoded by SH2D1a) cause a profound defect in germinal centre formation by an as yet unknown mechanism. Here, using two- photon intravital imaging, we show that SAP deficiency selectively impairs the ability of CD4(+) T cells to stably interact with cognate B cells but not antigen- presenting dendritic cells. This selective defect results in a failure of antigen- specific B cells to receive adequate levels of contact- dependent T- cell help to expand normally, despite Sap(-/-) T cells exhibiting the known characteristics of otherwise competent helper T cells. Furthermore, the lack of stable interactions with B cells renders Sap(-/-) T cells unable to be efficiently recruited to and retained in a nascent germinal centre to sustain the germinal centre reaction. These results offer an explanation for the germinal centre defect due to SAP deficiency and provide new insights into the bi- directional communication between cognate T and B cells in vivo.	[Qi, Hai; Klauschen, Frederick; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Cannons, Jennifer L.; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pams@nhgri.nih.gov; rgermain@niaid.nih.gov	Germain, Ronald N./Z-1945-2019; Qi, Hai/A-3955-2009; Klauschen, Frederick/C-5637-2015; Germain, Ronald/ABE-7090-2020	Qi, Hai/0000-0001-5475-3989	National Institute of Allergy and Infectious Disease; National Human Genome Research Institute; National Institutes of Health, USA.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health, USA.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	H. Q. is in debt to Y. Hong for support, encouragement and inspiration. This work was funded by the intramural research programs of the National Institute of Allergy and Infectious Disease and National Human Genome Research Institute, National Institutes of Health, USA.	ABBAS AK, 1985, J IMMUNOL, V135, P1661; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Andoh A, 2000, IMMUNOL LETT, V73, P35, DOI 10.1016/S0165-2478(00)00202-9; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; COICO RF, 1983, J IMMUNOL, V131, P2254; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GRIERSON HL, 1991, AM J MED GENET, V40, P294, DOI 10.1002/ajmg.1320400309; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KELSOE G, 1993, CURR OPIN IMMUNOL, V5, P418, DOI 10.1016/0952-7915(93)90062-W; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; MacLennan ICM, 1997, IMMUNOL REV, V156, P53, DOI 10.1111/j.1600-065X.1997.tb00958.x; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; Morra M, 2005, P NATL ACAD SCI USA, V102, P4819, DOI 10.1073/pnas.0408681102; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; PURTILO D T, 1975, Lancet, V1, P935; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Raff M C, 1970, Nature, V226, P1257, DOI 10.1038/2261257a0; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	44	467	488	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					764	U2		10.1038/nature07345	http://dx.doi.org/10.1038/nature07345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843362	Green Accepted			2022-12-01	WOS:000259854900039
J	Lee, TA; Pickard, AS; Au, DH; Bartle, B; Weiss, KB				Lee, Todd A.; Pickard, A. Simon; Au, David H.; Bartle, Brian; Weiss, Kevin B.			Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Article							INHALED CORTICOSTEROIDS; BIASED SELECTION; MORTALITY; COPD; HEALTH; HOSPITALIZATIONS; EXACERBATIONS; METAANALYSIS; FLUTICASONE; IPRATROPIUM	Background: Concerns exist regarding increased risk for mortality associated with some chronic obstructive pulmonary disease (COPD) medications. Objective: To examine the association between various respiratory medications and risk for death in veterans with newly diagnosed COPD. Design: Nested case - control study in a cohort identified between 1 October 1999 and 30 September 2003 and followed through 30 September 2004 by using National Veterans Affairs inpatient, outpatient, pharmacy, and mortality databases; Centers for Medicare & Medicaid Services databases; and National Death Index Plus data. Cause of death was ascertained for a random sample of 40% of those who died during follow-up. Case patients were categorized on the basis of all-cause, respiratory, or cardiovascular death. Mortality risk associated with medications was assessed by using conditional logistic regression adjusted for comorbid conditions, health care use, and markers of COPD severity. Setting: U. S. Veterans Health Administration health care system. Participants: 32 130 case patients and 320 501 control participants in the all-cause mortality analysis. Of 11 897 patients with cause-of-death data, 2405 case patients had respiratory deaths and 3159 case patients had cardiovascular deaths. Measurements: All-cause mortality; respiratory and cardiovascular deaths; and exposure to COPD medications, inhaled corticosteroids, ipratropium, long-acting beta-agonists, and theophylline in the 6 months preceding death. Results: Adjusted odds ratios (ORs) for all-cause mortality were 0.80 (95% CI, 0.78 to 0.83) for inhaled corticosteroids, 1.11 ( CI, 1.08 to 1.15) for ipratropium, 0.92 (CI, 0.88 to 0.96) for long-acting beta-agonists, and 1.05 (CI, 0.99 to 1.10) for theophylline. Ipratropium was associated with increased cardiovascular deaths (OR, 1.34 [CI, 1.22 to 1.47]), whereas inhaled corticosteroids were associated with reduced risk for cardiovascular death ( OR, 0.80 [ CI, 0.72 to 0.88]). Results were consistent across sensitivity analyses. Limitations: Current smoking status and lung function were not measured. Misclassification of cause-specific mortality is unknown. Conclusion: The possible association between ipratropium and elevated risk for all-cause and cardiovascular death needs further study.	[Lee, Todd A.] Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; NW Univ Feinberg, Sch Med, Chicago, IL USA; Univ Illinois, Chicago, IL USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA; Amer Board Med Specialties, Evanston, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Lee, TA (corresponding author), Vet Affairs Edward Hines Jr Hosp, 5000 S 5th Ave,151-H, Hines, IL 60141 USA.	todd.lee@va.gov		Pickard, A. Simon/0000-0001-5645-7091; Lee, Todd/0000-0003-3619-5367	the U. S. Department of Veterans Affairs Health Services Research and Development [IIR 03-307]	the U. S. Department of Veterans Affairs Health Services Research and Development(US Department of Veterans Affairs)	By the U. S. Department of Veterans Affairs Health Services Research and Development (IIR 03-307).	[Anonymous], 2000, PHARMACOEPIDEM DR S; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; *CTR DRUG EV RES, 2008, EARL COMM ONG SAF RE; de Luise C, 2007, EUR J EPIDEMIOL, V22, P267, DOI 10.1007/s10654-007-9106-5; Decramer Marc, 2004, COPD, V1, P303, DOI 10.1081/COPD-200026934; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; Doody MM, 2001, ANN EPIDEMIOL, V11, P46, DOI 10.1016/S1047-2797(00)00177-0; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Gartlehner G, 2006, ANN FAM MED, V4, P253, DOI 10.1370/afm.517; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Gudmundsson G, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-109; HOSMER DW, 1989, APPL LOGISTIC REGRES, P187; Jensen HH, 2006, EUR RESPIR J, V28, P781, DOI 10.1183/09031936.06.00152205; JOO MJ, 2008, PATTERNS HEALTHCARE; Lee TA, 2007, ANN EPIDEMIOL, V17, P380, DOI 10.1016/j.annepidem.2007.01.033; Lee TA, 2006, CHEST, V129, P1509, DOI 10.1378/chest.129.6.1509; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Ringbaek T, 2003, RESP MED, V97, P264, DOI 10.1053/rmed.2003.1423; ROBINS JM, 1986, BIOMETRICS, V42, P293, DOI 10.2307/2531050; Salpeter SR, 2006, CLIN REV ALLERG IMMU, V31, P219, DOI 10.1385/CRIAI:31:2:219; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Sin DD, 2004, AM J RESP CRIT CARE, V170, P760, DOI 10.1164/rccm.200404-543OC; Sin DD, 2000, THORAX, V55, P194, DOI 10.1136/thorax.55.3.194; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Sullivan SD, 2000, CHEST, V117, P5; Travers J, 2007, RESP MED, V101, P1313, DOI 10.1016/j.rmed.2006.10.011; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC	38	145	152	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					380	W73		10.7326/0003-4819-149-6-200809160-00004	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794557				2022-12-01	WOS:000259230200002
J	Ewald, SE; Lee, BL; Lau, L; Wickliffe, KE; Shi, GP; Chapman, HA; Barton, GM				Ewald, Sarah E.; Lee, Bettina L.; Lau, Laura; Wickliffe, Katherine E.; Shi, Guo-Ping; Chapman, Harold A.; Barton, Gregory M.			The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor	NATURE			English	Article							ANTIGEN PRESENTATION; STRANDED-RNA; CPG-DNA; TLR9; ER; TOLL-LIKE-RECEPTOR-9; RECOGNITION; CATHEPSINS; RESPONSES; MEMBRANE	Mammalian Toll-like receptors (TLRs) 3, 7, 8 and 9 initiate immune responses to infection by recognizing microbial nucleic acids(1,2); however, these responses come at the cost of potential autoimmunity owing to inappropriate recognition of self nucleic acids(3). The localization of TLR9 and TLR7 to intracellular compartments seems to have a role in facilitating responses to viral nucleic acids while maintaining tolerance to self nucleic acids, yet the cell biology regulating the transport and localization of these receptors remains poorly understood(4-6). Here we define the route by which TLR9 and TLR7 exit the endoplasmic reticulum and travel to endolysosomes in mouse macrophages and dendritic cells. The ectodomains of TLR9 and TLR7 are cleaved in the endolysosome, such that no full- length protein is detectable in the compartment where ligand is recognized. Notably, although both the full- length and cleaved forms of TLR9 are capable of binding ligand, only the processed form recruits MyD88 on activation, indicating that this truncated receptor, rather than the full- length form, is functional. Furthermore, conditions that prevent receptor proteolysis, including forced TLR9 surface localization, render the receptor non- functional. We propose that ectodomain cleavage represents a strategy to restrict receptor activation to endolysosomal compartments and prevent TLRs from responding to self nucleic acids.	[Ewald, Sarah E.; Lee, Bettina L.; Lau, Laura; Wickliffe, Katherine E.; Barton, Gregory M.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Shi, Guo-Ping] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Chapman, Harold A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chapman, Harold A.] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barton, GM (corresponding author), Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, 405 Life Sci Addit, Berkeley, CA 94720 USA.	barton@berkeley.edu	Ewald, Sarah/AAM-8918-2020	Ewald, Sarah/0000-0002-5327-7578; Barton, Gregory/0000-0002-3793-0100	Novel Research Grant; The Lupus Research Institute; Hellman Faculty Fund; NIH [HL67204, CA009179, AI072429]; NATIONAL CANCER INSTITUTE [T32CA009179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL067204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072429] Funding Source: NIH RePORTER	Novel Research Grant; The Lupus Research Institute; Hellman Faculty Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Barton and Vance laboratories for discussions, S. Akira for providing TLR knockout mice, and R. Vance and R. Medzhitov for advice. We acknowledge the CHPS Imaging Core and P. Herzmark for assistance with microscopy. This work was supported by a Novel Research Grant from The Lupus Research Institute (G.M.B.), the Hellman Faculty Fund (G.M.B.), and NIH grants HL67204 (H.A.C.), CA009179 (S.E.E.) and AI072429 (G.M.B.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Clair JMS, 2006, BIOL CHEM, V387, P1143, DOI 10.1515/BC.2006.141; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297	23	455	466	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					658	U88		10.1038/nature07405	http://dx.doi.org/10.1038/nature07405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18820679	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000261340000045
J	Winter, J; Ilbert, M; Graf, PCF; Ozcelik, D; Jakob, U				Winter, J.; Ilbert, M.; Graf, P. C. F.; Oezcelik, D.; Jakob, U.			Bleach Activates a Redox-Regulated Chaperone by Oxidative Protein Unfolding	CELL			English	Article							HYPOCHLOROUS ACID; HEAT-SHOCK; METHIONINE SULFOXIDE; SWITCH DOMAIN; CROSS-LINKING; STRESS; DNAK; HSP33; MYELOPEROXIDASE; INACTIVATION	Hypochlorous acid (HOCl), the active ingredient in household bleach, is an effective antimicrobial produced by the mammalian host defense to kill invading microorganisms. Despite the widespread use of HOCl, surprisingly little is known about its mode of action. In this study, we demonstrate that low molar ratios of HOCl to protein cause oxidative protein unfolding in vitro and target thermolabile proteins for irreversible aggregation in vivo. As a defense mechanism, bacteria use the redox-regulated chaperone Hsp33, which responds to bleach treatment with the reversible oxidative unfolding of its C-terminal redox switch domain. HOCl-mediated unfolding turns inactive Hsp33 into a highly active chaperone holdase, which protects essential Escherichia coli proteins against HOCl-induced aggregation and increases bacterial HOCl resistance. Our results substantially improve our molecular understanding about HOCl's functional mechanism. They suggest that the antimicrobial effects of bleach are largely based on HOCl's ability to cause aggregation of essential bacterial proteins.	[Winter, J.; Ilbert, M.; Graf, P. C. F.; Oezcelik, D.; Jakob, U.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Graf, P. C. F.; Jakob, U.] Univ Michigan, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Ilbert, marianne/ABG-5015-2021; Özcelik, Dennis/M-9961-2019	Özcelik, Dennis/0000-0002-7185-4690; Graf, Paul/0000-0002-1094-7498; ilbert, marianne/0000-0002-9070-2334	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065318, R01 GM065318-06A1, R01 GM065318] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; Aliev G, 2002, BRAIN PATHOL, V12, P21; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Britigan BE, 1996, BBA-GEN SUBJECTS, V1290, P231, DOI 10.1016/0304-4165(96)00014-1; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Dukan S, 1996, APPL ENVIRON MICROB, V62, P4003, DOI 10.1128/AEM.62.11.4003-4008.1996; Fu XY, 2004, J BIOL CHEM, V279, P6209, DOI 10.1074/jbc.C300506200; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Grimshaw JPA, 2003, J BIOL CHEM, V278, P19048, DOI 10.1074/jbc.M300924200; Hawkins CL, 2005, CHEM RES TOXICOL, V18, P1600, DOI 10.1021/tx050207b; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jayaraman S, 2008, BIOCHEMISTRY-US, V47, P3875, DOI 10.1021/bi7023783; Khor HK, 2004, J BIOL CHEM, V279, P19486, DOI 10.1074/jbc.M310045200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Lide D.R., 1994, CRC HDB CHEM PHYS; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; WEISS SJ, 1985, SCIENCE, V227, P747, DOI 10.1126/science.2982211; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004	34	267	274	4	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					691	701		10.1016/j.cell.2008.09.024	http://dx.doi.org/10.1016/j.cell.2008.09.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013278	Green Accepted, Bronze			2022-12-01	WOS:000260886900019
J	Zehr, JP; Bench, SR; Carter, BJ; Hewson, I; Niazi, F; Shi, T; Tripp, HJ; Affourtit, JP				Zehr, Jonathan P.; Bench, Shellie R.; Carter, Brandon J.; Hewson, Ian; Niazi, Faheem; Shi, Tuo; Tripp, H. James; Affourtit, Jason P.			Globally Distributed Uncultivated Oceanic N-2-Fixing Cyanobacteria Lack Oxygenic Photosystem II	SCIENCE			English	Article							NITROGEN-FIXATION; UNICELLULAR CYANOBACTERIA; RHOPALODIA-GIBBA; N-2; DIAZOTROPHS; EXPRESSION; EVOLUTION; PATTERNS		[Zehr, Jonathan P.; Bench, Shellie R.; Carter, Brandon J.; Hewson, Ian; Shi, Tuo; Tripp, H. James] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Niazi, Faheem; Affourtit, Jason P.] Life Sci 454, Branford, CT 06405 USA	University of California System; University of California Santa Cruz	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, 1156 High St, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	shi, tuo/E-6948-2017; Hewson, Ian/B-4871-2013; Shi, Tuo/T-7926-2017; Zehr, Jonathan P/B-3513-2014; Bench, Shellie R/E-7679-2010	shi, tuo/0000-0003-3362-8163; Shi, Tuo/0000-0003-3362-8163; Zehr, Jonathan P/0000-0002-5691-5408; 	Gordon and Betty Moore Foundation; Microbial Environmental Genomics; Modeling, Experimentation and Remote Sensing (MEGAMER) facility; NSF [OCE0425363]; NSF Center for Microbial Oceanography Research and Education [CCF424599]; 454 Life Sciences; Roche Company	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Microbial Environmental Genomics; Modeling, Experimentation and Remote Sensing (MEGAMER) facility; NSF(National Science Foundation (NSF)); NSF Center for Microbial Oceanography Research and Education(National Science Foundation (NSF)); 454 Life Sciences; Roche Company	We thank J. Montoya, D. Karl, M.J. Church, J.K. Doggett, the Hawaii Ocean Time- series crew, and the captain and crew of the R/V Kilo Moana for facilitating sample collection and analysis. We also thank E. Mondragon, P. Moisander, M. Hogan, K. Pennebaker, R. Beinart, and the Zehr laboratory for technical support. This work was partially supported by the Gordon and Betty Moore Foundation [J.P.Z. and the Microbial Environmental Genomics: Modeling, Experimentation and Remote Sensing (MEGAMER) facility], NSF (OCE0425363) (J.P.Z.), and the NSF Center for Microbial Oceanography Research and Education (CCF424599) (J.P.Z.). Support for sequencing was provided by 454 Life Sciences, a Roche Company. The GenBank accession numbers of the sequences generated from PCR in this study are EU187504 to EU187629 and FJ189800 to FJ190047. For a complete list of GenBank accessions, please see the supporting online material (21).	Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; COHEN Y, 1986, APPL ENVIRON MICROB, V51, P398, DOI 10.1128/AEM.51.2.398-407.1986; Falcon LI, 2002, APPL ENVIRON MICROB, V68, P5760, DOI 10.1128/AEM.68.11.5760-5764.2002; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hansell DA, 2004, MAR CHEM, V84, P243, DOI 10.1016/j.marchem.2003.08.004; Kneip C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-30; Krieg NR, 1989, BERGEYS MANUAL SYSTE, V3, P1728; LaRoche J, 2005, J SEA RES, V53, P67, DOI 10.1016/j.seares.2004.05.005; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Misra HS, 2003, J PLANT PHYSIOL, V160, P33, DOI 10.1078/0176-1617-00846; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Prechtl J, 2004, MOL BIOL EVOL, V21, P1477, DOI 10.1093/molbev/msh086; Shi T, 2005, MOL BIOL EVOL, V22, P2179, DOI 10.1093/molbev/msi216; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; VENRICK EL, 1974, LIMNOL OCEANOGR, V19, P437, DOI 10.4319/lo.1974.19.3.0437; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	25	244	256	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1110	1112		10.1126/science.1165340	http://dx.doi.org/10.1126/science.1165340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008448				2022-12-01	WOS:000260867700040
J	Hirota, K; Miyoshi, T; Kugou, K; Hoffman, CS; Shibata, T; Ohta, K				Hirota, Kouji; Miyoshi, Tomoichiro; Kugou, Kazuto; Hoffman, Charles S.; Shibata, Takehiko; Ohta, Kunihiro			Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs	NATURE			English	Article							BETA-GLOBIN LOCUS; PROTEIN-KINASE-A; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; INTERGENIC TRANSCRIPTION; RECOMBINATION HOTSPOT; GENE; ACTIVATION; RESOLUTION; ADE6-M26	Recent transcriptome analyses using high- density tiling arrays(1-3) and data from large- scale analyses of full- length complementary DNA libraries by the FANTOM3 consortium(4,5) demonstrate that many transcripts are non- coding RNAs ( ncRNAs). These transcriptome analyses indicate that many of the non- coding regions, previously thought to be functionally inert, are actually transcriptionally active regions with various features. Furthermore, most relatively large ( several kilobases) polyadenylated messenger RNA transcripts are transcribed from regions harbouring little coding potential. However, the function of such ncRNAs is mostly unknown and has been a matter of debate(2). Here we show that RNA polymerase II ( RNAPII) transcription of ncRNAs is required for chromatin remodelling at the fission yeast Schizosaccharomyces pombe fbp1(+) locus during transcriptional activation. The chromatin at fbp1(+) is progressively converted to an open configuration, as several species of ncRNAs are transcribed through fbp1(+). This is coupled with the translocation of RNAPII through the region upstream of the eventual fbp1(+) transcriptional start site. Insertion of a transcription terminator into this upstream region abolishes both the cascade of transcription of ncRNAs and the progressive chromatin alteration. Our results demonstrate that transcription through the promoter region is required to make DNA sequences accessible to transcriptional activators and to RNAPII.	[Hirota, Kouji; Kugou, Kazuto; Shibata, Takehiko; Ohta, Kunihiro] RIKEN, Adv Sci Inst, Mol & Cellular Biol Lab, Wako, Saitama 3510198, Japan; [Hirota, Kouji; Miyoshi, Tomoichiro; Kugou, Kazuto; Ohta, Kunihiro] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Hoffman, Charles S.] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA	RIKEN; University of Tokyo; Boston College	Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.	khirota@rg.med.kyoto-u.ac.jp; kohta@bio.c.u-tokyo.ac.jp		Kugou, Kazuto/0000-0002-7690-1249; Hoffman, Charles/0000-0001-8700-1863	Ministry of Education, Culture, Sports, Science and Technology, Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046226] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Lin for critically reading this manuscript. This work was supported by grants-in-aid for scientific research in a priority area, the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Hayashizaki Y, 2006, PLOS GENET, V2, P492, DOI 10.1371/journal.pgen.0020063; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hirota K, 2003, GENETICS, V165, P505; Hirota K, 2008, MOL BIOL CELL, V19, P1162, DOI 10.1091/mbc.E07-04-0377; Hirota K, 2007, EUKARYOT CELL, V6, P2072, DOI 10.1128/EC.00246-07; Hirota K, 2006, EUKARYOT CELL, V5, P1980, DOI 10.1128/EC.00272-06; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; Janoo RTK, 2001, GENETICS, V157, P1205; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; TAKEDA T, 1987, P NATL ACAD SCI USA, V84, P3580, DOI 10.1073/pnas.84.11.3580; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; WOLFFE AP, 1997, CHROMATIN STRUCTURE	24	196	204	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					130	U15		10.1038/nature07348	http://dx.doi.org/10.1038/nature07348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18820678				2022-12-01	WOS:000260674000055
J	McIntosh, JR; Grishchuk, EL; Morphew, MK; Efremov, AK; Zhudenkov, K; Volkov, VA; Cheeseman, IM; Desai, A; Mastronarde, DN; Ataullakhanov, FI				McIntosh, J. Richard; Grishchuk, Ekaterina L.; Morphew, Mary K.; Efremov, Artem K.; Zhudenkov, Kirill; Volkov, Vladimir A.; Cheeseman, Iain M.; Desai, Arshad; Mastronarde, David N.; Ataullakhanov, Fazly I.			Fibrils Connect Microtubule Tips with Kinetochores: A Mechanism to Couple Tubulin Dynamics to Chromosome Motion	CELL			English	Article							FISSION YEAST; IN-VITRO; MOLECULAR ARCHITECTURE; DISTINCT MECHANISMS; FORCE PRODUCTION; RING COMPLEX; DASH COMPLEX; DEPOLYMERIZATION; DAM1; ENDS	Kinetochores of mitotic chromosomes are coupled to spindle microtubules in ways that allow the energy from tubulin dynamics to drive chromosome motion. Most kinetochore-associated microtubule ends display curving "protofilaments,'' strands of tubulin dimers that bend away from the microtubule axis. Both a kinetochore "plate'' and an encircling, ring-shaped protein complex have been proposed to link protofilament bending to poleward chromosome motion. Here we show by electron tomography that slender fibrils connect curved protofilaments directly to the inner kinetochore. Fibril-protofilament associations correlate with a local straightening of the flared protofilaments. Theoretical analysis reveals that protofilament-fibril connections would be efficient couplers for chromosome motion, and experimental work on two very different kinetochore components suggests that filamentous proteins can couple shortening microtubules to cargo movements. These analyses define a ring-independent mechanism for harnessing microtubule dynamics directly to chromosome movement.	[McIntosh, J. Richard; Grishchuk, Ekaterina L.; Morphew, Mary K.; Efremov, Artem K.; Volkov, Vladimir A.; Mastronarde, David N.] Univ Colorado, Dept MCD Biol, Boulder, CO 80309 USA; [Grishchuk, Ekaterina L.] Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia; [Efremov, Artem K.; Zhudenkov, Kirill; Volkov, Vladimir A.; Ataullakhanov, Fazly I.] Natl Res Ctr Hematol, Moscow 117513, Russia; [Cheeseman, Iain M.] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ataullakhanov, Fazly I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119899, Russia; [Ataullakhanov, Fazly I.] RAS, Ctr Theoret Problems Physicochem Pharmacol, Moscow 119991, Russia	University of Colorado System; University of Colorado Boulder; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Massachusetts Institute of Technology (MIT); Whitehead Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences	McIntosh, JR (corresponding author), Univ Colorado, Dept MCD Biol, Boulder, CO 80309 USA.	richard.mcintosh@colorado.edu	Ataullakhanov, Fazoil/J-8076-2012; McIntosh, Richard/GLN-3533-2022; Zhudenkov, Kirill/AGG-2014-2022; Volkov, Vladimir/N-8746-2013	Volkov, Vladimir/0000-0002-5407-3366; Zhudenkov, Kirill/0000-0003-2991-6189; Efremov, Artem/0000-0002-1603-610X; Cheeseman, Iain/0000-0002-3829-5612	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033787] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR000592-35, RR000592, P41 RR000592] Funding Source: Medline; NIGMS NIH HHS [R01 GM033787, GM033787, R01 GM033787-24] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gachet Y, 2008, MOL BIOL CELL, V19, P1646, DOI 10.1091/mbc.E07-09-0910; Ganem NJ, 2006, CELL CYCLE, V5, P481, DOI 10.4161/cc.5.5.2519; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P15423, DOI 10.1073/pnas.0807859105; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Heermann D.W., 1990, COMPUTER SIMULATION; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Morphew MK, 2003, J MICROSC-OXFORD, V212, P21, DOI 10.1046/j.1365-2818.2003.01231.x; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Schittenhelm RB, 2007, CHROMOSOMA, V116, P385, DOI 10.1007/s00412-007-0103-y; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; VandenBeldt KJ, 2006, CURR BIOL, V16, P1217, DOI 10.1016/j.cub.2006.04.046; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	47	156	157	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					322	333		10.1016/j.cell.2008.08.038	http://dx.doi.org/10.1016/j.cell.2008.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957206	Bronze, Green Accepted			2022-12-01	WOS:000260130400021
J	Knickelbein, JE; Khanna, KM; Yee, MB; Baty, CJ; Kinchington, PR; Hendricks, RL				Knickelbein, Jared E.; Khanna, Kamal M.; Yee, Michael B.; Baty, Catherine J.; Kinchington, Paul R.; Hendricks, Robert L.			Noncytotoxic lytic granule-mediated CD8(+) T cell inhibition of HSV-1 reactivation from neuronal latency	SCIENCE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN TRIGEMINAL GANGLIA; GAMMA-INTERFERON; INSITU HYBRIDIZATION; TYPE-1 REACTIVATION; SENSORY GANGLIA; NERVOUS SYSTEMS; INFECTION; EXPRESSION; GRANZYME	Reactivation of herpes simplex virus type 1 (HSV-1) from neuronal latency is a common and potentially devastating cause of disease worldwide. CD8(+) T cells can completely inhibit HSV reactivation in mice, with interferon-gamma affording a portion of this protection. We found that CD8(+) T cell lytic granules are also required for the maintenance of neuronal latency both in vivo and in ex vivo ganglia cultures and that their directed release to the junction with neurons in latently infected ganglia did not induce neuronal apoptosis. Here, we describe a nonlethal mechanism of viral inactivation in which the lytic granule component, granzyme B, degrades the HSV-1 immediate early protein, ICP4, which is essential for further viral gene expression.	[Knickelbein, Jared E.; Khanna, Kamal M.; Yee, Michael B.; Kinchington, Paul R.; Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; [Baty, Catherine J.] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Baty, Catherine J.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Kinchington, Paul R.; Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Knickelbein, Jared E.] Univ Pittsburgh, Sch Med, Grad Program Immunol, Pittsburgh, PA 15213 USA; [Knickelbein, Jared E.] Univ Pittsburgh, Sch Med, Med Sci Training Program, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hendricks, RL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA.	hendricksrr@upmc.edu	Yee, Michael/AAI-4164-2020	Yee, Michael/0000-0002-6296-7757	NIH [F30NS061471, R01EY05945, R01EY015291, P30EY08098]; Research to Prevent Blindness Medical Student Eye Research Fellowship; Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE [P30EY008098, R01EY005945, R01EY015291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS061471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Medical Student Eye Research Fellowship(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Lathrop and J. Karlsson for assistance with microscopy and preparation of figures and N. Zurowski for assistance with flow cytometry. We have no conflicting financial interests. This work was supported by NIH grants F30NS061471 (J.E.K.), R01EY05945 (R.L.H.), R01EY015291 (P.R.K.), and P30EY08098 (R.L.H.); a Research to Prevent Blindness Medical Student Eye Research Fellowship (J.E.K.); and unrestricted grants from Research to Prevent Blindness and the Eye and Ear Foundation of Pittsburgh (R.L.H.).	Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; CROEN KD, 1987, NEW ENGL J MED, V317, P1427, DOI 10.1056/NEJM198712033172302; Decman V, 2005, J VIROL, V79, P10339, DOI 10.1128/JVI.79.16.10339-10347.2005; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Derfuss T, 2007, BRAIN PATHOL, V17, P389, DOI 10.1111/j.1750-3639.2007.00088.x; Freeman ML, 2007, J IMMUNOL, V179, P322, DOI 10.4049/jimmunol.179.1.322; Hoshino Y, 2007, J VIROL, V81, P8157, DOI 10.1128/JVI.00474-07; Hufner K, 2006, J NEUROPATH EXP NEUR, V65, P1022, DOI 10.1097/01.jnen.0000235852.92963.bf; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Sheridan BS, 2007, EXPERT OPIN BIOL TH, V7, P1323, DOI 10.1517/14712598.7.9.1323; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; STROOP WG, 1987, ACTA NEUROPATHOL, V74, P124, DOI 10.1007/BF00692842; Telford WG, 2002, CYTOMETRY, V47, P81, DOI 10.1002/cyto.10052; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104	25	252	258	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					268	271		10.1126/science.1164164	http://dx.doi.org/10.1126/science.1164164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845757	Green Accepted			2022-12-01	WOS:000259902300051
J	Paddock, M; O'Neil, B; Holwell, A				Paddock, Michael; O'Neil, Bernadette; Holwell, Andy			Actions speak louder than words	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Paddock, Michael; O'Neil, Bernadette] Kings Coll London, Sch Med, London WC2R 2LS, England; [Holwell, Andy] SW London & St Georges Mental Hlth NHS Trust, London, England	University of London; King's College London	Paddock, M (corresponding author), Kings Coll London, Sch Med, London WC2R 2LS, England.	michael.paddock@kcl.ac.uk	Paddock, Michael/AAF-4175-2020	Paddock, Michael/0000-0003-4508-8803					0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1882	10.1136/bmj.a1882	http://dx.doi.org/10.1136/bmj.a1882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356SN	18826973				2022-12-01	WOS:000259798000048
J	Blow, N				Blow, Nathan			Biochemistry's new look	NATURE			English	Editorial Material							METABOLOMICS											May P, 2008, GENETICS, V179, P157, DOI 10.1534/genetics.108.088336; Northen TR, 2007, NATURE, V449, P1033, DOI 10.1038/nature06195; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001	4	93	94	4	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					697	700		10.1038/455697a	http://dx.doi.org/10.1038/455697a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833281	Bronze			2022-12-01	WOS:000259639700054
J	Bush, A; Hedlin, G; Carlsen, KH; de Benedictis, F; Lodrup-Carlsen, K; Wilson, N				Bush, Andrew; Hedlin, Gunillo; Carlsen, Kai-Hon; de Benedictis, Fernando; Lodrup-Carlsen, Karin; Wilson, Nicola			Severe childhood asthma: a common international approach?	LANCET			English	Editorial Material							RECEPTOR-BINDING AFFINITY; TO-TREAT ASTHMA; MONOCLONAL-ANTIBODY; CHILDREN; HYPERRESPONSIVENESS; RESPONSIVENESS; EXPOSURE		[Bush, Andrew; Wilson, Nicola] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6JJ, England; [Hedlin, Gunillo] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Hedlin, Gunillo] Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Carlsen, Kai-Hon] Rikshosp Univ Hosp, Div Paediat, Voksentoppen, Oslo, Norway; [Carlsen, Kai-Hon; Lodrup-Carlsen, Karin] Univ Oslo, Fac Med, Oslo, Norway; [de Benedictis, Fernando] Salesi Childrens Hosp, Dept Paediat, Ancona, Italy; [Lodrup-Carlsen, Karin] Ullevaal Univ Hosp, Dept Paediat, Oslo, Norway	Royal Brompton Hospital; Karolinska Institutet; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Bush, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6JJ, England.	a.bush@imperial.ac.uk			Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bracken M, 2007, THORAX, V62, pA21; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Chinn S, 2007, AM J RESP CRIT CARE, V176, P20, DOI 10.1164/rccm.200612-1840OC; Chipps BE, 2007, J ALLERGY CLIN IMMUN, V119, P1156, DOI 10.1016/j.jaci.2006.12.668; Chung KF, 1999, EUR RESPIR J, V13, P1198; Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32, DOI 10.1016/S1081-1206(10)61707-3; KAM JC, 1993, J IMMUNOL, V151, P3460; Langley SJ, 2005, THORAX, V60, P17, DOI 10.1136/thx.2004.027839; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Nimmagadda SR, 1997, AM J RESP CRIT CARE, V155, P87, DOI 10.1164/ajrccm.155.1.9001294; Saglani S, 2006, EUR RESPIR J, V27, P29, DOI 10.1183/09031936.06.00030605; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; WARNER JO, 1995, BRIT MED J, V311, P663, DOI 10.1136/bmj.311.7006.663; World Health Organization, GLOB ALL CHRON RESP	16	70	70	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1019	1021		10.1016/S0140-6736(08)61422-1	http://dx.doi.org/10.1016/S0140-6736(08)61422-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805316				2022-12-01	WOS:000259648500009
J	Yildiz, A; Tomishige, M; Gennerich, A; Vale, RD				Yildiz, Ahmet; Tomishige, Michio; Gennerich, Arne; Vale, Ronald D.			Intramolecular strain coordinates kinesin stepping behavior along microtubules	CELL			English	Article							HAND-OVER-HAND; PROCESSIVE MOTOR; DIMERIC KINESIN; ATP HYDROLYSIS; NECK LINKER; MYOSIN-V; MECHANISM; MOLECULE; FORCE; HEAD	Kinesin advances 8 nm along a microtubule per ATP hydrolyzed, but the mechanism responsible for coordinating the enzymatic cycles of kinesin's two identical motor domains remains unresolved. Here, we have tested whether such coordination is mediated by intramolecular tension generated by the "neck linkers,'' mechanical elements that span between the motor domains. When tension is reduced by extending the neck linkers with artificial peptides, the coupling between ATP hydrolysis and forward stepping is impaired and motor's velocity decreases as a consequence. However, speed recovers to nearly normal levels when external tension is applied by an optical trap. Remarkably, external load also induces bidirectional stepping of an immotile kinesin that lacks its mechanical element (neck linker) and fuel (ATP). Our results indicate that the kinesin motor domain senses and responds to strain in a manner that facilitates its plus-end-directed stepping and communication between its two motor domains.	[Yildiz, Ahmet; Tomishige, Michio; Gennerich, Arne; Vale, Ronald D.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Tomishige, Michio] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Gennerich, Arne/W-5488-2019; Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X	Jane Coffin Childs Memorial Fund; Burroughs Wellcome Fund; German Research Foundation [GE 1609/1]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499, R37GM038499] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; Burroughs Wellcome Fund(Burroughs Wellcome Fund); German Research Foundation(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. P. Carter and N. Zhang for their help with protein purification and cloning and J. Kerssemakers and M. Dogterom for supplying their step finding algorithm. This work has been supported by Jane Coffin Childs Memorial Fund (A.Y. and A.G.), Burroughs Wellcome Fund (A.Y.), German Research Foundation (GE 1609/1 [A.G.]), and the Howard Hughes Medical Institute.	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CURR OPIN CELL BIOL, V18, P61, DOI 10.1016/j.ceb.2005.12.009; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Hackney DD, 2007, SCIENCE, V316, P58, DOI 10.1126/science.1141549; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; Hackney DD, 2003, BIOCHEMISTRY-US, V42, P12011, DOI 10.1021/bi0349118; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Schief WR, 2004, P NATL ACAD SCI USA, V101, P1183, DOI 10.1073/pnas.0304369101; Schief WR, 2001, CURR OPIN CELL BIOL, V13, P19, DOI 10.1016/S0955-0674(00)00169-1; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; Spudich JA, 2006, CELL, V126, P242, DOI 10.1016/j.cell.2006.07.009; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	46	219	225	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1030	1041		10.1016/j.cell.2008.07.018	http://dx.doi.org/10.1016/j.cell.2008.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805095	Bronze, Green Accepted			2022-12-01	WOS:000259318100022
J	Zieg, J; Greer, PL; Greenberg, ME				Zieg, Janine; Greer, Paul L.; Greenberg, Michael E.			SnapShot: Ca2+-dependent transcription in neurons	CELL			English	Editorial Material									[Zieg, Janine; Greer, Paul L.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zieg, J (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.							Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/S0092-8674(04)01159-6; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Ledo F, 2002, EMBO J, V21, P4583, DOI 10.1093/emboj/cdf440; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462	10	15	15	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6							1080.e2	10.1016/j.cell.2008.09.010	http://dx.doi.org/10.1016/j.cell.2008.09.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805099	Bronze			2022-12-01	WOS:000259318100026
J	Olive, DL				Olive, David L.			Gonadotropin-releasing hormone agonists for endometriosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEUPROLIDE ACETATE; ADD-BACK; DEPOT LEUPROLIDE; GNRH AGONIST; PELVIC PAIN; THERAPY; ESTROGEN; TRIAL; MANAGEMENT; NAFARELIN	A 36- year- old woman presents with long- standing pelvic pain, including dysmenorrhea and pain with intercourse. She has previously received oral contraceptives and depot medroxyprogesterone for presumed endometriosis. This regimen has not relieved her pain, and she has had side effects, including continual abnormal uterine bleeding and fluid retention. She is referred to a reproductive endocrinologist for further investigation and treatment. After a careful review and examination to rule out other explanations for the patient's symptoms, the endocrinologist recommends the use of a gonadotropin- releasing hormone agonist combined with norethindrone acetate as empirical treatment for endometriosis.	[Olive, David L.] Wisconsin Fertil Inst, Middleton, WI 53562 USA		Olive, DL (corresponding author), Wisconsin Fertil Inst, 3146 Deming Way, Middleton, WI 53562 USA.	dlolive1@aol.com			Nobelpharma; Procter Gamble	Nobelpharma; Procter Gamble(Procter & Gamble)	Dr. Olive reports receiving lecture fees from Nobelpharma and consulting fees from Procter & Gamble. No other potential conflict of interest relevant to this article was reported.	*AG HLTH CAR POL R, 1995, AHCPR PUBL; *AM COLL OBST GYN, 1999, ACOG PRACT B, V11; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; DiVasta AD, 2007, J PEDIATR ADOL GYNEC, V20, P293, DOI 10.1016/j.jpag.2007.04.008; DLUGI AM, 1990, FERTIL STERIL, V54, P419; DOSWELL L, 1992, FERTIL STERIL, V57, P514; Duleba A J, 1996, J Am Assoc Gynecol Laparosc, V3, P205, DOI 10.1016/S1074-3804(96)80004-1; Hornstein MD, 1998, OBSTET GYNECOL, V91, P16, DOI 10.1016/S0029-7844(97)00620-0; HORNSTEIN MD, 1995, FERTIL STERIL, V63, P955, DOI 10.1016/S0015-0282(16)57530-X; Hornstein MD, 1997, FERTIL STERIL, V68, P860, DOI 10.1016/S0015-0282(97)00360-9; KODAMAN PH, 2005, ENDOMETRIOSIS CLIN P, P13; LEMAY A, 1984, FERTIL STERIL, V41, P863; Ling FW, 1999, OBSTET GYNECOL, V93, P51, DOI 10.1016/S0029-7844(98)00341-X; MAHUTTE NG, 2005, ENDOMETRIOSIS CLIN P, P79; MELDRUM DR, 1982, J CLIN ENDOCR METAB, V54, P1081, DOI 10.1210/jcem-54-5-1081; Newton C, 1996, FERTIL STERIL, V65, P1253, DOI 10.1016/S0015-0282(16)58351-4; Olive D, 2005, FUJITSU SCI TECH J, V41, P10; Olive DL, 2005, DRUGS TODAY, V40, P23; Olive DL, 2001, NEW ENGL J MED, V345, P266, DOI 10.1056/NEJM200107263450407; OLIVE DL, 2003, J IRISH SOC PHYS SUR, V32, P9; Oral E, 1997, OBSTET GYN CLIN N AM, V24, P219, DOI 10.1016/S0889-8545(05)70301-6; PARAZZINI F, 1994, AM J OBSTET GYNECOL, V171, P1205, DOI 10.1016/0002-9378(94)90133-3; Pierce SJ, 2000, FERTIL STERIL, V74, P964, DOI 10.1016/S0015-0282(00)01537-5; POKRAS R, 1997, VITAL HLTH STAT, V13; PRENTICE A, 2000, COCHRANE DB SYST REV, V2; Sallam HN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004635.pub2; Schlaff WD, 2006, FERTIL STERIL, V85, P314, DOI 10.1016/j.fertnstert.2005.07.1315; SCHRIOCK E, 1985, FERTIL STERIL, V44, P583; SHAW RW, 1983, BRIT MED J, V287, P1667, DOI 10.1136/bmj.287.6406.1667; Sherwin BB, 1997, NEUROLOGY, V48, pS21, DOI 10.1212/WNL.48.5_Suppl_7.21S; Sherwin BB, 1996, J CLIN ENDOCR METAB, V81, P2545, DOI 10.1210/jc.81.7.2545; Shi ZQ, 2006, BIOL REPROD, V74, P850, DOI 10.1095/biolreprod.105.044917; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Vercellini P, 1999, BRIT J OBSTET GYNAEC, V106, P672, DOI 10.1111/j.1471-0528.1999.tb08366.x; VERCELLINI P, 1993, FERTIL STERIL, V60, P75; WHEELER JM, 1989, J REPROD MED, V34, P41; WITZ CA, 2005, ENDOMETRIOSIS CLIN P, P61	37	30	35	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1136	1142		10.1056/NEJMct0803719	http://dx.doi.org/10.1056/NEJMct0803719			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784103				2022-12-01	WOS:000259078200009
J	Filippakopoulos, P; Kofler, M; Hantschel, O; Gish, GD; Grebien, F; Salah, E; Neudecker, P; Kay, LE; Turk, BE; Superti-Furga, G; Pawson, T; Knapp, S				Filippakopoulos, Panagis; Kofler, Michael; Hantschel, Oliver; Gish, Gerald D.; Grebien, Florian; Salah, Eidarus; Neudecker, Philipp; Kay, Lewis E.; Turk, Benjamin E.; Superti-Furga, Giulio; Pawson, Tony; Knapp, Stefan			Structural coupling of SH2-kinase domains links fes and Abl substrate recognition and kinase activation	CELL			English	Article							PROTEIN-TYROSINE KINASE; FUJINAMI SARCOMA-VIRUS; TERMINAL SRC KINASE; C-ABL; CELL-ADHESION; V-FPS; PROCESSIVE PHOSPHORYLATION; ACTIVE CONFORMATION; CRYSTAL-STRUCTURE; FAMILY KINASES	The SH2 domain of cytoplasmic tyrosine kinases can enhance catalytic activity and substrate recognition, but the molecular mechanisms by which this is achieved are poorly understood. We have solved the structure of the prototypic SH2-kinase unit of the human Fes tyrosine kinase, which appears specialized for positive signaling. In its active conformation, the SH2 domain tightly interacts with the kinase N-terminal lobe and positions the kinase alpha C helix in an active configuration through essential packing and electrostatic interactions. This interaction is stabilized by ligand binding to the SH2 domain. Our data indicate that Fes kinase activation is closely coupled to substrate recognition through cooperative SH2-kinase-substrate interactions. Similarly, we find that the SH2 domain of the active Abl kinase stimulates catalytic activity and substrate phosphorylation through a distinct SH2-kinase interface. Thus, the SH2 and catalytic domains of active Fes and Abl pro-oncogenic kinases form integrated structures essential for effective tyrosine kinase signaling.	[Hantschel, Oliver; Grebien, Florian; Superti-Furga, Giulio] Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; [Filippakopoulos, Panagis; Salah, Eidarus; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Kofler, Michael; Gish, Gerald D.; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Neudecker, Philipp; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England	Austrian Academy of Sciences; University of Oxford; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Yale University; University of Toronto; University of Oxford	Superti-Furga, G (corresponding author), Austrian Acad Sci, Ctr Mol Med, Lazarettgasse 19, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at; pawson@mshri.on.ca; stefan.knapp@sgc.ox.ac.uk	Superti-Furga, Giulio/AAE-5681-2019; Pawson, Tony J/E-4578-2013; Hantschel, Oliver D/H-4705-2013; Superti-Furga, Giulio/F-4755-2015; Grebien, Florian/H-9234-2019; Neudecker, Philipp/AAP-9005-2020; Knapp, Stefan/AAG-2347-2019; Neudecker, Philipp/G-5265-2013; Gish, Gerald D/C-7228-2017; Hantschel, Oliver/M-7016-2019	Hantschel, Oliver D/0000-0001-8569-8169; Superti-Furga, Giulio/0000-0002-0570-1768; Grebien, Florian/0000-0003-4289-2281; Neudecker, Philipp/0000-0002-0557-966X; Knapp, Stefan/0000-0001-5995-6494; Neudecker, Philipp/0000-0002-0557-966X; Hantschel, Oliver/0000-0001-8569-8169; Filippakopoulos, Panagis/0000-0002-1515-1317	Canadian Institutes for Health Research (CIHR ) [MOP-6849, MOP-13466]; National Cancer Institute of Canada; Canadian Cancer Society; Genome Canada; Ontario Summit Award; Structural Genomics Consortium [1097737]; CIHR; Canadian Foundation for Innovation; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Foundation for Strategic Research; Wellcome Trust; Austrian Science Fund FWF [P18737-B11]	Canadian Institutes for Health Research (CIHR )(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada(Genome Canada); Ontario Summit Award; Structural Genomics Consortium(University of Toronto); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Austrian Science Fund FWF(Austrian Science Fund (FWF))	We thank Neil Warner for synthesis of the Spots blot membrane and Cristina Virag for excellent technical assistance, Karel Dorey for the initial observation of a positive function of the Abl SH2 domain, and Bhushan Nagar and John Kuriyan for a long-standing collaboration on the role of the SH2 domain in Abl regulation. This research was supported by grants from the Canadian Institutes for Health Research (CIHR grant numbers MOP-6849 and MOP-13466); the National Cancer Institute of Canada with funds from the Canadian Cancer Society; Genome Canada through the Ontario Genomics Institute; and an Ontario Summit Award to T. P. T. P. is a Distinguished Scientist of the CIHR. S. K., E. S., and P. F. are funded by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the CIHR, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Foundation for Strategic Research, and the Wellcome Trust. G. S.-F., O. H., and F. G. are funded by the Austrian Science Fund FWF (grant number P18737-B11).	Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; BROOKSWILSON AR, 1989, MOL CELL BIOL, V9, P2214, DOI 10.1128/MCB.9.5.2214; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eswaran J, 2008, STRUCTURE, V16, P115, DOI 10.1016/j.str.2007.10.026; Evans P., 2007, SCALA SCALE TOGETHER; FOSTER DA, 1985, CELL, V42, P105, DOI 10.1016/S0092-8674(85)80106-9; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; GREER P, 1994, MOL CELL BIOL, V14, P6755, DOI 10.1128/MCB.14.10.6755; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; GROFFEN J, 1983, VIROLOGY, V125, P480, DOI 10.1016/0042-6822(83)90219-2; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; HJERMSTAD SJ, 1993, ONCOGENE, V8, P2283; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5455, DOI 10.1021/bi602512e; Jucker M, 1997, J BIOL CHEM, V272, P2104; KOCH CA, 1989, MOL CELL BIOL, V9, P4131, DOI 10.1128/MCB.9.10.4131; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LEE WH, 1980, P NATL ACAD SCI-BIOL, V77, P2018, DOI 10.1073/pnas.77.4.2018; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; LESLIE AGW, 2007, MOSFLM; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moniakis J, 2001, GENE DEV, V15, P687, DOI 10.1101/gad.871001; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parsons SA, 2007, IMMUNOLOGY, V122, P542, DOI 10.1111/j.1365-2567.2007.02670.x; Parsons SA, 2006, J LEUKOCYTE BIOL, V80, P1522, DOI 10.1189/jlb.0506350; Read RD, 1997, J BIOL CHEM, V272, P18498, DOI 10.1074/jbc.272.29.18498; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Scott MP, 2000, BIOCHEMISTRY-US, V39, P14531, DOI 10.1021/bi001850u; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; SHIBUYA M, 1980, P NATL ACAD SCI-BIOL, V77, P6536, DOI 10.1073/pnas.77.11.6536; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; STONE JC, 1984, CELL, V37, P549, DOI 10.1016/0092-8674(84)90385-4; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; WEINMASTER G, 1984, CELL, V37, P559, DOI 10.1016/0092-8674(84)90386-6; WEINMASTER G, 1982, J CELL BIOCHEM, V20, P337, DOI 10.1002/jcb.240200404; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	54	146	150	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					793	803		10.1016/j.cell.2008.07.047	http://dx.doi.org/10.1016/j.cell.2008.07.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775312	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000258947500019
J	Schunemann, HJ; Woodhead, M; Anzueto, A; Buist, S; MacNee, W; Rabe, KF; Heffner, J				Schuenemann, Holger J.; Woodhead, Mark; Anzueto, Antonio; Buist, Sonia; MacNee, William; Rabe, Klaus F.; Heffner, John			A vision statement on guideline development for respiratory disease: the example of COPD	LANCET			English	Editorial Material							RECOMMENDATIONS; STRENGTH; QUALITY		[Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Med Ctr 2C9, CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada; [Schuenemann, Holger J.] SUNY Buffalo, Dept Med, Buffalo, NY USA; [Woodhead, Mark] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; [Woodhead, Mark] Univ Manchester, Manchester, Lancs, England; [Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Buist, Sonia; Heffner, John] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [MacNee, William] Queens Med Res Inst, ELEGI Colt Res Labs, UoE MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Rabe, Klaus F.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Manchester; University of Manchester; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Oregon Health & Science University; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schunemann, HJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Med Ctr 2C9, CLARITY Res Grp, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	schuneh@mcmaster.ca	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401; MacNee, William/0000-0002-3692-1448; Schunemann, Holger/0000-0003-3211-8479	NHLBI NIH HHS [1R13HL 90485-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL090485] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2008, COCHRANE HDB SYSTEMA; Bradbury J, 1999, LANCET, V353, P563, DOI 10.1016/S0140-6736(99)00028-8; Glasziou Paul, 2005, Evid Based Nurs, V8, P36, DOI 10.1136/ebn.8.2.36; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P12, DOI 10.1186/1478-4505-4-12; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3	11	49	53	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					774	779		10.1016/S0140-6736(08)61347-1	http://dx.doi.org/10.1016/S0140-6736(08)61347-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	18835641				2022-12-01	WOS:000263725400037
J	Petrovic, M; Hummel, T				Petrovic, Milan; Hummel, Thomas			Temporal identity in axonal target layer recognition	NATURE			English	Article							ZINC-FINGER PROTEIN; LAMINA-SPECIFIC CONNECTIVITY; N-CADHERIN; TRANSCRIPTION FACTORS; GENE-FUNCTION; DROSOPHILA; RECEPTOR; EXPRESSION; SYSTEM; REGULATOR	The segregation of axon and dendrite projections into distinct synaptic layers is a fundamental principle of nervous system organization and the structural basis for information processing in the brain(1). Layer- specific recognition molecules that allow projecting neurons to stabilize transient contacts and initiate synaptogenesis(2,3) have been identified. However, most of the neuronal cell- surface molecules critical for layer organization are expressed broadly in the developing nervous system(4,5), raising the question of how these so- called permissive adhesion molecules support synaptic specificity. Here we show that the temporal expression dynamics of the zinc- finger protein sequoia is the major determinant of Drosophila photoreceptor connectivity into distinct synaptic layers. Neighbouring R8 and R7 photoreceptors show consecutive peaks of elevated sequoia expression, which correspond to their sequential target- layer innervation. Loss of sequoia in R7 leads to a projection switch into the R8 recipient layer, whereas a prolonged expression in R8 induces a redirection of their axons into the R7 layer. The sequoia- induced axon targeting is mediated through the ubiquitously expressed Cadherin- N cell adhesion molecule. Our data support a model in which recognition specificity during synaptic layer formation is generated through a temporally restricted axonal competence to respond to broadly expressed adhesion molecules. Because developing neurons innervating the same target area often project in a distinct, birth- order- dependent sequence, temporal identity seems to contain crucial information in generating not only cell type diversity during neuronal division(6) but also connection diversity of projecting neurons.	[Petrovic, Milan; Hummel, Thomas] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Hummel, T (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	hummel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SFB629]; EMBO Young Investigator Programme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO))	We thank H. Bellen, J. Brenman, I. Salecker and R. Schuh for fly stocks and antibodies; D. Hawellek for the identification and analysis of seq<SUP>6</SUP>; and H. Aberle, S. Bogdan, C. Klambt, A. Puschel and members of the Hummel laboratory for critical comments on the manuscript. T. H. is supported by the Deutsche Forschungsgemeinschaft (SFB629) and the EMBO Young Investigator Programme.	BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; DESAI CJ, 1994, J NEUROSCI, V14, P7272; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Gil OD, 2002, J COMP NEUROL, V453, P372, DOI 10.1002/cne.10424; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MCGUIRE SE, 2004, SCI STKE, pPL6; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Sun Q, 2000, DEVELOPMENT, V127, P801; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Ting CY, 2007, CURR OPIN NEUROBIOL, V17, P65, DOI 10.1016/j.conb.2006.12.004; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	42	60	60	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					800	U87		10.1038/nature07407	http://dx.doi.org/10.1038/nature07407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18978776				2022-12-01	WOS:000261559900051
J	Dimitrov, A; Quesnoit, M; Moutel, S; Cantaloube, I; Pous, C; Perez, F				Dimitrov, Ariane; Quesnoit, Melanie; Moutel, Sandrine; Cantaloube, Isabelle; Pous, Christian; Perez, Franck			Detection of GTP-Tubulin Conformation in Vivo Reveals a Role for GTP Remnants in Microtubule Rescues	SCIENCE			English	Article							STABILIZE MICROTUBULES; DYNAMIC INSTABILITY; P-I; CAP; POLYMERIZATION; HYDROLYSIS; TAXOL	Microtubules display dynamic instability, with alternating phases of growth and shrinkage separated by catastrophe and rescue events. The guanosine triphosphate (GTP) cap at the growing end of microtubules, whose presence is essential to prevent microtubule catastrophes in vitro, has been difficult to observe in vivo. We selected a recombinant antibody that specifically recognizes GTP- bound tubulin in microtubules and found that GTP- tubulin was indeed present at the plus end of growing microtubules. Unexpectedly, GTP- tubulin remnants were also present in older parts of microtubules, which suggests that GTP hydrolysis is sometimes incomplete during polymerization. Observations in living cells suggested that these GTP remnants may be responsible for the rescue events in which microtubules recover from catastrophe.	[Dimitrov, Ariane; Quesnoit, Melanie; Perez, Franck] Inst Curie, CNRS, UMR144, F-75248 Paris 05, France; [Dimitrov, Ariane; Quesnoit, Melanie; Moutel, Sandrine; Perez, Franck] Inst Curie, Ctr Rech, F-75248 Paris 05, France; [Quesnoit, Melanie; Cantaloube, Isabelle; Pous, Christian] Univ Paris 11, Fac Pharm, IFR141, F-92296 Chatenay Malabry, France; [Moutel, Sandrine] Inst Curie, Translat Res Dept, F-75248 Paris 05, France; [Pous, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Perez, F (corresponding author), Inst Curie, CNRS, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.	franck.perez@curie.fr	Perez, Franck/A-1558-2014; POÜS, Christian/R-5089-2018	Perez, Franck/0000-0002-9129-9401; Moutel, Sandrine/0000-0002-9585-4855; POUS, Christian/0000-0002-2502-7854	Institut de Recherches International Servier; Association pour la Recherche sur le Cancer; French Ministry of Research; Association Francaise contre les Myopathies; CNRS; Agence Nationale de la Recherche; Human Frontier Science Program Organization; ARC; French Ministry of Research [ACI-BCMS 338]	Institut de Recherches International Servier; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontier Science Program Organization(Human Frontier Science Program); ARC(Australian Research Council); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We thank P. Benaroch for the selection of the TSB antibody, A. Khodjakov for the Ptk2 GFP-tubulin cell line, F. Severin and T. Hyman for help and advice, J. Sillibourne and D. Job for reading and commenting on the manuscript, and B. Goud for his constant support. Supported by the Institut de Recherches International Servier and the Association pour la Recherche sur le Cancer ( ARC) (M.Q.), by the French Ministry of Research and the Association Francaise contre les Myopathies ( A. D.), and by CNRS, the Agence Nationale de la Recherche (ANR non thematique), the Human Frontier Science Program Organization, ARC, and French Ministry of Research grant ACI-BCMS 338.	ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Caplow M, 1998, BIOCHEMISTRY-US, V37, P12994, DOI 10.1021/bi972602+; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CARLIER MF, 1991, J BIOL CHEM, V266, P12361; CARLIER MF, 1989, BIOCHEMISTRY-US, V28, P1783, DOI 10.1021/bi00430a054; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Dougherty CA, 1998, BIOCHEMISTRY-US, V37, P10861, DOI 10.1021/bi980677n; Draberova E, 2000, EUR J CELL BIOL, V79, P982, DOI 10.1078/0171-9335-00129; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Molodtsov MI, 2005, BIOPHYS J, V88, P3167, DOI 10.1529/biophysj.104.051789; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Vandecandelaere A, 1999, BIOCHEMISTRY-US, V38, P8179, DOI 10.1021/bi9830765; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606	18	181	181	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1353	1356		10.1126/science.1165401	http://dx.doi.org/10.1126/science.1165401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	18927356				2022-12-01	WOS:000261170600031
J	Grey, M; Haggart, JW; Smith, PL				Grey, Melissa; Haggart, James W.; Smith, Paul L.			Variation in Evolutionary Patterns Across the Geographic Range of a Fossil Bivalve	SCIENCE			English	Article							RANDOM-WALKS; MODE; RATES	The fossil record is the only direct source of data for studying modes ( patterns) and rates of morphological change over long periods of time. Determining modes and rates is important for understanding macroevolutionary processes, but just how modes and rates vary within a taxon, and why, remain largely unaddressed. We examined patterns of morphological change in the shell of the Mesozoic marine bivalve genus Buchia over its geographic and temporal range. Most modes conformed to either random walks or stasis, and both modes and rates showed variability between locations. For example, stasis was more common in deeper marine environments, whereas random walks occurred more often at the highest paleolatitudes studied. These results indicate that the environment can play an important role in shaping patterns of evolution.	[Grey, Melissa; Haggart, James W.; Smith, Paul L.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Haggart, James W.] Geol Survey Canada, Vancouver, BC V6B 5J3, Canada	University of British Columbia; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Grey, M (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada.	mgrey@eos.ubc.ca			Natural Sciences and Engineering Research of Canada (NSERC); NSERC PGS-A scholarship	Natural Sciences and Engineering Research of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-A scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by a Natural Sciences and Engineering Research of Canada (NSERC) grant (to P.L.S.) and an NSERC PGS-A scholarship (to M.G.). We are grateful to P. Alsen, T. Bogdanova, A. Crame, J.S. Crampton, J. Dougherty, J. Grant-Mackie, D.A.T. Harper, D. Hikuroa, N. Hudson, E. Kalacheva, J. Rassmussen, J. Sha, I. Sey, and F. Surlyk for use of their collections and hospitality; to P. G. Lelievre for creating the MatLab morphometrics program (MorphLab 1.0); and to G. Hunt and P. Roopnarine for help and program codes for analyzing mode. This manuscript was substantially improved by the comments and suggestions of three reviewers.	BELL MA, 2006, PALEOBIOLOGY, V58, P814; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Grey M, 2008, PALAEONTOLOGY, V51, P583, DOI 10.1111/j.1475-4983.2008.00765.x; Hannisdal B, 2007, PALEOBIOLOGY, V33, P98, DOI 10.1666/06038.1; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; JELETZKY JA, 1965, GEOL SURV CAN B, V103; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Roopnarine PD, 2003, ANNU REV ECOL EVOL S, V34, P605, DOI 10.1146/annurev.ecolsys.34.011802.132407; Roopnarine PD, 2001, PALEOBIOLOGY, V27, P446, DOI 10.1666/0094-8373(2001)027<0446:TDACOE>2.0.CO;2; Sey LI, 1999, PALAEOGEOGR PALAEOCL, V150, P49, DOI 10.1016/S0031-0182(99)00007-3; Sha JG, 2003, CRETACEOUS RES, V24, P715, DOI 10.1016/j.cretres.2003.07.006; Sheets HD, 2001, GENETICA, V112, P105, DOI 10.1023/A:1013308409951; SURLYK F, 1982, PALAEONTOLOGY, V25, P727	16	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1238	1241		10.1126/science.1162046	http://dx.doi.org/10.1126/science.1162046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18948502				2022-12-01	WOS:000261033400039
J	Doyle, JP; Dougherty, JD; Heiman, M; Schmidt, EF; Stevens, TR; Ma, G; Bupp, S; Shrestha, P; Shah, RD; Doughty, ML; Gong, S; Greengard, P; Heintz, N				Doyle, Joseph P.; Dougherty, Joseph D.; Heiman, Myriam; Schmidt, Eric F.; Stevens, Tanya R.; Ma, Guojun; Bupp, Sujata; Shrestha, Prerana; Shah, Rajiv D.; Doughty, Martin L.; Gong, Shiaoching; Greengard, Paul; Heintz, Nathaniel			Application of a Translational Profiling Approach for the Comparative Analysis of CNS Cell Types	CELL			English	Article							BACTERIAL ARTIFICIAL CHROMOSOMES; GENE-EXPRESSION; NERVOUS-SYSTEM; MOUSE-BRAIN; DIFFERENTIAL EXPRESSION; RECEPTOR SUBUNIT; SPINAL-CORD; TRANSCRIPTION; NETWORKS; FAMILY	Comparative analysis can provide important insights into complex biological systems. As demonstrated in the accompanying paper, translating ribosome affinity purification (TRAP) permits comprehensive studies of translated mRNAs in genetically defined cell populations after physiological perturbations. To establish the generality of this approach, we present translational profiles for 24 CNS cell populations and identify known cell-specific and enriched transcripts for each population. We report thousands of cell-specific mRNAs that were not detected in whole-tissue microarray studies and provide examples that demonstrate the benefits deriving from comparative analysis. To provide a foundation for further biological and in silico studies, we provide a resource of 16 transgenic mouse lines, their corresponding anatomic characterization, and translational profiles for cell types from a variety of central nervous system structures. This resource will enable a wide spectrum of molecular and mechanistic studies of both well-known and previously uncharacterized neural cell populations.	[Doyle, Joseph P.; Dougherty, Joseph D.; Schmidt, Eric F.; Stevens, Tanya R.; Ma, Guojun; Bupp, Sujata; Shrestha, Prerana; Shah, Rajiv D.; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Heiman, Myriam; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Doughty, Martin L.; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Schmidt, Eric F./AAE-8723-2019	Schmidt, Eric F./0000-0002-7869-0270; Greengard, Paul/0000-0002-4437-0893; Dougherty, Joseph/0000-0002-6385-3997	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021487, P01DA010044] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [AG09464, P01 AG009464-16A1, P01 AG009464-17, P01 AG009464] Funding Source: Medline; NIDA NIH HHS [P01 DA010044-09, F32 DA021487-01, DA10044, F32 DA021487, F32 DA021487-02, 5F32DA021487, P01 DA010044, P01 DA010044-11, P01 DA010044-10] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-029002, P50 MH074866-03, MH074866, P50 MH074866-049001, P50 MH074866-040002, P50 MH074866-030002, P50 MH074866-020005, P50 MH074866-039001, P50 MH074866-019002, P50 MH074866-010001, P50 MH074866-039002, P50 MH074866-029001, P50 MH074866-017204, P50 MH074866-020001, P50 MH074866-049002, P50 MH074866-010005, P50 MH074866-010002, P50 MH074866-030001, P50 MH074866-040001, P50 MH074866-019001, P50 MH074866-030005, P50 MH074866-02, P50 MH074866-04, P50 MH074866-040005, P50 MH074866-020002, P50 MH074866] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Berthele A, 1999, DEV BRAIN RES, V112, P39, DOI 10.1016/S0165-3806(98)00156-4; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; DENOLORENTE R, 1934, PHYSL NERVOUS SYSTEM, P291; Fuhrman S, 2000, BIOSYSTEMS, V55, P5, DOI 10.1016/S0303-2647(99)00077-5; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Kaelin-Lang A, 1999, NEUROSCI LETT, V261, P189, DOI 10.1016/S0304-3940(99)00022-1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Malgaretti N, 1997, J BIOL CHEM, V272, P17632, DOI 10.1074/jbc.272.28.17632; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Nishiyori A, 2004, J COMP NEUROL, V469, P214, DOI 10.1002/cne.11015; Nunzi MG, 2002, J COMP NEUROL, V451, P189, DOI 10.1002/cne.10344; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ramon y Cajal S., 1899, TEXTURE NERVOUS SYST; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Schneider T. D., 2007, INFORM THEORY PRIMER; SHANNON CE, 1969, MATH THEORY COMMUNIC; Shiraishi Y, 2004, J COMP NEUROL, V473, P582, DOI 10.1002/cne.20116; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; Wang SS, 1997, J NEUROSCI, V17, P4149; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Ziambaras K, 1997, WESTERN J MED, V167, P435; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	33	609	615	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					749	762		10.1016/j.cell.2008.10.029	http://dx.doi.org/10.1016/j.cell.2008.10.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013282	Green Accepted, Bronze			2022-12-01	WOS:000260886900024
J	Liu, SX; Abbondanzieri, EA; Rausch, JW; Le Grice, SFJ; Zhuang, XW				Liu, Shixin; Abbondanzieri, Elio A.; Rausch, Jason W.; Le Grice, Stuart F. J.; Zhuang, Xiaowei			Slide into Action: Dynamic Shuttling of HIV Reverse Transcriptase on Nucleic Acid Substrates	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; STRAND DISPLACEMENT SYNTHESIS; DEPENDENT DNA-POLYMERASE; RNASE-H; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SINGLE MOLECULES; ENERGY-TRANSFER	The reverse transcriptase ( RT) of human immunodeficiency virus ( HIV) catalyzes a series of reactions to convert single- stranded viral RNA into double- stranded DNA for host cell integration. This process requires a variety of enzymatic activities, including DNA polymerization, RNA cleavage, strand transfer, and strand displacement synthesis. We used single- molecule fluorescence resonance energy transfer to probe the interactions between RT and nucleic acid substrates in real time. RT was observed to slide on nucleic acid duplexes, rapidly shuttling between opposite termini of the duplex. Upon reaching the DNA 3' terminus, RT can spontaneously flip into a polymerization orientation. Sliding kinetics were regulated by cognate nucleotides and anti- HIV drugs, which stabilized and destabilized the polymerization mode, respectively. These long- range translocation activities facilitate multiple stages of the reverse transcription pathway, including normal DNA polymerization and strand displacement synthesis.	[Liu, Shixin; Abbondanzieri, Elio A.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Rausch, Jason W.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Liu, Shixin/A-4560-2012		NIH [GM 068518]; Intramural Research Program of the Center for Cancer Research; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by NIH (GM 068518 to X. Z.) and the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (to S.F.J.L.G.). X.Z. is a Howard Hughes Medical Institute investigator. E.A.A. is a Jane Coffin Childs postdoctoral fellow. Nevirapine was provided through the AIDS Research and Reference Reagent Program of NIH.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; Fuentes GM, 1996, NUCLEIC ACIDS RES, V24, P1719, DOI 10.1093/nar/24.9.1719; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HALL KB, 1991, BIOCHEMISTRY-US, V30, P10606, DOI 10.1021/bi00108a002; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HOSTOMSKY Z, 1992, J VIROL, V66, P3179, DOI 10.1128/JVI.66.5.3179-3182.1992; HOTTIGER M, 1994, J BIOL CHEM, V269, P986; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1989, J BIOL CHEM, V264, P4669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kelleher CD, 1998, J BIOL CHEM, V273, P9976, DOI 10.1074/jbc.273.16.9976; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lanciault C, 2004, J BIOL CHEM, V279, P32252, DOI 10.1074/jbc.M404117200; LEIS JP, 1973, P NATL ACAD SCI USA, V70, P466, DOI 10.1073/pnas.70.2.466; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; OMER CA, 1984, J VIROL, V50, P465, DOI 10.1128/JVI.50.2.465-470.1984; Quan YD, 1998, NUCLEIC ACIDS RES, V26, P5692, DOI 10.1093/nar/26.24.5692; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rausch JW, 2000, J BIOL CHEM, V275, P16015, DOI 10.1074/jbc.M909808199; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SMITH JK, 1984, J VIROL, V49, P200, DOI 10.1128/JVI.49.1.200-204.1984; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Telesnitsky A., 1997, P121; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WHITING SH, 1994, J VIROL, V68, P4747, DOI 10.1128/JVI.68.8.4747-4758.1994; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P18682; Winshell J, 2004, J BIOL CHEM, V279, P52924, DOI 10.1074/jbc.M409134200; Wisniewski M, 2000, J BIOL CHEM, V275, P37664, DOI 10.1074/jbc.M007381200	44	128	130	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1092	1097		10.1126/science.1163108	http://dx.doi.org/10.1126/science.1163108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008444	Green Accepted			2022-12-01	WOS:000260867700035
J	Xu, CQ; Gagnon, E; Call, ME; Schnell, JR; Schwieters, CD; Carman, CV; Chou, JJ; Wucherpfennig, KW				Xu, Chenqi; Gagnon, Etienne; Call, Matthew E.; Schnell, Jason R.; Schwieters, Charles D.; Carman, Christopher V.; Chou, James J.; Wucherpfennig, Kai W.			Regulation of T Cell Receptor Activation by Dynamic Membrane Binding of the CD3 epsilon Cytoplasmic Tyrosine-Based Motif	CELL			English	Article							EFFECTOR DOMAIN; PROTEIN; PHOSPHORYLATION; BICELLES; BILAYER; COMPLEX; ZAP-70; ZETA	Many immune system receptors signal through cytoplasmic tyrosine-based motifs (ITAMs), but how receptor ligation results in ITAM phosphorylation remains unknown. Live-cell imaging studies showed a close interaction of the CD3 epsilon cytoplasmic domain of the T cell receptor (TCR) with the plasma membrane through fluorescence resonance energy transfer between a C-terminal fluorescent protein and a membrane fluorophore. Electrostatic interactions between basic CD3 epsilon residues and acidic phospholipids enriched in the inner leaflet of the plasma membrane were required for binding. The nuclear magnetic resonance structure of the lipid-bound state of this cytoplasmic domain revealed deep insertion of the two key tyrosines into the hydrophobic core of the lipid bilayer. Receptor ligation thus needs to result in unbinding of the CD3 epsilon ITAM from the membrane to render these tyrosines accessible to Src kinases. Sequestration of key tyrosines into the lipid bilayer represents a previously unrecognized mechanism for control of receptor activation.	[Call, Matthew E.; Schnell, Jason R.; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Xu, Chenqi; Gagnon, Etienne; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Carman, Christopher V.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; [Schwieters, Charles D.] Natl Inst Hlth, Imaging Sci Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	james_chou@hms.harvard.edu; kai_wucherpfennig@dfci.harvard.edu	Chou, James/AAD-6230-2022; Carman, Christopher/L-8108-2016; Carman, Christopher V./AAX-8995-2020; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Carman, Christopher/0000-0001-7358-2548; Carman, Christopher V./0000-0001-7358-2548; Chou, James J/0000-0002-4442-0344; Xu, Chenqi/0000-0002-4968-6782; Call, Matthew/0000-0001-5846-6469	CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054520] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI054520, R01 AI054520, R01 AI054520-05] Funding Source: Medline	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chou JJ, 2002, J AM CHEM SOC, V124, P2450, DOI 10.1021/ja017875d; Davis M., 2003, FUNDAMENTAL IMMUNOLO, P227; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Lu J, 2006, J BIOL CHEM, V281, P8806, DOI 10.1074/jbc.M507305200; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Prosser RS, 2006, BIOCHEMISTRY-US, V45, P8453, DOI 10.1021/bi060615u; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Ross SR, 2006, J VIROL, V80, P9000, DOI 10.1128/JVI.00788-06; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	33	313	323	5	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					702	713		10.1016/j.cell.2008.09.044	http://dx.doi.org/10.1016/j.cell.2008.09.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013279	Green Accepted, Bronze			2022-12-01	WOS:000260886900020
J	Haruyama, J; Ohtake, M; Matsunaga, T; Morota, T; Honda, C; Yokota, Y; Pieters, CM; Hara, S; Hioki, K; Saiki, K; Miyamoto, H; Iwasaki, A; Abe, M; Ogawa, Y; Takeda, H; Shirao, M; Yamaji, A; Josset, JL				Haruyama, Junichi; Ohtake, Makiko; Matsunaga, Tsuneo; Morota, Tomokatsu; Honda, Chikatoshi; Yokota, Yasuhiro; Pieters, Carle M.; Hara, Seiichi; Hioki, Kazuyuki; Saiki, Kazuto; Miyamoto, Hideaki; Iwasaki, Akira; Abe, Masanao; Ogawa, Yoshiko; Takeda, Hiroshi; Shirao, Motomaro; Yamaji, Atsushi; Josset, Jean-Luc			Lack of Exposed Ice Inside Lunar South Pole Shackleton Crater	SCIENCE			English	Article							WATER ICE; DEPOSITS; HYDROGEN; SURFACE; REGIONS; MOON	The inside of Shackleton Crater at the lunar south pole is permanently shadowed; it has been inferred to hold water- ice deposits. The Terrain Camera ( TC), a 10- meter- resolution stereo camera onboard the Selenological and Engineering Explorer ( SELENE) spacecraft, succeeded in imaging the inside of the crater, which was faintly lit by sunlight scattered from the upper inner wall near the rim. The estimated temperature of the crater floor, based on the crater shape model derived from the TC data, is less than similar to 90 kelvin, cold enough to hold water- ice. However, at the TC's spatial resolution, the derived albedo indicates that exposed relatively pure water- ice deposits are not on the crater floor. Water- ice may be disseminated and mixed with soil over a small percentage of the area or may not exist at all.	[Haruyama, Junichi; Ohtake, Makiko; Morota, Tomokatsu; Honda, Chikatoshi; Yokota, Yasuhiro; Abe, Masanao] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Matsunaga, Tsuneo; Ogawa, Yoshiko] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Pieters, Carle M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Hara, Seiichi; Hioki, Kazuyuki] NTT DATA CCS Corp, Koto Ku, Tokyo 1360071, Japan; [Saiki, Kazuto] Osaka Univ, Dept Earth & Space Sci, Grad Sch Sci, Osaka 5600043, Japan; [Miyamoto, Hideaki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Iwasaki, Akira] Univ Tokyo, Dept Aerosp & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan; [Takeda, Hiroshi] Chiba Inst Technol, Chiba 2750016, Japan; [Yamaji, Atsushi] Kyoto Univ, Div Earth & Planetary Sci, Sakyo Ku, Kyoto 6068502, Japan; [Josset, Jean-Luc] Space Explorat Inst, CH-2002 Neuchatel, Switzerland	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institute for Environmental Studies - Japan; Brown University; Osaka University; University of Tokyo; University of Tokyo; Chiba Institute of Technology	Haruyama, J (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.		Miyamoto, Hideaki/E-3381-2012; Yamaji, Atsushi/ABB-2815-2021; Miyamoto, Hideaki/B-9666-2008; Matsunaga, Tsuneo/H-3040-2018	Yamaji, Atsushi/0000-0001-8074-543X; Miyamoto, Hideaki/0000-0001-8013-6124; Matsunaga, Tsuneo/0000-0002-3380-5230	KAKENHI [20540416, 20.9211]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the contributors to the SELENE ( Kaguya) project, especially members of the project management group (Y. Takizawa, M. Kato, S. Sasaki, R. Nagashima, K. Tsuruda, and H. Mizutani) and the Lunar Imager/ Spectrometer (LISM) working group (H. Otake, H. Kawasaki, R. Nakamura, S. Kodama, S. Minami, S. Takechi, A. Akiyama, T. Yokota, T. Arai, T. Sugihara, Y. Yamaguchi, S. Sasaki, N. Asada, H. Demura, N. Hirata, J. Terazono, T. Hiroi, T. Hashimoto, T. Michikami, K. Kitazato, M. Higa, P. Pinet, T. Nimura, T. Yamamoto, N. Harada, K. Iseki, T. Hodokuma, S. Kikuchi, S. Kawabe, S. Okuno, and T. Takayama) for their efforts in the development, operation, and data processing of SELENE and LISM/TC. We thank the three anonymous reviewers for their helpful comments. This work was supported by KAKENHI (grants 20540416 to J. H. and C. H. and 20.9211 to T. Morota).	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Campbell DB, 2006, NATURE, V443, P835, DOI 10.1038/nature05167; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P4175, DOI 10.1029/1999JE001129; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Hapke B., 1993, THEORY REFLECTANCE E; Haruyama J, 2008, EARTH PLANETS SPACE, V60, P243, DOI 10.1186/BF03352788; Mukai T, 1997, ADV SPACE RES-SERIES, V19, P1497, DOI 10.1016/S0273-1177(97)00348-7; *NASA, 1969, SP8023 NASA; Nozette S, 1996, SCIENCE, V274, P1495, DOI 10.1126/science.274.5292.1495; Nozette S, 2001, J GEOPHYS RES-PLANET, V106, P23253, DOI 10.1029/2000JE001417; Pike R.J., 1977, IMPACT EXPLOSION CRA, P489; Starukhina LV, 2000, ICARUS, V147, P585, DOI 10.1006/icar.2000.6476; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033	14	50	54	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					938	939		10.1126/science.1164020	http://dx.doi.org/10.1126/science.1164020			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18948501				2022-12-01	WOS:000260674100045
J	Yusufzai, T; Kadonaga, JT				Yusufzai, Timur; Kadonaga, James T.			HARP Is an ATP-Driven Annealing Helicase	SCIENCE			English	Article							REPLICATION PROTEIN-A; CHROMATIN REMODELING PROTEIN; IMMUNO-OSSEOUS DYSPLASIA; DNA; SUBFAMILIES; REGRESSION; CLONING; FAMILY; ENZYME; REPAIR	DNA- dependent adenosine triphosphatases ( ATPases) participate in a broad range of biological processes including transcription, DNA repair, and chromatin dynamics. Mutations in the HepA- related protein ( HARP) ATPase are responsible for Schimke immuno- osseous dysplasia ( SIOD), but the function of the protein is unknown. We found that HARP is an ATP- dependent annealing helicase that rewinds single- stranded DNA bubbles that are stably bound by replication protein A. Other related ATPases, including the DNA translocase Rad54, did not exhibit annealing helicase activity. Analysis of mutant HARP proteins suggests that SIOD is caused by a deficiency in annealing helicase activity. Moreover, the pleiotropy of HARP mutations is consistent with the function of HARP as an annealing helicase that acts throughout the genome to oppose the action of DNA- unwinding activities in the nucleus.	[Yusufzai, Timur; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jkadonaga@ucsd.edu			NIH [GM058272]; NIH National Research Service Award fellowship [F32 GM76936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076936, R01GM058272] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Rattner, J.-Y. A. Hsu, T. Juven-Gershon, D. Urwin, and J. Theisen for critical reading of the manuscript; M. Coleman for the gift of HARP cDNAs in the early stages of this study; M. Wold for the human RPA expression vector; B. Cairns for the triple- helix plasmid; R. Kingston for the BRG1 expression vector; and M. Gellert for a helpful discussion on this work prior to publication. Supported by NIH grant GM058272 (J.T.K.) and by NIH National Research Service Award fellowship F32 GM76936 (T.Y.).	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Coleman MA, 2000, GENOMICS, V65, P274, DOI 10.1006/geno.2000.6174; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Elizondo LI, 2006, AM J MED GENET A, V140A, P340, DOI 10.1002/ajmg.a.31089; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; HOCKENSMITH JW, 1986, BIOCHEMISTRY-US, V25, P7812, DOI 10.1021/bi00372a005; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Muthuswami R, 2000, J BIOL CHEM, V275, P7648, DOI 10.1074/jbc.275.11.7648; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636	19	136	141	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					748	750		10.1126/science.1161233	http://dx.doi.org/10.1126/science.1161233			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974355	Green Accepted			2022-12-01	WOS:000260605200051
J	Nagai, S; Dubrana, K; Tsai-Pflugfelder, M; Davidson, MB; Roberts, TM; Brown, GW; Varela, E; Hediger, F; Gasser, SM; Krogan, NJ				Nagai, Shigeki; Dubrana, Karine; Tsai-Pflugfelder, Monika; Davidson, Marta B.; Roberts, Tania M.; Brown, Grant W.; Varela, Elisa; Hediger, Florence; Gasser, Susan M.; Krogan, Nevan J.			Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; PROTEIN COMPLEXES; YEAST; DYNAMICS; REPAIR; RECOMBINATION; ORGANIZATION; REPLICATION; SUMOYLATION; INSTABILITY	Recent findings suggest important roles for nuclear organization in gene expression. In contrast, little is known about how nuclear organization contributes to genome stability. Epistasis analysis (E-MAP) using DNA repair factors in yeast indicated a functional relationship between a nuclear pore subcomplex and Slx5/Slx8, a small ubiquitin-like modifier (SUMO)-dependent ubiquitin ligase, which we show physically interact. Real-time imaging and chromatin immunoprecipitation confirmed stable recruitment of damaged DNA to nuclear pores. Relocation required the Nup84 complex and Mec1/Tel1 kinases. Spontaneous gene conversion can be enhanced in a Slx8- and Nup84-dependent manner by tethering donor sites at the nuclear periphery. This suggests that strand breaks are shunted to nuclear pores for a repair pathway controlled by a conserved SUMO-dependent E3 ligase.	[Nagai, Shigeki; Tsai-Pflugfelder, Monika; Varela, Elisa; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Nagai, Shigeki; Dubrana, Karine; Hediger, Florence; Gasser, Susan M.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Nagai, Shigeki; Dubrana, Karine; Hediger, Florence; Gasser, Susan M.] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; [Davidson, Marta B.; Roberts, Tania M.; Brown, Grant W.] Univ Toronto, Dept Biochem, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of Geneva; University of Toronto; University of California System; University of California San Francisco	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	dubrana, karine/AAK-1447-2020	dubrana, karine/0000-0002-1269-2564; Brown, Grant/0000-0002-9002-5003; Roberts, Tania/0000-0001-9518-3011; Gasser, Susan/0000-0003-3610-9123	Novartis Research Foundation; Swiss Cancer League; Swiss National Science Foundation; Sandler Family Foundation; NIH; National Cancer Institute of Canada; Canadian Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Novartis Research Foundation; Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sandler Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. E. Haber, M. Lisby, S. Jinks-Robertson, R. Kolodner, and R. Rothstein for generously providing strains; M. Shales for artwork; K. Saeturn and V. Kalck for technical help; and C. J. Ingles, J. E. Haber, and our laboratories for discussions. We acknowledge the Novartis Research Foundation, Swiss Cancer League, Swiss National Science Foundation, Sandler Family Foundation, NIH, National Cancer Institute of Canada, and Canadian Cancer Society for support.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Freedman JA, 2002, GENETICS, V162, P15; Hediger F, 2004, METHOD ENZYMOL, V375, P345; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Mullen JR, 2001, GENETICS, V157, P103; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168	29	327	332	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					597	602		10.1126/science.1162790	http://dx.doi.org/10.1126/science.1162790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948542	Green Accepted			2022-12-01	WOS:000260299100046
J	Konig, R; Zhou, YY; Elleder, D; Diamond, TL; Bonamy, GMC; Irelan, JT; Chiang, CY; Tu, BP; De Jesus, PD; Lilley, CE; Seidel, S; Opaluch, AM; Caldwell, JS; Weitzman, MD; Kuhen, KL; Bandyopadhyay, S; Ideker, T; Orth, AP; Miraglia, LJ; Bushman, FD; Young, JA; Chanda, SK				Konig, Renate; Zhou, Yingyao; Elleder, Daniel; Diamond, Tracy L.; Bonamy, Ghislain M. C.; Irelan, Jeffrey T.; Chiang, Chih-Yuan; Tu, Buu P.; De Jesus, Paul D.; Lilley, Caroline E.; Seidel, Shannon; Opaluch, Amanda M.; Caldwell, Jeremy S.; Weitzman, Matthew D.; Kuhen, Kelli L.; Bandyopadhyay, Sourav; Ideker, Trey; Orth, Anthony P.; Miraglia, Loren J.; Bushman, Frederic D.; Young, John A.; Chanda, Sumit K.			Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication	CELL			English	Article							DNA INTEGRATION; NUCLEAR IMPORT; VIRUS; TRANSCRIPTION; COMPLEX; CHROMATIN	Human Immunodeficiency Viruses (HIV-1 and HIV-2) rely upon host-encoded proteins to facilitate their replication. Here, we combined genome-wide siRNA analyses with interrogation of human interactome databases to assemble a host-pathogen biochemical network containing 213 confirmed host cellular factors and 11 HIV-1-encoded proteins. Protein complexes that regulate ubiquitin conjugation, proteolysis, DNA-damage response, and RNA splicing were identified as important modulators of early-stage HIV-1 infection. Additionally, over 40 new factors were shown to specifically influence the initiation and/or kinetics of HIV-1 DNA synthesis, including cytoskeletal regulatory proteins, modulators of post-translational modification, and nucleic acid-binding proteins. Finally, 15 proteins with diverse functional roles, including nuclear transport, prostaglandin synthesis, ubiquitination, and transcription, were found to influence nuclear import or viral DNA integration. Taken together, the multiscale approach described here has uncovered multiprotein virus-host interactions that likely act in concert to facilitate the early steps of HIV-1 infection.	[Elleder, Daniel; Seidel, Shannon; Young, John A.] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; [Konig, Renate; De Jesus, Paul D.; Opaluch, Amanda M.; Chanda, Sumit K.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Lilley, Caroline E.; Weitzman, Matthew D.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA; [Diamond, Tracy L.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Zhou, Yingyao; Bonamy, Ghislain M. C.; Irelan, Jeffrey T.; Chiang, Chih-Yuan; Tu, Buu P.; Caldwell, Jeremy S.; Kuhen, Kelli L.; Orth, Anthony P.; Miraglia, Loren J.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Bonamy, Ghislain M. C.] Hudson Alpha Inst Biotechnol, Huntsville, AL 35801 USA	Salk Institute; Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; University of California System; University of California San Diego; University of Pennsylvania; Novartis	Young, JA (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyoung@salk.edu; schanda@burnham.org	Elleder, Daniel/G-3551-2014; König, Renate/AAB-8918-2019	König, Renate/0000-0003-4882-9179; Bushman, Frederic/0000-0003-4740-4056; Bonamy, Ghislain/0000-0002-2826-5225; Ideker, Trey/0000-0002-1708-8454	United States National Institutes of Health [1 RO1 AI072645-01, RO1 AI052845]; University of Pennsylvania Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072645, R01AI052845] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Tracy L. Diamond is a Leukemia and Lymphoma Society Fellow (Grant #5217-06). We thank U. O'Doherty and J.J. Yu for technical advice with the Alu-PCR assay and Zhang J. for excellent technical assistance; Walter Tian and Eric Lader (Qiagen GMBGH) for facilitating the acquisition of reagents used for this study; and John Hogenesch for critical feedback on the manuscript. This work was supported by a grant from the United States National Institutes of Health (1 RO1 AI072645-01 to J.A.Y. and RO1 AI052845 to F.D.B.) and the University of Pennsylvania Center for AIDS Research.	Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cartier C, 2003, J BIOL CHEM, V278, P35211, DOI 10.1074/jbc.M301257200; Ciuffi A, 2006, TRENDS GENET, V22, P388, DOI 10.1016/j.tig.2006.05.006; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gomez PF, 2005, J IMMUNOL, V175, P6924, DOI 10.4049/jimmunol.175.10.6924; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.E03-10-0743; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kuraoka I, 2008, J BIOL CHEM, V283, P940, DOI 10.1074/jbc.M706647200; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Mannioui A, 2004, VIROLOGY, V329, P77, DOI 10.1016/j.virol.2004.08.022; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Yueh A, 2006, J VIROL, V80, P342, DOI 10.1128/JVI.80.1.342-352.2006; Zar JH., 1999, BIOSTAT ANAL	33	759	787	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					49	60		10.1016/j.cell.2008.07.032	http://dx.doi.org/10.1016/j.cell.2008.07.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854154	Green Accepted, Bronze			2022-12-01	WOS:000259728100008
J	Whitson, JA; Galinsky, AD				Whitson, Jennifer A.; Galinsky, Adam D.			Lacking control increases illusory pattern perception	SCIENCE			English	Article							SELF-AFFIRMATION; CAUSAL ATTRIBUTION; HELPLESSNESS; EVENTS; DESIRE	We present six experiments that tested whether lacking control increases illusory pattern perception, which we define as the identification of a coherent and meaningful interrelationship among a set of random or unrelated stimuli. Participants who lacked control were more likely to perceive a variety of illusory patterns, including seeing images in noise, forming illusory correlations in stock market information, perceiving conspiracies, and developing superstitions. Additionally, we demonstrated that increased pattern perception has a motivational basis by measuring the need for structure directly and showing that the causal link between lack of control and illusory pattern perception is reduced by affirming the self. Although these many disparate forms of pattern perception are typically discussed as separate phenomena, the current results suggest that there is a common motive underlying them.	[Whitson, Jennifer A.] Univ Texas Austin, Dept Management, Austin, TX 78712 USA; [Galinsky, Adam D.] Northwestern Univ, Dept Management & Org, Evanston, IL 60208 USA	University of Texas System; University of Texas Austin; Northwestern University	Whitson, JA (corresponding author), Univ Texas Austin, Dept Management, Austin, TX 78712 USA.	jennifer.whitson@mccombs.utexas.edu	sarinopoulos, isidoros/B-5453-2010		Kellogg School of Managemen	Kellogg School of Managemen	This work benefited from the generous financial support of the Dean's office of the Kellogg School of Management. We thank C. Appleton, K. Dover-Taylor, L. Howland, and A. Marfia for research help. The research was based in part on the doctoral dissertation submitted by J.W. to Northwestern University and has benefited from the comments of the committee members W. Gardner, V. Medvec, and K. Murnighan. We also thank L. Egan, Z. Kinias, G. Ku, K. Liljenquist, L. Nordgren, N. Sivanathan, C. Wang, and C. Zhong for their helpful comments.	[Anonymous], 2008, ESSENTIALS BEHAV RES; [Anonymous], 1992, MAGIC SCI RELIG OTHE; Brehm J.W., 1966, PSYCHOL REACTANCE TH; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; BURGER JM, 1988, J PERS, V56, P531, DOI 10.1111/j.1467-6494.1988.tb00901.x; CLARY EG, 1983, PERS SOC PSYCHOL B, V9, P609, DOI 10.1177/0146167283094010; Cohen S., 1986, BEHAV HLTH ENV STRES; deCharms R., 1969, PERSONAL CAUSATION; Ekstrom R.B., 1976, KIT FACTOR REFERENCE; GLASS DC, 1972, AM SCI, V60, P457; GLASS DC, 1973, J PERS, V41, P576, DOI 10.1111/j.1467-6494.1973.tb00112.x; GMELCH G, 1971, T ACTION, V9, P39; HASTIE R, 1984, J PERS SOC PSYCHOL, V46, P44, DOI 10.1037/0022-3514.46.1.44; KANAZAWA S, 1992, PERS SOC PSYCHOL B, V18, P659, DOI 10.1177/0146167292186001; Kelley HH., 1971, ATTRIBUTION SOCIAL I; KLEIN DC, 1976, J PERS SOC PSYCHOL, V33, P508, DOI 10.1037/0022-3514.33.5.508; Koole SL, 1999, J PERS SOC PSYCHOL, V77, P111, DOI 10.1037/0022-3514.77.1.111; KRAMER RM, 1994, MOTIV EMOTION, V18, P199, DOI 10.1007/BF02249399; Levine R, 1942, J PSYCHOL, V13, P283, DOI 10.1080/00223980.1942.9917096; LIU TJ, 1986, J PERS SOC PSYCHOL, V51, P531, DOI 10.1037/0022-3514.51.3.531; Luck A, 1999, LANCET, V354, P2032, DOI 10.1016/S0140-6736(98)10495-6; NEUBERG SL, 1993, J PERS SOC PSYCHOL, V65, P113, DOI 10.1037/0022-3514.65.1.113; Pipes Daniel, 1997, CONSPIRACY PARANOID; PITTMAN NL, 1979, J PERS SOC PSYCHOL, V37, P39, DOI 10.1037/0022-3514.37.1.39; PITTMAN TS, 1980, J PERS SOC PSYCHOL, V39, P377, DOI 10.1037/0022-3514.39.3.377; PYSZCZYNSKI TA, 1981, J PERS SOC PSYCHOL, V40, P31, DOI 10.1037/0022-3514.40.1.31; SALES SM, 1973, J PERS SOC PSYCHOL, V28, P44, DOI 10.1037/h0035588; SIMONOV PV, 1977, AVIAT SPACE ENVIR MD, V48, P856; STEELE CM, 1983, J PERS SOC PSYCHOL, V45, P5, DOI 10.1037/0022-3514.45.1.5; WEINER B, 1985, PSYCHOL BULL, V97, P74, DOI 10.1037/0033-2909.97.1.74; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934	32	563	585	13	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					115	117		10.1126/science.1159845	http://dx.doi.org/10.1126/science.1159845			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	355AE	18832647				2022-12-01	WOS:000259680200050
J	Mallet, V; Gilgenkrantz, H; Serpaggi, J; Verkarre, V; Vallet-Pichard, A; Fontaine, H; Pol, S				Mallet, Vincent; Gilgenkrantz, Helene; Serpaggi, Jeanne; Verkarre, Virginie; Vallet-Pichard, Anais; Fontaine, Helene; Pol, Stanislas			Brief communication: The relationship of regression of cirrhosis to outcome in chronic hepatitis C	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-RELATED CIRRHOSIS; SUSTAINED VIROLOGICAL RESPONSE; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; INTERFERON-ALPHA; REVERSIBILITY; THERAPY; RIBAVIRIN; REVERSAL; MANAGEMENT	Background: The effect of regression of cirrhosis in chronic hepatitis C is unknown. Objective: To evaluate the relation between regression of cirrhosis and clinical outcome in patients with chronic hepatitis C after antiviral therapy. Design: A cohort of patients with cirrhosis treated between 1988 and 2001. Setting: Hepatology unit of a tertiary care center in France. Patients: 96 patients with chronic hepatitis C and biopsy-proven cirrhosis (METAVIR score F4) who were treated with an interferon-based regimen and had at least 1 posttreatment liver biopsy. Patients were followed until November 2006. Measurements: Occurrence of a combined end point of liver-related events (ascites, hepatic encephalopathy, variceal bleeding, spontaneous bacterial peritonitis, hepatocellular carcinoma, or liver transplantation) and death in patients with regression of cirrhosis (defined as a decrease from 4 to <= 2 METAVIR units on post-therapy liver biopsy). Results: The median follow-up was 118 months (interquartile range, 86 to 138 months). Eighteen patients had regression of cirrhosis. The incidence of the combined end point per 100 patient-years was 0 in patients with regression of cirrhosis and 4 in patients without regression of cirrhosis (P = 0.002, log-rank test). The transplantation-free survival rate at 10 years was 100% in patients with regression of cirrhosis and 74.2% in patients without regression of cirrhosis (P = 0.025). Limitations: Selection of patients was retrospective; selection and survival biases may have influenced the estimates of the overall rate of regression of cirrhosis. The low number of patients who experienced regression of cirrhosis precludes analysis of factors that could predict regression of cirrhosis. Conclusion: Regression of cirrhosis occurs after antiviral therapy in some patients with chronic hepatitis C. Regression is associated with decreased disease-related morbidity and improved survival.	[Pol, Stanislas] Univ Paris 05, Hop Cochin, INSERM, U567,AP HP, F-75014 Paris, France; Hop Necker Enfants Malad, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Pol, S (corresponding author), Univ Paris 05, Hop Cochin, INSERM, U567,AP HP, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	stanislas.pol@cch.aphp.fr	Gilgenkrantz, Helene/G-5534-2017; Mallet, Vincent/G-4623-2011	gilgenkrantz, helene/0000-0001-6770-4561; Mallet, Vincent/0000-0003-2219-9201				BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bellentani S, 2001, J HEPATOL, V35, P531, DOI 10.1016/S0168-8278(01)00151-9; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Desmet VJ, 2004, J HEPATOL, V40, P860, DOI 10.1016/j.jhep.2004.03.007; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; El Braks R, 2007, WORLD J GASTROENTERO, V13, P5648, DOI 10.3748/wjg.v13.i42.5648; Farci P, 2004, GASTROENTEROLOGY, V126, P1740, DOI 10.1053/j.gastro.2004.03.017; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fontaine H, 2000, LANCET, V356, P41, DOI 10.1016/S0140-6736(00)02434-X; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Kaplan MM, 1997, ANN INTERN MED, V126, P682, DOI 10.7326/0003-4819-126-9-199705010-00002; Mallet VO, 2007, ANTIVIR THER, V12, P279; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; ORLANDO R, 1990, J CLIN GASTROENTEROL, V12, P47; Papatheodoridis GV, 2001, ALIMENT PHARM THER, V15, P689, DOI 10.1046/j.1365-2036.2001.00979.x; Pol S, 2004, HUM PATHOL, V35, P107, DOI 10.1016/j.humpath.2003.08.012; POWELL LW, 1970, AUSTRALAS ANN MED, V19, P54; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Serpaggi J, 2006, HUM PATHOL, V37, P1519, DOI 10.1016/j.humpath.2006.07.007; Shiratori Y, 2003, ANN INTERN MED, V138, P299, DOI 10.7326/0003-4819-138-4-200302180-00008; SOYER MT, 1976, SURGERY, V79, P601; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Valla DC, 1999, HEPATOLOGY, V29, P1870, DOI 10.1002/hep.510290616; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003	31	233	243	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					399	W76		10.7326/0003-4819-149-6-200809160-00006	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794559				2022-12-01	WOS:000259230200004
J	Bredemeyer, AL; Helmink, BA; Innes, CL; Calderon, B; McGinnis, LM; Mahowald, GK; Gapud, EJ; Walker, LM; Collins, JB; Weaver, BK; Mandik-Nayak, L; Schreiber, RD; Allen, PM; May, MJ; Paules, RS; Bassing, CH; Sleckman, BP				Bredemeyer, Andrea L.; Helmink, Beth A.; Innes, Cynthia L.; Calderon, Boris; McGinnis, Lisa M.; Mahowald, Grace K.; Gapud, Eric J.; Walker, Laura M.; Collins, Jennifer B.; Weaver, Brian K.; Mandik-Nayak, Laura; Schreiber, Robert D.; Allen, Paul M.; May, Michael J.; Paules, Richard S.; Bassing, Craig H.; Sleckman, Barry P.			DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes	NATURE			English	Article							NF-KAPPA-B; LEAKY SCID PHENOTYPE; V(D)J RECOMBINATION; LYMPHOID ORGANS; IONIZING-RADIATION; BONE-MARROW; ATM; EXPRESSION; DAMAGE; DIFFERENTIATION	DNA double- strand breaks are generated by genotoxic agents and by cellular endonucleases as intermediates of several important physiological processes. The cellular response to genotoxic DNA breaks includes the activation of transcriptional programs known primarily to regulate cell- cycle checkpoints and cell survival(1-5). DNA double- strand breaks are generated in all developing lymphocytes during the assembly of antigen receptor genes, a process that is essential for normal lymphocyte development. Here we show that in murine lymphocytes these physiological DNA breaks activate a broad transcriptional program. This program transcends the canonical DNA double- strand break response and includes many genes that regulate diverse cellular processes important for lymphocyte development. Moreover, the expression of several of these genes is regulated similarly in response to genotoxic DNA damage. Thus, physiological DNA double- strand breaks provide cues that can regulate cell- type- specific processes not directly involved in maintaining the integrity of the genome, and genotoxic DNA breaks could disrupt normal cellular functions by corrupting these processes.	[Bredemeyer, Andrea L.; Helmink, Beth A.; Calderon, Boris; McGinnis, Lisa M.; Mahowald, Grace K.; Gapud, Eric J.; Walker, Laura M.; Weaver, Brian K.; Mandik-Nayak, Laura; Schreiber, Robert D.; Allen, Paul M.; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Innes, Cynthia L.; Collins, Jennifer B.; Paules, Richard S.] NIEHS, Environm Stress & Canc Grp, Res Triangle Pk, NC 27709 USA; [Innes, Cynthia L.; Collins, Jennifer B.; Paules, Richard S.] NIEHS, Microarray Grp, Res Triangle Pk, NC 27709 USA; [May, Michael J.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Bassing, Craig H.] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Ctr Childhood Canc Res,Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bassing, Craig H.] Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Sleckman@immunology.wustl.edu	Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432; Bredemeyer, Andrea/0000-0003-2970-5998; Calderon, Boris/0000-0003-1575-0739; Helmink, Beth/0000-0002-8206-0351; Mahowald, Grace/0000-0003-4541-4920; Paules, Richard S/0000-0001-9106-7486; May, Michael/0000-0002-2485-3716; Schreiber, Robert/0000-0003-1590-2341	National Institutes of Health [AI47829]; Washington University Department of Pathology and Immunology; Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia; Abramson Family Cancer Research Institute; National Institute of Environmental Health Sciences; Research Scholar Award from the American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA125195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Department of Pathology and Immunology; Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia; Abramson Family Cancer Research Institute; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Research Scholar Award from the American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Bednarski, B. Van Honten andM. Diaz for critical review of the manuscript, F. W. Alt for providing us with the Artemis 2/2 mice and D. Ballard for providing us with the I kappa B alpha-Delta N construct. This research is supported by the National Institutes of Health (NIH, grant AI47829) and the Washington University Department of Pathology and Immunology ( to B.P.S.); the Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia, and the Abramson Family Cancer Research Institute (to C.H.B.); and the intramural research program of the NIH, National Institute of Environmental Health Sciences (to R.S.P.). B.P.S. is a recipient of a Research Scholar Award from the American Cancer Society. C.H.B. is a Pew Scholar in the Biomedical Sciences. A.L.B. is supported by a post-doctoral training grant from the NIH.	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Grawunder U, 1996, EUR J BIOCHEM, V241, P931, DOI 10.1111/j.1432-1033.1996.00931.x; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Innes CL, 2006, MOL CANCER RES, V4, P197, DOI 10.1158/1541-7786.MCR-05-0154; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Mandik-Nayak L, 2006, J EXP MED, V203, P1985, DOI 10.1084/jem.20060701; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Weaver BK, 2007, MOL CELL BIOL, V27, P4603, DOI 10.1128/MCB.00223-07; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	38	109	114	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					819	U113		10.1038/nature07392	http://dx.doi.org/10.1038/nature07392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18849970	Green Accepted			2022-12-01	WOS:000261559900055
J	Greenberg, JI; Shields, DJ; Barillas, SG; Acevedo, LM; Murphy, E; Huang, JH; Scheppke, L; Stockmann, C; Johnson, RS; Angle, N; Cheresh, DA				Greenberg, Joshua I.; Shields, David J.; Barillas, Samuel G.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Stockmann, Christian; Johnson, Randall S.; Angle, Niren; Cheresh, David A.			A role for VEGF as a negative regulator of pericyte function and vessel maturation	NATURE			English	Article							GROWTH-FACTOR PDGF; INDUCED ANGIOGENESIS; ENDOTHELIAL-CELLS; IN-SITU; BETA; BB; DIFFERENTIATION; RECRUITMENT; INHIBITION; PROMOTES	Angiogenesis does not only depend on endothelial cell invasion and proliferation: it alsorequires pericyte coverage of vascular sprouts for vessel stabilization(1,2). These processes are coordinated by vascular endothelial growth factor ( VEGF) and platelet- derived growth factor ( PDGF) through their cognate receptors on endothelial cells and vascular smooth muscle cells ( VSMCs), respectively(3,4). PDGF induces neovascularization by priming VSMCs/pericytes to release proangiogenic mediators(5-7). Although VEGF directly stimulates endothelial cell proliferation and migration, its role in pericyte biology is less clear. Here we define a role for VEGF as an inhibitor of neovascularization on the basis of its capacity to disrupt VSMC function. Specifically, under conditions of PDGF- mediated angiogenesis, VEGF ablates pericyte coverage of nascent vascular sprouts, leading to vessel destabilization. At the molecular level, VEGF- mediated activation of VEGF- R2 suppresses PDGF- R beta signalling in VSMCs through the assembly of a previously undescribed receptor complex consisting of PDGF- Rb and VEGF- R2. Inhibition of VEGF- R2 not only prevents assembly of this receptor complex but also restores angiogenesis in tissues exposed to both VEGF and PDGF. Finally, genetic deletion of tumour cell VEGF disrupts PDGF-R beta/VEGF-R2 complex formation and increases tumour vessel maturation. These findings underscore the importance of VSMCs/ pericytes in neovascularization(8,9) and reveal a dichotomous role forVEGF and VEGF-R2 signalling as both a promoter of endothelial cell function and a negative regulator of VSMCs and vessel maturation.	[Shields, David J.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Greenberg, Joshua I.; Barillas, Samuel G.; Angle, Niren] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Shields, David J.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Cheresh, David A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Stockmann, Christian; Johnson, Randall S.] Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	Johnson, Randall/AAM-1189-2021; Stockmann, Christian/L-6956-2017; Stockmann, Christian/Q-1615-2017	Johnson, Randall/0000-0002-4084-6639; Stockmann, Christian/0000-0002-9726-6838	National Institutes of Health [R37-CA50286, CA082515, GM 68524]; University of California Academic Senate Grant; Deutsche Forschungsgemeinschaft [DFG STO 787/1-1]; Institutional Research and Academic Career Development Award; NATIONAL CANCER INSTITUTE [R01CA095262, R01CA082515, P01CA078045, R01CA118165, R21CA129660, R37CA050286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Academic Senate Grant(University of California System); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institutional Research and Academic Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Stupack and D. Schlaepfer for advice and review of the manuscript. We also thank A. Tomar for assistance with the PLA imaging; C. Heldin for the PDGF-Rb complementary DNA; and J. Desgrosellier for processing pancreatic tumour samples. This work was supported by National Institutes of Health grants R37-CA50286 (D.A.C.) and CA082515 (R.S.J.), and by a University of California Academic Senate Grant (N.A.). C.S. was funded by the Deutsche Forschungsgemeinschaft (DFG STO 787/1-1), and L.M.A. received an Institutional Research and Academic Career Development Award postdoctoral fellowship (National Institutes of Health grant GM 68524).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Alavi AS, 2007, CANCER RES, V67, P2766, DOI 10.1158/0008-5472.CAN-06-3648; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fong TAT, 1999, CANCER RES, V59, P99; GRUNSTEIN J, 2004, CANCER RES, V23, P2800; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; INUI H, 1994, J BIOL CHEM, V269, P30546; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LUO J, 2007, NATURE PROTOC, V2, P1536; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Sennino B, 2007, CANCER RES, V67, P7358, DOI 10.1158/0008-5472.CAN-07-0293; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Vincent L, 2004, CANCER CELL, V6, P307, DOI 10.1016/j.ccr.2004.09.024; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988	27	469	499	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					809	U101		10.1038/nature07424	http://dx.doi.org/10.1038/nature07424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18997771	Green Accepted, Green Submitted			2022-12-01	WOS:000261559900053
J	Zilberman, D; Coleman-Derr, D; Ballinger, T; Henikoff, S				Zilberman, Daniel; Coleman-Derr, Devin; Ballinger, Tracy; Henikoff, Steven			Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks	NATURE			English	Article							GENOME-WIDE; VARIANT; ARABIDOPSIS; NUCLEOSOME; PROMOTERS; GENES; EUCHROMATIN; DYNAMICS; YEAST	Eukaryotic chromatin is separated into functional domains differentiated by post- translational histone modifications, histone variants and DNA methylation(1-6). Methylation is associated with repression of transcriptional initiation in plants and animals, and is frequently found in transposable elements. Proper methylation patterns are crucial for eukaryotic development(4,5), and aberrant methylation- induced silencing of tumour suppressor genes is a common feature of human cancer(7). In contrast to methylation, the histone variant H2A. Z is preferentially deposited by the Swr1 ATPase complex near 59 ends of genes where it promotes transcriptional competence(8-20). How DNA methylation and H2A.Z influence transcription remains largely unknown. Here we show that in the plant Arabidopsis thaliana regions of DNA methylation are quantitatively deficient in H2A.Z. Exclusion of H2A.Z is seen at sites of DNA methylation in the bodies of actively transcribed genes and in methylated transposons. Mutation of the MET1 DNA methyltransferase, which causes both losses and gains of DNA methylation(4,5), engenders opposite changes ( gains and losses) in H2A.Z deposition, whereas mutation of the PIE1 subunit of the Swr1 complex that deposits H2A.Z(17) leads to genome- wide hypermethylation. Our findings indicate that DNA methylation can influence chromatin structure and effect gene silencing by excluding H2A.Z, and that H2A.Z protects genes from DNA methylation.	[Zilberman, Daniel; Coleman-Derr, Devin] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ballinger, Tracy; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Ballinger, Tracy; Henikoff, Steven] Howard Hughes Med Inst, Seattle, WA 98109 USA	University of California System; University of California Berkeley; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Zilberman, D (corresponding author), Univ Calif Berkeley, 211 Koshland Hall, Berkeley, CA 94720 USA.	daniel.zilberman@nature.berkely.edu; steveh@fhcrc.org	Hu, Ruogu/B-2203-2008	Zilberman, Daniel/0000-0002-0123-8649; Henikoff, Steven/0000-0002-7621-8685	NSF	NSF(National Science Foundation (NSF))	We thank J. Henikoff and B. Nguyen for help with computational analyses, P. Talbert for assistance with cytology, T. Bryson and A. Morgan for technical support, M. Gehring and B. Staskawicz for the root culture protocol, R. Deal and R. Meagher for H2A.Z antibodies, the FHCRC DNA array facility for carrying out microarray hybridizations, and M. Orozco for transgenic lines. D.C.-D. is supported by an NSF predoctoral fellowship. D. Z. is a Leukemia and Lymphoma Society fellow.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	30	393	407	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					125	U14		10.1038/nature07324	http://dx.doi.org/10.1038/nature07324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18815594	Green Accepted			2022-12-01	WOS:000260674000054
J	Goodarzi, MO; Psaty, BM				Goodarzi, Mark O.; Psaty, Bruce M.			Glucose Lowering to Control Macrovascular Disease in Type 2 Diabetes Treating the Wrong Surrogate End Point?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; BLOOD-GLUCOSE; INSULIN; HYPERINSULINEMIA; EVENTS; TRIAL; RISK		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Inst Med Genet, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu	Goodarzi, Mark/AAH-7106-2021	Goodarzi, Mark/0000-0001-6364-5103	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL074745, R01HL080295, R01HL085251, R01HL087652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079888] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL087652, HL080295, HL74745, HL085251] Funding Source: Medline; NIDDK NIH HHS [DK079888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; Dandona P, 2004, METAB SYNDR RELAT D, V2, P137, DOI 10.1089/met.2004.2.137; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goalstone ML, 1998, ENDOCRINOLOGY, V139, P4067, DOI 10.1210/en.139.10.4067; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; HOLMAN RR, 10 YEAR FOLLOW UP IN; Kronmal RA, 2004, J CLIN ENDOCR METAB, V89, P2852, DOI 10.1210/jc.2003-031822; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Port SC, 2006, AM J EPIDEMIOL, V163, P342, DOI 10.1093/aje/kwj027; Pyorala M, 1998, CIRCULATION, V98, P398, DOI 10.1161/01.CIR.98.5.398; Schwartz TB, 2004, PERSPECT BIOL MED, V47, P564, DOI 10.1353/pbm.2004.0071; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	15	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2051	2053		10.1001/jama.2008.510	http://dx.doi.org/10.1001/jama.2008.510			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984894				2022-12-01	WOS:000260605400028
J	Leaper, D; Burman-Roy, S; Palanca, A; Cullen, K; Worster, D; Gautam-Aitken, E; Whittle, M				Leaper, David; Burman-Roy, Shona; Palanca, Ana; Cullen, Katherine; Worster, Danielle; Gautam-Aitken, Eva; Whittle, Martin		Guideline Dev Grp	GUIDELINES Prevention and treatment of surgical site infection: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Leaper, David; Burman-Roy, Shona; Palanca, Ana; Cullen, Katherine; Worster, Danielle; Gautam-Aitken, Eva; Whittle, Martin] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Leaper, David] Cardiff Univ, Dept Wound Healing, Cardiff, S Glam, Wales	Cardiff University	Leaper, D (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, Kings Court,2-16 Goodge St, London W1T 2QA, England.	profdavidleaper@doctors.org.uk	Palanca, Ana/E-1541-2018	Palanca, Ana/0000-0003-3513-4458; Cullen, Katherine/0000-0002-3704-4598	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Women's and Children's Health was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	National Institute for Health and Clinical Excellence, 2008, SURG SIT INF; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020	2	66	70	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a1924	10.1136/bmj.a1924	http://dx.doi.org/10.1136/bmj.a1924			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18957455				2022-12-01	WOS:000260593700032
J	Kelleher, RJ; Bear, MF				Kelleher, Raymond J., III; Bear, Mark F.			The Autistic Neuron: Troubled Translation?	CELL			English	Article							LONG-TERM DEPRESSION; FRAGILE-X-SYNDROME; OCULAR DOMINANCE PLASTICITY; DENDRITIC PROTEIN-SYNTHESIS; MAMMALIAN-CELL SIZE; SYNAPTIC PLASTICITY; MOUSE MODEL; TUBEROUS-SCLEROSIS; MENTAL-RETARDATION; SPECTRUM DISORDERS	Autism is a complex genetic disorder, but single-gene disorders with a high prevalence of autism offer insight into its pathogenesis. Recent evidence suggests that some molecular defects in autism may interfere with the mechanisms of synaptic protein synthesis. We propose that aberrant synaptic protein synthesis may represent one possible pathway leading to autistic phenotypes, including cognitive impairment and savant abilities.	[Kelleher, Raymond J., III] Harvard Univ, Sch Med, Harvard Partners Ctr, Ctr Human Genet Res, Boston, MA 02115 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Program Neurosci,Autism Consortium, Boston, MA 02115 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Bear, Mark F.] Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Bear, Mark F.] MIT, Autism Consortium, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Northwell Health; Massachusetts Institute of Technology (MIT)	Kelleher, RJ (corresponding author), Harvard Univ, Sch Med, Harvard Partners Ctr, Ctr Human Genet Res, Boston, MA 02115 USA.	kelleher@helix.mgh.harvard.edu; mbear@mit.edu		Bear, Mark/0000-0002-9903-2541				Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Courchesne E, 2004, CURR OPIN NEUROL, V17, P489, DOI 10.1097/01.wco.0000137542.14610.b4; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dasgupta B, 2003, CURR OPIN GENET DEV, V13, P20, DOI 10.1016/S0959-437X(02)00015-1; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Hanson JE, 2007, J NEUROSCI, V27, P4014, DOI 10.1523/JNEUROSCI.4717-06.2007; Heaton P, 2004, J CHILD PSYCHOL PSYC, V45, P899, DOI 10.1111/j.1469-7610.2004.t01-1-00284.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kanner L, 1943, NERV CHILD, V2, P217; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Maffei L, 2002, NEURON, V34, P328, DOI 10.1016/S0896-6273(02)00688-8; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zho WM, 2002, J NEUROSCI, V22, P8838; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	60	419	433	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					401	406		10.1016/j.cell.2008.10.017	http://dx.doi.org/10.1016/j.cell.2008.10.017			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984149	Bronze			2022-12-01	WOS:000260536300008
J	Williams, LE; Bargh, JA				Williams, Lawrence E.; Bargh, John A.			Experiencing physical warmth promotes interpersonal warmth	SCIENCE			English	Article							UNIVERSAL DIMENSIONS; SOCIAL-PERCEPTION; 1ST IMPRESSIONS	"Warmth" is the most powerful personality trait in social judgment, and attachment theorists have stressed the importance of warm physical contact with caregivers during infancy for healthy relationships in adulthood. Intriguingly, recent research in humans points to the involvement of the insula in the processing of both physical temperature and interpersonal warmth (trust) information. Accordingly, we hypothesized that experiences of physical warmth (or coldness) would increase feelings of interpersonal warmth (or coldness), without the person's awareness of this influence. In study 1, participants who briefly held a cup of hot (versus iced) coffee judged a target person as having a "warner" personality (generous, caring); in study 2, participants holding a hot (versus cold) therapeutic pad were more likely to choose a gift for a friend instead of for themselves.	[Williams, Lawrence E.] Univ Colorado, Leeds Sch Business, Boulder, CO 80309 USA; [Bargh, John A.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	University of Colorado System; University of Colorado Boulder; Yale University	Williams, LE (corresponding author), Univ Colorado, Leeds Sch Business, UCB 419, Boulder, CO 80309 USA.	lawrence.williams@colorado.edu	Williams, Lawrence/AAE-1725-2021		National Institute of Mental Health [MH-R01-60767]; NSF Graduate Research Fellowship; Yale International Center for Finance Whitebox Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060767] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Yale International Center for Finance Whitebox Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Bloom, J. Gray, F. Keil, E. Morsella, A. Poehlman, P. Winkielman, S. Gottlieb, K Connolly, S. Hennessey, and funding from National Institute of Mental Health (grant MH-R01-60767), a NSF Graduate Research Fellowship, and a Yale International Center for Finance Whitebox Fellowship.	Asch S., 1958, PERSON PERCEPTION IN, P86; ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; Balter M, 2007, SCIENCE, V315, P1208, DOI 10.1126/science.315.5816.1208; Bowlby J., 1969, ATTACHMENT LOSS, V1; Clark H.H., 1973, COGNITIVE DEV ACQUIS, P27, DOI DOI 10.1016/B978-0-12-505850-6.50008-6; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; Higgins E.T., 1996, SOCIAL PSYCHOL HDB B, P133; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Johnson M., 1987, BODY MIND BODILY BAS; KELLEY HH, 1950, J PERS, V18, P431, DOI 10.1111/j.1467-6494.1950.tb01260.x; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Lorenz K., 1966, AGGRESSION; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; Meyer-Lindenberg A, 2008, SCIENCE, V321, P778, DOI 10.1126/science.1162908; Niedenthal PM, 1999, PSYCHOL REV, V106, P337, DOI 10.1037/0033-295X.106.2.337; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sweetser E., 1990, ETYMOLOGY PRAGMATICS, V54; TAIMY L, 1988, COGNITIVE SCI, V12, P49; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wojciszke B, 1998, PERS SOC PSYCHOL B, V24, P1251, DOI 10.1177/01461672982412001	26	628	664	14	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					606	607		10.1126/science.1162548	http://dx.doi.org/10.1126/science.1162548			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948544	Green Accepted, Green Submitted			2022-12-01	WOS:000260299100048
J	Kim, N; Stiegler, AL; Cameron, TO; Hallock, PT; Gomez, AM; Huang, JH; Hubbard, SR; Dustin, ML; Burden, SJ				Kim, Natalie; Stiegler, Amy L.; Cameron, Thomas O.; Hallock, Peter T.; Gomez, Andrea M.; Huang, Julie H.; Hubbard, Stevan R.; Dustin, Michael L.; Burden, Steven J.			Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK	CELL			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; MUSCLE-SPECIFIC KINASE; ALPHA-DYSTROGLYCAN; SYNAPSE; PHOSPHORYLATION; AGGREGATION; PROTEIN-4; MEMBRANE; CALCIUM; PATHWAY	Neuromuscular synapse formation requires a complex exchange of signals between motor neurons and skeletal muscle fibers, leading to the accumulation of postsynaptic proteins, including acetylcholine receptors in the muscle membrane and specialized release sites, or active zones in the presynaptic nerve terminal. MuSK, a receptor tyrosine kinase that is expressed in skeletal muscle, and Agrin, a motor neuron-derived ligand that stimulates MuSK phosphorylation, play critical roles in synaptic differentiation, as synapses do not form in their absence, and mutations in MuSK or downstream effectors are a major cause of a group of neuromuscular disorders, termed congenital myasthenic syndromes (CMS). How Agrin activates MuSK and stimulates synaptic differentiation is not known and remains a fundamental gap in our understanding of signaling at neuromuscular synapses. Here, we report that Lrp4, a member of the LDLR family, is a receptor for Agrin, forms a complex with MuSK, and mediates MuSK activation by Agrin.	[Kim, Natalie; Stiegler, Amy L.; Hallock, Peter T.; Gomez, Andrea M.; Burden, Steven J.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA; [Stiegler, Amy L.; Hubbard, Stevan R.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Struct Biol Program, New York, NY 10016 USA; [Cameron, Thomas O.; Huang, Julie H.; Dustin, Michael L.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Pathogenesis Program, New York, NY 10016 USA	New York University; New York University; New York University	Burden, SJ (corresponding author), NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	burden@saturn.med.nyu.edu	Tuluc, Petronel/C-2527-2011; Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Hubbard, Stevan/0000-0002-2707-9383; Gomez, Andrea/0000-0002-2923-6362; Burden, Steven/0000-0002-3550-6891	National Cancer Institute Cancer Center Support [P30 CA016087]; National Institutes of Health [NS36193, R21 GM075180]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036193, R01NS053414, R01NS036193] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Katherine Anderson, Lee Niswander, and Scott Weatherbee for providing us with lrp4 mutant mice and David Russell for the human LDLR plasmid. We are grateful to Jihua Fan for excellent technical assistance and Peter Lopez for help with the flow cytometry analysis. The flow cytometry core is supported by a National Cancer Institute Cancer Center Support Grant (P30 CA016087). This work was supported with funds from the National Institutes of Health (NS36193 to S. J. B., R21 GM075180 to M.	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Beeson D, 2008, ANN NY ACAD SCI, V1132, P99, DOI 10.1196/annals.1405.049; Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Dustin ML, 2007, J BIOL CHEM, V282, P34748, DOI 10.1074/jbc.M705616200; Dustin ML, 1997, J BIOL CHEM, V272, P15782, DOI 10.1074/jbc.272.25.15782; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Engel AG, 2008, ANN NY ACAD SCI, V1132, P104, DOI 10.1196/annals.1405.039; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1996, COLD SPRING HARB SYM, V61, P435; Glass DJ, 1997, CURR OPIN NEUROBIOL, V7, P379, DOI 10.1016/S0959-4388(97)80066-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1093/emboj/19.1.67; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Hopf C, 1998, EUR J BIOCHEM, V253, P382, DOI 10.1046/j.1432-1327.1998.2530382.x; Jacobson C, 1998, J NEUROSCI, V18, P6340; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kleiman RJ, 1996, CELL, V85, P461, DOI 10.1016/S0092-8674(00)81245-3; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Megeath LJ, 1998, J NEUROSCI, V18, P672; Meier T, 1996, EMBO J, V15, P2625, DOI 10.1002/j.1460-2075.1996.tb00622.x; Mittaud P, 2004, MOL CELL BIOL, V24, P7841, DOI 10.1128/MCB.24.18.7841-7854.2004; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Tian QB, 2006, EUR J NEUROSCI, V23, P2864, DOI 10.1111/j.1460-9568.2006.04846.x; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Vincent A, 2005, CURR OPIN NEUROL, V18, P519, DOI 10.1097/01.wco.0000180660.57801.3f; Vincent Angela, 2002, Adv Neurol, V88, P159; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	47	458	477	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					334	342		10.1016/j.cell.2008.10.002	http://dx.doi.org/10.1016/j.cell.2008.10.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18848351	Green Accepted, Bronze			2022-12-01	WOS:000260130400022
J	Rodeheffer, MS; Birsoy, K; Friedman, JM				Rodeheffer, Matthew S.; Birsoy, Kivanc; Friedman, Jeffrey M.			Identification of White Adipocyte Progenitor Cells In Vivo	CELL			English	Article							MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; ADIPOSE-TISSUE; HEMATOPOIETIC STEM; FAT PADS; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MAMMARY-GLAND; CELLULARITY; OBESITY	The increased white adipose tissue (WAT) mass associated with obesity is the result of both hyperplasia and hypertrophy of adipocytes. However, the mechanisms controlling adipocyte number are unknown in part because the identity of the physiological adipocyte progenitor cells has not been defined in vivo. In this report, we employ a variety of approaches, including a noninvasive assay for following fat mass reconstitution in vivo, to identify a subpopulation of early adipocyte progenitor cells (Lin(-): CD29(+): CD34(+): Sca-1(+): CD24(+)) resident in adult WAT. When injected into the residual fat pads of A-Zip lipodystrophic mice, these cells reconstitute a normal WAT depot and rescue the diabetic phenotype that develops in these animals. This report provides the identification of an undifferentiated adipocyte precursor subpopulation resident within the adipose tissue stroma that is capable of proliferating and differentiating into an adipose depot in vivo.	[Rodeheffer, Matthew S.; Birsoy, Kivanc; Friedman, Jeffrey M.] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Rodeheffer, Matthew S.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10065 USA.	friedj@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BERNLOHR DA, 1985, J BIOL CHEM, V260, P5563; Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cinti S, 2000, METH MOL B, V155, P21; CINTI S, 1984, J SUBMICR CYTOL PATH, V16, P243; DEOME KB, 1959, CANCER RES, V19, P515; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036; FORD CE, 1956, NATURE, V177, P452, DOI 10.1038/177452a0; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gonzalez FJ, 2005, CELL METAB, V1, P85, DOI 10.1016/j.cmet.2005.01.004; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hong L, 2006, CELLS TISSUES ORGANS, V183, P133, DOI 10.1159/000095987; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; JOHNSON PR, 1971, J LIPID RES, V12, P706; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lane MD, 2005, BIRTH DEFECTS RES A, V73, P476, DOI 10.1002/bdra.20150; Lee JH, 2005, EXP CELL RES, V307, P174, DOI 10.1016/j.yexcr.2005.03.008; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; LEMONNIER D, 1970, EXPERIENTIA, V26, P974, DOI 10.1007/BF02114140; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SIMON G, 1965, HDB PHYSL 5; SMITH GH, 1988, J CELL SCI, V90, P173; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; TANG W, 2008, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1156232; Thayer KA, 2001, HUM REPROD, V16, P988, DOI 10.1093/humrep/16.5.988; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; WASSERMANN F, 1926, Z ZELLFORSCH MIKROSK, V3, P325; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; WISE A, 1975, NUTR METAB, V19, P291; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	54	658	678	5	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					240	249		10.1016/j.cell.2008.09.036	http://dx.doi.org/10.1016/j.cell.2008.09.036			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18835024	Bronze			2022-12-01	WOS:000260130400014
J	Yawar, A				Yawar, Athar			Can doctors think?	LANCET			English	Editorial Material									[Yawar, Athar] The Lancet, London NW1 7BY, England		Yawar, A (corresponding author), The Lancet, London NW1 7BY, England.							Borges Jorge Luis, 1970, ALEPH OTHER STORIES; DEIKMAN A, 1982, OBSERVING SELF; Evans-Pritchard E E, 1951, WITCHCRAFT ORACLES M; Illich I., 1995, LIMITS MED; Illich I., 1970, DESCHOOLING SOC; Kingsley P., 2003, REALITY INVERNESS; LESSING D, 1994, PRISONS WE CHOOSE LI; Littlewood R., 2000, CULTURAL PSYCHIAT ME; Micale Mark, 1995, APPROACHING HYSTERIA; Owen GS, 2007, BRIT J PSYCHIAT, V191, P453, DOI 10.1192/bjp.bp.107.037309; Polanyi M., 1962, PERSONAL KNOWLEDGE; RAHNEMA M, 1997, POST DEV READER; SHAH I, 1982, SEEKER TRUTH	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1285	1286		10.1016/S0140-6736(08)61533-0	http://dx.doi.org/10.1016/S0140-6736(08)61533-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929891				2022-12-01	WOS:000260060500010
J	Murray, H; Errington, J				Murray, Heath; Errington, Jeff			Dynamic control of the DNA replication initiation protein DnaA by Soj/ParA	CELL			English	Article							BACTERIAL CHROMOSOME SEGREGATION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SPO0J PARB; SOJ PARA; PSEUDOMONAS-AERUGINOSA; PARTITIONING PROTEIN; CELL-DIVISION; SPORULATION; PLASMID	Regulation of DNA replication and segregation is essential for all cells. Orthologs of the plasmid partitioning genes parA, parB, and parS are present in bacterial genomes throughout the prokaryotic evolutionary tree and are required for accurate chromosome segregation. However, the mechanism(s) by which parABS genes ensure proper DNA segregation have remained unclear. Here we report that the ParA ortholog in B. subtilis (Soj) controls the activity of the DNA replication initiator protein DnaA. Subcellular localization of several Soj mutants indicates that Soj acts as a spatially regulated molecular switch, capable of either inhibiting or activating DnaA. We show that the classical effect of Soj inhibiting sporulation is an indirect consequence of its action on DnaA through activation of the Sda DNA replication checkpoint. These results suggest that the pleiotropy manifested by chromosomal parABS mutations could be the indirect effects of a primary activity regulating DNA replication initiation.	[Murray, Heath; Errington, Jeff] Univ Newcastle Upon Tyne, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Murray, H (corresponding author), Univ Newcastle Upon Tyne, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	heath.murray@ncl.ac.uk	Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388; Murray, Heath/0000-0002-6467-3656	BBSRC [43/G18654]; European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP)	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	We thank Kenn Gerdes, Stephan Gruber, Leendert Hamoen, Christine Jacobs-Wagner, and Ling Juan Wu for critical reading of the manuscript. We thank Richard Daniel, Yoshikazu Kawai, and Ian Selmes for scientific and technical assistance. We are grateful to the Grossman Lab (MIT) for strains and Soj antibodies, to the Burkholder Lab (Stanford) for strains and communicating results prior to publication, and to the Spiegelman Lab for communicating results prior to publication. This work was supported by grant number 43/G18654 from the BBSRC to J.E. H.M. was supported by postdoctoral fellowships from the European Molecular Biology Organization (EMBO) and the Human Frontier Science Program (HFSP).	AUSTIN S, 1983, J MOL BIOL, V169, P373, DOI 10.1016/S0022-2836(83)80056-4; Autret S, 2003, MOL MICROBIOL, V47, P159, DOI 10.1046/j.1365-2958.2003.03264.x; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Carr KM, 1996, MOL MICROBIOL, V20, P1307, DOI 10.1111/j.1365-2958.1996.tb02649.x; Cervin MA, 1998, MOL MICROBIOL, V29, P85, DOI 10.1046/j.1365-2958.1998.00905.x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Errington J, 2005, PHILOS T R SOC B, V360, P497, DOI 10.1098/rstb.2004.1605; ERRINGTON J, 1983, J GEN MICROBIOL, V129, P2091; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Godfrin-Estevenon AM, 2002, MOL MICROBIOL, V43, P39, DOI 10.1046/j.1365-2958.2002.02735.x; Hassan AKM, 1997, J BACTERIOL, V179, P2494, DOI 10.1128/jb.179.8.2494-2502.1997; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; HRANUELI D, 1974, J BACTERIOL, V119, P684, DOI 10.1128/JB.119.3.684-690.1974; Imai Y, 2000, MOL MICROBIOL, V36, P1037, DOI 10.1046/j.1365-2958.2000.01928.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Ishikawa S, 2007, DNA RES, V14, P155, DOI 10.1093/dnares/dsm017; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Kornberg A., 1992, DNA REPLICATION; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lewis RA, 2002, MICROBIOL-SGM, V148, P537, DOI 10.1099/00221287-148-2-537; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; LOVE PE, 1984, J BACTERIOL, V160, P910, DOI 10.1128/JB.160.3.910-920.1984; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; McLeod BN, 2005, J BACTERIOL, V187, P2532, DOI 10.1128/JB.187.7.2532-2536.2005; Messer W, 2001, BIOCHIMIE, V83, P5, DOI 10.1016/S0300-9084(00)01216-5; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Moriya S, 1997, DNA Res, V4, P115, DOI 10.1093/dnares/4.2.115; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Ogura Y, 2003, J BACTERIOL, V185, P6316, DOI 10.1128/JB.185.21.6316-6324.2003; Quisel JD, 2000, J BACTERIOL, V182, P3446, DOI 10.1128/JB.182.12.3446-3451.2000; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Sharpe ME, 1996, MOL MICROBIOL, V21, P501, DOI 10.1111/j.1365-2958.1996.tb02559.x; SKARSTAD K, 1988, J BACTERIOL, V170, P852, DOI 10.1128/jb.170.2.852-858.1988; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x	57	155	155	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					74	84		10.1016/j.cell.2008.07.044	http://dx.doi.org/10.1016/j.cell.2008.07.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854156	Bronze			2022-12-01	WOS:000259728100010
J	Montalvo, G; Avanzini, F; Anselmi, M; Prandi, R; Ibarra, S; Marquez, M; Armani, D; Moreira, JM; Caicedo, C; Roncaglioni, MC; Colombo, F; Camisasca, P; Milani, V; Quimi, S; Gonzabay, F; Tognoni, G				Montalvo, Gregorio; Avanzini, Fausto; Anselmi, Mariella; Prandi, Rosanna; Ibarra, Samuel; Marquez, Monica; Armani, Daniela; Moreira, Juan-Martin; Caicedo, Cynthia; Roncaglioni, Maria Carla; Colombo, Fabio; Camisasca, Paola; Milani, Valentina; Quimi, Simon; Gonzabay, Felix; Tognoni, Gianni			Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; ADULT DEATHS; DISABILITY; MORTALITY; PREVENTION; INTERHEART; MANAGEMENT	Objectives To explore the predictive power of a risk stratification method for people with hypertension based on "essential" procedures ( that is, available in economically less developed areas of the world), comparing it in the same population with the results given by the method suggested by the 1999 World Health Organization-International Society of Hypertension ( WHO-ISH) guidelines. Design Prospective cohort study of outcomes according to cardiovascular risk profile at baseline. Setting Primary care in a poor rural area of the Ecuadorian forest. Participants 504 people with hypertension prospectively monitored for a mean of 6.7 ( SD 2.3) years. Interventions Essential data included blood pressure, medical history, smoking, age, sex, and diagnosis of diabetes; the WHO- ISH methods additionally included measurement of fasting blood glucose, total cholesterol, and creatinine, urinalysis, and electrocardiography. Main outcome measures Cardiovascular events and total deaths. Results With both methods there was a highly significant association between the level of predicted risk and the incidence of cardiovascular events and of total deaths: up to three quarters of all cardiovascular events and two thirds of all deaths were reported among people classified as at high or very high risk with either method. The predictive discrimination of the essential method is comparable with the WHO- ISH with C statistics ( 95% confidence interval) of 0.788 ( 0.721 to 0.855) and 0.744 ( 0.673 to 0.815), respectively, for cardiovascular events and 0.747 ( 0.678 to 0.816) and 0.705 ( 0.632 to 0.778) for total mortality. Conclusions The risk stratification of patients with hypertension with an essential package of variables ( that is, available and practicable even in the economically less developed areas of the world) serves at least as well as the more comprehensive method proposed by WHO- ISH.	[Montalvo, Gregorio; Anselmi, Mariella; Prandi, Rosanna; Marquez, Monica; Armani, Daniela; Moreira, Juan-Martin; Caicedo, Cynthia] Ctr Epidemiol Comunitaria & Med Trop CECOMET, Esmeraldas, Ecuador; [Avanzini, Fausto; Roncaglioni, Maria Carla; Colombo, Fabio; Camisasca, Paola] Ist Ric Farmacol Mario Negri, Lab Ric Med Gen, I-20156 Milan, Italy; [Anselmi, Mariella] Osped S Cuore, Ctr Malatt Trop, I-37034 Verona, Italy; [Ibarra, Samuel; Caicedo, Cynthia; Quimi, Simon; Gonzabay, Felix] Minist Salud Publ, Sist Local Salud, Borbon, Ecuador; [Milani, Valentina] Ist Ric Farmacol Mario Negri, Lab Stat Med, I-20156 Milan, Italy; [Tognoni, Gianni] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Avanzini, F (corresponding author), Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Via Masa 19, I-20156 Milan, Italy.	avanzini@marionegri.it	roncaglioni, maria carla/AAB-1875-2020; Milani, Valentina/AAB-5367-2019	roncaglioni, maria carla/0000-0002-2029-7847; Milani, Valentina/0000-0002-2989-981X; Avanzini, Fausto/0000-0002-4029-2891				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], 1996, World Health Organ Tech Rep Ser, V862, P1; [Anonymous], 1977, World Health Organ Tech Rep Ser, P1; Anselmi M, 2003, LANCET, V361, P1186, DOI 10.1016/S0140-6736(03)12918-2; Chalmers J, 1999, J HYPERTENS, V17, P151; CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213; Charlton RW, 2001, S AFR MED J, V91, P163; Cuspidi C, 2001, Ital Heart J, V2, P702; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gajalakshmi V, 2006, INT J EPIDEMIOL, V35, P748, DOI 10.1093/ije/dyl112; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lemogoum D, 2003, J HYPERTENS, V21, P1993, DOI 10.1097/00004872-200311000-00003; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Marmot MG, 2006, JAMA-J AM MED ASSOC, V295, P1304, DOI 10.1001/jama.295.11.1304; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; *PREV CARD DIS, 2007, GUID ASS MAN CARD RI; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Verdecchia P, 1998, J AM COLL CARDIOL, V31, P383, DOI 10.1016/S0735-1097(97)00493-2; *WHO, 2002, INT MAN CARD RISK RE; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, AM HEART J, V148, P1, DOI 10.1016/j.ahj.2004.03.045; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	33	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1387	10.1136/bmj.a1387	http://dx.doi.org/10.1136/bmj.a1387			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18805835	hybrid, Green Published			2022-12-01	WOS:000259797600039
J	Firestein, R; Bass, AJ; Kim, SY; Dunn, IF; Silver, SJ; Guney, I; Freed, E; Ligon, AH; Vena, N; Ogino, S; Chheda, MG; Tamayo, P; Finn, S; Shrestha, Y; Boehm, JS; Jain, S; Bojarski, E; Mermel, C; Barretina, J; Chan, JA; Baselga, J; Tabernero, J; Root, DE; Fuchs, CS; Loda, M; Shivdasani, RA; Meyerson, M; Hahn, WC				Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Silver, Serena J.; Guney, Isil; Freed, Ellen; Ligon, Azra H.; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Tamayo, Pablo; Finn, Stephen; Shrestha, Yashaswi; Boehm, Jesse S.; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Baselga, Jose; Tabernero, Josep; Root, David E.; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.			CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity	NATURE			English	Article							GENE-EXPRESSION; C-MYC; ACTIVATION; APC; IDENTIFICATION; MUTATIONS; PATHWAY; COMPLEX; CELLS; MELANOMA	Aberrant activation of the canonical WNT/beta-catenin pathway occurs in almost all colorectal cancers and contributes to their growth, invasion and survival(1,2). Although dysregulated beta-catenin activity drives colon tumorigenesis, further genetic perturbations are required to elaborate full malignant transformation(3). To identify genes that both modulate beta-catenin activity and are essential for colon cancer cell proliferation, we conducted two loss-of-function screens in human colon cancer cells and compared genes identified in these screens with an analysis of copy number alterations in colon cancer specimens. One of these genes, CDK8, which encodes a member of the mediator complex(4), is located at 13q12.13, a region of recurrent copy number gain in a substantial fraction of colon cancers. Here we show that the suppression of CDK8 expression inhibits proliferation in colon cancer cells characterized by high levels of CDK8 and beta-catenin hyperactivity. CDK8 kinase activity was necessary for beta-catenin-driven transformation and for expression of several beta-catenin transcriptional targets. Together these observations suggest that therapeutic interventions targeting CDK8 may confer a clinical benefit in beta-catenin-driven malignancies.	[Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Freed, Ellen; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Shrestha, Yashaswi; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Firestein, Ron; Ligon, Azra H.; Ogino, Shuji; Finn, Stephen; Chan, Jennifer A.; Loda, Massimo; Meyerson, Matthew] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bass, Adam J.; Kim, So Young; Shivdasani, Ramesh A.; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Freed, Ellen; Ligon, Azra H.; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Finn, Stephen; Shrestha, Yashaswi; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chheda, Milan G.] Massachusetts Gen Hosp, Dept Neurooncol, Boston, MA 02114 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Shrestha, Yashaswi; Mermel, Craig; Barretina, Jordi; Root, David E.; Fuchs, Charles S.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Silver, Serena J.; Guney, Isil; Chheda, Milan G.; Tamayo, Pablo; Shrestha, Yashaswi; Boehm, Jesse S.; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Root, David E.; Meyerson, Matthew; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Baselga, Jose; Tabernero, Josep] Hosp Gen Valle Hebron, Dept Med Oncol, Barcelona 08035, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Hospital Universitari Vall d'Hebron	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Mermel, Craig/AAZ-7322-2020; Meyerson, Matthew L/E-7123-2012; Finn, Stephen/V-3236-2019; Tabernero, Josep/AAG-5026-2019; Barretina, Jordi/A-7192-2013	Mermel, Craig/0000-0002-0816-3395; Finn, Stephen/0000-0002-8628-5814; Tabernero, Josep/0000-0002-2495-8139; Barretina, Jordi/0000-0002-3478-4080; Ogino, Shuji/0000-0002-3909-2323	US NCI/NIH [R33CA128625]; NIH [T32]; GI SPORE Career Development [P50CA127003]; Harvard-MIT Clinical Investigator Training Program Fellowship; Department of Defense Prostate Cancer Postdoctoral Fellowships; Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships; K12 award; NATIONAL CANCER INSTITUTE [P50CA127003, K08CA134931, T32CA009172, R33CA128625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	US NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GI SPORE Career Development; Harvard-MIT Clinical Investigator Training Program Fellowship; Department of Defense Prostate Cancer Postdoctoral Fellowships(United States Department of Defense); Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships; K12 award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Shin for technical assistance with immunohistochemistry, M. Miri for assistance with sample collection and G. Getz for assistance with SNP array analysis. This work was supported in part by a grant from the US NCI/NIH R33CA128625 (W.C.H.), T32 NIH grant (R.F.) and a GI SPORE Career Development Grant (P50CA127003; R.F.), a Harvard-MIT Clinical Investigator Training Program Fellowship (A.J.B), Department of Defense Prostate Cancer Postdoctoral Fellowships (I.G. and S.Y.K.), Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships (I.F.D.) and K12 award (M.G.C.). J.B. is a Beatriu de Pinos Fellow of the Departament d'Educacio i Universitats de la Generalita de Catalunya.	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gold MO, 1998, NUCLEIC ACIDS RES, V26, P3784, DOI 10.1093/nar/26.16.3784; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Sparks AB, 1998, CANCER RES, V58, P1130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	30	499	528	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					547	U60		10.1038/nature07179	http://dx.doi.org/10.1038/nature07179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18794900	Green Accepted			2022-12-01	WOS:000259449600049
J	Nichol, G; Thomas, E; Callaway, CW; Hedges, J; Powell, JL; Aufderheide, TP; Rea, T; Lowe, R; Brown, T; Dreyer, J; Davis, D; Idris, A; Stiell, I				Nichol, Graham; Thomas, Elizabeth; Callaway, Clifton W.; Hedges, Jerris; Powell, Judy L.; Aufderheide, Tom P.; Rea, Tom; Lowe, Robert; Brown, Todd; Dreyer, John; Davis, Dan; Idris, Ahamed; Stiell, Ian			Regional variation in out-of-hospital cardiac arrest incidence and outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY MEDICAL-SERVICES; AMERICAN-HEART-ASSOCIATION; MYOCARDIAL-INFARCTION; SOCIOECONOMIC-STATUS; COMATOSE SURVIVORS; DISEASE; CARE; RESUSCITATION; MORTALITY; COMMITTEE	Context The health and policy implications of regional variation in incidence and outcome of out-of-hospital cardiac arrest remain to be determined. Objective To evaluate whether cardiac arrest incidence and outcome differ across geographic regions. Design, Setting, and Patients Prospective observational study ( the Resuscitation Outcomes Consortium) of all out- of- hospital cardiac arrests in 10 North American sites ( 8 US and 2 Canadian) from May 1, 2006, to April 30, 2007, followed up to hospital discharge, and including data available as of June 28, 2008. Cases ( aged 0- 108 years) were assessed by organized emergency medical services ( EMS) personnel, did not have traumatic injury, and received attempts at external defibrillation or chest compressions or resuscitation was not attempted. Census data were used to determine rates adjusted for age and sex. Main Outcome Measures Incidence rate, mortality rate, case- fatality rate, and survival to discharge for patients assessed or treated by EMS personnel or with an initial rhythm of ventricular fibrillation. Results Among the 10 sites, the total catchment population was 21.4 million, and there were 20 520 cardiac arrests. A total of 11 898 ( 58.0%) had resuscitation attempted; 2729 ( 22.9% of treated) had initial rhythm of ventricular fibrillation or ventricular tachycardia or rhythms that were shockable by an automated external defibrillator; and 954 ( 4.6% of total) were discharged alive. The median incidence of EMS- treated cardiac arrest across sites was 52.1 ( interquartile range [ IQR], 48.0- 70.1) per 100 000 population; survival ranged from 3.0% to 16.3%, with a median of 8.4% ( IQR, 5.4%- 10.4%). Median ventricular fibrillation incidence was 12.6 ( IQR, 10.6- 5.2) per 100 000 population; survival ranged from 7.7% to 39.9%, with a median of 22.0% ( IQR, 15.0%- 24.4%), with significant differences across sites for incidence and survival ( P <. 001). Conclusion In this study involving 10 geographic regions in North America, there were significant and important regional differences in out- of- hospital cardiac arrest incidence and outcome.	[Nichol, Graham] Univ Washington, Harborview Ctr Prehosp Emergency Care, Dept Med, Seattle, WA 98104 USA; [Nichol, Graham; Thomas, Elizabeth; Powell, Judy L.] Univ Washington, Clin Trial Ctr, Dept Biostat, Seattle, WA 98195 USA; [Rea, Tom] Seattle King Cty Dept Publ Hlth, Seattle, WA USA; [Callaway, Clifton W.] Univ Pittsburgh, Pittsburgh, PA USA; [Hedges, Jerris; Lowe, Robert] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Brown, Todd] Univ Alabama Birmingham, Birmingham, AL USA; [Dreyer, John] Univ Western Ontario, London, ON, Canada; [Davis, Dan] Univ Calif San Diego, San Diego, CA 92103 USA; [Idris, Ahamed] SW Texas State Univ, Dallas, TX USA; [Stiell, Ian] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; Western University (University of Western Ontario); University of California System; University of California San Diego; Texas State University System; Texas State University San Marcos; University of Ottawa	Nichol, G (corresponding author), Univ Washington, Harborview Ctr Prehosp Emergency Care, Dept Med, Box 359727,325 9th Ave, Seattle, WA 98104 USA.	nichol@u.washington.edu	Nichol, Graham/Z-4996-2019; Lowe, Robert A/A-4926-2008; Hedges, Jerris/AAC-1847-2021	Lowe, Robert A/0000-0002-4732-9634; Stiell, Ian/0000-0002-2583-6408; Idris, Ahamed/0000-0001-7113-6499; Callaway, Clifton/0000-0002-3309-1573	National Heart, Lung, and Blood Institute [5U01 HL077863, 5U01 HL077881, 5U01 HL077871, 5U01 HL077873, 5U01 HL077872, 5U01 HL077866, 5U01 HL077908, 5U01 HL077867, 5U01 HL077885]; National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health; Defence Research and Development Canada; American Heart Association; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077871, U01HL077908, U01HL077866, U01HL077873, U01HL077863, U01HL077881, U01HL077872, U01HL077885, U01HL077867] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Defence Research and Development Canada; American Heart Association(American Heart Association); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a cooperative agreement (grants 5U01 HL077863, HL077881, HL077871, HL077873, HL077872, HL077866, HL077908, HL077867, HL077885, and HL077885) with the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, the Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, the American Heart Association, and the Heart and Stroke Foundation of Canada. Medtronic Physio-Control Inc loaned equipment to several EMS agencies participating in the Alabama ROC site. These devices were used routinely in the course of the EMS duties and were not exclusively for ROC, but they were also used with ROC patients.	BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; Bergner L, 1983, Am J Emerg Med, V1, P259, DOI 10.1016/0735-6757(83)90101-8; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brooks SC, 2007, CIRCULATION, V116, P934; Domanski MJ, 2003, J CARD FAIL, V9, P354, DOI 10.1054/S1071-9164(03)00133-7; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; EKSTROM L, 1994, RESUSCITATION, V27, P181, DOI 10.1016/0300-9572(94)90031-0; FRANDSEN F, 1991, CARDIOLOGY, V79, P256, DOI 10.1159/000174888; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Govindarajan A, 2003, ANN EMERG MED, V41, P481, DOI 10.1067/mem.2003.108; Graham J. W., 1999, STAT STRATEGIES SMAL, V1, P1, DOI DOI 10.1177/0013164496056006006; GRAY AJ, 1987, BRIT MED J, V294, P1133, DOI 10.1136/bmj.294.6580.1133; Grmec S, 2007, RESUSCITATION, V72, P404, DOI 10.1016/j.resuscitation.2006.07.012; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Herlitz J, 2003, HEART, V89, P25, DOI 10.1136/heart.89.1.25; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hsu JWY, 1996, ANN EMERG MED, V28, P597, DOI 10.1016/S0196-0644(96)70080-X; Institute of Medicine, 2006, EM MED SERV CROSSR; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Knafelj R, 2007, RESUSCITATION, V74, P227, DOI 10.1016/j.resuscitation.2007.01.016; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Laurent I, 2005, J AM COLL CARDIOL, V46, P432, DOI 10.1016/j.jacc.2005.04.039; Little R.J.A., 1987, STAT ANAL MISSING DA; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Menon V, 2006, AM J MED, V119, P584, DOI 10.1016/j.amjmed.2006.01.018; Mitchell LB, 2003, J AM COLL CARDIOL, V42, P81, DOI 10.1016/S0735-1097(03)00498-4; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Nichol G, 2008, CIRCULATION, V117, P2299, DOI 10.1161/CIRCULATIONAHA.107.189472; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; PEDERSEN TR, 1994, LANCET, V344, P1383; Rea TD, 2004, AM J CARDIOL, V93, P1455, DOI 10.1016/j.amjcard.2004.03.002; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Soo LH, 1999, EUR HEART J, V20, P535, DOI 10.1053/euhj.1998.1334; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Stiell IG, 2009, ANN EMERG MED, V53, P241, DOI 10.1016/j.annemergmed.2008.03.018; Stiell IG, 1998, ANN EMERG MED, V32, P180, DOI 10.1016/S0196-0644(98)70135-0; TILLINGHAST SJ, 1991, AM J EPIDEMIOL, V134, P851, DOI 10.1093/oxfordjournals.aje.a116160; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; VANDERHOEVEN JG, 1995, NETH J MED, V46, P123, DOI 10.1016/0300-2977(94)00106-J; Wilkins R., 2002, HLTH REP S, V13, P45	50	1445	1510	1	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1423	1431		10.1001/jama.300.12.1423	http://dx.doi.org/10.1001/jama.300.12.1423			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812533	Green Accepted, Bronze			2022-12-01	WOS:000259410400020
J	Cox, P; Jones, C				Cox, Peter; Jones, Chris			Climate change - Illuminating the modern dance of climate and CO2	SCIENCE			English	Editorial Material							CARBON-CYCLE FEEDBACKS		[Cox, Peter] Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England; [Jones, Chris] Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England	University of Exeter; Met Office - UK; Hadley Centre	Cox, P (corresponding author), Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England.	p.m.cox@exeter.ac.uk; chris.d.jones@metoffice.gov.uk	Jones, Chris/I-2983-2014; Cox, Peter Michae;/B-3299-2012	Jones, Chris/0000-0002-7141-9285; Cox, Peter Michae;/0000-0002-0679-2219	Natural Environment Research Council [earth010002, earth010004] Funding Source: researchfish; NERC [earth010004, earth010002] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Archer D, 1997, GEOPHYS RES LETT, V24, P405, DOI 10.1029/97GL00168; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; ETHERIDGE DM, 1993, J GEOPHYS RES, V101, P4115; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Jones CD, 2001, GLOBAL BIOGEOCHEM CY, V15, P453, DOI 10.1029/2000GB001281; Jones CD, 2001, J CLIMATE, V14, P4113, DOI 10.1175/1520-0442(2001)014<4113:TCCRTE>2.0.CO;2; Jones CD, 2006, TELLUS B, V58, P603, DOI 10.1111/j.1600-0889.2006.00215.x; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Scheffer M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025044; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497	12	68	69	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1642	1644		10.1126/science.1158907	http://dx.doi.org/10.1126/science.1158907			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801988				2022-12-01	WOS:000259300400022
J	Oxley, DR; Smith, KB; Alford, JR; Hibbing, MV; Miller, JL; Scalora, M; Hatemi, PK; Hibbing, JR				Oxley, Douglas R.; Smith, Kevin B.; Alford, John R.; Hibbing, Matthew V.; Miller, Jennifer L.; Scalora, Mario; Hatemi, Peter K.; Hibbing, John R.			Political attitudes vary with physiological traits	SCIENCE			English	Article							DISEASE-AVOIDANCE; GENETIC-VARIATION; AMYGDALA; FEAR; ANXIETY; SUPPORT; THREAT	Although political views have been thought to arise largely from individuals' experiences, recent research suggests that they may have a biological basis. We present evidence that variations in political attitudes correlate with physiological traits. In a group of 46 adult participants with strong political beliefs, individuals with measurably lower physical sensitivities to sudden noises and threatening visual images were more likely to support foreign aid, liberal immigration policies, pacifism, and gun control, whereas individuals displaying measurably higher physiological reactions to those same stimuli were more likely to favor defense spending, capital punishment, patriotism, and the Iraq War. Thus, the degree to which individuals are physiologically responsive to threat appears to indicate the degree to which they advocate policies that protect the existing social structure from both external ( outgroup) and internal ( norm- violator) threats.	[Oxley, Douglas R.; Smith, Kevin B.; Miller, Jennifer L.; Hibbing, John R.] Univ Nebraska, Dept Polit Sci, Lincoln, NE 68588 USA; [Alford, John R.] Rice Univ, Dept Polit Sci, Houston, TX 77251 USA; [Hibbing, Matthew V.] Univ Illinois, Dept Polit Sci, Urbana, IL 61801 USA; [Scalora, Mario] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Hatemi, Peter K.] Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA	University of Nebraska System; University of Nebraska Lincoln; Rice University; University of Illinois System; University of Illinois Urbana-Champaign; University of Nebraska System; University of Nebraska Lincoln; Virginia Commonwealth University	Hibbing, JR (corresponding author), Univ Nebraska, Dept Polit Sci, Lincoln, NE 68588 USA.	jhibbing@unl.edu	Alford, John R/A-2561-2009; sarinopoulos, isidoros/B-5453-2010; Hibbing, Matthew/AAF-3930-2020	Hatemi, Peter/0000-0001-6514-2614; Oxley, Douglas/0000-0003-2258-2112	NSF [SES-0721378, SES-0721707]; ManTech Corporation; University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	NSF(National Science Foundation (NSF)); ManTech Corporation; University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	We thank E. Whitaker, C. Jacobs, B. Sexton, K. A. Espy, J. Brehm, D. Bulling, and the James Long Company for their invaluable assistance. Financial support was provided by the NSF (SES-0721378 and SES-0721707), the ManTech Corporation, and the University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; [Anonymous], 1915, BODILY CHANGES PAIN; Bracha HS, 2005, J AFFECT DISORDERS, V88, P119, DOI 10.1016/j.jad.2005.05.013; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; CAMPBELL A, 1960, AM VOETER; Converse P.E, 1964, IDEOLOGY DISCONTENT; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Eaves L, 1999, Twin Res, V2, P62, DOI 10.1375/twin.2.2.62; Fahmy S, 2006, VIS COMMUN Q, V13, P4, DOI 10.1207/s15551407vcq1301_2; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Fowler JH, 2008, AM POLIT SCI REV, V102, P233, DOI 10.1017/S0003055408080209; GROSSER GH, 1971, THREAT IMPENDING DIS; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Huddy L, 2005, AM J POLIT SCI, V49, P593, DOI 10.2307/3647734; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Landau MJ, 2004, PERS SOC PSYCHOL B, V30, P1136, DOI 10.1177/0146167204267988; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Larson CL, 2006, BIOL PSYCHIAT, V60, P410, DOI 10.1016/j.biopsych.2006.03.079; Lemche E, 2006, HUM BRAIN MAPP, V27, P623, DOI 10.1002/hbm.20206; Lodge M, 2005, POLIT PSYCHOL, V26, P455, DOI 10.1111/j.1467-9221.2005.00426.x; Mainen ZF, 2007, NAT NEUROSCI, V10, P1511, DOI 10.1038/nn1207-1511; Marcus G.E.W., 2000, AFFECTIVE INTELLIGEN; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; McDermott R., 2004, PERSPECT POLIT, V2, P691, DOI DOI 10.1017/S1537592704040459; MILLER A, 2007, DEV PSYCHOPHYSIOLOGY; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Page B, 1992, RATIONAL PUBLIC; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Stenner K., 2005, AUTHORITARIAN DYNAMI; Thase M.E., 1995, HDB DEPRESSION; Westen D., 2007, PUBLIC AFFAIRS; WILSON GD, 1968, BRIT J SOC CLIN PSYC, V7, P264; Zaller J., 1992, NATURE ORIGINS MASS	38	303	307	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1667	1670		10.1126/science.1157627	http://dx.doi.org/10.1126/science.1157627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	349RG	18801995	Green Published			2022-12-01	WOS:000259300400032
J	Chen, CH; Budas, GR; Churchill, EN; Disatnik, MH; Hurley, TD; Mochly-Rosen, D				Chen, Che-Hong; Budas, Grant R.; Churchill, Eric N.; Disatnik, Marie-Helene; Hurley, Thomas D.; Mochly-Rosen, Daria			Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart	SCIENCE			English	Article							PROTEIN-KINASE-C; RAT-HEART; EPSILON; CARDIOPROTECTION; INHIBITION; PROTECTION; ETHANOL; CLONING; PKC	There is substantial interest in the development of drugs that limit the extent of ischemia- induced cardiac damage caused by myocardial infarction or by certain surgical procedures. Here, using an unbiased proteomic search, we identified mitochondrial aldehyde dehydrogenase 2 ( ALDH2) as an enzyme whose activation correlates with reduced ischemic heart damage in rodent models. A high- throughput screen yielded a small- molecule activator of ALDH2 ( Alda- 1) that, when administered to rats before an ischemic event, reduced infarct size by 60%, most likely through its inhibitory effect on the formation of cytotoxic aldehydes. In vitro, Alda- 1 was a particularly effective activator of ALDH2*2, an inactive mutant form of the enzyme that is found in 40% of East Asian populations. Thus, pharmacologic enhancement of ALDH2 activity may be useful for patients with wild- type or mutant ALDH2 who are subjected to cardiac ischemia, such as during coronary bypass surgery.	[Chen, Che-Hong; Budas, Grant R.; Churchill, Eric N.; Disatnik, Marie-Helene; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Hurley, Thomas D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Stanford University; Indiana University System; Indiana University-Purdue University Indianapolis	Mochly-Rosen, D (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mochly@stanford.edu		HURLEY, THOMAS/0000-0002-5942-1163; Mochly-Rosen, Daria/0000-0002-6691-8733	NIH [AA11147]; Stanford's SPARK Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011147, R37AA011147] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford's SPARK Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank K. Inagaki and C. L. Murriel for initial studies; D. Solow-Cordero for the high-throughput screen; and F. Conti, D. Cheng, and A. Masoud Sadaghiani for the biochemical characterization of Alda-1. Supported by NIH grant AA11147 (to D.M.-R.) and by Stanford's SPARK Program (C.-H.C.). D.M.-R. is the founder and a shareholder of KAI Pharmaceuticals; however, none of the work described here was done in collaboration with, or with support from, this company. C.-H.C., T.D.H., and D.M.-R. are listed as inventors in three pending patents filed by Stanford University that are related to this work.	Blasi P, 2002, MOL GENET METAB, V76, P348, DOI 10.1016/S1096-7192(02)00105-1; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Chen CH, 1999, P NATL ACAD SCI USA, V96, P12784, DOI 10.1073/pnas.96.22.12784; Chen CH, 2001, J MOL CELL CARDIOL, V33, P581, DOI 10.1006/jmcc.2000.1330; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; DEITRICH RA, 1976, BIOCHEM PHARMACOL, V25, P2733, DOI 10.1016/0006-2952(76)90265-3; Doorn JA, 2006, CHEM RES TOXICOL, V19, P102, DOI 10.1021/tx0501839; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; DUESTER G, 1984, P NATL ACAD SCI-BIOL, V81, P4055, DOI 10.1073/pnas.81.13.4055; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hill M, 2001, CIRCULATION, V104, P694, DOI 10.1161/hc3201.092218; HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771; Jaburek M, 2006, CIRC RES, V99, P878, DOI 10.1161/01.RES.0000245106.80628.d3; Larson HN, 2005, J BIOL CHEM, V280, P30550, DOI 10.1074/jbc.M502345200; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Nakano A, 2000, PHARMACOL THERAPEUT, V86, P263, DOI 10.1016/S0163-7258(00)00058-9	19	567	619	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1493	1495		10.1126/science.1158554	http://dx.doi.org/10.1126/science.1158554			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787169	Green Accepted			2022-12-01	WOS:000259121800042
J	Trumbore, SE; Czimczik, CI				Trumbore, Susan E.; Czimczik, Claudia I.			Geology - An uncertain future for soil carbon	SCIENCE			English	Editorial Material							ORGANIC-MATTER; CYCLE FEEDBACK; DYNAMICS; RELEASE; STORAGE; MODEL		[Trumbore, Susan E.; Czimczik, Claudia I.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Trumbore, SE (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	setrumbo@uci.edu; czimczik@uci.edu	Trumbore, Susan/B-1948-2013	Czimczik, Claudia/0000-0002-8251-6603				Brantley SL, 2008, SCIENCE, V321, P1454, DOI 10.1126/science.1161132; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Ekschmitt K, 2005, GEODERMA, V128, P167, DOI 10.1016/j.geoderma.2004.12.024; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Holmes KW, 2005, BIOGEOCHEMISTRY, V74, P173, DOI 10.1007/s10533-004-3544-x; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260	16	164	176	27	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1455	1456		10.1126/science.1160232	http://dx.doi.org/10.1126/science.1160232			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787159				2022-12-01	WOS:000259121800029
J	Hsu, PP; Sabatini, DM				Hsu, Peggy P.; Sabatini, David M.			Cancer cell metabolism: Warburg and beyond	CELL			English	Article							AEROBIC GLYCOLYSIS; PYRUVATE-KINASE; TUMOR-GROWTH; RAG GTPASES; C-MYC; EXPRESSION; HYPOXIA; OVEREXPRESSION; ACTIVATION; PROTEIN	Described decades ago, the Warburg effect of aerobic glycolysis is a key metabolic hallmark of cancer, yet its significance remains unclear. In this Essay, we re-examine the Warburg effect and establish a framework for understanding its contribution to the altered metabolism of cancer cells.	[Hsu, Peggy P.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@w.mit.edu		/0000-0002-1446-7256	NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129105, R01 CA129105-02] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fukumura D, 2001, CANCER RES, V61, P6020; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; KAELIN WG, 2008, J MOL CELL, V30, P393; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Koehler SE, 2004, MOL PHARMACOL, V66, P620; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; WARBURG O, 1956, SCIENCE, V124, P269; Wiesener MS, 2001, CANCER RES, V61, P5215; Yoshida Y, 2007, J PHYSIOL-LONDON, V582, P1317, DOI 10.1113/jphysiol.2007.135095; Zhong H, 1999, CANCER RES, V59, P5830	41	1626	1710	9	343	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					703	707		10.1016/j.cell.2008.08.021	http://dx.doi.org/10.1016/j.cell.2008.08.021			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775299	Bronze			2022-12-01	WOS:000258947500006
J	Kim, JV; Kang, SS; Dustin, ML; McGavern, DB				Kim, Jiyun V.; Kang, Silvia S.; Dustin, Michael L.; McGavern, Dorian B.			Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis	NATURE			English	Article							BLOOD-BRAIN-BARRIER; MURINE LYMPHOCYTIC CHORIOMENINGITIS; CENTRAL-NERVOUS-SYSTEM; VIRUS-INFECTION; T-CELLS; ANTICONVULSANT PROLONGATION; CHEMOKINE RECEPTOR; HOST-DEFENSE; MICE; PERMEABILITY	Lymphocytic choriomeningitis virus(1) infection of the mouse central nervous system (CNS) elicits fatal immunopathology through blood - brain barrier breakdown(2) and convulsive seizures(3). Although lymphocytic- choriomeningitis- virus- specific cytotoxic T lymphocytes ( CTLs) are essential for disease(4), their mechanism of action is not known. To gain insights into disease pathogenesis, we observed the dynamics of immune cells in the meninges by two-photon microscopy. Here we report visualization of motile CTLs and massive secondary recruitment of pathogenic monocytes and neutrophils that were required for vascular leakage and acute lethality. CTLs expressed multiple chemoattractants capable of recruiting myelomonocytic cells. We conclude that a CD8(+) T- cell- dependent disorder can proceed in the absence of direct T- cell effector mechanisms and rely instead on CTL- recruited myelomonocytic cells.	[Kim, Jiyun V.; Dustin, Michael L.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Program Mol Pathogenesis, New York, NY 10016 USA; [Kang, Silvia S.; McGavern, Dorian B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	New York University; Scripps Research Institute	Dustin, ML (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Program Mol Pathogenesis, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu; mcgad@scripps.edu	McGavern, Dorian/HCH-3601-2022; Dustin, Michael/AAM-4611-2020	McGavern, Dorian/0000-0001-9568-545X; Dustin, Michael/0000-0003-4983-6389	National Institutes of Health [AI070967-01, AI055037, NS041219-06]; The Burroughs Wellcome Fund; Dana Foundation; National Research Service [NS061447-01]; Multiple Sclerosis Society Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070967, R21AI055037, R01AI055037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061447, T32NS041219, ZIANS003112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Burroughs Wellcome Fund(Burroughs Wellcome Fund); Dana Foundation; National Research Service; Multiple Sclerosis Society Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants AI070967-01 (D.B.M.), AI055037 (M.L.D.), a grant from The Burroughs Wellcome Fund (D.B.M.) and the Dana Foundation (M.L.D.). S.S.K. was supported by a National Institutes of Health training grant NS041219-06 and is presently supported by a National Research Service Award (NS061447-01), and J.V.K. is supported by a Multiple Sclerosis Society Center Grant. We thank C. Yau for technical support and the Scripps DNA Array core for their assistance with the gene array experiment.	Ancuta P, 2004, IMMUNOBIOLOGY, V209, P11, DOI 10.1016/j.imbio.2004.04.001; ANDERSEN IH, 1991, J NEUROIMMUNOL, V31, P155, DOI 10.1016/0165-5728(91)90021-X; Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Bjork J, 1982, Agents Actions Suppl, V11, P63; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; CAMENGA DL, 1977, J NEUROPATH EXP NEUR, V36, P9, DOI 10.1097/00005072-197701000-00003; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; DOHERTY PC, 1990, IMMUNOL TODAY, V11, P55; Faust N, 2000, BLOOD, V96, P719; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hixenbaugh EA, 1997, AM J PHYSIOL-HEART C, V273, pH981, DOI 10.1152/ajpheart.1997.273.2.H981; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; JOHNSON ED, 1978, CELL IMMUNOL, V36, P143, DOI 10.1016/0008-8749(78)90257-5; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kang SS, 2008, FRONT BIOSCI-LANDMRK, V13, P4529, DOI 10.2741/3021; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lauterbach H, 2006, J EXP MED, V203, P1963, DOI 10.1084/jem.20060039; LEIST TP, 1987, J IMMUNOL, V138, P2278; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; MARKER O, 1984, ACTA NEUROPATHOL, V63, P229, DOI 10.1007/BF00685249; Maus U, 2002, AM J RESP CRIT CARE, V166, P268, DOI 10.1164/rccm.2112012; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; ROSENGREN S, 1989, MICROVASC RES, V38, P243, DOI 10.1016/0026-2862(89)90003-4; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Storm P, 2006, J VIROL, V80, P1222, DOI 10.1128/JVI.80.3.1222-1230.2006; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; WALKER DH, 1977, J NEUROPATH EXP NEUR, V36, P21, DOI 10.1097/00005072-197701000-00004; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	36	248	250	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					191	U85		10.1038/nature07591	http://dx.doi.org/10.1038/nature07591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19011611	Green Accepted			2022-12-01	WOS:000262360200032
J	Noor, AM; Mutheu, JJ; Tatem, AJ; Hay, SI; Snow, RW				Noor, Abdisalan M.; Mutheu, Juliette J.; Tatem, Andrew J.; Hay, Simon I.; Snow, Robert W.			Insecticide-treated net coverage in Africa: mapping progress in 2000-07	LANCET			English	Article							MALARIA CONTROL; PLASMODIUM-FALCIPARUM; TRANSMISSION	Background Insecticide-treated bednets (ITNs) provide a means to improve child survival across Africa. Sales figures of these nets and survey coverage data presented nationally mask inequities in populations at biological and economic risk, and do not allow for precision in the estimation of unmet commodity needs. We gathered subnational ITN coverage sample survey data from 40 malaria-endemic countries in Africa between 2000 and 2007. Methods We computed the projected ITN coverage among children aged less than 5 years for age-adjusted population data that were stratified according to malaria transmission risks, proximate determinants of poverty, and methods of ITN delivery. Findings In 2000, only 1.7 million (1.8%) African children living in stable malaria-endemic conditions were protected by an ITN and the number increased to 20.3 million (18. 5%) by 2007 leaving 89.6 million children unprotected. Of these, 30 million were living in some of the poorest areas of Africa: 54% were living in only seven countries and 25% in Nigeria alone. Overall, 33 (83%) countries were estimated to have ITN coverage of less than 40% in 2007. On average, we noted a greater increase in ITN coverage in areas where free distribution had operated between survey periods. Interpretation By mapping the distribution of populations in relation to malaria risk and intervention coverage, we provide a means to track the future requirements for scaling up essential disease- prevention strategies. The present coverage of ITN in Africa remains inadequate and a focused effort to improve distribution in selected areas would have a substantial effect on the continent's malaria burden. Funding Wellcome Trust.	[Noor, Abdisalan M.; Mutheu, Juliette J.; Tatem, Andrew J.; Hay, Simon I.; Snow, Robert W.] KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, CCVTM, Oxford, England; [Tatem, Andrew J.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England	University of Oxford; University of Oxford	Noor, AM (corresponding author), KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, POB 43640-00100, Nairobi, Kenya.	anoor@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022; Hay, Simon I/F-8967-2015	Snow, Robert William/0000-0003-3725-6088; Hay, Simon I/0000-0002-0611-7272; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	AMN (Research Training Fellowship, 081829), SIH (Senior Research Fellowship, 079091), and RWS (Principal Researcli Fellowship, 079081) are supported by the Wellcome Trust. This work forms part of die output of the Malaria Atlas Project, mainly funded by the Wellcome Trust, UK. We thank Priscilla Gikandi and Victor Alegana for their assistance during data abstraction and digitisation ofadministrative boundaries; Alfredo Fort of Opinion Research Corporation-Macro International for his assistance in connecting the authors with national survey teams; Pete Gething and Emelda Okiro for comments on earlier versions of this report. This report is published with the permission of the Director of KEMRI.	*CIESIN COL U IFPR, 2007, GLOB RUR URB MAPP PR; *DMSP, NIGHTT LIGHTS WORLD; *FED MIN HLTH, 2007, SUD HOUS HLTH SURV; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; HANSON K, 2007, MONITORING EVALUATIO; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; KULKARNI M, 2008, EVALUATION APPROPRAT; Lengeler C., 2004, COCHRANE DB SYST REV, V2; Lengeler C, 2007, AM J TROP MED HYG, V77, P222, DOI 10.4269/ajtmh.2007.77.222; Measure DHS, DEM HLTH SURV; *MIN HLTH ANG, 2007, ANG NAT MAL IND SURV; *MIN HLTH ETH, 2008, ETH NAT MAL IND SURV; *MIN HLTH KEN, 2008, KEN NAT MAL IND SURV; *MIN HLTH MOZ, 2007, MOZ NAT MAL IND SURV; *MIN HLTH SOC WELF, 2008, ZANZ NAT MAL IND SUR; *MIN SANT, 2007, ENQ NAT PAL SEN 2006; Ministry of Health [Zambia], 2006, ZAMB NAT MAL IND SUR; Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; *POP SERV INT, 2007, DET UT MOUST IMPR BU; RBM, 2005, GLOB STRAT PLAN ROLL; *RBM, 2000, WHOCDSRBM200017 RBM; *RBM MERG, COR HOUS QUEST; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 2004, NATURE, V430, P934, DOI 10.1038/430934a; Teklehaimanot A, 2007, AM J TROP MED HYG, V77, P138, DOI 10.4269/ajtmh.2007.77.138; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; *UNGIWG SALB, 2 ADM LEV BOUND; UNICEF, 2007, MAL CHILDR PROGR INT; *UNICEF, BEDN SUPPL UPD; *UNICEF, MULT CLUST IND SURV; United Nation, 2001, ROAD MAP IMPL UN MIL; *UNPD, WORLD POP PROSP 2006; *WHO UN CHILDR FUN, 2008, WORLD MAL REP; World Health Organization, 2000, GLOB PARTN ROLL BACK; [No title captured]	39	147	149	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					58	67		10.1016/S0140-6736(08)61596-2	http://dx.doi.org/10.1016/S0140-6736(08)61596-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19019422	Green Accepted, Green Submitted			2022-12-01	WOS:000262183800032
J	Bocquet, N; Nury, H; Baaden, M; Le Poupon, C; Changeux, JP; Delarue, M; Corringer, PJ				Bocquet, Nicolas; Nury, Hugues; Baaden, Marc; Le Poupon, Chantal; Changeux, Jean-Pierre; Delarue, Marc; Corringer, Pierre-Jean			X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP; CRYSTAL-STRUCTURE; GATING MECHANISM; BINDING-SITE; AMINO-ACIDS; DOMAIN; IDENTIFICATION; SELECTIVITY; PERMEATION	Pentameric ligand-gated ion channels from the Cys- loop family mediate fast chemo-electrical transduction(1-3), but the mechanisms of ion permeation and gating of these membrane proteins remain elusive. Here we present the X- ray structure at 2.9 angstrom resolution of the bacterial Gloeobacter violaceus pentameric ligand- gated ion channel homologue(4) ( GLIC) at pH 4.6 in an apparently open conformation. This cationic channel is known to be permanently activated by protons(5). The structure is arranged as a funnel- shaped transmembrane pore widely open on the outer side and lined by hydrophobic residues. On the inner side, a 5 angstrom constriction matches with rings of hydrophilic residues that are likely to contribute to the ionic selectivity(6-9). Structural comparison with ELIC, a bacterial homologue from Erwinia chrysanthemi solved in a presumed closed conformation(10), shows a wider pore where the narrow hydrophobic constriction found in ELIC is removed. Comparative analysis of GLIC and ELIC reveals, in concert, a rotation of each extracellular beta-sandwich domain as a rigid body, interface rearrangements, and a reorganization of the transmembrane domain, involving a tilt of the M2 and M3 alpha-helices away from the pore axis. These data are consistent with a model of pore opening based on both quaternary twist and tertiary deformation.	[Nury, Hugues; Delarue, Marc] Inst Pasteur, Unit Struct Dynam & Macromol, CNRS, URA 2185, F-75015 Paris, France; [Bocquet, Nicolas; Nury, Hugues; Le Poupon, Chantal; Changeux, Jean-Pierre; Corringer, Pierre-Jean] Inst Pasteur, Grp Channel Receptor G5, CNRS, URA 2182, F-75015 Paris, France; [Baaden, Marc] CNRS, Inst Biol Physicochim, UPR 9080, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Delarue, M (corresponding author), Inst Pasteur, Unit Struct Dynam & Macromol, CNRS, URA 2185, F-75015 Paris, France.	marc.delarue@pasteur.fr; pjcorrin@pasteur.fr	Baaden, Marc/C-6623-2008	Baaden, Marc/0000-0001-6472-0486; Nury, Hugues/0000-0002-3433-256X	Region Ile-de-France; Association Francaise contre les Myopathies; College de France; Commission of the European Communities; Network of European Neuroscience Institutes	Region Ile-de-France(Region Ile-de-France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); College de France; Commission of the European Communities(European Commission); Network of European Neuroscience Institutes	We thank P. Koehl for his program Aquasol and help with electrostatic calculations; P. Delepelaire and S. Edelstein for discussions; the staff of ESRF (Grenoble) ID14 and ID23 beamlines for data collection; facilities of the Pasteur Institute (A. Haouz for crystallogenesis, P. England for ultracentrifugation experiments, J. d'Alayer for mass spectroscopy controls and J. Bellalou for help in protein expression); and B. De Foresta (CEA, Orsay) for a gift of the two brominated DDM analogues. The latter diffraction data sets were collected at SLS and PSI (Villingen, Switzerland). We thank M. Fuchs for assistance during data collection; and the IDRIS supercomputer centre and its support staff for allocating CPU time at very short notice (project 082292). This work was supported by the Region Ile-de-France (N.B.), the Association Francaise contre les Myopathies, the College de France (C.L.P.), the Commission of the European Communities (Neurocypres project; H.N.) and the Network of European Neuroscience Institutes (ENI-NET).	Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer P.-J., 2008, SCHOLARPEDIA, V3, P3468; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1	30	580	585	6	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					111	114		10.1038/nature07462	http://dx.doi.org/10.1038/nature07462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18987633				2022-12-01	WOS:000262104900041
J	Tang, JL; Liu, BY; Ma, KW				Tang, Jin-Ling; Liu, Bao-Yan; Ma, Kan-Wen			Traditional Chinese medicine	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS		[Tang, Jin-Ling] Chinese Univ Hong Kong, Hong Kong Cochrane Ctr, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China; [Liu, Bao-Yan] Chinese Acad Med Sci, Beijing 100037, Peoples R China; [Ma, Kan-Wen] UCL, Wellcome Trust Ctr Hist Med, London, England	Chinese University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; University of London; University College London	Tang, JL (corresponding author), Chinese Univ Hong Kong, Hong Kong Cochrane Ctr, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China.	jltang@cuhk.edu.hk	Tang, JL/G-1759-2013; Tang, Jin-Ling/AAJ-4090-2021; Ran, Mao-Sheng/I-7957-2013; Al-Bayati, Lubna Lubna al Bayati/E-5100-2019					*BEIJ U CHIN MED, 2006, CHIN STAT YB CHIN ME; BROWN AC, 2002, POTENTIALLY LIFE THR; European Medicines Agency, 2005, PUBL STAT RISK ASS U; Ezzo JM, 2006, COCHRANE DB SYST REV, V19, P2285, DOI DOI 10.1002/14651858.CD002285.PUB2; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; KAPTCHUK TJ, 2000, WEB THAT HAS NO WEAV; Keji C., 2003, EUR REV, V11, P225, DOI DOI 10.1017/S106279870300022X; Liang MX, 1998, PREDICAMENTS FUTURE, P1; MA KW, 1993, EW MED EXCHANGES THE, P154; *MED HEALTHC PROD, 2006, TOUGH ACT UK MED REG; Pittler MH, 1999, CLIN INFECT DIS, V28, P597, DOI 10.1086/515148; STRATHERN P, 2005, BRIEF HIST MED, P179; Tang JL, 2006, BMJ-BRIT MED J, V333, P391, DOI 10.1136/bmj.333.7564.391; Tang JL, 1999, BMJ-BRIT MED J, V319, P160, DOI 10.1136/bmj.319.7203.160; Tomlinson B, 2000, J CLIN PHARMACOL, V40, P451, DOI 10.1177/00912700022009206; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Vines G, 2004, HERBAL HARVESTS FUTU; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Zhang W, 2005, COCHRANE DB SYST REV, V2	19	296	305	6	89	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1938	1940		10.1016/S0140-6736(08)61354-9	http://dx.doi.org/10.1016/S0140-6736(08)61354-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18930523				2022-12-01	WOS:000261471600010
J	Kobayashi, YM; Rader, EP; Crawford, RW; Iyengar, NK; Thedens, DR; Faulkner, JA; Parikh, SV; Weiss, RM; Chamberlain, JS; Moore, SA; Campbell, KP				Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Iyengar, Nikhil K.; Thedens, Daniel R.; Faulkner, John A.; Parikh, Swapnesh V.; Weiss, Robert M.; Chamberlain, Jeffrey S.; Moore, Steven A.; Campbell, Kevin P.			Sarcolemma-localized nNOS is required to maintain activity after mild exercise	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ALPHA-SARCOGLYCAN; NEUROMUSCULAR DISORDERS; MICE; DEFICIENT; FATIGUE; THERAPY; COMPLEX	Many neuromuscular conditions are characterized by an exaggerated exercise- induced fatigue response that is disproportionate to activity level. This fatigue is not necessarily correlated with greater central or peripheral fatigue in patients(1), and some patients experience severe fatigue without any demonstrable somatic disease(2). Except in myopathies that are due to specific metabolic defects, the mechanism underlying this type of fatigue remains unknown(2). With no treatment available, this form of inactivity is a major determinant of disability(3). Here we show, using mouse models, that this exaggerated fatigue response is distinct from a loss in specific force production by muscle, and that sarcolemma-localized signalling by neuronal nitric oxide synthase ( nNOS) in skeletal muscle is required to maintain activity after mild exercise. We show that nNOS- null mice do not have muscle pathology and have no loss of muscle- specific force after exercise but do display this exaggerated fatigue response to mild exercise. In mouse models of nNOS mislocalization from the sarcolemma, prolonged inactivity was only relieved by pharmacologically enhancing the cGMP signal that results from muscle nNOS activation during the nitric oxide signalling response to mild exercise. Our findings suggest that the mechanism underlying the exaggerated fatigue response to mild exercise is a lack of contraction- induced signalling from sarcolemma- localized nNOS, which decreases cGMP- mediated vasomodulation in the vessels that supply active muscle after mild exercise. Sarcolemmal nNOS staining was decreased in patient biopsies from a large number of distinct myopathies, suggesting a common mechanism of fatigue. Our results suggest that patients with an exaggerated fatigue response to mild exercise would show clinical improvement in response to treatment strategies aimed at improving exercise- induced signalling.	[Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Iyengar, Nikhil K.; Parikh, Swapnesh V.; Weiss, Robert M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Radiol, Iowa City, IA 52242 USA; [Moore, Steven A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Faulkner, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Chamberlain, Jeffrey S.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu		Chamberlain, Jeffrey/0000-0001-5299-0059; Campbell, Kevin/0000-0003-2066-5889; Moore, Steven/0000-0002-6353-7900	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant; University of Iowa Cardiovascular Interdisciplinary Research; National Research Service Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Senator Paul D. Wellstone Fellowship; Muscular Dystrophy Association Development Grant; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979, K26RR017369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR048742, R01AR051199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033610] Funding Source: NIH RePORTER	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant; University of Iowa Cardiovascular Interdisciplinary Research; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senator Paul D. Wellstone Fellowship; Muscular Dystrophy Association Development Grant(Muscular Dystrophy Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Anderson and M. Henry for comments, and M. M. Kilburg, K. Uppal, B. J. Steinmann and S. Watkins and members of the Campbell laboratory for scientific contributions. This work was supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant. Y.M.K. was supported by grants from the University of Iowa Cardiovascular Interdisciplinary Research/ National Research Service Award (NRSA) Fellowship, from an individual NRSA Fellowship from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, from the National Institutes of Health (NIH), and from a Senator Paul D. Wellstone Fellowship. E.P.R. was supported by a Muscular Dystrophy Association Development Grant. R.M.W. was supported by the NIH. K.P.C. is an investigator of the Howard Hughes Medical Institute.	Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Bloom TJ, 2005, CAN J PHYSIOL PHARM, V83, P1055, DOI 10.1139/Y05-085; Bloom TJ, 2002, CAN J PHYSIOL PHARM, V80, P1132, DOI 10.1139/Y02-149; Chao DS, 1998, J NEUROCHEM, V71, P784; Consolino CM, 2005, PHYSIOL GENOMICS, V22, P244, DOI 10.1152/physiolgenomics.00311.2004; Crosbie RH, 1998, HUM MOL GENET, V7, P823, DOI 10.1093/hmg/7.5.823; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Imamura M, 2005, HUM MOL GENET, V14, P775, DOI 10.1093/hmg/ddi072; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kalkman JS, 2007, J PSYCHOSOM RES, V62, P571, DOI 10.1016/j.jpsychores.2006.11.014; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Persson J, 2003, J VASC RES, V40, P538, DOI 10.1159/000075677; Phillips BA, 2000, CURR OPIN NEUROL, V13, P547, DOI 10.1097/00019052-200010000-00007; Radley HG, 2007, INT J BIOCHEM CELL B, V39, P469, DOI 10.1016/j.biocel.2006.09.009; Schillings ML, 2007, CLIN NEUROPHYSIOL, V118, P292, DOI 10.1016/j.clinph.2006.10.018; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Torelli S, 2004, NEUROPATH APPL NEURO, V30, P540, DOI 10.1111/j.1365-2990.2004.00561.x; Yokoyama T, 2007, J PAIN, V8, P692, DOI 10.1016/j.jpain.2007.05.008; Zwarts MJ, 2008, CLIN NEUROPHYSIOL, V119, P2, DOI 10.1016/j.clinph.2007.09.126	25	210	219	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					511	515		10.1038/nature07414	http://dx.doi.org/10.1038/nature07414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18953332	Green Accepted, Green Published			2022-12-01	WOS:000261170500040
J	Licatalosi, DD; Mele, A; Fak, JJ; Ule, J; Kayikci, M; Chi, SW; Clark, TA; Schweitzer, AC; Blume, JE; Wang, XN; Darnell, JC; Darnell, RB				Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Ule, Jernej; Kayikci, Melis; Chi, Sung Wook; Clark, Tyson A.; Schweitzer, Anthony C.; Blume, John E.; Wang, Xuning; Darnell, Jennifer C.; Darnell, Robert B.			HITS-CLIP yields genome-wide insights into brain alternative RNA processing	NATURE			English	Article							PRE-MESSENGER-RNA; BINDING PROTEIN; NOVA; POLYADENYLATION; GENE; IDENTIFICATION; NETWORK; DISEASE; ANTIGEN; TARGET	Protein - RNA interactions have critical roles in all aspects of gene expression. However, applying biochemical methods to understand such interactions in living tissues has been challenging. Here we develop a genome- wide means of mapping protein - RNA binding sites in vivo, by high- throughput sequencing of RNA isolated by crosslinking immunoprecipitation ( HITS- CLIP). HITS- CLIP analysis of the neuron- specific splicing factor Nova revealed extremely reproducible RNA- binding maps in multiple mouse brains. These maps provide genome- wide in vivo biochemical footprints confirming the previous prediction that the position of Nova binding determines the outcome of alternative splicing; moreover, they are sufficiently powerful to predict Nova action de novo. HITS- CLIP revealed a large number of Nova - RNA interactions in 39 untranslated regions, leading to the discovery that Nova regulates alternative polyadenylation in the brain. HITS- CLIP, therefore, provides a robust, unbiased means to identify functional protein - RNA interactions in vivo.	[Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Chi, Sung Wook; Wang, Xuning; Darnell, Jennifer C.; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; [Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Chi, Sung Wook; Darnell, Jennifer C.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Ule, Jernej; Kayikci, Melis] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Clark, Tyson A.; Schweitzer, Anthony C.; Blume, John E.] Affymetrix Inc, Express Res, Santa Clara, CA 95051 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; MRC Laboratory Molecular Biology; Affymetrix	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Ule, Jernej/C-6315-2013; Darnell, Robert B/B-9022-2008	Ule, Jernej/0000-0002-2452-4277; Darnell, Robert B/0000-0002-5134-8088; Blume, John/0000-0003-3026-953X; Clark, Tyson/0000-0002-7779-3227	NIH [R01 NS34389]; Howard Hughes Medical Institute; Medical Research Council [MC_U105185858] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389, R01NS040955] Funding Source: NIH RePORTER; MRC [MC_U105185858] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to members of the Darnell and Ule laboratories and J. Richter for critical discussions and review of the manuscript, B. Friedman for suggesting the use of exon arrays, F. Allain for communicating unpublished results, and M. Suarez- Farinas for help with statistics. This work was supported by NIH R01 NS34389 ( R. B. D.) and the Howard Hughes Medical Institute. R. B. D. is an HHMI Investigator.	Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell RB, 2006, COLD SPRING HARB SYM, V71, P321, DOI 10.1101/sqb.2006.71.002; David CJ, 2008, GENE DEV, V22, P279, DOI 10.1101/gad.1643108; DEDUVE C, 1993, GENE, V135, P29, DOI 10.1016/0378-1119(93)90045-5; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; MAIZELS N, 1987, NATURE, V330, P616, DOI 10.1038/330616a0; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	48	957	976	2	114	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					464	U22		10.1038/nature07488	http://dx.doi.org/10.1038/nature07488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18978773	Green Accepted			2022-12-01	WOS:000261170500030
J	Miller, W; Drautz, DI; Ratan, A; Pusey, B; Qi, J; Lesk, AM; Tomsho, LP; Packard, MD; Zhao, FQ; Sher, A; Tikhonov, A; Raney, B; Patterson, N; Lindblad-Toh, K; Lander, ES; Knight, JR; Irzyk, GP; Fredrikson, KM; Harkins, TT; Sheridan, S; Pringle, T; Schuster, SC				Miller, Webb; Drautz, Daniela I.; Ratan, Aakrosh; Pusey, Barbara; Qi, Ji; Lesk, Arthur M.; Tomsho, Lynn P.; Packard, Michael D.; Zhao, Fangqing; Sher, Andrei; Tikhonov, Alexei; Raney, Brian; Patterson, Nick; Lindblad-Toh, Kerstin; Lander, Eric S.; Knight, James R.; Irzyk, Gerard P.; Fredrikson, Karin M.; Harkins, Timothy T.; Sheridan, Sharon; Pringle, Tom; Schuster, Stephan C.			Sequencing the nuclear genome of the extinct woolly mammoth	NATURE			English	Article							DNA; HUMANS; SIZE	In 1994, two independent groups extracted DNA from several Pleistocene epoch mammoths and noted differences among individual specimens(1,2). Subsequently, DNA sequences have been published for a number of extinct species. However, such ancient DNA is often fragmented and damaged(3), and studies to date have typically focused on short mitochondrial sequences, never yielding more than a fraction of a per cent of any nuclear genome. Here we describe 4.17 billion bases ( Gb) of sequence from several mammoth specimens, 3.3 billion ( 80%) of which are from the woolly mammoth ( Mammuthus primigenius) genome and thus comprise an extensive set of genome- wide sequence from an extinct species. Our data support earlier reports(4) that elephantid genomes exceed 4 Gb. The estimated divergence rate between mammoth and African elephant is half of that between human and chimpanzee. The observed number of nucleotide differences between two particular mammoths was approximately one- eighth of that between one of them and the African elephant, corresponding to a separation between the mammoths of 1.5 - 2.0 Myr. The estimated probability that orthologous elephant and mammoth amino acids differ is 0.002, corresponding to about one residue per protein. Differences were discovered between mammoth and African elephant in amino- acid positions that are otherwise invariant over several billion years of combined mammalian evolution. This study shows that nuclear genome sequencing of extinct species can reveal population differences not evident from the fossil record, and perhaps even discover genetic factors that affect extinction.	[Miller, Webb; Drautz, Daniela I.; Ratan, Aakrosh; Pusey, Barbara; Qi, Ji; Lesk, Arthur M.; Tomsho, Lynn P.; Packard, Michael D.; Zhao, Fangqing; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Sher, Andrei] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; [Tikhonov, Alexei] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Raney, Brian] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Patterson, Nick; Lindblad-Toh, Kerstin; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Fredrikson, Karin M.; Harkins, Timothy T.; Sheridan, Sharon] Roche Diagnost Corp, Indianapolis, IN 46250 USA; [Pringle, Tom] Sperling Fdn, Eugene, OR 97405 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; University of California System; University of California Santa Cruz; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Roche Holding	Miller, W (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, 310 Wartik Bldg, University Pk, PA 16802 USA.	webb@bx.psu.edu; scs@bx.psu.edu	Raney, Brian/ABE-6267-2020; Zhao, Fangqing/P-6309-2019; Tikhonov, Alexei/G-7478-2016; QI, JI/E-2797-2016; Zhao, Fangqing/A-9992-2009	Zhao, Fangqing/0000-0002-6216-1235; Tikhonov, Alexei/0000-0002-7227-5797; Lesk, Arthur/0000-0002-2596-0601; Fredrikson, Karin/0000-0001-7360-4276	National Human Genome Research Institute [HG002238]; Gordon and Betty Moore Foundation; Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This sequencing-by-synthesis study was made possible through generous funding from Penn State University and Roche Applied Sciences. W. M. was supported by grant HG002238 from the National Human Genome Research Institute and S. C. S. is supported in part by the Gordon and Betty Moore Foundation. This project is funded in part under a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. We thank T. Gilbert for introducing us to the use of hair shafts as a source of ancient DNA, C. Grondahl for providing Asian elephant hair samples, and M. Wilson for suggestions. This paper is dedicated to the memory of Andrei Sher.	Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; HAGELBERG E, 1994, NATURE, V370, P333, DOI 10.1038/370333b0; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOSS M, 1994, NATURE, V370, P333, DOI 10.1038/370333a0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LANDER E S, 1988, Genomics, V2, P231; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Redi CA, 2007, J MOL EVOL, V64, P484, DOI 10.1007/s00239-006-0237-1; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TABERLET P, 1995, CONSERV BIOL, V9, P1255, DOI 10.1046/j.1523-1739.1995.951255.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	38	215	226	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					387	U51		10.1038/nature07446	http://dx.doi.org/10.1038/nature07446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020620	Bronze			2022-12-01	WOS:000261039600043
J	Fragoso, G; Spencer, T				Fragoso, Gerardo; Spencer, Tom			Physiographic Control on the Development of Spartina Marshes	SCIENCE			English	Article							SALT-MARSH; ALTERNIFLORA		[Fragoso, Gerardo] UNEP WCMC, Cambridge CB3 0DL, England; [Spencer, Tom] Univ Cambridge, Dept Geog, Cambridge Coastal Res Unit, Cambridge CB2 3EN, England	University of Cambridge	Fragoso, G (corresponding author), UNEP WCMC, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	gerardo.fragoso@unep-wcmc.org						GOODMAN PJ, 1961, J ECOL, V49, P391, DOI 10.2307/2257271; GRAY AJ, 1991, ADV ECOL RES, V21, P1, DOI 10.1016/S0065-2504(08)60096-3; MCKEE KL, 1988, ESTUARIES, V11, P143, DOI 10.2307/1351966; Mendelssohn IA, 2003, ECOL ENG, V21, P115, DOI 10.1016/j.ecoleng.2003.09.006; Morris JT, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P87; MORRIS JT, 1984, AM J BOT, V71, P979, DOI 10.2307/2443668; REDFIELD AC, 1965, SCIENCE, V147, P50, DOI 10.1126/science.147.3653.50; Tukey J.W., 1977, EXPLORATORY DATA ANA, P61, DOI 10.1007/978-0-387-32833-1_136	8	13	14	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1064	1064		10.1126/science.1159973	http://dx.doi.org/10.1126/science.1159973			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008437				2022-12-01	WOS:000260867700027
J	Formisano, E; De Martino, F; Bonte, M; Goebel, R				Formisano, Elia; De Martino, Federico; Bonte, Milene; Goebel, Rainer			"Who" Is Saying "What"? Brain-Based Decoding of Human Voice and Speech	SCIENCE			English	Article							AUDITORY-CORTEX; TEMPORAL CORTEX; PERCEPTION; CLASSIFICATION; STIMULI; FMRI; REPRESENTATIONS; ORGANIZATION; EXTRACTION; RESPONSES	Can we decipher speech content ("what" is being said) and speaker identity ("who" is saying it) from observations of brain activity of a listener? Here, we combine functional magnetic resonance imaging with a data- mining algorithm and retrieve what and whom a person is listening to from the neural fingerprints that speech and voice signals elicit in the listener's auditory cortex. These cortical fingerprints are spatially distributed and insensitive to acoustic variations of the input so as to permit the brain- based recognition of learned speech from unknown speakers and of learned voices from previously unheard utterances. Our findings unravel the detailed cortical layout and computational properties of the neural populations at the basis of human speech recognition and speaker identification.	[Formisano, Elia; De Martino, Federico; Bonte, Milene; Goebel, Rainer] Univ Maastricht, Dept Cognit Neurosci, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands	Maastricht University	Formisano, E (corresponding author), Univ Maastricht, Dept Cognit Neurosci, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands.	e.formisano@psychology.unimaas.nl	De Martino, Federico/I-1817-2012; De Martino, Federico/ABF-9850-2021	De Martino, Federico/0000-0002-0352-0648; De Martino, Federico/0000-0002-0352-0648; Formisano, Elia/0000-0001-5008-2460; Bonte, Milene/0000-0002-0203-8913; Goebel, Rainer/0000-0003-1780-2467	Maastricht University; Netherlands Organization for Scientific Research; Innovational Research Incentives Scheme Vidi [452-04-337]; Veni [451-07-002]	Maastricht University; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Innovational Research Incentives Scheme Vidi(Netherlands Organization for Scientific Research (NWO)); Veni(Netherlands Organization for Scientific Research (NWO))	Work supported by Maastricht University and the Netherlands Organization for Scientific Research (NWO), Innovational Research Incentives Scheme Vidi grant 452-04-337(E.F.) and Veni grant 451-07-002 (M.B.). We thank J. Obleser, U. Hasson, J.-D. Haynes, N. Kriegeskorte, J. Ashburner, and G. Valente for comments and discussions.	Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Davis MH, 2003, J NEUROSCI, V23, P3423; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Desai R, 2008, J COGNITIVE NEUROSCI, V20, P1174, DOI 10.1162/jocn.2008.20081; EGINEER CT, 2008, NAT NEUROSCI, V11, P603; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Obleser J, 2004, J COGNITIVE NEUROSCI, V16, P31, DOI 10.1162/089892904322755539; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034	28	375	385	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					970	973		10.1126/science.1164318	http://dx.doi.org/10.1126/science.1164318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988858	Green Submitted			2022-12-01	WOS:000260674100055
J	Takehara-Nishiuchi, K; McNaughton, BL				Takehara-Nishiuchi, Kaori; McNaughton, Bruce L.			Spontaneous Changes of Neocortical Code for Associative Memory During Consolidation	SCIENCE			English	Article							TIME-DEPENDENT REORGANIZATION; MEDIAL PREFRONTAL CORTEX; HIPPOCAMPAL; TRACE; AMNESIA; LESIONS; SLEEP; JUDGMENTS; MONKEYS; SYSTEMS	After learning, the medial prefrontal cortex (mPFC) gradually comes to modulate the expression of memories that initially depended on the hippocampus. We show that during this consolidation period, neural firing in the mPFC becomes selective for the acquired memories. After acquisition of memory associations, neuron populations in the mPFC of rats developed sustained activity during the interval between two paired stimuli, but reduced activity during the corresponding interval between two unpaired stimuli. These new patterns developed over a period of several weeks after learning, with and without continued conditioning trials. Thus, in agreement with a central tenet of consolidation theory, acquired associations initiate subsequent, gradual processes that result in lasting changes of the mPFC's code, without continued training.	[Takehara-Nishiuchi, Kaori; McNaughton, Bruce L.] Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	University of Arizona	McNaughton, BL (corresponding author), Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA.	bruce@nsma.arizona.edu	Takehara-Nishiuchi, Kaori/Q-9053-2019; Takehara, Kaori/ABD-2977-2020	Takehara-Nishiuchi, Kaori/0000-0002-7282-7838; Takehara, Kaori/0000-0002-7282-7838	NIH [NS020331, MH046823]; Human Frontier Science Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046823, R01MH046823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020331, R37NS020331] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS020331 and MH046823 (B.L.M.) and the Human Frontier Science Program (K.T.-N.). We thank M. Tatsuno and S. Cowen for helping with construction of the experimental apparatus and programming of the code for data analysis; J. Meltzer, J. Wang, H. DeFour, and A. Mosley for help with data collection and analysis; K. Bohne for constructing hyperdrives; and N. Insel for critical reading of the manuscript.	Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Freeman JH, 1999, NEUROBIOL LEARN MEM, V72, P259, DOI 10.1006/nlme.1998.3896; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McEchron MD, 1999, HIPPOCAMPUS, V9, P385, DOI 10.1002/(SICI)1098-1063(1999)9:4<385::AID-HIPO5>3.0.CO;2-K; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; MOSS M, 1981, J NEUROSCI, V1, P227; Paller KA, 1997, MEMORY, V5, P73, DOI 10.1080/741941150; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; Tatsuno M, 2006, J NEUROSCI, V26, P10727, DOI 10.1523/JNEUROSCI.3317-06.2006; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	27	165	165	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					960	963		10.1126/science.1161299	http://dx.doi.org/10.1126/science.1161299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988855				2022-12-01	WOS:000260674100052
J	Prainsack, B; Reardon, J; Hindmarsh, R; Gottweis, H; Naue, U; Lunshof, JE				Prainsack, Barbara; Reardon, Jenny; Hindmarsh, Richard; Gottweis, Herbert; Naue, Ursula; Lunshof, Jeantine E.			Personal genomes: Misdirected precaution	NATURE			English	Editorial Material							CONSUMER		[Prainsack, Barbara] Kings Coll London, Ctr Biomed & Soc, London WC2R 2LS, England; [Prainsack, Barbara] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Reardon, Jenny] Univ Calif Santa Cruz, Dept Sociol, Santa Cruz, CA 95064 USA; [Hindmarsh, Richard] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Hindmarsh, Richard] Griffith Univ, Ctr Governance & Publ Policy, Nathan, Qld 4111, Australia; [Gottweis, Herbert; Naue, Ursula] Univ Vienna, Dept Polit Sci, Life Sci Governance Res Platform, A-1010 Vienna, Austria; [Lunshof, Jeantine E.] Maastricht Univ, Dept Social Med, NL-6211 LK Maastricht, Netherlands; [Lunshof, Jeantine E.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, Amsterdam, Netherlands	University of London; King's College London; University of London; King's College London; University of California System; University of California Santa Cruz; Griffith University; Griffith University; University of Vienna; Maastricht University; Vrije Universiteit Amsterdam	Prainsack, B (corresponding author), Kings Coll London, Ctr Biomed & Soc, London WC2R 2LS, England.	barbara.prainsack@kcl.ac.uk	Prainsack, Barbara/AAF-5739-2021	Prainsack, Barbara/0000-0002-6335-1532; Naue, Ursula/0000-0003-2678-9962; Hindmarsh, Richard/0000-0001-5560-2904				Borry P, 2008, NAT BIOTECHNOL, V26, P736, DOI 10.1038/nbt0708-736; Gniady J, 2008, FORDHAM LAW REV, V76, P2429; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Reardon Jenny, 2007, BIOSOCIETIES, V2, P239, DOI DOI 10.1017/S174585520700573X; Rose NS., 2006, POLITICS LIFE ITSELF, DOI DOI 10.1515/9781400827503; van Ommen GB, 2008, EUR J HUM GENET, V16, P403, DOI 10.1038/ejhg.2008.32; 2008, NATURE BIOTECHNOL, V26, P716	8	83	87	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					34	35		10.1038/456034a	http://dx.doi.org/10.1038/456034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987720				2022-12-01	WOS:000260674000025
J	Adabag, AS; Therneau, TM; Gersh, BJ; Weston, SA; Roger, VL				Adabag, A. Selcuk; Therneau, Terry M.; Gersh, Bernard J.; Weston, Susan A.; Roger, Veronique L.			Sudden Death After Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; COMMUNITY-WIDE PERSPECTIVE; CARDIAC DEATH; TEMPORAL TRENDS; OLMSTED COUNTY; RISK-FACTORS; NATIONAL REGISTRY; CLINICAL-TRIALS; TIME-DEPENDENCE	Context Sudden cardiac death after myocardial infarction (MI) has not been assessed recently in the community. Risk stratification for sudden cardiac death after MI commonly relies on baseline characteristics and little is known about the relationship between recurrent ischemia or heart failure and sudden cardiac death. Objective To evaluate the risk of sudden cardiac death after MI and the impact of recurrent ischemia and heart failure on sudden cardiac death. Design, Setting, and Participants Population- based surveillance study of 2997 residents ( mean [ SD] age, 67 [ 14] years; 59% were men) experiencing an MI in Olmsted County, Minnesota, between 1979 and 2005, and followed up through February 29, 2008. Main Outcome Measures Sudden cardiac death defined as out- of- hospital death due to coronary disease; and observed survival free of sudden cardiac death compared with that expected in Olmsted County, Minnesota. Results During a median follow- up of 4.7 years ( 25th- 75th percentile, 1.6- 7.1 years), 1160 deaths occurred, 282 from sudden cardiac death ( 24%). The 30- day cumulative incidence of sudden cardiac death was 1.2% ( 95% confidence interval [ CI], 0.8%1.6%). Thereafter, the rate of sudden cardiac death was constant at 1.2% per year yielding a 5- year cumulative incidence of 6.9% ( 95% CI, 5.9%- 7.9%). The 30- day incidence of sudden cardiac death was 4- fold higher than expected ( standardized mortality ratio, 4.2; 95% CI, 2.9- 5.8). The risk of sudden cardiac death has declined significantly over time ( hazard ratio [ HR], 0.62 [ 95% CI, 0.44- 0.88] for MIs that occurred between 1997 and 2005 compared with between 1979 and 1987; P=. 03). The recurrent events of ischemia ( n= 842), heart failure ( n= 365), or both ( n= 873) occurred in 2080 patients. After adjustment for baseline characteristics, recurrent ischemia was not associated with sudden cardiac death ( HR, 1.26 [ 95% CI, 0.96- 1.65]; P=. 09), while heart failure markedly increased the risk of sudden cardiac death ( HR, 4.20 [ 95% CI, 3.10- 5.69]; P <. 001). Conclusions The risk of sudden cardiac death following MI in community practice has declined significantly over the past 30 years. Sudden cardiac death is independently associated with heart failure but not with recurrent ischemia.	[Therneau, Terry M.; Weston, Susan A.; Roger, Veronique L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Adabag, A. Selcuk] Vet Affairs Med Ctr, Div Cardiol, Minneapolis, MN USA; [Gersh, Bernard J.; Roger, Veronique L.] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Mayo Clinic	Roger, VL (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.	roger.veronique@mayo.edu	Roger, Veronique/AAV-5951-2020	Adabag, Selcuk/0000-0003-2154-8596	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072435, R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 72435, R01 HL072435-06, R01 HL059205-10A1, R01 HL 59205, R01 HL072435, R01 HL059205] Funding Source: Medline; NIAMS NIH HHS [AR30582, R01 AR030582, R01 AR030582-43] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abildstrom SZ, 2002, HEART, V88, P573, DOI 10.1136/heart.88.6.573; Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; BERGER CJ, 1992, JAMA-J AM MED ASSOC, V268, P1545, DOI 10.1001/jama.268.12.1545; Bunch TJ, 2007, CIRCULATION, V115, P2451, DOI 10.1161/CIRCULATIONAHA.106.683235; Bursi F, 2007, AM J MED, V120, P616, DOI 10.1016/j.amjmed.2006.07.039; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Devlin G, 2005, HEART, V91, P1394, DOI 10.1136/hrt.2004.054007; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Gandy A, 2008, STAT MED, V27, P831, DOI 10.1002/sim.2972; Gerber Y, 2006, CIRCULATION, V113, P2285, DOI 10.1161/CIRCULATIONAHA.105.590463; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Goraya TY, 2000, MAYO CLIN PROC, V75, P681; Goraya TY, 2003, AM J EPIDEMIOL, V157, P763, DOI 10.1093/aje/kwg057; Guidry UC, 1999, CIRCULATION, V100, P2054, DOI 10.1161/01.CIR.100.20.2054; Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hohnloser SH, 2003, CIRCULATION, V107, P941, DOI 10.1161/01.CIR.0000054211.00668.9B; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Jordaens L, 2001, EUR HEART J, V22, P1214, DOI 10.1053/euhj.2000.2464; KANNEL WB, 1979, AM J CARDIOL, V44, P53, DOI 10.1016/0002-9149(79)90250-9; Lloyd-Jones DM, 2006, ARCH INTERN MED, V166, P1342, DOI 10.1001/archinte.166.13.1342; Makikallio TH, 2006, AM J CARDIOL, V97, P480, DOI 10.1016/j.amjcard.2005.09.077; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Myerburg RJ, 1998, CIRCULATION, V97, P1514; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prineas R.J., 1982, MINNESOTA CODE MANUA; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Roger VL, 2002, J CLIN EPIDEMIOL, V55, P593, DOI 10.1016/S0895-4356(02)00390-6; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Salukhe TV, 2004, CIRCULATION, V109, P1848, DOI 10.1161/01.CIR.0000125522.10053.29; Singh JP, 2005, J AM COLL CARDIOL, V46, P1712, DOI 10.1016/j.jacc.2005.05.088; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Spencer FA, 1999, J AM COLL CARDIOL, V34, P1378, DOI 10.1016/S0735-1097(99)00390-3; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Watkins S, 2005, AM J CARDIOL, V96, P1349, DOI 10.1016/j.amjcard.2005.07.037; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07; Wiviott SD, 2006, J AM COLL CARDIOL, V47, P1553, DOI 10.1016/j.jacc.2005.11.075; Yap YG, 2005, EUR HEART J, V26, P1385, DOI 10.1093/eurheartj/ehi268	52	172	178	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2022	2029		10.1001/jama.2008.553	http://dx.doi.org/10.1001/jama.2008.553			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984889	Green Accepted, Bronze			2022-12-01	WOS:000260605400022
J	Coll, AP; Yeo, GSH; Farooqi, IS; O'Rahilly, S				Coll, Anthony P.; Yeo, Giles S. H.; Farooqi, I. Sadaf; O'Rahilly, Stephen			SnapShot: The Hormonal Control of Food Intake	CELL			English	Editorial Material							OBESITY; NEURONS		[Coll, Anthony P.; Yeo, Giles S. H.; Farooqi, I. Sadaf; O'Rahilly, Stephen] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England	University of Cambridge	Coll, AP (corresponding author), Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England.		O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Coll, Anthony Patrick/0000-0003-2594-7463; Farooqi, Sadaf/0000-0001-7609-3504; Yeo, Giles See How/0000-0001-8823-3615	MRC [G9824984, G108/617] Funding Source: UKRI; Medical Research Council [G9824984, G108/617] Funding Source: Medline; Wellcome Trust [082390] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007	10	8	9	2	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3							572.e1	10.1016/j.cell.2008.10.014	http://dx.doi.org/10.1016/j.cell.2008.10.014			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984167	Bronze			2022-12-01	WOS:000260536300026
J	Jackevicius, CA; Tu, JV; Demers, V; Melo, M; Cox, J; Rinfret, S; Kalavrouziotis, D; Johansen, H; Behlouli, H; Newman, A; Pilote, L				Jackevicius, Cynthia A.; Tu, Jack V.; Demers, Virginie; Melo, Magda; Cox, Jafna; Rinfret, Stephane; Kalavrouziotis, Dimitri; Johansen, Helen; Behlouli, Hassan; Newman, Alice; Pilote, Louise			Cardiovascular outcomes after a change in prescription policy for clopidogrel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PRIOR-AUTHORIZATION PROGRAMS; ACUTE MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; TIME-SERIES; PREMATURE DISCONTINUATION; STENT IMPLANTATION; HEART-ASSOCIATION; AMERICAN-COLLEGE; PREVALENCE	Background: Drug-reimbursement policies may have an adverse effect on patient outcomes if they interfere with timely access to efficacious medications for acute medical conditions. Clopidogrel in combination with aspirin is the recommended standard of care for patients receiving coronary stents to prevent thrombosis. We examined the population-level effect of a change by a Canadian provincial government in a pharmacy-benefits program from a prior-authorization policy to a less restrictive, limited-use policy on access to clopidogrel among patients undergoing percutaneous coronary intervention (PCI) with stenting after acute myocardial infarction. Methods: We conducted a population-based, retrospective, time-series analysis from April 1, 2000, to March 31, 2005, of all patients 65 years of age or older with acute myocardial infarction who underwent PCI with stenting in Ontario, Canada. The primary outcome was the composite rate of death, recurrent acute myocardial infarction, PCI, and coronary-artery bypass grafting at 1 year, with adjustment for sex and age. The secondary outcome was major bleeding. Results: The rate of clopidogrel use within 30 days after hospital discharge following myocardial infarction increased from 35% in the prior-authorization period to 88% in the limited-use period. The median time to the first dispensing of a clopidogrel prescription decreased from 9 days in the first period to 0 days in the second period. The 1-year composite cardiovascular outcome significantly decreased from 15% in the prior-authorization group to 11% in the limited-use group (P=0.02). Rates of bleeding in the two groups did not change. Conclusions: The removal of a prior-authorization program led to improvement in timely access to clopidogrel for coronary stenting and improved cardiovascular outcomes.	[Jackevicius, Cynthia A.] Western Univ Hlth Sci, Coll Pharm, Pomona, CA 91766 USA; [Jackevicius, Cynthia A.; Tu, Jack V.] Univ Toronto, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Jackevicius, Cynthia A.; Tu, Jack V.; Melo, Magda; Newman, Alice] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Tu, Jack V.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Demers, Virginie; Behlouli, Hassan; Pilote, Louise] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Rinfret, Stephane] Univ Montreal, Montreal, PQ, Canada; [Cox, Jafna; Kalavrouziotis, Dimitri] Dalhousie Univ, Halifax, NS, Canada; [Johansen, Helen] STAT Canada, Ottawa, ON, Canada	Western University of Health Sciences; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McGill University; Universite de Montreal; Dalhousie University; Statistics Canada	Jackevicius, CA (corresponding author), Western Univ Hlth Sci, Coll Pharm, 309 E 2nd St, Pomona, CA 91766 USA.	cjackevicius@westernu.edu		Cox, Jafna/0000-0001-7908-5323; Pilote, Louise/0000-0002-6159-0628; Tu, Jack/0000-0003-0111-722X	Canadian Institutes for Health Research; Canada Research Chair in Health Services Research, Ottawa; Heart and Stroke Foundation of Ontario; Ontario Ministry of Health and Long-Term Care, Toronto; Fonds de la Recherche en Sant, du Quebec (FRSQ)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research, Ottawa(Canada Research Chairs); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Ministry of Health and Long-Term Care, Toronto(Ministry of Health and Long-Term Care, Ontario); Fonds de la Recherche en Sant, du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	Supported by a Team Grant in Cardiovascular Outcomes Research to the Canadian Cardiovascular Outcomes Research Team (CCORT) from the Canadian Institutes for Health Research; by a Canada Research Chair in Health Services Research, Ottawa, and a Career Investigator Award from the Heart and Stroke Foundation of Ontario (to Dr. Tu); by an operating grant from the Ontario Ministry of Health and Long-Term Care, Toronto, to the Institute for Clinical Evaluative Sciences; by a CCORT Summer Student Award (to Dr. Demers); by the Fonds de la Recherche en Sant, du Quebec (FRSQ) (to Dr. Rinfret); by a CCORT master's student fellowship (to Dr. Kalavrouziotis); and by a James McGill chair and the FRSQ (to Dr. Pilote). Dr. Cox reports receiving consulting and lecture fees from Bristol-Myers Squibb, Merck, Pfizer, Sanofi-Aventis, and GlaxoSmithKline and research support from Merck and Pfizer and being a site investigator for a clinical trial sponsored by Sanofi-Aventis; and Dr. Rinfret, receiving consulting and lecture fees from Pfizer, Bristol-Myers Squibb, Sanofi-Aventis, and Abbott Vascular. No other potential conflict of interest relevant to this article was reported. We thank the Cardiac Care Network of Ontario for providing data regarding types of stents from its clinical registry.	Ackman ML, 2006, CAN J CARDIOL, V22, P1205, DOI 10.1016/S0828-282X(06)70960-6; *CAN I HLTH INF, 2007, DRUG EXP CAN 1985 20; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fischer MA, 2004, NEW ENGL J MED, V351, P2187, DOI 10.1056/NEJMsa042770; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Hamel MB, 2004, NEW ENGL J MED, V351, P2156, DOI 10.1056/NEJMp048294; JACKEVICIUS CA, 2006, CCORT CANADIAN CARDI, P180; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; Jackevicius CA, 2007, PHARMACOEPIDEM DR S, V16, P207, DOI 10.1002/pds.1289; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; McCombs JS, 2002, CLIN THER, V24, P1939, DOI 10.1016/S0149-2918(02)80090-X; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; PHILLIPS CR, 1997, J MANAGE CARE PHARM, V3, P699; Popma JJ, 2004, CHEST, V126, p576S, DOI 10.1378/chest.126.3_suppl.576S; Rubinfeld DL., 2013, MICROECONOMICS; Schneeweiss S, 2003, CLIN PHARMACOL THER, V74, P388, DOI 10.1016/S0009-9236(03)00227-3; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schneeweiss S, 2001, HEALTH POLICY, V55, P97, DOI 10.1016/S0168-8510(00)00120-2; Sheehy O, 2008, CAN MED ASSOC J, V178, P413, DOI 10.1503/cmaj.070586; SMALLEY WE, 1995, NEW ENGL J MED, V332, P1612, DOI 10.1056/NEJM199506153322406; Smith SC, 2006, J AM COLL CARDIOL, V47, P216, DOI 10.1016/j.jacc.2005.11.025; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Tricoci P, 2006, ARCH INTERN MED, V166, P806, DOI 10.1001/archinte.166.7.806; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; TU JV, 1999, CARDIOVASCULAR HLTH, P25; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yaffee R.A., 2000, INTRO TIME SERIES AN	32	57	57	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1802	1810		10.1056/NEJMsa0803410	http://dx.doi.org/10.1056/NEJMsa0803410			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946065				2022-12-01	WOS:000260245800007
J	Hyman, SE				Hyman, Steven E.			A glimmer of light for neuropsychiatric disorders	NATURE			English	Article							GENOME-WIDE ASSOCIATION; NATIONAL COMORBIDITY SURVEY; ALZHEIMERS-DISEASE; RETT-SYNDROME; COPY NUMBER; GENETICS; SCHIZOPHRENIA; GENES; LOCI; TRANSLOCATION		[Hyman, Steven E.] Harvard Univ, Sch Med, Off Provost, Dept Neurobiol, Cambridge, MA 02138 USA	Harvard University	Hyman, SE (corresponding author), Harvard Univ, Sch Med, Off Provost, Dept Neurobiol, Massachusetts Hall, Cambridge, MA 02138 USA.	seh@harvard.edu						American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hunter DJ, 2008, NEW ENGL J MED, V358, P2760, DOI 10.1056/NEJMp0804318; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kendler KS, 1997, BRIT J PSYCHIAT, V170, P541, DOI 10.1192/bjp.170.6.541; Kendler KS, 1998, AM J PSYCHIAT, V155, P172; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Lewis JC, 2004, J MED GENET, V41, P203, DOI 10.1136/jmg.2003.012757; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; Merikangas KR, 2003, AM J PSYCHIAT, V160, P625, DOI 10.1176/appi.ajp.160.4.625; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Murray C, 1996, GLOBAL BURDEN DIS; Nestler E. J., 2008, MOL NEUROPHARMACOLOG; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; Reddy Kavita S, 2005, BMC Med Genet, V6, P3, DOI 10.1186/1471-2350-6-3; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Watase K, 2003, NAT REV GENET, V4, P296, DOI 10.1038/nrg1045; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams NM, 2006, INT REV NEUROBIOL, V73, P1, DOI 10.1016/S0074-7742(06)73001-X; World Health Organization, 2001, WORLD HLTH REP 2001; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	48	81	84	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					890	893		10.1038/nature07454	http://dx.doi.org/10.1038/nature07454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923510	Bronze			2022-12-01	WOS:000260038300036
J	Schwalb, NK; Temps, F				Schwalb, Nina K.; Temps, Friedrich			Base sequence and higher-order structure induce the complex excited-state dynamics in DNA	SCIENCE			English	Article							MOLECULAR-SPECTROSCOPY; ENERGY-TRANSFER; FLUORESCENCE; CONVERSION; ADENINE; DELOCALIZATION; DEACTIVATION; SELECTIVITY; RELAXATION; EXCITATION	The high photostability of DNA is commonly attributed to efficient radiationless electronic relaxation processes. We used femtosecond time-resolved fluorescence spectroscopy to reveal that the ensuing dynamics are strongly dependent on base sequence and are also affected by higher-order structure. Excited electronic state lifetimes in dG-doped d(A)(20) single-stranded DNA and dG center dot dC-doped d(A)(20)center dot d(T)(20) double-stranded DNA decrease sharply with the substitution of only a few bases. In duplexes containing d(AGA) center dot d(TCT) or d(AG) center dot d(TC) repeats, deactivation of the fluorescing states occurs on the subpicosecond time scale, but the excited-state lifetimes increase again in extended d(G) runs. The results point at more complex and molecule-specific photodynamics in native DNA than may be evident in simpler model systems.	[Schwalb, Nina K.; Temps, Friedrich] Univ Kiel, Inst Chem Phys, D-24098 Kiel, Germany	University of Kiel	Schwalb, NK (corresponding author), Univ Kiel, Inst Chem Phys, Olshaussenstr 40, D-24098 Kiel, Germany.	schwalb@phc.uni-kiel.de; temps@phc.uni-kiel.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft. Furthermore, the authors thank J. Grotzinger for letting us take the CD spectra.	Abo-Riziq A, 2005, P NATL ACAD SCI USA, V102, P20, DOI 10.1073/pnas.0408574102; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE; Bouvier B, 2003, J PHYS CHEM B, V107, P13512, DOI 10.1021/jp036164u; Bouvier B, 2002, CHEM PHYS, V275, P75, DOI 10.1016/S0301-0104(01)00523-7; Buchvarov I, 2007, P NATL ACAD SCI USA, V104, P4794, DOI 10.1073/pnas.0606757104; Crespo-Hernandez CE, 2008, J AM CHEM SOC, V130, P10844, DOI 10.1021/ja802183s; Crespo-Hernandez CE, 2006, NATURE, V441, pE8, DOI 10.1038/nature04904; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; Crespo-Hernandez CE, 2004, J PHYS CHEM B, V108, P11182, DOI 10.1021/jp0496046; Czader A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2821384; Elias B, 2008, J AM CHEM SOC, V130, P1152, DOI 10.1021/ja710358p; Emanuele E, 2005, CHEMPHYSCHEM, V6, P1387, DOI 10.1002/cphc.200500014; Groenhof G, 2007, J AM CHEM SOC, V129, P6812, DOI 10.1021/ja069176c; Gustavsson T, 2002, CHEM PHYS LETT, V351, P195, DOI 10.1016/S0009-2614(01)01375-6; Hyeon-Deuk K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2894843; Kelley SO, 1999, SCIENCE, V283, P375, DOI 10.1126/science.283.5400.375; Kwok WM, 2006, J AM CHEM SOC, V128, P11894, DOI 10.1021/ja0622002; Markovitsi D, 2005, J AM CHEM SOC, V127, P17130, DOI 10.1021/ja054955z; Markovitsi D, 2003, CHEMPHYSCHEM, V4, P303, DOI 10.1002/cphc.200390050; Markovitsi D, 2006, NATURE, V441, pE7, DOI 10.1038/nature04903; Miannay FA, 2007, J AM CHEM SOC, V129, P14574, DOI 10.1021/ja077100q; Onidas D, 2002, J PHYS CHEM B, V106, P11367, DOI 10.1021/jp026063g; Onidas D, 2007, J PHYS CHEM B, V111, P9644, DOI 10.1021/jp072508v; Pancur T, 2005, CHEM PHYS, V313, P199, DOI 10.1016/j.chemphys.2004.12.019; Pecourt JML, 2001, J AM CHEM SOC, V123, P10370, DOI 10.1021/ja0161453; Peon J, 2001, CHEM PHYS LETT, V348, P255, DOI 10.1016/S0009-2614(01)01128-9; Schwalb NK, 2007, J AM CHEM SOC, V129, P9272, DOI 10.1021/ja073448+; Sobolewski AL, 2005, P NATL ACAD SCI USA, V102, P17903, DOI 10.1073/pnas.0504087102; Wan CZ, 2000, P NATL ACAD SCI USA, V97, P14052, DOI 10.1073/pnas.250483297	30	126	129	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					243	245		10.1126/science.1161651	http://dx.doi.org/10.1126/science.1161651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845751				2022-12-01	WOS:000259902300043
J	Guven-Ozkan, T; Nishi, Y; Robertson, SM; Lin, RL				Guven-Ozkan, Tugba; Nishi, Yuichi; Robertson, Scott M.; Lin, Rueyling			Global transcriptional repression in C-elegans germline precursors by regulated sequestration of TAF-4	CELL			English	Article							RNA-POLYMERASE-II; TO-EMBRYO TRANSITION; ZINC-FINGER PROTEINS; CAENORHABDITIS-ELEGANS; OOCYTE MATURATION; GENE-EXPRESSION; MATERNAL PROTEINS; PIE-1 PROTEIN; CHROMATIN; DEGRADATION	In C. elegans, four asymmetric divisions, beginning with the zygote (P0), generate transcriptionally repressed germline blastomeres (P1-P4) and somatic sisters that become transcriptionally active. The protein PIE-1 represses transcription in the later germline blastomeres but not in the earlier germline blastomeres P0 and P1. We show here that OMA-1 and OMA-2, previously shown to regulate oocyte maturation, repress transcription in P0 and P1 by binding to and sequestering in the cytoplasm TAF-4, a component critical for assembly of TFIID and the pol II pre-initiation complex. OMA-1/2 binding to TAF-4 is developmentally regulated, requiring phosphorylation by the DYRK kinase MBK-2, which is activated at meiosis II after fertilization. OMA-1/2 are normally degraded after the first mitosis, but ectopic expression of wild-type OMA-1 is sufficient to repress transcription in both somatic and later germline blastomeres. We propose that phosphorylation by MBK-2 serves as a developmental switch, converting OMA-1/2 from oocyte to embryo regulators.	[Guven-Ozkan, Tugba; Nishi, Yuichi; Robertson, Scott M.; Lin, Rueyling] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Lin, RL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	rueyling.lin@utsouthwestern.edu	Robertson, Scott/B-9018-2013		National Institutes of Health [HD37933]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Lin lab members for discussions, Angela Collins for technical assistance in the initial isolation of taf-4 clones, Jim Priess for antibodies to MEX-5 and PIE-1, Judith Austin for AZ212, Ed Kipreos for ET113, Geraldine Seydoux for the vet-5 clone and pID3.01B, Andy Fire for vet-5 sequence information, Yuji Kohara for all yk cDNA clones, Zheng Zhou and Bob Horvitz for sharing the yeast two-hybrid library, Keith Blackwell and Amy Walker for anti-TAF-4 antibody, and Hiroyuki Kawahara for anti-OMA-1a antibody. All other strains used were provided by C. elegans Genome Center. This work was supported by a National Institutes of Health grant (HD37933) to R. L.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; Deshpande G, 2005, MECH DEVELOP, V122, P645, DOI 10.1016/j.mod.2004.12.009; Deshpande G, 2004, DEVELOPMENT, V131, P1247, DOI 10.1242/dev.01004; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Ghosh D, 2008, GENETICS, V178, P235, DOI 10.1534/genetics.107.083212; Giadrossi S, 2007, CURR OPIN GENET DEV, V17, P132, DOI 10.1016/j.gde.2007.02.012; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoffmann A, 1996, J BIOL CHEM, V271, P18194, DOI 10.1074/jbc.271.30.18194; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; KOBAYASHI S, 1988, DEV GROWTH DIFFER, V30, P251; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Leatherman JL, 2002, CURR BIOL, V12, P1681, DOI 10.1016/S0960-9822(02)01182-X; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Liu J, 2004, DEVELOPMENT, V131, P3513, DOI 10.1242/dev.01245; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Praitis V, 2001, GENETICS, V157, P1217; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; SCHAUER IE, 1990, DEVELOPMENT, V110, P1303; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shimada M, 2002, GENES CELLS, V7, P933, DOI 10.1046/j.1365-2443.2002.00570.x; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; VARNUM BC, 1989, ONCOGENE, V4, P119; Walker AK, 2004, J BIOL CHEM, V279, P15339, DOI 10.1074/jbc.M310731200; Walker AK, 2003, J BIOL CHEM, V278, P6181, DOI 10.1074/jbc.M211056200; Walker AK, 2001, EMBO J, V20, P5269, DOI 10.1093/emboj/20.18.5269; Walker AK, 2007, DEV BIOL, V304, P382, DOI 10.1016/j.ydbio.2006.12.039; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203	61	78	92	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					149	160		10.1016/j.cell.2008.07.040	http://dx.doi.org/10.1016/j.cell.2008.07.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854162	Green Accepted, Bronze			2022-12-01	WOS:000259728100016
J	Scott, JJ; Oh, DC; Yuceer, MC; Klepzig, KD; Clardy, J; Currie, CR				Scott, Jarrod J.; Oh, Dong-Chan; Yuceer, M. Cetin; Klepzig, Kier D.; Clardy, Jon; Currie, Cameron R.			Bacterial protection of beetle-fungus mutualism	SCIENCE			English	Article							SOUTHERN PINE-BEETLE		[Oh, Dong-Chan; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Scott, Jarrod J.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Yuceer, M. Cetin] Mississippi State Univ, Dept Forestry, Mississippi State, MS 39762 USA; [Klepzig, Kier D.] So Res Stn, US Dept Agr Forest Serv, Pineville, LA 71360 USA	Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Mississippi State University; United States Department of Agriculture (USDA); United States Forest Service	Clardy, J (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu; currie@bact.wisc.edu		Scott, Jarrod/0000-0001-9863-1318	U. S. Department of Agriculture; NIH; NSF; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER	U. S. Department of Agriculture(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Adams, S. Adams, C. Booth, E. Caldera, J. Ensign, C. Hsu, Y. Kang, A. Lawrence, W. Monroe, P. Jeffreys, M. Palmisano, A. Pinto, M. Poulsen, K. Raffa, D. Stone, and E. Vallery for assistance. Support provided by the U. S. Department of Agriculture (C.R.C., K.D.K., and M.C.Y.), NIH (J.C.), and NSF (C.R.C.). We have a patent application submitted on mycangimycin.	Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Hofstetter RW, 2006, OECOLOGIA, V147, P679, DOI 10.1007/s00442-005-0312-0; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Klepzig KD, 1997, APPL ENVIRON MICROB, V63, P621, DOI 10.1128/AEM.63.2.621-627.1997; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019	7	345	366	6	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					63	63		10.1126/science.1160423	http://dx.doi.org/10.1126/science.1160423			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832638	Green Accepted			2022-12-01	WOS:000259680200035
J	Lu, L; Jia, MH; Ma, YL; Yang, L; Chen, ZW; Ho, DD; Jiang, Y; Zhang, LQ				Lu, Lin; Jia, Manhong; Ma, Yanling; Yang, Li; Chen, Zhiwei; Ho, David D.; Jiang, Yan; Zhang, Linqi			The changing face of HIV in China	NATURE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; CIRCULATING RECOMBINANT; INFECTION; HIV/AIDS; YUNNAN; DONORS; GENOME; STRAIN		[Lu, Lin; Jia, Manhong; Ma, Yanling; Yang, Li] Yunnan Ctr Dis Control & Prevent, Yunnan, Peoples R China; [Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Peoples R China; [Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Ho, David D.; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Jiang, Yan] Chinese Ctr Dis Control & Prevent, Natl AIDS Reference Lab, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhang, Linqi] Chinese Acad Med Sci, AIDS Res Ctr, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Zhang, Linqi] Peking Union Med Coll, Beijing 100021, Peoples R China	University of Hong Kong; Rockefeller University; Tsinghua University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lu, L (corresponding author), Yunnan Ctr Dis Control & Prevent, Yunnan, Peoples R China.		Chen, Zhiwei/B-7793-2019; ZHANG, LIN/GYD-9123-2022	Chen, Zhiwei/0000-0002-4511-2888; 	National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology [2006CB504200]; Tenth Five-year Key Technologies R&D Programme of China [2004BA719A14-1, 2004BA719A14-2]	National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology(National Basic Research Program of China); Tenth Five-year Key Technologies R&D Programme of China(National Key Technology R&D Program)	This work is supported by National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology to L. Z. (2006CB504200) and by the Tenth Five-year Key Technologies R&D Programme of China: 2004BA719A14-1, 2004BA719A14-2. We also thank Mark Goldin for helpful suggestions.	CHENG HH, 1994, LANCET, V344, P953, DOI 10.1016/S0140-6736(94)92304-3; Chin KC, 2007, CHINESE CONNECTION C; Gill Bates, 2007, DEMOGRAPHY HIV AIDS; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Parekh BS, 2001, AIDS RES HUM RETROV, V17, P137, DOI 10.1089/08892220150217229; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; *US BUR INT NARC L, 2007, INT NARC CONTR STRAT, V1; WENIGER BG, 1994, AIDS, V8, pS13; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Yang RG, 2003, J VIROL, V77, P685, DOI 10.1128/JVI.77.1.685-695.2003; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017	19	227	271	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					609	611		10.1038/455609a	http://dx.doi.org/10.1038/455609a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833270	Bronze			2022-12-01	WOS:000259639700035
J	Cars, O; Hogberg, LD; Murray, M; Nordberg, O; Sivaraman, S; Lundborg, CS; So, AD; Tomson, G				Cars, Otto; Hogberg, Liselotte Diaz; Murray, Mary; Nordberg, Olle; Sivaraman, Satya; Lundborg, Cecilia Stalsby; So, Anthony D.; Tomson, Goran			Meeting the challenge of antibiotic resistance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTIONS; TIME		[Cars, Otto] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Hogberg, Liselotte Diaz] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Murray, Mary] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Nordberg, Olle] Dag Hammarskjold Fdn, Uppsala, Sweden; [Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Div Int Hlth IHCAR, Stockholm, Sweden; [Lundborg, Cecilia Stalsby] Nordic Sch Publ Hlth, Gothenburg, Sweden; [So, Anthony D.] Duke Univ, Program Global Hlth & Technol Access, Terry Sanford Inst Publ Policy, Durham, NC USA; [Tomson, Goran] Karolinska Inst, MMC, Stockholm, Sweden	Uppsala University; Uppsala University; University of South Australia	Cars, O (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	otto.cars@medsci.uu.se		Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Tomson, Goran/0000-0001-9222-3604				Awad AI, 2006, EUR J CLIN PHARMACOL, V62, P135, DOI 10.1007/s00228-005-0089-4; Bavestrello L, 2002, REV MED CHILE, V130, P1265; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Butaye P, 2006, MICROBES INFECT, V8, P1891, DOI 10.1016/j.micinf.2005.12.020; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carbon C, 2002, CLIN MICROBIOL INFEC, V8, P92, DOI 10.1046/j.1469-0691.8.s.2.8.x; Cars O, 2007, ESCMID NEWS, V2, P22; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; Del Mar C, 2007, BMJ-BRIT MED J, V335, P407, DOI 10.1136/bmj.39307.642963.80; Dollman WB, 2005, MED J AUSTRALIA, V182, P617, DOI 10.5694/j.1326-5377.2005.tb06847.x; *EUR CDPC, 2007, ANN EP REP COMM DIS; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; HARBARTH S, 2005, EMERG INFECT DIS, V11; Hawkey PM, 1998, LANCET, V351, P1298, DOI 10.1016/S0140-6736(98)22018-6; Huovinen P, 1998, BRIT MED J, V317, P613, DOI 10.1136/bmj.317.7159.613; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Malani, 2007, EXTENDING CURE POLIC; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; *NAT STAT, MRSA DEATHS DECR 200; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Outterson K, 2007, LANCET INFECT DIS, V7, P559, DOI 10.1016/S1473-3099(07)70188-3; Payne D, 2004, CURR OPIN MICROBIOL, V7, P435, DOI 10.1016/j.mib.2004.08.017; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; *REACT ACT ANT RES, 2007, BURD RES MULT GRAM N; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; TREPKA M, 2001, PEDIATRICS, V107, P6; *WHO, 2000, REP INF DIS 2000 OV; World Health Organization, 2001, WHO GLOB STRAT CONT; World Health Organization, 2007, WORLD HLTH REP 2007; *WORLD HLTH ASS, 1998, EM OTH COMM DIS ANT; *WORLD HLTH ASS, 2005, IMPR CONT ANT RES; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; 2007, 21 CENTURY	38	103	105	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1438	10.1136/bmj.a1438	http://dx.doi.org/10.1136/bmj.a1438			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18801866				2022-12-01	WOS:000259797600036
J	McIvor, RA; Chapman, KR				McIvor, R. Andrew; Chapman, Kenneth R.			The coming of age of asthma guidelines	LANCET			English	Editorial Material							ACTING BETA-AGONISTS; SAFETY		[McIvor, R. Andrew] McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada; [Chapman, Kenneth R.] Univ Toronto, Asthma & Airway Ctr, Univ Hlth Network, Toronto, ON, Canada	McMaster University; University of Toronto; University Health Network Toronto	McIvor, RA (corresponding author), McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada.	amcivor@stjosham.on.ca						Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; *BRIT THOR SOC, 2008, BRIT GUID MAN ASTHM; Chapman KR, 2008, EUR RESPIR J, V31, P320, DOI 10.1183/09031936.00039707; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126	10	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1021	1022		10.1016/S0140-6736(08)61423-3	http://dx.doi.org/10.1016/S0140-6736(08)61423-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805317				2022-12-01	WOS:000259648500010
J	Malcolmson, SJ; Meek, SJ; Sattely, ES; Schrock, RR; Hoveyda, AH				Malcolmson, Steven J.; Meek, Simon J.; Sattely, Elizabeth S.; Schrock, Richard R.; Hoveyda, Amir H.			Highly efficient molybdenum-based catalysts for enantioselective alkene metathesis	NATURE			English	Article							RING-CLOSING METATHESIS; IMIDO ALKYLIDENE COMPLEXES; OLEFIN-METATHESIS; METAL-COMPLEXES; TUNGSTEN; AMINES; ETHERS; LIGAND	Discovery of efficient catalysts is one of the most compelling objectives of modern chemistry. Chiral catalysts are in particularly high demand, as they facilitate synthesis of enantiomerically enriched small molecules that are critical to developments in medicine, biology and materials science(1). Especially noteworthy are catalysts that promote - with otherwise inaccessible efficiency and selectivity levels - reactions demonstrated to be of great utility in chemical synthesis. Here we report a class of chiral catalysts that initiate alkene metathesis(1) with very high efficiency and enantioselectivity. Such attributes arise from structural fluxionality of the chiral catalysts and the central role that enhanced electronic factors have in the catalytic cycle. The new catalysts have a stereogenic metal centre and carry only monodentate ligands; the molybdenum- based complexes are prepared stereoselectively by a ligand exchange process involving an enantiomerically pure aryloxide, a class of ligands scarcely used in enantioselective catalysis(2,3). We demonstrate the application of the new catalysts in an enantioselective synthesis of the Aspidosperma alkaloid, quebrachamine, through an alkene metathesis reaction that cannot be promoted by any of the previously reported chiral catalysts.	[Malcolmson, Steven J.; Meek, Simon J.; Sattely, Elizabeth S.; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Malcolmson, Steven/C-6220-2015		US National Institutes of Health; Institute of General Medical Sciences [GM-59426]; US National Science Foundation [DBI-0619576]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (grant GM-59426 to A.H.H. and R.R.S.). We are grateful to B. C. Bailey and K. Wampler for assistance in obtaining the X-ray structure of the major diastereomer of molybdenum complex 13b. We thank A. R. Zhugralin for numerous discussions regarding the mechanistic aspects of these investigations and R. Singh for experimental suggestions. Mass spectrometry facilities at Boston College are supported by the US National Science Foundation (grant DBI-0619576).	Alexander JB, 1998, J AM CHEM SOC, V120, P4041, DOI 10.1021/ja974353i; BRUNNER H, 1990, ANGEW CHEM INT EDIT, V29, P1131, DOI 10.1002/anie.199011311; Brunner H, 1999, ANGEW CHEM INT EDIT, V38, P1195, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1194::AID-ANIE1194>3.0.CO;2-X; Brunner H, 1998, TETRAHEDRON-ASYMMETR, V9, P3231, DOI 10.1016/S0957-4166(98)00329-2; DEUTSCH HF, 1994, J PHARMACEUT BIOMED, V12, P1283, DOI 10.1016/0731-7085(94)00066-2; Dolman SJ, 2002, J AM CHEM SOC, V124, P6991, DOI 10.1021/ja012534l; Faller JW, 2001, J AM CHEM SOC, V123, P2525, DOI 10.1021/ja003528c; Fontecave M, 2005, TOP ORGANOMETAL CHEM, V15, P271; Fournier PA, 2007, ORGANOMETALLICS, V26, P2945, DOI 10.1021/om700312c; Funk TW, 2006, J AM CHEM SOC, V128, P1840, DOI 10.1021/ja055994d; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Grubbs R. H., 2003, HDB METATHESIS; HASHIMOTO S, 1979, J CHEM SOC CHEM COMM, P437, DOI 10.1039/c39790000437; Hock AS, 2006, J AM CHEM SOC, V128, P16373, DOI 10.1021/ja0665904; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Kiely AF, 2002, J AM CHEM SOC, V124, P2868, DOI 10.1021/ja012679s; Kozmin SA, 2002, J AM CHEM SOC, V124, P4628, DOI 10.1021/ja017863s; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Poater A, 2007, J AM CHEM SOC, V129, P8207, DOI 10.1021/ja070625y; Sattely ES, 2005, J AM CHEM SOC, V127, P8526, DOI 10.1021/ja051330s; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; SCHROCK RR, 1990, J AM CHEM SOC, V112, P3875, DOI 10.1021/ja00166a023; Singh R, 2007, J AM CHEM SOC, V129, P12654, DOI 10.1021/ja075569f; Solans-Monfort X, 2005, J AM CHEM SOC, V127, P14015, DOI 10.1021/ja053528i; Stewart IC, 2008, ORG LETT, V10, P441, DOI 10.1021/ol702624n; Tayama E, 2002, TETRAHEDRON, V58, P8307, DOI 10.1016/S0040-4020(02)00981-X; Tsang WCP, 2003, J AM CHEM SOC, V125, P2652, DOI 10.1021/ja0210603; Van Veldhuizen JJ, 2005, J AM CHEM SOC, V127, P6877, DOI 10.1021/ja050179j; Van Veldhuizen JJ, 2003, J AM CHEM SOC, V125, P12502, DOI 10.1021/ja0302228	29	212	231	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					933	937		10.1038/nature07594	http://dx.doi.org/10.1038/nature07594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	384TY	19011612	Green Accepted			2022-12-01	WOS:000261768300041
J	Jaakola, VP; Griffith, MT; Hanson, MA; Cherezov, V; Chien, EYT; Lane, JR; IJzerman, AP; Stevens, RC				Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.			The 2.6 Angstrom Crystal Structure of a Human A(2A) Adenosine Receptor Bound to an Antagonist	SCIENCE			English	Article							MUTAGENESIS; RESIDUES; INSIGHTS; TARGETS; PHARMACOLOGY; MECHANISMS; RHODOPSIN; PROTEINS; ZM241385; REVEALS	The adenosine class of heterotrimeric guanine nucleotide- binding protein ( G protein)- coupled receptors ( GPCRs) mediates the important role of extracellular adenosine in many physiological processes and is antagonized by caffeine. We have determined the crystal structure of the human A(2A) adenosine receptor, in complex with a high- affinity subtype- selective antagonist, ZM241385, to 2.6 angstrom resolution. Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helices relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally determined GPCRs. The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane. The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.	[Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Lane, J. Robert; IJzerman, Adriaan P.] Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands	Scripps Research Institute; Leiden University; Leiden University - Excl LUMC	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	IJzerman, Ad/ABG-1353-2020; Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; soler, martha maricel m gomez/L-6025-2014	IJzerman, Ad/0000-0002-1182-2259; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; soler, martha maricel m gomez/0000-0002-4412-8108; Jaakola, Veli-Pekka/0000-0003-2943-6417; Lane, J. Robert/0000-0002-7361-7875	NIH Roadmap Initiative [P50 GM073197]; Protein Structure Initiative [U54 GM074961]; Dutch Top Institute Pharma; GPCR forum program [D1-105]; National Institutes of Health [GM075915]; National Science Foundation [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089857, P50GM073197, U54GM074961, R01GM075915] Funding Source: NIH RePORTER	NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Structure Initiative; Dutch Top Institute Pharma; GPCR forum program(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH Roadmap Initiative grant P50 GM073197 for technology development, Protein Structure Initiative grant U54 GM074961 for target processing, and Pfizer (R.C.S.). A.P.IJ. and J.R.L. thank the Dutch Top Institute Pharma for financial support through the GPCR forum program (D1-105). The authors thank P. Kuhn for encouragement and support, J. Velasquez for help on molecular biology, T. Trinh and K. Allin for help on baculoviral expression, Q. Li and T. Mulder for biochemical and pharmacological characterization of the receptor constructs, A. Walker for assistance with manuscript preparation, and I. Wilson for scientific feedback and discussions. The authors acknowledge Y. Zheng, The Ohio State University, and M. Caffrey, University of Limerick, for the generous loan of the in meso robot [built with support from the National Institutes of Health (GM075915), the National Science Foundation (IIS0308078), and Science Foundation Ireland (02-IN1-B266)]; and J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3EML. The authors, R.C.S., V.-P.J., M.T.G., M.A.H., and V.C. have filed a patent related to the crystals of human adenosine A<INF>2A</INF> receptor.	Audet M, 2008, NAT CHEM BIOL, V4, P397, DOI 10.1038/nchembio.97; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Benarroch EE, 2008, NEUROLOGY, V70, P231, DOI 10.1212/01.wnl.0000297939.18236.ec; BIRNBAUMER L, 1994, TEX HEART I J, V21, P16; Blum D, 2003, LANCET NEUROL, V2, P366, DOI 10.1016/S1474-4422(03)00411-3; Brown RA, 2008, BRIT J PHARMACOL, V153, pS446, DOI 10.1038/bjp.2008.22; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cohen BE, 2005, P NATL ACAD SCI USA, V102, P965, DOI 10.1073/pnas.0409469102; de Zwart M, 1999, DRUG DEVELOP RES, V48, P95, DOI 10.1002/(SICI)1098-2299(199911)48:3<95::AID-DDR1>3.0.CO;2-B; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; Engel CK, 2002, BBA-BIOMEMBRANES, V1564, P38, DOI 10.1016/S0005-2736(02)00398-X; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Ferre S, 2008, FRONT BIOSCI-LANDMRK, V13, P2391, DOI 10.2741/2852; Ferre S, 2008, J NEUROCHEM, V105, P1067, DOI 10.1111/j.1471-4159.2007.05196.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Jaakola VP, 2005, PROTEIN ENG DES SEL, V18, P103, DOI 10.1093/protein/gzi004; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Joost P, 2002, GENOME BIOL, V3; Kim JH, 1996, MOL PHARMACOL, V49, P683; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lahiria S, 2007, RESP PHYSIOL NEUROBI, V157, P123, DOI 10.1016/j.resp.2007.02.015; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mantri M, 2008, J MED CHEM, V51, P4449, DOI 10.1021/jm701594y; Martinelli A, 2008, MED RES REV, V28, P247, DOI 10.1002/med.20106; Moro S, 2003, CHEM COMMUN, P2949, DOI 10.1039/b303439a; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; POUCHER SM, 1995, BRIT J PHARMACOL, V115, P1096, DOI 10.1111/j.1476-5381.1995.tb15923.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ratnaparkhi GS, 2000, BIOCHEMISTRY-US, V39, P12365, DOI 10.1021/bi000775k; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sawynok J, 2003, PROG NEUROBIOL, V69, P313, DOI 10.1016/S0301-0082(03)00050-9; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; Scholl DJ, 2000, BIOCHEM PHARMACOL, V60, P1647, DOI 10.1016/S0006-2952(00)00474-3; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shi YR, 2008, J CEREBR BLOOD F MET, V28, P111, DOI 10.1038/sj.jcbfm.9600511; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yuzlenko O, 2009, J COMPUT CHEM, V30, P14, DOI 10.1002/jcc.21001; Zezula J, 2008, BRIT J PHARMACOL, V153, pS184, DOI 10.1038/sj.bjp.0707674	52	1491	1547	0	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1211	1217		10.1126/science.1164772	http://dx.doi.org/10.1126/science.1164772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18832607	Green Accepted			2022-12-01	WOS:000261033400032
J	Bacaj, T; Tevlin, M; Lu, Y; Shaham, S				Bacaj, Taulant; Tevlin, Maya; Lu, Yun; Shaham, Shai			Glia Are Essential for Sensory Organ Function in C-elegans	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NEURONS; CILIA; THERMOTAXIS; CHEMOTAXIS; ASTROCYTES; RESPONSES; ENCODES; PROTEIN; CELLS		[Bacaj, Taulant; Tevlin, Maya; Lu, Yun; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10065 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064273] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS064273, R01 NS064273-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547	24	133	140	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					744	747		10.1126/science.1163074	http://dx.doi.org/10.1126/science.1163074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974354	Green Accepted			2022-12-01	WOS:000260605200050
J	Ding, L; Getz, G; Wheeler, DA; Mardis, ER; McLellan, MD; Cibulskis, K; Sougnez, C; Greulich, H; Muzny, DM; Morgan, MB; Fulton, L; Fulton, RS; Zhang, QY; Wendl, MC; Lawrence, MS; Larson, DE; Chen, K; Dooling, DJ; Sabo, A; Hawes, AC; Shen, H; Jhangiani, SN; Lewis, LR; Hall, O; Zhu, YM; Mathew, T; Ren, YR; Yao, JQ; Scherer, SE; Clerc, K; Metcalf, GA; Ng, B; Milosavljevic, A; Gonzalez-Garay, ML; Osborne, JR; Meyer, R; Shi, XQ; Tang, YZ; Koboldt, DC; Lin, L; Abbott, R; Miner, TL; Pohl, C; Fewell, G; Haipek, C; Schmidt, H; Dunford-Shore, BH; Kraja, A; Crosby, SD; Sawyer, CS; Vickery, T; Sander, S; Robinson, J; Winckler, W; Baldwin, J; Chirieac, LR; Dutt, A; Fennell, T; Hanna, M; Johnson, BE; Onofrio, RC; Thomas, RK; Tonon, G; Weir, BA; Zhao, XJ; Ziaugra, L; Zody, MC; Giordano, T; Orringer, MB; Roth, JA; Spitz, MR; Wistuba, II; Ozenberger, B; Good, PJ; Chang, AC; Beer, DG; Watson, MA; Ladanyi, M; Broderick, S; Yoshizawa, A; Travis, WD; Pao, W; Province, MA; Weinstock, GM; Varmus, HE; Gabriel, SB; Lander, ES; Gibbs, RA; Meyerson, M; Wilson, RK				Ding, Li; Getz, Gad; Wheeler, David A.; Mardis, Elaine R.; McLellan, Michael D.; Cibulskis, Kristian; Sougnez, Carrie; Greulich, Heidi; Muzny, Donna M.; Morgan, Margaret B.; Fulton, Lucinda; Fulton, Robert S.; Zhang, Qunyuan; Wendl, Michael C.; Lawrence, Michael S.; Larson, David E.; Chen, Ken; Dooling, David J.; Sabo, Aniko; Hawes, Alicia C.; Shen, Hua; Jhangiani, Shalini N.; Lewis, Lora R.; Hall, Otis; Zhu, Yiming; Mathew, Tittu; Ren, Yanru; Yao, Jiqiang; Scherer, Steven E.; Clerc, Kerstin; Metcalf, Ginger A.; Ng, Brian; Milosavljevic, Aleksandar; Gonzalez-Garay, Manuel L.; Osborne, John R.; Meyer, Rick; Shi, Xiaoqi; Tang, Yuzhu; Koboldt, Daniel C.; Lin, Ling; Abbott, Rachel; Miner, Tracie L.; Pohl, Craig; Fewell, Ginger; Haipek, Carrie; Schmidt, Heather; Dunford-Shore, Brian H.; Kraja, Aldi; Crosby, Seth D.; Sawyer, Christopher S.; Vickery, Tammi; Sander, Sacha; Robinson, Jody; Winckler, Wendy; Baldwin, Jennifer; Chirieac, Lucian R.; Dutt, Amit; Fennell, Tim; Hanna, Megan; Johnson, Bruce E.; Onofrio, Robert C.; Thomas, Roman K.; Tonon, Giovanni; Weir, Barbara A.; Zhao, Xiaojun; Ziaugra, Liuda; Zody, Michael C.; Giordano, Thomas; Orringer, Mark B.; Roth, Jack A.; Spitz, Margaret R.; Wistuba, Ignacio I.; Ozenberger, Bradley; Good, Peter J.; Chang, Andrew C.; Beer, David G.; Watson, Mark A.; Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William; Province, Michael A.; Weinstock, George M.; Varmus, Harold E.; Gabriel, Stacey B.; Lander, Eric S.; Gibbs, Richard A.; Meyerson, Matthew; Wilson, Richard K.			Somatic mutations affect key pathways in lung adenocarcinoma	NATURE			English	Article							HUMAN BREAST; MENDELIAN-INHERITANCE; HOMOZYGOUS DELETIONS; COLORECTAL CANCERS; EGFR MUTATIONS; TOBACCO-SMOKE; KRAS MUTATION; NEVER SMOKERS; RECEPTOR GENE; GEFITINIB	Determining the genetic basis of cancer requires comprehensive analyses of large collections of histopathologically well- classified primary tumours. Here we report the results of a collaborative study to discover somatic mutations in 188 human lung adenocarcinomas. DNA sequencing of 623 genes with known or potential relationships to cancer revealed more than 1,000 somatic mutations across the samples. Our analysis identified 26 genes that are mutated at significantly high frequencies and thus are probably involved in carcinogenesis. The frequently mutated genes include tyrosine kinases, among them the EGFR homologue ERBB4; multiple ephrin receptor genes, notably EPHA3; vascular endothelial growth factor receptor KDR; and NTRK genes. These data provide evidence of somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers - including NF1, APC, RB1 and ATM - and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B. The observed mutational profiles correlate with clinical features, smoking status and DNA repair defects. These results are reinforced by data integration including single nucleotide polymorphism array and gene expression array. Our findings shed further light on several important signalling pathways involved in lung adenocarcinoma, and suggest new molecular targets for treatment.	[Ding, Li; Mardis, Elaine R.; McLellan, Michael D.; Fulton, Lucinda; Fulton, Robert S.; Wendl, Michael C.; Larson, David E.; Chen, Ken; Dooling, David J.; Osborne, John R.; Meyer, Rick; Shi, Xiaoqi; Tang, Yuzhu; Koboldt, Daniel C.; Lin, Ling; Abbott, Rachel; Miner, Tracie L.; Pohl, Craig; Fewell, Ginger; Haipek, Carrie; Schmidt, Heather; Dunford-Shore, Brian H.; Crosby, Seth D.; Sawyer, Christopher S.; Vickery, Tammi; Sander, Sacha; Robinson, Jody; Weinstock, George M.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA; [Getz, Gad; Cibulskis, Kristian; Sougnez, Carrie; Greulich, Heidi; Lawrence, Michael S.; Winckler, Wendy; Baldwin, Jennifer; Dutt, Amit; Fennell, Tim; Hanna, Megan; Onofrio, Robert C.; Weir, Barbara A.; Zhao, Xiaojun; Ziaugra, Liuda; Zody, Michael C.; Gabriel, Stacey B.; Lander, Eric S.; Meyerson, Matthew] Broad Inst Harvard & MIT, Canc Program, Genome Biol Program, Cambridge, MA 02142 USA; [Wheeler, David A.; Muzny, Donna M.; Morgan, Margaret B.; Sabo, Aniko; Hawes, Alicia C.; Shen, Hua; Jhangiani, Shalini N.; Lewis, Lora R.; Hall, Otis; Zhu, Yiming; Mathew, Tittu; Ren, Yanru; Yao, Jiqiang; Scherer, Steven E.; Clerc, Kerstin; Metcalf, Ginger A.; Ng, Brian; Milosavljevic, Aleksandar; Gonzalez-Garay, Manuel L.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Greulich, Heidi; Winckler, Wendy; Dutt, Amit; Hanna, Megan; Johnson, Bruce E.; Tonon, Giovanni; Weir, Barbara A.; Zhao, Xiaojun; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhang, Qunyuan; Kraja, Aldi; Province, Michael A.] Washington Univ, Sch Med, Div Stat Genom, Dept Genet, St Louis, MO 63108 USA; [Chirieac, Lucian R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chirieac, Lucian R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chirieac, Lucian R.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Thomas, Roman K.] Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Giordano, Thomas] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Orringer, Mark B.; Chang, Andrew C.; Beer, David G.] Univ Michigan, Thorac Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA; [Roth, Jack A.; Wistuba, Ignacio I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Spitz, Margaret R.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Ozenberger, Bradley; Good, Peter J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Watson, Mark A.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10065 USA; [Ladanyi, Marc; Pao, William] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Varmus, Harold E.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wilson, RK (corresponding author), Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA.	matthew_meyerson@dfci.harvard.edu; rwilson@wustl.edu	Yoshizawa, Akihiko/AAM-9519-2020; Dutt, Amit/I-1911-2013; Chen, Ken/A-1074-2009; Tonon, Giovanni/J-9804-2018; Chen, Ken/AAU-1432-2021; Lawrence, Michael/AAC-8202-2020; Ladanyi, Marc/AAG-8585-2019; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Chirieac, Lucian R./AAD-2030-2019; Wheeler, David A/M-9740-2018; Cibulskis, Kristian/AAC-7380-2019; Wendl, Michael C/A-2741-2008; Meyerson, Matthew L/E-7123-2012; Weinstock, George M/C-6314-2013	Dutt, Amit/0000-0002-1119-4774; Tonon, Giovanni/0000-0003-2973-5038; Chen, Ken/0000-0003-4013-5279; Wilson, Richard K./0000-0002-1992-1358; Wheeler, David A/0000-0002-9056-6299; Weinstock, George M/0000-0002-2997-4592; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Cibulskis, Kristian/0000-0003-1343-1582; Giordano, Thomas/0000-0003-0641-8873; Larson, David/0000-0001-7934-5906; MCLELLAN, MICHAEL/0000-0002-2703-8784; Chang, Andrew/0000-0001-9506-0425	National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA154365, U19CA084953] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank A. Lash, M.F. Zakowski, M.G. Kris and V. Rusch for intellectual contributions, and many members of the Baylor Human Genome Sequencing Center, the Broad Institute of Harvard and MIT, and the Genome Center at Washington University for support. This work was funded by grants from the National Human Genome Research Institute to E.S.L., R.A.G. and R.K.W.	Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chehab NH, 2000, GENE DEV, V14, P278; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOWLEY PM, 1991, COLD SPRING HARB SYM, V56, P149; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Juergens Rosalyn A, 2006, J Natl Compr Canc Netw, V4, P595; Kim JH, 2006, HUM MOL GENET, V15, P1181, DOI 10.1093/hmg/ddl033; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Liu CX, 2000, CANCER RES, V60, P1961; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Packenham JP, 1995, CLIN CANCER RES, V1, P687; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; RODENHUIS S, 1988, CANCER RES, V48, P5738; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sandsmark DK, 2007, CANCER RES, V67, P4790, DOI 10.1158/0008-5472.CAN-06-4470; Sasaki H, 2007, ONCOL REP, V18, P623; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; Sellers TA, 1998, GENET EPIDEMIOL, V15, P251, DOI 10.1002/(SICI)1098-2272(1998)15:3<251::AID-GEPI4>3.0.CO;2-7; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	50	2009	2100	7	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1069	1075		10.1038/nature07423	http://dx.doi.org/10.1038/nature07423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948947	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000260252600036
J	Choi, PJ; Cai, L; Frieda, K; Xie, S				Choi, Paul J.; Cai, Long; Frieda, Kirsten; Xie, Sunney			A stochastic single-molecule event triggers phenotype switching of a bacterial cell	SCIENCE			English	Article							LAC REPRESSOR; ESCHERICHIA-COLI; GENE-EXPRESSION; OPERATOR COMPLEX; LEVEL; DYNAMICS; PROTEIN; OPERON; TRANSCRIPTION; BINDING	By monitoring fluorescently labeled lactose permease with single-molecule sensitivity, we investigated the molecular mechanism of how an Escherichia coli cell with the lac operon switches from one phenotype to another. At intermediate inducer concentrations, a population of genetically identical cells exhibits two phenotypes: induced cells with highly fluorescent membranes and uninduced cells with a small number of membrane-bound permeases. We found that this basal-level expression results from partial dissociation of the tetrameric lactose repressor from one of its operators on looped DNA. In contrast, infrequent events of complete dissociation of the repressor from DNA result in large bursts of permease expression that trigger induction of the lac operon. Hence, a stochastic single-molecule event determines a cell's phenotype.	[Choi, Paul J.; Cai, Long; Frieda, Kirsten; Xie, Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Xie, S (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010244] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank G. Church, A. Miyawaki, and B. Wanner for bacterial strains and plasmids; J. Hearn for technical assistance; and J. Elf, N. Friedman, and G.W. Li for helpful discussions. This work was supported by the NIH Director's Pioneer Award. P.J.C. acknowledges the John and Fannie Hertz Foundation.	Arkin A, 1998, GENETICS, V149, P1633; Artyomov MN, 2007, P NATL ACAD SCI USA, V104, P18958, DOI 10.1073/pnas.0706110104; BARKLEY MD, 1975, BIOCHEMISTRY-US, V14, P1700, DOI 10.1021/bi00679a024; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; COHEN GN, 1957, BACTERIOL REV, V21, P169, DOI 10.1128/MMBR.21.3.169-194.1957; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DUNAWAY M, 1980, J BIOL CHEM, V255, P115; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Hornos JEM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051907; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; Muller-Hill B, 1996, LAC OPERON SHORT HIS, V1st; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Ptashne M., 2004, GENETIC SWITCH PHAGE; REVZIN A, 1977, BIOCHEMISTRY-US, V16, P4769, DOI 10.1021/bi00641a002; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	26	332	334	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					442	446		10.1126/science.1161427	http://dx.doi.org/10.1126/science.1161427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927393	Green Submitted, Green Accepted			2022-12-01	WOS:000260094500047
J	Rougemaille, M; Dieppois, G; Kisseleva-Romanova, E; Gudipati, RK; Lemoine, S; Blugeon, C; Boulay, J; Jensen, TH; Stutz, F; Devaux, F; Libri, D				Rougemaille, Mathieu; Dieppois, Guennaelle; Kisseleva-Romanova, Elena; Gudipati, Rajani Kanth; Lemoine, Sophie; Blugeon, Corinne; Boulay, Jocelyne; Jensen, Torben Heick; Stutz, Francoise; Devaux, Frederic; Libri, Domenico			THO/Sub2p Functions to Coordinate 3 '-End Processing with Gene-Nuclear Pore Association	CELL			English	Article							MESSENGER-RNA EXPORT; QUALITY-CONTROL; COTRANSCRIPTIONAL RECRUITMENT; TRANSCRIPTION ELONGATION; YEAST-CELLS; THO COMPLEX; MRNP; MEX67P; LOCALIZATION; SUB2P	During transcription, proteins assemble sequentially with nascent RNA to generate a messenger ribonucleoprotein particle (mRNP). The THO complex and its associated Sub2p helicase are functionally implicated in both transcription and mRNP biogenesis but their precise function remains elusive. We show here that THO/Sub2p mutation leads to the accumulation of a stalled intermediate in mRNP biogenesis that contains nuclear pore components and polyadenylation factors in association with chromatin. Microarray analyses of genomic loci that are aberrantly docked to the nuclear pore in mutants allowed the identification of approximately 400 novel validated target genes that require THO /Sub2p for efficient expression. Our data strongly suggests that the THO complex/Sub2p function is required to coordinate events leading to the acquisition of export competence at a step that follows commitment to 30-processing.	[Rougemaille, Mathieu; Kisseleva-Romanova, Elena; Gudipati, Rajani Kanth; Boulay, Jocelyne; Jensen, Torben Heick; Libri, Domenico] CNRS, Ctr Genet Mol, LEA Lab Nucl RNA Metab, UPR2167, F-91190 Gif Sur Yvette, France; [Dieppois, Guennaelle; Stutz, Francoise] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Lemoine, Sophie; Blugeon, Corinne; Devaux, Frederic] Ecole Normale Super, IFR36, F-75231 Paris, France; [Rougemaille, Mathieu; Gudipati, Rajani Kanth; Lemoine, Sophie; Blugeon, Corinne; Boulay, Jocelyne; Devaux, Frederic] Ecole Normale Super, CNRS, Genet Mol Lab, UMR8541, F-75006 Paris, France; [Rougemaille, Mathieu; Gudipati, Rajani Kanth; Boulay, Jocelyne; Jensen, Torben Heick; Libri, Domenico] Aarhus Univ, Dept Mol Biol, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus C, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Geneva; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Aarhus University	Libri, D (corresponding author), CNRS, Ctr Genet Mol, LEA Lab Nucl RNA Metab, UPR2167, 1 Av Terrasse, F-91190 Gif Sur Yvette, France.	libri@cgm.cnrs-gif.fr	Jensen, Torben H/G-2954-2017; DEVAUX, Frédéric/N-2288-2019; Stutz, Françoise C/N-4329-2017	DEVAUX, Frédéric/0000-0002-0039-9096; gudipati, Rajani Kanth/0000-0002-7364-9279; Rougemaille, Mathieu/0000-0002-9675-3888				Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Cui YJ, 2003, MOL CELL BIOL, V23, P7887, DOI 10.1128/MCB.23.21.7887-7901.2003; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Jensen TH, 2004, MOL CELL, V16, P235, DOI 10.1016/j.molcel.2004.09.019; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Luna R, 2005, MOL CELL, V18, P711, DOI 10.1016/j.molcel.2005.05.001; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Thomsen R, 2003, RNA, V9, P1049, DOI 10.1261/rna.5170303; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	47	115	117	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					308	321		10.1016/j.cell.2008.08.005	http://dx.doi.org/10.1016/j.cell.2008.08.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957205	Bronze			2022-12-01	WOS:000260130400020
J	Robertson, GP; Dale, VH; Doering, OC; Hamburg, SP; Melillo, JM; Wander, MM; Parton, WJ; Adler, PR; Barney, JN; Cruse, RM; Duke, CS; Fearnside, PM; Follett, RF; Gibbs, HK; Goldemberg, J; Mladenoff, DJ; Ojima, D; Palmer, MW; Sharpley, A; Wallace, L; Weathers, KC; Wiens, JA; Wilhelm, WW				Robertson, G. Philip; Dale, Virginia H.; Doering, Otto C.; Hamburg, Steven P.; Melillo, Jerry M.; Wander, Michele M.; Parton, William J.; Adler, Paul R.; Barney, Jacob N.; Cruse, Richard M.; Duke, Clifford S.; Fearnside, Philip M.; Follett, Ronald F.; Gibbs, Holly K.; Goldemberg, Jose; Mladenoff, David J.; Ojima, Dennis; Palmer, Michael W.; Sharpley, Andrew; Wallace, Linda; Weathers, Kathleen C.; Wiens, John A.; Wilhelm, Wallace W.			Agriculture - Sustainable biofuels Redux	SCIENCE			English	Editorial Material							CORN STOVER; LAND; BIOMASS; CARBON		[Robertson, G. Philip] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Robertson, G. Philip] Michigan State Univ, Dept Crop & Soil Sci, Hickory Corners, MI 49060 USA; [Dale, Virginia H.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Doering, Otto C.] Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA; [Hamburg, Steven P.] Brown Univ, Ctr Environm Studies, Providence, RI 02906 USA; [Hamburg, Steven P.] Environm Def Fund, Boston, MA 01028 USA; [Melillo, Jerry M.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Wander, Michele M.] Univ Illinois, Urbana, IL 61801 USA; [Parton, William J.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Adler, Paul R.] USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA; [Barney, Jacob N.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Cruse, Richard M.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Duke, Clifford S.] Ecol Soc Amer, Washington, DC 20036 USA; [Fearnside, Philip M.] Natl Inst Res Amazon INPA, BR-69011970 Manaus, Amazonas, Brazil; [Follett, Ronald F.] USDA ARS, Ft Collins, CO 80526 USA; [Gibbs, Holly K.] Univ Wisconsin, Ctr Sustainabil & Global Environm SAGE, Nelson Inst Environm Studies, Madison, WI 53726 USA; [Goldemberg, Jose] Univ Sao Paulo, Inst Eletrotecn & Energia, Sao Paulo, Brazil; [Mladenoff, David J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Ojima, Dennis] H John Heinz Ctr Sci Econ & Environm, Washington, DC 20006 USA; [Palmer, Michael W.] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Sharpley, Andrew] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA; [Wallace, Linda] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Weathers, Kathleen C.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Wiens, John A.] PRBO Conservat Sci, Petaluma, CA 94954 USA; [Wilhelm, Wallace W.] Univ Nebraska, USDA ARS, Lincoln, NE 68583 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Brown University; Environmental Defense Fund; Marine Biological Laboratory - Woods Hole; University of Illinois System; University of Illinois Urbana-Champaign; Colorado State University; United States Department of Agriculture (USDA); University of California System; University of California Davis; Iowa State University; Institute Nacional de Pesquisas da Amazonia; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Universidade de Sao Paulo; University of Wisconsin System; University of Wisconsin Madison; Oklahoma State University System; Oklahoma State University - Stillwater; University of Arkansas System; University of Arkansas Fayetteville; University of Oklahoma System; University of Oklahoma - Norman; Cary Institute of Ecosystem Studies; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln	Robertson, GP (corresponding author), Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA.	robertson@kbs.msu.edu	Noojipady, Praveen/B-2511-2010; Fearnside, Philip M/D-6559-2011; Ojima, Dennis/C-5272-2016; Dale, Virginia H/B-6023-2009; Palmer, Michael W/A-2519-2008; /AAD-2154-2020; Dale, Virginia H/ABI-6672-2020; Fearnside, Philip M/GQA-6023-2022; Dale, Virginia/GSO-3448-2022; Barney, Jacob/C-2412-2008; Robertson, G Philip/H-3885-2011	Fearnside, Philip M/0000-0003-3672-9082; Dale, Virginia H/0000-0002-4123-7202; Fearnside, Philip M/0000-0003-3672-9082; Barney, Jacob/0000-0003-2949-5003; Robertson, G Philip/0000-0001-9771-9895				Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; KANTER J, 2008, NY TIMES        0912; Kline KL, 2008, SCIENCE, V321, P199, DOI 10.1126/science.321.5886.199; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150	10	290	299	3	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					49	50		10.1126/science.1161525	http://dx.doi.org/10.1126/science.1161525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832631				2022-12-01	WOS:000259680200028
J	Delgado, MR; Schotter, A; Ozbay, EY; Phelps, EA				Delgado, Mauricio R.; Schotter, Andrew; Ozbay, Erkut Y.; Phelps, Elizabeth A.			Understanding overbidding: using the neural circuitry of reward to design economic auctions	SCIENCE			English	Article							DECISION; BRAIN; NEUROECONOMICS; PUNISHMENT; TRUST; TASK	We take advantage of our knowledge of the neural circuitry of reward to investigate a puzzling economic phenomenon: Why do people overbid in auctions? Using functional magnetic resonance imaging (fMRI), we observed that the social competition inherent in an auction results in a more pronounced blood oxygen level- dependent ( BOLD) response to loss in the striatum, with greater overbidding correlated with the magnitude of this response. Leveraging these neuroimaging results, we design a behavioral experiment that demonstrates that framing an experimental auction to emphasize loss increases overbidding. These results highlight a role for the contemplation of loss in understanding the tendency to bid "too high." Current economic theories suggest overbidding may result from either "joy of winning" or risk aversion. By combining neuroeconomic and behavioral economic techniques, we find that another factor, namely loss contemplation in a social context, may mediate overbidding in auctions.	[Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Delgado, Mauricio R.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Schotter, Andrew] NYU, Dept Econ, New York, NY 10003 USA; [Schotter, Andrew] Ctr Expt Social Sci, New York, NY 10003 USA; [Ozbay, Erkut Y.] Univ Maryland, Dept Econ, College Pk, MD 20742 USA	New York University; Rutgers State University Newark; Rutgers State University New Brunswick; New York University; University System of Maryland; University of Maryland College Park	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu			James S. McDonnell Foundation; National Insttute of Mental Health; NIH [MH62104]; Seaver Foundation to NYU's Center for Brain Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Insttute of Mental Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation to NYU's Center for Brain Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to acknowledge support from the James S. McDonnell Foundation and National Insttute of Mental Health, NIH (MH62104) to E. A. P. and the support of the Seaver Foundation to NYU's Center for Brain Imaging. We also thank the Center for Experimental Social Science for its support. We are grateful to D. Schwarz for his efforts in the initial stages of collection and analysis of neuroimaging data. We thank J. Zakrzewski and K. Nearing for their assistance during data collection, M. Niznikiewicz for assistance during data analysis, and R. Advani for his programming help on the behavioral experiment.	Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Cassidy Ralph, 1967, AUCTIONS AUCTIONEERI; Cox JC., 1982, RES EXPT EC, V2, P1; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goeree JK, 2002, J ECON THEORY, V104, P247, DOI 10.1006/jeth.2001.2914; GUL F, HDB EC METH IN PRESS, V1; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; HUETTEL SA, 2004, FUNCTIONAL MAGNETIC, pR18; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Phelps Elizabeth A., 1999, P295; Rubinstein A., 2006, ADV EC THEORY, P246; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029	22	118	119	8	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1849	1852		10.1126/science.1158860	http://dx.doi.org/10.1126/science.1158860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818362	Green Accepted			2022-12-01	WOS:000259501300042
J	Dhalla, IA; Detsky, AS				Dhalla, Irfan A.; Detsky, Allan S.			Risks and benefits of importing prescription medications from lower-income countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dhalla, Irfan A.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 427-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						AUSTIN I, 2007, NY TIMES        1213; Choudhry NK, 2005, JAMA-J AM MED ASSOC, V293, P358, DOI 10.1001/jama.293.3.358; DECKER S, 2008, RANBAXY DELAY GENERI; *GREENE W, 2007, 200705A US INT TRAD; Hopkins-Tanne J, 2008, BRIT MED J, V336, P1266, DOI 10.1136/bmj.39601.618241.DB; Ricardo David, 1821, PRINCIPLES POLITICAL, V3rd; STAGNITTI MN, STAT BRIEF 205 TREND; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; Yusuf S, 2004, AM HEART J, V148, P1, DOI 10.1016/j.ahj.2004.03.045; ZAMISKA N, 2007, WALL STREET J   1009; ZHANG D, 2007, SOFTWOOD LUMBAR WAR; 2007, MED AD NEWS      SEP	12	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1453	1455		10.1001/jama.300.12.1453	http://dx.doi.org/10.1001/jama.300.12.1453			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812537				2022-12-01	WOS:000259410400024
J	Stern, DA; Morgan, WJ; Halonen, M; Wright, AL; Martinez, FD				Stern, Debra A.; Morgan, Wayne J.; Halonen, Marilyn; Wright, Anne L.; Martinez, Fernando D.			Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study	LANCET			English	Article							1ST 6 YEARS; RISK-FACTORS; FOLLOW-UP; POPULATION; ILLNESS; ALLERGEN; CHILDREN; RATIO; LIFE	Background Incidence of asthma increases during early adulthood. We aimed to estimate the contributions of sex and early life factors to asthma diagnosed in young adults. Methods 1246 healthy newborn babies were enrolled in the Tucson Children's Respiratory Study. Parental characteristics, early-life wheezing phenotypes, airway function, and bronchial hyper-responsiveness to cold dry air and sensitisation to Alternaria alternata were determined before age 6 years. Physician-diagnosed asthma, both chronic and newly diagnosed, and airway function were recorded at age 22 years. Findings Of 1246 babies enrolled, 849 had follow-up data at 22 years. Average incidence of asthma at age 16-22 years was 12.6 per thousand person-years. 49 (27%) of all 181 cases of active asthma at 22 years were newly diagnosed, of which 35 (71%) were women. Asthma remittance by 22 years was higher in men than in women (multinomial odds ratio [M-OR] 2.0, 95% CI 1.2-3.2, p=0 . 008). Age at diagnosis was linearly associated with the ratio of forced expiratory volume at 1 s to forced vital capacity at age 22 years. Factors independently associated with chronic asthma at 22 years included onset at 6 years (7.4, 3 . 9-14. 0) and persistent wheezing (14.0, 6.8-28 . 0) in early life, sensitisation to A alternata (3.6, 2.1-6.4), low airway function at age 6 years (2.1, 1.1-3.9.), and bronchial hyper-responsiveness at 6 years (4 . 5, 1.9-10 . 0). Bronchial hyper-responsiveness (6.9, 2.3-21 . 0), low airway function at 6 years (2.8, 1.1-6.9), and late-onset (4 . 6, 1.7-12 . 0) and persistent wheezing (4 . 0, 1.2-14. 0) predicted newly diagnosed asthma at age 22 years. Interpretation Asthma with onset in early adulthood has its origins in early childhood. Funding National Heart Lung and Blood Institute.	[Stern, Debra A.; Morgan, Wayne J.; Halonen, Marilyn; Wright, Anne L.; Martinez, Fernando D.] Univ Arizona, Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Morgan, Wayne J.; Wright, Anne L.] Univ Arizona, Dept Pediat, Tucson, AZ USA	University of Arizona; University of Arizona Health Sciences; University of Arizona	Martinez, FD (corresponding author), Univ Arizona, Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA.	fernando@arc.arizona.edu		Halonen, Marilyn/0000-0001-9606-935X	National Heart Lung and Blood Institute [HL-56177]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056177] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by grant HL-56177 from the National Heart Lung and Blood Institute. We gratefully acknowledge the contributions of Lynn Taussig who started the Tucson Children's Respiratory Study in 1980 We thank Bruce Saul for data management and our study nurses, Marilyn Lindell and Lydia de la Ossa, for data collection and participant follow-LIP.	Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; ANDERSON HR, 1992, THORAX, V47, P537, DOI 10.1136/thx.47.7.537; Avila L, 2005, J ASTHMA, V42, P543, DOI 10.1080/02770900500214791; Chen Y, 2002, AM J EPIDEMIOL, V155, P191, DOI 10.1093/aje/155.3.191; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; King ME, 2004, PANMINERVA MED, V46, P97; LARSSON L, 1995, THORAX, V50, P260, DOI 10.1136/thx.50.3.260; Lombardi E, 1997, AM J RESP CRIT CARE, V156, P1863, DOI 10.1164/ajrccm.156.6.9612066; Martinez FD, 2003, NEW ENGL J MED, V349, P1473, DOI 10.1056/NEJMe030041; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Nicolai T, 2003, PEDIATR ALLERGY IMMU, V14, P280, DOI 10.1034/j.1399-3038.2003.00047.x; Ownby DR, 1996, ANN ALLERG ASTHMA IM, V77, P304, DOI 10.1016/S1081-1206(10)63325-X; PATTEMORE PK, 1990, AM REV RESPIR DIS, V142, P549, DOI 10.1164/ajrccm/142.3.549; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Strachan DP, 1996, BRIT MED J, V312, P1195; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; TOELLE BG, 1992, AM REV RESPIR DIS, V146, P633, DOI 10.1164/ajrccm/146.3.633; WRIGHT AL, 1989, AM J EPIDEMIOL, V129, P1232, DOI 10.1093/oxfordjournals.aje.a115243; Wright AL, 2006, PEDIATR PULM, V41, P318, DOI 10.1002/ppul.20373; Xuan W, 2000, AM J RESP CRIT CARE, V161, P1820, DOI 10.1164/ajrccm.161.6.9809118	27	275	280	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1058	1064		10.1016/S0140-6736(08)61447-6	http://dx.doi.org/10.1016/S0140-6736(08)61447-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805334	Green Accepted			2022-12-01	WOS:000259648500032
J	Cao, HM; Gerhold, K; Mayers, JR; Wiest, MM; Watkins, SM; Hotamisligil, GS				Cao, Haiming; Gerhold, Kristin; Mayers, Jared R.; Wiest, Michelle M.; Watkins, Steven M.; Hotamisligil, Goekhan S.			Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism	CELL			English	Article							ACID-BINDING PROTEIN; STEAROYL-COA DESATURASE; FATTY-ACIDS; INSULIN-RESISTANCE; DIABETES-MELLITUS; KNOCKOUT MICE; OBESITY; EXPRESSION; LIVER; DIET	Dysregulation of lipid metabolism in individual tissues leads to systemic disruption of insulin action and glucose metabolism. Utilizing quantitative lipidomic analyses and mice deficient in adipose tissue lipid chaperones aP2 and mal1, we explored how metabolic alterations in adipose tissue are linked to whole-body metabolism through lipid signals. A robust increase in de novo lipogenesis rendered the adipose tissue of these mice resistant to the deleterious effects of dietary lipid exposure. Systemic lipid profiling also led to identification of C16:In7-palmitoleate as an adipose tissue-derived lipid hormone that strongly stimulates muscle insulin action and suppresses hepatosteatosis. Our data reveal a lipid-mediated endocrine network and demonstrate that adipose tissue uses lipokines such as C16: In7-palmitoleate to communicate with distant organs and regulate systemic metabolic homeostasis.	[Cao, Haiming; Gerhold, Kristin; Mayers, Jared R.; Hotamisligil, Goekhan S.] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Wiest, Michelle M.; Watkins, Steven M.] Lip Technol, W Sacramento, CA 95691 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hotamisligil, GS (corresponding author), Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Cao, Haiming/P-4634-2016	Mayers, Jared/0000-0002-8607-1787	National Institutes of Health (NIH) [DK064360, DK71507-04]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, P30DK040561, R01DK064360, R90DK071507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Deniz Hotamisligil for artistic rendition and design input. We gratefully acknowledge the assistance of Harold Emsheimer and UyenThao Nguyen (Lipomics Technologies) for their help with composing the figures and performing statistic analyses, respectively. We are grateful to the members of the Hotamisligil Lab for their input and contributions, especially Masato Furuhashi for his help with the hyperinsulinemic-euglycemic clamp studies and Rebecca Foote for administrative support. This work was supported by a National Institutes of Health (NIH) grant DK064360 (to G. S. H.), and H. C. is supported by a NIH roadmap fellowship (DK71507-04) and the American Diabetes Association. M. M. W. and S. M. W. are employees of Lipomics Technologies (West Sacramento, CA). G. S. H. serves as a member of the scientific advisory board at Lipomics Technologies.	Avramoglu RK, 2006, CLIN CHIM ACTA, V368, P1, DOI 10.1016/j.cca.2005.12.026; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; FIELD CJ, 1984, NUTR RES, V4, P743, DOI 10.1016/S0271-5317(84)80050-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; Hiraoka-Yamamoto J, 2004, CLIN EXP PHARMACOL P, V31, P107, DOI 10.1111/j.1440-1681.2004.04121.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Waters KM, 1997, BBA-LIPID LIPID MET, V1349, P33, DOI 10.1016/S0005-2760(97)00069-6; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	31	772	808	2	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					933	944		10.1016/j.cell.2008.07.048	http://dx.doi.org/10.1016/j.cell.2008.07.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805087	Green Accepted, Bronze			2022-12-01	WOS:000259318100014
J	Costello, C; Gaines, SD; Lynham, J				Costello, Christopher; Gaines, Steven D.; Lynham, John			Can catch shares prevent fisheries collapse?	SCIENCE			English	Article							BIODIVERSITY LOSS; PROPERTY; IMPACTS	Recent reports suggest that most of the world's commercial fisheries could collapse within decades. Although poor fisheries governance is often implicated, evaluation of solutions remains rare. Bioeconomic theory and case studies suggest that rights- based catch shares can provide individual incentives for sustainable harvest that is less prone to collapse. To test whether catch- share fishery reforms achieve these hypothetical benefits, we have compiled a global database of fisheries institutions and catch statistics in 11,135 fisheries from 1950 to 2003. Implementation of catch shares halts, and even reverses, the global trend toward widespread collapse. Institutional change has the potential for greatly altering the future of global fisheries.	[Costello, Christopher] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Gaines, Steven D.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Lynham, John] Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Costello, C (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, 4410 Bren Hall, Santa Barbara, CA 93106 USA.	costello@bren.ucsb.edu	Gaines, Steven/Y-3234-2019	Lynham, John/0000-0002-5816-9648	Paul G. Allen Family Foundation; Sea Around Us Project	Paul G. Allen Family Foundation; Sea Around Us Project	We thank the Paul G. Allen Family Foundation for generous financial support; the Sea Around Us Project for making the catch data publicly available; C. Wong and T. Kidman for helping to compile the database; B. Hansen for helpful comments; and J. Prince, K. Bonzon, and J. Toth for assisting with verifying the catch-share database.	Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; CLARK CW, 1973, J POLIT ECON, V81, P950, DOI 10.1086/260090; de Mutsert K, 2008, P NATL ACAD SCI USA, V105, P2740, DOI 10.1073/pnas.0704354105; Festa D, 2008, ISSUES SCI TECHNOL, V24, P75; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Grafton RQ, 2000, J LAW ECON, V43, P679, DOI 10.1086/467469; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Griffith DR, 2008, FRONT ECOL ENVIRON, V6, P191, DOI 10.1890/050060; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Holker F, 2007, SCIENCE, V316, P1285, DOI 10.1126/science.1139114; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newell RG, 2005, J ENVIRON ECON MANAG, V49, P437, DOI 10.1016/j.jeem.2004.06.005; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sanchirico James N., 2007, International Journal of Global Environmental Issues, V7, P106, DOI 10.1504/IJGENVI.2007.013569; Scott A, 1955, J POLIT ECON, V63, P116, DOI 10.1086/257653; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	19	570	575	1	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1678	1681		10.1126/science.1159478	http://dx.doi.org/10.1126/science.1159478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801999				2022-12-01	WOS:000259300400036
J	Sawaya, MR; Wojtowicz, WM; Andre, I; Qian, B; Wu, W; Baker, D; Eisenberg, D; Zipursky, SL				Sawaya, Michael R.; Wojtowicz, Woj M.; Andre, Ingemar; Qian, Bin; Wu, Wei; Baker, David; Eisenberg, David; Zipursky, S. Lawrence			A double S shape provides the structural basis for the extraordinary binding specificity of Dscam isoforms	CELL			English	Article							MOLECULAR DIVERSITY; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; AXON GUIDANCE; DROSOPHILA DSCAM; SELF-AVOIDANCE; RECOGNITION; REFINEMENT; SOFTWARE; ADHESION	Drosophila Dscam encodes a vast family of immunoglobulin (Ig)-containing proteins that exhibit isoform-specific homophilic binding. This diversity is essential for cell recognition events required for wiring the brain. Each isoform binds to itself but rarely to other isoforms. Specificity is determined by "matching'' of three variable Ig domains within an similar to 220 kD ectodomain. Here, we present the structure of the homophilic binding region of Dscam, comprising the eight N-terminal Ig domains (Dscam(1-8)). Dscam(1-8) forms a symmetric homodimer of S-shaped molecules. This conformation, comprising two reverse turns, allows each pair of the three variable domains to "match'' in an antiparallel fashion. Structural, genetic, and biochemical studies demonstrate that, in addition to variable domain "matching,'' intramolecular interactions between constant domains promote homophilic binding. These studies provide insight into how "matching'' at all three pairs of variable domains in Dscam mediates isoform-specific recognition.	[Sawaya, Michael R.; Eisenberg, David] Univ Calif Los Angeles, DOE Inst Genom & Prote, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Wojtowicz, Woj M.; Wu, Wei; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Andre, Ingemar; Qian, Bin; Baker, David] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eisenberg, D (corresponding author), Univ Calif Los Angeles, DOE Inst Genom & Prote, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu; lzipursky@mednet.ucla.edu	André, Ingemar/O-4777-2014; Baker, David/K-8941-2012	André, Ingemar/0000-0002-4753-8233; Baker, David/0000-0001-7896-6217; Sawaya, Michael/0000-0003-0874-9043; Zipursky, Stephen/0000-0001-5630-7181	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM07185, T32 GM007185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2007, NAT REV NEUROSCI, V8, P915, DOI 10.1038/nrn2256; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	26	84	85	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					1007	1018		10.1016/j.cell.2008.07.042	http://dx.doi.org/10.1016/j.cell.2008.07.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805093	Green Accepted, Bronze			2022-12-01	WOS:000259318100020
J	Li, N; DiCarlo, JJ				Li, Nuo; DiCarlo, James J.			Unsupervised natural experience rapidly alters invariant object representation in visual cortex	SCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; INFERIOR TEMPORAL CORTEX; LONG-TERM-MEMORY; EYE-MOVEMENTS; NEURONAL RESPONSES; SINGLE NEURONS; RECOGNITION; SELECTIVITY; ATTENTION; SYSTEM	Object recognition is challenging because each object produces myriad retinal images. Responses of neurons from the inferior temporal cortex ( IT) are selective to different objects, yet tolerant ("invariant") to changes in object position, scale, and pose. How does the brain construct this neuronal tolerance? We report a form of neuronal learning that suggests the underlying solution. Targeted alteration of the natural temporal contiguity of visual experience caused specific changes in IT position tolerance. This unsupervised temporal slowness learning (UTL) was substantial, increased with experience, and was significant in single IT neurons after just 1 hour. Together with previous theoretical work and human object perception experiments, we speculate that UTL may reflect the mechanism by which the visual stream builds and maintains tolerant object representations.	[Li, Nuo; DiCarlo, James J.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Li, Nuo; DiCarlo, James J.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DiCarlo, JJ (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dicarlo@mit.edu			NIH [R01-EY014970]; The McKnight Endowment Fund for Neuroscience; NATIONAL EYE INSTITUTE [R01EY014970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The McKnight Endowment Fund for Neuroscience; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Cox, R. Desimone, N. Kanwisher, J. Maunsell, and N. Rust for helpful comments and discussion, and J. Deutsch, B. Kennedy, M. Maloof, and R. Marini for technical support. This work was supported by the NIH (grant R01-EY014970) and The McKnight Endowment Fund for Neuroscience.	Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Cox DD, 2005, NAT NEUROSCI, V8, P1145, DOI 10.1038/nn1519; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; Dill M, 1998, PERCEPT PSYCHOPHYS, V60, P65, DOI 10.3758/BF03211918; Dill M, 2001, PERCEPTION, V30, P707, DOI 10.1068/p2953; Edelman S, 1997, NEURAL COMPUT, V9, P701, DOI 10.1162/neco.1997.9.4.701; Erickson CA, 1999, J NEUROSCI, V19, P10404; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kourtzi Z, 2006, CURR OPIN NEUROBIOL, V16, P152, DOI 10.1016/j.conb.2006.03.012; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MASQUELIER T, 2007, 269 CBCL MIT; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; NAZIR T A, 1990, Spatial Vision, V5, P81, DOI 10.1163/156856890X00011; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RINGO JL, 1994, J NEUROPHYSIOL, V71, P1285, DOI 10.1152/jn.1994.71.3.1285; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sprekeler H, 2007, PLOS COMPUT BIOL, V3, P1136, DOI 10.1371/journal.pcbi.0030112; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Wallis G, 2001, P NATL ACAD SCI USA, V98, P4800, DOI 10.1073/pnas.071028598; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wyss R, 2006, PLOS BIOL, V4, P836, DOI 10.1371/journal.pbio.0040120; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	46	172	175	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1502	1507		10.1126/science.1160028	http://dx.doi.org/10.1126/science.1160028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787171	Green Accepted			2022-12-01	WOS:000259121800045
J	Castilla, J; Gonzalez-Romero, D; Saa, P; Morales, R; De Castro, J; Soto, C				Castilla, Joaquin; Gonzalez-Romero, Dennisse; Saa, Paula; Morales, Rodrigo; De Castro, Jorge; Soto, Claudio			Crossing the species barrier by PrPSc replication in vitro generates unique infectious Prions	CELL			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; MOLECULAR-BASIS; PROTEIN; SCRAPIE; TRANSMISSION; PATHOGENESIS; ADAPTATION; STRAINS	Prions are unconventional infectious agents composed exclusively of misfolded prion protein (PrPSc), which transmits the disease by propagating its abnormal conformation to the cellular prion protein (PrPC). A key characteristic of prions is their species barrier, by which prions from one species can only infect a limited number of other species. Here, we report the generation of infectious prions by interspecies transmission of PrPSc misfolding by in vitro PMCA amplification. Hamster PrPC misfolded by mixing with mouse PrPSc generated unique prions that were infectious to wild-type hamsters, and similar results were obtained in the opposite direction. Successive rounds of PMCA amplification result in adaptation of the in vitro-produced prions, in a process reminiscent of strain stabilization observed upon serial passage in vivo. Our results indicate that PMCA is a valuable tool for the investigation of cross-species transmission and suggest that species barrier and strain generation are determined by the propagation of PrP misfolding.	[Castilla, Joaquin; Gonzalez-Romero, Dennisse; Saa, Paula; Morales, Rodrigo; De Castro, Jorge; Soto, Claudio] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Saa, Paula] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; [Morales, Rodrigo] Univ Chile, Santiago, Chile	University of Texas System; University of Texas Medical Branch Galveston; Autonomous University of Madrid; Universidad de Chile	Soto, C (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.	clsoto@utmb.edu	Morales, Rodrigo/K-7173-2015; Castilla, Joaquín/J-8414-2019; Castilla, Joaquin/D-5261-2011; Saa, Paula/AAB-6607-2019	Castilla, Joaquín/0000-0002-2216-1361; Castilla, Joaquin/0000-0002-2216-1361; Saa, Paula/0000-0001-6077-4532	National Institutes of Health [R01NS049173, P01AI77774]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by National Institutes of Health grants R01NS049173 and P01AI77774 to C. S. C. S. is a founder of Amprion, Inc., a company focused on the development of a diagnosis for prion diseases through the use of the PMCA technology.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; Buschmann A, 2005, BERL MUNCH TIERARZTL, V118, P365; Caramelli M, 2006, CNS DRUGS, V20, P15, DOI 10.2165/00023210-200620010-00002; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chen SG, 2000, ARCH VIROL, P209; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Doherr MG, 2003, ACTA VET SCAND, P33; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Hill Andrew F., 2004, V11, P33; Hunter N, 2003, BRIT MED BULL, V66, P171, DOI 10.1093/bmb/66.1.171; Hunter N, 1998, MOL BIOTECHNOL, V9, P225, DOI 10.1007/BF02915795; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Moore RA, 2005, ARCH VIROL, P187; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sarafoff NN, 2005, J BIOCHEM BIOPH METH, V63, P213, DOI 10.1016/j.jbbm.2005.05.004; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Weber P, 2007, VET MICROBIOL, V123, P346, DOI 10.1016/j.vetmic.2007.04.004; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Xie ZL, 2006, J BIOL CHEM, V281, P4199, DOI 10.1074/jbc.M509052200	44	142	144	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					757	768		10.1016/j.cell.2008.07.030	http://dx.doi.org/10.1016/j.cell.2008.07.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775309	Green Accepted, Bronze			2022-12-01	WOS:000258947500016
J	Mekhail, K; Seebacher, J; Gygi, SP; Moazed, D				Mekhail, Karim; Seebacher, Jan; Gygi, Steven P.; Moazed, Danesh			Role for perinuclear chromosome tethering in maintenance of genome stability	NATURE			English	Article							RIBOSOMAL-RNA GENES; SACCHAROMYCES-CEREVISIAE; RENT COMPLEX; YEAST RDNA; PROTEIN; DNA; RECOMBINATION; REPLICATION; SIR2; TRANSCRIPTION	Repetitive DNA sequences, which constitute half the genome in some organisms, often undergo homologous recombination. This can instigate genomic instability resulting from a gain or loss of DNA(1). Assembly of DNA into silent chromatin is generally thought to serve as a mechanism ensuring repeat stability by limiting access to the recombination machinery(2). Consistent with this notion is the observation, in the budding yeast Saccharomyces cerevisiae, that stability of the highly repetitive ribosomal DNA( rDNA) sequences requires a Sir2- containing chromatin silencing complex that also inhibits transcription from foreign promoters and transposons inserted within the repeats by a process called rDNA silencing(2-5). Here we describe a protein network that stabilizes rDNA repeats of budding yeast by means of interactions between rDNA- associated silencing proteins and two proteins of the inner nuclear membrane (INM). Deletion of either the INM or silencing proteins reduces perinuclear rDNA positioning, disrupts the nucleolus nucleoplasm boundary, induces the formation of recombination foci, and destabilizes the repeats. In addition, artificial targeting of rDNA repeats to the INM suppresses the instability observed in cells lacking an rDNA- associated silencing protein that is typically required for peripheral tethering of the repeats. Moreover, in contrast to Sir2 and its associated nucleolar factors, the INM proteins are not required for rDNA silencing, indicating that Sir2-dependent silencing is not sufficient to inhibit recombination within the rDNA locus. These findings demonstrate a role for INM proteins in the perinuclear localization of chromosomes and show that tethering to the nuclear periphery is required for the stability of rDNA repeats. The INM proteins studied here are conserved and have been implicated in chromosome organization in metazoans(6,7). Our results therefore reveal an ancient mechanism in which interactions between INM proteins and chromosomal proteins ensure genome stability.	[Mekhail, Karim; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Mekhail, Karim; Seebacher, Jan; Gygi, Steven P.; Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	danesh@hms.harvard.edu		Mekhail, Karim/0000-0002-6084-020X	National Institutes of Health; Howard Hughes Medical Institute; Canadian Institutes of Health Research Institute of Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research Institute of Aging(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Yip, T. Walz, J. Huang, M. Buhler, D. Koshland, A. Palazzo, D. E. Libuda, F. Winston, L. Vasiljeva, S. Buratowski, J. E. Warner, C. Anderson, G. A. Beltz, M. Lisby, T. Daniel, L. Ding and the Harvard NeuroDiscovery Optical Imaging Center for technical assistance or materials, and T. Rapoport, T. Iida, M. Motamedi, A. Johnson, M. Onishi, E. Gerace, S. Buker, M. Halic and members of the Moazed laboratory for helpful discussions and comments. This work was supported by the National Institutes of Health and the Howard Hughes Medical Institute (D.M.), and the Canadian Institutes of Health Research Institute of Aging (K.M.). D.M. is a scholar of the Leukemia and Lymphoma Society.	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KEIL RL, 1984, CELL, V39, P377, DOI 10.1016/0092-8674(84)90016-3; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; SZOSTAK JW, 1980, NATURE, V284, P426, DOI 10.1038/284426a0; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775	36	179	183	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					667	U98		10.1038/nature07460	http://dx.doi.org/10.1038/nature07460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18997772	Green Accepted			2022-12-01	WOS:000261340000047
J	Biver, S; Belge, H; Bourgeois, S; Van Vooren, P; Nowik, M; Scohy, S; Houillier, P; Szpirer, J; Szpirer, C; Wagner, CA; Devuyst, O; Marini, AM				Biver, Sophie; Belge, Hendrica; Bourgeois, Soline; Van Vooren, Pascale; Nowik, Marta; Scohy, Sophie; Houillier, Pascal; Szpirer, Josiane; Szpirer, Claude; Wagner, Carsten A.; Devuyst, Olivier; Marini, Anna Maria			A role for Rhesus factor Rhcg in renal ammonium excretion and male fertility	NATURE			English	Article							TUBULAR-ACIDOSIS; RHAG PROTEIN; TRANSPORT; GLYCOPROTEIN; KIDNEY; RHBG; EXPRESSION; MECHANISMS; MOUSE; IDENTIFICATION	The kidney has an important role in the regulation of acid - base homeostasis. Renal ammonium production and excretion are essential for net acid excretion under basal conditions and during metabolic acidosis. Ammonium is secreted into the urine by the collecting duct, a distal nephron segment where ammonium transport is believed to occur by non- ionic NH3 diffusion coupled to H+ secretion. Here we show that this process is largely dependent on the Rhesus factor Rhcg. Mice lacking Rhcg have abnormal urinary acidification due to impaired ammonium excretion on acid loading - a feature of distal renal tubular acidosis. In vitro microperfused collecting ducts of Rhcg(-/-) acid- loaded mice show reduced apical permeability to NH3 and impaired transepithelial NH3 transport. Furthermore, Rhcg is localized in epididymal epithelial cells and is required for normal fertility and epididymal fluid pH. We anticipate a critical role for Rhcg in ammonium handling and pH homeostasis both in the kidney and the male reproductive tract.	[Biver, Sophie; Van Vooren, Pascale; Scohy, Sophie; Szpirer, Josiane; Szpirer, Claude; Marini, Anna Maria] Univ Libre Bruxelles, Inst Biol & Med Mol, Labs Biol Dev & Physiol Mol Cellule, B-6041 Gosselies, Belgium; [Belge, Hendrica; Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, B-1200 Brussels, Belgium; [Bourgeois, Soline; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Houillier, Pascal] INSERM, UMS 872, F-75006 Paris, France; [Bourgeois, Soline; Houillier, Pascal] Univ Paris 06, F-75006 Paris, France; [Bourgeois, Soline; Houillier, Pascal] Univ Paris 05, F-75006 Paris, France	Universite Libre de Bruxelles; Universite Catholique Louvain; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Marini, AM (corresponding author), Univ Libre Bruxelles, Inst Biol & Med Mol, Labs Biol Dev & Physiol Mol Cellule, Rue Prof Jeener & Brachet 12, B-6041 Gosselies, Belgium.	ammarini@dbm.ulb.ac.be	Houillier, Pascal/AAD-4903-2019	Houillier, Pascal/0000-0003-4953-6917; Biver, Sophie/0000-0002-7903-2413; Devuyst, Olivier/0000-0003-3744-4767	Belgian agencies FNRS; FRSM [3.4.546.04. F, 3.4.635.05. F, 3.4592.06. F]; Fonds Brachet-recherche; Fonds Van Buuren; Fondation Alphonse Jean Forton; Concerted Research Action [05/10-328]; Inter-university Attraction Pole [IUAP P6/05]; Swiss National Science Foundation [31-109677]; INSERM; EuReGene; EUNEFRON [GA#201590]; European Community [FP6, FP7]; FRIA fellowship	Belgian agencies FNRS(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); Fonds Brachet-recherche; Fonds Van Buuren; Fondation Alphonse Jean Forton; Concerted Research Action; Inter-university Attraction Pole(Belgian Federal Science Policy Office); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EuReGene; EUNEFRON; European Community(European Commission); FRIA fellowship(Fonds de la Recherche Scientifique - FNRS)	We are grateful to P. Dreze, B. Andre and P. Gabant for their contribution to the initial step of this study. We thank H. Mezdour, L. Pouilly and P. Persoons for microinjection experiments, B. Pajak for help in broad- spectrum histological assessment, V. Beaujean, Y. Cnops, H. Debaix and T. Nishino for excellent technical assistance, and A. Tamah and M.-F. Vincent for amino acid chromatography. These studies were supported by the Belgian agencies FNRS and FRSM (3.4.546.04. F, 3.4.635.05. F, 3.4592.06. F), the 'Fonds Brachet-recherche', the 'Fonds Van Buuren', the 'Fondation Alphonse & Jean Forton', a Concerted Research Action (05/10-328), an Inter-university Attraction Pole (IUAP P6/05), the Swiss National Science Foundation (31-109677), an INSERM grant, and the EuReGene and EUNEFRON (GA#201590) projects of the European Community (FP6 and FP7). S. Bi. was the recipient of a FRIA fellowship; H.B., A.M.M. and C.S. are Research fellow, Research associate and Research director of the FNRS, respectively.	Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; BEVENSEE MO, 2008, CONTROL INTRACELLULA, P1429; Butterworth RF, 2003, ALCOHOL RES HEALTH, V27, P240; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; CHERIFZAHAR B, 1994, GENOMICS, V19, P68, DOI 10.1006/geno.1994.1014; DUBOSE TD, 1991, J AM SOC NEPHROL, V1, P1193; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; HAMM LL, 1987, AM J PHYSIOL, V253, pF595, DOI 10.1152/ajprenal.1987.253.4.F595; Ji QM, 2006, P NATL ACAD SCI USA, V103, P5881, DOI 10.1073/pnas.0600901103; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Kim SC, 1998, INT J ANDROL, V21, P29; KNEPPER MA, 1991, KIDNEY INT, V40, pS95; Laing CM, 2005, INT J BIOCHEM CELL B, V37, P1151, DOI 10.1016/j.biocel.2005.01.002; LEVANKIM C, 1992, P NATL ACAD SCI USA, V89, P10925, DOI 10.1073/pnas.89.22.10925; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Philip L., 1939, JAMA-J AM MED ASSOC, V113, P126; PITTS RF, 1948, FED PROC, V7, P418; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; RIDGWELL K, 1992, BIOCHEM J, V287, P223, DOI 10.1042/bj2870223; SARTORIUS OW, 1949, J CLIN INVEST, V28, P423, DOI 10.1172/JCI102087; Soriano JR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023430.92674.E5; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weiner ID, 2007, ANNU REV PHYSIOL, V69, P317, DOI 10.1146/annurev.physiol.69.040705.142215; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	40	129	131	1	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					339	343		10.1038/nature07518	http://dx.doi.org/10.1038/nature07518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020613				2022-12-01	WOS:000261039600033
J	Hanna, RA; Campbell, RL; Davies, PL				Hanna, Rachel A.; Campbell, Robert L.; Davies, Peter L.			Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin	NATURE			English	Article							CRYSTAL-STRUCTURES; ACTIVE-SITE; MU-CALPAIN; ACTIVATION; PEPTIDE; BINDING; MODEL; COMPLEXES	Calpains are non-lysosomal calcium-dependent cysteine proteinases that selectively cleave proteins in response to calcium signals(1) and thereby control cellular functions such as cytoskeletal remodelling, cell cycle progression, gene expression and apoptotic cell death(2-4). In mammals, the two best-characterized members of the calpain family, calpain 1 and calpain 2 ( mu-calpain and m-calpain, respectively), are ubiquitously expressed. The activity of calpains is tightly controlled by the endogenous inhibitor calpastatin, which is an intrinsically unstructured protein capable of reversibly binding and inhibiting four molecules of calpain, but only in the presence of calcium(5,6). To date, the mechanism of inhibition by calpastatin and the basis for its absolute specificity have remained speculative(7-9). It was not clear how this unstructured protein inhibits calpains without being cleaved itself, nor was it known how calcium induced changes that facilitated the binding of calpastatin to calpain. Here we report the 2.4-angstrom-resolution crystal structure of the calcium-bound calpain 2 heterodimer bound by one of the four inhibitory domains of calpastatin. Calpastatin is seen to inhibit calpain by occupying both sides of the active site cleft. Although the inhibitor passes through the active site cleft it escapes cleavage in a novel manner by looping out and around the active site cysteine. The inhibitory domain of calpastatin recognizes multiple lower affinity sites present only in the calcium-bound form of the enzyme, resulting in an interaction that is tight, specific and calcium dependent. This crystal structure, and that of a related complex(10), also reveal the conformational changes that calpain undergoes on binding calcium, which include opening of the active site cleft and movement of the domains relative to each other to produce a more compact enzyme.	[Hanna, Rachel A.; Campbell, Robert L.; Davies, Peter L.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca		Campbell, Robert/0000-0002-5473-5876	Canadian Institutes for Health Research; Bauman Fellowship; R. J. Wilson Fellowship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Bauman Fellowship; R. J. Wilson Fellowship	This work was funded by the Canadian Institutes for Health Research. R. A. H. is the recipient of a Bauman Fellowship and an R. J. Wilson Fellowship. P. L. D. holds a Canada Research Chair in Protein Engineering. We are grateful to S. Gauthier for technical assistance, to M. Kuiper for the simulation of the conformational change in calpain on binding Ca<SUP>2+</SUP>, to the Queen's University Protein Function Discovery (PFD) Facility and D. McLeod for mass spectrometry, Z. Jia for access to data collection on a home source and to M. Allaire at Brookhaven National Laboratory for assistance with data collection on beam line X6A.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; CROALL DE, 1994, BIOCHEMISTRY-US, V33, P13223, DOI 10.1021/bi00249a008; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; ISHIMA R, 1991, FEBS LETT, V294, P64, DOI 10.1016/0014-5793(91)81344-8; Li M, 2000, NAT STRUCT BIOL, V7, P113, DOI 10.1038/72378; Maekawa A, 2003, J MOL CELL CARDIOL, V35, P1277, DOI 10.1016/S0022-2828(03)00238-4; MAKI M, 1989, J BIOL CHEM, V264, P18866; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2004, J BIOL CHEM, V279, P6106, DOI 10.1074/jbc.M310460200; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Neffe AT, 2005, CURR OPIN DRUG DISC, V8, P684; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Pfizer J, 2008, BIOL CHEM, V389, P83, DOI 10.1515/BC.2008.004; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	32	221	240	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					409	U78		10.1038/nature07451	http://dx.doi.org/10.1038/nature07451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020623				2022-12-01	WOS:000261039600048
J	Gunnell, D; Hawton, K; Ho, D; Evans, J; O'Connor, S; Potokar, J; Donovan, J; Kapur, N				Gunnell, David; Hawton, Keith; Ho, Davidson; Evans, Jonathan; O'Connor, Susan; Potokar, John; Donovan, Jenny; Kapur, Nav			Hospital admissions for self harm after discharge from psychiatric inpatient care: cohort study	BRITISH MEDICAL JOURNAL			English	Article							SUICIDE-PREVENTION; RISK; ADOLESCENTS; MANAGEMENT	Objective To determine the risk of non- fatal self harm in the 12 months after discharge from psychiatric inpatient care. Design Cohort study based on national hospital episode statistics. Setting England. Population Patients aged 16- 64 years discharged from psychiatric inpatient care between 1 April 2004 and 31 March 2005 and followed up for one year. Results 75 401 people were discharged from psychiatric inpatient care over the study period, 4935 ( 6.5%) of whom were admitted at least once for self harm in the following 12 months. Risk of self harm was greatest in the four weeks after discharge; one third ( 32%, n= 1578) of admissions for self harm occurred in this period. The strongest risk factor for self harm after discharge was admission for self harm in the previous 12 months ( hazard ratio 4.9, 95% confidence interval 4.6 to 5.2). The risk of self harm was also higher in females, younger people, those with diagnoses of depression, personality disorders, and substance misuse, and those with short lengths of stay. Conclusion More than 6% of patients discharged from psychiatric inpatient care are readmitted for an episode of self harm within 12 months, with one third of these episodes occurring in the month after discharge. Self harm after discharge from hospital shares many of the features of suicide after discharge. Interventions should be developed to reduce risk in this period.	[Gunnell, David; Ho, Davidson; Donovan, Jenny] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Hawton, Keith] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford, England; [Ho, Davidson] SW Publ Hlth Observ, Bristol, Avon, England; [Evans, Jonathan; Potokar, John] Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England; [O'Connor, Susan] Avon & Wiltshire Partnership NHS Trust, Chippenham, Wilts, England; [Kapur, Nav] Univ Manchester, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England	University of Bristol; University of Oxford; University of Bristol; University of Manchester	Gunnell, D (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	d.j.gunnell@bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Evans, Jonathan/0000-0003-3171-640X; Kapur, Nav/0000-0002-3100-3234	National Institute of Health Research	National Institute of Health Research(National Institute for Health Research (NIHR))	This work was funded by a National Institute of Health Research programme grant for applied research.	Department of Health, 2002, NAT SUIC PREV STRAT; GEDDES JR, 1995, BRIT MED J, V311, P357, DOI 10.1136/bmj.311.7001.357; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; Goldston DB, 1999, J AM ACAD CHILD PSY, V38, P660, DOI 10.1097/00004583-199906000-00012; Gunnell D, 2005, J PUBLIC HEALTH-UK, V27, P67, DOI 10.1093/pubmed/fdh192; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; King EA, 2001, BRIT J PSYCHIAT, V178, P531, DOI 10.1192/bjp.178.6.531; Meehan J, 2006, BRIT J PSYCHIAT, V188, P129, DOI 10.1192/bjp.188.2.129; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; MOTTO JA, 1976, SUICIDE LIFE-THREAT, V6, P223; National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Manchester: University of Manchester, 2006, MAKING MENTAL HLTH C; Prinstein MJ, 2008, J CONSULT CLIN PSYCH, V76, P92, DOI 10.1037/0022-006X.76.1.92; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; SELLAR C, 1990, J EPIDEMIOL COMMUN H, V44, P313, DOI 10.1136/jech.44.4.313; Skeem JL, 2006, BEHAV SCI LAW, V24, P731, DOI 10.1002/bsl.726; Taylor SJ, 1997, ACTA PSYCHIAT SCAND, V95, P457, DOI 10.1111/j.1600-0447.1997.tb10132.x	16	62	62	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2278	10.1136/bmj.a2278	http://dx.doi.org/10.1136/bmj.a2278			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19018041	Green Submitted, hybrid, Green Published			2022-12-01	WOS:000262653900003
J	Hawkes, N				Hawkes, Nigel			National obesity strategy: what's the big idea?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2548	10.1136/bmj.a2548	http://dx.doi.org/10.1136/bmj.a2548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19017715				2022-12-01	WOS:000262653900006
J	McColl, K				McColl, Karen			The fattening truth about restaurant food	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFORMATION					karen@karenmccoll.co.uk						BARRON J, 2008, NY TIMES        0422; Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020; Berman M, 2008, JAMA-J AM MED ASSOC, V300, P433, DOI 10.1001/jama.300.4.433; BRUNI F, 2008, NY TIMES        0422; Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973; *CTR SCI PUBL INT, 2003, AN GUESS NEED NUTR L; DIGREGORIA A, VILLAGE VOICE; *FOOD COMM, 2008, FOOD MAGAZINE    AUG, P82; Food Standards Agency, 2008, CONS GIV THEIR VIEWS; *NEW YORK CIT DEP, 2008, CAL POST LEG TIM; US Centers for Disease control and Prevention, 2008, OV OB	11	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2229	10.1136/bmj.a2229	http://dx.doi.org/10.1136/bmj.a2229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19017714				2022-12-01	WOS:000262653900002
J	Chadwick, DW; Baker, GA; Jacoby, A; Marson, AG; Smith, PE				Chadwick, David W.; Baker, Gus A.; Jacoby, Ann; Marson, Anthony G.; Smith, Phil E.			What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DRUG; LAMOTRIGINE; TOPIRAMATE; SEIZURES; OUTCOMES; SANAD		[Chadwick, David W.; Baker, Gus A.; Jacoby, Ann; Marson, Anthony G.] Univ Liverpool, Walton Ctr, Liverpool L9 7LJ, Merseyside, England; [Smith, Phil E.] Univ Wales Hosp, Cardiff CF14 4XW, Wales	University of Liverpool; Walton Centre; Cardiff University	Chadwick, DW (corresponding author), Univ Liverpool, Walton Ctr, Liverpool L9 7LJ, Merseyside, England.	d.w.chadwick@liverpool.ac.uk	Marson, Anthony/AAW-9776-2020	Marson, Anthony/0000-0002-6861-8806				ANNEGERS JF, 1979, EPILEPSIA, V20, P729, DOI 10.1111/j.1528-1157.1979.tb04857.x; Beghi E, 2003, EPILEPSY RES, V57, P1, DOI 10.1016/j.eplepsyres.2003.09.007; Deckers CLP, 2000, EPILEPSIA, V41, P1364, DOI 10.1111/j.1528-1157.2000.tb00111.x; Gilliam Frank, 2003, Curr Neurol Neurosci Rep, V3, P357, DOI 10.1007/s11910-003-0014-0; Jacoby A, 2007, NEUROLOGY, V68, P1188, DOI 10.1212/01.wnl.0000259411.78423.50; JACOBY A, 1992, EPILEPSIA, V33, P1123, DOI 10.1111/j.1528-1157.1992.tb01769.x; Jacoby A, 1996, EPILEPSIA, V37, P148, DOI 10.1111/j.1528-1157.1996.tb00006.x; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; McCorry D, 2004, LANCET NEUROL, V3, P729, DOI 10.1016/S1474-4422(04)00935-4; *NAT I HLTH CLIN E, 2004, EP AD NEW DRUGS GUID; *NAT I HLTH CLIN E, 2004, EP AD CHILDR NICE GU	12	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 14	2008	337								a2199	10.1136/bmj.a2199	http://dx.doi.org/10.1136/bmj.a2199			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AF	19010969				2022-12-01	WOS:000261784600001
J	Kohanski, MA; Dwyer, DJ; Wierzbowski, J; Cottarel, G; Collins, JJ				Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.			Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death	CELL			English	Article							COLI PLASMA-MEMBRANE; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; GENE ONTOLOGY; FTSH HFLB; PERIPLASMIC PROTEASE; BACTERICIDAL ACTION; GYRASE INHIBITORS; AMINOGLYCOSIDES; ENVELOPE	Aminoglycoside antibiotics, such as gentamicin and kanamycin, directly target the ribosome, yet the mechanisms by which these bactericidal drugs induce cell death are not fully understood. Recently, oxidative stress has been implicated as one of the mechanisms whereby bactericidal antibiotics kill bacteria. Here, we use systems-level approaches and phenotypic analyses to provide insight into the pathway whereby aminoglycosides ultimately trigger hydroxyl radical formation. We show, by disabling systems that facilitate membrane protein traffic, that mistranslation and misfolding of membrane proteins are central to aminoglycoside-induced oxidative stress and cell death. Signaling through the envelope stress-response two-component system is found to be a key player in this process, and the redox-responsive two-component system is shown to have an associated role. Additionally, we show that these two-component systems play a general role in bactericidal antibiotic-mediated oxidative stress and cell death, expanding our understanding of the common mechanism of killing induced by bactericidal antibiotics.	[Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Kohanski, Michael A.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Dwyer, Daniel J.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, 44 Cummington St, Boston, MA 02215 USA.	jcollins@bu.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003644-02, DP1 OD003644] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; Buelow DR, 2005, J BACTERIOL, V187, P6622, DOI 10.1128/JB.187.19.6622-6630.2005; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cottarel G, 2007, TRENDS BIOTECHNOL, V25, P547, DOI 10.1016/j.tibtech.2007.09.004; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; DOUGHERTY TJ, 1985, ANTIMICROB AGENTS CH, V28, P200, DOI 10.1128/AAC.28.2.200; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Economou A, 1999, TRENDS MICROBIOL, V7, P315, DOI 10.1016/S0966-842X(99)01555-3; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; HANCOCK REW, 1981, J ANTIMICROB CHEMOTH, V8, P429, DOI 10.1093/jac/8.6.429; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; IUCHI S, 1989, J BACTERIOL, V171, P2889, DOI 10.1128/jb.171.5.2889-2893.1989; Jepras RI, 1997, ANTIMICROB AGENTS CH, V41, P2001, DOI 10.1128/AAC.41.9.2001; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; Kihara A, 1996, EMBO J, V15, P6122, DOI 10.1002/j.1460-2075.1996.tb01000.x; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; MARTIN JP, 1987, J BACTERIOL, V169, P2516, DOI 10.1128/jb.169.6.2516-2522.1987; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; RAHAL JJ, 1979, ANTIMICROB AGENTS CH, V16, P13, DOI 10.1128/AAC.16.1.13; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; RONSON CW, 1987, CELL, V49, P579, DOI 10.1016/0092-8674(87)90530-7; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Saikawa N, 2004, J STRUCT BIOL, V146, P123, DOI 10.1016/j.jsb.2003.09.020; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Umezawa N, 1997, ARCH BIOCHEM BIOPHYS, V342, P275, DOI 10.1006/abbi.1997.0124; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; WEISBLUM B, 1968, BACTERIOL REV, V32, P493, DOI 10.1128/MMBR.32.4_Pt_2.493-528.1968; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wu WJ, 2002, AUDIOL NEURO-OTOL, V7, P171, DOI 10.1159/000058305; ZASKE DE, 1982, ANTIMICROB AGENTS CH, V21, P407, DOI 10.1128/AAC.21.3.407	59	379	391	9	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					679	690		10.1016/j.cell.2008.09.038	http://dx.doi.org/10.1016/j.cell.2008.09.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013277	Green Accepted, Bronze			2022-12-01	WOS:000260886900018
J	Schenck, S				Schenck, Sarah			A Lesson Learned by Accident	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sschenck@christianacare.org							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2101	2101		10.1001/jama.2008.630	http://dx.doi.org/10.1001/jama.2008.630			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001611				2022-12-01	WOS:000260793800001
J	Djukanovic, R; Gadola, SD				Djukanovic, Ratko; Gadola, Stephan D.			Virus Infection, Asthma, and Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							KILLER T-CELLS		[Djukanovic, Ratko; Gadola, Stephan D.] Southampton Gen Hosp, Div Infect Inflammat & Repair, Southampton SO9 4XY, Hants, England	University of Southampton	Djukanovic, R (corresponding author), Southampton Gen Hosp, Div Infect Inflammat & Repair, Southampton SO9 4XY, Hants, England.			Djukanovic, Ratko/0000-0001-6039-5612	GlaxoSmithKline; Synairgen; Boehringer Ingelheim; Cellestis; Medigene	GlaxoSmithKline(GlaxoSmithKline); Synairgen; Boehringer Ingelheim(Boehringer Ingelheim); Cellestis; Medigene	Dr. Djukanovic reports receiving consulting and lecture fees and grant support from GlaxoSmithKline, receiving consulting fees and having an equity interest in Synairgen, and receiving consulting fees from Boehringer Ingelheim; and Dr. Gadola, receiving lecture fees from Cellestis and Medigene. No other potential conflict of interest relevant to this article was reported.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691	5	10	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2062	2064		10.1056/NEJMcibr0806978	http://dx.doi.org/10.1056/NEJMcibr0806978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987374				2022-12-01	WOS:000260632700015
J	Ley, TJ; Mardis, ER; Ding, L; Fulton, B; McLellan, MD; Chen, K; Dooling, D; Dunford-Shore, BH; McGrath, S; Hickenbotham, M; Cook, L; Abbott, R; Larson, DE; Koboldt, DC; Pohl, C; Smith, S; Hawkins, A; Abbott, S; Locke, D; Hillier, LW; Miner, T; Fulton, L; Magrini, V; Wylie, T; Glasscock, J; Conyers, J; Sander, N; Shi, XQ; Osborne, JR; Minx, P; Gordon, D; Chinwalla, A; Zhao, Y; Ries, RE; Payton, JE; Westervelt, P; Tomasson, MH; Watson, M; Baty, J; Ivanovich, J; Heath, S; Shannon, WD; Nagarajan, R; Walter, MJ; Link, DC; Graubert, TA; DiPersio, JF; Wilson, RK				Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Fulton, Bob; McLellan, Michael D.; Chen, Ken; Dooling, David; Dunford-Shore, Brian H.; McGrath, Sean; Hickenbotham, Matthew; Cook, Lisa; Abbott, Rachel; Larson, David E.; Koboldt, Dan C.; Pohl, Craig; Smith, Scott; Hawkins, Amy; Abbott, Scott; Locke, Devin; Hillier, LaDeana W.; Miner, Tracie; Fulton, Lucinda; Magrini, Vincent; Wylie, Todd; Glasscock, Jarret; Conyers, Joshua; Sander, Nathan; Shi, Xiaoqi; Osborne, John R.; Minx, Patrick; Gordon, David; Chinwalla, Asif; Zhao, Yu; Ries, Rhonda E.; Payton, Jacqueline E.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark; Baty, Jack; Ivanovich, Jennifer; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.			DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome	NATURE			English	Article							ADULT PATIENTS; MUTATIONS; AML; NUCLEOPHOSMIN; CANCER; GENES; FLT3	Acute myeloid leukaemia is a highly malignant haematopoietic tumour that affects about 13,000 adults in the United States each year. The treatment of this disease has changed little in the past two decades, because most of the genetic events that initiate the disease remain undiscovered. Whole- genome sequencing is now possible at a reasonable cost and timeframe to use this approach for the unbiased discovery of tumour- specific somatic mutations that alter the protein- coding genes. Here we present the results obtained from sequencing a typical acute myeloid leukaemia genome, and its matched normal counterpart obtained from the same patient's skin. We discovered ten genes with acquired mutations; two were previously described mutations that are thought to contribute to tumour progression, and eight were new mutations present in virtually all tumour cells at presentation and relapse, the function of which is not yet known. Our study establishes whole- genome sequencing as an unbiased method for discovering cancer- initiating mutations in previously unidentified genes that may respond to targeted therapies.	[Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Magrini, Vincent; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Ley, Timothy J.; Zhao, Yu; Ries, Rhonda E.; Westervelt, Peter; Tomasson, Michael H.; Heath, Sharon; Shannon, William D.; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA; [Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Fulton, Bob; McLellan, Michael D.; Chen, Ken; Dooling, David; Dunford-Shore, Brian H.; McGrath, Sean; Hickenbotham, Matthew; Cook, Lisa; Abbott, Rachel; Larson, David E.; Koboldt, Dan C.; Pohl, Craig; Smith, Scott; Hawkins, Amy; Abbott, Scott; Locke, Devin; Hillier, LaDeana W.; Miner, Tracie; Fulton, Lucinda; Magrini, Vincent; Wylie, Todd; Glasscock, Jarret; Conyers, Joshua; Sander, Nathan; Shi, Xiaoqi; Osborne, John R.; Minx, Patrick; Chinwalla, Asif; Watson, Mark; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Ley, Timothy J.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark; Ivanovich, Jennifer; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Payton, Jacqueline E.; Watson, Mark; Nagarajan, Rakesh] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Baty, Jack] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63108 USA; [Ivanovich, Jennifer] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63108 USA; [Hillier, LaDeana W.; Gordon, David] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Mardis, ER (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA.	emardis@wustl.edu	Mardis, Elaine/W-2202-2019; Magrini, Vincent/AAT-5830-2020; Chen, Ken/A-1074-2009; Walter, Matthew J/S-7758-2018; Wilson, Richard K./AAF-4139-2019; McGrath, Sean David/AAT-3540-2020; Chen, Ken/AAU-1432-2021	Magrini, Vincent/0000-0002-2019-4872; Wilson, Richard K./0000-0002-1992-1358; McGrath, Sean David/0000-0001-9064-8449; Chen, Ken/0000-0003-4013-5279; MCLELLAN, MICHAEL/0000-0002-2703-8784; Locke, Devin/0000-0002-2527-0475; Tomasson, Michael/0000-0003-4518-7123; Larson, David/0000-0001-7934-5906; Graubert, Timothy/0000-0002-7710-1171; Chinwalla, Asif/0000-0001-7831-3996; Ries, Rhonda/0000-0002-3702-7923	National Cancer Institute; National Human Genome Research Institute; Barnes-Jewish Hospital Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002042] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Barnes-Jewish Hospital Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to our AML patients and their families, and to A.J. Siteman, whose generous and visionary gift provided the main funding source for this study. We thank G. Flance, D. Kipnis and K. Polonsky for their support, and C. Bloomfield, M. Caligiuri and J. Vardiman from the Cancer and Leukemia Group B for providing important AML samples for validation studies. We also thank the staff of The Genome Center at Washington University for their support of and their many contributions to this project, and H. Li of the Sanger Institute for assistance with the use of Maq. Further funding was provided by the National Cancer Institute (T.J.L.), the National Human Genome Research Institute (R.K.W.), and the Barnes-Jewish Hospital Foundation (T.J.L.).	Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; den Besten W, 2005, CELL CYCLE, V4, P1593; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kelly LM, 2002, P NATL ACAD SCI USA, V99, P8283, DOI 10.1073/pnas.122233699; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Loriaux MM, 2008, BLOOD, V111, P4788, DOI 10.1182/blood-2007-07-101394; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Owen C, 2008, BRIT J HAEMATOL, V140, P123, DOI 10.1111/j.1365-2141.2007.06909.x; Paulsson K, 2006, LEUKEMIA, V20, P840, DOI 10.1038/sj.leu.2404145; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN, P302; Raghavan M, 2005, CANCER RES, V65, P375; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Wendl MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-239; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	29	895	997	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					66	72		10.1038/nature07485	http://dx.doi.org/10.1038/nature07485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987736	hybrid, Green Accepted			2022-12-01	WOS:000260674000041
J	Holzmann, J; Frank, P; Loffler, E; Bennett, KL; Gerner, C; Rossmanith, W				Holzmann, Johann; Frank, Peter; Loeffler, Esther; Bennett, Keiryn L.; Gerner, Christopher; Rossmanith, Walter			RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing Enzyme	CELL			English	Article							RIBONUCLEASE-P; AQUIFEX-AEOLICUS; PROTEIN; MATURATION; EVOLUTION; SEQUENCES; GENE; DEHYDROGENASE; MUTATIONS; MECHANISM	tRNAs are synthesized as immature precursors, and on their way to functional maturity, extra nucleotides at their 50 ends are removed by an endonuclease called RNase P. All RNase P enzymes characterized so far are composed of an RNA plus one or more proteins, and tRNA 50 end maturation is considered a universal ribozyme-catalyzed process. Using a combinatorial purification/proteomics approach, we identified the components of human mitochondrial RNase P and reconstitutedthe enzymatic activity from three recombinant proteins. We thereby demonstrate that human mitochondrial RNase P is a protein enzyme that does not require a trans-acting RNA component for catalysis. Moreover, the mitochondrial enzyme turns out to be an unexpected type of patchwork enzyme, composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase-family member, and a protein of hitherto unknown functional and evolutionary origin, possibly representing the enzyme's metallonuclease moiety. Apparently, animal mitochondria lost the seemingly ubiquitous RNA world remnant after reinventing RNase P from preexisting components.	[Holzmann, Johann; Loeffler, Esther; Rossmanith, Walter] Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria; [Frank, Peter; Gerner, Christopher] Med Univ Vienna, Dept Med 1, Inst Canc Res, A-1090 Vienna, Austria; [Bennett, Keiryn L.] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Austrian Academy of Sciences	Rossmanith, W (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria.	walter.rossmanith@meduniwien.ac.at	Rossmanith, Walter/F-3662-2010	Rossmanith, Walter/0000-0003-2337-2248; Bennett, Keiryn L./0000-0001-9356-7708; Gerner, Christopher/0000-0003-4964-0642	Austrian Science Fund [P17453]	Austrian Science Fund(Austrian Science Fund (FWF))	We thank Maria Selmer for comments on the manuscript and Philippe Giege for pointing out a third Arabidopsis homolog of MRPP3. This work was supported by Austrian Science Fund grant P17453 to W. R.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Chen JX, 2007, J ALZHEIMERS DIS, V12, P177; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DANG YL, 1993, J BIOL CHEM, V268, P19791; Dupureur CM, 2008, CURR OPIN CHEM BIOL, V12, P250, DOI 10.1016/j.cbpa.2008.01.012; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Gegenheimer P, 1996, MOL BIOL REP, V22, P147, DOI 10.1007/BF00988720; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; HENTZE MW, 1994, TRENDS BIOCHEM SCI, V19, P101, DOI 10.1016/0968-0004(94)90198-8; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Marszalkowski M, 2008, BIOL CHEM, V389, P395, DOI 10.1515/BC.2008.042; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Prokisch Holger, 2007, Methods Mol Biol, V372, P573, DOI 10.1007/978-1-59745-365-3_39; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; ROBERTSON HD, 1972, J BIOL CHEM, V247, P5243; Rossmanith W, 2001, MOL CELL BIOL, V21, P8236, DOI 10.1128/MCB.21.23.8236-8237.2001; ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Rossmanith W, 1997, J MOL BIOL, V265, P365, DOI 10.1006/jmbi.1996.0750; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; Salavati R, 2001, MOL BIOCHEM PARASIT, V115, P109, DOI 10.1016/S0166-6851(01)00273-0; Schafer B, 2005, GENE, V354, P80, DOI 10.1016/j.gene.2005.03.032; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; STARK BC, 1978, P NATL ACAD SCI USA, V75, P3717, DOI 10.1073/pnas.75.8.3717; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUSSMAN JL, 1976, SCIENCE, V192, P853, DOI 10.1126/science.775636; Swanson RV, 2001, METHOD ENZYMOL, V330, P158; Thomas B C, 1995, Nucleic Acids Symp Ser, P95; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; Willkomm DK, 2007, TRENDS BIOCHEM SCI, V32, P247, DOI 10.1016/j.tibs.2007.04.005; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006	48	411	421	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					462	474		10.1016/j.cell.2008.09.013	http://dx.doi.org/10.1016/j.cell.2008.09.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984158	Bronze			2022-12-01	WOS:000260536300017
J	Lin, YX; Bloodgood, BL; Hauser, JL; Lapan, AD; Koon, AC; Kim, TK; Hu, LS; Malik, AN; Greenberg, ME				Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Lapan, Ariya D.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.			Activity-dependent regulation of inhibitory synapse development by Npas4	NATURE			English	Article							NEUROTROPHIC FACTOR; CRITICAL PERIOD; MICE DEFICIENT; 65-KDA ISOFORM; VISUAL-CORTEX; PLASTICITY; TRANSCRIPTION; EXPRESSION; GENES; MOUSE	Neuronal activity regulates the development and maturation of excitatory and inhibitory synapses in the mammalian brain. Several recent studies have identified signalling networks within neurons that control excitatory synapse development. However, less is known about the molecular mechanisms that regulate the activity- dependent development of GABA (gamma-aminobutyric acid)- releasing inhibitory synapses. Here we report the identification of a transcription factor, Npas4, that plays a role in the development of inhibitory synapses by regulating the expression of activity- dependent genes, which in turn control the number of GABA- releasing synapses that form on excitatory neurons. These findings demonstrate that the activity- dependent gene program regulates inhibitory synapse development, and suggest a new role for this program in controlling the homeostatic balance between synaptic excitation and inhibition.	[Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, Boston, MA 02115 USA; [Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Lapan, Ariya D.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Malik, Athar N.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	meg@hms.harvard.edu	Kim, Tae-Kyung/AAX-4230-2020	Kim, Tae-Kyung/0000-0001-5161-9864; Koon, Alex/0000-0002-4274-7052; /0000-0002-7002-1275; Bloodgood, Brenda/0000-0002-4797-9119; Hauser Chatterjee, Jessica/0000-0002-9992-1736	F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital; Nancy Lurie Marks Family Foundation; Lefler Foundation postdoctoral fellowship; Ruth L. Kirschstein National Research Service Award; Helen Hay Whitney postdoctoral fellowship; National Science Foundation Graduate Research Fellowship; Jane Coffin Childs Memorial Fund; Mental Retardation Research Center [HD18655]; National Institutes of Health [NS27572, NS48276]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276, P01NS047572] Funding Source: NIH RePORTER	F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital; Nancy Lurie Marks Family Foundation; Lefler Foundation postdoctoral fellowship; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney postdoctoral fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; Mental Retardation Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Greenberg laboratory for suggestions; S. Paradis, J. M. Gray, S. S. Margolis, J. Zieg and C. M. Fletcher for reading the manuscript; S. Vasquez for preparing primary neuronal cell cultures; M. Thompson, Y. Zhou and H. Ye for assistance in generating Npas4<SUP>-/-</SUP> mice; T. Diefenbach and the Neurobiology Program Imaging Center for assistance with confocal microscopy; M. Fagiolini for help with dissection of the visual cortex; and X. J. Liu and C. Chen for help with electrophysiology. M. E. G. acknowledges the generous support of the F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital and support from the Nancy Lurie Marks Family Foundation. This work was supported by a Lefler Foundation postdoctoral fellowship (Y.L.), a Ruth L. Kirschstein National Research Service Award and a Helen Hay Whitney postdoctoral fellowship (B.L.B.), a National Science Foundation Graduate Research Fellowship (A.D.L.), the Jane Coffin Childs Memorial Fund (T.- K.K.) and Mental Retardation Research Center grant HD18655 and National Institutes of Health grants NS27572 and NS48276 (M.E.G.).	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Benson DL, 1996, J NEUROSCI, V16, P6424; Brown P, 1996, BRAIN, V119, P309, DOI 10.1093/brain/119.1.309; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Buschges A, 1998, CURR OPIN NEUROBIOL, V8, P733, DOI 10.1016/S0959-4388(98)80115-3; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hester I, 2007, BRAIN RES, V1135, P1, DOI 10.1016/j.brainres.2006.11.083; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kenet T, 2007, P NATL ACAD SCI USA, V104, P7646, DOI 10.1073/pnas.0701944104; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marty S, 2000, J NEUROSCI, V20, P8087; Micheva KD, 1997, CAN J PHYSIOL PHARM, V75, P470, DOI 10.1139/cjpp-75-5-470; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Seil FJ, 1996, EXP NEUROL, V138, P327, DOI 10.1006/exnr.1996.0071; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; WORLEY PF, 1990, PROG BRAIN RES, V86, P277; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	50	382	391	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1198	U23		10.1038/nature07319	http://dx.doi.org/10.1038/nature07319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815592	Green Accepted			2022-12-01	WOS:000260462100035
J	Falkowski, PG; Isozaki, Y				Falkowski, Paul G.; Isozaki, Yukio			Geology - The story of O(2)	SCIENCE			English	Editorial Material							ATMOSPHERIC OXYGEN; CARBON-CYCLE; EVOLUTION; WATER; NITROGEN; ORIGIN; EARTH; MODEL; TIME; RISE		[Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA; [Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Isozaki, Yukio] Univ Tokyo, Dept Earth Sci & Astron, Tokyo 1538902, Japan	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Tokyo	Falkowski, PG (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	falko@imcs.rutgers.edu; isozaki@ea.c.u-tokyo.ac.jp	Isozaki, Yukio/A-1806-2009	Isozaki, Yukio/0000-0002-3596-581X	Grants-in-Aid for Scientific Research [20224012] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barber J, 2008, PHILOS T R SOC B, V363, P1125, DOI 10.1098/rstb.2007.2227; Berner R., 2004, PHANEROZOIC CARBON C; Berner RA, 2006, GEOLOGY, V34, P413, DOI 10.1130/G22470.1; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Catling DC, 2005, EARTH PLANET SC LETT, V237, P1, DOI 10.1016/j.epsl.2005.06.013; Falkowski P, 2007, EVOLUTION PRIMARY PR; Falkowski PG, 2008, PHILOS T R SOC B, V363, P2705, DOI 10.1098/rstb.2008.0054; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Holland H. D., 1984, CHEM EVOLUTION ATMOS; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KEELING RF, 1993, GLOBAL BIOGEOCHEM CY, V7, P37, DOI 10.1029/92GB02733; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Maruyama S, 2005, INT GEOL REV, V47, P775, DOI 10.2747/0020-6814.47.8.775; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Robert F, 2001, SCIENCE, V293, P1056, DOI 10.1126/science.1064051; Tappert R, 2005, GEOLOGY, V33, P565, DOI 10.1130/G21637.1	22	45	49	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					540	542		10.1126/science.1162641	http://dx.doi.org/10.1126/science.1162641			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948530				2022-12-01	WOS:000260299100028
J	Tottey, S; Waldron, KJ; Firbank, SJ; Reale, B; Bessant, C; Sato, K; Cheek, TR; Gray, J; Banfield, MJ; Dennison, C; Robinson, NJ				Tottey, Steve; Waldron, Kevin J.; Firbank, Susan J.; Reale, Brian; Bessant, Conrad; Sato, Katsuko; Cheek, Timothy R.; Gray, Joe; Banfield, Mark J.; Dennison, Christopher; Robinson, Nigel J.			Protein-folding location can regulate manganese-binding versus copper- or zinc-binding	NATURE			English	Article							OXALATE DECARBOXYLASE; QUERCETIN 2,3-DIOXYGENASE; BACILLUS-SUBTILIS; SENSITIVITY; EXPRESSION; CHAPERONE; PATHWAY; YEAST; EPR	Metals are needed by at least one-quarter of all proteins(1,2). Although metallochaperones(3-8) insert the correct metal into some proteins, they have not been found for the vast majority, and the view is that most metalloproteins acquire their metals directly from cellular pools. However, some metals form more stable complexes with proteins than do others. For instance, as described in the Irving Williams series(9), Cu2+ and Zn2+ typically form more stable complexes than Mn2+. Thus it is unclear what cellular mechanisms manage metal acquisition by most nascent proteins. To investigate this question, we identified the most abundant Cu2+-protein, CucA (Cu2+- cupin A), and the most abundant Mn2+- protein, MncA (Mn2+- cupin A), in the periplasm of the cyanobacterium Synechocystis PCC 6803. Each of these newly identified proteins binds its respective metal via identical ligands within a cupin fold. Consistent with the Irving - Williams series, MncA only binds Mn2+ after folding in solutions containing at least a 10(4) times molar excess of Mn2+ over Cu2+ or Zn2+. However once MncA has bound Mn2+, the metal does not exchange with Cu2+. MncA and CucA have signal peptides for different export pathways into the periplasm, Tat and Sec respectively. Export by the Tat pathway allows MncA to fold in the cytoplasm, which contains only tightly bound copper or Zn2+ ( refs 10-12) but micromolar Mn2+ ( ref. 13). In contrast, CucA folds in the periplasm to acquire Cu2+. These results reveal a mechanism whereby the compartment in which a protein folds overrides its binding preference to control its metal content. They explain why the cytoplasm must contain only tightly bound and buffered copper and Zn2+.	[Tottey, Steve; Waldron, Kevin J.; Firbank, Susan J.; Reale, Brian; Sato, Katsuko; Cheek, Timothy R.; Gray, Joe; Banfield, Mark J.; Dennison, Christopher; Robinson, Nigel J.] Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bessant, Conrad] Cranfield Univ, Cranfield Bioinformat Grp, Cranfield MK43 0AL, Beds, England	Newcastle University - UK; Cranfield University	Robinson, NJ (corresponding author), Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.robinson@ncl.ac.uk	Bessant, Conrad/E-7620-2010; Waldron, Kevin/J-2368-2016; Banfield, Mark/C-7453-2013; Johnson, Michael D. L./B-4352-2012; Robinson, Nigel J/J-6363-2012	Waldron, Kevin/0000-0002-5577-7357; Banfield, Mark/0000-0001-8921-3835; Robinson, Nigel J/0000-0001-5586-1092; Gray, Joseph/0000-0003-2338-0301; Dennison, Christopher/0000-0001-8665-052X; Bessant, Conrad/0000-0002-7983-1020	BBSRC PMS committee [BBS/B/02576, BB/E001688/1]; J. Gitlin and the Children's Discovery Institute; Royal Society University Research Fellow; BBSRC [BB/E001688/1] Funding Source: UKRI; MRC [G0500367, G0600759] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001688/1, BBS/B/02576] Funding Source: researchfish; Medical Research Council [G0500367, G0600759] Funding Source: researchfish	BBSRC PMS committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); J. Gitlin and the Children's Discovery Institute; Royal Society University Research Fellow(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the BBSRC PMS committee (BBS/B/02576 and BB/E001688/1). B. R. was supported by J. Gitlin and the Children's Discovery Institute. M. J. B. is a Royal Society University Research Fellow. J. Kotz provided advice on the draft manuscript. We thank T. Palmer, B. Ize and G. Buchanan for donating E. coli BL21 tat deletion strains and for advice.	Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Angerhofer A, 2007, J PHYS CHEM B, V111, P5043, DOI 10.1021/jp0715326; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Da Silva JJRF., 2001, INORGANIC CHEM LIFE; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Fusetti F, 2002, STRUCTURE, V10, P259, DOI 10.1016/S0969-2126(02)00704-9; Helmann JD, 2007, MOL CELL, V27, P859, DOI 10.1016/j.molcel.2007.09.002; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kooter IM, 2002, EUR J BIOCHEM, V269, P2971, DOI 10.1046/j.1432-1033.2002.02973.x; Leslie AGW, 1992, RECENT CHANGES MOSFL; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Svedruzic D, 2007, ARCH BIOCHEM BIOPHYS, V464, P36, DOI 10.1016/j.abb.2007.03.016; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey Stephen, 2007, V6, P3, DOI 10.1007/7171_2006_072; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; Waldron KJ, 2007, J BIOL CHEM, V282, P3837, DOI 10.1074/jbc.M609916200; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	42	235	242	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1138	U17		10.1038/nature07340	http://dx.doi.org/10.1038/nature07340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948958				2022-12-01	WOS:000260252600051
J	Nishino, J; Kim, I; Chada, K; Morrison, SJ				Nishino, Jinsuke; Kim, Injune; Chada, Kiran; Morrison, Sean J.			Hmga2 Promotes Neural Stem Cell Self-Renewal in Young but Not Old Mice by Reducing p16(Ink4a) and p19(Arf) Expression	CELL			English	Article							TUMOR SUPPRESSION; DEPENDENCE DISTINGUISHES; TRANSGENIC MICE; INK4A LOCUS; BMI-1; MOUSE; PROTEINS; PROLIFERATION; SENESCENCE; GENE	Stem cells persist throughout life in diverse tissues by undergoing self-renewing divisions. Self-renewal capacity declines with age, partly because of increasing expression of the tumor suppressor p16(Ink4a). We discovered that the Hmga2 transcriptional regulator is highly expressed in fetal neural stem cells but that expression declines with age. This decrease is partly caused by the increasing expression of let-7b microRNA, which is known to target HMGA2. Hmga2-deficient mice show reduced stem cell numbers and self-renewal throughout the central and peripheral nervous systems of fetal and young-adult mice but not old-adult mice. Furthermore, p16(Ink4a) and p19(Arf) expression were increased in Hmga2-deficient fetal and young-adult stem cells, and deletion of p16(Ink4a) and/or p19(Arf) partially restored self-renewal capacity. let-7b overexpression reduced Hmga2 and increased p16(Ink4a)/p19(Arf) expression. Hmga2 thus promotes fetal and young-adult stem cell self-renewal by decreasing p16(Ink4a)/p19(Arf) expression. Changes in let-7 and Hmga2 expression during aging contribute to the decline in neural stem cell function.	[Nishino, Jinsuke; Kim, Injune; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nishino, Jinsuke; Kim, Injune; Morrison, Sean J.] Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Chada, Kiran] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08554 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University Medical Center	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; Kim, Injune/C-1710-2011	Kim, Injune/0000-0001-9244-815X; Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; National Institute of Neurological Disorder and Stroke [R01 NS040750]; National Institute on Aging [R01 AG024945-01]; University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) [CA46592]; National Institute of Diabetes, Digestive, and Kidney Diseases [NIH5P60-DK20572]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024945] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Howard Hughes Medical Institute, the National Institute of Neurological Disorder and Stroke (R01 NS040750), and the National Institute on Aging (R01 AG024945-01). Flow cytometry was partially supported by the University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) CA46592. Antibody production was supported in part by National Institute of Diabetes, Digestive, and Kidney Diseases grant NIH5P60-DK20572 to the Michigan Diabetes Research and Training Center. J.N. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. Thanks to David Adams and Martin White for flow cytometry and to Elizabeth Smith (UM Hybridoma Core) for antibody production. Thanks to Charles Sherr for providing p19<SUP>Arf-/-</SUP> mice and to Ron DePinho for providing p16<SUP>Ink4a</SUP>/p19Arf<SUP>-/-</SUP> and p16<SUP>Ink4a-/-</SUP> mice. Thanks to Scott Lowe and to Masashi Narita for providing anti-Hmga2 antibody and to Tom Lanigan in the UM Vector Core for generating	Arlotta P, 2000, J BIOL CHEM, V275, P14394, DOI 10.1074/jbc.M000564200; BENSON KF, 1994, GENET RES, V64, P27, DOI 10.1017/S0016672300032511; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kiel MJ, 2005, DEV BIOL, V283, P29, DOI 10.1016/j.ydbio.2005.03.037; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	39	471	480	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					227	239		10.1016/j.cell.2008.09.017	http://dx.doi.org/10.1016/j.cell.2008.09.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957199	Bronze, Green Accepted			2022-12-01	WOS:000260130400013
J	Karelis, AD				Karelis, Antony D.			Metabolically healthy but obese individuals	LANCET			English	Editorial Material							NORMAL-WEIGHT; WOMEN; IDENTIFICATION; POPULATION; PREVALENCE; PROFILE; RISK		[Karelis, Antony D.] Univ Quebec, Dept Kinesiol, Montreal, PQ H2X 3R9, Canada	University of Quebec; University of Quebec Montreal	Karelis, AD (corresponding author), Univ Quebec, Dept Kinesiol, Montreal, PQ H2X 3R9, Canada.	karelis.antony@uqam.ca						AGUILARSALINAS CA, 2008, J CLIN ENDOCRIN 0805; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210; Iacobellis G, 2005, OBES RES, V13, P1116, DOI 10.1038/oby.2005.130; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Karelis AD, 2008, DIABETES METAB, V34, P183, DOI 10.1016/j.diabet.2007.11.004; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Perseghin G, 2008, DIABETOLOGIA, V51, P1567, DOI 10.1007/s00125-008-1077-x; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	13	191	196	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1281	1283		10.1016/S0140-6736(08)61531-7	http://dx.doi.org/10.1016/S0140-6736(08)61531-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929889				2022-12-01	WOS:000260060500008
J	Cai, L; Dalal, CK; Elowitz, MB				Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.			Frequency-modulated nuclear localization bursts coordinate gene regulation	NATURE			English	Article							TRANSCRIPTION FACTOR; PROTEIN EXPRESSION; GLOBAL ANALYSIS; CALCINEURIN; YEAST; OSCILLATIONS; VARIABILITY; NOISE; CELLS; DEPENDENCE	In yeast, the transcription factor Crz1 is dephosphorylated and translocates into the nucleus in response to extracellular calcium. Here we show, using time- lapse microscopy, that Crz1 exhibits short bursts of nuclear localization ( typically lasting 2 min) that occur stochastically in individual cells and propagate to the expression of downstream genes. Strikingly, calcium concentration controls the frequency, but not the duration, of localization bursts. Using an analytic model, we also show that this frequency modulation of bursts ensures proportional expression of multiple target genes across a wide dynamic range of expression levels, independent of promoter characteristics. We experimentally confirm this theory with natural and synthetic Crz1 target promoters. Another stress- response transcription factor, Msn2, exhibits similar, but largely uncorrelated, localization bursts under calcium stress suggesting that frequency- modulation regulation of localization bursts may be a general control strategy used by the cell to coordinate multi- gene responses to external signals.	[Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, M-C 114-96, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Dalal, Chiraj/0000-0002-3624-8409	Beckman Fellows Program at Caltech; National Institutes of Health [R01GM079771]; National Centers of Systems Biology, and the Packard Foundation [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, P50GM068763] Funding Source: NIH RePORTER	Beckman Fellows Program at Caltech; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers of Systems Biology, and the Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Cyert for the CDRE and Crz1 mutant plasmids, K. Cunningham for the Crz1 overexpression plasmid pLE66, J. Stadler for the pGW845FRET plasmid, S. Ramanathan for image analysis code, and K. Thorn, C.- L. Guo and L. LeBon for technical assistance. We thank U. Alon, M. Carlson, M. Cyert, H. Garcia, R. Kishony, G. Lahav, J.-G. Ojalvo, I. Riedel-Kruse, B. Shraiman, G. Suel, members of the laboratory, and especially N. Friedman for discussions. L. C. is supported by the Beckman Fellows Program at Caltech. This work was supported by National Institutes of Health grants R01GM079771 and P50 GM068763 for National Centers of Systems Biology, and the Packard Foundation.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Armstrong EH, 1936, P IRE, V24, P689, DOI 10.1109/JRPROC.1936.227383; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; BREUDER T, 1994, P NATL ACAD SCI USA, V91, P5372, DOI 10.1073/pnas.91.12.5372; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1111/j.1574-6976.2000.tb00551.x; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquet M, 2003, J CELL BIOL, V161, P497, DOI 10.1083/jcb.200303030; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Song GB, 1999, J GUID CONTROL DYNAM, V22, P433, DOI 10.2514/2.4415; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Wiesenberger G, 2007, EUKARYOT CELL, V6, P592, DOI 10.1128/EC.00382-06; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	48	352	359	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					485	U16		10.1038/nature07292	http://dx.doi.org/10.1038/nature07292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818649	Green Accepted			2022-12-01	WOS:000259449600036
J	Forde, SE; Beardmore, RE; Gudelj, I; Arkin, SS; Thompson, JN; Hurst, LD				Forde, Samantha E.; Beardmore, Robert E.; Gudelj, Ivana; Arkin, Sinan S.; Thompson, John N.; Hurst, Laurence D.			Understanding the limits to generalizability of experimental evolutionary models	NATURE			English	Article							HOST-PARASITOID INTERACTION; ESCHERICHIA-COLI; BACTERIA; COEVOLUTION; PHAGE; COMMUNITIES; ADAPTATION; RESISTANCE; GENETICS; VIRUS	Given the difficulty of testing evolutionary and ecological theory in situ, in vitro model systems are attractive alternatives(1); however, can we appraise whether an experimental result is particular to the in vitro model, and, if so, characterize the systems likely to behave differently and understand why? Here we examine these issues using the relationship between phenotypic diversity and resource input in the T7 - Escherichia coli co- evolving system as a case history. We establish a mathematical model of this interaction, framed as one instance of a super- class of host - parasite co- evolutionary models, and show that it captures experimental results. By tuning this model, we then ask how diversity as a function of resource input could behave for alternative co- evolving partners ( for example, E. coli with lambda bacteriophages). In contrast to populations lacking bacteriophages, variation in diversity with differences in resources is always found for co- evolving populations, supporting the geographic mosaic theory of co- evolution(2). The form of this variation is not, however, universal. Details of infectivity are pivotal: in T7 - E. coli with a modified gene- for- gene interaction, diversity is low at high resource input, whereas, for matching- allele interactions, maximal diversity is found at high resource input. A combination of in vitro systems and appropriately configured mathematical models is an effective means to isolate results particular to the in vitro system, to characterize systems likely to behave differently and to understand the biology underpinning those alternatives.	[Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Forde, Samantha E.; Thompson, John N.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Beardmore, Robert E.; Gudelj, Ivana; Arkin, Sinan S.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Gudelj, Ivana] Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England	University of Bath; University of California System; University of California Santa Cruz; Imperial College London; University of Bath	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054; Arkin, Sinan/0000-0001-7805-4015	NERC Advanced Fellowship; ORS award; Department of Mathematics at Imperial College London; National Science Foundation [DEB 0515598]; EPSRC [EP/F037856/1] Funding Source: UKRI; NERC [NE/E013007/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F037856/1] Funding Source: researchfish; Natural Environment Research Council [NE/E013007/2, NE/B501998/1, NE/B501998/2] Funding Source: researchfish	NERC Advanced Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ORS award; Department of Mathematics at Imperial College London; National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. Buckling, S. Nuismer, K. Rich, J. Hoeksema and C. Jessup for their comments on an earlier version of this manuscript. L. D. H. is a Royal Society Wolfson Research Merit Award Holder. I. G. is supported by a NERC Advanced Fellowship. S. S. A. is funded by an ORS award and a studentship for the Department of Mathematics at Imperial College London. S. E. F. and J. N. T. are supported by the National Science Foundation DEB 0515598.	Agrawal A, 2002, EVOL ECOL RES, V4, P79; Bohannan BJM, 2002, ANTON LEEUW INT J G, V81, P107, DOI 10.1023/A:1020585711378; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Ferris MT, 2007, GENETICS, V176, P1013, DOI 10.1534/genetics.106.064634; Forde SE, 2007, AM NAT, V169, P794, DOI 10.1086/516848; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; KRUGER DH, 1981, MICROBIOL REV, V45, P9; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Poullain V, 2008, EVOLUTION, V62, P1, DOI 10.1111/j.1558-5646.2007.00260.x; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Sasaki A, 1999, P ROY SOC B-BIOL SCI, V266, P455, DOI 10.1098/rspb.1999.0659; SEN K, 1991, J BACTERIOL, V173, P926, DOI 10.1128/jb.173.2.926-928.1991; SPANAKIS E, 1987, J GEN MICROBIOL, V133, P353; TAMAKI S, 1971, J BACTERIOL, V105, P968, DOI 10.1128/JB.105.3.968-975.1971; Thompson J.N., 2005, INTERSPEC INTERACT; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818	21	31	32	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					220	U44		10.1038/nature07152	http://dx.doi.org/10.1038/nature07152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784724	Green Submitted			2022-12-01	WOS:000259090800046
J	Berger, JM				Berger, James M.			SnapShot: Nucleic acid helicases and translocases	CELL			English	Editorial Material							MECHANISMS		Univ Calif Berkeley, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071747] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300	10	30	33	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5							888.e1	10.1016/j.cell.2008.08.027	http://dx.doi.org/10.1016/j.cell.2008.08.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775318	Green Accepted, Bronze			2022-12-01	WOS:000258947500027
J	Ginsberg, J; Mohebbi, MH; Patel, RS; Brammer, L; Smolinski, MS; Brilliant, L				Ginsberg, Jeremy; Mohebbi, Matthew H.; Patel, Rajan S.; Brammer, Lynnette; Smolinski, Mark S.; Brilliant, Larry			Detecting influenza epidemics using search engine query data	NATURE			English	Article								Seasonal influenza epidemics are a major public health concern, causing tens of millions of respiratory illnesses and 250,000 to 500,000 deaths worldwide each year(1). In addition to seasonal influenza, a new strain of influenza virus against which no previous immunity exists and that demonstrates human- to- human transmission could result in a pandemic with millions of fatalities(2). Early detection of disease activity, when followed by a rapid response, can reduce the impact of both seasonal and pandemic influenza(3,4). One way to improve early detection is to monitor health- seeking behaviour in the form of queries to online search engines, which are submitted by millions of users around the world each day. Here we present a method of analysing large numbers of Google search queries to track influenza- like illness in a population. Because the relative frequency of certain queries is highly correlated with the percentage of physician visits in which a patient presents with influenza- like symptoms, we can accurately estimate the current level of weekly influenza activity in each region of the United States, with a reporting lag of about one day. This approach may make it possible to use search queries to detect influenza epidemics in areas with a large population of web search users.	[Ginsberg, Jeremy; Mohebbi, Matthew H.; Patel, Rajan S.; Smolinski, Mark S.; Brilliant, Larry] Google Inc, Mountain View, CA 94043 USA; [Brammer, Lynnette] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Google Incorporated; Centers for Disease Control & Prevention - USA	Ginsberg, J (corresponding author), Google Inc, 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA.	flutrends-support@google.com		Ginsberg, Jeremy/0000-0001-9527-0510				DAVID FN, 1949, BIOMETRIKA, V36, P394, DOI 10.1093/biomet/36.3-4.394; DEAN J, 2004, 6 S OP SYST DES IMP; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FOX S, 2006, PEW INTERNET AM LIFE; Johnson HA, 2004, STUD HEALTH TECHNOL, V107, P1202; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Magruder SF, 2003, J HOPKINS APL TECH D, V24, P349; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; World Health Organization, 2003, INFL FACT SHEET; World Health Organization, 2004, WHO CONS PRIOR PUBL	12	2303	2423	23	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1012	U4		10.1038/nature07634	http://dx.doi.org/10.1038/nature07634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19020500				2022-12-01	WOS:000263425400042
J	Wang, SY; Li, YH; Chi, GB; Xiao, SY; Ozanne-Smith, J; Stevenson, M; Phillips, MR				Wang, S. Y.; Li, Y. H.; Chi, G. B.; Xiao, S. Y.; Ozanne-Smith, J.; Stevenson, M.; Phillips, M. R.			Health System Reform in China 4 Injury-related fatalities in China: an under-recognised public-health problem	LANCET			English	Article							RISK-FACTORS; SUICIDE; MORTALITY	The May 2008 earthquake in Wenchuan drew attention to the important but largely unrecognised public-health problem of injury-related mortality and morbidity in China. Injuries account for more than 10% of all deaths and more than 30% of all potentially productive years of life lost due to premature mortality in China. Traffic-related injuries (mainly among cyclists and pedestrians), suicide, drowning, and falls account for 79% of all injury deaths. Rural injury death rates are double those of urban rates and male rates are double those of female rates. Despite an 81% increase in the traffic-related mortality from 1987 to 2006-associated with rapid motorisation-the overall injury mortality decreased by 17%, largely due to a surprising (and unexplained) 57% reduction in the suicide rate. Low-cost prevention measures that are most likely to produce large reductions in injury deaths include enforcement of laws for drinking and driving and for seat belt and helmet use, restriction of access to the most potent pesticides, and teaching children to swim. China needs to improve monitoring of fatal and non-fatal injuries, promote intersectoral collaboration, build institutional capacities, and, most importantly, mobilise community support and political will for investment in prevention.	[Phillips, M. R.] Beijing Hui Long Guan Hosp, WHO Coordinating Ctr Res & Training Suicide Preve, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China; [Wang, S. Y.; Chi, G. B.] Jinan Univ, Coll Med, Ctr Injury Prevent & Control, Guangzhou, Guangdong, Peoples R China; [Li, Y. H.] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Xiao, S. Y.] Cent S Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Ozanne-Smith, J.] Monash Univ, Accident Res Ctr, Clayton, Vic 3800, Australia; [Ozanne-Smith, J.] Monash Univ, Dept Forens Med, Clayton, Vic 3800, Australia; [Stevenson, M.] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Stevenson, M.] Peking Univ, Hlth Sci Ctr, George Inst China, Beijing 100871, Peoples R China; [Phillips, M. R.] Columbia Univ, Dept Psychiat, New York, NY USA; [Phillips, M. R.] Columbia Univ, Dept Epidemiol, New York, NY USA	Jinan University; Shanghai Center for Disease Control & Prevention; Central South University; Monash University; Monash University; University of Sydney; Peking University; Columbia University; Columbia University	Phillips, MR (corresponding author), Beijing Hui Long Guan Hosp, WHO Coordinating Ctr Res & Training Suicide Preve, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China.	phillipschina@yahoo.com	stevenson, mark/AAE-9706-2019; Phillips, Michael Robert/AAE-7585-2021	stevenson, mark/0000-0003-3166-5876; Phillips, Michael Robert/0000-0002-5973-2439				[Anonymous], WHO MORT DAT; Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; BRENNER RA, ARCH PEDIAT IN PRESS; *CHIN IND RES MARK, 2008, AUT PARTS ACC MAN IN; *CHIN MIN HLTH, 2003, ANN REP CHIN HLTH ST; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Conner KR, 2007, AM J PUBLIC HEALTH, V97, P1842, DOI 10.2105/AJPH.2005.077420; Conner KR, 2005, PSYCHOL MED, V35, P1197, DOI 10.1017/S003329170500454X; *DIS PREV CONTR BU, 2007, REP INJ PREV CHIN; Dollar D, 2007, 4253 WORLD BANK; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Fahquist JN, 2006, ACCIDENT ANAL PREV, V38, P1113, DOI 10.1016/j.aap.2006.04.020; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; JING RW, 2004, BEIJING INJURY SURVE; [李献云 Li Xianyun], 2005, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V31, P272; [李献云 Li Xianyun], 2003, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V29, P27; [刘娜 Liu Na], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P746; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mathers CD, 2003, GLOBAL BURDEN DIS 20; Moniruzzaman S, 2004, PUBLIC HEALTH, V118, P346, DOI 10.1016/j.puhe.2003.10.004; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; *NAT BUR STAT CHIN, 1996, B 1995 NAT 1 SAMPL S; *NAT BUR STAT CHIN, 2007, B 2005 NAT 1 SAMPL S; *NAT BUR STAT CHIN, 2006, B MAIN RES 2005 1 SA; National Bureau of Statistics of China, 1988, CHIN STAT YB; OZANNESMITH J, 2008, WORLD REPOR IN PRESS; Passmore J, 2006, Int J Inj Contr Saf Promot, V13, P187, DOI 10.1080/17457300500248444; Peden M., 2004, WORLD REPORT ROAD TR; PERREMENT M, 2006, DROWNING IS NUMBER 1; Phillips M. R., 2004, Morbidity and Mortality Weekly Report, V53, P481; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Phillips MR, 1998, CHINA J, V39, P1, DOI 10.2307/2667691; RAHMIN A, 2005, BANGLADESH HLTH INJU; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Routley V, 2007, INJURY PREV, V13, P388, DOI 10.1136/ip.2007.015701; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; STAINES C, CHILD EARLY ADOLESCE; *STAT COUNC INF OF, LAT DEV WENCH EARTHQ; STEVENSON M, INJ PREV IN PRESS; United Nations, 1996, PREV SUIC GUID FORM; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61365-3; Wang Li-Jun, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P889; [王艳红 WANG Yanhong], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P195; Wasserman D., 2016, SUICIDE UNNECESSARY, DOI 10.1093/med/9780198717393.001.0001; *WHO, 2008, WORLD HLTH STAT REP; WHO, 2006, SAF ACC PEST COMM IN; WHO, 2002, INJ CHARTB GRAPH OV; *WHO, HUM AN RAB; World Health Organization (WHO), INT STAT CLASS DIS R; Yang GH, 2005, BIOMED ENVIRON SCI, V18, P379; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Yang L, 2007, INJURY PREV, V13, P178, DOI 10.1136/ip.2006.013409; ZHANG KL, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61357-4; Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124	55	202	274	2	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1765	1773		10.1016/S0140-6736(08)61367-7	http://dx.doi.org/10.1016/S0140-6736(08)61367-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374XV	18930527				2022-12-01	WOS:000261077900026
J	Bosmans, F; Martin-Eauclaire, MF; Swartz, KJ				Bosmans, Frank; Martin-Eauclaire, Marie-France; Swartz, Kenton J.			Deconstructing voltage sensor function and pharmacology in sodium channels	NATURE			English	Article							ALPHA-SCORPION TOXIN; DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; GATING MODIFIER; SKELETAL-MUSCLE; MOLECULAR DETERMINANTS; TARANTULA TOXINS; IONIC CURRENTS; RAT-BRAIN; DOMAIN IV	Voltage- activated sodium (Na-v) channels are crucial for the generation and propagation of nerve impulses, and as such are widely targeted by toxins and drugs. The four voltage sensors in Na-v channels have distinct amino acid sequences, raising fundamental questions about their relative contributions to the function and pharmacology of the channel. Here we use four- fold symmetric voltage- activated potassium ( K-v) channels as reporters to examine the contributions of individual S3b-S4 paddle motifs within Na-v channel voltage sensors to the kinetics of voltage sensor activation and to forming toxin receptors. Our results uncover binding sites for toxins from tarantula and scorpion venom on each of the four paddle motifs in Nav channels, and reveal how paddle- specific interactions can be used to reshape Na-v channel activity. One paddle motif is unique in that it slows voltage sensor activation, and toxins selectively targeting this motif impede Na-v channel inactivation. This reporter approach and the principles that emerge will be useful in developing new drugs for treating pain and Na-v channelopathies.	[Bosmans, Frank; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Bosmans, Frank] Catholic Univ Louvain, Toxicol Lab, B-3000 Louvain, Belgium; [Martin-Eauclaire, Marie-France] Univ Mediterranee, CNRS, Inst Jean Roche, UMR 6231,CRN2M, Marseille, France	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov	Bosmans, Frank/A-9660-2013; Bosmans, Frank/T-5589-2017	Bosmans, Frank/0000-0002-6476-235X; Bosmans, Frank/0000-0002-6476-235X; Bosmans, Frank/0000-0002-0451-6050	Intramural Research Program; NINDS; NIH; NIH- FWO postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003017] Funding Source: NIH RePORTER	Intramural Research Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH- FWO postdoctoral fellowship(FWO); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J.W. Kyle, D.A. Hanck and A.L. Goldin for the rNa<INF>v</INF>1.2a, rNa<INF>v</INF>1.4 and beta<INF>1</INF> clones, C. Deutsch for K<INF>v</INF>1.3, M.M. Smith for GxTx-1E, K.M. Blumenthal and J.B. Herrington for ProTx-II, L.D. Possani for a sample of TsVII, the NINDS DNA sequencing facility for DNA sequencing, and the NINDS protein sequencing facility for mass spectrometry and peptide sequencing. We thank A.A. Alabi for helping with Kv and Nav channel alignments and T.-H. Chang for assistance with Nav channel mutants. We also thank A. A. Alabi, M. Holmgren, M. Mayer, M. Milescu, J. Mindell, A. Plested, S. Silberberg and members of the Swartz laboratory for discussions. This work was supported by the Intramural Research Program of the NINDS, NIH (K.J.S.) and by an NIH- FWO postdoctoral fellowship (F.B.).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Bendahhou S, 1999, J NEUROSCI, V19, P4762; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; CAHALAN MD, 1975, J PHYSIOL-LONDON, V244, P511, DOI 10.1113/jphysiol.1975.sp010810; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; CEARD B, 1992, TOXICON, V30, P105, DOI 10.1016/0041-0101(92)90506-Z; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; KOPPENHOFER E, 1968, PFLUG ARCH EUR J PHY, V303, P150, DOI 10.1007/BF00592632; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; MARTIN MF, 1987, TOXICON, V25, P569, DOI 10.1016/0041-0101(87)90293-5; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sheets MF, 2000, J GEN PHYSIOL, V115, P609, DOI 10.1085/jgp.115.5.609; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Spampanato J, 2003, NEUROSCIENCE, V116, P37, DOI 10.1016/S0306-4522(02)00698-X; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TEJEDOR FJ, 1988, P NATL ACAD SCI USA, V85, P8742, DOI 10.1073/pnas.85.22.8742; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Wan XP, 2001, AM J PHYSIOL-HEART C, V280, pH354, DOI 10.1152/ajpheart.2001.280.1.H354; Wang GK, 2000, PFLUG ARCH EUR J PHY, V439, P705, DOI 10.1007/s004240050996; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	62	219	232	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					202	U28		10.1038/nature07473	http://dx.doi.org/10.1038/nature07473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005548	Green Accepted			2022-12-01	WOS:000261039300032
J	Freiberg, JJ; Tybjaerg-Hansen, A; Jensen, JS; Nordestgaard, BG				Freiberg, Jacob J.; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.			Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETICALLY HYPERLIPIDEMIC RABBITS; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; FOLLOW-UP; SELECTIVE RETENTION; ARTERIAL INTIMA; IN-VIVO; PLASMA; MUTATIONS	Context The role of triglycerides in the risk of ischemic stroke remains controversial. Recently, a strong association was found between elevated levels of nonfasting triglycerides, which indicate the presence of remnant lipoproteins, and increased risk of ischemic heart disease. Objective To test the hypothesis that increased levels of nonfasting triglycerides are associated with ischemic stroke in the general population. Design, Setting, and Participants The Copenhagen City Heart Study, a prospective, Danish population - based cohort study initiated in 1976, with follow- up through July 2007. Participants were 13 956 men and women aged 20 through 93 years. A cross- sectional study included 9637 individuals attending the 1991- 1994 examination of the prospective study. Main Outcome Measures Prospective study: baseline levels of nonfasting triglycerides, other risk factors at baseline and at follow- up examinations, and incidence of ischemic stroke. Cross- sectional study: levels of nonfasting triglycerides, levels of remnant cholesterol, and prevalence of ischemic stroke. Results Of the 13 956 participants in the prospective study, 1529 developed ischemic stroke. Cumulative incidence of ischemic stroke increased with increasing levels of nonfasting triglycerides ( log- rank trend, P <. 001). Men with elevated nonfasting triglyceride levels of 89 through 176 mg/ dL had multivariate- adjusted hazard ratios ( HRs) for ischemic stroke of 1.3 ( 95% CI, 0.8- 1.9; 351 events); for 177 through 265 mg/ dL, 1.6 ( 95% CI, 1.0- 2.5; 189 events); for 266 through 353 mg/ dL, 1.5 ( 95% CI, 0.9- 2.7; 73 events); for 354 through 442 mg/ dL, 2.2 ( 95% CI, 1.1- 4.2; 40 events); and for 443 mg/ dL or greater, 2.5 ( 95% CI, 1.3- 4.8; 41 events) vs men with nonfasting levels less than 89 mg/ dL ( HR, 1.0; 85 events) ( P <. 001 for trend). Corresponding values for women were 1.3 ( 95% CI, 0.9- 1.7; 407 events), 2.0 ( 95% CI, 1.3- 2.9; 135 events), 1.4 ( 95% CI, 0.7- 2.9; 26 events), 2.5 ( 95% CI, 1.0- 6.4; 13 events), and 3.8 ( 95% CI, 1.3- 11; 10 events) vs women with nonfasting triglyceride levels less than 89 mg/ dL ( HR, 1.0; 159 events) ( P <. 001 for trend). Absolute 10- year risk of ischemic stroke ranged from 2.6% in men younger than 55 years with nonfasting triglyceride levels of less than 89 mg/ dL to 16.7% in men aged 55 years or older with levels of 443 mg/ dL or greater. Corresponding values in women were 1.9% and 12.2%. In the cross- sectional study, men with a previous ischemic stroke vs controls had nonfasting triglyceride levels of 191 ( IQR, 131- 259) mg/ dL vs 148 ( IQR, 104- 214) mg/ dL ( P <. 01); corresponding values for women were 167 ( IQR, 121- 229) mg/ dL vs 127 ( IQR, 91- 181) mg/ dL ( P <. 05). For remnant cholesterol, corresponding values were 38 ( IQR, 26- 51) mg/ dL vs 29 ( IQR, 20- 42) mg/ dL in men ( P <. 01) and 33 ( IQR, 2445) mg/ dL vs 25 ( IQR, 18- 35) mg/ dL in women ( P <. 05). Conclusion In this study population, nonfasting triglyceride levels were associated with risk of ischemic stroke.	[Freiberg, Jacob J.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Univ Copenhagen Hosp, Bispebjerg Hosp, Copenhagen City Heart Study, DK-2100 Copenhagen, Denmark; [Tybjaerg-Hansen, Anne] Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Jensen, Jan Skov] Univ Copenhagen Hosp, Gentofte Hosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020; Adiels, Martin/C-9278-2011		University of Copenhagen; Danish Heart Foundation; Danish Medical Research Council; Research Fund at Rigshospitalet; Copenhagen University Hospital; European Union	University of Copenhagen; Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Fund at Rigshospitalet; Copenhagen University Hospital; European Union(European Commission)	This study was supported by the University of Copenhagen, the Danish Heart Foundation, the Danish Medical Research Council, the Research Fund at Rigshospitalet, Copenhagen University Hospital, and the European Union, Sixth Framework Programme Priority (FP-2005-LIFESCIHEALTH-6), contract 037631.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; Bowman TS, 2003, STROKE, V34, P2930, DOI 10.1161/01.STR.0000102171.91292.DC; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COHN JS, 1988, J LIPID RES, V29, P925; Friberg J, 2003, AM J CARDIOL, V92, P1419, DOI 10.1016/j.amjcard.2003.08.050; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; Graham I, 2007, ATHEROSCLEROSIS, V194, P1, DOI 10.1016/j.atherosclerosis.2007.08.024; HAHEIM LL, 1993, STROKE, V24, P1484, DOI 10.1161/01.STR.24.10.1484; Hokanson JE, 1999, CURR OPIN LIPIDOL, V10, P393, DOI 10.1097/00041433-199910000-00003; Kolovou GD, 2005, CURR MED CHEM, V12, P1931, DOI 10.2174/0929867054546609; LINDENSTROM E, 1994, BMJ-BRIT MED J, V309, P11, DOI 10.1136/bmj.309.6946.11; Mahley RW, 2001, METABOLIC MOL BASES, P2835; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Nordestgaard BG, 1996, CURR OPIN LIPIDOL, V7, P269, DOI 10.1097/00041433-199610000-00002; NORDESTGAARD BG, 1992, ARTERIOSCLER THROMB, V12, P6, DOI 10.1161/01.ATV.12.1.6; NORDESTGAARD BG, 1988, J LIPID RES, V29, P1491; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; NORDESTGAARD BG, 1988, ARTERIOSCLEROSIS, V8, P421, DOI 10.1161/01.ATV.8.4.421; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Proctor SD, 2002, CURR OPIN LIPIDOL, V13, P461, DOI 10.1097/00041433-200210000-00001; RIFAI N, 2006, TIETZ TXB CLIN CHEM, P903; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rutledge JC, 2000, CIRC RES, V86, P768, DOI 10.1161/01.RES.86.7.768; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Shahar E, 2003, STROKE, V34, P623, DOI 10.1161/01.STR.0000057812.51734.FF; SHAIKH M, 1991, ARTERIOSCLER THROMB, V11, P569, DOI 10.1161/01.ATV.11.3.569; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Truelsen T, 2002, NEUROEPIDEMIOLOGY, V21, P22, DOI 10.1159/000048610; Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473; 1988, J CLIN EPIDEMIOL, V41, P105, DOI [10.1016/0895-4356(88)90084-4, DOI 10.1016/0895-4356(88)90084-4]	40	373	390	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2142	2152		10.1001/jama.2008.621	http://dx.doi.org/10.1001/jama.2008.621			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001625	Bronze			2022-12-01	WOS:000260793800024
J	Wang, MC; O'Rourke, EJ; Ruvkun, G				Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary			Fat Metabolism Links Germline Stem Cells and Longevity in C. elegans	SCIENCE			English	Article							LIFE-SPAN; SEX-DETERMINATION; DAF-16; GLP-1; REPRODUCTION; DROSOPHILA; RECEPTOR; PATHWAY; DFOXO	Fat metabolism, reproduction, and aging are intertwined regulatory axes; however, the mechanism by which they are coupled remains poorly understood. We found that germline stem cells (GSCs) actively modulate lipid hydrolysis in Caenorhabditis elegans, which in turn regulates longevity. GSC arrest promotes systemic lipolysis via induction of a specific fat lipase. Subsequently, fat mobilization is promoted and life span is prolonged. Constitutive expression of this lipase in fat storage tissue generates lean and long- lived animals. This lipase is a key factor in the lipid hydrolysis and increased longevity that are induced by decreased insulin signaling. These results suggest a link between C. elegans fat metabolism and longevity.	[Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	O'Rourke, Eyleen Jorgelina/AAG-2009-2021; Wang, Meng/F-2951-2019	O'Rourke, Eyleen Jorgelina/0000-0003-0503-4181; Wang, Meng/0000-0002-5898-6007	Life Sciences Research Foundation; Ellison Medical Foundation; Human Frontier Science Program; NIH [5R01AG016636, 5R37AG14161]; NATIONAL INSTITUTE ON AGING [R37AG014161, R01AG016636] Funding Source: NIH RePORTER	Life Sciences Research Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Mak, J. Dittman, and J. Avruch for critical reading of the manuscript; N. Ringstad for laser ablation techniques; V. Rottiers, A. Antebi, and the Caenorhabditis Genetics Center for providing strains; A. Fire for GFP vectors; and members of the Ruvkun lab for discussions. Supported by Life Sciences Research Foundation and Ellison Medical Foundation fellowships (M.C.W.), a Human Frontier Science Program fellowship (E.J.O.), and NIH grants 5R01AG016636 and 5R37AG14161 (G.R.).	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BARTON MK, 1987, GENETICS, V115, P107; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; FRANCIS R, 1995, GENETICS, V139, P607; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; HODGKIN J, 1986, GENETICS, V114, P15; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pepper ASR, 2003, GENETICS, V163, P115; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Tissenbaum HA, 1998, GENETICS, V148, P703; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c	24	273	291	10	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					957	960		10.1126/science.1162011	http://dx.doi.org/10.1126/science.1162011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988854	Green Accepted			2022-12-01	WOS:000260674100051
J	Taylor, P				Taylor, Patrick			Personal genomes: When consent gets in the way	NATURE			English	Editorial Material							PRIVACY RULE; HEALTH		[Taylor, Patrick] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Taylor, Patrick] Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Taylor, P (corresponding author), Harvard Univ, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	patrick.taylor@childrens.harvard.edu						Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA; Breese P, 2005, JAMA-J AM MED ASSOC, V293, P1593, DOI 10.1001/jama.293.13.1593; Churchill LR, 1999, DAEDALUS, V128, P253; Gostin LO, 2002, MINN LAW REV, V86, P1439; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Huang N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-18; Ingelfinger JR, 2004, NEW ENGL J MED, V350, P1452, DOI 10.1056/NEJMe048027; JONAS H, 1969, DAEDALUS, V98, P219; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; MANOS D, HEALTHCARE IT N 1018; Ness RB, 2007, JAMA-J AM MED ASSOC, V298, P2164, DOI 10.1001/jama.298.18.2164; Westin A. E., 2008, PUBLIC VIEWS PRIVACY	13	30	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					32	33		10.1038/456032a	http://dx.doi.org/10.1038/456032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369DH	18987719				2022-12-01	WOS:000260674000024
J	O'Meara, WP; Bejon, P; Mwangi, TW; Okiro, EA; Peshu, N; Snow, RW; Newton, CRJC; Marsh, K				O'Meara, Wendy P.; Bejon, Phillip; Mwangi, Tabitha W.; Okiro, Emelda A.; Peshu, Norbert; Snow, Robert W.; Newton, Charles R. J. C.; Marsh, Kevin			Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya	LANCET			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; INSECTICIDE-TREATED BEDNETS; PROGNOSTIC INDICATORS; CHILDHOOD MALARIA; SEVERE DISEASE; DRUG POLICY; CHILDREN; AGE; INTENSITY; EXPOSURE	Background As efforts to control malaria are expanded across the world, understanding the role of transmission intensity in determining the burden of clinical malaria is crucial to the prediction and measurement of the effectiveness of interventions to reduce transmission. Furthermore, studies comparing several endemic sites led to speculation that as transmission decreases morbidity and mortality caused by severe malaria might increase. We aimed to assess the epidemiological characteristics of malaria in Kilifi, Kenya, during a period of decreasing transmission intensity. Methods We analyse 18 years (1990-2007) of surveillance data from a paediatric ward in a malaria-endemic region of Kenya. The hospital has a catchment area of 250000 people. Clinical data and blood-film results for more than 61000 admissions are reported. Findings Hospital admissions for malaria decreased from 18-43 per 1000 children in 2003 to 3.42 in 2007. Over 18 years of surveillance, the incidence of cerebral malaria initially increased; however, malaria mortality decreased overall because of a decrease in incidence of severe malarial anaemia since 1997 (4.75 to 0.37 per 1000 children) and improved survival among children admitted with non-severe malaria. Parasite prevalence, the mean age of children admitted with malaria, and the proportion of children with cerebral malaria began to change 10 years before hospitalisation for malaria started to fall. Interpretation Sustained reduction in exposure to infection leads to changes in mean age and presentation of disease similar to those described in multisite studies. Changes in transmission might not lead to immediate reductions incidence of clinical disease. However, longitudinal data do not indicate that reductions in transmission intensity lead to transient increases in morbidity and mortality. Funding Wellcome Trust, Kenya Medical Research Institute.	[O'Meara, Wendy P.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Okiro, Emelda A.; Snow, Robert W.] Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Program, Nairobi, Kenya; [Bejon, Phillip; Snow, Robert W.; Marsh, Kevin] Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Newton, Charles R. J. C.] UCL, Inst Child Hlth, London, England; [O'Meara, Wendy P.; Bejon, Phillip; Mwangi, Tabitha W.; Peshu, Norbert; Newton, Charles R. J. C.; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Wellcome Trust Collaborat Program, Kilifi, Kenya	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Kenya Medical Research Institute; University of Oxford; University of London; University College London; Kenya Medical Research Institute	O'Meara, WP (corresponding author), NIH, Fogarty Int Ctr, 16 Ctr Dr, Bethesda, MD 20892 USA.	prudhomw@mail.nih.gov	Snow, Robert William/AFR-1436-2022; Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019	Snow, Robert William/0000-0003-3725-6088; Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Okiro, Emelda/0000-0001-9543-8360	Fogarty International Center; Wellcome Trust	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work is published with the permission of the Director of Kenya Medical Research Institute. We wish to thank all the clinical, field, and laboratory staff at the Kenya Medical Research Institute-Wellcome Must Programme who made this study possible. WPO is funded by the Fogarty International Center. CRJCN is funded by the Wellcome Trust. RWS is a Wellcome Trust Principal Research Fellow (#079080).	Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Graves PM, 2008, TROP MED INT HEALTH, V13, P218, DOI 10.1111/j.1365-3156.2007.01993.x; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MBOGO CNM, 1995, AM J TROP MED HYG, V52, P201, DOI 10.4269/ajtmh.1995.52.201; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; MOLYNEUX ME, 1989, Q J MED, V71, P441; Mwangi TW, 2003, T ROY SOC TROP MED H, V97, P369, DOI 10.1016/S0035-9203(03)90056-3; MWANGI TW, 2003, CLIN EPIDEMIOLOGY MA; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; SNOW RW, 1995, PARASITOL TODAY, V11, P188, DOI 10.1016/0169-4758(95)80156-1; SNOW RW, 1992, T ROY SOC TROP MED H, V86, P237, DOI 10.1016/0035-9203(92)90290-S; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6	38	322	323	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1555	1562		10.1016/S0140-6736(08)61655-4	http://dx.doi.org/10.1016/S0140-6736(08)61655-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984188	Green Published			2022-12-01	WOS:000260590500027
J	Chou, YF; Chen, HH; Eijpe, M; Yabuuchi, A; Chenoweth, JG; Tesar, P; Lu, J; McKay, RDG; Geijsen, N				Chou, Yu-Fen; Chen, Hsu-Hsin; Eijpe, Maureen; Yabuuchi, Akiko; Chenoweth, Joshua G.; Tesar, Paul; Lu, Jun; Mckay, Ronald D. G.; Geijsen, Niels			The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells	CELL			English	Article							PRIMORDIAL GERM-CELLS; E-CADHERIN; REGULATORY CIRCUITRY; SELF-RENEWAL; FREE CULTURE; LINES; DIFFERENTIATION; GENERATION; FIBROBLASTS; DERIVATION	Pluripotent stem cell lines can be derived from blastocyst embryos, which yield embryonic stem cell lines (ES cells), as well as the postimplantation epiblast, which gives rise to epiblast stem cell lines (EpiSCs). Remarkably, ES cells and EpiSCs display profound differences in the combination of growth factors that maintain their pluripotent state. Molecular and functional differences between these two stem cell types demonstrate that the tissue of origin and/or the growth factor milieu may be important determinants of the stem cell identity. We explored how developmental stage of the tissue of origin and culture growth factor conditions affect the stem cell pluripotent state. Our findings indicate that novel stem cell lines, with unique functional and molecular properties, can be generated from murine blastocyst embryos. We demonstrate that the culture growth factor environment and cell-cell interaction play a critical role in defining several unique and stable stem cell ground states.	[Chou, Yu-Fen; Chen, Hsu-Hsin; Geijsen, Niels] Massachusetts Gen Hosp, Harvard Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; [Eijpe, Maureen] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Yabuuchi, Akiko] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Chenoweth, Joshua G.; Mckay, Ronald D. G.] Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Tesar, Paul] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Lu, Jun] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; [Lu, Jun] MIT, Cambridge, MA 02141 USA	Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Case Western Reserve University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Geijsen, N (corresponding author), Massachusetts Gen Hosp, Harvard Stem Cell Inst, Ctr Regenerat Med, CPZN-4256,185 Cambridge St, Boston, MA 02114 USA.	ngeijsen@mgh.harvard.edu	Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155	National Institutes of Health [RO1HD048769-01A1]; Harvard Stem Cell Institute; Dutch Cancer Society (Koningin Wilhelmina Fonds); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Dutch Cancer Society (Koningin Wilhelmina Fonds)(KWF Kankerbestrijding); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. George Daley for his review of our manuscript and help with the blastocyst injections; Dr. Paul Tesar for the EpiSC image; Dr. Roger Tsien for the use of the tdTomato fluorescent reporter; Dr. Keith Orford for critical review of the manuscript; Kelly Shea for providing technical support; and Laura Prickett and Kat Folz-Donahue at the HSCI/MGH Flow Cytometry Core Facility for help with cell purifications. This work was supported by grants from the National Institutes of Health (RO1HD048769-01A1) and the Harvard Stem Cell Institute. M. E. was supported by the Dutch Cancer Society (Koningin Wilhelmina Fonds).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Denning C, 2006, INT J DEV BIOL, V50, P27, DOI 10.1387/ijdb.052107cd; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GIBRALTER D, 1985, DEV BIOL, V112, P292, DOI 10.1016/0012-1606(85)90400-2; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kan NG, 2007, DEVELOPMENT, V134, P31, DOI 10.1242/dev.02722; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Larue L, 1996, DEVELOPMENT, V122, P3185; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Rathjen J, 1999, J CELL SCI, V112, P601; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	56	171	188	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					449	461		10.1016/j.cell.2008.08.035	http://dx.doi.org/10.1016/j.cell.2008.08.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984157	Bronze, Green Accepted			2022-12-01	WOS:000260536300016
J	Geschwind, DH				Geschwind, Daniel H.			Autism: Many Genes, Common Pathways?	CELL			English	Article							SPECTRUM DISORDERS; CHROMOSOMAL REARRANGEMENTS; PATERNAL AGE; LINKAGE; CONTACTIN-ASSOCIATED-PROTEIN-LIKE-2; TRANSCRIPTION; ASSOCIATION; CNTNAP2; VARIANT; RISK	Autism is a heterogeneous neurodevelopmental syndrome with a complex genetic etiology. It is still not clear whether autism comprises a vast collection of different disorders akin to intellectual disability or a few disorders sharing common aberrant pathways. Unifying principles among cases of autism are likely to be at the level of brain circuitry in addition to molecular pathways.	Univ Calif Los Angeles, David Geffen Sch Med, Neurogenet Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Neurogenet Program, Los Angeles, CA 90095 USA.	dhg@ucla.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH068172, R37MH060233, R01MH064547] Funding Source: NIH RePORTER; NICHD NIH HHS [P50 HD055784] Funding Source: Medline; NIMH NIH HHS [U54 MH68172, U54 MH068172, R01 MH64547, R37 MH060233-08, R37 MH060233, R01 MH064547, R37 MH60233] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; ABRAHAMS BS, 2008, NAT REV GENET, V9, P493; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Benayed R, 2005, AM J HUM GENET, V77, P851, DOI 10.1086/497705; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Cantor RM, 2007, MOL PSYCHIATR, V12, P419, DOI 10.1038/sj.mp.4001966; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	26	225	233	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					391	395		10.1016/j.cell.2008.10.016	http://dx.doi.org/10.1016/j.cell.2008.10.016			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984147	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000260536300006
J	Zacho, J; Tybjaerg-Hansen, A; Jensen, JS; Grande, P; Sillesen, H; Nordestgaard, BG				Zacho, Jeppe; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Grande, Peer; Sillesen, Henrik; Nordestgaard, Borge G.			Genetically elevated C-reactive protein and ischemic vascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; CRP GENE POLYMORPHISMS; MENDELIAN RANDOMIZATION; CARDIOVASCULAR EVENTS; SERUM CRP; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; REGRESSION DILUTION; PROMOTER REGION	Background: Elevated levels of C-reactive protein (CRP) are associated with increased risks of ischemic heart disease and ischemic cerebrovascular disease. We tested whether this is a causal association. Methods: We studied 10,276 persons from a general population cohort, including 1786 in whom ischemic heart disease developed and 741 in whom ischemic cerebrovascular disease developed. We examined another 31,992 persons from a cross-sectional general population study, of whom 2521 had ischemic heart disease and 1483 had ischemic cerebrovascular disease. Finally, we compared 2238 patients with ischemic heart disease with 4474 control subjects and 612 patients with ischemic cerebrovascular disease with 1224 control subjects. We measured levels of high-sensitivity CRP and conducted genotyping for four CRP polymorphisms and two apolipoprotein E polymorphisms. Results: The risk of ischemic heart disease and ischemic cerebrovascular disease was increased by a factor of 1.6 and 1.3, respectively, in persons who had CRP levels above 3 mg per liter, as compared with persons who had CRP levels below 1 mg per liter. Genotype combinations of the four CRP polymorphisms were associated with an increase in CRP levels of up to 64%, resulting in a theoretically predicted increased risk of up to 32% for ischemic heart disease and up to 25% for ischemic cerebrovascular disease. However, these genotype combinations were not associated with an increased risk of ischemic vascular disease. In contrast, apolipoprotein E genotypes were associated with both elevated cholesterol levels and an increased risk of ischemic heart disease. Conclusions: Polymorphisms in the CRP gene are associated with marked increases in CRP levels and thus with a theoretically predicted increase in the risk of ischemic vascular disease. However, these polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease.	[Zacho, Jeppe; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Clin Biochem,Herlev Hosp, DK-2730 Herlev, Denmark; [Zacho, Jeppe; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Copenhagen Gen Populat Study,Herlev Hosp, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Clin Biochem, DK-2730 Herlev, Denmark; [Grande, Peer] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Cardiol, DK-2730 Herlev, Denmark; [Sillesen, Henrik] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Vasc Surg, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Copenhagen City Heart Study,Bispebjerg Hosp, DK-2730 Herlev, Denmark; [Jensen, Jan Skov] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Cardiol,Gentofte Hosp, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Clin Biochem,Herlev Hosp, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Sillesen, Henrik/ABB-5668-2020; Nordestgaard, Borge Gronne/ABF-1310-2020		Danish Heart Foundation; BG Medicine; AstraZeneca; Sanofi-Aventis; Merck; Pfizer; Boehringer Ingelheim	Danish Heart Foundation; BG Medicine; AstraZeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); Merck(Merck & Company); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim)	Supported by the Danish Heart Foundation. Dr. Nordestgaard reports receiving consulting fees from BG Medicine and AstraZeneca and lecture fees from AstraZeneca, Sanofi-Aventis, Merck, Pfizer, and Boehringer Ingelheim; Dr. Sillesen, consulting fees from Merck, Pfizer, BG Medicine, Boehringer Ingelheim, Sanofi-Aventis, and AstraZeneca; Dr. Grande, consulting fees from AstraZeneca; and Dr. Tybjaerg-Hansen, lecture fees from Pfizer and Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.; We thank Hanne Damm, Dorthe Uldall Andersen, and Dorthe Kjeldgaard Hansen for their assistance with the large-scale genotyping and the staff and participants of the Copenhagen City Heart Study, the Copenhagen General Population Study, the Copenhagen Ischemic Heart Disese Study, and the Copenhagen Carotid Stroke Study for their important contributions to our study.	AgerholmLarsen B, 1997, ANN INTERN MED, V127, P346, DOI 10.7326/0003-4819-127-5-199709010-00002; Balistreri CR, 2006, ANN NY ACAD SCI, V1067, P276, DOI 10.1196/annals.1354.036; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bis JC, 2008, ATHEROSCLEROSIS, V198, P166, DOI 10.1016/j.atherosclerosis.2007.09.031; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Everett BM, 2006, J AM COLL CARDIOL, V48, P2235, DOI 10.1016/j.jacc.2006.09.030; Flex A, 2004, STROKE, V35, P2270, DOI 10.1161/01.STR.0000140740.19421.fe; Frikke-Schmidt R, 2000, J AM COLL CARDIOL, V35, P1192, DOI 10.1016/S0735-1097(00)00520-9; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Klein, 2003, SURVIVAL ANAL TECHNI, P295, DOI [10.1007/b97377, DOI 10.1007/B97377]; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Ladenvall C, 2006, STROKE, V37, P2018, DOI 10.1161/01.STR.0000231872.86071.68; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lowe Gordon D O, 2006, Curr Atheroscler Rep, V8, P421, DOI 10.1007/s11883-006-0040-x; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Reitz C, 2007, STROKE, V38, P2356, DOI 10.1161/STROKEAHA.107.482661; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Sattar N, 2007, CIRCULATION, V115, P981, DOI 10.1161/CIRCULATIONAHA.106.643114; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Szalai AJ, 2005, RHEUMATOLOGY, V44, P864, DOI 10.1093/rheumatology/keh613; Wang QW, 2006, AM J PHYSIOL-HEART C, V291, pH2752, DOI 10.1152/ajpheart.01164.2005; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	36	624	647	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1897	1908		10.1056/NEJMoa0707402	http://dx.doi.org/10.1056/NEJMoa0707402			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971492				2022-12-01	WOS:000260454500006
J	Hammond, P				Hammond, Phil			(Not) warts and all	BRITISH MEDICAL JOURNAL			English	Editorial Material												hamm82@msn.com						2008, SEXUALLY TRANSMITTED, V84, P251, DOI DOI 10.1136/STI.2008.032755	1	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a2186	10.1136/bmj.a2186	http://dx.doi.org/10.1136/bmj.a2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18948345				2022-12-01	WOS:000260298800050
J	Kraft, NJB; Valencia, R; Ackerly, DD				Kraft, Nathan J. B.; Valencia, Renato; Ackerly, David D.			Functional traits and niche-based tree community assembly in an amazonian forest	SCIENCE			English	Article							DISTRIBUTIONS; STRATEGIES; HERBIVORES; MECHANISMS; DIVERSITY	It is debated whether species-level differences in ecological strategy, which play a key role in much of coexistence theory, are important in structuring highly diverse communities. We examined the co-occurrence patterns of over 1100 tree species in a 25-hectare Amazonian forest plot in relation to field-measured functional traits. Using a null model approach, we show that co-occurring trees are often less ecologically similar than a niche-free (neutral) model predicts. Furthermore, we find evidence for processes that simultaneously drive convergence and divergence in key aspects of plant strategy, suggesting that at least two distinct niche-based processes are occurring. Our results show that strategy differentiation among species contributes to the maintenance of diversity in one of the most diverse tropical forests in the world.	[Kraft, Nathan J. B.; Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Valencia, Renato] Pontificia Univ Catolica Ecuador, Lab Ecol Plantas, Escuela Ciencias Biol, Quito, Ecuador	University of California System; University of California Berkeley; Pontificia Universidad Catolica del Ecuador	Kraft, NJB (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.		Kraft, Nathan J. B./A-2817-2012; Ackerly, David/A-1247-2009	Kraft, Nathan J. B./0000-0001-8867-7806; Ackerly, David/0000-0002-1847-7398; Valencia, Renato/0000-0001-9770-6568	Center for Tropical Forest Science; University of California, Berkeley; Department of Integrative Biology; NSF [DEB-614525, DEB-614055, DEB-614659]	Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of California, Berkeley(University of California System); Department of Integrative Biology; NSF(National Science Foundation (NSF))	N.I.B.K. is grateful to A. Martin, L. Williams, P. Avia, and L. Dunn for field assistance and to A. Thompson, T. Aftandilians, and M. Piven for help with sample analysis. Leaf trait collection was supported by the Center for Tropical Forest Science and the University of California, Berkeley, Department of Integrative Biology. We benefited from interactions with R. Condit, W. Cornwell, P. Fine, S. Kembel, J. Lake, M. Metz, N. Swenson, and four anonymous reviewers. S. J. Wright and N. Gat-wood generously provided unpublished seed data front collection efforts supported by NSF grants DEB-614525, DEB-614055, and DEB-614659. R.V. thanks the government of Ecuador (Donaciones de Impuesto a la Rento 2004-2006), Pontificia Universidad Catolica del Ecuador, the Mellon Foundation, the Tapper Family Foundation, the Smithsonian Tropical Research Institute, and NSF (grants DEB-0090311 and DEB-9806828) for support of the forest census. This research was possible because of the kind permission of the Ministerio del Ambiente of Ecuador.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Chase J.M., 2003, ECOLOGICAL NICHES LI; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; CORNWELL WK, ECOL MONOGR IN PRESS, DOI DOI 10.1890/07-1134.A; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; TURNER IM, 2001, CAM TROP B, P1; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Weiher E., 1999, ECOLOGICAL ASSEMBLY; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	27	766	847	26	647	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					580	582		10.1126/science.1160662	http://dx.doi.org/10.1126/science.1160662			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948539				2022-12-01	WOS:000260299100041
J	Disson, O; Grayo, S; Huillet, E; Nikitas, G; Langa-Vives, F; Dussurget, O; Ragon, M; Le Monnier, A; Babinet, C; Cossart, P; Lecuit, M				Disson, Olivier; Grayo, Solene; Huillet, Eugenie; Nikitas, Georgios; Langa-Vives, Francina; Dussurget, Olivier; Ragon, Marie; Le Monnier, Alban; Babinet, Charles; Cossart, Pascale; Lecuit, Marc			Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis	NATURE			English	Article							SURFACE PROTEIN; E-CADHERIN; MONOCYTOGENES; INTERNALIN; RECEPTOR; ENTRY; MODEL; INIB; SUFFICIENT; PREGNANCY	The ability to cross host barriers is an essential virulence determinant of invasive microbial pathogens. Listeria monocytogenes is a model microorganism that crosses human intestinal and placental barriers, and causes severe maternofetal infections by an unknown mechanism(1). Several studies have helped to characterize the bacterial invasion proteins InlA and InlB(2). However, their respective species specificity has complicated investigations on their in vivo role(3,4). Here we describe two novel and complementary animal models for human listeriosis: the gerbil, a natural host for L. monocytogenes, and a knock- in mouse line ubiquitously expressing humanized E- cadherin. Using these two models, we uncover the essential and interdependent roles of InlA and InlB in fetoplacental listeriosis, and thereby decipher the molecular mechanism underlying the ability of a microbe to target and cross the placental barrier.	[Disson, Olivier; Grayo, Solene; Huillet, Eugenie; Nikitas, Georgios; Dussurget, Olivier; Cossart, Pascale; Lecuit, Marc] Inst Pasteur, Grp Microorganismes & Barrieres Hote, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Disson, Olivier; Grayo, Solene; Nikitas, Georgios; Lecuit, Marc] Inserm Avenir, U604, F-75015 Paris, France; [Grayo, Solene; Ragon, Marie; Le Monnier, Alban; Lecuit, Marc] Inst Pasteur, Ctr Natl Reference Listeria, F-75015 Paris, France; [Huillet, Eugenie; Dussurget, Olivier; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Huillet, Eugenie; Dussurget, Olivier; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Langa-Vives, Francina] Inst Pasteur, Ctr Ingn Genet Murine, F-75015 Paris, France; [Babinet, Charles] Inst Pasteur, Dev Biol Unit, F-75015 Paris, France; [Lecuit, Marc] Univ Paris 05, Ctr Infectiol Necker Pasteur, Serv Malad Infect & Trop, Hop Necker Enfants Malad,Assistance Publ Hop Pari, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lecuit, M (corresponding author), Inst Pasteur, Grp Microorganismes & Barrieres Hote, Unite Interact Bacteries Cellules, F-75015 Paris, France.	mlecuit@pasteur.fr	Lecuit, Marc/J-4073-2013; Disson, Olivier/H-6359-2016; Lecuit, Marc/M-4126-2019; Disson, Olivier/P-9935-2019	Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Disson, Olivier/0000-0002-7791-9782; Dussurget, Olivier/0000-0001-9924-0837; LE MONNIER, Alban/0000-0001-6181-281X	Institut Pasteur, Inserm; INRA; Fondation pour la Recherche Medicale; Howard Hughes Medical Institute international research scholar	Institut Pasteur, Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); INRA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Howard Hughes Medical Institute international research scholar(Howard Hughes Medical Institute)	This paper is dedicated to the memory of Charles Babinet, our friend and colleague, who died a few days before the submission of thismanuscript. We thank his collaborators S. Vandormael- Pournin, C. Kress and M. Cohen- Tannoudji, as well as L. Larue and S. Tajbakhsh for help in generating the knock- in mice. We thank C. Hill for the gift of the pPL2lux- P<INF>hlyA</INF> plasmid, M.-A. Nahori for help with animal experiments, P. Roux for help with confocal imaging, P.- M. Lledo and M. Gabellec for help with vibratome sectioning, V. Masse for help with statistical analysis and O. Lortholary for his support. We also thank S. Mostowy for reading the paper. This work received financial support from the Institut Pasteur, Inserm and INRA. O. Disson received financial support from the Fondation pour la Recherche Medicale (FRM) and Inserm, P.C. is an Howard Hughes Medical Institute international research scholar and M.L. is a recipient of an Inserm interface contract.	Abram M, 2003, FEMS IMMUNOL MED MIC, V35, P177, DOI 10.1016/S0928-8244(02)00449-2; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Bierne H, 2002, J CELL SCI, V115, P3357; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Dramsi S, 1998, INFECT IMMUN, V66, P4461; Glaser P, 2001, SCIENCE, V294, P849; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Khelef N, 2006, CELL MICROBIOL, V8, P457, DOI 10.1111/j.1462-5822.2005.00634.x; Le Monnier A, 2007, INFECT IMMUN, V75, P950, DOI 10.1128/IAI.01570-06; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 2002, TRENDS MOL MED, V8, P537, DOI 10.1016/S1471-4914(02)02413-9; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Perez-Garcia CC, 2003, LAB ANIM-UK, V37, P68, DOI 10.1258/002367703762226719; Pirie JHH., 1927, PUBLICATIONS S AFRIC, V3, P163; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001	30	184	190	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1114	1118		10.1038/nature07303	http://dx.doi.org/10.1038/nature07303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806773				2022-12-01	WOS:000260252600046
J	Goodyear, LJ				Goodyear, Laurie J.			The exercise pill - Too good to be true?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHRONIC ACTIVATION; GLYCOGEN; MUSCLE		[Goodyear, Laurie J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Goodyear, Laurie J.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Goodyear, LJ (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.							Barre L, 2007, AM J PHYSIOL-ENDOC M, V292, pE802, DOI 10.1152/ajpendo.00369.2006; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Leff T, 2003, BIOCHEM SOC T, V31, P224; Musi Nicolas, 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P119; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051	5	76	81	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1842	1844		10.1056/NEJMcibr0806723	http://dx.doi.org/10.1056/NEJMcibr0806723			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946072				2022-12-01	WOS:000260245800015
J	Zheng, HW; Ying, HQ; Yan, HY; Kimmelman, AC; Hiller, DJ; Chen, AJ; Perry, SR; Tonon, G; Chu, GC; Ding, ZH; Stommel, JM; Dunn, KL; Wiedemeyer, R; You, MJJ; Brennan, C; Wang, YA; Ligon, KL; Wong, WH; Chin, L; DePinho, RA				Zheng, Hongwu; Ying, Haoqiang; Yan, Haiyan; Kimmelman, Alec C.; Hiller, David J.; Chen, An-Jou; Perry, Samuel R.; Tonon, Giovanni; Chu, Gerald C.; Ding, Zhihu; Stommel, Jayne M.; Dunn, Katherine L.; Wiedemeyer, Ruprecht; You, Mingjian J.; Brennan, Cameron; Wang, Y. Alan; Ligon, Keith L.; Wong, Wing H.; Chin, Lynda; DePinho, Ronald A.			p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation	NATURE			English	Article							CANCER STEM-CELLS; SELF-RENEWAL; INITIATING CELLS; C-MYC; TUMORS; GLIOBLASTOMA; EXPRESSION; RECEPTOR; PATHWAYS; BIOLOGY	Glioblastoma ( GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF ( also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low- grade disease that classically possesses PDGF and TP53 events(1-3). Here we show that concomitant central nervous system (CNS)- specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute- onset high- grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells ( NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/ promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/ progenitor cell differentiation, self- renewal and tumorigenic potential.	[Zheng, Hongwu; Ying, Haoqiang; Yan, Haiyan; Kimmelman, Alec C.; Chen, An-Jou; Perry, Samuel R.; Tonon, Giovanni; Chu, Gerald C.; Ding, Zhihu; Stommel, Jayne M.; Dunn, Katherine L.; Wiedemeyer, Ruprecht; You, Mingjian J.; Wang, Y. Alan; Ligon, Keith L.; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Perry, Samuel R.; Chu, Gerald C.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Ctr Appl Canc Sci, Belfer Fdn Inst Innovat Canc Sci, Boston, MA 02115 USA; [Ligon, Keith L.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Kimmelman, Alec C.] Harvard Univ, Sch Med, Harvard Radiat Oncol Program, Boston, MA 02115 USA; [Chu, Gerald C.; Ligon, Keith L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.] Harvard Univ, Sch Med, Div Neuropathol, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hiller, David J.; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Brennan, Cameron] Weill Cornell Med Coll, Dept Neurosurg, New York, NY 10065 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Tonon, Giovanni/J-9804-2018; Ying, Haoqiang/AAK-4325-2020; Brennan, Cameron/R-7082-2019; Stommel, Jayne M/M-3439-2017	Tonon, Giovanni/0000-0003-2973-5038; Brennan, Cameron/0000-0003-4064-8891; DePinho, Ronald/0000-0002-5625-577X; Zheng, Hongwu/0000-0002-5823-4913	Helen Hay Whitney Foundation; Marsha Mae Moeslein Fellowship; American Brain Tumor Association; Leonard B. Holman Research Pathway Fellowship; Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award Fellowship; Mildred Scheel Fellowship (Deutsche Krebshilfe); Goldhirsh Foundation; NIH [U01 CA84313, RO1CA99041, 5P01CA95616]; Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science; NATIONAL CANCER INSTITUTE [P01CA095616, U01CA084313, R01CA099041] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Marsha Mae Moeslein Fellowship; American Brain Tumor Association; Leonard B. Holman Research Pathway Fellowship; Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mildred Scheel Fellowship (Deutsche Krebshilfe)(Deutsche Krebshilfe); Goldhirsh Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Berns for providing p53 L mice; S. Zhou and S. Jiang for mouse husbandry and care; R. T. Bronson for discussion on pathology analysis; K. Montgomery for discussion on sequencing; and Y.- H. Xiao, B. Feng and J. Zhang for bioinformatic help. H. Z. was supported by Helen Hay Whitney Foundation. H. Ying is a recipient of the Marsha Mae Moeslein Fellowship from the American Brain Tumor Association. A. C. K. is a recipient of the Leonard B. Holman Research Pathway Fellowship. Z. D. is supported by the Damon Runyon Cancer Research Foundation. J. M. S. is supported by a Ruth L. Kirschstein National Research Service Award Fellowship. R. W. is supported by a Mildred Scheel Fellowship ( Deutsche Krebshilfe). Grant support comes from the Goldhirsh Foundation (R.A.D.), and NIH grants U01 CA84313 (R.A.D.), RO1CA99041 ( L. C.) and 5P01CA95616 (R.A.D., L.C., W.H.W., C.B. and K.L.L.). R.A.D. is an American Cancer Society Research Professor supported by the Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science.	Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Fukushima T, 2006, J NEUROPATH EXP NEUR, V65, P12, DOI 10.1097/01.jnen.0000196132.66464.96; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Louis D. N., 2007, WHO CLASSIFICATION T; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	35	533	546	4	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1129	U13		10.1038/nature07443	http://dx.doi.org/10.1038/nature07443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948956	Green Accepted, Green Submitted			2022-12-01	WOS:000260252600049
J	Kunkes, EL; Simonetti, DA; West, RM; Serrano-Ruiz, JC; Gartner, CA; Dumesic, JA				Kunkes, Edward L.; Simonetti, Dante A.; West, Ryan M.; Serrano-Ruiz, Juan Carlos; Gartner, Christian A.; Dumesic, James A.			Catalytic conversion of biomass to monofunctional hydrocarbons and targeted liquid-fuel classes	SCIENCE			English	Article							ALKANES; HYDROGENATION; CONDENSATION; METAL; REDUCTION; ETHANOL; MIBK	It is imperative to develop more efficient processes for conversion of biomass to liquid fuels, such that the cost of these fuels would be competitive with the cost of fuels derived from petroleum. We report a catalytic approach for the conversion of carbohydrates to specific classes of hydrocarbons for use as liquid transportation fuels, based on the integration of several flow reactors operated in a cascade mode, where the effluent from the one reactor is simply fed to the next reactor. This approach can be tuned for production of branched hydrocarbons and aromatic compounds in gasoline, or longer-chain, less highly branched hydrocarbons in diesel and jet fuels. The liquid organic effluent from the first flow reactor contains monofunctional compounds, such as alcohols, ketones, carboxylic acids, and heterocycles, that can also be used to provide reactive intermediates for fine chemicals and polymers markets.	[Kunkes, Edward L.; Simonetti, Dante A.; West, Ryan M.; Serrano-Ruiz, Juan Carlos; Gartner, Christian A.; Dumesic, James A.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Gaertner, Christian/A-7509-2011; Serrano-Ruiz, Juan Carlos/U-6297-2018	Serrano-Ruiz, Juan Carlos/0000-0002-9078-7390	U.S. Department of Energy Office of Basic Energy Sciences; NSF Chemical and Transport Systems Division of the Directorate for Engineering; German Academic Exchange Service (DAAD); Spanish Ministry of Science and Innovation	U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF Chemical and Transport Systems Division of the Directorate for Engineering(National Science Foundation (NSF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the U.S. Department of Energy Office of Basic Energy Sciences and the NSF Chemical and Transport Systems Division of the Directorate for Engineering. We thank M. Mavrikakis for valuable discussions throughout this project, and E.I. Gurbuz for help with flow reactor experiments. J.C.S.-R. thanks the Spanish Ministry of Science and Innovation for postdoctoral support; C.A.G. thanks the German Academic Exchange Service (DAAD) for a scholarship. J.A.D. owns founders stock in Virent Energy Systems, a company with interest in the area of this research. The Wisconsin Alumni Research Foundation at University of Wisconsin has applied for a patent based partly on the work described here.	Alcala R, 2003, J CATAL, V218, P178, DOI 10.1016/S0021-9517(03)00090-3; Barlow M. T., 1983, Fuel composition. Eur. Pat., Patent No. [EP0082689, 0082689]; BARRATT DJ, 1999, Patent No. 5925152; Bartholomew CH, 2006, FUNDAMENTALS OF INDUSTRIAL CATALYTIC PROCESSES, 2ND EDITION, P1, DOI 10.1002/9780471730071; BOND GC, 1965, J CATAL, V4, P211, DOI 10.1016/0021-9517(65)90011-4; BRIDGWATER AV, 1994, APPL CATAL A-GEN, V116, P5, DOI 10.1016/0926-860X(94)80278-5; Carlini C, 2004, J MOL CATAL A-CHEM, V220, P215, DOI 10.1016/j.molcata.2004.05.034; Cho CS, 2005, J MOL CATAL A-CHEM, V240, P55, DOI 10.1016/j.molcata.2005.06.043; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Davda RR, 2005, APPL CATAL B-ENVIRON, V56, P171, DOI 10.1016/j.apcatb.2004.04.027; Di Cosimo JI, 2002, J CATAL, V208, P114, DOI 10.1006/jcat.2002.3551; Gayubo AG, 2004, IND ENG CHEM RES, V43, P2610, DOI 10.1021/ie030791o; Hamelinck CN, 2004, ENERGY, V29, P1743, DOI 10.1016/j.energy.2004.01.002; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Klass D. L., 1998, BIOMASS RENEWABLE EN, DOI DOI 10.1016/B978-0-12-410950-6.X5000-4; Lopez J, 2002, J CATAL, V208, P30, DOI 10.1006/jcat.2002.3563; MCMURRY J, 2000, ORGANIC CHEM, P938; Nagashima O, 2005, J MOL CATAL A-CHEM, V227, P231, DOI 10.1016/j.molcata.2004.10.042; Nikolopoulos AA, 2005, APPL CATAL A-GEN, V296, P128, DOI 10.1016/j.apcata.2005.08.022; Pallassana V, 2002, J CATAL, V209, P289, DOI 10.1006/jcat.2002.3585; Perrard A, 2007, APPL CATAL A-GEN, V331, P100, DOI 10.1016/j.apcata.2007.07.033; POWELL SG, 1948, J AM CHEM SOC, V70, P3627, DOI 10.1021/ja01191a027; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; TAKIZAWA TH, 1994, Patent No. 5925152; West RM, 2008, CHEMSUSCHEM, V1, P417, DOI 10.1002/cssc.200800001; Zhang JL, 2005, J AM CHEM SOC, V127, P12480, DOI 10.1021/ja053695i	28	762	831	20	595	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					417	421		10.1126/science.1159210	http://dx.doi.org/10.1126/science.1159210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18801970				2022-12-01	WOS:000260094500040
J	Mathew-Fenn, RS; Das, R; Harbury, PAB				Mathew-Fenn, Rebecca S.; Das, Rhiju; Harbury, Pehr A. B.			Remeasuring the double helix	SCIENCE			English	Article							PROTEIN-DNA COMPLEXES; OPTICAL TWEEZERS; NUCLEIC-ACIDS; STRANDED-DNA; SINGLE; DISTANCES; FLUCTUATIONS; TRANSITIONS; ELASTICITY; MICROSCOPY	DNA is thought to behave as a stiff elastic rod with respect to the ubiquitous mechanical deformations inherent to its biology. To test this model at short DNA lengths, we measured the mean and variance of end-to-end length for a series of DNA double helices in solution, using small-angle x-ray scattering interference between gold nanocrystal labels. In the absence of applied tension, DNA is at least one order of magnitude softer than measured by single-molecule stretching experiments. Further, the data rule out the conventional elastic rod model. The variance in end-to-end length follows a quadratic dependence on the number of base pairs rather than the expected linear dependence, indicating that DNA stretching is cooperative over more than two turns of the DNA double helix. Our observations support the idea of long-range allosteric communication through DNA structure.	[Mathew-Fenn, Rebecca S.; Harbury, Pehr A. B.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Mathew-Fenn, Rebecca S.; Das, Rhiju; Harbury, Pehr A. B.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Harbury, PAB (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	harbury@cmgm.stanford.edu		Das, Rhiju/0000-0001-7497-0972	NIH [GM068126-01, DP OD000429-01]; NSF; U.S. Department of Energy [W-31-109 Eng-438]; Stanford Synchrotron Radiation Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Stanford Synchrotron Radiation Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C.J. Ackerson for discussions on nanocrystal synthesis; R.L. Baldwin, F.E. Boas, Z.D. Bryant, L.S. Churchman, A.R. Dunn, D.R. Halpin, D. Herschlag, W.L. Martin, B.H. Robinson, J.M. Schurr, A.L. Smith, R.M. Weisinger, and S.J. Wrenn for insights into DNA; Y. Bai, S. Doniach, K. Ito, J. Lipfert, I. S. Millett, S. Seifert, P. Thiyagarajan and H. Tsuruta for assistance and advice on x-ray scattering; T.D. Fenn for writing code that was used to calculate crystallographic dispersion values and for valuable discussions throughout this work; P.A. Walker for expert assistance with DNA synthesis; and P. Bradley and D. Baker for permitting use of unpublished code to prepare Fig. 4. Supported by NIH grants GM068126-01 and DP OD000429-01 (P.A.B.H.), an NIH training grant fellowship (R.S.F.), an NSF graduate fellowship (R.D.), and the U.S. Department of Energy (contract W-31-109 Eng-438 to the Advanced Photon Source, and support of Stanford Synchrotron Radiation Laboratory).	Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Cai Q, 2006, NUCLEIC ACIDS RES, V34, P4722, DOI 10.1093/nar/gkl546; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974; GRIFFITH JD, 1978, SCIENCE, V201, P525, DOI 10.1126/science.663672; HARBURY PAB, 2008, PLOS 1, V3, pE3329; Hillisch A, 2001, CURR OPIN STRUC BIOL, V11, P201, DOI 10.1016/S0959-440X(00)00190-1; Kosikov KM, 1999, J MOL BIOL, V289, P1301, DOI 10.1006/jmbi.1999.2798; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Liu YX, 2001, J BIOMOL STRUCT DYN, V18, P505, DOI 10.1080/07391102.2001.10506684; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Sakata-Sogawa K, 1998, EUR BIOPHYS J BIOPHY, V27, P55, DOI 10.1007/s002490050110; Schurr JM, 2000, BIOPOLYMERS, V54, P561, DOI 10.1002/1097-0282(200012)54:7<561::AID-BIP80>3.0.CO;2-M; Schurr JM, 1997, BIOPOLYMERS, V44, P283, DOI 10.1002/(SICI)1097-0282(1997)44:3<283::AID-BIP7>3.0.CO;2-R; SHORE D, 1983, J MOL BIOL, V170, P983, DOI 10.1016/S0022-2836(83)80199-5; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; Ulyanov NB, 1995, METHOD ENZYMOL, V261, P90; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Zhu PZ, 2005, BIOPHYS J, V89, pL37, DOI 10.1529/biophysj.105.071027; ZIMMERMAN SB, 1979, J MOL BIOL, V135, P1023, DOI 10.1016/0022-2836(79)90526-6	31	167	168	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					446	449		10.1126/science.1158881	http://dx.doi.org/10.1126/science.1158881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927394	Green Accepted			2022-12-01	WOS:000260094500048
J	Oard, DW				Oard, Douglas W.			Social science - Unlocking the potential of the spoken word	SCIENCE			English	Editorial Material									[Oard, Douglas W.] Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA; [Oard, Douglas W.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Oard, DW (corresponding author), Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA.	oard@umd.edu						Bell G, 2007, SCI AM, V296, P58, DOI 10.1038/scientificamerican0307-58; HACKFORD R, 1952, PLATOS PHAEDRUS; HOOKER FJ, 1996, READING PAST ANCIENT; Lieberman P, 2007, CURR ANTHROPOL, V48, P39, DOI 10.1086/509092; LIN WH, 2002, JOINT C DIG LIB JCDL; ROSEN J, 2008, NY TIMES        0327	6	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1787	1788		10.1126/science.1157353	http://dx.doi.org/10.1126/science.1157353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818348				2022-12-01	WOS:000259501300024
J	Morris, EJ; Ji, JY; Yang, FJ; Di Stefano, L; Herr, A; Moon, NS; Kwon, EJ; Haigis, KM; Naar, AM; Dyson, NJ				Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Kwon, Eun-Jeong; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.			E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8	NATURE			English	Article							COLON-CANCER; EXPRESSION; ACTIVATION; PROTEIN; GENE; APC; P53; SPECIFICITY; DROSOPHILA; MEDIATOR	The E2F1 transcription factor can promote proliferation or apoptosis when activated, and is a key downstream target of the retinoblastoma tumour suppressor protein ( pRB). Here we show that E2F1 is a potent and specific inhibitor of beta-catenin/T-cell factor (TCF)- dependent transcription, and that this function contributes to E2F1- induced apoptosis. E2F1 deregulation suppresses beta-catenin activity in an adenomatous polyposis coli ( APC)/glycogen synthase kinase- 3 ( GSK3)- independent manner, reducing the expression of key beta-catenin targets including c- MYC. This interaction explains why colorectal tumours, which depend on beta- catenin transcription for their abnormal proliferation, keep RB1 intact. Remarkably, E2F1 activity is also repressed by cyclin- dependent kinase- 8 ( CDK8), a colorectal oncoprotein(1). Elevated levels of CDK8 protect beta-catenin/TCF-dependent transcription from inhibition by E2F1. Thus, by retaining RB1 and amplifying CDK8, colorectal tumour cells select conditions that collectively suppress E2F1 and enhance the activity of beta-catenin.	[Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.] Massachusetts Gen Hosp, Ctr Canc, Mol Oncol Lab, Charlestown, MA 02129 USA; [Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Yang, Fajun; Naar, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kwon, Eun-Jeong] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kwon, Eun-Jeong] Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Haigis, Kevin M.] Massachusetts Gen Hosp, Ctr Canc, Lab Mol Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Dyson, NJ (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Mol Oncol Lab, 13th St,Bldg 149, Charlestown, MA 02129 USA.	dyson@helix.mgh.harvard.edu	Di Stefano, Luisa/ABB-6457-2020	Di Stefano, Luisa/0000-0003-3437-9066; Morris, Erick/0000-0002-3566-5630; Moon, Nam-Sung/0000-0002-0455-927X; Ji, Jun-yuan/0000-0002-4483-4336	Ruth L. Kirschstein Award; Tosteson Postdoctoral Fellowship; MGH ECOR Fund for Medical Discovery; Career Development award; Harvard Gastrointestinal Specialized Program of Research Excellence [P50-CA127003]; Saltonstall Foundation; National Institutes of Health [GM81607, GM053203, GM071449]; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071449, R01GM053203, R01GM081607] Funding Source: NIH RePORTER	Ruth L. Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tosteson Postdoctoral Fellowship; MGH ECOR Fund for Medical Discovery; Career Development award; Harvard Gastrointestinal Specialized Program of Research Excellence; Saltonstall Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank many investigators for their gifts of cell lines, plasmids and fly stocks, especially S. Artavanis-Tsakonas. We thank D. Rennie and the Massachusetts General Hospital Cutaneous Biology Research Center Transgenic Fly Core for embryo injections, and B. Fowle for his help with SEM imaging. We thank A. McClatchey, J. Settleman, C. Seum and T. Orr-Weaver for their gifts of antibodies. We thank our colleagues at the Massachusetts General Hospital (MGH) Cancer Center for discussions. E.J.M. and J.-Y.J. are supported in part by a Ruth L. Kirschstein Award and a Tosteson Postdoctoral Fellowship, respectively. L. D. S. is supported by the MGH ECOR Fund for Medical Discovery. N.-S.M. is a Leukemia and Lymphoma Society Special Fellow. K.M.H. was supported by a Career Development award from the Harvard Gastrointestinal Specialized Program of Research Excellence (GI-SPORE) (P50-CA127003). N.J.D. was supported by a scholarship from the Saltonstall Foundation. This study was supported by grants from the National Institutes of Health to N.J.D. (GM81607, GM053203) and A. M. N. (GM071449).	Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; GOPE R, 1990, J NATL CANCER I, V82, P310, DOI 10.1093/jnci/82.4.310; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hughes TA, 2005, BIOCHEM BIOPH RES CO, V329, P1267, DOI 10.1016/j.bbrc.2005.02.102; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kucherlapati MH, 2006, CANCER RES, V66, P3576, DOI 10.1158/0008-5472.CAN-05-2699; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Ueda Y, 2001, BIOCHEM BIOPH RES CO, V283, P327, DOI 10.1006/bbrc.2001.4788; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006	29	234	238	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					552	U67		10.1038/nature07310	http://dx.doi.org/10.1038/nature07310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18794899	Green Accepted, Green Submitted			2022-12-01	WOS:000259449600050
J	Pavord, ID; Shaw, DE; Gibson, PG; Taylor, DR				Pavord, Ian D.; Shaw, Dominick E.; Gibson, Peter G.; Taylor, D. Robin			Inflammometry to assess airway diseases	LANCET			English	Editorial Material							EXHALED NITRIC-OXIDE; RANDOMIZED CONTROLLED-TRIAL; CHRONIC ASTHMA; INFLAMMATION; SPUTUM; EXACERBATIONS; CHILDREN; PREDNISOLONE; COUNTS; ADULTS		[Pavord, Ian D.; Shaw, Dominick E.] Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England; [Gibson, Peter G.] John Hunter Hosp, Hunter Med Res Inst, Dept Resp & Sleep Med, New Lambton, NSW, Australia; [Taylor, D. Robin] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Otago	Pavord, ID (corresponding author), Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England.	ian.pavord@uhl-tr.nhs.uk	shaw, dominick/N-1293-2014; gibson, peter/G-6194-2014	shaw, dominick/0000-0003-4106-8469; Pavord, Ian/0000-0002-4288-5973; gibson, peter/0000-0001-5865-489X				Berry MA, 2005, CLIN EXP ALLERGY, V35, P1175, DOI 10.1111/j.1365-2222.2005.02314.x; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2000, EUR RESPIR J, V15, P682, DOI 10.1034/j.1399-3003.2000.15d10.x; BROWN HM, 1958, LANCET, V2, P1245; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Hunter CJ, 2002, CHEST, V121, P1051, DOI 10.1378/chest.121.4.1051; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Pavord ID, 2006, EUR RESPIR J, V27, P884, DOI 10.1183/09031936.06.00128105; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pijnenburg MW, 2005, THORAX, V60, P215, DOI 10.1136/thx.2004.023374; Pijnenburg MW, 2005, AM J RESP CRIT CARE, V172, P831, DOI 10.1164/rccm.200503-458OC; Shaw DE, 2007, AM J RESP CRIT CARE, V176, P231, DOI 10.1164/rccm.200610-1427OC; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Zacharasiewicz A, 2005, AM J RESP CRIT CARE, V171, P1077, DOI 10.1164/rccm.200409-1242OC	17	65	68	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1017	1019		10.1016/S0140-6736(08)61421-X	http://dx.doi.org/10.1016/S0140-6736(08)61421-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805315				2022-12-01	WOS:000259648500008
J	Del Bene, F; Wehman, AM; Link, BA; Baier, H				Del Bene, Filippo; Wehman, Ann M.; Link, Brian A.; Baier, Herwig			Regulation of neurogenesis by interkinetic nuclear migration through an apical-basal Notch gradient	CELL			English	Article							CELL-FATE DETERMINATION; RETINAL GANGLION-CELL; ZEBRAFISH; PROGENITOR; NUMB; GLIOGENESIS; EXPRESSION; DIVISION; MUTATION; REVEALS	The different cell types in the central nervous system develop from a common pool of progenitor cells. The nuclei of progenitors move between the apical and basal surfaces of the neuroepithelium in phase with their cell cycle, a process termed interkinetic nuclear migration (INM). In the retina of zebrafish mikre oko (mok) mutants, in which the motor protein Dynactin-1 is disrupted, interkinetic nuclei migrate more rapidly and deeply to the basal side and more slowly to the apical side. We found that Notch signaling is predominantly activated on the apical side in both mutants and wild-type. Mutant progenitors are, thus, less exposed to Notch and exit the cell cycle prematurely. This leads to an overproduction of early-born retinal ganglion cells (RGCs) at the expense of later-born interneurons and glia. Our data indicate that the function of INM is to balance the exposure of progenitor nuclei to neurogenic versus proliferative signals.	[Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Genet Program, San Francisco, CA 94158 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Dev Biol, San Francisco, CA 94158 USA	Medical College of Wisconsin; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Link, BA (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	blink@mcw.edu; herwig.baier@ucsf.edu	del bene, filippo/D-1245-2010; Wehman, Ann M/J-7860-2019	del bene, filippo/0000-0001-8551-2846; Wehman, Ann M/0000-0001-9826-4132	NEI NIH HHS [R01 EY013855-04, EY012406, R01 EY012406-09, R01 EY012406-05, R01 EY013855-06, EY01467, R01 EY012406, EY013855, R01 EY013855] Funding Source: Medline; NINDS NIH HHS [R01 NS053358-02, R01 NS053358] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012406, R01EY013855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Baye LM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-28; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Brown NL, 2001, DEVELOPMENT, V128, P2497; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Doerre G, 2001, J NEUROSCI, V21, P6745, DOI 10.1523/JNEUROSCI.21-17-06745.2001; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fan SS, 1997, DEVELOPMENT, V124, P1497; Frade JM, 2002, PROG BRAIN RES, V136, P67; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; Meng A, 1999, METHOD CELL BIOL, V60, P133; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Muto A, 2006, DEV BIOL, V292, P90, DOI 10.1016/j.ydbio.2005.12.050; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Passini MA, 1997, J COMP NEUROL, V388, P495, DOI 10.1002/(SICI)1096-9861(19971124)388:3<495::AID-CNE11>3.0.CO;2-L; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Poggi L, 2005, CURR OPIN CELL BIOL, V17, P676, DOI 10.1016/j.ceb.2005.09.004; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Scheer N, 2001, DEVELOPMENT, V128, P1099; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Takke C, 1999, DEVELOPMENT, V126, P1811; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010; Wehman AM, 2007, DEV BIOL, V303, P144, DOI 10.1016/j.ydbio.2006.10.043; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yan RT, 2005, MOL NEUROBIOL, V32, P157, DOI 10.1385/MN:32:2:157; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	68	238	239	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1055	1065		10.1016/j.cell.2008.07.017	http://dx.doi.org/10.1016/j.cell.2008.07.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805097	Green Accepted, Bronze			2022-12-01	WOS:000259318100024
J	Ludwig, DS; Kabat-Zinn, J				Ludwig, David S.; Kabat-Zinn, Jon			Mindfulness in medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRESS REDUCTION; MEDITATION; PROGRAM		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Kabat-Zinn, Jon] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544				Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Grepmair L, 2007, PSYCHOTHER PSYCHOSOM, V76, P332, DOI 10.1159/000107560; Groopman JE., 2007, DOCTORS THINK; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; Proulx Kathryn, 2008, Eat Disord, V16, P52, DOI 10.1080/10640260701773496; Santorelli S, 1998, HEAL THY SELF; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; Speca M, 2000, PSYCHOSOM MED, V62, P613, DOI 10.1097/00006842-200009000-00004; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12	15	467	474	7	189	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1350	1352		10.1001/jama.300.11.1350	http://dx.doi.org/10.1001/jama.300.11.1350			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	348ST	18799450				2022-12-01	WOS:000259231100033
J	Nygaard, I; Barber, MD; Burgio, KL; Kenton, K; Meikle, S; Schaffer, J; Spino, C; Whitehead, WE; Wu, J; Brody, DJ				Nygaard, Ingrid; Barber, Matthew D.; Burgio, Kathryn L.; Kenton, Kimberly; Meikle, Susan; Schaffer, Joseph; Spino, Cathie; Whitehead, William E.; Wu, Jennifer; Brody, Debra J.		Pelvic Floor Disorders Network	Prevalence of symptomatic pelvic floor disorders in US women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; FEMALE URINARY-INCONTINENCE; FECAL INCONTINENCE; GENITAL PROLAPSE; ORGAN PROLAPSE; ANAL INCONTINENCE; NATIONAL-HEALTH; SEVERITY INDEX; RISK-FACTORS; COMMUNITY	Context Pelvic floor disorders ( urinary incontinence, fecal incontinence, and pelvic organ prolapse) affect many women. No national prevalence estimates derived from the same population- based sample exists for multiple pelvic floor disorders in women in the United States. Objective To provide national prevalence estimates of symptomatic pelvic floor disorders in US women. Design, Setting, and Participants A cross- sectional analysis of 1961 nonpregnant women ( >= 20 years) who participated in the 2005- 2006 National Health and Nutrition Examination Survey, a nationally representative survey of the US noninstitutionalized population. Women were interviewed in their homes and then underwent standardized physical examinations in a mobile examination center. Urinary incontinence ( score of >= 3 on a validated incontinence severity index, constituting moderate to severe leakage), fecal incontinence ( at least monthly leakage of solid, liquid, or mucous stool), and pelvic organ prolapse ( seeing/ feeling a bulge in or outside the vagina) symptoms were assessed. Main Outcome Measures Weighted prevalence estimates of urinary incontinence, fecal incontinence, and pelvic organ prolapse symptoms. Results The weighted prevalence of at least 1 pelvic floor disorder was 23.7% ( 95% confidence interval [ CI], 21.2%- 26.2%), with 15.7% of women ( 95% CI, 13.2%-18.2%) experiencing urinary incontinence, 9.0% of women ( 95% CI, 7.3%- 10.7%) experiencing fecal incontinence, and 2.9% of women ( 95% CI, 2.1%- 3.7%) experiencing pelvic organ prolapse. The proportion of women reporting at least 1 disorder increased incrementally with age, ranging from 9.7% ( 95% CI, 7.8%- 11.7%) in women between ages 20 and 39 years to 49.7% ( 95% CI, 40.3%- 59.1%) in those aged 80 years or older ( P <. 001), and parity ( 12.8% [ 95% CI, 9.0%- 16.6%], 18.4% [ 95% CI, 12.9%- 23.9%], 24.6% [ 95% CI, 19.5%- 29.8%], and 32.4% [ 95% CI, 27.8%-37.1%] for 0, 1, 2, and 3 or more deliveries, respectively; P <. 001). Overweight and obese women were more likely to report at least 1 pelvic floor disorder than normal weight women ( 26.3% [ 95% CI, 21.7%- 30.9%], 30.4% [ 95% CI, 25.8%- 35.0%], and 15.1% [ 95% CI, 11.6%- 18.7%], respectively; P <. 001). We detected no differences in prevalence by racial/ ethnic group. Conclusion Pelvic floor disorders affect a substantial proportion of women and increase with age.	[Nygaard, Ingrid] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; [Barber, Matthew D.] Obstet Gynecol & Womens Hlth Inst, Cleveland, OH USA; [Barber, Matthew D.] Cleveland Clin, Cleveland, OH 44106 USA; [Burgio, Kathryn L.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Burgio, Kathryn L.] Dept Vet Affairs, Birmingham, AL USA; [Kenton, Kimberly] Loyola Univ, Stritch Sch Med, Dept Obstet & Gynecol, Maywood, IL 60153 USA; [Kenton, Kimberly] Loyola Univ, Stritch Sch Med, Dept Urol, Maywood, IL 60153 USA; [Meikle, Susan] NICHHD, Bethesda, MD 20892 USA; [Schaffer, Joseph] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Spino, Cathie] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Whitehead, William E.] Univ N Carolina, Sch Med, Dept Internal Med, Chapel Hill, NC USA; [Wu, Jennifer] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA; [Brody, Debra J.] Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Utah System of Higher Education; University of Utah; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; Loyola University Chicago; Loyola University Chicago; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Nygaard, I (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, 30 N 1900 E, Salt Lake City, UT 84132 USA.	ingrid.nygaard@hsc.utah.edu	Wu, Jennifer/GRX-1831-2022	Wu, Jennifer/0000-0002-3171-1054; Wu, Jennifer/0000-0002-4477-3932	Eunice Kennedy Shriver NICHD [U01 HD41249, U10 HD41268, U10 HD41248, U10 HD41250, U10 HD41261, U10 HD41263, U10 HD41269, U10 HD41267, U10 HD54136, U10 HD54214, U10 HD54215]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD041267, U10HD054214, U10HD041261, U10HD041250, U10HD041267, U10HD054136, U10HD054215] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD041268, U10HD041248, U10HD041263, U01HD041249, U10HD041269] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants U01 HD41249, U10 HD41268, U10 HD41248, U10 HD41250, U10 HD41261, U10 HD41263, U10 HD41269, U10 HD41267, U10 HD54136, U10 HD54214, and U10 HD54215 from the Eunice Kennedy Shriver NICHD and funding from the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health Office of Research on Women's Health.	Abramov Y, 2005, OBSTET GYNECOL, V106, P726, DOI 10.1097/01.AOG.0000161367.65261.16; Anger JT, 2006, J UROLOGY, V175, P601, DOI 10.1016/S0022-5347(05)00242-9; [Anonymous], 2000, Eur J Obstet Gynecol Reprod Biol, V93, P135; Barber MD, 2006, AM J OBSTET GYNECOL, V195, P942, DOI 10.1016/j.ajog.2006.02.050; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Bharucha AE, 2005, GASTROENTEROLOGY, V129, P42, DOI 10.1053/j.gastro.2005.04.006; Boreham MK, 2005, AM J OBSTET GYNECOL, V192, P1637, DOI 10.1016/j.ajog.2004.11.030; Bradley CS, 2005, OBSTET GYNECOL, V106, P759, DOI 10.1097/01.AOG.0000180183.03897.72; Dooley Y, 2008, J UROLOGY, V179, P656, DOI 10.1016/j.juro.2007.09.081; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; Eva UF, 2003, ACTA OBSTET GYN SCAN, V82, P280, DOI 10.1034/j.1600-0412.2003.00103.x; FANTL J, 1996, PUBLICATION US DEP H; Ghetti C, 2005, AM J OBSTET GYNECOL, V193, P53, DOI 10.1016/j.ajog.2004.12.004; Goode PS, 2005, J AM GERIATR SOC, V53, P629, DOI 10.1111/j.1532-5415.2005.53211.x; Graham CA, 2001, AM J OBSTET GYNECOL, V185, P116, DOI 10.1067/mob.2001.114914; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Hunskaar S, 2005, INCONTINENCE, VOLS 1 AND 2, P255; Luber KM, 2001, AM J OBSTET GYNECOL, V184, P1496, DOI 10.1067/mob.2001.114868; Lukacz ES, 2006, OBSTET GYNECOL, V107, P1253, DOI 10.1097/01.AOG.0000218096.54169.34; MacLennan AH, 2000, BRIT J OBSTET GYNAEC, V107, P1460, DOI 10.1111/j.1471-0528.2000.tb11669.x; Mant J, 1997, BRIT J OBSTET GYNAEC, V104, P579, DOI 10.1111/j.1471-0528.1997.tb11536.x; Melville JL, 2005, OBSTET GYNECOL, V106, P585, DOI 10.1097/01.AOG.0000173985.39533.37; NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Ostbye T, 2004, CAN J AGING, V23, P319, DOI 10.1353/cja.2005.0024; Quander CR, 2005, AM J GASTROENTEROL, V100, P905, DOI 10.1111/j.1572-0241.2005.30511.x; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; Sandvik H, 2006, INT UROGYNECOL J, V17, P520, DOI 10.1007/s00192-005-0060-z; Shah AD, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.042; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Swift SE, 2003, AM J OBSTET GYNECOL, V189, P372, DOI 10.1067/S0002-9378(03)00698-7; Swithinbank LV, 1999, WORLD J UROL, V17, P225, DOI 10.1007/s003450050137; Teunissen TAM, 2004, INT UROGYNECOL J, V15, P10, DOI 10.1007/s00192-003-1106-8; Thom DH, 2006, J UROLOGY, V175, P259, DOI 10.1016/S0022-5347(05)00039-X; United States Census Bureau, US INT PROJ AG SEX R; Varma MG, 2006, DIS COLON RECTUM, V49, P841, DOI 10.1007/s10350-006-0535-0; Waetjen LE, 2007, AM J EPIDEMIOL, V165, P309, DOI 10.1093/aje/kwk018	42	1078	1115	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1311	1316		10.1001/jama.300.11.1311	http://dx.doi.org/10.1001/jama.300.11.1311			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799443	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000259231100026
J	Inomata, H; Haraguchi, T; Sasai, Y				Inomata, Hidehiko; Haraguchi, Tomoko; Sasai, Yoshiki			Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation	CELL			English	Article							DORSALIZING-MORPHOGENETIC-PROTEIN; SPEMANN ORGANIZER; NEURAL INDUCTION; XENOPUS EMBRYOS; GASTRULATION; INHIBITION; MOVEMENTS; CLEAVAGE; SIGNALS; BIOLOGY	Dorsal axial formation during vertebrate embryogenesis exhibits robust resistance to perturbations in patterning signals. However, how such stability is supported at the molecular level remains largely elusive. Here we show that Xenopus ONT1, an Olfactomedin-class secreted protein, stabilizes axial formation by restricting Chordin activity on the dorsal side. When ONT1 function is attenuated, the embryo becomes hyperdorsalized by a normally subeffective dose of Chordin. ONT1 binds Chordin and BMP1/Tolloid-class proteinases (B1TP) via distinct domains and acts as a secreted scaffold that enhances B1TP-mediated Chordin degradation by facilitating enzyme-substrate association. ONT1 is indispensable for fine-tuning BMP signaling in the axial tissue, and a similar role has been suggested for dorsally expressed BMPs such as ADMP. Simultaneous inhibition of ONT1 and dorsally expressed BMPs (ADMP and BMP2) synergistically caused drastic dorsalization. These results indicate that stable axial formation depends on two compensatory regulatory pathways involving ONT1/B1TP and dorsally expressed BMPs.	[Inomata, Hidehiko; Haraguchi, Tomoko; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan	RIKEN	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Inomata, Hidehiko/N-7390-2015		MEXT; Kobe Cluster Project; Leading Project	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project	We would like to thank Drs. M. Hibi and G. Sheng for invaluable comments, Dr. L. Dale for the Xlr plasmid, Drs. N. Sasai and M. Ikeya for critical reading, Dr. M. Sakuragi for chick ONT1 information, and Ms. M. Suzuki for Xenopus husbandry. This work was supported by grants in aid from MEXT, the Kobe Cluster Project, and the Leading Project (Y. S.).	Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; COOKE J, 1975, J EMBRYOL EXP MORPH, V33, P147; COOKE J, 1973, J EMBRYOL EXP MORPH, V30, P49; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; FERRELL JE, 2000, SCI STKE, pPE1; GALLERA J, 1974, EXPERIENTIA, V30, P183, DOI 10.1007/BF01927723; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; Moos M, 1995, DEVELOPMENT, V121, P4293; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Niehrs C, 2002, NATURE, V417, P35, DOI 10.1038/417035a; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Plouhinec JL, 2007, MOL BIOSYST, V3, P454, DOI 10.1039/b701571b; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Sakuragi M, 2006, MECH DEVELOP, V123, P114, DOI 10.1016/j.mod.2005.11.005; Salic AN, 1997, DEVELOPMENT, V124, P4739; Spemann H, 1903, ARCH ENTWICKLUNG ORG, V16, P551, DOI 10.1007/BF02301267; Spemann H, 2001, INT J DEV BIOL, V45, P13; Tsuda H, 2002, NEURON, V33, P515, DOI 10.1016/S0896-6273(02)00590-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Zenga LC, 2005, FEBS LETT, V579, P5443, DOI 10.1016/j.febslet.2005.08.064	34	85	91	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					854	865		10.1016/j.cell.2008.07.008	http://dx.doi.org/10.1016/j.cell.2008.07.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775317	Bronze			2022-12-01	WOS:000258947500024
J	Yoder, A; Yu, DY; Dong, L; Iyer, SR; Xu, XH; Kelly, J; Liu, J; Wang, WF; Vorster, PJ; Agulto, L; Stephany, DA; Cooper, JN; Marsh, JW; Wu, YT				Yoder, Alyson; Yu, Dongyang; Dong, Li; Iyer, Subashini R.; Xu, Xuehua; Kelly, Jeremy; Liu, Juan; Wang, Weifeng; Vorster, Paul J.; Agulto, Liane; Stephany, David A.; Cooper, James N.; Marsh, Jon W.; Wu, Yuntao			HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells	CELL			English	Article							IMMUNOLOGICAL SYNAPSE; CHEMOKINE; PROTEIN; ENTRY; NEF; LYMPHOCYTES; INFECTION; COMPLEX; CXCR4; PHOSPHORYLATION	Binding of the HIV envelope to the chemokine coreceptors triggers membrane fusion and signal transduction. The fusion process has been well characterized, yet the role of coreceptor signaling remains elusive. Here, we describe a critical function of the chemokine coreceptor signaling in facilitating HIV infection of resting CD4 T cells. We find that static cortical actin in resting T cells represents a restriction and that HIV utilizes the G alpha i-dependent signaling from the chemokine coreceptor CXCR4 to activate a cellular actin-depolymerizing factor, cofilin, to overcome this restriction. HIV envelope-mediated cofilin activation and actin dynamics are important for a postentry process that leads to viral nuclear localization. Inhibition of HIV-mediated actin rearrangement markedly diminishes viral latent infection of resting T cells. Conversely, induction of active cofilin greatly facilitates it. These findings shed light on viral exploitation of cellular machinery in resting T cells, where chemokine receptor signaling becomes obligatory.	[Marsh, Jon W.; Wu, Yuntao] NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Yoder, Alyson; Yu, Dongyang; Dong, Li; Iyer, Subashini R.; Kelly, Jeremy; Liu, Juan; Wang, Weifeng; Vorster, Paul J.; Agulto, Liane; Cooper, James N.] George Mason Univ, Dept Mol & Microbiol, Manassas, VA 20110 USA; [Xu, Xuehua] NIAID, Immunogenet Lab, NIH, Rockville, MD 20851 USA; [Stephany, David A.] NIAID, Flow Cytometry Sect, NIH, Bethesda, MD 20892 USA; [Marsh, Jon W.; Wu, Yuntao] NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Marsh, JW (corresponding author), NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA.	marshj@mail.nih.gov; ywu8@gmu.edu	wang, weifeng/N-4140-2013; xu, xuehua/R-1163-2019	xu, xuehua/0000-0002-3863-9593; Love, Zelda/0000-0002-2478-7720	National Defense Science and Engineering Fellowship; GMU; NIMH/NIH; NIAID [AI069981]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002629] Funding Source: NIH RePORTER	National Defense Science and Engineering Fellowship(United States Department of Defense); GMU; NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the George Mason University (GMU) Student Health Center; the Department of Transfusion Medicine, the National Institutes of Health (NIH); V. Chandhoke and C. Bailey for blood donation; the NIH AIDS Research and Reference Reagent Program for reagents; H. A. Nash of the National Institute of Mental Health (NIMH)/NIH; K. Jeang of the National Institute of Allergy and Infectious Diseases (NIAID)/NIH; D. Rekosh of the University of Virginia; L. Liotta, E. Petricoin and D. Cox for comments; T. Meckel and T. Jin of NIAID/NIH for confocal microscopy and imaging analyses; K. L. Holmes of NIAID/NIH for fusion assay; A. Biancotto and L. Margolis of the National Institute of Child Health and Human Development/NIH for tonsillar T cells; Y. Samstag for protocols; and A. Wu for digital graphic design. A. Y. was supported by the National Defense Science and Engineering Fellowship. This work was supported by GMU, the Intramural Program of the NIMH/NIH, and in part by the Public Health Service grant AI069981 from NIAID to Y. W.	Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; DE BP, 1993, J BIOL CHEM, V268, P5703; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; FENYO EM, 1988, J VIROL, V62, P4414; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GRAY LS, 1989, J IMMUNOL, V142, P1631; HOTTIGER M, 1995, NUCLEIC ACIDS RES, V23, P736; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; KUBBIES M, 1989, EUR J IMMUNOL, V19, P1393, DOI 10.1002/eji.1830190807; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Naghavi MH, 2005, GENE DEV, V19, P1105, DOI 10.1101/gad.1290005; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Spina CA, 1997, J CLIN INVEST, V99, P1774, DOI 10.1172/JCI119342; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu Y, 2007, CURR HIV RES, V5, P394; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	48	213	218	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					782	792		10.1016/j.cell.2008.06.036	http://dx.doi.org/10.1016/j.cell.2008.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775311	Green Accepted, Bronze			2022-12-01	WOS:000258947500018
J	Stockmann, C; Doedens, A; Weidemann, A; Zhang, N; Takeda, N; Greenberg, JI; Cheresh, DA; Johnson, RS				Stockmann, Christian; Doedens, Andrew; Weidemann, Alexander; Zhang, Na; Takeda, Norihiko; Greenberg, Joshua I.; Cheresh, David A.; Johnson, Randall S.			Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis	NATURE			English	Article							BREAST-CANCER; MOUSE MODEL; MACROPHAGES; EXPRESSION; ANGIOGENESIS; VEGF; MICE	Angiogenesis and the development of a vascular network are required for tumour progression, and they involve the release of angiogenic factors, including vascular endothelial growth factor ( VEGF-A), from both malignant and stromal cell types(1). Infiltration by cells of the myeloid lineage is a hallmark of many tumours, and in many cases the macrophages in these infiltrates express VEGF-A(2). Here we show that the deletion of inflammatory-cell-derived VEGF- A attenuates the formation of a typical high-density vessel network, thus blocking the angiogenic switch in solid tumours in mice. Vasculature in tumours lacking myeloid- cell-derived VEGF-A was less tortuous, with increased pericyte coverage and decreased vessel length, indicating vascular normalization. In addition, loss of myeloid-derived VEGF- A decreases the phosphorylation of VEGF receptor 2 (VEGFR2) in tumours, even though overall VEGF- A levels in the tumours are unaffected. However, deletion of myeloid- cell VEGF- A resulted in an accelerated tumour progression in multiple subcutaneous isograft models and an autochthonous transgenic model of mammary tumorigenesis, with less overall tumour cell death and decreased tumour hypoxia. Furthermore, loss of myeloid- cell VEGF- A increased the susceptibility of tumours to chemotherapeutic cytotoxicity. This shows that myeloid- derived VEGF- A is essential for the tumorigenic alteration of vasculature and signalling to VEGFR2, and that these changes act to retard, not promote, tumour progression.	[Stockmann, Christian; Doedens, Andrew; Weidemann, Alexander; Zhang, Na; Takeda, Norihiko; Johnson, Randall S.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Greenberg, Joshua I.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Cheresh, David A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Johnson, RS (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	rsjohnson@ucsd.edu	Johnson, Randall/AAM-1189-2021; Stockmann, Christian/L-6956-2017; Stockmann, Christian/Q-1615-2017	Johnson, Randall/0000-0002-4084-6639; Doedens, Andrew/0000-0003-2461-3496; Stockmann, Christian/0000-0002-9726-6838	Deutsche Forschungsgemeinschaft [STO 787/1-1, WE 4275/1-1]; Susan G. Komen Dissertation Research Award [DISS0402406]; National Institutes of Health [CA82515, CA118165, AI060840]; NATIONAL CANCER INSTITUTE [R01CA082515, R01CA118165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060840] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Susan G. Komen Dissertation Research Award(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. DuRose, N. Ferrara, L. Iruela- Arispe, L. Coussens, M. Karin, V. Nizet and H.- P. Gerber for helpful conversations. Financial support was provided by the Deutsche Forschungsgemeinschaft to C. S. (STO 787/1-1) and A. W. (WE 4275/ 1- 1), a Susan G. Komen Dissertation Research Award ( DISS0402406) to A. D., and National Institutes of Health grants CA82515, CA118165 and AI060840 to R. S. J.	Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Grunstein J, 1999, CANCER RES, V59, P1592; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hurwitz HI, 2006, CLIN COLORECTAL CANC, V6, P66, DOI 10.3816/CCC.2006.n.023; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Mayer Erica L, 2007, J Natl Compr Canc Netw, V5, P314	12	342	357	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					814	U107		10.1038/nature07445	http://dx.doi.org/10.1038/nature07445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18997773	Green Accepted, Green Submitted			2022-12-01	WOS:000261559900054
J	Liang, HL; Nien, CY; Liu, HY; Metzstein, MM; Kirov, N; Rushlow, C				Liang, Hsiao-Lan; Nien, Chung-Yi; Liu, Hsiao-Yun; Metzstein, Mark M.; Kirov, Nikolai; Rushlow, Christine			The zinc-finger protein Zelda is a key activator of the early zygotic genome in Drosophila	NATURE			English	Article							POLARIZED MEMBRANE GROWTH; REPRESSION; BINDING; CELLULARIZATION; INSERTIONS; TRANSITION; REGULATOR; CLEAVAGE; ENCODES; TARGETS	In all animals, the initial events of embryogenesis are controlled by maternal gene products that are deposited into the developing oocyte. At some point after fertilization, control of embryogenesis is transferred to the zygotic genome in a process called the maternal- to-zygotic transition. During this time, many maternal RNAs are degraded and transcription of zygotic RNAs ensues(1). There is a long-standing question as to which factors regulate these events. The recent findings that microRNAs(2,3) and Smaug(4) mediate maternal transcript degradation have shed new light on this aspect of the problem. However, the transcription factor(s) that activate the zygotic genomeremain elusive. The discovery that many of the early transcribed genes in Drosophila share a cis- regulatory heptamer motif, CAGGTAG and related sequences(5,6), collectively referred to as TAGteam sites(5) raised the possibility that a dedicated transcription factor could interact with these sites to activate transcription. Here we report that the zinc- finger protein Zelda ( Zld; Zinc- finger early Drosophila activator) binds specifically to these sites and is capable of activating transcription in transient transfection assays. Mutant embryos lacking zld are defective in cellular blastoderm formation, and fail to activate many genes essential for cellularization, sex determination and pattern formation. Global expression profiling confirmed that Zld has an important role in the activation of the early zygotic genome and suggests that Zld may also regulate maternal RNA degradation during the maternal- to- zygotic transition.	[Liang, Hsiao-Lan; Nien, Chung-Yi; Liu, Hsiao-Yun; Kirov, Nikolai; Rushlow, Christine] NYU, Dept Biol, New York, NY 10003 USA; [Metzstein, Mark M.] Univ Utah, Inst Human Genet, Salt Lake City, UT 84112 USA	New York University; Utah System of Higher Education; University of Utah	Rushlow, C (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	chris.rushlow@nyu.edu			National Institutes of Health [GM63024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following people for gifts of RNA probes, plasmids, antibodies and fly stocks: J. Erickson, R. Lehmann, R. Cinalli, R. Martinho, C. Navarro, J. Treisman and L. Pick. We thank J. Rhee and A. Chung for help with isolating and characterizing zld null mutants, and S. Fu for help locating TAGteam sites in Zelda target genes. We are grateful to M. Siegel and K. Birnbaum for help with the microarray analysis, and C. Desplan, P. Struffi, S. Small and R. Lehmann for critical reading of the manuscript. This work was supported by a grant from the National Institutes of Health (GM63024).	Biemar F, 2005, P NATL ACAD SCI USA, V102, P15907, DOI 10.1073/pnas.0507817102; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Grosshans J, 2003, DEV CELL, V5, P285, DOI 10.1016/S1534-5807(03)00208-9; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SCHWEISGUTH F, 1990, GENE DEV, V4, P922, DOI 10.1101/gad.4.6.922; SIMPSON L, 1990, DEVELOPMENT, V110, P851; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Staudt N, 2006, MOL BIOL CELL, V17, P2356, DOI 10.1091/mbc.E05-11-1056; Stein JA, 2002, DEVELOPMENT, V129, P3925; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0	28	310	316	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					400	U67		10.1038/nature07388	http://dx.doi.org/10.1038/nature07388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18931655	Green Accepted			2022-12-01	WOS:000261039600046
J	Park, KK; Liu, K; Hu, Y; Smith, PD; Wang, C; Cai, B; Xu, BG; Connolly, L; Kramvis, I; Sahin, M; He, ZG				Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang			Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway	SCIENCE			English	Article							TUBEROUS SCLEROSIS; GROWTH; INJURY; MTOR; HYPOXIA; CELLS; TSC1	The failure of axons to regenerate is a major obstacle for functional recovery after central nervous system (CNS) injury. Removing extracellular inhibitory molecules results in limited axon regeneration in vivo. To test for the role of intrinsic impediments to axon regrowth, we analyzed cell growth control genes using a virus- assisted in vivo conditional knockout approach. Deletion of PTEN ( phosphatase and tensin homolog), a negative regulator of the mammalian target of rapamycin ( mTOR) pathway, in adult retinal ganglion cells ( RGCs) promotes robust axon regeneration after optic nerve injury. In wild- type adult mice, the mTOR activity was suppressed and new protein synthesis was impaired in axotomized RGCs, which may contribute to the regeneration failure. Reactivating this pathway by conditional knockout of tuberous sclerosis complex 1, another negative regulator of the mTOR pathway, also leads to axon regeneration. Thus, our results suggest the manipulation of intrinsic growth control pathways as a therapeutic approach to promote axon regeneration after CNS injury.	[Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang] Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	He, ZG (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	SAHIN, MUSTAFA/I-8653-2019	SAHIN, MUSTAFA/0000-0001-7044-2953; Liu, Kai/0000-0001-9351-1640; Hu, Yang/0000-0002-7980-1649; Smith, Patrice/0000-0002-0731-2803	Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke; Wings for Life, and Adelson Foundation; Ruth L. Kirschstein National Research Service Award; Canadian Institute of Health Research; NINDS; Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051788, R01NS058956] Funding Source: NIH RePORTER	Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wings for Life, and Adelson Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Hasegawa and F. Wang for providing Rosa-stop-PLAP mice, D. Kwiatkowski for proving TSC1<SUP>f/f</SUP> mice, C. Deng for Smad4<SUP>f/f</SUP> mice, M. Ericsson and L. Bu for microscopic analysis, and L. Benowitz, M. Greenberg, T. Hensch and J. Kanter for reading the manuscript. This study was supported by grants from Craig H. Neilson Foundation (to K. K. P.); National Institute of Neurological Disorders and Stroke ( NINDS), Wings for Life, and Adelson Foundation (to Z.H.); Ruth L. Kirschstein National Research Service Award (NRSA) (to Y.H.); Canadian Institute of Health Research (to P.D.S.); and NINDS and Tuberous Sclerosis Alliance (to M.S.).	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Marino S, 2000, GENE DEV, V14, P994; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Namikawa K, 2000, J NEUROSCI, V20, P2875; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Weinberg RA, 2007, BIOL CANC, P209; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	27	1078	1132	3	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					963	966		10.1126/science.1161566	http://dx.doi.org/10.1126/science.1161566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988856	Green Accepted			2022-12-01	WOS:000260674100053
J	Huang, J; Lesser, CF; Lory, S				Huang, Jin; Lesser, Cammie F.; Lory, Stephen			The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth	NATURE			English	Article							III SECRETION; SACCHAROMYCES-CEREVISIAE; INFECTED CELLS; HELA-CELLS; YEAST; EXPRESSION; BACTERIAL; IDENTIFICATION; TRANSLOCATION; APOPTOSIS	Bacterial virulence determinants can be identified, according to the molecular Koch's postulates(1), if inactivation of a gene associated with a suspected virulence trait results in a loss in pathogenicity. This approach is commonly used with genetically tractable organisms. However, the current lack of tools for targeted gene disruptions in obligate intracellular microbial pathogens seriously hampers the identification of their virulence factors. Here we demonstrate an approach to studying potential virulence factors of genetically intractable organisms, such as Chlamydia. Heterologous expression of Chlamydia pneumoniae CopN in yeast and mammalian cells resulted in a cell cycle arrest, presumably owing to alterations in the microtubule cytoskeleton. A screen of a small molecule library identified two compounds that alleviated CopN-induced growth inhibition in yeast. These compounds interfered with C. pneumoniae replication in mammalian cells, presumably by 'knocking out' CopN function, revealing an essential role of CopN in the support of C. pneumoniae growth during infection. This work demonstrates the role of a specific chlamydial protein in virulence. The chemical biology approach described here can be used to identify virulence factors, and the reverse chemical genetic strategy can result in the identification of lead compounds for the development of novel therapeutics.	[Huang, Jin; Lesser, Cammie F.; Lory, Stephen] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lesser, Cammie F.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lory, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	stephen_lory@hms.harvard.edu			NIAID NIH HHS [R01 AI064285-03, R01 AI064285] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064285] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2003, METH MOL B; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; CROCKER TT, 1965, J INFECT DIS, V115, P105, DOI 10.1093/infdis/115.2.105; Cross NA, 1999, ANTIMICROB AGENTS CH, V43, P2311, DOI 10.1128/AAC.43.9.2311; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guichon A, 2001, J BACTERIOL, V183, P1269, DOI 10.1128/JB.183.4.1269-1276.2001; Hackstadt T, 1999, CHLAMYDIA, P101; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; HOROSCHAK KD, 1978, INFECT IMMUN, V19, P281, DOI 10.1128/IAI.19.1.281-286.1978; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Huang J, 2002, P NATL ACAD SCI USA, V99, P3914, DOI 10.1073/pnas.062578399; Khan MA, 1996, J ANTIMICROB CHEMOTH, V37, P677, DOI 10.1093/jac/37.4.677; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Li D, 2005, J MICROBIOL METH, V61, P17, DOI 10.1016/j.mimet.2004.10.020; Lugert R, 2004, MED MICROBIOL IMMUN, V193, P163, DOI 10.1007/s00430-003-0206-x; MILLER RK, 2003, METH MOL B, V241, P341; MOULDER JW, 1982, CHLAMYDIA INFECTI S1, V10, pS10; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Perkins E, 2001, CANCER RES, V61, P4175; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tugendreich S, 2001, GENOME RES, V11, P1899, DOI 10.1101/gr.191601; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Verma A, 2003, INFECT IMMUN, V71, P5772, DOI 10.1128/IAI.71.10.5772-5784.2003; Zhang Hong, 2004, Methods Mol Biol, V241, P77	38	53	54	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					112	U10		10.1038/nature07355	http://dx.doi.org/10.1038/nature07355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18830244	Green Accepted			2022-12-01	WOS:000260674000051
J	Keenan, HT; Hall, GC; Marshall, SW				Keenan, Heather T.; Hall, Gillian C.; Marshall, Stephen W.			Early head injury and attention-deficit/hyperactivity disorder: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; DEFICIT-HYPERACTIVITY DISORDER; CHILDREN; SYMPTOMS; ILLNESS	Objective To explore the hypothesis that medically attended head injury in young children may be causal in the later development of attention- deficit/ hyperactivity disorder. Design Retrospective cohort study. Setting Health improvement network database ( 1988-2003), a longitudinal UK general practice dataset. Participants All children registered in the database from birth until their 10th birthday. Main outcome measures Risk of a child with a head injury before age 2 developing attention- deficit/ hyperactivity disorder before age 10 compared with children with a burn injury before age 2 and children with neither a burn nor a head injury. Results Of the 62 088 children who comprised the cohort, 2782 ( 4.5%) had a head injury and 1116 ( 1.8%) had a burn injury. The risk of diagnosis of attention- deficit/ hyperactivity disorder before 10 years of age after adjustment for sex, prematurity, socioeconomic status, and practice identification number was similar in the head injury ( relative risk 1.9, 95% confidence interval 1.5 to 2.5) and burn injury groups ( 1.7, 1.2 to 2.5) compared with all other children. Discussion Medically attended head injury before 2 years of age does not seem to be causal in the development of attention- deficit/ hyperactivity disorder. Medically attended injury before 2 years of age may be a marker for subsequent diagnosis of attention- deficit/ hyperactivity disorder.	[Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27699 USA	Utah System of Higher Education; University of Utah	Keenan, HT (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu		Marshall, Stephen/0000-0002-2664-9233				Bourke Alison, 2004, Inform Prim Care, V12, P171; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Huff N, 1999, J PUBLIC HEALTH MED, V21, P81, DOI 10.1093/pubmed/21.1.81; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	14	33	33	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2008	337								a1984	10.1136/bmj.a1984	http://dx.doi.org/10.1136/bmj.a1984			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377FC	18988644	hybrid, Green Published			2022-12-01	WOS:000261236100001
J	Walsh, CA; Morrow, EM; Rubenstein, JLR				Walsh, Christopher A.; Morrow, Eric M.; Rubenstein, John L. R.			Autism and Brain Development	CELL			English	Article							MENTAL-RETARDATION; MOUSE MODEL; MUTATIONS; GENES; MECP2; TRANSCRIPTION; DISRUPTION; PLASTICITY; DISORDERS; CHILDREN	Genetic studies are refining our understanding of neurodevelopmental mechanisms in autism. Some autism-related mutations appear to disrupt genes regulated by neuronal activity, which are especially important in development of the postnatal nervous system. Gene replacement studies in mice indicate that the developmental window to ameliorate symptoms may be wider than previously anticipated.	[Walsh, Christopher A.; Morrow, Eric M.] Childrens Hosp, Dept Neurol, Div Genet, Boston, MA 02115 USA; [Walsh, Christopher A.; Morrow, Eric M.] Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; [Morrow, Eric M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Walsh, CA (corresponding author), Childrens Hosp, Dept Neurol, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Morrow, Eric/J-2767-2013; Warfield, Simon/B-3352-2009	Morrow, Eric/0000-0003-3430-3520; Warfield, Simon/0000-0002-7659-3880	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [1K23MH080954, R01 MH083565-02, R01 MH49428, K23 MH080954-05, 1R01 MH083565, R01 MH049428, R01 MH083565, K23 MH080954] Funding Source: Medline; NINDS NIH HHS [R01 NS34661, R01 NS034661] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, R01MH083565, K23MH080954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, R01NS034661] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gomot M, 2006, NEUROIMAGE, V29, P475, DOI 10.1016/j.neuroimage.2005.07.027; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hamilton SP, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-52; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scearce-Levie K, 2008, GENES BRAIN BEHAV, V7, P344, DOI 10.1111/j.1601-183X.2007.00357.x; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Turner G, 2002, AM J MED GENET, V112, P405, DOI 10.1002/ajmg.10714; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	42	133	140	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					396	400		10.1016/j.cell.2008.10.015	http://dx.doi.org/10.1016/j.cell.2008.10.015			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984148	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000260536300007
J	Downs, JP; Daeschler, EB; Jenkins, FA; Shubin, NH				Downs, Jason P.; Daeschler, Edward B.; Jenkins, Farish A., Jr.; Shubin, Neil H.			The cranial endoskeleton of Tiktaalik roseae	NATURE			English	Article							EARLIEST-KNOWN TETRAPOD; EARLY EVOLUTION; DEVONIAN FISH; BRAINCASE; STAPES; AUSTRALIA; ORIGIN; EAR	Among themorphological changes that occurred during the 'fish- to- tetrapod' transition was a marked reorganization of the cranial endoskeleton. Details of this transition, including the sequence of character acquisition, have not been evident from the fossil record. Here we describe the braincase, palatoquadrate and branchial skeleton of Tiktaalik roseae, the Late Devonian sarcopterygian fish most closely related to tetrapods. Although retaining a primitive configuration in many respects, the cranial endoskeleton of T. roseae shares derived features with tetrapods such as a large basal articulation and a flat, horizontally oriented entopterygoid. Other features in T. roseae, like the short, straight hyomandibula, show morphology intermediate between the condition observed in more primitive fish and that observed in tetrapods. The combination of characters in T. roseae helps to resolve the relative timing of modifications in the cranial endoskeleton. The sequence of modifications suggests changes in head mobility and intracranial kinesis that have ramifications for the origin of vertebrate terrestriality.	[Downs, Jason P.; Daeschler, Edward B.] Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; [Jenkins, Farish A., Jr.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Jenkins, Farish A., Jr.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Shubin, Neil H.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Shubin, Neil H.] Field Museum Nat Hist, Chicago, IL 60605 USA	Drexel University; Harvard University; Harvard University; University of Chicago; Field Museum of Natural History (Chicago)	Downs, JP (corresponding author), Acad Nat Sci Philadelphia, 1900 Benjamin Franklin Pkwy, Philadelphia, PA 19103 USA.	downs@ansp.org; nshubin@uchicago.edu			Polar Continental Shelf Project; Canadian Museum of Nature; Academy of Natural Sciences of Philadelphia; Putnam Expeditionary Fund (Harvard University); University of Chicago; National Science Foundation; National Geographic Society Committee for Research and Exploration	Polar Continental Shelf Project(Natural Resources Canada); Canadian Museum of Nature; Academy of Natural Sciences of Philadelphia; Putnam Expeditionary Fund (Harvard University); University of Chicago(University of Chicago); National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee for Research and Exploration(National Geographic Society)	The illustrations are the work of K. Monoyios. Specimen preparation was performed by C.F. Mullison. This research was made possible by permits from the Nunavut Ministry of Culture, Languages, Elders and Youth, the Grise Fiord Hamlet and HTA, with logistical support from the Polar Continental Shelf Project and collections support from the Canadian Museum of Nature. M. Brazeau improved interpretation of P. rhombolepis and offered input. Assistance in the field (1999-2006) was provided by W. Amaral, B. Atagootak, J. Conrad, M. Davis, S. Gatesy, A. Gillis, B. Kilbourne, S. Madsen, K. Middleton, J. Miller, K. Monoyios, C. Schaff, M. Shapiro, R. Shearman and C. Sullivan. This research was supported by an anonymous donor, the Academy of Natural Sciences of Philadelphia, the Putnam Expeditionary Fund (Harvard University), the University of Chicago, the National Science Foundation, and the National Geographic Society Committee for Research and Exploration.	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Carroll R. L., 1980, TERRESTRIAL ENV ORIG, P293; Clack J.A., 1994, Meddelelser om Gronland Geoscience, V31, P1; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; CLACK JA, 1989, NATURE, V342, P425, DOI 10.1038/342425a0; CLACK JA, 1996, EVOLUTIONARY BIOL HE, P405; Clack Jennifer A., 2000, Amphibian Biology, V4, P979; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Fox Richard C., 1995, Memoirs of the Queensland Museum, V38, P97; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Johanson Z, 2003, PALAEONTOLOGY, V46, P271, DOI 10.1111/1475-4983.00298; Johanson Z, 1997, T ROY SOC EDIN-EARTH, V88, P39, DOI 10.1017/S0263593300002303; Lebedev Oleg A., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P287; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; ROMER ALFRED S., 1937, BULL MUS COMP ZOOL, V82, P1; Romer AS, 1941, J MORPHOL, V69, P141, DOI 10.1002/jmor.1050690106; Schultze Hans-Peter, 1996, P316; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P292; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SMITHSON TR, 1982, ZOOL J LINN SOC-LOND, V74, P93, DOI 10.1111/j.1096-3642.1982.tb01142.x; Thomson K. S., 1965, Proceedings of the Linnean Society of London, V176, P181; THOMSON KEITH STEWART, 1967, J LINN SOC LONDON ZOOL, V46, P223; Vorobyeva E., 1991, P68; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x	31	43	46	4	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					925	929		10.1038/nature07189	http://dx.doi.org/10.1038/nature07189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923515				2022-12-01	WOS:000260038300041
J	George, RE; Sanda, T; Hanna, M; Frohling, S; Luther, W; Zhang, JM; Ahn, Y; Zhou, WJ; London, WB; McGrady, P; Xue, LQ; Zozulya, S; Gregor, VE; Webb, TR; Gray, NS; Gilliland, DG; Diller, L; Greulich, H; Morris, SW; Meyerson, M; Look, AT				George, Rani E.; Sanda, Takaomi; Hanna, Megan; Frohling, Stefan; Luther, William, II; Zhang, Jianming; Ahn, Yebin; Zhou, Wenjun; London, Wendy B.; McGrady, Patrick; Xue, Liquan; Zozulya, Sergey; Gregor, Vlad E.; Webb, Thomas R.; Gray, Nathanael S.; Gilliland, D. Gary; Diller, Lisa; Greulich, Heidi; Morris, Stephan W.; Meyerson, Matthew; Look, A. Thomas			Activating mutations in ALK provide a therapeutic target in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; HIGH-RISK NEUROBLASTOMA; EML4-ALK FUSION GENE; CELL LUNG-CANCER; GEFITINIB; IDENTIFICATION; INHIBITOR; TRANSPLANTATION; TRANSFORMATION; PLEIOTROPHIN	Neuroblastoma, an embryonal tumour of the peripheral sympathetic nervous system, accounts for approximately 15% of all deaths due to childhood cancer(1). High- risk neuroblastomas are rapidly progressive; even with intensive myeloablative chemotherapy, relapse is common and almost uniformly fatal(2,3). Here we report the detection of previously unknown mutations in the ALK gene, which encodes a receptor tyrosine kinase, in 8% of primary neuroblastomas. Five non- synonymous sequence variations were identified in the kinase domain of ALK, of which three were somatic and two were germ line. The most frequent mutation, F1174L, was also identified in three different neuroblastoma cell lines. ALK complementary DNAs encoding the F1174L and R1275Q variants, but not the wild- type ALK cDNA, transformed interleukin-3-dependent murine haematopoietic Ba/F3 cells to cytokine-independent growth. Ba/F3 cells expressing these mutations were sensitive to the small- molecule inhibitor of ALK, TAE684 (ref. 4). Furthermore, two human neuroblastoma cell lines harbouring the F1174L mutation were also sensitive to the inhibitor. Cytotoxicity was associated with increased amounts of apoptosis as measured by TdT-mediated dUTP nick end labelling ( TUNEL). Short hairpin RNA (shRNA)- mediated knockdown of ALK expression in neuroblastoma cell lines with the F1174L mutation also resulted in apoptosis and impaired cell proliferation. Thus, activating alleles of the ALK receptor tyrosine kinase are present in primary neuroblastoma tumours and in established neuroblastoma cell lines, and confer sensitivity to ALK inhibition with small molecules, providing a molecular rationale for targeted therapy of this disease.	[George, Rani E.; Sanda, Takaomi; Luther, William, II; Ahn, Yebin; Diller, Lisa; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Zhang, Jianming; Zhou, Wenjun; Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA; [Frohling, Stefan; Gilliland, D. Gary] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [London, Wendy B.; McGrady, Patrick] Univ Florida, Childrens Oncol Grp Stat & Data Ctr, Gainesville, FL 32601 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Webb, Thomas R.] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Zozulya, Sergey; Gregor, Vlad E.] ChemBridge Res Labs Inc, San Diego, CA 92127 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Children's Oncology Group (COG); State University System of Florida; University of Florida; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu; thomas_look@dfci.harvard.edu	London, Wendy Beth/ABA-8948-2021; George, Rani/AAG-7635-2019; Zozulya, Sergey A/F-2986-2015; Webb, Thomas/J-4511-2013; London, Wendy/ABD-4624-2021; Meyerson, Matthew L/E-7123-2012	London, Wendy Beth/0000-0003-3571-6538; Zozulya, Sergey A/0000-0002-1179-2993; Zhang, Jianming/0000-0001-6326-3906	National Institutes of Health; Friends for Life Neuroblastoma Fund; Children's Oncology Group; Alex's Lemonade Stand Foundation; NCI [CA69129]; Cancer Center Core [CA21765]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA069129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends for Life Neuroblastoma Fund; Children's Oncology Group; Alex's Lemonade Stand Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Core; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Elechko and L. Moreau for technical assistance, A. Azarova for help with cell culture and cell growth assays, Q. Jiang and X. Cui for assistance during ALK small-molecule inhibitor development, and A. Kung for Ba/F3 cells and retroviral vectors. Weacknowledge the Children's Oncology Group for provision of neuroblastoma tumour and matched normal DNAs, and tumour touch prep slides. We thank J. Maris for neuroblastoma cell lines. We thank Abbott Molecular International for the Vysis LSI ALK Dual Color, Break Apart Rearrangement Probe. This work was supported by grants from the National Institutes of Health (R.E.G.), the Friends for Life Neuroblastoma Fund (R.E.G.), the Children's Oncology Group (R.E.G.), Alex's Lemonade Stand Foundation (M.H. and M.M.), NCI CA69129 (L.X. and S.W.M.), Cancer Center Core grant CA21765 (T.R.W., L.X. and S.W.M.), the American Lebanese Syrian Associated Charities and St. Jude Children's Research Hospital (T.R.W., L.X. and S.W.M.).	Calvet L, 2006, ONCOGENE, V25, P3150, DOI 10.1038/sj.onc.1209348; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; NAKAGAWARA A, 1995, CANCER RES, V55, P1792; *NCI, 2005, SURV EP END RES DAT; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946	27	630	671	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					975	978		10.1038/nature07397	http://dx.doi.org/10.1038/nature07397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923525	Green Accepted			2022-12-01	WOS:000260038300052
J	Feehally, J; Griffith, KE; Lamb, EJ; O'Donoghue, DJ; Tomson, CRV				Feehally, J.; Griffith, K. E.; Lamb, E. J.; O'Donoghue, D. J.; Tomson, C. R. V.			Early detection of chronic kidney disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOMERULAR-FILTRATION-RATE; POPULATION; MANAGEMENT; EQUATIONS		[Feehally, J.] Univ Hosp Leicester NHS Trust, Leicester LE5 4PW, Leics, England; [Griffith, K. E.] Wenlock Terrace Surg, York, N Yorkshire, England; [Lamb, E. J.] E Kent Hosp NHS Trust, Canterbury, Kent, England; [O'Donoghue, D. J.] Dept Hlth, London SE1 6TE, England; [O'Donoghue, D. J.] Salford Royal Hosp NHS Trust, Salford, Lancs, England; [Tomson, C. R. V.] N Bristol Hosp NHS Trust, Bristol, Avon, England	University Hospitals of Leicester NHS Trust; University of Leicester; Salford Royal NHS Foundation Trust; Salford Royal Hospital	Feehally, J (corresponding author), Univ Hosp Leicester NHS Trust, Leicester LE5 4PW, Leics, England.	jf27@le.ac.uk		Tomson, Charles/0000-0002-0224-8726				[Anonymous], 2003, EPIDEMIOLOGY UNINITI; *DEP HLTH, 2004, NAT QUAL REQ DEL OUT, P1; Department of Health, 2005, NAT SERV FRAM LONG T, P1; Giles PD, 2007, BMJ-BRIT MED J, V334, P1198, DOI 10.1136/bmj.39226.400694.80; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; *INF CTR, 2007, NAT QUAL OUTC FRAM S; Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association and the Royal College of General Practitioners, 2006, CHRON KIDN DIS AD UK; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; *KIDN DIS QUAL OUT, 2002, K DOQI CLIN PRACT GU; Klebe B, 2007, NEPHROL DIAL TRANSPL, V22, P2504, DOI 10.1093/ndt/gfm248; Lamb EJ, 2007, AGE AGEING, V36, P689, DOI 10.1093/ageing/afm121; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Mathew TH, 2007, MED J AUSTRALIA, V187, P459, DOI 10.5694/j.1326-5377.2007.tb01357.x; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; *NHS EMPL, 2008, QUAL OUTC FRAM; Preiss DJ, 2007, ANN CLIN BIOCHEM, V44, P35, DOI 10.1258/000456307779595995; Quinn MP, 2008, NEPHROL DIAL TRANSPL, V23, P542, DOI 10.1093/ndt/gfm599; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P549, DOI 10.1093/ndt/gfm857; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P556, DOI 10.1093/ndt/gfm839; Sarnak MJ, 2003, AM J KIDNEY DIS, V41, pS11, DOI 10.1016/S0272-6386(03)00372-X; *SCOTT INT GUID NE, 2008, DIAGN MAN CHRON KIDN	21	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2008	337	7674							a1618	10.1136/bmj.a1618	http://dx.doi.org/10.1136/bmj.a1618			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18829639				2022-12-01	WOS:000259903300031
J	Holt, TA; Holt, CJ				Holt, Tim A.; Holt, Claire J.			10-minute consultation - Raised blood glucose concentration	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Holt, Tim A.] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Holt, Claire J.] Kenyon Med Ctr, Coventry CV3 3AD, W Midlands, England	University of Warwick	Holt, TA (corresponding author), Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England.	tim.holt@warwick.ac.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1073	10.1136/bmj.a1073	http://dx.doi.org/10.1136/bmj.a1073			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18818257				2022-12-01	WOS:000259903300039
J	Vakil, N; Vaira, D				Vakil, Nimish; Vaira, Dino			Sequential therapy for Helicobacter pylori - Time to consider making the switch?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIPLE THERAPY; ERADICATION; MANAGEMENT; METAANALYSIS		[Vakil, Nimish] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Vaira, Dino] Univ Bologna, Bologna, Italy	University of Wisconsin System; University of Wisconsin Madison; University of Bologna	Vakil, N (corresponding author), Aurora Med Ctr, 945 N 12th St,Room 4040, Milwaukee, WI 53233 USA.	nvakil@wisc.edu						Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Duck WM, 2004, EMERG INFECT DIS, V10, P1088, DOI 10.3201/eid1006.030744; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Laine L, 2003, AM J GASTROENTEROL, V98, P562, DOI [10.1016/S0002-9270(02)06010-0, 10.1111/j.1572-0241.2003.t01-1-07288.x]; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Rinaldi V, 1997, ALIMENT PHARM THERAP, V11, P929, DOI 10.1046/j.1365-2036.1997.00228.x; SANCHEZDELGADO J, AM J GASTROENTEROL, DOI DOI 10.1111/J.1572-0241.2008.01924X; Vaira D, 2007, ANN INTERN MED, V146, P556, DOI 10.7326/0003-4819-146-8-200704170-00006; Vakil N, 2004, ALIMENT PHARM THERAP, V20, P99, DOI 10.1111/j.1365-2036.2004.02029.x; Vakil N, 2007, GASTROENTEROLOGY, V133, P985, DOI 10.1053/j.gastro.2007.07.008; Van Der Poorten D, 2007, ALIMENT PHARM THER, V26, P1537, DOI 10.1111/j.1365-2036.2007.03531.x; Wu DC, 2008, GASTROENTEROLOGY, V134, pA24; Zullo A, 2007, GUT, V56, P1353, DOI 10.1136/gut.2007.125658	15	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1346	1347		10.1001/jama.300.11.1346	http://dx.doi.org/10.1001/jama.300.11.1346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799448				2022-12-01	WOS:000259231100031
J	Goldfine, AB				Goldfine, Allison B.			Assessing the cardiovascular safety of diabetes therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldfine, Allison B.] Joslin Diabet Ctr, Sect Clin Res, Boston, MA 02215 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Goldfine, AB (corresponding author), Joslin Diabet Ctr, Sect Clin Res, Boston, MA 02215 USA.			Goldfine, Allison/0000-0002-0345-1048				Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; KLIMT CR, 1970, DIABETES, V19, P747; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987	5	85	86	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1092	1095		10.1056/NEJMp0805758	http://dx.doi.org/10.1056/NEJMp0805758			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784098				2022-12-01	WOS:000259078200004
J	Wheeler, TD; Stroock, AD				Wheeler, Tobias D.; Stroock, Abraham D.			The transpiration of water at negative pressures in a synthetic tree	NATURE			English	Article							SYSTEM; CAVITATION; RESISTANCE; CAPILLARY; TRANSPORT; SUCTION; PLANTS	Plant scientists believe that transpiration - the motion of water from the soil, through a vascular plant, and into the air - occurs by a passive, wicking mechanism. This mechanism is described by the cohesion- tension theory: loss of water by evaporation reduces the pressure of the liquid water within the leaf relative to atmospheric pressure; this reduced pressure pulls liquid water out of the soil and up the xylem to maintain hydration(1-3). Strikingly, the absolute pressure of the water within the xylem is often negative, such that the liquid is under tension and is thermodynamically metastable with respect to the vapour phase(1,4). Qualitatively, this mechanism is the same as that which drives fluid through the synthetic wicks that are key elements in technologies for heat transfer(5), fuel cells(6,7) and portable chemical systems(8-10). Quantitatively, the differences in pressure generated in plants to drive flow can be more than a hundredfold larger than those generated in synthetic wicks. Here we present the design and operation of a microfluidic system formed in a synthetic hydrogel. This synthetic 'tree' captures the main attributes of transpiration in plants: transduction of subsaturation in the vapour phase of water into negative pressures in the liquid phase, stabilization and flow of liquid water at large negative pressures (-1.0 MPa or lower), continuous heat transfer with the evaporation of liquid water at negative pressure, and continuous extraction of liquid water from subsaturated sources. This development opens the opportunity for technological uses of water under tension and for new experimental studies of the liquid state of water.	[Wheeler, Tobias D.; Stroock, Abraham D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Cornell University	Stroock, AD (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	ads10@cornell.edu		Stroock, Abraham/0000-0002-8145-9977	Office of Naval Research Young Investigator Program; Camille and Henry Dreyfus Foundation; Corning Foundation; National Science Foundation (NSF); Nanobiotechnology Center; STC Program of the NSF [ECS-98767710]; Cornell Center for Materials Research; NSF [DMR- 0520404]	Office of Naval Research Young Investigator Program(Office of Naval Research); Camille and Henry Dreyfus Foundation; Corning Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); Nanobiotechnology Center; STC Program of the NSF; Cornell Center for Materials Research; NSF(National Science Foundation (NSF))	We thank M. A. Zwieniecki, N. M. Holbrook, P. J. Melcher, C. Cohen, K. J. Niklas, C. Cottin- Bizonne, A. Lassiter and F. Caupin for discussions and suggestions. Wethank G. Swan and E. Velez- Rosa for technical assistance with experiments. Support was provided by the Office of Naval Research Young Investigator Program and the Camille and Henry Dreyfus Foundation. T. D. W. acknowledges partial support by a graduate fellowship from the Corning Foundation. The experiments made use of the following facilities: Cornell NanoScale Science and Technology Facility (a member of the National Nanotechnology Infrastructure Network, supported by the National Science Foundation (NSF)), the Nanobiotechnology Center ( supported by the STC Program of the NSF under Agreement No. ECS-98767710) and the Cornell Center for Materials Research ( supported by the NSF under Award No. DMR- 0520404).	Arce A, 2004, PHYS CHEM CHEM PHYS, V6, P103, DOI 10.1039/b307996a; ASKENASY E, 1896, VERH NATURH MED VER, V5, P429; Atkins P, 2002, PHYS CHEM; Aybar HS, 2005, DESALINATION, V180, P285, DOI 10.1016/j.desal.2005.01.009; Bohm, 1893, BER DEUT BOT GES, V11, P203; BRINKER CJ, 1989, SOL GEL SCI PHYS CHE; Caupin F, 2006, CR PHYS, V7, P1000, DOI 10.1016/j.crhy.2006.10.015; Chen J, 2004, J POWER SOURCES, V131, P155, DOI 10.1016/j.jpowsour.2004.01.007; Debenedetti P G, 1996, METASTABLE LIQUIDS; Dixon HH., 1895, PHILOS T R SOC B, V186, P563, DOI DOI 10.1098/RSTB.1895.0012; Effenhauser CS, 2002, BIOMED MICRODEVICES, V4, P27, DOI 10.1023/A:1014215728074; Errington JR, 2001, NATURE, V409, P318, DOI 10.1038/35053024; Flory P, 1955, PRINCIPLES POLYM CHE; Guan Y, 1997, CAN GEOTECH J, V34, P604, DOI 10.1139/t97-014; Guan YX, 2006, TALANTA, V68, P1384, DOI 10.1016/j.talanta.2005.08.021; HAYWARD ATJ, 1970, NATURE, V225, P376, DOI 10.1038/225376b0; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Holbrook NM, 1999, PLANT PHYSIOL, V120, P7, DOI 10.1104/pp.120.1.7; Jacobsen AL, 2007, ECOL MONOGR, V77, P99, DOI 10.1890/05-1879; Juncker D, 2002, ANAL CHEM, V74, P6139, DOI 10.1021/ac0261449; Karan K, 2007, ELECTROCHEM SOLID ST, V10, pB34, DOI 10.1149/1.2398728; Machin WD, 1998, CAN J CHEM, V76, P1578, DOI 10.1139/cjc-76-11-1578; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Nobel, 1999, PHYSICOCHEMICAL ENV; Peterson GP, 1994, INTRO HEAT PIPES; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; THUT HIRAM F., 1928, OHIO JOUR SCI, V28, P292; Zwieniecki MA, 2001, SCIENCE, V291, P1059, DOI 10.1126/science.1057175	28	337	347	20	353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					208	212		10.1038/nature07226	http://dx.doi.org/10.1038/nature07226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784721				2022-12-01	WOS:000259090800043
J	Karim, Z; Gerard, B; Bakouh, N; Alili, R; Leroy, C; Beck, L; Silve, C; Planelles, G; Urena-Torres, P; Grandchamp, B; Friedlander, G; Prie, D				Karim, Zoubida; Gerard, Benedicte; Bakouh, Naziha; Alili, Rohia; Leroy, Christine; Beck, Laurent; Silve, Caroline; Planelles, Gabrielle; Urena-Torres, Pablo; Grandchamp, Bernard; Friedlander, Gerard; Prie, Dominique			NHERF1 mutations and responsiveness of renal parathyroid hormone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SODIUM-PHOSPHATE COTRANSPORTER; PROXIMAL TUBULE CELLS; OPOSSUM KIDNEY-CELLS; REGULATORY FACTOR-I; PHOSPHOLIPASE-C; RECEPTOR; PTH; IIA; NEPHROLITHIASIS; TRANSPORT	Impaired renal phosphate reabsorption, as measured by dividing the tubular maximal reabsorption of phosphate by the glomerular filtration rate (TmP/GFR), increases the risks of nephrolithiasis and bone demineralization. Data from animal models suggest that sodium-hydrogen exchanger regulatory factor 1 (NHERF1) controls renal phosphate transport. We sequenced the NHERF1 gene in 158 patients, 94 of whom had either nephrolithiasis or bone demineralization. We identified three distinct mutations in seven patients with a low TmP/GFR value. No patients with normal TmP/GFR values had mutations. The mutants expressed in cultured renal cells increased the generation of cyclic AMP (cAMP) by parathyroid hormone (PTH) and inhibited phosphate transport. These NHERF1 mutations suggest a previously unrecognized cause of renal phosphate loss in humans.	[Karim, Zoubida; Bakouh, Naziha; Alili, Rohia; Leroy, Christine; Beck, Laurent; Planelles, Gabrielle; Urena-Torres, Pablo; Friedlander, Gerard; Prie, Dominique] Univ Paris 05, INSERM, Unite 845, Fac Med, Paris, France; [Gerard, Benedicte; Silve, Caroline; Grandchamp, Bernard] Assistance Publ Hop Paris, Hop Bichat Claude Bernard, Paris, France; [Urena-Torres, Pablo; Friedlander, Gerard; Prie, Dominique] Assistance Publ Hop Paris, Hop Necker Enfants Malad, Paris, France; [Friedlander, Gerard] Assistance Publ Hop Paris, Hop Europeen Georges Pompidou, Paris, France; [Silve, Caroline] Univ Paris Diderot, INSERM Unite 773, Unite Format & Rech Med, Paris, France; [Grandchamp, Bernard] Univ Paris Diderot, Inst Federat Rech 02, Paris, France; [Urena-Torres, Pablo] Clin Landy, St Ouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Prie, D (corresponding author), Hop Necker Enfants Malad, Serv Explorat Fonctionelles, 149 Rue Sevres, F-75015 Paris, France.	prie@necker.fr	BECK, Laurent/P-2952-2014; Planelles, Gabrielle/F-9603-2013	BECK, Laurent/0000-0002-6730-2762; Planelles, Gabrielle/0000-0002-7314-8837; Friedlander, Gerard/0000-0002-6854-4261; KARIM, Zoubida/0000-0002-3724-5592; Bastepe, Murat/0000-0002-2643-3504	INSERM; Universit, Paris Descartes; Association Laboratoire de Recherches Physiologiques; l'Agence Nationale pour la Recherche [ANR-07-PHYSIO-017-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universit, Paris Descartes; Association Laboratoire de Recherches Physiologiques; l'Agence Nationale pour la Recherche(French National Research Agency (ANR))	Supported by a grant from INSERM, Universit, Paris Descartes, Association Laboratoire de Recherches Physiologiques, and l'Agence Nationale pour la Recherche (ANR-07-PHYSIO-017-01).	ARMBRECHT HJ, 1984, AM J PHYSIOL, V246, pE102; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DEVERNEJOUL MC, 1982, CALCIFIED TISSUE INT, V34, P219, DOI 10.1007/BF02411240; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Lee KC, 1996, AM J PHYSIOL-RENAL, V270, pF186, DOI 10.1152/ajprenal.1996.270.1.F186; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Prie D, 2004, CURR OPIN NEPHROL HY, V13, P675, DOI 10.1097/00041552-200411000-00015; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Prie D, 2001, KIDNEY INT, V60, P272, DOI 10.1046/j.1523-1755.2001.00796.x; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sun C, 2005, J PEPT RES, V65, P411, DOI 10.1111/j.1399-3011.2005.00240.x; VANDOP C, 1989, SEMIN NEPHROL, V9, P168; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1; Weinman EJ, 2006, AM J PHYSIOL-RENAL, V291, pF254; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2006, AM J PHYSIOL-RENAL, V290, pF838, DOI 10.1152/ajprenal.00374.2005; Weinman EJ, 2002, PATHOBIOLOGY, V70, P314, DOI 10.1159/000071271	26	127	130	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1128	1135		10.1056/NEJMoa0802836	http://dx.doi.org/10.1056/NEJMoa0802836			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	19073985				2022-12-01	WOS:000259078200008
